PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chapman, SJ; Schrader, JM; Uhlenbeck, OC				Chapman, Stephen J.; Schrader, Jared M.; Uhlenbeck, Olke C.			Histidine 66 in Escherichia coli Elongation Factor Tu Selectively Stabilizes Aminoacyl-tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOPHILUS EF-TU; PROTEIN-BIOSYNTHESIS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; GTP HYDROLYSIS; RIBOSOME; AFFINITY; BINDING; ACID; PHE-TRNA(PHE)	The universally conserved His-66 of elongation factor Tu (EF-Tu) stacks on the side chain of the esterified Phe of Phe-tRNA(Phe). The affinities of eight aminoacyl-tRNAs were differentially destabilized by the introduction of the H66A mutation into Escherichia coli EF-Tu, whereas Ala-tRNA(Ala) and Gly-tRNA(Gly) were unaffected. The H66F and H66W proteins each show a different pattern of binding of 10 different aminoacyl-tRNAs, clearly showing that this position is critical in establishing the specificity of EF-Tu for different esterified amino acids. However, the H66A mutation does not greatly affect the ability of the ternary complex to bind ribosomes, hydrolyze GTP, or form dipeptide, suggesting that this residue does not directly participate in ribosomal decoding. Selective mutation of His-66 may improve the ability of certain unnatural amino acids to be incorporated by the ribosome.	[Chapman, Stephen J.; Schrader, Jared M.; Uhlenbeck, Olke C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Uhlenbeck, OC (corresponding author), 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	o-uhlenbeck@northwestern.edu	schrader, jared/H-6580-2019	schrader, jared/0000-0002-5728-5882	National Institutes of Health [GM037552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM037552 (to O. C. U.).	ANDERSEN C, 1994, EUR J BIOCHEM, V220, P739, DOI 10.1111/j.1432-1033.1994.tb18674.x; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; CHLADEK S, 1985, ANGEW CHEM INT EDIT, V24, P371, DOI 10.1002/anie.198503711; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; KNOWLTON RG, 1980, J MOL BIOL, V139, P721, DOI 10.1016/0022-2836(80)90057-1; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Miller D L, 1974, Methods Enzymol, V30, P219; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; RAVEL JM, 1967, BIOCHEM BIOPH RES CO, V29, P68, DOI 10.1016/0006-291X(67)90542-6; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; Sanderson LE, 2007, J MOL BIOL, V368, P119, DOI 10.1016/j.jmb.2007.01.075; Schlosser A, 2001, J BIOMOL STRUCT DYN, V19, P285, DOI 10.1080/07391102.2001.10506739; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; Schrader JM, 2009, J MOL BIOL, V386, P1255, DOI 10.1016/j.jmb.2009.01.021; Schulman R G, 1974, J Mol Biol, V90, P601; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Vorstenbosch ELH, 2000, J BIOCHEM BIOPH METH, V42, P1, DOI 10.1016/S0165-022X(99)00032-9	31	11	11	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1229	1234		10.1074/jbc.M111.294850	http://dx.doi.org/10.1074/jbc.M111.294850			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22105070	Green Published, hybrid			2022-12-25	WOS:000299170300038
J	Hirsch, ML; Fagan, BM; Dumitru, R; Bower, JJ; Yadav, S; Porteus, MH; Pevny, LH; Samulski, RJ				Hirsch, Matthew L.; Fagan, B. Matthew; Dumitru, Raluca; Bower, Jacquelyn J.; Yadav, Swati; Porteus, Matthew H.; Pevny, Larysa H.; Samulski, R. Jude			Viral Single-Strand DNA Induces p53-Dependent Apoptosis in Human Embryonic Stem Cells	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; CYCLE ARREST; INFECTION; GENOME; DAMAGE; P53	Human embryonic stem cells (hESCs) are primed for rapid apoptosis following mild forms of genotoxic stress. A natural form of such cellular stress occurs in response to recombinant adeno-associated virus (rAAV) single-strand DNA genomes, which exploit the host DNA damage response for replication and genome persistence. Herein, we discovered a unique DNA damage response induced by rAAV transduction specific to pluripotent hESCs. Within hours following rAAV transduction, host DNA damage signaling was elicited as measured by increased gamma-H2AX, ser15-p53 phosphorylation, and subsequent p53-dependent transcriptional activation. Nucleotide incorporation assays demonstrated that rAAV transduced cells accumulated in early S-phase followed by the induction of apoptosis. This lethal signaling sequalae required p53 in a manner independent of transcriptional induction of Puma, Bax and Bcl-2 and was not evident in cells differentiated towards a neural lineage. Consistent with a lethal DNA damage response induced upon rAAV transduction of hESCs, empty AAV protein capsids demonstrated no toxicity. In contrast, DNA microinjections demonstrated that the minimal AAV origin of replication and, in particular, a 40 nucleotide G-rich tetrad repeat sequence, was sufficient for hESC apoptosis. Our data support a model in which rAAV transduction of hESCs induces a p53-dependent lethal response that is elicited by a telomeric sequence within the AAV origin of replication.	[Hirsch, Matthew L.; Yadav, Swati; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA; [Samulski, R. Jude] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Pevny, Larysa H.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Fagan, B. Matthew] Univ N Carolina, Human Embryon Stem Cell Core Facil, Chapel Hill, NC USA; [Dumitru, Raluca; Pevny, Larysa H.] Univ N Carolina, Ctr Neurosci, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Bower, Jacquelyn J.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Porteus, Matthew H.] Stanford Univ, Dept Pediat Canc Biol, Palo Alto, CA 94304 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Stanford University	Hirsch, ML (corresponding author), Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA.	mhirsch@email.unc.edu; rjs@med.unc.edu		Fagan, Barry Matthew/0000-0003-2267-886X	National Institutes of Health (NIH) [GM0529299, HL066973, HL051818, AI072176]; University of North Carolina (UNC) Lineberger Comprehensive Cancer Center (LCCC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC) Lineberger Comprehensive Cancer Center (LCCC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding sources of this work include: National Institutes of Health (NIH) grants GM0529299, HL066973, HL051818, and AI072176 awarded to Dr. Samulski and a University of North Carolina (UNC) Lineberger Comprehensive Cancer Center (LCCC) pilot grant awarded to Dr. Hirsch. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barta T, 2010, STEM CELLS, V28, P1143, DOI 10.1002/stem.451; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Cervelli T, 2008, J CELL SCI, V121, P349, DOI 10.1242/jcs.003632; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choi VW, 2006, J VIROL, V80, P10346, DOI 10.1128/JVI.00841-06; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; GARTLEL AL, 2005, CANCER RES, V10, P3980; Grandela C, 2007, STEM CELL REV, V3, P183, DOI 10.1007/s12015-007-0008-4; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Hewitt FC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008850; Hirsch ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007705; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Inagaki K, 2007, J VIROL, V81, P11304, DOI 10.1128/JVI.01225-07; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Mitsui K, 2009, BIOCHEM BIOPH RES CO, V388, P711, DOI 10.1016/j.bbrc.2009.08.075; Morita E, 2003, J VIROL, V77, P2915, DOI 10.1128/JVI.77.5.2915-2921.2003; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; SAMULSKI RJ, 1987, J VIROL, V61, P3096, DOI 10.1128/JVI.61.10.3096-3101.1987; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166; WANG Y, 2009, CANCER RES, V10, P4093; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000	38	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27520	10.1371/journal.pone.0027520	http://dx.doi.org/10.1371/journal.pone.0027520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114676	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800024
J	Fu, JD; Rushing, SN; Lieu, DK; Chan, CW; Kong, CW; Geng, L; Wilson, KD; Chiamvimonvat, N; Boheler, KR; Wu, JC; Keller, G; Hajjar, RJ; Li, RA				Fu, Ji-Dong; Rushing, Stephanie N.; Lieu, Deborah K.; Chan, Camie W.; Kong, Chi-Wing; Geng, Lin; Wilson, Kitchener D.; Chiamvimonvat, Nipavan; Boheler, Kenneth R.; Wu, Joseph C.; Keller, Gordon; Hajjar, Roger J.; Li, Ronald A.			Distinct Roles of MicroRNA-1 and-499 in Ventricular Specification and Functional Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNA; TRANSCRIPTION FACTOR; GENE-TRANSFER; DIFFERENTIATION; PACEMAKER; EXPRESSION; HEART; MOUSE; OVEREXPRESSION; DETERMINANTS	Background: MicroRNAs (miRs) negatively regulate transcription and are important determinants of normal heart development and heart failure pathogenesis. Despite the significant knowledge gained in mouse studies, their functional roles in human (h) heart remain elusive. Methods and Results: We hypothesized that miRs that figure prominently in cardiac differentiation are differentially expressed in differentiating, developing, and terminally mature human cardiomyocytes (CMs). As a first step, we mapped the miR profiles of human (h) embryonic stem cells (ESCs), hESC-derived (hE), fetal (hF) and adult (hA) ventricular (V) CMs. 63 miRs were differentially expressed between hESCs and hE-VCMs. Of these, 29, including the miR-302 and -371/372/373 clusters, were associated with pluripotency and uniquely expressed in hESCs. Of the remaining miRs differentially expressed in hE-VCMs, 23 continued to express highly in hF- and hA-VCMs, with miR-1, -133, and -499 displaying the largest fold differences; others such as miR-let-7a, -let-7b, -26b, -125a and -143 were non-cardiac specific. Functionally, LV-miR-499 transduction of hESC-derived cardiovascular progenitors significantly increased the yield of hE-VCMs (to 72% from 48% of control; p < 0.05) and contractile protein expression without affecting their electrophysiological properties (p > 0.05). By contrast, LV-miR-1 transduction did not bias the yield (p > 0.05) but decreased APD and hyperpolarized RMP/MDP in hE-VCMs due to increased I-to, I-Ks and I-Kr, and decreased If (p < 0.05) as signs of functional maturation. Also, LV-miR-1 but not 499 augmented the immature Ca2+ transient amplitude and kinetics. Molecular pathway analyses were performed for further insights. Conclusion: We conclude that miR-1 and -499 play differential roles in cardiac differentiation of hESCs in a context-dependent fashion. While miR-499 promotes ventricular specification of hESCs, miR-1 serves to facilitate electrophysiological maturation.	[Fu, Ji-Dong; Rushing, Stephanie N.; Lieu, Deborah K.; Chan, Camie W.; Chiamvimonvat, Nipavan; Li, Ronald A.] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Rushing, Stephanie N.; Lieu, Deborah K.; Hajjar, Roger J.; Li, Ronald A.] Mt Sinai Sch Med, Ctr Cardiovasc Res, New York, NY USA; [Chan, Camie W.; Kong, Chi-Wing; Li, Ronald A.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Camie W.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Li, Ronald A.] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Kong, Chi-Wing; Geng, Lin; Boheler, Kenneth R.; Li, Ronald A.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China; [Kong, Chi-Wing; Li, Ronald A.] Univ Hong Kong, LKS Fac Med, Heart Brain Hormone & Hlth Aging Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Wilson, Kitchener D.; Wu, Joseph C.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Wilson, Kitchener D.; Wu, Joseph C.] Stanford Univ, Dept Radiol, Palo Alto, CA 94304 USA; [Boheler, Kenneth R.] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Keller, Gordon] Univ Hlth Network, McEwen Cent Regenerat Med, Toronto, ON, Canada	University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fu, JD (corresponding author), Univ Calif Davis, Sch Med, Davis, CA 95616 USA.	ronald.li@mssm.edu	Fu, Jidong/E-8173-2012; Wilson, Kitchener/A-7146-2016	Keller, Gordon/0000-0001-9309-9297; Fu, Jidong/0000-0003-2797-5193; Lieu, Deborah/0000-0002-3765-3203	National Institutes of Health [R01 HL72857, 5R33HL089027-05, 1DP2OD004437-01, T32]; California Institute for Regenerative Medicine; WCC Foundation; Council of HKSAR [T13-706/11]; NIH, National Institute on Aging; VistaGen Therapeutics, Inc., South San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085844, R33HL089027, R01HL085727, R01HL072857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000849] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); WCC Foundation; Council of HKSAR; NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VistaGen Therapeutics, Inc., South San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by extramural grants from the National Institutes of Health (R01 HL72857 to RAL, 5R33HL089027-05 and 1DP2OD004437-01 to JCW, T32 to SR), the California Institute for Regenerative Medicine (to JDF and RAL), the WCC Foundation Stem Cell Fund (to RAL), Research Grant Council of HKSAR (T13-706/11) and by the Intramural Research Program of the NIH, National Institute on Aging (KRB). This work has received partial support from VistaGen Therapeutics, Inc., South San Francisco, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has received support from VistaGen Therapeutics, Inc., South San Francisco, CA. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Enright AJ, 2004, GENOME BIOL, V5; Fu JD, 2005, FASEB J, V19, P181, DOI 10.1096/fj.05-4501fje; Fu JD, 2010, STEM CELLS DEV, V19, P773, DOI 10.1089/scd.2009.0184; Fu YC, 1998, DEVELOPMENT, V125, P4439; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jesus ABD, 2009, CELL CYCLE, V8, P394; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QY, 1997, NAT GENET, V15, P21; Lieu DK, 2008, HEART RHYTHM, V5, P1310, DOI 10.1016/j.hrthm.2008.05.010; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu J, 2009, AM J PHYSIOL-CELL PH, V297, pC152, DOI 10.1152/ajpcell.00060.2009; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Moore JC, 2008, BIOCHEM BIOPH RES CO, V372, P553, DOI 10.1016/j.bbrc.2008.05.076; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; TSE HF, 2009, J CARDIAC ELECTROPHY, V81, P1324; Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONAHA.106.615385; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang K, 2005, STEM CELLS, V23, P1526, DOI 10.1634/stemcells.2004-0299; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Xue T, 2007, CIRCULATION, V115, P1839, DOI 10.1161/CIRCULATIONAHA.106.659391; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	53	124	131	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27417	10.1371/journal.pone.0027417	http://dx.doi.org/10.1371/journal.pone.0027417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110643	Green Published, gold			2022-12-25	WOS:000297555400043
J	Sun, TZ; Yang, WW; Liu, J; Shen, PP				Sun, Tingzhe; Yang, Weiwei; Liu, Jing; Shen, Pingping			Modeling the Basal Dynamics of P53 System	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; CELL-CYCLE; PLAUSIBLE MODEL; HISTONE H2AX; M-PHASE; OSCILLATIONS; PULSES; ATM; KINASES	Background: The tumor suppressor p53 has become one of most investigated genes. Once activated by stress, p53 leads to cellular responses such as cell cycle arrest and apoptosis. Methodology/Principal Findings: Most previous models have ignored the basal dynamics of p53 under nonstressed conditions. To explore the basal dynamics of p53, we constructed a stochastic delay model by incorporating two negative feedback loops. We found that protein distribution of p53 under nonstressed condition is highly skewed with a fraction of cells showing high p53 levels comparable to those observed under stressed conditions. Under nonstressed conditions, asynchronous and spontaneous p53 pulses are triggered by basal DNA double strand breaks produced during normal cell cycle progression. The first peaking times show a predominant G1 distribution while the second ones are more widely distributed. The spontaneous pulses are triggered by an excitable mechanism. Once initiated, the amplitude and duration of pulses remain unchanged. Furthermore, the spontaneous pulses are filtered by ataxia telangiectasia mutated protein mediated posttranslational modifications and do not result in substantial p21 transcription. If challenged by externally severe DNA damage, cells generate synchronous p53 pulses and induce significantly high levels of p21. The high expression of p21 can also be partially induced by lowering the deacetylation rate. Conclusions: Our results demonstrated that the dynamics of p53 under nonstressed conditions is initiated by an excitable mechanism and cells become fully responsive only when cells are confronted with severe damage. These findings advance our understanding of the mechanism of p53 pulses and unlock many opportunities to p53-based therapy.	[Sun, Tingzhe; Yang, Weiwei; Liu, Jing; Shen, Pingping] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Life Sci, Nanjing 210008, Jiangsu Provinc, Peoples R China	Nanjing University	Sun, TZ (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Life Sci, Nanjing 210008, Jiangsu Provinc, Peoples R China.	ppshen@nju.edu.cn		Sun, Tingzhe/0000-0002-9575-4993	National Natural Science Foundation of China [30870588, 30821006, 91013015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 30870588, 30821006, 91013015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bottani S, 2007, J THEOR BIOL, V249, P235, DOI 10.1016/j.jtbi.2007.04.026; Cai XD, 2009, J COMPUT BIOL, V16, P917, DOI 10.1089/cmb.2008.0231; Cesari F, 2009, NAT REV MOL CELL BIO, V10, DOI 10.1038/nrm2612; Chatterjee A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1833357; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; CHEOK CF, 2011, Clin Oncol, V8, P25; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Engelborghs K, 2002, ACM T MATH SOFTWARE, V28, P1, DOI 10.1145/513001.513002; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hirai Y, 2001, JPN J CANCER RES, V92, P710, DOI 10.1111/j.1349-7006.2001.tb01152.x; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Ichijima Y, 2005, CELL STRUCT FUNCT, V30, P41; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Kato TA, 2009, J CELL PHYSIOL, V219, P760, DOI 10.1002/jcp.21726; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Leier A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919124; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Muers M, 2009, NAT REV GENET, V10, P592, DOI 10.1038/nrg2658; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Olivier M, 1998, MOL CARCINOGEN, V23, P1; Pang LY, 2011, CELL CYCLE, V10, P932, DOI 10.4161/cc.10.6.15012; Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sun TZ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036008; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	62	31	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27882	10.1371/journal.pone.0027882	http://dx.doi.org/10.1371/journal.pone.0027882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114721	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400135
J	Viader, A; Wright-Jin, EC; Vohra, BPS; Heuckeroth, RO; Milbrandt, J				Viader, Andreu; Wright-Jin, Elizabeth C.; Vohra, Bhupinder P. S.; Heuckeroth, Robert O.; Milbrandt, Jeffrey			Differential Regional and Subtype-Specific Vulnerability of Enteric Neurons to Mitochondrial Dysfunction	PLOS ONE			English	Article							MYENTERIC PLEXUS; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTION FACTOR; DISEASE; FREQUENCY; MUSCLE; MICE	Mitochondrial dysfunction is a central mediator of disease progression in diverse neurodegenerative diseases that often present with prominent gastrointestinal abnormalities. Gastrointestinal dysfunction in these disorders is related, at least in part, to defects in the enteric nervous system (ENS). The role of mitochondrial deficits in ENS neurodegeneration and their relative contribution to gastrointestinal dysfunction, however, are unclear. To better understand how mitochondrial abnormalities in the ENS influence enteric neurodegeneration and affect intestinal function, we generated mice (Tfam-ENSKOs) with impaired mitochondrial metabolism in enteric neurons and glia through the targeted deletion of the mitochondrial transcription factor A gene (Tfam). Tfam-ENSKO mice were initially viable but, at an early age, they developed severe gastrointestinal motility problems characterized by intestinal pseudo-obstruction resulting in premature death. This gastrointestinal dysfunction was caused by extensive, progressive neurodegeneration of the ENS involving both neurons and glia. Interestingly, mitochondrial defects differentially affected specific subpopulations of enteric neurons and regions of the gastrointestinal tract. Mitochondrial deficiency-related neuronal and glial loss was most prominent in the proximal small intestine, but the first affected neurons, nitrergic inhibitory neurons, had the greatest losses in the distal small intestine. This regional and subtype-specific variability in susceptibility to mitochondrial defects resulted in an imbalance of inhibitory and excitatory neurons that likely accounts for the observed phenotype in Tfam-ENSKO mice. Mitochondrial dysfunction, therefore, is likely to be an important driving force of neurodegeneration in the ENS and contribute to gastrointestinal symptoms in people with neurodegenerative disorders.	[Viader, Andreu; Vohra, Bhupinder P. S.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wright-Jin, Elizabeth C.; Heuckeroth, Robert O.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wright-Jin, Elizabeth C.; Heuckeroth, Robert O.] Washington Univ, Sch Med, Dept Dev Regenerat & Stem Cell Biol, St Louis, MO 63110 USA; [Vohra, Bhupinder P. S.] Univ Cent Arkansas, Dept Biol, Conway, AR USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Central Arkansas	Viader, A (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu	Wright-Jin, Elizabeth/N-1111-2019	Milbrandt, Jeffrey/0000-0002-5477-7689; Wright-Jin, Elizabeth/0000-0002-2411-9351; Heuckeroth, Robert/0000-0002-3282-1765	National Institutes of Health Neuroscience Blueprint Center [P30 NS057105]; HOPE Center for Neurological Disorders, National Institutes of Health [AG13730]; Muscular Dystrophy Association [10040]; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research [1008525]; Children's Discovery Institute [CH-II-1008-123];  [RO1 DK087715]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730, RF1AG013730] Funding Source: NIH RePORTER	National Institutes of Health Neuroscience Blueprint Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HOPE Center for Neurological Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Children's Discovery Institute; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University, the HOPE Center for Neurological Disorders, National Institutes of Health grant AG13730 (J.M.), and Muscular Dystrophy Association grant 10040 (J.M.). ROH is supported by RO1 DK087715, Burroughs Wellcome Fund Clinical Scientist Award in Translational Research 1008525, and the Children's Discovery Institute CH-II-1008-123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Abbott RD, 2007, MOVEMENT DISORD, V22, P1581, DOI 10.1002/mds.21560; Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; Ashraf W, 1997, MOVEMENT DISORD, V12, P946, DOI 10.1002/mds.870120617; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Chandrasekharan B, 2007, NEUROGASTROENT MOTIL, V19, P951, DOI 10.1111/j.1365-2982.2007.01023.x; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Furness J.B., 2006, ENTERIC NERVOUS SYST; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Goetze O, 2006, NEUROGASTROENT MOTIL, V18, P369, DOI 10.1111/j.1365-2982.2006.00780.x; Greene JG, 2009, EXP NEUROL, V218, P154, DOI 10.1016/j.expneurol.2009.04.023; Hao MM, 2010, NEUROGASTROENT MOTIL, V22, pe127, DOI 10.1111/j.1365-2982.2009.01462.x; Hom XB, 2004, MITOCHONDRION, V4, P601, DOI 10.1016/j.mito.2004.07.014; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; KURLAN R, 1988, NEUROLOGY, V38, P419, DOI 10.1212/WNL.38.3.419; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; NEUHUBER WL, 1994, CELL TISSUE RES, V276, P23, DOI 10.1007/BF00354780; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003; Phillips RJ, 2004, J NEUROSCI METH, V133, P99, DOI 10.1016/j.jneumeth.2003.10.004; Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011; Sang Q, 1996, CELL TISSUE RES, V284, P39, DOI 10.1007/s004410050565; Schafer KH, 2000, J AUTOIMMUN, V15, P479, DOI 10.1006/jaut.2000.0454; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tian YM, 2008, NEUROSCIENCE, V153, P634, DOI 10.1016/j.neuroscience.2008.02.033; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; WAKABAYASHI K, 1993, ADV NEUROL, V60, P609; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Wiskur Brandt, 2010, Curr Gastroenterol Rep, V12, P507, DOI 10.1007/s11894-010-0139-7; Wood JD, 1999, GUT, V45, P6; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499	44	22	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27727	10.1371/journal.pone.0027727	http://dx.doi.org/10.1371/journal.pone.0027727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110743	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400098
J	Bavagnoli, L; Dundon, WG; Garbelli, A; Zecchin, B; Milani, A; Parakkal, G; Baldanti, F; Paolucci, S; Volmer, R; Tu, YZ; Wu, CY; Capua, I; Maga, G				Bavagnoli, Laura; Dundon, William G.; Garbelli, Anna; Zecchin, Bianca; Milani, Adelaide; Parakkal, Geetha; Baldanti, Fausto; Paolucci, Stefania; Volmer, Romain; Tu, Yizeng; Wu, Chuanyue; Capua, Ilaria; Maga, Giovanni			The PDZ-Ligand and Src-Homology Type 3 Domains of Epidemic Avian Influenza Virus NS1 Protein Modulate Human Src Kinase Activity during Viral Infection	PLOS ONE			English	Article							A-VIRUS; FAMILY KINASES; BINDING MOTIF; REPLICATION; VIRULENCE; GENE; H1N1; H7N1; CIRCULATION; ORGANISMS	The Non-structural 1 (NS1) protein of avian influenza (AI) viruses is important for pathogenicity. Here, we identify a previously unrecognized tandem PDZ-ligand (TPL) domain in the extreme carboxy terminus of NS1 proteins from a subset of globally circulating AI viruses. By using protein arrays we have identified several human PDZ-cellular ligands of this novel domain, one of which is the RIL protein, a known regulator of the cellular tyrosine kinase Src. We found that the AI NS1 proteins bind and stimulate human Src tyrosine kinase, through their carboxy terminal Src homology type 3-binding (SHB) domain. The physical interaction between NS1 and Src and the ability of AI viruses to modulate the phosphorylation status of Src during the infection, were found to be influenced by the TPL arrangement. These results indicate the potential for novel host-pathogen interactions mediated by the TPL and SHB domains of AI NS1 protein.	[Bavagnoli, Laura; Garbelli, Anna; Parakkal, Geetha; Maga, Giovanni] CNR, Inst Mol Genet, Pavia, Italy; [Dundon, William G.; Zecchin, Bianca; Milani, Adelaide; Capua, Ilaria] Food & Agr Org, World Org Anim Hlth, Legnaro, Italy; [Dundon, William G.; Zecchin, Bianca; Milani, Adelaide; Capua, Ilaria] Ist Zooprofilatt Sperimentale Venezie, Natl Reference Lab Newcastle Dis & Avian Influenz, Legnaro, Italy; [Baldanti, Fausto; Paolucci, Stefania] Fdn Ist Ricovero & Cura Carattere Sci Policlin S, Mol Virol Unit, Pavia, Italy; [Volmer, Romain] Univ Toulouse, Inst Natl Polytech, Unite Mixte Rech 1225, Ecole Natl Vet, Toulouse, France; [Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Food & Agriculture Organization of the United Nations (FAO); IZS delle Venezie; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bavagnoli, L (corresponding author), CNR, Inst Mol Genet, Pavia, Italy.	maga@igm.cnr.it	Paolucci, Stefania/J-4055-2018; Maga, Giovanni/C-5409-2009; Baldanti, Fausto/J-4924-2018; Zecchin, Bianca/I-8591-2019	Paolucci, Stefania/0000-0001-8447-8586; Maga, Giovanni/0000-0001-8092-1552; Baldanti, Fausto/0000-0002-3358-8969; Dundon, William G./0000-0002-2776-169X; Zecchin, Bianca/0000-0001-9566-6531; Volmer, Romain/0000-0003-1591-3251	EU [SSPE-CT-2007-044220]; National Institutes of Health [DK54639]; Ministero della Salute Ricerca Corrente [80622]; Ricerca Finalizzata [89302]; National Interest Research Project [PRIN2007_N7KYCY]; Superpig Program; Lombardy Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER	EU(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero della Salute Ricerca Corrente(Ministry of Health, Italy); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); National Interest Research Project; Superpig Program; Lombardy Region(Regione Lombardia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been partially supported by the EU FLUPATH project (SSPE-CT-2007-044220) to WGD and IC, by the National Institutes of Health grant DK54639 to CW, by the Ministero della Salute Ricerca Corrente grant no. 80622 and Ricerca Finalizzata grant no. 89302 to FB and by the National Interest Research Project PRIN2007_N7KYCY to GM. Work has been partially supported by the Superpig Program, project co-financed by Lombardy Region through the "Fund for promoting institutional agreements'' to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2009, VIROLOGY, V390, P212, DOI 10.1016/j.virol.2009.05.008; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Campanini G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-209; Cauthen AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000; Dundon WG, 2006, VIRUS RES, V119, P171, DOI 10.1016/j.virusres.2006.01.005; Dundon WG, 2009, VIRUSES-BASEL, V1, P1057, DOI 10.3390/v1031057; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J GEN VIROL, V91, P1737, DOI 10.1099/vir.0.020925-0; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Keiner B, 2010, J VIROL, V84, P11858, DOI 10.1128/JVI.01011-10; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krauss S, 2010, AVIAN DIS, V54, P394, DOI 10.1637/8703-031609-Review.1; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Rigoni M, 2007, VIROLOGY, V364, P28, DOI 10.1016/j.virol.2007.02.031; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Thomas M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-25; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	39	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27789	10.1371/journal.pone.0027789	http://dx.doi.org/10.1371/journal.pone.0027789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110760	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000297554300054
J	Izaks, GJ; Gansevoort, RT; van der Knaap, AM; Navis, G; Dullaart, RPF; Slaets, JPJ				Izaks, Gerbrand J.; Gansevoort, Ron T.; van der Knaap, Aafke M.; Navis, Gerjan; Dullaart, Robin P. F.; Slaets, Joris P. J.			The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; WHITE-MATTER LESIONS; ALZHEIMERS-DISEASE; ADULTS; ROTTERDAM; RISK	APOE genotype is associated with the risk of Alzheimer's disease. In the present study, we investigated whether APOE genotype was associated with cognitive function in predominantly middle-aged persons. In a population-based cohort of 4,135 persons aged 35 to 82 years (mean age (SD), 55 (12) years), cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0 points; best score, 175 points). APOE genotype (rs429358 and rs7412) was determined by polymerase chain reaction. The mean RFFT score (SD) of the total cohort was 69 (26) points. Unadjusted, the mean RFFT score in homozygous APOE epsilon 4 carriers was 4.66 points lower than in noncarriers (95% confidence interval, -9.84 to 0.51; p = 0.08). After adjustment for age and other risk factors, the mean RFFT score in homozygous APOE epsilon 4 carriers was 5.24 points lower than in noncarriers (95% confidence interval, -9.41 to -1.07; p = 0.01). The difference in RFFT score was not dependent on age. There was no difference in RFFT score between heterozygous APOE epsilon 4 carriers and noncarriers. The results indicated that homozygous APOE epsilon 4 carriers aged 35 years or older had worse cognitive function than heterozygous carriers and noncarriers.	[Izaks, Gerbrand J.; Slaets, Joris P. J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Izaks, Gerbrand J.; Slaets, Joris P. J.] Univ Groningen, Univ Med Ctr Groningen, Alzheimer Ctr Groningen, Groningen, Netherlands; [Gansevoort, Ron T.; Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [van der Knaap, Aafke M.; Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Izaks, GJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands.	g.j.izaks@umcg.nl	Izaks, Gerbrand/F-5089-2014	Izaks, Gerbrand/0000-0003-3213-7637	Dutch Alzheimer Foundation; Dutch Kidney Foundation [E.033]	Dutch Alzheimer Foundation; Dutch Kidney Foundation	This study was supported by the Dutch Alzheimer Foundation (www.alzheimer-nederland.nl). The PREVEND study in general was supported by the Dutch Kidney Foundation (www.nierstichting.nl; grant E.033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blaauwwiekel EE, 1998, DIABETIC MED, V15, P1031, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1031::AID-DIA705>3.0.CO;2-6; Bronge L, 1999, DEMENT GERIATR COGN, V10, P89, DOI 10.1159/000017107; Bryan J, 2000, J CLIN EXP NEUROPSYC, V22, P40, DOI 10.1076/1380-3395(200002)22:1;1-8;FT040; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bunce D, 2011, NEUROPSYCHOLOGIA, V49, P1693, DOI 10.1016/j.neuropsychologia.2011.02.042; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; Godin O, 2009, STROKE, V40, P3186, DOI 10.1161/STROKEAHA.109.555839; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017045; Jorm AF, 2007, NEUROPSYCHOLOGY, V21, P1, DOI 10.1037/0894-4105.21.1.1; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Liu F, 2010, NEUROBIOL AGING, V31, P1831, DOI 10.1016/j.neurobiolaging.2008.09.015; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Monster TBM, 2002, PHARMACOEPIDEM DR S, V11, P379, DOI 10.1002/pds.722; Pantoni L, 2007, CURR OPIN NEUROL, V20, P390, DOI 10.1097/WCO.0b013e328172d661; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reitz C, 2007, NEUROLOGY, V69, P998, DOI 10.1212/01.wnl.0000271395.29695.9a; REYMER PWA, 1995, CLIN CHEM, V41, P1046; Ruff R. M., 1996, RUFF FIGURAL FLUENCY; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Slooter AJC, 2001, STROKE, V32, P1947, DOI 10.1161/hs0901.095377; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Twamley EW, 2006, J INT NEUROPSYCH SOC, V12, P707, DOI 10.1017/S1355617706060863; United Nations Educational Scientific and Cultural Organization, 2006, INT STAND CLASS ED 1; World Health Organization, 1999, WHONCDNCS992 1	33	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27415	10.1371/journal.pone.0027415	http://dx.doi.org/10.1371/journal.pone.0027415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110642	Green Submitted, gold, Green Published			2022-12-25	WOS:000297554300028
J	Jorge, AM; Hoiczyk, E; Gomes, JP; Pinho, MG				Jorge, Ana M.; Hoiczyk, Egbert; Gomes, Joao P.; Pinho, Mariana G.			EzrA Contributes to the Regulation of Cell Size in Staphylococcus aureus	PLOS ONE			English	Article							FTSZ RING FORMATION; BACILLUS-SUBTILIS; WALL SYNTHESIS; DIVISION MACHINERY; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; IDENTIFICATION; INACTIVATION; SPORULATION; INHIBITION	EzrA is a negative regulator of FtsZ in Bacillus subtilis, involved in the coordination between cell growth and cell division and in the control of the cell elongation-division cycle. We have now studied the role of the Staphylococcus aureus homologue of the B. subtilis EzrA protein and shown that it is not essential for cell viability. EzrA conditional and null mutants have an overall increase of the average cell size, compared to wild type strains. In the larger ezrA mutant S. aureus cells, cell division protein FtsZ and the cell wall synthesizing Penicillin Binding Proteins (PBPs) are not properly localized. This suggests that there may be a maximum cell diameter that allows formation of a Z-ring capable of recruiting the other components of the divisome and of driving cytokinesis. We propose that the major role of EzrA in S. aureus is in cell size homeostasis.	[Jorge, Ana M.; Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Biol, Oeiras, Portugal; [Hoiczyk, Egbert] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal	Universidade Nova de Lisboa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jorge, AM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Biol, Oeiras, Portugal.	mgpinho@itqb.unl.pt	Pinho, Mariana/B-9192-2008	Pinho, Mariana/0000-0002-7132-8842; Gomes, Joao Paulo/0000-0002-2697-2399	Fundacao para a Cieancia e Tecnologia [PTDC/BIA-BCM/66449/2006, PTDC/BIA-MIC/099151/2008]; National Institutes of Health [GM85024];  [SFRH/BD/28480/2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085024] Funding Source: NIH RePORTER	Fundacao para a Cieancia e Tecnologia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Fundacao para a Cieancia e Tecnologia through research grant PTDC/BIA-BCM/66449/2006 and PTDC/BIA-MIC/099151/2008 awarded to Dr. Pinho. Dr. Jorge was supported by fellowship SFRH/BD/28480/2006. Work in the laboratory of Dr. Hoiczyk was supported by a grant from the National Institutes of Health (GM85024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; BEALL B, 1992, J BACTERIOL, V174, P2398, DOI 10.1128/JB.174.7.2398-2403.1992; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chung KM, 2007, J BIOL CHEM, V282, P14891, DOI 10.1074/jbc.M605177200; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Haeusser DP, 2007, J BACTERIOL, V189, P9001, DOI 10.1128/JB.01172-07; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2006, MICROBIOL-SGM, V152, P1129, DOI 10.1099/mic.0.28497-0; KOCH AL, 1986, J GEN MICROBIOL, V132, P3441; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Reed P, 2011, J BACTERIOL, V193, P2549, DOI 10.1128/JB.01474-10; Sambrook J, 1989, MOL CLONNING LAB MAN; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Singh P, 2010, DRUG NEWS PERSPECT, V23, P295, DOI 10.1358/dnp.2010.23.5.1429489; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Steele VR, 2011, MOL MICROBIOL, V80, P542, DOI 10.1111/j.1365-2958.2011.07591.x; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VEIGA H, 2011, MOL MICROBIOL; Veiga H, 2009, APPL ENVIRON MICROB, V75, P3034, DOI 10.1128/AEM.01862-08; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	42	46	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27542	10.1371/journal.pone.0027542	http://dx.doi.org/10.1371/journal.pone.0027542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110668	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300035
J	Siegert, S; Huang, HY; Yang, CY; Scarpellino, L; Carrie, L; Essex, S; Nelson, PJ; Heikenwalder, M; Acha-Orbea, H; Buckley, CD; Marsland, BJ; Zehn, D; Luther, SA				Siegert, Stefanie; Huang, Hsin-Ying; Yang, Chen-Ying; Scarpellino, Leonardo; Carrie, Lucie; Essex, Sarah; Nelson, Peter J.; Heikenwalder, Matthias; Acha-Orbea, Hans; Buckley, Christopher D.; Marsland, Benjamin J.; Zehn, Dietmar; Luther, Sanjiv A.			Fibroblastic Reticular Cells From Lymph Nodes Attenuate T Cell Expansion by Producing Nitric Oxide	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; STROMAL CELLS; STEADY-STATE; DIFFERENTIATION; CHEMOKINES; ANTIGEN; IMMUNOSUPPRESSION; HOMEOSTASIS; CONDUITS	Adaptive immune responses are initiated when T cells encounter antigen on dendritic cells (DC) in T zones of secondary lymphoid organs. T zones contain a 3-dimensional scaffold of fibroblastic reticular cells (FRC) but currently it is unclear how FRC influence T cell activation. Here we report that FRC lines and ex vivo FRC inhibit T cell proliferation but not differentiation. FRC share this feature with fibroblasts from non-lymphoid tissues as well as mesenchymal stromal cells. We identified FRC as strong source of nitric oxide (NO) thereby directly dampening T cell expansion as well as reducing the T cell priming capacity of DC. The expression of inducible nitric oxide synthase (iNOS) was up-regulated in a subset of FRC by both DC-signals as well as interferon-gamma produced by primed CD8+ T cells. Importantly, iNOS expression was induced during viral infection in vivo in both LN FRC and DC. As a consequence, the primary T cell response was found to be exaggerated in Inos(-/-) mice. Our findings highlight that in addition to their established positive roles in T cell responses FRC and DC cooperate in a negative feedback loop to attenuate T cell expansion during acute inflammation.	[Siegert, Stefanie; Huang, Hsin-Ying; Yang, Chen-Ying; Scarpellino, Leonardo; Acha-Orbea, Hans; Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Carrie, Lucie; Zehn, Dietmar] Swiss Vaccine Res Inst, Lausanne, Switzerland; [Carrie, Lucie; Zehn, Dietmar] CHU Vaudois, Serv Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Essex, Sarah; Buckley, Christopher D.] Univ Birmingham, Inst Biomed Res, Sch Immun & Infect, Med Res Council Ctr Immune Regulat, Birmingham, W Midlands, England; [Nelson, Peter J.] Univ Munich, Helmholtz Zentrum Munchen, Med Policlin, Munich, Germany; [Heikenwalder, Matthias] Tech Univ Munich, Inst Virol, Munich, Germany; [Marsland, Benjamin J.] Univ Lausanne, CHU Vaudois, Serv Pneumol, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Birmingham; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Siegert, S (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Sanjiv.Luther@unil.ch	Luther, Sanjiv A/B-4380-2016; Buckley, Christopher/AAN-6378-2021; Luther, Sanjiv/AAP-6525-2020; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Buckley, Christopher/0000-0001-6924-6402; Luther, Sanjiv/0000-0002-8758-957X; , Sanjiv/0000-0002-0614-561X	Swiss National Science Foundation [PPOOA-116896/1, 31003A-130488/1]; Boehringer Ingelheim Fonds; Taiwan National Science Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033068, R37AI033068] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Swiss National Science Foundation grants #PPOOA-116896/1 and #31003A-130488/1 to S. A. L; by the Boehringer Ingelheim Fonds to S.S.; and by the Taiwan National Science Council to H-Y.H.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24; Bouffi C, 2011, ANN RHEUM DIS, V70, P1671, DOI 10.1136/ard.2010.143297; Cesson V, 2006, CLIN CANCER RES, V12, P7422, DOI 10.1158/1078-0432.CCR-06-1862; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Flanagan K, 2004, CELL IMMUNOL, V231, P75, DOI 10.1016/j.cellimm.2004.12.006; Fletcher AL, 2011, TRENDS IMMUNOL, V32, P12, DOI 10.1016/j.it.2010.11.002; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hou TZ, 2010, EUR J IMMUNOL, V40, P359, DOI 10.1002/eji.200939776; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kasic T, 2011, EUR J IMMUNOL, V41, P1843, DOI 10.1002/eji.201040868; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; LAVNIKOVA N, 1995, J LEUKOCYTE BIOL, V58, P451, DOI 10.1002/jlb.58.4.451; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Niedbala W, 2006, ANN RHEUM DIS, V65, P37, DOI 10.1136/ard.2006.058446; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi FD, 2001, J IMMUNOL, V167, P3000, DOI 10.4049/jimmunol.167.5.3000; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Svensson M, 2006, TRENDS IMMUNOL, V27, P580, DOI 10.1016/j.it.2006.10.006; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Worbs T, 2008, IMMUNOL REV, V221, P44, DOI 10.1111/j.1600-065X.2008.00580.x; Xiao BG, 2008, MOL IMMUNOL, V45, P1191, DOI 10.1016/j.molimm.2007.07.003; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zischek C, 2009, ANN SURG, V250, P747, DOI 10.1097/SLA.0b013e3181bd62d0	57	92	93	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27618	10.1371/journal.pone.0027618	http://dx.doi.org/10.1371/journal.pone.0027618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110693	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300038
J	Barriuso, J; Marin, S; Mellado, RP				Barriuso, Jorge; Marin, Silvia; Mellado, Rafael P.			Potential Accumulative Effect of the Herbicide Glyphosate on Glyphosate-Tolerant Maize Rhizobacterial Communities over a Three-Year Cultivation Period	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; BACTERIAL DIVERSITY; RESISTANT CROPS; RARE BIOSPHERE; CORN; IMPACTS; ACIDOBACTERIA; RHIZOSPHERES; UNIFRAC; SYSTEMS	Background: Glyphosate is a herbicide that is liable to be used in the extensive cultivation of glyphosate-tolerant cultivars. The potential accumulation of the relative effect of glyphosate on the rhizobacterial communities of glyphosate-tolerant maize has been monitored over a period of three years. Methodology/Principal Findings: The composition of rhizobacterial communities is known to vary with soil texture, hence, the analyses have been performed in two agricultural fields with a different soil texture. The accumulative effects of glyphosate have been monitored by means of high throughput DNA pyrosequencing of the bacterial DNA coding for the 16S rRNA hypervariable V6 region from rhizobacterial communities. The relative composition of the rhizobacterial communities does vary in each field over the three-year period. The overall distribution of the bacterial phyla seems to change from one year to the next similarly in the untreated and glyphosate-treated soils in both fields. The two methods used to estimate bacterial diversity offered consistent results and are equally suitable for diversity assessment. Conclusions/Significance: The glyphosate treatment during the three-year period of seasonal cultivation in two different fields did not seem to significantly change the maize rhizobacterial communities when compared to those of the untreated soil. This may be particularly relevant with respect to a potential authorisation to cultivate glyphosate-tolerant maize in the European Union.	[Barriuso, Jorge; Marin, Silvia; Mellado, Rafael P.] Ctr Nacl Biotecnol CNB CSIC, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Barriuso, J (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Dept Biotecnol Microbiana, Madrid, Spain.	rpmellado@cnb.csic.es	Mellado, Rafael P/D-2680-2009; Barriuso, Jorge/AAF-6118-2020	Barriuso, Jorge/0000-0003-0916-6560	Spanish Ministry of the Environment and Rural and Marine affairs [EGO22008]; Spanish Research Council [200420E397]	Spanish Ministry of the Environment and Rural and Marine affairs(Spanish Government); Spanish Research Council	The Spanish Ministry of the Environment and Rural and Marine affairs has commissioned, supported and officially authorised this research (Grant No. EGO22008). The Spanish Research Council has also partially supported this research (PIE No. 200420E397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Barriuso J, 2010, ENVIRON MICROBIOL, V12, P1021, DOI 10.1111/j.1462-2920.2009.02146.x; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; da Rocha UN, 2009, FEMS MICROBIOL ECOL, V69, P313, DOI 10.1111/j.1574-6941.2009.00702.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang M, 2005, APPL ENVIRON MICROB, V71, P4132, DOI 10.1128/AEM.71.7.4132-4136.2005; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hart MM, 2009, PEDOBIOLOGIA, V52, P253, DOI 10.1016/j.pedobi.2008.10.005; Heck GR, 2005, CROP SCI, V45, P329, DOI 10.2135/cropsci2005.0329; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; Kielak AM, 2010, APPL ENVIRON MICROB, V76, P6769, DOI 10.1128/AEM.00343-10; Kremer RJ, 2009, EUR J AGRON, V31, P153, DOI 10.1016/j.eja.2009.06.004; Locke MA, 2008, PEST MANAG SCI, V64, P457, DOI 10.1002/ps.1549; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lupwayi NZ, 2007, SOIL BIOL BIOCHEM, V39, P1418, DOI 10.1016/j.soilbio.2006.12.038; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mijangos I, 2009, SOIL BIOL BIOCHEM, V41, P505, DOI 10.1016/j.soilbio.2008.12.009; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sidhu RS, 2000, J AGR FOOD CHEM, V48, P2305, DOI 10.1021/jf000172f; Sluszny C, 1999, WATER AIR SOIL POLL, V115, P395, DOI 10.1023/A:1005105020757; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Val G, 2009, MICROB ECOL, V58, P108, DOI 10.1007/s00248-008-9451-2; Zobiole LHS, 2011, J APPL MICROBIOL, V110, P118, DOI 10.1111/j.1365-2672.2010.04864.x	34	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27558	10.1371/journal.pone.0027558	http://dx.doi.org/10.1371/journal.pone.0027558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096595	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900058
J	Galetovic, A; Souza, RT; Santos, MRM; Cordero, EM; Bastos, IMD; Santana, JM; Ruiz, JC; Lima, FM; Marini, MM; Mortara, RA; da Silveira, JF				Galetovic, Alexandra; Souza, Renata T.; Santos, Marcia R. M.; Cordero, Esteban M.; Bastos, Izabela M. D.; Santana, Jaime M.; Ruiz, Jeronimo C.; Lima, Fabio M.; Marini, Marjorie M.; Mortara, Renato A.; da Silveira, Jose Franco			The Repetitive Cytoskeletal Protein H49 of Trypanosoma cruzi Is a Calpain-Like Protein Located at the Flagellum Attachment Zone	PLOS ONE			English	Article							CLONE CL BRENER; CHAGAS-DISEASE; RECOMBINANT ANTIGENS; POLYACRYLAMIDE-GELS; SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; CELL MOTILITY; ANTIBODIES; GENOME; FORMS	Background: Trypanosoma cruzi has a single flagellum attached to the cell body by a network of specialized cytoskeletal and membranous connections called the flagellum attachment zone. Previously, we isolated a DNA fragment (clone H49) which encodes tandemly arranged repeats of 68 amino acids associated with a high molecular weight cytoskeletal protein. In the current study, the genomic complexity of H49 and its relationships to the T. cruzi calpain-like cysteine peptidase family, comprising active calpains and calpain-like proteins, is addressed. Immunofluorescence analysis and biochemical fractionation were used to demonstrate the cellular location of H49 proteins. Methods and Findings: All of H49 repeats are associated with calpain-like sequences. Sequence analysis demonstrated that this protein, now termed H49/calpain, consists of an amino-terminal catalytic cysteine protease domain II, followed by a large region of 68-amino acid repeats tandemly arranged and a carboxy-terminal segment carrying the protease domains II and III. The H49/calpains can be classified as calpain-like proteins as the cysteine protease catalytic triad has been partially conserved in these proteins. The H49/calpains repeats share less than 60% identity with other calpain-like proteins in Leishmania and T. brucei, and there is no immunological cross reaction among them. It is suggested that the expansion of H49/calpain repeats only occurred in T. cruzi after separation of a T. cruzi ancestor from other trypanosomatid lineages. Immunofluorescence and immunoblotting experiments demonstrated that H49/calpain is located along the flagellum attachment zone adjacent to the cell body. Conclusions: H49/calpain contains large central region composed of 68-amino acid repeats tandemly arranged. They can be classified as calpain-like proteins as the cysteine protease catalytic triad is partially conserved in these proteins. H49/calpains could have a structural role, namely that of ensuring that the cell body remains attached to the flagellum by connecting the subpellicular microtubule array to it.	[Galetovic, Alexandra; Souza, Renata T.; Cordero, Esteban M.; Lima, Fabio M.; Marini, Marjorie M.; Mortara, Renato A.; da Silveira, Jose Franco] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Galetovic, Alexandra] Univ Antofagasta, Lab Bioquim, Dept Biomed, Antofagasta, Chile; [Santos, Marcia R. M.] Univ Bandeirante Sao Paulo, Sao Paulo, Brazil; [Bastos, Izabela M. D.; Santana, Jaime M.] Univ Brasilia, Dept Biol Celular, Inst Biol, Brasilia, DF, Brazil; [Ruiz, Jeronimo C.] Fiocruz MS, Ctr Pesquisa Rene Rachou CPqRR, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidad de Antofagasta; Universidade Bandeirante de Sao Paulo; Universidade de Brasilia; Fundacao Oswaldo Cruz	Galetovic, A (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	jose.franco@unifesp.br	Lima, Fabio Mitsuo/AHD-6582-2022; Cordero, Esteban M/F-2511-2012; Mortara, Renato A./C-1864-2012; marini, marjorie/O-9713-2014; da Silveira, Jose Franco/F-5390-2012; Lima, Fabio Mitsuo/GQH-9488-2022; Cordero, Esteban M./Q-6513-2019; Lima, Fabio M/C-9018-2013; Ruiz, Jeronimo/D-2511-2011; Santana, Jaime/H-5319-2013	Lima, Fabio Mitsuo/0000-0002-1953-2950; Cordero, Esteban M/0000-0002-6099-5113; Mortara, Renato A./0000-0002-2311-8349; Lima, Fabio Mitsuo/0000-0002-1953-2950; Cordero, Esteban M./0000-0002-6099-5113; Lima, Fabio M/0000-0002-1953-2950; Bastos, Izabela/0000-0002-2785-4255; /0000-0002-1361-9721	FAPESP; CNPq (Brazil); Beca Presidente de la Republica-Chile; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Beca Presidente de la Republica-Chile; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from FAPESP (www.fapesp.br) and CNPq (www.cnpq.br) (Brazil) to JFS. AGC and FML were awarded doctoral fellowships by Beca Presidente de la Republica-Chile and FAPESP, respectively; RTS and MMM were awarded postdoctoral fellowships by FAPESP and CNPq, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araya J, 1997, PARASITOLOGY, V115, P563, DOI 10.1017/S0031182097001674; Bastin P, 2000, MICROBES INFECT, V2, P1865, DOI 10.1016/S1286-4579(00)01344-7; Bisaggio DFR, 2006, ACTA TROP, V98, P162, DOI 10.1016/j.actatropica.2006.04.003; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P128; Buchanan KT, 2005, J BIOL CHEM, V280, P40104, DOI 10.1074/jbc.M505777200; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; COTRIM PC, 1995, MOL BIOCHEM PARASIT, V71, P89, DOI 10.1016/0166-6851(95)00036-Z; COTRIM PC, 1990, J CLIN MICROBIOL, V28, P519, DOI 10.1128/JCM.28.3.519-524.1990; da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9; DEJESUS AR, 1993, J CELL SCI, V106, P1023; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; FRASCH ACC, 1991, PARASITOL TODAY, V7, P148, DOI 10.1016/0169-4758(91)90284-U; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6; KERNER N, 1991, EXP PARASITOL, V73, P451, DOI 10.1016/0014-4894(91)90069-9; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LAFAILLE JJ, 1989, MOL BIOCHEM PARASIT, V35, P127, DOI 10.1016/0166-6851(89)90115-1; LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530; Lorena VMB, 2010, SCAND J IMMUNOL, V72, P529, DOI 10.1111/j.1365-3083.2010.02462.x; Mortara RA, 2001, J EUKARYOT MICROBIOL, V48, P27, DOI 10.1111/j.1550-7408.2001.tb00413.x; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; PARANHOSBACALLA GS, 1994, PARASITE IMMUNOL, V16, P165, DOI 10.1111/j.1365-3024.1994.tb00336.x; Pereira VRA, 2005, PARASITOL RES, V96, P154, DOI 10.1007/s00436-005-1336-4; Pereira VRA, 2004, PARASITOLOGY, V129, P563, DOI 10.1017/S0031182004006043; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rocha GM, 2006, J STRUCT BIOL, V154, P89, DOI 10.1016/j.jsb.2005.11.008; Rocha GM, 2008, MICROSC RES TECHNIQ, V71, P133, DOI 10.1002/jemt.20535; RUIZ AM, 1985, ACTA TROP, V42, P299; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santana JM, 1997, BIOCHEM J, V325, P129, DOI 10.1042/bj3250129; Santos MRM, 1999, GENOME RES, V9, P1268, DOI 10.1101/gr.9.12.1268; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vasconcelos RHT, 2010, HUM IMMUNOL, V71, P964, DOI 10.1016/j.humimm.2010.07.004; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016	53	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27634	10.1371/journal.pone.0027634	http://dx.doi.org/10.1371/journal.pone.0027634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096606	gold, Green Published			2022-12-25	WOS:000297553900065
J	Barbagallo, M; Di Martino, ML; Marcocci, L; Pietrangeli, P; De Carolis, E; Casalino, M; Colonna, B; Prosseda, G				Barbagallo, Marialuisa; Di Martino, Maria Letizia; Marcocci, Lucia; Pietrangeli, Paola; De Carolis, Elena; Casalino, Mariassunta; Colonna, Bianca; Prosseda, Gianni			A New Piece of the Shigella Pathogenicity Puzzle: Spermidine Accumulationby Silencing of the speG Gene	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; BACTERIAL PATHOGENS; OXIDATIVE STRESS; POLYMORPHONUCLEAR LEUKOCYTES; PATHOADAPTIVE MUTATIONS; INTRACELLULAR SURVIVAL; ENTEROCOCCUS-FAECALIS; PROTEUS-MIRABILIS; DEFICIENT MUTANT; CELL INVASION	The genome of Shigella, a gram negative bacterium which is the causative agent of bacillary dysentery, shares strong homologies with that of its commensal ancestor, Escherichia coli. The acquisition, by lateral gene transfer, of a large plasmid carrying virulence determinants has been a crucial event in the evolution towards the pathogenic lifestyle and has been paralleled by the occurrence of mutations affecting genes, which negatively interfere with the expression of virulence factors. In this context, we have analysed to what extent the presence of the plasmid-encoded virF gene, the major activator of the Shigella regulon for invasive phenotype, has modified the transcriptional profile of E. coli. Combining results from transcriptome assays and comparative genome analyses we show that in E. coli VirF, besides being able to up-regulate several chromosomal genes, which potentially influence bacterial fitness within the host, also activates genes which have been lost by Shigella. We have focused our attention on the speG gene, which encodes spermidine acetyltransferase, an enzyme catalysing the conversion of spermidine into the physiologically inert acetylspermidine, since recent evidence stresses the involvement of polyamines in microbial pathogenesis. Through identification of diverse mutations, which prevent expression of a functional SpeG protein, we show that the speG gene has been silenced by convergent evolution and that its inactivation causes the marked increase of intracellular spermidine in all Shigella spp. This enhances the survival of Shigella under oxidative stress and allows it to better face the adverse conditions it encounters inside macrophage. This is supported by the outcome of infection assays performed in mouse peritoneal macrophages and of a competitive-infection assay on J774 macrophage cell culture. Our observations fully support the pathoadaptive nature of speG inactivation in Shigella and reveal that the accumulation of spermidine is a key determinant in the pathogenicity strategy adopted by this microrganism.	[Barbagallo, Marialuisa; Di Martino, Maria Letizia; Colonna, Bianca; Prosseda, Gianni] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Inst Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Marcocci, Lucia; Pietrangeli, Paola] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [De Carolis, Elena] Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy; [Casalino, Mariassunta] Univ Roma, Dept Biol, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; University of Rome Tor Vergata	Barbagallo, M (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Inst Pasteur, Fdn Cenci Bolognetti, Rome, Italy.	gianni.prosseda@uniroma1.it	Di Martino, Maria Letizia/L-7066-2019; De+Carolis, Elena/ABD-9703-2020; Barbagallo, Marialuisa/ABG-1234-2020	Di Martino, Maria Letizia/0000-0002-9491-4000; De+Carolis, Elena/0000-0003-4757-7256; Barbagallo, Marialuisa/0000-0003-0294-2299; Marcocci, Lucia/0000-0003-2301-7166; PROSSEDA, Gianni/0000-0001-5235-0086	Ministero della Ricerca e dell'Istruzione [2007/W52X9B]; Uniiversity Sapienza of Rome [C26A10KP9X]	Ministero della Ricerca e dell'Istruzione; Uniiversity Sapienza of Rome	This work was supported by grants from Ministero della Ricerca e dell'Istruzione (PRIN 2007/W52X9B) and from Uniiversity Sapienza of Rome (C26A10KP9X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON C, 1992, INFECT IMMUN, V60, P4740, DOI 10.1128/IAI.60.11.4740-4746.1992; Ashida H, 2009, CURR TOP MICROBIOL, V337, P231, DOI 10.1007/978-3-642-01846-6_8; Bachrach U, 1989, PHYSL POLYAMINES; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bu Xin, 2008, Weishengwu Xuebao, V48, P905; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; CASALINO M, 1994, J CLIN MICROBIOL, V32, P1179, DOI 10.1128/JCM.32.5.1179-1183.1994; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S.S., 1997, GUIDE POLYAMINES; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Durand JMB, 2009, MICROBIOL-SGM, V155, P2498, DOI 10.1099/mic.0.028191-0; Durand JMB, 2003, MOL MICROBIOL, V47, P519, DOI 10.1046/j.1365-2958.2003.03314.x; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Fernandez IM, 2001, J INFECT DIS, V184, P743, DOI 10.1086/323035; FUKUCHI JI, 1995, J BIOL CHEM, V270, P18831, DOI 10.1074/jbc.270.32.18831; Gentry-Weeks CR, 1999, INFECT IMMUN, V67, P2160, DOI 10.1128/IAI.67.5.2160-2165.1999; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Igarashi K, 2009, BIOCHEM J, V344, P633; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; KAKEGAWA T, 1991, J BIOCHEM, V109, P627, DOI 10.1093/oxfordjournals.jbchem.a123431; KASHIWAGI K, 1988, J BACTERIOL, V170, P3131, DOI 10.1128/jb.170.7.3131-3135.1988; Kikuchi Y, 1997, J BACTERIOL, V179, P4486, DOI 10.1128/jb.179.14.4486-4492.1997; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Lasbury ME, 2007, J BIOL CHEM, V282, P11009, DOI 10.1074/jbc.M611686200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Mariggio MA, 2004, IMMUNOPHARM IMMUNOT, V26, P93, DOI 10.1081/IPH-120029947; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; McCormick BA, 1999, CELL MICROBIOL, V1, P143, DOI 10.1046/j.1462-5822.1999.00014.x; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; MENG SY, 1992, J BACTERIOL, V174, P2659, DOI 10.1128/jb.174.8.2659-2669.1992; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; OSBORNE DL, 1990, AM J PHYSIOL, V258, pG576, DOI 10.1152/ajpgi.1990.258.4.G576; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Perez-Cano FJ, 2003, CELL IMMUNOL, V226, P86, DOI 10.1016/j.cellimm.2003.09.009; Prosseda G, 2004, MOL MICROBIOL, V51, P523, DOI 10.1046/j.1365-2958.2003.03848.x; Prosseda G, 2002, RES MICROBIOL, V153, P461, DOI 10.1016/S0923-2508(02)01346-3; Prosseda G, 2007, RES MICROBIOL, V158, P487, DOI 10.1016/j.resmic.2007.05.001; SAKAI T, 1986, INFECT IMMUN, V54, P395, DOI 10.1128/IAI.54.2.395-402.1986; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Sansonetti PJ, 2006, ANN NY ACAD SCI, V1072, P307, DOI 10.1196/annals.1326.025; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; Verneuil N, 2004, INFECT IMMUN, V72, P4424, DOI 10.1128/IAI.72.8.4424-4431.2004; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; XIE QW, 1989, J BACTERIOL, V171, P4457, DOI 10.1128/JB.171.8.4457-4465.1989; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291	63	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27226	10.1371/journal.pone.0027226	http://dx.doi.org/10.1371/journal.pone.0027226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102881	Green Published, gold			2022-12-25	WOS:000297348800018
J	Hon, WC; Berndt, A; Williams, RL				Hon, W-C; Berndt, A.; Williams, R. L.			Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases	ONCOGENE			English	Article						PIK3CA mutations; p110 alpha; lipid binding; crystal structure; inhibitor; growth factor signalling	KINASE-C-ALPHA; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3'-KINASE; PIK3CA MUTATIONS; CANCER; DOMAIN; PATHWAY; PI3K; PI3K-ALPHA; P110-ALPHA	Somatic missense mutations in PIK3CA, which encodes the p110 alpha catalytic subunit of phosphoinositide 3-kinases, occur frequently in human cancers. Activating mutations spread across multiple domains, some of which are located at inhibitory contact sites formed with the regulatory subunit p85 alpha. PIK3R1, which encodes p85 alpha, also has activating somatic mutations. We find a strong correlation between lipid kinase and lipid-binding activities for both wild-type (WT) and a representative set of oncogenic mutant complexes of p110 alpha/p85 alpha. Lipid binding involves both electrostatic and hydrophobic interactions. Activation caused by a phosphorylated receptor tyrosine kinase (RTK) peptide binding to the p85 alpha N-terminal SH2 domain (nSH2) induces lipid binding. This depends on the polybasic activation loop as well as a conserved hydrophobic motif in the C-terminal region of the kinase domain. The hotspot E545K mutant largely mimics the activated WT p110 alpha. It shows the highest basal activity and lipid binding, and is not significantly activated by an RTK phosphopeptide. Both the hotspot H1047R mutant and rare mutations (C420R, M1043I, H1047L, G1049R and p85 alpha-N564D) also show increased basal kinase activities and lipid binding. However, their activities are further enhanced by an RTK phosphopeptide to levels markedly exceeding that of activated WT p110 alpha. Phosphopeptide binding to p110 beta/p85 alpha and p110 delta/p85 alpha complexes also induces their lipid binding. We present a crystal structure of WT p110 alpha complexed with the p85 alpha inter-SH2 domain and the inhibitor PIK-108. Additional to the ATP-binding pocket, an unexpected, second PIK-108 binding site is observed in the kinase C-lobe. We show a global conformational change in p110 alpha consistent with allosteric regulation of the kinase domain by nSH2. These findings broaden our understanding of the differential biological outputs exhibited by distinct types of mutations regarding growth factor dependence, and suggest a two-tier classification scheme relating p110 alpha and p85 alpha mutations with signalling potential. Oncogene (2012) 31, 3655-3666; doi:10.1038/onc.2011.532; published online 28 November 2011	[Hon, W-C; Berndt, A.; Williams, R. L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Williams, RL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	rlw@mrc-lmb.cam.ac.uk		Williams, Roger/0000-0001-7754-4207	Medical Research Council, UK; MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Kevan Shokat and co-workers (UCSF, USA), including Beth Apsel, Benjamin Houseman, Eli Zunder, Morri Feldman and Zachary Knight, for their generous gift of PI3K inhibitors, which were crucial for crystallization screening. We thank the beamline scientists and members of the staff at the ESRF beamlines ID14-1, ID14-2, ID14-4, ID23-1, ID23-2, and ID29 (Grenoble, France) and Diamond Light Source beamlines I02 and I03 (UK). We also thank past and present members of the Williams's group, particularly Simon Miller, for assistance with remote crystal data collection, Olga Perisic for providing baculovirus of mouse p110 beta, Alexey Murzin for his structural insight of the WIF motif conformation, Andrew Leslie and Nicolas Soler for providing scripts to create Figure 4d. This work was supported by the Medical Research Council, UK.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Chakrabarty A, 2010, ONCOGENE, V29, P5193, DOI 10.1038/onc.2010.257; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Drees BE, 2003, COMB CHEM HIGH T SCR, V6, P321; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Bayascas JR, 2010, CURR TOP MICROBIOL, V346, P9, DOI 10.1007/82_2010_43; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Wu HY, 2009, P NATL ACAD SCI USA, V106, P20258, DOI 10.1073/pnas.0902369106; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	51	73	75	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	32					3655	3666		10.1038/onc.2011.532	http://dx.doi.org/10.1038/onc.2011.532			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22120714	Green Accepted			2022-12-25	WOS:000307653800001
J	Rao, JN; Rivera-Santiago, R; Li, XE; Lehman, W; Dominguez, R				Rao, Jampani Nageswara; Rivera-Santiago, Roland; Li, Xiaochuan Edward; Lehman, William; Dominguez, Roberto			Structural Analysis of Smooth Muscle Tropomyosin alpha and beta Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETAL DYNAMICS; COILED-COIL; CRYSTAL-STRUCTURE; BINDING; TROPONIN; POLYMERIZATION; RECOGNITION; FLEXIBILITY; ACTIVATION; SEQUENCE	A large number of tropomyosin (Tm) isoforms function as gatekeepers of the actin filament, controlling the spatiotemporal access of actin-binding proteins to specialized actin networks. Residues similar to 40-80 vary significantly among Tm isoforms, but the impact of sequence variation on Tm structure and interactions with actin is poorly understood, because structural studies have focused on skeletal muscle Tm beta. We describe structures of N-terminal fragments of smooth muscle Tm alpha and Tm beta (sm-Tm alpha and sm-Tm beta). The 2.0-angstrom structure of sm-Tm alpha 81 (81-aa) resembles that of skeletal Tm alpha, displaying a similar super-helical twist matching the contours of the actin filament. The 1.8-angstrom structure of sm-Tm alpha 98 (98-aa) unexpectedly reveals an antiparallel coiled coil, with the two chains staggered by only 4 amino acids and displaying hydrophobic core interactions similar to those of the parallel dimer. In contrast, the 2.5-angstrom structure of sm-Tm beta 98, containing Gly-Ala-Ser at the N terminus to mimic acetylation, reveals a parallel coiled coil. None of the structures contains coiled-coil stabilizing elements, favoring the formation of head-to-tail overlap complexes in four of five crystallographically independent parallel dimers. These complexes show similarly arranged 4-helix bundles stabilized by hydrophobic interactions, but the extent of the overlap varies between sm-Tm beta 98 and sm-Tm alpha 81 from 2 to 3 helical turns. The formation of overlap complexes thus appears to be an intrinsic property of the Tm coiled coil, with the specific nature of hydrophobic contacts determining the extent of the overlap. Overall, the results suggest that sequence variation among Tm isoforms has a limited effect on actin binding but could determine its gatekeeper function.	[Rao, Jampani Nageswara; Rivera-Santiago, Roland; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Li, Xiaochuan Edward; Lehman, William] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of Pennsylvania; Pennsylvania Medicine; Boston University	Dominguez, R (corresponding author), A-507 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu		Lehman, William/0000-0002-9430-9521	National Institutes of Health [P01 HL086655, RR-01646]; Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; Department of Energy [W-31-109-Eng-38]; National Science Foundation [DMR-0936384]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL086655 (to R. D. and W. L.).; Use of IMCA-CAT beamline 17-ID was supported by the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. The Advanced Photon Source was supported by the Department of Energy Contract W-31-109-Eng-38. Crystal data collection at CHESS was supported by National Science Foundation Grant DMR-0936384 and National Institutes of Health Grant RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali F, 2005, CAN J PHYSIOL PHARM, V83, P825, DOI 10.1139/Y05-052; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Conley CA, 2001, AM J PHYSIOL-CELL PH, V280, pC1645, DOI 10.1152/ajpcell.2001.280.6.C1645; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; Dominguez R, 2011, BIOPHYS J, V100, P797, DOI 10.1016/j.bpj.2011.01.018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Gallant C, 2011, AM J PHYSIOL-CELL PH, V300, pC1356, DOI 10.1152/ajpcell.00450.2010; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; Gunning P, 1998, BIOESSAYS, V20, P892, DOI 10.1002/(SICI)1521-1878(199811)20:11<892::AID-BIES4>3.3.CO;2-4; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; HitchcockDeGregori SE, 1996, J BIOL CHEM, V271, P3600; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; Ishikawa R, 1998, J BIOL CHEM, V273, P26991, DOI 10.1074/jbc.273.41.26991; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P63, DOI 10.1007/s10974-011-9254-9; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P19, DOI 10.1007/s10974-011-9249-6; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Lord M, 2011, CURR BIOL, V21, pR255, DOI 10.1016/j.cub.2011.02.043; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; Martin C, 2008, ADV EXP MED BIOL, V644, P187; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Minakata S, 2008, BIOPHYS J, V95, P710, DOI 10.1529/biophysj.107.126144; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Paulucci AA, 2004, EUR J BIOCHEM, V271, P589, DOI 10.1111/j.1432-1033.2003.03961.x; Perrin BJ, 2010, CYTOSKELETON, V67, P630, DOI 10.1002/cm.20475; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; Seow CY, 2011, J APPL PHYSIOL, V110, P1130, DOI 10.1152/japplphysiol.01192.2010; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Sousa D, 2010, BIOPHYS J, V99, P862, DOI 10.1016/j.bpj.2010.05.004; Tobacman LS, 2008, ADV EXP MED BIOL, V644, P85; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Whitby FG, 2000, PROTEINS, V38, P49	53	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3165	3174		10.1074/jbc.M111.307330	http://dx.doi.org/10.1074/jbc.M111.307330			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22119916	Green Published, hybrid			2022-12-25	WOS:000300295100022
J	Belkaya, S; Silge, RL; Hoover, AR; Medeiros, JJ; Eitson, JL; Becker, AM; de la Morena, MT; Bassel-Duby, RS; van Oers, NSC				Belkaya, Serkan; Silge, Robert L.; Hoover, Ashley R.; Medeiros, Jennifer J.; Eitson, Jennifer L.; Becker, Amy M.; de la Morena, M. Teresa; Bassel-Duby, Rhonda S.; van Oers, Nicolai S. C.			Dynamic Modulation of Thymic MicroRNAs in Response to Stress	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; T-CELL DEVELOPMENT; BONE-MARROW-TRANSPLANTATION; IMMUNE-RESPONSE; EXPRESSION; ATROPHY; RECEPTOR; ACTIVATION; INFECTION; APOPTOSIS	Background: Physiological stress evokes rapid changes in both the innate and adaptive immune response. Immature ab T cells developing in the thymus are particularly sensitive to stress, with infections and/or exposure to lipopolysaccharide or glucocorticoids eliciting a rapid apoptotic program. MicroRNAs are a class of small, non-coding RNAs that regulate global gene expression by targeting diverse mRNAs for degradation. We hypothesized that a subset of thymically encoded microRNAs would be stress responsive and modulate thymopoiesis. We performed microRNA profiling of thymic microRNAs isolated from control or stressed thymic tissue obtained from mice. We identified 18 microRNAs that are dysregulated >1.5fold in response to lipopolysaccharide or the synthetic corticosteroid dexamethasone. These included the miR-17-90 cluster, which have anti-apoptotic functions, and the miR-181 family, which contribute to T cell tolerance. The stress-induced changes in the thymic microRNAs are dynamically and distinctly regulated in the CD4(-) CD8(-), CD4(+) CD8(+), CD4(+) CD8(-), and CD4(-) CD8(+) thymocyte subsets. Several of the differentially regulated murine thymic miRs are also stress responsive in the heart, kidney, liver, brain, and/or spleen. The most dramatic thymic microRNA down modulated is miR-181d, exhibiting a 15-fold reduction following stress. This miR has both similar and distinct gene targets as miR-181a, another member of miR-181 family. Many of the differentially regulated microRNAs have known functions in thymopoiesis, indicating that their dysregulation will alter T cell repertoire selection and the formation of naive T cells. This data has implications for clinical treatments involving anti-inflammatory steroids, ablation therapies, and provides mechanistic insights into the consequences of infections.	[Belkaya, Serkan; Silge, Robert L.; Hoover, Ashley R.; Medeiros, Jennifer J.; Eitson, Jennifer L.; Becker, Amy M.; van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [de la Morena, M. Teresa; van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bassel-Duby, Rhonda S.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Belkaya, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	nicolai.vanoers@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021; Belkaya, Serkan/ABD-4504-2020	Belkaya, Serkan/0000-0003-4214-382X; van Oers, Nicolai/0000-0002-6545-8405	National Institutes of Health [AI42953, AI31839]; Jeffery Modell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jeffery Modell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institutes of Health AI42953 and AI31839 (NvO), and the Jeffery Modell Foundation (MdlM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEEV AK, 1986, ARK PATOL, V48, P33; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Brewer JA, 2003, NAT MED, V9, P1318, DOI 10.1038/nm895; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; DeFord-Watts LM, 2009, J IMMUNOL, V183, P1055, DOI 10.4049/jimmunol.0900404; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169; Hoffman HM, 2009, NAT REV RHEUMATOL, V5, P249, DOI 10.1038/nrrheum.2009.40; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lowenberg M, 2007, TRENDS MOL MED, V13, P158, DOI 10.1016/j.molmed.2007.02.001; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Murgita R A, 1981, Prog Allergy, V29, P54; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; ROCKLIN RE, 1979, ANNU REV MED, V30, P375, DOI 10.1146/annurev.me.30.020179.002111; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sempowski GD, 2002, EUR J IMMUNOL, V32, P3066, DOI 10.1002/1521-4141(200211)32:11<3066::AID-IMMU3066>3.0.CO;2-J; Shimon I, 1997, J CLIN INVEST, V100, P357, DOI 10.1172/JCI119541; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; WANG SD, 1994, J IMMUNOL, V152, P5014; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	61	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27580	10.1371/journal.pone.0027580	http://dx.doi.org/10.1371/journal.pone.0027580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110677	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400060
J	Chi, XY; Yang, QL; Chen, XP; Wang, JY; Pan, LJ; Chen, MN; Yang, Z; He, YA; Liang, XQ; Yu, SL				Chi, Xiaoyuan; Yang, Qingli; Chen, Xiaoping; Wang, Jinyan; Pan, Lijuan; Chen, Mingna; Yang, Zhen; He, Yanan; Liang, Xuanqiang; Yu, Shanlin			Identification and Characterization of microRNAs from Peanut (Arachis hypogaea L.) by High-Throughput Sequencing	PLOS ONE			English	Article							WHEAT TRITICUM-AESTIVUM; CONSERVED MICRORNAS; TARGET GENES; SMALL RNAS; POLYPHENOL OXIDASE; ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; NONCODING RNAS; PLANTS; MIRBASE	Background: MicroRNAs (miRNAs) are noncoding RNAs of approximately 21 nt that regulate gene expression in plants post-transcriptionally by endonucleolytic cleavage or translational inhibition. miRNAs play essential roles in numerous developmental and physiological processes and many of them are conserved across species. Extensive studies of miRNAs have been done in a few model plants; however, less is known about the diversity of these regulatory RNAs in peanut (Arachis hypogaea L.), one of the most important oilseed crops cultivated worldwide. Results: A library of small RNA from peanut was constructed for deep sequencing. In addition to 126 known miRNAs from 33 families, 25 novel peanut miRNAs were identified. The miRNA* sequences of four novel miRNAs were discovered, providing additional evidence for the existence of miRNAs. Twenty of the novel miRNAs were considered to be species-specific because no homolog has been found for other plant species. qRT-PCR was used to analyze the expression of seven miRNAs in different tissues and in seed at different developmental stages and some showed tissue-and/or growth stage-specific expression. Furthermore, potential targets of these putative miRNAs were predicted on the basis of the sequence homology search. Conclusions: We have identified large numbers of miRNAs and their related target genes through deep sequencing of a small RNA library. This study of the identification and characterization of miRNAs in peanut can initiate further study on peanut miRNA regulation mechanisms, and help toward a greater understanding of the important roles of miRNAs in peanut.	[Chi, Xiaoyuan; Yang, Qingli; Wang, Jinyan; Pan, Lijuan; Chen, Mingna; Yang, Zhen; He, Yanan; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China; [Chen, Xiaoping; Liang, Xuanqiang] Guangdong Acad Agr Sci, Crops Res Inst, Guangzhou, Guangdong, Peoples R China; [Wang, Jinyan] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China	Guangdong Academy of Agricultural Sciences; Nanjing Agricultural University	Chi, XY (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	yshanlin1956@163.com			China Agriculture Research System [CARS-14]; National Natural Science Foundation of China [31000728, 31100205]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Qingdao Municipal Science and Technology Plan Project [11-2-4-9-(3)-jch, 11-2-3-26-nsh]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shangdong Province; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from the China Agriculture Research System (CARS-14), the National Natural Science Foundation of China (31000728; 31100205), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), Qingdao Municipal Science and Technology Plan Project (11-2-4-9-(3)-jch; 11-2-3-26-nsh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Byrne ME, 2006, PLOS GENET, V2, P785, DOI 10.1371/journal.pgen.0020089; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2008, CURR TOP MICROBIOL, V320, P117; Chen ZB, 2010, PLANT MOL BIOL REP, V28, P542, DOI 10.1007/s11105-010-0181-5; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Constabel CP, 2000, PLANT PHYSIOL, V124, P285, DOI 10.1104/pp.124.1.285; DAI X, 2011, NUCLEIC ACIDS RES, P1; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; MOORE KM, 1989, J HERED, V80, P252, DOI 10.1093/oxfordjournals.jhered.a110845; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; VAUGHN KC, 1988, PHYSIOL PLANTARUM, V72, P659, DOI 10.1111/j.1399-3054.1988.tb09180.x; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang FX, 2009, J PLANT BIOL, V52, P475, DOI 10.1007/s12374-009-9061-7; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yin ZJ, 2010, GENET MOL RES, V9, P1186, DOI 10.4238/vol9-2gmr805; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	106	109	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27530	10.1371/journal.pone.0027530	http://dx.doi.org/10.1371/journal.pone.0027530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110666	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400053
J	de Carvalho, F; Costa, ET; Camargo, AA; Gregorio, JC; Masotti, C; Andrade, VCC; Strauss, BE; Caballero, OL; Atanackovic, D; Colleoni, GWB				de Carvalho, Fabricio; Costa, Erico T.; Camargo, Anamaria A.; Gregorio, Juliana C.; Masotti, Cibele; Andrade, Valeria C. C.; Strauss, Bryan E.; Caballero, Otavia L.; Atanackovic, Djordje; Colleoni, Gisele W. B.			Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines	PLOS ONE			English	Article							CANCER/TESTIS ANTIGENS; BREAST-CANCER; CT7 MAGE-C1; APOPTOSIS; GENES; IDENTIFICATION; IMMUNOGLOBULIN; SUPPRESSION; RESISTANCE; SURVIVAL	The MAGE-C1/CT7 encodes a cancer/testis antigen (CTA), is located on the chromosomal region Xq26-27 and is highly polymorphic in humans. MAGE-C1/CT7 is frequently expressed in multiple myeloma (MM) that may be a potential target for immunotherapy in this still incurable disease. MAGEC1/CT7 expression is restricted to malignant plasma cells and it has been suggested that MAGE-C1/CT7 might play a pathogenic role in MM; however, the exact function this protein in the pathophysiology of MM is not yet understood. Our objectives were (1) to clarify the role of MAGE-C1/CT7 in the control of cellular proliferation and cell cycle in myeloma and (2) to evaluate the impact of silencing MAGE-C1/CT7 on myeloma cells treated with bortezomib. Myeloma cell line SKO-007 was transduced for stable expression of shRNA-MAGE-C1/CT7. Downregulation of MAGE-C1/CT7 was confirmed by real time quantitative PCR and western blot. Functional assays included cell proliferation, cell invasion, cell cycle analysis and apoptosis. Western blot showed a 70-80% decrease in MAGE-C1/CT7 protein expression in inhibited cells (shRNA-MAGE-C1/CT7) when compared with controls. Functional assays did not indicate a difference in cell proliferation and DNA synthesis when inhibited cells were compared with controls. However, we found a decreased percentage of cells in the G2/M phase of the cell cycle among inhibited cells, but not in the controls (p < 0.05). When myeloma cells were treated with bortezomib, we observed a 48% reduction of cells in the G2/M phase among inhibited cells while controls showed 13% (empty vector) and 9% (ineffective shRNA) reduction, respectively (p < 0.01). Furthermore, inhibited cells treated with bortezomib showed an increased percentage of apoptotic cells (Annexin V+/PI-) in comparison with bortezomib-treated controls (p < 0.001). We found that MAGE-C1/CT7 protects SKO-007 cells against bortezomib-induced apoptosis. Therefore, we could speculate that MAGE-C1/CT7 gene therapy could be a strategy for future therapies in MM, in particular in combination with proteasome inhibitors.	[de Carvalho, Fabricio; Andrade, Valeria C. C.; Colleoni, Gisele W. B.] Univ Fed Sao Paulo, Disciplina Hematol & Hemoterapia, Sao Paulo, Brazil; [Costa, Erico T.; Camargo, Anamaria A.; Masotti, Cibele] Ludwig Inst Canc Res, Lab Mol Biol & Genom, Sao Paulo, Brazil; [Gregorio, Juliana C.] Recepta Biopharma, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Strauss, Bryan E.] InCor, Fac Med, Setor Vetores Virais, Lab Genet & Cardiol Mol, Sao Paulo, Brazil; [Caballero, Otavia L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ludwig Collaborat Grp, Baltimore, MD 21205 USA; [Atanackovic, Djordje] Univ Med Ctr Hamburg Eppendorf, Dept Med 2, Hamburg, Germany	Universidade Federal de Sao Paulo (UNIFESP); Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; Universidade de Sao Paulo; Johns Hopkins University; University of Hamburg; University Medical Center Hamburg-Eppendorf	de Carvalho, F (corresponding author), Univ Fed Sao Paulo, Disciplina Hematol & Hemoterapia, Sao Paulo, Brazil.	fcarvalho@unifesp.br	Costa, Erico/D-5750-2014; Masotti, Cibele/D-8237-2017; Camargo, Anamaria A/E-9388-2012; Colleoni, Gisele W. B./F-9185-2014; Masotti, Cibele/AAG-2454-2020; Strauss, Bryan/AAO-6653-2021; Strauss, Bryan E./L-5070-2016	Masotti, Cibele/0000-0003-4462-0941; Camargo, Anamaria A/0000-0002-6076-9597; Colleoni, Gisele W. B./0000-0002-7144-4878; Masotti, Cibele/0000-0003-4462-0941; Strauss, Bryan/0000-0002-4113-9450; Strauss, Bryan E./0000-0002-4113-9450	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; CNPq; Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, Sao Paulo Branch, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, Sao Paulo Branch, Brazil	FC was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br), Brazil. This work was supported by grants from CNPq and the Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, Sao Paulo Branch, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2610; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Bajgelman MC, 2003, J BIOTECHNOL, V103, P97, DOI 10.1016/S0168-1656(03)00103-2; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Caballero OL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012773; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Cho Hearn J, 2006, Cancer Immun, V6, P12; Condomines M, 2007, J IMMUNOL, V178, P3307, DOI 10.4049/jimmunol.178.5.3307; Costa FF, 2007, STEM CELLS, V25, P707, DOI 10.1634/stemcells.2006-0469; Costanzi-Strauss E, 1998, EXP CELL RES, V238, P51, DOI 10.1006/excr.1997.3810; Curioni-Fontecedro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021418; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; ETON O, 1989, LEUKEMIA, V3, P729; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Holt RU, 2005, HAEMATOLOGICA, V90, P479; Huff CA, 2005, BLOOD, V106, P5, DOI 10.1182/blood-2005-04-1477; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kruger S, 2007, PATHOL ONCOL RES, V13, P91; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Lendvai Nikoletta, 2010, Cancer Immun, V10, P4; Leonard JP, 2006, INT J CANCER, V119, P971, DOI 10.1002/ijc.21805; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Lucas S, 1998, CANCER RES, V58, P743; Ludwig H, 2005, ANN ONCOL, V16, P106, DOI 10.1093/annonc/mdi717; Ludwig H, 2010, ONCOLOGIST, V15, P6, DOI 10.1634/theoncologist.2009-0203; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; Nadav L, 2006, CANCER RES, V66, P8608, DOI 10.1158/0008-5472.CAN-06-1301; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; OLSSON L, 1980, P NATL ACAD SCI-BIOL, V77, P5429, DOI 10.1073/pnas.77.9.5429; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Richardson PG, 2007, ONCOLOGIST, V12, P664, DOI 10.1634/theoncologist.12-6-664; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Song Lun, 2002, Cancer Cell Int, V2, P9, DOI 10.1186/1475-2867-2-9; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Strait KA, 2002, MOL CANCER THER, V1, P1181; Suzuki T, 2007, ONCOL REP, V18, P329; Tamura D, 2010, CANCER SCI, V101, P1403, DOI 10.1111/j.1349-7006.2010.01544.x; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; White D J, 2007, Curr Oncol, V14, P61, DOI 10.3747/co.2007.107; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548	53	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27707	10.1371/journal.pone.0027707	http://dx.doi.org/10.1371/journal.pone.0027707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110734	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400091
J	Kuster, A; Tea, I; Ferchaud-Roucher, V; Le Borgne, S; Plouzennec, C; Winer, N; Roze, JC; Robins, RJ; Darmaun, D				Kuester, Alice; Tea, Illa; Ferchaud-Roucher, Veronique; Le Borgne, Sabrina; Plouzennec, Claire; Winer, Norbert; Roze, Jean-Christophe; Robins, Richard J.; Darmaun, Dominique			Cord Blood Glutathione Depletion in Preterm Infants: Correlation with Maternal Cysteine Depletion	PLOS ONE			English	Article							HUMAN-FETAL LIVER; CHROMATOGRAPHY-MASS SPECTROMETRY; ERYTHROCYTE GLUTATHIONE; PREMATURE-INFANTS; AMINO-ACIDS; OXIDATIVE STRESS; ENZYME-ACTIVITIES; NORMAL-PREGNANCY; SYNTHESIS RATES; REDOX RATIO	Background: Depletion of blood glutathione (GSH), a key antioxidant, is known to occur in preterm infants. Objective: Our aim was to determine: 1) whether GSH depletion is present at the time of birth; and 2) whether it is associated with insufficient availability of cysteine (cys), the limiting GSH precursor, or a decreased capacity to synthesize GSH. Methodology: Sixteen mothers delivering very low birth weight infants (VLBW), and 16 mothers delivering healthy, full term neonates were enrolled. Immediately after birth, erythrocytes from umbilical vein, umbilical artery, and maternal blood were obtained to assess GSH [GSH] and cysteine [cys] concentrations, and the GSH synthesis rate was determined from the incorporation of labeled cysteine into GSH in isolated erythrocytes ex vivo, measured using gas chromatography mass spectrometry. Principal Findings: Compared with mothers delivering at full term, mothers delivering prematurely had markedly lower erythrocyte [GSH] and [cys] and these were significantly depressed in VLBW infants, compared with term neonates. A strong correlation was found between maternal and fetal GSH and cysteine levels. The capacity to synthesize GSH was as high in VLBW as in term infants. Conclusion: The current data demonstrate that: 1) GSH depletion is present at the time of birth in VLBW infants; 2) As VLBW neonates possess a fully active capacity to synthesize glutathione, the depletion may arise from inadequate cysteine availability, potentially due to maternal depletion. Further studies would be needed to determine whether maternal-fetal cysteine transfer is decreased in preterm infants, and, if so, whether cysteine supplementation of mothers at risk of delivering prematurely would strengthen antioxidant defense in preterm neonates.	[Kuester, Alice; Winer, Norbert; Roze, Jean-Christophe; Darmaun, Dominique] Univ Nantes, INRA, UMR Physiol Adaptat Nutr, Nantes, France; [Kuester, Alice; Roze, Jean-Christophe] CHU Nantes, Div Neonatol, F-44035 Nantes 01, France; [Kuester, Alice; Winer, Norbert; Roze, Jean-Christophe] Ctr Invest Clin, INSERM, Nantes, France; [Tea, Illa; Le Borgne, Sabrina; Plouzennec, Claire; Robins, Richard J.] Univ Nantes, CNRS, CEISAM, UMR 6230, Nantes, France; [Winer, Norbert] CHU Nantes, Div Obstet, F-44035 Nantes 01, France; [Ferchaud-Roucher, Veronique] CRNH, Mass Spectrometry Core Facil, Nantes, France; [Darmaun, Dominique] Nemours Childrens Clin, Res Lab, Jacksonville, FL USA	INRAE; Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; Nantes Universite; CHU de Nantes	Kuster, A (corresponding author), Univ Nantes, INRA, UMR Physiol Adaptat Nutr, Nantes, France.	ddarmaun@chu-nantes.fr	Rozé, Jean-Christophe/AAS-1314-2021; Darmaun, Dominique/X-8453-2018; roze, jean christophe/B-5433-2012	Darmaun, Dominique/0000-0002-0366-3227; Roze, Jean-Christophe/0000-0003-3367-512X; FERCHAUD-ROUCHER, Veronique/0000-0001-6809-1488; Robins, Richard/0000-0002-5325-8983	Delegation a la Recherche Clinique of the University Hospital of Nantes	Delegation a la Recherche Clinique of the University Hospital of Nantes	The study was investigator-initiated and funded by the Delegation a la Recherche Clinique of the University Hospital of Nantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola T, 2004, SCAND J CLIN LAB INV, V64, P649, DOI 10.1080/00365510410002959; Ahola T, 2004, PEDIATR RES, V56, P88, DOI 10.1203/01.PDR.0000130478.05324.9D; Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Badaloo A, 2002, AM J CLIN NUTR, V76, P646, DOI 10.1093/ajcn/76.3.646; Battaglia FC, 2000, J NUTR, V130, p974S, DOI 10.1093/jn/130.4.974S; Boda D, 1998, BIOL NEONATE, V74, P281, DOI 10.1159/000014035; Braake FWJT, 2009, PEDIATRICS, V124, pE978, DOI 10.1542/peds.2008-2477; Braake FWJT, 2005, J PEDIATR-US, V147, P457, DOI 10.1016/j.jpeds.2005.05.038; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cetin I, 1996, AM J OBSTET GYNECOL, V174, P1575, DOI 10.1016/S0002-9378(96)70609-9; Chung M, 1998, AM J PHYSIOL-ENDOC M, V274, pE13, DOI 10.1152/ajpendo.1998.274.1.E13; CORRALES F, 1991, HEPATOLOGY, V14, P528, DOI 10.1002/hep.1840140320; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Frosali S, 2004, BIOL NEONATE, V85, P188, DOI 10.1159/000075814; GAULL G, 1972, PEDIATR RES, V6, P538, DOI 10.1203/00006450-197206000-00002; Gitto E, 2002, BIOL NEONATE, V81, P146, DOI 10.1159/000051527; Giustarini D, 2008, BLOOD CELL MOL DIS, V40, P174, DOI 10.1016/j.bcmd.2007.09.001; Grillo MA, 2008, AMINO ACIDS, V34, P517, DOI 10.1007/s00726-007-0006-5; HEINONEN K, 1974, BIOCHEM J, V144, P607, DOI 10.1042/bj1440607; Hiesmayr M, 2009, CLIN NUTR, V28, P484, DOI 10.1016/j.clnu.2009.05.013; Humbert B, 2001, J MASS SPECTROM, V36, P726, DOI 10.1002/jms.185; Jackson AA, 2004, AM J CLIN NUTR, V80, P101; Jackson AA, 1997, ARCH DIS CHILD-FETAL, V76, pF152, DOI 10.1136/fn.76.3.F152; Jahoor F, 1999, AM J PHYSIOL-ENDOC M, V276, pE205, DOI 10.1152/ajpendo.1999.276.1.E205; JAIN A, 1995, PEDIATR PULM, V20, P160, DOI 10.1002/ppul.1950200306; Jean-Baptiste D, 2003, BIOL NEONATE, V84, P142, DOI 10.1159/000071948; Kuster A, 2008, ANAL BIOANAL CHEM, V390, P1403, DOI 10.1007/s00216-007-1799-5; Lavoie JC, 1998, FREE RADICAL BIO MED, V24, P994, DOI 10.1016/S0891-5849(97)00384-5; Lavoie JC, 1997, FREE RADICAL BIO MED, V23, P648, DOI 10.1016/S0891-5849(97)00011-7; LESTAS AN, 1984, BRIT J HAEMATOL, V57, P695, DOI 10.1111/j.1365-2141.1984.tb02947.x; Levonen AL, 2000, BIOCHEM J, V347, P291, DOI 10.1042/0264-6021:3470291; Levonen AL, 2000, PEDIATR RES, V47, P266, DOI 10.1203/00006450-200002000-00019; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Moison RMW, 1997, ACTA PAEDIATR, V86, P1363, DOI 10.1111/j.1651-2227.1997.tb14914.x; NEMETH I, 1994, FREE RADICAL BIO MED, V16, P347, DOI 10.1016/0891-5849(94)90036-1; Raijmakers MTM, 2008, EUR J OBSTET GYN R B, V138, P39, DOI 10.1016/j.ejogrb.2007.08.005; Raijmakers MTM, 2001, OBSTET GYNECOL, V97, P272, DOI 10.1016/S0029-7844(00)01127-3; Raijmakers MTM, 2001, CLIN CHEM, V47, P749; Redman C W, 2001, Gynecol Obstet Fertil, V29, P518, DOI 10.1016/S1297-9589(01)00180-1; Riedijk MA, 2007, AM J CLIN NUTR, V86, P1120, DOI 10.1093/ajcn/86.4.1120; ROLLINS D, 1981, J PHARMACOL EXP THER, V217, P697; Rook D, 2010, PEDIATR RES, V67, P407, DOI 10.1203/PDR.0b013e3181d22cf6; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SAUGSTAD OD, 1998, SEMIN NEONATOL, V3, P129; Shew SB, 2005, J PEDIATR SURG, V40, P52, DOI 10.1016/j.jpedsurg.2004.09.011; SMITH CV, 1993, PEDIATR RES, V34, P360, DOI 10.1203/00006450-199309000-00024; SOGHIER LM, 2006, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858.CD004869.PUB2; Stabler SP, 2000, AM J CLIN NUTR, V72, P1548; STIPANUK MH, 1992, J NUTR, V122, P420, DOI 10.1093/jn/122.3.420; STURMAN JA, 1970, SCIENCE, V169, P74, DOI 10.1126/science.169.3940.74; te Braake FWJ, 2008, AM J CLIN NUTR, V88, P333, DOI 10.1093/ajcn/88.2.333; Tea I, 2007, RAPID COMMUN MASS SP, V21, P3245, DOI 10.1002/rcm.3197; Thibeault DW, 2000, AM J PERINAT, V17, P167, DOI 10.1055/s-2000-9422; Thomas B, 2008, PEDIATR RES, V64, P381, DOI 10.1203/PDR.0b013e318180e499; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; VANGOUDOEVER JB, 1995, J PEDIATR-US, V127, P458, DOI 10.1016/S0022-3476(95)70083-8; Vento M, 2009, ANTIOXID REDOX SIGN, V11, P2945, DOI 10.1089/ars.2009.2671; VINA J, 1995, AM J CLIN NUTR, V61, P1067, DOI 10.1093/ajcn/61.5.1067; Viskova H, 2007, FETAL DIAGN THER, V22, P254, DOI 10.1159/000100785; Woods JR, 2001, PLACENTA, V22, pS38, DOI 10.1053/plac.2001.0638; YOUNG VR, 1989, AM J CLIN NUTR, V50, P80, DOI 10.1093/ajcn/50.1.80; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	62	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27626	10.1371/journal.pone.0027626	http://dx.doi.org/10.1371/journal.pone.0027626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110699	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400075
J	Takeda, E; Murakami, T; Matsuda, G; Murakami, H; Zako, T; Maeda, M; Aida, Y				Takeda, Eri; Murakami, Tomoyuki; Matsuda, Go; Murakami, Hironobu; Zako, Tamotsu; Maeda, Mizuo; Aida, Yoko			Nuclear Exportin Receptor CAS Regulates the NPI-1-Mediated Nuclear Import of HIV-1 Vpr	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL PROTEIN R; PRE-MESSENGER-RNA; CELL-CYCLE ARREST; LOCALIZATION SIGNAL; G(2) ARREST; NUCLEOCYTOPLASMIC TRANSPORT; PREINTEGRATION COMPLEX; PORE COMPLEX; ALPHA FAMILY	Vpr, an accessory protein of human immunodeficiency virus type 1, is a multifunctional protein that plays an important role in viral replication. We have previously shown that the region between residues 17 and 74 of Vpr (Vpr(N17C74)) contained a bona fide nuclear localization signal and it is targeted Vpr(N17C74) to the nuclear envelope and then imported into the nucleus by importin alpha (Imp alpha) alone. The interaction between Imp alpha and Vpr is important not only for the nuclear import of Vpr but also for HIV-1 replication in macrophages; however, it was unclear whether full-length Vpr enters the nucleus in a manner similar to Vpr(N17C74). This study investigated the nuclear import of full-length Vpr using the three typical Imp alpha isoforms, Rch1, Qip1 and NPI-1, and revealed that full-length Vpr is selectively imported by NPI-1, but not Rch1 and Qip1, after it makes contact with the perinuclear region in digitonin-permeabilized cells. A binding assay using the three Imp alpha isoforms showed that Vpr bound preferentially to the ninth armadillo repeat (ARM) region (which is also essential for the binding of CAS, the export receptor for Imp alpha) in all three isoforms. Comparison of biochemical binding affinities between Vpr and the Imp alpha isoforms using surface plasmon resonance analysis demonstrated almost identical values for the binding of Vpr to the full-length isoforms and to their C-terminal domains. By contrast, the data showed that, in the presence of CAS, Vpr was released from the Vpr/NPI-1 complex but was not released from Rch1 or Qip1. Finally, the NPI-1-mediated nuclear import of Vpr was greatly reduced in semi-intact CAS knocked-down cells and was recovered by the addition of exogenous CAS. This report is the first to show the requirement for and the regulation of CAS in the functioning of the Vpr-Imp alpha complex.	[Takeda, Eri; Murakami, Tomoyuki; Matsuda, Go; Murakami, Hironobu; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Murakami, Tomoyuki; Aida, Yoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Viral Infect Dis, Wako, Saitama, Japan; [Murakami, Hironobu] Japan Fdn AIDS Prevent, Chiyoda Ku, Tokyo, Japan; [Zako, Tamotsu; Maeda, Mizuo] RIKEN, Bioengn Lab, Wako, Saitama, Japan	RIKEN; University of Tokyo; RIKEN	Takeda, E (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp	Murakami, Hironobu/O-3452-2017; Zako, Tamotsu/C-3004-2012; Maeda, Mizuo/I-3498-2014	Murakami, Hironobu/0000-0002-7560-4445; 	Ministry of Health, Labor and Welfare of Japan; National Institute of Biomedical Innovation (NIBIO) of Japan [06-01]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was supported by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS: http://www.jhsf.or.jp/English/index_e.html) and by the program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (ID 06-01: http://www.nibio.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Aida Y, 2009, CURR HIV RES, V7, P136, DOI 10.2174/157016209787581418; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO;2-3; Bukrinsky MI, 1998, MOL MED, V4, P138, DOI 10.1007/BF03401911; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Emerman M, 1996, CURR BIOL, V6, P1096, DOI 10.1016/S0960-9822(02)00676-0; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goodwin DJ, 2001, J BIOL CHEM, V276, P19905, DOI 10.1074/jbc.M009513200; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; HAGIWARA K, 2010, BIOCH BIOPHYS RES CO; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Herbein G, 2010, RETROVIROLOGY, V7, P33; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kamata M, 2000, J VIROL, V74, P7179, DOI 10.1128/JVI.74.15.7179-7186.2000; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Kitayama H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Kuramitsu M, 2005, MICROBES INFECT, V7, P1150, DOI 10.1016/j.micinf.2005.03.022; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Nishino Y, 1997, BIOCHEM BIOPH RES CO, V232, P550, DOI 10.1006/bbrc.1997.6186; Nishizawa M, 1999, VIROLOGY, V263, P313, DOI 10.1006/viro.1999.9905; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Roshal M, 2001, APOPTOSIS, V6, P103, DOI 10.1023/A:1009636530839; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Suzuki T, 2009, BIOCHEM BIOPH RES CO, V380, P838, DOI 10.1016/j.bbrc.2009.01.180; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zhou Y, 1998, VIROLOGY, V242, P414, DOI 10.1006/viro.1998.9028	52	14	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27815	10.1371/journal.pone.0027815	http://dx.doi.org/10.1371/journal.pone.0027815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110766	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400119
J	Schumacher, JA; Hashiguchi, M; Nguyen, VH; Mullins, MC				Schumacher, Jennifer A.; Hashiguchi, Megumi; Nguyen, Vu H.; Mullins, Mary C.			An Intermediate Level of BMP Signaling Directly Specifies Cranial Neural Crest Progenitor Cells in Zebrafish	PLOS ONE			English	Article							INDUCTION; XENOPUS; GRADIENT; WNT; EXPRESSION; RECEPTOR; GENES; SPECIFICATION; BMP2B/SWIRL; INHIBITION	The specification of the neural crest progenitor cell (NCPC) population in the early vertebrate embryo requires an elaborate network of signaling pathways, one of which is the Bone Morphogenetic Protein (BMP) pathway. Based on alterations in neural crest gene expression in zebrafish BMP pathway component mutants, we previously proposed a model in which the gastrula BMP morphogen gradient establishes an intermediate level of BMP activity establishing the future NCPC domain. Here, we tested this model and show that an intermediate level of BMP signaling acts directly to specify the NCPC. We quantified the effects of reducing BMP signaling on the number of neural crest cells and show that neural crest cells are significantly increased when BMP signaling is reduced and that this increase is not due to an increase in cell proliferation. In contrast, when BMP signaling is eliminated, NCPC fail to be specified. We modulated BMP signaling levels in BMP pathway mutants with expanded or no NCPCs to demonstrate that an intermediate level of BMP signaling specifies the NCPC. We further investigated the ability of Smad5 to act in a graded fashion by injecting smad5 antisense morpholinos and show that increasing doses first expand the NCPCs and then cause a loss of NCPCs, consistent with Smad5 acting directly in neural crest progenitor specification. Using Western blot analysis, we show that P-Smad5 levels are dose-dependently reduced in smad5 morphants, consistent with an intermediate level of BMP signaling acting through Smad5 to specify the neural crest progenitors. Finally, we performed chimeric analysis to demonstrate for the first time that BMP signal reception is required directly by NCPCs for their specification. Together these results add substantial evidence to a model in which graded BMP signaling acts as a morphogen to pattern the ectoderm, with an intermediate level acting in neural crest specification.	[Schumacher, Jennifer A.; Hashiguchi, Megumi; Nguyen, Vu H.; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Schumacher, JA (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH USA.	mullins@mail.med.upenn.edu			National Institutes of Health (NIH) [GM56326, T32 HD0075165, T32 GM07229-28]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, R56GM056326, R01GM056326] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an National Institutes of Health (NIH) grant to MCM (GM56326), NIH training grants (T32 HD0075165 and T32 GM07229-28) to JAS, and an NIH predoctoral fellowship to VHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth KA, 1999, DEVELOPMENT, V126, P4977; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; ESSEX LJ, 1993, DEV DYNAM, V198, P108, DOI 10.1002/aja.1001980205; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Grinblat Y, 1998, DEVELOPMENT, V125, P4403; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li W, 2007, DEV BIOL, V304, P338, DOI 10.1016/j.ydbio.2006.12.042; Liedtke D, 2008, DEV DYNAM, V237, P62, DOI 10.1002/dvdy.21384; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; MAYOR R, 1995, DEVELOPMENT, V121, P767; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Mintzer KA, 2001, DEVELOPMENT, V128, P859; MOURY JD, 1990, DEV BIOL, V141, P243, DOI 10.1016/0012-1606(90)90380-2; Mullins MC, 1996, DEVELOPMENT, V123, P81; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Sasai N, 2001, DEVELOPMENT, V128, P2525; Schmid B, 2000, DEVELOPMENT, V127, P957; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Steventon B, 2009, DEVELOPMENT, V136, P771, DOI 10.1242/dev.029017; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; Takahashi T, 1997, J BIOL CHEM, V272, P22667, DOI 10.1074/jbc.272.36.22667; THISSE C, 1995, DEV BIOL, V172, P86, DOI 10.1006/dbio.1995.0007; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Villanueva S, 2002, DEV BIOL, V241, P289, DOI 10.1006/dbio.2001.0485; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; WOO K, 1995, DEVELOPMENT, V121, P2595; Woo K, 1998, DEV BIOL, V197, P283, DOI 10.1006/dbio.1998.8870; Wu JL, 2005, DEV BIOL, V279, P220, DOI 10.1016/j.ydbio.2004.12.016; Ye L, 2011, FRONT BIOSCI-LANDMRK, V16, P865, DOI 10.2741/3725	47	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27403	10.1371/journal.pone.0027403	http://dx.doi.org/10.1371/journal.pone.0027403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102893	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300019
J	Fisman, DN; Tuite, AR				Fisman, David N.; Tuite, Ashleigh R.			Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canada	PLOS ONE			English	Article							MF59-ADJUVANTED VACCINE; YOUNG-CHILDREN; MF59 ADJUVANT; UNITED-STATES; MORTALITY; TRIAL; IMMUNOGENICITY; IMMUNIZATION; POPULATION; NARCOLEPSY	Introduction: The propensity for influenza viruses to mutate and recombine makes them both a familiar threat and a prototype emerging infectious disease. Emerging evidence suggests that the use of MF59-adjuvanted vaccines in older adults and young children enhances protection against influenza infection and reduces adverse influenza-attributable outcomes compared to unadjuvanted vaccines. The health and economic impact of such vaccines in the Canadian population are uncertain. Methods: We constructed an age-structured compartmental model simulating the transmission of influenza in the Canadian population over a ten-year period. We compared projected health outcomes (quality-adjusted life years (QALY) lost), costs, and incremental cost-effectiveness ratios (ICERs) for three strategies: (i) current use of unadjuvanted trivalent influenza vaccine; (ii) use of MF59-adjuvanted influenza vaccine adults >= 65 in the Canadian population, and (iii) adjuvanted vaccine used in both older adults and children aged < 6. Results: In the base case analysis, use of adjuvanted vaccine in older adults was highly cost-effective (ICER = $2111/QALY gained), but such a program was "dominated" by a program that extended the use of adjuvanted vaccine to include young children (ICER = $1612/QALY). Results were similar whether or not a universal influenza immunization program was used in other age groups; projections were robust in the face of wide-ranging sensitivity analyses. Interpretation: Based on the best available data, it is projected that replacement of traditional trivalent influenza vaccines with MF59-adjuvanted vaccines would confer substantial benefits to vaccinated and unvaccinated individuals, and would be economically attractive relative to other widely-used preventive interventions.	[Fisman, David N.; Tuite, Ashleigh R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	University of Toronto	Fisman, DN (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	david.fisman@utoronto.ca			Novartis	Novartis(Novartis)	This research was supported by Novartis, which manufactures an adjuvanted influenza vaccine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019; Beyer WEP, 2011, VACCINE, V29, P5785, DOI 10.1016/j.vaccine.2011.05.040; Black S, 2010, VACCINE, V28, P7331, DOI 10.1016/j.vaccine.2010.08.075; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Heinonen S, 2011, LANCET INFECT DIS, V11, P23, DOI 10.1016/S1473-3099(10)70255-3; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2007, ARCH INTERN MED, V167, P1553, DOI 10.1001/archinte.167.14.1553-b; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Mannino S, 2010, AM J EPIDEMIOL, V171, pS157; Montastruc JL, 2011, VACCINE, V29, P2010, DOI 10.1016/j.vaccine.2010.12.092; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; O'Hagan DT, 2011, EXPERT REV VACCINES, V10, P447, DOI [10.1586/erv.11.23, 10.1586/ERV.11.23]; O'Reilly FW, 2002, OCCUP MED-OXFORD, V52, P265, DOI 10.1093/occmed/52.5.265; Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0; Postma MJ, 2002, DRUGS, V62, P1013, DOI 10.2165/00003495-200262070-00003; Praditsuwan Rungnirand, 2005, Journal of the Medical Association of Thailand, V88, P256; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Statistics Canada, 2007, AG SEX HIGHL TABL 20; Statistics Canada, 2006, COMPL LIF TABL CAN 2; Tsai TF, 2011, SCAND J INFECT DIS, V43, P702, DOI 10.3109/00365548.2011.580777; TUITE A, 2009, PLOS CURR INFLUENZA; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010520; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; VESIKARI T, 2010, INF DIS SOC AM 48 AN; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; World Health Organization, 2019, CHOOSING INT AR COST; Zarocostas J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d909	47	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27420	10.1371/journal.pone.0027420	http://dx.doi.org/10.1371/journal.pone.0027420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110645	gold, Green Published, Green Submitted			2022-12-25	WOS:000297554300030
J	Khan, O; Headley, M; Gerard, A; Wei, W; Liu, LM; Krummel, MF				Khan, Omar; Headley, Mark; Gerard, Audrey; Wei, Wei; Liu, Limin; Krummel, Matthew F.			Regulation of T Cell Priming by Lymphoid Stroma	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FIBROBLASTIC RETICULAR CELLS; DENDRITIC CELLS; BACTERIAL-INFECTION; IMMUNE-RESPONSES; IN-VIVO; NODES; IMMUNOSUPPRESSION; PROLIFERATION; CHEMOKINES	The priming of immune T cells by their interaction with dendritic cells (DCs) in lymph nodes (LN), one of the early events in productive adaptive immune responses, occurs on a scaffold of lymphoid stromal cells, which have largely been seen as support cells or sources of chemokines and homeostatic growth factors. Here we show that murine fibroblastic reticular cells (FRCs), isolated from LN of B6 mice, play a more direct role in the immune response by sensing and modulating T cell activation through their upregulation of inducible nitric oxide synthase (iNOS) in response to early T cell IFN gamma production. Stromal iNOS, which only functions in very close proximity, attenuates responses to inflammatory DC immunization but not to other priming regimens and preferentially affects Th1 cells rather than Th2. The resultant nitric oxide production does not affect T cell-DC coupling or initial calcium signaling, but restricts homotypic T cell clustering, cell cycle progression, and proliferation. Stromal feedback inhibition thus provides basal attenuation of T cell responses, particularly those characterized by strong local inflammatory cues.	[Khan, Omar; Headley, Mark; Gerard, Audrey; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Wei, Wei; Liu, Limin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Khan, O (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	matthew.krummel@ucsf.edu		Headley, Mark/0000-0002-0924-9326; Khan, Omar/0000-0002-7641-6163	NIH [R01 CA134622-01A1]; Foundation Rothshild;  [CA122359]; NATIONAL CANCER INSTITUTE [R01CA122359, U01CA141451, R01CA134622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Rothshild; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 CA134622-01A1 (MFK), The Foundation Rothshild (MFK), and CA122359(LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1991, J IMMUNOL, V147, P144; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beuneu H, 2010, IMMUNITY, V33, P412, DOI 10.1016/j.immuni.2010.08.016; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Winkel KD, 1997, EUR J IMMUNOL, V27, P3350, DOI 10.1002/eji.1830271234	28	71	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e26138	10.1371/journal.pone.0026138	http://dx.doi.org/10.1371/journal.pone.0026138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110583	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300004
J	Steiner, C; Othman, A; Saely, CH; Rein, P; Drexel, H; von Eckardstein, A; Rentsch, KM				Steiner, Carine; Othman, Alaa; Saely, Christoph H.; Rein, Philipp; Drexel, Heinz; von Eckardstein, Arnold; Rentsch, Katharina M.			Bile Acid Metabolites in Serum: Intraindividual Variation and Associations with Coronary Heart Disease, Metabolic Syndrome and Diabetes Mellitus	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; LOW-DENSITY LIPOPROTEIN; NUCLEAR RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE; TRIGLYCERIDE LEVELS; DIURNAL-VARIATION; FASTING PLASMA; FXR; GLUCOSE; EXPRESSION	Bile acids (BAs) regulate glucose and lipid metabolism. In longitudinal and case-control-studies, we investigated the diurnal variation of serum concentrations of the 15 major BAs as well as the biosynthetic precursor 7 alpha-hydroxy-4-cholesten-3-one (C4) and their associations, respectively, with coronary artery disease (CAD), diabetes mellitus type 2 (T2DM), and non-diabetic metabolic syndrome (MetS). In hourly taken blood samples of four healthy probands, the intraindividual 24 h variation of C4, conjugated and unconjugated BAs ranged from 42% to 72%, from 23% to 91%, and from 49% to 90%, respectively. Conjugated BA concentrations mainly increased following food intake. Serum levels of C4 and unconjugated BAs changed with daytime with maxima varying interindividually between 20h00 and 1h00 and between 3h00 and 8h00, respectively. Comparisons of data from 75 CAD patients with 75 CAD-free controls revealed no statistically significant association of CAD with BAs or C4. Comparisons of data from 50 controls free of T2DM or MetS, 50 MetS patients, and 50 T2DM patients revealed significantly increased fasting serum levels of C4 in patients with MetS and T2DM. Multiple regression analysis revealed body mass index (BMI) and plasma levels of triglycerides (TG) as independent determinants of C4 levels. Upon multivariate and principle component analyses the association of C4 with T2DM and/or MetS was not independent of or superior to the canonical MetS components. In conclusion, despite large intra- and interindividual variation, serum levels of C4,are significantly increased in patients with MetS and T2DM but confounded with BMI and TG.	[Steiner, Carine; Othman, Alaa; von Eckardstein, Arnold; Rentsch, Katharina M.] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Othman, Alaa; von Eckardstein, Arnold; Rentsch, Katharina M.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Steiner, Carine; Othman, Alaa; von Eckardstein, Arnold] Swiss Fed Inst Technol, Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland; [Saely, Christoph H.; Rein, Philipp; Drexel, Heinz] VIVIT, Feldkirch, Austria; [Saely, Christoph H.; Rein, Philipp; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Saely, Christoph H.; Rein, Philipp; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich; Drexel University	Steiner, C (corresponding author), Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland.	arnold.voneckardstein@usz.ch	Othman, Alaa/K-1388-2015; Othman, Alaa/H-1485-2011; Othman, Alaa/AAE-5897-2019	Othman, Alaa/0000-0002-0092-5594; Othman, Alaa/0000-0002-0092-5594	European Union [LSHBCT-2006-037631]	European Union(European Commission)	Funding was provided by the Specific Target Research Project (STREP) grant from the European Union, Sixth Framework Programme Priority [FP-2005-LIFESCIHEALTH-6], contract #LSHBCT-2006-037631. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2010, J BIOL CHEM, V285, P36759, DOI 10.1074/jbc.M110.166231; ABRAMS JJ, 1982, DIABETES, V31, P903, DOI 10.2337/diabetes.31.10.903; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSEN E, 1987, DIABETES RES CLIN PR, V3, P207, DOI 10.1016/S0168-8227(87)80041-4; ANGELIN B, 1977, GUT, V18, P606, DOI 10.1136/gut.18.8.606; ANGELIN B, 1987, P NATL ACAD SCI USA, V84, P5434, DOI 10.1073/pnas.84.15.5434; ANGELIN B, 1978, J LIPID RES, V19, P1017; Anisfeld AM, 2003, J BIOL CHEM, V278, P20420, DOI 10.1074/jbc.M302505200; BENNION LJ, 1977, NEW ENGL J MED, V296, P1365, DOI 10.1056/NEJM197706162962401; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Castro J, 2007, HEPATOLOGY, V45, P1261, DOI 10.1002/hep.21616; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; CROUSE JR, 1987, AM J MED, V83, P243, DOI 10.1016/0002-9343(87)90692-9; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; DUANE WC, 1983, J CLIN INVEST, V72, P1930, DOI 10.1172/JCI111157; ENGELKING LR, 1980, AM J CLIN PATHOL, V73, P196; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guo GL, 2006, BBA-MOL CELL BIOL L, V1761, P1401, DOI 10.1016/j.bbalip.2006.09.018; Hageman J, 2010, ARTERIOSCL THROM VAS, V30, P1519, DOI 10.1161/ATVBAHA.109.197897; Hanniman EA, 2005, J LIPID RES, V46, P2595, DOI 10.1194/jlr.M500390-JLR200; HASSAN AS, 1981, BIOCHEM MED METAB B, V25, P168, DOI 10.1016/0006-2944(81)90073-9; HASSAN AS, 1980, P SOC EXP BIOL MED, V164, P449; HEPNER GW, 1977, GASTROENTEROLOGY, V72, P499; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Kovar J, 2010, PHYSIOL RES, V59, P233, DOI 10.33549/physiolres.931753; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lin YG, 1996, BIOCHEM J, V316, P531, DOI 10.1042/bj3160531; Lin YG, 1996, HEPATOLOGY, V23, P218; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; POLS TW, 2010, J HEPATOL; POOLER PA, 1988, HEPATOLOGY, V8, P1140, DOI 10.1002/hep.1840080530; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Saely CH, 2008, CLIN CHIM ACTA, V397, P82, DOI 10.1016/j.cca.2008.07.024; Sauter G, 1996, HEPATOLOGY, V24, P123, DOI 10.1053/jhep.1996.v24.pm0008707250; SCHALM SW, 1978, GUT, V19, P1006, DOI 10.1136/gut.19.11.1006; SETCHELL KDR, 1982, GUT, V23, P637, DOI 10.1136/gut.23.8.637; SHEPHERD J, 1979, ATHEROSCLEROSIS, V33, P433, DOI 10.1016/0021-9150(79)90036-4; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sirvent A, 2004, FEBS LETT, V566, P173, DOI 10.1016/j.febslet.2004.04.026; Staels B, 2007, DRUGS, V67, P1383, DOI 10.2165/00003495-200767100-00001; Staels B, 2010, CURR DIABETES REP, V10, P70, DOI 10.1007/s11892-009-0087-5; Stayrook KR, 2005, ENDOCRINOLOGY, V146, P984, DOI 10.1210/en.2004-0965; Steiner C, 2010, J CHROMATOGR B, V878, P2870, DOI 10.1016/j.jchromb.2010.08.045; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; UCHIDA K, 1985, DIABETES, V34, P79, DOI 10.2337/diabetes.34.1.79; van Waarde WM, 2002, GASTROENTEROLOGY, V122, P1842, DOI 10.1053/gast.2002.33582; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zhang YQ, 2006, ARTERIOSCL THROM VAS, V26, P2316, DOI 10.1161/01.ATV.0000235697.35431.05; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	70	87	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e25006	10.1371/journal.pone.0025006	http://dx.doi.org/10.1371/journal.pone.0025006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110577	Green Published, Green Accepted, gold			2022-12-25	WOS:000297554300001
J	Arvidsson, L; Fagerlund, M; Jaff, N; Ossoinak, A; Jansson, K; Hagerstrand, A; Johansson, CB; Brundin, L; Svensson, M				Arvidsson, Lisa; Fagerlund, Michael; Jaff, Nasren; Ossoinak, Amina; Jansson, Katarina; Hagerstrand, Anders; Johansson, Clas B.; Brundin, Lou; Svensson, Mikael			Distribution and Characterization of Progenitor Cells within the Human Filum Terminale	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ADULT HUMAN BRAIN; SPINAL-CORD; DIFFERENTIATION; NEURONS; RAT; NEUROGENESIS; HIPPOCAMPUS; GENERATION	Background: Filum terminale (FT) is a structure that is intimately associated with conus medullaris, the most caudal part of the spinal cord. It is well documented that certain regions of the adult human central nervous system contains undifferentiated, progenitor cells or multipotent precursors. The primary objective of this study was to describe the distribution and progenitor features of this cell population in humans, and to confirm their ability to differentiate within the neuroectodermal lineage. Methodology/Principal Findings: We demonstrate that neural stem/progenitor cells are present in FT obtained from patients treated for tethered cord. When human or rat FT-derived cells were cultured in defined medium, they proliferated and formed neurospheres in 13 out of 21 individuals. Cells expressing Sox2 and Musashi-1 were found to outline the central canal, and also to be distributed in islets throughout the whole FT. Following plating, the cells developed antigen profiles characteristic of astrocytes (GFAP) and neurons (beta-III-tubulin). Addition of PDGF-BB directed the cells towards a neuronal fate. Moreover, the cells obtained from young donors shows higher capacity for proliferation and are easier to expand than cells derived from older donors. Conclusion/Significance: The identification of bona fide neural progenitor cells in FT suggests a possible role for progenitor cells in this extension of conus medullaris and may provide an additional source of such cells for possible therapeutic purposes. Filum terminale, human, progenitor cells, neuron, astrocytes, spinal cord.	[Arvidsson, Lisa; Fagerlund, Michael; Jaff, Nasren; Brundin, Lou; Svensson, Mikael] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Dept Neurosurg & Neurol, Stockholm, Sweden; [Ossoinak, Amina; Jansson, Katarina; Hagerstrand, Anders] NeuroNova, Stockholm, Sweden; [Johansson, Clas B.] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Arvidsson, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Dept Neurosurg & Neurol, Stockholm, Sweden.	lou.brundin@karolinska.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003; Brundin, Lou/0000-0003-4408-7817; Arvidsson, Lisa/0000-0003-2129-5357	Torsten and Ragnar Soderberg Foundation; Swedish medical research council; Karolinska Institutet	Torsten and Ragnar Soderberg Foundation; Swedish medical research council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet)	This work was supported by Torsten and Ragnar Soderberg Foundation(www.soderbergsstiftelser.se), the Swedish medical research council (www.vr.se) and Karolinska Institutet (www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ND, 2005, DEV BIOL, V279, P356, DOI 10.1016/j.ydbio.2004.12.026; Al-Omari MH, 2011, J MED IMAG RADIAT ON, V55, P286, DOI 10.1111/j.1754-9485.2011.02266.x; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chen J, 2006, NEUROSCIENCE, V140, P377, DOI 10.1016/j.neuroscience.2006.02.064; CHESLER M, 1985, J COMP NEUROL, V239, P431, DOI 10.1002/cne.902390409; CHOI BH, 1992, HUM PATHOL, V23, P916, DOI 10.1016/0046-8177(92)90405-R; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; Gomes FC, 2002, NEUROSURGERY, V51, P725, DOI 10.1227/01.NEU.0000023605.47661.EA; Hansasuta A, 1999, PEDIATR NEUROSURG, V30, P176, DOI 10.1159/000028790; Harmeier JW, 1933, ARCH NEURO PSYCHIATR, V29, P308, DOI 10.1001/archneurpsyc.1933.02240080098008; Iskandar B J, 2001, Neurosurg Focus, V10, pe7; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; KUNIMOTO K, 1918, CONTRIBUTIONS EMBRYO, P161; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Okano H, 2002, J CELL SCI, V115, P1355; Rethelyi M, 2004, BRAIN RES, V1028, P133, DOI 10.1016/j.brainres.2004.08.069; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; Shum ASW, 2010, DEV DYNAM, V239, P3192, DOI 10.1002/dvdy.22457; SONNELAND PRL, 1985, CANCER, V56, P883, DOI 10.1002/1097-0142(19850815)56:4<883::AID-CNCR2820560431>3.0.CO;2-6; STANDRING S, 2005, GRAYS ANATOMY, P775; Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1; Varghese M, 2009, STEM CELLS DEV, V18, P603, DOI 10.1089/scd.2008.0144; Weiss S, 1996, J NEUROSCI, V16, P7599; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4	36	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27393	10.1371/journal.pone.0027393	http://dx.doi.org/10.1371/journal.pone.0027393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096566	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900040
J	Segarra, TJ; Fakioglu, E; Cheshenko, N; Wilson, SS; Mesquita, PMM; Doncel, GF; Herold, BC				Segarra, Theodore J.; Fakioglu, Esra; Cheshenko, Natalia; Wilson, Sarah S.; Mesquita, Pedro M. M.; Doncel, Gustavo F.; Herold, Betsy C.			Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NONOXYNOL-9 VAGINAL GEL; DEFENSIN GENE-CLUSTER; CELLULOSE SULFATE GEL; FEMALE SEX WORKERS; HIV-INFECTION; IN-VITRO; PREVENTION; HERPES; TRANSMISSION	Background: Despite significant protection in preclinical studies, cellulose sulfate (CS) failed to protect women against HIV-1/2 and was associated with a trend toward increased HIV-1 acquisition in one of the clinical trials. These results highlight the need for preclinical tests more predictive of clinical outcomes. The objective of this study was to test coded vaginal gels, including CS, in murine models of safety and efficacy to determine the models' utility for evaluating future products. Methods: Four coded formulations, including 6% CS, 2% PRO 2000 and two placebo gels, were administered intravaginally to medroxyprogesterone-treated mice and their ability to prevent genital herpes (efficacy) or to alter the susceptibility to low dose HSV challenge (safety) was determined. Nonoyxnol-9 served as a positive toxicity control. Results: CS and PRO 2000 significantly protected mice from genital herpes following infection with a laboratory or clinical isolate of HSV-2 introduced in buffer (p<0.001). However, protection was reduced when virus was introduced in seminal plasma. Moreover, mice were significantly more susceptible to infection with low doses of HSV-2 when challenged 12 h after the 7th daily dose of CS or nonoxynol-9 (p<0.05). The increased susceptibility was associated with alterations in epithelial architecture. Conclusions: CS prevented genital herpes when present at the time of viral challenge, but increased the rate of infection when gel was applied daily for 7 days with a vaginal wash prior to viral inoculation. The findings presumably reflect altered epithelial architecture, which may have contributed to the trend towards increased HIV observed clinically.	[Segarra, Theodore J.; Fakioglu, Esra; Cheshenko, Natalia; Wilson, Sarah S.; Mesquita, Pedro M. M.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat & Microbiol Immunol, Bronx, NY 10467 USA; [Doncel, Gustavo F.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA	Yeshiva University; Albert Einstein College of Medicine; Eastern Virginia Medical School	Segarra, TJ (corresponding author), Albert Einstein Coll Med, Dept Pediat & Microbiol Immunol, Bronx, NY 10467 USA.	betsy.herold@einstein.yu.edu	Cheshenko, Natalia/ABF-5896-2021	Wilson, Sarah/0000-0002-0838-6847; Herold, Betsy/0000-0001-9974-0786; Mesquita, Pedro/0000-0002-6591-4896	CONRAD [GCR3-10-04]; National Institutes of Health (NIH) [AI079763, AI076980, AI-51519]; Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079763, R21AI079763, P30AI051519, U19AI076980] Funding Source: NIH RePORTER	CONRAD(United States Agency for International Development (USAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from CONRAD (www.conrad.org) (GCR3-10-04) and National Institutes of Health (AI079763 and AI076980) and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Anderson RA, 2004, CONTRACEPTION, V70, P415, DOI 10.1016/j.contraception.2004.05.014; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; CRITCHLOW CW, 1995, AM J OBSTET GYNECOL, V173, P534, DOI 10.1016/0002-9378(95)90279-1; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; FICHOROVA RNY, 2011, MBIO IN PRESS; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hendrickson BA, 2000, VIROLOGY, V271, P155, DOI 10.1006/viro.2000.0303; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; Herold BC, 2011, AM J REPROD IMMUNOL, V65, P325, DOI 10.1111/j.1600-0897.2010.00932.x; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Linehan MM, 2004, J VIROL, V78, P2530, DOI 10.1128/JVI.78.5.2530-2536.2004; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Mauck CK, 2004, CONTRACEPTION, V70, P233, DOI 10.1016/j.contraception.2004.04.010; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; MCCORMACK S, 2010, LANCET; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Patton DL, 2008, SEX TRANSM DIS, V35, P889, DOI 10.1097/OLQ.0b013e31817dfdb8; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Radhakrishnan Y, 2005, GENES IMMUN, V6, P203, DOI 10.1038/sj.gene.6364184; Radhakrishnan Y, 2007, PHYSIOL GENOMICS, V30, P213, DOI 10.1152/physiolgenomics.00263.2006; Saifuddin M, 2008, MICR 2008 NEW DELH I; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Van Damme L, 2000, AIDS, V14, P85, DOI 10.1097/00002030-200001070-00010; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Vincent KL, 2008, SEX TRANSM DIS, V35, P269, DOI 10.1097/OLQ.0b013e31815abad8; Vincent KL, 2009, SEX TRANSM DIS, V36, P312, DOI 10.1097/OLQ.0b013e31819496e4; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber J, 2001, AIDS, V15, P1563, DOI 10.1097/00002030-200108170-00014; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463	40	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27675	10.1371/journal.pone.0027675	http://dx.doi.org/10.1371/journal.pone.0027675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096611	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900070
J	Chen, SP; Chahar, HS; Abraham, S; Wu, HQ; Pierson, TC; Wang, XZA; Manjunath, N				Chen, Shuiping; Chahar, Harendra S.; Abraham, Sojan; Wu, Haoquan; Pierson, Theodore C.; Wang, Xiaozhong A.; Manjunath, N.			Ago-2-Mediated Slicer Activity Is Essential for Anti-Flaviviral Efficacy of RNAi	PLOS ONE			English	Article							CELLULAR MICRORNAS; HIV-1 REPLICATION; VIRUS-INFECTION; CODING REGIONS; WEST-NILE; P-BODIES; EXPRESSION; CELLS; INTERFERES; SUPPRESSION	RNA interference can be mediated by fully complementary siRNA or partially complementary miRNA. siRNAs are widely used to suppress viral replication and the fully complementary siRNA bound Ago-2 in the RISC is known to degrade the target RNA. Although other argonaute proteins lacking slicer activity can also bind oligonucleotides with both si and miRNA structures, whether they can also contribute to antiviral effects is not entirely clear. We tested si and miRNA structured oligos for target repression in dual luciferase assays as well as for inhibition of Dengue and West Nile virus replication in ES cells expressing individual Ago proteins. In luciferase assays, both fully complementary and partially complementary oligos effectively repressed their targets in all individual Ago expressing cell lines, although the efficacy with fully complementary oligos was higher in Ago-2+ cells. However, partially complementary oligos had no effect on virus replication in any cell line, while fully complementary siRNAs were highly effective in Ago-2 expressing, but not in cells expressing other Ago proteins. This occurred irrespective of whether the target sequences were located in the coding region or 39UTR of the virus. We conclude that Ago-2 slicer activity is essential for anti-viral efficacy of siRNAs and miRNA-mediated translational repression/transcript destabilization is too weak to suppress the abundantly expressed flaviviral proteins.	[Chen, Shuiping; Chahar, Harendra S.; Abraham, Sojan; Wu, Haoquan; Manjunath, N.] Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis Res, Paul L Foster Sch Med, El Paso, TX 79905 USA; [Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Wang, Xiaozhong A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA	Texas Tech University System; Texas Tech University Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Northwestern University	Chen, SP (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis Res, Paul L Foster Sch Med, El Paso, TX 79905 USA.	manjunath.swamy@ttuhsc.edu		Wu, Haoquan/0000-0001-9386-3187; Chen, Shuiping/0000-0001-6186-6017	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U01AI075419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000957, U01AI075419] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health/National Institute of Allergy and Infectious Diseases grant U01AI075419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Ehsani A, 2010, MOL THER, V18, P796, DOI 10.1038/mt.2009.321; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564; Kim SS, 2010, MOL THER, V18, P993, DOI 10.1038/mt.2010.27; Kim SS, 2009, TRENDS MOL MED, V15, P491, DOI 10.1016/j.molmed.2009.09.001; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Manjunath N, 2006, TRENDS IMMUNOL, V27, P328, DOI 10.1016/j.it.2006.05.006; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Moens U, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/419539; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Rossbach M, 2010, CURR MOL MED, V10, P361, DOI 10.2174/156652410791317048; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	38	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27551	10.1371/journal.pone.0027551	http://dx.doi.org/10.1371/journal.pone.0027551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102908	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800033
J	Greenberg, E; Rechavi, G; Amariglio, N; Solomon, O; Schachter, J; Markel, G; Eyal, E				Greenberg, Eyal; Rechavi, Gideon; Amariglio, Ninette; Solomon, Oz; Schachter, Jacob; Markel, Gal; Eyal, Eran			Mutagen-Specific Mutation Signature Determines Global microRNA Binding	PLOS ONE			English	Article							MYELOID-LEUKEMIA GENOME; MALIGNANT-MELANOMA; HUMAN CANCER; TARGET RECOGNITION; EXPRESSION; PROGRESSION; CELLS; GENE; TRANSFORMATION; MELANOCYTES	Micro-RNAs (miRNAs) are small non-coding RNAs that regulate gene products at the post-transcriptional level. It is thought that loss of cell regulation by miRNAs supports cancer development. Based on whole genome sequencing of a melanoma tumor, we predict, using three different computational algorithms, that the melanoma somatic mutations globally reduce binding of miRNAs to the mutated 3'UTRs. This phenomenon reflects the nature of the characteristic UV-induced mutation, C-to-T. Furthermore, we show that seed regions are enriched with Guanine, thus rendering miRNAs prone to reduced binding to UV-mutated 3'UTRs. Accordingly, mutation patterns in non UV-induced malignancies e.g. lung cancer and leukemia do not yield similar predictions. It is suggested that UV-induced disruption of miRNA-mediated gene regulation plays a carcinogenic role. Remarkably, dark-skinned populations have significantly higher GC content in 3'UTR SNPs than light-skinned populations, which implies on evolutionary pressure to preserve regulation by trans-acting oligonucleotides under conditions with excess UV radiation.	[Greenberg, Eyal; Schachter, Jacob; Markel, Gal] Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel; [Greenberg, Eyal; Markel, Gal] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Rechavi, Gideon; Amariglio, Ninette; Solomon, Oz; Eyal, Eran] Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Solomon, Oz] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Markel, Gal] Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Bar Ilan University; Chaim Sheba Medical Center	Greenberg, E (corresponding author), Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel.	Markel@post.tau.ac.il; eran.eyal@sheba.health.gov.il			Flight Attendants Medical Research Institute (FAMRI); Recanati Foundation for Medical Research [6713]	Flight Attendants Medical Research Institute (FAMRI); Recanati Foundation for Medical Research	This work was supported by the Flight Attendants Medical Research Institute (FAMRI) and the Recanati Foundation for Medical Research (#6713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Blake J, 2003, HISTOL HISTOPATHOL, V18, P529, DOI 10.14670/HH-18.529; Bradford Porcia T, 2009, Dermatol Nurs, V21, P170; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Calin GA, 2009, GENOME MED, V1, DOI 10.1186/gm78; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; DROBETSKY EA, 1987, P NATL ACAD SCI USA, V84, P9103, DOI 10.1073/pnas.84.24.9103; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giehl A, 2007, J CUTAN PATHOL, V34, P7, DOI 10.1111/j.1600-0560.2006.00569.x; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Howlader N, 2011, SEER CANC STAT REV 1; Israel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006045; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Ottaiano A, 2005, ANTICANCER RES, V25, P4519; Patino Willmar D, 2008, Adv Dermatol, V24, P59, DOI 10.1016/j.yadr.2008.09.003; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sobolewski AL, 2005, P NATL ACAD SCI USA, V102, P17903, DOI 10.1073/pnas.0504087102; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	56	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27400	10.1371/journal.pone.0027400	http://dx.doi.org/10.1371/journal.pone.0027400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096567	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800051
J	Macas, J; Kejnovsky, E; Neumann, P; Novak, P; Koblizkova, A; Vyskot, B				Macas, Jiri; Kejnovsky, Eduard; Neumann, Pavel; Novak, Petr; Koblizkova, Andrea; Vyskot, Boris			Next Generation Sequencing-Based Analysis of Repetitive DNA in the Model Dioceous Plant Silene latifolia	PLOS ONE			English	Article							GENOME SIZE VARIATION; DIOECIOUS PLANT; Y-CHROMOSOME; SATELLITE REPEATS; AMPLIFICATION; ACCUMULATION; EVOLUTION; ALIGNMENT; ELEMENTS; SUBFAMILIES	Background: Silene latifolia is a dioceous plant with well distinguished X and Y chromosomes that is used as a model to study sex determination and sex chromosome evolution in plants. However, efficient utilization of this species has been hampered by the lack of large-scale sequencing resources and detailed analysis of its genome composition, especially with respect to repetitive DNA, which makes up the majority of the genome. Methodology/Principal Findings: We performed low-pass 454 sequencing followed by similarity-based clustering of 454 reads in order to identify and characterize sequences of all major groups of S. latifolia repeats. Illumina sequencing data from male and female genomes were also generated and employed to quantify the genomic proportions of individual repeat families. The majority of identified repeats belonged to LTR-retrotransposons, constituting about 50% of genomic DNA, with Ty3/gypsy elements being more frequent than Ty1/copia. While there were differences between the male and female genome in the abundance of several repeat families, their overall repeat composition was highly similar. Specific localization patterns on sex chromosomes were found for several satellite repeats using in situ hybridization with probes based on k-mer frequency analysis of Illumina sequencing data. Conclusions/Significance: This study provides comprehensive information about the sequence composition and abundance of repeats representing over 60% of the S. latifolia genome. The results revealed generally low divergence in repeat composition between the sex chromosomes, which is consistent with their relatively recent origin. In addition, the study generated various data resources that are available for future exploration of the S. latifolia genome.	[Macas, Jiri; Neumann, Pavel; Novak, Petr; Koblizkova, Andrea] Acad Sci Czech Republ, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Kejnovsky, Eduard; Vyskot, Boris] Acad Sci Czech Republ, Inst Biophys, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Macas, J (corresponding author), Acad Sci Czech Republ, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic.	macas@umbr.cas.cz	Vyskot, Boris/H-1962-2014; Macas, Jiri/G-8618-2014; Neumann, Pavel/H-7345-2013; Kejnovsky, Eduard/D-8878-2012; Novak, Petr/A-3059-2013	Macas, Jiri/0000-0003-0829-1570; Neumann, Pavel/0000-0001-6711-6639; Novak, Petr/0000-0002-5068-9681	Ministry of Education, Youth and Sports [OC10037, LC06004, LH11058]; Czech Science Foundation [P305/10/0930, P501/10/0102]; Academy of Sciences of the Czech Republic [AVOZ50510513]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The work was funded by projects OC10037, LC06004 and LH11058 from the Ministry of Education, Youth and Sports, P305/10/0930 and P501/10/0102 from the Czech Science Foundation and AVOZ50510513 from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buzek J, 1997, CHROMOSOME RES, V5, P57, DOI 10.1023/A:1011693603279; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CIUPERCESCU DD, 1990, GENOME, V33, P556, DOI 10.1139/g90-082; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dong H, 2011, ACTA BIOCH BIOPH SIN, V43, P496, DOI 10.1093/abbs/gmr030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filatov DA, 2009, GENETICS, V181, P811, DOI 10.1534/genetics.108.099267; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Ishii K, 2008, GENOME, V51, P251, DOI 10.1139/G08-005; Kazama Y, 2006, GENOME, V49, P520, DOI 10.1139/G05-130; Kejnovsky E, 2010, CYTOGENET GENOME RES, V129, P250, DOI 10.1159/000314285; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Lengerova M, 2004, THEOR APPL GENET, V108, P1193, DOI 10.1007/s00122-003-1568-6; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Macas J, 2003, CHROMOSOMA, V112, P152, DOI 10.1007/s00412-003-0255-3; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2007, GENE, V390, P108, DOI 10.1016/j.gene.2006.08.007; Macas J, 2010, BIOINFORMATICS, V26, P2101, DOI 10.1093/bioinformatics/btq343; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Siroky J, 2001, CHROMOSOME RES, V9, P387, DOI 10.1023/A:1016783501674; Song JQ, 2001, GENOME, V44, P463, DOI 10.1139/gen-44-3-463; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Sykorova E, 2003, MOL GENET GENOMICS, V269, P13, DOI 10.1007/s00438-003-0811-9; Sykorova E, 2001, CHROMOSOME RES, V9, P309, DOI 10.1023/A:1016698713959; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Torres GA, 2011, G3-GENES GENOM GENET, V1, P85, DOI 10.1534/g3.111.000125; Uchida W, 2002, CHROMOSOMA, V111, P313, DOI 10.1007/s00412-002-0213-5; VAGERA J, 1994, ANN BOT-LONDON, V73, P455, DOI 10.1006/anbo.1994.1056; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Wicker T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-518; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	48	83	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27335	10.1371/journal.pone.0027335	http://dx.doi.org/10.1371/journal.pone.0027335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096552	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800044
J	Church, DN; Phillips, BR; Stuckey, DJ; Barnes, DJ; Buffa, FM; Manek, S; Clarke, K; Harris, AL; Carter, EJ; Hassan, AB				Church, D. N.; Phillips, B. R.; Stuckey, D. J.; Barnes, D. J.; Buffa, F. M.; Manek, S.; Clarke, K.; Harris, A. L.; Carter, E. J.; Hassan, A. B.			Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse	ONCOGENE			English	Article						PTEN; IGF2; Cowden syndrome; imprinting; placenta; mammary gland	GROWTH-FACTOR-II; INSULIN-RECEPTOR SUBSTRATE-1; BREAST-CANCER; INTESTINAL ADENOMA; COLORECTAL-CANCER; HETEROZYGOUS MICE; MURINE PLACENTA; GLYCOGEN CELLS; H19 GENE; PTEN	The tumour suppressor PTEN is a key negative regulator of the PI3K-Akt pathway, and is frequently either reduced or lost in human tumours. Murine genetic studies have confirmed that reduction of Pten promotes tumourigenesis in multiple organs, and demonstrated dependency of tumour development on the activation of downstream components such as Akt. Insulin-like growth factors (IGFs) act via IGF1R to activate the PI3K-Akt pathway, and are commonly upregulated in cancer. A context-dependent interplay between IGFs and PTEN exists in normal tissue and tumours; increased IGF2 ligand supply induces Pten expression creating an autoregulatory negative feedback loop, whereas complete loss of PTEN may either cooperate with IGF overexpression in tumour promotion, or result in desensitisation to IGF ligand. However, it remains unknown whether neoplasia associated with Pten loss is dependent on upstream IGF ligand supply in vivo. We evaluated this by generation of Pten(+/-) mice with differing allelic dosage of Igf2, an imprinted gene encoding the potent embryonic and tumour growth factor Igf2. We show that biallelic Igf2 supply potentiates a previously unreported Pten(+/-) placental phenotype and results in strain-dependent cardiac hyperplasia and neonatal lethality. Importantly, we also show that the effects of Pten loss in vivo are modified by Igf2 supply, as lack of Igf2 results in extended survival and delayed tumour development while biallelic supply is associated with reduced lifespan and accelerated neoplasia in females. Furthermore, we demonstrate that reduction of PTEN protein to heterozygote levels in human MCF7 cells is associated with increased proliferation in response to IGF2, and does not result in desensitisation to IGF2 signalling. These data indicate that the effects of Pten loss at heterozygote levels commonly observed in human tumours are modified by Igf2 ligand, and emphasise the importance of the evaluation of upstream pathways in tumours with Pten loss. Oncogene (2012) 31, 3635-3646; doi:10.1038/onc.2011.526; published online 28 November 2011	[Church, D. N.; Barnes, D. J.; Carter, E. J.; Hassan, A. B.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Phillips, B. R.; Manek, S.] John Radcliffe Hosp, Dept Histopathol, Oxford OX3 9DU, England; [Stuckey, D. J.; Clarke, K.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3RE, England; [Buffa, F. M.; Harris, A. L.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX1 3RE, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Hassan, AB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	bass.hassan@path.ox.ac.uk	Harris, Adrian L/ABA-3343-2020; Buffa, Francesca/D-2574-2013	Harris, Adrian L/0000-0003-1376-8409; Buffa, Francesca/0000-0003-0409-406X; Carter, Emma/0000-0002-0825-2793; Church, David/0000-0002-4617-962X; stuckey, daniel/0000-0001-8888-627X; Hassan, Andrew/0000-0002-2517-6681; Barnes, David/0000-0002-7937-2004	Cancer Research UK (CRUK) Clinical Research Training Fellowship (DC); CRUK Programme Grant [C429]; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish; National Institute for Health Research [CL-2010-13-007] Funding Source: researchfish	Cancer Research UK (CRUK) Clinical Research Training Fellowship (DC); CRUK Programme Grant; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	Igf2 knockout mice were a kind gift from Argiris Efstratidiadis, H19/ICR knockout mice from Shirley Tilghman and Pten knockout mice from Ramon Parsons. PTEN shRNA sequences were generously provided by Nick Leslie. We also thank Richard Stillion (histology), Miguel Constancia, Ionel Sandovici, Elisabeth Robertson, Yoichi Sekita and Shuomo Bhattacharya for their helpful discussions. This work was funded by a Cancer Research UK (CRUK) Clinical Research Training Fellowship (DC) and CRUK Programme Grant C429 (ABH).	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Burns JL, 2001, DEVELOPMENT, V128, P3819; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carter AM, 2006, PLACENTA, V27, P278, DOI 10.1016/j.placenta.2005.01.014; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Corcoran RB, 2008, CANCER RES, V68, P8788, DOI 10.1158/0008-5472.CAN-08-2135; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cui HM, 2002, CANCER RES, V62, P6442; Cully M, 2004, P NATL ACAD SCI USA, V101, P15358, DOI 10.1073/pnas.0406613101; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Esquiliano DR, 2009, PLACENTA, V30, P693, DOI 10.1016/j.placenta.2009.05.004; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Hassan AB, 2000, CANCER RES, V60, P1070; Lackey J, 2007, ONCOGENE, V26, P7132, DOI 10.1038/sj.onc.1210520; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Lopez MF, 1996, ENDOCRINOLOGY, V137, P2100, DOI 10.1210/en.137.5.2100; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Moorehead RA, 2003, J BIOL CHEM, V278, P50422, DOI 10.1074/jbc.M306894200; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Reardon W, 2001, J MED GENET, V38, P820, DOI 10.1136/jmg.38.12.820; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; SINGER C, 1995, CANCER RES, V55, P2448; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105	51	16	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	31					3635	3646		10.1038/onc.2011.526	http://dx.doi.org/10.1038/onc.2011.526			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22120709	Green Published, hybrid			2022-12-25	WOS:000307245600006
J	Hesdorffer, CS; Malchinkhuu, E; Biragyn, A; Mabrouk, OS; Kennedy, RT; Madara, K; Taub, DD; Longo, DL; Schwartz, JB; Ferrucci, L; Goetzl, EJ				Hesdorffer, Charles S.; Malchinkhuu, Enkhzol; Biragyn, Arya; Mabrouk, Omar S.; Kennedy, Robert T.; Madara, Karen; Taub, Dennis D.; Longo, Dan L.; Schwartz, Janice B.; Ferrucci, Luigi; Goetzl, Edward J.			Distinctive immunoregulatory effects of adenosine on T cells of older humans	FASEB JOURNAL			English	Article						cytokines; cellular antigens; chemotaxis; immunosenescence; immunodeficiency	EXPRESSION; LYMPHOCYTES; ACTIVATION; CD39; INTERLEUKIN-2; CD73	A role for adenosine in immunosenescence was investigated in T cells from older (>= 65 yr) and younger (24-45 yr) healthy humans. Adenosine concentrations in cultures of activated T cells were significantly higher (P<0.0001) for older (145 +/- 47 nM, mean +/- SD) than younger (58 +/- 5.5 nM) subjects. Expression of the activation coreceptor CD28 was suppressed significantly by 0.1 to 1 mu M exogenous adenosine, with greater effects of 1 mu M (P<0.01) on T cells of younger (mean suppression of 67 and 65% for CD4 and CD8 T cells, respectively) than older (means of 42 and 46%) subjects. T-cell chemotaxis to CCL21 was suppressed significantly by 0.3 and 1 mu M exogenous adenosine, with mean maximum decreases of 39 and 49%, respectively, for younger subjects and 28 and 31% for older subjects. Generation of IL-2 and IFN-gamma by T cells of younger and older subjects was suppressed substantially only at adenosine levels of 3 mu M or higher. Lower baseline expression of CD28 and chemotaxis to CCL21 and S1P for T cells from older subjects attributable to endogenous adenosine were reversed completely by two different A(2A) adenosine receptor antagonists without affecting T cells of younger subjects. Adenosine is an endogenous T-cell immunosuppressor in older humans, and A(2A) antagonists reverse adenosine-induced T-cell deficiencies of aging.-Hesdorffer, H. S., Malchinkhuu, E., Biragyn, A., Mabrouk, O. S., Kennedy, R. T., Madara, K., Taub, D. D., Longo, D. L., Schwartz, J. B., Ferrucci, L., Goetzl, E. J. Distinctive immunoregulatory effects of adenosine on T cells of older humans. FASEB J. 26, 1301-1310 (2012). www.fasebj.org	[Goetzl, Edward J.] JHSF, Geriatr Res Ctr, Geriatr Res Labs, San Francisco, CA 94112 USA; [Hesdorffer, Charles S.; Malchinkhuu, Enkhzol; Biragyn, Arya; Madara, Karen; Taub, Dennis D.; Longo, Dan L.; Ferrucci, Luigi; Goetzl, Edward J.] NIA, NIH, Baltimore, MD 21224 USA; [Mabrouk, Omar S.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Schwartz, Janice B.; Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Goetzl, EJ (corresponding author), JHSF, Geriatr Res Ctr, Geriatr Res Labs, 302 Silver Ave, San Francisco, CA 94112 USA.	edward.goetzl@ucsf.edu	Longo, Dan L./F-6022-2011; Schwartz, Janice/K-6354-2019; Malchinkhuu, Enkhzol/AAH-4600-2019; Kennedy, Robert/G-9095-2016	Kennedy, Robert/0000-0003-2447-7471; Malchinkhuu, Enkhzol/0000-0003-0744-079X	U.S. National Institute on Aging; Jewish Home of San Francisco; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB003320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000104, ZIAAG000443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007268] Funding Source: NIH RePORTER	U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Jewish Home of San Francisco; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the intramural research program of the U.S. National Institute on Aging and endowment funds of the Jewish Home of San Francisco. The authors are grateful to Judith H. Goetzl for preparation of the figures and tables. C. S. H., E. M., A. B., O.S.M., R. T. K., J.B.S., and E.J.G. designed research; C. S. H., K. M., J.B.S., and L. F. evaluated and selected subjects; C. S. H., E. M., O.S.M., D. D. T., and E.J.G. performed laboratory research; C. S. H., E. M., O.S.M., D. L. L., L. F., and E.J.G. analyzed data and wrote the paper.	Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Algars A, 2011, BLOOD, V117, P4387, DOI 10.1182/blood-2010-11-321646; Blay J, 1997, CANCER RES, V57, P2602; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Butler JJ, 2003, J CELL BIOCHEM, V89, P975, DOI 10.1002/jcb.10562; Caruso C, 1996, IMMUNOL RES, V15, P84, DOI 10.1007/BF02918286; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DOSREIS GA, 1986, CELL IMMUNOL, V101, P213, DOI 10.1016/0008-8749(86)90199-1; El Yacoubi M, 2001, BRIT J PHARMACOL, V134, P68, DOI 10.1038/sj.bjp.0704240; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Gessi S, 2007, PURINERG SIGNAL, V3, P109, DOI 10.1007/s11302-006-9042-y; GILLIS S, 1981, J CLIN INVEST, V67, P937, DOI 10.1172/JCI110143; Grahler MH, 2005, J IMMUNOL, V174, P1997; Himer L, 2010, FASEB J, V24, P2631, DOI 10.1096/fj.10-155192; Hoskin DW, 2008, INT J ONCOL, V32, P527; Huang MC, 2011, CLIN IMMUNOL, V138, P201, DOI 10.1016/j.clim.2010.11.002; Kase H., 1999, ADENOSINE RECEPTORS; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Parish ST, 2010, J IMMUNOL, V184, P2847, DOI 10.4049/jimmunol.0903647; Rea IM, 1996, GERONTOLOGY, V42, P69, DOI 10.1159/000213775; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Takedachi M, 2008, J IMMUNOL, V180, P6288, DOI 10.4049/jimmunol.180.9.6288; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Zheng YH, 2000, FASEB J, V14, P2387; Zhoua Q, 2009, AM J TRANSPLANT, V9, P2303, DOI 10.1111/j.1600-6143.2009.02777.x	26	11	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1301	1310		10.1096/fj.11-197046	http://dx.doi.org/10.1096/fj.11-197046			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22121051	Green Published, Green Submitted			2022-12-25	WOS:000300949300032
J	Nunes-Xavier, CE; Elson, A; Pulido, R				Nunes-Xavier, Caroline E.; Elson, Ari; Pulido, Rafael			Epidermal Growth Factor Receptor (EGFR)-mediated Positive Feedback of Protein-tyrosine Phosphatase epsilon (PTP epsilon) on ERK1/2 and AKT Protein Pathways Is Required for Survival of Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PHORBOL 12-MYRISTATE 13-ACETATE; THERAPEUTIC TARGET; MAP KINASE; IN-VIVO; ALPHA; SRC; NEU; EXPRESSION; TRANSCRIPTION	Increased tyrosine phosphorylation has been correlated with human cancer, including breast cancer. In general, the activation of tyrosine kinases (TKs) can be antagonized by the action of protein-tyrosine phosphatases (PTPs). However, in some cases PTPs can potentiate the activation of TKs. In this study, we have investigated the functional role of PTP is an element of in human breast cancer cell lines. We found the up-regulation and activation of receptor PTP is an element of (RPTP is an element of) in MCF-7 cells and MDA-MB-231 upon PMA, FGF, and serum stimulation, which depended on EGFR and ERK1/2 activity. Diminishing the expression of PTP is an element of in human breast cancer cells abolished ERK1/2 and AKT activation, and decreased the viability and anchorage-independent growth of the cells. Conversely, stable MCF-7 cell lines expressing inducible high levels of ectopic PTP is an element of displayed higher activation of ERK1/2 and anchorage-independent growth. Our results demonstrate that expression of PTP is an element of is up-regulated and activated in breast cancer cell lines, through EGFR, by sustained activation of the ERK1/2 pathway, generating a positive feedback regulatory loop required for survival of human breast cancer cells.	[Nunes-Xavier, Caroline E.; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46013, Spain; [Elson, Ari] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Prince Felipe Research Center; Weizmann Institute of Science	Pulido, R (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16-3, Valencia 46013, Spain.	rpulido@cipf.es	Ruiz-Lopez, Maria Dolores/U-1925-2017; Nunes-Xavier, Caroline E./R-5893-2018; Fernandez, Mariana F./C-9877-2012; Olea, Nicolas/H-3198-2014	Ruiz-Lopez, Maria Dolores/0000-0001-8523-0689; Nunes-Xavier, Caroline E./0000-0002-1875-6645; Fernandez, Mariana F./0000-0001-6417-8914; Olea, Nicolas/0000-0002-8938-3743; Elson, Ari/0000-0001-9808-9135; Pulido, Rafael/0000-0001-9100-248X	Ministerio de Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional) [SAF2009-10226]; Generalitat Valenciana (Spain and Fondo Europeo de Desarrollo Regional) [AP-040/10, ACOMP/2010/222, ACOMP/2011/164]; EU Research Training Network [MRTN-CT-2006-035830]; Israel Science Foundation; EU	Ministerio de Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (Spain and Fondo Europeo de Desarrollo Regional)(Center for Forestry Research & Experimentation (CIEF)); EU Research Training Network; Israel Science Foundation(Israel Science Foundation); EU(European Commission)	This work was supported by Grants SAF2009-10226 from Ministerio de Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional), AP-040/10, ACOMP/2010/222, and ACOMP/2011/164 from Generalitat Valenciana (Spain and Fondo Europeo de Desarrollo Regional) (to R. P.); by EU Research Training Network MRTN-CT-2006-035830, and by the Israel Science Foundation (to A. E.).; Supported by the EU Marie Curie Research Training Programme and by Ministerio de Ciencia e Innovacion.	Alblas J, 1998, ONCOGENE, V16, P131, DOI 10.1038/sj.onc.1201485; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Berman-Golan D, 2008, CANCER METAST REV, V27, P193, DOI 10.1007/s10555-008-9124-0; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; De Franceschi L, 2008, PROTEOMICS, V8, P4695, DOI 10.1002/pmic.200700596; Dube N, 2004, CELL CYCLE, V3, P550; Elson A, 1999, ONCOGENE, V18, P7535, DOI 10.1038/sj.onc.1203098; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Elson A, 1995, P NATL ACAD SCI USA, V92, P12235, DOI 10.1073/pnas.92.26.12235; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fortino V, 2008, CANCER INVEST, V26, P13, DOI 10.1080/07357900701637949; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Gauthier ML, 2003, BIOCHEM BIOPH RES CO, V307, P839, DOI 10.1016/S0006-291X(03)01273-7; Gil-Henn H, 2000, ONCOGENE, V19, P4375, DOI 10.1038/sj.onc.1203790; Gil-Henn H, 2001, J BIOL CHEM, V276, P31772, DOI 10.1074/jbc.M103395200; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Granot-Attas S, 2004, EXP CELL RES, V294, P236, DOI 10.1016/j.yexcr.2003.11.003; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Johnson AC, 1996, J BIOL CHEM, V271, P3033; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kraut J, 2002, EXP CELL RES, V281, P182, DOI 10.1006/excr.2002.5661; Kraut-Cohen J, 2008, J BIOL CHEM, V283, P4612, DOI 10.1074/jbc.M708822200; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Morgan Liam, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P273, DOI 10.2174/187153008786848295; Mukouyama Y, 1997, MOL BRAIN RES, V50, P230, DOI 10.1016/S0169-328X(97)00193-9; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Nord H, 2009, NEURO-ONCOLOGY, V11, P803, DOI 10.1215/15228517-2009-013; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sandgren J, 2010, EXP MOL MED, V42, P484, DOI 10.3858/emm.2010.42.7.050; Schumann G, 1998, MOL BRAIN RES, V62, P56, DOI 10.1016/S0169-328X(98)00237-X; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1144, DOI 10.1152/ajpcell.00536.2009; Sines T, 2007, MOL CELL BIOL, V27, P7102, DOI 10.1128/MCB.02096-06; Sully V, 2001, BIOCHEM BIOPH RES CO, V286, P184, DOI 10.1006/bbrc.2001.5360; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tanuma N, 2003, ONCOGENE, V22, P1758, DOI 10.1038/sj.onc.1206267; Tanuma N, 2001, BLOOD, V98, P3030, DOI 10.1182/blood.V98.10.3030; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Toledano-Katchalski H, 2003, MOL CANCER RES, V1, P541; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Wabakken T, 2002, SCAND J IMMUNOL, V56, P195, DOI 10.1046/j.1365-3083.2002.01126.x; Wabakken T, 2002, SCAND J IMMUNOL, V56, P276, DOI 10.1046/j.1365-3083.2002.01127.x; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	58	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3433	3444		10.1074/jbc.M111.293928	http://dx.doi.org/10.1074/jbc.M111.293928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22117074	hybrid, Green Published			2022-12-25	WOS:000300295100048
J	Mahabeleshwar, GH; Qureshi, MA; Takami, Y; Sharma, N; Lingrel, JB; Jain, MK				Mahabeleshwar, Ganapati H.; Qureshi, Muhammad Awais; Takami, Yoichi; Sharma, Nikunj; Lingrel, Jerry B.; Jain, Mukesh K.			A Myeloid Hypoxia-inducible Factor 1 alpha-Kruppel-like Factor 2 Pathway Regulates Gram-positive Endotoxin-mediated Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; SHOCK; ACTIVATION; KLF2; LIPOPOLYSACCHARIDE; IDENTIFICATION; EPIDEMIOLOGY; HIF-1-ALPHA	Although Gram-positive infections account for the majority of cases of sepsis, the molecular mechanisms underlying their effects remains poorly understood. We investigated how cell wall components of Gram-positive bacteria contribute to the development of sepsis. Experimental observations derived from cultured primary macrophages and the cell line indicate that Gram-positive bacterial endotoxins induce hypoxia-inducible factor 1 alpha (HIF-1 alpha) mRNA and protein expression. Inoculation of live or heat-inactivated Gram-positive bacteria with macrophages induced HIF-1 transcriptional activity in macrophages. Concordant with these results, myeloid deficiency of HIF-1 alpha attenuated Gram-positive bacterial endotoxin-induced cellular motility and proinflammatory gene expression in macrophages. Conversely, Gram-positive bacteria and their endotoxins reduced expression of the myeloid anti-inflammatory transcription factor Kruppel-like transcription factor 2 (KLF2). Sustained expression of KLF2 reduced and deficiency of KLF2 enhanced Gram-positive endotoxins induced HIF-1 alpha mRNA and protein expression in macrophages. More importantly, KLF2 attenuated Gram-positive endotoxins induced cellular motility and proinflammatory gene expression in myeloid cells. Consistent with these results, mice deficient in myeloid HIF-1 alpha were protected from Gram-positive endotoxin-induced sepsis mortality and clinical symptomatology. By contrast, myeloid KLF2-deficient mice were susceptible to Gram-positive sepsis induced mortality and clinical symptoms. Collectively, these observations identify HIF-1 alpha and KLF2 as critical regulators of Gram-positive endotoxin-mediated sepsis.	[Mahabeleshwar, Ganapati H.; Qureshi, Muhammad Awais; Takami, Yoichi; Sharma, Nikunj; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Dept Med,Univ Hosp Case Med Ctr, Case Cardiovasc Res Inst,Harrington McLaughlin He, Cleveland, OH 44106 USA; [Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Case Western Reserve University; Case Western Reserve University Hospital; University System of Ohio; University of Cincinnati	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med,Univ Hosp Case Med Ctr, Case Cardiovasc Res Inst,Harrington McLaughlin He, Cleveland, OH 44106 USA.	ghm4@case.edu; mukesh.jain2@case.edu		Takami, Yoichi/0000-0001-9018-6707	National Institutes of Health [HL72952, HL75427, HL76754, HL086548, HL084154, HL097023, HL78806]; American Heart Association [11POST7200004]; Sankyo Foundation of Life Science; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075427, R00HL097023, R01HL076754, R01HL084154, K99HL097023, R01HL110630, R01HL086548, R01HL072952, R01HL078806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Sankyo Foundation of Life Science; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72952, HL75427, HL76754, HL086548, and HL084154 (to M.K.J.); HL097023 (to G.H.M); and HL78806 (to J.B.L.). This work was also supported by American Heart Association Grants 11POST7200004 (to N.S.), Sankyo Foundation of Life Science grants, and a Kanae Foundation for the Promotion of Medical Science grant (to Y.T.).	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Humbert M, 2011, LEUKEMIA RES, V35, P909, DOI 10.1016/j.leukres.2011.03.010; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Opal SM, 1999, CRIT CARE MED, V27, P1608, DOI 10.1097/00003246-199908000-00039; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; van Zoelen MAD, 2011, MOL IMMUNOL, V48, P1468, DOI 10.1016/j.molimm.2011.04.001; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000	32	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1448	1457		10.1074/jbc.M111.312702	http://dx.doi.org/10.1074/jbc.M111.312702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110137	Green Published, hybrid			2022-12-25	WOS:000299170300058
J	Nili, M; Mukherjee, A; Shinde, U; David, L; Rotwein, P				Nili, Mahta; Mukherjee, Aditi; Shinde, Ujwal; David, Larry; Rotwein, Peter			Defining the Disulfide Bonds of Insulin-like Growth Factor-binding Protein-5 by Tandem Mass Spectrometry with Electron Transfer Dissociation and Collision-induced Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; IGF-BINDING; TERMINAL DOMAINS; STRUCTURAL BASIS; FACTOR-I; LC-MS; IGFBP-5; DIFFERENTIATION; SUBSTITUTIONS; LINKAGES	The six high-affinity insulin-like growth factor-binding proteins (IGFBPs) comprise a conserved family of secreted molecules that modulate IGF actions by regulating their half-life and access to signaling receptors, and also exert biological effects that are independent of IGF binding. IGFBPs are composed of cysteine-rich amino-(N-) and carboxyl-(C-) terminal domains, along with a cysteine-poor central linker segment. IGFBP-5 is the most conserved IGFBP, and contains 18 cysteines, but only 2 of 9 putative disulfide bonds have been mapped to date. Using a mass spectrometry (MS)-based strategy combining sequential electron transfer dissociation (ETD) and collision-induced dissociation (CID) steps, in which ETD fragmentation preferentially induces cleavage of disulfide bonds, and CID provides exact disulfide linkage assignments between liberated peptides, we now have definitively mapped 5 disulfide bonds in IGFBP-5. In addition, in conjunction with ab initio molecular modeling we are able to assign the other 4 disulfide linkages to within a GCGCCXXC motif that is conserved in five IGFBPs. Because of the nature of ETD fragmentation MS experiments were performed without chemical reduction of IGFBP-5. Our results not only establish a disulfide bond map of IGFBP-5 but also define a general approach that takes advantage of the specificity of ETD and the scalability of tandem MS, and the predictive power of ab initio molecular modeling to characterize unknown disulfide linkages in proteins.	[Nili, Mahta; Mukherjee, Aditi; Shinde, Ujwal; David, Larry; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [5R01 DK042748-22, 5R01 EY007755-18, 5P30 EY10572, F31 HL095271-03]; NSF [0746589]; NATIONAL EYE INSTITUTE [R01EY007755, P30EY010572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL095271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants 5R01 DK042748-22 (to P.R.) and 5R01 EY007755-18 and 5P30 EY10572 (to L.D.) and by NSF Grant 0746589 (to U.S.).; Supported by National Institutes of Health Predoctoral Fellowship F31 HL095271-03.	Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Chrisman PA, 2005, J AM SOC MASS SPECTR, V16, P1020, DOI 10.1016/j.jasms.2005.02.010; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; Cobb LJ, 2004, J CELL SCI, V117, P1737, DOI 10.1242/jcs.01028; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Daza DO, 2011, ENDOCRINOLOGY, V152, P2278, DOI 10.1210/en.2011-0047; Fernandez-Tornero C, 2005, J BIOL CHEM, V280, P18899, DOI 10.1074/jbc.M500587200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fleishman S. J., 2011, J MOL BIOL; Forbes BE, 1998, J BIOL CHEM, V273, P4647, DOI 10.1074/jbc.273.8.4647; Gleason CE, 2010, MOL ENDOCRINOL, V24, P178, DOI 10.1210/me.2009-0167; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; HISE MK, 1994, AM J PHYSIOL, V266, pF147, DOI 10.1152/ajprenal.1994.266.1.F147; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; JAMES PL, 1993, J BIOL CHEM, V268, P22305; Kalus W, 1998, EMBO J, V17, P6558, DOI 10.1093/emboj/17.22.6558; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P1238, DOI 10.1210/me.2008-0001; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; Mukherjee A, 2007, GROWTH HORM IGF RES, V17, P179, DOI 10.1016/j.ghir.2007.01.005; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Osaki T, 2011, J PROTEOME RES, V10, P1870, DOI 10.1021/pr101114a; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Sala A, 2005, J BIOL CHEM, V280, P29812, DOI 10.1074/jbc.M504304200; Salih DAM, 2005, ENDOCRINOLOGY, V146, P931, DOI 10.1210/en.2004-0816; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shand JH, 2003, J BIOL CHEM, V278, P17859, DOI 10.1074/jbc.M300526200; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Siwanowicz I, 2005, STRUCTURE, V13, P155, DOI 10.1016/j.str.2004.11.009; Sorrell AM, 2006, J BIOL CHEM, V281, P10883, DOI 10.1074/jbc.M508505200; Tripathi G, 2009, FASEB J, V23, P2616, DOI 10.1096/fj.08-114124; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Wu SL, 2010, ANAL CHEM, V82, P5296, DOI 10.1021/ac100766r; Wu SL, 2009, ANAL CHEM, V81, P112, DOI 10.1021/ac801560k; Yasuoka H, 2009, AM J RESP CELL MOL, V41, P179, DOI 10.1165/rcmb.2008-0211OC; Zeslawski W, 2001, EMBO J, V20, P3638, DOI 10.1093/emboj/20.14.3638; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	52	10	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1510	1519		10.1074/jbc.M111.285528	http://dx.doi.org/10.1074/jbc.M111.285528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117064	Green Published, hybrid			2022-12-25	WOS:000299170300064
J	Rush, JS; Quinalty, LM; Engelman, L; Sherry, DM; Ceresa, BP				Rush, Jamie S.; Quinalty, Leslie M.; Engelman, Luke; Sherry, David M.; Ceresa, Brian P.			Endosomal Accumulation of the Activated Epidermal Growth Factor Receptor (EGFR) Induces Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB SIGNALING NETWORK; ENDOCYTIC TRAFFICKING; CELL-GROWTH; HELA-CELLS; A431 CELLS; CANCER; DEGRADATION; EXPRESSION; SEQUESTRATION; INHIBITORS	Endocytosis positively and negatively regulates cell surface receptor signaling by temporally and spatially controlling interactions with downstream effectors. This process controls receptor-effector communication. However, the relationship between receptor endocytic trafficking and cell physiology is unclear. In MDA-MB-468 cells, cell surface EGF receptors (EGFRs) promote cell growth, whereas intracellular EGFRs induce apoptosis, making these cells an excellent model for studying the endocytic regulation of EGFR signaling. In addition, MDA-MB-468 cells have limited EGFR degradation following stimulation. Here, we report that in MDA-MB-468 cells the phosphorylated EGFR accumulates on the limiting membrane of the endosome with its carboxyl terminus oriented to the cytoplasm. To determine whether perturbation of EGFR trafficking is sufficient to cause apoptosis, we used pharmacological and biochemical strategies to disrupt EGFR endocytic trafficking in HeLa cells, which do not undergo EGF-dependent apoptosis. Manipulation of HeLa cells so that active EGF center dot EGFRs accumulate on the limiting membrane of endosomes reveals that receptor phosphorylation is sustained and leads to apoptosis. When EGF center dot EGFR complexes accumulated in the intraluminal vesicles of the late endosome, phosphorylation of the receptor was not sustained, nor did the cells undergo apoptosis. These data demonstrate that EGFR-mediated apoptosis is initiated by the activated EGFR from the limiting membrane of the endosome.	[Rush, Jamie S.; Quinalty, Leslie M.; Engelman, Luke; Sherry, David M.; Ceresa, Brian P.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73106 USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ceresa, BP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	brian-ceresa@ouhsc.edu	Driskill, Leslie/AAI-8748-2021	Driskill, Leslie/0000-0003-3484-2794	National Institutes of Health from National Center for Research Resources [P20 RR 017703]; Oklahoma Center for Advancement of Science and Technology [HR10-012];  [1R01GM092874]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092874] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oklahoma Center for Advancement of Science and Technology; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR 017703 from the COBRE Program of the National Center for Research Resources (to B. P. C.) and 1R01GM092874 (to B. P. C.). This work was also supported by Oklahoma Center for Advancement of Science and Technology Grant HR10-012 (to B. P. C.).	ARMSTRONG DK, 1994, CANCER RES, V54, P5280; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DIAZ R, 1989, METHOD CELL BIOL, V31, P25; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; KING AC, 1984, BIOCHEM BIOPH RES CO, V124, P585, DOI 10.1016/0006-291X(84)91594-8; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; LEY KD, 1992, CARCINOGENESIS, V13, P183, DOI 10.1093/carcin/13.2.183; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tikhomirov O, 2004, J BIOL CHEM, V279, P12988, DOI 10.1074/jbc.M311655200; Tullo AB, 2005, EYE, V19, P729, DOI 10.1038/sj.eye.6701630; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang G, 2007, CORNEA, V26, P858, DOI 10.1097/ICO.0b013e318064584a	28	63	64	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					712	722		10.1074/jbc.M111.294470	http://dx.doi.org/10.1074/jbc.M111.294470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102283	hybrid, Green Published			2022-12-25	WOS:000298682400069
J	Hsu, JBK; Bretana, NA; Lee, TY; Huang, HD				Hsu, Justin Bo-Kai; Bretana, Neil Arvin; Lee, Tzong-Yi; Huang, Hsien-Da			Incorporating Evolutionary Information and Functional Domains for Identifying RNA Splicing Factors in Humans	PLOS ONE			English	Article							BINDING-SITES; PROTEOMIC ANALYSIS; WEB SERVER; PREDICTION; PROTEINS; DATABASE; SVM; CLASSIFICATION; SEQUENCE; IDENTIFICATION	Regulation of pre-mRNA splicing is achieved through the interaction of RNA sequence elements and a variety of RNA-splicing related proteins (splicing factors). The splicing machinery in humans is not yet fully elucidated, partly because splicing factors in humans have not been exhaustively identified. Furthermore, experimental methods for splicing factor identification are time-consuming and lab-intensive. Although many computational methods have been proposed for the identification of RNA-binding proteins, there exists no development that focuses on the identification of RNA-splicing related proteins so far. Therefore, we are motivated to design a method that focuses on the identification of human splicing factors using experimentally verified splicing factors. The investigation of amino acid composition reveals that there are remarkable differences between splicing factors and non-splicing proteins. A support vector machine (SVM) is utilized to construct a predictive model, and the five-fold cross-validation evaluation indicates that the SVM model trained with amino acid composition could provide a promising accuracy (80.22%). Another basic feature, amino acid dipeptide composition, is also examined to yield a similar predictive performance to amino acid composition. In addition, this work presents that the incorporation of evolutionary information and domain information could improve the predictive performance. The constructed models have been demonstrated to effectively classify (73.65% accuracy) an independent data set of human splicing factors. The result of independent testing indicates that in silico identification could be a feasible means of conducting preliminary analyses of splicing factors and significantly reducing the number of potential targets that require further in vivo or in vitro confirmation.	[Hsu, Justin Bo-Kai; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Bretana, Neil Arvin; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Tao Yuan, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Core Facil Struct Bioinformat, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Yuan Ze University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, JBK (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	francis@saturn.yzu.edu.tw; bryan@mail.nctu.edu.tw	Huang, Hsien-Da/AAA-7376-2019; Hsu, Justin BoKai/ABB-4597-2021	Hsu, Justin BoKai/0000-0002-4563-2672; Bretana, Neil Arvin/0000-0003-4743-348X	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council [NSC-99-2911-I-009-101]; National Science Council of the Republic of China, Taiwan [NSC98-2311-B-009-004-MY3, NSC100-2627-B-009-002, NSC100-2319-B-400-001, NSC100-2221-E-155-079]	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-99-2911-I-009-101. The authors would also like to thank the National Science Council of the Republic of China, Taiwan, for financially supporting this research under Contract No. NSC98-2311-B-009-004-MY3, NSC100-2627-B-009-002, and NSC100-2319-B-400-001 to H-DH and NSC100-2221-E-155-079 to T-YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATTWOOD TK, 1994, NUCLEIC ACIDS RES, V22, P3590; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Johnson PJ, 2002, P NATL ACAD SCI USA, V99, P3359, DOI 10.1073/pnas.072084199; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kasyapa CS, 2005, EXP CELL RES, V309, P78, DOI 10.1016/j.yexcr.2005.05.019; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liu ZP, 2010, BIOINFORMATICS, V26, P1616, DOI 10.1093/bioinformatics/btq253; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Panwar B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-507; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; Sadygov RG, 2003, ANAL CHEM, V75, P3792, DOI 10.1021/ac034157w; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tong J, 2008, COMPUT METH PROG BIO, V90, P148, DOI 10.1016/j.cmpb.2007.12.003; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LJ, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P2382; Wang LJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S2; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang Y, 2008, AMINO ACIDS, V35, P295, DOI 10.1007/s00726-007-0634-9; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zheng GY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-282; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	57	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27567	10.1371/journal.pone.0027567	http://dx.doi.org/10.1371/journal.pone.0027567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110674	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400057
J	Lefkowitz, GK; Mukhopadhyay, A; Cowing-Zitron, C; Yu, BD				Lefkowitz, Gloria K.; Mukhopadhyay, Anandaroop; Cowing-Zitron, Christopher; Yu, Benjamin D.			The Post-Apoptotic Fate of RNAs Identified Through High-Throughput Sequencing of Human Hair	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; 28S RIBOSOMAL-RNA; DNA; GENETICS; KERATIN; DEATH; NOMENCLATURE; RIBONUCLEASE; FOLLICLES; BIOLOGY	The hair of all mammals consists of terminally differentiated cells that undergo a specialized form of apoptosis called cornification. While DNA is destroyed during cornification, the extent to which RNA is lost is unknown. Here we find that multiple types of RNA are incompletely degraded after hair shaft formation in both mouse and human. Notably, mRNAs and short regulatory microRNAs (miRNAs) are stable in the hair as far as 10 cm from the scalp. To better characterize the post-apoptotic RNAs that escape degradation in the hair, we performed sequencing (RNA-seq) on RNA isolated from hair shafts pooled from several individuals. This hair shaft RNA library, which encompasses different hair types, genders, and populations, revealed 7,193 mRNAs, 449 miRNAs and thousands of unannotated transcripts that remain in the post-apoptotic hair. A comparison of the hair shaft RNA library to that of viable keratinocytes revealed surprisingly similar patterns of gene coverage and indicates that degradation of RNA is highly inefficient during apoptosis of hair lineages. The generation of a hair shaft RNA library could be used as months of accumulated transcriptional history useful for retrospective detection of disease, drug response and environmental exposure.	[Lefkowitz, Gloria K.; Mukhopadhyay, Anandaroop; Cowing-Zitron, Christopher; Yu, Benjamin D.] Univ Calif San Diego, Dept Med, Stem Cell Program, Div Dermatol,Inst Genom Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	Lefkowitz, GK (corresponding author), Univ Calif San Diego, Dept Med, Stem Cell Program, Div Dermatol,Inst Genom Med, San Diego, CA 92103 USA.	byu@ucsd.edu		Yu, Benjamin/0000-0001-6663-6616	National Institutes of Health [AR056667]; California Institute for Regenerative Medicine [RN2-00908]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health AR056667 and the California Institute for Regenerative Medicine RN2-00908, and institutional funds for B.D.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Budowle B, 2003, ANNU REV GENOM HUM G, V4, P119, DOI 10.1146/annurev.genom.4.070802.110352; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; Cheng AS, 2008, J AM ACAD DERMATOL, V59, P1, DOI 10.1016/j.jaad.2008.04.002; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; FINCH C, 2009, J FORENSIC SCI, V54, P346; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOUGE G, 1995, MOL CELL BIOL, V15, P2051; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Koike M, 2007, BIOCHEM BIOPH RES CO, V363, P1009, DOI 10.1016/j.bbrc.2007.09.080; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; LAU NC, 2004, THESIS MIT; LeBeau MA, 2011, FORENSIC SCI INT, V210, P110, DOI 10.1016/j.forsciint.2011.02.015; LEVEQUE JL, 1981, BIOPOLYMERS, V20, P2649, DOI 10.1002/bip.1981.360201211; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Lo YMD, 2004, ANN NY ACAD SCI, V1022, P135, DOI 10.1196/annals.1318.022; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Morioka K, 2005, HAIR FOLLICLE DIFFER; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Porter RM, 2006, J INVEST DERMATOL, V126, P2366, DOI 10.1038/sj.jid.5700532; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rogers MA, 2005, J INVEST DERMATOL, V124, pVII, DOI 10.1111/j.0022-202X.2005.23728.x; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rozen S, 2000, Methods Mol Biol, V132, P365; Samali A, 1997, CELL DEATH DIFFER, V4, P289, DOI 10.1038/sj.cdd.4400246; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shimomura Y, 2003, J DERMATOL SCI, V31, P43, DOI 10.1016/S0923-1811(02)00140-8; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Soma T, 1998, J INVEST DERMATOL, V111, P948, DOI 10.1046/j.1523-1747.1998.00408.x; Stelzer G, 2009, OMICS, V13, P477, DOI 10.1089/omi.2009.0069; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Whiting DA, 2006, SEMIN CUTAN MED SURG, V25, P24, DOI 10.1016/j.sder.2006.01.004; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27603	10.1371/journal.pone.0027603	http://dx.doi.org/10.1371/journal.pone.0027603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110684	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400066
J	Priyadarshini, CGP; Ambika, MV; Tippeswamy, R; Savithri, HS				Priyadarshini, C. G. Poornima; Ambika, M. V.; Tippeswamy, R.; Savithri, H. S.			Functional Characterization of Coat Protein and V2 Involved in Cell to Cell Movement of Cotton Leaf Curl Kokhran Virus-Dabawali	PLOS ONE			English	Article							NUCLEAR SHUTTLE PROTEIN; ABUTILON MOSAIC GEMINIVIRUS; MAIZE STREAK VIRUS; MONOPARTITE BEGOMOVIRUS; DNA-BETA; VIRAL MOVEMENT; TRANSPORT; INTERACTS; DISEASE; PREDICTION	The functional attributes of coat protein (CP) and V2 of the monopartite begomovirus, Cotton leaf curl Kokhran virus-Dabawali were analyzed in vitro and in vivo by their overexpression in E coli, insect cells and transient expression in the plant system. Purified recombinant V2 and CP proteins were shown to interact with each other using ELISA and surface plasmon resonance. Confocal microscopy of Sf21 cells expressing V2 and CP proteins revealed that V2 localized to the cell periphery and CP to the nucleus. Deletion of the N terminal nuclear localization signal of CP restricted its distribution to the cytoplasm. GFP-V2 and YFP-CP transiently expressed in N. benthamiana plants by agroinfiltration substantiated the localization of V2 to the cell periphery and CP predominantly to the nucleus. Interestingly, upon coinfiltration, CP was found both in the nucleus and in the cytoplasm along with V2. These results suggest that the interaction of V2 and CP may have important implications in the cell to cell movement.	[Priyadarshini, C. G. Poornima; Ambika, M. V.; Tippeswamy, R.; Savithri, H. S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Priyadarshini, CGP (corresponding author), Heinrich Pette Inst Leibniz Inst Expt Virol, Hamburg, Germany.	bchss@biochem.iisc.ernet.in	Murthy, Ambika Mosale Venkatesh/C-8021-2017	Murthy, Ambika Mosale Venkatesh/0000-0002-9767-1999; , Poornima Priyadarshini/0000-0002-7449-5777	Department of Biotechnology, New Delhi, India [BT/04(SIBRI)/05/2006, BT/PR6914/PBD/16/644/2005-111]; Council of Scientific and Industrial Research, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank the Department of Biotechnology, New Delhi, India, grant numbers BT/04(SIBRI)/05/2006, BT/PR6914/PBD/16/644/2005-111 for financial support. CGPP thanks Council of Scientific and Industrial Research, New Delhi, India for research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briddon RW, 2004, VIROLOGY, V324, P462, DOI 10.1016/j.virol.2004.03.041; Briddon RW, 2003, VIROLOGY, V312, P106, DOI 10.1016/S0042-6822(03)00200-9; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Brill LM, 2000, P NATL ACAD SCI USA, V97, P7112, DOI 10.1073/pnas.130187897; Carvalho MF, 2006, PLANT PHYSIOL, V140, P1317, DOI 10.1104/pp.105.075556; Chowdhury SR, 2011, FEBS J, V278, P257, DOI 10.1111/j.1742-4658.2010.07943.x; Florentino LH, 2006, J VIROL, V80, P6648, DOI 10.1128/JVI.00173-06; Frischmuth S, 2007, PROTOPLASMA, V230, P117, DOI 10.1007/s00709-006-0223-x; Frischmuth S, 2004, ARCH VIROL, V149, P2349, DOI 10.1007/s00705-004-0381-0; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gopal P, 2007, VIRUS RES, V123, P9, DOI 10.1016/j.virusres.2006.07.014; Haywood V, 2002, PLANT CELL, V14, pS303, DOI 10.1105/tpc.000778; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; Jeske H, 2009, CURR TOP MICROBIOL, V331, P185; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JUPIN I, 1994, VIROLOGY, V204, P82, DOI 10.1006/viro.1994.1512; Kirthi N, 2004, ARCH VIROL, V149, P2047, DOI 10.1007/s00705-004-0352-5; Kirthi N, 2003, ARCH VIROL, V148, P2369, DOI 10.1007/s00705-003-0174-x; Kumar P, 2006, VIRUS RES, V122, P127, DOI 10.1016/j.virusres.2006.07.007; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LAZAROWITZ SG, 1992, CRIT REV PLANT SCI, V11, P327, DOI [10.1080/07352689209382350, 10.1080/713608038]; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Liu HT, 2001, J GEN VIROL, V82, P35, DOI 10.1099/0022-1317-82-1-35; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; Mariano AC, 2004, VIROLOGY, V318, P24, DOI 10.1016/j.virol.2003.09.038; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLean BG, 1995, PLANT CELL, V7, P2101, DOI 10.1105/tpc.7.12.2101; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Priyadarshini CGP, 2009, VIROLOGY, V386, P427, DOI 10.1016/j.virol.2009.01.016; Qin SW, 1998, J VIROL, V72, P9247, DOI 10.1128/JVI.72.11.9247-9256.1998; RIGDEN JE, 1993, VIROLOGY, V193, P1001, DOI 10.1006/viro.1993.1215; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; Saeed M, 2007, J GEN VIROL, V88, P2881, DOI 10.1099/vir.0.83049-0; Sanderfoot AA, 1996, TRENDS CELL BIOL, V6, P353, DOI 10.1016/0962-8924(96)10031-3; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Selth LA, 2006, PLANT MOL BIOL, V61, P297, DOI 10.1007/s11103-006-0028-5; Sharma P, 2011, PROTOPLASMA, V248, P281, DOI 10.1007/s00709-010-0166-0; Sharma P, 2010, VIROLOGY, V396, P85, DOI 10.1016/j.virol.2009.10.012; Tzfira T, 2000, ANNU REV MICROBIOL, V54, P187, DOI 10.1146/annurev.micro.54.1.187; Wartig L, 1997, VIROLOGY, V228, P132, DOI 10.1006/viro.1996.8406; Zhang W, 2001, VIROLOGY, V279, P471, DOI 10.1006/viro.2000.0739; Zrachya A, 2007, VIROLOGY, V358, P159, DOI 10.1016/j.virol.2006.08.016	51	24	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e26929	10.1371/journal.pone.0026929	http://dx.doi.org/10.1371/journal.pone.0026929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110597	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400017
J	Song, XF; Zhou, T; Jia, H; Guo, XJ; Zhang, XB; Han, P; Sha, JH				Song, Xiaofeng; Zhou, Tao; Jia, Hao; Guo, Xuejiang; Zhang, Xiaobai; Han, Ping; Sha, Jiahao			SProtP: A Web Server to Recognize Those Short-Lived Proteins Based on Sequence-Derived Features in Human Cells	PLOS ONE			English	Article							END RULE PATHWAY; GENE-EXPRESSION; HALF-LIFE; PREDICTION; SIGNAL; DEGRADATION; REGIONS; CLASSIFICATION; PROTEOLYSIS; STABILITY	Protein turnover metabolism plays important roles in cell cycle progression, signal transduction, and differentiation. Those proteins with short half-lives are involved in various regulatory processes. To better understand the regulation of cell process, it is important to study the key sequence-derived factors affecting short-lived protein degradation. Until now, most of protein half-lives are still unknown due to the difficulties of traditional experimental methods in measuring protein half-lives in human cells. To investigate the molecular determinants that affect short-lived proteins, a computational method was proposed in this work to recognize short-lived proteins based on sequence-derived features in human cells. In this study, we have systematically analyzed many features that perhaps correlated with short-lived protein degradation. It is found that a large fraction of proteins with signal peptides and transmembrane regions in human cells are of short half-lives. We have constructed an SVM-based classifier to recognize short-lived proteins, due to the fact that short-lived proteins play pivotal roles in the control of various cellular processes. By employing the SVM model on human dataset, we achieved 80.8% average sensitivity and 79.8% average specificity, respectively, on ten testing dataset (TE1-TE10). We also obtained 89.9%, 99% and 83.9% of average accuracy on an independent validation datasets iTE1, iTE2 and iTE3 respectively. The approach proposed in this paper provides a valuable alternative for recognizing the short-lived proteins in human cells, and is more accurate than the traditional N-end rule. Furthermore, the web server SProtP (http://reprod.njmu.edu.cn/sprotp) has been developed and is freely available for users.	[Song, Xiaofeng; Jia, Hao; Zhang, Xiaobai] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing 210016, Peoples R China; [Zhou, Tao; Guo, Xuejiang; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Peoples R China; [Han, Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Nanjing, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing Medical University; Nanjing Medical University	Song, XF (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing 210016, Peoples R China.	guo_xuejiang@njmu.edu.cn; hanping200701@163.com	Zhou, Tao/H-1094-2013; Guo, Xuejiang/J-9600-2014	Zhou, Tao/0000-0003-2219-6385; Guo, Xuejiang/0000-0002-0475-5705	National Key Basic Research Program [2011CB944304]; National Natural Science Foundation of China [61171191]; Specialized Research Fund for the Doctoral Program of Higher Education [20103234120002]; Natural Science Foundation of Jiangsu Province in China [BK2010500]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu Province in China(Natural Science Foundation of Jiangsu Province)	The study was supported by grants from National Key Basic Research Program Grant (2011CB944304), National Natural Science Foundation of China (No. 61171191), Specialized Research Fund for the Doctoral Program of Higher Education (20103234120002), and Natural Science Foundation of Jiangsu Province in China (BK2010500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang XLL, 2009, NAT CHEM BIOL, V5, P9, DOI 10.1038/nchembio0109-9; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BELLE A, 2006, PNAS, V103; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; Cox CJ, 2002, FEBS LETT, V527, P303, DOI 10.1016/S0014-5793(02)03246-5; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; Cui J, 2007, MOL IMMUNOL, V44, P514, DOI 10.1016/j.molimm.2006.02.010; de Souza N, 2011, NAT METHODS, V8, P536, DOI 10.1038/nmeth0711-536; Debigare R, 2003, AM J PHYSIOL-RENAL, V285, pF1, DOI 10.1152/ajprenal.00244.2002; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Donner A, 2009, NAT METHODS, V6, P8, DOI 10.1038/nmeth0109-8b; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Mathes E, 2010, J BIOL CHEM, V285, P32927, DOI 10.1074/jbc.M110.107326; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Pfleger CM, 2000, GENE DEV, V14, P655; Polo S, 2008, CELL, V135, P590, DOI 10.1016/j.cell.2008.10.032; Reuter CJ, 2010, MICROBIOL-SGM, V156, P248, DOI 10.1099/mic.0.032995-0; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHERRY YHC, 2008, SCIENCE, V322, P918; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Song XF, 2009, INFORM PROCESS MANAG, V45, P584, DOI 10.1016/j.ipm.2009.05.002; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27836	10.1371/journal.pone.0027836	http://dx.doi.org/10.1371/journal.pone.0027836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114707	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400125
J	Toxopeus, CM; de Jong, BM; Valsan, G; Conway, BA; Leenders, KL; Maurits, NM				Toxopeus, Carolien M.; de Jong, Bauke M.; Valsan, Gopal; Conway, Bernard A.; Leenders, Klaus L.; Maurits, Natasha M.			Direction of Movement Is Encoded in the Human Primary Motor Cortex	PLOS ONE			English	Article							ARM MOVEMENTS; VISUAL TARGETS; SENSORIMOTOR TRANSFORMATIONS; VISUOMOTOR TRANSFORMATIONS; MUSCLE REPRESENTATION; CORTICAL MECHANISMS; PARIETAL CORTEX; DIFFERENT PARTS; CELL DISCHARGE; HAND AREA	The present study investigated how direction of hand movement, which is a well-described parameter in cerebral organization of motor control, is incorporated in the somatotopic representation of the manual effector system in the human primary motor cortex (M1). Using functional magnetic resonance imaging (fMRI) and a manual step-tracking task we found that activation patterns related to movement in different directions were spatially disjoint within the representation area of the hand on M1. Foci of activation related to specific movement directions were segregated within the M1 hand area; activation related to direction 0 degrees (right) was located most laterally/superficially, whereas directions 180 degrees (left) and 270 degrees (down) elicited activation more medially within the hand area. Activation related to direction 90 degrees was located between the other directions. Moreover, by investigating differences between activations related to movement along the horizontal (0 degrees+180 degrees) and vertical (90 degrees+270 degrees) axis, we found that activation related to the horizontal axis was located more anterolaterally/dorsally in M1 than for the vertical axis, supporting that activations related to individual movement directions are direction- and not muscle related. Our results of spatially segregated direction-related activations in M1 are in accordance with findings of recent fMRI studies on neural encoding of direction in human M1. Our results thus provide further evidence for a direct link between direction as an organizational principle in sensorimotor transformation and movement execution coded by effector representations in M1.	[Toxopeus, Carolien M.; de Jong, Bauke M.; Leenders, Klaus L.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Valsan, Gopal; Conway, Bernard A.] Univ Strathclyde, Bioengn Unit, Glasgow, Lanark, Scotland	University of Groningen; University of Strathclyde	Toxopeus, CM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	c.m.toxopeus@umcg.nl	Conway, Bernard/A-9625-2016	Conway, Bernard/0000-0002-0069-0131; de Jong, Bauke M./0000-0002-6568-5739; Maurits, Natasha/0000-0001-6231-7044	International Parkinson Foundation	International Parkinson Foundation	This study was part of a series of studies funded by the International Parkinson Foundation; Grant title: "Initiation and Inhibition of Movement in Patients with Parkinson's Disease: New Insights Using a Direct Coupling Between Movement, Muscle and Brain Activity'' (Website:http://www.parkinsonfonds.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; ASHE J, MOTOR CORTEX VOLUNTA, P146; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; BURNOD Y, 1992, J NEUROSCI, V12, P1435; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Contreras-Vidal JL, 1998, ACTA PSYCHOL, V100, P25, DOI 10.1016/S0001-6918(98)00023-7; Contreras-Vidal JL, 2004, NEUROIMAGE, V21, P936, DOI 10.1016/j.neuroimage.2003.10.037; Cowper-Smith CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013330; Davidson AG, 2007, SCIENCE, V318, P1934, DOI 10.1126/science.1149774; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Eisenberg M, 2010, J NEUROSCI, V30, P8897, DOI 10.1523/JNEUROSCI.0007-10.2010; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; Fabbri S, 2010, J NEUROSCI, V30, P13488, DOI 10.1523/JNEUROSCI.2571-10.2010; Fink GR, 2003, NEUROIMAGE, V20, P1505, DOI 10.1016/j.neuroimage.2003.07.006; FLANDERS M, 1990, J NEUROSCI, V10, P2420; FLASH T, 1985, NEUROSCIENCE, V7, P1688; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GEORGOPOULOS AP, 1986, ANNU REV NEUROSCI, V9, P147, DOI 10.1146/annurev.ne.09.030186.001051; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Griffin DM, 2011, J NEUROSCI, V31, P13088, DOI 10.1523/JNEUROSCI.6322-10.2011; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Jackson J H, 1873, Br Med J, V1, P531; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Lacquaniti F, 1998, EUR J NEUROSCI, V10, P195; Leopold DA, 2010, NATURE, V465, P700, DOI 10.1038/465700a; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3237, DOI 10.1152/jn.00488.2006; Penfield W, 1950, CEREBRAL CORTEX MAN; Post M, 2009, J NEUROSCI, V29, P6353, DOI 10.1523/JNEUROSCI.0631-09.2009; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Stenekes MW, 2006, NEUROIMAGE, V32, P676, DOI 10.1016/j.neuroimage.2006.04.198; Terumitsu M, 2009, NEUROREPORT, V20, P679, DOI 10.1097/WNR.0b013e32832a1820; Vallar G, 1999, EXP BRAIN RES, V124, P281, DOI 10.1007/s002210050624; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Z'Graggen WJ, 2009, J PHYSIOL-LONDON, V587, P1977, DOI 10.1113/jphysiol.2009.171066	58	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27838	10.1371/journal.pone.0027838	http://dx.doi.org/10.1371/journal.pone.0027838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110768	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000297555400126
J	Yang, JD; Zheng, J; Wu, L; Shi, M; Zhang, HT; Wang, X; Xia, N; Wang, DS; Liu, XP; Yao, LB; Li, Y; Dou, KF				Yang, Jiandong; Zheng, Jin; Wu, Lin; Shi, Ming; Zhang, Hongtao; Wang, Xing; Xia, Ning; Wang, Desheng; Liu, Xinping; Yao, Libo; Li, Yan; Dou, Kefeng			NDRG2 Ameliorates Hepatic Fibrosis by Inhibiting the TGF-beta 1/Smad Pathway and Altering the MMP2/TIMP2 Ratio in Rats	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; DOWNSTREAM REGULATED GENE-2; STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; TGF-BETA; EXPRESSION; APOPTOSIS; METALLOPROTEINASE; REGENERATION	Liver fibrosis is a worldwide clinical issue. It has been well established that activated hepatic stellate cells (HSCs) are responsible for excessive extracellular matrix (ECM) deposition in chronically damaged livers. The identification of key elements that control HSCs activation will help to further our understanding of liver fibrosis and improve the outcome of clinical treatment. This study demonstrates that N-Myc downstream-regulated gene 2 (NDRG2) is a potential regulator of liver fibrosis as NDRG2 mRNA and protein levels were reduced during HSCs activation. In addition, enhanced NDRG2 expression reduced Smad3 transcription and phosphorylation, which inhibited HSCs activation by blocking the TGF-beta 1 signal. Moreover, NDRG2 contributed to an increase in the ratio of matrix metalloproteinase 2 (MMP2) to tissue inhibitor of matrix metalloproteinase 2 (TIMP2), which may facilitate the degradation of the ECM. In dimethylnitrosamine (DMN)-induced fibrotic rat livers, adenovirus-mediated NDRG2 overexpression resulted in decreased ECM deposition and improved liver function compared with controls. In conclusion, the present findings indicate that the modulation of NDRG2 is a promising strategy for the treatment of liver fibrosis.	[Yang, Jiandong; Zhang, Hongtao; Wang, Xing; Xia, Ning; Wang, Desheng; Dou, Kefeng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Yang, Jiandong; Wu, Lin; Liu, Xinping; Yao, Libo; Li, Yan] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zheng, Jin] Fourth Mil Med Univ, Tangdu Hosp, Dept Tradit Chinese & Western Med Oncol, Xian 710032, Peoples R China; [Shi, Ming] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yang, JD (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China.	lsqfmmu@fmmu.edu.cn; doukef@163.com	Li, Yan/AAA-6908-2021; Li, Yan/A-7115-2018; Shi, Ming/B-7829-2012	Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0002-7465-7705; 	National Natural Science Foundation of China [81072973, 81100764, 30830054, 31070681, 81170400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grants 81072973; 81100764; 30830054; 31070681; 81170400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt E, 2005, CELL PROLIFERAT, V38, P287, DOI 10.1111/j.1365-2184.2005.00350.x; ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bodey B, 2001, IN VIVO, V15, P71; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Chen AP, 2000, MOL CELL BIOL, V20, P2818, DOI 10.1128/MCB.20.8.2818-2826.2000; Choi SC, 2003, FEBS LETT, V553, P413, DOI 10.1016/S0014-5793(03)01030-5; Dooley S, 2001, BIOCHEM BIOPH RES CO, V283, P554, DOI 10.1006/bbrc.2001.4811; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518; Hu Xiao-Lan, 2006, Shengli Xuebao, V58, P331; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Liu N, 2007, BIOCHEM BIOPH RES CO, V358, P164, DOI 10.1016/j.bbrc.2007.04.089; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; Okamoto K, 2005, J GASTROEN HEPATOL, V20, P1102, DOI 10.1111/j.1440-1746.2005.03860.x; Ozaki I, 2000, CANCER RES, V60, P6519; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Senties-Gomez Maria Daniela, 2005, Gac Med Mex, V141, P315; Shen L, 2008, NEUROREPORT, V19, P927, DOI 10.1097/WNR.0b013e32830163d0; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Taimr P, 2003, HEPATOLOGY, V37, P87, DOI 10.1053/jhep.2003.50002; Takahara Y, 2006, WORLD J GASTROENTERO, V12, P6473, DOI 10.3748/wjg.v12.i40.6473; Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758; Uemura M, 2005, MOL BIOL CELL, V16, P4214, DOI 10.1091/mbc.E05-02-0149; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wu Guo-Qiang, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P357; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang JD, 2010, WOUND REPAIR REGEN, V18, P524, DOI 10.1111/j.1524-475X.2010.00614.x; Zhang J, 2007, BIOCHEM BIOPH RES CO, V352, P6, DOI 10.1016/j.bbrc.2006.10.141	39	29	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27710	10.1371/journal.pone.0027710	http://dx.doi.org/10.1371/journal.pone.0027710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110735	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400092
J	Agouni, A; Ducluzeau, PH; Benameur, T; Faure, S; Sladkova, M; Duluc, L; Leftheriotis, G; Pechanova, O; Delibegovic, M; Martinez, MC; Andriantsitohaina, R				Agouni, Abdelali; Ducluzeau, Pierre-Henri; Benameur, Tarek; Faure, Sebastien; Sladkova, Martina; Duluc, Lucie; Leftheriotis, Georges; Pechanova, Olga; Delibegovic, Mirela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson			Microparticles from Patients with Metabolic Syndrome Induce Vascular Hypo-Reactivity via Fas/Fas-Ligand Pathway in Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SHED-MEMBRANE MICROPARTICLES; NITRIC-OXIDE; CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; PROINFLAMMATORY PROTEINS; UP-REGULATION; FAS; DISEASE; EXPRESSION	Microparticles are membrane vesicles with pro-inflammatory properties. Circulating levels of microparticles have previously been found to be elevated in patients with metabolic syndrome (MetS). The present study aimed to evaluate the effects of in vivo treatment with microparticles, from patients with MetS and from healthy subjects (HS), on ex vivo vascular function in mice. Microparticles isolated from MetS patients or HS, or a vehicle were intravenously injected into mice, following which vascular reactivity in response to vasoconstrictor agonists was assessed by myography with respect to cyclo-oxygenase pathway, oxidative and nitrosative stress. Injection of microparticles from MetS patients into mice induced vascular hyporeactivity in response to serotonin. Hypo-reactivity was associated with up-regulation of inducible NO-synthase and increased production of NO, and was reversed by the NO-synthase inhibitor (N(G)-nitro-L-arginine). The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin. MetS microparticle-mediated vascular dysfunction was associated with increased reactive oxygen species (ROS) and enhanced expression of the NADPH oxidase subunits. Neutralization of the proinflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1). Our data provide evidence that microparticles from MetS patients induce ex vivo vascular dysfunction by increasing both ROS and NO release and by altering cyclo-oxygenase metabolites and MCP-1 through the Fas/FasL pathway.	[Agouni, Abdelali; Ducluzeau, Pierre-Henri; Benameur, Tarek; Faure, Sebastien; Sladkova, Martina; Duluc, Lucie; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] INSERM, U694, Angers, France; [Agouni, Abdelali; Ducluzeau, Pierre-Henri; Benameur, Tarek; Faure, Sebastien; Sladkova, Martina; Duluc, Lucie; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] Univ Angers, Angers, France; [Agouni, Abdelali; Delibegovic, Mirela] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Ducluzeau, Pierre-Henri] CHU Angers, Dept Endocrinol & Diabet, Angers, France; [Sladkova, Martina] Slovak Acad Sci, Inst Normal & Pathol Physiol, Bratislava, Slovakia; [Leftheriotis, Georges; Pechanova, Olga] INSERM, U771, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; University of Aberdeen; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Slovak Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Agouni, A (corresponding author), INSERM, U694, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; Sladkova-Faure, Martina/AAD-1505-2019; BENAMEUR, TAREK/P-9053-2019; ducluzeau, pierre-henri/ABE-1092-2021; Clere, Nicolas/K-4414-2015; B, T/ABD-6713-2020; Agouni, Abdelali/AAP-5298-2020	Agouni, Abdelali/0000-0002-8363-1582; Delibegovic, Mirela/0000-0001-6193-3152; Faure, Sebastien/0000-0001-7524-8295; Sladkova-Faure, Martina/0000-0003-4548-0290; andriantsitohaina, ramaroson/0000-0002-4770-3585; Duluc, Lucie/0000-0002-5952-8008	Fonds Europeen pour le Developpement Regional [8891]; Fondation pour la Recherche Medicale [INE20050303433, INE20060306500]; CNRS; INSERM; Universite d'Angers; French Education Ministry (MENRT)	Fonds Europeen pour le Developpement Regional; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Angers; French Education Ministry (MENRT)	This work was supported in part by grants from Fonds Europeen pour le Developpement Regional (R.A. n degrees 8891), Fondation pour la Recherche Medicale (R.A. n degrees INE20050303433 and MCM n degrees INE20060306500), CNRS, INSERM and Universite d'Angers. A.A. and T.B. are recipients of doctoral fellowships from the French Education Ministry (MENRT). R.A. is supported by a "Contrat d'Interface" INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FUND CLIN PHARMACOL, V21, P21; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arteaga RB, 2006, AM J CARDIOL, V98, P70, DOI 10.1016/j.amjcard.2006.01.054; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chew GT, 2006, MED J AUSTRALIA, V185, P445, DOI 10.5694/j.1326-5377.2006.tb00644.x; Chironi G, 2006, ARTERIOSCL THROM VAS, V26, P2775, DOI 10.1161/01.ATV.0000249639.36915.04; Ehrenschwender M, 2009, ADV EXP MED BIOL, V647, P64, DOI 10.1007/978-0-387-89520-8_5; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Fukuo K, 1996, HYPERTENSION, V27, P823, DOI 10.1161/01.HYP.27.3.823; Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002; Geng YJ, 1997, ARTERIOSCL THROM VAS, V17, P2200, DOI 10.1161/01.ATV.17.10.2200; Gonzalez-Quintero VH, 2004, AM J OBSTET GYNECOL, V191, P1418, DOI 10.1016/j.ajog.2004.06.044; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HANSSON GK, 1994, J EXP MED, V180, P733, DOI 10.1084/jem.180.2.733; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Magliano DJ, 2006, ANN MED, V38, P34, DOI 10.1080/07853890500300311; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; MARTINEZ MC, 2011, TRENDS PHARM SCI; MARTINEZ MC, CIRC RES, V109, P110; Meziani F, 2006, AM J PATHOL, V169, P1473, DOI 10.2353/ajpath.2006.051304; Mostefai HA, 2008, PHYSIOL RES, V57, P311, DOI 10.33549/physiolres.931533; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; PRIOU P, AM J PATHOL, V177, P974; Sata M, 2000, ARTERIOSCL THROM VAS, V20, P309, DOI 10.1161/01.ATV.20.2.309; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Schaub FJ, 2003, CIRC RES, V93, P515, DOI 10.1161/01.RES.0000093205.42313.7C; Seizer P, 2008, CURR MED CHEM, V15, P1976, DOI 10.2174/092986708785132852; Sesti G, 2006, BEST PRACT RES CL EN, V20, P665, DOI 10.1016/j.beem.2006.09.007; Tesse A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P287, DOI 10.2174/187153006778249976; Tesse A, 2005, ARTERIOSCL THROM VAS, V25, P2522, DOI 10.1161/01.ATV.0000189298.62240.5d; Tesse A, 2008, J PHARMACOL EXP THER, V324, P539, DOI 10.1124/jpet.107.130278; Tesse A, 2007, AM J PHYSIOL-HEART C, V293, pH520, DOI 10.1152/ajpheart.01094.2006; TUALCHALOT S, MOL INTERV, V11, P88; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	42	46	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27809	10.1371/journal.pone.0027809	http://dx.doi.org/10.1371/journal.pone.0027809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110764	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300053
J	Iwakami, S; Misu, H; Takeda, T; Sugimori, M; Matsugo, S; Kaneko, S; Takamura, T				Iwakami, Satoshi; Misu, Hirofumi; Takeda, Takashi; Sugimori, Makoto; Matsugo, Seiichi; Kaneko, Shuichi; Takamura, Toshinari			Concentration-dependent Dual Effects of Hydrogen Peroxide on Insulin Signal Transduction in H4IIEC Hepatocytes	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MITOCHONDRIAL; GLUCOSE; RISK; SUPPLEMENTATION; PHOSPHORYLATION; THIOREDOXIN; RESISTANCE; VANADATE; STRESS	Background: Oxidative stress induced by the accumulation of reactive oxygen species (ROS) has a causal role in the development of insulin resistance, whereas ROS themselves function as intracellular second messengers that promote insulin signal transduction. ROS can act both positively and negatively on insulin signaling, but the molecular mechanisms controlling these dual actions of ROS are not fully understood. Methodology/Principal Findings: Here, we directly treated H4IIEC hepatocytes with hydrogen peroxide (H2O2), a representative membrane-permeable oxidant and the most abundant ROS in cells, to identify the key factors determining whether ROS impair or enhance intracellular insulin signaling. Treatment with high concentrations of H2O2 (25-50 mu M) for 3 h reduced insulin-stimulated Akt phosphorylation, and increased the phosphorylation of both JNK and its substrate c-Jun. In contrast, lower concentrations of H2O2 (5-10 mu M) enhanced insulin-stimulated phosphorylation of Akt. Moreover, lower concentrations suppressed PTP1B activity, suggesting that JNK and phosphatases such as PTP1B may play roles in determining the thresholds for the diametrical effects of H2O2 on cellular insulin signaling. Pretreatment with antioxidant N-acetyl-L-cysteine (10 mM) canceled the signal-promoting action of low H2O2 (5 mu M), and it canceled out further impairment of insulin of insulin signaling induced by high H2O2 (25 mu M). Conclusions/Significance: Our results demonstrate that depending on its concentration, H2O2 can have the positive or negative effect on insulin signal transduction in H4IIEC hepatocytes, suggesting that the concentration of intracellular ROS may be a major factor in determining whether ROS impair or enhance insulin signaling.	[Iwakami, Satoshi; Misu, Hirofumi; Takeda, Takashi; Sugimori, Makoto; Kaneko, Shuichi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Iwakami, Satoshi; Takeda, Takashi; Matsugo, Seiichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Engn, Kanazawa, Ishikawa 9201192, Japan; [Matsugo, Seiichi] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst Bioengn Course, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Iwakami, S (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	ttakamura@m-kanazawa.jp			Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Banerjee D, 2003, CLIN CHIM ACTA, V337, P147, DOI 10.1016/j.cccn.2003.08.004; Czernichow S, 2006, AM J CLIN NUTR, V84, P395; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Eriksson JW, 2007, FEBS LETT, V581, P3734, DOI 10.1016/j.febslet.2007.06.044; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; KOSHIO O, 1988, BIOCHEM J, V250, P95, DOI 10.1042/bj2500095; Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456; Liu SM, 1999, JAMA-J AM MED ASSOC, V282, P1073, DOI 10.1001/jama.282.11.1073; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Pugazhenthi S, 1996, ARCH BIOCHEM BIOPHYS, V335, P273, DOI 10.1006/abbi.1996.0508; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Srivastava AK, 2005, DIABETIC MED, V22, P2, DOI 10.1111/j.1464-5491.2004.01381.x; WINTERBOURN CC, 1985, BIOCHEM J, V228, P583, DOI 10.1042/bj2280583; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	27	74	78	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27401	10.1371/journal.pone.0027401	http://dx.doi.org/10.1371/journal.pone.0027401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102892	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300018
J	Visani, G; Sapienza, MR; Isidori, A; Tripodo, C; Laginestra, MA; Righi, S; Sacchetti, CAS; Gazzola, A; Mannu, C; Rossi, M; De Nictolis, M; Valentini, M; Donati, M; Emiliani, R; Alesiani, F; Paolini, S; Finelli, C; Pileri, SA; Piccaluga, PP				Visani, Giuseppe; Sapienza, Maria Rosaria; Isidori, Alessandro; Tripodo, Claudio; Laginestra, Maria Antonella; Righi, Simona; Sacchetti, Carlo A. Sagramoso; Gazzola, Anna; Mannu, Claudia; Rossi, Maura; De Nictolis, Michele; Valentini, Massimo; Donati, Meris; Emiliani, Roberto; Alesiani, Francesco; Paolini, Stefania; Finelli, Carlo; Pileri, Stefano A.; Piccaluga, Pier Paolo			SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis	PLOS ONE			English	Article							RISK MYELODYSPLASTIC SYNDROMES; TYROSINE-PHOSPHATASE SHP-1; MYELOPROLIFERATIVE DISORDERS; UNIPARENTAL DISOMY; HUMAN GENOME; CYTOGENETIC ABNORMALITIES; MYELOID MALIGNANCIES; CLINICAL-RELEVANCE; COPY NUMBER; POLYMORPHISM	The molecular pathogenesis of primary mielofibrosis (PMF) is still largely unknown. Recently, single-nucleotide polymorphism arrays (SNP-A) allowed for genome-wide profiling of copy-number alterations and acquired uniparental disomy (aUPD) at high-resolution. In this study we analyzed 20 PMF patients using the Genome-Wide Human SNP Array 6.0 in order to identify novel recurrent genomic abnormalities. We observed a complex karyotype in all cases, detecting all the previously reported lesions (del(5q), del(20q), del(13q), +8, aUPD at 9p24 and abnormalities on chromosome 1). In addition, we identified several novel cryptic lesions. In particular, we found a recurrent alteration involving cytoband 20p13 in 55% of patients. We defined a minimal affected region (MAR), an amplification of 9,911 base-pair (bp) overlapping the SIRPB1 gene locus. Noteworthy, by extending the analysis to the adjacent areas, the cytoband was overall affected in 95% of cases. Remarkably, these results were confirmed by real-time PCR and validated in silico in a large independent series of myeloproliferative diseases. Finally, by immunohistochemistry we found that SIRPB1 was over-expressed in the bone marrow of PMF patients carrying 20p13 amplification. In conclusion, we identified a novel highly recurrent genomic lesion in PMF patients, which definitely warrant further functional and clinical characterization.	[Visani, Giuseppe; Isidori, Alessandro] San Salvatore Hosp, Hematol & Hematopoiet Stem Cell Transplant Ctr, Pesaro, Italy; [Sapienza, Maria Rosaria; Laginestra, Maria Antonella; Righi, Simona; Sacchetti, Carlo A. Sagramoso; Gazzola, Anna; Mannu, Claudia; Rossi, Maura; Paolini, Stefania; Finelli, Carlo; Pileri, Stefano A.; Piccaluga, Pier Paolo] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol L&A Seragnoli, Mol Pathol Lab,Hematopathol Sect, Bologna, Italy; [Sapienza, Maria Rosaria; Laginestra, Maria Antonella; Righi, Simona; Sacchetti, Carlo A. Sagramoso; Gazzola, Anna; Mannu, Claudia; Rossi, Maura; Paolini, Stefania; Finelli, Carlo; Pileri, Stefano A.; Piccaluga, Pier Paolo] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol L&A Seragnoli, Mol Pathol Lab,Hematol Sect, Bologna, Italy; [Tripodo, Claudio] Univ Palermo, Dept Human Pathol, Palermo, Italy; [De Nictolis, Michele] San Salvatore Hosp, Dept Pathol, Pesaro, Italy; [Valentini, Massimo; Donati, Meris; Emiliani, Roberto] San Salvatore Hosp, Clin Pathol Lab, Pesaro, Italy; [Alesiani, Francesco] Bartolomeo Eustachio Hosp, San Severino Marche, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Palermo	Visani, G (corresponding author), San Salvatore Hosp, Hematol & Hematopoiet Stem Cell Transplant Ctr, Pesaro, Italy.	pierpaolo.piccaluga@unibo.it	Tripodo, Claudio/AAB-6004-2022; Tripodo, Claudio/O-4536-2016; Piccaluga, Pier Paolo/H-7132-2019; Isidori, Alessandro/ABE-8256-2020; Sapienza, Maria Rosaria/AAR-7803-2020; Pileri, Stefano/AAP-6337-2020; Paolini, Stefania/K-9514-2016	Tripodo, Claudio/0000-0002-0821-6231; Tripodo, Claudio/0000-0002-0821-6231; Piccaluga, Pier Paolo/0000-0002-9432-0595; Isidori, Alessandro/0000-0002-5723-9229; Sapienza, Maria Rosaria/0000-0002-1078-2128; Rossi, Maura/0000-0002-9522-1601; gazzola, anna/0000-0001-8131-7170; PAOLINI, Stefania/0000-0002-5645-0364; Paolini, Stefania/0000-0003-4958-1013	AIL Pesaro onlus, BolognAIL, Centro Interdipartimentale per la Ricerca sul Cancro; AIRC [IG4987, 10007 5xMille, IG10519]; RFO; Fondazione Cassa di Risparmio in Bologna; Fondazione della Banca del Monte e Ravenna; Progetto Strategico di Ateneo	AIL Pesaro onlus, BolognAIL, Centro Interdipartimentale per la Ricerca sul Cancro; AIRC(Fondazione AIRC per la ricerca sul cancro); RFO; Fondazione Cassa di Risparmio in Bologna(Fondazione Carisbo); Fondazione della Banca del Monte e Ravenna; Progetto Strategico di Ateneo	This work was supported by AIL Pesaro onlus, BolognAIL, Centro Interdipartimentale per la Ricerca sul Cancro "G. Prodi", AIRC (IG4987; 10007 5xMille; IG10519), RFO (Prof. Pileri, Dr. Piccaluga), Fondazione Cassa di Risparmio in Bologna, Fondazione della Banca del Monte e Ravenna, Progetto Strategico di Ateneo 2006 (Prof. Pileri and Dr. Piccaluga). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219; Carobbio A, 2008, J CLIN ONCOL, V26, P2732, DOI 10.1200/JCO.2007.15.3569; Deininger MWN, 2007, CANCER-AM CANCER SOC, V110, P1509, DOI 10.1002/cncr.22936; Douet-Guilbert N, 2008, ANN HEMATOL, V87, P537, DOI 10.1007/s00277-008-0462-3; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; GAIDANO G, 1994, LEUKEMIA, V8, pS27; Gaikwad S, 2009, AM J PATHOL, V175, P2528, DOI 10.2353/ajpath.2009.090147; Gondek LP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001225; Gondek LP, 2007, EXP HEMATOL, V35, P1728, DOI 10.1016/j.exphem.2007.08.009; Huh J, 2010, GENE CHROMOSOME CANC, V49, P390, DOI 10.1002/gcc.20748; Hussein K, 2009, EUR J HAEMATOL, V82, P329, DOI 10.1111/j.1600-0609.2009.01224.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kawamata N, 2008, EXP HEMATOL, V36, P1471, DOI 10.1016/j.exphem.2008.06.006; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Levine RL, 2009, NEW ENGL J MED, V360, P2355, DOI 10.1056/NEJMe0902257; Maciejewski JP, 2008, BLOOD, V112, P965, DOI 10.1182/blood-2008-02-130435; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Pedersen-Bjergaard J, 2006, LEUKEMIA, V20, P1943, DOI 10.1038/sj.leu.2404381; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stein BL, 2010, JAMA-J AM MED ASSOC, V303, P2513, DOI 10.1001/jama.2010.853; Swerdlow S.H., 2008, WHO CLASSIFICATIONS, V4th, P44; Tam CS, 2009, BLOOD, V113, P4171, DOI 10.1182/blood-2008-09-178541; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Tefferi A, 2001, BRIT J HAEMATOL, V113, P763, DOI 10.1046/j.1365-2141.2001.02796.x; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Thoennissen NH, 2010, BLOOD, V115, P2882, DOI 10.1182/blood-2009-07-235119; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; TRIPODO C, 2011, NATURE REV IN PRESS; Tripodo C, 2009, HAEMATOL-HEMATOL J, V94, P127, DOI 10.3324/haematol.13598; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Volik S, 2006, GENOME RES, V16, P394, DOI 10.1101/gr.4247306; Walker BA, 2006, BLOOD, V108, P1733, DOI 10.1182/blood-2006-02-005496	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27560	10.1371/journal.pone.0027560	http://dx.doi.org/10.1371/journal.pone.0027560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110671	gold, Green Submitted, Green Published			2022-12-25	WOS:000297554300037
J	He, Y; Correa, AM; Raso, MG; Hofstetter, WL; Fang, BL; Behrens, C; Roth, JA; Zhou, YH; Yu, LP; Wistuba, II; Swisher, SG; Pataer, A				He, Yong; Correa, Arlene M.; Raso, Maria Gabriela; Hofstetter, Wayne L.; Fang, Bingliang; Behrens, Carmen; Roth, Jack A.; Zhou, Yihong; Yu, Liping; Wistuba, Ignacio I.; Swisher, Stephen G.; Pataer, Apar			The Role of PKR/eIF2 alpha Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DEPENDENT-PROTEIN-KINASE; COLON-CANCER; EXPRESSION; PKR; INTERFERON; CARCINOMA; APOPTOSIS; MELANOMA; P68	Background: In this study, we investigated whether PKR protein expression is correlated with mRNA levels and also evaluated molecular biomarkers that are associated with PKR, such as phosphorylated PKR (p-PKR) and phosphorylated eIF2 alpha (p-eIF2 alpha). Methodology and Findings: We determined the levels of PKR protein expression and mRNA in 36 fresh primary lung tumor tissues by using Western blot analysis and real-time reverse-transcriptase PCR (RT-PCR), respectively. We used tissue microarrays for immunohistochemical evaluation of the expression of p-PKR and p-eIF2 alpha proteins. We demonstrated that PKR mRNA levels are significantly correlated with PKR protein levels (Spearman's rho = 0.55, p, 0.001), suggesting that PKR protein levels in tumor samples are regulated by PKR mRNA. We also observed that the patients with high p-PKR or p-eIF2 alpha expression had a significantly longer median survival than those with little or no p-PKR or p-eIF2 alpha expression (p = 0.03 and p = 0.032, respectively). We further evaluated the prognostic effect of combined expression of p-PKR plus PKR and p-eIF2 alpha plus PKR and found that both combinations were strong independent prognostic markers for overall patient survival on stage I and all stage patients. Conclusions: Our findings suggest that PKR protein expression may controlled by transcription level. Combined expression levels of PKR and p-PKR or p-eIF2 alpha can be new markers for predicting the prognosis of patients with NSCLC.	[He, Yong] Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China; [He, Yong; Correa, Arlene M.; Hofstetter, Wayne L.; Fang, Bingliang; Roth, Jack A.; Swisher, Stephen G.; Pataer, Apar] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Raso, Maria Gabriela; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Behrens, Carmen; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Zhou, Yihong] Univ Calif Irvine, Dept Neurol Surg & Biol Chem, Irvine, CA USA; [Yu, Liping] Ziren Res LLC, Irvine, CA USA	Army Medical University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Irvine	He, Y (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China.	apataer@mdanderson.org	raso, maria/AAS-2118-2020; Raso, Maria Gabriela/J-9898-2019	raso, maria/0000-0003-2105-5556; 	National Institutes of Health through M.D. Anderson's Cancer Center [CA-016672, CA-070907, CA-124591]; Department of Defense [W81XWH-07-1-0306]; National Natural Science Foundation of China [30600611, 81071912]; Third Military Medical University of China; Homer Flower Gene Therapy Fund; Charles Rogers Gene Therapy Fund; Margaret Wiess Elkins Endowed Research Fund; Flora and Stuart Mason Lung Cancer Research Fund; Phalan Thoracic Gene Therapy Fund; George P. Sweeney Esophageal Research Fund; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through M.D. Anderson's Cancer Center; Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University of China; Homer Flower Gene Therapy Fund; Charles Rogers Gene Therapy Fund; Margaret Wiess Elkins Endowed Research Fund; Flora and Stuart Mason Lung Cancer Research Fund; Phalan Thoracic Gene Therapy Fund; George P. Sweeney Esophageal Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant CA-016672 - Lung Program, a Specialized Program of Research Excellence (SPORE) Grant CA-070907 (to IW), and an R01 Grant CA-124591 (to BF). Further support came from Department of Defense grant W81XWH-07-1-0306 (to IW), the National Natural Science Foundation of China (30600611, 81071912) (to YH) and "1510 project'' of Third Military Medical University of China (to YH), and from the Homer Flower Gene Therapy Fund, the Charles Rogers Gene Therapy Fund, the Margaret Wiess Elkins Endowed Research Fund, the Flora and Stuart Mason Lung Cancer Research Fund, the Phalan Thoracic Gene Therapy Fund, and the George P. Sweeney Esophageal Research Fund (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; DACQUISTO F, 2001, SCI STKE, pRE1; HAINES GK, 1993, ARCH OTOLARYNGOL, V119, P1142; Hii SI, 2004, INT J CANCER, V109, P329, DOI 10.1002/ijc.11714; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; Hu WX, 2009, J PHARMACOL EXP THER, V328, P866, DOI 10.1124/jpet.108.141754; Kim SH, 2002, ONCOGENE, V21, P8741, DOI 10.1038/sj.onc.1205987; Kim SH, 2000, ONCOGENE, V19, P3086, DOI 10.1038/sj.onc.1203632; Li SY, 2001, J BIOL CHEM, V276, P13881, DOI 10.1074/jbc.M008140200; Mounir Z, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000389; Pataer A, 2002, CANCER RES, V62, P2239; Pataer A, 2010, CLIN CANCER RES, V16, P5522, DOI 10.1158/1078-0432.CCR-10-0753; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Shimada A, 1998, CANCER RES, V58, P4434; SINGH C, 1995, TUMOR BIOL, V16, P281, DOI 10.1159/000217945; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Travis WD, 2006, J THORAC ONCOL, V1, pS13, DOI 10.1097/01243894-200611001-00004; Trisciuoglio D, 2008, J NATL CANCER I, V100, P1233, DOI 10.1093/jnci/djn239; Vorburger Stephan A, 2004, Am J Pharmacogenomics, V4, P189, DOI 10.2165/00129785-200404030-00006; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Zhou YH, 2005, NEURO-ONCOLOGY, V7, P485, DOI 10.1215/S1152851704000730; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	23	30	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e24855	10.1371/journal.pone.0024855	http://dx.doi.org/10.1371/journal.pone.0024855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102852	Green Submitted, Green Published, gold			2022-12-25	WOS:000297348800001
J	McGregor, S; Polani, D; Dautenhahn, K				McGregor, Simon; Polani, Daniel; Dautenhahn, Kerstin			Generation of Tactile Maps for Artificial Skin	PLOS ONE			English	Article							SENSORS	Prior research has shown that representations of retinal surfaces can be learned from the intrinsic structure of visual sensory data in neural simulations, in robots, as well as by animals. Furthermore, representations of cochlear ( frequency) surfaces can be learned from auditory data in neural simulations. Advances in hardware technology have allowed the development of artificial skin for robots, realising a new sensory modality which differs in important respects from vision and audition in its sensorimotor characteristics. This provides an opportunity to further investigate ordered sensory map formation using computational tools. We show that it is possible to learn representations of non-trivial tactile surfaces, which require topologically and geometrically involved three-dimensional embeddings. Our method automatically constructs a somatotopic map corresponding to the configuration of tactile sensors on a rigid body, using only intrinsic properties of the tactile data. The additional complexities involved in processing the tactile modality require the development of a novel multi-dimensional scaling algorithm. This algorithm, ANISOMAP, extends previous methods and outperforms them, producing high-quality reconstructions of tactile surfaces in both simulation and hardware tests. In addition, the reconstruction turns out to be robust to unanticipated hardware failure.	[McGregor, Simon; Polani, Daniel; Dautenhahn, Kerstin] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	McGregor, S (corresponding author), Univ Hertfordshire, Hatfield AL10 9AB, Herts, England.	d.polani@herts.ac.uk	Polani, Daniel/AAJ-9529-2020	Dautenhahn, Kerstin/0000-0002-9263-3897	European Commission [231500]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was partially funded by the European Commission's Seventh Framework Programme FP7/2007-2013) under grant agreement number 231500. The work described in this paper is conducted within the EU project RoboSKIN. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacardit J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-6; Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Cannata G, 2010, COGSYS 2010 4 INT C, P121; Cannata G, 2010, IEEE INT CONF ROBOT, P4849, DOI 10.1109/ROBOT.2010.5509370; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; CRUTCHFIELD JP, 1990, WOODW CONF, P119; De Leeuw J., 1977, RECENT DEV STAT, P133; Farah MJ, 1998, NEURAL COMPUT, V10, P1983, DOI 10.1162/089976698300016936; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; HELD R, 1963, J COMP PHYSIOL PSYCH, V56, P872, DOI 10.1037/h0040546; Kohonen T., 1995, ICANN '95. International Conference on Artificial Neural Networks. Neuronimes '95 Scientific Conference, P3; Kuniyoshi Y, 2007, PROG BRAIN RES, V164, P425, DOI 10.1016/S0079-6123(07)64023-0; McGregor S, 2010, AISB2010 ANN CONV SO, V18, P121; McGregor S, 2010, P 36 ANN CONV SOC ST; Miikkulainen R, 2005, COMPUTATIONAL MAPS V; Modayil J, 2010, IEEE INT C DEV LEARN; Obermayer K, 1989, PARALLEL PROCESSING, P71; Olsson L, 2005, 2005 IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, PROCEEDINGS, P587, DOI 10.1109/CIRA.2005.1554340; Olsson L, 2004, 2004 NASA/DOD CONFERENCE ON EVOLVABLE HARDWARE, PROCEEDINGS, P153; Olsson LA, 2006, CONNECT SCI, V18, P121, DOI 10.1080/09540090600768542; Overduin SA, 2004, NEUROIMAGE, V23, P462, DOI 10.1016/j.neuroimage.2004.06.024; PALAKAL MJ, 1995, MATH COMPUT MODEL, V22, P7, DOI 10.1016/0895-7177(95)00107-D; Philipona D, 2003, NEURAL COMPUT, V15, P2029, DOI 10.1162/089976603322297278; Pierce D, 1997, ARTIF INTELL, V92, P169, DOI 10.1016/S0004-3702(96)00051-3; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; Sporns O, 2006, ARTIFICIAL LIFE; Stafford T, 2007, NEUROCOMPUTING, V70, P1932, DOI 10.1016/j.neucom.2006.10.134; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Yu Y, 1999, IEEE VIS 99 C P, P61	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26561	10.1371/journal.pone.0026561	http://dx.doi.org/10.1371/journal.pone.0026561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102863	gold, Green Submitted, Green Published			2022-12-25	WOS:000297348800007
J	Mattia, K; Puffer, BA; Williams, KL; Gonzalez, R; Murray, M; Sluzas, E; Pagano, D; Ajith, S; Bower, M; Berdougo, E; Harris, E; Doranz, BJ				Mattia, Kimberly; Puffer, Bridget A.; Williams, Katherine L.; Gonzalez, Ritela; Murray, Meredith; Sluzas, Emily; Pagano, Dan; Ajith, Sandya; Bower, Megan; Berdougo, Eli; Harris, Eva; Doranz, Benjamin J.			Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes	PLOS ONE			English	Article							WEST-NILE-VIRUS; PACKAGING CELL-LINE; DC-SIGN; MONOCLONAL-ANTIBODIES; INFECTION; DETERMINANTS; ASSAY; IDENTIFICATION; ENCEPHALITIS; PATHOGENESIS	The lack of reliable, high-throughput tools for characterizing anti-dengue virus (DENV) antibodies in large numbers of serum samples has been an obstacle in understanding the impact of neutralizing antibodies on disease progression and vaccine efficacy. A reporter system using pseudoinfectious DENV reporter virus particles (RVPs) was previously developed by others to facilitate the genetic manipulation and biological characterization of DENV virions. In the current study, we demonstrate the diagnostic utility of DENV RVPs for measuring neutralizing antibodies in human serum samples against all four DENV serotypes, with attention to the suitability of DENV RVPs for large-scale, long-term studies. DENV RVPs used against human sera yielded serotype-specific responses and reproducible neutralization titers that were in statistical agreement with Plaque Reduction Neutralization Test (PRNT) results. DENV RVPs were also used to measure neutralization titers against the four DENV serotypes in a panel of human sera from a clinical study of dengue patients. The high-throughput capability, stability, rapidity, and reproducibility of assays using DENV RVPs offer advantages for detecting immune responses that can be applied to large-scale clinical studies of DENV infection and vaccination.	[Mattia, Kimberly; Puffer, Bridget A.; Murray, Meredith; Sluzas, Emily; Pagano, Dan; Ajith, Sandya; Bower, Megan; Berdougo, Eli; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA; [Williams, Katherine L.; Gonzalez, Ritela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mattia, K (corresponding author), Integral Mol Inc, Philadelphia, PA USA.	bdoranz@integralmolecular.com		Pagano, Daniel/0000-0002-6513-3870	National Institutes of Health [AI062100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI062100, R42AI062100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health, Grant # AI062100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Dowd KA, PLOS PATHOG, V7; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.1.531-538.2004; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Lai CY, 2008, J BIOMED SCI, V15, P15, DOI 10.1007/s11373-007-9204-0; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Martin NC, 2006, J VIROL METHODS, V134, P74, DOI 10.1016/j.jviromet.2005.12.002; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Puffer BA, 2010, [Flavivirus reporter virus and methods of making and using the same, US Pat #], Patent No. [12/942,632, 12942632]; Putnak JR, 2008, AM J TROP MED HYG, V79, P115, DOI 10.4269/ajtmh.2008.79.115; Rocha C, 2009, AM J TROP MED HYG, V81, P287, DOI 10.4269/ajtmh.2009.81.287; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Shanaka W. W., 2009, American Journal of Tropical Medicine and Hygiene, V80, P61; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; WHO, 2005, REP COLL STUD ASS SU	34	51	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27252	10.1371/journal.pone.0027252	http://dx.doi.org/10.1371/journal.pone.0027252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096543	Green Submitted, gold, Green Published			2022-12-25	WOS:000297350800040
J	Moles, A; Tarrats, N; Fernandez-Checa, JC; Mari, M				Moles, Anna; Tarrats, Nuria; Fernandez-Checa, Jose C.; Mari, Montserrat			Cathepsin B Overexpression Due to Acid Sphingomyelinase Ablation Promotes Liver Fibrosis in Niemann-Pick Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; DEFICIENT MICE; KNOCKOUT MICE; ROLES; PATHOGENESIS; METABOLISM; ACTIVATION; APOPTOSIS; PATHOLOGY; CIRRHOSIS	Niemann-Pick disease (NPD) is a lysosomal storage disease caused by the loss of acid sphingomyelinase (ASMase) that features neurodegeneration and liver disease. Because ASMase-knock-out mice models NPD and our previous findings revealed that ASMase activates cathepsins B/D (CtsB/D), our aim was to investigate the expression and processing of CtsB/D in hepatic stellate cells (HSCs) from ASMase-null mice and their role in liver fibrosis. Surprisingly, HSCs from ASMase-knock-out mice exhibit increased basal level and activity of CtsB as well as its in vitro processing in culture, paralleling the enhanced expression of fibrogenic markers alpha-smooth muscle actin (alpha-SMA), TGF-beta, and pro-collagen alpha 1(I) (Col1A1). Moreover, pharmacological inhibition of CtsB blunted the expression of alpha-SMA and Col1A1 and proliferation of HSCs from ASMase-knock-out mice. Consistent with the enhanced activation of CtsB in HSCs from ASMase-null mice, the in vivo liver fibrosis induced by chronic treatment with CCl4 increased in ASMase-null compared with wild-type mice, an effect that was reduced upon CtsB inhibition. In addition to liver, the enhanced proteolytic processing of CtsB was also observed in brain and lung of ASMase-knock-out mice, suggesting that the overexpression of CtsB may underlie the phenotype of NPD. Thus, these findings reveal a functional relationship between ASMase and CtsB and that the ablation of ASMase leads to the enhanced processing and activation of CtsB. Therefore, targeting CtsB may be of relevance in the treatment of liver fibrosis in patients with NPD.	[Moles, Anna; Tarrats, Nuria; Fernandez-Checa, Jose C.; Mari, Montserrat] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red,Area Temat Entermedades Hep, E-08036 Barcelona, Spain; [Moles, Anna; Tarrats, Nuria; Fernandez-Checa, Jose C.; Mari, Montserrat] CSIC, Dept Cell Death & Proliferat, Inst Invest Biomed Barcelona, Barcelona 08036, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90089 USA	CIBER - Centro de Investigacion Biomedica en Red; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; University of Southern California	Fernandez-Checa, JC (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red,Area Temat Entermedades Hep, C Villarroel 170, E-08036 Barcelona, Spain.	checa229@yahoo.com; monmari@clinic.ub.es	MARI, MONTSERRAT/M-2871-2019; Moles, Ana/A-5889-2017; Mari, Montserrat/A-7376-2013; Fernández-Checa, José Carlos/L-8342-2014	Moles, Ana/0000-0002-3915-0060; Mari, Montserrat/0000-0002-6116-3247; Fernández-Checa, José Carlos/0000-0003-3422-2990	Research Center for Liver and Pancreatic Diseases, National Institute on Alcohol Abuse and Alcoholism [P50-AA-11999]; Instituto de Salud Carlos III [PI10/02114]; Plan Nacional de I+D, Spain [2009-11417]; Fundacio La Marato de TV3; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	Research Center for Liver and Pancreatic Diseases, National Institute on Alcohol Abuse and Alcoholism; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional de I+D, Spain; Fundacio La Marato de TV3; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported, in whole or in part, by Grant P50-AA-11999 from the Research Center for Liver and Pancreatic Diseases, National Institute on Alcohol Abuse and Alcoholism. This work was carried out in part at the Esther Koplowitz Center in Barcelona, and it was also supported by Grants PI10/02114 (Instituto de Salud Carlos III), 2009-11417 (Plan Nacional de I+D), Spain; and the and Fundacio La Marato de TV3.	Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Fotoulaki M, 2007, J INHERIT METAB DIS, V30, P986, DOI 10.1007/s10545-007-0557-3; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; GRABER D, 1994, J NEUROCHEM, V63, P1060; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; LABRUNE P, 1991, J PEDIATR GASTR NUTR, V13, P104, DOI 10.1097/00005176-199107000-00020; Leto G, 1996, EUR J CLIN CHEM CLIN, V34, P555; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mari M, 2004, J CLIN INVEST, V113, P895, DOI 10.1172/JCI200419852; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Moles A, 2010, AM J PATHOL, V177, P1214, DOI 10.2353/ajpath.2010.091257; Moles A, 2009, HEPATOLOGY, V49, P1297, DOI 10.1002/hep.22753; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Prinetti A, 2011, NEUROCHEM RES, V36, P1654, DOI 10.1007/s11064-010-0380-3; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; Schuchman EH, 2009, INT J CLIN PHARM TH, V47, pS48; Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Takahashi T, 1997, HUM PATHOL, V28, P385, DOI 10.1016/S0046-8177(97)90141-6; TASSONI JP, 1991, GASTROENTEROLOGY, V100, P567, DOI 10.1016/0016-5085(91)90233-B; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200	38	42	42	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1178	1188		10.1074/jbc.M111.272393	http://dx.doi.org/10.1074/jbc.M111.272393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102288	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000299170300033
J	Huey, DJ; Athanasiou, KA				Huey, Daniel J.; Athanasiou, Kyriacos A.			Tension-Compression Loading with Chemical Stimulation Results in Additive Increases to Functional Properties of Anatomic Meniscal Constructs	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; GROWTH-FACTORS; MECHANICAL COMPRESSION; HYDROSTATIC-PRESSURE; GENE-EXPRESSION; II COLLAGEN; TISSUE; CHONDROCYTES; CULTURE; CELLS	Objective: This study aimed to improve the functional properties of anatomically-shaped meniscus constructs through simultaneous tension and compression mechanical stimulation in conjunction with chemical stimulation. Methods: Scaffoldless meniscal constructs were subjected to simultaneous tension and compressive stimulation and chemical stimulation. The temporal aspect of mechanical loadingwas studied by employing two separate five day stimulation periods. Chemical stimulation consisted of the application of a catabolic GAG-depleting enzyme, chondroitinase ABC (C-ABC), and an anabolic growth factor, TGF-beta 1. Mechanical and chemical stimulation combinations were studied through a full-factorial experimental design and assessed for histological, biochemical, and biomechanical properties following 4 wks of culture. Results: Mechanical loading applied from days 10-14 resulted in significant increases in compressive, tensile, and biochemical properties of meniscal constructs. When mechanical and chemical stimuliwere combined significant additive increases in collagen per wet weight (4-fold), compressive instantaneous (3-fold) and relaxation (2-fold) moduli, and tensile moduli in the circumferential (4-fold) and radial (6-fold) directions were obtained. Conclusions: This study demonstrates that a stimulation regimen of simultaneous tension and compression mechanical stimulation, C-ABC, and TGF-beta 1 is able to create anatomic meniscus constructs replicating the compressive mechanical properties, and collagen and GAG content of native tissue. In addition, this study significantly advances meniscus tissue engineering by being the first to apply simultaneous tension and compression mechanical stimulation and observe enhancement of tensile and compressive properties following mechanical stimulation.	[Huey, Daniel J.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Huey, DJ (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	athanasiou@ucdavis.edu			National Institute for Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [R01-AR-047839]; National Football League (NFL) Charities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047839] Funding Source: NIH RePORTER	National Institute for Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Football League (NFL) Charities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (R01-AR-047839 from the National Institute for Arthritis and Musculoskeletal and Skin Diseases) and National Football League (NFL) Charities (http://www.nflcharities.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298; Athanasiou K.A., 2009, SYNTH LECT TISSUE EN, V1, P1, DOI DOI 10.2200/S00212ED1V01Y200910TIS003; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Aufderheide AC, 2006, ANN BIOMED ENG, V34, P1463, DOI 10.1007/s10439-006-9157-x; BAKER B, 2010, DYNAMIC TENSION IMPR; Ballyns JJ, 2011, J BIOMECH, V44, P509, DOI 10.1016/j.jbiomech.2010.09.017; Bernstein P, 2009, BIOTECHNOL PROGR, V25, P1146, DOI 10.1002/btpr.186; Bian LM, 2009, TISSUE ENG PT A, V15, P2065, DOI 10.1089/ten.tea.2008.0495; Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; Butler DL, 2009, TISSUE ENG PT A, V15, P741, DOI 10.1089/ten.tea.2008.0292; Chia HN, 2008, J ORTHOP RES, V26, P951, DOI 10.1002/jor.20573; Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006; ELDER BD, 2008, TISSUE ENG A; Elder BD, 2008, J ORTHOP RES, V26, P238, DOI 10.1002/jor.20480; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Gunja NJ, 2010, J BIOMED MATER RES A, V92A, P896, DOI 10.1002/jbm.a.32451; Gunja NJ, 2009, J TISSUE ENG REGEN M, V3, P521, DOI 10.1002/term.191; Gunja NJ, 2009, BIOMATERIALS, V30, P565, DOI 10.1016/j.biomaterials.2008.10.007; Hsieh AH, 2002, J ORTHOP RES, V20, P325, DOI 10.1016/S0736-0266(01)00112-7; Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Huey DJ, 2011, BIOMATERIALS, V32, P2052, DOI 10.1016/j.biomaterials.2010.11.041; Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42; Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9; Imler SM, 2004, OSTEOARTHR CARTILAGE, V12, P736, DOI 10.1016/j.joca.2004.05.007; IMLER SM, 2005, IN VITRO MODULATION, P213; Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Kobayashi K, 2004, KNEE, V11, P271, DOI 10.1016/j.knee.2002.03.001; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, V149, P283; Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205; Lee DA, 2000, BIORHEOLOGY, V37, P149; Lietman SA, 2003, ORTHOPEDICS, V26, P799; Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1; Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304; Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676; McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140; Natoli RM, 2010, ARTHRITIS RHEUM-US, V62, P1097, DOI 10.1002/art.27313; Natoli RM, 2009, J ORTHOP RES, V27, P949, DOI 10.1002/jor.20821; Nehrer S, 1997, J BIOMED MATER RES, V38, P95; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Pangborn CA, 2005, J ORTHOP RES, V23, P1184, DOI 10.1016/j.orthres.2005.01.019; RANGGER C, 1995, AM J SPORT MED, V23, P240, DOI 10.1177/036354659502300219; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Sweigart MA, 2005, P I MECH ENG H, V219, P337, DOI 10.1243/095441105X34329; Takahashi I, 1998, J CELL SCI, V111, P2067; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Upton ML, 2006, CONNECT TISSUE RES, V47, P207, DOI 10.1080/03008200600846663; Valhmu WB, 1998, ARCH BIOCHEM BIOPHYS, V353, P29, DOI 10.1006/abbi.1998.0633; Vanderploeg EJ, 2004, J BIOMECH, V37, P1941, DOI 10.1016/j.jbiomech.2004.02.048; Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zaffagnini S, 2007, KNEE SURG SPORT TR A, V15, P175, DOI 10.1007/s00167-006-0144-4	58	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27857	10.1371/journal.pone.0027857	http://dx.doi.org/10.1371/journal.pone.0027857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114714	Green Published, gold			2022-12-25	WOS:000297555400131
J	Wuriyanghan, H; Rosa, C; Falk, BW				Wuriyanghan, Hada; Rosa, Cristina; Falk, Bryce W.			Oral Delivery of Double-Stranded RNAs and siRNAs Induces RNAi Effects in the Potato/Tomato Psyllid, Bactericerca cockerelli	PLOS ONE			English	Article							GENE KNOCKDOWN; INTERFERENCE; EXPRESSION; RESISTANCE; HOMOPTERA; DISEASE; PHLOEM; POTATO; CITRUS; PLANTS	The potato/tomato psyllid, Bactericerca cockerelli (B. cockerelli), and the Asian citrus psyllid, Diaphorina citri (D. citri), are very important plant pests, but they are also vectors of phloem-limited bacteria that are associated with two devastating plant diseases. B. cockerelli is the vector of Candidatus Liberibacter psyllaurous (solanacearum), which is associated with zebra chip disease of potatoes, and D. citri is the vector of Ca. Liberibacter asiaticus, which is associated with the Huanglongbing (citrus greening) disease that currently threatens the entire Florida citrus industry. Here we used EST sequence information from D. citri to identify potential targets for RNA interference in B. cockerelli. We targeted ubiquitously expressed and gut-abundant mRNAs via injection and oral acquisition of double-stranded RNAs and siRNAs and were able to induce mortality in recipient psyllids. We also showed knockdown of target mRNAs, and that oral acquisition resulted primarily in mRNA knockdown in the psyllid gut. Concurrent with gene knockdown was the accumulation of target specific, 21 nucleotide siRNAs for an abundant mRNA for BC-Actin. These results showed that RNAi can be a powerful tool for gene function studies in psyllids, and give support for continued efforts for investigating RNAi approaches as possible tools for psyllid and plant disease control.	[Wuriyanghan, Hada; Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Rosa, Cristina] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wuriyanghan, H (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bwfalk@ucdavis.edu		Yan, Zhiyong/0000-0001-8253-0694	Florida Citrus Advanced Technology Program (FDACS) [NAS ID 122]	Florida Citrus Advanced Technology Program (FDACS)	This research was supported by the Florida Citrus Advanced Technology Program (FDACS Contract Number NAS ID 122; http://www.citrusrdf.org/blog/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Levin DM, 2005, INSECT BIOCHEM MOLEC, V35, P369, DOI 10.1016/j.ibmb.2005.01.003; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDiarmid R, 2005, ANNU REV PHYTOPATHOL, V43, P523, DOI 10.1146/annurev.phyto.43.040204.140204; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rosa Cristina, 2010, J RNAi Gene Silencing, V6, P361; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wang JB, 2009, VIROLOGY, V386, P217, DOI 10.1016/j.virol.2009.01.004; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	47	82	85	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27736	10.1371/journal.pone.0027736	http://dx.doi.org/10.1371/journal.pone.0027736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110747	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400101
J	Aguilera, AG; Colon-Carmona, A; Kesseli, R; Dukes, JS				Aguilera, Anna G.; Colon-Carmona, Adan; Kesseli, Rick; Dukes, Jeffrey S.			No Accession-Specific Effect of Rhizosphere Soil Communities on the Growth and Competition of Arabidopsis thaliana Accessions	PLOS ONE			English	Article							EXOTIC PLANT INVASIONS; NITROGEN MINERALIZATION; TERRESTRIAL ECOSYSTEMS; MICROBIAL COMMUNITIES; GENETIC DIVERSITY; FEEDBACK; METAANALYSIS; COEXISTENCE; BIOTA; MICROORGANISMS	Soil communities associated with specific plant species affect individual plants' growth and competitive ability. Limited evidence suggests that unique soil communities can also differentially influence growth and competition at the ecotype level. Previous work with Arabidopsis thaliana has shown that accessions produce distinct and reproducible rhizosphere bacterial communities, with significant differences in both species composition and relative abundance. We tested the hypothesis that soil communities uniquely affect the growth and reproduction of the plant accessions with which they are associated. Specifically, we examined the growth of four accessions when exposed to their own soil communities and the communities generated by each of the other three accessions. To do this we planted focal accessions inside a ring of six plants that created a "background" soil community. We grew focal plants in this design in three separate soil treatments: non-sterile soil, sterilized soil, and "preconditioned" soil. We preconditioned soil by growing accessions in non-sterile soil for six weeks before the start of the experiment. The main experiment was harvested after seven weeks of growth and we recorded height, silique number, and dry weight of each focal plant. Plants grown in the preconditioned soil treatment showed less growth relative to the non-sterile and sterile soil treatments. In addition, plants in the sterile soil grew larger than those in non-sterile soil. However, we saw no interaction between soil treatment and background accession. We conclude that the soil communities have a negative net impact on Arabidopsis thaliana growth, and that the unique soil communities associated with each accession do not differentially affect growth and competition of study species.	[Aguilera, Anna G.; Colon-Carmona, Adan; Kesseli, Rick; Dukes, Jeffrey S.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Dukes, Jeffrey S.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Dukes, Jeffrey S.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Massachusetts System; University of Massachusetts Boston; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Aguilera, AG (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	Anna.Aguilera001@umb.edu	Dukes, Jeffrey/AAD-8791-2019; Dukes, Jeffrey S/C-9765-2009	Dukes, Jeffrey S/0000-0001-9482-7743	U.S. National Science Foundation [IOS-0847691]; Direct For Biological Sciences [0847691] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U.S. National Science Foundation, through a Graduate Research Fellowship to AGA and through grant IOS-0847691 to RK, JSD, ACC, and M. Shiaris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bossdorf O, 2009, OIKOS, V118, P1541, DOI 10.1111/j.1600-0706.2009.17559.x; Bressan R, 2009, MOL PLANT, V2, P1, DOI 10.1093/mp/ssn097; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Dunn RM, 2006, PLANT SOIL, V289, P321, DOI 10.1007/s11104-006-9142-z; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; JAMES FC, 2005, J ECOL, V93, P958; Jordan NR, 2008, BIOL INVASIONS, V10, P177, DOI 10.1007/s10530-007-9121-1; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; LAVELLE P, 1995, PLANT SOIL, V170, P23, DOI 10.1007/BF02183052; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; MCARTHUR JV, 1988, P NATL ACAD SCI USA, V85, P9621, DOI 10.1073/pnas.85.24.9621; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Morris WF, 2007, ECOLOGY, V88, P1021, DOI 10.1890/06-0442; Niu HB, 2007, PLANT SOIL, V294, P73, DOI 10.1007/s11104-007-9230-8; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; SNAYDON RW, 1991, J APPL ECOL, V28, P930, DOI 10.2307/2404218; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANDERPUTTEN WH, 1993, NATURE, V362, P53; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; Weltzin JF, 2003, OIKOS, V103, P505, DOI 10.1034/j.1600-0706.2003.12389.x; Westover KM, 2001, ECOLOGY, V82, P3285, DOI 10.1890/0012-9658(2001)082[3285:MOPSCR]2.0.CO;2; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x; Zhang ZB, 2003, ECOL MODEL, V164, P271, DOI 10.1016/S0304-3800(03)00069-3	39	5	5	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27585	10.1371/journal.pone.0027585	http://dx.doi.org/10.1371/journal.pone.0027585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110679	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300031
J	Matsuo, E; Roy, P				Matsuo, Eiko; Roy, Polly			Bluetongue Virus VP1 Polymerase Activity In Vitro: Template Dependency, Dinucleotide Priming and Cap Dependency	PLOS ONE			English	Article							ROTAVIRUS RNA REPLICATION; CIS-ACTING REPLICATION; MINUS-STRAND SYNTHESIS; INFLUENZA-VIRUS; GENOME REPLICATION; MESSENGER-RNA; VIRAL-RNA; 3' END; TRANSCRIPTION; INITIATION	Background: Bluetongue virus (BTV) protein, VP1, is known to possess an intrinsic polymerase function, unlike rotavirus VP1, which requires the capsid protein VP2 for its catalytic activity. However, compared with the polymerases of other members of the Reoviridae family, BTV VP1 has not been characterized in detail. Methods and Findings: Using an in vitro polymerase assay system, we demonstrated that BTV VP1 could synthesize the ten dsRNAs simultaneously from BTV core-derived ssRNA templates in a single in vitro reaction as well as genomic dsRNA segments from rotavirus core-derived ssRNA templates that possess no sequence similarity with BTV. In contrast, dsRNAs were not synthesized from non-viral ssRNA templates by VP1, unless they were fused with specific BTV sequences. Further, we showed that synthesis of dsRNAs from capped ssRNA templates was significantly higher than that from uncapped ssRNA templates and the addition of dinucleotides enhanced activity as long as the last base of the dinucleotide complemented the 3' -terminal nucleotide of the ssRNA template. Conclusions: We showed that the polymerase activity was stimulated by two different factors: cap structure, likely due to allosteric effect, and dinucleotides due to priming. Our results also suggested the possible presence of cis-acting elements shared by ssRNAs in the members of family Reoviridae.	[Matsuo, Eiko; Roy, Polly] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Matsuo, E (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	polly.roy@lshtm.ac.uk		Roy, Polly/0000-0001-6535-6911	Biotechnology and Biological Sciences Research Council (UK) [BB/Fo21771/1]; National Institutes of Health (USA) [AI045000]; Biotechnology and Biological Sciences Research Council [BB/F021771/1] Funding Source: researchfish; BBSRC [BB/F021771/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045000] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Biotechnology and Biological Sciences Research Council (UK, BB/Fo21771/1) and the National Institutes of Health (USA, AI045000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE AK, 1970, J VIROL, V6, P1; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Boyce M, 2007, J VIROL, V81, P2179, DOI 10.1128/JVI.01819-06; Butcher SJ, 2000, ACTA CRYSTALLOGR D, V56, P1473, DOI 10.1107/S0907444900010702; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Chen DY, 2000, RNA, V6, P1455, DOI 10.1017/S1355838200001187; CHEN DY, 1994, J VIROL, V68, P7030, DOI 10.1128/JVI.68.11.7030-7039.1994; Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015; COHEN J, 1977, J GEN VIROL, V36, P395, DOI 10.1099/0022-1317-36-3-395; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Ferrer-Orta C, 2009, CURR OPIN STRUC BIOL, V19, P752, DOI 10.1016/j.sbi.2009.10.016; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Gorchakov R, 2004, J VIROL, V78, P61, DOI 10.1128/JVI.78.1.61-75.2004; GRAY J, ROTAVIRUSES METHODS; Guglielmi KM, 2010, J BIOL CHEM, V285, P18123, DOI 10.1074/jbc.R110.117671; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; HONDA A, 1986, J BIOL CHEM, V261, P5987; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; KAWAKAMI K, 1985, J BIOCHEM-TOKYO, V97, P655, DOI 10.1093/oxfordjournals.jbchem.a135101; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; KRUG RM, 1980, P NATL ACAD SCI-BIOL, V77, P5874, DOI 10.1073/pnas.77.10.5874; Laurila MRL, 2005, J GEN VIROL, V86, P521, DOI 10.1099/vir.0.80492-0; Laurila MRL, 2002, J BIOL CHEM, V277, P17117, DOI 10.1074/jbc.M111220200; Lawton JA, 2000, ADV VIRUS RES, V55, P185, DOI 10.1016/S0065-3527(00)55004-0; Lee MTM, 2003, NUCLEIC ACIDS RES, V31, P1624, DOI 10.1093/nar/gkg253; Li ML, 1998, EMBO J, V17, P5844, DOI 10.1093/emboj/17.19.5844; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Lourenco S, 2011, P NATL ACAD SCI USA, V108, P13746, DOI 10.1073/pnas.1108667108; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Makeyev EV, 2000, EMBO J, V19, P6275, DOI 10.1093/emboj/19.22.6275; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; MASON BB, 1980, J VIROL, V33, P1111, DOI 10.1128/JVI.33.3.1111-1121.1980; Matsuo E, 2010, FEBS LETT, V584, P3386, DOI 10.1016/j.febslet.2010.06.030; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; McDonald SM, 2011, TRENDS MICROBIOL, V19, P136, DOI 10.1016/j.tim.2010.12.002; McDonald SM, 2009, CURR OPIN STRUC BIOL, V19, P775, DOI 10.1016/j.sbi.2009.10.007; MCGEOCH D, 1975, J VIROL, V15, P686, DOI 10.1128/JVI.15.4.686-695.1975; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Olson AC, 2010, BIOCHEMISTRY-US, V49, P10208, DOI 10.1021/bi101011j; Patton JT, 1997, J VIROL, V71, P9618, DOI 10.1128/JVI.71.12.9618-9626.1997; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; PATTON JT, 1990, J GEN VIROL, V71, P1087, DOI 10.1099/0022-1317-71-5-1087; PENN CR, 1984, VIRUS RES, V1, P1, DOI 10.1016/0168-1702(84)90030-3; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; Ranjith-Kumar CT, 2003, VIROLOGY, V312, P270, DOI 10.1016/S0042-6822(03)00247-2; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; Roy P, 2008, J GEN VIROL, V89, P1789, DOI 10.1099/vir.0.2008/002089-0; Sarin LP, 2009, NUCLEIC ACIDS RES, V37, P1182, DOI 10.1093/nar/gkn1035; SHATKIN AJ, 1968, P NATL ACAD SCI USA, V61, P1462, DOI 10.1073/pnas.61.4.1462; STARNES MC, 1993, VIROLOGY, V193, P356, DOI 10.1006/viro.1993.1132; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; URAKAWA T, 1989, NUCLEIC ACIDS RES, V17, P7395, DOI 10.1093/nar/17.18.7395; VANDIJK AA, 1988, J GEN VIROL, V69, P573, DOI 10.1099/0022-1317-69-3-573; VERWOERD D W, 1972, Onderstepoort Journal of Veterinary Research, V39, P185; VERWOERD DW, 1969, VIROLOGY, V38, P203, DOI 10.1016/0042-6822(69)90361-4; Wehrfritz JM, 2007, BIOPOLYMERS, V86, P83, DOI 10.1002/bip.20706; Wentz MJ, 1996, ARCH VIROL, P59; You SY, 2004, J VIROL, V78, P1352, DOI 10.1128/JVI.78.3.1352-1366.2004; Zeng CQY, 1996, J VIROL, V70, P2736, DOI 10.1128/JVI.70.5.2736-2742.1996	69	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27702	10.1371/journal.pone.0027702	http://dx.doi.org/10.1371/journal.pone.0027702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110731	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300046
J	Pope, BD; Tsumagari, K; Battaglia, D; Ryba, T; Hiratani, I; Ehrlich, M; Gilbert, DM				Pope, Benjamin D.; Tsumagari, Koji; Battaglia, Dana; Ryba, Tyrone; Hiratani, Ichiro; Ehrlich, Melanie; Gilbert, David M.			DNA Replication Timing Is Maintained Genome-Wide in Primary Human Myoblasts Independent of D4Z4 Contraction in FSH Muscular Dystrophy	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; FACIOSCAPULOHUMERAL DYSTROPHY; SMOOTH-MUSCLE; CHROMATIN; GENE; EXPRESSION; LOCUS; DIFFERENTIATION; REPEAT; MOUSE	Facioscapulohumeral muscular dystrophy (FSHD) is linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.2 from 11-100 copies to 1-10 copies. The extent to which D4Z4 contraction at 4q35.2 affects overall 4q35.2 chromatin organization remains unclear. Because DNA replication timing is highly predictive of long-range chromatin interactions, we generated genome-wide replication-timing profiles for FSHD and control myogenic precursor cells. We compared non-immortalized myoblasts from four FSHD patients and three control individuals to each other and to a variety of other human cell types. This study also represents the first genome- wide comparison of replication timing profiles in non-immortalized human cell cultures. Myoblasts from both control and FSHD individuals all shared a myoblast-specific replication profile. In contrast, male and female individuals were readily distinguished by monoallelic differences in replication timing at DXZ4 and other regions across the X chromosome affected by X inactivation. We conclude that replication timing is a robust cell-type specific feature that is unaffected by FSHD-related D4Z4 contraction.	[Pope, Benjamin D.; Battaglia, Dana; Ryba, Tyrone; Hiratani, Ichiro; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Tsumagari, Koji; Ehrlich, Melanie] Dept Biochem, Human Genet Program, New Orleans, LA USA; [Tsumagari, Koji; Ehrlich, Melanie] Tulane Canc Ctr, Tulane Med Sch, New Orleans, LA USA	State University System of Florida; Florida State University; Tulane University	Pope, BD (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	ehrlich@tulane.edu; gilbert@bio.fsu.edu	Pope, Ben/Y-4326-2019; Hiratani, Ichiro/AAH-6330-2020; Hiratani, Ichiro/N-6424-2015	Pope, Ben/0000-0003-1847-9163; Hiratani, Ichiro/0000-0003-3710-3540; Hiratani, Ichiro/0000-0003-3710-3540	National Institutes of Health [GM083337, AA3768G2]; FSHD Global Research Foundation; Grants-in-Aid for Scientific Research [23770235] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSHD Global Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grants GM083337 to DMG and AA3768G2 to ME, and a grant from the FSHD Global Research Foundation to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Chadwick BP, 2009, CHROMOSOMA, V118, P675, DOI 10.1007/s00412-009-0233-5; CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Desprat R, 2009, GENOME RES, V19, P2288, DOI 10.1101/gr.094060.109; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Pope BD, 2010, CHROMOSOME RES, V18, P127, DOI 10.1007/s10577-009-9100-8; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; RYBA T, 2011, PLOS COMPUT IN PRESS; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Stevens Troy, 2008, Proc Am Thorac Soc, V5, P783, DOI 10.1513/pats.200803-027HR; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; TSUMAGARI K, 2011, BMC MED GEN IN PRESS; Tsumagari K, 2008, NUCLEIC ACIDS RES, V36, P2196, DOI 10.1093/nar/gkn055; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wu R, 2006, J CELL BIOL, V174, P185, DOI 10.1083/jcb.200601113; Xu XQ, 2009, NUCLEIC ACIDS RES, V37, P7381, DOI 10.1093/nar/gkp833; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Yang F, 2004, CHROMOSOMA, V112, P350, DOI 10.1007/s00412-004-0280-x; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	51	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27413	10.1371/journal.pone.0027413	http://dx.doi.org/10.1371/journal.pone.0027413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096571	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900043
J	Ramakrishnan, R; Donahue, H; Garcia, D; Tan, J; Shimizu, N; Rice, AP; Ling, PD				Ramakrishnan, Rajesh; Donahue, Hart; Garcia, David; Tan, Jie; Shimizu, Norio; Rice, Andrew P.; Ling, Paul D.			Epstein-Barr Virus BART9 miRNA Modulates LMP1 Levels and Affects Growth Rate of Nasal NK T Cell Lymphomas	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; NF-KAPPA-B; MICRORNAS; EXPRESSION; EBV; LATENCY; LINES; IDENTIFICATION; CARCINOMA; TARGETS	Nasal NK/T cell lymphomas (NKTCL) are a subset of aggressive Epstein-Barr virus (EBV)-associated non-Hodgkin's lymphomas. The role of EBV in pathogenesis of NKTCL is not clear. Intriguingly, EBV encodes more than 40 microRNAs (miRNA) that are differentially expressed and largely conserved in lymphocryptoviruses. While miRNAs play a critical role in the pathogenesis of cancer, especially lymphomas, the expression and function of EBV transcribed miRNAs in NKTCL are not known. To examine the role of EBV miRNAs in NKTCL, we used microarray profiling and qRT-PCR to identify and validate expression of viral miRNAs in SNK6 and SNT16 cells, which are two independently derived NKTCL cell lines that maintain the type II EBV latency program. All EBV BART miRNAs except BHRF-derived miRNAs were expressed and some of these miRNAs are expressed at higher levels than in nasopharyngeal carcinomas. Modulating the expression of BART9 with antisense RNAs consistently reduced SNK6 and SNT16 proliferation, while antisense RNAs to BARTs-7 and -17-5p affected proliferation only in SNK6 cells. Furthermore, the EBV LMP-1 oncoprotein and transcript levels were repressed when an inhibitor of BART9 miRNA was transfected into SNK6 cells, and overexpression of BART9 miRNA increased LMP-1 protein and mRNA expression. Our data indicate that BART9 is involved in NKTCL proliferation, and one of its mechanisms of action appears to be regulating LMP-1 levels. Our findings may have direct application for improving NKTCL diagnosis and for developing possible novel treatment approaches for this tumor, for which current chemotherapeutic drugs have limited effectiveness.	[Ramakrishnan, Rajesh; Donahue, Hart; Garcia, David; Tan, Jie; Rice, Andrew P.; Ling, Paul D.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Shimizu, Norio] Tokyo Med & Dent Univ, Med Res Inst, Dept Virol, Div Virol & Immunol, Tokyo, Japan	Baylor College of Medicine; Tokyo Medical & Dental University (TMDU)	Ramakrishnan, R (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	pling@bcm.edu		Rice, Andrew/0000-0002-1237-4769	National Institute of Allergy and Infectious Diseases [AI036211]; NIH [T32AI7456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007456, P30AI036211] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by the Baylor-UT Houston Center for AIDS Research Core Support Grant number AI036211 from the National Institute of Allergy and Infectious Diseases to APR and PDL. RR was supported by NIH grant T32AI7456. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amoroso R, 2011, J VIROL, V85, P996, DOI 10.1128/JVI.01528-10; Aozasa K, 2008, INT J HEMATOL, V87, P110, DOI 10.1007/s12185-008-0021-7; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brooks JM, 2009, J IMMUNOL, V182, P1919, DOI 10.4049/jimmunol.0713607; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Cameron JE, 2008, VIROLOGY, V382, P257, DOI 10.1016/j.virol.2008.09.018; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Chiang AKS, 1996, INT J CANCER, V68, P285, DOI 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Goormachtigh G, 2006, J VIROL, V80, P7382, DOI 10.1128/JVI.02052-05; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Haaland RE, 2005, MOL IMMUNOL, V42, P627, DOI 10.1016/j.molimm.2004.09.012; HARABUCHI Y, 1990, LANCET, V335, P128, DOI 10.1016/0140-6736(90)90002-M; HO FCS, 1990, HEMATOL ONCOL, V8, P271, DOI 10.1002/hon.2900080505; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Johansson P, 2010, J VIROL, V84, P2787, DOI 10.1128/JVI.01052-09; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; KANAVAROS P, 1993, BLOOD, V81, P2688; Kaykas A, 2000, ONCOGENE, V19, P1400, DOI 10.1038/sj.onc.1203365; Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06; Kohrt H, 2009, LEUKEMIA LYMPHOMA, V50, P1773, DOI 10.3109/10428190903186502; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Nagata H, 2001, BLOOD, V97, P708, DOI 10.1182/blood.V97.3.708; Narbonnet S, 2006, VIROLOGY, V350, P381, DOI 10.1016/j.virol.2006.02.010; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Ramakrishnan R, 2009, J LEUKOCYTE BIOL, V86, P1345, DOI 10.1189/jlb.0509309; SAMPLE J, 1990, J VIROL, V64, P1667, DOI 10.1128/JVI.64.4.1667-1674.1990; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shah KM, 2009, CLIN MICROBIOL INFEC, V15, P982, DOI 10.1111/j.1469-0691.2009.03033.x; Tao Q, 2006, FRONT BIOSCI-LANDMRK, V11, P2672, DOI 10.2741/2000; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x	50	47	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27271	10.1371/journal.pone.0027271	http://dx.doi.org/10.1371/journal.pone.0027271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102884	Green Submitted, gold, Green Published			2022-12-25	WOS:000297348800020
J	Lee, JJ; Drakaki, A; Iliopoulos, D; Struhl, K				Lee, J-J; Drakaki, A.; Iliopoulos, D.; Struhl, K.			MiR-27b targets PPAR gamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells	ONCOGENE			English	Article						miR-27b; PPAR gamma; NHE1; NF-kappa beta; inflammation; neuroblastomas	ACTIVATED-RECEPTOR-GAMMA; BREAST-CANCER; TERMINAL DIFFERENTIATION; KAPPA-B; EXPRESSION; ROSIGLITAZONE; MICRORNAS; AGONISTS; TRANSFORMATION; PROLIFERATION	The peroxisome proliferators-activated receptor (PPAR)gamma pathway is involved in cancer, but it appears to have both tumor suppressor and oncogenic functions. In neuroblastoma cells, miR-27b targets the 30 untranslated region of PPAR gamma and inhibits its mRNA and protein expression. miR-27b overexpression or PPAR gamma inhibition blocks cell growth in vitro and tumor growth in mouse xenografts. PPAR gamma activates expression of the pH regulator NHE1, which is associated with tumor progression. Lastly, miR-27b through PPAR gamma regulates nuclear factor-kappa B activity and transcription of inflammatory target genes. Thus, in neuroblastoma, miR-27b functions as a tumor suppressor by inhibiting the tumor-promoting function of PPAR gamma, which triggers an increased inflammatory response. In contrast, in breast cancer cells, PPAR gamma inhibits NHE1 expression and the inflammatory response, and it functions as a tumor suppressor. We suggest that the ability of PPAR gamma to promote or suppress tumor formation is linked to cell type-specific differences in regulation of NHE1 and other target genes. Oncogene (2012) 31, 3818-3825; doi: 10.1038/onc.2011.543; published online 28 November 2011	[Lee, J-J; Iliopoulos, D.; Struhl, K.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Drakaki, A.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Iliopoulos, D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Iliopoulos, Dimitrios/AAE-9106-2019		Dana Farber Cancer Institute; National Institutes of Health [CA 107486]; NATIONAL CANCER INSTITUTE [R01CA107486] Funding Source: NIH RePORTER	Dana Farber Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by start-up funds to DI from the Dana Farber Cancer Institute and by a research grant to KS from the National Institutes of Health (CA 107486).	Abe A, 2002, EUR J PHARMACOL, V436, P7, DOI 10.1016/S0014-2999(01)01577-1; Aziz N, 1999, MOL CELL BIOL, V19, P1101; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Burton JD, 2008, PPAR RES, V2008, DOI 10.1155/2008/494161; Cellai I, 2006, BRIT J CANCER, V95, P879, DOI 10.1038/sj.bjc.6603344; Cellai I, 2010, BRIT J CANCER, V102, P685, DOI 10.1038/sj.bjc.6605506; Chattopadhyay N, 2000, J NEUROSCI RES, V61, P67, DOI 10.1002/1097-4547(20000701)61:1<67::AID-JNR8>3.0.CO;2-7; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; HAGAG N, 1987, MOL CELL BIOL, V7, P1984, DOI 10.1128/MCB.7.5.1984; Han S, 2007, ANTI-CANCER DRUG, V18, P237, DOI 10.1097/CAD.0b013e328011e67d; Han SW, 2001, CLIN CANCER RES, V7, P98; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim KY, 2006, BIOCHEM PHARMACOL, V72, P530, DOI 10.1016/j.bcp.2006.05.009; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kumar AP, 2009, CANCER RES, V69, P8636, DOI 10.1158/0008-5472.CAN-09-0219; Lecomte J, 2008, BREAST CANCER RES TR, V112, P437, DOI 10.1007/s10549-007-9886-z; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mehta RG, 2000, J NATL CANCER I, V92, P418, DOI 10.1093/jnci/92.5.418; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Morosetti R, 2004, INT J ONCOL, V25, P493; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nwankwo JO, 2001, PROSTAG LEUKOTR ESS, V64, P241, DOI 10.1054/plef.2001.0266; OBER SS, 1987, P NATL ACAD SCI USA, V84, P2766, DOI 10.1073/pnas.84.9.2766; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; SICZKOWSKI M, 1994, AM J PHYSIOL, V267, pC745, DOI 10.1152/ajpcell.1994.267.3.C745; SOULE HD, 1990, CANCER RES, V50, P6075; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Venkatachalam G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S5; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005	44	117	121	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	33					3818	3825		10.1038/onc.2011.543	http://dx.doi.org/10.1038/onc.2011.543			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22120719	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000307924900008
J	Neeb, A; Wallbaum, S; Novac, N; Dukovic-Schulze, S; Scholl, I; Schreiber, C; Schlag, P; Moll, J; Stein, U; Sleeman, JP				Neeb, A.; Wallbaum, S.; Novac, N.; Dukovic-Schulze, S.; Scholl, I.; Schreiber, C.; Schlag, P.; Moll, J.; Stein, U.; Sleeman, J. P.			The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients	ONCOGENE			English	Article						Ier2; Pip92; ETR101; metastasis; motility; invasion	SIGNALING PATHWAYS; T-LYMPHOCYTE; PC12 CELLS; EXPRESSION; GROWTH; PIP92; PROTEIN; IDENTIFICATION; TRANSCRIPTION; DIFFERENTIATION	Here, we report unbiased screens for genes expressed in metastatic tumor cells that are associated with cell motility. These screens identified Ier2, an immediate early gene of unknown function, as potentially having a role in tumor cell motility and metastasis. Knockdown of Ier2 in 3T3 fibroblasts inhibited their motility upon relief of contact inhibition in monolayer wounding assays. Furthermore, ectopic Ier2 expression promoted the motility and invasiveness of poorly metastatic 1AS pancreatic tumor cells in vitro. Relief of contact inhibition was associated with translocation of the Ier2 protein from the cytoplasm to the nucleus in both 3T3 fibroblasts and 1AS tumor cells. Importantly, ectopic Ier2 expression in 1AS cells stimulated metastasis formation when cells were implanted into experimental animals. Furthermore, we found elevated Ier2 expression in a wide variety of human tumor types. This correlated with poor metastasis-free and overall survival in patients with colorectal adenocarcinomas. Together, these data reveal Ier2 as a new player in the regulation of tumor progression and metastasis, and suggest that Ier2 may be useful prognostically and therapeutically in the management of cancer. Oncogene (2012) 31, 3796-3806; doi: 10.1038/onc.2011.535; published online 28 November 2011	[Sleeman, J. P.] Heidelberg Univ, Univ Med Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, D-68167 Mannheim, Germany; [Neeb, A.; Wallbaum, S.; Novac, N.; Dukovic-Schulze, S.; Scholl, I.; Schreiber, C.; Moll, J.; Sleeman, J. P.] Karlsruhe Inst Technol, Inst Genet & Toxikol, Karlsruhe, Germany; [Schlag, P.] Charite Comprehens Canc Ctr, Berlin, Germany; [Stein, U.] Charite, Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, D-13353 Berlin, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sleeman, JP (corresponding author), Heidelberg Univ, Univ Med Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, TRIDOMUS Gebaude Haus C,Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany.	sleeman@medma.uni-heidelberg.de	Sleeman, Jonathan P/H-2515-2013; Dukowic-Schulze, Stefanie/AAC-8685-2019	Sleeman, Jonathan P/0000-0003-1718-7687; Dukowic-Schulze, Stefanie/0000-0003-2675-1075; Stein, Ulrike/0000-0001-7006-282X; Neeb, Antje/0000-0002-6516-2938	BMBF NGFN2 CancerNet Programme; European Union [LSHC-CT-2004-503224, HEALTH-F2-2008-201662]	BMBF NGFN2 CancerNet Programme(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	We are very grateful to Norma Howells, Selma Huber and Manuela Sauer for their assistance with the animal experiments, to Anja Steffen for expert technical support and to Wilko Thiele for critical reading of this manuscript. The contribution of Franziska Arlt and Markus Niederstrasser is also gratefully acknowledged. This work was supported by grants to JPS and US from the BMBF NGFN2 CancerNet Programme and to JPS from the European Union (FP6 STREP project BRECOSM, contract no. LSHC-CT-2004-503224 and FP7 Collaborative Project TuMIC, contract no. HEALTH-F2-2008-201662).	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bradley LM, 2003, CURR OPIN IMMUNOL, V15, P343, DOI 10.1016/S0952-7915(03)00043-8; CHARLES CH, 1990, MOL CELL BIOL, V10, P6769, DOI 10.1128/MCB.10.12.6769; Chen L, 2003, J GEN VIROL, V84, P3203, DOI 10.1099/vir.0.19283-0; Chiou CC, 2001, GUT, V48, P598, DOI 10.1136/gut.48.5.598; Chung KC, 2000, EUR J BIOCHEM, V267, P4676, DOI 10.1046/j.1432-1327.2000.01517.x; Chung KC, 1998, MOL CELL BIOL, V18, P2272, DOI 10.1128/MCB.18.4.2272; Chung KC, 2000, J NEUROCHEM, V75, P9, DOI 10.1046/j.1471-4159.2000.0750009.x; COLECLOUGH C, 1990, P NATL ACAD SCI USA, V87, P1753, DOI 10.1073/pnas.87.5.1753; Eschelbach A, 1998, ANN NY ACAD SCI, V865, P181, DOI 10.1111/j.1749-6632.1998.tb11177.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Gutmann DH, 2002, CANCER RES, V62, P2085; Harlow E., 1988, ANTIBODIES LAB MANUA; HERRLICH P, 1993, IMMUNOL TODAY, V14, P395, DOI 10.1016/0167-5699(93)90141-7; Hippo Y, 2002, CANCER RES, V62, P233; Hofmann M, 1998, J CELL SCI, V111, P1673; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Keeton AB, 2002, J BIOL CHEM, V277, P48565, DOI 10.1074/jbc.M207837200; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Li W, 2004, MOL BIOL CELL, V15, P294, DOI 10.1091/mbc.e03-05-0352; Mengwasser J, 2004, ONCOGENE, V23, P7430, DOI 10.1038/sj.onc.1207987; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Nestl A, 2001, CANCER RES, V61, P1569; Niebuhr K, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P398; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; Schneider A, 2004, J CEREBR BLOOD F MET, V24, P224, DOI 10.1097/01.WCB.0000104960.26014.7A; SCOTT JL, 1994, J CELL BIOCHEM, V54, P135, DOI 10.1002/jcb.240540202; SHIMIZU N, 1991, J BIOL CHEM, V266, P12157; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Sleeman JP, 2011, INT J CANCER, V128, P2511, DOI 10.1002/ijc.26027; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stein U, 2002, J CLIN ONCOL, V20, P3282, DOI 10.1200/JCO.2002.01.003; Takaya T, 2009, BIOSCI BIOTECH BIOCH, V73, P1653, DOI 10.1271/bbb.90162; Wallbaum S, 2009, BIOTECHNIQUES, V46, P433, DOI 10.2144/000113121; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	37	29	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	33					3796	3806		10.1038/onc.2011.535	http://dx.doi.org/10.1038/onc.2011.535			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22120713				2022-12-25	WOS:000307924900006
J	Davis, SP; Amrein, M; Gillrie, MR; Lee, K; Muruve, DA; Ho, M				Davis, Shevaun P.; Amrein, Matthias; Gillrie, Mark R.; Lee, Kristine; Muruve, Daniel A.; Ho, May			Plasmodium falciparum-induced CD36 clustering rapidly strengthens cytoadherence via p130CAS-mediated actin cytoskeletal rearrangement	FASEB JOURNAL			English	Article						adhesion; endothelium; malaria; pathogenesis	INTERCELLULAR-ADHESION MOLECULE-1; CELL FORCE SPECTROSCOPY; HUMAN CEREBRAL MALARIA; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; IN-VIVO; MICROVASCULAR ENDOTHELIUM; TYROSINE PHOSPHORYLATION; SEQUESTRATION; MIGRATION	The adhesion of infected red blood cells (IRBCs) to microvascular endothelium is critical in the pathogenesis of severe malaria. Here we used atomic force and confocal microscopy to examine the adhesive forces between IRBCs and human dermal microvascular endothelial cells. Initial contact of the cells generated a mean +/- SD adhesion force of 167 +/- 208 pN from the formation of single or multiple bonds with CD36. The strength of adhesion increased by 5-to 6-fold within minutes of contact through a signaling pathway initiated by CD36 ligation by live IRBCs, or polystyrene beads coated with anti-CD36 or PpMC-179, a recombinant peptide representing the minimal binding domain of the parasite ligand PfEMP1 to CD36. Engagement of CD36 led to localized phosphorylation of Src family kinases and the adaptor protein p130CAS, resulting in actin recruitment and CD36 clustering by 50-60% of adherent beads. Uninfected red blood cells or IgGcoated beads had no effect. Inhibition of the increase in adhesive strength by the Src family kinase inhibitor PP1 or gene silencing of p130CAS decreased adhesion by 39 +/- 12 and 48 +/- 20%, respectively, at 10 dyn/cm2 in a flow chamber assay. Modulation of adhesive strength at PfEMP1-CD36-actin cytoskeleton synapses could be a novel target for antiadhesive therapy.Davis, S. P., Amrein, M., Gillrie, M. R., Lee, K., Muruve, D. A., Ho, M. Plasmodium falciparum-induced CD36 clustering rapidly strengthens cytoadherence via p130CAS-mediated actin cytoskeletal rearrangement. FASEB J. 26, 1119-1130 (2012). www.fasebj.org	[Davis, Shevaun P.; Gillrie, Mark R.; Lee, Kristine; Ho, May] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Amrein, Matthias] Univ Calgary, Dept Anat & Cell Biol, Calgary, AB T2N 4N1, Canada; [Muruve, Daniel A.; Ho, May] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Ho, M (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	mho@ucalgary.ca			Canadian Institutes of Health Research (CIHR) [MT14104, MGC-48374]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant (MT14104) to M. H. and a group grant (MGC-48374) from the Canadian Institutes of Health Research (CIHR). M. H. is a scientist and D. A. M. is a senior scholar of Alberta Innovates-Health Solutions, Canada. M. R. G. is supported by a CIHR M.D./Ph.D. studentship. The authors are grateful to Dr. Carolyn Lane (Valley View Family Practice Clinic, Calgary, AB, Canada) for providing skin specimens, Dr. Ciaran Brady [National Institute of Allergy and Infectious Diseases (NAIAD), U.S. National Institutes of Health, Bethesda, MD, USA] for the PpMC-179 peptide, Dr. Dror I. Baruch (NAIAD) for the mAb (clone 4B3) against PpMC-179, Dr. Richard M. Fairhurst (NAIAD) for the parasite line 7G8, and Dr. John F. Elliott (University of Alberta, Edmonton, AB, Canada) for the human CD36 plasmid.	Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; Chaudhuri O, 2009, NAT METHODS, V6, P383, DOI [10.1038/NMETH.1320, 10.1038/nmeth.1320]; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2007, J INFECT DIS, V196, P460, DOI 10.1086/519287; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Ho M, 2005, INFECT IMMUN, V73, P8179, DOI 10.1128/IAI.73.12.8179-8187.2005; Imai Y, 2011, J BIOMECH, V44, P1553, DOI 10.1016/j.jbiomech.2011.02.084; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Kang S, 2009, LANGMUIR, V25, P9656, DOI 10.1021/la902247w; Li A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016929; Lipowsky H. H., 1995, PHYSL PATHOPHYSIOLOG, P140; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Marchiafava E., 1894, 2 MONOGRAPHS MALAIRA, P1; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; TURNER GDH, 1994, AM J PATHOL, V145, P1057; WARRELL DA, 1988, LANCET, V2, P534; WHITE NJ, 1985, LANCET, V1, P776; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841; Yipp BG, 2003, BLOOD, V101, P331, DOI 10.1182/blood-2002-06-1725; Yipp BG, 2007, MICROCIRCULATION, V14, P593, DOI 10.1080/10739680701404705	38	20	21	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1119	1130		10.1096/fj.11-196923	http://dx.doi.org/10.1096/fj.11-196923			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22106368	Green Published			2022-12-25	WOS:000300949300016
J	Hutchison, S; Benson, RA; Gibson, VB; Pollock, AH; Garside, P; Brewer, JM				Hutchison, Sharon; Benson, Robert A.; Gibson, Vivienne B.; Pollock, Abigail H.; Garside, Paul; Brewer, James M.			Antigen depot is not required for alum adjuvanticity	FASEB JOURNAL			English	Article						vaccine; in vivo	CD4 T-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSE; SELF-TOLERANCE; IN-VIVO; ABSENCE; INJECTION; COMPLEX	Alum adjuvants have been in continuous clinical use for more than 80 yr. While the prevailing theory has been that depot formation and the associated slow release of antigen and/or inflammation are responsible for alum enhancement of antigen presentation and subsequent T-and B-cell responses, this has never been formally proven. To examine antigen persistence, we used the chimeric fluorescent protein E alpha GFP, which allows assessment of antigen presentation in situ, using the Y-Ae antibody. We demonstrate that alum and/or CpG adjuvants induced similar uptake of antigen, and in all cases, GFP signal did not persist beyond 24 h in draining lymph node antigen-presenting cells. Antigen presentation was first detectable on B cells within 6-12 h of antigen administration, followed by conventional dendritic cells (DCs) at 12-24 h, then finally plasmacytoid DCs at 48 h or later. Again, alum and/or CpG adjuvants did not have an effect on the magnitude or sequence of this response; furthermore, they induced similar antigen-specific T-cell activation in vivo. Notably, removal of the injection site and associated alum depot, as early as 2 h after administration, had no appreciable effect on antigen-specific T- and B-cell responses. This study clearly rules out a role for depot formation in alum adjuvant activity.-Hutchison, S., Benson, R. A., Gibson, V. B., Pollock, A. H., Garside, P., Brewer, J. M. Antigen depot is not required for alum adjuvanticity. FASEB J. 26, 1272-1279 (2012). www.fasebj.org	[Hutchison, Sharon; Benson, Robert A.; Gibson, Vivienne B.; Pollock, Abigail H.; Garside, Paul; Brewer, James M.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Brewer, JM (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Sir Graeme Davies Bldg,120 Univ Ave, Glasgow G12 8TA, Lanark, Scotland.	james.brewer@glasgow.ac.uk	Brewer, James/A-7186-2010	Brewer, James/0000-0001-7933-0915; Hutchison, Sharon/0000-0002-8932-8349; Benson, Robert/0000-0003-3687-0481	UK Biotechnology and Biological Sciences Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/E00069X/1, BB/E00069X/2] Funding Source: researchfish; BBSRC [BB/E00069X/1, BB/E00069X/2] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the UK Biotechnology and Biological Sciences Research Council and The Wellcome Trust.	Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Benson RA, 2010, J IMMUNOL, V184, P6378, DOI 10.4049/jimmunol.0903951; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Brewer JM, 1999, J IMMUNOL, V163, P6448; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Glenny AT, 1931, J PATHOL BACTERIOL, V34, P267, DOI 10.1002/path.1700340214; Glenny AT, 1925, J PATHOL BACTERIOL, V28, P273, DOI 10.1002/path.1700280217; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Guery JC, 1996, J EXP MED, V183, P485, DOI 10.1084/jem.183.2.485; Hansen B, 2007, VACCINE, V25, P6618, DOI 10.1016/j.vaccine.2007.06.049; Harrison WT, 1935, AM J PUBLIC HEALTH N, V25, P298, DOI 10.2105/AJPH.25.3.298; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Holt L.B., 1950, DEV DIPHTHERIA PROPH; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jongbloed SL, 2009, J IMMUNOL, V182, P963, DOI 10.4049/jimmunol.182.2.963; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kreig A. M., 1995, NATURE, V374, P546; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MURPHY DB, 1992, J IMMUNOL, V148, P3483; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Oakley C. L., 1966, BIOGR MEMS FELL R SO, V12, P163; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rush CM, 2010, METHODS MOL BIOL, V626, P169, DOI 10.1007/978-1-60761-585-9_12; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; WARD JR, 1962, ARTHRITIS RHEUM, V5, P557, DOI 10.1002/art.1780050604; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833; WEISSBURG RP, 1995, PHARMACEUT RES, V12, P1439, DOI 10.1023/A:1016266916893; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228	36	138	148	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1272	1279		10.1096/fj.11-184556	http://dx.doi.org/10.1096/fj.11-184556			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22106367	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000300949300029
J	Ma, KL; He, YH; Zhang, HY; Fei, Q; Niu, DD; Wang, DM; Ding, X; Xu, H; Chen, XP; Zhu, JD				Ma, Kelong; He, Yinghua; Zhang, Hongyu; Fei, Qi; Niu, Dandan; Wang, Dongmei; Ding, Xia; Xu, Hua; Chen, Xiaoping; Zhu, Jingde			DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; THERAPY; CHEMORESISTANCE; APOPTOSIS; MICRORNA; METHYLTRANSFERASES; TRANSCRIPTOME; ESTABLISHMENT; ACTIVATION; BIOMARKERS	Chemoresistance prevents effective cancer therapy and is rarely predictable prior to treatment, particularly for hepatocellular carcinoma (HCC). Following the chemoresistance profiling of eight HCC cell lines to each of nine chemotherapeutics, two cell lines (QGY-7703 as a sensitive and SMMC-7721 as a resistant cell line to 5-fluorouracil (5-FU) treatment) were systematically studied for mechanistic insights underpinning HCC 5-FU chemoresistance. Genomic profiling at both DNA methylation and microRNA (miR) levels and subsequent mechanistic studies illustrate a new mechanism for how DNA methylation-regulated miR-193a-3p dictates the 5-FU resistance of HCC cells via repression of serine/arginine-rich splicing factor 2 (SRSF2) expression. In turn, SRSF2 preferentially up-regulates the proapoptotic splicing form of caspase 2 (CASP2L) and sensitizes HCC cells to 5-FU. Forced changes of miR-193a-3p level reverse all of the phenotypic features examined, including cell proliferation, cell cycle progression, and 5-FU sensitivity, in cell culture and in nude mice. Importantly, the siRNA-mediated repression of SRSF2 phenocopies all of the miR-193a-3p mimic-triggered changes in QGY-7703. This newly identified miR193a-3p-SRSF2 axis highlights a new set of companion diagnostics required for optimal 5-FU therapy of HCC, which involve assaying both the DNA methylation state of the miR-193a gene and the expression of miR-193a-3p and SRSF2 and the relative level of the proapoptotic versus antiapoptotic splicing forms of caspase 2 in clinical samples.	[Ma, Kelong; He, Yinghua; Zhang, Hongyu; Fei, Qi; Niu, Dandan; Zhu, Jingde] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, Canc Epigenet Program, Shanghai 200032, Peoples R China; [Ma, Kelong] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Wang, Dongmei; Ding, Xia] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Xu, Hua; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Liver Surg, Wuhan 430074, Peoples R China; [Zhu, Jingde] Anhui Med Univ, Sch Life Sci, Ctr Basic & Translat Epigenet Res Dis, Hefei 230032, Peoples R China	Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology; Anhui Medical University	Zhu, JD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, Canc Epigenet Program, Shanghai 200032, Peoples R China.	jdzhu@sjtu.edu.cn			National Science Foundation [30921140312]; National Research Program for Basic Research [2009CB825606, 2009CB825607, 2010CB912802]; International Collaboration Grant [2009DFA31010]; China National Key Projects for Infectious Disease Grant [2008ZX10002-021]; Shanghai Science Foundation [09JC141300]	National Science Foundation(National Science Foundation (NSF)); National Research Program for Basic Research; International Collaboration Grant; China National Key Projects for Infectious Disease Grant; Shanghai Science Foundation	This work is supported by National Science Foundation Grant 30921140312 (to J. Z.), National Research Program for Basic Research Grants 2009CB825606, 2009CB825607, and 2010CB912802 (to J. Z.), and International Collaboration Grant 2009DFA31010 (to X. D.). This work was also supported by China National Key Projects for Infectious Disease Grant 2008ZX10002-021 (to D. W.), and Shanghai Science Foundation Grant 09JC141300.	Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; Andrisano V, 2001, J CHROMATOGR B, V753, P375, DOI 10.1016/S0378-4347(00)00571-5; Barbour AP, 2003, CANCER RES, V63, P887; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Bonnette MD, 2009, DIAGN MOL PATHOL, V18, P165, DOI 10.1097/PDM.0b013e31818d34d1; Bourgo RJ, 2011, MOL BIOL CELL, V22, P931, DOI 10.1091/mbc.E10-11-0895; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Couzin J, 2009, SCIENCE, V323, P865, DOI 10.1126/science.323.5916.865a; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Ignath I, 2009, PANCREAS, V38, P921, DOI 10.1097/MPA.0b013e3181b65d34; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kantar M, 2009, LEUKEMIA LYMPHOMA, V50, P912, DOI 10.1080/10428190902893819; Lachenmayer A, 2010, DIGEST LIVER DIS, V42, pS264, DOI 10.1016/S1590-8658(10)60515-4; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lin Q, 2009, J CANCER RES CLIN, V135, P1675, DOI 10.1007/s00432-009-0614-4; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Meenhuis A, 2011, BLOOD, V118, P916, DOI 10.1182/blood-2011-02-336487; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Orban TI, 2003, J CLIN PATHOL-MOL PA, V56, P191, DOI 10.1136/mp.56.4.191; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sharma A, 2009, CANCER BIOL THER, V8, P2106, DOI 10.4161/cbt.8.22.9687; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	47	95	101	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5639	5649		10.1074/jbc.M111.291229	http://dx.doi.org/10.1074/jbc.M111.291229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22117060	hybrid, Green Published			2022-12-25	WOS:000300638000041
J	Lin-Moshier, Y; Walseth, TF; Churamani, D; Davidson, SM; Slama, JT; Hooper, R; Brailoiu, E; Patel, S; Marchant, JS				Lin-Moshier, Yaping; Walseth, Timothy F.; Churamani, Dev; Davidson, Sean M.; Slama, James T.; Hooper, Robert; Brailoiu, Eugen; Patel, Sandip; Marchant, Jonathan S.			Photoaffinity Labeling of Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Targets in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; 2-PORE CHANNELS; SENSITIVE CA2+; CALCIUM; RECEPTORS; ROLES; LINE	Nicotinic acid adenine dinucleotide phosphate (NAADP) is an agonist-generated second messenger that releases Ca2+ from intracellular acidic Ca2+ stores. Recent evidence has identified the two-pore channels (TPCs) within the endolysosomal system as NAADP-regulated Ca2+ channels that release organellar Ca2+ in response to NAADP. However, little is known about the mechanism coupling NAADP binding to calcium release. To identify the NAADP binding site, we employed a photoaffinity labeling method using a radioactive photoprobe based on 5-azido-NAADP ([P-32-5N(3)]NAADP) that exhibits high affinity binding to NAADP receptors. In several systems that are widely used for studying NAADP-evoked Ca2+ signaling, including sea urchin eggs, human cell lines (HEK293, SKBR3), and mouse pancreas, 5N(3)-NAADP selectively labeled low molecular weight sites that exhibited the diagnostic pharmacology of NAADP-sensitive Ca2+ release. Surprisingly, we were unable to demonstrate labeling of endogenous, or overexpressed, TPCs. Furthermore, labeling of high affinity NAADP binding sites was preserved in pancreatic samples from TPC1 and TPC2 knockout mice. These photolabeling data suggest that an accessory component within a larger TPC complex is responsible for binding NAADP that is unique from the core channel itself. This observation necessitates critical evaluation of current models of NAADP-triggered activation of the TPC family.	[Lin-Moshier, Yaping; Walseth, Timothy F.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Churamani, Dev; Hooper, Robert; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Davidson, Sean M.] UCL, Hatter Cardiovasc Inst, Dept Med, London WC1E 6HX, England; [Slama, James T.] Univ Toledo, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; University of London; University College London; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Marchant, JS (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	march029@umn.edu	Walseth, Timothy F/F-9518-2010; Marchant, Jonathan/Q-5484-2019; Davidson, Sean M/F-5275-2010; MARCHANT, Jonathan/B-8051-2009; Patel, Sandip/O-9591-2015	Walseth, Timothy F/0000-0003-2558-7859; Marchant, Jonathan/0000-0001-6592-0877; Davidson, Sean M/0000-0001-5182-4980; MARCHANT, Jonathan/0000-0001-6592-0877; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [GM088790, HL90804]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G013721/1]; University of Minnesota Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G013721/1] Funding Source: researchfish; British Heart Foundation [PG/10/005/28175] Funding Source: researchfish; BBSRC [BB/G013721/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Minnesota Graduate School(University of Minnesota System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants GM088790 (to J. S. M.) and HL90804 (to E. B.). This work was also supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/G013721/1 (to S. P.).; Supported by a doctoral dissertation fellowship from the University of Minnesota Graduate School.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Dionisio N, 2011, BBA-MOL CELL RES, V1813, P1483, DOI 10.1016/j.bbamcr.2011.05.005; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Galione A, 2011, SCI CHINA LIFE SCI, V54, P725, DOI 10.1007/s11427-011-4207-5; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Gambara G, 2008, J CELL PHYSIOL, V216, P396, DOI 10.1002/jcp.21407; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Hooper R., 2012, CALCIUM SIG IN PRESS, V740; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; Lamos SM, 2006, ANGEW CHEM INT EDIT, V45, P4329, DOI 10.1002/anie.200600743; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Robinette D, 2006, EXPERT REV PROTEOMIC, V3, P399, DOI 10.1586/14789450.3.4.399; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Tomizawa M, 2007, BIOCHEMISTRY-US, V46, P8798, DOI 10.1021/bi700667v; Tomizawa M, 2009, J MED CHEM, V52, P3735, DOI 10.1021/jm900153c; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Weber PJA, 1997, J PEPT RES, V49, P375; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	32	125	126	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2296	2307		10.1074/jbc.M111.305813	http://dx.doi.org/10.1074/jbc.M111.305813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117075	Green Published, hybrid			2022-12-25	WOS:000300292300006
J	Majka, J; Alford, B; Ausio, J; Finn, RM; McMurray, CT				Majka, Jerzy; Alford, Brian; Ausio, Juan; Finn, Ron M.; McMurray, Cynthia T.			ATP Hydrolysis by RAD50 Protein Switches MRE11 Enzyme from Endonuclease to Exonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; NUCLEASE ACTIVITY; COMPLEX; MRE11/RAD50; CHECKPOINT; DYNAMICS; BINDING; SAE2; CONFORMATIONS	MRE11-RAD50 is a key early response protein for processing DNA ends of broken chromosomes for repair, yet how RAD50 nucleotide dynamics regulate MRE11 nuclease activity is poorly understood. We report here that ATP binding and ATP hydrolysis cause a striking butterfly-like opening and closing of the RAD50 subunits, and each structural state has a dramatic functional effect on MRE11. RAD50-MRE11 has an extended conformation in solution when MRE11 is an active nuclease. However, ATP binding to RAD50 induces a closed conformation, and in this state MRE11 is an endonuclease. ATP hydrolysis opens the RAD50-MRE11 complex, and MRE11 maintains exonuclease activity. Thus, ATP hydrolysis is a molecular switch that converts MRE11 from an endonuclease to an exonuclease. We propose a testable model in which the open-closed transitions are used by RAD50-MRE11 to discriminate among DNA ends and drive the choice of recombination pathways.	[Majka, Jerzy; Alford, Brian; McMurray, Cynthia T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ausio, Juan; Finn, Ron M.] Univ Victoria, Dept Biochem, Victoria, BC V8W 3P6, Canada	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Mayo Clinic; Mayo Clinic; University of Victoria	McMurray, CT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	ctmcmurray@lbl.gov	Classen, Scott/AAY-8176-2020		National Institutes of Health [NS40738, GM066359, NS062384, NS060115, CA092584]; Mayo Foundation; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738, R01NS062384, R01NS060115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40738, GM066359, NS062384, and NS060115, and CA092584 (all to C. T. M.). This work was also supported by the Mayo Foundation.	ALANI E, 1989, GENETICS, V122, P47; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cao WM, 2005, BIOPHYS J, V89, P1589, DOI 10.1529/biophysj.105.061135; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mantiero D, 2007, EMBO REP, V8, P380, DOI 10.1038/sj.embor.7400911; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Owen BAL, 2009, NAT STRUCT MOL BIOL, V16, P550, DOI 10.1038/nsmb.1596; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033	55	30	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2328	2341		10.1074/jbc.M111.307041	http://dx.doi.org/10.1074/jbc.M111.307041			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22102415	Green Published, hybrid			2022-12-25	WOS:000300292300009
J	Lonsdorf, AS; Kramer, BF; Fahrleitner, M; Schonberger, T; Gnerlich, S; Ring, S; Gehring, S; Schneider, SW; Kruhlak, MJ; Meuth, SG; Nieswandt, B; Gawaz, M; Enk, AH; Langer, HF				Lonsdorf, Anke S.; Kraemer, Bjoern F.; Fahrleitner, Manuela; Schoenberger, Tanja; Gnerlich, Stephan; Ring, Sabine; Gehring, Sarah; Schneider, Stefan W.; Kruhlak, Michael J.; Meuth, Sven G.; Nieswandt, Bernhard; Gawaz, Meinrad; Enk, Alexander H.; Langer, Harald F.			Engagement of alpha IIb beta 3 (GPIIb/IIIa) with alpha nu beta 3 Integrin Mediates Interaction of Melanoma Cells with Platelets A CONNECTION TO HEMATOGENOUS METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATION-SPECIFIC BLOCKADE; ENDOTHELIAL PROGENITOR CELLS; SINGLE-CHAIN ANTIBODIES; GLYCOPROTEIN IB-ALPHA; IN-VITRO; ADHERENT PLATELETS; COUNTER-RECEPTOR; LUNG METASTASIS; VESSEL WALL; V INTEGRINS	A mutual relationship exists between metastasizing tumor cells and components of the coagulation cascade. The exact mechanisms as to how platelets influence blood-borne metastasis, however, remain poorly understood. Here, we used murine B16 melanoma cells to observe functional aspects of how platelets contribute to the process of hematogenous metastasis. We found that platelets interfere with a distinct step of the metastasis cascade, as they promote adhesion of melanoma cells to the endothelium in vitro under shear conditions. Constitutively active platelet receptor GPIIb/IIIa (integrin alpha IIb beta 3) expressed on Chinese hamster ovary cells promoted melanoma cell adhesion in the presence of fibrinogen, whereas blocking antibodies to a nu beta 3 integrin on melanoma cells or to GPIIb/IIIa significantly reduced melanoma cell adhesion to platelets. Furthermore, using intravital microscopy, we observed functional platelet-melanoma cell interactions, as platelet depletion resulted in significantly reduced melanoma cell adhesion to the injured vascular wall in vivo. Using a mouse model of hematogenous metastasis to the lung, we observed decreased metastasis of B16 melanoma cells to the lung by treatment with a mAb blocking the a nu subunit of a nu beta 3 integrin. This effect was significantly reduced when platelets were depleted in vivo. Thus, the engagement of GPIIb/IIIa with a nu beta 3 integrin interaction mediates tumor cell-platelet interactions and highlights how this interaction is involved in hematogenous tumor metastasis.	[Lonsdorf, Anke S.; Ring, Sabine; Enk, Alexander H.] Univ Heidelberg, Dept Dermatol, Univ Hosp, D-69115 Heidelberg, Germany; [Kraemer, Bjoern F.; Fahrleitner, Manuela; Schoenberger, Tanja; Gnerlich, Stephan; Gehring, Sarah; Gawaz, Meinrad; Langer, Harald F.] Univ Tubingen, Dept Cardiovasc Med, Univ Hosp, D-72076 Tubingen, Germany; [Schneider, Stefan W.] Univ Heidelberg, Dept Dermatol, D-68167 Mannheim, Germany; [Schneider, Stefan W.] Med Fac Mannheim, D-68167 Mannheim, Germany; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Meuth, Sven G.] Univ Munster, Inst Physiol, Neurol Clinic Inflammatory Disorders Nervous Syst, D-48149 Munster, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Dept Vasc Med, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97080 Wurzburg, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Munster; University of Wurzburg; University of Wurzburg	Lonsdorf, AS (corresponding author), Univ Heidelberg, Dept Dermatol, Univ Hosp, Vossstr 11, D-69115 Heidelberg, Germany.	anke.lonsdorf@med.uni-heidelberg.de; harald.langer@med.uni-tuebingen.de	Meuth, Sven G/HHM-8941-2022; Sauter, Manuela/AAU-5685-2021	Meuth, Sven G/0000-0003-2571-3501; Sauter, Manuela/0000-0002-6411-5697	National Institutes of Health; University of Tubingen (Center for Interdisciplinary Clinical Research); Volkswagen Foundation; Wilhelm Sander Foundation; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-University of Heidelberg; Clinical Research Unit of German Research Council [KFO 274]; Deutsche Forschungsgemeinschaft [SFB/TR23]; NATIONAL CANCER INSTITUTE [ZICBC010915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tubingen (Center for Interdisciplinary Clinical Research); Volkswagen Foundation(Volkswagen); Wilhelm Sander Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-University of Heidelberg; Clinical Research Unit of German Research Council; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health research career transition award (to A. S. L.). This work was also supported by the University of Tubingen (Center for Interdisciplinary Clinical Research, junior group program), the Volkswagen Foundation (Lichtenberg program), and Wilhelm Sander Foundation (to H. F. L.).; Supported in part by Deutsche Forschungsgemeinschaft and the Olympia-Morata-Programme of the Ruprecht-Karls-University of Heidelberg.; Members of the Tuebingen Platelet Investigative Consortium funded by the Clinical Research Unit KFO 274 of the German Research Council.; Supported by Deutsche Forschungsgemeinschaft Grant SFB/TR23.	Amirkhosravi A, 2003, THROMB HAEMOSTASIS, V90, P549, DOI 10.1160/TH03-02-0102; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; Ehlers R, 2003, J EXP MED, V198, P1077, DOI 10.1084/jem.20022181; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Erpenbeck L, 2010, J INVEST DERMATOL, V130, P576, DOI 10.1038/jid.2009.278; Fang L, 2008, J LEUKOCYTE BIOL, V84, P965, DOI 10.1189/jlb.1107776; Felding-Habermann B, 2002, CLIN EXP METASTAS, V19, P427, DOI 10.1023/A:1016377114119; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gawaz M, 2009, NAT REV CARDIOL, V6, P391, DOI 10.1038/nrcardio.2009.76; GAWAZ MP, 1991, J CLIN INVEST, V88, P1128, DOI 10.1172/JCI115412; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gosslar U, 1996, P NATL ACAD SCI USA, V93, P4821, DOI 10.1073/pnas.93.10.4821; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Karpatkin S, 1981, Ann N Y Acad Sci, V370, P101, DOI 10.1111/j.1749-6632.1981.tb29726.x; KATAGIRI Y, 1991, CANCER RES, V51, P1286; Kerk N, 2010, J INVEST DERMATOL, V130, P2259, DOI 10.1038/jid.2010.136; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Langer HF, 2008, BASIC RES CARDIOL, V103, P299, DOI 10.1007/s00395-008-0721-4; Langer HF, 2008, THROMB HAEMOSTASIS, V99, P480, DOI 10.1160/TH07-11-0685; Langer HF, 2007, ARTERIOSCL THROM VAS, V27, P1463, DOI 10.1161/ATVBAHA.107.141515; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Langer HF, 2009, J MOL CELL CARDIOL, V47, P315, DOI 10.1016/j.yjmcc.2009.03.011; Li XW, 2001, J CELL SCI, V114, P2665; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Murakami T, 2002, CANCER RES, V62, P7328; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nieswandt B, 1999, CANCER RES, V59, P1295; Peter K, 1996, BLOOD COAGUL FIBRIN, V7, P233, DOI 10.1097/00001721-199603000-00031; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Puerschel WC, 1996, BRIT J DERMATOL, V135, P883, DOI 10.1046/j.1365-2133.1996.d01-1090.x; Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y; Ring S, 2009, J ALLERGY CLIN IMMUN, V123, P1287, DOI 10.1016/j.jaci.2009.03.022; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schwarz M, 2004, FASEB J, V18, P1704, DOI 10.1096/fj.04-1513fje; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2010, ARTERIOSCL THROM VAS, V30, P1127, DOI 10.1161/ATVBAHA.110.204370; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Wang YQ, 2008, THROMB RES, V123, P324, DOI 10.1016/j.thromres.2008.06.021; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Wiesner T, 2010, CLIN EXP METASTAS, V27, P141, DOI 10.1007/s10585-010-9311-6; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38	63	79	85	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2168	2178		10.1074/jbc.M111.269811	http://dx.doi.org/10.1074/jbc.M111.269811			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22102277	Green Published, hybrid			2022-12-25	WOS:000299321000056
J	Cabart, P; Luse, DS				Cabart, Pavel; Luse, Donal S.			Inactivated RNA Polymerase II Open Complexes Can Be Reactivated with TFIIE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IIE; PREINITIATION COMPLEX; PROMOTER ESCAPE; BASAL TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; MINIMAL SET; INITIATION; DNA; ELONGATION	Transcript initiation by RNA polymerase II (pol II) requires a helicase within TFIIH to generate the unpaired template strand. However, pol II preinitiation complexes (PICs) lose the ability to synthesize RNA very rapidly upon exposure to ATP alone in the absence of other NTPs. This inactivation is not caused by the TFIIH kinase activity, the loss of transcription factors or pol II from the PIC, or the collapse of the initially formed transcription bubble. TFIIE is necessary for PIC formation, but TFIIE is not retained as a stable component in PICs prepared by our protocol. Nevertheless, activity can be at least partially restored to ATP-treated PICs by the readdition of TFIIE. PICs formed on premelted (bubble) templates require TFIIH for effective transcript elongation to +20. Incubation of bubble template PICs with ATP caused reduced yields of 20-mers, but this effect was partially reversed by the addition of TFIIE. Our results suggest that once the open complex is formed, TFIIH decays into an inactive configuration in the absence of nucleotides for transcription. Although TFIIE does not play a role in transcript initiation itself, inactivation resulting from ATP preincubation can be reversed by a remodeling process mediated by TFIIE. Finally, we have also uncovered a major role for TFIIF in the earliest stages of transcript elongation that is unique to bubble templates.	[Cabart, Pavel; Luse, Donal S.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	lused@ccf.org		Cabart, Pavel/0000-0003-0065-367X	National Institutes of Health, NIGMS, Public Health Service [GM 29487]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS, Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Public Health Service Grant GM 29487 (to D. S. L.).	Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Di Lello P, 2008, P NATL ACAD SCI USA, V105, P106, DOI 10.1073/pnas.0707892105; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; LUSE DS, 1987, J BIOL CHEM, V262, P289; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1994, J BIOL CHEM, V269, P18414; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Sakurai H, 1997, J BIOL CHEM, V272, P15936, DOI 10.1074/jbc.272.25.15936; Sakurai H, 2003, GENES CELLS, V8, P41, DOI 10.1046/j.1365-2443.2003.00613.x; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2011, J BIOL CHEM, V286, P23160, DOI 10.1074/jbc.M110.205658; Wang XX, 2003, J BIOL CHEM, V278, P10250, DOI 10.1074/jbc.M210848200; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	42	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					961	967		10.1074/jbc.M111.297572	http://dx.doi.org/10.1074/jbc.M111.297572			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22119917	Green Published, hybrid			2022-12-25	WOS:000299170300014
J	Huang, YJ; Wang, WW; Yao, P; Wang, XW; Liu, X; Zhuang, XX; Yan, F; Zhou, JH; Du, J; Ward, T; Zou, HF; Zhang, JC; Fang, GW; Ding, X; Dou, Z; Yao, XB				Huang, Yuejia; Wang, Wenwen; Yao, Phil; Wang, Xiwei; Liu, Xing; Zhuang, Xiaoxuan; Yan, Feng; Zhou, Jinhua; Du, Jian; Ward, Tarsha; Zou, Hanfa; Zhang, Jiancun; Fang, Guowei; Ding, Xia; Dou, Zhen; Yao, Xuebiao			CENP-E Kinesin Interacts with SKAP Protein to Orchestrate Accurate Chromosome Segregation in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS ENDS; MITOTIC CHECKPOINT; SPINDLE MICROTUBULES; KINETOCHORE PROTEIN; OUTER PLATE; ATTACHMENT; LOCALIZATION; MOTOR; ANEUPLOIDY; COMPLEX	Mitotic chromosome segregation is orchestrated by the dynamic interaction of spindle microtubules with the kinetochore. Although previous studies show that the mitotic kinesin CENP-E forms a link between attachment of the spindle microtubule to the kinetochore and the mitotic checkpoint signaling cascade, the molecular mechanism underlying dynamic kinetochore-microtubule interactions in mammalian cells remains elusive. Here, we identify a novel interaction between CENP-E and SKAP that functions synergistically in governing dynamic kinetochore-microtubule interactions. SKAP binds to the C-terminal tail of CENP-E in vitro and is essential for an accurate kinetochore-microtubule attachment in vivo. Immunoelectron microscopic analysis indicates that SKAP is a constituent of the kinetochore corona fibers of mammalian centromeres. Depletion of SKAP or CENP-E by RNA interference results in a dramatic reduction of inter-kinetochore tension, which causes chromosome mis-segregation with a prolonged delay in achieving metaphase alignment. Importantly, SKAP binds to microtubules in vitro, and this interaction is synergized by CENP-E. Based on these findings, we propose that SKAP cooperates with CENP-E to orchestrate dynamic kinetochore-microtubule interaction for faithful chromosome segregation.	[Huang, Yuejia; Wang, Wenwen; Wang, Xiwei; Liu, Xing; Zhuang, Xiaoxuan; Yan, Feng; Zhou, Jinhua; Du, Jian; Zhang, Jiancun; Fang, Guowei; Dou, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Sch Life Sci, Hefei 230027, Peoples R China; [Huang, Yuejia; Yao, Phil; Wang, Xiwei; Liu, Xing; Yan, Feng; Ward, Tarsha] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Zou, Hanfa] Dalian Inst Chem Phys, Dalian 116023, Peoples R China; [Ding, Xia] Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China; [Zhang, Jiancun] Guangzhou Inst Hlth Sci, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Beijing University of Chinese Medicine	Dou, Z (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Sch Life Sci, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; yaoxb@ustc.edu.cn	WANG, WENWEN/AAF-1080-2020; Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Zhuang, Xiaoxuan/R-7836-2019; Liu, Xing/H-2989-2018	WANG, WENWEN/0000-0002-1545-4369; Zhuang, Xiaoxuan/0000-0003-4004-5329; Liu, Xing/0000-0002-7480-5085; Zhou, Jinhua/0000-0002-3704-4459; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK-56292, U54CA118948, P20CA132389]; NCRR Clinical and Translational Science [UL1 RR025008]; NCRR [G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB945002, 2007CB914503, 2002CB713700]; Chinese Natural Science Foundation [91129714, 30870990, 31071184, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195]; International Collaboration Grant [2009DFA31010]; Anhui Province Project [08040102005]; NATIONAL CANCER INSTITUTE [P20CA132389, U54CA118948, R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK115812] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR Clinical and Translational Science; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese 973 Project(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); International Collaboration Grant; Anhui Province Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, U54CA118948, and P20CA132389 (to X.Y.), Grant UL1 RR025008 from the NCRR Clinical and Translational Science Award Program, and Grant G12RR03034 from NCRR. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB945002, 2007CB914503, and 2002CB713700 (to X.Y.), Chinese Natural Science Foundation Grants 91129714 and 30870990 (to X.D.), 31071184 (to Z.D.), 90508002 and 90913016 (to X.Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, International Collaboration Grant 2009DFA31010 (to X.D.), and Anhui Province Project Grant 08040102005 (to X.Y.).	Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Dou Z, 2003, CELL RES, V13, P443, DOI 10.1038/sj.cr.7290186; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Garcia-Saez I, 2004, J MOL BIOL, V340, P1107, DOI 10.1016/j.jmb.2004.05.053; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	40	35	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1500	1509		10.1074/jbc.M111.277194	http://dx.doi.org/10.1074/jbc.M111.277194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110139	Green Published, hybrid			2022-12-25	WOS:000299170300063
J	Xu, XJ; Yasuda, M; Nakamura-Tsuruta, S; Mizuno, M; Ashida, H				Xu, Xiaojuan; Yasuda, Michiko; Nakamura-Tsuruta, Sachiko; Mizuno, Masashi; Ashida, Hitoshi			beta-Glucan from Lentinus edodes Inhibits Nitric Oxide and Tumor Necrosis Factor-alpha Production and Phosphorylation of Mitogen-activated Protein Kinases in Lipopolysaccharide-stimulated Murine RAW 264.7 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON-GAMMA; INOS GENE; PERITONEAL-MACROPHAGES; CYTOKINE INDUCTION; SYNTHASE; EXPRESSION; DECTIN-1; RECOGNITION; DEXAMETHASONE	Lentinan (LNT), a beta-glucan from the fruiting bodies of Lentinus edodes, is well known to have immunomodulatory activity. NO and TNF-alpha are associated with many inflammatory diseases. In this study, we investigated the effects of LNT extracted by sonication (LNT-S) on the NO and TNF-alpha production in LPS-stimulated murine RAW 264.7 macrophages. The results suggested that treatment with LNT-S not only resulted in the striking inhibition of TNF-alpha and NO production in LPS-activated macrophage RAW 264.7 cells, but also the protein expression of inducible NOS (iNOS) and the gene expression of iNOS mRNA and TNF-alpha mRNA. It is surprising that LNT-S enhanced LPS-induced NF-kappa B p65 nuclear translocation and NF-kappa B luciferase activity, but severely inhibited the phosphorylation of JNK1/2 and ERK1/2. The neutralizing antibodies of anti-Dectin-1 and anti-TLR2 hardly affected the inhibition of NO production. All of these results suggested that the suppression of LPS-induced NO and TNF-alpha production was at least partially attributable to the inhibition of JNK1/2 and ERK1/2 activation. This work discovered a promising molecule to control the diseases associated with overproduction of NO and TNF-alpha.	[Xu, Xiaojuan] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China; [Yasuda, Michiko; Nakamura-Tsuruta, Sachiko] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Xu, Xiaojuan; Mizuno, Masashi; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan	Wuhan University; Kobe University; Kobe University	Xu, XJ (corresponding author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.	xuxj626@263.net; ashida@kobe-u.ac.jp		Xu, Xiaojuan/0000-0002-1404-5088; Yasuda, Michiko/0000-0002-8984-6138	Japan Society for the Promotion of Science [20.08431]; National Natural Science Foundation [20874078]; Youth Technology Chenguang Project of Wuhan [200950431193]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Technology Chenguang Project of Wuhan	This work was supported by Japan Society for the Promotion of Science Postdoctoral Fellowship 20.08431 (to X. X.), National Natural Science Foundation Grant 20874078, and Youth Technology Chenguang Project of Wuhan 200950431193.	ABEL G, 1989, INT J IMMUNOPHARMACO, V11, P615, DOI 10.1016/0192-0561(89)90146-X; AKIYAMA T, 1987, MANIPULATION HOST DE, P227; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Casale TB, 1996, AM J RESP CELL MOL, V15, P35, DOI 10.1165/ajrcmb.15.1.8679220; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; De Vera ME, 1997, AM J PHYSIOL-GASTR L, V273, pG1290, DOI 10.1152/ajpgi.1997.273.6.G1290; FEHSEL K, 1995, J IMMUNOL, V155, P2858; FRUEHAUF JP, 1982, IMMUNOPHARMACOLOGY, V5, P65, DOI 10.1016/0162-3109(82)90037-6; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Gess B, 1997, AM J PHYSIOL-REG I, V273, pR905, DOI 10.1152/ajpregu.1997.273.3.R905; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hashimoto T, 1997, FEMS IMMUNOL MED MIC, V19, P131, DOI 10.1111/j.1574-695X.1997.tb01082.x; HERLYN D, 1985, JPN J CANCER RES, V76, P37; Hogaboam CM, 1998, INFECT IMMUN, V66, P650, DOI 10.1128/IAI.66.2.650-655.1998; Jeon YJ, 1998, BIOCHEM MOL BIOL INT, V45, P435; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kerekgyarto C, 1996, INT J IMMUNOPHARMACO, V18, P347, DOI 10.1016/S0192-0561(96)00038-0; Kim JW, 2005, BIOCHEM PHARMACOL, V70, P1352, DOI 10.1016/j.bcp.2005.08.006; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 1996, MOL PHARMACOL, V49, P15; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kupfahl C, 2006, INT IMMUNOPHARMACOL, V6, P686, DOI 10.1016/j.intimp.2005.10.008; LADANYI A, 1993, CANCER IMMUNOL IMMUN, V36, P123, DOI 10.1007/BF01754412; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; LIEW FY, 1995, CURR OPIN IMMUNOL, V7, P396, DOI 10.1016/0952-7915(95)80116-2; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Manjeet R, 1999, INT J IMMUNOPHARMACO, V21, P435, DOI 10.1016/S0192-0561(99)00024-7; Miralles C, 2000, FEBS LETT, V476, P253, DOI 10.1016/S0014-5793(00)01748-8; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; NANBA H, 1987, CHEM PHARM BULL, V35, P2453; NANBA H, 1987, CHEM PHARM BULL, V35, P2459; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Noel M., 1997, INT J IMMUNOPHARMACO, V19, P463; Ohno N, 1996, IMMUNOL LETT, V52, P1, DOI 10.1016/0165-2478(96)02538-2; OKAMURA K, 1986, CANCER, V58, P865, DOI 10.1002/1097-0142(19860815)58:4<865::AID-CNCR2820580411>3.0.CO;2-S; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Osei SY, 1996, BLOOD, V88, P3583, DOI 10.1182/blood.V88.9.3583.bloodjournal8893583; PETER G, 1988, IMMUNOPHARM IMMUNOT, V10, P157; RIGGI SJ, 1961, AM J PHYSIOL, V200, P297, DOI 10.1152/ajplegacy.1961.200.2.297; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Ruttimann J, 2007, J EXP MED, V204, P3057, DOI 10.1084/jem.20413fta; Saura M, 1998, KIDNEY INT, V53, P38, DOI 10.1046/j.1523-1755.1998.00725.x; SUGA T, 1984, CANCER RES, V44, P5132; Taguchi T., 1986, HOST DEFENSE MECHANI, P221; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; TEBO JM, 1994, J IMMUNOL, V153, P4713; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Williams DL, 1997, MEDIAT INFLAMM, V6, P247, DOI 10.1080/09629359791550; Williams DL, 1996, CLIN IMMUNOTHER, V5, P392, DOI 10.1007/BF03259335; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Xu XJ, 2011, J BIOL CHEM, V286, P31194, DOI 10.1074/jbc.M111.246470; Yang Eun-Jin, 2009, Interdiscip Toxicol, V2, P245, DOI 10.2478/v10102-009-0022-2; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200	74	56	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					871	878		10.1074/jbc.M111.297887	http://dx.doi.org/10.1074/jbc.M111.297887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102286	Green Published, hybrid			2022-12-25	WOS:000299170300006
J	Kudelko, M; Brault, JB; Kwok, K; Li, MY; Pardigon, N; Peiris, JSM; Bruzzone, R; Despres, P; Nal, B; Wang, PG				Kudelko, Mateusz; Brault, Jean-Baptiste; Kwok, Kevin; Li, Ming Yuan; Pardigon, Nathalie; Peiris, J. S. Malik; Bruzzone, Roberto; Despres, Philippe; Nal, Beatrice; Wang, Pei Gang			Class II ADP-ribosylation Factors Are Required for Efficient Secretion of Dengue Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK-BORNE ENCEPHALITIS; GTP-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; ARF FAMILY; BETA-COP; GOLGI MEMBRANES; PHOSPHOLIPASE-D; FLAVIVIRUS; TRANSPORT; PARTICLES	Identification and characterization of virus-host interactions are very important steps toward a better understanding of the molecular mechanisms responsible for disease progression and pathogenesis. To date, very few cellular factors involved in the life cycle of flaviviruses, which are important human pathogens, have been described. In this study, we demonstrate a crucial role for class II Arf proteins (Arf4 and Arf5) in the dengue flavivirus life cycle. We show that simultaneous depletion of Arf4 and Arf5 blocks recombinant subviral particle secretion for all four dengue serotypes. Immunostaining analysis suggests that class II Arf proteins are required at an early pre-Golgi step for dengue virus secretion. Using a horseradish peroxidase protein fused to a signal peptide, we show that class II Arfs act specifically on dengue virus secretion without altering the secretion of proteins through the constitutive secretory pathway. Co-immunoprecipitation data demonstrate that the dengue prM glycoprotein interacts with class II Arf proteins but not through its C-terminal VXPX motif. Finally, experiments performed with replication-competent dengue and yellow fever viruses demonstrate that the depletion of class II Arfs inhibits virus secretion, thus confirming their implication in the virus life cycle, although data obtained with West Nile virus pointed out the differences in virus-host interactions among flaviviruses. Our findings shed new light on a molecular mechanism used by dengue viruses during the late stages of the life cycle and demonstrate a novel function for class II Arf proteins.	[Kudelko, Mateusz; Kwok, Kevin; Li, Ming Yuan; Peiris, J. S. Malik; Bruzzone, Roberto; Nal, Beatrice; Wang, Pei Gang] Univ Hong Kong, HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Nal, Beatrice] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Brault, Jean-Baptiste; Pardigon, Nathalie; Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, F-75724 Paris, France; [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, F-75724 Paris, France; [Nal, Beatrice] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge UB8 3PH, Middx, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Brunel University	Nal, B (corresponding author), 1-F Dexter HC Man Bldg,8 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	bnal@hku.hk; pgwang@hku.hk	NAL, Beatrice/GYU-8888-2022; Bruzzone, Roberto/C-4719-2009; Bruzzone, Roberto/G-9355-2017; Peiris, Joseph Sriyal Malik/C-4380-2009	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Nal, Beatrice/0000-0003-3452-7524; Brault, Jean-Baptiste/0000-0001-5950-2601; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Wang, Peigang/0000-0001-6045-2007	Research Fund for Control of Infectious Diseases of Hong Kong [RFCID 08070952, RFCID 10091312]; BNP Paribas Corporate and Investment Banking	Research Fund for Control of Infectious Diseases of Hong Kong; BNP Paribas Corporate and Investment Banking	This work was supported by Research Fund for Control of Infectious Diseases of Hong Kong Grants RFCID 08070952 and RFCID 10091312 and by a donation from BNP Paribas Corporate and Investment Banking.	ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	49	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					767	777		10.1074/jbc.M111.270579	http://dx.doi.org/10.1074/jbc.M111.270579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105072	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000298682400074
J	Cuyas, E; Verdejo-Garcia, A; Fagundo, AB; Khymenets, O; Rodriguez, J; Cuenca, A; Llopis, SD; Langohr, K; Pena-Casanova, J; Torrens, M; Martin-Santos, R; Farre, M; de la Torre, R				Cuyas, Elisabet; Verdejo-Garcia, Antonio; Beatriz Fagundo, Ana; Khymenets, Olha; Rodriguez, Joan; Cuenca, Aida; de Sola Llopis, Susana; Langohr, Klaus; Pena-Casanova, Jordi; Torrens, Marta; Martin-Santos, Rocio; Farre, Magi; de la Torre, Rafael			The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; OSTERRIETH COMPLEX FIGURE; SEROTONIN TRANSPORTER; ECSTASY USERS; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; EXTENSIVE METABOLIZERS; POSITRON EMISSION; MEMORY; BRAIN; POLYMORPHISM	This study is aimed to clarify the association between MDMA cumulative use and cognitive dysfunction, and the potential role of candidate genetic polymorphisms in explaining individual differences in the cognitive effects of MDMA. Gene polymorphisms related to reduced serotonin function, poor competency of executive control and memory consolidation systems, and high enzymatic activity linked to bioactivation of MDMA to neurotoxic metabolites may contribute to explain variations in the cognitive impact of MDMA across regular users of this drug. Sixty ecstasy polydrug users, 110 cannabis users and 93 non-drug users were assessed using cognitive measures of Verbal Memory (California Verbal Learning Test, CVLT), Visual Memory (Rey-Osterrieth Complex Figure Test, ROCFT), Semantic Fluency, and Perceptual Attention (Symbol Digit Modalities Test, SDMT). Participants were also genotyped for polymorphisms within the 5HTT, 5HTR2A, COMT, CYP2D6, BDNF, and GRIN2B genes using polymerase chain reaction and TaqMan polymerase assays. Lifetime cumulative MDMA use was significantly associated with poorer performance on visuospatial memory and perceptual attention. Heavy MDMA users (> 100 tablets lifetime use) interacted with candidate gene polymorphisms in explaining individual differences in cognitive performance between MDMA users and controls. MDMA users carrying COMT val/val and SERT s/s had poorer performance than paired controls on visuospatial attention and memory, and MDMA users with CYP2D6 ultra-rapid metabolizers performed worse than controls on semantic fluency. Both MDMA lifetime use and gene-related individual differences influence cognitive dysfunction in ecstasy users.	[Cuyas, Elisabet; Verdejo-Garcia, Antonio; Beatriz Fagundo, Ana; Khymenets, Olha; Rodriguez, Joan; de Sola Llopis, Susana; Langohr, Klaus; Martin-Santos, Rocio; Farre, Magi; de la Torre, Rafael] IMIM Hosp Mar Res Inst, Neurosci Res Program, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain; [Cuyas, Elisabet; Beatriz Fagundo, Ana; Pena-Casanova, Jordi; Torrens, Marta; Farre, Magi] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci, Granada, Spain; [Khymenets, Olha; de la Torre, Rafael] Hosp Clin Univ, CIBEROBN, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Cuenca, Aida] IMIM Hosp Mar Res Inst, Publ Hlth & Epidemiol Res Program, Epidemiol Drugs Abuse Res Grp, Barcelona, Spain; [Langohr, Klaus] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Pena-Casanova, Jordi] IMIM Hosp Mar Res Inst, Neurosci Res Program, Behav Neurol & Dementias Res Grp, Barcelona, Spain; [Torrens, Marta] IMIM Hosp Mar Res Inst, Neurosci Res Program, Disorders Use Subst Res Grp, Barcelona, Spain; [Martin-Santos, Rocio] Hosp Clin Barcelona, IDIBAPS, CIBER SAM, Dept Psychiat,Inst Neurosci, Barcelona, Spain; [de la Torre, Rafael] Univ Pompeu Fabra CEXS UPF, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat Politecnica de Catalunya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pompeu Fabra University	Cuyas, E (corresponding author), IMIM Hosp Mar Res Inst, Neurosci Res Program, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain.	rtorre@imim.es	de la Torre, Rafael/D-3561-2018; Khymenets, Olha/I-9752-2014; Langohr, Klaus/B-7825-2012; Cuyas, Elisabet/G-8582-2018; Verdejo-Garcia, Antonio/AAV-1147-2021	de la Torre, Rafael/0000-0002-6765-1866; Khymenets, Olha/0000-0002-8668-580X; Langohr, Klaus/0000-0001-7075-9192; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Fagundo, Ana Beatriz/0000-0003-1703-9457; Cuyas, Elisabet/0000-0001-5353-440X; Cuenca Royo, Aida/0000-0001-8551-5457	National Institutes of Health (NIH) [1 R01 DA017987, 2005SGR00032]; Fondo de Investigaciones Sanitarias [FIS-00/00777]; Plan Nacional Sobre Drogas, Spain [INT/2012/2002, PNSD 2006/101(2007-2009)]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017987] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Plan Nacional Sobre Drogas, Spain; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes of Health (NIH) grant no. 1 R01 DA017987, Grant 2005SGR00032, Fondo de Investigaciones Sanitarias (FIS-00/00777), Plan Nacional Sobre Drogas (INT/2012/2002) Spain, Plan Nacional Sobre Drogas: PNSD 2006/101(2007-2009) Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antshel KM, 2008, DEV NEUROPSYCHOL, V33, P601, DOI 10.1080/87565640802254422; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bedi G, 2008, PSYCHOL MED, V38, P1319, DOI 10.1017/S0033291708002730; Benton AL, 1983, MULTILINGUAL APHASIA; Biezonski DK, 2010, J NEUROCHEM, V112, P951, DOI 10.1111/j.1471-4159.2009.06515.x; Brown J, 2010, PSYCHOPHARMACOLOGY, V209, P51, DOI 10.1007/s00213-009-1766-2; Buchert R, 2004, AM J PSYCHIAT, V161, P1181, DOI 10.1176/appi.ajp.161.7.1181; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Carlesimo GA, 2010, NEUROLOGY, V74, P194, DOI 10.1212/WNL.0b013e3181cb3e39; Cherner M, 2010, J INT NEUROPSYCH SOC, V16, P890, DOI 10.1017/S1355617710000779; CUYA SE, 2010, PHARMACOGENOMICS, V11, P257; Daumann J, 2003, COGNITIVE BRAIN RES, V16, P479, DOI 10.1016/S0926-6410(03)00075-2; de la Torre R, 2005, EUR J CLIN PHARMACOL, V61, P551, DOI 10.1007/s00228-005-0965-y; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; de la Torre R, 2010, FORENSIC SCI INT, V196, P18, DOI 10.1016/j.forsciint.2009.12.039; De Luca V, 2005, PSYCHOPHARMACOLOGY, V182, P128, DOI 10.1007/s00213-005-0046-z; LLopis SD, 2008, J PSYCHOPHARMACOL, V22, P498, DOI 10.1177/0269881107081545; de Win MML, 2007, NEUROPSYCHOPHARMACOL, V32, P458, DOI 10.1038/sj.npp.1301225; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dennis NA, 2010, CEREB CORTEX, V20, P672, DOI 10.1093/cercor/bhp132; Fagundo AB, 2010, J PSYCHOPHARMACOL, V24, P1381, DOI 10.1177/0269881109354926; Farre M, 2004, PSYCHOPHARMACOLOGY, V173, P364, DOI 10.1007/s00213-004-1789-7; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Haroon E, 2009, PSYCHIAT RES-NEUROIM, V171, P10, DOI 10.1016/j.pscychresns.2008.03.006; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kalechstein AD, 2007, PSYCHOPHARMACOLOGY, V189, P531, DOI 10.1007/s00213-006-0601-2; Kish SJ, 2010, J PSYCHOPHARMACOL, V24, P281, DOI 10.1177/0269881108097724; Kish SJ, 2010, BRAIN, V133, P1779, DOI 10.1093/brain/awq103; Krebs TS, 2009, PSYCHOL MED, V39, P876, DOI 10.1017/S0033291708005096; Ludwig KU, 2010, AM J MED GENET B, V153B, P503, DOI 10.1002/ajmg.b.31007; Martocchio JJ, 2009, RES PERS H, V28, P1; McCann UD, 2008, PSYCHOPHARMACOLOGY, V200, P439, DOI 10.1007/s00213-008-1218-4; Medina KL, 2005, J INT NEUROPSYCH SOC, V11, P753, DOI 10.1017/S1355617705050915; Parrott AC, 2002, HUM PSYCHOPHARM CLIN, V17, P309, DOI 10.1002/hup.415; Perfetti X, 2009, DRUG METAB DISPOS, V37, P1448, DOI 10.1124/dmd.108.026393; Pichini S, 2006, THER DRUG MONIT, V28, P106, DOI 10.1097/01.ftd.0000189900.01060.92; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Roussos P, 2008, NEUROPSYCHOLOGIA, V46, P757, DOI 10.1016/j.neuropsychologia.2007.10.009; Schilt T, 2008, PSYCHOL MED, V38, P1309, DOI 10.1017/S0033291707002140; Schilt T, 2009, EUR NEUROPSYCHOPHARM, V19, P116, DOI 10.1016/j.euroneuro.2008.10.004; Seripa D, 2008, DEMENT GERIATR COGN, V25, P287, DOI 10.1159/000118634; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; SMITH RA, 1982, SYMBOL DIGIT MODALIT; Stein J, 2010, DEMENT GERIATR COGN, V29, P275, DOI 10.1159/000289779; Thomasius R, 2006, J PSYCHOPHARMACOL, V20, P211, DOI 10.1177/0269881106059486; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Ullsperger M, 2010, NEUROSCI BIOBEHAV R, V34, P649, DOI 10.1016/j.neubiorev.2009.06.009; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Wagner M, 2008, INT J NEUROPSYCHOPH, V11, P1163, DOI 10.1017/S146114570800905X; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873	56	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27206	10.1371/journal.pone.0027206	http://dx.doi.org/10.1371/journal.pone.0027206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110616	Green Published, gold			2022-12-25	WOS:000297555400027
J	Danzeisen, JL; Kim, HB; Isaacson, RE; Tu, ZJ; Johnson, TJ				Danzeisen, Jessica L.; Kim, Hyeun Bum; Isaacson, Richard E.; Tu, Zheng Jin; Johnson, Timothy J.			Modulations of the Chicken Cecal Microbiome and Metagenome in Response to Anticoccidial and Growth Promoter Treatment	PLOS ONE			English	Article							ENTEROCOCCUS-FAECIUM; GEN.-NOV.; BROILER PERFORMANCE; ESCHERICHIA-COLI; ANTIBIOTICS; POPULATIONS; DIVERSITY; DIETS; SUPPLEMENTATION; ANTIMICROBIALS	With increasing pressures to reduce or eliminate the use of antimicrobials for growth promotion purposes in production animals, there is a growing need to better understand the effects elicited by these agents in order to identify alternative approaches that might be used to maintain animal health. Antibiotic usage at subtherapeutic levels is postulated to confer a number of modulations in the microbes within the gut that ultimately result in growth promotion and reduced occurrence of disease. This study examined the effects of the coccidiostat monensin and the growth promoters virginiamycin and tylosin on the broiler chicken cecal microbiome and metagenome. Using a longitudinal design, cecal contents of commercial chickens were extracted and examined using 16S rRNA and total DNA shotgun metagenomic pyrosequencing. A number of genus-level enrichments and depletions were observed in response to monensin alone, or monensin in combination with virginiamycin or tylosin. Of note, monensin effects included depletions of Roseburia, Lactobacillus and Enterococcus, and enrichments in Coprococcus and Anaerofilum. The most notable effect observed in the monensin/virginiamycin and monensin/tylosin treatments, but not in the monensin-alone treatments, was enrichments in Escherichia coli. Analysis of the metagenomic dataset identified enrichments in transport system genes, type I fimbrial genes, and type IV conjugative secretion system genes. No significant differences were observed with regard to antimicrobial resistance gene counts. Overall, this study provides a more comprehensive glimpse of the chicken cecum microbial community, the modulations of this community in response to growth promoters, and targets for future efforts to mimic these effects using alternative approaches.	[Danzeisen, Jessica L.; Kim, Hyeun Bum; Isaacson, Richard E.; Johnson, Timothy J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Tu, Zheng Jin] Univ Minnesota, Minnesota Supercomp Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Danzeisen, JL (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	joh04207@umn.edu		Johnson, Timothy/0000-0001-7556-9347	University of Minnesota College of Veterinary Medicine; Minnesota Agricultural Experiment Station [MIN-63-050]	University of Minnesota College of Veterinary Medicine; Minnesota Agricultural Experiment Station	Funding for this study was provided by the University of Minnesota College of Veterinary Medicine and Minnesota Agricultural Experiment Station, grant MIN-63-050. This work was carried out in part using computing resources at the University of Minnesota Supercomputing Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agtarap A, 1967, Antimicrob Agents Chemother (Bethesda), V7, P359; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; ANDERSON DB, 2002, NUTR ABSTR REV, V70, P101; Baurhoo B, 2009, POULTRY SCI, V88, P2262, DOI 10.3382/ps.2008-00562; Biggs P, 2008, POULTRY SCI, V87, P2581, DOI 10.3382/ps.2008-00080; Breitenstein A, 2002, INT J SYST EVOL MICR, V52, P801, DOI [10.1099/ijs.0.01998-0, 10.1099/00207713-52-3-801]; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Bywater R, 2005, J ANTIMICROB CHEMOTH, V56, P538, DOI 10.1093/jac/dki273; Chapman HD, 2010, POULTRY SCI, V89, P1788, DOI 10.3382/ps.2010-00931; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collier CT, 2003, J ANIM SCI, V81, P3035; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escalante A, 2010, METABOLIC PATHWAY ENGINEERING HANDBOOK: FUNDAMENTALS; GLASS EM, 2010, CSH PROTOC; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Hammerum AM, 2007, INT J ANTIMICROB AG, V30, P466, DOI 10.1016/j.ijantimicag.2007.07.012; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Holmstrom K, 2004, ANAEROBE, V10, P197, DOI 10.1016/j.anaerobe.2004.01.004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jackson CR, 2006, AVIAN DIS, V50, P115, DOI 10.1637/7367-041305R.1; Janczyk P, 2009, POULTRY SCI, V88, P2324, DOI 10.3382/ps.2009-00250; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2009, METHODS MOL BIOL, V551, P27, DOI 10.1007/978-1-60327-999-4_3; Jozefiak D, 2010, BRIT POULTRY SCI, V51, P546, DOI 10.1080/00071668.2010.507243; Kieke AL, 2006, J INFECT DIS, V194, P1200, DOI 10.1086/508189; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Ladely SR, 2007, J FOOD PROTECT, V70, P1945, DOI 10.4315/0362-028X-70.8.1945; Lawson PA, 2004, INT J SYST EVOL MICR, V54, P413, DOI 10.1099/ijs.0.02653-0; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEYRINCK AM, 2011, J NUTR BIOC IN PRESS; Opapeju FO, 2009, J ANIM SCI, V87, P2635, DOI 10.2527/jas.2008-1310; Owens B, 2008, BRIT POULTRY SCI, V49, P202, DOI 10.1080/00071660802004890; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen JA, 2010, ARCH MICROBIOL, V192, P959, DOI 10.1007/s00203-010-0628-y; Smirnov A, 2005, J NUTR, V135, P187, DOI 10.1093/jn/135.2.187; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Thibodeau A, 2008, CAN J VET RES, V72, P129; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zellner G, 1996, INT J SYST BACTERIOL, V46, P871, DOI 10.1099/00207713-46-4-871; Zou LK, 2011, NEW MICROBIOL, V34, P73	53	236	250	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27949	10.1371/journal.pone.0027949	http://dx.doi.org/10.1371/journal.pone.0027949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114729	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400142
J	Hosokawa, Y; Ochi, H; Iino, T; Hiraoka, A; Tanaka, M				Hosokawa, Yoichiroh; Ochi, Haruki; Iino, Takanori; Hiraoka, Akihiro; Tanaka, Mikiko			Photoporation of Biomolecules into Single Cells in Living Vertebrate Embryos Induced by a Femtosecond Laser Amplifier	PLOS ONE			English	Article							TARGETED TRANSFECTION; MECHANISMS; EXPRESSION; TISSUES; MOUSE; CNS	Introduction of biomolecules into cells in living animals is one of the most important techniques in molecular and developmental biology research, and has potentially broad biomedical implications. Here we report that biomolecules can be introduced into single cells in living vertebrate embryos by photoporation using a femtosecond laser amplifier with a high pulse energy and a low repetition rate. First, we confirmed the efficiency of this photoporation technique by introducing dextran, morpholino oligonucleotides, or DNA plasmids into targeted single cells of zebrafish, chick, shark, and mouse embryos. Second, we demonstrated that femtosecond laser irradiation efficiently delivered DNA plasmids into single neurons of chick embryos. Finally, we successfully manipulated the fate of single neurons in zebrafish embryos by delivering mRNA. Our observations suggest that photoporation using a femtosecond laser with a high pulse energy and low repetition rate offers a novel way to manipulate the function(s) of individual cells in a wide range of vertebrate embryos by introduction of selected biomolecules.	[Hosokawa, Yoichiroh; Iino, Takanori; Hiraoka, Akihiro] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara, Japan; [Ochi, Haruki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; [Tanaka, Mikiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology; Tokyo Institute of Technology	Hosokawa, Y (corresponding author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara, Japan.	hosokawa@hskw.jp; mitanaka@bio.titech.ac.jp	Tanaka, Mikiko/X-1904-2019; Ochi, Haruki/AAR-7235-2020; Tanaka, Mikiko/B-9329-2015	Tanaka, Mikiko/0000-0001-8092-8594; Ochi, Haruki/0000-0002-0088-581X; Tanaka, Mikiko/0000-0001-8092-8594	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science to YH and a Grant-in-Aid for Challenging Exploratory Research to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hosokawa Y, 2011, P NATL ACAD SCI USA, V108, P1777, DOI 10.1073/pnas.1006847108; Hosokawa Y, 2009, APPL SURF SCI, V255, P9880, DOI 10.1016/j.apsusc.2009.04.111; HUGGEL H, 1959, Z VERGL PHYSIOL, V42, P63, DOI 10.1007/BF00297690; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Martin Paul, 2008, V461, P7, DOI 10.1007/978-1-60327-483-8_2; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogino H, 2008, DEVELOPMENT, V135, P249, DOI 10.1242/dev.009548; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; Tanaka M, 2000, DEVELOPMENT, V127, P4011; Tawk Marcel, 2009, V546, P145, DOI 10.1007/978-1-60327-977-2_10; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Uchugonova A, 2008, OPT EXPRESS, V16, P9357, DOI 10.1364/OE.16.009357; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Zohdy MJ, 2006, IEEE T ULTRASON FERR, V53, P117, DOI 10.1109/TUFFC.2006.1588397	21	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27677	10.1371/journal.pone.0027677	http://dx.doi.org/10.1371/journal.pone.0027677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110717	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400082
J	L'Hote, D; Vatin, M; Auer, J; Castille, J; Passet, B; Montagutelli, X; Serres, C; Vaiman, D				L'Hote, David; Vatin, Magalie; Auer, Jana; Castille, Johan; Passet, Bruno; Montagutelli, Xavier; Serres, Catherine; Vaiman, Daniel			Fidgetin-Like1 Is a Strong Candidate for a Dynamic Impairment of Male Meiosis Leading to Reduced Testis Weight in Mice	PLOS ONE			English	Article							BINDING-PROTEINS; IKAROS GENE; EXPRESSION; FERTILITY; MOUSE; BIOGENESIS; ATPASES; ENCODES; MITOSIS; TRAITS	Background: In a previous work, using an interspecific recombinant congenic mouse model, we reported a genomic region of 23 Mb on mouse chromosome 11 implicated in testis weight decrease and moderate teratozoospermia (similar to 20-30%), a Quantitative Trait Locus (QTL) called Ltw1. The objective of the present study is to identify the gene underlying this phenotype. Results: In the present study, we refined the QTL position to a 5 Mb fragment encompassing only 11 genes. We showed that the low testis weight phenotype was due to kinetic alterations occurring during the first wave of the spermatogenesis where we could point out to an abnormal lengthening of spermatocyte prophase. We identify Fidgetin-like 1 (Fignl1) as the gene underlying the phenotype, since if fulfilled both the physiological and molecular characteristics required. Indeed, amongst the 11 positional candidates it is the only gene that is expressed during meiosis at the spermatocyte stage, and that presents with non-synonymous coding variations differentiating the two mouse strains at the origin of the cross. Conclusions: This work prompted us to propose Fignl1 as a novel actor in mammal's male meiosis dynamics which has fundamental interest. Besides, this gene is a new potential candidate for human infertilities caused by teratozoospermia and blockades of spermatogenesis. In addition this study demonstrates that interspecific models may be useful for understanding complex quantitative traits.	[L'Hote, David] CNRS, UMR 7592, Inst Jacques Monod, Equipe Genet & Gen Dev Gonad, Paris, France; [L'Hote, David] Univ Paris 07, Paris, France; [Vatin, Magalie; Auer, Jana; Serres, Catherine; Vaiman, Daniel] INSERM, Inst Cochin, Dept Genet & Dev U1016, Paris, France; [Vatin, Magalie; Auer, Jana; Serres, Catherine; Vaiman, Daniel] Univ Paris 05, Paris, France; [Montagutelli, Xavier] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; [Castille, Johan; Passet, Bruno] INRA, Dept Genet Anim, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay	L'Hote, D (corresponding author), CNRS, UMR 7592, Inst Jacques Monod, Equipe Genet & Gen Dev Gonad, Paris, France.	vaiman@cochin.inserm.fr	LHOTE, David/AAD-5390-2020; Vaiman, Daniel/O-6030-2015; L'Hote, David/L-2653-2017	Vaiman, Daniel/0000-0002-1915-0717; L'Hote, David/0000-0001-5658-5018				BAKER VV, 1988, AM J OBSTET GYNECOL, V158, P762, DOI 10.1016/0002-9378(88)90069-5; Burgio G, 2007, GENETICS, V177, P2321, DOI 10.1534/genetics.107.078006; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dochi O, 2010, J REPROD DEVELOP, V56, pS61, DOI 10.1262/jrd.1056S61; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; L'Hote D, 2010, BIOESSAYS, V32, P132, DOI 10.1002/bies.200900027; L'Hote D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r133; Laissue P, 2009, ANIMAL, V3, P55, DOI 10.1017/S1751731108003315; Leroy JLMR, 2008, REPROD DOMEST ANIM, V43, P612, DOI 10.1111/j.1439-0531.2007.00960.x; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Luke-Glaser S, 2007, J CELL SCI, V120, P3179, DOI 10.1242/jcs.015883; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Molnar A, 1996, J IMMUNOL, V156, P585; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park SJ, 2007, J BONE MINER RES, V22, P889, DOI 10.1359/JBMR.070311; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Schraenen A, 2010, DIABETOLOGIA, V53, P2579, DOI 10.1007/s00125-010-1912-8; Vogt PH, 2008, INT J ANDROL, V31, P383, DOI 10.1111/j.1365-2605.2008.00890.x; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; YASUDA K, 2008, NAT GENET	27	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27582	10.1371/journal.pone.0027582	http://dx.doi.org/10.1371/journal.pone.0027582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110678	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400061
J	Manoukis, NC; Baber, I; Diallo, M; Sogoba, N; Ribeiro, JMC				Manoukis, Nicholas C.; Baber, Ibrahima; Diallo, Moussa; Sogoba, Nafomon; Ribeiro, Jose M. C.			Seasonal Climate Effects Anemotaxis in Newly Emerged Adult Anopheles gambiae Giles in Mali, West Africa	PLOS ONE			English	Article							MALARIA TRANSMISSION; MOSQUITOS DIPTERA; CARBON-DIOXIDE; FLIGHT; WIND; ORIENTATION; CULICIDAE; BEHAVIOR; VILLAGE; ABSENCE	The direction and magnitude of movement by the malaria vector Anopheles gambiae Giles has been of great interest to medical entomologists for over 70 years. This direction of movement is likely to be affected by many factors, from environmental conditions and stage of life history of the mosquito to the existence of attractants in the vicinity. We report here the direction of movement of newly emerged An. gambiae in nature, around the village of Doneguebougou, Mali. We assessed the direction of movement for individual mosquitoes by placing them in a novel enclosure with exit traps oriented in the direction of the cardinal and intermediate points of the compass. We consistently found predominantly Southward directions of movement during 2009 and 2010, with an additional Eastward component during the dry season and a Westward one during the wet season. Our data indicate that wind has an important effect on the direction of movement, but that this effect varied by season: Average directions of movement were downwind during the dry season and upwind during the wet season. A switch in anemotactic response suggests that the direction of movement of An. gambiae relative to the wind immediately after emergence under varying conditions of humidity should be further investigated under controlled conditions.	[Manoukis, Nicholas C.] ARS, US Pacific Basin Agr Res Ctr, USDA, Hilo, HI 96720 USA; [Baber, Ibrahima; Diallo, Moussa; Sogoba, Nafomon] Univ Mali, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Ribeiro, Jose M. C.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	United States Department of Agriculture (USDA); University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Manoukis, NC (corresponding author), ARS, US Pacific Basin Agr Res Ctr, USDA, Hilo, HI 96720 USA.	nicholas.manoukis@ars.usda.gov	Ribeiro, Jose/J-7011-2015; Manoukis, Nicholas C./V-9063-2019	Manoukis, Nicholas C./0000-0001-5062-7256; Ribeiro, Jose/0000-0002-9107-0818	NIAID/NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural program of the NIAID/NIH. These funds paid for fuel, materials and lodging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; BAKER TC, 1989, PHYSIOL ENTOMOL, V14, P1, DOI 10.1111/j.1365-3032.1989.tb00931.x; Bates M., 1949, NATURAL HIST MOSQUIT; Berens P., 2009, J STAT SOFTWARE, V31; BERTRAM D. S., 1956, Bulletin of Entomological Research, V47, P669, DOI 10.1017/S0007485300046915; BIDLINGMAYER WL, 1987, J AM MOSQUITO CONTR, V3, P369; CARTER R, 2000, B WORLD HEALTH ORGAN, V78; DAVID CT, 1982, J CHEM ECOL, V8, P1207, DOI 10.1007/BF00990753; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Dolo G, 2004, ACTA TROP, V89, P147, DOI 10.1016/j.actatropica.2003.10.014; GILLETT JD, 1979, MOSQ NEWS, V39, P221; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILLIES MT, 1974, NATURE, V252, P388, DOI 10.1038/252388b0; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; HADDOW AJ, 1946, B ENTOMOL RES, V36, P33; Kennedy JS, 1940, P ZOOL SOC LOND A-GE, V109, P221, DOI 10.1111/j.1096-3642.1940.tb00831.x; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Lund U., 2007, CIRCSTATS CIRCULAR S; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Manoukis NC, 2006, J MED ENTOMOL, V43, P820, DOI 10.1603/0022-2585(2006)43[820:IVBSTK]2.0.CO;2; MUIRHEADTHOMSON RC, 1938, B ENTOMOL RES, V29, P125; NIELSEN ET, 1960, ECOLOGY, V41, P375, DOI 10.2307/1930235; PROVOST MAURICE W., 1953, MOSQUITO NEWS, V13, P106; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; SNOW WF, 1976, B ENTOMOL RES, V65, P555, DOI 10.1017/S0007485300006234; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; TAYLOR CE, 2003, ECOLOGICAL ASPECTS A; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; *WHO DIV MAL OTH P, 1975, MAN PRACT ENT MAL	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e26910	10.1371/journal.pone.0026910	http://dx.doi.org/10.1371/journal.pone.0026910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114663	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400016
J	Muschik, D; Braspenning-Wesch, I; Stockfleth, E; Rosl, F; Hofmann, TG; Nindl, I				Muschik, Dorothea; Braspenning-Wesch, Ilona; Stockfleth, Eggert; Roesl, Frank; Hofmann, Thomas G.; Nindl, Ingo			Cutaneous HPV23 E6 Prevents p53 Phosphorylation through Interaction with HIPK2	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NONMELANOMA SKIN-CANCER; HUMAN PAPILLOMAVIRUSES; EPIDERMODYSPLASIA VERRUCIFORMIS; BETAPAPILLOMAVIRUS INFECTION; PROTEIN KINASE-2; APOPTOSIS; CLASSIFICATION; KERATINOCYTES; ASSOCIATION	Ultraviolet irradiation (UV) is the major risk factor for the development of skin cancer. Moreover, increasing evidence suggests cutaneotropic human papillomaviruses (HPV) from the beta genus to play a causal role as a co-factor in the development of cutaneous squamous cell carcinoma. Homeodomain-interacting protein kinase 2 (HIPK2) operates as a potential suppressor in skin tumorigenesis and is stabilized by UV-damage. HIPK2 is an important regulator of apoptosis, which forms a complex with the tumor suppressor p53, mediating p53 phosphorylation at Ser 46 and thus promoting proapoptotic gene expression. In our study, we demonstrate that cutaneous HPV23 E6 protein directly targets HIPK2 function. Accordingly, HPV23 E6 interacts with HIPK2 both in vitro and in vivo. Furthermore, upon massive UVB-damage HPV23 E6 co-localizes with endogenous HIPK2 at nuclear bodies. Functionally, we demonstrate that HPV23 E6 inhibits HIPK2-mediated p53 Ser 46 phosphorylation through enforcing dissociation of the HIPK2/p53 complex. In addition, HPV23 E6 co-accumulates with endogenous HIPK2 upon UV damage suggesting a mechanism by which HPV23 E6 keeps HIPK2 in check after UV damage. Thus, cutaneous HPV23 E6 prevents HIPK2-mediated p53 Ser 46 phosphorylation, which may favour survival of UV-damaged keratinocytes and skin carcinogenesis by apoptosis evasion.	[Muschik, Dorothea; Braspenning-Wesch, Ilona; Roesl, Frank; Nindl, Ingo] DKFZ Charite, German Canc Res Ctr DKFZ, Viral Skin Carcinogenesis Grp, Div Viral Transformat Mech, Heidelberg, Germany; [Stockfleth, Eggert; Nindl, Ingo] Univ Hosp Berlin, Charite, Skin Canc Ctr Charite, Dept Dermatol Venereol & Allergy, Berlin, Germany; [Hofmann, Thomas G.] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Cellular Senescence Grp, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ)	Muschik, D (corresponding author), DKFZ Charite, German Canc Res Ctr DKFZ, Viral Skin Carcinogenesis Grp, Div Viral Transformat Mech, Heidelberg, Germany.	ingo.nindl@charite.de			Deutsche Krebshilfe [109125-Ni]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant of the Deutsche Krebshilfe to IN (109125-Ni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKGU LB, 2006, J PATHOL, V208, P165; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Caldeira S, 2003, J VIROL, V77, P2195, DOI 10.1128/JVI.77.3.2195-2206.2003; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; de Koning MNC, 2009, J GEN VIROL, V90, P1611, DOI 10.1099/vir.0.010017-0; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Guccione E, 2002, VIROLOGY, V293, P20, DOI 10.1006/viro.2001.1290; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hofmann TG, 2005, J BIOL CHEM, V280, P29224, DOI 10.1074/jbc.M503921200; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, P64; JABLONSKA S, 1972, CANCER RES, V32, P583; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Massimi P, 2008, VIROLOGY, V371, P374, DOI 10.1016/j.virol.2007.10.015; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; ORTH G, 1978, P NATL ACAD SCI USA, V75, P1537, DOI 10.1073/pnas.75.3.1537; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Sherman L, 1996, J VIROL, V70, P3269, DOI 10.1128/JVI.70.5.3269-3279.1996; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H., 2006, INFECT CAUSING HUMAN	37	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27655	10.1371/journal.pone.0027655	http://dx.doi.org/10.1371/journal.pone.0027655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110707	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400077
J	Park, EJ; Kim, SA; Choi, YM; Kwon, HK; Shim, W; Lee, G; Choi, S				Park, Eun-Jung; Kim, Sun A.; Choi, Yong-Min; Kwon, Hyuk-Kwon; Shim, Wooyoung; Lee, Gwang; Choi, Sangdun			Capric Acid Inhibits NO Production and STAT3 Activation during LPS-Induced Osteoclastogenesis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B LIGAND; COLONY-STIMULATING FACTOR; BONE-RESORPTION; RECEPTOR ACTIVATOR; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; FATTY-ACIDS	Capric acid is a second medium-chain fatty acid, and recent studies have shown that fatty acids are associated with bone density and reduce bone turnover. In this study, we investigated the effects of capric acid on lipopolysaccharide (LPS)-induced osteoclastogenesis in RAW264.7 cells. After treatment with capric acid (1 mM), the number of tartrate resistant acid phosphatase (TRAP)-positive cells decreased significantly. Capric acid reduced LPS-induced TRAP expression, an osteoclast differentiation marker, without inhibiting cell viability. LPS strongly upregulated inducible nitric oxide synthase (iNOS) mRNA levels and nitric oxide (NO) production, whereas capric acid inhibited them. Furthermore, capric acid also inhibited monocyte chemoattractant protein-1 (MCP-1) mRNA expression. Subsequently, we investigated various intracellular signaling proteins, including nuclear factor-kappa B (NF-kappa B), c-Jun-N-terminal kinase (JNK), extracellular signal regulated kinase 1/2 (ERK1/2), and signal transducer and activator of transcription 1 (STAT1) and STAT3 associated with osteoclastogenesis. Capric acid had no effects on LPS-induced activation of the NF-kappa B, JNK, ERK1/2, and STAT1 pathways. However, capric acid inhibited LPS-induced phosphorylation of Ser(727) in STAT3. Additionally, stattic (a STAT3 inhibitor) inhibited LPS-induced iNOS and MCP-1 gene expression. In conclusion, we demonstrated that capric acid inhibited LPS-induced osteoclastogenesis by suppressing NO production via the STAT3 pathway. These results suggest that capric acid has important therapeutic implications for treating bone diseases associated with excessive osteoclastogenesis.	[Park, Eun-Jung; Kim, Sun A.; Choi, Yong-Min; Kwon, Hyuk-Kwon; Shim, Wooyoung; Lee, Gwang; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea	Ajou University	Park, EJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	kwon, hyukkwon/GRS-1775-2022; Park, Eun-Jung/Y-4427-2019; kwon, hyuk-kwon/AAS-4154-2021	kwon, hyuk-kwon/0000-0002-4723-4061	NRF of Korea; MEST [2010-0015356]; Korea Food & Drug Administration [10182KFDA992-2302]; Priority Research Centers [NRF 2010-0028294]	NRF of Korea; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Priority Research Centers	This work was supported by the Basic Science Research Program through the NRF of Korea funded by the MEST (2010-0015356). This work was also partly supported by a grant from the Korea Food & Drug Administration (10182KFDA992-2302) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chae HJ, 1997, J PHARM PHARMACOL, V49, P897, DOI 10.1111/j.2042-7158.1997.tb06132.x; Chole RA, 1998, ACTA OTO-LARYNGOL, V118, P705; Collin-Osdoby P, 2000, J BONE MINER RES, V15, P474, DOI 10.1359/jbmr.2000.15.3.474; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Das UN, 2000, NUTRITION, V16, P386, DOI 10.1016/S0899-9007(00)00262-8; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Goldring SR, 2000, ARTHRITIS RES, V2, P33, DOI 10.1186/ar67; Hirayama T, 2002, RHEUMATOLOGY, V41, P1232, DOI 10.1093/rheumatology/41.11.1232; Holliday LS, 1997, AM J PHYSIOL-RENAL, V272, pF283, DOI 10.1152/ajprenal.1997.272.3.F283; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Kirkwood KL, 2007, J PHARMACOL EXP THER, V320, P56, DOI 10.1124/jpet.106.112466; Kitamoto Shiro, 2002, J Atheroscler Thromb, V9, P261; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; LAMAS S, 1992, J CLIN INVEST, V90, P879, DOI 10.1172/JCI115963; LAMAS S, 1991, AM J PHYSIOL, V261, pC634, DOI 10.1152/ajpcell.1991.261.4.C634; Lee AK, 2003, BRIT J PHARMACOL, V139, P11, DOI 10.1038/sj.bjp.0705231; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Nilforoushan D, 2009, NITRIC OXIDE-BIOL CH, V21, P27, DOI 10.1016/j.niox.2009.04.002; Quinn JMW, 2005, BIOCHEM BIOPH RES CO, V328, P739, DOI 10.1016/j.bbrc.2004.11.076; Rahman MM, 2006, J LIPID RES, V47, P1739, DOI 10.1194/jlr.M600151-JLR200; Rogers JE, 2007, J PERIODONTOL, V78, P1992, DOI 10.1902/jop.2007.070101; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Scott MJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1153, DOI 10.1128/CDLI.9.6.1153-1159.2002; Smith BJ, 2006, BONE, V38, P378, DOI 10.1016/j.bone.2005.09.008; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Suda T, 2001, Novartis Found Symp, V232, P235; Sunyer T, 1997, ENDOCRINOLOGY, V138, P2148, DOI 10.1210/en.138.5.2148; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tangirala RK, 1997, J BIOL CHEM, V272, P8050, DOI 10.1074/jbc.272.12.8050; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; van't Hof RJ, 2000, P NATL ACAD SCI USA, V97, P7993, DOI 10.1073/pnas.130511497; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zhang ZY, 2005, BIOCHEM BIOPH RES CO, V328, P800, DOI 10.1016/j.bbrc.2005.01.019	47	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27739	10.1371/journal.pone.0027739	http://dx.doi.org/10.1371/journal.pone.0027739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110749	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400103
J	Shu, XH; Luhmann, UFO; Aleman, TS; Barker, SE; Lennon, A; Tulloch, B; Chen, M; Xu, HP; Jacobson, SG; Ali, R; Wright, AF				Shu, Xinhua; Luhmann, Ulrich F. O.; Aleman, Tomas S.; Barker, Susan E.; Lennon, Alan; Tulloch, Brian; Chen, Mei; Xu, Heping; Jacobson, Samuel G.; Ali, Robin; Wright, Alan F.			Characterisation of a C1qtnf5 Ser163Arg Knock-In Mouse Model of Late-Onset Retinal Macular Degeneration	PLOS ONE			English	Article							ANTERIOR LENS ZONULES; CYSTIC-FIBROSIS; LIPOFUSCIN ACCUMULATION; GENETIC MODEL; MICE; MODIFIER; PHENOTYPE; MUTATION; DISEASE; IDENTIFICATION	A single founder mutation resulting in a Ser163Arg substitution in the C1QTNF5 gene product causes autosomal dominant late-onset retinal macular degeneration (L-ORMD) in humans, which has clinical and pathological features resembling age-related macular degeneration. We generated and characterised a mouse "knock-in" model carrying the Ser163Arg mutation in the orthologous murine C1qtnf5 gene by site-directed mutagenesis and homologous recombination into mouse embryonic stem cells. Biochemical, immunological, electron microscopic, fundus autofluorescence, electroretinography and laser photocoagulation analyses were used to characterise the mouse model. Heterozygous and homozygous knock-in mice showed no significant abnormality in any of the above measures at time points up to 2 years. This result contrasts with another C1qtnf5 Ser163Arg knock-in mouse which showed most of the features of L-ORMD but differed in genetic background and targeting construct.	[Shu, Xinhua; Lennon, Alan; Tulloch, Brian; Wright, Alan F.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Luhmann, Ulrich F. O.; Barker, Susan E.; Ali, Robin] UCL Inst Ophthalmol, London, England; [Shu, Xinhua] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow G4 0BA, Lanark, Scotland; [Shu, Xinhua] Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland; [Aleman, Tomas S.; Jacobson, Samuel G.] Univ Penn, Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Chen, Mei; Xu, Heping] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland	University of Edinburgh; University of London; University College London; Glasgow Caledonian University; Glasgow Caledonian University; University of Pennsylvania; Pennsylvania Medicine; Queens University Belfast	Shu, XH (corresponding author), Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	alan.wright@hgu.mrc.ac.uk	Xu, Heping/A-4430-2008; Luhmann, Ulrich/D-8905-2012	Xu, Heping/0000-0003-4000-931X; Ali, Robin/0000-0003-3126-6517; Jacobson, Samuel/0000-0003-2122-169X	European Commission [FP7]; EVI GENORET [LSHG-CT-2005-512036]; Medical Research Council (UK); Macula Vision Research Foundation; RP Fighting Blindness; TENOVUS Scotland; Vision Research Trust; W.H. Ross Foundation; National Eye Research Centre; Carnegie Trust for the Universities of Scotland; MRC [MC_U127584475] Funding Source: UKRI; Medical Research Council [MC_PC_U127584475, MC_U127584475] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); EVI GENORET(European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Macula Vision Research Foundation; RP Fighting Blindness; TENOVUS Scotland; Vision Research Trust; W.H. Ross Foundation; National Eye Research Centre; Carnegie Trust for the Universities of Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The European Commission (FP7), Integrated project "EVI GENORET" (LSHG-CT-2005-512036), Medical Research Council (UK), Macula Vision Research Foundation, RP Fighting Blindness, TENOVUS Scotland, Vision Research Trust, W.H. Ross Foundation, National Eye Research Centre, and Carnegie Trust for the Universities of Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Balaggan KS, 2006, GENE THER, V13, P1153, DOI 10.1038/sj.gt.3302769; BRUNNER S, INVEST OPHTHALMOL VI, V51, P1106; CHAVALI VR, 2011, HUM MOL GENET; Danciger M, 2007, MOL VIS, V13, P79; Demaison C, 2000, HUM GENE THER, V11, P91, DOI 10.1089/10430340050016184; DICKINSON P, 1995, MOL MED TODAY, V1, P140, DOI 10.1016/S1357-4310(95)80092-1; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Elsea Sarah H, 2002, ILAR J, V43, P66; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Haston CK, 2002, MAMM GENOME, V13, P605, DOI 10.1007/s00335-002-2190-7; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Kameya S, 2002, HUM MOL GENET, V11, P1879, DOI 10.1093/hmg/11.16.1879; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Kiernan AE, 2007, GENETICS, V177, P307, DOI 10.1534/genetics.107.075960; Kuntz CA, 1996, INVEST OPHTH VIS SCI, V37, P1772; Lima BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014136; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Milam AH, 2000, OPHTHALMOLOGY, V107, P2256, DOI 10.1016/S0161-6420(00)00419-X; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Robson MG, 2003, CLIN EXP IMMUNOL, V133, P326, DOI 10.1046/j.1365-2249.2003.02233.x; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Samardzija M, 2006, EUR J NEUROSCI, V23, P1028, DOI 10.1111/j.1460-9568.2006.04639.x; Shu XH, 2006, ADV EXP MED BIOL, V572, P41; Shu XH, 2006, HUM MOL GENET, V15, P1680, DOI 10.1093/hmg/ddl091; Shu XH, 2006, INVEST OPHTH VIS SCI, V47, P348, DOI 10.1167/iovs.05-0858; Silverman KA, 2002, GENOME RES, V12, P88, DOI 10.1101/gr.206002; Smith AJ, 2003, MOL THER, V8, P188, DOI 10.1016/S1525-0016(03)00144-8; Stone EM, 2009, CURR OPIN GENET DEV, V19, P283, DOI 10.1016/j.gde.2009.03.006; Subrayan V, 2005, AM J OPHTHALMOL, V140, P1127, DOI 10.1016/j.ajo.2005.06.023; Sundin OH, 2005, P NATL ACAD SCI USA, V102, P9553, DOI 10.1073/pnas.0501451102; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Weber BHF, 2002, INVEST OPHTH VIS SCI, V43, P2732; Wheeler FC, 2005, MAMM GENOME, V16, P414, DOI 10.1007/s00335-005-2468-7; Wheeler FC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000647; Williams DS, 2009, INVEST OPHTH VIS SCI, V50, P3881, DOI 10.1167/iovs.08-3358; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448; Yang TX, 2005, AM J PHYSIOL-RENAL, V288, pF1125, DOI 10.1152/ajprenal.00219.2004; Zeiss CJ, 2010, VET PATHOL, V47, P396, DOI 10.1177/0300985809359598	47	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27433	10.1371/journal.pone.0027433	http://dx.doi.org/10.1371/journal.pone.0027433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110650	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400045
J	Sutherland, RE; Xu, X; Kim, SS; Seeley, EJ; Caughey, GH; Wolters, PJ				Sutherland, Rachel E.; Xu, Xiang; Kim, Sophia S.; Seeley, Eric J.; Caughey, George H.; Wolters, Paul J.			Parasitic Infection Improves Survival from Septic Peritonitis by Enhancing Mast Cell Responses to Bacteria in Mice	PLOS ONE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; INNATE IMMUNITY; EXPRESSION; PNEUMONIA; SEPSIS; PROTECTION; CLEARANCE; MOUSE; MODEL; IL-13	Mammals are serially infected with a variety of microorganisms, including bacteria and parasites. Each infection reprograms the immune system's responses to re-exposure and potentially alters responses to first-time infection by different microorganisms. To examine whether infection with a metazoan parasite modulates host responses to subsequent bacterial infection, mice were infected with the hookworm-like intestinal nematode Nippostrongylus brasiliensis, followed in 2-4 weeks by peritoneal injection of the pathogenic bacterium Klebsiella pneumoniae. Survival from Klebsiella peritonitis two weeks after parasite infection was better in Nippostrongylus-infected animals than in unparasitized mice, with Nippostrongylus-infected mice having fewer peritoneal bacteria, more neutrophils, and higher levels of protective interleukin 6. The improved survival of Nippostrongylus-infected mice depends on IL-4 because the survival benefit is lost in mice lacking IL-4. Because mast cells protect mice from Klebsiella peritonitis, we examined responses in mast cell-deficient Kit(W-sh)/Kit(W-sh) mice, in which parasitosis failed to improve survival from Klebsiella peritonitis. However, adoptive transfer of cultured mast cells to Kit(W-sh)/Kit(W-sh) mice restored survival benefits of parasitosis. These results show that recent infection with Nippostrongylus brasiliensis protects mice from Klebsiella peritonitis by modulating mast cell contributions to host defense, and suggest more generally that parasitosis can yield survival advantages to a bacterially infected host.	[Sutherland, Rachel E.; Xu, Xiang; Kim, Sophia S.; Seeley, Eric J.; Caughey, George H.; Wolters, Paul J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sutherland, RE (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	paul.wolters@ucsf.edu			National Institutes of Health (NIH) [HL024136, HL075026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075026, P01HL024136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL024136 (GHC) and HL075026 (PJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Baumhofer JM, 1998, EUR J IMMUNOL, V28, P610, DOI 10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Di Nardo A, 2008, J IMMUNOL, V180, P7565, DOI 10.4049/jimmunol.180.11.7565; DUTTLINGER R, 1995, P NATL ACAD SCI USA, V92, P3754, DOI 10.1073/pnas.92.9.3754; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Fellous S, 2009, TRENDS PARASITOL, V25, P62, DOI 10.1016/j.pt.2008.11.010; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Friend DS, 1998, J IMMUNOL, V160, P5537; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; JACOBSON RH, 1974, P SOC EXP BIOL MED, V147, P667, DOI 10.3181/00379727-147-38412; Jain-Vora S, 1998, INFECT IMMUN, V66, P4229; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; McDermott JR, 2003, P NATL ACAD SCI USA, V100, P7761, DOI 10.1073/pnas.1231488100; MUNGER JC, 1988, CAN J ZOOL, V66, P222, DOI 10.1139/z88-032; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; RAZIN E, 1984, J IMMUNOL, V132, P1479; Sutherland RE, 2008, J IMMUNOL, V181, P5598, DOI 10.4049/jimmunol.181.8.5598; THAKURDAS SM, 2007, J BIOL CHEM; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zelmer DA, 1998, INT J PARASITOL, V28, P531, DOI 10.1016/S0020-7519(97)00199-9	29	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27564	10.1371/journal.pone.0027564	http://dx.doi.org/10.1371/journal.pone.0027564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110673	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400056
J	Zhang, W; Johnston, JA; Ross, MA; Smith, AA; Coakley, BJ; Gleason, EA; Dueck, AC; Santello, M				Zhang, Wei; Johnston, Jamie A.; Ross, Mark A.; Smith, Anthony A.; Coakley, Brandon J.; Gleason, Elizabeth A.; Dueck, Amylou C.; Santello, Marco			Effects of Carpal Tunnel Syndrome on Adaptation of Multi-Digit Forces to Object Weight for Whole-Hand Manipulation	PLOS ONE			English	Article							PRECISION GRIP; FINGERTIP FORCES; MEDIAN NERVE; MULTIFINGER PREHENSION; MEMORY REPRESENTATIONS; SENSORIMOTOR MEMORY; CUTANEOUS FEEDBACK; SYNERGIES; DIAGNOSIS; INFORMATION	The delicate tuning of digit forces to object properties can be disrupted by a number of neurological and musculoskeletal diseases. One such condition is Carpal Tunnel Syndrome (CTS), a compression neuropathy of the median nerve that causes sensory and motor deficits in a subset of digits in the hand. Whereas the effects of CTS on median nerve physiology are well understood, the extent to which it affects whole-hand manipulation remains to be addressed. CTS affects only the lateral three and a half digits, which raises the question of how the central nervous system integrates sensory feedback from affected and unaffected digits to plan and execute whole-hand object manipulation. We addressed this question by asking CTS patients and healthy controls to grasp, lift, and hold a grip device (445, 545, or 745 g) for several consecutive trials. We found that CTS patients were able to successfully adapt grip force to object weight. However, multi-digit force coordination in patients was characterized by lower discrimination of force modulation to lighter object weights, higher across-trial digit force variability, the consistent use of excessively large digit forces across consecutive trials, and a lower ability to minimize net moments on the object. Importantly, the mechanical requirement of attaining equilibrium of forces and torques caused CTS patients to exert excessive forces at both CTS-affected digits and digits with intact sensorimotor capabilities. These findings suggest that CTS-induced deficits in tactile sensitivity interfere with the formation of accurate sensorimotor memories of previous manipulations. Consequently, CTS patients use compensatory strategies to maximize grasp stability at the expense of exerting consistently larger multi-digit forces than controls. These behavioral deficits might be particularly detrimental for tasks that require fine regulation of fingertip forces for manipulating light or fragile objects.	[Zhang, Wei; Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85069 USA; [Johnston, Jamie A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Ross, Mark A.; Smith, Anthony A.; Coakley, Brandon J.; Gleason, Elizabeth A.; Dueck, Amylou C.] Mayo Clin Hosp, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; University of Calgary; Mayo Clinic; Mayo Clinic Phoenix	Zhang, W (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85069 USA.	marco.santello@asu.edu	zhang, wei/AAV-9554-2021	zhang, wei/0000-0002-2341-0876	National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH) [1R01 HD057152]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057152] Funding Source: NIH RePORTER	National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by grant number 1R01 HD057152 from the National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2007, J MOTOR BEHAV, V39, P276, DOI 10.3200/JMBR.39.4.276-290; Aoki T, 2006, EXP BRAIN RES, V172, P425, DOI 10.1007/s00221-006-0350-9; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; BUCHJAEGER N, 1994, J HAND SURG-BRIT EUR, V19B, P720, DOI 10.1016/0266-7681(94)90244-5; Cole KJ, 2003, EXP BRAIN RES, V148, P150, DOI 10.1007/s00221-002-1283-6; DEKROM MCTFM, 1990, LANCET, V335, P393, DOI 10.1016/0140-6736(90)90218-T; Dun S, 2007, J ELECTROMYOGR KINES, V17, P348, DOI 10.1016/j.jelekin.2006.02.002; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Flanagan JR, 2001, CAN J EXP PSYCHOL, V55, P87, DOI 10.1037/h0087355; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gunnarson LG, 1997, J HAND SURG-BRIT EUR, V22B, P34, DOI 10.1016/S0266-7681(97)80011-3; Hilburn JW, 1996, HAND CLIN, V12, P205; Jablecki CK, 2002, NEUROLOGY, V58, P1589, DOI 10.1212/WNL.58.11.1589; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Jenmalm P, 2000, J NEUROPHYSIOL, V84, P2984, DOI 10.1152/jn.2000.84.6.2984; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1994, CAN J PHYSIOL PHARM, V72, P511, DOI 10.1139/y94-075; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P204, DOI 10.1007/BF00229017; Kanaan N, 2001, BRIT J GEN PRACT, V51, P311; Kimura J, 2001, ELECTRODIAGNOSIS DIS; KINOSHITA H, 1995, ERGONOMICS, V38, P1212; Lowe BD, 1999, ERGONOMICS, V42, P550, DOI 10.1080/001401399185469; Mackinnon SE, 2000, JAMA-J AM MED ASSOC, V284, P1924, DOI 10.1001/jama.284.15.1924; MOBERG E, 1962, NEUROLOGY, V12, P8, DOI 10.1212/WNL.12.1.8; Monzee J, 2003, J NEUROPHYSIOL, V89, P672, DOI 10.1152/jn.00434.2001; Nora DB, 2004, CLIN NEUROL NEUROSUR, V107, P64, DOI 10.1016/j.clineuro.2004.08.003; Nowak DA, 2003, NEUROREPORT, V14, P1803, DOI 10.1097/00001756-200310060-00009; Nowak DA, 2003, CLIN NEUROPHYSIOL, V114, P472, DOI 10.1016/S1388-2457(02)00386-3; Nowak DA, 2002, SOMATOSENS MOT RES, V19, P49, DOI 10.1080/08990220120113048; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Oh S, 1993, CLIN ELECTROMYOGRAPH; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OH SJ, 2001, NEUROMUSCULAR DIS EX, P1; Oh SJ, 1998, PRINCIPLES CLIN ELEC, P78; Olafsdottir H, 2007, J APPL PHYSIOL, V102, P1490, DOI 10.1152/japplphysiol.00966.2006; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; TANAKA S, 1994, AM J PUBLIC HEALTH, V84, P1846, DOI 10.2105/AJPH.84.11.1846; Thonnard JL, 1999, EXP BRAIN RES, V128, P61, DOI 10.1007/s002210050817; WELFORD A T, 1972, Research Quarterly American Association for Health Physical Education and Recreation, V43, P295; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Witt JC, 2004, MUSCLE NERVE, V29, P515, DOI 10.1002/mus.20019; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476; Zatsiorsky VM, 2004, EXERC SPORT SCI REV, V32, P75, DOI 10.1097/00003677-200404000-00007; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO; Zhang W, 2011, EXP BRAIN RES, V211, P17, DOI 10.1007/s00221-011-2628-9; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010; Zhang W, 2009, MOTOR CONTROL, V13, P251, DOI 10.1123/mcj.13.3.251	54	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27715	10.1371/journal.pone.0027715	http://dx.doi.org/10.1371/journal.pone.0027715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110738	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400095
J	Carvalho, CR; Fernandes, RC; Carvalho, GMA; Barreto, RW; Evans, HC				Carvalho, Carlos Roberto; Fernandes, Ronaldo C.; Almeida Carvalho, Guilherme Mendes; Barreto, Robert W.; Evans, Harry C.			Cryptosexuality and the Genetic Diversity Paradox in Coffee Rust, Hemileia vastatrix	PLOS ONE			English	Article							NUCLEAR LIFE-CYCLE; CRYPTOSTEGIA-GRANDIFLORA; MARAVALIA-CRYPTOSTEGIAE; TELIOSPORES; WEED	Background: Despite the fact that coffee rust was first investigated scientifically more than a century ago, and that the disease is one of the major constraints to coffee production - constantly changing the socio-economic and historical landscape of the crop - critical aspects of the life cycle of the pathogen, Hemileia vastatrix, remain unclear. The asexual urediniospores are regarded as the only functional propagule: theoretically, making H. vastatrix a clonal species. However, the well-documented emergence of new rust pathotypes and the breakdown in genetic resistance of coffee cultivars, present a paradox. Methods and Results: Here, using computer-assisted DNA image cytometry, following a modified nuclear stoichiometric staining technique with Feulgen, we show that meiosis occurs within the urediniospores. Stages of spore development were categorised based on morphology, from the spore-mother cell through to the germinating spore, and the relative nuclear DNA content was quantified statistically at each stage. Conclusions: Hidden sexual reproduction disguised within the asexual spore (cryptosexuality) could explain why new physiological races have arisen so often and so quickly in Hemileia vastatrix. This could have considerable implications for coffee breeding strategies and may be a common event in rust fungi, especially in related genera occupying the same basal phylogenetic lineages.	[Carvalho, Carlos Roberto; Almeida Carvalho, Guilherme Mendes] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Fernandes, Ronaldo C.; Barreto, Robert W.; Evans, Harry C.] Univ Fed Vicosa, Dept Fitopatol, Vicosa, MG, Brazil; [Evans, Harry C.] CAB Int, Egham, Surrey, England	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Carvalho, CR (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.	h.evans@cabi.org	Carvalho, Guilherme/J-3604-2016		Brazilian Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq)	Brazilian Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Brazilian Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq) funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Aime M. Catherine, 2006, Mycoscience, V47, P112, DOI 10.1007/s10267-006-0281-0; AYRES P, 2005, HM WARD FUNGAL THREA; Berkeley M.J., 1869, GARD CHRON, V45, P1157; Carvalho CR, 2011, METHODS MOL BIOL, V689, P51, DOI 10.1007/978-1-60761-950-5_4; CHINNAPP.CC, 1965, CARYOLOGIA, V18, P625, DOI 10.1080/00087114.1965.10796194; CHINNAPPA CC, 1968, CARYOLOGIA, V21, P75, DOI 10.1080/00087114.1968.10796284; Mendonca MAC, 2010, J HISTOCHEM CYTOCHEM, V58, P229, DOI 10.1369/jhc.2009.954727; Cristancho-Ardila M.A., 2007, CENICAF, V58, P340; DELGADO AE, 2004, PESQU AGROPECU BRAS, V39, P1057; EVANS HC, 1993, MYCOPATHOLOGIA, V124, P163, DOI 10.1007/BF01103734; FERNANDES RC, 2007, THESIS U FEDERAL VIC; Fernandes RD, 2009, TROP PLANT PATHOL, V34, P108, DOI 10.1590/S1982-56762009000200005; Fernandez D, 2004, MOL PLANT PATHOL, V5, P527, DOI [10.1111/j.1364-3703.2004.00250.x, 10.1111/J.1364-3703.2004.00250.X]; GOPALKRISHNAN KS, 1951, MYCOLOGIA, V43, P271, DOI 10.2307/3755591; Gouveia MMC, 2005, MYCOLOGIA, V97, P396, DOI 10.3852/mycologia.97.2.396; Hardie DC, 2002, J HISTOCHEM CYTOCHEM, V50, P735, DOI 10.1177/002215540205000601; HENNEN JF, 1984, S FERR CAF, P47; KUSHALAPPA AC, 1989, ANNU REV PHYTOPATHOL, V27, P503; LARGE EC, 1940, ADVANCE FUNGI; Maurin O, 2007, ANN BOT-LONDON, V100, P1565, DOI 10.1093/aob/mcm257; Mayne WW, 1932, NATURE, V129, P510, DOI 10.1038/129510a0; McCook S, 2006, J GLOBAL HIST, V1, P177, DOI 10.1017/S174002280600012X; RAJENDREN RB, 1967, MYCOLOGIA, V59, P279, DOI 10.2307/3756801; RAJENDREN RB, 1967, MYCOLOGIA, V59, P918, DOI 10.2307/3757202; RAYNER RW, 1972, MICOLOGIA HIST BIOL; Ritschel A, 2005, V200; RODRIGUES C J JR, 1990, Fitopatologia Brasileira, V15, P5; Savile D. B. O., 1976, Evolutionary Biology, V9, P137; THIRUMALACHAR MJ, 1947, ANN BOT-LONDON, V11, P77, DOI 10.1093/oxfordjournals.aob.a083149; Tomley AJ, 2004, PLANT PATHOL, V53, P475, DOI 10.1111/j.1365-3059.2004.01054.x; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; VISHVESHWARA S., 1962, PHYTON REV INTERNAC BOT EXPTL ARGENTINA, V18, P75; Ward H. M., 1882, J LINN SOC LOND BOT, V19, P299, DOI DOI 10.1111/J.1095-8339.1882.TB00377.X; Ward M.H., 1882, Q J MICROSC SCI, V22, P1; Wingfield BD, 2004, AUSTRALAS PLANT PATH, V33, P327, DOI 10.1071/AP04020	36	35	38	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e26387	10.1371/journal.pone.0026387	http://dx.doi.org/10.1371/journal.pone.0026387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102860	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300004
J	Gonzalez-Segura, A; Morales, JM; Gonzalez-Darder, JM; Cardona-Marsal, R; Lopez-Gines, C; Cerda-Nicolas, M; Monleon, D				Gonzalez-Segura, Ana; Manuel Morales, Jose; Manuel Gonzalez-Darder, Jose; Cardona-Marsal, Ramon; Lopez-Gines, Concepcion; Cerda-Nicolas, Miguel; Monleon, Daniel			Magnetic Resonance Microscopy at 14 Tesla and Correlative Histopathology of Human Brain Tumor Tissue	PLOS ONE			English	Article							FORMALIN FIXATION; WATER DIFFUSION; NERVOUS-SYSTEM; RETICULIN; COLLAGEN; LESIONS; FIBERS	Magnetic Resonance Microscopy (MRM) can provide high microstructural detail in excised human lesions. Previous MRM images on some experimental models and a few human samples suggest the large potential of the technique. The aim of this study was the characterization of specific morphological features of human brain tumor samples by MRM and correlative histopathology. We performed MRM imaging and correlative histopathology in 19 meningioma and 11 glioma human brain tumor samples obtained at surgery. To our knowledge, this is the first MRM direct structural characterization of human brain tumor samples. MRM of brain tumor tissue provided images with 35 to 40 mm spatial resolution. The use of MRM to study human brain tumor samples provides new microstructural information on brain tumors for better classification and characterization. The correlation between MRM and histopathology images allowed the determination of image parameters for critical microstructures of the tumor, like collagen patterns, necrotic foci, calcifications and/or psammoma bodies, vascular distribution and hemorrhage among others. Therefore, MRM may help in interpreting the Clinical Magnetic Resonance images in terms of cell biology processes and tissue patterns. Finally, and most importantly for clinical diagnosis purposes, it provides three-dimensional information in intact samples which may help in selecting a preferential orientation for the histopathology slicing which contains most of the informative elements of the biopsy. Overall, the findings reported here provide a new and unique microstructural view of intact human brain tumor tissue. At this point, our approach and results allow the identification of specific tissue types and pathological features in unprocessed tumor samples.	[Gonzalez-Segura, Ana; Cardona-Marsal, Ramon; Monleon, Daniel] Hosp Clin Univ Valencia, Fdn Invest, Inst Invest Sanitaria INCLIVA, Valencia, Spain; [Manuel Morales, Jose] Univ Valencia, Unidad Cent Invest Med, Valencia, Spain; [Manuel Gonzalez-Darder, Jose] Univ Valencia, Hosp Clin, Serv Neurocirugia, Valencia, Spain; [Lopez-Gines, Concepcion; Cerda-Nicolas, Miguel] Univ Valencia, Dept Patol, Valencia, Spain; [Cerda-Nicolas, Miguel] Ctr Invest Biomed Red Enfermedades Resp CIBER RES, Valencia, Spain	Hospital Clinic Universitari de Valencia; University of Valencia; University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Gonzalez-Segura, A (corresponding author), Hosp Clin Univ Valencia, Fdn Invest, Inst Invest Sanitaria INCLIVA, Valencia, Spain.	jose.m.cerda@uv.es; daniel.monleon@uv.es	Monleon, Daniel/GNP-4083-2022; Monleon, Daniel/A-5078-2010; tatay, jose manuel morales/L-7972-2014	Monleon, Daniel/0000-0002-4803-1573; Monleon, Daniel/0000-0002-4803-1573; tatay, jose manuel morales/0000-0002-4404-6735	Conselleria de Sanidad [GV-AP014/09, GV-AP119/10, GV-AP023/10]; Conselleria de Educacion de la Generalitat Valenciana [ACOMP2009-200, ACOMP2010-184, ACOMP2011-237]; Ministerio de Educacion y Ciencia del Gobierno de Espana [SAF2008-00270]; Ministerio de Sanidad del Gobierno de Espana (CIBER-BBN)	Conselleria de Sanidad; Conselleria de Educacion de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia del Gobierno de Espana(Spanish Government); Ministerio de Sanidad del Gobierno de Espana (CIBER-BBN)	This study was partly financed by grants from the Conselleria de Sanidad (GV-AP014/09, GV-AP119/10 AND GV-AP023/10) and the Conselleria de Educacion (ACOMP2009-200, ACOMP2010-184 and ACOMP2011-237) de la Generalitat Valenciana, from the Ministerio de Educacion y Ciencia del Gobierno de Espana (SAF2008-00270 and a Ramon y Cajal Contract to DM) and from the Ministerio de Sanidad del Gobierno de Espana (CIBER-BBN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Black P. M., 2005, CANC NERVOUS SYSTEM; Blamire AM, 1999, ACTA RADIOL, V40, P593, DOI 10.3109/02841859909175593; BOLONYI F, 1958, J NEUROPATH EXP NEUR, V17, P240; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Castro CA, 2010, STEM CELL RES, V5, P201, DOI 10.1016/j.scr.2010.07.005; Christoforidis GA, 2004, AM J NEURORADIOL, V25, P756; Cleary JO, 2011, NEUROIMAGE, V56, P974, DOI 10.1016/j.neuroimage.2011.01.082; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; DUCKETT S, 1978, ACTA NEUROPATHOL, V44, P145, DOI 10.1007/BF00691481; Duran Isis, 2007, Expert Rev Anticancer Ther, V7, pS15, DOI 10.1586/14737140.7.12s.S15; Golfinos John G, 2004, Top Magn Reson Imaging, V15, P337, DOI 10.1097/00002142-200410000-00006; GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661; HAN J, 1995, CANCER LETT, V88, P127, DOI 10.1016/0304-3835(94)03627-U; Johnson GA, 1997, ANN NY ACAD SCI, V820, P139, DOI 10.1111/j.1749-6632.1997.tb46193.x; KIM E, 2011, J CEREB BLOOD FLOW M; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MACKENZIE DH, 1958, BRIT J CANCER, V12, P14, DOI 10.1038/bjc.1958.3; Manoranjan B, 2011, J CHILD NEUROL, V26, P599, DOI 10.1177/0883073810394848; McLendon R, 2006, RUSSELL RUBINSTEINS, V7th; O'Leary-Moore SK, 2010, BIRTH DEFECTS RES A, V88, P953, DOI 10.1002/bdra.20719; OGAWA K, 1989, J NEURO-ONCOL, V7, P357, DOI 10.1007/BF02147093; PUCHTLER H, 1978, HISTOCHEMISTRY, V57, P177, DOI 10.1007/BF00492078; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; Schiller F, 1996, NEUROSURGERY, V38, P1023, DOI 10.1097/00006123-199605000-00034; Shenkar R, 2008, NEUROSURGERY, V63, P782, DOI 10.1227/01.NEU.0000325490.80694.A2; Shenkar R, 2008, NEUROSURGERY, V63, P790, DOI 10.1227/01.NEU.0000315862.24920.49; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; van Duijn S, 2011, MAGN RESON MED, V65, P1750, DOI 10.1002/mrm.22758; Yong-Hing CJ, 2005, MAGN RESON MED, V54, P324, DOI 10.1002/mrm.20578; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27442	10.1371/journal.pone.0027442	http://dx.doi.org/10.1371/journal.pone.0027442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110653	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300021
J	Li, JD; Sun, ZX				Li, Jade; Sun, Zhaoxia			Qilin Is Essential for Cilia Assembly and Normal Kidney Development in Zebrafish	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT IFT; BARDET-BIEDL-SYNDROME; DISEASE GENE TG737; CAENORHABDITIS-ELEGANS; CYSTIC KIDNEY; SYNDROME PROTEIN; SENSORY NEURONS; HOMOLOG; CILIOGENESIS; FLAGELLAR	Defects in the cilium, a once thought vestigial organelle, have recently been implicated in many human diseases, including a number of cystic kidney diseases such as polycystic kidney disease (PKD), Bardet Bieldl Syndrome, and Meckel-Gruber Syndrome. In a forward genetic screen, qilin was identified as a novel gene important in the pathogenesis of kidney cysts in zebrafish. In this paper we characterized qilin(hi3959A) mutant's phenotypes in detail, investigated cilia formation in this mutant and performed structural and functional analysis of the Qilin protein. Results reveal Qilin's essential role in cilia assembly and maintenance in multiple organs, including the kidney, the lateral line organ, and the outer segment of the photoreceptor cell. In addition, rescue experiments suggest that defective pronephric cilia correlate with the formation of kidney cysts in qilin(hi3959A) mutants. Further, genetic analysis suggests that qilin interacts with multiple intraflagellar transport (IFT) complex B genes, which is supported by the striking phenotypic similarities between qilin(hi3959A) and IFT complex B mutants. Finally, through deletion analysis we provide evidence that the well-conserved N-terminus and the coiled-coil domain of Qilin are both essential and sufficient for its function. Taken all the observations together, we propose that Qilin acts in a similar role as IFT complex B proteins in cilia assembly, maintenance and kidney development in zebrafish.	[Li, Jade; Sun, Zhaoxia] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University	Li, JD (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	Zhaoxia.sun@yale.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1 DK069528, P50 DK057328]; American Cancer Society (ACS) [RSG-10-247-01-DDC]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328, R01DK069528] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society (ACS)(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	1) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): RO1 DK069528 and P50 DK057328 (project #3) to ZS (www.niddk.nih.gov), 2) American Cancer Society (ACS): RSG-10-247-01-DDC to ZS (www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; CAO Y, J AM SOC NEPHROL, V21, P1326; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; DOHERTY D, 2009, PEDIATR NEUROL, V16, P143; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; LUCKER BF, J BIOL CHEM, V285, P21508; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Marshall WF, 2004, CURR BIOL, V14, pR913, DOI 10.1016/j.cub.2004.10.011; Murayama T, 2005, J MOL BIOL, V346, P677, DOI 10.1016/j.jmb.2004.12.005; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Ou GS, 2005, CURR BIOL, V15, pR410, DOI 10.1016/j.cub.2005.05.044; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Senti G, 2008, MOL BIOL CELL, V19, P5517, DOI 10.1091/mbc.E08-04-0416; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Takahashi M, 2004, ONCOGENE, V23, P9289, DOI 10.1038/sj.onc.1208100	34	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27365	10.1371/journal.pone.0027365	http://dx.doi.org/10.1371/journal.pone.0027365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102889	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300016
J	Otani, Y; Yamaguchi, Y; Sato, Y; Furuichi, T; Ikenaka, K; Kitani, H; Baba, H				Otani, Yoshinori; Yamaguchi, Yoshihide; Sato, Yumi; Furuichi, Teiichi; Ikenaka, Kazuhiro; Kitani, Hiroshi; Baba, Hiroko			PLD4 Is Involved in Phagocytosis of Microglia: Expression and Localization Changes of PLD4 Are Correlated with Activation State of Microglia	PLOS ONE			English	Article							PHOSPHOLIPASE-D; POSTNATAL-DEVELOPMENT; RECEPTOR ENDOCYTOSIS; MOUSE CEREBELLUM; EGF RECEPTOR; CELL; MEMBRANE; FOREBRAIN; MECHANISM; TRANSPORT	Phospholipase D4 (PLD4) is a recently identified protein that is mainly expressed in the ionized calcium binding adapter molecule 1 (Iba1)-positive microglia in the early postnatal mouse cerebellar white matter. Unlike PLD1 and PLD2, PLD4 exhibits no enzymatic activity for conversion of phosphatidylcholine into choline and phosphatidic acid, and its function is completely unknown. In the present study, we examined the distribution of PLD4 in mouse cerebellar white matter during development and under pathological conditions. Immunohistochemical analysis revealed that PLD4 expression was associated with microglial activation under such two different circumstances. A primary cultured microglia and microglial cell line (MG6) showed that PLD4 was mainly present in the nucleus, except the nucleolus, and expression of PLD4 was upregulated by lipopolysaccharide (LPS) stimulation. In the analysis of phagocytosis of LPS-stimulated microglia, PLD4 was co-localized with phagosomes that contained BioParticles. Inhibition of PLD4 expression using PLD4 specific small interfering RNA (siRNA) in MG6 cells significantly reduced the ratio of phagocytotic cell numbers. These results suggest that the increased PLD4 in the activation process is involved in phagocytosis of activated microglia in the developmental stages and pathological conditions of white matter.	[Otani, Yoshinori; Yamaguchi, Yoshihide; Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Mol Neurobiol, Hachioji, Tokyo 19203, Japan; [Sato, Yumi] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Furuichi, Teiichi] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 278, Japan; [Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan; [Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan	Tokyo University of Pharmacy & Life Sciences; RIKEN; Tokyo University of Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institute of Agrobiological Sciences - Japan	Otani, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Mol Neurobiol, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	hirobaba@toyaku.ac.jp	Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888; Yamaguchi, Yoshihide/0000-0002-5686-9325; OTANI, YOSHINORI/0000-0002-3214-4637	Japanese Health and Labor Sciences Research Grant for Research on Psychiatry and Neurological Diseases and Mental Health [H20-015]; Promotion and Mutual Aid Corporation for Private Schools of Japan	Japanese Health and Labor Sciences Research Grant for Research on Psychiatry and Neurological Diseases and Mental Health; Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This research was supported by a Japanese Health and Labor Sciences Research Grant for Research on Psychiatry and Neurological Diseases and Mental Health (H20-015), and the Promotion and Mutual Aid Corporation for Private Schools of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; ASHWELL K, 1990, DEV BRAIN RES, V55, P219, DOI 10.1016/0165-3806(90)90203-B; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hodgkin MN, 2000, CURR BIOL, V10, P43, DOI 10.1016/S0960-9822(99)00264-X; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Kusner DJ, 1999, J IMMUNOL, V162, P2266; Lee MY, 2000, GLIA, V30, P311, DOI 10.1002/(SICI)1098-1136(200005)30:3<311::AID-GLIA10>3.0.CO;2-K; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Min DS, 2007, ACTA NEUROPATHOL, V114, P157, DOI 10.1007/s00401-007-0218-5; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Pedersen KM, 1998, J BIOL CHEM, V273, P31494, DOI 10.1074/jbc.273.47.31494; Pyo H, 1998, NEUROREPORT, V9, P871, DOI 10.1097/00001756-199803300-00020; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Streit Wolfgang J., 1995, P85; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; WOLSWIJK G, 1995, GLIA, V13, P13, DOI 10.1002/glia.440130103; Yamaguchi Y, 2008, J NEUROSCI RES, V86, P755, DOI 10.1002/jnr.21547; Yoshikawa F, 2008, J BIOL CHEM, V283, P20830, DOI 10.1074/jbc.M801314200; Yoshikawa F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013932	36	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27544	10.1371/journal.pone.0027544	http://dx.doi.org/10.1371/journal.pone.0027544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102906	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555300028
J	Takata, K; Kinoshita, M; Okuno, T; Moriya, M; Kohda, T; Honorat, JA; Sugimoto, T; Kumanogoh, A; Kayama, H; Takeda, K; Sakoda, S; Nakatsuji, Y				Takata, Kazushiro; Kinoshita, Makoto; Okuno, Tatsusada; Moriya, Masayuki; Kohda, Tohru; Honorat, Josephe A.; Sugimoto, Tomoyuki; Kumanogoh, Atsushi; Kayama, Hisako; Takeda, Kiyoshi; Sakoda, Saburo; Nakatsuji, Yuji			The Lactic Acid Bacterium Pediococcus acidilactici Suppresses Autoimmune Encephalomyelitis by Inducing IL-10-Producing Regulatory T Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LACTOBACILLUS-CASEI; MULTIPLE-SCLEROSIS; IL-10; POLYSACCHARIDE; TH17	Background: Certain intestinal microflora are thought to regulate the systemic immune response. Lactic acid bacteria are one of the most studied bacteria in terms of their beneficial effects on health and autoimmune diseases; one of which is Multiple sclerosis (MS) which affects the central nervous system. We investigated whether the lactic acid bacterium Pediococcus acidilactici, which comprises human commensal bacteria, has beneficial effects on experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Methodology/Principal Findings: P. acidilactici R037 was orally administered to EAE mice to investigate the effects of R037. R037 treatment suppressed clinical EAE severity as prophylaxis and therapy. The antigen-specific production of inflammatory cytokines was inhibited in R037-treated mice. A significant increase in the number of CD4(+) Interleukin (IL)10-producing cells was observed in the mesenteric lymph nodes (MLNs) and spleens isolated from R037-treated naive mice, while no increase was observed in the number of these cells in the lamina propria. Because only a slight increase in the CD4(+) Foxp3(+) cells was observed in MLNs, R037 may primarily induce Foxp3(-) IL10-producing T regulatory type 1 (Tr1) cells in MLNs, which contribute to the beneficial effect of R037 on EAE. Conclusions/Significance: An orally administered single strain of P. acidilactici R037 ameliorates EAE by inducing IL10-producing Tr1 cells. Our findings indicate the therapeutic potential of the oral administration of R037 for treating multiple sclerosis.	[Takata, Kazushiro; Kinoshita, Makoto; Okuno, Tatsusada; Moriya, Masayuki; Kohda, Tohru; Honorat, Josephe A.; Nakatsuji, Yuji] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Sugimoto, Tomoyuki] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka, Japan; [Okuno, Tatsusada; Kumanogoh, Atsushi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immune Regulat, Suita, Osaka, Japan; [Sakoda, Saburo] Toneyama Natl Hosp, Natl Hosp Org, Dept Neurol, Toyonaka, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Takata, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan.	yuji@neurol.med.osaka-u.ac.jp	Takeda, Kiyoshi/C-9331-2009; Sugimoto, Tomoyuki/J-9717-2019	Takeda, Kiyoshi/0000-0002-1778-6332	National Institute of Biomedical Innovation (NIBIO); Ministry of Health, Labour and Welfare of Japan; Mishima Kaiun Memorial Foundation	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This study was supported in part by the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Health and Labour Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan and the Mishima Kaiun Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Baken KA, 2006, INT J FOOD MICROBIOL, V112, P8, DOI 10.1016/j.ijfoodmicro.2006.06.009; Bettelli E, 1998, J IMMUNOL, V161, P3299; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; BHUNIA AK, 1988, J APPL BACTERIOL, V65, P261, DOI 10.1111/j.1365-2672.1988.tb01893.x; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kheadr E, 2010, J APPL MICROBIOL, V109, P54, DOI 10.1111/j.1365-2672.2009.04644.x; Kim JY, 2008, J MICROBIOL BIOTECHN, V18, P1393; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Kobayashi T, 2010, IMMUNOPHARM IMMUNOT, V32, P116, DOI 10.3109/08923970903200716; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; LEE YK, 2009, P NATL ACAD SCI US; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; LUCHANSKY JB, 1992, APPL ENVIRON MICROB, V58, P3053, DOI 10.1128/AEM.58.9.3053-3059.1992; Maassen CBM, 2008, VACCINE, V26, P2056, DOI 10.1016/j.vaccine.2008.02.035; Mathys S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-55; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622; Zhou YF, 2010, NAT MED, V16, P1128, DOI 10.1038/nm.2201; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	41	79	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27644	10.1371/journal.pone.0027644	http://dx.doi.org/10.1371/journal.pone.0027644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110705	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555300039
J	Tan, MJ; Li, Y; Yang, RG; Xi, N; Sun, Y				Tan, Mingjia; Li, Yun; Yang, Ruiguo; Xi, Ning; Sun, Yi			Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid	PLOS ONE			English	Article							APOPTOSIS GENE PROTEIN; ACUTE MYELOID-LEUKEMIA; NEOPLASTIC TRANSFORMATION; NEDD8-ACTIVATING ENZYME; CANCER-THERAPY; BETA-TRCP; DEGRADATION; SAG/ROC2/RBX2; INHIBITION; EXPRESSION	Sensitive to Apoptosis Gene (SAG), also known as RBX2 (RING box protein-2), is the RING component of SCF (SKP1, Cullin, and F-box protein) E3 ubiquitin ligase. Our previous studies have demonstrated that SAG is an anti-apoptotic protein and an attractive anti-cancer target. We also found recently that Sag knockout sensitized mouse embryonic stem cells (mES) to radiation and blocked mES cells to undergo endothelial differentiation. Here, we reported that compared to wild-type mES cells, the Sag(-/-) mES cells were much more sensitive to all-trans retinoic acid (RA)-induced suppression of cell proliferation and survival. While wild-type mES cells underwent differentiation upon exposure to RA, Sag(-/-) mES cells were induced to death via apoptosis instead. The cell fate change, reflected by cellular stiffness, can be detected as early as 12 hrs post RA exposure by AFM (Atomic Force Microscopy). We then extended this novel finding to RA differentiation therapy of leukemia, in which the resistance often develops, by testing our hypothesis that SAG inhibition would sensitize leukemia to RA. Indeed, we found a direct correlation between SAG overexpression and RA resistance in multiple leukemia lines. By using MLN4924, a small molecule inhibitor of NEDD8-Activating Enzyme (NAE), that inactivates SAG-SCF E3 ligase by blocking cullin neddylation, we were able to sensitize two otherwise resistant leukemia cell lines, HL-60 and KG-1 to RA. Mechanistically, RA sensitization by MLN4924 was mediated via enhanced apoptosis, likely through accumulation of proapoptotic proteins NOXA and c-JUN, two well-known substrates of SAG-SCF E3 ligase. Taken together, our study provides the proof-of-concept evidence for effective treatment of leukemia patients by RA-MLN4924 combination.	[Tan, Mingjia; Li, Yun; Sun, Yi] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA; [Li, Yun] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Li, Yun] Ocean Univ China, Sch Med & Pharm, Qingdao, Peoples R China; [Yang, Ruiguo; Xi, Ning] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA	University of Michigan System; University of Michigan; Ocean University of China; Ocean University of China; Michigan State University	Tan, MJ (corresponding author), Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA.	sunyi@umich.edu	Sun, Yi/K-1025-2014; Yang, Ruiguo/A-7374-2015	Sun, Yi/0000-0002-5841-4287; Yang, Ruiguo/0000-0002-1361-4277	National Cancer Institute [CA111554, CA118762, CA156744]; National Science Foundation [IIS0713346]; National Institutes of Health [R43 GM084520]; China Scholarship Council; Ocean University of China; NATIONAL CANCER INSTITUTE [R01CA156744, R01CA118762, R01CA111554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM084520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Ocean University of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Cancer Institute grants CA111554, CA118762 and CA156744 to YS. This work is also supported by National Science Foundation grant IIS0713346 and National Institutes of Health grant R43 GM084520 to NX. YL was supported in part by the fellowship from China Scholarship Council and Ocean University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2004, INT J BIOCHEM CELL B, V36, P178, DOI 10.1016/S1357-2725(03)00247-4; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Camacho LH, 2003, J BIOL REG HOMEOS AG, V17, P98; Chanalaris A, 2003, J MOL CELL CARDIOL, V35, P257, DOI 10.1016/S0022-2828(03)00003-8; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dragnev KH, 2003, CANCER BIOL THER, V2, pS150; Duan HJ, 1999, MOL CELL BIOL, V19, P3145; Duan HJ, 2001, MOL CARCINOGEN, V30, P37, DOI 10.1002/1098-2744(200101)30:1<37::AID-MC1011>3.0.CO;2-7; Gu QY, 2007, J CELL BIOL, V178, P1009, DOI 10.1083/jcb.200612067; Gu QY, 2007, CANCER RES, V67, P3616, DOI 10.1158/0008-5472.CAN-06-4020; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; He HB, 2008, CARCINOGENESIS, V29, P858, DOI 10.1093/carcin/bgn021; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Huang YH, 2001, MOL CARCINOGEN, V30, P62, DOI 10.1002/1098-2744(200101)30:1<62::AID-MC1014>3.3.CO;2-1; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Jia LJ, 2010, CLIN CANCER RES, V16, P814, DOI 10.1158/1078-0432.CCR-09-1592; Jimenez-Lara AM, 2004, TRENDS MOL MED, V10, P508, DOI 10.1016/j.molmed.2004.08.006; Kim SY, 2007, NEUROSCI LETT, V413, P132, DOI 10.1016/j.neulet.2006.11.074; Kirmizis D, 2010, INT J NANOMED, V5, P137; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P167, DOI 10.1016/j.freeradbiomed.2008.03.026; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okuno M, 2004, CURR CANCER DRUG TAR, V4, P285, DOI 10.2174/1568009043333023; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Sasaki H, 2001, INT J CANCER, V95, P375, DOI 10.1002/1097-0215(20011120)95:6<375::AID-IJC1066>3.0.CO;2-L; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun Y, 2003, CANCER BIOL THER, V2, P623; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Sun Y, 1999, CARCINOGENESIS, V20, P1899, DOI 10.1093/carcin/20.10.1899; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Swaroop M, 2000, ONCOGENE, V19, P2855, DOI 10.1038/sj.onc.1203635; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; TAN M, 2011, DEV CELL IN PRESS; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Tan MJ, 2010, FREE RADICAL BIO MED, V49, P976, DOI 10.1016/j.freeradbiomed.2010.05.030; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wei Dongping, 2010, Genes Cancer, V1, P700, DOI 10.1177/1947601910382776; Yang ES, 2006, FREE RADICAL RES, V40, P279, DOI 10.1080/10715760500511500	55	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27726	10.1371/journal.pone.0027726	http://dx.doi.org/10.1371/journal.pone.0027726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110742	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300049
J	von Wyl, V; Gianella, S; Fischer, M; Niederoest, B; Kuster, H; Battegay, M; Bernasconi, E; Cavassini, M; Rauch, A; Hirschel, B; Vernazza, P; Weber, R; Joos, B; Gunthard, HF				von Wyl, Viktor; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Guenthard, Huldrych F.		Swiss HIV Cohort Study SHCS	Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption	PLOS ONE			English	Article							VIROLOGICAL FAILURE; IN-VIVO; DYNAMICS; CLEARANCE; CESSATION; RESERVOIR; HAART; MODEL; TRIAL; TIME	Background: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. Methods: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessation of cART (median exposure 18 months) was described for 33 participants from the Zurich Primary HIV Infection Study using linear regression and compared with 545 measurements from 79 untreated controls with clinically diagnosed primary HIV infection, respectively a known date for seroconversion. Results: On average, early treated individuals were followed for 37 months (median) after cART cessation; controls had 34 months of pre-cART follow-up. HIV-RNA levels one year after cART interruption were -0.8 log(10) copies/ mL [95% confidence interval -1.2; 20.4] lower in early treated patients compared with controls, but this difference was no longer statistically significant by year three of follow-up (-0.3 [-0.9; 0.3]). Mean HIV-DNA levels rebounded from 2 log(10) copies [1.8; 2.3] on cART to a stable plateau of 2.7 log(10) copies [2.5; 3.0] attained 1 year after therapy stop, which was not significantly different from cross-sectional measurements of 9 untreated members of the control group (2.8 log(10) copies [2.5; 3.1]). Conclusions: The rebound dynamics of viral markers after therapy cessation suggest that early cART may indeed limit reservoir size of latently infected cells, but that much of the initial benefits are only transient. Owing to the non-randomized study design the observed treatment effects must be interpreted with caution.	[von Wyl, Viktor; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Weber, Rainer; Joos, Beda; Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [von Wyl, Viktor] UCL, Res Dept Infect & Populat Hlth, London, England; [Gianella, Sara] Univ Calif San Diego, Sch Med, Div Infect Dis, La Jolla, CA 92093 USA; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Div Infect Dis & Hosp Epidemiol, Lausanne, Switzerland; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Hirschel, Bernard] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Vernazza, Pietro] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland	University of Zurich; University Zurich Hospital; University of London; University College London; University of California System; University of California San Diego; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Bern; University of Geneva; Kantonsspital St. Gallen	von Wyl, V (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	vowv@usz.uzh.ch	Joos, Beda/D-5547-2009; Weber, Rainer/D-5175-2012; Kuster, Herbert/A-3912-2013; Rauch, Andri/E-9948-2017; gunthard, huldrych f/F-1724-2011; cavassini, matthias/F-8987-2017	Joos, Beda/0000-0002-3082-8875; Rauch, Andri/0000-0001-5297-6062; gunthard, huldrych f/0000-0002-1142-6723; cavassini, matthias/0000-0003-0933-7833; Kuster, Herbert/0000-0001-6873-0091; Gianella, Sara/0000-0002-9927-0849; von Wyl, Viktor/0000-0002-8754-9797	Swiss National Science Foundation [324730-116035, 324730-130865, 31003A-112670, 33CS30-134277, PBEZP3-125726]; Novartis Foundation; Roche; Abbott; BMS; GSK; Tibotec; Merck Sharp Dohme (MSD); Boehringer Ingelheim; Gilead	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Roche(Roche Holding); Abbott(Abbott Laboratories); BMS(Bristol-Myers Squibb); GSK(GlaxoSmithKline); Tibotec; Merck Sharp Dohme (MSD)(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences)	This study was supported by the Swiss National Science Foundation (SNF grant no. 324730-116035 and 324730-130865 to HFG, no. 31003A-112670 to MF and HFG) and financed in the framework of the Swiss HIV Cohort study, supported by the Swiss National Science Foundation (SNF grant no. 33CS30-134277). Further support was provided by the "Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich"to MF, by a fellowship from the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation), and by a Swiss National Science Foundation Grant (PBEZP3-125726) to VvW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors delcare the following competing interest: HFG has been an advisor and consultant for GlaxoSmithKline (GSK), Abbott, Novartis, Boehringer Ingelheim, Roche, Tibotec, and Bristol-Myers Squibb (BMS) and has received unrestricted research and educational grants from Roche, Abbott, BMS, GSK, Tibotec, and Merck Sharp & Dohme (MSD) (all money to the institution). SY has participated in advisory boards of BMS and Tibotec and has received travel grants from GSK and MSD. MC has received travel grants from Abbott, Boehringer Ingelheim, and Gilead. EB has been an advisor and consultant for Gilead and Abbott, has been a member of an advisory board of ViiV, Gilead, Tibotec, Pfitzer, and MSD, and has received research grants from Gilead and Abbott as well as travel grants from BMS, Gilead, ViiV, MSD, Abbott, and Tibotec. PV has been a member of an advisory board of MSD, Tibotec, Gilead, and ViiV and has received payment for lectures from Gilead, Tibotec, and GSK. All the unrestricted research grants do not relate to the current study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors report no potential conflicts.	Aceto L, 2005, Praxis (Bern 1994), V94, P1199; Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Cellerai C, 2008, CURR OPIN HIV AIDS, V3, P67, DOI 10.1097/COH.0b013e3282f31d4b; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clements Mark, 2003, HIV Med, V4, P332; Desquilbet L, 2004, AIDS, V18, P2361; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; FIDLER S, 2011, 6 IAS C HIV PATH; Fidler S, 2007, AIDS, V21, P1283, DOI 10.1097/QAD.0b013e3280b07b5b; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Hoen B, 2005, JAIDS-J ACQ IMM DEF, V40, P307, DOI 10.1097/01.qai.0000182628.66713.31; HOGAN C, 2010, 17 C RETR OPP INF BO; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Kinloch-de Loes S, 2006, J INFECT DIS, V194, P721, DOI 10.1086/506625; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lampe FC, 2007, ANTIVIR THER, V12, P189; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Markowitz M, 2002, J INFECT DIS, V186, P634, DOI 10.1086/342559; Pantazis N, 2008, AIDS, V22, P2441, DOI 10.1097/QAD.0b013e328319ea4e; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rizopoulos D, 2008, BIOMETRICS, V64, P611, DOI 10.1111/j.1541-0420.2007.00894.x; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Schmid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013310; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Seng R, 2008, JAIDS-J ACQ IMM DEF, V49, P251, DOI 10.1097/QAI.0b013e318189a739; Smith DE, 2004, AIDS, V18, P709, DOI 10.1097/00002030-200403260-00001; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Steingrover R, 2010, AIDS RES HUM RETROV, V26, P379, DOI 10.1089/aid.2009.0041; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Streeck H, 2006, J INFECT DIS, V194, P734, DOI 10.1086/503811; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Volberding P, 2009, AIDS, V23, P1987, DOI 10.1097/QAD.0b013e32832eb285; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	42	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27463	10.1371/journal.pone.0027463	http://dx.doi.org/10.1371/journal.pone.0027463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102898	Green Accepted, Green Published, gold			2022-12-25	WOS:000297555300023
J	Wang, G; Pan, L; Zhang, YG; Wang, YL; Zhang, ZW; Lu, JL; Zhou, P; Fang, YZ; Jiang, ST				Wang, Gang; Pan, Li; Zhang, Yongguang; Wang, Yonglu; Zhang, Zhongwang; Lu, Jianliang; Zhou, Peng; Fang, Yuzhen; Jiang, Shoutian			Intranasal Delivery of Cationic PLGA Nano/Microparticles- Loaded FMDV DNA Vaccine Encoding IL-6 Elicited Protective Immunity against FMDV Challenge	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; NANOPARTICLES; PARTICLES; MUCOSAL; IMMUNOGENICITY; SYSTEMS; ANTIGEN; INTERLEUKIN-6; IMMUNIZATION; NANOSPHERES	Mucosal vaccination has been demonstrated to be an effective means of eliciting protective immunity against aerosol infections of foot and mouth disease virus (FMDV) and various approaches have been used to improve mucosal response to this pathogen. In this study, cationic PLGA (poly(lactide-co-glycolide)) nano/microparticles were used as an intranasal delivery vehicle as a means administering FMDV DNA vaccine encoding the FMDV capsid protein and the bovine IL-6 gene as a means of enhancing mucosal and systemic immune responses in animals. Three eukaryotic expression plasmids with or without bovine IL-6 gene (pc-P12A3C, pc-IL2AP12A3C and pc-P12AIL3C) were generated. The two latter plasmids were designed with the IL-6 gene located either before or between the P12A and 3C genes, respectively, as a means of determining if the location of the IL-6 gene affected capsid assembly and the subsequent immune response. Guinea pigs and rats were intranasally vaccinated with the respective chitosan-coated PLGA nano/microparticles-loaded FMDV DNA vaccine formulations. Animals immunized with pc-P12AIL3C (followed by animals vaccinated with pc-P12A3C and pc-IL2AP12A3C) developed the highest levels of antigen-specific serum IgG and IgA antibody responses and the highest levels of sIgA (secretory IgA) present in mucosal tissues. However, the highest levels of neutralizing antibodies were generated in pc-IL2AP12A3C-immunized animals (followed by pc-P12AIL3C- and then in pc-P12A3C-immunized animals). pc-IL2AP12A3C-immunized animals also developed stronger cell mediated immune responses (followed by pc-P12AIL3C- and pc-P12A3C-immunized animals) as evidenced by antigen-specific T-cell proliferation and expression levels of IFN-gamma by both CD4+ and CD8+ splenic T cells. The percentage of animals protected against FMDV challenge following immunizations with pc-IL2AP12A3C, pc-P12AIL3C or pc-P12A3C were 3/5, 1/5 and 0/5, respectively. These data suggested that intranasal delivery of cationic PLGA nano/microparticles loaded with various FMDV DNA vaccine formulations encoding IL-6 as a molecular adjuvant enhanced protective immunity against FMDV, particularly pc-IL2AP12A3C with IL-6 gene located before P12A3C gene.	[Wang, Gang; Pan, Li; Zhang, Yongguang; Wang, Yonglu; Zhang, Zhongwang; Lu, Jianliang; Zhou, Peng; Fang, Yuzhen; Jiang, Shoutian] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Minist Agr, State Key Lab Vet Etiol Biol,Natl Foot & Mouth Di, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wang, G (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Minist Agr, State Key Lab Vet Etiol Biol,Natl Foot & Mouth Di, Lanzhou, Gansu, Peoples R China.	yongguang.zhang@163.com			European Community [FP7/2007-2013, 226556]; Chinese "863" National Programs for High Technology Research and Development [2011AA10A211]; International Science and Technology Cooperation Program of Gansu Province [1011WCGA160]	European Community(European Commission); Chinese "863" National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program of Gansu Province	This work was supported by grants from the European Community's Seventh Framework Programme (FP7/2007-2013)(No. 226556) http://ec.europa.eu/research/fp7/index_en.cfm, Chinese "863" National Programs for High Technology Research and Development (Grant No.: 2011AA10A211) http://www.most.gov.cn/, and the International Science and Technology Cooperation Program of Gansu Province (Grant No. 1011WCGA160) http://www.gsstc.gov.cn/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CC, 1995, J GEN VIROL, V76, P3089, DOI 10.1099/0022-1317-76-12-3089; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Balamurugan V, 2003, VIRUS RES, V92, P141, DOI 10.1016/S0168-1702(02)00357-X; BARTELING SJ, 1991, VACCINE, V9, P75, DOI 10.1016/0264-410X(91)90261-4; Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8; Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3; Bordelon H, 2011, J NANOMATER, V2011, DOI 10.1155/2011/952060; Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Cao YM, 2009, VET MICROBIOL, V137, P10, DOI 10.1016/j.vetmic.2008.12.007; Cegnar M, 2004, EXP CELL RES, V301, P223, DOI 10.1016/j.yexcr.2004.07.021; Chorny M, 2002, J CONTROL RELEASE, V83, P389, DOI 10.1016/S0168-3659(02)00211-0; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; DU NX, 1989, VET IMMUNOLOGY; Goodwin S, 2009, J VIROL, V83, P11275, DOI 10.1128/JVI.01263-09; Guo HC, 2005, VACCINE, V23, P3236, DOI 10.1016/j.vaccine.2004.03.074; HEYDER J, 1986, J AEROSOL SCI, V17, P811, DOI 10.1016/0021-8502(86)90035-2; HEYDER J, 1984, J AEROSOL SCI, V15, P697, DOI 10.1016/0021-8502(84)90007-7; Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X; Kim SJ, 2003, VIROLOGY, V314, P84, DOI 10.1016/S0042-6822(03)00417-3; Kim SA, 2006, J GENE MED, V8, P1182, DOI 10.1002/jgm.941; Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069; La Flamme AC, 2000, J IMMUNOL, V164, P2419, DOI 10.4049/jimmunol.164.5.2419; LEWIS SA, 1991, J VIROL, V65, P6572, DOI 10.1128/JVI.65.12.6572-6580.1991; Mingxiao M, 2007, ANTIVIR RES, V76, P59, DOI 10.1016/j.antiviral.2007.05.003; Mizoe T, 2007, J CONTROL RELEASE, V122, P10, DOI 10.1016/j.jconrel.2007.06.001; Nafee N, 2007, NANOMED-NANOTECHNOL, V3, P173, DOI 10.1016/j.nano.2007.03.006; Ober BT, 1998, J VIROL, V72, P4866, DOI 10.1128/JVI.72.6.4866-4873.1998; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Otten GR, 2005, J VIROL, V79, P8189, DOI 10.1128/JVI.79.13.8189-8200.2005; Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6; Periwal SB, 1999, J VIROL, V73, P7633; Rice J, 1999, VACCINE, V17, P3030, DOI 10.1016/S0264-410X(99)00171-1; ROSEJOHN S, 1993, J BIOL CHEM, V268, P22084; Shiver JW, 1996, J PHARM SCI-US, V85, P1317, DOI 10.1021/js9600991; TERPSTRA C, 1976, VET MICROBIOL, V1, P71, DOI 10.1016/0378-1135(76)90011-0; Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999; [王刚 WANG Gang], 2011, [生物学杂志, Journal of Biology], V28, P1; Wang X, 2008, VACCINE, V26, P5135, DOI 10.1016/j.vaccine.2008.03.088; Weiss R, 1999, VACCINE, V18, P815, DOI 10.1016/S0264-410X(99)00338-2; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Xu W, 2004, VACCINE, V22, P3603, DOI 10.1016/j.vaccine.2004.03.033; YANG HC, 1996, IMMUNOLOGY ANIMALS; Yu D., 1997, GUIDELINE ENTRY EXIT	45	48	56	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27605	10.1371/journal.pone.0027605	http://dx.doi.org/10.1371/journal.pone.0027605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110686	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555300033
J	Ahmad, KM; Oh, SS; Kim, S; McClellen, FM; Xiao, Y; Soh, HT				Ahmad, Kareem M.; Oh, Seung Soo; Kim, Seon; McClellen, Forrest M.; Xiao, Yi; Soh, H. Tom			Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform	PLOS ONE			English	Article							RNA APTAMER; MICROMAGNETIC SELECTION; CRYSTAL-STRUCTURE; APOLIPOPROTEIN-E; ALPHA-THROMBIN; DNA APTAMER; LIGANDS; GENERATION; MOLECULES; DISEASE	Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein-based affinity reagents, including facile chemical synthesis, reversible folding, improved thermal stability and lower cost. However, their selection requires significant time and resources and selections often fail to yield molecules with affinities sufficient for molecular diagnostics or therapeutics. Toward a selection technique that can efficiently and reproducibly generate high performance aptamers, we have developed a microfluidic selection process (M-SELEX) that can be used to obtain high affinity aptamers against diverse protein targets. Here, we isolated DNA aptamers against three protein targets with different isoelectric points (pI) using a common protocol. After only three rounds of selection, we discovered novel aptamer sequences that bind to platelet derived growth factor B (PDGF-BB; pI = 9.3) and thrombin (pI = 8.3) with respective dissociation constants (K-d) of 0.028 nM and 0.33 nM, which are both superior to previously reported aptamers against these targets. In parallel, we discovered a new aptamer that binds to apolipoprotein E3 (ApoE; pI = 5.3) with a K-d of 3.1 nM. Furthermore, we observe that the net protein charge may exert influence on the affinity of the selected aptamers. To further explore this relationship, we performed selections against PDGF-BB under different pH conditions using the same selection protocol, and report an inverse correlation between protein charge and aptamer K-d.	[Ahmad, Kareem M.; Soh, H. Tom] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Oh, Seung Soo; Xiao, Yi; Soh, H. Tom] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Kim, Seon] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; [McClellen, Forrest M.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Soh, H. Tom] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Ahmad, KM (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA.	yixiao@physics.ucsb.edu; tsoh@engineering.ucsb.edu	Xiao, Yi/L-6606-2016; Ahmad, Kareem/G-7856-2011; Oh, Seung Soo/N-6315-2016; Oh, Seung Soo/AAV-2496-2021	Xiao, Yi/0000-0001-7278-9811; Oh, Seung Soo/0000-0001-8045-080X; Oh, Seung Soo/0000-0001-8045-080X	Armed Forces Institute for Regenerative Medicine [0010745]; National Institutes of Health [NIH R01EB009764, NIH U01HL099773-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009764] Funding Source: NIH RePORTER	Armed Forces Institute for Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was funded by Armed Forces Institute for Regenerative Medicine Sub-Award 0010745, and National Institutes of Health NIH R01EB009764 NIH U01HL099773-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Ghosh G, 2004, CURR OPIN STRUC BIOL, V14, P21, DOI 10.1016/j.sbi.2004.01.004; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; HALL B, 2009, CURR PROTOC NUCL ACI, V9, P1; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaeger J, 1998, EMBO J, V17, P4535, DOI 10.1093/emboj/17.15.4535; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Liu YL, 2009, LAB CHIP, V9, P1033, DOI 10.1039/b820985e; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Qian JR, 2009, ANAL CHEM, V81, P5490, DOI 10.1021/ac900759k; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g	26	79	87	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27051	10.1371/journal.pone.0027051	http://dx.doi.org/10.1371/journal.pone.0027051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110600	Green Published, gold			2022-12-25	WOS:000297554300011
J	Martin-Alonso, A; Foronda, P; Quispe-Ricalde, MA; Feliu, C; Valladares, B				Martin-Alonso, Aaron; Foronda, Pilar; Antonieta Quispe-Ricalde, Maria; Feliu, Carlos; Valladares, Basilio			Seroprevalence of Angiostrongylus cantonensis in Wild Rodents from the Canary Islands	PLOS ONE			English	Article							EOSINOPHILIC-MENINGITIS; RATTUS-RATTUS; OUTBREAK	Background: Angiostrongylus cantonensis is a lungworm of rats (Muridae) that is the causative agent of human cerebral angiostrongyliasis. The life cycle of A. cantonensis involves rats and mollusks as the definitive and intermediate hosts, respectively. This study was designed to increase the knowledge about the occurrence and distribution of A. cantonensis in its definitive host in the Canary Islands, using parasitological and serological analysis in different areas and age groups. Methodology/Principal Findings: Between 2009 and 2010, 54 black rats (Rattus rattus) from Tenerife were captured from six human-inhabited areas and sera samples were obtained. The lung nematodes were identified by morphological and molecular tools as A. cantonensis. The 31-kDa glycoprotein antigen was purified from A. cantonensis adult worms by electrophoresis and electroelution. Of the 54 tested rodents, 30 showed IgG antibodies against A. cantonensis 31-kDa antigen by ELISA. Therefore, the overall seroprevalence was 55.6% (95% CI: 42.4-68). Seroprevalent rodents were found in all the 6 areas. This 31-kDa antigen was not recognized by some sera of rats infected by other helminth species (but not A. cantonensis). Seroprevalence of IgG antibodies against A. cantonensis and prevalence based on the presence of adult worms showed significant correlation (R-2 = 0.954, p<0.05). Conclusions/Significance: The present results could indicate a high prevalence of A. cantonensis in Tenerife and suggest the inclusion of two new zones in the distribution area of the parasite. The commonness and wide distribution of A. cantonensis in rats implies the presence of intermediate hosts, indicating that humans may be at risk of getting infected.	[Martin-Alonso, Aaron; Foronda, Pilar; Antonieta Quispe-Ricalde, Maria; Valladares, Basilio] Univ La Laguna, Univ Inst Trop Dis & Publ Hlth Canary Isl, E-38207 San Cristobal la Laguna, Islas Canarias, Spain; [Feliu, Carlos] Univ Barcelona, Dept Microbiol & Parasitol, Barcelona, Cataluna, Spain	Universidad de la Laguna; University of Barcelona	Martin-Alonso, A (corresponding author), Univ La Laguna, Univ Inst Trop Dis & Publ Hlth Canary Isl, E-38207 San Cristobal la Laguna, Islas Canarias, Spain.	pforonda@ull.es	Foronda, Pilar/H-4680-2015	Quispe-Ricalde, Maria Antonieta/0000-0001-6349-1095; Foronda, Pilar/0000-0001-9526-5113	Red de Investigacion Colaborativa de Centros de Enfermedades Tropicales [RD06/0021/0005]; Ministerio de Ciencia y Educacion [CGL2009-07759BOS]	Red de Investigacion Colaborativa de Centros de Enfermedades Tropicales; Ministerio de Ciencia y Educacion(Spanish Government)	This work was supported by projects "Red de Investigacion Colaborativa de Centros de Enfermedades Tropicales'' (RD06/0021/0005) and "Programa Nacional de Biodiversidad, Ciencias de la Tierra y Cambio Global: Subprograma de Biologia de Organismos y Sistemas'' (CGL2009-07759BOS) of the "Ministerio de Ciencia y Educacion''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWDEN DK, 1981, AM J TROP MED HYG, V30, P1141, DOI 10.4269/ajtmh.1981.30.1141; Chen E. R., 2007, V11, P263; Chen S.-N., 1974, Journal of the Formosan Medical Association, V73, P393; Chikweto A, 2009, VET PARASITOL, V162, P160, DOI 10.1016/j.vetpar.2009.02.020; Chotmongkol Verajit, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P231; DELATTRE P, 1981, MAMMALIA, V45, P275, DOI 10.1515/mamm.1981.45.3.275; Delgado JD, 2001, ECOGRAPHY, V24, P539, DOI 10.1034/j.1600-0587.2001.d01-209.x; Eamsobhana P., 1999, Japanese Journal of Tropical Medicine and Hygiene, V27, P1; Eamsobhana P, 2006, J HELMINTHOL, V80, P249, DOI 10.1079/JOH2006335; EAMSOBHANA P, 2005, FOOD BORNE HELMINTHI, P183; Eamsobhana P, 1994, THESIS U MALAYA; Eamsobhana P., 2006, RAT LUNGWORM PARASTR; Eamsobhana Praphathip, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P308; Eamsobhana P, 2009, INT J INFECT DIS, V13, P425, DOI 10.1016/j.ijid.2008.09.021; Foronda P, 2010, ACTA TROP, V114, P123, DOI 10.1016/j.actatropica.2010.02.004; Groh K., 2004, LISTA ESPECIES SILVE, P149; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindo JF, 2002, EMERG INFECT DIS, V8, P324, DOI 10.3201/eid0803.010316; Martuin A., 2000, PALOMAS ENDEMICAS CA; Nuamtanong Supaporn, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P291; PUNYAGUPTA S, 1990, J NEUROL SCI, V96, P241, DOI 10.1016/0022-510X(90)90136-B; Slom TJ, 2002, NEW ENGL J MED, V346, P668, DOI 10.1056/NEJMoa012462; Tung KC, 2009, J VET MED SCI, V71, P43, DOI 10.1292/jvms.71.43; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Wu G.H., 2006, NATURE BORNE DIS, P1182; YII CY, 1976, AM J TROP MED HYG, V25, P233, DOI 10.4269/ajtmh.1976.25.233; Zhang RL, 2008, EMERG INFECT DIS, V14, P1955, DOI 10.3201/eid1412.080695	27	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27747	10.1371/journal.pone.0027747	http://dx.doi.org/10.1371/journal.pone.0027747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110752	Green Submitted, gold, Green Published			2022-12-25	WOS:000297554300051
J	Ma, LN; Lu, XT; Liu, Y; Guo, JX; Zhang, NY; Yang, JQ; Wang, RZ				Ma, Lin-Na; Lu, Xiao-Tao; Liu, Yang; Guo, Ji-Xun; Zhang, Nan-Yi; Yang, Jian-Qin; Wang, Ren-Zhong			The Effects of Warming and Nitrogen Addition on Soil Nitrogen Cycling in a Temperate Grassland, Northeastern China	PLOS ONE			English	Article							REACTIVE NITROGEN; INNER-MONGOLIA; CLIMATE-CHANGE; MINERALIZATION; CARBON; ECOSYSTEM; RESPONSES; FOREST; NITRIFICATION; MECHANISMS	Background: Both climate warming and atmospheric nitrogen (N) deposition are predicted to affect soil N cycling in terrestrial biomes over the next century. However, the interactive effects of warming and N deposition on soil N mineralization in temperate grasslands are poorly understood. Methodology/Principal Findings: A field manipulation experiment was conducted to examine the effects of warming and N addition on soil N cycling in a temperate grassland of northeastern China from 2007 to 2009. Soil samples were incubated at a constant temperature and moisture, from samples collected in the field. The results showed that both warming and N addition significantly stimulated soil net N mineralization rate and net nitrification rate. Combined warming and N addition caused an interactive effect on N mineralization, which could be explained by the relative shift of soil microbial community structure because of fungal biomass increase and strong plant uptake of added N due to warming. Irrespective of strong intra-and inter-annual variations in soil N mineralization, the responses of N mineralization to warming and N addition did not change during the three growing seasons, suggesting independence of warming and N responses of N mineralization from precipitation variations in the temperate grassland. Conclusions/Significance: Interactions between climate warming and N deposition on soil N cycling were significant. These findings will improve our understanding on the response of soil N cycling to the simultaneous climate change drivers in temperate grassland ecosystem.	[Ma, Lin-Na; Wang, Ren-Zhong] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Liu, Yang; Guo, Ji-Xun; Zhang, Nan-Yi; Yang, Jian-Qin] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Changchun, Jilin, Peoples R China; [Ma, Lin-Na] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Lu, Xiao-Tao] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Northeast Normal University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Ma, LN (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	malinna27@gmail.com	Lu (ü), Xiao-Tao/B-3905-2008	Lu (ü), Xiao-Tao/0000-0001-5571-1895	Natural Science Foundation of China [30590382, 30570273]; National Basic Research Development Program of China (973 Program) [2010CB951303, 2007CB106806]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the Natural Science Foundation of China (30590382 and 30570273) and the National Basic Research Development Program of China (973 Program No. 2010CB951303 and 2007CB106806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Allen S. E., 1974, Chemical analysis of ecological materials.; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; BAO SD, 1999, AGR SOIL CHEM ANAL, P263; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Carpenter-Boggs L, 2000, SOIL SCI SOC AM J, V64, P2038, DOI 10.2136/sssaj2000.6462038x; Cookson WR, 2002, SOIL BIOL BIOCHEM, V34, P1401, DOI 10.1016/S0038-0717(02)00083-4; Dalias P, 2002, SOIL BIOL BIOCHEM, V34, P691, DOI 10.1016/S0038-0717(01)00234-6; DeNeve S, 1996, SOIL BIOL BIOCHEM, V28, P1451, DOI 10.1016/S0038-0717(96)00154-X; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Garten CT, 2000, WATER AIR SOIL POLL, V120, P295, DOI 10.1023/A:1005270012802; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Lee JA, 1998, NEW PHYTOL, V139, P127, DOI 10.1046/j.1469-8137.1998.00165.x; Li XY, 2006, BIOGEOCHEMISTRY, V77, P217, DOI 10.1007/s10533-005-1391-z; Loiseau P, 2000, GLOB CHANGE BIOL, V6, P953, DOI 10.1046/j.1365-2486.2000.00373.x; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; MARRS RH, 1988, J ECOL, V76, P466, DOI 10.2307/2260606; Mikola J, 1999, BIOL FERT SOILS, V28, P212, DOI 10.1007/s003740050485; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; PERRY DA, 1991, NORTHWEST ENVIRON J, V7, P203; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; SEASTEDT TR, 1991, OECOLOGIA, V87, P72, DOI 10.1007/BF00323782; Shaw MR, 2001, GLOBAL CHANGE BIOL, V7, P193, DOI 10.1046/j.1365-2486.2001.00390.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STENGER R, 1995, PLANT SOIL, V171, P323, DOI 10.1007/BF00010288; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vourlitis GL, 2007, BIOL FERT SOILS, V43, P611, DOI 10.1007/s00374-006-0137-y; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; Zhang Lu, 2009, Chinese Journal of Plant Ecology, V33, P563, DOI 10.3773/j.issn.1005-264x.2009.03.015; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015; Zhou DW, 1997, J ARID ENVIRON, V36, P53, DOI 10.1006/jare.1996.0204; [周广胜 Zhou Guangsheng], 2002, [地学前缘, Earth science frontiers], V9, P198; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019; ZHU TC, 2004, YANGCAO BIOL ECOLOGY	50	32	41	22	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27645	10.1371/journal.pone.0027645	http://dx.doi.org/10.1371/journal.pone.0027645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096609	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900068
J	Ramos, I; Gomes, F; Koeller, CM; Saito, K; Heise, N; Masuda, H; Docampo, R; de Souza, W; Machado, EA; Miranda, K				Ramos, Isabela; Gomes, Fabio; Koeller, Carolina M.; Saito, Katsuharu; Heise, Norton; Masuda, Hatisaburo; Docampo, Roberto; de Souza, Wanderley; Machado, Ednildo A.; Miranda, Kildare			Acidocalcisomes as Calcium- and Polyphosphate-Storage Compartments during Embryogenesis of the Insect Rhodnius prolixus Stahl	PLOS ONE			English	Article							PROTON-PUMPING PYROPHOSPHATASE; VACUOLAR H+-PYROPHOSPHATASE; YOLK GRANULES; INORGANIC POLYPHOSPHATE; PERIPLANETA-AMERICANA; TRYPANOSOMA-CRUZI; UNICELLULAR EUKARYOTES; ENDOPLASMIC-RETICULUM; MALARIA PARASITES; ESCHERICHIA-COLI	Background: The yolk of insect eggs is a cellular domain specialized in the storage of reserve components for embryo development. The reserve macromolecules are stored in different organelles and their interactions with the embryo cells are mostly unknown. Acidocalcisomes are lysosome-related organelles characterized by their acidic nature, high electron density and large content of polyphosphate bound to several cations. In this work, we report the presence of acidocalcisome-like organelles in eggs of the insect vector Rhodnius prolixus. Methodology/Principal findings: Characterization of the elemental composition of electron-dense vesicles by electron probe X-ray microanalysis revealed a composition similar to that previously described for acidocalcisomes. Following subcellular fractionation experiments, fractions enriched in acidocalcisomes were obtained and characterized. Immunofluorescence showed that polyphosphate polymers and the vacuolar proton translocating pyrophosphatase (V-H+-PPase, considered as a marker for acidocalcisomes) are found in the same vesicles and that these organelles are mainly localized in the egg cortex. Polyphosphate quantification showed that acidocalcisomes contain a significant amount of polyphosphate detected at day-0 eggs. Elemental analyses of the egg fractions showed that 24.5 +/- 0.65% of the egg calcium are also stored in such organelles. During embryogenesis, incubation of acidocalcisomes with acridine orange showed that these organelles are acidified at day-3 (coinciding with the period of yolk mobilization) and polyphosphate quantification showed that the levels of polyphosphate tend to decrease during early embryogenesis, being approximately 30% lower at day-3 compared to day-0 eggs. Conclusions: We found that acidocalcisomes are present in the eggs and are the main storage compartments of polyphosphate and calcium in the egg yolk. As such components have been shown to be involved in a series of dynamic events that may control embryo growth, results reveal the potential involvement of a novel organelle in the storage and mobilization of inorganic elements to the embryo cells.	[Ramos, Isabela; Gomes, Fabio; Koeller, Carolina M.; Heise, Norton; de Souza, Wanderley; Machado, Ednildo A.; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Ramos, Isabela; Masuda, Hatisaburo] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [de Souza, Wanderley; Machado, Ednildo A.; Miranda, Kildare] Inst Nacl Metrol Normalizacao & Qualidade Ind, Diretoria Programas, Xerem, Brazil; [Saito, Katsuharu] Shinshu Univ, Fac Agr, Nagano, Japan; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Shinshu University; University System of Georgia; University of Georgia	Ramos, I (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	ednildo@biof.ufrj.br; kmiranda@biof.ufrj.br	Koeller, Carolina/ABB-1968-2021; Ramos, Isabela B/N-7091-2017; Heise, Norton/I-4098-2013; Saito, Katsuharu/I-9304-2014; Machado, Ednildo A/G-9725-2013	Koeller, Carolina/0000-0002-1919-7582; Ramos, Isabela B/0000-0003-0874-7902; Saito, Katsuharu/0000-0003-2557-1726; Heise, Norton/0000-0003-0154-7406; Machado, Ednildo/0000-0002-4428-3829; Gomes, Fabio/0000-0001-8439-8762	Conselho Nacional de Desenvolvimento CientUfico e Tccnoloegico (CNPq/Brazil); Programa Jovens Pesquisadores (CNPq/Brazil); Grupos Emergentes of Fundaca Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Barbara and Sanford Orkin/Georgia Research Alliance Chair; Grants-in-Aid for Scientific Research [23780062] Funding Source: KAKEN	Conselho Nacional de Desenvolvimento CientUfico e Tccnoloegico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Jovens Pesquisadores (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Grupos Emergentes of Fundaca Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Barbara and Sanford Orkin/Georgia Research Alliance Chair; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Conselho Nacional de Desenvolvimento CientUfico e Tccnoloegico (CNPq/Brazil). Programa Jovens Pesquisadores (CNPq/Brazil) (to K.M.) and Grupos Emergentes of Fundaca Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). R.D. was funded by the Barbara and Sanford Orkin/Georgia Research Alliance Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu LA, 2004, INSECT BIOCHEM MOLEC, V34, P443, DOI 10.1016/j.ibmb.2004.01.006; Andersen S.O., 1985, COMPREHENSIVE INSECT, V3, P59, DOI 10.1016/0020-711X(85)90033-3; ANDERSON RGW, 1988, J CELL BIOL, V106, P539, DOI 10.1083/jcb.106.3.539; Atella GC, 2005, AN ACAD BRAS CIENC, V77, P405, DOI 10.1590/S0001-37652005000300005; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Briano MVM, 1995, ARCH LATINOAM NUTR, V45, P172; Campos E, 2007, INSECT BIOCHEM MOLEC, V37, P1103, DOI 10.1016/j.ibmb.2007.06.003; Chestkov VV, 1998, J BIOL CHEM, V273, P2445, DOI 10.1074/jbc.273.4.2445; COLMAN A, 1976, EUR J BIOCHEM, V61, P387, DOI 10.1111/j.1432-1033.1976.tb10032.x; DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Docampo R, 2010, PHILOS T R SOC B, V365, P775, DOI 10.1098/rstb.2009.0179; FAGOTTO F, 1995, J CELL SCI, V108, P3645; FAGOTTO F, 1991, DEV GROWTH DIFFER, V33, P57; Fausto AM, 2001, CELL TISSUE RES, V305, P433, DOI 10.1007/s004410100392; Fialho E, 2002, INSECT BIOCHEM MOLEC, V32, P871, DOI 10.1016/S0965-1748(01)00175-8; Fiske CH, 1925, J BIOL CHEM, V66, P375; Garcia CRS, 1998, EUR J CELL BIOL, V76, P133, DOI 10.1016/S0171-9335(98)80026-5; Gomes FM, 2010, J CELL PHYSIOL, V222, P606, DOI 10.1002/jcp.21975; Gomes FM, 2008, J INSECT PHYSIOL, V54, P1459, DOI 10.1016/j.jinsphys.2008.07.018; HEMING BS, 1994, CAN J ZOOL, V72, P1100, DOI 10.1139/z94-148; Kornberg A, 1999, Prog Mol Subcell Biol, V23, P1; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marchesini N, 2000, BIOCHEM J, V347, P243, DOI 10.1042/0264-6021:3470243; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; McNeil PL, 2000, J CELL SCI, V113, P1891; Miranda K, 2004, PROTIST, V155, P395, DOI 10.1078/1434461042650361; Miranda K, 2004, HISTOCHEM CELL BIOL, V121, P407, DOI 10.1007/s00418-004-0646-4; Miranda K, 2000, PARASITOL RES, V86, P373, DOI 10.1007/s004360050682; Miranda K, 2008, EXP PARASITOL, V118, P2, DOI 10.1016/j.exppara.2007.07.009; Motta LS, 2004, INSECT BIOCHEM MOLEC, V34, P19, DOI 10.1016/j.ibmb.2003.07.002; Motta LS, 2009, INSECT BIOCHEM MOLEC, V39, P198, DOI 10.1016/j.ibmb.2008.11.003; NORDIN JH, 1991, ARCH INSECT BIOCHEM, V18, P177, DOI 10.1002/arch.940180306; OLIVEIRA PL, 1986, J INSECT PHYSIOL, V32, P859, DOI 10.1016/0022-1910(86)90101-0; OLIVEIRA PL, 1989, INSECT BIOCHEM, V19, P489; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Ramos IB, 2007, J EXP BIOL, V210, P138, DOI 10.1242/jeb.02652; Ramos IB, 2006, MOL REPROD DEV, V73, P1247, DOI 10.1002/mrd.20560; Ramos IB, 2011, MOL BIOL REP, V38, P1757, DOI 10.1007/s11033-010-0290-0; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Ramos IB, 2010, BIOL CELL, V102, P421, DOI 10.1042/BC20100011; REIMER CL, 1995, DEV BIOL, V167, P439, DOI 10.1006/dbio.1995.1040; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saito K, 2005, APPL ENVIRON MICROB, V71, P5692, DOI 10.1128/AEM.71.10.5692-5701.2005; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Seufferheld M, 2004, J BIOL CHEM, V279, P51193, DOI 10.1074/jbc.M406099200; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; Singla PN, 1998, J TROP PEDIATRICS, V44, P117, DOI 10.1093/tropej/44.2.117; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; TERASAKI M, 1991, DEV BIOL, V148, P398, DOI 10.1016/0012-1606(91)90348-7; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; *WHO, 2008, REP EXP COMM CONTR C, V905; Yamahama Y, 2003, J INSECT PHYSIOL, V49, P131, DOI 10.1016/S0022-1910(02)00257-3; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153	68	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27276	10.1371/journal.pone.0027276	http://dx.doi.org/10.1371/journal.pone.0027276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096545	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900029
J	Hudson, D; Guevara, D; Yaish, MW; Hannam, C; Long, N; Clarke, JD; Bi, YM; Rothstein, SJ				Hudson, Darryl; Guevara, David; Yaish, Mahmoud W.; Hannam, Carol; Long, Nykoll; Clarke, Joseph D.; Bi, Yong-Mei; Rothstein, Steven J.			GNC and CGA1 Modulate Chlorophyll Biosynthesis and Glutamate Synthase (GLU1/Fd-GOGAT) Expression in Arabidopsis	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; GREEN-REVOLUTION; CAROTENOID BIOSYNTHESIS; NITRATE ASSIMILATION; SIGNAL-TRANSDUCTION; NITROGEN LIMITATION; PLASTID DIVISION; CIRCADIAN CLOCK	Chloroplast development is an important determinant of plant productivity and is controlled by environmental factors including amounts of light and nitrogen as well as internal phytohormones including cytokinins and gibberellins (GA). The paralog GATA transcription factors GNC and CGA1/GNL up-regulated by light, nitrogen and cytokinin while also being repressed by GA signaling. Modifying the expression of these genes has previously been shown to influence chlorophyll content in Arabidopsis while also altering aspects of germination, elongation growth and flowering time. In this work, we also use transgenic lines to demonstrate that GNC and CGA1 exhibit a partially redundant control over chlorophyll biosynthesis. We provide novel evidence that GNC and CGA1 influence both chloroplast number and leaf starch in proportion to their transcript level. GNC and CGA1 were found to modify the expression of chloroplast localized GLUTAMATE SYNTHASE (GLU1/Fd-GOGAT), which is the primary factor controlling nitrogen assimilation in green tissue. Altering GNC and CGA1 expression was also found to modulate the expression of important chlorophyll biosynthesis genes (GUN4, HEMA1, PORB, and PORC). As previously demonstrated, the CGA1 transgenic plants demonstrated significantly altered timing to a number of developmental events including germination, leaf production, flowering time and senescence. In contrast, the GNC transgenic lines we analyzed maintain relatively normal growth phenotypes outside of differences in chloroplast development. Despite some evidence for partial divergence, results indicate that regulation of both GNC and CGA1 by light, nitrogen, cytokinin, and GA acts to modulate nitrogen assimilation, chloroplast development and starch production. Understanding the mechanisms controlling these processes is important for agricultural biotechnology.	[Hudson, Darryl; Guevara, David; Yaish, Mahmoud W.; Hannam, Carol; Bi, Yong-Mei; Rothstein, Steven J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Long, Nykoll; Clarke, Joseph D.] Syngenta Biotechnol Inc, Res Triangle Pk, NC USA	University of Guelph; Syngenta	Hudson, D (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rothstei@uoguelph.ca	Yaish, Mahmoud W/F-7168-2014; Rothstein, Steven J/A-4947-2013	Yaish, Mahmoud W/0000-0002-5171-3014; Rothstein, Steven J/0000-0003-0737-1878	Natural Sciences and Engineering Research Council of Canada (NSERC) [45663]; Green Crop Network (GCN) [47426]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Green Crop Network (GCN)	This work was supported by two government funding agencies: the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/; Grant # 45663) and the Green Crop Network (GCN, http://www.greencropnetwork.com/; Grant # 47426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Argueso CT, 2010, CURR OPIN PLANT BIOL, V13, P533, DOI 10.1016/j.pbi.2010.08.006; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Barry CS, 2009, PLANT SCI, V176, P325, DOI 10.1016/j.plantsci.2008.12.013; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Bondada BR, 2003, TREE PHYSIOL, V23, P553, DOI 10.1093/treephys/23.8.553; Bouton S, 2002, PLANT PHYSIOL BIOCH, V40, P939, DOI 10.1016/S0981-9428(02)01453-5; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Cheminant S, 2011, PLANT CELL, V23, P1849, DOI 10.1105/tpc.111.085233; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; Criado MV, 2009, J PLANT PHYSIOL, V166, P1775, DOI 10.1016/j.jplph.2009.05.007; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Feraud M, 2005, PLANTA, V222, P667, DOI 10.1007/s00425-005-0013-2; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Gan YB, 2007, DEVELOPMENT, V134, P2073, DOI 10.1242/dev.005017; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Gough SP, 2003, J PLANT BIOL, V46, P135, DOI 10.1007/BF03030443; Greenboim-Wainberg Y, 2005, PLANT CELL, V17, P92, DOI 10.1105/tpc.104.028472; Guo SW, 2007, PEDOSPHERE, V17, P601, DOI 10.1016/S1002-0160(07)60071-X; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; Hedtke B, 2007, PLANT MOL BIOL, V64, P733, DOI 10.1007/s11103-007-9194-3; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Huang SS, 1998, PLANT PHYSIOL, V118, P773, DOI 10.1104/pp.118.3.773; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Hussain F, 2000, AGRON J, V92, P875; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Ishizaki T, 2010, AMINO ACIDS, V38, P943, DOI 10.1007/s00726-009-0303-2; Ito S, 2007, PLANT CELL PHYSIOL, V48, P971, DOI 10.1093/pcp/pcm063; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Jonassen EM, 2009, J PLANT PHYSIOL, V166, P2071, DOI 10.1016/j.jplph.2009.05.010; Kiba T, 2005, PLANT CELL PHYSIOL, V46, P339, DOI 10.1093/pcp/pci033; Kim YC, 2005, PLANT CELL PHYSIOL, V46, P1317, DOI 10.1093/pcp/pci141; Kissen R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-190; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Lillo C, 2001, PLANT PHYSIOL, V125, P1554, DOI 10.1104/pp.125.4.1554; Liu XY, 2010, J INTEGR PLANT BIOL, V52, P750, DOI 10.1111/j.1744-7909.2010.00980.x; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Maple J, 2007, ANN BOT-LONDON, V99, P565, DOI 10.1093/aob/mcl249; Mara CD, 2008, PLANT PHYSIOL, V147, P707, DOI 10.1104/pp.107.115634; Mas P, 2009, CURR OPIN PLANT BIOL, V12, P574, DOI 10.1016/j.pbi.2009.07.010; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Miyagishima SY, 2006, PLANT CELL, V18, P2517, DOI 10.1105/tpc.106.045484; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Moon J, 2008, P NATL ACAD SCI USA, V105, P9433, DOI 10.1073/pnas.0803611105; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moore BD, 1999, TRENDS PLANT SCI, V4, P250, DOI 10.1016/S1360-1385(99)01433-8; Muller Bruno, 2007, Sci STKE, V2007, pcm5, DOI 10.1126/stke.4072007cm5; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1557, DOI 10.1271/bbb.60692; Needham CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-85; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Okazaki K, 2010, PLANT SIGNAL BEHAV, V5, P164, DOI 10.4161/psb.5.2.10461; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Potel F, 2009, FEBS J, V276, P4061, DOI 10.1111/j.1742-4658.2009.07114.x; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Rastogi R, 1997, PLANT MOL BIOL, V34, P465, DOI 10.1023/A:1005842812321; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rothstein SJ, 2007, PLANT CELL, V19, P2695, DOI 10.1105/tpc.107.053074; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Scharf PC, 2006, AGRON J, V98, P655, DOI 10.2134/agronj2005.0070; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Stephenson PG, 2009, P NATL ACAD SCI USA, V106, P7654, DOI 10.1073/pnas.0811684106; Stewart JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019894; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; Takei K, 2002, J EXP BOT, V53, P971, DOI 10.1093/jexbot/53.370.971; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071	110	95	104	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26765	10.1371/journal.pone.0026765	http://dx.doi.org/10.1371/journal.pone.0026765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102866	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800010
J	Wang, F; Zhou, XL; Yang, QG; Xu, WH; Wang, F; Chen, YP; Chen, GH				Wang, Fang; Zhou, Xian-Ling; Yang, Qi-Gang; Xu, Wen-Hua; Wang, Fei; Chen, Yong-Ping; Chen, Gui-Hai			A Peptide That Binds Specifically to the beta-Amyloid of Alzheimer's Disease: Selection and Assessment of Anti-beta-Amyloid Neurotoxic Effects	PLOS ONE			English	Article							SHEET BREAKER PEPTIDES; IMAGE PHAGE DISPLAY; METHYL AMINO-ACIDS; MEMORY IMPAIRMENT; PROTEIN AGGREGATION; NEURONAL APOPTOSIS; OXIDATIVE STRESS; FIBRIL FORMATION; PC12 CELLS; RAT-BRAIN	The accumulation of the amyloid-beta peptide (A beta) into amyloid plaques, an essential event in Alzheimer's disease (AD) pathogenesis, has caused researchers to seek compounds that physiologically bind A beta and modulate its aggregation and neurotoxicity. In order to develop new A beta-specific peptides for AD, a randomized 12-mer peptide library with A beta(1-10) as the target was used to identify peptides in the present study. After three rounds of selection, specific phages were screened, and their binding affinities to A beta(1-10) were found to be highly specific. Finally, a special peptide was synthesized according to the sequences of the selected phages. In addition, the effects of the special peptide on A beta aggregation and A beta-mediated neurotoxicity in vitro and in vivo were assessed. The results show that the special peptide not only inhibited the aggregation of A beta into plaques, but it also alleviated A beta-induced PC12 cell viability and apoptosis at appropriate concentrations as assessed by the cell counting kit-8 assay and propidium iodide staining. Moreover, the special peptide exhibited a protective effect against A beta-induced learning and memory deficits in rats, as determined by the Morris water maze task. In conclusion, we selected a peptide that specifically binds A beta(1-10) and can modulate A beta aggregation and A beta-induced neuronal damage. This opens up possibilities for the development of a novel therapeutic approach for the treatment of AD.	[Wang, Fang; Zhou, Xian-Ling; Yang, Qi-Gang; Xu, Wen-Hua; Wang, Fei; Chen, Gui-Hai] Anhui Med Univ, Dept Neurol, Affiliated Hosp 1, Hefei, Peoples R China; [Chen, Yong-Ping] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Anhui Medical University; Johns Hopkins University	Wang, F (corresponding author), Anhui Med Univ, Dept Neurol, Affiliated Hosp 1, Hefei, Peoples R China.	chenguihai1964@163.com		xu, wenhua/0000-0002-6990-2542	tackle key problems in science and technology of Anhui Science and Technology Department [7010302199]	tackle key problems in science and technology of Anhui Science and Technology Department	This research is supported by a grant from the Major Program from tackle key problems in science and technology of Anhui Science and Technology Department (www.ahkjt.gov.cn)(No. 7010302199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2006, J NEUROSCI RES, V84, P398, DOI 10.1002/jnr.20877; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Amijee H, 2009, BIOCHEM SOC T, V37, P692, DOI 10.1042/BST0370692; Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Baldi Elisabetta, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P9, DOI 10.2201/nonlin.003.01.002; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Chacon MA, 2004, MOL PSYCHIATR, V9, P953, DOI 10.1038/sj.mp.4001516; Chen GH, 2007, NEUROBIOL AGING, V28, P611, DOI 10.1016/j.neurobiolaging.2006.03.001; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Frisardi V, 2010, CURR ALZHEIMER RES, V7, P40, DOI 10.2174/156720510790274400; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gordon DJ, 2002, J PEPT RES, V60, P37, DOI 10.1034/j.1399-3011.2002.11002.x; Granic I, 2010, J ALZHEIMERS DIS, V19, P991, DOI 10.3233/JAD-2010-1297; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hatip FFB, 2010, CURR ALZHEIMER RES, V7, P602; Hughes E, 2000, J BIOL CHEM, V275, P25109, DOI 10.1074/jbc.M003554200; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Jellinger Kurt A., 2006, Current Alzheimer Research, V3, P377, DOI 10.2174/156720506778249434; Kang CK, 2003, NEUROBIOL DIS, V14, P146, DOI 10.1016/S0969-9961(03)00105-0; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Larbanoix L, 2010, NEUROBIOL AGING, V31, P1679, DOI 10.1016/j.neurobiolaging.2008.09.021; Liu RT, 2004, J NEUROSCI RES, V75, P162, DOI 10.1002/jnr.10859; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Majd S, 2008, BRAIN RES, V1218, P224, DOI 10.1016/j.brainres.2008.04.050; Martin D, 2001, J NEUROCHEM, V78, P1000, DOI 10.1046/j.1471-4159.2001.00472.x; Matharu B, 2010, PEPTIDES, V31, P1866, DOI 10.1016/j.peptides.2010.06.033; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Nelson TJ, 2007, J BIOL CHEM, V282, P31238, DOI 10.1074/jbc.M705558200; Olariu A, 2002, BRAIN RES, V957, P278, DOI 10.1016/S0006-8993(02)03608-9; Orner BP, 2006, J AM CHEM SOC, V128, P11882, DOI 10.1021/ja0619861; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Qahwash I, 2003, J BIOL CHEM, V278, P23187, DOI 10.1074/jbc.M213298200; SAMBROOK J, 1989, NATURE, V342, P224, DOI 10.1038/342224a0; Schenk D, 2004, NATURE, V431, P398, DOI 10.1038/431398b; Sciarretta KL, 2006, BIOCHEMISTRY-US, V45, P9485, DOI 10.1021/bi0605585; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Shin EJ, 2004, BEHAV BRAIN RES, V151, P267, DOI 10.1016/j.bbr.2003.09.004; Solomon B, 2007, DRUG TODAY, V43, P333, DOI 10.1358/dot.2007.43.5.1062670; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Tan J, 1999, NEUROSCI LETT, V272, P5, DOI 10.1016/S0304-3940(99)00525-X; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Thomas T, 2001, NEUROREPORT, V12, P3263, DOI 10.1097/00001756-200110290-00024; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Yamada M, 2005, BEHAV BRAIN RES, V164, P139, DOI 10.1016/j.bbr.2005.03.026; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005; Zwick MB, 1998, CURR OPIN BIOTECH, V9, P427, DOI 10.1016/S0958-1669(98)80017-7	66	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27649	10.1371/journal.pone.0027649	http://dx.doi.org/10.1371/journal.pone.0027649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102917	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800039
J	Comeau, AM; Li, WKW; Tremblay, JE; Carmack, EC; Lovejoy, C				Comeau, Andre M.; Li, William K. W.; Tremblay, Jean-Eric; Carmack, Eddy C.; Lovejoy, Connie			Arctic Ocean Microbial Community Structure before and after the 2007 Record Sea Ice Minimum	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; BEAUFORT SEA; DIVERSITY; BACTERIAL; GROWTH; PICOPHYTOPLANKTON; PHYSIOLOGY; ECOLOGY; RIVER	Increasing global temperatures are having a profound impact in the Arctic, including the dramatic loss of multiyear sea ice in 2007 that has continued to the present. The majority of life in the Arctic is microbial and the consequences of climate-mediated changes on microbial marine food webs, which are responsible for biogeochemical cycling and support higher trophic levels, are unknown. We examined microbial communities over time by using high-throughput sequencing of microbial DNA collected between 2003 and 2010 from the subsurface chlorophyll maximum (SCM) layer of the Beaufort Sea (Canadian Arctic). We found that overall this layer has freshened and concentrations of nitrate, the limiting nutrient for photosynthetic production in Arctic seas, have decreased. We compared microbial communities from before and after the record September 2007 sea ice minimum and detected significant differences in communities from all three domains of life. In particular, there were significant changes in species composition of Eukarya, with ciliates becoming more common and heterotrophic marine stramenopiles (MASTs) accounting for a smaller proportion of sequences retrieved after 2007. Within the Archaea, Marine Group I Thaumarchaeota, which earlier represented up to 60% of the Archaea sequences in this layer, have declined to <10%. Bacterial communities overall were less diverse after 2007, with a significant decrease of the Bacteroidetes. These significant shifts suggest that the microbial food webs are sensitive to physical oceanographic changes such as those occurring in the Canadian Arctic over the past decade.	[Comeau, Andre M.; Tremblay, Jean-Eric; Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Comeau, Andre M.; Tremblay, Jean-Eric; Lovejoy, Connie] Univ Laval, IBIS, Quebec City, PQ G1K 7P4, Canada; [Li, William K. W.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Carmack, Eddy C.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	Laval University; Laval University; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Comeau, AM (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	andre.comeu@ibis.ulaval.ca; connie.lovejoy@bio.ulaval.ca	Lovejoy, Connie/A-3756-2008; Comeau, André/E-7461-2012	Lovejoy, Connie/0000-0001-8027-2281; 	Natural Science and Engineering Research Council of Canada (NSERC); Canadian Healthy Oceans Network	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Healthy Oceans Network	C.L.'s multiple cruise participations were funded by ongoing Natural Science and Engineering Research Council of Canada (NSERC) Discovery grants and the Canadian Healthy Oceans Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2008, ENVIRON MICROBIOL, V10, P2444, DOI 10.1111/j.1462-2920.2008.01674.x; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bachy C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00106; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Brugel S, 2009, MAR ECOL PROG SER, V377, P63, DOI 10.3354/meps07808; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Falk-Petersen S, 2009, DEEP-SEA RES PT II, V56, P2080, DOI 10.1016/j.dsr2.2008.11.020; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Forest A, 2010, DEEP-SEA RES PT I, V57, P125, DOI 10.1016/j.dsr.2009.10.002; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Garneau ME, 2006, AQUAT MICROB ECOL, V42, P27, DOI 10.3354/ame042027; Gosink JJ, 1998, INT J SYST BACTERIOL, V48, P223, DOI 10.1099/00207713-48-1-223; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Guo JP, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015140; Hansen PJ, 1999, J EUKARYOT MICROBIOL, V46, P382, DOI 10.1111/j.1550-7408.1999.tb04617.x; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jackson JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005265; Jeong HJ, 1999, J EUKARYOT MICROBIOL, V46, P390, DOI 10.1111/j.1550-7408.1999.tb04618.x; Kalanetra KM, 2009, ENVIRON MICROBIOL, V11, P2434, DOI 10.1111/j.1462-2920.2009.01974.x; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Kwok R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044678; Lavoie D, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005493; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lo Giudice A, 2012, MICROB ECOL, V63, P210, DOI 10.1007/s00248-011-9904-x; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Lovejoy C., 2010, MAR BIODIVERS, V41, P5, DOI DOI 10.1007/s12526-010-0062-z; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Lovejoy C, 2011, J PLANKTON RES, V33, P431, DOI 10.1093/plankt/fbq124; Marie D, 2006, FEMS MICROBIOL ECOL, V55, P403, DOI 10.1111/j.1574-6941.2005.00058.x; Martin J, 2010, MAR ECOL PROG SER, V412, P69, DOI 10.3354/meps08666; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; McLaughlin FA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045459; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Nicol GW, 2006, TRENDS MICROBIOL, V14, P207, DOI 10.1016/j.tim.2006.03.004; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Piquet AMT, 2011, FEMS MICROBIOL ECOL, V76, P413, DOI 10.1111/j.1574-6941.2011.01062.x; Proshutinsky A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005162; Purcell JE, 2010, DEEP-SEA RES PT II, V57, P127, DOI 10.1016/j.dsr2.2009.08.011; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rainville L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041291; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; STOLTE W, 1995, MICROBIOL-SGM, V141, P1221, DOI 10.1099/13500872-141-5-1221; STREY ST, 2010, J GEOPHYS RES, V115, P1; Terrado R, 2011, POLAR BIOL, V34, P1901, DOI 10.1007/s00300-011-1039-5; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Tremblay JE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004547; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006; Vincent WF, 2010, ISME J, V4, P1089, DOI 10.1038/ismej.2010.108; Zeder M, 2009, ENVIRON MICROBIOL, V11, P2676, DOI 10.1111/j.1462-2920.2009.01994.x	64	254	258	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27492	10.1371/journal.pone.0027492	http://dx.doi.org/10.1371/journal.pone.0027492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096583	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800055
J	Palermo, R; Checquolo, S; Giovenco, A; Grazioli, P; Kumar, V; Campese, AF; Giorgi, A; Napolitano, M; Canettieri, G; Ferrara, G; Schinina, ME; Maroder, M; Frati, L; Gulino, A; Vacca, A; Screpanti, I				Palermo, R.; Checquolo, S.; Giovenco, A.; Grazioli, P.; Kumar, V.; Campese, A. F.; Giorgi, A.; Napolitano, M.; Canettieri, G.; Ferrara, G.; Schinina, M. E.; Maroder, M.; Frati, L.; Gulino, A.; Vacca, A.; Screpanti, I.			Acetylation controls Notch3 stability and function in T-cell leukemia	ONCOGENE			English	Article						leukemia; Notch3; T-ALL; acetylation	HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; ACUTE LYMPHOBLASTIC-LEUKEMIA; PRE-TCR; HDAC INHIBITORS; TRANSGENIC MICE; DNA-DAMAGE; EXPRESSION; TARGET; CANCER	Post-translational modifications of Notch3 and their functional role with respect to Notch3 overexpression in T-cell leukemia are still poorly understood. We identify here a specific novel property of Notch3 that is acetylated and deacetylated at lysines 1692 and 1731 by p300 and HDAC1, respectively, a balance impaired by HDAC inhibitors (HDACi) that favor hyperacetylation. By using HDACi and a non-acetylatable Notch3 mutant carrying K/R1692-1731 mutations in the intracellular domain, we show that Notch3 acetylation primes ubiquitination and proteasomal-mediated degradation of the protein. As a consequence, Notch3 protein expression and its transcriptional activity are decreased both in vitro and in vivo in Notch3 transgenic (tg) mice, thus impairing downstream signaling upon target genes. Consistently, Notch3-induced T-cell proliferation is inhibited by HDACi, whereas it is enhanced by the non-acetylatable Notch3-K/R1692-1731 mutant. Finally, HDACi-induced Notch3 hyperacetylation prevents in vivo growth of T-cell leukemia/lymphoma in Notch3 tg mice. Together, our findings suggest a novel level of Notch signaling control in which Notch3 acetylation/deacetylation process represents a key regulatory switch, thus representing a suitable druggable target for Notch3-sustained T-cell acute lymphoblastic leukemia therapy. Oncogene (2012) 31, 3807-3817; doi: 10.1038/onc.2011.533; published online 28 November 2011	[Palermo, R.; Giovenco, A.; Vacca, A.] Sapienza Univ, Dept Expt Med, I-00161 Rome, Italy; [Checquolo, S.; Maroder, M.] Sapienza Univ, Dept Biotechnol & Med Surg Sci, Latina, Italy; [Grazioli, P.; Kumar, V.; Campese, A. F.; Napolitano, M.; Canettieri, G.; Ferrara, G.; Frati, L.; Gulino, A.; Screpanti, I.] Sapienza Univ, Dept Mol Med, I-00161 Rome, Italy; [Giorgi, A.; Schinina, M. E.] Sapienza Univ, Dept Biochem Sci, I-00161 Rome, Italy; [Napolitano, M.] IRCCS OASI, Troina, Italy; [Frati, L.; Gulino, A.] Neuromed Inst, Pozzilli, Italy; [Screpanti, I.] Sapienza Univ, Inst Pasteur, Cenci Bolognetti Fdn, I-00161 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; IRCCS Neuromed; Fondazione Cenci Bolognetti; Sapienza University Rome	Vacca, A (corresponding author), Sapienza Univ, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy.	alessandra.vacca@uniroma1.it; isabella.screpanti@uniroma1.it	Campese, Antonio/A-9783-2015; Frati, Luigi/ABI-7437-2020; Palermo, Rocco/I-5140-2016	Palermo, Rocco/0000-0003-0134-9370; VACCA, Alessandra/0000-0002-0006-5379; CHECQUOLO, Saula/0000-0001-5109-8392; CAMPESE, Antonio Francesco/0000-0002-8535-6609; CANETTIERI, Gianluca/0000-0001-6694-2613	Italian Association for Cancer Research (AIRC); Italian Ministry of University and Research (MIUR); Italian Ministry of Health; European Union [FP7-MC-ITN 215761]; Eleonora Lorillard Spencer Cenci Foundation; Fondazione Roma	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission); Eleonora Lorillard Spencer Cenci Foundation; Fondazione Roma(Fondazione RomaEuropean Commission)	We are grateful to Dr Sonia Coni for experimental support. This work was supported by the Italian Association for Cancer Research (AIRC), the Italian Ministry of University and Research (MIUR), PRIN and FIRB Programs, the Italian Ministry of Health, the European Union (NotchIT ITN Project; FP7-MC-ITN 215761), Eleonora Lorillard Spencer Cenci Foundation and the Fondazione Roma (fellowship to RP).	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Checquolo S, 2010, ONCOGENE, V29, P1463, DOI 10.1038/onc.2009.446; Clappier E, 2010, LEUKEMIA, V24, P2023, DOI 10.1038/leu.2010.205; Felli MP, 2005, ONCOGENE, V24, P992, DOI 10.1038/sj.onc.1208302; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Insinga A, 2005, CELL CYCLE, V4, P741, DOI 10.4161/cc.4.6.1717; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Leduc C, 2006, ONCOGENE, V25, P4147, DOI 10.1038/sj.onc.1209446; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Mercurio C, 2010, PHARMACOL RES, V62, P18, DOI 10.1016/j.phrs.2010.02.010; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Piekarz RL, 2007, CANCER J, V13, P30, DOI 10.1097/PPO.0b013e31803c73cc; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Screpanti I, 2003, TRENDS MOL MED, V9, P30, DOI 10.1016/S1471-4914(02)00003-5; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Talora C, 2006, BLOOD, V107, P3313, DOI 10.1182/blood-2005-07-2823; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Tsapis M, 2007, INT J BIOCHEM CELL B, V39, P1500, DOI 10.1016/j.biocel.2007.03.009; Vacca A, 2006, EMBO J, V25, P1000, DOI 10.1038/sj.emboj.7600996; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011	41	44	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	33					3807	3817		10.1038/onc.2011.533	http://dx.doi.org/10.1038/onc.2011.533			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22120716				2022-12-25	WOS:000307924900007
J	Zhang, S; Shan, C; Kong, G; Du, Y; Ye, L; Zhang, X				Zhang, S.; Shan, C.; Kong, G.; Du, Y.; Ye, L.; Zhang, X.			MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappa B-inducing kinase (NIK)	ONCOGENE			English	Article						microRNA-520e; DNA methylation; hepatocellular carcinoma; cell proliferation; NF-kappa B-inducing kinase	HUMAN HEPATOCELLULAR-CARCINOMA; FREQUENT EPIGENETIC INACTIVATION; HUMAN CANCER-CELLS; CONSTITUTIVE ACTIVATION; P38 MAPK; EXPRESSION; PROLIFERATION; BIOGENESIS; TUMORS; FAMILY	MicroRNAs (miRNAs) are small, non-coding RNAs that can act as oncogenes or tumor suppressor genes in human cancer. Emerging evidence indicates that deregulation of miRNAs contributes to the hepatocarcinogenesis. In the present study, we demonstrated that the levels of miR-520e were dramatically decreased in examined hepatoma cell lines and clinical hepatocellular carcinoma (HCC) tissues. Moreover, we found that DNA hypermethylation in the upstream region of miR-520e resulted in the downregulation of miR-520e. Next, we demonstrated that introduction of miR-520e dramatically suppressed the growth of hepatoma cells in vitro and in vivo, whereas silencing the expression of miR-520e by anti-miR-520e resulted in a promoted cell proliferation, suggesting that miR-520e may be a novel tumor suppressor. Further studies revealed that NF-kappa B-inducing kinase (NIK) was one of the direct target genes of miR-520e, as miR-520e directly bound to the 3'untranslated region of NIK, which reduced the expression of NIK at the levels of mRNA and protein. Moreover, silencing of NIK was able to inhibit the growth of hepatoma cells, similar to the effect of miR-520e overexpression on growth of hepatoma cells. Meanwhile, the knockdown of NIK expression reversed the enhanced proliferation mediated by anti-miR-520e. In addition, miR-520e significantly decreased the phosphorylation of ERK1/2 (p-ERK1/2) and depressed the transcriptional activity and nuclear translocation of nuclear factor kappa B (NF-kappa B) (p65). These results suggest that miR-520e suppresses the growth of hepatoma cells by targeting NIK involving the NIK/p-ERK1/2/NF-kappa B signaling pathway. Finally, we showed that the intratumoral injection with miR-520e was able to directly repress the growth of hepatoma cells in the nude mice. Thus, our finding provides new insight into the mechanism of hepatocarcinogenesis, indicating a therapeutic potential of miR-520e in the treatment of HCC. Oncogene (2012) 31, 3607-3620; doi:10.1038/onc.2011.523; published online 21 November 2011	[Zhang, S.; Shan, C.; Kong, G.; Du, Y.; Zhang, X.] Nankai Univ, Key Lab Mol Microbiol & Technol, Dept Canc Res, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Ye, L.] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, X (corresponding author), Nankai Univ, Key Lab Mol Microbiol & Technol, Dept Canc Res, Minist Educ,Inst Mol Biol,Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Kong, Guangyao/L-2162-2013; Shan, changliang/L-9029-2016		National Basic Research Program of China (973 Program) [2009CB521702]; National Natural Science Foundation of China [81071624]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2009CB521702) and National Natural Science Foundation of China (No. 81071624).	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen KH, 2007, BIOCHEM PHARMACOL, V73, P215, DOI 10.1016/j.bcp.2006.09.018; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Cui W, 2010, CANCER BIOL THER, V10, P232; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Foehr ED, 2000, J BIOL CHEM, V275, P34021, DOI 10.1074/jbc.C000507200; Gessi M, 2011, NEUROPATH APPL NEURO, V37, P406, DOI 10.1111/j.1365-2990.2010.01151.x; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ji JF, 2009, CANCER BIOL THER, V8, P1683, DOI 10.4161/cbt.8.18.8898; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li Q, 2010, J GASTROEN HEPATOL, V25, P164, DOI 10.1111/j.1440-1746.2009.05971.x; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Nishina T, 2009, BIOCHEM BIOPH RES CO, V388, P96, DOI 10.1016/j.bbrc.2009.07.125; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Ying SY, 2005, BIOCHEM BIOPH RES CO, V326, P515, DOI 10.1016/j.bbrc.2004.10.215	45	100	106	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	31					3607	3620		10.1038/onc.2011.523	http://dx.doi.org/10.1038/onc.2011.523			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22105365				2022-12-25	WOS:000307245600004
J	Niespodziana, K; Napora, K; Cabauatan, C; Focke-Tejkl, M; Keller, W; Niederberger, V; Tsolia, M; Christodoulou, I; Papadopoulos, NG; Valenta, R				Niespodziana, Katarzyna; Napora, Kamila; Cabauatan, Clarissa; Focke-Tejkl, Margarete; Keller, Walter; Niederberger, Verena; Tsolia, Maria; Christodoulou, Ioannis; Papadopoulos, Nikolaos G.; Valenta, Rudolf			Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections	FASEB JOURNAL			English	Article						asthma; rhinovirus infection	COMMON COLD VIRUS; NEUTRALIZATION; EXACERBATIONS; RECEPTOR; BACTERIA; ASTHMA	Rhinoviruses (RVs) are the primary cause of upper respiratory tract infections, generally known as the common cold. Moreover, RV infections can trigger severe exacerbations of asthma and chronic obstructive pulmonary disease (COPD). We expressed the 4 major RV capsid proteins, VP1-VP4, in Escherichia coli and used these proteins as well as recombinant and synthetic VP1 fragments to study and map antibody responses in RV-infected humans. VP1, which on infection binds to ICAM 1, was identified as a major target for the memory immune response, residing in the IgG1 subclass and IgA class. Interestingly, this response was mainly directed against an N-terminal 20mer peptide in VP1, P1a, which becomes exposed on intact RV only when it docks to its receptor ICAM 1. Molecular modeling using the 3-dimensional RV capsid structures revealed that P1a was localized inside the capsid and outside the areas involved in receptor binding or RV neutralization. Our results suggest misdirection of antibody responses against a nonprotective epitope as a mechanism how RV escapes immunity and causes recurrent infections. Based on these findings, it may be possible to design vaccines against RV infections and RV-induced respiratory diseases.-Niespodziana, K., Napora, K., Cabauatan, C., Focke-Tejkl, M., Keller, W., Niederberger, V., Tsolia, M., Christodoulou, I., Papadopoulos, N. G., Valenta, R. Misdirected antibody responses against an N-terminal epitope on human RV VP1 as explanation for recurrent RV infections. FASEB J. 26, 1001-1008 (2012). www.fasebj.org	[Valenta, Rudolf] Med Univ Vienna, Christian Doppler Lab Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Div Immunopathol,Dept Pathophysiol & Allergy Res, A-1090 Vienna, Austria; [Niederberger, Verena] Med Univ Vienna, Dept Otorhinolaryngol, A-1090 Vienna, Austria; [Keller, Walter] Karl Franzens Univ Graz, Inst Chem, Graz, Austria; [Tsolia, Maria; Christodoulou, Ioannis; Papadopoulos, Nikolaos G.] Univ Athens, Pediat Clin 2, Allergy Res Ctr, Athens, Greece	Medical University of Vienna; Medical University of Vienna; University of Graz; National & Kapodistrian University of Athens	Valenta, R (corresponding author), Med Univ Vienna, Christian Doppler Lab Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Div Immunopathol,Dept Pathophysiol & Allergy Res, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	rudolf.valenta@meduniwien.ac.at	Keller, Walter/AAW-1501-2021; Papadopoulos, Nikolaos/ABE-1774-2021; N.G., Papadopoulos/L-8670-2013	Keller, Walter/0000-0002-2261-958X; Papadopoulos, Nikolaos/0000-0002-4448-3468; N.G., Papadopoulos/0000-0002-4448-3468; Valenta, Rudolf/0000-0001-5944-3365; Cabauatan, Clarissa/0000-0001-8404-7065; Papadopoulos, Nikolaos/0000-0002-2508-3872; Niespodziana, Katarzyna/0000-0003-0700-965X	Austrian Science Fund (FWF) [DK-W1212-B13, F1805, F1818]; Biomay (Vienna, Austria); Christian Doppler Research Association (Austria); European Commission [260895]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biomay (Vienna, Austria); Christian Doppler Research Association (Austria); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study is supported by grants DK-W1212-B13, F1805, and F1818 of the Austrian Science Fund (FWF); by a research grant from Biomay (Vienna, Austria); by the Christian Doppler Research Association (Austria); and by the European Commission's Seventh Framework program under grant agreement 260895 (PreDicta). N.G.P is coordinator of the PreDicta Consortium.	ARNOLD E, 1990, J MOL BIOL, V211, P763, DOI 10.1016/0022-2836(90)90076-X; BARCLAY WS, 1989, EPIDEMIOL INFECT, V103, P659, DOI 10.1017/S095026880003106X; Braciale T. J., 2007, FIELDS VIROLOGY; Che ZW, 1998, J VIROL, V72, P4610, DOI 10.1128/JVI.72.6.4610-4622.1998; Donaldson GC, 2003, EUR RESPIR J, V22, P931, DOI 10.1183/09031936.03.00038303; Edlmayr J, 2011, EUR RESPIR J, V37, P44, DOI 10.1183/09031936.00149109; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Katpally U, 2009, J VIROL, V83, P7040, DOI 10.1128/JVI.00557-09; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; LI QH, 1994, J VIROL, V68, P3965, DOI 10.1128/JVI.68.6.3965-3970.1994; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Papadopoulos NG, 2001, QJM-INT J MED, V94, P1, DOI 10.1093/qjmed/94.1.1; ROSSMANN M G, 1989, Viral Immunology, V2, P143, DOI 10.1089/vim.1989.2.143; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rotbart HA, 2000, ARCH FAM MED, V9, P913, DOI 10.1001/archfami.9.9.913; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Spyridaki IS, 2009, J VIROL METHODS, V156, P102, DOI 10.1016/j.jviromet.2008.10.027; Stripeli F, 2010, EUR J CLIN MICROBIOL, V29, P683, DOI 10.1007/s10096-010-0914-2	25	40	41	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1001	1008		10.1096/fj.11-193557	http://dx.doi.org/10.1096/fj.11-193557			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22121050				2022-12-25	WOS:000300949300005
J	Bruscoli, S; Velardi, E; Di Sante, M; Bereshchenko, O; Venanzi, A; Coppo, M; Berno, V; Mameli, MG; Colella, R; Cavaliere, A; Riccardi, C				Bruscoli, Stefano; Velardi, Enrico; Di Sante, Moises; Bereshchenko, Oxana; Venanzi, Alessandra; Coppo, Maddalena; Berno, Valeria; Mameli, Maria Grazia; Colella, Renato; Cavaliere, Antonio; Riccardi, Carlo			Long Glucocorticoid-induced Leucine Zipper (L-GILZ) Protein Interacts with Ras Protein Pathway and Contributes to Spermatogenesis Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMATOGONIAL STEM-CELLS; HORMONE-INDUCED GENE; SELF-RENEWAL; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; SERTOLI-CELLS; T-LYMPHOCYTES; KINASE; MOUSE; ACTIVATION	Correct function of spermatogonia is critical for the maintenance of spermatogenesis throughout life, but the cellular pathways regulating undifferentiated spermatogonia proliferation, differentiation, and survival are only partially known. We show here that long glucocorticoid-induced leucine zipper (L-GILZ) is highly expressed in spermatogonia and primary spermato-cytes and controls spermatogenesis. Gilz deficiency in knockout (gilz KO) mice leads to a complete loss of germ cell lineage within first cycles of spermatogenesis, resulting in male sterility. Spermatogenesis failure is intrinsic to germ cells and is associated with increased proliferation and aberrant differentiation of undifferentiated spermatogonia and with hyperactivity of Ras signaling pathway as indicated by an increase of ERK and Akt phosphorylation. Spermatogonia differentiation does not proceed beyond the prophase of the first meiotic division due to massive apoptosis associated with accumulation of unrepaired chromosomal damage. These results identify L-GILZ as a novel important factor for undifferentiated spermatogonia function and spermatogenesis.	[Bruscoli, Stefano; Velardi, Enrico; Di Sante, Moises; Bereshchenko, Oxana; Venanzi, Alessandra; Coppo, Maddalena; Riccardi, Carlo] Univ Perugia, Sch Med, Dept Clin & Expt Med, Sect Pharmacol Toxicol & Chemotherapy, I-06122 Perugia, Italy; [Mameli, Maria Grazia; Colella, Renato; Cavaliere, Antonio] Univ Perugia, Sch Med, Inst Pathol Anat & Histol, I-06122 Perugia, Italy; [Berno, Valeria] European Mol Biol Lab, Mouse Biol Unit, I-00015 Rome, Italy	University of Perugia; University of Perugia; European Molecular Biology Laboratory (EMBL)	Riccardi, C (corresponding author), Univ Perugia, Dept Clin & Expt Med, Pharmacol Sect, Via Giochetto, I-06100 Perugia, Italy.	riccardi@unipg.it	di sante, moises/AAZ-4936-2020; Berno, Valeria/AAN-3997-2020; Mameli, Maria Grazia/AAC-2478-2019; Velardi, Enrico/AAB-7443-2019; Riccardi, Carlo/N-4610-2014; velardi, Enrico/AAC-5440-2022	Berno, Valeria/0000-0001-5848-494X; Velardi, Enrico/0000-0001-8383-0453; Riccardi, Carlo/0000-0001-9257-3997; Di Sante, Moises/0000-0002-4174-1257; Bereshchenko, Oxana/0000-0002-2772-6042; bruscoli, stefano/0000-0003-0313-1615	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy (to C. R.).	Almog T, 2008, MOL CELL ENDOCRINOL, V282, P39, DOI 10.1016/j.mce.2007.11.011; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; CHAGANTI RSK, 1980, AM J HUM GENET, V32, P833; Clotman F, 2000, MAMM GENOME, V11, P696, DOI 10.1007/s003350010116; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee J, 2011, CELL RES, V21, P1164, DOI 10.1038/cr.2011.111; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Li WQ, 2000, GENE DEV, V14, P895; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang PJ, 2007, CHROMOSOME RES, V15, P623, DOI 10.1007/s10577-007-1141-2; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	52	59	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1242	1251		10.1074/jbc.M111.316372	http://dx.doi.org/10.1074/jbc.M111.316372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110132	hybrid, Green Published			2022-12-25	WOS:000299170300040
J	Busygina, V; Saro, D; Williams, G; Leung, WK; Say, AF; Sehorn, MG; Sung, P; Tsubouchi, H				Busygina, Valeria; Saro, Dorina; Williams, Gareth; Leung, Wing-Kit; Say, Amanda F.; Sehorn, Michael G.; Sung, Patrick; Tsubouchi, Hideo			Novel Attributes of Hed1 Affect Dynamics and Activity of the Rad51 Presynaptic Filament during Meiotic Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; X-RAY SOLUTION; HOMOLOGOUS RECOMBINATION; RECA HOMOLOGS; DNA; DMC1; PROTEINS; EXCHANGE; PROMOTE; REPAIR	During meiosis, recombination events that occur between homologous chromosomes help prepare the chromosome pairs for proper disjunction in meiosis I. The concurrent action of the Rad51 and Dmc1 recombinases is necessary for an interhomolog bias. Notably, the activity of Rad51 is tightly controlled, so as to minimize the use of the sister chromatid as recombination partner. We demonstrated recently that Hed1, a meiosis-specific protein in Saccharomyces cerevisiae, restricts the access of the recombinase accessory factor Rad54 to presynaptic filaments of Rad51. We now show that Hed1 undergoes self-association in a Rad51-dependent manner and binds ssDNA. We also find a strong stabilizing effect of Hed1 on the Rad51 presynaptic filament. Biochemical and genetic analyses of mutants indicate that these Hed1 attributes are germane for its recombination regulatory and Rad51 presynaptic filament stabilization functions. Our results shed light on the mechanism of action of Hed1 in meiotic recombination control.	[Busygina, Valeria; Saro, Dorina; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Williams, Gareth] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Leung, Wing-Kit; Tsubouchi, Hideo] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Say, Amanda F.; Sehorn, Michael G.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA	Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Sussex; Clemson University	Sung, P (corresponding author), Yale Univ, Sch Med Mol Biophys & Biochem, 333 Cedar St,SHM C130A, New Haven, CT 06520 USA.	patrick.sung@yale.edu; h.tsubouchi@sussex.ac.uk		Tsubouchi, Hideo/0000-0003-0814-8432; Leung, Wing-Kit/0000-0003-3039-4904	National Institutes of Health Research [R01ES07061, R01ES015632, R01GM57814, R01GM098510]; Ruth L. Kirschstein National Research Service [GM079816]; Marie Curie Cancer Care Transitional Programme; Clemson University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079816, R01GM057814, R01GM098510] Funding Source: NIH RePORTER; Medical Research Council [G0801130B] Funding Source: researchfish	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Cancer Care Transitional Programme; Clemson University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Research Grants R01ES07061, R01ES015632, and R01GM57814 (to P.S.) and R01GM098510 (to M.G.S.), Ruth L. Kirschstein National Research Service Award GM079816 (to V. B.), Marie Curie Cancer Care Transitional Programme Grant (to H.T.), and by Clemson University (to M.G.S.).	Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Guinier A., 1955, SMALL ANGLE SCATTERI; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Hyppa RW, 2010, CELL, V142, P243, DOI 10.1016/j.cell.2010.05.041; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106	46	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1566	1575		10.1074/jbc.M111.297309	http://dx.doi.org/10.1074/jbc.M111.297309			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22115747	hybrid, Green Published			2022-12-25	WOS:000299170300070
J	Jang, WG; Kim, EJ; Kim, DK; Ryoo, HM; Lee, KB; Kim, SH; Choi, HS; Koh, JT				Jang, Won-Gu; Kim, Eun-Jung; Kim, Don-Kyu; Ryoo, Hyun-Mo; Lee, Keun-Bae; Kim, Sun-Hun; Choi, Hueng-Sik; Koh, Jeong-Tae			BMP2 Protein Regulates Osteocalcin Expression via Runx2-mediated Atf6 Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; IN-VIVO; RECEPTOR; PATHWAY; BINDING; DOMAIN; CELLS; OASIS	Bone morphogenetic protein 2 (BMP2) activates unfolded protein response (UPR) transducers, such as PERK and OASIS, in osteoblast cells. ATF6, a bZIP transcription factor, is also a UPR transducer. However, the involvement of ATF6 in BMP2-induced osteoblast differentiation has not yet been elucidated. In the present study, BMP2 treatment was shown to markedly induce the expression and activation of ATF6 with an increase in alkaline phosphatase (ALP) and OC expression in MC3T3E1 cells. In contrast, ATF6 activation by BMP2 was not observed in the Runx2(-/-) primary calvarial osteoblasts, and Runx2 overexpression recovered BMP2 action. BMP2 stimulated ATF6 transcription by enhancing the direct binding of Runx2 to the osteoblast-specific cis-acting element 2 (OSE2, ACCACA, -205 to -200 bp) motif of the Atf6 promoter region. In addition, the overexpression of ATF6 increased the Oc promoter activity by enhancing the direct binding to a putative ATF6 binding motif (TGACGT, -1126 to -1121 bp). The inhibition of ATF6 function with the dominant negative form of ATF6 (DN-ATF6) blocked BMP2- or Runx2-induced OC expression. Interestingly, OASIS, which is structurally similar to ATF6, did not induce Oc expression. ALP and Alizarin red staining results confirmed that BMP2-induced matrix mineralization was also dependent on ATF6 in vitro. Overall, these results suggest that BMP2 induces osteoblast differentiation through Runx2-dependent ATF6 expression, which directly regulates Oc transcription.	[Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Jang, Won-Gu; Kim, Eun-Jung; Kim, Sun-Hun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Kwangju 500757, South Korea; [Jang, Won-Gu; Kim, Eun-Jung; Kim, Sun-Hun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, BK21, Kwangju 500757, South Korea; [Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Lee, Keun-Bae] Chonnam Natl Univ, Med Sch & Hosp, Dept Orthoped Surg, Kwangju 501746, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea; [Jang, Won-Gu; Kim, Sun-Hun; Koh, Jeong-Tae] Chonnam Natl Univ, Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU); Chonnam National University; Chonnam National University; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr; jtkoh@chonnam.ac.kr	Ryoo, Hyun-Mo/D-5839-2012	Ryoo, Hyun-Mo/0000-0001-6769-8341	National Research Foundation of Korea [2011-0010666, 2011-0030759]; Korea government; Chonnam National University Hospital Research Institute of Clinical Medicine [CRI 11-078-22]; Korean Ministry of Education; National Research Foundation of Korea; Ministry of Education, Science and Technology [20100019512]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); Chonnam National University Hospital Research Institute of Clinical Medicine; Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Research Foundation of Korea Grants 2011-0010666 and 2011-0030759 funded by the Korea government and Chonnam National University Hospital Research Institute of Clinical Medicine Grant CRI 11-078-22 (to J.-T.K.) and partly supported by the National Creative Research Initiatives Grant from the Korean Ministry of Education and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology Grant 20100019512 (to H.-S.C.).	Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Gouveia CH, 2001, J ENDOCRINOL, V170, P667, DOI 10.1677/joe.0.1700667; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori Toshihisa, 2006, Clin Calcium, V16, P801; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; LIAN JB, 1993, J CELL BIOCHEM, V52, P206, DOI 10.1002/jcb.240520212; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; NAKASE T, 1994, BONE MINER, V26, P109, DOI 10.1016/S0169-6009(08)80056-6; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shin CS, 2006, J MOL ENDOCRINOL, V36, P531, DOI 10.1677/jme.1.01944; Sims NA, 1997, MOL ENDOCRINOL, V11, P1695, DOI 10.1210/me.11.11.1695; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	39	125	131	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					905	915		10.1074/jbc.M111.253187	http://dx.doi.org/10.1074/jbc.M111.253187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102412	Green Published, hybrid			2022-12-25	WOS:000299170300009
J	Schmucker, AC; Wright, JB; Cole, MD; Brinckerhoff, CE				Schmucker, Adam C.; Wright, Jason B.; Cole, Michael D.; Brinckerhoff, Constance E.			Distal Interleukin-1 beta (IL-1 beta) Response Element of Human Matrix Metalloproteinase-13 (MMP-13) Binds Activator Protein 1 (AP-1) Transcription Factors and Regulates Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLLAGENASE-3 GENE; RETINOID-X-RECEPTOR; HUMAN GENOME; CHONDROCYTES; CLONING; CARTILAGE; DISTINCT; P38	The collagenase matrix metalloproteinase-13 (MMP-13) plays an important role in the destruction of cartilage in arthritic joints. MMP-13 expression is strongly up-regulated in arthritis, largely because of stimulation by inflammatory cytokines such as IL-1 beta. Treatment of chondrocytes with IL-1 beta induces transcription of MMP-13 in vitro. IL-1 beta signaling converges upon the activator protein-1 transcription factors, which have been shown to be required for IL-1 beta-induced MMP-13 gene expression. Using chromatin immunoprecipitation (ChIP), we detected activator protein-1 binding within an evolutionarily conserved DNA sequence similar to 20 kb 5' relative to the MMP-13 transcription start site (TSS). Also using ChIP, we detected histone modifications and binding of RNA polymerase II within this conserved region, all of which are consistent with transcriptional activation. Chromosome conformation capture indicates that chromosome looping brings this region in close proximity with the MMP-13 TSS. Finally, a luciferase reporter construct driven by a component of the conserved region demonstrated an expression pattern similar to that of endogenous MMP-13. These data suggest that a conserved region at 20 kb upstream from the MMP-13 TSS includes a distal transcriptional response element of MMP-13, which contributes to MMP-13 gene expression.	[Schmucker, Adam C.; Brinckerhoff, Constance E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Wright, Jason B.; Cole, Michael D.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Brinckerhoff, Constance E.] Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Schmucker, AC (corresponding author), Dartmouth Med Sch, Dept Med, 1 Med Ctr Dr,Rubin Bldg,HB 7936, Lebanon, NH 03756 USA.	brinckerhoff@dartmouth.edu			National Institutes of Health [AR-26599, CA-77267, T32-AR-007576, CA-080320]; NATIONAL CANCER INSTITUTE [R01CA080320, R01CA077267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR026599, T32AR007576, R01AR026599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-26599, CA-77267 (to C. E. B.), T32-AR-007576 (to A. C. S.), and CA-080320 (to M. D. C.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Burrage PS, 2007, ARTHRITIS RHEUM-US, V56, P892, DOI 10.1002/art.22417; Burrage PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2564; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caron JP, 1996, AM J VET RES, V57, P1631; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S; Sakabe NJ, 2010, WIRES SYST BIOL MED, V2, P422, DOI 10.1002/wsbm.70; Tardif G, 1997, BIOCHEM J, V323, P13, DOI 10.1042/bj3230013; Tardif Ginette, 2004, Mod Rheumatol, V14, P197; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vincenti MP, 1998, BIOCHEM J, V331, P341, DOI 10.1042/bj3310341	23	17	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1189	1197		10.1074/jbc.M111.264077	http://dx.doi.org/10.1074/jbc.M111.264077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102411	hybrid, Green Published			2022-12-25	WOS:000299170300034
J	Djouaka, R; Irving, H; Tukur, Z; Wondji, CS				Djouaka, Rousseau; Irving, Helen; Tukur, Zainab; Wondji, Charles S.			Exploring Mechanisms of Multiple Insecticide Resistance in a Population of the Malaria Vector Anopheles funestus in Benin	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; PYRETHROID RESISTANCE; KNOCKDOWN RESISTANCE; GAMBIAE; DIPTERA; CULICIDAE; MUTATION; DDT; IDENTIFICATION; EXPRESSION	Background: The insecticide resistance status of the malaria vector Anopheles funestus and the underlying resistance mechanisms remain uncharacterised in many parts of Africa, notably in Benin, West Africa. To fill this gap in our knowledge, we assessed the susceptibility status of a population of this species in Pahou, Southern Benin and investigated the potential resistance mechanisms. Methodology/Principal Findings: WHO bioassays revealed a multiple resistance profile for An. funestus in Pahou. This population is highly resistant to DDT with no mortality in females after 1h exposure to 4% DDT. Resistance was observed against the Type I pyrethroid permethrin and the carbamate bendiocarb. A moderate resistance was detected against deltamethrin (type II pyrethroids). A total susceptibility was observed against malathion, an organophosphate. Pre-exposure to PBO did not change the mortality rates for DDT indicating that cytochrome P450s play no role in DDT resistance in Pahou. No L1014F kdr mutation was detected but a correlation between haplotypes of two fragments of the Voltage-Gated Sodium Channel gene and resistance was observed suggesting that mutations in other exons may confer the knockdown resistance in this species. Biochemical assays revealed elevated levels of GSTs and cytochrome mono-oxygenases in Pahou. No G119S mutation and no altered acetylcholinesterase gene were detected in the Pahou population. qPCR analysis of five detoxification genes revealed that the GSTe2 is associated to the DDT resistance in this population with a significantly higher expression in DDT resistant samples. A significant over-expression of CYP6P9a and CYP6P9b previously associated with pyrethroid resistance was also seen but at a lower fold change than in southern Africa. Conclusion: The multiple insecticide resistance profile of this An. funestus population in Benin shows that more attention should be paid to this important malaria vector for the implementation and management of current and future malaria vector control programs in this country.	[Djouaka, Rousseau] Int Inst Trop Agr, Cotonou, Benin; [Irving, Helen; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Tukur, Zainab] Bayero Univ, Kano, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool; Bayero University	Djouaka, R (corresponding author), Int Inst Trop Agr, Cotonou, Benin.	c.s.wondji@liverpool.ac.uk	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673	Wellcome Trust [083515/Z/07/Z]	Wellcome Trust(Wellcome Trust)	This work was funded by a Wellcome Trust Research Career Development Fellowship 083515/Z/07/Z to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; CORBEL V, 2007, ACTA TROP; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djogbenou L, 2010, MED VET ENTOMOL; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Gillies MT, 1987, ANOPHELINAE AFRICA S, P143; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Koekemoer LL, 2006, J MED ENTOMOL, V43, P1178, DOI 10.1603/0022-2585(2006)43[1178:IOTRVO]2.0.CO;2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; *WHO, 1998, WHOCDSCPCMAL9812D; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2008, TROP MED INT HEALTH, V13, P548, DOI 10.1111/j.1365-3156.2008.02033.x; Wondji CS, 2011, INSECT BIOCHEM MOLEC, V41, P484, DOI 10.1016/j.ibmb.2011.03.012; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	36	56	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27760	10.1371/journal.pone.0027760	http://dx.doi.org/10.1371/journal.pone.0027760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110757	gold, Green Published, Green Accepted			2022-12-25	WOS:000297555400107
J	Lublin, A; Isoda, F; Patel, H; Yen, K; Nguyen, L; Hajje, D; Schwartz, M; Mobbs, C				Lublin, Alex; Isoda, Fumiko; Patel, Harshil; Yen, Kelvin; Nguyen, Linda; Hajje, Daher; Schwartz, Marc; Mobbs, Charles			FDA-Approved Drugs that Protect Mammalian Neurons from Glucose Toxicity Slow Aging Dependent on Cbp and Protect Against Proteotoxicity	PLOS ONE			English	Article							BETA-AMYLOID PEPTIDE; EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; C-ELEGANS; PARKINSONS-DISEASE; GENETIC MECHANISMS; RESTRICTION; EXPRESSION; MODEL	Screening a library of drugs with known safety profiles in humans yielded 30 drugs that reliably protected mammalian neurons against glucose toxicity. Subsequent screening demonstrated that 6 of these 30 drugs increase lifespan in C. elegans: caffeine, ciclopirox olamine, tannic acid, acetaminophen, bacitracin, and baicalein. Every drug significantly reduced the age-dependent acceleration of mortality rate. These protective effects were blocked by RNAi inhibition of cbp-1 in adults only, which also blocks protective effects of dietary restriction. Only 2 drugs, caffeine and tannic acid, exhibited a similar dependency on DAF-16. Caffeine, tannic acid, and bacitracin also reduced pathology in a transgenic model of proteotoxicity associated with Alzheimer's disease. These results further support a key role for glucose toxicity in driving age-related pathologies and for CBP-1 in protection against age-related pathologies. These results also provide novel lead compounds with known safety profiles in human for treatment of age-related diseases, including Alzheimer's disease and diabetic complications.	[Lublin, Alex; Isoda, Fumiko; Nguyen, Linda; Hajje, Daher; Schwartz, Marc; Mobbs, Charles] Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY 10029 USA; [Yen, Kelvin] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA	Icahn School of Medicine at Mount Sinai; University of Massachusetts System; University of Massachusetts Worcester	Lublin, A (corresponding author), Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY 10029 USA.	charles.mobbs@mssm.edu	Yen, Kelvin/J-5378-2019	Yen, Kelvin/0000-0003-4595-971X; Mobbs, Charles/0000-0002-5815-8711	National Institutes of Health [1R01HD060914-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the National Institutes of Health, grant 1R01HD060914-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; CIRO A, 2011, CURR ALZHEIMER RES; Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525; Cui LL, 2010, PHARMACOL BIOCHEM BE, V96, P469, DOI 10.1016/j.pbb.2010.07.007; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Grant MM, 2005, PROTEOMICS, V5, P534, DOI 10.1002/pmic.200300924; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kullyev A, 2010, GENETICS, V186, P929, DOI 10.1534/genetics.110.118877; Lebeau A, 2001, NEUROREPORT, V12, P2199, DOI 10.1097/00001756-200107200-00031; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Santos C, 2010, J ALZHEIMERS DIS, V20, pS187, DOI 10.3233/JAD-2010-091387; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Tripathy D, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-10; Tripathy D, 2009, MICROVASC RES, V77, P289, DOI 10.1016/j.mvr.2009.02.002; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xu K, 2010, NEUROSCIENCE, V167, P475, DOI 10.1016/j.neuroscience.2010.02.020; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Yazawa K, 2006, FEBS LETT, V580, P6623, DOI 10.1016/j.febslet.2006.11.011; Yen K, 2008, EXP GERONTOL, V43, P1058, DOI 10.1016/j.exger.2008.08.048; Yen K, 2010, AGE, V32, P39, DOI 10.1007/s11357-009-9110-7; Yen K, 2008, EXP GERONTOL, V43, P1044, DOI 10.1016/j.exger.2008.09.006; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	35	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27762	10.1371/journal.pone.0027762	http://dx.doi.org/10.1371/journal.pone.0027762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114686	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400109
J	Nawroth, R; Stellwagen, F; Schulz, WA; Stoehr, R; Hartmann, A; Krause, BJ; Gschwend, JE; Retz, M				Nawroth, Roman; Stellwagen, Florian; Schulz, Wolfgang A.; Stoehr, Robert; Hartmann, Arndt; Krause, Bernd J.; Gschwend, Juergen E.; Retz, Margitta			S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; IN-VIVO; MTOR; PI3K; CARCINOMA; KINASE; RAS; AKT	Aberrant activation and mutation status of proteins in the phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) and the mitogen activated protein kinase (MAPK) signaling pathways have been linked to tumorigenesis in various tumors including urothelial carcinoma (UC). However, anti-tumor therapy with small molecule inhibitors against mTOR turned out to be less successful than expected. We characterized the molecular mechanism of this pathway in urothelial carcinoma by interfering with different molecular components using small chemical inhibitors and siRNA technology and analyzed effects on the molecular activation status, cell growth, proliferation and apoptosis. In a majority of tested cell lines constitutive activation of the PI3K was observed. Manipulation of mTOR or Akt expression or activity only regulated phosphorylation of S6K1 but not 4E-BP1. Instead, we provide evidence for an alternative mTOR independent but PI3K dependent regulation of 4E-BP1. Only the simultaneous inhibition of both S6K1 and 4E-BP1 suppressed cell growth efficiently. Crosstalk between PI3K and the MAPK signaling pathway is mediated via PI3K and indirect by S6K1 activity. Inhibition of MEK1/2 results in activation of Akt but not mTOR/S6K1 or 4E-BP1. Our data suggest that 4E-BP1 is a potential new target molecule and stratification marker for anti cancer therapy in UC and support the consideration of a multi-targeting approach against PI3K, mTORC1/2 and MAPK.	[Nawroth, Roman; Stellwagen, Florian; Gschwend, Juergen E.; Retz, Margitta] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-8000 Munich, Germany; [Stoehr, Robert; Hartmann, Arndt] Univ Hosp Erlangen, Dept Pathol, Erlangen, Germany; [Schulz, Wolfgang A.] Univ Dusseldorf, Dept Urol, Dusseldorf, Germany; [Krause, Bernd J.] Univ Rostock, Dept Nucl Med, Rostock, Germany	Technical University of Munich; University of Erlangen Nuremberg; Heinrich Heine University Dusseldorf; University of Rostock	Nawroth, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-8000 Munich, Germany.	roman.nawroth@lrz.tum.de	Schulz, Wolfgang/N-3402-2019	Schulz, Wolfgang/0000-0002-2196-463X	Siegfried Gruber Foundation	Siegfried Gruber Foundation	The study was supported by the Siegfried Gruber Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI X, 2009, CELL MOL LIFE SCI; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Cheng LA, 2010, EXPERT REV ANTICANC, V10, P865, DOI 10.1586/era.10.73; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Ehdaie Behfar, 2009, Can Urol Assoc J, V3, pS232; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fechner G, 2009, UROLOGY, V73, P665, DOI 10.1016/j.urology.2008.09.070; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gomez-Roman JJ, 2005, CLIN CANCER RES, V11, P459; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hautmann RE, 2006, J UROLOGY, V176, P486, DOI 10.1016/j.juro.2006.03.038; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim IA, 2005, CANCER RES, V65, P7902, DOI 10.1158/0008-5472.CAN-05-0513; KNOWLES MA, 2009, CANC METASTASIS REV; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Le Tourneau C, 2008, BRIT J CANCER, V99, P1197, DOI 10.1038/sj.bjc.6604636; Li C, 2005, BRIT J CANCER, V92, P80, DOI 10.1038/sj.bjc.6602272; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schultz L, 2010, CANCER-AM CANCER SOC, V116, P5517, DOI 10.1002/cncr.25502; Seager CM, 2009, CANCER PREV RES, V2, P1008, DOI 10.1158/1940-6207.CAPR-09-0169; Seront E, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4622; Seront E, 2010, J CLIN ONCOL, V28; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Willett M, 2009, CELL SIGNAL, V21, P1504, DOI 10.1016/j.cellsig.2009.05.009; Wu DY, 2011, UROL INT, V86, P346, DOI 10.1159/000322986; Wu X, 2004, BJU INT, V93, P143, DOI 10.1111/j.1464-410X.2004.04574.x; Wu XR, 2009, CANCER METAST REV, V28, P281, DOI 10.1007/s10555-009-9189-4; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200; Zachos I, 2010, EXPERT OPIN INV DRUG, V19, P875, DOI 10.1517/13543784.2010.496450; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	56	70	71	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27509	10.1371/journal.pone.0027509	http://dx.doi.org/10.1371/journal.pone.0027509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110663	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555300026
J	Gotte, DR; Benestad, SL; Laude, H; Zurbriggen, A; Oevermann, A; Seuberlich, T				Goette, Dorothea R.; Benestad, Sylvie L.; Laude, Hubert; Zurbriggen, Andreas; Oevermann, Anna; Seuberlich, Torsten			Atypical Scrapie Isolates Involve a Uniform Prion Species with a Complex Molecular Signature	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SHEEP SCRAPIE; NORMAL BRAIN; PROTEIN; PRP; DISEASE; STRAINS; TRANSMISSION; AGENT; GENOTYPE	The pathobiology of atypical scrapie, a prion disease affecting sheep and goats, is still poorly understood. In a previous study, we demonstrated that atypical scrapie affecting small ruminants in Switzerland differs in the neuroanatomical distribution of the pathological prion protein (PrPd). To investigate whether these differences depend on host-related vs. pathogen-related factors, we transmitted atypical scrapie to transgenic mice over-expressing the ovine prion protein (tg338). The clinical, neuropathological, and molecular phenotype of tg338 mice is similar between mice carrying the Swiss atypical scrapie isolates and the Nor98, an atypical scrapie isolate from Norway. Together with published data, our results suggest that atypical scrapie is caused by a uniform type of prion, and that the observed phenotypic differences in small ruminants are likely host-dependant. Strikingly, by using a refined SDS-PAGE technique, we established that the prominent proteinase K-resistant prion protein fragment in atypical scrapie consists of two separate, unglycosylated peptides with molecular masses of roughly 5 and 8 kDa. These findings show similarities to those for other prion diseases in animals and humans, and lay the groundwork for future comparative research.	[Goette, Dorothea R.; Zurbriggen, Andreas; Oevermann, Anna; Seuberlich, Torsten] Univ Bern, NeuroCtr, Natl & OIE Reference Labs BSE & Scrapie, Div Expt Clin Res,Vetsuisse Fac, Bern, Switzerland; [Benestad, Sylvie L.] Norwegian Vet Inst, Dept Pathol, Oslo, Norway; [Laude, Hubert] INRA, Virol Immunol Mol 3U892, Jouy En Josas, France	University of Bern; Norwegian Veterinary Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gotte, DR (corresponding author), Univ Bern, NeuroCtr, Natl & OIE Reference Labs BSE & Scrapie, Div Expt Clin Res,Vetsuisse Fac, Bern, Switzerland.	torsten.seuberlich@vetsuisse.unibe.ch		Oevermann, Anna/0000-0002-3569-8547	Swiss Federal Veterinary Office [1.08.13]	Swiss Federal Veterinary Office	This study was funded by the Swiss Federal Veterinary Office (grant #1.08.13.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arsac JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007300; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bouzalas IG, 2011, J CLIN MICROBIOL, V49, P2109, DOI 10.1128/JCM.02033-10; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Bruce Moira E., 1996, P223; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; DICKINSON AG, 1977, SLOW VIRUS INFECTION, P3; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Everest SJ, 2006, J GEN VIROL, V87, P471, DOI 10.1099/vir.0.81539-0; Fediaevsky A, 2010, VET J, V185, P338, DOI 10.1016/j.tvjl.2009.06.019; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gonzalez L, 2010, J GEN VIROL, V91, P2630, DOI 10.1099/vir.0.022574-0; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Griffiths PC, 2010, J GEN VIROL, V91, P2132, DOI 10.1099/vir.0.018986-0; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Krebs B, 2007, ACTA NEUROPATHOL, V114, P195, DOI 10.1007/s00401-007-0242-5; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Langeveld JPM, 2011, J CLIN MICROBIOL, V49, P3026, DOI 10.1128/JCM.01102-11; Laude H, 2002, CR BIOL, V325, P49, DOI 10.1016/S1631-0691(02)01393-8; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Nentwig A, 2007, PLOS PATHOG, V3, P743, DOI 10.1371/journal.ppat.0030082; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rodriguez-Martinez AB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-17; Schneider K, 2008, BRAIN RES BULL, V77, P343, DOI 10.1016/j.brainresbull.2008.09.012; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; Simmons MM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-14; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Wemheuer WM, 2009, VET REC, V164, P677, DOI 10.1136/vr.164.22.677; Wemheuer WM, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-32; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	42	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27510	10.1371/journal.pone.0027510	http://dx.doi.org/10.1371/journal.pone.0027510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096587	Green Published, gold			2022-12-25	WOS:000297553900055
J	Ye, DZ; Jin, SH; Zhuo, Y; Field, J				Ye, Diana Z.; Jin, Shenghao; Zhuo, Ya; Field, Jeffrey			p21-Activated Kinase 1 (Pak1) Phosphorylates BAD Directly at Serine 111 In Vitro and Indirectly through Raf-1 at Serine 112	PLOS ONE			English	Article							DEATH AGONIST BAD; PROTEIN-KINASE; CELL-DEATH; INHIBITS APOPTOSIS; SIGNALING PATHWAY; SURVIVAL; RAS; TARGETS; MITOCHONDRIA; ACTIVATION	Background: Cell survival depends on the balance between protective and apoptotic signals. When the balance of signals tips towards apoptosis, cells undergo programmed cell death. This balance has profound implications in diseases including cancer. Oncogenes and tumor suppressors are mutated to promote cell survival during tumor development, and many chemotherapeutic drugs kill tumor cells by stimulating apoptosis. BAD is a pro-apoptotic member of the Bcl-2 family of proteins, which can be phosphorylated on numerous sites to modulate binding to Bcl-2 and 14-3-3 proteins and inhibit its pro-apoptotic activities. One of the critical phosphorylation sites is the serine 112 (S112), which can be phosphorylated by several kinases including Pak1. Methodology/Principal Findings: We mapped the Pak phosphorylation sites by making serine to alanine mutations in BAD and testing them as substrates in in vitro kinase assays. We found that the primary phosphorylation site is not S112 but serine 111 (S111), a site that is sometimes found phosphorylated in vivo. In transfection assays of HEK293T cells, we showed that Pak1 required Raf-1 to stimulate phosphorylation on S112. Mutating either S111 or S112 to alanine enhanced binding to Bcl-2, but the double mutant S111/112A bound better to Bcl-2. Moreover, BAD phosphorylation at S111 was observed in several other cell lines, and treating one of them with the Pak1 inhibitor 2,2'-Dihydroxy-1,1'-dinaphthyldisulfide (IPA-3) reduced phosphorylation primarily at S112 and to a smaller extent at S111, while Raf inhibitors only reduced phosphorylation at S112. Conclusion/Significance: Together, these findings demonstrate that Pak1 phosphorylates BAD directly at S111, but phosphorylated S112 through Raf-1. These two sites of BAD serve as redundant regulatory sites for Bcl-2 binding.	[Ye, Diana Z.; Jin, Shenghao; Zhuo, Ya; Field, Jeffrey] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Ye, DZ (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.	jfield@upenn.edu			NIH [GM48241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048241] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (GM48241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Baccarini M, 2002, CELL DEATH DIFFER, V9, P783, DOI 10.1038/sj.cdd.4401070; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hindley A, 2002, J CELL SCI, V115, P1575; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Menard RE, 2005, NEOPLASIA, V7, P638, DOI 10.1593/neo.04736; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PETER VH, 2004, PROTEOMICS, V4, P1551; Polzien L, 2009, J BIOL CHEM, V284, P28004, DOI 10.1074/jbc.M109.010702; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wu XC, 2008, J CELL BIOCHEM, V105, P167, DOI 10.1002/jcb.21809; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004	49	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27637	10.1371/journal.pone.0027637	http://dx.doi.org/10.1371/journal.pone.0027637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096607	gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900066
J	Geula, S; Naveed, H; Liang, J; Shoshan-Barmatz, V				Geula, Shay; Naveed, Hammad; Liang, Jie; Shoshan-Barmatz, Varda			Structure-based Analysis of VDAC1 Protein DEFINING OLIGOMER CONTACT SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; MITOCHONDRIAL OUTER-MEMBRANE; PEPTIDE-SPECIFIC ANTIBODIES; CYTOCHROME-C RELEASE; CELL-DEATH; SELECTIVE CHANNEL; NEUROSPORA-CRASSA; CRYSTAL-STRUCTURE; APOPTOSIS; TOPOLOGY	The outer mitochondrial membrane protein, the voltage-dependent anion channel (VDAC), is increasingly implicated in the control of apoptosis. Oligomeric assembly of VDAC1 was shown to be coupled to apoptosis induction, with oligomerization increasing substantially upon apoptosis induction and inhibited by apoptosis blockers. In this study, structure-and computation-based selection of the predicated VDAC1 dimerization site, in combination with site-directed mutagenesis, cysteine replacement, and chemical cross-linking, were employed to identify contact sites between VDAC1 molecules in dimers and higher oligomers. The predicted weakly stable beta-strands were experimentally found to represent the interfaces between VDAC1 monomers composing the oligomer. Replacing hydrophobic amino acids with charged residues in beta-strands 1, 2, and 19 interfered with VDAC1 oligomerization. The proximity of beta-strands 1, 2, and 19 within the VDAC1 dimer and the existence of other association sites involving beta-strand 16 were confirmed when a cysteine was introduced at defined positions in cysteineless VDAC1 mutants, together with the use of cysteine-specific cross-linker bis(maleimido) ethane. Moreover, the results suggest that VDAC1 also exists as a dimer that upon apoptosis induction undergoes conformational changes and that its oligomerization proceeds through a series of interactions involving two distinct interfaces. Dissection of VDAC1 dimerization/oligomerization as presented here provides structural insight into the oligomeric status of cellular VDAC1 under physiological and apoptotic conditions.	[Geula, Shay; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Geula, Shay; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Naveed, Hammad; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	Ben Gurion University; Ben Gurion University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	Geula, Shay Yosef/Z-3789-2019; Naveed, Hammad/N-8851-2013	Geula, Shay Yosef/0000-0001-8111-4410; 	Israel Science Foundation [649/09]; Div Of Biological Infrastructure [1062328] Funding Source: National Science Foundation	Israel Science Foundation(Israel Science Foundation); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Israel Science Foundation Grant 649/09.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Granville DJ, 2003, CURR MED CHEM, V10, P1527, DOI 10.2174/0929867033457214; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Jimenez-Morales D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026400; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; MANNELLA CA, 1983, P NATL ACAD SCI-BIOL, V80, P2243, DOI 10.1073/pnas.80.8.2243; Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356	38	54	55	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2179	2190		10.1074/jbc.M111.268920	http://dx.doi.org/10.1074/jbc.M111.268920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117062	Green Published, hybrid			2022-12-25	WOS:000299321000057
J	Porotto, M; Palmer, SG; Palermo, LM; Moscona, A				Porotto, Matteo; Palmer, Samantha G.; Palermo, Laura M.; Moscona, Anne			Mechanism of Fusion Triggering by Human Parainfluenza Virus Type III COMMUNICATION BETWEEN VIRAL GLYCOPROTEINS DURING ENTRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION ANALYSIS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; RECEPTOR-BINDING; PARAMYXOVIRUS FUSION; MEMBRANE-FUSION; MEASLES-VIRUS; CELL-FUSION; HN PROTEIN; F-PROTEIN; N-GLYCANS	Parainfluenza viruses enter host cells by fusing the viral and target cell membranes via concerted action of their two envelope glycoproteins: the hemagglutinin-neuraminidase (HN) and the fusion protein (F). Receptor-bound HN triggers F to undergo conformational changes that render it fusion-competent. To address the role of receptor engagement and to elucidate how HN and F interact during the fusion process, we used bimolecular fluorescence complementation to follow the dynamics of human parainfluenza virus type 3 (HPIV3) HN/F pairs in living cells. We show that HN and F associate before receptor engagement. HN drives the formation of HN-F clusters at the site of fusion, and alterations in HN-F interaction determine the fusogenicity of the glycoprotein pair. An interactive site, at the HN dimer interface modulates HN fusion activation property, which is critical for infection of the natural host. This first evidence for the sequence of initial events that lead to viral entry may indicate a new paradigm for understanding Paramyxovirus infection.	[Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University	Moscona, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, 515 E 71st St,Box 309, New York, NY 10021 USA.	anm2047@med.cornell.edu		POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health [R01AI31971, 3R01AI031971-19S1, U54AI057158, P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031971, U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI31971 (to A. M.), 3R01AI031971-19S1 (Research Supplement to Promote Diversity in Health-Related Research Program; to A. M.), and U54AI057158 (Northeast Center of Excellence for Biodefense and Emerging Infectious Disease Research (NIAID; to M. P. and A. M. (Principal Investigator of Center of Excellence grant to W. I. Lipkin)).; We are grateful to Ashton Kutcher and Jonathan Ledecky for support without which the microscopy critical to this work would not have been possible, to Dan and Nancy Paduano for their essential support of innovative research projects, and to the Friedman Family Foundation for our laboratories at Weill Cornell Medical College. We thank Tim McGraw for helpful scientific discussions and advice, Eric M. Jurgens for help with statistical analysis, and Christine C. Yokoyama for critical reading of the manuscript. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081). We acknowledge the Northeast Center of Excellence for Bio-defense and Emerging Infections Disease Research Proteomics Core for peptide synthesis and purification.	Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Corey EA, 2007, J VIROL, V81, P9900, DOI 10.1128/JVI.00909-07; Dutch RE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000881; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Farzan SF, 2011, J BIOL CHEM, V286, P37945, DOI 10.1074/jbc.M111.256248; Greengard O, 2000, J VIROL, V74, P11108, DOI 10.1128/JVI.74.23.11108-11114.2000; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Li JR, 2004, J VIROL, V78, P5299, DOI 10.1128/JVI.78.10.5299-5310.2004; Lin HP, 2010, BIOL CELL, V102, P525, DOI 10.1042/BC20100033; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mahon PJ, 2008, J VIROL, V82, P10386, DOI 10.1128/JVI.00581-08; Mahon PJ, 2011, J VIROL, V85, P12079, DOI 10.1128/JVI.05679-11; Maurer UE, 2008, P NATL ACAD SCI USA, V105, P10559, DOI 10.1073/pnas.0801674105; MCKIMMBRESCHKIN JL, 1990, J IMMUNOL METHODS, V135, P277, DOI 10.1016/0022-1759(90)90282-Z; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; Moscona A, 2005, J CLIN INVEST, V115, P1688, DOI 10.1172/JCI25669; MOSCONA A, 1993, J VIROL, V67, P6463, DOI 10.1128/JVI.67.11.6463-6468.1993; Ottmann C, 2009, BIOL CHEM, V390, P81, DOI 10.1515/BC.2009.008; Palermo LM, 2007, J VIROL, V81, P9152, DOI 10.1128/JVI.00888-07; Palermo LM, 2009, J VIROL, V83, P6900, DOI 10.1128/JVI.00475-09; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; Popa A, 2011, BIOCHEMISTRY-US, V50, P945, DOI 10.1021/bi101597k; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Porotto M, 2011, J VIROL, V85, P12867, DOI 10.1128/JVI.05873-11; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Robach JG, 2010, VIROLOGY, V406, P189, DOI 10.1016/j.virol.2010.06.049; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Saphire EO, 2011, NAT STRUCT MOL BIOL, V18, P115, DOI 10.1038/nsmb0211-115; SCHEID A, 1974, VIROLOGY, V57, P475, DOI 10.1016/0042-6822(74)90187-1; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Vigant Frederic, 2011, Infectious Disorders - Drug Targets, V11, P315; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	53	54	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					778	793		10.1074/jbc.M111.298059	http://dx.doi.org/10.1074/jbc.M111.298059			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22110138	Green Published, hybrid			2022-12-25	WOS:000298682400075
J	Schnitger, AKD; Machova, A; Mueller, RU; Androulidaki, A; Schermer, B; Pasparakis, M; Kronke, M; Papadopoulou, N				Schnitger, Anna K. D.; Machova, Alzbeta; Mueller, Roman Ulrich; Androulidaki, Ariadne; Schermer, Bernhard; Pasparakis, Manolis; Kroenke, Martin; Papadopoulou, Nikoletta			Listeria monocytogenes Infection in Macrophages Induces Vacuolar-Dependent Host miRNA Response	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IMMUNE-RESPONSES; MICRORNA; INNATE; EXPRESSION; INDUCTION; MIR-155; STIMULATION; RECOGNITION; REGULATORS	Listeria monocytogenes is a Gram-positive facultative intracellular pathogen, causing serious illness in immunocompromised individuals and pregnant women. Upon detection by macrophages, which are key players of the innate immune response against infection, L. monocytogenes induces specific host cell responses which need to be tightly controlled at transcriptional and post-transcriptional levels. Here, we ask whether and how host miRNAs, which represent an important mechanism of post-transcriptional regulation in a wide array of biological processes, are altered by a model pathogen upon live infection of murine bone marrow derived macrophages. We first report that L. monocytogenes subverts the host genome-wide miRNA profile of macrophages in vitro. Specifically, we show that miR-155, miR-146a, miR-125a-3p/5p and miR-149 were amongst the most significantly regulated miRNAs in infected macrophages. Strikingly, these miRNAs were highly upregulated upon infection with the Listeriolysin-deficient L. monocytogenes mutant Delta hly, that cannot escape from the phagosome thus representing a vacuolar-contained infection. The vacuolar miRNA response was significantly reduced in macrophages deficient for MyD88. In addition, miR-146a and miR-125a-3p/5p were regulated at transcriptional levels upon infection, and miR-125a-3p/5p were found to be TLR2 responsive. Furthermore, miR-155 transactivation in infection was regulated by NF-kappa B p65, while miR-146a and miR-125a-3p/5p expression was unaffected in p65-deficient primary macrophages upon L. monocytogenes infection. Our results demonstrate that L. monocytogenes promotes significant changes in the miRNA expression profile in macrophages, and reveal a vacuolar-dependent miRNA signature, listeriolysin-independent and MyD88-dependent. These miRNAs are predicted to target immune genes and are therefore most likely involved in regulation of the macrophage innate immune response against infection at post-transcriptional levels.	[Schnitger, Anna K. D.; Machova, Alzbeta; Kroenke, Martin; Papadopoulou, Nikoletta] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Mueller, Roman Ulrich; Schermer, Bernhard] Univ Cologne, Dept Med, Cologne, Germany; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-5000 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Schnitger, AKD (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany.	nikol.papadopoulou@uni-koeln.de	Schermer, Bernhard/E-9972-2014; Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019; Müller, Roman-Ulrich/AAK-3493-2021	Schermer, Bernhard/0000-0002-5194-9000; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Müller, Roman-Ulrich/0000-0001-6910-0745	University of Cologne	University of Cologne	This work was supported by funds from the University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Peters C, 2003, FEMS IMMUNOL MED MIC, V35, P243, DOI 10.1016/S0928-8244(02)00469-8; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Schuster L, 2011, ETHNIC RACIAL STUD, V34, P1392, DOI 10.1080/01419870.2010.535550; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	49	62	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27435	10.1371/journal.pone.0027435	http://dx.doi.org/10.1371/journal.pone.0027435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114673	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555800021
J	Vaz, C; Mer, AS; Bhattacharya, A; Ramaswamy, R				Vaz, Candida; Mer, Arvind Singh; Bhattacharya, Alok; Ramaswamy, Ramakrishna			MicroRNAs Modulate the Dynamics of the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; TEMPORAL CONTROL; IMMUNE-SYSTEM; OSCILLATIONS; ACTIVATION; INDUCTION; ALPHA; CELLS; MECHANISMS	Background: NF-kappa B, a major transcription factor involved in mammalian inflammatory signaling, is primarily involved in regulation of response to inflammatory cytokines and pathogens. Its levels are tightly regulated since uncontrolled inflammatory response can cause serious diseases. Mathematical models have been useful in revealing the underlying mechanisms, the dynamics, and other aspects of regulation in NF-kappa B signaling. The recognition that miRNAs are important regulators of gene expression, and that a number of miRNAs target different components of the NF-kappa B network, motivate the incorporation of miRNA regulated steps in existing mathematical models to help understand the quantitative aspects of miRNA mediated regulation. Methodology/Principal findings: In this study, two separate scenarios of miRNA regulation within an existing model are considered. In the first, miRNAs target adaptor proteins involved in the synthesis of IKK that serves as the NF-kappa B activator. In the second, miRNAs target different isoforms of I kappa B that act as NF-kappa B inhibitors. Simulations are carried out under two different conditions: when all three isoforms of IkB are present (wild type), and when only one isoform (I kappa B alpha) is present (knockout type). In both scenarios, oscillations in the NF-kappa B levels are observed and are found to be dependent on the levels of miRNAs. Conclusions/Significance: Computational modeling can provide fresh insights into intricate regulatory processes. The introduction of miRNAs affects the dynamics of the NF-kappa B signaling pathway in a manner that depends on the role of the target. This "fine-tuning" property of miRNAs helps to keep the system in check and prevents it from becoming uncontrolled. The results are consistent with earlier experimental findings.	[Vaz, Candida; Mer, Arvind Singh; Bhattacharya, Alok; Ramaswamy, Ramakrishna] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Ramaswamy, Ramakrishna] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Vaz, C (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	r.ramaswamy@gmail.com	Vaz, Candida/HHZ-7196-2022; Ramaswamy, Ramakrishna/L-5306-2019	Ramaswamy, Ramakrishna/0000-0002-9085-8224; Vaz, Candida/0000-0002-6650-7889	Council for Scientific and Industrial Research (CSIR) [9/263/(0772)/9]	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Funding provided by the Council for Scientific and Industrial Research (CSIR) http://csirhrdg.res.in/. CV acknowledges fellowship support from CSIR (CSIR Senior Research Fellowship award no: 9/263/(0772)/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Khanin R, 2008, J COMPUT BIOL, V15, P305, DOI 10.1089/cmb.2007.0184; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	38	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27774	10.1371/journal.pone.0027774	http://dx.doi.org/10.1371/journal.pone.0027774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114691	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555800035
J	Bowen, MT; Carson, DS; Spiro, A; Arnold, JC; McGregor, IS				Bowen, Michael T.; Carson, Dean S.; Spiro, Adena; Arnold, Jonathon C.; McGregor, Iain S.			Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; BLOOD-PRESSURE; STRUCTURAL PLASTICITY; SUPRAOPTIC NUCLEUS; OPEN-FIELD; NEUROHYPOPHYSEAL HORMONES; ETHANOL TOLERANCE; SECRETING NEURONS; BEER CONSUMPTION; BODY-WEIGHT	Previous studies have suggested that administration of oxytocin (OT) can have modulatory effects on social and anxiety-like behavior in mammals that may endure beyond the time of acute OT administration. The current study examined whether repeated administration of OT to male Wistar rats (n = 48) during a key developmental epoch (early adolescence) altered their physiology and behavior in later-life. Group housed rats were given intraperitoneal injections of either 1 mg/kg OT or vehicle during early adolescence (post natal-days [PND] 33-42). OT treatment caused a transient inhibition of body weight gain that recovered quickly after the cessation of treatment. At PND 50, the rats pre-treated with OT displayed less anxiety-like behavior on the emergence test, while at PND 55 they showed greater levels of social interaction. A subgroup of OT pretreated rats examined at PND 63 showed a strong trend towards increased plasma OT levels, and also displayed significantly increased OT receptor mRNA in the hypothalamus. Rats pre-treated with OT and their controls showed similar induction of beer intake in daily 70 min test sessions (PND 63 onwards) in which the alcohol concentration of beer was gradually increased across days from 0.44% to 4.44%. However, when given ad libitum access to beer in their home cages from PND 72 onwards (early adulthood), consumption of beer but not water was significantly less in the OT pre-treated rats. A "booster" shot of OT (1 mg/kg) given after 25 days of ad libitum access to beer had a strong acute inhibitory effect on beer intake without affecting water intake. Overall these results suggest that exogenous OT administered during adolescence can have subtle yet enduring effects on anxiety, sociability and the motivation to consume alcohol. Such effects may reflect the inherent neuroplasticity of brain OT systems and a feed-forward effect whereby exogenous OT upregulates endogenous OT systems.	[Bowen, Michael T.; Carson, Dean S.; McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Carson, Dean S.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Spiro, Adena; Arnold, Jonathon C.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Bowen, MT (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	mbowen@psych.usyd.edu.au	Arnold, Jonathon C/ACF-5231-2022; Carson, Dean/K-3505-2014	Carson, Dean/0000-0001-7065-5051; Arnold, Jonathon/0000-0002-0159-9997; mcgregor, iain/0000-0002-9307-7159; Bowen, Michael/0000-0002-8965-4136	Australian Research Council [DP0988609]	Australian Research Council(Australian Research Council)	Research supported by an Australian Research Council grant to ISM. Grant number DP0988609 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvik A, 2006, ACTA PAEDIATR, V95, P686, DOI 10.1080/08035250600649266; ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Bealer SL, 2006, AM J PHYSIOL-REG I, V291, pR53, DOI 10.1152/ajpregu.00766.2005; Breslow RA, 2007, BREASTFEED MED, V2, P152, DOI 10.1089/bfm.2007.0012; Cabrera RJ, 1999, BRAZ J MED BIOL RES, V32, P1229, DOI 10.1590/S0100-879X1999001000009; Caldwell HK, 2009, MOL PSYCHIATR, V14, P190, DOI 10.1038/sj.mp.4002150; CARLI M, 1989, NEUROPHARMACOLOGY, V28, P471, DOI 10.1016/0028-3908(89)90081-6; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Carson DS, 2010, NEUROPHARMACOLOGY, V58, P38, DOI 10.1016/j.neuropharm.2009.06.018; CARTER CS, 1992, ANN NY ACAD SCI, V652, P204, DOI 10.1111/j.1749-6632.1992.tb34356.x; Cetinel S, 2010, REGUL PEPTIDES, V160, P146, DOI 10.1016/j.regpep.2009.11.011; CHAPMAN DB, 1986, NEUROSCIENCE, V17, P679, DOI 10.1016/0306-4522(86)90039-4; CORNWALL A, 1988, PAIN, V35, P105, DOI 10.1016/0304-3959(88)90282-5; Di S, 2004, ENDOCRINOLOGY, V145, P5141, DOI 10.1210/en.2004-0702; Eckertova M, 2011, BRIT J PHARMACOL, V162, P452, DOI 10.1111/j.1476-5381.2010.01037.x; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Gallate JE, 2004, PSYCHOPHARMACOLOGY, V173, P210, DOI 10.1007/s00213-003-1694-5; Gallate JE, 2003, PSYCHOPHARMACOLOGY, V166, P51, DOI 10.1007/s00213-002-1291-z; Gallate JE, 1999, PSYCHOPHARMACOLOGY, V142, P302, DOI 10.1007/s002130050893; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; Guastella AJ, 2009, PSYCHONEUROENDOCRINO, V34, P917, DOI 10.1016/j.psyneuen.2009.01.005; Hargreaves GA, 2007, ALCOHOL CLIN EXP RES, V31, P1900, DOI 10.1111/j.1530-0277.2007.00485.x; Hargreaves GA, 2009, ALCOHOL, V43, P305, DOI 10.1016/j.alcohol.2009.02.005; Holst S, 2002, AUTON NEUROSCI-BASIC, V99, P85, DOI 10.1016/S1566-0702(02)00134-0; INSEL TR, 1991, EUR J PHARMACOL, V203, P149, DOI 10.1016/0014-2999(91)90806-2; JAMES GD, 1986, PSYCHOSOM MED, V48, P502, DOI 10.1097/00006842-198609000-00005; JODOGNE C, 1991, PHARMACOL BIOCHEM BE, V40, P261, DOI 10.1016/0091-3057(91)90549-H; Jupp B, 2010, PHARMACOL THERAPEUT, V125, P138, DOI 10.1016/j.pharmthera.2009.11.002; Karolyi IJ, 1999, P NATL ACAD SCI USA, V96, P11595, DOI 10.1073/pnas.96.20.11595; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Klenerova V, 2009, J PHYSIOL PHARMACOL, V60, P57; Klenerova V, 2010, NEUROENDOCRINOL LETT, V31, P622; Klenerova V, 2009, NEUROENDOCRINOL LETT, V30, P335; Kovacs GL, 1998, PSYCHONEUROENDOCRINO, V23, P945; Kramer KM, 2004, CAN J ZOOL, V82, P1194, DOI 10.1139/Z04-098; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1643, DOI 10.1001/jama.2009.535; Labuschagne I, 2010, NEUROPSYCHOPHARMACOL, V35, P2403, DOI 10.1038/npp.2010.123; Langle SL, 2003, EUR J NEUROSCI, V18, P206, DOI 10.1046/j.1460-9568.2003.02741.x; LARCHER A, 1995, ENDOCRINOLOGY, V136, P5350, DOI 10.1210/en.136.12.5350; LE AD, 1988, PSYCHOPHARMACOLOGY, V94, P479, DOI 10.1007/BF00212841; LEBLANC AE, 1969, J PHARMACOL EXP THER, V168, P244; Lee PR, 2007, BRAIN RES, V1156, P152, DOI 10.1016/j.brainres.2007.04.042; Li J, 2008, ACTA PHARMACOL SIN, V29, P646, DOI 10.1111/j.1745-7254.2008.00805.x; Lipschitz DL, 2005, EXP NEUROL, V196, P210, DOI 10.1016/j.expneurol.2005.08.003; Liston J, 1998, Breastfeed Rev, V6, P27; Lukas M, 2010, NEUROPHARMACOLOGY, V58, P78, DOI 10.1016/j.neuropharm.2009.06.020; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; Marazziti D, 2008, CURR MED CHEM, V15, P698, DOI 10.2174/092986708783885291; McCool BA, 2009, ALCOHOL CLIN EXP RES, V33, P273, DOI 10.1111/j.1530-0277.2008.00830.x; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; McGregor IS, 2004, ADDICT BEHAV, V29, P1341, DOI 10.1016/j.addbeh.2004.06.011; McGregor IS, 1999, ALCOHOL, V17, P47, DOI 10.1016/S0741-8329(98)00033-0; McMurray MS, 2008, NEUROTOXICOL TERATOL, V30, P475, DOI 10.1016/j.ntt.2008.07.001; MONTAGNESE C, 1990, J NEUROENDOCRINOL, V2, P225, DOI 10.1111/j.1365-2826.1990.tb00855.x; MONTAGNESE CM, 1987, J ENDOCRINOL, V115, P97, DOI 10.1677/joe.0.1150097; Morley KC, 2001, EUR J PHARMACOL, V433, P91, DOI 10.1016/S0014-2999(01)01512-6; Murata T, 2000, J ENDOCRINOL, V166, P45, DOI 10.1677/joe.0.1660045; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; PELLOW S, 1985, PHYSIOL BEHAV, V35, P587, DOI 10.1016/0031-9384(85)90145-3; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petersson M, 1999, NEUROSCI LETT, V264, P41, DOI 10.1016/S0304-3940(99)00159-7; Petersson M, 1996, NEUROSCI LETT, V212, P87, DOI 10.1016/0304-3940(96)12773-7; Petersson M, 1996, PHYSIOL BEHAV, V60, P1311, DOI 10.1016/S0031-9384(96)00261-2; Petersson M, 2007, PSYCHONEUROENDOCRINO, V32, P959, DOI 10.1016/j.psyneuen.2007.06.015; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; PUCILOWSKI O, 1985, PEPTIDES, V6, P7, DOI 10.1016/0196-9781(85)90067-1; Qi J, 2009, NEUROPHARMACOLOGY, V56, P856, DOI 10.1016/j.neuropharm.2009.01.010; RAGLIN JS, 1987, MED SCI SPORT EXER, V19, P456; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Ring RH, 2010, NEUROPHARMACOLOGY, V58, P69, DOI [10.1016/j.neuropharm.2009.07.016, 10.1016/j.neuropharm.2009.08.015]; SARNYAI Z, 1994, PSYCHONEUROENDOCRINO, V19, P85, DOI 10.1016/0306-4530(94)90062-0; Slattery DA, 2010, NEUROPHARMACOLOGY, V58, P56, DOI 10.1016/j.neuropharm.2009.06.038; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; SPEAR L, 2000, ALCOHOL RES HLTH, V24; Stairs DJ, 2009, PHARMACOL BIOCHEM BE, V92, P377, DOI 10.1016/j.pbb.2009.01.016; Succu S, 2008, EUR J NEUROSCI, V28, P813, DOI 10.1111/j.1460-9568.2008.06385.x; SZABO G, 1987, FRONT HORM RES, V15, P128; SZABO G, 1987, ALCOHOL ALCOHOLISM, V22, P71; SZABO G, 1985, ALCOHOL, V2, P567, DOI 10.1016/0741-8329(85)90082-5; SZABO G, 1989, ACTA PHYSIOL HUNG, V73, P97; THEODOSIS DT, 1986, NATURE, V322, P738, DOI 10.1038/322738a0; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; THEODOSIS DT, 1984, NEUROSCIENCE, V11, P183, DOI 10.1016/0306-4522(84)90222-7; THEODOSIS DT, 2001, ABSTR SOC NEUROSCI, V27, P2150; Uvnas-Moberg K, 1998, NEWS PHYSIOL SCI, V13, P22, DOI 10.1152/physiologyonline.1998.13.1.22; UvnasMoberg K, 1996, INTEGR PHYS BEH SCI, V31, P44, DOI 10.1007/BF02691480; van Nieuwenhuijzen PS, 2010, PSYCHOPHARMACOLOGY, V212, P663, DOI 10.1007/s00213-010-1986-5; Williams SK, 2009, NEUROTOXICOL TERATOL, V31, P291, DOI 10.1016/j.ntt.2009.06.001; WITT DM, 1992, PHARMACOL BIOCHEM BE, V43, P855, DOI 10.1016/0091-3057(92)90418-F; Young LJ, 2002, BIOL PSYCHIAT, V51, P18, DOI 10.1016/S0006-3223(01)01268-9	97	111	113	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27237	10.1371/journal.pone.0027237	http://dx.doi.org/10.1371/journal.pone.0027237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110618	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400028
J	Fontaine, KR; Robertson, HT; Holst, C; Desmond, R; Stunkard, AJ; Sorensen, TIA; Allison, DB				Fontaine, Kevin R.; Robertson, Henry T.; Holst, Claus; Desmond, Renee; Stunkard, Albert J.; Sorensen, Thorkild I. A.; Allison, David B.			Is Socioeconomic Status of the Rearing Environment Causally Related to Obesity in the Offspring?	PLOS ONE			English	Article							PARENTAL SOCIAL-CLASS; BODY-MASS INDEX; EDUCATIONAL-ATTAINMENT; ADULT ADOPTEES; INCREASED RISK; CHILDHOOD; INTELLIGENCE; ASSOCIATIONS; DETERMINANTS; ADOLESCENTS	We attempt to elucidate whether there might be a causal connection between the socioeconomic status (SES) of the rearing environment and obesity in the offspring using data from two large-scale adoption studies: (1) The Copenhagen Adoption Study of Obesity (CASO), and (2) The Survey of Holt Adoptees and Their Families (HOLT). In CASO, the SES of both biological and adoptive parents was known, but all children were adopted. In HOLT, only the SES of the rearing parents was known, but the children could be either biological or adopted. After controlling for relevant covariates (e. g., adoptee age at measurement, adoptee age at transfer, adoptee sex) the raw (unstandardized) regression coefficients for adoptive and biological paternal SES on adoptee body mass index (BMI: kg/m(2)) in CASO were -.22 and -.23, respectively, both statistically significant (p = 0.01). Controlling for parental BMI (both adoptive and biological) reduced the coefficient for biological paternal SES by 44% (p =.034) and the coefficient for adoptive paternal SES by 1%. For HOLT, the regression coefficients for rearing parent SES were -.42 and -.25 for biological and adoptive children, respectively. Controlling for the average BMI of the rearing father and mother (i.e., mid-parental BMI) reduced the SES coefficient by 47% in their biological offspring (p <= .0001), and by 12% in their adoptive offspring (p =.09). Thus, despite the differing structures of the two adoption studies, both suggest that shared genetic diathesis and direct environmental transmission contribute about equally to the association between rearing SES and offspring BMI.	[Fontaine, Kevin R.] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21218 USA; [Robertson, Henry T.; Allison, David B.] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Holst, Claus; Sorensen, Thorkild I. A.] Univ Copenhagen, Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Desmond, Renee; Allison, David B.] Univ Alabama, Clin Nutr Res Ctr, Birmingham, AL USA; [Desmond, Renee] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Stunkard, Albert J.] Univ Penn, Dept Psychiat, Weight & Eating Disorders Program, Philadelphia, PA 19104 USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; University of Copenhagen; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine	Fontaine, KR (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21218 USA.	DAllison@uab.edu		Allison, David/0000-0003-3566-9399	National Institutes of Health (NIH) [DK056336]; Vivus Pharmaceuticals; Kraft Foods Frontiers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vivus Pharmaceuticals; Kraft Foods Frontiers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institutes of Health (NIH) grant DK056336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Allison has received grants, honoraria, donations, and consulting fees from numerous food, beverage, pharmaceutical companies, and other commercial, government, and nonprofit entities with interests in obesity and nutrition, and receives royalties from obesity-related books, Vivus Pharmaceuticals, and Kraft Foods Frontiers Foundation. Dr. Sorensen has had industrial collaborations indicated at http://www.ipm.hosp.dk/person/tias/Disclosures.html. This does not alter the authors' adherence to all PLos ONE policies on sharing data and materials. The remaining authors have declared that no competing interests exist.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Averett S, 1999, INT J OBESITY, V23, P166, DOI 10.1038/sj.ijo.0800805; AYRES I, 2007, SUPER CRUNCHERS WHY, P64; Baum CL, 2004, HEALTH ECON, V13, P885, DOI 10.1002/hec.881; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; CLOGG CC, 1992, J EDUC STAT, V17, P51, DOI 10.3102/10769986017001051; Connor J, 1999, J EPIDEMIOL COMMUN H, V53, P725, DOI 10.1136/jech.53.11.725; CRANDALL CS, 1995, PERS SOC PSYCHOL B, V21, P724, DOI 10.1177/0146167295217007; Due P, 2009, INT J OBESITY, V33, P1084, DOI 10.1038/ijo.2009.128; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; GARN SM, 1989, AM J CLIN NUTR, V50, P740, DOI 10.1093/ajcn/50.4.740; GOLDBLATT PB, 1965, J AMER MED ASSOC, V192, P1039, DOI 10.1001/jama.1965.03080250017004; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Johnson W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016290; Lieb DC, 2009, CLIN SPORT MED, V28, P349, DOI 10.1016/j.csm.2009.02.004; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; LISSAULUNDSOREN.J, 1992, INT J OBESI, V16, P169; MOORE SE, 1962, JAMA-J AM MED ASSOC, V181, P962; NETER J, 1990, APPL LINEAR STAT MOD, P284; O'Dea JA, 2010, INT J PUBLIC HEALTH, V55, P185, DOI 10.1007/s00038-009-0079-x; Pagan JA, 1997, SOC SCI QUART, V78, P756; Pravosudov VV, 1999, CONDOR, V101, P880, DOI 10.2307/1370081; Redden DT, 2006, BEHAV GENET, V36, P678, DOI 10.1007/s10519-006-9060-0; SACERDOTE B, 2007, ICPSR04637V1 NAT BUR, DOI DOI 10.3886/ICPSR04637; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Senese LC, 2009, EPIDEMIOL REV, V31, P21, DOI 10.1093/epirev/mxp006; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Singh GK, 2008, ANN EPIDEMIOL, V18, P682, DOI 10.1016/j.annepidem.2008.05.001; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Solomon MB, 2007, AM J PHYSIOL-REG I, V292, pR283, DOI 10.1152/ajpregu.00330.2006; SONNEHOLM S, 1986, BRIT MED J, V292, P586, DOI 10.1136/bmj.292.6520.586; SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87; SORENSEN TIA, 1983, INT J OBESITY, V7, P115; SORENSEN TIA, 1992, INT J OBESITY, V16, P227; SORENSEN TIA, 1985, J BIOSOC SCI, V17, P379; SORENSEN TIA, 1995, INT J OBESITY, V19, pS6; Sorensen TIA, 1998, INT J OBESITY, V22, P73, DOI 10.1038/sj.ijo.0800548; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1993, NEW ENGL J MED, V329, P1036, DOI 10.1056/NEJM199309303291411; Tamashiro KLK, 2007, PHYSIOL BEHAV, V91, P440, DOI 10.1016/j.physbeh.2007.04.004; TEASDALE TW, 1990, BRIT MED J, V300, P1615, DOI 10.1136/bmj.300.6740.1615; TEASDALE TW, 1983, J BIOSOC SCI, V15, P509, DOI 10.1017/S0021932000020964; TEASDALE TW, 1992, HUM BIOL, V64, P99; TEASDALE TW, 1979, BEHAV GENET, V9, P103, DOI 10.1007/BF01074329; TEASDALE TW, 1984, BEHAV GENET, V14, P587, DOI 10.1007/BF01068129; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Wilson ME, 2008, PHYSIOL BEHAV, V94, P586, DOI 10.1016/j.physbeh.2008.03.019	47	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27692	10.1371/journal.pone.0027692	http://dx.doi.org/10.1371/journal.pone.0027692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110724	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400086
J	Ghinet, MG; Bordeleau, E; Beaudin, J; Brzezinski, R; Roy, S; Burrus, V				Ghinet, Mariana Gabriela; Bordeleau, Eric; Beaudin, Julie; Brzezinski, Ryszard; Roy, Sebastien; Burrus, Vincent			Uncovering the Prevalence and Diversity of Integrating Conjugative Elements in Actinobacteria	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; CONSERVED SEQUENCE; GENETIC ELEMENTS; GENOMIC ISLANDS; TANDEM ARRAYS; SXT ELEMENT; HOST-RANGE; STREPTOMYCES	Horizontal gene transfer greatly facilitates rapid genetic adaptation of bacteria to shifts in environmental conditions and colonization of new niches by allowing one-step acquisition of novel functions. Conjugation is a major mechanism of horizontal gene transfer mediated by conjugative plasmids and integrating conjugative elements (ICEs). While in most bacterial conjugative systems DNA translocation requires the assembly of a complex type IV secretion system (T4SS), in Actinobacteria a single DNA FtsK/SpoIIIE-like translocation protein is required. To date, the role and diversity of ICEs in Actinobacteria have received little attention. Putative ICEs were searched for in 275 genomes of Actinobacteria using HMM-profiles of proteins involved in ICE maintenance and transfer. These exhaustive analyses revealed 144 putative FtsK/SpoIIIE-type ICEs and 17 putative T4SS-type ICEs. Grouping of the ICEs based on the phylogenetic analyses of maintenance and transfer proteins revealed extensive exchanges between different sub-families of ICEs. 17 ICEs were found in Actinobacteria from the genus Frankia, globally important nitrogen-fixing microorganisms that establish root nodule symbioses with actinorhizal plants. Structural analysis of ICEs from Frankia revealed their unexpected diversity and a vast array of predicted adaptive functions. Frankia ICEs were found to excise by site-specific recombination from their host's chromosome in vitro and in planta suggesting that they are functional mobile elements whether Frankiae live as soil saprophytes or plant endosymbionts. Phylogenetic analyses of proteins involved in ICEs maintenance and transfer suggests that active exchange between ICEs cargo-borne and chromosomal genes took place within the Actinomycetales order. Functionality of Frankia ICEs in vitro as well as in planta lets us anticipate that conjugation and ICEs could allow the development of genetic manipulation tools for this challenging microorganism and for many other Actinobacteria.	[Ghinet, Mariana Gabriela; Bordeleau, Eric; Beaudin, Julie; Brzezinski, Ryszard; Roy, Sebastien; Burrus, Vincent] Univ Sherbrooke, Ctr Etud & Valorisat Divers Microbienne, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Ghinet, MG (corresponding author), Univ Sherbrooke, Ctr Etud & Valorisat Divers Microbienne, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	Sebastien.Roy@USherbrooke.ca; Vincent.Burrus@USherbrooke.ca	Burrus, Vincent/H-5000-2019; Roy, Sébastien/A-5615-2008	Burrus, Vincent/0000-0001-6318-6904; Roy, Sébastien/0000-0001-7183-0691; Brzezinski, Ryszard/0000-0002-9090-5051	Centre d'etude et de valorisation de la diversite microbienne (Universite de Sherbrooke); Centre SEVE (Fonds quebecois de la recherche sur la nature et les technologies); Natural Sciences and Engineering Research Council of Canada (NSERC)	Centre d'etude et de valorisation de la diversite microbienne (Universite de Sherbrooke); Centre SEVE (Fonds quebecois de la recherche sur la nature et les technologies)(FQRNT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this work was provided by Centre d'etude et de valorisation de la diversite microbienne (Universite de Sherbrooke), Centre SEVE (Fonds quebecois de la recherche sur la nature et les technologies), and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to RB, SR, and VB. EB is the recipient of an Alexander Graham Bell Canada Graduate Scholarship from NSERC. VB holds a Canada Research Chair in molecular biology, impact and evolution of bacterial mobile elements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abajy MY, 2007, J BACTERIOL, V189, P2487, DOI 10.1128/JB.01491-06; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Askora A, 2011, J BIOSCI BIOENG, V111, P109, DOI 10.1016/j.jbiosc.2010.10.001; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; BERKMEN M, 2011, INTEGRATIVE IN PRESS; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Biller SJ, 2009, MOL MICROBIOL, V74, P790, DOI 10.1111/j.1365-2958.2009.06893.x; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2004, J BACTERIOL, V186, P2636, DOI 10.1128/JB.186.9.2636-2645.2004; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Daccord A, 2010, MOL MICROBIOL, V78, P576, DOI 10.1111/j.1365-2958.2010.07364.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DAVIS NK, 1992, MOL GEN GENET, V232, P351, DOI 10.1007/BF00266237; Dawson J. O., 2008, V6, P199, DOI 10.1007/978-1-4020-3547-0_8; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dixon R.O.D., 1986, NITROGEN FIXATION PL; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FLANNAGAN SE, 1991, J BACTERIOL, V173, P7136, DOI 10.1128/jb.173.22.7136-7141.1991; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Garriss G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000775; Gomis-Ruth FX, 2004, CURR PHARM DESIGN, V10, P1551, DOI 10.2174/1381612043384817; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo P, 2011, ACTA BIOCH BIOPH SIN, V43, P630, DOI 10.1093/abbs/gmr052; HAGEGE J, 1993, MOL MICROBIOL, V10, P799, DOI 10.1111/j.1365-2958.1993.tb00950.x; HAGEGE J, 1994, PLASMID, V31, P166, DOI 10.1006/plas.1994.1018; Hochhut B, 2001, J BACTERIOL, V183, P1124, DOI 10.1128/JB.183.4.1124-1132.2001; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Igual JM, 1999, CAN J BOT, V77, P1321, DOI 10.1139/cjb-77-9-1321; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Jayapal KP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-229; Kaimer C, 2009, MOL MICROBIOL, V74, P810, DOI 10.1111/j.1365-2958.2009.06894.x; Kamiya H, 2004, J BIOCHEM, V136, P359, DOI 10.1093/jb/mvh132; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; Lalonde M., 1981, Current perspectives in nitrogen fixation., P296; Lechevalier MP., 1986, ACTINOMYCETES, V19, P131; Lee CA, 2010, MOL MICROBIOL, V75, P268, DOI 10.1111/j.1365-2958.2009.06985.x; Lemire S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002149; Lerat S, 2009, MOL PLANT PATHOL, V10, P579, DOI [10.1111/J.1364-3703.2009.00561.X, 10.1111/j.1364-3703.2009.00561.x]; Letunic I, 2011, NUCL ACIDS RES; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Mavaro A, 2011, J BIOL CHEM, V286, P30552, DOI 10.1074/jbc.M111.263210; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; Murphy DB, 1999, FEMS MICROBIOL LETT, V174, P355, DOI 10.1111/j.1574-6968.1999.tb13590.x; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; NORMAND P, 1982, CAN J MICROBIOL, V28, P1133, DOI 10.1139/m82-168; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; OMER CA, 1989, MOBILE DNA, P289; Orozco BM, 1998, J BIOL CHEM, V273, P24448, DOI 10.1074/jbc.273.38.24448; Orozco BM, 1998, VIROLOGY, V242, P346, DOI 10.1006/viro.1997.9013; Osorio CR, 2008, J BACTERIOL, V190, P3353, DOI 10.1128/JB.00109-08; Panis G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001149; Pavlovic G, 2004, MICROBIOL-SGM, V150, P759, DOI 10.1099/mic.0.26883-0; Pembroke JT, 2000, FEMS MICROBIOL LETT, V187, P133, DOI 10.1111/j.1574-6968.2000.tb09149.x; PETTIS GS, 1994, MOL MICROBIOL, V13, P955, DOI 10.1111/j.1365-2958.1994.tb00487.x; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Possoz C, 2003, MOL MICROBIOL, V47, P1385, DOI 10.1046/j.1365-2958.2003.03380.x; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raynal A, 1998, MOL MICROBIOL, V28, P333, DOI 10.1046/j.1365-2958.1998.00799.x; Raynal A, 2006, APPL ENVIRON MICROB, V72, P4839, DOI 10.1128/AEM.00167-06; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Roy S, 2007, CAN J BOT, V85, P237, DOI 10.1139/B07-017; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; SEZONOV G, 1995, MOL MICROBIOL, V17, P533, DOI 10.1111/j.1365-2958.1995.mmi_17030533.x; Sezonov G, 2000, J BACTERIOL, V182, P1243, DOI 10.1128/JB.182.5.1243-1250.2000; Sezonov G, 1998, J BACTERIOL, V180, P3056, DOI 10.1128/JB.180.12.3056-3061.1998; SMOKVINA T, 1991, PLASMID, V25, P40, DOI 10.1016/0147-619X(91)90005-H; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; TISA LS, 1987, ARCH MICROBIOL, V147, P383, DOI 10.1007/BF00406137; Vogelmann J, 2011, EMBO J, V30, P2246, DOI 10.1038/emboj.2011.121; Warth L, 2011, ARCH MICROBIOL, V193, P187, DOI 10.1007/s00203-010-0662-9; Weigel C, 2006, FEMS MICROBIOL REV, V30, P321, DOI 10.1111/j.1574-6976.2006.00015.x; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Zhang L, 2008, J BACTERIOL, V190, P6392, DOI 10.1128/JB.00777-08; ZHANG Z, 1984, PLANT SOIL, V78, P79, DOI 10.1007/BF02277841; Zotchev S, 2000, MICROBIOL-UK, V146, P611, DOI 10.1099/00221287-146-3-611	88	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27846	10.1371/journal.pone.0027846	http://dx.doi.org/10.1371/journal.pone.0027846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114709	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400127
J	Harrison, F; El Mouden, C				Harrison, Freya; El Mouden, Claire			Exploring the Effects of Working for Endowments on Behaviour in Standard Economic Games	PLOS ONE			English	Article							CONDITIONAL COOPERATION; INDIVIDUAL-DIFFERENCES; HUMAN ALTRUISM; SOCIAL NORMS; EVOLUTION; COMMONS; HUMANS; PREFERENCES; PERSPECTIVE; RECIPROCITY	In recent years, significant advances have been made in understanding the adaptive (ultimate) and mechanistic (proximate) explanations for the evolution and maintenance of cooperation. Studies of cooperative behaviour in humans invariably use economic games. These games have provided important insights into the mechanisms that maintain economic and social cooperation in our species. However, they usually rely on the division of monetary tokens which are given to participants by the investigator. The extent to which behaviour in such games may reflect behaviour in the real world of biological markets - where money must be earned and behavioural strategies incur real costs and benefits - is unclear. To provide new data on the potential scale of this problem, we investigated whether people behaved differently in two standard economic games (public goods game and dictator game) when they had to earn their monetary endowments through the completion of dull or physically demanding tasks, as compared with simply being given the endowment. The requirement for endowments to be 'earned' through labour did not affect behaviour in the dictator game. However, the requirement to complete a dull task reduced cooperation in the public goods game among the subset of participants who were not familiar with game theory. There has been some effort to test whether the conclusions drawn from standard, token-based cooperation games adequately reflect cooperative behaviour 'in the wild.' However, given the almost total reliance on such games to study cooperation, more exploration of this issue would be welcome. Our data are not unduly worrying, but they do suggest that further exploration is needed if we are to make general inferences about human behaviour from the results of structured economic games.	[Harrison, Freya; El Mouden, Claire] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [El Mouden, Claire] Univ Oxford, Nuffield Coll, Oxford, England	University of Oxford; University of Oxford	Harrison, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	freya.andersdottir@gmail.com			Oxford University Press's John Fell Foundation; University of Oxford; Examination at Magdalen College, Oxford; BBSRC; Nuffield College, Oxford	Oxford University Press's John Fell Foundation; University of Oxford; Examination at Magdalen College, Oxford; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nuffield College, Oxford	This study was funded by an award from Oxford University Press's John Fell Foundation to FH, and also by the University of Oxford via an undergraduate project studentship. FH is funded by a Fellowship by Examination at Magdalen College, Oxford and CEM by a BBSRC Doctoral Training Grant and a Postdoctoral Prize Research Fellowship at Nuffield College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1995, Q J ECON, V110, P1, DOI 10.2307/2118508; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; Burton-Chellew MN, 2010, EVOL HUM BEHAV, V31, P104, DOI 10.1016/j.evolhumbehav.2009.07.005; Camerer C, 2003, BEHAV GAME THEORY; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Carpenter J., 2010, ECON INQ, V49, P612; CHAUDHURI A, 2011, EXPT EC IN PRESS; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Clark J, 2002, EXP ECON, V5, P223, DOI 10.1023/A:1020832203804; COOKSON R, 2006, EXPT EC, V3, P55; Dufwenberg M, 2011, GAME ECON BEHAV, V73, P459, DOI 10.1016/j.geb.2011.02.003; ENGEL C, 2010, EXPT EC IN PRESS, DOI DOI 10.1007/S10683-10011-19283-10687; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; FRANK SA, 1998, FDN SOCIAL EVOLUTION, pR9; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gardner Andy, 2008, P1, DOI 10.1007/978-3-540-75957-7_1; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P, 2005, TRENDS ECOL EVOL, V20, P604, DOI 10.1016/j.tree.2005.07.012; Harrison F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018338; Harrison GW, 2007, EXP ECON, V10, P429, DOI 10.1007/s10683-006-9145-x; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J., 2005, FDN HUMAN SOCIALITY; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Hertel G, 2000, COGNITION EMOTION, V14, P441, DOI 10.1080/026999300402754; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P10125, DOI 10.1073/pnas.1000829107; KUMMERLI R, 2007, SCIENCES, V274, P2965; Kurzban R, 2001, EUR J PERSONALITY, V15, pS37, DOI 10.1002/per.420; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Larrick RP, 1997, J PERS SOC PSYCHOL, V72, P810, DOI 10.1037/0022-3514.72.4.810; Ledyard J., 1995, HDB EXPT EC; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Madsen EA, 2007, BRIT J PSYCHOL, V98, P339, DOI 10.1348/000712606X129213; MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501; Mellers BA, 2010, J EXP PSYCHOL GEN, V139, P743, DOI 10.1037/a0020280; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; PUURTINEN M, 2009, P ROYAL SOC B, P355; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sommerfeld RD, 2007, P NATL ACAD SCI USA, V104, P17435, DOI 10.1073/pnas.0704598104; Stevens JR, 2005, ANNU REV ECOL EVOL S, V36, P499, DOI 10.1146/annurev.ecolsys.36.113004.083814; Suzuki S, 2011, SOC COGN AFFECT NEUR, V6, P338, DOI 10.1093/scan/nsq042; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tinbergen N., 1963, Z TIERPSYCHOL, V20, P410, DOI DOI 10.1111/J.1439-0310.1963.TB01161.X); Tracer DP, 2003, CURR ANTHROPOL, V44, P432, DOI 10.1086/374904; Trivers R, 2004, SCIENCE, V304, P964, DOI 10.1126/science.1095994; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Vilares I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017113; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; West SA, 2006, CURR BIOL, V16, P1103, DOI 10.1016/j.cub.2006.03.069; WEST SA, 2011, EVOL HUM BEHAV, P32231; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Willinger M, 1999, ECON LETT, V65, P323, DOI 10.1016/S0165-1765(99)00177-9; Wischniewski J, 2009, NEUROSCI BIOBEHAV R, V33, P305, DOI 10.1016/j.neubiorev.2008.09.008; Zelmer J., 2003, Experimental Economics, V6, P299, DOI 10.1023/A:1026277420119	67	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27623	10.1371/journal.pone.0027623	http://dx.doi.org/10.1371/journal.pone.0027623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110696	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400072
J	Lue, HW; Yang, XJ; Wang, RX; Qian, WP; Xu, RZH; Lyles, R; Osunkoya, AO; Zhou, BHP; Vessella, RL; Zayzafoon, M; Liu, ZR; Zhau, HE; Chung, LWK				Lue, Hui-Wen; Yang, Xiaojian; Wang, Ruoxiang; Qian, Weiping; Xu, Roy Z. H.; Lyles, Robert; Osunkoya, Adeboye O.; Zhou, Binhua P.; Vessella, Robert L.; Zayzafoon, Majd; Liu, Zhi-Ren; Zhau, Haiyen E.; Chung, Leland W. K.			LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling	PLOS ONE			English	Article							ESTROGEN-REGULATED GENES; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; BREAST-CANCER; GROWTH-FACTOR; TUMOR PROGRESSION; ZINC TRANSPORTERS; CELLS; RECEPTOR; MCF-7	LIV-1, a zinc transporter, is an effector molecule downstream from soluble growth factors. This protein has been shown to promote epithelial-to-mesenchymal transition (EMT) in human pancreatic, breast, and prostate cancer cells. Despite the implication of LIV-1 in cancer growth and metastasis, there has been no study to determine the role of LIV-1 in prostate cancer progression. Moreover, there was no clear delineation of the molecular mechanism underlying LIV-1 function in cancer cells. In the present communication, we found increased LIV-1 expression in benign, PIN, primary and bone metastatic human prostate cancer. We characterized the mechanism by which LIV-1 drives human prostate cancer EMT in an androgen-refractory prostate cancer cells (ARCaP) prostate cancer bone metastasis model. LIV-1, when overexpressed in ARCaP(E) (derivative cells of ARCaP with epithelial phenotype) cells, promoted EMT irreversibly. LIV-1 overexpressed ARCaP(E) cells had elevated levels of HB-EGF and matrix metalloproteinase (MMP) 2 and MMP 9 proteolytic enzyme activities, without affecting intracellular zinc concentration. The activation of MMPs resulted in the shedding of heparin binding-epidermal growth factor (HB-EGF) from ARCaP(E) cells that elicited constitutive epidermal growth factor receptor (EGFR) phosphorylation and its downstream extracellular signal regulated kinase (ERK) signaling. These results suggest that LIV-1 is involved in prostate cancer progression as an intracellular target of growth factor receptor signaling which promoted EMT and cancer metastasis. LIV-1 could be an attractive therapeutic target for the eradication of pre-existing human prostate cancer and bone and soft tissue metastases.	[Lue, Hui-Wen; Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Yang, Xiaojian; Wang, Ruoxiang; Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Qian, Weiping] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA; [Xu, Roy Z. H.; Lyles, Robert] Emory Univ, Sch Publ Hlth, Dept Biostat, Atlanta, GA USA; [Osunkoya, Adeboye O.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Zhou, Binhua P.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX USA; [Vessella, Robert L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Zayzafoon, Majd] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Yang, Xiaojian] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China	University System of Georgia; Georgia State University; Cedars Sinai Medical Center; Emory University; Emory University; Emory University; University of Texas System; University of Texas Medical Branch Galveston; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; Air Force Military Medical University	Lue, HW (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	haiyen.zhau@cshs.org; leland.chung@cshs.org			National Institutes of Health/National Cancer Institute [2PO1CA098912, 5RO1CA122602]; Department of Defense of the United States [W81XWH-07-0172]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA122602] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense of the United States; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by research grants 2PO1CA098912 and 5RO1CA122602 (LWKC) of the National Institutes of Health/National Cancer Institute (http://www.nih.gov) and W81XWH-07-0172 (LWKC) of the Department of Defense of the United States (http://cdmrp.army.mil/pcrp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bataineh ZM, 2002, SAUDI MED J, V23, P218; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; Costello LC, 2005, MITOCHONDRION, V5, P143, DOI 10.1016/j.mito.2005.02.001; Dressman M. A., 2001, Pharmacogenomics Journal, V1, P135; ElTanani MKK, 1996, MOL CELL ENDOCRINOL, V121, P29, DOI 10.1016/0303-7207(96)03844-0; ElTanani MKK, 1997, J STEROID BIOCHEM, V60, P269, DOI 10.1016/S0960-0760(96)00226-9; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Franklin RB, 2005, FRONT BIOSCI-LANDMRK, V10, P2230, DOI 10.2741/1692; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; JANIK P, 1975, CANCER RES, V35, P3698; JOSSON S, CANC RES, V71; Lopez V, 2010, EXP CELL RES, V316, P366, DOI 10.1016/j.yexcr.2009.10.011; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; MANNING DL, 1995, ACTA ONCOL, V34, P641, DOI 10.3109/02841869509094041; MANNING DL, 1994, EUR J CANCER, V30A, P675, DOI 10.1016/0959-8049(94)90543-6; MANNING DL, 1988, MOL CELL ENDOCRINOL, V59, P205, DOI 10.1016/0303-7207(88)90105-0; McClelland RA, 1998, BRIT J CANCER, V77, P1653, DOI 10.1038/bjc.1998.271; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Odero-Marah VA, 2008, CELL RES, V18, P858, DOI 10.1038/cr.2008.84; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Shen H, 2009, MOL BIOL REP, V36, P653, DOI 10.1007/s11033-008-9225-4; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Taylor KM, 2000, IUBMB LIFE, V49, P249, DOI 10.1080/15216540050033087; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Thalmann GN, 2000, PROSTATE, V44, P91; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; Wang RX, 2007, CLIN CANCER RES, V13, P6040, DOI 10.1158/1078-0432.CCR-07-0640; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhao Le, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1590; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1	42	80	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27720	10.1371/journal.pone.0027720	http://dx.doi.org/10.1371/journal.pone.0027720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110740	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400097
J	Xavier, AC; Edwards, H; Dombkowski, AA; Balci, TB; Berman, JN; Dellaire, G; Xie, CZ; Buck, SA; Matherly, LH; Ge, YB; Taub, JW				Xavier, Ana C.; Edwards, Holly; Dombkowski, Alan A.; Balci, Tugce B.; Berman, Jason N.; Dellaire, Graham; Xie, Chengzhi; Buck, Steven A.; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.			A Unique Role of GATA1s in Down Syndrome Acute Megakaryocytic Leukemia Biology and Therapy	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MEGAKARYOBLASTIC LEUKEMIA; TRANSCRIPTION FACTOR GATA-1; TRANSIENT LEUKEMIA; CHEMOTHERAPY SENSITIVITY; SYNDROME CHILDREN; GENE-EXPRESSION; CELL-LINE; MUTATIONS; TRISOMY-21	Background: Acute megakaryocytic leukemia (AMkL) in Down syndrome (DS) children is uniformly associated with somatic GATA1 mutations, which result in the synthesis of a shorter protein (GATA1s) with altered transactivation activity compared to the wild-type GATA1. It is not fully established whether leukemogenesis and therapeutic responses in DS AMkL patients are due to loss of the wild-type GATA1 or due to a unique function of GATA1s. Methodology: Stable clones of CMK cells with decreased GATA1s or Bcl-2 levels were generated by using GATA1- or BCL-2-specific lentivirus shRNAs. In vitro ara-C, daunorubicin, and VP-16 cytotoxicities of the shRNA stable clones were determined by using the Cell Titer-blue reagent. Apoptosis and cell cycle distribution were determined by flow cytometry analysis. Changes in gene transcript levels were determined by gene expression microarray and/or real-time RT-PCR. Changes in protein levels were measured by Western blotting. In vivo binding of GATA1s to IL1A promoter was determined by chromatin immunoprecipitation assays. Results: Lentivirus shRNA knockdown of the GATA1 gene in the DS AMkL cell line, CMK (harbors a mutated GATA1 gene and only expresses GATA1s), resulting in lower GATA1s protein levels, promoted cell differentiation towards the megakaryocytic lineage and repressed cell proliferation. Increased basal apoptosis and sensitivities to ara-C, daunorubicin, and VP-16 accompanied by down-regulated Bcl-2 were also detected in the CMK GATA1 shRNA knockdown clones. Essentially the same results were obtained when Bcl-2 was knocked down with lentivirus shRNA in CMK cells. Besides Bcl-2, down-regulation of GATA1s also resulted in altered expression of genes (e.g., IL1A, PF4, and TUBB1) related to cell death, proliferation, and differentiation. Conclusion: Our results suggest that GATA1s may facilitate leukemogenesis and potentially impact therapeutic responses in DS AMkL by promoting proliferation and survival, and by repressing megakaryocytic lineage differentiation, potentially by regulating expression of Bcl-2 protein and other relevant genes.	[Xavier, Ana C.; Buck, Steven A.; Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Edwards, Holly; Xie, Chengzhi; Matherly, Larry H.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Edwards, Holly; Xie, Chengzhi; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dev Therapeut Program, Detroit, MI USA; [Dombkowski, Alan A.] Childrens Hosp Michigan, Div Pharmacol & Toxicol, Detroit, MI 48201 USA; [Dombkowski, Alan A.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Balci, Tugce B.; Berman, Jason N.; Taub, Jeffrey W.] Dalhousie Univ, Dept Pediat, IWK Hlth Ctr, Halifax, NS, Canada; [Dellaire, Graham] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Children's Hospital of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Children's Hospital of Michigan; Wayne State University; Dalhousie University; Dalhousie University; Wayne State University	Xavier, AC (corresponding author), Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA.	jtaub@med.wayne.edu	Dellaire, Graham/L-9948-2014; Balci, Tugce/AAA-8617-2021; xie, chengzhi/F-9615-2012	Dellaire, Graham/0000-0002-3466-6316; Dombkowski, Alan/0000-0002-0312-8750; Balci, Tugce/0000-0002-5409-8387; Ge, Yubin/0000-0002-8748-716X	Karmanos Cancer Institute, Children's Research Center of Michigan, Leukemia Research Life, Children's Leukemia Foundation of Michigan, National Cancer Institute [CA120772]; Herrick Foundation, Justin's Gift Charity; Buric Family, Leukemia and Lymphoma Society, Sehn Family Foundation, Dale Meyer Memorial Endowment for Leukemia Research; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; Microarray and Bioinformatics Facility Core, Wayne State University, National Institute of Environmental Health Sciences center [P30 ES06639]; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [R01CA120772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	Karmanos Cancer Institute, Children's Research Center of Michigan, Leukemia Research Life, Children's Leukemia Foundation of Michigan, National Cancer Institute; Herrick Foundation, Justin's Gift Charity; Buric Family, Leukemia and Lymphoma Society, Sehn Family Foundation, Dale Meyer Memorial Endowment for Leukemia Research(Leukemia and Lymphoma Society); Ring Screw Textron Endowed Chair for Pediatric Cancer Research; Microarray and Bioinformatics Facility Core, Wayne State University, National Institute of Environmental Health Sciences center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from the Karmanos Cancer Institute, Children's Research Center of Michigan, Leukemia Research Life, Children's Leukemia Foundation of Michigan, National Cancer Institute (CA120772), Elana Fund, the Herrick Foundation, Justin's Gift Charity, The Buric Family, Leukemia and Lymphoma Society, Sehn Family Foundation, Dale Meyer Memorial Endowment for Leukemia Research, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. Microarray data analysis was supported by the Microarray and Bioinformatics Facility Core, Wayne State University, National Institute of Environmental Health Sciences center Grant P30 ES06639. AX is a recipient of a St. Baldrick's Foundation/Post-Doctoral Fellowship for Childhood Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athale UH, 2001, BLOOD, V97, P3727, DOI 10.1182/blood.V97.12.3727; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Chou ST, 2008, BLOOD, V112, P4503, DOI 10.1182/blood-2008-05-157859; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Edwards H, 2009, BLOOD, V114, P2744, DOI 10.1182/blood-2008-09-179812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gamis AS, 2003, J CLIN ONCOL, V21, P3415, DOI 10.1200/JCO.2003.08.060; Ge Y, 2008, LEUKEMIA, V22, P521, DOI 10.1038/sj.leu.2405066; Ge YB, 2006, BLOOD, V107, P1570, DOI 10.1182/blood-2005-06-2219; Ge YB, 2005, JNCI-J NATL CANCER I, V97, P226, DOI 10.1093/jnci/dji026; Ge YB, 2003, BLOOD, V101, P1551, DOI 10.1182/blood-2002-07-2337; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Harigae H, 2004, BLOOD, V103, P3242, DOI 10.1182/blood-2004-01-0016; Hitzler JK, 2003, BLOOD, V101, P4301, DOI 10.1182/blood-2003-01-0013; Inaba H, 2011, J CLIN ONCOL, V29, pE230, DOI 10.1200/JCO.2010.32.3634; Kanezaki R, 2010, BLOOD, V116, P4631, DOI 10.1182/blood-2010-05-282426; Klusmann JH, 2008, BLOOD, V111, P2991, DOI 10.1182/blood-2007-10-118810; Lange BJ, 1998, BLOOD, V91, P608; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Liu MJ, 2006, CLIN CANCER RES, V12, P608, DOI 10.1158/1078-0432.CCR-05-1954; LOEW TW, 2004, BLOOD, V104; Mundschau G, 2003, BLOOD, V101, P4298, DOI 10.1182/blood-2002-12-3904; O'Brien MM, 2008, J CLIN ONCOL, V26, P414, DOI 10.1200/JCO.2007.13.2209; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Rajagopalan D, 2003, BIOINFORMATICS, V19, P1469, DOI 10.1093/bioinformatics/btg202; RAVINDRANATH Y, 1992, BLOOD, V80, P2210; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; SHIMAMOTO T, 1995, BLOOD, V86, P3173; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Su RJ, 2005, STEM CELLS DEV, V14, P223, DOI 10.1089/scd.2005.14.223; TAKAHASHI T, 1991, BRIT J HAEMATOL, V78, P480, DOI 10.1111/j.1365-2141.1991.tb04476.x; Taub JW, 2004, BLOOD, V104, P1588, DOI 10.1182/blood-2004-04-1563; Taub JW, 1996, BLOOD, V87, P3395, DOI 10.1182/blood.V87.8.3395.bloodjournal8783395; Taub JW, 2001, J PEDIAT HEMATOL ONC, V23, P175, DOI 10.1097/00043426-200103000-00012; Tunstall-Pedoe O, 2008, BLOOD, V112, P4507, DOI 10.1182/blood-2008-04-152967; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Zipursky A, 2003, BRIT J HAEMATOL, V120, P930, DOI 10.1046/j.1365-2141.2003.04229.x; ZIPURSKY A, 1994, LEUKEMIA RES, V18, P163, DOI 10.1016/0145-2126(94)90111-2	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27486	10.1371/journal.pone.0027486	http://dx.doi.org/10.1371/journal.pone.0027486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110660	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400050
J	Yuan, LH; Zhao, XD; Lin, BF; Rossiter, SJ; He, LJ; Zuo, XG; He, GM; Jones, G; Geiser, F; Zhang, SY				Yuan, Lihong; Zhao, Xudong; Lin, Benfu; Rossiter, Stephen J.; He, Lingjiang; Zuo, Xueguo; He, Guimei; Jones, Gareth; Geiser, Fritz; Zhang, Shuyi			Adaptive Evolution of Leptin in Heterothermic Bats	PLOS ONE			English	Article							DAILY TORPOR; BODY-WEIGHT; MAMMALIAN HIBERNATION; SERUM LEPTIN; FOOD-INTAKE; SYNTHETIC PEPTIDES; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; LOW-TEMPERATURE; OB/OB MICE	Heterothermy (hibernation and daily torpor) is a key strategy that animals use to survive in harsh conditions and is widely employed by bats, which are found in diverse habitats and climates. Bats comprise more than 20% of all mammals and although heterothermy occurs in divergent lineages of bats, suggesting it might be an ancestral condition, its evolutionary history is complicated by complex phylogeographic patterns. Here, we use Leptin, which regulates lipid metabolism and is crucial for thermogenesis of hibernators, as molecular marker and combine physiological, molecular and biochemical analyses to explore the possible evolutionary history of heterothermy in bat. The two tropical fruit bats examined here were homeothermic; in contrast, the two tropical insectivorous bats were clearly heterothermic. Molecular evolutionary analyses of the Leptin gene revealed positive selection in the ancestors of all bats, which was maintained or further enhanced the lineages comprising mostly heterothermic species. In contrast, we found evidence of relaxed selection in homeothermic species. Biochemical assays of bat Leptin on the activity on adipocyte degradation revealed that Leptin in heterothermic bats was more lipolytic than in homeothermic bats. This shows that evolutionary sequence changes in this protein are indeed functional and support the interpretation of our physiological results and the molecular evolutionary analyses. Our combined data strongly support the hypothesis that heterothermy is the ancestral state of bats and that this involved adaptive changes in Leptin. Subsequent loss of heterothermy in some tropical lineages of bats likely was associated with range and dietary shifts.	[Yuan, Lihong; Lin, Benfu] S China Inst Endangered Anim, Guangzhou, Guangdong, Peoples R China; [Yuan, Lihong] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Appl Marine Biol Guangdong Prov, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [Zhao, Xudong] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [He, Lingjiang; Zuo, Xueguo; He, Guimei; Zhang, Shuyi] E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Geiser, Fritz] Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of London; Queen Mary University London; East China Normal University; University of Bristol; University of New England	Yuan, LH (corresponding author), S China Inst Endangered Anim, Guangzhou, Guangdong, Peoples R China.	syzhang@bio.ecnu.edu.cn	Geiser, Fritz/O-4175-2018; Rossiter, Stephen J/E-2111-2011	Geiser, Fritz/0000-0001-7621-5049; He, Guimei/0000-0002-4889-0933; Jones, Gareth/0000-0002-1904-3735; Rossiter, Stephen/0000-0002-3881-4515	Key Construction Program of the National "985" Project and "211" Project; BBSRC [BB/G530392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish	Key Construction Program of the National "985" Project and "211" Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant awarded to SZ under the Key Construction Program of the National "985" Project and "211" Project. The funders had no role in study design, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati S, 2007, BIOCHEM PHARMACOL, V73, P378, DOI 10.1016/j.bcp.2006.10.009; Andrews MT, 1998, P NATL ACAD SCI USA, V95, P8392, DOI 10.1073/pnas.95.14.8392; Bartels W, 1998, J COMP PHYSIOL B, V168, P233, DOI 10.1007/s003600050141; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Concannon P, 2001, AM J PHYSIOL-REG I, V281, pR951, DOI 10.1152/ajpregu.2001.281.3.R951; COTTRELL J, 2003, MODELING HEAT FLOWS; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Florant GL, 2004, J COMP PHYSIOL B, V174, P633, DOI 10.1007/s00360-004-0454-0; FRENCH AR, 1985, J COMP PHYSIOL B, V156, P13, DOI 10.1007/BF00692921; Gaucher EA, 2003, GENETICS, V163, P1549; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Geiser F, 1996, J ZOOL, V239, P583, DOI 10.1111/j.1469-7998.1996.tb05944.x; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; Geiser F, 2008, COMP BIOCHEM PHYS A, V150, P176, DOI 10.1016/j.cbpa.2007.02.041; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Geiser Fritz, 2010, Australian Zoologist, V35, P204; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Grasso P, 1997, ENDOCRINOLOGY, V138, P1413, DOI 10.1210/en.138.4.1413; Grasso P, 1999, REGUL PEPTIDES, V85, P93, DOI 10.1016/S0167-0115(99)00082-8; Grasso P, 1999, DIABETES, V48, P2204, DOI 10.2337/diabetes.48.11.2204; He LJ, 2010, GEN COMP ENDOCR, V168, P29, DOI 10.1016/j.ygcen.2010.04.001; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Hiroike T, 2000, BIOCHEM BIOPH RES CO, V275, P154, DOI 10.1006/bbrc.2000.3275; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imagawa K, 1998, J BIOL CHEM, V273, P35245, DOI 10.1074/jbc.273.52.35245; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kelm DH, 2007, J COMP PHYSIOL B, V177, P667, DOI 10.1007/s00360-007-0164-5; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LYMAN CP, 1970, THERMOREGULATION MET, P301; Maddison D.R., 2007, MESQUITE 2 MODULAR S; McNab BK, 2001, J COMP PHYSIOL B, V171, P201, DOI 10.1007/s003600000163; Moss CF, 2003, CURR OPIN NEUROBIOL, V13, P751, DOI 10.1016/j.conb.2003.10.016; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Ormseth OA, 1996, AM J PHYSIOL-REG I, V271, pR1775, DOI 10.1152/ajpregu.1996.271.6.R1775; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pride DT, 2000, SWAAP TOOL ANAL SUBS; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; RANSOME RD, 1990, C HELM MAMMAL SERIES, P83; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thomas DW, 1997, J COMP PHYSIOL B, V167, P146, DOI 10.1007/s003600050058; Townsend KL, 2008, J COMP PHYSIOL B, V178, P217, DOI 10.1007/s00360-007-0215-y; TWENTW JW, 1964, ANN ACAD SCI FENN A, V1, P435; Withers PC, 2000, AUST J ZOOL, V48, P241, DOI 10.1071/ZO99073; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	55	26	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27189	10.1371/journal.pone.0027189	http://dx.doi.org/10.1371/journal.pone.0027189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110614	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400026
J	Wilson, DW; Fowkes, FJI; Gilson, PR; Elliott, SR; Tavul, L; Michon, P; Dabod, E; Siba, PM; Mueller, I; Crabb, BS; Beeson, JG				Wilson, Danny W.; Fowkes, Freya J. I.; Gilson, Paul R.; Elliott, Salenna R.; Tavul, Livingstone; Michon, Pascal; Dabod, Elija; Siba, Peter M.; Mueller, Ivo; Crabb, Brendan S.; Beeson, James G.			Quantifying the Importance of MSP1-19 as a Target of Growth-Inhibitory and Protective Antibodies against Plasmodium falciparum in Humans	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; NEW-GUINEAN CHILDREN; NATURALLY ACQUIRED ANTIBODIES; APICAL MEMBRANE ANTIGEN-1; GLUTAMATE-RICH PROTEIN; BLOOD-STAGE INFECTION; C-TERMINAL FRAGMENT; CLINICAL MALARIA; IN-VITRO; ERYTHROCYTE INVASION	Background: Antibodies targeting blood stage antigens are important in protection against malaria, but the key targets and mechanisms of immunity are not well understood. Merozoite surface protein 1 (MSP1) is an abundant and essential protein. The C-terminal 19 kDa region (MSP1-19) is regarded as a promising vaccine candidate and may also be an important target of immunity. Methodology/Findings: Growth inhibitory antibodies against asexual-stage parasites and IgG to recombinant MSP1-19 were measured in plasma samples from a longitudinal cohort of 206 children in Papua New Guinea. Differential inhibition by samples of mutant P. falciparum lines that expressed either the P. falciparum or P. chabaudi form of MSP1-19 were used to quantify MSP1-19 specific growth-inhibitory antibodies. The great majority of children had detectable IgG to MSP1-19, and high levels of IgG were significantly associated with a reduced risk of symptomatic P. falciparum malaria during the 6-month follow-up period. However, there was little evidence of PfMSP1-19 specific growth inhibition by plasma samples from children. Similar results were found when testing non-dialysed or dialysed plasma, or purified antibodies, or when measuring growth inhibition in flow cytometry or microscopy-based assays. Rabbit antisera generated by immunization with recombinant MSP1-19 demonstrated strong MSP1-19 specific growth-inhibitory activity, which appeared to be due to much higher antibody levels than human samples; antibody avidity was similar between rabbit antisera and human plasma. Conclusions/Significance: These data suggest that MSP1-19 is not a major target of growth inhibitory antibodies and that the protective effects of antibodies to MSP1-19 are not due to growth inhibitory activity, but may instead be mediated by other mechanisms. Alternatively, antibodies to MSP1-19 may act as a marker of protective immunity.	[Wilson, Danny W.; Fowkes, Freya J. I.; Elliott, Salenna R.; Mueller, Ivo; Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Wilson, Danny W.; Crabb, Brendan S.] Univ Melbourne, Melbourne, Vic, Australia; [Fowkes, Freya J. I.; Gilson, Paul R.; Elliott, Salenna R.; Crabb, Brendan S.; Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Gilson, Paul R.] Monash Univ, Clayton, Vic, Australia; [Tavul, Livingstone; Michon, Pascal; Dabod, Elija; Siba, Peter M.; Mueller, Ivo] PNGIMR, Goroka, Papua N Guinea; [Michon, Pascal] Divine Word Univ, Fac Hlth Sci, Madang, Papua N Guinea; [Mueller, Ivo] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Burnet Institute; Monash University; PNG Institute Of Medical Research; ISGlobal; CRESIB	Wilson, DW (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	beeson@burnet.edu.au	Crabb, Brendan/F-5287-2013; Wilson, Danny W/E-6186-2019; Mueller, Ivo/C-7251-2013	Wilson, Danny W/0000-0002-5073-1405; Mueller, Ivo/0000-0001-6554-6889; Fowkes, Freya/0000-0001-5832-9464	National Health and Medical Research Council of Australia; Australian Research Council; Victorian State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian State Government	Funding was provided by the National Health and Medical Research Council of Australia (project grant and career development award to JB; training award to FF, postgraduate research fellowship to DW; Infrastructure for Research Institutes Support Scheme Grant), Australian Research Council (Future Fellowship to JB), and the Victorian State Government Operational Infrastructure Support grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborg N, 2002, INFECT IMMUN, V70, P820, DOI 10.1128/IAI.70.2.820-825.2002; Alifrangis M, 1999, PARASITOLOGY, V119, P337, DOI 10.1017/S0031182099004825; ALYAMAN F, 1995, PARASITE IMMUNOL, V17, P493, DOI 10.1111/j.1365-3024.1995.tb00920.x; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; CHAPPEL JA, 1994, INFECT IMMUN, V62, P4488, DOI 10.1128/IAI.62.10.4488-4494.1994; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; COOPER JA, 1992, MOL BIOCHEM PARASIT, V51, P301, DOI 10.1016/0166-6851(92)90080-4; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; DALY TM, 1995, J IMMUNOL, V155, P236; Dent A, 2006, J IMMUNOL, V177, P7139, DOI 10.4049/jimmunol.177.10.7139; Dent AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-162; Dutta S, 2005, INFECT IMMUN, V73, P5936, DOI 10.1128/IAI.73.9.5936-5944.2005; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Eisen DP, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-86; Elliott SR, 2008, CLIN INFECT DIS, V46, P1794, DOI 10.1086/588049; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOGH B, 1995, INFECT IMMUN, V63, P4034; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Lin E, 2010, AM J TROP MED HYG, V83, P828, DOI 10.4269/ajtmh.2010.09-0713; LYON JA, 1986, P NATL ACAD SCI USA, V83, P2989, DOI 10.1073/pnas.83.9.2989; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Migot-Nabias F, 1999, AM J TROP MED HYG, V61, P488; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Murhandarwati EEH, 2008, J INFECT DIS, V198, P1212, DOI 10.1086/591943; Murhandarwati EEH, 2009, INFECT IMMUN, V77, P4510, DOI 10.1128/IAI.00360-09; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Nwuba RI, 2002, INFECT IMMUN, V70, P5328, DOI 10.1128/IAI.70.9.5328-5331.2002; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; SHAI S, 1995, PARASITE IMMUNOL, V17, P269, DOI 10.1111/j.1365-3024.1995.tb01025.x; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Shi YP, 1996, INFECT IMMUN, V64, P2716, DOI 10.1128/IAI.64.7.2716-2723.1996; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152; Wipasa J, 2002, INFECT IMMUN, V70, P6013, DOI 10.1128/IAI.70.11.6013-6020.2002	76	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27705	10.1371/journal.pone.0027705	http://dx.doi.org/10.1371/journal.pone.0027705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110733	Green Published, gold			2022-12-25	WOS:000297555300047
J	Silva, FAB				Barbosa Silva, Fernando Augusto			A New Species of the Genus Scybalocanthon (Coleoptera: Scarabaeinae) from Southeast Brazil	PLOS ONE			English	Article							GENERA	A new species of the genus Scybalocanthon Martinez 1948, Scybalocanthon korasakiae sp. nov., from Atlantic forest ecosystem, state of Minas Gerais, Brazil is described based on external and genital morphology.	[Barbosa Silva, Fernando Augusto] Univ Fed Lavras, Dept Entomol, Lavras, Brazil; [Barbosa Silva, Fernando Augusto] Univ Fed Lavras, Dept Biol, Setor Ecol, Lavras, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras	Silva, FAB (corresponding author), Univ Fed Lavras, Dept Entomol, Campus Univ, Lavras, Brazil.	fernandoabsilva@yahoo.com.br	Silva, Fernando/AAQ-9496-2020; Silva, Fernando A.B./G-8697-2013	Silva, Fernando/0000-0002-3894-4846; Silva, Fernando A.B./0000-0002-3894-4846	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior provided a scholarship to the author, http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	MARTINEZ A, 1972, Entomologische Arbeiten aus dem Museum G. Frey Tutzing bei Muenchen, V23, P33; MARTINEZ ANTONIO, 1948, REV SOC ENT ARGENTINA, V14, P3; MARTINEZ ANTONIO, 1949, REV SOC ENT ARGENTINA, V14, P175; Medina CA, 2003, DEUT ENTOMOL Z, V50, P23, DOI 10.1002/mmnd.20030500105; Rendon FM, 2010, REV MEX BIODIVERS, V81, P689; Pereira F. S., 1956, Revista Brasileira de Entomologia, V6, P91; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Vaz-de-Mello FZ, 2011, ZOOTAXA, P1	8	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27790	10.1371/journal.pone.0027790	http://dx.doi.org/10.1371/journal.pone.0027790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110761	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300055
J	Huang, XT; Bi, K; Hu, LP; Sun, Y; Lu, W; Bao, ZM				Huang, Xiaoting; Bi, Ke; Hu, Liping; Sun, Yan; Lu, Wei; Bao, Zhenmin			Fertilization and Cytogenetic Examination of Interspecific Reciprocal Hybridization between the Scallops, Chlamys farreri and Mimachlamys nobilis	PLOS ONE			English	Article							ZHIKONG SCALLOP; UNISEXUAL SALAMANDERS; GENUS AMBYSTOMA; CHROMOSOME; HYBRID; IDENTIFICATION; FEMALE; GENOME; JONES	Crossbreeding is a powerful tool for improving productivity and profitability in aquaculture. We conducted a pilot study of an artificial cross between two important cultivated scallops in China, Chlamys farreri and Mimachlamys nobilis, to test the feasibility of interspecific hybridization. Reciprocal hybridization experiments were performed using a single-pair mating strategy (M. nobilis female x C. farreri male and C. farreri female x M. nobilis male). The fertilization of each pair was tracked using fluorescence staining of the gametes, and the chromosomes of the F1 hybrid larvae were examined via conventional karyotyping and genomic in situ hybridization (GISH). We observed moderate fertilization success in both interspecific crosses, although the overall fertilization was generally less rapid than that of intraspecific crosses. Conventional karyotyping showed that 70.4% of the viable F1 larvae in M. nobilis female x C. farreri male and 55.4% in C. farreri female x M. nobilis male comprised hybrid karyotypes (2n = 35 = 6m+5sm+11st+13t), and the results were further confirmed by GISH. Interestingly, we detected a few F1 from the M. nobilis female x C. farreri male cross that appeared to have developed gynogenetically. In addition, chromosome fragmentations, aneuploids and allopolyploids were observed in some F1 individuals. Our study presents evidence that the artificial cross between M. nobilis and C. farreri is experimentally possible. Further investigations of the potential heterosis of the viable F1 offspring at various developmental stages should be conducted to obtain a comprehensive evaluation of the feasibility of crossbreeding between these two scallop species.	[Huang, Xiaoting; Hu, Liping; Sun, Yan; Lu, Wei; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China; [Bi, Ke] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Ocean University of China; University of California System; University of California Berkeley	Huang, XT (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	zmbao@ouc.edu.cn	Bi, Ke/E-7427-2012		National Natural Science Foundation of China [30901096]; National High Technology Research and Development Program of China [2010AA10A401]; National Basic Research Program of China [2010CB126406, 2010CB126402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This research was funded by the National Natural Science Foundation of China (30901096), the National High Technology Research and Development Program of China (2010AA10A401), and the National Basic Research Program of China (2010CB126406 and 2010CB126402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAMTHAWATJONSSON K, 1990, THEOR APPL GENET, V79, P721, DOI 10.1007/BF00224236; AVISE JC, 2008, CLONALITY GENETICS E, P87; BECK ML, 1982, EXPERIENTIA, V38, P319, DOI 10.1007/BF01949366; Bi K, 2006, CYTOGENET GENOME RES, V112, P307, DOI 10.1159/000089885; [毕克 Bi Ke], 2005, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V35, P283; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Bower Susan M., 1997, Journal of Shellfish Research, V16, P333; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Cai MY, 2010, J SHELLFISH RES, V29, P735, DOI 10.2983/035.029.0327; [陈省平 Chen Shengping], 2005, [海洋学报, Acta Oceanologica Sinica], V27, P160; Cruz P, 1997, J EXP MAR BIOL ECOL, V212, P95, DOI 10.1016/S0022-0981(96)02742-6; DAWLEY RM, 1989, NY STATE MUS B, V466; Dunham R. A., 2001, AQUACULTURE 3 MILLEN, P137; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fujiwara A, 1997, CHROMOSOMA, V106, P44, DOI 10.1007/s004120050223; GUO X, 1991, J SHELLFISH RES, V10, P236; KOMARU A, 1985, Venus the Japanese Journal of Malacology, V44, P249; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; LOU YD, 1989, FISH BREEDING, P121; Lu ZM, 2006, J SHELLFISH RES, V25, P509, DOI 10.2983/0730-8000(2006)25[509:AFICFA]2.0.CO;2; Lu ZM, 2006, HIGH TECH LETT, V16, P853; MACGREGOR HC, 1964, SCIENCE, V143, P1043, DOI 10.1126/science.143.3610.1043; Markova M, 2009, CYTOGENET GENOME RES, V126, P368, DOI 10.1159/000275796; McGoldrick DJ, 2000, J SHELLFISH RES, V19, P779; RAGGHIANTI M, 1995, CHROMOSOME RES, V3, P497, DOI 10.1007/BF00713965; Raina S. N., 2001, Methods in Cell Science, V23, P83, DOI 10.1023/A:1013197705523; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; Sambrook J., 1989, MOL CLONING LAB MANU, P456; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; STANLEY JG, 1976, T AM FISH SOC, V105, P10, DOI 10.1577/1548-8659(1976)105<10:POHAAG>2.0.CO;2; Stears RL, 1997, DEV BIOL, V187, P200, DOI 10.1006/dbio.1997.8608; Tang BJ, 2010, FISH SHELLFISH IMMUN, V29, P42, DOI 10.1016/j.fsi.2010.02.019; Valente GT, 2009, CHROMOSOME RES, V17, P791, DOI 10.1007/s10577-009-9067-5; WADA KT, 1989, AQUACULTURE, V76, P11, DOI 10.1016/0044-8486(89)90247-0; Wang CD, 2011, AQUACULTURE, V310, P380, DOI 10.1016/j.aquaculture.2010.11.014; WANG J, 2006, BIOTECH B, V6, P122; Wang m., 1990, Journal of Ocean University of Qingdao, V20, P81; Wang R, 2008, SCI MARINE SHELLFISH, P61; Wang Yun-tao, 1999, Oceanologia et Limnologia Sinica, V30, P770; Wu Xiangyun, 2009, BMC Res Notes, V2, P69, DOI 10.1186/1756-0500-2-69; Yan JP, 1999, MARINE FISHERIES RES, V20, P35; [杨爱国 Yang Aiguo], 2004, [海洋水产研究, Marine Fisheries Research], V25, P1; Yang HP, 2000, MAR BIOTECHNOL, V2, P466; Ye Y. Z., 1989, Acta Hydrobiologica Sinica, V13, P234; Zhang LL, 2008, DNA SEQUENCE, V19, P195, DOI 10.1080/10425170701462316; Zhang LL, 2008, MAR BIOTECHNOL, V10, P151, DOI 10.1007/s10126-007-9045-x; [赵洋 ZHAO Yang], 2006, [海洋学报, Acta Oceanologica Sinica], V28, P100	48	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27235	10.1371/journal.pone.0027235	http://dx.doi.org/10.1371/journal.pone.0027235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110617	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300018
J	Cheng, M; Chan, SYW; Zhao, Q; Chan, EYM; Au, SWN; Lee, SST; Cheung, WT				Cheng, Man; Chan, Shirley Y. W.; Zhao, Qi; Chan, Elaine Y. M.; Au, Shannon W. N.; Lee, Susanna S. T.; Cheung, Wing-Tai			Construction and Characterization of Single-Chain Variable Fragment Antibody Library Derived from Germline Rearranged Immunoglobulin Variable Genes	PLOS ONE			English	Article							PHAGE DISPLAY LIBRARY; SARS-CORONAVIRUS; IMMUNE-RESPONSE; HYPERVARIABLE REGIONS; SOMATIC HYPERMUTATION; CROSS-REACTIVITY; PEPTIDE LIBRARY; CDR3 REGION; PROTEIN; MATURATION	Antibody repertoires for library construction are conventionally harvested from mRNAs of immune cells. To examine whether germline rearranged immunoglobulin (Ig) variable region genes could be used as source of antibody repertoire, an immunized phage-displayed scFv library was prepared using splenocytic genomic DNA as template. In addition, a novel frame-shifting PCR (fsPCR) step was introduced to rescue stop codon and to enhance diversity of the complementarity-determining region 3 (CDR3). The germline scFv library was initially characterized against the hapten antigen phenyloxazolone (phOx). Sequence analysis of the phOx-selective scFvs indicated that the CDRs consisted of novel as well as conserved motifs. In order to illustrate that the diversity of CDR3 was increased by the fsPCR step, a second scFv library was constructed using a single scFv clone L3G7C as a template. Despite showing similar binding characteristics towards phOx, the scFv clones that were obtained from the L3G7C-derived antibody library gave a lower non-specific binding than that of the parental L3G7C clone. To determine whether germline library represented the endogenous immune status, specific scFv clones for nucleocapsid (N) protein of SARS-associated coronavirus (SCoV) were obtained both from naive and immunized germline scFv libraries. Both libraries yielded specific anti-N scFvs that exhibited similar binding characteristics towards recombinant N protein, except the immunized library gave a larger number of specific anti-N scFv, and clones with identical nucleotide sequences were found. In conclusion, highly diversified antibody library can be efficiently constructed using germline rearranged immunoglobulin variable genes as source of antibody repertoires and fsPCR to diversify the CDR3.	[Cheng, Man; Chan, Shirley Y. W.; Zhao, Qi; Chan, Elaine Y. M.; Cheung, Wing-Tai] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Au, Shannon W. N.; Lee, Susanna S. T.] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Cheng, M (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	wtcheung@cuhk.edu.hk	Chan, Elaine/GRR-5490-2022; Cheung, Wing-Tai/AAE-2658-2020	Cheung, Wing-Tai/0000-0001-6358-7855; Zhao, Qi/0000-0002-5969-6407	CUHK [44M4028]; Research Grants Council of Hong Kong Special Administrative Region (HKSAR) [CUHK4536/03M]; HKSAR Innovation and Technology Commission [GHP/030/06];  [US7241598 B2]	CUHK(Chinese University of Hong Kong); Research Grants Council of Hong Kong Special Administrative Region (HKSAR)(Hong Kong Research Grants Council); HKSAR Innovation and Technology Commission; 	This work was partly supported by a CUHK Strategic Research Program Grant (44M4028), an Earmarked research grant (CUHK4536/03M) from Research Grants Council of Hong Kong Special Administrative Region (HKSAR) and a research grant from HKSAR Innovation and Technology Commission (GHP/030/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: A United States patent (US7241598 B2) on frame-shifting PCR had been granted in 2007, which is indicated in the manuscript (Materials and Methods) and the patent is listed in the References (Ref. 32). The authors declare that at the present moment, no product is in development. Neither direct or indirect interests exist, nor funding, consultancy, nor employment provided by companies for commercial-related purposes and activities. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; BARBAS CF, 2001, PHADE DISPLAY LAB MA, P9; Barrios Y, 2004, J MOL RECOGNIT, V17, P332, DOI 10.1002/jmr.679; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Carcamo J, 1998, P NATL ACAD SCI USA, V95, P11146, DOI 10.1073/pnas.95.19.11146; Cheng M, 2005, BIOCHEM BIOPH RES CO, V338, P1654, DOI 10.1016/j.bbrc.2005.10.088; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; FROYEN G, 1995, MOL IMMUNOL, V32, P515, DOI 10.1016/0161-5890(95)00010-C; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Goldman E, 2000, FASEB J, V14, P603, DOI 10.1096/fasebj.14.3.603; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; Johnson G, 1998, INT IMMUNOL, V10, P1801, DOI 10.1093/intimm/10.12.1801; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Koh WWL, 2010, J BIOL CHEM, V285, P19116, DOI 10.1074/jbc.M110.116699; Krichevsky A, 2003, VIROLOGY, V305, P77, DOI 10.1006/viro.2002.1765; Kuan CT, 2000, INT J CANCER, V88, P962, DOI 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U; Kupsch JM, 1999, CLIN CANCER RES, V5, P925; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; Lim TS, 2010, NEW BIOTECHNOL, V27, P108, DOI 10.1016/j.nbt.2010.01.001; MAKELA O, 1978, J EXP MED, V148, P1644, DOI 10.1084/jem.148.6.1644; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Ramsland PA, 2001, EXP CLIN IMMUNOGENET, V18, P176, DOI 10.1159/000049197; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wen YJ, 1998, BRIT J HAEMATOL, V100, P464, DOI 10.1046/j.1365-2141.1998.00592.x; White H, 2000, J EXP MED, V191, P2209, DOI 10.1084/jem.191.12.2209; Wilson DR, 1998, CAN J MICROBIOL, V44, P313, DOI 10.1139/cjm-44-4-313; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011; ZAGHOUANI H, 1993, SCIENCE, V259, P224, DOI 10.1126/science.7678469; Zhao Q, 2009, PROTEIN EXPRES PURIF, V68, P190, DOI 10.1016/j.pep.2009.08.004	54	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27406	10.1371/journal.pone.0027406	http://dx.doi.org/10.1371/journal.pone.0027406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096568	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900041
J	Koutsopoulos, OS; Koch, C; Tosch, V; Bohm, J; North, KN; Laporte, J				Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; North, Kathryn N.; Laporte, Jocelyn			Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; MAMMALIAN-CELLS; NEONATAL ONSET; SH3 DOMAIN; MICROTUBULES; BINDING; TUBULIN; GTPASE; FAMILY; DIFFERENTIATION	The large GTPase dynamin 2 is a key player in membrane and cytoskeletal dynamics mutated in centronuclear myopathy (CNM) and Charcot-Marie Tooth (CMT) neuropathy, two discrete dominant neuromuscular disorders affecting skeletal muscle and peripheral nerves respectively. The molecular basis for the tissue-specific phenotypes observed and the physiopathological mechanisms linked to dynamin 2 mutations are not well established. In this study, we have analyzed the impact of CNM and CMT implicated dynamin 2 mutants using ectopic expression of four CNM and two CMT mutations, and patient fibroblasts harboring two dynamin 2 CNM mutations in established cellular processes of dynamin 2 action. Wild type and CMT mutants were seen in association with microtubules whereas CNM mutants lacked microtubules association and did not disrupt interphase microtubules dynamics. Most dynamin 2 mutants partially decreased clathrin-mediated endocytosis when ectopically expressed in cultured cells; however, experiments in patient fibroblasts suggested that endocytosis is overall not defective. Furthermore, CNM mutants were seen in association with enlarged clathrin stained structures whereas the CMT mutant constructs were associated with clathrin structures that appeared clustered, similar to the structures observed in Dnm1 and Dnm2 double knock-out cells. Other roles of dynamin 2 including its interaction with BIN1 (amphiphysin 2), and its function in Golgi maintenance and centrosome cohesion were not significantly altered. Taken together, these mild functional defects are suggestive of differences between CMT and CNM disease-causing dynamin 2 mutants and suggest that a slight impairment in clathrin-mediated pathways may accumulate over time to foster the respective human diseases.	[Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] IGBMC, Dept Translat Med, Illkirch Graffenstaden, France; [Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] CNRS, UMR7104, Illkirch Graffenstaden, France; [Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [North, Kathryn N.] Univ Sydney, Discipline Paediat & Child Hlth, Fac Med, Sydney, NSW 2006, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Sydney; University of Sydney	Koutsopoulos, OS (corresponding author), IGBMC, Dept Translat Med, Illkirch Graffenstaden, France.	Jocelyn@igbmc.fr	Laporte, Jocelyn/H-6801-2016; Böhm, Johann/O-1652-2016; North, Kathryn N/K-6476-2012; laporte, jocelyn/O-4888-2019; laporte, jocelyn/J-7008-2012	Böhm, Johann/0000-0001-8019-9504; North, Kathryn N/0000-0003-0841-8009; Koch, Catherine/0000-0003-0790-1429; Bohm, Johann/0000-0001-7370-3469	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg (UdS); College de France; Association Francaise contre les Myopathies (AFM); Fondation Recherche Medicale [DEQ20071210538]; E-rare program; Agence Nationale de la Recherche [ANR-07-BLAN-0065-01, ANR-08-GENOPAT-005]; Deutsche Forschungsgemeinschaft (DFG)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (UdS)(European Commission); College de France; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Recherche Medicale; E-rare program; Agence Nationale de la Recherche(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), University of Strasbourg (UdS), College de France, Association Francaise contre les Myopathies (AFM), Fondation Recherche Medicale (DEQ20071210538), E-rare program, and Agence Nationale de la Recherche (ANR-07-BLAN-0065-01 and ANR-08-GENOPAT-005). Johann Bohm was supported by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chang W, 2002, J BIOL CHEM, V277, P30690, DOI 10.1074/jbc.M204930200; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Claeys KG, 2009, BRAIN, V132, P1741, DOI 10.1093/brain/awp115; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; DIATLOFFZITO C, 1995, GENE, V163, P301, DOI 10.1016/0378-1119(95)00275-B; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P955, DOI 10.1016/j.nmd.2007.06.467; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gonzalez-Bellido PT, 2009, J NEUROSCI, V29, P14199, DOI 10.1523/JNEUROSCI.2873-09.2009; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Hamao K, 2009, EXP CELL RES, V315, P1336, DOI 10.1016/j.yexcr.2009.01.025; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maier O, 1996, BIOCHEM BIOPH RES CO, V223, P229, DOI 10.1006/bbrc.1996.0876; Melberg A, 2010, NEUROMUSCULAR DISORD, V20, P53, DOI 10.1016/j.nmd.2009.10.006; NAKATA T, 1993, J CELL SCI, V105, P1; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Susman RD, 2010, NEUROMUSCULAR DISORD, V20, P229, DOI 10.1016/j.nmd.2010.02.016; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	43	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27498	10.1371/journal.pone.0027498	http://dx.doi.org/10.1371/journal.pone.0027498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096584	Green Published, gold			2022-12-25	WOS:000297553900053
J	Mayr, MI; Storch, M; Howard, J; Mayer, TU				Mayr, Monika I.; Storch, Marko; Howard, Jonathon; Mayer, Thomas U.			A Non-Motor Microtubule Binding Site Is Essential for the High Processivity and Mitotic Function of Kinesin-8 Kif18A	PLOS ONE			English	Article							SPINDLE LENGTH; CENP-E; MOTOR; DYNAMICS; DEPOLYMERIZATION; PHOSPHORYLATION; DEPOLYMERASE; SUPERFAMILY; CONGRESSION; ALIGNMENT	Background: Members of the kinesin-8 subfamily are plus end-directed molecular motors that accumulate at the plus-ends of kinetochore-microtubules (kt-MTs) where they regulate MT dynamics. Loss of vertebrate kinesin-8 function induces hyperstable MTs and elongated mitotic spindles accompanied by severe chromosome congression defects. It has been reported that the motility of human kinesin-8, Kif18A, is required for its accumulation at the plus tips of kt-MTs. Methodology/Findings: Here, we investigate how Kif18A localizes to the plus-ends of kt-MTs. We find that Kif18A lacking its C-terminus does not accumulate on the tips of kt-MTs and fails to fulfill its mitotic function. In vitro studies reveal that Kif18A possesses a non-motorMT binding site located within its C-proximal 121 residues. Using single molecule measurements we find that Kif18A is a highly processive motor and, furthermore, that the C-terminal tail is essential for the high processivity of Kif18A. Conclusion/Significance: These results show that Kif18A like its yeast orthologue is a highly processive motor. The ability of Kif18A to walk on MTs for a long distance without dissociating depends on a non-motor MT binding site located at the C-terminus of Kif18A. This C-proximal tail of Kif18A is essential for its plus-end accumulation and mitotic function. These findings advance our understanding of how Kif18A accumulates at the tips of kt-MTs to fulfill its function in mitosis.	[Mayr, Monika I.; Mayer, Thomas U.] Univ Konstanz, Dept Biol, Constance, Germany; [Mayr, Monika I.; Mayer, Thomas U.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Storch, Marko; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Konstanz; University of Konstanz; Max Planck Society	Mayr, MI (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	thomas.u.mayer@uni-konstanz.de	Howard, Jonathon/D-4229-2011; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Mayer, Thomas/0000-0001-6954-2287	Deutsche Forschungsgemeinschaft (DFG) [Ma-1559/7-1]; Human Frontiers Science Program [RGP0035]; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontiers Science Program(Human Frontier Science Program); Max Planck Society(Max Planck Society)	TUM and MIM were supported by the Deutsche Forschungsgemeinschaft (DFG, Ma-1559/7-1). JH and MS were supported by the Human Frontiers Science Program (Grant RGP0035) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Grissom PM, 2009, MOL BIOL CELL, V20, P963, DOI 10.1091/mbc.E08-09-0979; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; PETERS C, 2010, EMBO J; Sarli V, 2005, CHEMBIOCHEM, V6, P2005, DOI 10.1002/cbic.200500168; Savoian MS, 2010, J CELL SCI, V123, P767, DOI 10.1242/jcs.055905; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; TAN EM, 1980, ARTHRITIS RHEUM, V23, P617, DOI 10.1002/art.1780230602; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Walczak CE, 2003, MOL CELL, V11, P286, DOI 10.1016/S1097-2765(03)00067-4; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; West RR, 2002, J CELL SCI, V115, P931; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	28	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27471	10.1371/journal.pone.0027471	http://dx.doi.org/10.1371/journal.pone.0027471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102900	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800028
J	Gu, GY; Hu, JH; Cevallos-Cevallos, JM; Richardson, SM; Bartz, JA; van Bruggen, AHC				Gu, Ganyu; Hu, Jiahuai; Cevallos-Cevallos, Juan M.; Richardson, Susanna M.; Bartz, Jerry A.; van Bruggen, Ariena H. C.			Internal Colonization of Salmonella enterica Serovar Typhimurium in Tomato Plants	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; O-ANTIGEN CAPSULE; MULTISTATE OUTBREAK; AGGREGATIVE FIMBRIAE; IRRIGATION WATER; GENETIC-ANALYSIS; ALFALFA SPROUTS; UNITED-STATES; CELLULOSE; SURVIVAL	Several Salmonella enterica outbreaks have been traced back to contaminated tomatoes. In this study, the internalization of S. enterica Typhimurium via tomato leaves was investigated as affected by surfactants and bacterial rdar morphotype, which was reported to be important for the environmental persistence and attachment of Salmonella to plants. Surfactants, especially Silwet L-77, promoted ingress and survival of S. enterica Typhimurium in tomato leaves. In each of two experiments, 84 tomato plants were inoculated two to four times before fruiting with GFP-labeled S. enterica Typhimurium strain MAE110 (with rdar morphotype) or MAE119 (without rdar). For each inoculation, single leaflets were dipped in 10(9) CFU/ml Salmonella suspension with Silwet L-77. Inoculated and adjacent leaflets were tested for Salmonella survival for 3 weeks after each inoculation. The surface and pulp of ripe fruits produced on these plants were also examined for Salmonella. Populations of both Salmonella strains in inoculated leaflets decreased during 2 weeks after inoculation but remained unchanged (at about 10(4) CFU/g) in week 3. Populations of MAE110 were significantly higher (P<0.05) than those of MAE119 from day 3 after inoculation. In the first year, nine fruits collected from one of the 42 MAE119 inoculated plants were positive for S. enterica Typhimurium. In the second year, Salmonella was detected in adjacent non-inoculated leaves of eight tomato plants (five inoculated with strain MAE110). The pulp of 12 fruits from two plants inoculated with MAE110 was Salmonella positive (about 10(6) CFU/g). Internalization was confirmed by fluorescence and confocal laser microscopy. For the first time, convincing evidence is presented that S. enterica can move inside tomato plants grown in natural field soil and colonize fruits at high levels without inducing any symptoms, except for a slight reduction in plant growth.	[Gu, Ganyu; Hu, Jiahuai; Cevallos-Cevallos, Juan M.; Richardson, Susanna M.; van Bruggen, Ariena H. C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Gu, Ganyu; Hu, Jiahuai; Cevallos-Cevallos, Juan M.; Richardson, Susanna M.; Bartz, Jerry A.; van Bruggen, Ariena H. C.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gu, GY (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	ggu@ufl.edu; ahcvanbruggen@ufl.edu		Cevallos-Cevallos, Juan/0000-0003-4609-7998; Ravel, Jacques/0000-0002-0851-2233	Institute of Food and Agricultural Sciences, University of Florida	Institute of Food and Agricultural Sciences, University of Florida(University of Florida)	This work was supported by Institute of Food and Agricultural Sciences, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P325; Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Bedunah D. J., 1995, WILDLAND PLANTS PHYS; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Calvin L., 2005, Amber Waves, V3, P20; Campbell JV, 2001, J INFECT DIS, V183, P984, DOI 10.1086/319254; Cating RA, 2010, FLA ENTOMOL, V93, P100, DOI 10.1653/024.093.0113; Chen YL, 2006, FOREST ECOL MANAG, V222, P439, DOI 10.1016/j.foreco.2005.10.050; CHUNG KC, 1970, J FOOD SCI, V35, P326, DOI 10.1111/j.1365-2621.1970.tb12176.x; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; Food and Drug Administration (FDA), 2010, FDA TREND AN REP OCC; Franz E, 2008, J APPL MICROBIOL, V105, P1569, DOI 10.1111/j.1365-2672.2008.03915.x; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gong ChunMing, 2005, Japanese Journal of Soil Science and Plant Nutrition, V76, P865; Gottwald TR, 1997, PLANT DIS, V81, P1305, DOI 10.1094/PDIS.1997.81.11.1305; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Guo X, 2002, J FOOD PROTECT, V65, P274, DOI 10.4315/0362-028X-65.2.274; Guo X, 2001, APPL ENVIRON MICROB, V67, P4760, DOI 10.1128/AEM.67.10.4760-4764.2001; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; HO LC, 1987, PLANT CELL ENVIRON, V10, P157, DOI 10.1111/j.1365-3040.1987.tb02092.x; HOLLOWAY PJ, 1992, PESTIC SCI, V34, P109, DOI 10.1002/ps.2780340204; Horby PW, 2003, EPIDEMIOL INFECT, V130, P169, DOI 10.1017/S0950268802008063; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Jablasone J, 2004, J SCI FOOD AGR, V84, P287, DOI 10.1002/jsfa.1646; Jafari R. A., 2006, International Journal of Poultry Science, V5, P491; Kirk J, 2002, PREV VET MED, V54, P169, DOI 10.1016/S0167-5877(02)00025-9; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Liang ZB, 2011, SOIL BIOL BIOCHEM, V43, P1591, DOI 10.1016/j.soilbio.2011.04.010; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Mohle-Boetani JC, 1999, J INFECT DIS, V180, P1361, DOI 10.1086/314995; Noel JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012406; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P229, DOI 10.1017/S0950268800059392; OYARZABAL OA, 1995, POULTRY SCI, V74, P1418, DOI 10.3382/ps.0741418; PLATZ S, 1980, ZBL BAKT MIK HYG B, V171, P256; Robinson R. A., 1968, ELECTROLYTE SOLUTION; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005; Semenov AV, 2007, FEMS MICROBIOL ECOL, V60, P419, DOI 10.1111/j.1574-6941.2007.00306.x; Sieverding E, 2006, J PLANT DIS PROTECT, P1005; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Suarez A, 1997, GENE, V196, P69, DOI 10.1016/S0378-1119(97)00197-2; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; VANBRUGGEN AHC, 1987, PHYTOPATHOLOGY, V77, P401, DOI 10.1094/Phyto-77-401; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winthrop KL, 2003, J FOOD PROTECT, V66, P13, DOI 10.4315/0362-028X-66.1.13; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	66	113	116	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27340	10.1371/journal.pone.0027340	http://dx.doi.org/10.1371/journal.pone.0027340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096553	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800045
J	Knapp, CW; McCluskey, SM; Singh, BK; Campbell, CD; Hudson, G; Graham, DW				Knapp, Charles W.; McCluskey, Seanin M.; Singh, Brajesh K.; Campbell, Colin D.; Hudson, Gordon; Graham, David W.			Antibiotic Resistance Gene Abundances Correlate with Metal and Geochemical Conditions in Archived Scottish Soils	PLOS ONE			English	Article							COPPER AMENDMENT; BACTERIAL; LAGOONS; WASTE	The vast majority of antibiotic resistant genes (ARG) acquired by human pathogens have originated from the natural environment. Therefore, understanding factors that influence intrinsic levels of ARG in the environment could be epidemiologically significant. The selection for metal resistance often promotes AR in exposed organisms; however, the relationship between metal levels in nature and the intrinsic presence of ARG has not been fully assessed. Here, we quantified, using qPCR, the abundance of eleven ARG and compared their levels with geochemical conditions in randomly selected soils from a Scottish archive. Many ARG positively correlated with soil copper levels, with approximately half being highly significant (p<0.05); whereas chromium, nickel, lead, and iron also significantly correlated with specific ARG. Results show that geochemical metal conditions innately influence the potential for AR in soil. We suggest soil geochemical data might be used to estimate baseline gene presence on local, regional and global scales within epidemiological risk studies related to AR transmission from the environment.	[Knapp, Charles W.; McCluskey, Seanin M.] Univ Strathclyde, David Livingstone Ctr Sustainabil, Dept Civil Engn, Glasgow, Lanark, Scotland; [Singh, Brajesh K.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Campbell, Colin D.; Hudson, Gordon] James Hutton Inst, Aberdeen, Scotland; [Campbell, Colin D.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Graham, David W.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Strathclyde; Western Sydney University; James Hutton Institute; Swedish University of Agricultural Sciences; Newcastle University - UK	Knapp, CW (corresponding author), Univ Strathclyde, David Livingstone Ctr Sustainabil, Dept Civil Engn, Glasgow, Lanark, Scotland.	charles.knapp@strath.ac.uk	Knapp, Charles W/D-3373-2009; Singh, Brajesh/R-6321-2019; Campbell, Colin D/B-3944-2010	Knapp, Charles W/0000-0001-7997-8543; Singh, Brajesh/0000-0003-4413-4185; Campbell, Colin D/0000-0002-5163-7656; Mccluskey, Seanin/0000-0002-5200-4076; Graham, David W/0000-0002-9753-496X	ECOSERV; EU [MEXT-CT-2006-023469]; University of Strathclyde [2009-1551]	ECOSERV; EU(European Commission); University of Strathclyde	Funding for the project was provided by ECOSERV, an EU Marie Curie Excellence Programme (#MEXT-CT-2006-023469), and University of Strathclyde Research Development Fund (#2009-1551). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CA, 2007, CHEMOSPHERE, V69, P1428, DOI 10.1016/j.chemosphere.2007.04.068; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Berg J, 2005, LETT APPL MICROBIOL, V40, P146, DOI 10.1111/j.1472-765X.2004.01650.x; Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r; Berger Antony R., 2003, P5; BROWN NL, 1991, J CELL BIOCHEM, V46, P106; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Knapp CW, 2008, ENVIRON SCI TECHNOL, V42, P5348, DOI 10.1021/es703199g; Knapp CW, 2010, ENVIRON POLLUT, V158, P1506, DOI 10.1016/j.envpol.2009.12.020; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Macdonald CA, 2008, FEMS MICROBIOL ECOL, V65, P555, DOI 10.1111/j.1574-6941.2008.00538.x; MAFF Ministry of Agriculture Fisheries Food, 1986, AN AGR MAT MAFF REF; Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x; Rosen BP, 1996, J BIOL INORG CHEM, V1, P273, DOI 10.1007/s007750050053; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Stepanauskas R, 2005, ENVIRON SCI TECHNOL, V39, P3671, DOI 10.1021/es048468f; Stepanauskas R, 2006, ENVIRON MICROBIOL, V8, P1510, DOI 10.1111/j.1462-2920.2006.01091.x; Tom-Petersen A, 2003, FEMS MICROBIOL ECOL, V46, P53, DOI 10.1016/S0168-6496(03)00192-2; Tzeneva VA, 2009, RES MICROBIOL, V160, P89, DOI 10.1016/j.resmic.2008.12.001; Ugur A, 2003, ARCH MED RES, V34, P130, DOI 10.1016/S0188-4409(03)00006-7; Wright MS, 2006, FEMS MICROBIOL ECOL, V58, P293, DOI 10.1111/j.1574-6941.2006.00154.x	24	224	250	6	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27300	10.1371/journal.pone.0027300	http://dx.doi.org/10.1371/journal.pone.0027300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096547	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000297350800042
J	Almolda, B; Costa, M; Montoya, M; Gonzalez, B; Castellano, B				Almolda, Beatriz; Costa, Manuela; Montoya, Maria; Gonzalez, Berta; Castellano, Bernardo			Increase in Th17 and T-reg Lymphocytes and Decrease of IL22 Correlate with the Recovery Phase of Acute EAE IN Rat	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; LEWIS RATS; MULTIPLE-SCLEROSIS; SPINAL-CORD; LINEAGE COMMITMENT; REGULATORY-CELLS; CUTTING EDGE; CD4(+)	Experimental autoimmune encephalomyelitis (EAE), a well-established model of multiple sclerosis, is characterised by microglial activation and lymphocyte infiltration. Induction of EAE in Lewis rats produces an acute monophasic disease characterised by a single peak of disability followed by a spontaneous and complete recovery and a subsequent tolerance to further immunizations. In the current study we have performed a detailed analysis of the dynamics of different lymphocyte populations and cytokine profile along the induction, peak, recovery and post-recovery phases in this paradigm. MBP-injected rats were sacrificed attending exclusively to their clinical score, and the different populations of T-lymphocytes as well as the dynamics of different pro-and anti-inflammatory cytokines were analysed in the spinal cord by flow cytometry, immunohistochemistry and ELISA. Our results revealed that, during the induction and peak phases, in parallel to an increase in symptomatology, the number of CD3+ and CD4+ cells increased progressively, showing a Th1 phenotype, but unexpectedly during recovery, although clinical signs progressively decreased, the number and proportion of CD3+ and CD4+ populations remained unaltered. Interestingly, during this recovery phase, we observed a marked decrease of Th1 and an important increase in Th17 and T-reg cells. Moreover, our results indicate a specific cytokine expression profile along the EAE course characterized by no changes of IL10 and IL17 levels, decrease of IL21 on the peak, and high IL22 levels during the induction and peak phases that markedly decrease during recovery. In summary, these results revealed the existence of a specific pattern of lymphocyte infiltration and cytokine secretion along the different phases of the acute EAE model in Lewis rat that differs from those already described in chronic or relapsing-remitting mouse models, where Th17-cells were found mostly during the peak, suggesting a specific role of these lymphocytes and cytokines in the evolution of this acute EAE model.	[Almolda, Beatriz; Gonzalez, Berta; Castellano, Bernardo] Univ Autonoma Barcelona, Inst Neurosci, Dept Cell Biol Physiol & Immunol, Unit Histol, Bellaterra, Spain; [Costa, Manuela] Univ Autonoma Barcelona, Serv Cultius Cel Lulars Prod Anticossos & Ciometr, Bellaterra, Spain; [Montoya, Maria] Campus Univ Autonoma Barcelona, UAB IRTA, Ctr Recerca Sanitat Anim, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Almolda, B (corresponding author), Univ Autonoma Barcelona, Inst Neurosci, Dept Cell Biol Physiol & Immunol, Unit Histol, Bellaterra, Spain.	beatriz.almolda@uab.cat	Castellano, Bernardo/G-1428-2010; Montoya, Maria/G-3430-2015; Almolda, Beatriz/L-6920-2014; Gonzalez, Berta/G-1428-2010	Castellano, Bernardo/0000-0003-1976-971X; Montoya, Maria/0000-0002-5703-7360; Almolda, Beatriz/0000-0001-6631-4385; Gonzalez, Berta/0000-0002-1860-3980	Fundacio Marato TV3; Spanish Ministry of Science and Innovation [BFU2008-04407/BFI, BFU2011-27400]; Fundacion Alicia Koplowitz	Fundacio Marato TV3; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Alicia Koplowitz	This work was supported by the Fundacio Marato TV3, Fundacion Alicia Koplowitz and Spanish Ministry of Science and Innovation (BFU2008-04407/BFI and BFU2011-27400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781; Almolda B, 2010, J NEUROIMMUNOL, V223, P39, DOI 10.1016/j.jneuroim.2010.03.021; Almolda B, 2009, J NEUROIMMUNOL, V209, P65, DOI 10.1016/j.jneuroim.2009.01.026; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; BARTEN DM, 1995, J IMMUNOL, V155, P5409; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Brandt K, 2003, J INVEST DERMATOL, V121, P1379, DOI 10.1046/j.1523-1747.2003.12603.x; Conant SB, 2004, J IMMUNOL, V172, P5322, DOI 10.4049/jimmunol.172.9.5322; Dittel BN, 2008, BRAIN BEHAV IMMUN, V22, P421, DOI 10.1016/j.bbi.2007.11.010; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Koenders MI, 2010, CLIN EXP IMMUNOL, V159, P131, DOI 10.1111/j.1365-2249.2009.04039.x; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, J NEUROIMMUNOL, V191, P51, DOI 10.1016/j.jneuroim.2007.09.009; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Leonard WJ, 2008, J LEUKOCYTE BIOL, V84, P348, DOI 10.1189/jlb.0308149; Liu RL, 2008, EXP NEUROL, V211, P14, DOI 10.1016/j.expneurol.2007.11.004; MACPHEE IAM, 1990, J NEUROIMMUNOL, V27, P9, DOI 10.1016/0165-5728(90)90131-6; McCombe PA, 1996, J NEUROL SCI, V139, P1; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miller SA, 2009, IMMUNOLOGY, V126, P306, DOI 10.1111/j.1365-2567.2008.03040.x; Moline-Velazquez V, 2011, BRAIN PATHOL; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; NAMIKAWA T, 1986, J NEUROIMMUNOL, V12, P235, DOI 10.1016/S0165-5728(86)80007-8; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; PENDER MP, 1991, J NEUROL SCI, V104, P81, DOI 10.1016/0022-510X(91)90219-W; PENDER MP, 1992, J AUTOIMMUN, V5, P401, DOI 10.1016/0896-8411(92)90001-7; Piao WH, 2008, SCAND J IMMUNOL, V67, P37, DOI 10.1111/j.1365-3083.2007.02035.x; Reinhardt RL, 2006, CURR OPIN IMMUNOL, V18, P271, DOI 10.1016/j.coi.2006.03.003; Rigolio R, 2008, J NEUROIMMUNOL, V199, P67, DOI 10.1016/j.jneuroim.2008.05.008; SCHMIED M, 1993, AM J PATHOL, V143, P446; Siffrin V, 2009, BRAIN, V132, P1247, DOI 10.1093/brain/awn354; Sonobe Y, 2007, TOHOKU J EXP MED, V213, P329, DOI 10.1620/tjem.213.329; Sun DM, 1998, J NEUROIMMUNOL, V81, P177, DOI 10.1016/S0165-5728(97)00176-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takatori H, 2008, MOD RHEUMATOL, V18, P533, DOI 10.1007/s10165-008-0099-z; van der Laan LJW, 2002, J NEUROSCI RES, V67, P191, DOI 10.1002/jnr.10095; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Xiao BG, 1998, J NEUROIMMUNOL, V84, P230, DOI 10.1016/S0165-5728(97)00264-6; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	52	47	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27473	10.1371/journal.pone.0027473	http://dx.doi.org/10.1371/journal.pone.0027473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22110656	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700057
J	Lindzen, M; Carvalho, S; Starr, A; Ben-Chetrit, N; Pradeep, CR; Koestler, WJ; Rabinkov, A; Lavi, S; Bacus, SS; Yarden, Y				Lindzen, M.; Carvalho, S.; Starr, A.; Ben-Chetrit, N.; Pradeep, C-R; Koestler, W. J.; Rabinkov, A.; Lavi, S.; Bacus, S. S.; Yarden, Y.			A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis	ONCOGENE			English	Article						cancer therapy; EGF; growth factor; tyrosine kinase; signal transduction	CORRESPONDING PRIMARY TUMORS; FACTOR RECEPTOR; IN-VIVO; BREAST-CANCER; LUNG-CANCER; SIGNALING NETWORK; FAMILY-MEMBERS; FACTOR-ALPHA; CELL-LINES; CARCINOMA	Epidermal growth factor (EGF)-like growth factors control tumor progression as well as evasion from the toxic effects of chemotherapy. Accordingly, antibodies targeting the cognate receptors, such as EGFR/ErbB-1 and the co-receptor HER2/ErbB-2, are widely used to treat cancer patients, but agents that target the EGF-like growth factors are not available. To circumvent the existence of 11 distinct ErbB ligands, we constructed a soluble fusion protein (hereinafter: TRAP-Fc) comprising truncated extracellular domains of EGFR/ErbB-1 and ErbB-4. The recombinant TRAP-Fc retained high-affinity ligand binding to EGF-like growth factors and partially inhibited growth of a variety of cultured tumor cells. Consistently, TRAP-Fc displayed an inhibitory effect in xenograft models of human cancer, as well as synergy with chemotherapy. Additionally, TRAP-Fc inhibited invasive growth of mammary tumor cells and reduced their metastatic seeding in the lungs of animals. Taken together, the activities displayed by TRAP-Fc reinforce critical roles of EGF-like growth factors in tumor progression, and they warrant further tests of TRAP-Fc in preclinical models. Oncogene (2012) 31, 3505-3515; doi:10.1038/onc.2011.518; published online 21 November 2011	[Lindzen, M.; Carvalho, S.; Ben-Chetrit, N.; Pradeep, C-R; Koestler, W. J.; Lavi, S.; Yarden, Y.] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Starr, A.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Pulm Dis, IL-69978 Tel Aviv, Israel; [Rabinkov, A.] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Bacus, S. S.] Quintiles, Westmont, IL USA	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; IQVIA	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	YARDEN, YOSEF/K-1467-2012	Starr, Alexander/0000-0002-9329-3740	National Cancer Institute [CA072981]; Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Linda and Michael Jacobs Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA072981, R37CA072981] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Linda and Michael Jacobs Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the help of the Israel Structural Proteomics Center. Our lab is supported by the National Cancer Institute (CA072981), the Israel Cancer Research Fund and Dr Miriam and Sheldon G Adelson Medical Research Foundation. WJK received a fellowship for PhD track for specialist medical doctors from the Linda and Michael Jacobs Charitable Trust. YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair.	ABOUDPIRAK E, 1988, J NATL CANCER I, V80, P1605, DOI 10.1093/jnci/80.20.1605; Adams TE, 2009, GROWTH FACTORS, V27, P141, DOI 10.1080/08977190902843565; Atlas E, 2003, MOL CANCER RES, V1, P165; Barozzi C, 2002, CANCER-AM CANCER SOC, V94, P647, DOI 10.1002/cncr.10278; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Bianchi S, 2006, J CELL PHYSIOL, V206, P702, DOI 10.1002/jcp.20535; Bijman MNA, 2009, ANTI-CANCER DRUG, V20, P450, DOI 10.1097/CAD.0b013e32832afc24; Britten CD, 2004, MOL CANCER THER, V3, P1335; Chen XM, 1996, J BIOL CHEM, V271, P7620, DOI 10.1074/jbc.271.13.7620; De Jong KP, 1998, HEPATOLOGY, V28, P971, DOI 10.1002/hep.510280411; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; Domagala T, 2000, GROWTH FACTORS, V18, P11, DOI 10.3109/08977190009003231; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; Freeman DJ, 2009, MOL CANCER THER, V8, P1536, DOI 10.1158/1535-7163.MCT-08-0978; Grandis JR, 1998, J CELL BIOCHEM, V69, P55, DOI 10.1002/(SICI)1097-4644(19980401)69:1<55::AID-JCB6>3.0.CO;2-U; Hsieh SY, 2011, HEPATOLOGY, V53, P504, DOI 10.1002/hep.24083; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Karamouzis MV, 2007, INT J BIOCHEM CELL B, V39, P851, DOI 10.1016/j.biocel.2006.11.017; Krane IM, 1996, ONCOGENE, V12, P1781; Lindzen M, 2010, P NATL ACAD SCI USA, V107, P12559, DOI 10.1073/pnas.1006218107; Mackenzie RP, 2009, EXPERT REV ANTICANC, V9, P1473, DOI [10.1586/era.09.109, 10.1586/ERA.09.109]; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Sanui A, 2010, ANTICANCER RES, V30, P3143; Sarup J, 2008, MOL CANCER THER, V7, P3223, DOI 10.1158/1535-7163.MCT-07-2151; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Thogersen VB, 2001, CANCER RES, V61, P6227; Tsujioka H, 2011, CURR OPIN OBSTET GYN, V23, P24, DOI 10.1097/GCO.0b013e3283409c91; Valabrega G, 2005, ONCOGENE, V24, P3002, DOI 10.1038/sj.onc.1208478; Weiner Louis M., 2006, Human Antibodies, V15, P103; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	40	25	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	30					3505	3515		10.1038/onc.2011.518	http://dx.doi.org/10.1038/onc.2011.518			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22105361	Green Accepted			2022-12-25	WOS:000306844100003
J	Shrestha, Y; Schafer, EJ; Boehm, JS; Thomas, SR; He, F; Du, J; Wang, S; Barretina, J; Weir, BA; Zhao, JJ; Polyak, K; Golub, TR; Beroukhim, R; Hahn, WC				Shrestha, Y.; Schafer, E. J.; Boehm, J. S.; Thomas, S. R.; He, F.; Du, J.; Wang, S.; Barretina, J.; Weir, B. A.; Zhao, J. J.; Polyak, K.; Golub, T. R.; Beroukhim, R.; Hahn, W. C.			PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling	ONCOGENE			English	Article						PAK1; transformation; MAPK; MET; merlin	COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; ANTITUMOR-ACTIVITY; OVARIAN-CARCINOMA; TYROSINE KINASE; PROTEIN-KINASE; EGF RECEPTOR; IN-VIVO; PATHWAY; CELLS	Activating mutations in the RAS family or BRAF frequently occur in many types of human cancers but are rarely detected in breast tumors. However, activation of the RAS-RAF-MEK-ERK MAPK pathway is commonly observed in human breast cancers, suggesting that other genetic alterations lead to activation of this signaling pathway. To identify breast cancer oncogenes that activate the MAPK pathway, we screened a library of human kinases for their ability to induce anchorage-independent growth in a derivative of immortalized human mammary epithelial cells (HMLE). We identified p21-activated kinase 1 (PAK1) as a kinase that permitted HMLE cells to form anchorage-independent colonies. PAK1 is amplified in several human cancer types, including 30-33% of breast tumor samples and cancer cell lines. The kinase activity of PAK1 is necessary for PAK1-induced transformation. Moreover, we show that PAK1 simultaneously activates MAPK and MET signaling; the latter via inhibition of merlin. Disruption of these activities inhibits PAK1-driven anchorage-independent growth. These observations establish PAK1 amplification as an alternative mechanism for MAPK activation in human breast cancer and credential PAK1 as a breast cancer oncogene that coordinately regulates multiple signaling pathways, the cooperation of which leads to malignant transformation. Oncogene (2012) 31, 3397-3408; doi:10.1038/onc.2011.515; published online 21 November 2011	[Shrestha, Y.; Schafer, E. J.; Thomas, S. R.; Barretina, J.; Weir, B. A.; Polyak, K.; Beroukhim, R.; Hahn, W. C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shrestha, Y.; Schafer, E. J.; Boehm, J. S.; Thomas, S. R.; He, F.; Du, J.; Barretina, J.; Weir, B. A.; Golub, T. R.; Beroukhim, R.; Hahn, W. C.] Broad Inst Harvard & MIT, Cambridge, MA USA; [He, F.; Du, J.; Golub, T. R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Wang, S.] Dana Farber Harvard Canc Ctr, Cytogenet Core Facil, Boston, MA USA; [Barretina, J.; Polyak, K.; Golub, T. R.; Hahn, W. C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Zhao, J. J.; Beroukhim, R.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Polyak, K.; Beroukhim, R.; Hahn, W. C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Polyak, K.; Beroukhim, R.; Hahn, W. C.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Dana 1538, Boston, MA 02215 USA.	William_Hahn@dfci.harvard.edu	Barretina, Jordi/A-7192-2013	Barretina, Jordi/0000-0002-3478-4080; Boehm, Jesse/0000-0002-6795-6336	Department of Defense [W81XWH-08-1-0767]; US National Cancer Institute [R33 CA128625, R01 CA130988]; Cancer Center Support Grant [NIH 5 P30 CA06516]; NATIONAL CANCER INSTITUTE [R33CA128625, R01CA130988, P30CA006516, RC2CA148268] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Nicole A Spardy, Christine L Nguyen and Yaara C Zwang for critical reading of the manuscript. We also thank the Dana-Farber/Harvard Cancer Center Cytogenetics Core for their assistance with fluorescence in situ hybridization studies. This work was supported in part by a Department of Defense Breast Cancer Research Program Pre-doctoral Fellowship (W81XWH-08-1-0767, YS), grants from the US National Cancer Institute (R33 CA128625 and R01 CA130988, WCH) and a Cancer Center Support Grant no. NIH 5 P30 CA06516 (Cytogenetics Core).	Appledorn DM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-13; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Bostner J, 2007, ONCOGENE, V26, P6997, DOI 10.1038/sj.onc.1210506; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; Christensen JG, 2003, CANCER RES, V63, P7345; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Freihoff D, 1999, BRIT J CANCER, V79, P754, DOI 10.1038/sj.bjc.6690121; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hirokawa Y, 2004, CANCER J, V10, P20, DOI 10.1097/00130404-200401000-00006; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kim DH, 2006, ONCOL REP, V16, P1053; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Knoll JH, 2005, CURR PROTOC HUM GENE; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; McClatchey AI, 2007, ANNU REV PATHOL-MECH, V2, P191, DOI 10.1146/annurev.pathol.2.010506.091940; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Miyakis S, 1998, BIOCHEM BIOPH RES CO, V251, P609, DOI 10.1006/bbrc.1998.9527; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Scheid MP, 2001, J MAMMARY GLAND BIOL, V6, P83, DOI 10.1023/A:1009520616247; Schraml P, 2003, AM J PATHOL, V163, P985, DOI 10.1016/S0002-9440(10)63458-X; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tu HF, 2011, ORAL ONCOL, V47, P211, DOI 10.1016/j.oraloncology.2011.01.003; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200	60	108	115	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	29					3397	3408		10.1038/onc.2011.515	http://dx.doi.org/10.1038/onc.2011.515			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	976FN	22105362	Green Submitted, Green Accepted			2022-12-25	WOS:000306566400001
J	Eylenstein, A; Schmidt, S; Gu, SC; Yang, WT; Schmid, E; Schmidt, EM; Alesutan, I; Szteyn, K; Regel, I; Shumilina, E; Lang, F				Eylenstein, Anja; Schmidt, Sebastian; Gu, Shuchen; Yang, Wenting; Schmid, Evi; Schmidt, Eva-Maria; Alesutan, Ioana; Szteyn, Kalina; Regel, Ivonne; Shumilina, Ekaterina; Lang, Florian			Transcription Factor NF-kappa B Regulates Expression of Pore-forming Ca2+ Channel Unit, Orai1, and Its Activator, STIM1, to Control Ca2+ Entry and Affect Cellular Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; CRAC CHANNEL; EPITHELIAL-CELLS; GENE-EXPRESSION; CALCIUM-ENTRY; MICE LACKING; KINASE; MUSCLE; MIGRATION; APOPTOSIS	The serum and glucocorticoid-inducible kinase SGK1 increases the activity of Orai1, the pore forming unit of store-operated Ca2+ entry, and thus influences Ca2+-dependent cellular functions such as migration. SGK1 further regulates transcription factor nuclear factor kappa B (NF-kappa B). This study explored whether SGK1 influences transcription of Orai1 and/or STIM1, the Orai1-activating Ca2+ sensor. Orai1 and STIM1 transcript levels were decreased in mast cells from SGK1 knock-out mice and increased in HEK293 cells transfected with active (S422D)SGK1 but not with inactive (K127N)SGK1 or in (S422D)SGK1-transfected cells treated with the NF-kappa B inhibitor Wogonin (100 mu M). Treatment with the stem cell factor enhanced transcript levels of STIM1 and Orai1 in sgk1(+/+) but not in sgk1(-/-) mast cells and not in sgk1(+/+) cells treated with Wogonin. Orai1 and STIM1 transcript levels were further increased in sgk1(+/+) and sgk1(-/-) mast cells by transfection with active NF-kappa B subunit p65 as well as in HEK293 cells by transfection with NF-kappa B subunits p65/p50 or p65/p52. They were decreased by silencing of NF-kappa B subunits p65, p50, or p52 or by NF-kappa B inhibitor Wogonin (100 mu M). Luciferase assay and chromatin immuno-precipitation defined NF-kappa B-binding sites in promoter regions accounting for NF-kappa B sensitive genomic regulation of STIM1 and Orai1. Store-operated Ca2+ entry was similarly increased by overexpression of p65/p50 or p65/p52 and decreased by treatment with Wogonin. Transfection of HEK293 cells with p65/p50 or p65/p52 further augmented migration. The present observations reveal powerful genomic regulation of Orai1/STIM1 by SGK1-dependent NF-kappa B signaling.	[Eylenstein, Anja; Schmidt, Sebastian; Gu, Shuchen; Yang, Wenting; Schmid, Evi; Schmidt, Eva-Maria; Alesutan, Ioana; Szteyn, Kalina; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Regel, Ivonne] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, D-81675 Munich, Germany	Eberhard Karls University of Tubingen; Technical University of Munich	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Regel, Ivonne/AFS-1831-2022		Deutsche Forschungsgemeinschaft [GK 1302, SFB 773]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GK 1302 and SFB 773).	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chung SC, 2007, J CELL BIOL, V177, P317, DOI 10.1083/jcb.200702050; Criollo A, 2010, AUTOPHAGY, V6, P189, DOI 10.4161/auto.6.1.10818; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Edwards JN, 2010, AM J PHYSIOL-CELL PH, V299, pC42, DOI 10.1152/ajpcell.00524.2009; Eylenstein A, 2011, FASEB J, V25, P2012, DOI 10.1096/fj.10-178210; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Faouzi M, 2011, J CELL PHYSIOL, V226, P542, DOI 10.1002/jcp.22363; Fas SC, 2006, BLOOD, V108, P3700, DOI 10.1182/blood-2006-03-011973; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Johnstone LS, 2010, J CELL MOL MED, V14, P1890, DOI 10.1111/j.1582-4934.2010.01097.x; Jung ID, 2009, CELL SIGNAL, V21, P1698, DOI 10.1016/j.cellsig.2009.07.008; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Keil JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013465; Lang F, 2000, P NATL ACAD SCI USA, V97, P8157, DOI 10.1073/pnas.97.14.8157; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Reid IR, 2008, SEMIN CELL DEV BIOL, V19, P473, DOI 10.1016/j.semcdb.2008.08.002; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ruan H, 2009, CURR OPIN INVEST DR, V10, P346; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Salter RD, 2009, IMMUNOL REV, V231, P278, DOI 10.1111/j.1600-065X.2009.00806.x; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Shin DM, 2008, NAT CELL BIOL, V10, P639, DOI 10.1038/ncb0608-639; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Vallon V, 2006, J MOL MED, V84, P396, DOI 10.1007/s00109-005-0027-z; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang K, 2010, CELL PHYSIOL BIOCHEM, V25, P271, DOI 10.1159/000276561; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	66	64	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2719	2730		10.1074/jbc.M111.275925	http://dx.doi.org/10.1074/jbc.M111.275925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22110130	hybrid, Green Published			2022-12-25	WOS:000300292300043
J	Masola, V; Gambaro, G; Tibaldi, E; Brunati, AM; Gastaldello, A; D'Angelo, A; Onisto, M; Lupo, A				Masola, Valentina; Gambaro, Giovanni; Tibaldi, Elena; Brunati, Anna Maria; Gastaldello, Alessandra; D'Angelo, Angela; Onisto, Maurizio; Lupo, Antonio			Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULOINTERSTITIAL FIBROSIS; DIABETIC-NEPHROPATHY; EXPRESSION; DISEASE; KIDNEY; BETA; ANGIOGENESIS; MECHANISMS; PATHWAYS; ALVEOLAR	The epithelial-mesenchymal transition (EMT) of proximal tubular epithelial cells (PTECs) into myofibroblasts contributes to the establishment of fibrosis that leads to end stage renal disease. FGF-2 induces EMT in PTECs. Because the interaction between FGF-2 and its receptor is mediated by heparan sulfate (HS) and syndecans, we speculated that a deranged HS/syndecans regulation impairs FGF-2 activity. Heparanase is crucial for the correct turnover of HS/syndecans. The aim of the present study was to assess the role of heparanase on epithelial-mesenchymal transition induced by FGF-2 in renal tubular cells. In human kidney 2 (HK2) PTEC cultures, although FGF-2 induces EMT in the wild-type clone, it is ineffective in heparanase-silenced cells. The FGF-2 induced EMT is through a stable activation of PI3K/AKT which is only transient in heparanase-silenced cells. In PTECs, FGF-2 induces an autocrine loop which sustains its signal through multiple mechanisms (reduction in syndecan-1, increase in heparanase, and matrix metalloproteinase 9). Thus, heparanase is necessary for FGF-2 to produce EMT in PTECs and to sustain FGF-2 intracellular signaling. Heparanase contributes to a synergistic loop for handling syndecan-1, facilitating FGF-2 induced-EMT. In conclusion, heparanase plays a role in the tubular-interstitial compartment favoring the FGF-2-dependent EMT of tubular cells. Hence, heparanase is an interesting pharmacological target for the prevention of renal fibrosis.	[Gambaro, Giovanni] Catholic Univ, Div Nephrol & Dialysis, Columbus Gemelli Univ Hosp, Renal Program,Inst Internal Med & Med Specialties, I-00168 Rome, Italy; [Masola, Valentina; Gastaldello, Alessandra; Onisto, Maurizio] Univ Padua, Dept Expt Biomed Sci, I-35122 Padua, Italy; [Tibaldi, Elena; Brunati, Anna Maria] Univ Padua, Dept Biol Chem, I-35122 Padua, Italy; [D'Angelo, Angela] Univ Padua, Dept Med & Surg Sci, Nephrol Unit, I-35122 Padua, Italy; [Lupo, Antonio] Univ Verona, Dept Med, Nephrol Sect, I-37129 Verona, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua; University of Padua; University of Padua; University of Verona	Gambaro, G (corresponding author), Catholic Univ, Div Nephrol & Dialysis, Columbus Gemelli Univ Hosp, Renal Program,Inst Internal Med & Med Specialties, Via Moscati 31, I-00168 Rome, Italy.	giovanni.gambaro@rm.unicatt.it	Onisto, Maurizio/K-5281-2014; Brunati, Anna Maria/I-8136-2018	Onisto, Maurizio/0000-0002-1191-7418; Brunati, Anna Maria/0000-0002-3481-9503; Masola, Valentina/0000-0003-2341-2481; Gambaro, Giovanni/0000-0001-5733-2370				Almeida S, 2010, NEUROTOX RES, V17, P399, DOI 10.1007/s12640-009-9116-z; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; GAMBARO G, 1992, ACTA DIABETOL, V29, P149, DOI 10.1007/BF00573480; Ha H, 2003, J AM SOC NEPHROL, V14, pS246, DOI 10.1097/01.ASN.0000077411.98742.54; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MALI M, 1993, J BIOL CHEM, V268, P24215; Masola V, 2011, BBA-MOL CELL RES, V1813, P1475, DOI 10.1016/j.bbamcr.2011.05.004; Masola V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-304; MORITA H, 1994, LAB INVEST, V71, P528; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Onisto M, 2005, INT J ONCOL, V27, P791; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; RAY PE, 1994, KIDNEY INT, V46, P759, DOI 10.1038/ki.1994.331; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Strutz FM, 2009, KIDNEY INT, V75, P475, DOI 10.1038/ki.2008.425; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	36	82	89	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1478	1488		10.1074/jbc.M111.279836	http://dx.doi.org/10.1074/jbc.M111.279836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102278	hybrid, Green Published			2022-12-25	WOS:000299170300061
J	Di Domizio, J; Zhang, R; Stagg, LJ; Gagea, M; Zhuo, M; Ladbury, JE; Cao, W				Di Domizio, Jeremy; Zhang, Ran; Stagg, Loren J.; Gagea, Mihai; Zhuo, Ming; Ladbury, John E.; Cao, Wei			Binding with Nucleic Acids or Glycosaminoglycans Converts Soluble Protein Oligomers to Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; RECOMBINANT PRION PROTEIN; BOVINE SERUM-ALBUMIN; FUNCTIONAL AMYLOIDS; ALZHEIMERS-DISEASE; COMMON MECHANISM; BETA-PEPTIDE; DARK SIDE; AGGREGATION; BETA(2)-MICROGLOBULIN	Ample evidence suggests that almost all polypeptides can either adopt a native structure (folded or intrinsically disordered) or form misfolded amyloid fibrils. Soluble protein oligomers exist as an intermediate between these two states, and their cytotoxicity has been implicated in the pathology of multiple human diseases. However, the mechanism by which soluble protein oligomers develop into insoluble amyloid fibrils is not clear, and investigation of this important issue is hindered by the unavailability of stable protein oligomers. Here, we have obtained stabilized protein oligomers generated from common native proteins. These oligomers exert strong cytotoxicity and display a common conformational structure shared with known protein oligomers. They are soluble and remain stable in solution. Intriguingly, the stabilized protein oligomers interact preferentially with both nucleic acids and glycosaminoglycans (GAG), which facilitates their rapid conversion into insoluble amyloid. Concomitantly, binding with nucleic acids or GAG strongly diminished the cytotoxicity of the protein oligomers. EGCG, a small molecule that was previously shown to directly bind to protein oligomers, effectively inhibits the conversion to amyloid. These results indicate that stabilized oligomers of common proteins display characteristics similar to those of disease-associated protein oligomers and represent immediate precursors of less toxic amyloid fibrils. Amyloid conversion is potently expedited by certain physiological factors, such as nucleic acids and GAGs. These findings concur with reports of cofactor involvement with disease-associated amyloid and shed light on potential means to interfere with the pathogenic properties of misfolded proteins.	[Di Domizio, Jeremy; Zhang, Ran; Zhuo, Ming; Cao, Wei] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Stagg, Loren J.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cao, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Unit 901, 7455 Fannin St, Houston, TX 77054 USA.	wcao@mdanderson.org	Di Domizio, Jeremy/L-1777-2019	Cao, Wei/0000-0002-8952-9159; Ladbury, John/0000-0002-6328-7200	National Institutes of Health [AI074809]; University of Texas M. D. Anderson Cancer Center; National Institutes of Health through M. D. Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas M. D. Anderson Cancer Center; National Institutes of Health through M. D. Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported, in whole or in part, by National Institutes of Health Grant AI074809 (to W. C.) and grants from The University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program (to W. C.). This work is also supported, in part, by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant (CA016672).	Ahn BW, 2000, ANAL BIOCHEM, V284, P401, DOI 10.1006/abio.2000.4719; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ellis RJ, 2002, NATURE, V416, P483, DOI 10.1038/416483a; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; Hooper NM, 2011, J NEUROCHEM, V116, P721, DOI 10.1111/j.1471-4159.2010.06936.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez JS, 2010, J ALZHEIMERS DIS, V22, P375, DOI 10.3233/JAD-2010-100189; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; McBride PA, 1998, EXP NEUROL, V149, P447, DOI 10.1006/exnr.1997.6740; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Nandi PK, 1998, ARCH VIROL, V143, P1251, DOI 10.1007/s007050050373; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Rysava R, 2007, KIDNEY BLOOD PRESS R, V30, P359, DOI 10.1159/000107980; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Schnabel J, 2010, NATURE, V464, P828, DOI 10.1038/464828a; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yu HJ, 2007, BIOPHYS J, V92, P185, DOI 10.1529/biophysj.106.093559; Zhang X., 2010, PROGR MOL BIOL TRANS, P309	54	41	42	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					736	747		10.1074/jbc.M111.238477	http://dx.doi.org/10.1074/jbc.M111.238477			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102410	Green Published, hybrid			2022-12-25	WOS:000298682400071
J	Al-Ani, GK; Patel, N; Pirani, KA; Zhu, TT; Dhalladoo, S; Zufferey, R				Al-Ani, Gada K.; Patel, Nipul; Pirani, Karim A.; Zhu, Tongtong; Dhalladoo, Subbhalakshmi; Zufferey, Rachel			The N-Terminal Domain and Glycosomal Localization of Leishmania Initial Acyltransferase LmDAT Are Important for Lipophosphoglycan Synthesis	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; GENE DELETION MUTANTS; TRYPANOSOMA-BRUCEI; MAJOR PROMASTIGOTES; TARGETING SIGNAL; VIRULENCE; DONOVANI; METABOLISM; INFECTION; PARASITES	Ether glycerolipids of Leishmania major are important membrane components as well as building blocks of various virulence factors. In L. major, the first enzyme of the ether glycerolipid biosynthetic pathway, LmDAT, is an unusual, glycosomal dihydroxyacetonephosphate acyltransferase important for parasite's growth and survival during the stationary phase, synthesis of ether lipids, and virulence. The present work extends our knowledge of this important biosynthetic enzyme in parasite biology. Site-directed mutagenesis of LmDAT demonstrated that an active enzyme was critical for normal growth and survival during the stationary phase. Deletion analyses showed that the large N-terminal extension of this initial acyltransferase may be important for its stability or activity. Further, abrogation of the C-terminal glycosomal targeting signal sequence of LmDAT led to extraglycosomal localization, did not impair its enzymatic activity but affected synthesis of the ether glycerolipid-based virulence factor lipophosphoglycan. In addition, expression of this recombinant form of LmDAT in a null mutant of LmDAT did not restore normal growth and survival during the stationary phase. These results emphasize the importance of this enzyme's compartmentalization in the glycosome for the generation of lipophosphoglycan and parasite's biology.	[Al-Ani, Gada K.; Pirani, Karim A.; Zufferey, Rachel] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Patel, Nipul; Zhu, Tongtong; Dhalladoo, Subbhalakshmi; Zufferey, Rachel] St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA	Kansas State University; Saint John's University	Al-Ani, GK (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	zufferer@stjohns.edu		Zhu, Tongtong/0000-0002-8201-2341	American Heart Association [0630001N]; National Institutes of Health [P20 RR016475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by an American Heart Association award (0630001N; www.americanheart.org) and by the National Institutes of Health (www.nih.gov/) Grant Number P20 RR016475 from the Institutional Development Award Network of Biomedical Research Excellence (INBRE) Program for Research Resources to RZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH DH, 1979, J PARASITOL, V65, P203, DOI 10.2307/3280147; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; Descoteaux A, 2002, MICROBES INFECT, V4, P975, DOI 10.1016/S1286-4579(02)01624-6; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; Heise N, 1997, MOL BIOCHEM PARASIT, V89, P61, DOI 10.1016/S0166-6851(97)00101-1; Ilg T, 2001, MED MICROBIOL IMMUN, V190, P13, DOI 10.1007/s004300100071; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Jardim A, 2002, MOL BIOCHEM PARASIT, V124, P51, DOI 10.1016/S0166-6851(02)00164-0; KELLEHER M, 1992, P NATL ACAD SCI USA, V89, P6, DOI 10.1073/pnas.89.1.6; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Matlashewski G, 2001, MED MICROBIOL IMMUN, V190, P37, DOI 10.1007/s004300100076; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; SOMMER JM, 1993, FEBS LETT, V316, P53, DOI 10.1016/0014-5793(93)81735-I; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; WASSEF MK, 1985, LIPIDS, V20, P108, DOI 10.1007/BF02534216; ZHANG K, MOL BIOCH PARASITOL, V170, P55; Zufferey R, 2006, J BIOL CHEM, V281, P7952, DOI 10.1074/jbc.M512911200; Zufferey R, 2005, MOL MICROBIOL, V56, P800, DOI 10.1111/j.1365-2958.2005.04579.x; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200; Zufferey R, 2009, MOL BIOCHEM PARASIT, V168, P177, DOI 10.1016/j.molbiopara.2009.08.006	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27802	10.1371/journal.pone.0027802	http://dx.doi.org/10.1371/journal.pone.0027802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114698	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555800037
J	Lamouse-Smith, ES; Tzeng, A; Starnbach, MN				Lamouse-Smith, Esi S.; Tzeng, Alice; Starnbach, Michael N.			The Intestinal Flora Is Required to Support Antibody Responses to Systemic Immunization in Infant and Germ Free Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIGEN-FREE DIET; COMMENSAL MICROBIOTA; CD8(+) T; GASTROINTESTINAL-TRACT; ANTIBIOTIC-TREATMENT; FUNGAL MICROBIOTA; IMMUNE-RESPONSES; INNATE IMMUNITY; B-CELLS	The presence of a complex and diverse intestinal flora is functionally important for regulating intestinal mucosal immune responses. However, the extent to which a balanced intestinal flora regulates systemic immune responses is still being defined. In order to specifically examine whether the acquisition of a less complex flora influences responses to immunization in the pre-weaning stages of life, we utilize a model in which infant mice acquire an intestinal flora from their mothers that has been altered by broad-spectrum antibiotics. In this model, pregnant dams are treated with a cocktail of antibiotics that alters both the density and microbial diversity of the intestinal flora. After challenge with a subcutaneous immunization, the antibiotic altered flora infant mice have lower antigen specific antibody titers compared to control age-matched mice. In a second model, we examined germ free (GF) mice to analyze how the complete lack of flora influences the ability to mount normal antibody responses following subcutaneous immunization. GF mice do not respond well to immunization and introduction of a normal flora into GF mice restores the capacity of these mice to respond. These results indicate that a gastrointestinal flora reduced in density and complexity at critical time points during development adversely impacts immune responses to systemic antigens.	[Lamouse-Smith, Esi S.] Childrens Hosp, Div Gastroenterol & Nutr, Boston, MA 02115 USA; [Tzeng, Alice; Starnbach, Michael N.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Lamouse-Smith, ES (corresponding author), Childrens Hosp, Div Gastroenterol & Nutr, 300 Longwood Ave, Boston, MA 02115 USA.	starnbach@hms.harvard.edu		Lamouse-Smith, Esi/0000-0002-1067-5795; Tzeng, Alice/0000-0001-7316-6923	NIH [DK07477]; Child Health Research Career Development Award [HD052896]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Health Research Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Esi S. Lamouse-Smith was supported by NIH grant DK07477 and Child Health Research Career Development Award HD052896. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Fak F, 2008, AM J PHYSIOL-GASTR L, V294, pG148, DOI 10.1152/ajpgi.00023.2007; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; HANSSON J, 2011, MOL IMMUNOL; Hasegawa M, 2010, INFECT IMMUN, V78, P639, DOI 10.1128/IAI.01043-09; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; HOOIJKAAS H, 1985, ADV EXP MED BIOL, V186, P131; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Huang T, 2005, CLIN IMMUNOL, V117, P221, DOI 10.1016/j.clim.2005.09.012; Huffnagle GB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000549; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iweala OI, 2009, J IMMUNOL, V183, P2252, DOI 10.4049/jimmunol.0804011; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Marodi L, 2006, INFECT IMMUN, V74, P1999, DOI 10.1128/IAI.74.4.1999-2006.2006; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P4996, DOI 10.1128/IAI.72.9.4996-5003.2004; Nutten S, 2007, CLIN VACCINE IMMUNOL, V14, P190, DOI 10.1128/CVI.00055-06; OHWAKI M, 1977, IMMUNOLOGY, V32, P43; Oyama N, 2001, J ALLERGY CLIN IMMUN, V107, P153, DOI 10.1067/mai.2001.111142; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Shreiner A, 2008, ADV EXP MED BIOL, V635, P113, DOI 10.1007/978-0-387-09550-9_10; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Takebayashi K, 2009, MICROCIRCULATION, V16, P251, DOI 10.1080/10739680802574166; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Wei B, 2008, CLIN IMMUNOL, V127, P303, DOI 10.1016/j.clim.2008.01.001; Wei B, 2008, EUR J IMMUNOL, V38, P3411, DOI 10.1002/eji.200838432; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yuan J, 2010, CURR MICROBIOL, V60, P6, DOI 10.1007/s00284-009-9492-x; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	54	64	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27662	10.1371/journal.pone.0027662	http://dx.doi.org/10.1371/journal.pone.0027662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114681	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800029
J	Ganaie, AA; Lella, RK; Solanki, R; Sharma, C				Ganaie, Arsheed A.; Lella, Ravi K.; Solanki, Rahul; Sharma, Charu			Thermostable Hexameric Form of Eis (Rv2416c) Protein of M. tuberculosis Plays an Important Role for Enhanced Intracellular Survival within Macrophages	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE; ACETYLTRANSFERASE EIS; RESISTANCE; OVEREXPRESSION; PERSISTENCE; STABILITY; GENE	Eis protein is reported to enhance the intracellular survival of Mycobacterium tuberculosis in human macrophages. Eis protein is not only known to skew away the immunity by disturbing the protective T(H)1 response, but aminoglycoside acetyltransferase activity of Eis is reported to regulate autophagy, inflammation and cell death. Here we have gained insight into the structure-function properties of Eis. Eis protein is a hexameric alpha beta protein. Although urea and guanidinium hydrochloride (GdmCl) was found to induce one-step unfolding of Eis but size exclusion chromatography showed that GdmCl treated Eis maintained its hexameric form. SDS-PAGE assay confirmed that hexameric form of Eis is partially stable to SDS and converts into trimers and monomers. Out of these three forms, aminoglycoside acetyltransferase activity is found to be associated only with hexamers. The Tm of Eis was found to be similar to 75 degrees C. Aminoglycoside acetyltransferase Eis demonstrated remarkable heat stability retaining >80% of their activity at 70 degrees C which falls down to similar to 50% at 75 degrees C and is completely inactive at 80 degrees C. Further, intracellular survival assay with heated samples of M. smegmatis harboring eis gene of M. tuberculosis H37Rv demonstrated a possible role for the thermostability associated with Eis protein in the enhanced intracellular survival within macrophages. In sum, these data reveal that only hexameric form of Eis has a thermostable aminoglycoside acetyltransferase activity. This is the first report showing the thermostability associated with aminoglycoside acetyltransferase activity of Eis protein being one of the essential features for the execution of its biological role.	[Ganaie, Arsheed A.; Solanki, Rahul; Sharma, Charu] CSIR, Inst Microbial Technol, Chandigarh, India; [Lella, Ravi K.] CSIR, Cent Drug Res Inst, Drug Target Discovery & Dev Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sharma, C (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	chash71@yahoo.com	Ganaie, Arsheed/Y-1556-2019	Ganaie, Arsheed/0000-0003-3460-1755	Council of Scientific and Industrial Research, New Delhi, India [NWP0038, SIP10]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Funding from Council of Scientific and Industrial Research [NWP0038 and SIP10], New Delhi, India, supported this work. RKL, AAG and RS thankfully acknowledge the Senior Research Fellowship from the Council of Scientific and Industrial Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa JA, 1997, MOL MICROBIOL, V24, P431, DOI 10.1046/j.1365-2958.1997.3471717.x; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Chen WJ, 2011, P NATL ACAD SCI USA, V108, P9804, DOI 10.1073/pnas.1105379108; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hamano Y, 2004, J BIOCHEM, V136, P517, DOI 10.1093/jb/mvh146; Hegde SS, 2001, J BIOL CHEM, V276, P45876, DOI 10.1074/jbc.M108810200; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Jones C H, 1867, Br Med J, V2, P84; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lella RK, 2007, J BIOL CHEM, V282, P18671, DOI 10.1074/jbc.C600280200; LOWRIE DB, 1983, J MED MICROBIOL, V16, P1, DOI 10.1099/00222615-16-1-1; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; MUHLEGOLL C, 1995, BIOCHEMISTRY-US, V34, P13554, DOI 10.1021/bi00041a035; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Samuel LP, 2007, MICROBIOL-SGM, V153, P529, DOI 10.1099/mic.0.2006/002642-0; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2002, NAT STRUCT BIOL, V9, P653, DOI 10.1038/nsb830; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	26	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27590	10.1371/journal.pone.0027590	http://dx.doi.org/10.1371/journal.pone.0027590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110681	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400063
J	Xuan, P; Guo, MZ; Huang, YC; Li, WB; Huang, YF				Xuan, Ping; Guo, Maozu; Huang, Yangchao; Li, Wenbin; Huang, Yufei			MaturePred: Efficient Identification of MicroRNAs within Novel Plant Pre-miRNAs	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; PREDICTION; CLASSIFICATION; SEQUENCE; MODEL; BIOGENESIS; REAL	Background: MicroRNAs (miRNAs) are a set of short (19 similar to 24 nt) non-coding RNAs that play significant roles as posttranscriptional regulators in animals and plants. The ab initio prediction methods show excellent performance for discovering new pre-miRNAs. While most of these methods can distinguish real pre-miRNAs from pseudo pre-miRNAs, few can predict the positions of miRNAs. Among the existing methods that can also predict the miRNA positions, most of them are designed for mammalian miRNAs, including human and mouse. Minority of methods can predict the positions of plant miRNAs. Accurate prediction of the miRNA positions remains a challenge, especially for plant miRNAs. This motivates us to develop MaturePred, a machine learning method based on support vector machine, to predict the positions of plant miRNAs for the new plant pre-miRNA candidates. Methodology/Principal Findings: A miRNA: miRNA* duplex is regarded as a whole to capture the binding characteristics of miRNAs. We extract the position-specific features, the energy related features, the structure related features, and stability related features from real/pseudo miRNA:miRNA* duplexes. A set of informative features are selected to improve the prediction accuracy. Two-stage sample selection algorithm is proposed to combat the serious imbalance problem between real and pseudo miRNA: miRNA* duplexes. The prediction method, MaturePred, can accurately predict plant miRNAs and achieve higher prediction accuracy compared with the existing methods. Further, we trained a prediction model with animal data to predict animal miRNAs. The model also achieves higher prediction performance. It further confirms the efficiency of our miRNA prediction method. Conclusions: The superior performance of the proposed prediction model can be attributed to the extracted features of plant miRNAs and miRNA*s, the selected training dataset, and the carefully selected features. The web service of MaturePred, the training datasets, the testing datasets, and the selected features are freely available at http://nclab.hit.edu.cn/maturepred/.	[Xuan, Ping; Guo, Maozu; Huang, Yangchao] Harbin Inst Technol, Dept Comp Sci & Engn, Harbin 150006, Peoples R China; [Xuan, Ping] Heilongjiang Univ, Sch Comp Sci & Technol, Harbin, Peoples R China; [Li, Wenbin] NE Agr Univ, Chinese Educ Minist, Soybean Res Inst, Key Lab Soybean Biol, Harbin, Peoples R China; [Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX USA	Harbin Institute of Technology; Heilongjiang University; Northeast Agricultural University - China; University of Texas System; University of Texas at San Antonio (UTSA)	Xuan, P (corresponding author), Harbin Inst Technol, Dept Comp Sci & Engn, Harbin 150006, Peoples R China.	maozuguo@hit.edu.cn; yufei.huang@utsa.edu	Huang, Yufei/AAU-2891-2021		Natural Science Foundation of China [60932008, 61172098, 60871092]; Fundamental Research Funds for the Central Universities [HIT.ICRST.2010 022]; Natural Science Foundation of Heilongjiang Province [F201119]; National Science Foundation [CCF-0546345]; National Institute of Health [R01 CA096512]; Qatar National Research Fund [09-874-3-235]; NATIONAL CANCER INSTITUTE [R01CA096512] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund(Qatar National Research Fund (QNRF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by the Natural Science Foundation of China (60932008, 61172098, and 60871092), the Fundamental Research Funds for the Central Universities (HIT.ICRST.2010 022), and the Natural Science Foundation of Heilongjiang Province (F201119). Yufei Huang is supported by the National Science Foundation Grant CCF-0546345, the National Institute of Health Grant R01 CA096512, and the Qatar National Research Fund Grant 09-874-3-235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Chang DTH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S2; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GaryWeiss M., 2004, SIGKDD EXPLOR NEWSL, V6, P7, DOI DOI 10.1145/1007730.1007734; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P734, DOI 10.1109/TPAMI.2002.1008381; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; Perez-Quintero AL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-138; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xuan P, 2011, BIOINFORMATICS, V27, P1368, DOI 10.1093/bioinformatics/btr153; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094	26	45	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27422	10.1371/journal.pone.0027422	http://dx.doi.org/10.1371/journal.pone.0027422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110646	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400044
J	Schulz-Mirbach, T; Hess, M; Plath, M				Schulz-Mirbach, Tanja; Hess, Martin; Plath, Martin			Inner Ear Morphology in the Atlantic Molly Poecilia mexicana-First Detailed Microanatomical Study of the Inner Ear of a Cyprinodontiform Species	PLOS ONE			English	Article							TOXIC HYDROGEN-SULFIDE; OTOLITHIC-MEMBRANE; SENSORY EPITHELIA; TELEOST; FISH; TOADFISH; SACCULUS; ORGANS; POPULATIONS; DIVERGENCE	Background: Fishes show an amazing diversity in hearing abilities, inner ear structures, and otolith morphology. Inner ear morphology, however, has not yet been investigated in detail in any member of the diverse order Cyprinodontiformes. We, therefore, studied the inner ear of the cyprinodontiform freshwater fish Poecilia mexicana by analyzing the position of otoliths in situ, investigating the 3D structure of sensory epithelia, and examining the orientation patterns of ciliary bundles of the sensory hair cells, while combining mu-CT analyses, scanning electron microscopy, and immunocytochemical methods. P. mexicana occurs in different ecotypes, enabling us to study the intra-specific variability (on a qualitative basis) of fish from regular surface streams, and the Cueva del Azufre, a sulfidic cave in southern Mexico. Results: The inner ear of Poecilia mexicana displays a combination of several remarkable features. The utricle is connected rostrally instead of dorso-rostrally to the saccule, and the macula sacculi, therefore, is very close to the utricle. Moreover, the macula sacculi possesses dorsal and ventral bulges. The two studied ecotypes of P. mexicana showed variation mainly in the shape and curvature of the macula lagenae, in the curvature of the macula sacculi, and in the thickness of the otolithic membrane. Conclusions: Our study for the first time provides detailed insights into the auditory periphery of a cyprinodontiform inner ear and thus serves a basis-especially with regard to the application of 3D techniques-for further research on structure-function relationships of inner ears within the species-rich order Cyprinodontiformes. We suggest that other poeciliid taxa, or even other non-poeciliid cyprinodontiforms, may display similar inner ear morphologies as described here.	[Schulz-Mirbach, Tanja] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Hess, Martin] Univ Munich, Dept Biol 1, Martinsried, Germany; [Plath, Martin] Goethe Univ Frankfurt, Frankfurt, Germany	University of Munich; University of Munich; Goethe University Frankfurt	Schulz-Mirbach, T (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	tanja.schulz-mirbach@univie.ac.at			Bayerische Gleichstellungsforderung; University of Bavaria e.V.; Deutsche Forschungsgemeinschaft (DFG) [PL 470/1-2]; initiative Nachwuchswissenschaftler im Fokus of the Presidential Office of the J.W. Goethe University of Frankfurt	Bayerische Gleichstellungsforderung; University of Bavaria e.V.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); initiative Nachwuchswissenschaftler im Fokus of the Presidential Office of the J.W. Goethe University of Frankfurt	Financial support was provided by postdoctoral scholarships of the "Bayerische Gleichstellungsforderung" and the University of Bavaria e.V. (to TSM), and by Deutsche Forschungsgemeinschaft (DFG; PL 470/1-2) and the initiative Nachwuchswissenschaftler im Fokus of the Presidential Office of the J.W. Goethe University of Frankfurt (to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang PI, 2001, J COMP NEUROL, V438, P173, DOI 10.1002/cne.1308; BENSER ME, 1993, HEARING RES, V68, P243, DOI 10.1016/0378-5955(93)90128-N; Buran BN, 2005, J MORPHOL, V265, P215, DOI 10.1002/jmor.10355; Deng XH, 2011, DEEP-SEA RES PT I, V58, P27, DOI 10.1016/j.dsr.2010.11.001; DUNKELBERGER DG, 1980, J MORPHOL, V163, P367, DOI 10.1002/jmor.1051630309; Edds-Walton PL, 2009, J EXP BIOL, V212, P1483, DOI 10.1242/jeb.026898; Fay Richard R., 2008, V32, P49; Fay RR, 1997, HEARING RES, V111, P1, DOI 10.1016/S0378-5955(97)00083-X; Ghanem TA, 1998, HEARING RES, V124, P27, DOI 10.1016/S0378-5955(98)00108-7; GORDON MALCOLM S., 1962, COPEIA, V2, P360; Hertwig I, 1999, EUR J MORPHOL, V37, P17, DOI 10.1076/ejom.37.1.17.4765; Hertwig ST, 2008, ZOOL SCR, V37, P141, DOI 10.1111/j.1463-6409.2007.00314.x; Ibsch M, 1998, ADV SPACE RES, V22, P287, DOI 10.1016/S0273-1177(98)80022-7; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Lombarte A, 2004, MAR ECOL PROG SER, V267, P233, DOI 10.3354/meps267233; LOMBARTE A, 1992, J MORPHOL, V214, P97, DOI 10.1002/jmor.1052140107; Lu ZM, 1998, HEARING RES, V126, P47, DOI 10.1016/S0378-5955(98)00149-X; Lu ZM, 2001, J COMP PHYSIOL A, V187, P453, DOI 10.1007/s003590100218; Nolf D., 1985, Handbook of Paleoichthyology, V10, P1; Noro S., 2007, FISH BIOL J MEDAKA, V11, P31; NORRIS S. M., 2005, FRESHWATER FISHES ME; Plath M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-256; Plath M, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P281; PLATT C, 1981, HEARING SOUND COMMUN, P3, DOI DOI 10.1007/978-1-4615-7186-5_; Popper AN, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P252; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; POPPER AN, 1981, J COMP NEUROL, V200, P357, DOI 10.1002/cne.902000306; POPPER AN, 1982, AM ZOOL, V22, P311; POPPER AN, 1976, SCIENCE, V192, P1020, DOI 10.1126/science.1273585; POPPER AN, 1977, J MORPHOL, V153, P397, DOI 10.1002/jmor.1051530306; POPPER AN, 1983, J MORPHOL, V176, P121, DOI 10.1002/jmor.1051760202; Popper AN, 2000, FISH RES, V46, P15, DOI 10.1016/S0165-7836(00)00129-6; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Popper Arthur N., 2003, P3, DOI 10.1007/978-0-387-22628-6_1; Popper Arthur N., 2008, V32, P17; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Retzius G., 1881, GEHORORGAN WIRBELTHI, V1; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Riesch R, 2011, J EVOLUTION BIOL, V24, P596, DOI 10.1111/j.1420-9101.2010.02194.x; Rogers Peter H., 2008, V32, P233; Rohlf F.J., 2004, TPSDIG VER 2 0; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; SCHELLART NAM, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P295; Schulz-Mirbach T, 2008, EVOL ECOL RES, V10, P537; Schulz-Mirbach T, 2010, HEARING RES, V267, P137, DOI 10.1016/j.heares.2010.04.001; SCHULZMIRBACH T, ZOOLOGY IN PRESS; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler M, 2006, EXTREMOPHILES, V10, P577, DOI 10.1007/s00792-006-0531-2; Tobler Michael, 2011, P120; Tobler M, 2009, EVOL ECOL RES, V11, P935; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199	52	25	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27734	10.1371/journal.pone.0027734	http://dx.doi.org/10.1371/journal.pone.0027734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110746	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300050
J	Thudi, M; Bohra, A; Nayak, SN; Varghese, N; Shah, TM; Penmetsa, RV; Thirunavukkarasu, N; Gudipati, S; Gaur, PM; Kulwal, PL; Upadhyaya, HD; KaviKishor, PB; Winter, P; Kahl, G; Town, CD; Kilian, A; Cook, DR; Varshney, RK				Thudi, Mahendar; Bohra, Abhishek; Nayak, Spurthi N.; Varghese, Nicy; Shah, Trushar M.; Penmetsa, R. Varma; Thirunavukkarasu, Nepolean; Gudipati, Srivani; Gaur, Pooran M.; Kulwal, Pawan L.; Upadhyaya, Hari D.; KaviKishor, Polavarapu B.; Winter, Peter; Kahl, Guenter; Town, Christopher D.; Kilian, Andrzej; Cook, Douglas R.; Varshney, Rajeev K.			Novel SSR Markers from BAC-End Sequences, DArT Arrays and a Comprehensive Genetic Map with 1,291 Marker Loci for Chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; DIVERSITY ARRAYS; LINKAGE MAP; MEDICAGO-TRUNCATULA; TECHNOLOGY DART; CONSENSUS MAP; INTEGRATION; GENOME; CONSTRUCTION; RESISTANCE	Chickpea (Cicer arietinum L.) is the third most important cool season food legume, cultivated in arid and semi-arid regions of the world. The goal of this study was to develop novel molecular markers such as microsatellite or simple sequence repeat (SSR) markers from bacterial artificial chromosome (BAC)-end sequences (BESs) and diversity arrays technology (DArT) markers, and to construct a high-density genetic map based on recombinant inbred line (RIL) population ICC 4958 (C. arietinum) 6PI 489777 (C. reticulatum). A BAC-library comprising 55,680 clones was constructed and 46,270 BESs were generated. Mining of these BESs provided 6,845 SSRs, and primer pairs were designed for 1,344 SSRs. In parallel, DArT arrays with ca. 15,000 clones were developed, and 5,397 clones were found polymorphic among 94 genotypes tested. Screening of newly developed BES-SSR markers and DArT arrays on the parental genotypes of the RIL mapping population showed polymorphism with 253 BES-SSR markers and 675 DArT markers. Segregation data obtained for these polymorphic markers and 494 markers data compiled from published reports or collaborators were used for constructing the genetic map. As a result, a comprehensive genetic map comprising 1,291 markers on eight linkage groups (LGs) spanning a total of 845.56 cM distance was developed (http://cmap.icrisat.ac.in/cmap/sm/cp/thudi/). The number of markers per linkage group ranged from 68 (LG 8) to 218 (LG 3) with an average inter-marker distance of 0.65 cM. While the developed resource of molecular markers will be useful for genetic diversity, genetic mapping and molecular breeding applications, the comprehensive genetic map with integrated BES-SSR markers will facilitate its anchoring to the physical map (under construction) to accelerate map-based cloning of genes in chickpea and comparative genome evolution studies in legumes.	[Thudi, Mahendar; Bohra, Abhishek; Nayak, Spurthi N.; Varghese, Nicy; Shah, Trushar M.; Gudipati, Srivani; Gaur, Pooran M.; Upadhyaya, Hari D.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Grain Legumes Res Program, Hyderabad, Andhra Pradesh, India; [Bohra, Abhishek; Nayak, Spurthi N.; KaviKishor, Polavarapu B.] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Penmetsa, R. Varma; Cook, Douglas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Thirunavukkarasu, Nepolean] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Kulwal, Pawan L.] Mahatma Phule Krishi Vidyapeeth, State Level Biotechnol Ctr, Ahmednagar, India; [Winter, Peter] GenXPro GmbH, Frankfurt, Germany; [Kahl, Guenter] Goethe Univ Frankfurt, Frankfurt, Germany; [Town, Christopher D.] J Craig Venter Inst, Rockville, MD USA; [Kilian, Andrzej] DArT Pty Ltd, Yarralumla, Australia; [Varshney, Rajeev K.] CIMMYT, CGIAR Generat Challenge Programme, Mexico City 06600, DF, Mexico	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Osmania University; University of California System; University of California Davis; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Goethe University Frankfurt; J. Craig Venter Institute; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Thudi, M (corresponding author), Int Crops Res Inst Semi Arid Trop, Grain Legumes Res Program, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014; Gaur, Pooran Mal/ABE-6102-2020; Updhayaya, Hari/C-4858-2014; Gaur, Pooran/AAR-5729-2021; THUDI, MAHENDAR/GXA-1578-2022; Kulwal, Pawan/CAJ-1065-2022	Varshney, Rajeev K/0000-0002-4562-9131; Gaur, Pooran Mal/0000-0002-7086-5873; Updhayaya, Hari/0000-0002-5166-6844; THUDI, MAHENDAR/0000-0003-2851-6837; Kilian, Andrzej/0000-0002-2730-7462; KULWAL, PAWAN/0000-0002-3077-183X; Shah, Trushar/0000-0002-0091-7981	CGIAR; Bill and Melinda Gates Foundation (BMGF); Indian Council of Agricultural Research (ICAR) and Department of Biotechnology (DBT), Government of India	CGIAR(CGIAR); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Indian Council of Agricultural Research (ICAR) and Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) IndiaIndian Council of Agricultural Research (ICAR))	Financial support from Tropical Legumes I of Generation Challenge Program (GCP; http://www.generationcp.org/) of CGIAR, Bill and Melinda Gates Foundation (BMGF) and National Fund for Basic and Strategic Research in Agriculture (NFBSRA; http://www.icar.org.in/nfbsfara/index.html) of Indian Council of Agricultural Research (ICAR) and Department of Biotechnology (DBT), Government of India, are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Cordoba JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-436; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; GAUR PM, 2005, FOCUS 2005 CHICKPEA, P8; Gaur R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-117; Gujaria N, 2011, THEOR APPL GENET, V122, P1577, DOI 10.1007/s00122-011-1556-1; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Huettel B, 2002, THEOR APPL GENET, V105, P479, DOI 10.1007/s00122-002-0933-1; Huttel B, 1999, GENOME, V42, P210, DOI 10.1139/gen-42-2-210; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kofler R, 2008, THEOR APPL GENET, V117, P915, DOI 10.1007/s00122-008-0831-2; Kopecky D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-473; KOROL AB, 1994, HEREDITY, V70, P254; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lichtenzveig J, 2005, THEOR APPL GENET, V110, P492, DOI 10.1007/s00122-004-1857-8; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Millan T, 2010, EUPHYTICA, V175, P175, DOI 10.1007/s10681-010-0157-4; Moore G, 2000, ANNU REV PLANT PHYS, V51, P195, DOI 10.1146/annurev.arplant.51.1.195; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Nayak SN, 2010, THEOR APPL GENET, V120, P1415, DOI 10.1007/s00122-010-1265-1; Peleg Z, 2008, THEOR APPL GENET, V117, P103, DOI 10.1007/s00122-008-0756-9; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; Radhika P, 2007, THEOR APPL GENET, V115, P209, DOI 10.1007/s00122-007-0556-7; Rajesh PN, 2008, EUPHYTICA, V162, P291, DOI 10.1007/s10681-008-9675-8; Rajesh PN, 2004, THEOR APPL GENET, V108, P663, DOI 10.1007/s00122-003-1464-0; Rakshit S, 2003, EUPHYTICA, V132, P23, DOI 10.1023/A:1024681422799; Ramsay L, 2000, GENETICS, V156, P1997; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Sewell MM, 1999, GENETICS, V151, P321; Sharma B. C., 2008, Journal of Food Legumes, V21, P211; Shultz JL, 2007, THEOR APPL GENET, V114, P1081, DOI 10.1007/s00122-007-0501-9; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Supriya A, 2011, THEOR APPL GENET, V123, P239, DOI 10.1007/s00122-011-1580-1; TANKSLEY SD, 1992, GENETICS, V132, P1141; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Upadhyaya HD, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-106; *VAN, 2006, JOINMAP 4 SOFTW CALC; Varshney RK, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P119, DOI 10.1007/978-90-481-2967-6_5; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Varshney RK, 2010, PLANT BREEDING REV, V33, P257; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Winter P, 1999, MOL GEN GENET, V262, P90, DOI 10.1007/s004380051063; Winter P, 2000, THEOR APPL GENET, V101, P1155, DOI 10.1007/s001220051592; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	63	124	124	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27275	10.1371/journal.pone.0027275	http://dx.doi.org/10.1371/journal.pone.0027275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102885	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000297555300014
J	Furuhashi, M; Ishimura, S; Ota, H; Hayashi, M; Nishitani, T; Tanaka, M; Yoshida, H; Shimamoto, K; Hotamisligil, GS; Miura, T				Furuhashi, Masato; Ishimura, Shutaro; Ota, Hideki; Hayashi, Manabu; Nishitani, Takahiro; Tanaka, Marenao; Yoshida, Hideaki; Shimamoto, Kazuaki; Hotamisligil, Goekhan S.; Miura, Tetsuji			Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease	PLOS ONE			English	Article							METABOLIC SYNDROME; HEMODIALYSIS-PATIENTS; APOLIPOPROTEIN-E; ADIPOCYTE; ATHEROSCLEROSIS; AP2; MICE; OBESITY; DEFICIENT; BIOMARKER	Background: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both adipocytes and macrophages. Recent studies have shown that FABP4 is secreted from adipocytes and that FABP4 level is associated with obesity, insulin resistance, and atherosclerosis. However, little is known about the impact of FABP4 concentrations on prognosis. We tested the hypothesis that FABP4 level predicts prognosis of patients with end-stage renal disease (ESRD), a group at high risk for atherosclerosis-associated morbidity and mortality. Methods and Results: Biochemical markers including FABP4 were determined in 61 ESRD patients on chronic hemodialysis (HD). Serum FABP4 level in females (404.2 +/- 30.5 ng/ml) was significantly higher than that in males (315.8 +/- 30.0 ng/ml), and the levels in ESRD patients were about 20-times higher than those in age-, gender- and body mass index (BMI)-matched control subjects with normal renal function. FABP4 level was decreased by 57.2% after HD and was positively correlated with blood pressure, BMI, and levels of lipids and insulin. Multiple regression analysis indicated that HD duration, BMI, and triglycerides level were independent determinants for FABP4 level. ESRD patients with high FABP4 levels had higher cardiovascular mortality during the 7-year follow-up period. Cox proportional hazard regression analysis showed that logarithmically transformed FABP4 level was an independent predictor of cardiovascular death adjusted for age, gender, HD duration, BMI, and triglycerides level (hazard ratio, 7.75; 95% CI, 1.05-25.31). Conclusion: These findings suggest that FABP4 level, being related to adiposity and metabolic disorders, is a novel predictor of cardiovascular mortality in ESRD.	[Furuhashi, Masato; Ishimura, Shutaro; Ota, Hideki; Tanaka, Marenao; Yoshida, Hideaki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Hayashi, Manabu] Obihiro Kosei Hosp, Dept Internal Med 2, Obihiro, Hokkaido, Japan; [Nishitani, Takahiro] Obihiro E Med & Cardiovasc Clin, Obihiro, Hokkaido, Japan; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Sapporo Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Furuhashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp	Marenao, Tanaka/ABA-4054-2020; Furuhashi, Masato/AAT-5518-2021	Furuhashi, Masato/0000-0002-0145-3541; Tanaka, Marenao/0000-0002-6575-9996	The Ministry of Education, Culture, Sports, Science and Technology; Uehara Memorial Foundation; Senshin Medical Research Foundation; Naito Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Cardiovascular Research Foundation; Suzuken Memorial Foundation; Sumitomo Foundation; Tokyo Biochemical Research Foundation; Japan Diabetes Foundation; Ono Medical Research Foundation; Novartis Foundation (Japan) for the Promotion of Science; Japan Foundation for Applied Enzymology; The Ichiro Kanehara Foundation; Grants-in-Aid for Scientific Research [23591106] Funding Source: KAKEN	The Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Cardiovascular Research Foundation; Suzuken Memorial Foundation; Sumitomo Foundation; Tokyo Biochemical Research Foundation; Japan Diabetes Foundation; Ono Medical Research Foundation; Novartis Foundation (Japan) for the Promotion of Science(Novartis); Japan Foundation for Applied Enzymology; The Ichiro Kanehara Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Grant-in-Aid for Scientific Research for The Ministry of Education, Culture, Sports, Science and Technology, Uehara Memorial Foundation, Senshin Medical Research Foundation, Naito Foundation Natural Science Scholarship, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Kanae Foundation for the Promotion of Medical Science, Cardiovascular Research Foundation, Suzuken Memorial Foundation, Sumitomo Foundation, Tokyo Biochemical Research Foundation, Japan Diabetes Foundation, Ono Medical Research Foundation, Novartis Foundation (Japan) for the Promotion of Science, Japan Foundation for Applied Enzymology, and The Ichiro Kanehara Foundation (to M. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; El Nahas M, 2010, KIDNEY INT, V78, P14, DOI 10.1038/ki.2010.123; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Furuhashi M, 2003, NEPHRON CLIN PRACT, V93, pC69, DOI 10.1159/000068520; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Sommer G, 2008, CLIN ENDOCRINOL, V69, P901, DOI 10.1111/j.1365-2265.2008.03277.x; Tsai JP, 2010, ARCH MED RES, V41, P536, DOI 10.1016/j.arcmed.2010.09.007; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yeung DCY, 2009, DIABETES CARE, V32, P132, DOI 10.2337/dc08-1333; Ziegelmeier M, 2007, DIABETES CARE, V30, P2588, DOI 10.2337/dc07-0275; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	22	73	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27356	10.1371/journal.pone.0027356	http://dx.doi.org/10.1371/journal.pone.0027356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102888	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800022
J	Freire, MAM; Morya, E; Faber, J; Santos, JR; Guimaraes, JS; Lemos, NAM; Sameshima, K; Pereira, A; Ribeiro, S; Nicolelis, MAL				Freire, Marco Aurelio M.; Morya, Edgard; Faber, Jean; Santos, Jose Ronaldo; Guimaraes, Joanilson S.; Lemos, Nelson A. M.; Sameshima, Koichi; Pereira, Antonio; Ribeiro, Sidarta; Nicolelis, Miguel A. L.			Comprehensive Analysis of Tissue Preservation and Recording Quality from Chronic Multielectrode Implants	PLOS ONE			English	Article							NADPH-DIAPHORASE HISTOCHEMISTRY; BRAIN-COMPUTER INTERFACES; RATS BARREL FIELD; SPINAL-CORD; NEUROLOGICAL REHABILITATION; MICROELECTRODE ARRAYS; REACTIVE ASTROCYTES; MACHINE INTERFACES; MOTOR CORTEX; INJURY	Multielectrodes have been used with great success to simultaneously record the activity of neuronal populations in awake, behaving animals. In particular, there is great promise in the use of this technique to allow the control of neuroprosthetic devices by human patients. However, it is crucial to fully characterize the tissue response to the chronic implants in animal models ahead of the initiation of human clinical trials. Here we evaluated the effects of unilateral multielectrode implants on the motor cortex of rats weekly recorded for 1-6 months using several histological methods to assess metabolic markers, inflammatory response, immediate-early gene (IEG) expression, cytoskeletal integrity and apoptotic profiles. We also investigated the correlations between each of these features and firing rates, to estimate the impact of post-implant time on neuronal recordings. Overall, limited neuronal loss and glial activation were observed on the implanted sites. Reactivity to enzymatic metabolic markers and IEG expression were not significantly different between implanted and non-implanted hemispheres. Multielectrode recordings remained viable for up to 6 months after implantation, and firing rates correlated well to the histochemical and immunohistochemical markers. Altogether, our results indicate that chronic tungsten multielectrode implants do not substantially alter the histological and functional integrity of target sites in the cerebral cortex.	[Freire, Marco Aurelio M.; Faber, Jean; Santos, Jose Ronaldo; Guimaraes, Joanilson S.; Lemos, Nelson A. M.; Nicolelis, Miguel A. L.] Edmond & Lily Safra Int Inst Neurosci Natal, Natal, RN, Brazil; [Morya, Edgard; Sameshima, Koichi; Nicolelis, Miguel A. L.] Sirio Libanes Hosp, Clin Neurophysiol Lab, Assoc Alberto Santos Dumont Apoio Pesquisa, Sao Paulo, Brazil; [Faber, Jean] CEA, LETI, Fdn Nanosci & Clinatec, Grenoble, France; [Sameshima, Koichi] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil; [Pereira, Antonio; Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Ctr Neuroengn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Brain Sci, Durham, NC USA	Hospital Sirio Libanes; CEA; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte; Duke University; Duke University; Duke University	Freire, MAM (corresponding author), Yale Univ, John B Pierce Lab, New Haven, CT 06520 USA.	nicoleli@neuro.duke.edu	Morya, Edgard/K-4153-2012; MORYA, EDGARD/R-1251-2019; Pereira, Antonio/AAY-4372-2020; Sameshima, Koichi/AHA-5593-2022; Sameshima, Koichi/C-2857-2012; Santos, José R/N-2505-2013; Incemaq, Inct/J-8752-2013; Freire, Marco/A-1450-2010; Alessandretti de Mello Lemos, Nelson/N-1413-2014; Ribeiro, Sidarta/C-5794-2016	Morya, Edgard/0000-0003-0954-5317; MORYA, EDGARD/0000-0003-0954-5317; Pereira, Antonio/0000-0002-0808-1058; Sameshima, Koichi/0000-0002-0290-2927; Sameshima, Koichi/0000-0002-0290-2927; Freire, Marco/0000-0002-6483-0498; Faber, Jean/0000-0002-2129-8251; Alessandretti de Mello Lemos, Nelson/0000-0001-9382-9982; Ribeiro, Sidarta/0000-0001-9325-9545; Santos, Jose Ronaldo/0000-0001-9108-7532	Financiadora de Estudos e Projetos [01.06.1092.00]; Instituto Nacional de Interface Cerebro-Maquina [704134/2009]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Edital Universal [481506/2007-1]; Pew Latin-American Program in Biomedical Science; Defense Advanced Research Projects Agency (DARPA) [N66001-06-C-2019]; National Institutes of Dental and Craniofacial Research (NIDCR) [R01-DE011451]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011451] Funding Source: NIH RePORTER	Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Nacional de Interface Cerebro-Maquina; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Edital Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pew Latin-American Program in Biomedical Science; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Associacao Alberto Santos Dumont para Apoio a Pesquisa, Financiadora de Estudos e Projetos (01.06.1092.00), Instituto Nacional de Interface Cerebro-Maquina (704134/2009), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Edital Universal (481506/2007-1), Pew Latin-American Program in Biomedical Science, Defense Advanced Research Projects Agency (DARPA) contract (N66001-06-C-2019) and the National Institutes of Dental and Craniofacial Research (NIDCR) (R01-DE011451). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW WF, 1993, NEUROSCIENCE, V52, P45, DOI 10.1016/0306-4522(93)90180-N; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chaudhuri A, 1997, NEUROREPORT, V8, pR5; Colton C, 1996, MOL CHEM NEUROPATHOL, V28, P15, DOI 10.1007/BF02815200; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Freire MAM, 2005, J CHEM NEUROANAT, V30, P71, DOI 10.1016/j.jchemneu.2005.04.006; Freire MAM, 2004, NEUROSCI RES, V50, P55, DOI 10.1016/j.neures.2004.05.009; Freire MAM, 2007, NEUROTOXICOLOGY, V28, P175, DOI 10.1016/j.neuro.2006.06.007; Freire MAM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00146; GARRISON CJ, 1994, EXP NEUROL, V129, P237, DOI 10.1006/exnr.1994.1165; GIESE H, 1995, NEUROSCI LETT, V191, P169, DOI 10.1016/0304-3940(95)11584-J; GINTY DD, 1991, J BIOL CHEM, V266, P17454; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018; Guimaraes JS, 2010, BRAIN RES, V1329, P182, DOI 10.1016/j.brainres.2010.03.007; Guimares JS, 2009, REV NEUROLOGIA, V48, P304, DOI 10.33588/rn.4806.2008512; Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lasiene J, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/718987; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Marin Cristina, 2010, Front Neuroeng, V3, P8, DOI 10.3389/fneng.2010.00008; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Nguyen DP, 2009, J VIS EXP, V26, P1098; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1993, NATURE, V361, P533, DOI 10.1038/361533a0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nunes ACL, 2010, BRAIN RES, V1345, P125, DOI 10.1016/j.brainres.2010.05.041; Ojakangas CL, 2006, J CLIN NEUROPHYSIOL, V23, P577, DOI 10.1097/01.wnp.0000233323.87127.14; Oka J, 2000, NEUROSCI RES, V36, P93, DOI 10.1016/S0168-0102(99)00106-6; Patel S, 2004, NEUROSURGERY, V55, P201, DOI 10.1227/01.NEU.0000126949.28912.71; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pesaran B, 2010, CURR OPIN NEUROBIOL, V20, P166, DOI 10.1016/j.conb.2010.03.003; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; Roitbak T, 1999, GLIA, V28, P40, DOI 10.1002/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6; Rothschild Ryan Mark, 2010, Front Neuroeng, V3, P112, DOI 10.3389/fneng.2010.00112; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SCHERERSINGLER U, 1983, J NEUROSCI METH, V9, P229, DOI 10.1016/0165-0270(83)90085-7; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stieglitz T, 2004, BIOMED TECH, V49, P72, DOI 10.1515/BMT.2004.015; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Vasconcelos N, 2011, P NATL ACAD SCI USA, V108, P15408, DOI 10.1073/pnas.1102780108; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Weldon DT, 1998, J NEUROSCI, V18, P2161; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	74	66	67	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27554	10.1371/journal.pone.0027554	http://dx.doi.org/10.1371/journal.pone.0027554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096594	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800061
J	Ferrero, GO; Velazquez, FN; Caputto, BL				Ferrero, G. O.; Velazquez, F. N.; Caputto, B. L.			The kinase c-Src and the phosphatase TC45 coordinately regulate c-Fos tyrosine phosphorylation and c-Fos phospholipid synthesis activation capacity	ONCOGENE			English	Article						cytoplasmic c-Fos; phospholipid synthesis regulation; c-Fos-tyr phosphorylation; c-Src; TC45 phosphatase	GROWTH-FACTOR RECEPTOR; NEGATIVE REGULATOR; SIGNALING PATHWAY; INSULIN-RECEPTOR; PC12 CELLS; PROTEIN; LIGHT; TCPTP; NUCLEUS; RETINA	Our previous work showed that in T98G cells, a human glioblastoma multiforme-derived cell line, the association of c-Fos to the endoplasmic reticulum (ER) and consequently, the capacity of c-Fos to activate phospholipid synthesis, is regulated by the phosphorylation state of tyrosine (tyr) residues # 10 and # 30 of c-Fos. The small amount of c-Fos present in quiescent cells is tyrphosphorylated, is dissociated from the ER membranes and does not activate phospholipid synthesis. However, on induction of the cell to re-enter growth, c-Fos expression is rapidly induced, it is found dephosphorylated, associated to ER membranes and activating phospholipid synthesis (Portal et al., 2007). Herein, using in vivo and in vitro experimental strategies, we show that the kinase c-Src is capable of phosphorylating tyr residues of c-Fos whereas the phosphatase TC45 T-cell protein-tyr phosphatase (TC-PTP) dephosphorylates them, thus enabling c-Fos/ER association and activation of phospholipid synthesis. Results also suggest that the regulation of the phosphorylation/dephosphorylation cycle of c-Fos occurs at the TC-PTP level: induction of cells to re-enter growth promotes the translocation of TC45 from a nuclear to a cytoplasmic location concomitant with its activation. Activated TC45 in its turn promotes dephosphorylation of pre-formed c-Fos, enabling cells to rapidly activate phospholipid synthesis to respond to its growth demands. Oncogene (2012) 31, 3381-3391; doi: 10.1038/onc.2011.510; published online 21 November 2011	[Ferrero, G. O.; Velazquez, F. N.; Caputto, B. L.] Univ Nacl Cordoba, CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Caputto, BL (corresponding author), Univ Nacl Cordoba, CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, Ciudad Univ, RA-5000 Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar			ANPCyT; CONICET; Ministerio de Ciencia, Tecnologi a e Innovacio n Productiva de Argentina; SECyT-Universidad Nacional de Cordoba, Argentina; JS McDonnell Foundation	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Ciencia, Tecnologi a e Innovacio n Productiva de Argentina; SECyT-Universidad Nacional de Cordoba, Argentina(Secretaria de Ciencia y Tecnologia (SECYT)); JS McDonnell Foundation	We thank HJF Maccioni for helpful discussions and H Carbonneau (Pardue University, West Lafayette, IN, USA) for providing pET-TC45a. pCG-TC45 and pCG-D182A were kind gifts from T Tiganis (Cold Spring Harbor Laboratory, New York, NY, USA) and pET-c-Src from MA Seelinger (University of California, Berkeley, CA, USA). Excellent technical assistance from Susana Deza and Gabriela Schachner is acknowledged. This work was supported by grants from the ANPCyT and CONICET, Ministerio de Ciencia, Tecnologi a e Innovacio n Productiva de Argentina, SECyT-Universidad Nacional de Cordoba, Argentina and the JS McDonnell Foundation. BLC is a career member and GOF and FV are fellows of CONICET.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; GUIDO ME, 1990, J NEUROCHEM, V55, P1855, DOI 10.1111/j.1471-4159.1990.tb05768.x; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Hu X, 2007, CHEM BIOL, V14, P764, DOI 10.1016/j.chembiol.2007.05.010; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Klingler-Hoffmann M, 2001, J BIOL CHEM, V276, P46313, DOI 10.1074/jbc.M106571200; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Morgan James J., 1995, Trends in Neurosciences, V18, P66, DOI 10.1016/0166-2236(95)93874-W; OPPERMANN H, 1979, P NATL ACAD SCI USA, V76, P1804, DOI 10.1073/pnas.76.4.1804; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Sambrook J, 2001, MOL CLONING LAB MANU; Silvestre DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009544; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2002, IUBMB LIFE, V53, P3, DOI 10.1080/15216540210811; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	39	14	18	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	28					3381	3391		10.1038/onc.2011.510	http://dx.doi.org/10.1038/onc.2011.510			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	973NT	22105363				2022-12-25	WOS:000306367600007
J	Sulzmaier, FJ; Valmiki, MKG; Nelson, DA; Caliva, MJ; Geerts, D; Matter, ML; White, EP; Ramos, JW				Sulzmaier, F. J.; Valmiki, M. K. G.; Nelson, D. A.; Caliva, M. J.; Geerts, D.; Matter, M. L.; White, E. P.; Ramos, J. W.			PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D	ONCOGENE			English	Article						PEA-15; PLD; cell cycle; H-Ras; cell transformation	PHOSPHATIDIC-ACID; CYCLIN D1/CDK4; CANCER-CELLS; PROTEIN; EXPRESSION; KINASE; SIGNAL; ACTIVATION; APOPTOSIS; RECEPTOR	The small GTPase H-Ras is a proto-oncogene that activates a variety of different pathways including the extracellular-signal-regulated kinase (ERK)/mitogen-activated protein kinase pathway. H-Ras is mutated in many human malignancies, and these mutations cause the protein to be constitutively active. Phosphoprotein enriched in astrocytes, 15 kDa (PEA-15) blocks ERK-dependent gene transcription and inhibits proliferation by sequestering ERK in the cytoplasm. We therefore investigated whether PEA-15 influences H-Ras-mediated transformation. We found that PEA-15 does not block H-Ras-activated proliferation when H-Ras is constitutively active. We show instead that in H-Ras-transformed mouse kidney epithelial cells, co-expression of PEA-15 resulted in enhanced soft agar colony growth and increased tumor growth in vivo. Overexpression of both H-Ras and PEA-15 resulted in accelerated G1/S cell cycle transition and increased activation of the ERK signaling pathway. PEA-15 mediated these effects through activation of its binding partner phospholipase D1 (PLD1). Inhibition of PLD1 or interference with PEA-15/PLD1 binding blocked PEA-15's ability to increase ERK activation. Our findings reveal a novel mechanism by which PEA-15 positively regulates Ras/ERK signaling and increases the proliferation of H-Ras-transformed epithelial cells through enhanced PLD1 expression and activation. Thus, our work provides a surprising mechanism by which PEA-15 augments H-Ras-driven transformation. These data reveal that PEA-15 not only suppresses ERK signaling and tumorigenesis but also alternatively enhances tumorigenesis in the context of active Ras. Oncogene (2012) 31, 3547-3560; doi:10.1038/onc.2011.514; published online 21 November 2011	[Sulzmaier, F. J.; Valmiki, M. K. G.; Caliva, M. J.; Ramos, J. W.] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, Honolulu, HI 96813 USA; [Sulzmaier, F. J.; Valmiki, M. K. G.; Ramos, J. W.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI USA; [Nelson, D. A.; White, E. P.] Inst Canc Res, New Brunswick, NJ USA; [Caliva, M. J.; Matter, M. L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI USA; [Geerts, D.] Sophia Childrens Univ Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Ramos, JW (corresponding author), Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, Biosciences Bldg,Room 241C,651 Halo St, Honolulu, HI 96813 USA.	jramos@cc.hawaii.edu	Matter, Michelle/GSN-9703-2022; Ramos, Joe/G-4074-2010; White, Eileen/ABD-6745-2021; Gudur Valmiki, Mohana/H-2391-2017; Geerts, Dirk/K-8260-2015	Ramos, Joe/0000-0002-9708-2115; White, Eileen/0000-0003-2961-3065; Gudur Valmiki, Mohana/0000-0002-7313-9092; Geerts, Dirk/0000-0002-6386-8187; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health National Cancer Institute [R01CA93849]; National Institute of General Medicine [R01GM088266]; Victoria S and Bradley Geist Foundation; NIH National Center for Reasearch Resources [RR016453]; National Institutes of Health [R37CA53370]; NATIONAL CANCER INSTITUTE [P30CA071789, R37CA053370, R01CA093849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088266] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Victoria S and Bradley Geist Foundation; NIH National Center for Reasearch Resources; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Maarit Tiirikainen and the University of Hawaii Cancer Center Genomics Shared Resource laboratory for their assistance with the mRNA expression analysis. We also thank Anna Knapinska, Shirley Young-Robbins and Marci Takemoto for their excellent technical assistance. This work was supported by the National Institutes of Health National Cancer Institute (R01CA93849 to JWR) and National Institute of General Medicine (R01GM088266 to JWR) and the Victoria S and Bradley Geist Foundation (to JWR). MLM was supported by NIH National Center for Reasearch Resources Grant RR016453. DAN and EPW were supported by a grant from the National Institutes of Health (R37CA53370 to EPW).	Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bartholomeusz C, 2008, CANCER RES, V68, P9302, DOI 10.1158/0008-5472.CAN-08-2592; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Cordova-Alarcon E, 2005, ARCH MED RES, V36, P311, DOI 10.1016/j.arcmed.2005.04.001; Degenhardt K, 2006, CLIN CANCER RES, V12, P5298, DOI 10.1158/1078-0432.CCR-06-0439; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Doti N, 2010, MOL BIOSYST, V6, P2039, DOI 10.1039/c005272h; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Haling JR, 2010, MOL BIOL CELL, V21, P664, DOI 10.1091/mbc.E09-08-0659; Hancock JF, 2007, NAT CELL BIOL, V9, P615, DOI 10.1038/ncb0607-615; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Joseph T, 2002, ONCOGENE, V21, P3651, DOI 10.1038/sj.onc.1205380; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; LIN HJL, 1995, MOL CELL BIOL, V15, P4536; LOVEC H, 1994, ONCOGENE, V9, P323; Lu ZM, 2000, MOL CELL BIOL, V20, P462, DOI 10.1128/MCB.20.2.462-467.2000; Macaluso M, 2002, J CELL PHYSIOL, V192, P125, DOI 10.1002/jcp.10109; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Noh DY, 2000, CANCER LETT, V161, P207, DOI 10.1016/S0304-3835(00)00612-1; Pastorino S, 2010, FASEB J, V24, P2818, DOI 10.1096/fj.09-144295; Radig K, 1998, PATHOL RES PRACT, V194, P157, DOI 10.1016/S0344-0338(98)80016-2; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; Revet I, 2008, EXP CELL RES, V314, P707, DOI 10.1016/j.yexcr.2007.12.008; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; WABER PG, 1993, CANCER, V72, P3732, DOI 10.1002/1097-0142(19931215)72:12<3732::AID-CNCR2820721228>3.0.CO;2-U; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Yang HZ, 2001, BBA-PROTEIN STRUCT M, V1547, P313, DOI 10.1016/S0167-4838(01)00202-3; Zeng X, 2010, ONCOGENE, V29, P5103, DOI 10.1038/onc.2010.253; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	50	26	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	30					3547	3560		10.1038/onc.2011.514	http://dx.doi.org/10.1038/onc.2011.514			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22105357	Green Accepted			2022-12-25	WOS:000306844100007
J	Mavridou, DAI; Stevens, JM; Monkemeyer, L; Daltrop, O; di Gleria, K; Kessler, BM; Ferguson, SJ; Allen, JWA				Mavridou, Despoina A. I.; Stevens, Julie M.; Moenkemeyer, Leonie; Daltrop, Oliver; di Gleria, Katalin; Kessler, Benedikt M.; Ferguson, Stuart J.; Allen, James W. A.			A Pivotal Heme-transfer Reaction Intermediate in Cytochrome c Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION CCM SYSTEM; IN-VITRO FORMATION; ESCHERICHIA-COLI; APOCYTOCHROME-C; BINDING MOTIF; HYDROGENOBACTER-THERMOPHILUS; CHAPERONE CCME; THIOETHER BOND; ACTIVE-SITE; PROTEIN	c-Type cytochromes are widespread proteins, fundamental for respiration or photosynthesis in most cells. They contain heme covalently bound to protein in a highly conserved, highly stereospecific post-translational modification. In many bacteria, mitochondria, and archaea this heme attachment is catalyzed by the cytochrome c maturation (Ccm) proteins. Here we identify and characterize a covalent, ternary complex between the heme chaperone CcmE, heme, and cytochrome c. Formation of the complex from holo-CcmE occurs in vivo and in vitro and involves the specific heme-binding residues of both CcmE and apocytochrome c. The enhancement and attenuation of the amounts of this complex correlates completely with known consequences of mutations in genes for other Ccm proteins. We propose the complex is a trapped catalytic intermediate in the cytochrome c biogenesis process, at the point of heme transfer from CcmE to the cytochrome, the key step in the maturation pathway.	[Mavridou, Despoina A. I.; Stevens, Julie M.; Moenkemeyer, Leonie; Daltrop, Oliver; Ferguson, Stuart J.; Allen, James W. A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [di Gleria, Katalin] Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England; [Kessler, Benedikt M.] Univ Oxford, Dept Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Mavridou, Despoina/ABG-5940-2020	Kessler, Benedikt/0000-0002-8160-2446; Mavridou, Despoina/0000-0002-7449-1151	Biotechnology and Biological Sciences Research Council [BB/D019753/1, BB/H017887/1]; Wellcome Trust [092532]; Value-in-People Award; Gustav Born Trust; Edward Penley Abraham Cephalosporin Fund; Biomedical Research Centre (NIHR), Oxford, UK; BBSRC [BB/D019753/1, BB/H017887/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Value-in-People Award; Gustav Born Trust; Edward Penley Abraham Cephalosporin Fund; Biomedical Research Centre (NIHR), Oxford, UK(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council Grants BB/D019753/1 and BB/H017887/1, Wellcome Trust Grant 092532, and a Value-in-People Award.; Supported by the Gustav Born Trust and the Edward Penley Abraham Cephalosporin Fund.; Supported by the Biomedical Research Centre (NIHR), Oxford, UK.	Ahuja U, 2005, J BIOL CHEM, V280, P236, DOI 10.1074/jbc.M410912200; Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; Allen JWA, 2003, BIOCHEM J, V375, P721, DOI 10.1042/BJ20030752; Allen JWA, 2005, BIOCHEM J, V389, P587, DOI 10.1042/BJ20041894; Allen JWA, 2003, J BIOL CHEM, V278, P52075, DOI 10.1074/jbc.M307196200; Allen JWA, 2003, PHILOS T ROY SOC B, V358, P255, DOI 10.1098/rstb.2002.1192; Allen JWA, 2002, J BIOL CHEM, V277, P33559, DOI 10.1074/jbc.M204963200; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Barker PD, 1999, STRUCTURE, V7, pR281, DOI 10.1016/S0969-2126(00)88334-3; BARKER PD, 1995, BIOCHEMISTRY-US, V34, P15191, DOI 10.1021/bi00046a027; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; Daltrop O, 2004, J BIOL CHEM, V279, P45347, DOI 10.1074/jbc.M408637200; Daltrop O, 2003, J BIOL CHEM, V278, P24308, DOI 10.1074/jbc.M301967200; Daltrop O, 2003, J BIOL CHEM, V278, P4404, DOI 10.1074/jbc.M211124200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P9703, DOI 10.1073/pnas.152120699; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; de Vitry C, 2011, FEBS J, V278, P4189, DOI 10.1111/j.1742-4658.2011.08373.x; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Goddard AD, 2010, J BIOL CHEM, V285, P22880, DOI 10.1074/jbc.M110.133421; Goddard AD, 2010, FEBS J, V277, P726, DOI 10.1111/j.1742-4658.2009.07517.x; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Reid E, 1998, FEMS MICROBIOL LETT, V166, P369, DOI 10.1016/S0378-1097(98)00357-7; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Robertson IB, 2008, FEBS LETT, V582, P3067, DOI 10.1016/j.febslet.2008.07.052; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x	38	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2342	2352		10.1074/jbc.M111.313692	http://dx.doi.org/10.1074/jbc.M111.313692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22121193	Green Published, hybrid			2022-12-25	WOS:000300292300010
J	Dahiya, Y; Pandey, RK; Sodhi, A				Dahiya, Yogesh; Pandey, Rajeev Kumar; Sodhi, Ajit			Nod2 Downregulates TLR2/1 Mediated IL1 beta Gene Expression in Mouse Peritoneal Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; CROHNS-DISEASE; MURAMYL DIPEPTIDE; IMMUNE-SYSTEM; HOST-DEFENSE; PEPTIDOGLYCAN; TRANSCRIPTION; RECOGNITION; PATHOGENS; RESPONSES	Nod2 is a cytosolic pattern recognition receptor. It has been implicated in many inflammatory conditions. Its signaling has been suggested to modulate TLR responses in a variety of ways, yet little is known about the mechanistic details of the process. We show in this study that Nod2 knockdown mouse peritoneal macrophages secrete more IL1 beta than normal macrophages when stimulated with peptidoglycan (PGN). Muramyl dipeptide (MDP, a Nod2 ligand) + PGN co-stimulated macrophages have lower expression of IL1b than PGN (TLR2/1 ligand) stimulated macrophages. MDP co-stimulation have similar effects on Pam3CSK4 (synthetic TLR2/1 ligand) mediated IL1b expression suggesting that MDP mediated down regulating effects are receptor dependent and ligand independent. MDP mediated down regulation was specific for TLR2/1 signaling as MDP does not affect LPS (TLR4 ligand) or zymosan A (TLR2/6 ligand) mediated IL1b expression. Mechanistically, MDP exerts its down regulating effects by lowering PGN/Pam3CSK4 mediated nuclear cRel levels. Lower nuclear cRel level were observed to be because of enhanced transporting back rather than reduced nuclear translocation of cRel in MDP + PGN stimulated macrophages. These results demonstrate that Nod2 and TLR2/1 signaling pathways are independent and do not interact at the level of MAPK or NF-kappa B activation.	[Dahiya, Yogesh; Pandey, Rajeev Kumar; Sodhi, Ajit] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Dahiya, Y (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	ajit.sodhi@lycos.com		Dahiya, Yogesh/0000-0002-8604-739X; Pandey, Rajeev/0000-0002-7883-1854	Department of Biotechnology, Government of India [BT/PR10492/10/601/2008]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Yogesh Dahiya and Rajeev Kumar Pandey are CSIR-SRF (Human Resource Development Group, Council of Scientific & Industrial Research), New Delhi. The study was supported financially by a grant (no. BT/PR10492/10/601/2008) from the Department of Biotechnology, Government of India to Dr. Ajit Sodhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canto E, 2009, INFLAMM BOWEL DIS, V15, P1686, DOI 10.1002/ibd.21013; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Dahiya Y, 2010, FEBS LETT, V584, P4227, DOI 10.1016/j.febslet.2010.09.009; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Shaw MH, 2011, TRENDS IMMUNOL, V32, P73, DOI 10.1016/j.it.2010.12.007; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; TAKEUCHI O, 2010, PATTERN RECOGN, V140, P805; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Yang ZQ, 2007, GASTROENTEROLOGY, V133, P1510, DOI 10.1053/j.gastro.2007.07.025	26	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27828	10.1371/journal.pone.0027828	http://dx.doi.org/10.1371/journal.pone.0027828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114704	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800038
J	Amo, L; Caro, SP; Visser, ME				Amo, Luisa; Caro, Samuel P.; Visser, Marcel E.			Sleeping Birds Do Not Respond to Predator Odour	PLOS ONE			English	Article							RISK; VIGILANCE; TEMPERATURE; HYPOTHERMIA; AVOIDANCE; SURVIVAL; RHYTHMS; INNATE; SCENT; RATS	Background: During sleep animals are relatively unresponsive and unaware of their environment, and therefore, more exposed to predation risk than alert and awake animals. This vulnerability might influence when, where and how animals sleep depending on the risk of predation perceived before going to sleep. Less clear is whether animals remain sensitive to predation cues when already asleep. Methodology/Principal Findings: We experimentally tested whether great tits are able to detect the chemical cues of a common nocturnal predator while sleeping. We predicted that birds exposed to the scent of a mammalian predator (mustelid) twice during the night would not go into torpor (which reduces their vigilance) and hence would not reduce their body temperature as much as control birds, exposed to the scent of another mammal that does not represent a danger for the birds (rabbit). As a consequence of the higher body temperature birds exposed to the scent of a predator are predicted to have a higher resting metabolic rate (RMR) and to lose more body mass. In the experiment, all birds decreased their body temperature during the night, but we did not find any influence of the treatment on body temperature, RMR, or body mass. Conclusions/Significance: Our results suggest that birds are not able to detect predator chemical cues while sleeping. As a consequence, antipredatory strategies taken before sleep, such as roosting sites inspection, may be crucial to cope with the vulnerability to predation risk while sleeping.	[Amo, Luisa; Caro, Samuel P.; Visser, Marcel E.] Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Amo, L (corresponding author), CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Carretera Sacramento, La Canada De San Urbano, Almeria, Spain.	luisa.amo@eeza.csic.es	Amo, Luisa/K-5960-2014; Visser, Marcel E/A-9151-2009; P, Samuel/A-5750-2008	Amo, Luisa/0000-0003-4621-3493; Visser, Marcel E/0000-0002-1456-1939; P, Samuel/0000-0002-5405-7753	MEC; programme Juan de la Cierva; Netherlands Organisation for Scientific Research (NWO)-Rubicon [825.07.008]; NWO-VENI; NWO-VICI	MEC(European Commission); programme Juan de la Cierva; Netherlands Organisation for Scientific Research (NWO)-Rubicon(Netherlands Organization for Scientific Research (NWO)); NWO-VENI(Netherlands Organization for Scientific Research (NWO)); NWO-VICI(Netherlands Organization for Scientific Research (NWO))	LA was supported by a MEC postdoctoral fellowship and by the programme Juan de la Cierva while writing. SC was supported by a Netherlands Organisation for Scientific Research (NWO)-Rubicon (grant number: 825.07.008) and a NWO-VENI postdoctoral fellowships. MV was supported by a NWO-VICI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; Ball N. J., 1992, WHY WE NAP EVOLUTION, P31; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BRINCK C, 1983, J CHEM ECOL, V9, P727, DOI 10.1007/BF00988779; Caro SP, 2009, J EXP BIOL, V212, P1994, DOI 10.1242/jeb.026344; Carskadon MA, 2004, SLEEP, V27, P402; CATTARELLI M, 1979, PHYSIOL BEHAV, V23, P831, DOI 10.1016/0031-9384(79)90186-0; Clark CW, 2000, EVOL ECOL RES, V2, P473; Dhondt AA, 2010, J ORNITHOL, V151, P95, DOI 10.1007/s10336-009-0430-2; DRENT PJ, 1987, ARDEA, V75, P59; Ekner A, 2008, ACTA ORNITHOL, V43, P107, DOI 10.3161/000164508X345392; FENN MGP, 1995, J MAMMAL, V76, P130, DOI 10.2307/1382321; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Laurila M, 2005, J THERM BIOL, V30, P392, DOI 10.1016/j.jtherbio.2005.04.001; LENDREM DW, 1983, ANIM BEHAV, V31, P532, DOI 10.1016/S0003-3472(83)80076-1; LENDREM DW, 1984, ANIM BEHAV, V32, P243, DOI 10.1016/S0003-3472(84)80343-7; Lesku JA, 2008, BEHAV BRAIN RES, V189, P298, DOI 10.1016/j.bbr.2008.01.006; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lima SL, 2007, ANIM BEHAV, V74, P189, DOI 10.1016/j.anbehav.2006.12.007; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; McKechnie AE, 2002, CONDOR, V104, P705, DOI 10.1650/0010-5422(2002)104[0705:AFHRAR]2.0.CO;2; MEDDIS R, 1975, ANIM BEHAV, V23, P676, DOI 10.1016/0003-3472(75)90144-X; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; Reinertsen Randi Eidsmo, 1996, P125; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; TOBLER I, 1989, CHRONOBIOLOGICAL BEH, P9; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; VEKY M, 2010, J ORNITHOL, V151, P147; Warham J., 1996, BEHAV POPULATION BIO; WEBB WB, 1974, PERCEPT MOTOR SKILL, V38, P1023, DOI 10.2466/pms.1974.38.3c.1023; Zepelin H, 2000, PRINCIPLES PRACTICE, P82; Zhang JX, 2007, J CHEM ECOL, V33, P603, DOI 10.1007/s10886-006-9220-y	39	30	30	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27576	10.1371/journal.pone.0027576	http://dx.doi.org/10.1371/journal.pone.0027576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110676	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400059
J	Gurung, M; Moon, DC; Choi, CW; Lee, JH; Bae, YC; Kim, J; Lee, YC; Seol, SY; Cho, DT; Kim, SI; Lee, JC				Gurung, Mamata; Moon, Dong Chan; Choi, Chi Won; Lee, Jung Hwa; Bae, Yong Chul; Kim, Jungmin; Lee, Yoo Chul; Seol, Sung Yong; Cho, Dong Taek; Kim, Seung Il; Lee, Je Chul			Staphylococcus aureus Produces Membrane-Derived Vesicles That Induce Host Cell Death	PLOS ONE			English	Article							PYLORI OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; PERIPLASMIC PROTEINS; SHIGELLA-FLEXNERI; DNA; PROTEOMICS; DELIVERY; RELEASE; SECRETION; EMERGENCE	Gram-negative bacteria produce outer membrane vesicles that play a role in the delivery of virulence factors to host cells. However, little is known about the membrane-derived vesicles (MVs) produced by Gram-positive bacteria. The present study examined the production of MVs from Staphylococcus aureus and investigated the delivery of MVs to host cells and subsequent cytotoxicity. Four S. aureus strains tested, two type strains and two clinical isolates, produced spherical nanovesicles during in vitro culture. MVs were also produced during in vivo infection of a clinical S. aureus isolate in a mouse pneumonia model. Proteomic analysis showed that 143 different proteins were identified in the S. aureus-derived MVs. S. aureus MVs were interacted with the plasma membrane of host cells via a cholesterol-rich membrane microdomain and then delivered their component protein A to host cells within 30 min. Intact S. aureus MVs induced apoptosis of HEp-2 cells in a dose-dependent manner, whereas lysed MVs neither delivered their component into the cytosol of host cells nor induced cytotoxicity. In conclusion, this study is the first report that S. aureus MVs are an important vehicle for delivery of bacterial effector molecules to host cells.	[Gurung, Mamata; Moon, Dong Chan; Lee, Jung Hwa; Kim, Jungmin; Lee, Yoo Chul; Seol, Sung Yong; Cho, Dong Taek; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Choi, Chi Won; Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, Taegu, South Korea	Kyungpook National University; Korea Basic Science Institute (KBSI); Kyungpook National University	Gurung, M (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	ksi@kbsi.re.kr; leejc@knu.ac.kr			Korea Science and Engineering Foundation (KOSEF); Korea government (MEST) [R01-2008-000-11083-0]; Korea Basic Science Institute [K-MeP T31130]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Basic Science Institute	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (Project No. R01-2008-000-11083-0). SI Kim & CW Choi were supported by a grant (K-MeP T31130) from the Korea Basic Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Beveridge TJ, 1996, MICROB DRUG RESIST, V2, P1, DOI 10.1089/mdr.1996.2.1; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; CROSSLEY KB, 1997, STAPHYLOCOCCI HUMAN; DEICH RA, 1982, J BACTERIOL, V152, P855; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; FISCHETTI VA, 2000, GRAM POSITIVE PATHOG, V1; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; Kadurugamuwa JL, 1998, ANTIMICROB AGENTS CH, V42, P1476, DOI 10.1128/AAC.42.6.1476; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Keenan JI, 2008, INNATE IMMUN, V14, P279, DOI 10.1177/1753425908096857; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149, DOI 10.1111/j.1348-0421.1993.tb03192.x; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li ZS, 1998, J BACTERIOL, V180, P5478, DOI 10.1128/JB.180.20.5478-5483.1998; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2	40	138	145	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27958	10.1371/journal.pone.0027958	http://dx.doi.org/10.1371/journal.pone.0027958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114730	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400143
J	Reichmann, WM; Walensky, RP; Case, A; Novais, A; Arbelaez, C; Katz, JN; Losina, E				Reichmann, William M.; Walensky, Rochelle P.; Case, Amy; Novais, Anna; Arbelaez, Christian; Katz, Jeffrey N.; Losina, Elena			Estimation of the Prevalence of Undiagnosed and Diagnosed HIV in an Urban Emergency Department	PLOS ONE			English	Article							INNER-CITY EMERGENCY; IMMUNODEFICIENCY VIRUS-INFECTION; SEVERITY INDEX; ADOLESCENTS; ADULTS; WOMEN	Objective: To estimate the prevalence of undiagnosed HIV, the prevalence of diagnosed HIV, and proportion of HIV that is undiagnosed in populations with similar demographics as the Universal Screening for HIV in the Emergency Room (USHER) Trial and the Brigham and Women's Hospital (BWH) Emergency Department (ED) in Boston, MA. We also sought to estimate these quantities within demographic and risk behavior subgroups. Method: We used data from the USHER Trial, which was a randomized clinical trial of HIV screening conducted in the BWH ED. Since eligible participants were HIV-free at time of enrollment, we were able to calculate the prevalence of undiagnosed HIV. We used data from the Massachusetts Department of Public Health (MA/DPH) to estimate the prevalence of diagnosed HIV since the MA/DPH records the number of persons within MA who are HIV-positive. We calculated the proportion of HIV that is undiagnosed using these estimates of the prevalence of undiagnosed and diagnosed HIV. Estimates were stratified by age, sex, race/ethnicity, history of testing, and risk behaviors. Results: The overall expected prevalence of diagnosed HIV in a population similar to those presenting to the BWH ED was 0.71% (95% CI: 0.63%, 0.78%). The prevalence of undiagnosed HIV was estimated at 0.22% (95% CI: 0.10%, 0.42%) and resultant overall prevalence was 0.93%. The proportion of HIV-infection that is undiagnosed in this ED-based setting was estimated to be 23.7% (95% CI: 11.6%, 34.9%) of total HIV-infections. Conclusions: Despite different methodology, our estimate of the proportion of HIV that is undiagnosed in an ED-setting was similar to previous estimates based on national surveillance data. Universal routine testing programs in EDs should use these data to help plan their yield of HIV detection.	[Reichmann, William M.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Reichmann, William M.; Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Walensky, Rochelle P.; Losina, Elena] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Case, Amy; Novais, Anna; Arbelaez, Christian] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Reichmann, WM (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA.	wreichmann@partners.org		Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X	National Institute of Mental Health [R01 MH073445, R01 MH65869]; National Institute of Arthritis and Skin Diseases [K24 AR 057827]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869, R01MH073445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Arthritis and Skin Diseases; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the National Institute of Mental Health (R01 MH073445, R01 MH65869), National Institute of Arthritis and Skin Diseases (K24 AR 057827) and the Doris Duke Charitable Foundation, Clinical Scientist Development Award to Rochelle P. Walensky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert PL, 1996, ANN EMERG MED, V28, P159, DOI 10.1016/S0196-0644(96)70056-2; [Anonymous], 2006, MMWR RECOMM REP; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Clauss H, 2011, AIDS PATIENT CARE ST, V25, P207, DOI 10.1089/apc.2010.0196; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x; Eitel DR, 2003, ACAD EMERG MED, V10, P1070, DOI 10.1197/S1069-6563(03)00350-6; FLEMING PL, 2002, 9 C RETR OPP INF SEA; Goggin MA, 2000, J EMERG MED, V19, P13, DOI 10.1016/S0736-4679(00)00175-X; KELEN GD, 1989, JAMA-J AM MED ASSOC, V262, P516, DOI 10.1001/jama.262.4.516; KELEN GD, 1995, CLIN INFECT DIS, V21, P867, DOI 10.1093/clinids/21.4.867; KELEN GD, 1988, NEW ENGL J MED, V318, P1645, DOI 10.1056/NEJM198806233182503; LINDSELL CJ, ANN EMERG MED S1, V58, pS23; Nagachinta T, 1996, INFECT CONT HOSP EP, V17, P174; PISCULLI M, 2011, AIDS BEHAV, P1; Reichmann WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008728; REICHMANN WM, PLOS ONE, V5, pE8728; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHOENBAUM EE, 1993, AM J PUBLIC HEALTH, V83, P363, DOI 10.2105/AJPH.83.3.363; STURM JT, 1991, ANN EMERG MED, V20, P276, DOI 10.1016/S0196-0644(05)80939-4; US Bureau of the Census, POP EST; WALENSKY, 2010, COMMUNICATION   0413; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Wuerz RC, 2001, ACAD EMERG MED, V8, P170, DOI 10.1111/j.1553-2712.2001.tb01283.x; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x; MMWR MORB MORTAL WKL, V60, P689	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27701	10.1371/journal.pone.0027701	http://dx.doi.org/10.1371/journal.pone.0027701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110730	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400089
J	Wang, PG; Gong, J; Wang, SQ; Talbott, EO; Zhang, B; He, QQ				Wang, Pei-gang; Gong, Jie; Wang, Su-qing; Talbott, Evelyn O.; Zhang, Bo; He, Qi-qiang			Relationship of Body Fat and Cardiorespiratory Fitness with Cardiovascular Risk in Chinese Children	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; METABOLIC SYNDROME; AEROBIC FITNESS; MASS INDEX; MEN; CHILDHOOD; OBESITY; AGE	Backgrounds/Objectives: Cardiorespiratory fitness (CRF) and body fat play an important role in elevated risk for cardiovascular disease (CVD). However, the combined effects of CRF and obesity on metabolic health in Chinese children are unclear. The purpose of this study was to investigate the independent and combined associations between body fat, CRF, and CVD risk in Chinese schoolchildren. Methods: The study subjects comprised 676 schoolchildren (392 boys and 284 girls, aged 9.6 +/- 0.7 yrs old) in Wuhan, China. Their body mass index (BMI), waist circumference (WC), CRF, blood pressure (BP), lipids, glucose, and pubertal status were assessed. Children were categorized into different groups based on their BMI, WC, and CRF using Chinese obesity cut-off points and CRF sex-specific median points. Metabolic Risk Score (MRS) was computed based on the standardized scores of BP, lipids, and glucose. Results: Multiple linear regression models showed that, in the separate models, body fat was positively associated with MRS while CRF was inversely associated with MRS (p<0.001). However, when assessed simultaneously, only body fat had a significant association with MRS (p<0.001). In general, low-fit children had a lower MRS compared to their counterparts, and a significant difference between the two extreme groups was observed (low CRF and high fat vs. high CRF and low fat, p<0.001). Conclusions: These findings suggest that both body fat and CRF should be considered when interpreting CVD risk in Chinese children, while body fat may be correlated with CVD risk more than CRF.	[Wang, Pei-gang; Wang, Su-qing; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Gong, Jie] Wuhan Univ, Wuhan Ctr Dis Control & Prevent, Wuhan 430072, Peoples R China; [Talbott, Evelyn O.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Zhang, Bo] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sun Yat Sen University	Wang, PG (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	heqiqiang@gmail.com	He, Qiqiang/A-7990-2012; ZHANG, BO/K-4561-2013	ZHANG, BO/0000-0002-6352-1757; Talbott, Evelyn/0000-0002-5198-7939				Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; Ara I, 2007, OBESITY, V15, P1918, DOI 10.1038/oby.2007.228; BERENSON GS, 1992, AM J CARDIOL, V70, P851, DOI 10.1016/0002-9149(92)90726-F; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Cummings DM, 2010, J OBES, V2010, DOI 10.1155/2010/195729; Dencker M, 2007, EUR J APPL PHYSIOL, V99, P19, DOI 10.1007/s00421-006-0310-x; Eisenmann JC, 2005, INT J OBESITY, V29, P1077, DOI 10.1038/sj.ijo.0802995; Eisenmann JC, 2007, MED SCI SPORT EXER, V39, P1251, DOI 10.1249/MSS.0b013e318064c8b0; Froberg K, 2005, INT J OBESITY, V29, pS34, DOI 10.1038/sj.ijo.0803096; He QQ, 2011, PREV MED, V52, P109, DOI 10.1016/j.ypmed.2010.11.005; Hirschler V, 2010, CLIN BIOCHEM, V43, P435, DOI 10.1016/j.clinbiochem.2009.11.003; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Kriemler S, 2008, DIABETOLOGIA, V51, P1408, DOI 10.1007/s00125-008-1067-z; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Ma Guan-sheng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P609; Mahoney C, 1992, Br J Sports Med, V26, P45; Martins CL, 2010, OPEN SPORTS SCI, V3, P149; Mason C, 2008, OBESITY, V16, P2690, DOI 10.1038/oby.2008.438; Matsuzaka A, 2004, PEDIATR EXERC SCI, V16, P113, DOI 10.1123/pes.16.2.113; Mori M, 2009, J PHYSIOL-LONDON, V587, P5577, DOI 10.1113/jphysiol.2009.179283; National Task Force on Childhood Obesity National Center for Women's and Children's Health, 2008, Zhonghua Er Ke Za Zhi, V46, P179; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Ruiz JR, 2007, J HYPERTENS, V25, P2027, DOI 10.1097/HJH.0b013e328277597f; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Watts K, 2008, J PAEDIATR CHILD H, V44, P709, DOI 10.1111/j.1440-1754.2008.01411.x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; 1962, GROWTH ADOLESENCE	28	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27896	10.1371/journal.pone.0027896	http://dx.doi.org/10.1371/journal.pone.0027896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114722	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000297555400136
J	Adamek, M; Overhage, J; Bathe, S; Winter, J; Fischer, R; Schwartz, T				Adamek, Martina; Overhage, Joerg; Bathe, Stephan; Winter, Josef; Fischer, Reinhard; Schwartz, Thomas			Genotyping of Environmental and Clinical Stenotrophomonas maltophilia Isolates and their Pathogenic Potential	PLOS ONE			English	Article							SP-NOV.; XANTHOMONAS-MALTOPHILIA; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; HOST MODEL; HUGH 1981; GENUS; DIVERSITY; VIRULENCE; BACTERIA	Stenotrophomonas maltophilia is a highly versatile species with useful biotechnological potential but also with pathogenic properties. In light of possible differences in virulence characteristics, knowledge about genomic subgroups is therefore desirable. Two different genotyping methods, rep-PCR fingerprinting and partial gyrB gene sequencing were used to elucidate S. maltophilia intraspecies diversity. Rep-PCR fingerprinting revealed the presence of 12 large subgroups, while gyrB gene sequencing distinguished 10 subgroups. For 8 of them, the same strain composition was shown with both typing methods. A subset of 59 isolates representative for the gyrB groups was further investigated with regards to their pathogenic properties in a virulence model using Dictyostelium discoideum and Acanthamoeba castellanii as host organisms. A clear tendency towards accumulation of virulent strains could be observed for one group with A. castellanii and for two groups with D. discoideum. Several virulent strains did not cluster in any of the genetic groups, while other groups displayed no virulence properties at all. The amoeba pathogenicity model proved suitable in showing differences in S. maltophilia virulence. However, the model is still not sufficient to completely elucidate virulence as critical for a human host, since several strains involved in human infections did not show any virulence against amoeba.	[Adamek, Martina; Overhage, Joerg; Schwartz, Thomas] KIT, Inst Funct Interfaces IFG, Microbiol Nat & Tech Interfaces Dept, Karlsruhe, Germany; [Bathe, Stephan] German Natl Acad Fdn, Bonn, Germany; [Winter, Josef] KIT, Dept Biol Engineers & Biotechnol Wastewater Treat, Karlsruhe, Germany; [Fischer, Reinhard] KIT, Inst Appl Biosci, Dept Microbiol, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Adamek, M (corresponding author), KIT, Inst Funct Interfaces IFG, Microbiol Nat & Tech Interfaces Dept, Karlsruhe, Germany.	thomas.schwartz@kit.edu	Overhage, Joerg/H-2033-2013; Schwartz, Thomas/H-2920-2013	Overhage, Joerg/0000-0001-5278-2479; 	DFG (Deutsche Forschungsgemeinschaft)	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was funded by the DFG (Deutsche Forschungsgemeinschaft) www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P269, DOI 10.1086/502197; Assih EA, 2002, INT J SYST EVOL MICR, V52, P559, DOI 10.1099/00207713-52-2-559; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; BOLLET C, 1995, APPL ENVIRON MICROB, V61, P1653, DOI 10.1128/AEM.61.4.1653-1654.1995; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Coenye T, 2004, INT J SYST EVOL MICR, V54, P1235, DOI 10.1099/ijs.0.63093-0; Coenye T, 2004, FEMS IMMUNOL MED MIC, V40, P181, DOI 10.1016/S0928-8244(03)00307-9; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Di Bonaventura G, 2010, INFECT IMMUN, V78, P2466, DOI 10.1128/IAI.01391-09; Drancourt M, 1997, INT J SYST BACTERIOL, V47, P160, DOI 10.1099/00207713-47-1-160; Falagas ME, 2009, EUR J CLIN MICROBIOL, V28, P719, DOI 10.1007/s10096-009-0709-5; Fenner L, 2006, CRIT CARE MED, V34, P823, DOI 10.1097/01.CCM.0000201878.51343.F1; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Figueiredo PMS, 2006, LETT APPL MICROBIOL, V43, P443, DOI 10.1111/j.1472-765X.2006.01965.x; Finkmann W, 2000, INT J SYST EVOL MICR, V50, P273, DOI 10.1099/00207713-50-1-273; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; Goy G, 2007, RES MICROBIOL, V158, P393, DOI 10.1016/j.resmic.2007.01.003; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Hagstrom A, 2000, AQUAT MICROB ECOL, V21, P231, DOI 10.3354/ame021231; Hauben L, 1999, INT J SYST BACTERIOL, V49, P1749, DOI 10.1099/00207713-49-4-1749; Heylen K, 2007, INT J SYST EVOL MICR, V57, P2056, DOI 10.1099/ijs.0.65044-0; HUGH R, 1961, J GEN MICROBIOL, V26, P123; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; JUHNKE ME, 1989, APPL ENVIRON MICROB, V55, P747, DOI 10.1128/AEM.55.3.747-750.1989; Kaiser S, 2009, J BACTERIOL, V191, P2934, DOI 10.1128/JB.00892-08; Kaparullina E, 2009, SYST APPL MICROBIOL, V32, P157, DOI 10.1016/j.syapm.2008.12.003; Kim HB, 2010, INT J SYST EVOL MICR, V60, P1522, DOI 10.1099/ijs.0.014662-0; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Lai CH, 2006, CLIN MICROBIOL INFEC, V12, P986, DOI 10.1111/j.1469-0691.2006.01511.x; Lee DS, 2008, INT J SYST EVOL MICR, V58, P2235, DOI 10.1099/ijs.0.65678-0; Lee M, 2010, INT J SYST EVOL MICR, V60, P2056, DOI 10.1099/ijs.0.018887-0; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Minkwitz A, 2001, J CLIN MICROBIOL, V39, P139, DOI 10.1128/JCM.39.1.139-145.2001; PALLERONI NJ, 1993, INT J SYST BACTERIOL, V43, P606, DOI 10.1099/00207713-43-3-606; POMPILIO A, 2010, CLIN MICROBIOL INFEC, V16, pS590; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; Ramos PL, 2011, INT J SYST EVOL MICR, V61, P926, DOI 10.1099/ijs.0.019372-0; Ribbeck-Busch K, 2005, ENVIRON MICROBIOL, V7, P1853, DOI 10.1111/j.1462-2920.2005.00928.x; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Schaumann R, 2001, INFECTION, V29, P205, DOI 10.1007/s15010-001-1055-4; SWINGS J, 1983, INT J SYST BACTERIOL, V33, P409, DOI 10.1099/00207713-33-2-409; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Travassos LH, 2004, J APPL MICROBIOL, V96, P1143, DOI 10.1111/j.1365-2672.2004.02248.x; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Vasileuskaya-Schulz Z, 2011, SYST APPL MICROBIOL, V34, P35, DOI 10.1016/j.syapm.2010.11.011; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Wang XH, 1997, CURR MICROBIOL, V34, P212, DOI 10.1007/s002849900170; Wolf A, 2002, INT J SYST EVOL MICR, V52, P1937, DOI [10.1099/ijs.0.02135-0, 10.1099/00207713-52-6-1937]; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yang HC, 2006, INT J SYST EVOL MICR, V56, P81, DOI 10.1099/ijs.0.63826-0; Yi H, 2010, J MICROBIOL, V48, P30, DOI 10.1007/s12275-010-0006-0; Yoon JH, 2006, INT J SYST EVOL MICR, V56, P1363, DOI 10.1099/ijs.0.64091-0	64	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27615	10.1371/journal.pone.0027615	http://dx.doi.org/10.1371/journal.pone.0027615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110692	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300036
J	Kersemans, V; Cornelissen, B; Hueting, R; Tredwell, M; Hussien, K; Allen, PD; Falzone, N; Hill, SA; Dilworth, JR; Gouverneur, V; Muschel, RJ; Smart, SC				Kersemans, Veerle; Cornelissen, Bart; Hueting, Rebekka; Tredwell, Matthew; Hussien, Kamila; Allen, Philip D.; Falzone, Nadia; Hill, Sally A.; Dilworth, Jonathan R.; Gouverneur, Veronique; Muschel, Ruth J.; Smart, Sean C.			Hypoxia Imaging Using PET and SPECT: The Effects of Anesthetic and Carrier Gas on [Cu-64]-ATSM, [(99)mTc]-HL91 and [F-18]-FMISO Tumor Hypoxia Accumulation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; NORMOBARIC OXYGEN; BLOOD-FLOW; CARBOGEN; ISOFLURANE; AGENTS; MICE; RADIOSENSITIZATION; HYPERTHERMIA	Background: Preclinical imaging requires anaesthesia to reduce motion-related artefacts. For direct translational relevance, anaesthesia must not significantly alter experimental outcome. This study reports on the effects of both anaesthetic and carrier gas upon the uptake of [Cu-64]-CuATSM, [(99)mTc]-HL91 and [F-18]-FMISO in a preclinical model of tumor hypoxia. Methodology/Principal Findings: The effect of carrier gas and anaesthetic was studied in 6 groups of CaNT-bearing CBA mice using [Cu-64]-CuATSM, [(99)mTc]-HL91 or [F-18]-FMISO. Mice were anaesthetised with isoflurane in air, isoflurane in pure oxygen, with ketamine/xylazine or hypnorm/hypnovel whilst breathing air, or in the awake state whilst breathing air or pure oxygen. PET or SPECT imaging was performed after which the mice were killed for organ/tumor tracer quantitation. Tumor hypoxia was confirmed. Arterial blood gas analysis was performed for the different anaesthetic regimes. The results demonstrate marked influences on tumor uptake of both carrier gas and anaesthetic, and show differences between [(99)mTc]-HL91, [F-18]-FMISO and [Cu-64]-CuATSM. [(99)mTc]-HL91 tumor uptake was only altered significantly by administration of 100% oxygen. The latter was not the case for [F-18]-FMISO and [Cu-64]-CuATSM. Tumor-to-muscle ratio (TMR) for both compounds was reduced significantly when either oxygen or anaesthetics (isoflurane in air, ketamine/xylazine or hypnorm/hypnovel) were introduced. For [F-18]-FMISO no further decrease was measured when both isoflurane and oxygen were administered, [Cu-64]-CuATSM did show an additional significant decrease in TMR. When using the same anaesthetic regimes, the extent of TMR reduction was less pronounced for [Cu-64]-CuATSM than for [F-18]-FMISO (40-60% versus 70% reduction as compared to awake animals breathing air). Conclusions/Significance: The use of anaesthesia can have profound effects on the experimental outcome. More importantly, all tested anaesthetics reduced tumor-hypoxia uptake. Anaesthesia cannot be avoided in preclinical studies but great care has to be taken in preclinical models of hypoxia as anaesthesia effects cannot be generalised across applications, nor disease states.	[Kersemans, Veerle; Cornelissen, Bart; Hussien, Kamila; Allen, Philip D.; Falzone, Nadia; Hill, Sally A.; Muschel, Ruth J.; Smart, Sean C.] Univ Oxford, Canc Res United Kingdom Med Res Council, Gray Inst Radiat Oncol & Biol, Oxford, England; [Hueting, Rebekka; Tredwell, Matthew; Dilworth, Jonathan R.; Gouverneur, Veronique] Univ Oxford, Chem Res Lab, Oxford, England	University of Oxford; University of Oxford	Kersemans, V (corresponding author), Univ Oxford, Canc Res United Kingdom Med Res Council, Gray Inst Radiat Oncol & Biol, Oxford, England.	Veerle.Kersemans@oncology.ox.ac.uk	Kersemans, Veerle/AAG-3005-2020	Kersemans, Veerle/0000-0002-4669-236X; Tredwell, Matthew/0000-0002-4184-5611; Allen, Danny/0000-0002-6200-0925; Cornelissen, Bart/0000-0001-7581-3303; falzone, nadia/0000-0002-0102-2813	Cancer Research United Kingdom [C5255/A12678, C5255/A10339]; Oxford Cancer Imaging Centre	Cancer Research United Kingdom(Cancer Research UK); Oxford Cancer Imaging Centre	This work was supported by Cancer Research United Kingdom (C5255/A12678 and C5255/A10339) and by Oxford Cancer Imaging Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BATES ML, 1975, AM J CLIN PATHOL, V64, P448; Bayly SR, 2008, J NUCL MED, V49, P1862, DOI 10.2967/jnumed.108.054015; BRIZEL DM, 1995, BRIT J CANCER, V72, P1120, DOI 10.1038/bjc.1995.474; Cerniglia GJ, 1997, J APPL PHYSIOL, V82, P1939, DOI 10.1152/jappl.1997.82.6.1939; CHAPMAN JD, 1991, RADIOTHER ONCOL, V20, P13, DOI 10.1016/0167-8140(91)90181-F; Flores JE, 2008, MOL IMAGING BIOL, V10, P192, DOI 10.1007/s11307-008-0137-4; GRAU C, 1992, INT J RADIAT ONCOL, V22, P415, DOI 10.1016/0360-3016(92)90844-8; Griffin RJ, 1996, CANCER RES, V56, P5590; Hill SA, 1998, INT J RADIAT ONCOL, V40, P943, DOI 10.1016/S0360-3016(97)00892-4; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; HODES JE, 1985, ANESTHESIOLOGY, V63, P633, DOI 10.1097/00000542-198512000-00013; Holland JP, 2009, Q J NUCL MED MOL IM, V53, P193; Hsia CC, 2010, APPL RADIAT ISOTOPES, V68, P1610, DOI 10.1016/j.apradiso.2010.03.008; Imam SK, 2010, CANCER BIOTHER RADIO, V25, P365, DOI 10.1089/cbr.2009.0740; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Lee J, 1996, INT J CANCER, V67, P372, DOI 10.1002/(SICI)1097-0215(19960729)67:3<372::AID-IJC11>3.0.CO;2-A; Lee J, 1998, CANCER RES, V58, P1478; Lee KH, 2005, J NUCL MED, V46, P1531; Lewis JS, 2001, J NUCL MED, V42, P655; Matsumoto KI, 2007, INT J ONCOL, V30, P873; Mees G, 2009, EUR J NUCL MED MOL I, V36, P1674, DOI 10.1007/s00259-009-1195-9; MENKE H, 1988, RADIAT RES, V114, P64, DOI 10.2307/3577144; MUELLERKLIESER W, 1991, RADIOTHER ONCOL, V20, P21, DOI 10.1016/0167-8140(91)90182-G; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Robinson SP, 1999, NMR BIOMED, V12, P98, DOI 10.1002/(SICI)1099-1492(199904)12:2<98::AID-NBM556>3.0.CO;2-I; ROJAS A, 1991, RADIOTHER ONCOL, V20, P65, DOI 10.1016/0167-8140(91)90190-R; Russell J, 2009, INT J RADIAT ONCOL, V73, P1177, DOI 10.1016/j.ijrobp.2008.12.004; Smith GS, 1998, NEUROPSYCHOPHARMACOL, V18, P18; Song CW, 2001, RADIAT RES, V155, P515, DOI 10.1667/0033-7587(2001)155[0515:IOTOBM]2.0.CO;2; STONE HB, 1993, RADIAT RES, V136, P422, DOI 10.2307/3578556; Szczesny G, 2004, LAB ANIM-UK, V38, P64, DOI 10.1258/00236770460734416; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Yuan H, 2006, J NUCL MED, V47, P989; ZANELLI GD, 1975, BRIT J CANCER, V32, P380, DOI 10.1038/bjc.1975.238; ZHAO M, 1995, MAGN RESON MED, V33, P610, DOI 10.1002/mrm.1910330505	37	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e25911	10.1371/journal.pone.0025911	http://dx.doi.org/10.1371/journal.pone.0025911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102855	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300001
J	Zhang, AM; Jia, XY; Bi, R; Salas, A; Li, SQ; Xiao, XS; Wang, PF; Guo, XM; Kong, QP; Zhang, QJ; Yao, YG				Zhang, A-Mei; Jia, Xiaoyun; Bi, Rui; Salas, Antonio; Li, Shiqiang; Xiao, Xueshan; Wang, Panfeng; Guo, Xiangming; Kong, Qing-Peng; Zhang, Qingjiong; Yao, Yong-Gang			Mitochondrial DNA Haplogroup Background Affects LHON, but Not Suspected LHON, in Chinese Patients	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; CLINICAL EXPRESSION; PRIMARY MUTATIONS; HOT-SPOT; FAMILIES; GENE; M.3635G-GREATER-THAN-A; PENETRANCE; HAPLOTYPE; GENOTYPE	Recent studies have shown that mtDNA background could affect the clinical expression of Leber hereditary optic neuropathy (LHON). We analyzed the mitochondrial DNA (mtDNA) variation of 304 Chinese patients with m.11778G > A (sample #1) and of 843 suspected LHON patients who lack the three primary mutations (sample #2) to discern mtDNA haplogroup effect on disease onset. Haplogroup frequencies in the patient group was compared to frequencies in the general Han Chinese population (n = 1,689; sample #3). The overall matrilineal composition of the suspected LHON population resembles that of the general Han Chinese population, suggesting no association with mtDNA haplogroup. In contrast, analysis of these LHON patients confirms mtDNA haplogroup effect on LHON. Specifically, the LHON sample significantly differs from the general Han Chinese and suspected LHON populations by harboring an extremely lower frequency of haplogroup R9, in particular of its main sub-haplogroup F (#1 vs. #3, P-value = 1.46x10(-17), OR = 0.051, 95% CI: 0.016-0.162; # 1 vs. # 2, P-value = 4.44x10(-17), OR = 0.049, 95% CI: 0.015-0.154; in both cases, adjusted P-value < 10(-5)) and higher frequencies of M7b (# 1 vs. # 3, adjusted P-value = 0.001 and # 1 vs. # 2, adjusted P-value = 0.004). Our result shows that mtDNA background affects LHON in Chinese patients with m.11778G > A but not suspected LHON. Haplogroup F has a protective effect against LHON, while M7b is a risk factor.	[Zhang, A-Mei; Bi, Rui; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China; [Jia, Xiaoyun; Li, Shiqiang; Xiao, Xueshan; Wang, Panfeng; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Inst Med Legal, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Fac Med, Galicia, Spain; [Kong, Qing-Peng] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Zhang, A-Mei; Bi, Rui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Sun Yat Sen University; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, AM (corresponding author), Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China.	qingjiongzhang@yahoo.com; ygyaozh@yahoo.com	Zhang, Qingjiong/AAR-6331-2021; Salas, Antonio/E-3977-2012; Yao, Yong-Gang/AAH-2303-2021; Salas, Antonio/U-2029-2019	Zhang, Qingjiong/0000-0001-7508-848X; Salas, Antonio/0000-0002-2336-702X; Yao, Yong-Gang/0000-0002-2955-0693; Salas, Antonio/0000-0002-2336-702X	Ministry of Science and Technology of China [2011CB910900]; National Natural Science Foundation of China [30925021]; Yunnan Province [2009CI119]; Guangdong Province [2009B091300150]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province; Guangdong Province	This work was supported by the Ministry of Science and Technology of China (2011CB910900), the National Natural Science Foundation of China (30925021), Yunnan Province (2009CI119), and Guangdong Province (2009B091300150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bi R, 2010, CLIN CHIM ACTA, V411, P1671, DOI 10.1016/j.cca.2010.06.026; Brown MD, 1997, AM J HUM GENET, V60, P381; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; Jia XY, 2010, BIOCHEM BIOPH RES CO, V403, P237, DOI 10.1016/j.bbrc.2010.11.017; Kaewsutthi S, 2011, INVEST OPHTH VIS SCI, V52, P4742, DOI 10.1167/iovs.10-5816; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017; Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8; PINOS T, 2011, AGE DORDR IN PRESS, DOI DOI 10.1007/S11357-11011-19209-11355; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Torroni A, 1997, AM J HUM GENET, V60, P1107; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang HW, 2008, MUTAT RES-FUND MOL M, V643, P48, DOI 10.1016/j.mrfmmm.2008.06.004; Yao YG, 2002, HUM GENET, V111, P462, DOI 10.1007/s00439-002-0826-z; Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002; Yu DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013426; Yu DD, 2010, NEUROGENETICS, V11, P349, DOI 10.1007/s10048-010-0236-7; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zhang AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026511; Zhang AM, 2010, HUM GENET, V128, P465, DOI 10.1007/s00439-010-0875-7; Zhang AM, 2009, BIOCHEM BIOPH RES CO, V386, P392, DOI 10.1016/j.bbrc.2009.06.051; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	45	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27750	10.1371/journal.pone.0027750	http://dx.doi.org/10.1371/journal.pone.0027750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110754	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300052
J	Motard, J; Rouxel, R; Paun, A; von Messling, V; Bisaillon, M; Perreault, JP				Motard, Julie; Rouxel, Ronan; Paun, Alexandra; von Messling, Veronika; Bisaillon, Martin; Perreault, Jean-Pierre			A Novel Ribozyme-Based Prophylaxis Inhibits Influenza A Virus Replication and Protects from Severe Disease	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VIVO; AVIAN INFLUENZA; DELTA-RIBOZYME; MESSENGER-RNA; CATALYTIC RNA; GENE; EXPRESSION; CLEAVAGE; TARGET	Influenza A virus seasonal outbreaks and occasional pandemics represent a global health threat. The high genetic instability of this virus permits rapid escape from the host immune system and emergence of resistance to antivirals. There is thus an urgent need to develop novel approaches for efficient treatment of newly emerging strains. Based on a sequence alignment of representatives from every subtype known to infect humans, we identified nucleic acid regions that are conserved amongst these influenza A populations. We then engineered SOFA-HDV-Ribozymes as therapeutic tools recognizing these conserved regions to catalytically cleave the corresponding viral mRNA targets. The most promising ribozymes were chosen based on an initial in silico screening, and their efficacy was assessed using in vitro cleavage assays. Further characterization of their antiviral effect in cell culture and in mice led to the gradual identification of prophylactic SOFA-HDV-Ribozyme combinations, providing proof-of-principle for the potential of this novel strategy to develop antivirals against genetically highly variable viruses.	[Motard, Julie; Paun, Alexandra; Bisaillon, Martin; Perreault, Jean-Pierre] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, RNA Grp,Grp ARN, Sherbrooke, PQ J1K 2R1, Canada; [Rouxel, Ronan; von Messling, Veronika] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada	University of Sherbrooke; University of Quebec; Institut national de la recherche scientifique (INRS)	Motard, J (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, RNA Grp,Grp ARN, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Bisaillon@USherbrooke.ca; Jean-Pierre.Perreault@USherbrooke.ca		Rouxel, Ronan/0000-0003-1664-5615	Canadian Institutes of Health Research (CIHR) [PAP-99021]; Universite de Sherbrooke	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR; grant number PAP-99021) to Dr. Bisaillon, Dr. Perreault and Dr. von Messling. The RNA group is also supported by grants from both the Universite de Sherbrooke and CIHR (Resource program). Dr. Perreault holds the Canada Research Chair in Genomics and Catalytic RNA. Dr. Motard is a Chercheur Boursier Junior 2 from the Fonds de recherche en sante du Quebec. Dr. Bisaillon and Dr. Perreault are members of the Centre de Recherche Clinique Etienne-Lebel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan A, 2009, ANTIVIR RES, V84, P159, DOI 10.1016/j.antiviral.2009.08.009; [Anonymous], 2007, Lancet, V369, P1056; Asif-Ullah M, 2007, CURR GENE THER, V7, P205, DOI 10.2174/156652307780859008; Bai Y, 2008, P NATL ACAD SCI USA, V105, P10919, DOI 10.1073/pnas.0804922105; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bergeron LJ, 2005, NUCLEIC ACIDS RES, V33, P1240, DOI 10.1093/nar/gki278; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Bussiere F, 1999, J VIROL, V73, P6353; Cheng CS, 2009, J DRUG TARGET, V17, P133, DOI [10.1080/10611860802473048, 10.1080/10611860802473048 ]; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Deschenes P, 2003, NUCLEIC ACIDS RES, V31, P2087, DOI 10.1093/nar/gkg307; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fiola K, 2006, APPL ENVIRON MICROB, V72, P869, DOI 10.1128/AEM.72.1.869-879.2006; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Ilyinskii PO, 2009, OMICS, V13, P421, DOI 10.1089/omi.2009.0036; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007366; Kumar P, 2010, ANTIVIR RES, V87, P204, DOI 10.1016/j.antiviral.2010.05.001; Laine S, 2011, RNA BIOL, V8, P343, DOI 10.4161/rna.8.2.15200; Lazarev VN, 1999, ANTIVIR RES, V42, P47, DOI 10.1016/S0166-3542(99)00015-7; Levesque D, 2002, RNA, V8, P464, DOI 10.1017/S1355838202020289; Levesque MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009627; Lucier JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-480; Luscher-Mattli M, 2000, ARCH VIROL, V145, P2233, DOI 10.1007/s007050070017; Maxwell SRJ, 2007, BRIT MED J, V334, P1232, DOI 10.1136/bmj.39240.497025.80; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nishikawa F, 2000, NUCLEIC ACIDS RES, V28, P925, DOI 10.1093/nar/28.4.925; Robbins M, 2008, HUM GENE THER, V19, P991, DOI 10.1089/hum.2008.131; Robichaud GA, 2008, NUCLEIC ACIDS RES, V36, P4609, DOI 10.1093/nar/gkn432; TANG XB, 1994, J MED VIROL, V42, P385, DOI 10.1002/jmv.1890420411; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zhang W, 2009, BIOCHEM BIOPH RES CO, V390, P421, DOI 10.1016/j.bbrc.2009.09.039; Zhiqiang W, 2010, ANTIVIR RES, V85, P559, DOI 10.1016/j.antiviral.2009.12.010; Zhou HB, 2007, ANTIVIR RES, V76, P186, DOI 10.1016/j.antiviral.2007.07.002; Zhou K, 2008, J BIOTECHNOL, V135, P140, DOI 10.1016/j.jbiotec.2008.03.007	42	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27327	10.1371/journal.pone.0027327	http://dx.doi.org/10.1371/journal.pone.0027327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110627	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300021
J	Wu, CHY; Chan, JYH; Chan, SHH; Chang, AYW				Wu, Carol H. Y.; Chan, Julie Y. H.; Chan, Samuel H. H.; Chang, Alice Y. W.			A Double-Edged Sword Role for Ubiquitin-Proteasome System in Brain Stem Cardiovascular Regulation During Experimental Brain Death	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ROSTRAL VENTROLATERAL MEDULLA; FACTOR-KAPPA-B; ARTERIAL-PRESSURE SIGNALS; VASOMOTOR COMPONENT; SPECTRAL-ANALYSIS; HEAT-SHOCK-PROTEIN-70; ENDOTOXEMIA; INHIBITION; ACTIVATION	Background: Brain stem cardiovascular regulatory dysfunction during brain death is underpinned by an upregulation of nitric oxide synthase II (NOS II) in rostral ventrolateral medulla (RVLM), the origin of a life-and-death signal detected from blood pressure of comatose patients that disappears before brain death ensues. Furthermore, the ubiquitin-proteasome system (UPS) may be involved in the synthesis and degradation of NOS II. We assessed the hypothesis that the UPS participates in brain stem cardiovascular regulation during brain death by engaging in both synthesis and degradation of NOS II in RVLM. Methodology/Principal Findings: In a clinically relevant experimental model of brain death using Sprague-Dawley rats, pretreatment by microinjection into the bilateral RVLM of proteasome inhibitors (lactacystin or proteasome inhibitor II) antagonized the hypotension and reduction in the life-and-death signal elicited by intravenous administration of Escherichia coli lipopolysaccharide (LPS). On the other hand, pretreatment with an inhibitor of ubiquitin-recycling (ubiquitin aldehyde) or ubiquitin C-terminal hydrolase isozyme L1 (UCH-L1) potentiated the elicited hypotension and blunted the prevalence of the life-and-death signal. Real-time polymerase chain reaction, Western blot, electrophoresis mobility shift assay, chromatin immunoprecipitation and co-immunoprecipitation experiments further showed that the proteasome inhibitors antagonized the augmented nuclear presence of NF-kappa B or binding between NF-kappa B and nos II promoter and blunted the reduced cytosolic presence of phosphorylated I kappa B. The already impeded NOS II protein expression by proteasome inhibitor II was further reduced after gene-knockdown of NF-kappa B in RVLM. In animals pretreated with UCH-L1 inhibitor and died before significant increase in nos II mRNA occurred, NOS II protein expression in RVLM was considerably elevated. Conclusions/Significance: We conclude that UPS participates in the defunct and maintained brain stem cardiovascular regulation during experimental brain death by engaging in both synthesis and degradation of NOS II at RVLM. Our results provide information on new therapeutic initiatives against this fatal eventuality.	[Wu, Carol H. Y.; Chan, Julie Y. H.; Chan, Samuel H. H.; Chang, Alice Y. W.] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Wu, Carol H. Y.] Natl Sun Yat Sen Univ, Inst Biomed Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Academia Sinica - Taiwan; National Sun Yat Sen University	Wu, CHY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan.	shhchan@adm.cgmh.org.tw; cgmf.kmc@gmail.com	Chan, Julie/X-5253-2019		National Science Council, Taiwan, Republic of China [NSC-96-2320-B-110-002, NSC-97-2320-B-182A-007-MY3, NSC99-2321-B-182A-007, NSC99-2321-B-182A-006]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, NSC-96-2320-B-110-002, NSC-97-2320-B-182A-007-MY3 and NSC99-2321-B-182A-007 to SHHC, and NSC99-2321-B-182A-006 to AYWC, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, BMJ-BRIT MED J, V2, P1187; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Chan JYH, 2007, J PHYSIOL-LONDON, V581, P1293, DOI 10.1113/jphysiol.2007.130872; Chan JYH, 2007, MOL PHARMACOL, V71, P1129, DOI 10.1124/mol.106.031161; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chan JYH, 2005, PROG NEUROBIOL, V77, P396, DOI 10.1016/j.pneurobio.2005.11.004; Chan JYH, 2004, CIRCULATION, V110, P3560, DOI 10.1161/01.CIR.0000143082.63063.33; Chan JYH, 2001, SHOCK, V15, P65, DOI 10.1097/00024382-200115010-00011; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chan SHH, 2005, FREE RADICAL BIO MED, V39, P603, DOI 10.1016/j.freeradbiomed.2005.04.012; Chang AYW, 2006, J PHYSIOL-LONDON, V574, P547, DOI 10.1113/jphysiol.2006.110890; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; HUNG TP, 1995, J NEUROL NEUROSUR PS, V58, P75, DOI 10.1136/jnnp.58.1.75; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Keinanen R, 1999, GENE, V234, P297, DOI 10.1016/S0378-1119(99)00196-1; Kimura Y, 2005, CIRC RES, V96, P252, DOI 10.1161/01.RES.0000152965.75127.9d; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V273, pH1291, DOI 10.1152/ajpheart.1997.273.3.H1291; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Li PL, 2001, CIRCULATION, V103, P2114; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; PALLIS C, 1983, A B C BRAIN STEM DEA; Pingle SC, 2003, MOL PHARMACOL, V63, P1238, DOI 10.1124/mol.63.6.1238; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Thompson SJ, 2008, CURR OPIN PHARMACOL, V8, P90, DOI 10.1016/j.coph.2007.09.010; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Wei JP, 2004, BIOCHEM J, V377, P809, DOI 10.1042/bj20031235; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yen DHT, 2000, CRIT CARE MED, V28, P2805, DOI 10.1097/00003246-200008000-00021; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011; Ying WZ, 2003, BIOCHEM J, V376, P789, DOI 10.1042/BJ20031058	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27404	10.1371/journal.pone.0027404	http://dx.doi.org/10.1371/journal.pone.0027404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110641	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300027
J	Peurala, H; Greco, D; Heikkinen, T; Kaur, S; Bartkova, J; Jamshidi, M; Aittomaki, K; Heikkila, P; Bartek, J; Blomqvist, C; Butzow, R; Nevanlinna, H				Peurala, Hanna; Greco, Dario; Heikkinen, Tuomas; Kaur, Sippy; Bartkova, Jirina; Jamshidi, Maral; Aittomaki, Kristiina; Heikkila, Paivi; Bartek, Jiri; Blomqvist, Carl; Butzow, Ralf; Nevanlinna, Heli			MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer	PLOS ONE			English	Article							DOWN-REGULATION; GENE-EXPRESSION; MICRORNAS; FAMILY; TARGET; BIOINFORMATICS	MiR-34a acts as a candidate tumour suppressor gene, and its expression is reduced in several cancer types. We aimed to study miR-34a expression in breast cancer and its correlation with tumour characteristics and clinical outcome, and regulatory links with other genes. We analysed miR-34a expression in 1,172 breast tumours on TMAs. 25% of the tumours showed high, 43% medium and 32% low expression of miR-34a. High miR-34a expression associated with poor prognostic factors for breast cancer: positive nodal status (p = 0.006), high tumour grade (p < 0.0001), ER-negativity (p = 0.0002), HER2-positivity (p = 0.0002), high proliferation rate (p < 0.0001), p53-positivity (p < 0.0001), high cyclin E (p < 0.0001) and gamma H2AX (p < 0.0001). However, multivariate analysis adjusting for conventional prognostic factors indicated that high miR-34a expression in fact associated with a lower risk of recurrence or death from breast cancer (HR = 0.63, 95% CI = 0.41-0.96, p = 0.031). Gene expression analysis by differential miR-34a expression revealed an expression signature with an effect on both the 5-year and 10-year survival of the patients (p < 0.001). Functional genomic analysis highlighted a novel regulatory role of the transcription factor MAZ, apart from the known control by p53, on the expression of miR-34a and a number of miR-34a targets. Our findings suggest that while miR-34a expression activation is a marker of aggressive breast tumour phenotype it exerts an independent effect for a lower risk of recurrence or death from breast cancer. We also present an expression signature of 190 genes associated with miR-34a expression. Our analysis for regulatory loops suggest that MAZ and p53 transcription factors co-operate in modulating miR-34a, as well as miR-34a targets involved in several cellular pathways. Taken together, these results suggest that the network of genes co-regulated with and targeted by miR-34a form a group of down-stream effectors that maybe of use in predicting clinical outcome, and that highlight novel regulatory mechanisms in breast cancer.	[Peurala, Hanna; Greco, Dario; Heikkinen, Tuomas; Kaur, Sippy; Jamshidi, Maral; Butzow, Ralf; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Heikkila, Paivi; Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; [Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Danish Cancer Society; Danish Cancer Society; Palacky University Olomouc	Peurala, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland.	heli.nevanlinna@hus.fi	Greco, Dario/T-7113-2019; Bartek, Jiri/G-5870-2014	Greco, Dario/0000-0001-9195-9003; Blomqvist, Carl/0000-0003-3041-1938; Nevanlinna, Heli/0000-0002-0916-2976; Heikkinen, Tuomas/0000-0003-1154-6204	Helsinki University Central Hospital; Sigrid Juselius Foundation; Finnish Cancer Society; Academy of Finland [132473]; Danish National Research Foundation; Czech Ministry of Education [MSM6198959216]; European Commission; National Graduate School of Clinical Investigation of Finland; Finnish Lakaresallskapet	Helsinki University Central Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Academy of Finland(Academy of Finland); Danish National Research Foundation(Danmarks Grundforskningsfond); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); European Commission(European CommissionEuropean Commission Joint Research Centre); National Graduate School of Clinical Investigation of Finland; Finnish Lakaresallskapet	This study has been funded by the Helsinki University Central Hospital Research Fund, the Sigrid Juselius Foundation, the Finnish Cancer Society, the Academy of Finland (132473), the Danish National Research Foundation, Czech Ministry of Education (MSM6198959216), the European Commission (projects Infla-Care and Biomedreg), the National Graduate School of Clinical Investigation of Finland and the Finnish Lakaresallskapet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dijkstra MK, 2009, LEUKEMIA, V23, P625, DOI 10.1038/leu.2008.264; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Eerola H, 2000, EUR J CANCER, V36, P1143, DOI 10.1016/S0959-8049(00)00093-9; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito Y, 2006, ANTICANCER RES, V26, P4391; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Kilpivaara O, 2005, INT J CANCER, V113, P575, DOI 10.1002/ijc.20638; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lukes L, 2009, CANCER RES, V69, P310, DOI 10.1158/0008-5472.CAN-08-3520; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; NAGAI H, 1995, CANCER RES, V55, P1752; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; PA Pizzo, 2006, PRINCIPLES PRACTICE, P931; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tatusova T, 2010, METHODS MOL BIOL, V609, P17, DOI 10.1007/978-1-60327-241-4_2; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Wang X, 2008, BREAST CANCER RES TR, V111, P103, DOI 10.1007/s10549-007-9765-7; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zaytseva YY, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-90	48	68	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26122	10.1371/journal.pone.0026122	http://dx.doi.org/10.1371/journal.pone.0026122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102859	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800005
J	Morandi, A; Barbetti, V; Riverso, M; Dello Sbarba, P; Rovida, E				Morandi, Andrea; Barbetti, Valentina; Riverso, Maria; Dello Sbarba, Persio; Rovida, Elisabetta			The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines	PLOS ONE			English	Article							C-FMS PROTOONCOGENE; GENE-EXPRESSION; GROWTH-FACTOR; CONSTITUTIVE PRODUCTION; SIGNAL-TRANSDUCTION; MICROARRAY ANALYSIS; SUPPRESSES GROWTH; TUMOR XENOGRAFTS; MAMMARY-TUMORS; COPY NUMBER	Breast cancer is the second leading cause of cancer-related deaths in western countries. Colony-Stimulating Factor-1 (CSF-1) and its receptor (CSF-1R) regulate macrophage and osteoclast production, trophoblast implantation and mammary gland development. The expression of CSF-1R and/or CSF-1 strongly correlates with poor prognosis in several human epithelial tumors, including breast carcinomas. We demonstrate that CSF-1 and CSF-1R are expressed, although at different levels, in 16/17 breast cancer cell lines tested with no differences among molecular subtypes. The role of CSF-1/CSF-1R in the proliferation of breast cancer cells was then studied in MDAMB468 and SKBR3 cells belonging to different subtypes. CSF-1 administration induced ERK1/2 phosphorylation and enhanced cell proliferation in both cell lines. Furthermore, the inhibition of CSF-1/CSF-1R signaling, by CSF-1R siRNA or imatinib treatment, impaired CSF-1 induced ERK1/2 activation and cell proliferation. We also demonstrate that c-Jun, cyclin D1 and c-Myc, known for their involvement in cell proliferation, are downstream CSF-1R in breast cancer cells. The presence of a proliferative CSF-1/CSF-1R autocrine loop involving ERK1/2 was also found. The wide expression of the CSF-1/CSF-1R pair across breast cancer cell subtypes supports CSF-1/CSF-1R targeting in breast cancer therapy.	Univ Florence, Dipartimento Patol & Oncol Sperimentali, Florence, Italy; Ist Toscano Tumori, Florence, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Morandi, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	persio@unifi.it; erovida@unifi.it	Rovida, Elisabetta/F-3565-2015; Morandi, Andrea/AAC-1901-2022; Dello Sbarba, Persio/AAX-9887-2020	Rovida, Elisabetta/0000-0002-5949-3239; Morandi, Andrea/0000-0002-9222-5332; 	Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG5220]; Ministero della Salute (Ricerca Finalizzata); Regione Toscana (Programma per la Ricerca in Materia di Salute); Associazione Italiana per la lotta contro le Leucemie e i Linfomi; sezione di Prato; Fondazione Cassa di Risparmio di Volterra; Federazione Italiana per la Ricerca sul Cancro (FIRC/AIRC)	Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Regione Toscana (Programma per la Ricerca in Materia di Salute)(Regione Toscana); Associazione Italiana per la lotta contro le Leucemie e i Linfomi(Fondazione AIRC per la ricerca sul cancro); sezione di Prato; Fondazione Cassa di Risparmio di Volterra; Federazione Italiana per la Ricerca sul Cancro (FIRC/AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Istituto Toscano Tumori (PDS), Associazione Italiana per la Ricerca sul Cancro (AIRC, contr.n. IG5220; PDS), Ministero della Salute (Ricerca Finalizzata; PDS), Regione Toscana (Programma per la Ricerca in Materia di Salute; PDS), Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL) sezione di Prato (PDS), Fondazione Cassa di Risparmio di Volterra (PDS). VB was recipient of a fellowship from Federazione Italiana per la Ricerca sul Cancro (FIRC/AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Aharinejad S, 2002, CANCER RES, V62, P5317; ASHMUN RA, 1989, BLOOD, V73, P827; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brownlow N, 2008, LEUKEMIA, V22, P649, DOI 10.1038/sj.leu.2404944; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Espinosa I, 2009, AM J PATHOL, V174, P2347, DOI 10.2353/ajpath.2009.081037; FILDERMAN AE, 1992, CANCER RES, V52, P3661; FlidelRimon O, 1997, J PEDIATR-US, V131, P748, DOI 10.1016/S0022-3476(97)70105-7; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gallet M, 2006, APOPTOSIS, V11, P1909, DOI 10.1007/s10495-006-9507-z; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; HORIGUCHI J, 1988, BIOCHEM BIOPH RES CO, V157, P395, DOI 10.1016/S0006-291X(88)80060-3; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; KACINSKI BM, 1991, ONCOGENE, V6, P941; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kirma N, 2004, CANCER RES, V64, P4162, DOI 10.1158/0008-5472.CAN-03-2971; Kirma N, 2007, CANCER RES, V67, P1918, DOI 10.1158/0008-5472.CAN-06-1991; Kluger HM, 2004, LAB INVEST, V84, P320, DOI 10.1038/labinvest.3700044; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AWM, 1999, ONCOGENE, V18, P7477, DOI 10.1038/sj.onc.1203123; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Mashkani B, 2010, BIOORGAN MED CHEM, V18, P1789, DOI 10.1016/j.bmc.2010.01.056; Meegalla SK, 2008, BIOORG MED CHEM LETT, V18, P3632, DOI 10.1016/j.bmcl.2008.04.059; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; RAMAKRISHNAN S, 1989, J CLIN INVEST, V83, P921, DOI 10.1172/JCI113977; ROHRSCHNEIDER LR, 1989, ONCOGENE, V4, P1015; Roussel MF, 1997, MOL REPROD DEV, V46, P11, DOI 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U; ROUSSEL MF, 1989, P NATL ACAD SCI USA, V86, P7924, DOI 10.1073/pnas.86.20.7924; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sapi E, 2004, EXP BIOL MED, V229, P1; Sapi E, 1996, CANCER RES, V56, P5704; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; SHERR CJ, 1990, BLOOD, V75, P1; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Tamimi RM, 2008, CANCER RES, V68, P18, DOI 10.1158/0008-5472.CAN-07-3234; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yee LD, 2000, ANTICANCER RES, V20, P4379	62	35	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27450	10.1371/journal.pone.0027450	http://dx.doi.org/10.1371/journal.pone.0027450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096574	Green Submitted, gold, Green Published			2022-12-25	WOS:000297350800053
J	Zhou, X; Xu, Y; Wang, J; Zhou, HB; Liu, X; Ayub, Q; Wang, XL; Tyler-Smith, C; Wu, LJ; Xue, YL				Zhou, Xue; Xu, Yang; Wang, Jia; Zhou, Hongbo; Liu, Xian; Ayub, Qasim; Wang, Xuelai; Tyler-Smith, Chris; Wu, Lijie; Xue, Yali			Replication of the Association of a MET Variant with Autism in a Chinese Han Population	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; LINKAGE DISEQUILIBRIUM; SPECTRUM DISORDER; GENE; PREVALENCE; CHILDREN; TWIN	Background: Autism is a common, severe and highly heritable neurodevelopmental disorder in children, affecting up to 100 children per 10,000. The MET gene has been regarded as a promising candidate gene for this disorder because it is located within a replicated linkage interval, is involved in pathways affecting the development of the cerebral cortex and cerebellum in ways relevant to autism patients, and has shown significant association signals in previous studies. Principal Findings: Here, we present new ASD patient and control samples from Heilongjiang, China and use them in a case-control and family-based replication study of two MET variants. One SNP, rs38845, was successfully replicated in a case-control association study, but failed to replicate in a family-based study, possibly due to small sample size. The other SNP, rs1858830, failed to replicate in both case-control and family-based studies. Conclusions: This is the first attempt to replicate associations in Chinese autism samples, and our result provides evidence that MET variants may be relevant to autism susceptibility in the Chinese Han population.	[Zhou, Xue; Xu, Yang; Wang, Jia; Liu, Xian; Wang, Xuelai; Wu, Lijie] Harbin Med Univ, Coll Publ Hlth, Dept Childrens & Adolescent Hlth, Harbin, Heilongjiang, Peoples R China; [Zhou, Xue; Zhou, Hongbo; Ayub, Qasim; Tyler-Smith, Chris; Xue, Yali] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Zhou, Hongbo] Harbin Med Univ, Basic Med Sci Coll, Dept Biochem & Mol Biol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Wellcome Trust Sanger Institute; Harbin Medical University	Zhou, X (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Childrens & Adolescent Hlth, Harbin, Heilongjiang, Peoples R China.	wulijie_123@yahoo.com.cn		Ayub, Qasim/0000-0003-3291-0917	Wellcome Trust (UK); National Natural Science Foundation of China [30771817, 81072315]	Wellcome Trust (UK)(Wellcome Trust); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Wellcome Trust (UK) http://www.wellcome.ac.uk/funding/index.htm, National Natural Science Foundation of China (No. 30771817 and 81072315) http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beilmann M, 2000, BLOOD, V95, P3964; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Dodds L, 2009, CHRONIC DIS CAN, V29, P102; Eagleson KL, 2011, AUTISM RES, V4, P68, DOI 10.1002/aur.172; Eisen GE, 2009, DEV BIOL, V335, P78, DOI 10.1016/j.ydbio.2009.08.024; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; He Y, PSYCHIAT RES; Jackson PB, 2009, AUTISM RES, V2, P232, DOI 10.1002/aur.87; Judson MC, 2010, J COMP NEUROL, V518, P4463, DOI 10.1002/cne.22467; Judson MC, 2009, J COMP NEUROL, V513, P511, DOI 10.1002/cne.21969; Kakinuma H, 2008, PHARMACOGENOMICS, V9, P1143, DOI 10.2217/14622416.9.8.1143; Khaniani MS, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-5; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; [刘靖 LIU Jing], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P290; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Sousa I, 2009, EUR J HUM GENET, V17, P749, DOI 10.1038/ejhg.2008.215; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tahara Y, 2003, J PHARMACOL EXP THER, V307, P146, DOI 10.1124/jpet.103.054106; Thanseem I, 2010, NEUROSCI RES, V68, P137, DOI 10.1016/j.neures.2010.06.014; Wang W, 2002, CHINESE J CLIN PSYCH, V12, P48; Wong VCN, 2008, J CHILD NEUROL, V23, P67, DOI 10.1177/0883073807308702; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yu C, 2010, CHIN J CHILD HLTH CA, V18, P750; Zhang X, 2004, CHIN J REPROD HLTH, V15, P206	43	14	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27428	10.1371/journal.pone.0027428	http://dx.doi.org/10.1371/journal.pone.0027428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HZ	22110649	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700043
J	Tamura, T; Sone, M; Iwatsubo, T; Tagawa, K; Wanker, EE; Okazawa, H				Tamura, Takuya; Sone, Masaki; Iwatsubo, Takeshi; Tagawa, Kazuhiko; Wanker, Erich E.; Okazawa, Hitoshi			Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; SPINOCEREBELLAR ATAXIA; CELL-DEATH; PROTEINS; TRANSCRIPTION; TOXICITY; MICE; GENE	DNA damage accumulates in genome DNA during the long life of neurons, thus DNA damage repair is indispensable to keep normal functions of neurons. We previously reported that Ku70, a critical molecule for DNA double strand break (DSB) repair, is involved in the pathology of Huntington's disease (HD). Mutant huntingtin (Htt) impaired Ku70 function via direct interaction, and Ku70 supplementation recovered phenotypes of a mouse HD model. In this study, we generate multiple Drosophila HD models that express mutant huntingtin (Htt) in eye or motor neuron by different drivers and show various phenotypes. In such fly models, Ku70 co-expression recovers lifespan, locomotive activity and eye degeneration. In contrast, Ku70 reduction by heterozygous null mutation or siRNA-mediated knock down accelerates lifespan shortening and locomotion disability. These results collectively support that Ku70 is a critical mediator of the HD pathology and a candidate therapeutic target in HD.	[Tamura, Takuya; Sone, Masaki; Tagawa, Kazuhiko; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Tokyo, Japan; [Sone, Masaki] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo, Japan; [Wanker, Erich E.] Max Delbruck Ctr Mol Med, Dept Neurogenet, Berlin, Germany; [Okazawa, Hitoshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Toho University; University of Tokyo; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Japan Science & Technology Agency (JST)	Tamura, T (corresponding author), Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Sone, Masaki/Q-9058-2019	Wanker, Erich/0000-0001-8072-1630	Japan Science Technology Agency (CREST, JST, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan [16390249, 16650076, 18390254, 18650097, 17025017, 18023014, 20023011]; Foundation of Synapse and Neurocircuit Pathology; National Genome Research Network (NGFN); DFG Collaborative Research Centre [SFB577, SFB740, SFB618]	Japan Science Technology Agency (CREST, JST, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Synapse and Neurocircuit Pathology; National Genome Research Network (NGFN); DFG Collaborative Research Centre(German Research Foundation (DFG))	This work was supported by grants to H.O. from Japan Science Technology Agency (CREST, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011) and Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology). Financial support to E. E. W. was provided by National Genome Research Network (NGFN) grants and DFG Collaborative Research Centre grants (SFB577, SFB740, SFB618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Johnson-Schlitz DM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030050; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Sekelsky JJ, 1998, GENETICS, V148, P1587; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Sone M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004466; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052	42	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27408	10.1371/journal.pone.0027408	http://dx.doi.org/10.1371/journal.pone.0027408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22096569	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700049
J	Kortholt, A; van Egmond, WN; Plak, K; Bosgraaf, L; Keizer-Gunnink, I; van Haastert, PJM				Kortholt, Arjan; van Egmond, Wouter N.; Plak, Katarzyna; Bosgraaf, Leonard; Keizer-Gunnink, Ineke; van Haastert, Peter J. M.			Multiple Regulatory Mechanisms for the Dictyostelium Roco Protein GbpC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; MYOSIN PHOSPHORYLATION; SIGNALING PATHWAY; GTP-BINDING; GRAM DOMAIN; LRRK2; CHEMOTAXIS; CGMP	GbpC is a multidomain Roco protein in Dictyostelium, involved in transduction of intracellular cGMP that is produced by chemotactic signals. We have shown previously that cGMP binding to GbpC induces an intramolecular signaling cascade by activating subsequently the GEF, Ras, and kinase domains. In this study, we report on the cellular localization of GbpC. In resting cells, the protein is present in the cytoplasm, but GbpC rapidly translocates to the cell boundary upon stimulation with the chemoattractant cAMP. Also, during the formation of cell-cell streams and osmotic shock, the protein localizes toward the plasma membrane and actin cytoskeleton. The translocation upon cAMP stimulation occurs downstream of heterotrimeric G proteins but is independent of guanylyl cyclases and the previously identified cGMP-induced intramolecular signaling cascade in GbpC. Mutations in the GRAM domain of GbpC lead to disturbed membrane association and inactivation of GbpC function during chemotaxis in vivo. Furthermore, we show that the GRAM domain itself associates with cellular membranes and binds various phospholipids in vitro. Together, the results show that GbpC receives multiple input signals that are both required for functional activity in vivo. cAMP-stimulation induces a cGMP-dependent signaling cascade, leading to activation of kinase activity, and, independently, cAMP induces a GRAM-dependent translocation of GbpC toward the plasma membrane and cell cortex, where it may locally phosphorylate effector proteins, which are needed for proper biological activity.	[Kortholt, Arjan; van Egmond, Wouter N.; Plak, Katarzyna; Bosgraaf, Leonard; Keizer-Gunnink, Ineke; van Haastert, Peter J. M.] Univ Groningen, Dept Cell Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	P.J.M.van.haastert@rug.nl	kortholt, arjan/L-9795-2017	kortholt, arjan/0000-0001-8174-6397; Plak, Katarzyna/0000-0001-5268-4289				Araki T, 2003, J CELL SCI, V116, P2907, DOI 10.1242/jcs.00501; Araki T, 2010, J CELL SCI, V123, P837, DOI 10.1242/jcs.064436; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bosgraaf L, 2008, J CELL SCI, V121, P3589, DOI 10.1242/jcs.031781; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Goldberg JM, 2002, P NATL ACAD SCI USA, V99, P6749, DOI 10.1073/pnas.102167299; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; KONIJN TM, 1970, EXPERIENTIA, V26, P367, DOI 10.1007/BF01896891; Kuwayama H, 1996, SCIENCE, V271, P207, DOI 10.1126/science.271.5246.207; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Liao XH, 2008, AMINO ACIDS, V35, P761, DOI 10.1007/s00726-008-0100-3; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Roelofs J, 2002, J BIOL CHEM, V277, P9167, DOI 10.1074/jbc.M111437200; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; van Egmond WN, 2010, EUKARYOT CELL, V9, P751, DOI 10.1128/EC.00366-09; van Egmond Wouter N, 2008, J Biol Chem, V283, P30412, DOI 10.1074/jbc.M804265200; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2008, J CELL SCI, V121, P120, DOI 10.1242/jcs.015602; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; WEEKS G, 1980, J LIPID RES, V21, P681; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	44	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2749	2758		10.1074/jbc.M111.315739	http://dx.doi.org/10.1074/jbc.M111.315739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22119747	hybrid, Green Published			2022-12-25	WOS:000300292300046
J	Murphy, L; Cruys-Bagger, N; Damgaard, HD; Baumann, MJ; Olsen, SN; Borch, K; Lassen, SF; Sweeney, M; Tatsumi, H; Westh, P				Murphy, Leigh; Cruys-Bagger, Nicolaj; Damgaard, Heidi Delcomyn; Baumann, Martin J.; Olsen, Soren Nymand; Borch, Kim; Lassen, Soren Flensted; Sweeney, Matt; Tatsumi, Hirosuke; Westh, Peter			Origin of Initial Burst in Activity for Trichoderma reesei endo-Glucanases Hydrolyzing Insoluble Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGLUCANASE-I CEL7B; ENZYMATIC-HYDROLYSIS; CELLOBIOSE DEHYDROGENASE; CELLOBIOHYDROLASE-II; CRYSTAL-STRUCTURE; REACTION-KINETICS; X-RAY; CELLULASES; MODEL; INHIBITION	The kinetics of cellulose hydrolysis have longbeen described by an initial fast hydrolysis rate, tapering rapidly off, leading to a process that takes days rather than hours to complete. This behavior has been mainly attributed to the action of cellobiohydrolases and often linked to the processive mechanism of this exo-acting group of enzymes. The initial kinetics of endo-glucanases (EGs) is far less investigated, partly due to a limited availability of quantitative assay technologies. We have used isothermal calorimetry to monitor the early time course of the hydrolysis of insoluble cellulose by the three main EGs from Trichoderma reesei (Tr): TrCel7B (formerly EG I), TrCel5A (EG II), and TrCel12A (EG III). These endo-glucanases show a distinctive initial burst with a maximal rate that is about 5-fold higher than the rate after 5 min of hydrolysis. The burst is particularly conspicuous for TrCel7B, which reaches a maximal turnover of about 20 s(-1) at 30 degrees C and conducts about 1200 catalytic cycles per enzyme molecule in the initial fast phase. For TrCel5A and TrCel12A the extent of the burst is 2-300 cycles per enzyme molecule. The availability of continuous data on EG activity allows an analysis of the mechanisms underlying the initial kinetics, and it is suggested that the slowdown is linked to transient inactivation of enzyme on the cellulose surface. We propose, therefore, that the frequency of structures on the substrate surface that cause transient inactivation determine the extent of the burst phase.	[Murphy, Leigh; Cruys-Bagger, Nicolaj; Damgaard, Heidi Delcomyn; Westh, Peter] Roskilde Univ, NSM, DK-4000 Roskilde, Denmark; [Murphy, Leigh; Baumann, Martin J.; Olsen, Soren Nymand; Borch, Kim; Lassen, Soren Flensted] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Sweeney, Matt] Novozymes Inc, Davis, CA 95618 USA; [Tatsumi, Hirosuke] Shinshu Univ, Int Young Researchers Empowerment Ctr, Matsumoto, Nagano 3908621, Japan	Roskilde University; Novozymes; Novozymes; Shinshu University	Westh, P (corresponding author), Roskilde Univ, NSM, 1 Univ Vej, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Westh, Peter/0000-0002-6185-0637	Danish Agency for Science, Technology, and Innovation [2104-07-0028]; Carlsberg Foundation	Danish Agency for Science, Technology, and Innovation; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Danish Agency for Science, Technology, and Innovation Grant 2104-07-0028 (to P. W.) and the Carlsberg Foundation.	Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; BAILEY MJ, 1993, BIOTECHNOL APPL BIOC, V17, P65; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bertilsson M, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-8; Bohlin C, 2010, BIOTECHNOL BIOENG, V107, P943, DOI 10.1002/bit.22885; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; BRIGGNER LE, 1991, J BIOCHEM BIOPH METH, V22, P101, DOI 10.1016/0165-022X(91)90023-P; CALVET E, 1951, J POLYM SCI, V6, P33, DOI 10.1002/pol.1951.120060106; Cao Y, 2002, CARBOHYD RES, V337, P1291, DOI 10.1016/S0008-6215(02)00134-9; CHILD JJ, 1973, CAN J BIOCHEM CELL B, V51, P39, DOI 10.1139/o73-006; Coward-Kelly G, 2003, BIOTECHNOL BIOENG, V82, P745, DOI 10.1002/bit.10620; DALE BE, 1982, J APPL POLYM SCI, V27, P1233, DOI 10.1002/app.1982.070270412; DIVNE C, 1993, J MOL BIOL, V234, P905, DOI 10.1006/jmbi.1993.1640; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hilden L, 2001, ANAL BIOCHEM, V290, P245, DOI 10.1006/abio.2000.4959; HOLTZAPPLE MT, 1984, BIOTECHNOL BIOENG, V26, P753, DOI 10.1002/bit.260260719; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2005, ANAL BIOCHEM, V347, P244, DOI 10.1016/j.ab.2005.09.031; JOOS P, 1969, J PHARM PHARMACOL, V21, P848, DOI 10.1111/j.2042-7158.1969.tb08184.x; Karim N, 2005, THERMOCHIM ACTA, V431, P9, DOI 10.1016/j.tca.2005.01.025; Karim N, 2004, THERMOCHIM ACTA, V412, P91, DOI 10.1016/j.tca.2003.09.001; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; KlemanLeyer KM, 1996, APPL ENVIRON MICROB, V62, P2883, DOI 10.1128/AEM.62.8.2883-2887.1996; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lee JM, 2007, BIORESOURCES, V2, P20; LEE YH, 1983, BIOTECHNOL BIOENG, V25, P939, DOI 10.1002/bit.260250406; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; LOBLICH KR, 1994, THERMOCHIM ACTA, V231, P7, DOI 10.1016/0040-6031(94)80002-2; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackenzie LF, 1998, BIOCHEM J, V335, P409, DOI 10.1042/bj3350409; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; MULLINGS R, 1985, ENZYME MICROB TECH, V7, P586, DOI 10.1016/0141-0229(85)90025-0; Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020; Murphy L, 2010, ENZYME MICROB TECH, V46, P141, DOI 10.1016/j.enzmictec.2009.09.009; Nakazawa H, 2009, APPL MICROBIOL BIOT, V83, P649, DOI 10.1007/s00253-009-1901-3; Nelson N, 1944, J BIOL CHEM, V153, P375; NIDETZKY B, 1993, BIOTECHNOL BIOENG, V42, P469, DOI 10.1002/bit.260420410; Okada H, 2000, J MOL CATAL B-ENZYM, V10, P249, DOI 10.1016/S1381-1177(00)00137-5; Olsen SN, 2006, THERMOCHIM ACTA, V448, P12, DOI 10.1016/j.tca.2006.06.019; PENTTILA M, 1986, GENE, V45, P253, DOI 10.1016/0378-1119(86)90023-5; Peri S, 2007, BIOTECHNOL PROGR, V23, P626, DOI 10.1021/bp060322s; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Rabinovich ML, 2002, APPL BIOCHEM MICRO+, V38, P305, DOI 10.1023/A:1016264219885; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; SHARROCK KR, 1988, J BIOCHEM BIOPH METH, V17, P81, DOI 10.1016/0165-022X(88)90040-1; SHOEMAKER S, 1983, BIO-TECHNOL, V1, P687, DOI 10.1038/nbt1083-687; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; STAHLBERG J, 1988, EUR J BIOCHEM, V173, P179, DOI 10.1111/j.1432-1033.1988.tb13982.x; Tatsumi H, 2005, J AGR FOOD CHEM, V53, P8123, DOI 10.1021/jf050934c; Tatsumi H, 2006, ANAL BIOCHEM, V357, P257, DOI 10.1016/j.ab.2006.07.019; TAYLOR JB, 1957, T FARADAY SOC, V53, P1198, DOI 10.1039/tf9575301198; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Valjamae P, 2001, EUR J BIOCHEM, V268, P4520, DOI 10.1046/j.1432-1327.2001.02377.x; VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009; Vlasenko E., 2005, PCTInternational Patent Appl., Patent No. [WO/2005/067531, 2005067531]; Vlasenko EY, 1998, ENZYME MICROB TECH, V23, P350, DOI 10.1016/S0141-0229(98)00052-0; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115, DOI 10.1385/ABAB:115:1-3:1115; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang S, 1999, BIOTECHNOL BIOENG, V66, P35, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;35::AID-BIT3&gt;3.0.CO;2-G; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhang YHP, 2006, BIOTECHNOL BIOENG, V94, P888, DOI 10.1002/bit.20906; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhang YHP, 2003, ANAL BIOCHEM, V322, P225, DOI 10.1016/j.ab.2003.07.021; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	87	40	45	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1252	1260		10.1074/jbc.M111.276485	http://dx.doi.org/10.1074/jbc.M111.276485			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110134	Green Published, hybrid			2022-12-25	WOS:000299170300041
J	Zhang, YJ; Shi, JM; Bai, CJ; Wang, H; Li, HY; Wu, Y; Ji, SR				Zhang, Yi-Jiong; Shi, Jing-Ming; Bai, Cai-Juan; Wang, Han; Li, Hai-Yun; Wu, Yi; Ji, Shang-Rong			Intra-membrane Oligomerization and Extra-membrane Oligomerization of Amyloid-beta Peptide Are Competing Processes as a Result of Distinct Patterns of Motif Interplay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMS ION CHANNELS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; LIPID MONOLAYERS; FIBRIL FORMATION; CELL-MEMBRANES; PATHOGENESIS; MECHANISM; INSERTION; FIBRILLOGENESIS	Soluble oligomers of amyloid-beta peptide (A beta) are emerging as the primary neurotoxic species in Alzheimer disease, however, whether the membrane is among their direct targets that mediate the downstream adverse effects remains elusive. Herein, we show that multiple soluble oligomeric A beta preparations, including A beta-derived diffusible ligand, protofibril, and zinc-induced A beta oligomer, exhibit much weaker capability to insert into the membrane than A beta monomer. A beta monomers prefer incorporating into membrane rather than oligomerizing in solution, and such preference can be reversed by the aggregation-boosting factor, zinc ion. Further analyses indicate that the membrane-embedded oligomers of A beta are derived from rapid assembly of inserted monomers but not due to the insertion of soluble A beta oligomers. By comparing the behavior of a panel of A beta truncation variants, we demonstrate that the intra- and extra-membrane oligomerization are mutually exclusive processes that proceed through distinct motif interplay, both of which require the action of amino acids 37-40/42 to overcome the auto-inhibitory interaction between amino acids 29-36 and the N-terminal portion albeit via different mechanisms. These results indicate that intra- and extra-membrane oligomerization of A beta are competing processes and emphasize a critical regulation of membrane on the behavior of A beta monomer and soluble oligomers, which may determine distinct neurotoxic mechanisms.	[Zhang, Yi-Jiong; Shi, Jing-Ming; Bai, Cai-Juan; Wang, Han; Li, Hai-Yun; Wu, Yi; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Lanzhou University	Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Life Sci Bldg,Room 227, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn; jsr@lzu.edu.cn	Shi, Jing-Ming/ACS-3321-2022	Shi, Jing-Ming/0000-0002-8185-3130; Ji, Shang-Rong/0000-0001-8595-3756; Wu, Yi/0000-0003-0365-5590	National Nature Science Foundation of China [30970605, 30930024]; Ministry of Education of China [20100211110006, 121108, 109155]; Ministry of Science and Technology of China [2011CB910500]; Lanzhou University [lzujbky-2012-k18, lzujbky-2010-k03]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Lanzhou University(Lanzhou University)	This work was supported by the National Nature Science Foundation of China (Grants 30970605 and 30930024), the Ministry of Education of China (Grants 20100211110006, 121108 and 109155), the Ministry of Science and Technology of China (Grant 2011CB910500), and Lanzhou University (Grants lzujbky-2012-k18 and lzujbky-2010-k03).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Ege C, 2004, BIOPHYS J, V87, P1732, DOI 10.1529/biophysj.104.043265; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; Millucci L, 2009, J BIOSCIENCES, V34, P293, DOI 10.1007/s12038-009-0033-3; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Qi JS, 2001, NEUROSCIENCE, V105, P845, DOI 10.1016/S0306-4522(01)00244-5; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang Lan Y. Y., 2010, ACTA BIOPHYS SIN, V26, P649	49	35	43	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					748	756		10.1074/jbc.M111.281295	http://dx.doi.org/10.1074/jbc.M111.281295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105077	hybrid, Green Published			2022-12-25	WOS:000298682400072
J	Du, JM; Chen, C; Ding, BX; Tu, JJ; Qin, ZQ; Parsons, C; Salgado, C; Cai, QJ; Song, YL; Bao, QY; Zhang, LM; Pan, JY; Wang, LX; Yu, FY				Du, Jimei; Chen, Chun; Ding, Baixing; Tu, Jinjing; Qin, Zhiqiang; Parsons, Chris; Salgado, Cassandra; Cai, Qiangjun; Song, Yulong; Bao, Qiyu; Zhang, Liming; Pan, Jingye; Wang, Liangxing; Yu, Fangyou			Molecular Characterization and Antimicrobial Susceptibility of Nasal Staphylococcus aureus Isolates from a Chinese Medical College Campus	PLOS ONE			English	Article							VALENTINE LEUKOCIDIN GENES; MULTIPLEX PCR ASSAY; METHICILLIN-RESISTANT; COMMUNITY; CARRIAGE; COLONIZATION; PREVALENCE; CHILDREN; INFECTIONS; VIRULENCE	Staphylococcus aureus colonization and infection occur more commonly among persons living or working in crowded conditions, but characterization of S. aureus colonization within medical communities in China is lacking. A total of 144 (15.4%, 144/935) S. aureus isolates, including 28 (3.0%, 28/935) MRSA isolates, were recovered from the nares of 935 healthy human volunteers residing on a Chinese medical college campus. All S. aureus isolates were susceptible to vancomycin, quinupristin/dalfopristin and linezolid but the majority were resistant to penicillin (96.5%), ampicillin/sulbactam (83.3%) and trimethoprim/sulfamethoxazole (93.1%). 82%, (23/28) of the MRSA isolates and 66% (77/116) of the MSSA isolates were resistant to multiple antibiotics, and 3 MRSA isolates were resistant to mupirocin-an agent commonly used for nasal decolonization. 16 different sequence types (STs), as well as SCCmec genes II, III, IVd, and V, were represented among MRSA isolates. We also identified, for the first time, two novel STs (ST1778 and ST1779) and 5 novel spa types for MRSA. MRSA isolates were distributed in different sporadic clones, and ST59-MRSA-VId-t437 was found within 3 MRSA isolates. Moreover, one isolate with multidrug resistance belonging to ST398-MRSA-V-t571 associated with animal infections was identified, and 3 isolates distributed in three different clones harbored PVL genes. Collectively, these data indicate a high prevalence of nasal MRSA carriage and molecular heterogeneity of S. aureus isolates among persons residing on a Chinese medical college campus. Identification of epidemic MRSA clones associated with community infection supports the need for more effective infection control measures to reduce nasal carriage and prevent dissemination of MRSA to hospitalized patients and health care workers in this community.	[Du, Jimei; Cai, Qiangjun; Song, Yulong; Bao, Qiyu] Wenzhou Med Coll, Sch Lab Med, Wenzhou, Peoples R China; [Chen, Chun; Tu, Jinjing; Wang, Liangxing] Wenzhou Med Coll, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Peoples R China; [Ding, Baixing; Pan, Jingye] Wenzhou Med Coll, Affiliated Hosp 1, Dept Intens Care Unit, Wenzhou, Peoples R China; [Qin, Zhiqiang; Parsons, Chris; Salgado, Cassandra] Med Univ S Carolina, Dept Med, Hollings Canc Ctr, Div Infect Dis, Charleston, SC 29425 USA; [Yu, Fangyou] Wenzhou Med Coll, Dept Lab Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhang, Liming] Taizhou Ctr Hosp, Dept Clin Lab, Taizhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Medical University of South Carolina; Wenzhou Medical University	Du, JM (corresponding author), Wenzhou Med Coll, Sch Lab Med, Wenzhou, Peoples R China.	wzyxywlx@163.com; wzjxyfy@163.com	Bao, Qiyu/AAH-6113-2020	Bao, Qiyu/0000-0001-6523-8763; Song, Yulong/0000-0003-4384-8311	Wenzhou Municipal Science and Technology Bureau, China [H2010064]; Ministry of Sciences and Technology [2010DFA32100, 2009ZX09303-005, 2008ZX10003-016]	Wenzhou Municipal Science and Technology Bureau, China; Ministry of Sciences and Technology	This study was supported by grants from Wenzhou Municipal Science and Technology Bureau, China (H2010064) and the 11th Five-Year Plan of the Ministry of Sciences and Technology (2010DFA32100, 2009ZX09303-005, 2008ZX10003-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 1999, EUR J CLIN MICROBIOL, V18, P30, DOI 10.1007/s100960050222; Bischoff WE, 2004, INFECT CONT HOSP EP, V25, P485, DOI 10.1086/502427; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Choi Chong Seng, 2006, Journal of Microbiology Immunology and Infection, V39, P458; Cohen PR, 2007, AM J CLIN DERMATOL, V8, P259, DOI 10.2165/00128071-200708050-00001; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; FUCHS PC, 1990, J CLIN MICROBIOL, V28, P608, DOI 10.1128/JCM.28.3.608-609.1990; Geng WJ, 2010, FEMS IMMUNOL MED MIC, V58, P356, DOI [10.1111/j.1574-695X.2009.00648.x, 10.1111/j.1574-695X.2010.00648.x]; Gomes AR, 2006, ANTIMICROB AGENTS CH, V50, P3237, DOI 10.1128/AAC.00521-06; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; *I CALS, 2008, M100S18 I CALS; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; Lamaro-Cardoso J, 2009, J CLIN MICROBIOL, V47, P3991, DOI 10.1128/JCM.01322-09; Liu QZ, 2010, INT J ANTIMICROB AG, V35, P114, DOI 10.1016/j.ijantimicag.2009.09.018; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lo WT, 2008, PEDIATR INFECT DIS J, V27, P713, DOI 10.1097/INF.0b013e31816f63b5; Lo WT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015791; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2007, J INFECT DIS, V196, P911, DOI 10.1086/520933; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Pathak A, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-100; Qu F, 2010, J CLIN MICROBIOL, V48, P64, DOI 10.1128/JCM.01572-09; Sdougkos G, 2008, CLIN MICROBIOL INFEC, V14, P995, DOI 10.1111/j.1469-0691.2008.02064.x; Taiwo S S, 2009, West Afr J Med, V28, P281; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang H, 2008, DIAGN MICR INFEC DIS, V62, P226, DOI 10.1016/j.diagmicrobio.2008.06.003; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Xiao YH, 2008, EUR J CLIN MICROBIOL, V27, P697, DOI 10.1007/s10096-008-0494-6; Yao D, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-133; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	45	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27328	10.1371/journal.pone.0027328	http://dx.doi.org/10.1371/journal.pone.0027328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114670	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800018
J	Goedhart, J; van Weeren, L; Adjobo-Hermans, MJW; Elzenaar, I; Hink, MA; Gadella, TWJ				Goedhart, Joachim; van Weeren, Laura; Adjobo-Hermans, Merel J. W.; Elzenaar, Ies; Hink, Mark A.; Gadella, Theodorus W. J., Jr.			Quantitative Co-Expression of Proteins at the Single Cell Level - Application to a Multimeric FRET Sensor	PLOS ONE			English	Article							FLUORESCENT PROTEINS; LIVING CELLS; RETROVIRAL VECTOR; KINASE-ACTIVITY; ACTIVATION; VISUALIZATION; RECEPTORS; CYAN	Background: Co-expression of proteins is generally achieved by introducing two (or more) independent plasmids into cells, each driving the expression of a different protein of interest. However, the relative expression levels may vary strongly between individual cells and cannot be controlled. Ideally, co-expression occurs at a defined ratio, which is constant among cells. This feature is of particular importance for quantitative single cell studies, especially those employing bimolecular Forster Resonance Energy Transfer (FRET) sensors. Methodology/Principal Findings: Four co-expression strategies based on co-transfection, a dual promotor plasmid, an internal ribosome entry site (IRES) and a viral 2A peptide were selected. Co-expression of two spectrally separable fluorescent proteins in single living cells was quantified. It is demonstrated that the 2A peptide strategy can be used for robust equimolar co-expression, while the IRES sequence allows expression of two proteins at a ratio of approximately 3:1. Combined 2A and IRES elements were used for the construction of a single plasmid that drives expression of three individual proteins, which generates a FRET sensor for measuring heterotrimeric G-protein activation. The plasmid drives co-expression of donor and acceptor tagged subunits, with reduced heterogeneity, and can be used to measure G-protein activation in single living cells. Conclusions/Significance: Quantitative co-expression of two or more proteins can be achieved with little cell-to-cell variability. This finding enables reliable co-expression of donor and acceptor tagged proteins for FRET studies, which is of particular importance for the development of novel bimolecular sensors that can be expressed from single plasmid.	[Goedhart, Joachim; van Weeren, Laura; Adjobo-Hermans, Merel J. W.; Elzenaar, Ies; Hink, Mark A.; Gadella, Theodorus W. J., Jr.] Univ Amsterdam, van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Adjobo-Hermans, Merel J. W.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Radboud University Nijmegen	Goedhart, J (corresponding author), Univ Amsterdam, van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	j.goedhart@uva.nl; Th.W.J.Gadella@uva.nl	Adjobo-Hermans, M.J.W./L-4170-2015; Adjobo-Hermans, Merel/AAN-5989-2020	Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Adjobo-Hermans, Merel/0000-0002-5947-2876; Gadella, Theodorus/0000-0002-7639-219X; Goedhart, Joachim/0000-0002-0630-3825	Netherlands Organization for Scientific Research (NWO) [834.09.003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Middelgroot investment grant (834.09.003) of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Schwake G, 2010, BIOTECHNOL BIOENG, V105, P805, DOI 10.1002/bit.22604; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	24	41	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27321	10.1371/journal.pone.0027321	http://dx.doi.org/10.1371/journal.pone.0027321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114669	Green Published, gold			2022-12-25	WOS:000297555800017
J	Chen, AS; Dong, LX; Leffler, NR; Asch, AS; Witte, ON; Yang, LV				Chen, Aishe; Dong, Lixue; Leffler, Nancy R.; Asch, Adam S.; Witte, Owen N.; Yang, Li V.			Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac Pathway	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LEUKOCYTE TRANSENDOTHELIAL MIGRATION; SENSITIVE POTASSIUM CHANNELS; CORONARY ARTERIOLAR DILATION; CYCLIC-AMP; METABOLIC-ACIDOSIS; P-SELECTIN; HYPERCAPNIC ACIDOSIS; INTRACELLULAR PH; EXTRACELLULAR PH	Endothelium-leukocyte interaction is critical for inflammatory responses. Whereas the tissue microenvironments are often acidic at inflammatory sites, the mechanisms by which cells respond to acidosis are not well understood. Using molecular, cellular and biochemical approaches, we demonstrate that activation of GPR4, a proton-sensing G protein-coupled receptor, by isocapnic acidosis increases the adhesiveness of human umbilical vein endothelial cells (HUVECs) that express GPR4 endogenously. Acidosis in combination with GPR4 overexpression further augments HUVEC adhesion with U937 monocytes. In contrast, overexpression of a G protein signaling-defective DRY motif mutant (R115A) of GPR4 does not elicit any increase of HUVEC adhesion, indicating the requirement of G protein signaling. Downregulation of GPR4 expression by RNA interference reduces the acidosis-induced HUVEC adhesion. To delineate downstream pathways, we show that inhibition of adenylate cyclase by inhibitors, 29,59-dideoxyadenosine (DDA) or SQ 22536, attenuates acidosis/GPR4-induced HUVEC adhesion. Consistently, treatment with a cAMP analog or a G(i) signaling inhibitor increases HUVEC adhesiveness, suggesting a role of the G(s)/cAMP signaling in this process. We further show that the cAMP downstream effector Epac is important for acidosis/GPR4-induced cell adhesion. Moreover, activation of GPR4 by acidosis increases the expression of vascular adhesion molecules E-selectin, VCAM-1 and ICAM-1, which are functionally involved in acidosis/GPR4-mediated HUVEC adhesion. Similarly, hypercapnic acidosis can also activate GPR4 to stimulate HUVEC adhesion molecule expression and adhesiveness. These results suggest that acidosis/GPR4 signaling regulates endothelial cell adhesion mainly through the G(s)/cAMP/Epac pathway and may play a role in the inflammatory response of vascular endothelial cells.	[Chen, Aishe; Dong, Lixue; Leffler, Nancy R.; Asch, Adam S.; Yang, Li V.] E Carolina Univ, Dept Internal Med, Brody Sch Med, Greenville, NC 27858 USA; [Yang, Li V.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC USA; [Asch, Adam S.; Yang, Li V.] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Chen, AS (corresponding author), E Carolina Univ, Dept Internal Med, Brody Sch Med, Greenville, NC 27858 USA.	yangl@ecu.edu		Yang, Li/0000-0002-8654-4927	North Carolina Biotechnology Center; Brody Brothers Endowment Fund; Golfers Against Cancer; American Heart Association; Department of Internal Medicine, East Carolina University	North Carolina Biotechnology Center; Brody Brothers Endowment Fund; Golfers Against Cancer; American Heart Association(American Heart Association); Department of Internal Medicine, East Carolina University	This work was supported in part by research grants from North Carolina Biotechnology Center, Brody Brothers Endowment Fund, Golfers Against Cancer, the American Heart Association, and the Startup Fund from the Department of Internal Medicine, East Carolina University (to L.V.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 1997, ACTA PHYSIOL SCAND, V161, P557, DOI 10.1046/j.1365-201X.1997.00263.x; AN SZ, 1995, FEBS LETT, V375, P121, DOI 10.1016/0014-5793(95)01196-L; Bektas M, 2003, BIOCHEMISTRY-US, V42, P12181, DOI 10.1021/bi035051y; Burbridge M F, 1999, Angiogenesis, V3, P281, DOI 10.1023/A:1009092511894; Castellone RD, 2011, CANCER LETT, V312, P197, DOI 10.1016/j.canlet.2011.08.013; Cha SH, 2005, MOL CELLS, V19, P232; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; CHUNG WS, AM J PHYSL CELL PHYS, V298, pC1198; Cleator JH, 2006, BLOOD, V107, P2736, DOI 10.1182/blood-2004-07-2698; Curley G, 2010, ANESTHESIOLOGY, V112, P462, DOI 10.1097/ALN.0b013e3181ca361f; Du GW, 2002, METHOD ENZYMOL, V345, P265; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gloerich M, ANN REV PHARM TOXICO, V50, P355; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Huang YZ, 2004, CELL, V118, P665, DOI 10.1016/j.cell.2004.09.004; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Ishizaka H, 1999, CIRCULATION, V99, P558, DOI 10.1161/01.CIR.99.4.558; Ishizaka H, 1996, CIRC RES, V78, P50, DOI 10.1161/01.RES.78.1.50; Ismaiel NM, 2011, MINERVA ANESTESIOL, V77, P723; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kiely JM, 1999, METH MOL B, V96, P131; Kim K, 2005, FASEB J, V19, P819, DOI 10.1096/fj.04-2988fje; Kottyan LC, 2009, BLOOD, V114, P2774, DOI 10.1182/blood-2009-05-220681; Koul PB, 2009, CLIN PEDIATR, V48, P135, DOI 10.1177/0009922808323907; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Liu JP, 2010, PHARMACOL RES, V61, P499, DOI 10.1016/j.phrs.2010.02.013; Liu YL, 2008, CYTOKINE, V44, P108, DOI 10.1016/j.cyto.2008.06.016; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lum H, 2003, AM J PHYSIOL-HEART C, V285, pH1786, DOI 10.1152/ajpheart.00359.2003; MAHADEVAN MS, 1995, GENOMICS, V30, P84, DOI 10.1006/geno.1995.0013; Malhotra A, 2007, NEW ENGL J MED, V357, P1113, DOI 10.1056/NEJMct074213; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Poschet J, 2002, TRENDS MOL MED, V8, P512, DOI 10.1016/S1471-4914(02)02414-0; QIAO J, 2006, AM J PHYSL LUNG CELL; Radu CG, 2006, MOL CELL BIOL, V26, P668, DOI 10.1128/MCB.26.2.668-677.2006; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Ribatti D, 2002, J HEMATOTH STEM CELL, V11, P81, DOI 10.1089/152581602753448559; Rollin S, 2004, BLOOD, V103, P3789, DOI 10.1182/blood-2003-07-2272; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Siesjo BK, 1996, ADV NEUROL, V71, P209; Solito E, 2000, J IMMUNOL, V165, P1573, DOI 10.4049/jimmunol.165.3.1573; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; van Buul JD, 2004, ARTERIOSCL THROM VAS, V24, P824, DOI 10.1161/01.ATV.0000122854.76267.5c; Wahl ML, 2000, GEN PHARMACOL-VASC S, V35, P277, DOI 10.1016/S0306-3623(01)00115-X; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wongdee K, 2009, MOL CELL BIOCHEM, V321, P173, DOI 10.1007/s11010-008-9931-1; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhu K, 2005, J BIOL CHEM, V280, P43280; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200; Zou Y, 2007, FEBS J, V274, P2573, DOI 10.1111/j.1742-4658.2007.05792.x; Zund G, 1997, AM J PHYSIOL-CELL PH, V273, pC1571, DOI 10.1152/ajpcell.1997.273.5.C1571	80	54	55	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27586	10.1371/journal.pone.0027586	http://dx.doi.org/10.1371/journal.pone.0027586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110680	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400062
J	Ichii, O; Otsuka, S; Namiki, Y; Hashimoto, Y; Kon, Y				Ichii, Osamu; Otsuka, Saori; Namiki, Yuka; Hashimoto, Yoshiharu; Kon, Yasuhiro			Molecular Pathology of Murine Ureteritis Causing Obstructive Uropathy with Hydronephrosis	PLOS ONE			English	Article							EXPRESSION; MOUSE; 129S4/SVJAE; HYALINOSIS; PNEUMONIA; PROTEINS; YM1	Primary causes of urinary tract obstruction that induces urine retention and results in hydronephrosis include uroliths, inflammation, and tumors. In this study, we analyzed the molecular pathology of ureteritis causing hydronephrosis in laboratory rodents. F2 progenies of C57BL/6 and DBA/2 mice were studied histopathologically and by comprehensive gene expression analysis of their ureters. Incidence of hydronephrosis was approximately 5% in F2 progenies. Histopathologically, this hydronephrosis was caused by stenosis of the proximal ureter, which showed fibrosis and papillary malformations of the proliferative epithelium with infiltrations of B-cell-dominated lymphocytes. Additionally, CD16-positive large granular leukocytes and eosinophils infiltrated from the ureteral mucosa to the muscular layer. Eosinophilic crystals were characteristically observed in the lumen of the ureter and the cytoplasm of large granular leukocytes, eosinophils, and transitional epithelial cells. Comprehensive gene profiling revealed remarkably elevated expression of genes associated with hyperimmune responses through activation of B cells in diseased ureters. Furthermore, diseased ureters showed dramatically higher gene expression of chitinase 3-like 3, known as Ym1, which is associated with formation both of adenomas in the transitional epithelium and of eosinophilic crystals in inflammatory conditions. The Ym1 protein was mainly localized to the cytoplasm of the transitional epithelium, infiltrated cells, and eosinophilic crystals in diseased ureters. We determined that the primary cause of hydronephrosis in F2 mice was ureteritis mediated by the local hyperimmune response with malformation of the transitional epithelium. Our data provide a novel molecular pathogenesis for elucidating causes of aseptic inflammation in human upper urinary tracts.	[Ichii, Osamu; Otsuka, Saori; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan; [Namiki, Yuka; Hashimoto, Yoshiharu] Hokkaido Univ, Grad Sch Vet Med, Off Fac Dev & Teaching Enriched Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ichii, O (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan.	ichi-o@vetmed.hokudai.ac.jp	Kon, Yasuhiro/F-8525-2012; Otsuka, Saori/F-8531-2012	Kon, Yasuhiro/0000-0002-8859-6122	Akiyama Life Science Foundation; Takeda Science Foundation; Inamori Foundation	Akiyama Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation	This work was supported by grants from Akiyama Life Science Foundation (2010, http://www.akiyama-foundation.org/), Takeda Science Foundation (2010, http://www.takeda-sci.or.jp/), and Inamori Foundation (2011, http://www.inamori-f.or.jp/ja_fd_gra_out.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 2011, PATHOL RES PRACT; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Asia S, 2008, LUPUS, V17, P46, DOI 10.1177/0961203307084711; Bierer S, 2005, AKTUEL UROL, V36, P329, DOI 10.1055/s-2005-870931; Corradi D, 2007, KIDNEY INT, V72, P742, DOI 10.1038/sj.ki.5002427; Hirasawa M, 1998, VIRCHOWS ARCH, V432, P461, DOI 10.1007/s004280050192; Hirasawa M, 2003, INT ARCH ALLERGY IMM, V130, P73, DOI 10.1159/000068371; Hoenerhoff MJ, 2006, VET PATHOL, V43, P682, DOI 10.1354/vp.43-5-682; IMAOKA K, 1986, LAB ANIM, V20, P321, DOI 10.1258/002367786780808686; Joo M, 2010, PATHOL INT, V60, P779, DOI 10.1111/j.1440-1827.2010.02598.x; KIM SA, 2011, HUM PATHOL; Lin TA, 2010, BIOMARKERS, V15, P646, DOI 10.3109/1354750X.2010.511266; Marchesi F, 2006, VET PATHOL, V43, P773, DOI 10.1354/vp.43-5-773; Marchesi F, 2003, J VET MED A, V50, P103, DOI 10.1046/j.1439-0442.2003.00486.x; Mattson JC, 2000, CLIN LAB MED, V20, P83; MURRAY AB, 1990, VET PATHOL, V27, P274, DOI 10.1177/030098589002700409; Nio J, 2004, HISTOCHEM CELL BIOL, V121, P473, DOI 10.1007/s00418-004-0654-4; Sergeant G, 2003, INT UROL NEPHROL, V36, P23; Siddiqui MM, 2011, MED CLIN N AM, V95, P161, DOI 10.1016/j.mcna.2010.08.031; SPARK RP, 1991, J UROLOGY, V145, P1256, DOI 10.1016/S0022-5347(17)38594-4; Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x; Truong LD, 2011, CONTRIB NEPHROL, V169, P311, DOI 10.1159/000314578; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200	24	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27783	10.1371/journal.pone.0027783	http://dx.doi.org/10.1371/journal.pone.0027783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114694	gold, Green Published			2022-12-25	WOS:000297555400113
J	Kanda, T; Shibata, S; Saito, S; Murata, T; Isomura, H; Yoshiyama, H; Takada, K; Tsurumi, T				Kanda, Teru; Shibata, Sachiko; Saito, Satoru; Murata, Takayuki; Isomura, Hiroki; Yoshiyama, Hironori; Takada, Kenzo; Tsurumi, Tatsuya			Unexpected Instability of Family of Repeats (FR), the Critical cis-Acting Sequence Required for EBV Latent Infection, in EBV-BAC Systems	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; GENE PROMOTER ACTIVITY; DNA-SEQUENCE; CELL-LINE; REPLICATION; MAINTENANCE; PLASMIDS; BINDING; EBNA-1; ORIP	A group of repetitive sequences, known as the Family of Repeats (FR), is a critical cis-acting sequence required for EBV latent infection. The FR sequences are heterogeneous among EBV strains, and they are sometimes subject to partial deletion when subcloned in E. coli-based cloning vectors. However, the FR stability in EBV-BAC (bacterial artificial chromosome) system has never been investigated. We found that the full length FR of the Akata strain EBV was not stably maintained in a BAC vector. By contrast, newly obtained BAC clones of the B95-8 strain of EBV stably maintained the full length FR during recombinant virus production and B-cell transformation. Investigation of primary DNA sequences of Akata-derived EBV-BAC clones indicates that the FR instability is most likely due to a putative secondary structure of the FR region. We conclude that the FR instability in EBV-BAC clones can be a pitfall in E. coli-mediated EBV genetics.	[Kanda, Teru; Murata, Takayuki; Isomura, Hiroki; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Shibata, Sachiko; Saito, Satoru; Yoshiyama, Hironori] Hokkaido Univ, Res Ctr Infect Associated Canc, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan; [Takada, Kenzo] Hokkaido Univ, Dept Tumor Virol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan	Aichi Cancer Center; Hokkaido University; Hokkaido University	Kanda, T (corresponding author), Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 464, Japan.	tkanda@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Takada, Kenzo/A-6666-2012; Yoshiyama, Hironori/H-5674-2019; Yoshiyama, Hironori/D-7902-2012; Kanda, Teru/J-7313-2019	Murata, Takayuki/0000-0001-7228-0839; Yoshiyama, Hironori/0000-0001-7588-278X; Yoshiyama, Hironori/0000-0002-9904-0736; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (TK and TT) and by a grant from the Naito Foundation (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2005, J VIROL, V79, P4415, DOI 10.1128/JVI.79.7.4415-4424.2005; Ali AKM, 2009, J VIROL, V83, P9163, DOI 10.1128/JVI.01979-08; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BIERNE H, 1994, MOL MICROBIOL, V13, P17, DOI 10.1111/j.1365-2958.1994.tb00398.x; BLOSS TA, 1994, J VIROL, V68, P8217, DOI 10.1128/JVI.68.12.8217-8222.1994; de Jesus O, 2003, J GEN VIROL, V84, P1443, DOI 10.1099/vir.0.19054-0; Delecluse HJ, 2000, J CLIN PATHOL-MOL PA, V53, P270, DOI 10.1136/mp.53.5.270; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Fruscalzo A, 2001, GENE, V265, P165, DOI 10.1016/S0378-1119(01)00345-6; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRIFFIN BE, 1984, NATURE, V309, P78, DOI 10.1038/309078a0; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; Kanda T, 2004, J VIROL, V78, P7004, DOI 10.1128/JVI.78.13.7004-7015.2004; Kanda T, 2001, MOL CELL BIOL, V21, P3576, DOI 10.1128/MCB.21.10.3576-3588.2001; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kieff E, 2007, FIELDS VIROLOGY, P2603; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Mackey D, 1999, METHOD ENZYMOL, V306, P308; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PARKER BD, 1990, VIROLOGY, V179, P339, DOI 10.1016/0042-6822(90)90302-8; Puglielli MT, 1996, J VIROL, V70, P5758, DOI 10.1128/JVI.70.9.5758-5768.1996; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27758	10.1371/journal.pone.0027758	http://dx.doi.org/10.1371/journal.pone.0027758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114684	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400106
J	Monzen, S; Hosoda, M; Tokonami, S; Osanai, M; Yoshino, H; Hosokawa, Y; Yoshida, MA; Yamada, M; Asari, Y; Satoh, K; Kashiwakura, I				Monzen, Satoru; Hosoda, Masahiro; Tokonami, Shinji; Osanai, Minoru; Yoshino, Hironori; Hosokawa, Yoichiro; Yoshida, Mitsuaki A.; Yamada, Masatoshi; Asari, Yasushi; Satoh, Kei; Kashiwakura, Ikuo			Individual Radiation Exposure Dose Due to Support Activities at Safe Shelters in Fukushima Prefecture	PLOS ONE			English	Article							RESUSPENDED AEROSOL; CHERNOBYL AREA; WASH-OFF	Immediately after the accidents in the nuclear power stations in Fukushima on March 11, the Japanese Government ordered the evacuation of the residents within a 20-km radius from the station on March 12, and asked various institutions to monitor the contamination levels of the residents. Hirosaki University, which is located 355 km north of Fukushima City, decided to send support staff to Fukushima. This report summarizes the results of the exposure of 13 individual teams from March 15 to June 20. The support teams surveyed more than 5,000 people during this period. Almost all subjects had external contamination levels of less than 13 kcpm on Geiger-Muller (GM) survey meter, which is categorized as "no contamination level.'' The 1(st) team showed the highest external exposure dose, but the 4(th) team onward showed no significant change. Subsequently, the internal radiation exposure was measured using a whole body counter that indicated undetectable levels in all staff members. Although the measured external radiation exposure dose cannot have serious biological effects on the health of an individual, a follow-up study of the residents in Fukushima and other regions where the radioactive material has spread will be required for a long time.	[Monzen, Satoru; Hosoda, Masahiro; Osanai, Minoru; Yoshino, Hironori; Hosokawa, Yoichiro; Kashiwakura, Ikuo] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan; [Tokonami, Shinji; Yoshida, Mitsuaki A.; Yamada, Masatoshi; Satoh, Kei] Hirosaki Univ, Res Inst Radiat Emergency Med, Hirosaki, Aomori, Japan; [Asari, Yasushi] Hirosaki Univ, Grad Sch Med, Dept Emergency & Disaster Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University; Hirosaki University	Monzen, S (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan.	ikashi@cc.hirosaki-u.ac.jp	Monzen, Satoru/AAF-9870-2021; Kashiwakura, Ikuo/F-2080-2013; Yoshino, Hironori/E-7961-2013; Yamada, Masatoshi/F-2023-2013; Tokonami, Shinji/AAH-6042-2020; monzen, satoru/F-1468-2013	Monzen, Satoru/0000-0003-2436-8048; Yoshino, Hironori/0000-0003-2705-9929; Yamada, Masatoshi/0000-0001-7803-2692; monzen, satoru/0000-0003-2436-8048; Tokonami, Shinji/0000-0002-6617-7402	Hirosaki University	Hirosaki University	This study was supported by a Grant for Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHRISTODOULEAS JP, 2011, N ENGI J MED    0420; Clery D, 2011, SCIENCE, V331, P1506, DOI 10.1126/science.331.6024.1506; Garger EK, 1997, RADIAT ENVIRON BIOPH, V36, P139, DOI 10.1007/s004110050065; Garger EK, 1998, RADIAT ENVIRON BIOPH, V36, P275, DOI 10.1007/s004110050082; Geller RJ, 2011, NATURE, V472, P407, DOI 10.1038/nature10105; HALLDIN S, 1990, WATER AIR SOIL POLL, V49, P139, DOI 10.1007/BF00279517; Hosoda M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00087; MINATO S, 2011, SCS0073 RESL, P1; Minato S, 2006, J GEOGR-TOKYO, V115, P87; MUECK K, 1991, RADIAT PROT DOSIM, V37, P189, DOI 10.1093/oxfordjournals.rpd.a081051; Sengor AMC, 2011, NATURE, V472, P169, DOI 10.1038/472169c; Stone R, 2011, SCIENCE, V331, P1507, DOI 10.1126/science.331.6024.1507; Tanimoto T, 2011, LANCET, V377, P1489, DOI 10.1016/S0140-6736(11)60519-9	13	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27761	10.1371/journal.pone.0027761	http://dx.doi.org/10.1371/journal.pone.0027761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114685	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400108
J	Qin, Y; Li, Y; Liu, W; Tian, RR; Guo, QQ; Li, SY; Li, HB; Zhang, DJ; Zheng, YT; Wu, L; Lan, K; Wang, JH				Qin, Yan; Li, Yuye; Liu, Wan; Tian, Renrong; Guo, Qianqian; Li, Shaoyou; Li, Hongbin; Zhang, Daojun; Zheng, Yongtang; Wu, Li; Lan, Ke; Wang, Jianhua			Penicillium marneffei-Stimulated Dendritic Cells Enhance HIV-1 Trans-Infection and Promote Viral Infection by Activating Primary CD4(+) T Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; DC-SIGN; PRODUCTIVE INFECTION; LANGERHANS CELLS; TRANSMISSION; IMMATURE; MATURE; REPLICATION; RESERVOIRS; IMMUNITY	Penicillium marneffei (P. marneffei) is considered an indicator pathogen of AIDS, and the endemicity and clinical features of P. marneffei have been described. While, how the co-infection of P. marneffei exacerbate deterioration of the immune response remains poorly understood. Here we isolated P. marneffei from the cutaneous lesions of AIDS patients and analyzed its effects on HIV-1-dendritic cells (DCs) interaction. We demonstrated that the monocyte-derived dendritic cells (MDDCs) could be activated by both thermally dimorphic forms of P. marneffei for significantly promoting HIV-1 trans-infection of CD4(+) T cells, while these activated MDDCs were refractory to HIV-1 infection. Mechanistically, P. marneffei-activated MDDCs endocytosed large amounts of HIV-1 and sequestrated the internalized viruses into tetrapasnin CD81(+) compartments potentially for proteolysis escaping. The activated MDDCs increased expression of intercellular adhesion molecule 1 and facilitated the formation of DC-T-cell conjunctions, where much more viruses were recruited. Moreover, we found that P. marneffei-stimulated MDDCs efficiently activated resting CD4+ T cells and induced more susceptible targets for viral infection. Our findings demonstrate that DC function and its interaction with HIV-1 have been modulated by opportunistic pathogens such as P. marneffei for viral dissemination and infection amplification, highlighting the importance of understanding DC-HIV-1 interaction for viral immunopathogenesis elucidation.	[Qin, Yan; Liu, Wan; Tian, Renrong; Guo, Qianqian; Lan, Ke; Wang, Jianhua] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Li, Yuye; Li, Shaoyou; Li, Hongbin; Zhang, Daojun] Kunming Med Coll, Affiliated Hosp 1, Kunming, Peoples R China; [Zheng, Yongtang] Chinese Acad Sci, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China; [Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Kunming Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; University System of Ohio; Ohio State University	Qin, Y (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	lanke@sibs.ac.cn; Jh_wang@sibs.ac.cn	Wu, Li/ABB-2813-2020; Qin, Yan/L-3631-2016; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487	Chinese Academy of Sciences [KSCX2-KW-BR-1, KSCX2-YW-R210, KSCX2-EW-Q-2, 2009KIP209]; Natural Science Foundation of Shanghai [10ZR1435200]; Natural Science Foundation of China [81171567]; Shanghai Rising-Star Program (A type) [11QA1407700]; National Basic Research Program of China (973 Program) [2012CB519004]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program (A type); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants to Dr. Wang from the 100 Talent Program of the Chinese Academy of Sciences (KSCX2-KW-BR-1), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R210, KSCX2-EW-Q-2), the Natural Science Foundation of Shanghai (10ZR1435200), and the Natural Science Foundation of China (No. 81171567). The work was also sponsored by Shanghai Rising-Star Program (A type) (11QA1407700), the National Basic Research Program of China (973 Program) (2012CB519004) and by the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2009KIP209), and to Dr. Wang. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhoopat L, 2006, MODERN PATHOL, V19, P255, DOI 10.1038/modpathol.3800527; Bounou S, 2004, FASEB J, V18, P1294, DOI 10.1096/fj.04-1755fje; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Chung NPY, 2010, J BIOL CHEM, V285, P2100, DOI 10.1074/jbc.M109.030619; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Cunningham AL, 2008, EUR J IMMUNOL, V38, P2377, DOI 10.1002/eji.200838521; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Devi S Bhagyabati, 2009, J Indian Med Assoc, V107, P208; Dion J, 2010, J IMMUNOL, V184, P2899, DOI 10.4049/jimmunol.0901513; Diou J, 2010, CELL MICROBIOL, V12, P615, DOI 10.1111/j.1462-5822.2009.01420.x; Dobson-Belaire WN, 2010, CELL MICROBIOL, V12, P1703, DOI 10.1111/j.1462-5822.2010.01502.x; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Hansasuta P, 2001, BRIT MED BULL, V58, P109, DOI 10.1093/bmb/58.1.109; Ho A, 2010, INT J STD AIDS, V21, P780, DOI 10.1258/ijsa.2010.010164; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lekkerkerker AN, 2006, CURR HIV RES, V4, P169, DOI 10.2174/157016206776055020; LI PCK, 1992, AIDS, V6, P240, DOI 10.1097/00002030-199202000-00021; Lore K, 2003, APMIS, V111, P776, DOI 10.1034/j.1600-0463.2003.11107809.x; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Reuter MA, 2010, J VIROL, V84, P8549, DOI 10.1128/JVI.02303-09; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Taruishi M, 2004, MICROBIOL IMMUNOL, V48, P693, DOI 10.1111/j.1348-0421.2004.tb03480.x; Thuy L, 2011, CLIN INFECT DIS, V52, P945, DOI 10.1093/cid/cir028; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Vachot L, 2008, JAIDS-J ACQ IMM DEF, V48, P398, DOI 10.1097/QAI.0b013e3181776bc7; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; Wang JH, 2008, VIROLOGY, V381, P143, DOI 10.1016/j.virol.2008.08.028; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wang JH, 2009, J VIROL, V83, P4195, DOI 10.1128/JVI.00006-09; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wilflingseder D, 2005, MOL IMMUNOL, V42, P229, DOI 10.1016/j.molimm.2004.06.019; Wilkinson J, 2006, CURR DRUG TARGETS, V7, P1563, DOI 10.2174/138945006779025482; Wong SSY, 2001, J CLIN MICROBIOL, V39, P4535, DOI 10.1128/JCM.39.12.4535-4540.2001; WONG SY, 2011, PATHOLOG RES INT; Wu L, 2008, CURR OPIN HIV AIDS, V3, P534, DOI 10.1097/COH.0b013e32830634c6; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zhang Jian-quan, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P740	49	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27609	10.1371/journal.pone.0027609	http://dx.doi.org/10.1371/journal.pone.0027609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110688	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400068
J	Schleuning, M; Farwig, N; Peters, MK; Bergsdorf, T; Bleher, B; Brandl, R; Dalitz, H; Fischer, G; Freund, W; Gikungu, MW; Hagen, M; Garcia, FH; Kagezi, GH; Kaib, M; Kraemer, M; Lung, T; Naumann, CM; Schaab, G; Templin, M; Uster, D; Wagele, JW; Bohning-Gaese, K				Schleuning, Matthias; Farwig, Nina; Peters, Marcell K.; Bergsdorf, Thomas; Bleher, Baerbel; Brandl, Roland; Dalitz, Helmut; Fischer, Georg; Freund, Wolfram; Gikungu, Mary W.; Hagen, Melanie; Garcia, Francisco Hita; Kagezi, Godfrey H.; Kaib, Manfred; Kraemer, Manfred; Lung, Tobias; Naumann, Clas M.; Schaab, Gertrud; Templin, Mathias; Uster, Dana; Waegele, J. Wolfgang; Boehning-Gaese, Katrin			Forest Fragmentation and Selective Logging Have Inconsistent Effects on Multiple Animal-Mediated Ecosystem Processes in a Tropical Forest	PLOS ONE			English	Article							ANT-FOLLOWING BIRDS; LAND-USE CHANGE; HABITAT FRAGMENTATION; RAIN-FOREST; FUNCTIONAL DIVERSITY; PLANTATION FORESTS; AMAZONIAN FOREST; PRUNUS-AFRICANA; SEED DISPERSAL; LOGGED FORESTS	Forest fragmentation and selective logging are two main drivers of global environmental change and modify biodiversity and environmental conditions in many tropical forests. The consequences of these changes for the functioning of tropical forest ecosystems have rarely been explored in a comprehensive approach. In a Kenyan rainforest, we studied six animal-mediated ecosystem processes and recorded species richness and community composition of all animal taxa involved in these processes. We used linear models and a formal meta-analysis to test whether forest fragmentation and selective logging affected ecosystem processes and biodiversity and used structural equation models to disentangle direct from biodiversity-related indirect effects of human disturbance on multiple ecosystem processes. Fragmentation increased decomposition and reduced antbird predation, while selective logging consistently increased pollination, seed dispersal and army-ant raiding. Fragmentation modified species richness or community composition of five taxa, whereas selective logging did not affect any component of biodiversity. Changes in the abundance of functionally important species were related to lower predation by antbirds and higher decomposition rates in small forest fragments. The positive effects of selective logging on bee pollination, bird seed dispersal and army-ant raiding were direct, i.e. not related to changes in biodiversity, and were probably due to behavioural changes of these highly mobile animal taxa. We conclude that animal-mediated ecosystem processes respond in distinct ways to different types of human disturbance in Kakamega Forest. Our findings suggest that forest fragmentation affects ecosystem processes indirectly by changes in biodiversity, whereas selective logging influences processes directly by modifying local environmental conditions and resource distributions. The positive to neutral effects of selective logging on ecosystem processes show that the functionality of tropical forests can be maintained in moderately disturbed forest fragments. Conservation concepts for tropical forests should thus include not only remaining pristine forests but also functionally viable forest remnants.	[Schleuning, Matthias; Bleher, Baerbel; Templin, Mathias; Boehning-Gaese, Katrin] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-6500 Mainz, Germany; [Schleuning, Matthias; Templin, Mathias; Boehning-Gaese, Katrin] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Schleuning, Matthias; Templin, Mathias; Boehning-Gaese, Katrin] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Farwig, Nina; Brandl, Roland; Kagezi, Godfrey H.] Univ Marburg, Dept Ecol, Marburg, Germany; [Peters, Marcell K.; Bergsdorf, Thomas; Fischer, Georg; Freund, Wolfram; Garcia, Francisco Hita; Naumann, Clas M.; Waegele, J. Wolfgang] Zool Res Museum A Koenig, Bonn, Germany; [Peters, Marcell K.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany; [Dalitz, Helmut; Uster, Dana] Univ Hohenheim, Inst Bot, D-7000 Stuttgart, Germany; [Gikungu, Mary W.] Natl Museums Kenya, Nairobi, Kenya; [Hagen, Melanie; Kraemer, Manfred] Univ Bielefeld, Bielefeld, Germany; [Hagen, Melanie] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Kaib, Manfred] Univ Bayreuth, Dept Anim Physiol, Bayreuth, Germany; [Lung, Tobias; Schaab, Gertrud] Karlsruhe Univ Appl Sci, Dept Geomat, Karlsruhe, Germany; [Boehning-Gaese, Katrin] Goethe Univ, Dept Biol Sci, Frankfurt, Germany	Johannes Gutenberg University of Mainz; Senckenberg Gesellschaft fur Naturforschung (SGN); Philipps University Marburg; University of Wurzburg; University Hohenheim; University of Bielefeld; Aarhus University; University of Bayreuth; Karlsruhe University of Applied Sciences; Goethe University Frankfurt	Schleuning, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Saarstr 21, D-6500 Mainz, Germany.	matthias.schleuning@senckenberg.de	Hagen, Melanie/I-7939-2013; Fischer, Georg/Y-3059-2019; Fischer, Georg/G-2484-2015; Garcia, Francisco Hita/C-9636-2015; Schleuning, Matthias/H-2154-2015; Böhning-Gaese, Katrin/W-2601-2019	Fischer, Georg/0000-0002-4033-2005; Fischer, Georg/0000-0002-0637-6485; Garcia, Francisco Hita/0000-0003-4709-3083; Schleuning, Matthias/0000-0001-9426-045X; Böhning-Gaese, Katrin/0000-0003-0477-5586; Peters, Marcell/0000-0002-1262-0827	German Federal Ministry of Education and Research [01LC0025, 01LC0405, 01LC0625]; Hesse's Ministry of Higher Education, Research, and the Arts	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Hesse's Ministry of Higher Education, Research, and the Arts	Financial support for this study was provided by the German Federal Ministry of Education and Research (http://www.bmbf.de) as part of the BIOTA Africa project (http://www.biota-africa.org; grant numbers: 01LC0025, 01LC0405, 01LC0625) and by the research funding program "Landes-Offensive zur Entwicklung wissenschaftlich okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts (http://www.hessen.de/irj/HMWK_Internet?cid=a2396939885f8c8c0a3ba39bda517cbd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attignon SE, 2004, APPL SOIL ECOL, V27, P109, DOI 10.1016/j.apsoil.2004.05.003; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bihn JH, 2010, ECOLOGY, V91, P782, DOI 10.1890/08-1276.1; Bivand R, 2010, SPDEP SPATIAL DEPEND; Bleher B, 2006, BIODIVERS CONSERV, V15, P1159, DOI 10.1007/s10531-004-3509-3; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Breitbach N, 2010, OECOLOGIA, V162, P965, DOI 10.1007/s00442-009-1547-y; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Costa FRC, 2003, BIOTROPICA, V35, P103, DOI 10.1111/j.1744-7429.2003.tb00267.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; EARDLEY CD, 1989, ENTOMOLOGY MEMOIR DE, V75; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farwig N, 2006, OECOLOGIA, V147, P238, DOI 10.1007/s00442-005-0288-9; Farwig N, 2008, BIOTROPICA, V40, P218, DOI 10.1111/j.1744-7429.2007.00365.x; Farwig N, 2009, LANDSCAPE ECOL, V24, P919, DOI 10.1007/s10980-009-9376-2; Garcia D, 2007, CONSERV BIOL, V21, P400, DOI 10.1111/j.1523-1739.2006.00593.x; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.2307/177061; Hagen M, 2010, BIOL CONSERV, V143, P1654, DOI 10.1016/j.biocon.2010.03.036; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Herrera JM, 2011, LANDSCAPE ECOL, V26, P125, DOI 10.1007/s10980-010-9541-7; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Kingdon J, 1997, KINGDON FIELD GUIDE; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Koh LP, 2007, J APPL ECOL, V44, P703, DOI 10.1111/j.1365-2664.2007.01324.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Laube I, 2008, J ORNITHOL, V149, P181, DOI 10.1007/s10336-007-0258-6; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Laurance W.F., 1997, TROPICAL FOREST REMN, V1st; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Herrera JM, 2009, BIOL CONSERV, V142, P149, DOI 10.1016/j.biocon.2008.10.008; Marsden SJ, 1998, CONSERV BIOL, V12, P605, DOI 10.1046/j.1523-1739.1998.96404.x; Michener C.D., 2000, BEES WORLD, V1st; Miller SD, 2007, AGR FOREST METEOROL, V142, P25, DOI 10.1016/j.agrformet.2006.10.008; Mitchell N, 2009, KARLSRUHER GEOWISS A, V17; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Nagy KA, 2001, NUTR ABSTR REV B, V71, P21; Oksanen J., 2013, R PACKAGE VERSION 2, P292; OTIS GW, 1986, BIOTROPICA, V18, P56, DOI 10.2307/2388363; Peters MK, 2008, ECOL APPL, V18, P847, DOI 10.1890/07-1295.1; Peters MK, 2009, BIOL CONSERV, V142, P2050, DOI 10.1016/j.biocon.2009.03.035; Peters MK, 2009, BIOL CONSERV, V142, P668, DOI 10.1016/j.biocon.2008.11.021; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Schoning C, 2005, ECOL ENTOMOL, V30, P532, DOI 10.1111/j.0307-6946.2005.00720.x; Sethi P, 2009, CONSERV BIOL, V23, P710, DOI 10.1111/j.1523-1739.2008.01155.x; Shipley B., 2000, CAUSE CORRELATIONS B; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x	69	57	61	4	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27785	10.1371/journal.pone.0027785	http://dx.doi.org/10.1371/journal.pone.0027785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114695	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400114
J	Yang, RL; Han, YH; Ye, YW; Liu, YC; Jiang, ZM; Gui, YT; Cai, ZM				Yang, Ruilin; Han, Yonghua; Ye, Yiwang; Liu, Yuchen; Jiang, Zhimao; Gui, Yaoting; Cai, Zhiming			Chemical Synthesis of Bacteriophage G4	PLOS ONE			English	Article							PHIX-LIKE PHAGES; NUCLEOTIDE-SEQUENCE; GENOME; VIRUS; SUSCEPTIBILITY; PATHOGENS; BIOLOGY; GENE	Background: Due to recent leaps forward in DNA synthesis and sequencing technology, DNA manipulation has been extended to the level of whole-genome synthesis. Bacteriophages occupy a special niche in the micro-organic ecosystem and have potential as a tool for therapeutic agent. The purpose of this study was to carry out chemical synthesis of the bacteriophage G4 and the study of its infectivity. Methodology/Principal Findings: Full-sized genomes of bacteriophage G4 molecules were completed from short overlapping synthetic oligonucleotides by direct assembly polymerase chain reaction and ligase chain reaction followed by fusion polymerase chain reaction with flanking primers. Three novel restriction endonuclease sites were introduced to distinguish the synthetic G4 from the wild type. G4 particles were recovered after electroporation into Escherichia coli and were efficient enough to infect another strain. The phage was validated by electron microscope. Specific polymerase chain reaction assay and restriction analyses of the plaques verified the accuracy of the chemical synthetic genomes. Conclusions: Our results showed that the bacteriophage G4 obtained is synthetic rather than a wild type. Our study demonstrated that a phage can be synthesized and manipulated genetically according to the sequences, and can be efficient enough to infect the Escherichia coli, showing the potential use of synthetic biology in medical application.	[Yang, Ruilin; Han, Yonghua; Ye, Yiwang; Liu, Yuchen; Jiang, Zhimao; Gui, Yaoting; Cai, Zhiming] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Yang, Ruilin] Guangzhou Panyu Cent Hosp, Guangzhou, Guangdong, Peoples R China; [Yang, Ruilin; Liu, Yuchen] Shantou Univ Med Coll, Shantou, Peoples R China; [Cai, Zhiming] Shenzhen Univ, Urogenital Inst, Shenzhen Peoples Hosp 2, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Shenzhen University	Yang, RL (corresponding author), Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022; liu, yuchen/GYQ-6286-2022		Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]; Ph.D. Programs Foundation of Ministry of Education of China [200800010106]	Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was funded by the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A to ZC); and the Ph.D. Programs Foundation of Ministry of Education of China (200800010106 to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; GIBSON DG, 2010, SCIENCE, V2, P38; GODSON GN, 1974, VIROLOGY, V62, P270, DOI 10.1016/0042-6822(74)90321-3; GODSON GN, 1974, VIROLOGY, V58, P272, DOI 10.1016/0042-6822(74)90161-5; GODSON GN, 1978, NATURE, V276, P236, DOI 10.1038/276236a0; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Mueller S, 2009, CHEM BIOL, V16, P337, DOI 10.1016/j.chembiol.2009.03.002; Rad'ko S. P., 2007, Biomeditsinskaya Khimiya, V53, P237; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Swaminathan Subramanian, 2010, Curr Infect Dis Rep, V12, P455, DOI 10.1007/s11908-010-0138-8; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593; ZECHEL K, 1975, J BIOL CHEM, V250, P4684	21	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27062	10.1371/journal.pone.0027062	http://dx.doi.org/10.1371/journal.pone.0027062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110602	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400018
J	Ganoth, A; Alhadeff, R; Kohen, D; Arkin, IT				Ganoth, Assaf; Alhadeff, Raphael; Kohen, Dovrat; Arkin, Isaiah T.			Characterization of the Na+/H+ Antiporter from Yersinia pestis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; 3-DIMENSIONAL STRUCTURES; VIBRIO-PARAHAEMOLYTICUS; MEMBRANE-VESICLES; NHAA; PH; PROTEINS; GENE; MECHANISM	Yersinia pestis, the bacterium that historically accounts for the Black Death epidemics, has nowadays gained new attention as a possible biological warfare agent. In this study, its Na+/H+ antiporter is investigated for the first time, by a combination of experimental and computational methodologies. We determined the protein's substrate specificity and pH dependence by fluorescence measurements in everted membrane vesicles. Subsequently, we constructed a model of the protein's structure and validated the model using molecular dynamics simulations. Taken together, better understanding of the Yersinia pestis Na+/H+ antiporter's structure-function relationship may assist in studies on ion transport, mechanism of action and designing specific blockers of Naz/Hz antiporter to help in fighting Yersinia pestis -associated infections. We hope that our model will prove useful both from mechanistic and pharmaceutical perspectives.	[Ganoth, Assaf; Alhadeff, Raphael; Kohen, Dovrat; Arkin, Isaiah T.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Ganoth, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	arkin@huji.ac.il	Arkin, Isaiah/GQA-4328-2022	Arkin, Isaiah/0000-0002-7659-1746	Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Rudin Fellowship Trust; Amirim Teva program; Israeli Science Foundation [784/01, 1249/05, 1581/08]	Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Rudin Fellowship Trust; Amirim Teva program(Teva Pharmaceutical Industries); Israeli Science Foundation(Israel Science Foundation)	This work was supported in part by grants from The Lady Davis Fellowship Trust and The Valazzi-Pikovsky Fellowship Fund (to A. G.), The Rudin Fellowship Trust (to R. A.), the Amirim Teva program (to D. K.) and the Israeli Science Foundation (784/01, 1249/05, 1581/08 to I. T. A.). I. T. A. is the Arthur Lejwa Professor of Structural Biochemistry at the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCHON A, PEST LAND NEW WORLD; ALHADEFF R, MOL BASIS N IN PRESS; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Capener CE, 2000, BIOPHYS J, V78, P2929, DOI 10.1016/S0006-3495(00)76833-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; GANOTH A, 2011, J MOL MODEL IN PRESS; Herz K, 2010, J BIOL CHEM, V285, P2211, DOI 10.1074/jbc.M109.047134; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INABA K, 1994, BIOL PHARM BULL, V17, P573; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Ivetac A, 2008, EUR BIOPHYS J BIOPHY, V37, P403, DOI 10.1007/s00249-007-0225-4; Josko Deborah, 2004, Clin Lab Sci, V17, P25; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Michaelis L, 1913, BIOCHEM Z, V49, P333; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nozaki K, 1996, BIOCHEM BIOPH RES CO, V222, P774, DOI 10.1006/bbrc.1996.0820; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Olkhova E, 2009, PROTEINS, V76, P548, DOI 10.1002/prot.22368; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; PADAN E, 1989, J BIOL CHEM, V264, P20297; Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1; Radchenko MV, 2006, MOL MICROBIOL, V59, P651, DOI 10.1111/j.1365-2958.2005.04966.x; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; Rollins Sarah E, 2003, Am J Clin Pathol, V119 Suppl, pS78; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Titball RW, 2003, BIOCHEM SOC T, V31, P104, DOI 10.1042/BST0310104; TSUCHIYA T, 1975, J BIOL CHEM, V250, P7687; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zietz BP, 2004, INT J HYG ENVIR HEAL, V207, P165, DOI 10.1078/1438-4639-00259; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e26115	10.1371/journal.pone.0026115	http://dx.doi.org/10.1371/journal.pone.0026115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102858	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300003
J	Mason, TA; Kolobova, E; Liu, J; Roland, JT; Chiang, C; Goldenring, JR				Mason, Twila A.; Kolobova, Elena; Liu, Jiang; Roland, Joseph T.; Chiang, Chin; Goldenring, James R.			Darinaparsin Is a Multivalent Chemotherapeutic Which Induces Incomplete Stress Response with Disruption of Microtubules and Shh Signaling	PLOS ONE			English	Article							ARSENIC TRIOXIDE; HEDGEHOG PATHWAY; APOPTOSIS; GRANULES; NOCODAZOLE	Chemotherapeutics and other pharmaceuticals are common sources of cellular stress. Darinaparsin (ZIO-101) is a novel organic arsenical under evaluation as a cancer chemotherapeutic, but the drug's precise mechanism of action is unclear. Stress granule formation is an important cellular stress response, but the mechanisms of formation, maintenance, and dispersal of RNA-containing granules are not fully understood. During stress, small, diffuse granules initially form throughout the cytoplasm. These granules then coalesce near the nucleus into larger granules that disperse once the cellular stress is removed. Complete stress granule formation is dependent upon microtubules. Human cervical cancer (HeLa) cells, pre-treated with nocodazole for microtubule depolymerization, formed only small, diffuse stress granules upon sodium arsenite treatment. Darinaparsin, as a single agent, also induced the formation of small, diffuse stress granules, an effect similar to that of the combination of nocodazole with sodium arsenite. Darinaparsin inhibited the polymerization of microtubules both in vivo and in vitro. Interestingly, upon removal of darinaparsin, the small, diffuse stress granules completed formation with coalescence in the perinuclear region prior to disassembly. These results indicate that RNA stress granules must complete formation prior to disassembly, and completion of stress granule formation is dependent upon microtubules. Finally, treatment of cells with darinaparsin led to a reduction in Sonic hedgehog (Shh) stimulated activation of Gli1 and a loss of primary cilia. Therefore, darinaparsin represents a unique multivalent chemotherapeutic acting on stress induction, microtubule polymerization, and Shh signaling.	[Mason, Twila A.; Liu, Jiang; Chiang, Chin; Goldenring, James R.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Mason, Twila A.; Kolobova, Elena; Roland, Joseph T.; Goldenring, James R.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN USA; [Kolobova, Elena; Roland, Joseph T.; Goldenring, James R.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Mason, TA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA.	jim.goldenring@vanderbilt.edu	Roland, Joseph/C-9592-2013		National Institutes of Health [RO1DK43405, NS042205, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Childhood Brain Tumor Foundation; Ziopharm; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, P60DK020593, R01DK043405, U24DK059637, P30DK020593, U2CDK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS042205, R01NS042205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Childhood Brain Tumor Foundation; Ziopharm; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1DK43405 (to J.R.G.) and NS042205 (to C.C.). Funding was also provided by the Childhood Brain Tumor Foundation (to C.C.). Confocal images were generated using the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by National Institutes of Health grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126). Ziopharm provided funding for E.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Campas C, 2009, DRUG FUTURE, V34, P97, DOI 10.1358/dof.2009.034.02.1337397; Carre M, 2002, BIOCHEM PHARMACOL, V63, P1831, DOI 10.1016/S0006-2952(02)00922-X; Chan JYW, 2006, CANCER LETT, V236, P250, DOI 10.1016/j.canlet.2005.05.017; Diaz Z, 2008, LEUKEMIA, V22, P1853, DOI 10.1038/leu.2008.194; Duan XF, 2010, CHEM-BIOL INTERACT, V183, P222, DOI 10.1016/j.cbi.2009.09.012; Ehtesham M, 2007, ONCOGENE, V26, P5752, DOI 10.1038/sj.onc.1210359; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; JORDAN MA, 1992, J CELL SCI, V102, P401; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Kolobova E, 2009, EXP CELL RES, V315, P542, DOI 10.1016/j.yexcr.2008.11.011; Ling YH, 2002, MOL PHARMACOL, V62, P529, DOI 10.1124/mol.62.3.529; Mann KK, 2009, EXPERT OPIN INV DRUG, V18, P1727, DOI 10.1517/13543780903282759; Matulis SM, 2009, MOL CANCER THER, V8, P1197, DOI 10.1158/1535-7163.MCT-08-1072; Quintas-Cardama A, 2008, ANTI-CANCER AGENT ME, V8, P904, DOI 10.2174/187152008786847666; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; TIAN J, 2010, EJC SUPPL, V8, P161; Tsimberidou AM, 2009, CLIN CANCER RES, V15, P4769, DOI 10.1158/1078-0432.CCR-08-2984; Verstovsek S, 2006, HEMATOL ONCOL, V24, P181, DOI 10.1002/hon.787; Wu J, 2010, INVEST NEW DRUG, V28, P670, DOI 10.1007/s10637-009-9286-9; Xu K, 2002, DRUG DEVELOP RES, V55, P91, DOI 10.1002/ddr.10023	25	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27699	10.1371/journal.pone.0027699	http://dx.doi.org/10.1371/journal.pone.0027699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110729	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300045
J	Jewell, OJD; Wcisel, MA; Gennari, E; Towner, AV; Bester, MN; Johnson, RL; Singh, S				Jewell, Oliver J. D.; Wcisel, Michelle A.; Gennari, Enrico; Towner, Alison V.; Bester, Marthan N.; Johnson, Ryan L.; Singh, Sarika			Effects of Smart Position Only (SPOT) Tag Deployment on White Sharks Carcharodon carcharias in South Africa	PLOS ONE			English	Article							MIGRATION; MOVEMENTS; BEHAVIOR; HABITAT	We present 15 individual cases of sub-adult white sharks that were SPOT tagged in South Africa from 2003-2004 and have been re-sighted as recently as 2011. Our observations suggest SPOT tags can cause permanent cosmetic and structural damage to white shark dorsal fins depending on the duration of tag attachment. SPOT tags that detached within 12-24 months did not cause long term damage to the dorsal fin other than pigmentation scarring. Within 12 months of deployment, tag fouling can occur. After 24 months of deployment permanent damage to the dorsal fin occurred. A shark survived this prolonged attachment and there seems little compromise on the animal's long term survival and resultant body growth. This is the first investigation detailing the long term effects of SPOT deployment on the dorsal fin of white sharks.	[Jewell, Oliver J. D.; Bester, Marthan N.; Johnson, Ryan L.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Jewell, Oliver J. D.; Wcisel, Michelle A.; Towner, Alison V.] Dyer Isl Conservat Trust, Kleinbaai, Western Cape, South Africa; [Gennari, Enrico; Johnson, Ryan L.] Oceans Res, Res, Mossel Bay, Western Cape, South Africa; [Wcisel, Michelle A.; Towner, Alison V.] Univ Cape Town, ADU Zool Dept, Ronderbosch, Western Cape, South Africa; [Gennari, Enrico] S African Inst Aquat Biodivers, Grahamstown, South Africa; [Singh, Sarika] Dept Environm Affairs, Cape Town, Western Cape, South Africa	University of Pretoria; University of Cape Town; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Department of Environment, Forestry & Fisheries	Jewell, OJD (corresponding author), Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	Oli@sharkwatchsa.com	Bester, Marthán N/E-5387-2010	Gennari, Enrico/0000-0002-4334-727X; Jewell, Oliver/0000-0001-7680-8960	Marine Dynamics/Dyer Island Conservation Trust and Oceans Research; DEA, Oceans and Coasts Research	Marine Dynamics/Dyer Island Conservation Trust and Oceans Research; DEA, Oceans and Coasts Research	This project uses data from recent and ongoing projects of Marine Dynamics/Dyer Island Conservation Trust and Oceans Research as well as past projects from DEA, Oceans and Coasts Research (formerly Marine and Coastal Management, MCM) -thanks to all organisations for your support. Thanks to Nick Jones of Marine Dynamics for figure 1C. Thanks to David Edwards of Creative-Resolve.com for figure editing.	Balmer BC, 2010, AQUAT MAMM, V36, P1, DOI 10.1578/AM.36.1.2010.1; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, INTEGR COMP BIOL, V45, P305, DOI 10.1093/icb/45.2.305; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; JOHNSON R, 2011, THESIS U PRETORIA S; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Malcolm H., 2001, REV BIOL STATUS WHIT; Nasby-Lucas N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008163; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; TOWNER A, 2011, P WHIT SHARK RES; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211	19	19	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27242	10.1371/journal.pone.0027242	http://dx.doi.org/10.1371/journal.pone.0027242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110620	gold, Green Published, Green Submitted			2022-12-25	WOS:000297554300019
J	Kuhl, BD; Cheng, V; Donahue, DA; Sloan, RD; Liang, C; Wilkinson, J; Wainberg, MA				Kuhl, Bjoern D.; Cheng, Vicky; Donahue, Daniel A.; Sloan, Richard D.; Liang, Chen; Wilkinson, John; Wainberg, Mark A.			The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism	PLOS ONE			English	Article							ION-CHANNEL ACTIVITY; SURFACE DOWN-MODULATION; TRANS-MEMBRANE DOMAIN; VIRUS TYPE-1 VPU; VIRAL PROTEIN-U; CELL-SURFACE; TRANSMEMBRANE DOMAIN; RESTRICTION FACTORS; HUMAN MACROPHAGES; RELEASE	Among its many roles, the HIV-1 accessory protein Vpu performs a viroporin function and also antagonizes the host cell restriction factor tetherin through its transmembrane domain. BIT225 is a small molecule inhibitor that specifically targets the Vpu viroporin function, which, in macrophages, resulted in late stage inhibition of virus release and decreased infectivity of released virus, a phenotype similar to tetherin-mediated restriction. Here, we investigated whether BIT225 might mediate its antiviral function, at least in part, via inhibition of Vpu-mediated tetherin antagonism. Using T-cell lines inducible for tetherin expression, we found that BIT225 does not exert its antiviral function by inhibiting Vpu-mediated tetherin downmodulation from the cell surface, the main site of action of tetherin activity. In addition, results from a bioluminescence resonance energy transfer (BRET) assay showed that the Vpu-tetherin interaction was not affected by BIT225. Our data provide support for the concept that tetherin antagonism and viroporin function are separable on the Vpu transmembrane and that viroporin function might be cell-type dependent. Further, this work contributes to the characterization of BIT225 as an inhibitor that specifically targets the viroporin function of Vpu.	[Kuhl, Bjoern D.; Cheng, Vicky; Donahue, Daniel A.; Sloan, Richard D.; Liang, Chen; Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Kuhl, Bjoern D.; Cheng, Vicky; Liang, Chen; Wainberg, Mark A.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Donahue, Daniel A.; Liang, Chen; Wainberg, Mark A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Wilkinson, John] Biotron Ltd, St Vincents Ctr Appl Med Res, Sydney, NSW, Australia	Lady Davis Institute; McGill University; McGill University; McGill University	Kuhl, BD (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA USA.	mark.wainberg@mcgill.ca	Sloan, Richard/E-1151-2011	wilkinson, john/0000-0001-8728-4146	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Canadian Institutes of Health Research (CIHR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JL, 2004, HIV AIDS REP, V1, P47; ANDREW AJ, 2010, J VIROL, P1; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bolduan S, 2011, VIROLOGY, V416, P75, DOI 10.1016/j.virol.2011.04.009; Bour S, 2003, MICROBES INFECT, V5, P1029, DOI 10.1016/S1286-4579(03)00191-6; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Cook G. A., 2010, BIOCH BIOPHYS ACTA; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Ewart GD, 2004, ANTIMICROB AGENTS CH, V48, P2325, DOI 10.1128/AAC.48.6.2325-2330.2004; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Guatelli JC, 2009, CURR TOP MICROBIOL, V339, P27, DOI 10.1007/978-3-642-02175-6_2; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; HABERMANN A, 2010, J VIROL, P1; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; IWABU Y, 2009, J BIOL CHEM; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jolly C, 2010, J VIROLOGY; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Khoury G, 2010, ANTIMICROB AGENTS CH, V54, P835, DOI 10.1128/AAC.01308-09; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; KUHL B, 2011, J NEUROIMMUNE PHARM, P1; Kuhl BD, 2011, VIROLOGY, V417, P353, DOI 10.1016/j.virol.2011.06.012; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Kuhl BD, 2010, AIDS, V24, P1970, DOI 10.1097/QAD.0b013e32833bfe3d; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; LIM ES, 2011, KES S HIV EV GEN PAT; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Luscombe CA, 2010, ANTIVIR RES, V86, P144, DOI 10.1016/j.antiviral.2010.02.312; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Niewiadomska AM, 2009, CURR TOP MICROBIOL, V339, P1, DOI 10.1007/978-3-642-02175-6_1; Oliveira Maureen, 2009, V485, P427, DOI 10.1007/978-1-59745-170-3_29; Park SH, 2007, PROTEIN SCI, V16, P2205, DOI 10.1110/ps.073041107; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	54	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27660	10.1371/journal.pone.0027660	http://dx.doi.org/10.1371/journal.pone.0027660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110710	gold, Green Published, Green Submitted			2022-12-25	WOS:000297554300044
J	Pinet, P; Jaeger, A; Cordier, E; Potin, G; Le Corre, M				Pinet, Patrick; Jaeger, Audrey; Cordier, Emmanuel; Potin, Gael; Le Corre, Matthieu			Celestial Moderation of Tropical Seabird Behavior	PLOS ONE			English	Article							PETRELS PROCELLARIA-AEQUINOCTIALIS; PELAGIC SEABIRD; INDIAN-OCEAN; LUNAR SYNCHRONIZATION; CIRCANNUAL RHYTHMS; PTERODROMA-BARAUI; ACTIVITY PATTERNS; PLASMA MELATONIN; SOUTH-GEORGIA; ANNUAL CYCLE	Most animals, including birds, have cyclic life histories and numerous studies generally conducted on captive animals have shown that photoperiod is the main factor influencing this periodicity. Moon cycles can also affect periodic behavior of birds. Few studies have investigated the influence of these environmental cues in natural settings, and particularly in tropical areas where the change in photoperiod is slight and some bird species keep cyclic behaviors. Using miniaturized light sensors, we simultaneously investigated under natural conditions the influence of photoperiod and moon phases on the migration dates and at-sea activity of a tropical seabird species, the Barau's petrel, throughout its annual cycle. Firstly, we found that birds consistently started their pre- and post-breeding migrations at precise dates corresponding in both cases to a day-duration of 12.5 hours, suggesting a strong influence of the photoperiod in the regulation of migration behavior. We also found that mean population arrival dates to the colony changed from year to year and they were influenced by moon phases. Returns at their colonies occurred around the last full moon of the austral winter, suggesting that moon cycle is used by birds to synchronize their arrival. Secondly, variations of day-time activity were sinusoidal and correlated to seasonal changes of daylength. We thus hypothesize that the photoperiod could directly affect the behavior of the birds at sea. Night-time at-sea activity exhibited a clear cycle of 29.2 days, suggesting that nocturnal foraging was highly regulated by moon phase, particularly during the non-breeding season. To our knowledge, this is the first study to document a mixed regulation of the behavior of a wild bird by photoperiod and moon phases throughout its annual cycle.	[Pinet, Patrick; Jaeger, Audrey; Cordier, Emmanuel; Potin, Gael; Le Corre, Matthieu] Univ Reunion, Lab Ecol Marine, St Denis, Reunion, France	University of La Reunion	Pinet, P (corresponding author), Univ Reunion, Lab Ecol Marine, St Denis, Reunion, France.	patrick.pinet@univ-reunion.fr	Cordier, Emmanuel/ABE-9646-2021; Cordier, Emmanuel/N-1540-2013	Cordier, Emmanuel/0000-0001-5194-4026; Jaeger, Audrey/0000-0002-5649-0315	Pew Environment Group; French Federation de Recherche sur la Biodiversite (FRB) [AOOI-07 011]; European Union [RegPot 2008-1]; French Secretariat d'Etat a l'Outre MER (SEOM); Parc National de La Reunion; Conseil Regional de la Reunion; European Social Fund; European Union	Pew Environment Group; French Federation de Recherche sur la Biodiversite (FRB); European Union(European Commission); French Secretariat d'Etat a l'Outre MER (SEOM); Parc National de La Reunion; Conseil Regional de la Reunion; European Social Fund(European Social Fund (ESF)); European Union(European Commission)	This study is a contribution to a regional seabird tracking program funded by the Pew Environment Group (Pew Fellowship Award in Marine Conservation to MLC), the French Federation de Recherche sur la Biodiversite (FRB, programme "Biodiversite des Iles de L'Ocean Indien'' convention AOOI-07 011), the European Union (program Run Sea Sciences FP7, Capacities, RegPot 2008-1), the French Secretariat d'Etat a l'Outre MER (SEOM, programme REPONCE), and the Parc National de La Reunion. PP benefited from a Ph.D. Grant of the Conseil Regional de la Reunion and the European Social Fund. AJ and EC both benefited from postdoc grants of the European Union (programs Run EMERGE and Run Sea Science, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Bird KJ, 2009, LIMNOL OCEANOGR, V54, P1789, DOI 10.4319/lo.2009.54.5.1789; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Brandstatter R, 2000, P NATL ACAD SCI USA, V97, P12324, DOI 10.1073/pnas.200354997; Brandstatter R, 2001, J PINEAL RES, V31, P120, DOI 10.1034/j.1600-079x.2001.310205.x; BRETAGNOLLE V, 1991, COLON WATERBIRD, V14, P25, DOI 10.2307/1521275; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; Buehler DM, 2009, J COMP PHYSIOL A, V195, P445, DOI 10.1007/s00359-009-0422-y; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; CHAPIN JAMES P., 1959, AUK, V76, P153; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Coverdill AJ, 2008, J BIOL RHYTHM, V23, P59, DOI 10.1177/0748730407311456; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; DAWSON A, 1994, J BIOL RHYTHM, V9, P137, DOI 10.1177/074873049400900204; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2007, P ROY SOC B-BIOL SCI, V274, P721, DOI 10.1098/rspb.2006.0067; FARNER DS, 1985, ANNU REV PHYSIOL, V47, P65, DOI 10.1146/annurev.ph.47.030185.000433; Girard C, 2004, ANIM BEHAV, V67, P319, DOI 10.1016/j.anbehav.2003.07.007; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; GWINNER E, 1993, GEN COMP ENDOCR, V90, P119, DOI 10.1006/gcen.1993.1066; Gwinner E, 1998, J ORNITHOL, V139, P407, DOI 10.1007/BF01653467; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Gwinner E, 1996, J EXP BIOL, V199, P39; Hau M, 1998, P ROY SOC B-BIOL SCI, V265, P89, DOI 10.1098/rspb.1998.0268; Hill Roger D., 1994, P227; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Jaquemet S, 2007, DEEP-SEA RES PT I, V54, P130, DOI 10.1016/j.dsr.2006.10.003; KUMAR V, 1993, J PINEAL RES, V14, P192, DOI 10.1111/j.1600-079X.1993.tb00502.x; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Leitner S, 2003, GEN COMP ENDOCR, V130, P102, DOI 10.1016/S0016-6480(02)00574-9; Sabato MAL, 2006, BEHAV PROCESS, V73, P228, DOI 10.1016/j.beproc.2006.05.012; Mackley EK, 2011, MAR BIOL, V158, P429, DOI 10.1007/s00227-010-1570-x; Martin G., 1990, BIRDS NIGHT; Murton RK, 1977, AVIAN BREEDING CYCLE; NEUMANN D, 1981, HDB BEHAVIOURAL NEUR, V4, P351; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Parrish JK, 1999, ENVIRON BIOL FISH, V55, P157, DOI 10.1023/A:1007472602017; Penteriani V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008696; Peron C, 2010, MAR ECOL PROG SER, V416, P267, DOI 10.3354/meps08785; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2007, MAR ECOL PROG SER, V345, P281, DOI 10.3354/meps06991; Phillips RA, 2005, MAR ECOL PROG SER, V285, P259, DOI 10.3354/meps285259; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; Pinet Patrick, 2009, Marine Ornithology, V37, P107; POCKLINGTON R, 1979, MAR BIOL, V51, P9, DOI 10.1007/BF00389026; Rahman MS, 2001, COMP BIOCHEM PHYS B, V129, P367, DOI 10.1016/S1096-4959(01)00323-2; STAHL J-C, 1991, Notornis, V38, P211; Tarling GA, 1999, J PLANKTON RES, V21, P1475, DOI 10.1093/plankt/21.8.1475; Tarlow EM, 2003, GEN COMP ENDOCR, V133, P297, DOI 10.1016/S0016-6480(03)00192-8; TAYLOR MH, 1984, T AM FISH SOC, V113, P484, DOI 10.1577/1548-8659(1984)113<484:LSOFR>2.0.CO;2; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147; Wilson R.P., 1992, P131; Wolfson A, 1952, SCI MON, V74, P191; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019	64	37	38	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27663	10.1371/journal.pone.0027663	http://dx.doi.org/10.1371/journal.pone.0027663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110711	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300045
J	Seitz, V; Butzhammer, P; Hirsch, B; Hecht, J; Gutgemann, I; Ehlers, A; Lenze, D; Oker, E; Sommerfeld, A; von der Wall, E; Konig, C; Zinser, C; Spang, R; Hummel, M				Seitz, Volkhard; Butzhammer, Peter; Hirsch, Burkhard; Hecht, Jochen; Guetgemann, Ines; Ehlers, Anke; Lenze, Dido; Oker, Elisabeth; Sommerfeld, Anke; von der Wall, Edda; Koenig, Christoph; Zinser, Christian; Spang, Rainer; Hummel, Michael			Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma	PLOS ONE			English	Article							C-MYC; GENE ANALYSIS; TRANSCRIPTION; CELLS; RECRUITMENT; IDENTIFICATION; TUMORIGENESIS; BIOGENESIS; ACTIVATION; REPRESSION	Background: MYC is a key transcription factor involved in central cellular processes such as regulation of the cell cycle, histone acetylation and ribosomal biogenesis. It is overexpressed in the majority of human tumors including aggressive B-cell lymphoma. Especially Burkitt lymphoma (BL) is a highlight example for MYC overexpression due to a chromosomal translocation involving the c-MYC gene. However, no genome-wide analysis of MYC-binding sites by chromatin immunoprecipitation (ChIP) followed by next generation sequencing (ChIP-Seq) has been conducted in BL so far. Methodology/Principal Findings: ChIP-Seq was performed on 5 BL cell lines with a MYC-specific antibody giving rise to 7,054 MYC-binding sites after bioinformatics analysis of a total of approx. 19 million sequence reads. In line with previous findings, binding sites accumulate in gene sets known to be involved in the cell cycle, ribosomal biogenesis, histone acetyltransferase and methyltransferase complexes demonstrating a regulatory role of MYC in these processes. Unexpectedly, MYC-binding sites also accumulate in many B-cell relevant genes. To assess the functional consequences of MYC binding, the ChIP-Seq data were supplemented with siRNA-mediated knock-downs of MYC in BL cell lines followed by gene expression profiling. Interestingly, amongst others, genes involved in the B-cell function were up-regulated in response to MYC silencing. Conclusion/Significance: The 7,054 MYC-binding sites identified by our ChIP-Seq approach greatly extend the knowledge regarding MYC binding in BL and shed further light on the enormous complexity of the MYC regulatory network. Especially our observations that (i) many B-cell relevant genes are targeted by MYC and (ii) that MYC down-regulation leads to an upregulation of B-cell genes highlight an interesting aspect of BL biology.	[Seitz, Volkhard; Hirsch, Burkhard; Ehlers, Anke; Lenze, Dido; Oker, Elisabeth; Sommerfeld, Anke; von der Wall, Edda; Hummel, Michael] Charite, Inst Pathol, D-13353 Berlin, Germany; [Butzhammer, Peter; Spang, Rainer] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Hecht, Jochen] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Guetgemann, Ines] Univ Hosp Bonn, Dept Pathol, Bonn, Germany; [Koenig, Christoph] ImaGenes GmbH, Berlin, Germany; [Zinser, Christian] Genomatix Software GmbH, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn	Seitz, V (corresponding author), Charite, Inst Pathol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	michael.hummel@charite.de	Gütgemann, Ines/ABH-6426-2020	Hummel, Michael/0000-0001-6717-605X; Spang, Rainer/0000-0002-1326-4297	Deutsche Krebshilfe [107558]; Deutsche Forschungsgemeinschaft [TRR 54/1-08]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant ( no. 107558) from the network project of the Deutsche Krebshilfe "Molecular Mechanisms in Malignant Lymphoma,'' subproject B2 (www.krebshilfe.de) and by a grant (TRR 54/1-08) from the Deutsche Forschungsgemeinschaft (www.dfg.de) SFB/Transregio 54, subproject B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bellan C, 2005, BLOOD, V106, P1031, DOI 10.1182/blood-2005-01-0168; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Bui Thi V, 2010, Genes Cancer, V1, P568; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chapman CJ, 1998, LEUKEMIA LYMPHOMA, V30, P257, DOI 10.3109/10428199809057539; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; God JM, 2010, J ONCOL, V2010, DOI 10.1155/2010/516047; HAUPT Y, 1993, ONCOGENE, V8, P3161; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirsch B, 2008, AM J PATHOL, V172, P510, DOI 10.2353/ajpath.2008.070858; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Isobe K, 2002, LEUKEMIA LYMPHOMA, V43, P159, DOI 10.1080/10428190210199; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lenze D, 2011, LEUKEMIA, V25, P1869, DOI 10.1038/leu.2011.156; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vallespinos M, 2011, J IMMUNOL, V186, P6726, DOI 10.4049/jimmunol.1002753; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Weigelt K, 2008, BIOTECHNIQUES, V45, P131, DOI 10.2144/000112819; Wolfertstetter F, 1996, COMPUT APPL BIOSCI, V12, P71; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	53	75	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26837	10.1371/journal.pone.0026837	http://dx.doi.org/10.1371/journal.pone.0026837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102868	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800012
J	Economopoulos, V; Noad, JC; Krishnamoorthy, S; Rutt, BK; Foster, PJ				Economopoulos, Vasiliki; Noad, Jennifer C.; Krishnamoorthy, Shruti; Rutt, Brian K.; Foster, Paula J.			Comparing the MRI Appearance of the Lymph Nodes and Spleen in Wild-Type and Immuno-Deficient Mouse Strains	PLOS ONE			English	Article							BREAST-CANCER; MICE; NUDE; METASTASIS; ENGRAFTMENT; GROWTH; MODELS; CELLS	The goal of this study was to investigate the normal MRI appearance of lymphoid organs in immuno-competent and immuno-deficient mice commonly used in research. Four mice from each of four different mouse strains (nude, NOG, C57BL/6, CB-17 SCID (SCID)) were imaged weekly for one month. Images were acquired with a 3D balanced steady state free precession (bSSFP) sequence. The volume of the lymph nodes and spleens were measured from MR images. In images of nude and SCID mice, lymph nodes sometimes contained a hyperintense region visible on MRI images. Volumes of the nodes were highly variable in nude mice. Nodes in SCID mice were smaller than in nude or C57Bl/6 mice (p<0.0001). Lymph node volumes changed slightly over time in all strains. The spleens of C57Bl/6 and nude mice were similar in size and appearance. Spleens of SCID and NOG mice were significantly smaller (p<0.0001) and abnormal in appearance. The MRI appearance of the normal lymph nodes and spleen varies considerably in the various mouse strains examined in this study. This is important to recognize in order to avoid the misinterpretation of MRI findings as abnormal when these strains are used in MRI imaging studies.	[Economopoulos, Vasiliki; Noad, Jennifer C.; Krishnamoorthy, Shruti; Foster, Paula J.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Economopoulos, Vasiliki; Noad, Jennifer C.; Krishnamoorthy, Shruti; Foster, Paula J.] Univ Western Ontario, Imaging Res Grp, Robarts Res Inst, London, ON, Canada; [Rutt, Brian K.] Stanford Univ, Dept Radiol, Richard M Lucas Ctr Imaging, Stanford, CA 94305 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Stanford University	Foster, PJ (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	pfoster@imaging.robarts.ca	Foster, Paula/M-2201-2013	Foster, Paula/0000-0002-4868-3395; Economopoulos, Vasiliki/0000-0001-7187-7254	Canadian Cancer Society Research Institute [19397]; Canadian Breast Cancer Foundation - Ontario Region; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR062068] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation - Ontario Region; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this study was provided by the Canadian Cancer Society Research Institute (Grant # 19397). VE is supported by a fellowship from the Canadian Breast Cancer Foundation - Ontario Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2006, CONTRAST MEDIA MOL I, V1, P230, DOI 10.1002/cmmi.116; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BRUNNER N, 1993, BREAST CANCER RES TR, V24, P257, DOI 10.1007/BF01833265; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Clarke R, 1996, BREAST CANCER RES TR, V39, P69, DOI 10.1007/BF01806079; Croy BA, 2001, COMPARATIVE MED, V51, P300; Dadiani M, 2006, CANCER RES, V66, P8037, DOI 10.1158/0008-5472.CAN-06-0728; Dewan MZ, 2005, BIOMED PHARMACOTHER, V59, pS375, DOI 10.1016/S0753-3322(05)80082-4; GE W, 1991, CHINESE J CANCER RES, V3, P6; GREINER DL, 1995, AM J PATHOL, V146, P888; Hudson WA, 1998, LEUKEMIA, V12, P2029, DOI 10.1038/sj.leu.2401236; HUTTER R V P, 1984, P175; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Matsui J, 2008, CLIN CANCER RES, V14, P5459, DOI 10.1158/1078-0432.CCR-07-5270; MIKHAILOV AD, 1995, B EXP BIOL MED+, V119, P201, DOI 10.1007/BF02445879; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; PRICE JE, 1990, CANCER RES, V50, P717; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SAINTEMARIE G, 1983, LAB INVEST, V49, P420; SCHULER W, 1989, CURR TOP MICROBIOL, V152, P55; SHULTZ LD, 1995, J IMMUNOL, V154, P180; TAGHIAN A, 1993, CANCER RES, V53, P5012; Troiani T, 2008, CRIT REV ONCOL HEMAT, V65, P200, DOI 10.1016/j.critrevonc.2007.10.003; XIE X, 1992, CLIN EXP METASTAS, V10, P201, DOI 10.1007/BF00132752	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27508	10.1371/journal.pone.0027508	http://dx.doi.org/10.1371/journal.pone.0027508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096586	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800056
J	Tkocz, D; Crawford, NT; Buckley, NE; Berry, FB; Kennedy, RD; Gorski, JJ; Harkin, DP; Mullan, PB				Tkocz, D.; Crawford, N. T.; Buckley, N. E.; Berry, F. B.; Kennedy, R. D.; Gorski, J. J.; Harkin, D. P.; Mullan, P. B.			BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers	ONCOGENE			English	Article						BRCA1; GATA3; FOXC1; basal-like; corepression	EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; PROGNOSTIC-SIGNIFICANCE; MAMMARY-GLAND; CELLS; TUMORS; DIFFERENTIATION; METASTASIS; DOCETAXEL; SUBTYPES	In this study we describe a novel interaction between the breast/ovarian tumor suppressor gene BRCA1 and the transcription factor GATA3, an interaction, which is important for normal breast differentiation. We show that the BRCA1-GATA3 interaction is important for the repression of genes associated with triple-negative and basal-like breast cancer (BLBCs) including FOXC1, and that GATA3 interacts with a C-terminal region of BRCA1. We demonstrate that FOXC1 is an essential survival factor maintaining the proliferation of BLBCs cell lines. We define the mechanistic basis of this corepression and identify the GATA3-binding site within the FOXC1 distal promoter region. We show that BRCA1 and GATA3 interact on the FOXC1 promoter and that BRCA1 requires GATA3 for recruitment to this region. This interaction requires fully functional BRCA1 as a mutant BRCA1 protein is unable to localize to the FOXC1 promoter or repress FOXC1 expression. We demonstrate that this BRCA1-GATA3 repression complex is not a FOXC1-specific phenomenon as a number of other genes associated with BLBCs such as FOXC2, CXCL1 and p-cadherin were also repressed in a similar manner. Finally, we demonstrate the importance of our findings by showing that loss of GATA3 expression or aberrant FOXC1 expression contributes to the drug resistance and epithelial-to-mesenchymal transition-like phenotypes associated with aggressive BLBCs. Oncogene (2012) 31, 3667-3678; doi:10.1038/onc.2011.531; published online 28 November 2011	[Tkocz, D.; Crawford, N. T.; Buckley, N. E.; Kennedy, R. D.; Gorski, J. J.; Harkin, D. P.; Mullan, P. B.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Berry, F. B.] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	Queens University Belfast; University of Alberta	Mullan, PB (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, CCRCB Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	p.mullan@qub.ac.uk	Kennedy, Richard/J-3489-2012	Kennedy, Richard/0000-0003-4737-6163; Buckley, Niamh/0000-0001-9326-8513	Action Cancer Northern Ireland; Breast Cancer Campaign; Medical Research Council [G0600267] Funding Source: researchfish; MRC [G0600267] Funding Source: UKRI	Action Cancer Northern Ireland; Breast Cancer Campaign; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to acknowledge the kind gift of mouse antihuman fibronectin antibody from Professor Philip Rudland (University of Liverpool). This work was supported by grants from the Action Cancer Northern Ireland (DT) and the Breast Cancer Campaign (NTC).	Ademuyiwa FO, 2010, MODERN PATHOL, V23, P270, DOI 10.1038/modpathol.2009.172; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Arnold JM, 2010, BREAST CANCER RES TR, V119, P491, DOI 10.1007/s10549-008-0269-x; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Bierie B, 2008, CANCER RES, V68, P1809, DOI 10.1158/0008-5472.CAN-07-5597; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Buckley NE, 2007, MOL CANCER RES, V5, P261, DOI 10.1158/1541-7786.MCR-06-0250; Buckley NE, 2011, CANCER RES, V71, P1933, DOI 10.1158/0008-5472.CAN-10-2717; Campora E, 2008, ANTICANCER RES, V28, P3993; D'Anello L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-300; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jacquemier J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2249; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kouroussis C, 1999, ANN ONCOL, V10, P547, DOI 10.1023/A:1026441804889; Laakso M, 2005, MODERN PATHOL, V18, P1321, DOI 10.1038/modpathol.3800456; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Marchini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014131; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wang HQ, 2010, CHINESE MED J-PEKING, V123, P3212, DOI 10.3760/cma.j.issn.0366-6999.2010.22.007; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang QF, 2001, CANCER-AM CANCER SOC, V92, P54, DOI 10.1002/1097-0142(20010701)92:1<54::AID-CNCR1291>3.0.CO;2-8; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	50	57	63	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	32					3667	3678		10.1038/onc.2011.531	http://dx.doi.org/10.1038/onc.2011.531			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22120723				2022-12-25	WOS:000307653800002
J	Mysliwiec, MR; Carlson, CD; Tietjen, J; Hung, H; Ansari, AZ; Lee, Y				Mysliwiec, Matthew R.; Carlson, Clayton D.; Tietjen, Josh; Hung, Holly; Ansari, Aseem Z.; Lee, Youngsook			Jarid2 (Jumonji, AT Rich Interactive Domain 2) Regulates NOTCH1 Expression via Histone Modification in the Developing Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC DEVELOPMENT; GENE-EXPRESSION; TARGET GENES; PRC2; METHYLTRANSFERASE; DIFFERENTIATION; JARID2/JUMONJI; PROLIFERATION; PROTEIN; H3	Jarid2/Jumonji, the founding member of the Jmj factor family, critically regulates various developmental processes, including cardiovascular development. The Jmj family was identified as histone demethylases, indicating epigenetic regulation by Jmj proteins. Deletion of Jarid2 in mice resulted in cardiac malformation and increased endocardial Notch1 expression during development. Although Jarid2 has been shown to occupy the Notch1 locus in the developing heart, the precise molecular role of Jarid2 remains unknown. Here we show that deletion of Jarid2 results in reduced methylation of lysine 9 on histone H3 (H3K9) at the Notch1 genomic locus in embryonic hearts. Interestingly, SETDB1, a histone H3K9 methyltransferase, was identified as a putative cofactor of Jarid2 by yeast two-hybrid screening, and the physical interaction between Jarid2 and SETDB1 was confirmed by coimmunoprecipitation experiments. Concurrently, accumulation of SETDB1 at the site of Jarid2 occupancy was significantly reduced in Jarid2 knock out (KO) hearts. Employing genome-wide approaches, putative Jarid2 target genes regulated by SETDB1 via H3K9 methylation were identified in the developing heart by ChIP-chip. These targets are involved in biological processes that, when dysregulated, could manifest in the phenotypic defects observed in Jarid2 KO mice. Our data demonstrate that Jarid2 functions as a transcriptional repressor of target genes, including Notch1, through a novel process involving the modification of H3K9 methylation via specific interaction with SETDB1 during heart development. Therefore, our study provides new mechanistic insights into epigenetic regulation by Jarid2, which will enhance our understanding of the molecular basis of other organ development and biological processes.	[Mysliwiec, Matthew R.; Hung, Holly; Lee, Youngsook] Univ Wisconsin Madison, Dept Cellular & Regenerat Biol, Madison, WI 53706 USA; [Carlson, Clayton D.; Tietjen, Josh; Ansari, Aseem Z.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin Madison, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mysliwiec, MR (corresponding author), 1300 Univ Ave,SMI 321, Madison, WI 53706 USA.	youngsooklee@wisc.edu	Ansari, Aseem/AAF-4945-2019		National Institutes of Health [HL067050, NIGMS069420]; American Heart Association [10POST2600279, 0615615Z]; U.S. National Human Genome Research Institute (NHGRI) [5T32HG002760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); U.S. National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL067050 (to Y. L.) and NIGMS069420 (to A. Z. A.). This work was also supported by American Heart Association Grant 10POST2600279 (to M. R. M.) and predoctoral fellowship 0615615Z (to C. D. C.), and by U.S. National Human Genome Research Institute (NHGRI) training grant to the Genomic Sciences Training Program (GSTP) 5T32HG002760 (to J. T.).	Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Kim T, 2005, BIOCHEM BIOPH RES CO, V329, P544, DOI 10.1016/j.bbrc.2005.01.154; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen AL, 2004, MOL CELL BIOL, V24, P5184, DOI 10.1128/MCB.24.12.5184-5196.2004; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578	29	52	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1235	1241		10.1074/jbc.M111.315945	http://dx.doi.org/10.1074/jbc.M111.315945			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110129	hybrid, Green Published			2022-12-25	WOS:000299170300039
J	Zhao, HW; Jin, SH; Gewirtz, AM				Zhao, Huiwu; Jin, Shenghao; Gewirtz, Alan M.			The Histone Acetyltransferase TIP60 Interacts with c-Myb and Inactivates Its Transcriptional Activity in Human Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; COACTIVATOR; ACTIVATION; ACETYLATION; SEQUENCE; GENE; TRANSFORMATION; PROLIFERATION; TRANSLOCATION; EXPRESSION	The histone acetyltransferase TIP60 is a coregulator of transcription factors and is implicated in tumorigenesis. In this study, we explored potential regulatory relationships between TIP60 and the c-Myb oncoprotein in hematopoietic cells. We first showed that TIP60 is a c-Myb interacting protein and that the interaction is dependent on the TIP60 acetyltransferase domain and c-Myb transactivation domain. We then found that coexpressing TIP60 decreases the transcriptional activation ability of c-Myb in functional reporter assays. A ChIP assay also revealed that TIP60 binds to the c-Myb target gene c-Myc promoter in a c-Myb-dependent manner. Consistently, knockdown of Tip60 expression by siRNA increased endogenous c-Myc expression. Furthermore, coimmunoprecipitation of Jurkat cell lysates revealed that c-Myb is associated with histone deacetylases HDAC1 and HDAC2, known to interact with TIP60 and repress transcription. Finally, we compared Tip60 expression in six primary AML samples with three normal CD34(+) cell samples using quantitative RT-PCR. Tip60 expression was significantly (similar to 60%) lower in the AML samples. In summary, these studies demonstrate that TIP60 negatively modulates c-Myb transcriptional activity by recruiting histone deacetylases in human hematopoietic cells, leading us to hypothesize that TIP60 is a normal regulator of c-Myb function and that dysregulated or mutated TIP60 may contribute to c-Myb-driven leukemogenesis.	[Zhao, Huiwu; Jin, Shenghao; Gewirtz, Alan M.] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania	Zhao, HW (corresponding author), Rm 370 CRB,415 Curie Bld, Philadelphia, PA 19104 USA.	huiwuz@mail.med.upenn.edu			National Institutes of Health [5T32DK007780]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32DK007780. This work was also supported by a tobacco settlement grant from the Pennsylvania Department of Health (the Department specifically disclaims responsibility for any analysis, interpretations, or conclusions).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; BARLETTA C, 1987, SCIENCE, V235, P1064, DOI 10.1126/science.3469751; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Friedman AD, 2002, J CELL BIOCHEM, V86, P624, DOI 10.1002/jcb.10271; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; GEWIRTZ AM, 1989, SCIENCE, V245, P180, DOI 10.1126/science.2665077; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Lidonnici MR, 2008, BLOOD, V111, P4771, DOI 10.1182/blood-2007-08-105072; Muller-Tidow C, 2004, LEUKEMIA, V18, P720, DOI 10.1038/sj.leu.2403296; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; NASONBURCHENAL K, 1993, P NATL ACAD SCI USA, V90, P1619, DOI 10.1073/pnas.90.4.1619; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Shiota M, 2010, PROSTATE, V70, P540, DOI 10.1002/pros.21088; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	35	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					925	934		10.1074/jbc.M111.279950	http://dx.doi.org/10.1074/jbc.M111.279950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110127	hybrid, Green Published			2022-12-25	WOS:000299170300011
J	Butzloff, PR				Butzloff, Peter R.			Micro-CT Imaging of Denatured Chitin by Silver to Explore Honey Bee and Insect Pathologies	PLOS ONE			English	Article							MOLECULAR-WEIGHT MANIPULATION; CHITOSAN; DEPOLYMERIZATION; OZONE; DEGRADATION; ACID; AGE; POLYSACCHARIDES; FLUORESCENCE; TEMPERATURE	Background: Chitin and cuticle coatings are important to the environmental and immune defense of honey bees and insect pollinators. Pesticides or environmental effects may target the biochemistry of insect chitin and cuticle coating. Denaturing of chitin involves a combination of deacetylation, intercalation, oxidation, Schweiger-peeling, and the formation of amine hydrochloride salt. The term "denatured chitin" calls attention to structural and property changes to the internal membranes and external carapace of organisms so that some properties affecting biological activities are diminished. Methodology/Principal Findings: A case study was performed on honey bees using silver staining and microscopic computer-tomographic x-ray radiography (micro-CT). Silver nitrate formed counter-ion complexes with labile ammonium cations and reacted with amine hydrochloride. Silver was concentrated in the peritrophic membrane, on the abdomen, in the glossa, at intersegmental joints (tarsi), at wing attachments, and in tracheal air sacs. Imaged mono-esters and fatty acids from cuticle coating on external surfaces were apparently reduced by an alcohol pretreatment. Conclusions/Significance: The technique provides 3-dimensional and sectional images of individual honey bees consistent with the chemistries of silver reaction and complex formation with denatured chitin. Environmental exposures and influences such as gaseous nitric oxide intercalant, trace oxidants such as ozone gas, oligosachharide salt conversion, exposure to acid rain, and chemical or biochemical denaturing by pesticides may be studied using this technique. Peritrophic membranes, which protect against food abrasion, microorganisms, and permit efficient digestion, were imaged. Apparent surface damage to the corneal lenses of compound eyes by dilute acid exposure consistent with chitin amine hydrochloride formation was imaged. The technique can contribute to existing insect pathology research, and may provide an additional tool for research on CCD.	Honey Bee Res Inst & Nat Ctr, St David, ME USA		Butzloff, PR (corresponding author), Honey Bee Res Inst & Nat Ctr, St David, ME USA.	pbutzloff@gmail.com		Butzloff, Peter/0000-0002-7154-4625				ALLAN GG, 1995, CARBOHYD RES, V277, P273, DOI 10.1016/0008-6215(95)00208-B; ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A; BARBEHENN RV, 1995, J INSECT PHYSIOL, V41, P303, DOI 10.1016/0022-1910(94)00118-Z; BLOMQUIST GJ, 1980, INSECT BIOCHEM, V10, P313, DOI 10.1016/0020-1790(80)90026-8; BRANDT CR, 1978, J INVERTEBR PATHOL, V32, P12, DOI 10.1016/0022-2011(78)90169-6; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Butler CD, 2008, ENVIRON POLLUT, V156, P1, DOI 10.1016/j.envpol.2007.12.026; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; COHEN E, 1993, ARCH INSECT BIOCHEM, V22, P245, DOI 10.1002/arch.940220118; CRAILSHEIM K, 1986, J INSECT PHYSIOL, V32, P629, DOI 10.1016/0022-1910(86)90092-2; de Alvarenga ES, 2010, CARBOHYD POLYM, V80, P1155, DOI 10.1016/j.carbpol.2010.01.037; Draczynski Z, 2008, J APPL POLYM SCI, V109, P1974, DOI 10.1002/app.28356; Furlan CM, 2006, ENVIRON EXP BOT, V58, P100, DOI 10.1016/j.envexpbot.2005.06.020; Helmig D, 2007, ATMOS ENVIRON, V41, P5031, DOI 10.1016/j.atmosenv.2006.05.084; Holme HK, 2008, CARBOHYD POLYM, V73, P656, DOI 10.1016/j.carbpol.2008.01.007; Huang QZ, 2007, CARBOHYD POLYM, V68, P761, DOI 10.1016/j.carbpol.2006.08.015; Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20176; Jaworska M, 2003, POLYM INT, V52, P198, DOI 10.1002/pi.1159; Jia ZS, 2002, CARBOHYD POLYM, V49, P393, DOI 10.1016/S0144-8617(02)00026-7; JOHNSTON R, 2010, RL33938 CONGR RES SE; Jull AB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005083.pub2; Khan TA, 2002, J PHARM PHARM SCI, V5, P205; Kim SW, 2007, ATMOS ENVIRON, V41, P7069, DOI 10.1016/j.atmosenv.2007.04.063; Kim SS, 1996, J POLYM SCI POL PHYS, V34, P2367, DOI 10.1002/(SICI)1099-0488(199610)34:14<2367::AID-POLB6>3.0.CO;2-T; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Konieczna-Molenda A, 2008, CARBOHYD RES, V343, P3117, DOI 10.1016/j.carres.2008.09.007; Kumar ABV, 2004, CARBOHYD POLYM, V58, P275, DOI 10.1016/j.carbpol.2004.07.001; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; Kumar PTS, 2010, CARBOHYD POLYM, V80, P761, DOI 10.1016/j.carbpol.2009.12.024; Martin GL, 2009, CARBOHYD POLYM, V77, P695, DOI 10.1016/j.carbpol.2009.02.021; Martinou A, 1998, CARBOHYD RES, V311, P71, DOI 10.1016/S0008-6215(98)00183-9; MUZZARELLI RA, 1973, ANAL CHIM ACTA, V64, P371; NAGASAWA K, 1971, CARBOHYD RES, V18, P95, DOI 10.1016/S0008-6215(00)80261-X; *OFF AIR QUAL RAD, EPA456F08001 OFF AIR; OGAWA K, 1993, CHEM MATER, V5, P726, DOI 10.1021/cm00029a026; Paoletti E, 2007, ENVIRON POLLUT, V150, P85, DOI 10.1016/j.envpol.2007.06.037; Pestov AV, 2008, J APPL POLYM SCI, V108, P119, DOI 10.1002/app.26784; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; QIN Y, 1993, J APPL POLYM SCI, V49, P727, DOI 10.1002/app.1993.070490418; Rigouin C, 2009, CARBOHYD POLYM, V76, P279, DOI 10.1016/j.carbpol.2008.10.022; Rinaudo M, 2006, MACROMOL SYMP, V245, P549, DOI 10.1002/masy.200651379; Rouget C., 1859, COMP REND, V48, P792; Schroeder JP, 2010, AQUACULTURE, V305, P6, DOI 10.1016/j.aquaculture.2010.03.030; SCHWEIGER RG, 1972, CARBOHYD RES, V21, P219, DOI 10.1016/S0008-6215(00)82148-5; Seo S, 2007, J FOOD SCI, V72, pC522, DOI 10.1111/j.1750-3841.2007.00563.x; Sharpe R.J., 2009, BIOSCI HYPOTHESES, V2, P439, DOI [10.1016/j.bihy.2009.01.004, DOI 10.1016/J.BIHY.2009.01.004]; SHIGENO Y, 1980, J APPL POLYM SCI, V25, P731, DOI 10.1002/app.1980.070250502; Sogias IA, 2010, MACROMOL CHEM PHYS, V211, P426, DOI 10.1002/macp.200900385; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Stindl R, 2010, MED HYPOTHESES, V75, P387, DOI 10.1016/j.mehy.2010.04.003; Teerawanichpan P, 2010, INSECT BIOCHEM MOLEC, V40, P641, DOI 10.1016/j.ibmb.2010.06.004; Tian F, 2004, CARBOHYD POLYM, V57, P31, DOI 10.1016/j.carbpol.2004.03.016; Toffey A, 1999, J APPL POLYM SCI, V73, P1879, DOI 10.1002/(SICI)1097-4628(19990906)73:10<1879::AID-APP7>3.3.CO;2-V; Trung TS, 2006, BIORESOURCE TECHNOL, V97, P659, DOI 10.1016/j.biortech.2005.03.023; Tsao CT, 2011, CARBOHYD RES, V346, P94, DOI 10.1016/j.carres.2010.10.010; UNEP (United Nations Environment Program), 2010, EM ISS GLOB HON BEE; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Varum KM, 2001, CARBOHYD POLYM, V46, P89, DOI 10.1016/S0144-8617(00)00288-5; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; von Sonntag C, 2003, RADIAT PHYS CHEM, V67, P353, DOI 10.1016/S0969-806X(03)00066-5; Wan A, 2010, J APPL POLYM SCI, V117, P2183, DOI 10.1002/app.31130; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003; Yang KH, 2011, MATER CHEM PHYS, V126, P993, DOI 10.1016/j.matchemphys.2010.09.069; YOUNG RG, 1983, EXP GERONTOL, V18, P471, DOI 10.1016/0531-5565(83)90026-8; Yue W, 2008, POLYM DEGRAD STABIL, V93, P1814, DOI 10.1016/j.polymdegradstab.2008.07.010; Yue W, 2009, CARBOHYD POLYM, V77, P639, DOI 10.1016/j.carbpol.2009.02.015; 6261594	69	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27448	10.1371/journal.pone.0027448	http://dx.doi.org/10.1371/journal.pone.0027448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110654	gold, Green Published			2022-12-25	WOS:000297555400047
J	Denoth, F; Siciliano, V; Iozzo, P; Fortunato, L; Molinaro, S				Denoth, Francesca; Siciliano, Valeria; Iozzo, Patricia; Fortunato, Loredana; Molinaro, Sabrina			The Association between Overweight and Illegal Drug Consumption in Adolescents: Is There an Underlying Influence of the Sociocultural Environment?	PLOS ONE			English	Article							EATING-DISORDERS; PHYSICAL-ACTIVITY; BULIMIA-NERVOSA; RISK-FACTORS; OBESITY; HEALTH; PREVALENCE; ADDICTION; BEHAVIORS; RESTRICTION	Background: The aims of the study were to: a) Examine the distribution of gender-stratified body mass index (BMI), eating attitudes and use of addictive substances, under the hypothesis of a confluent prevalence of weight abnormalities, eating disorders and substance abuse. b) Demonstrate the extent to which family, peer-related and psychosocial factors are common elements in categories of compulsive behaviour. Methodology/Principal Findings: In the present cross-sectional study, data were collected through self reported questionnaires administered to a large sample of 33,185 15-19 years old adolescents (ESPAD (R) Italia), divided into weight categories based on the BMI percentile distribution. Multinomial analyses were adopted to address the influence of social, family, leisure time factors, Eating Attitude Test (EAT26) on the association between weight categories and drug use. Recent drugs use was more frequent in overweight and underweight adolescents (p < 0.05), especially in females. An EAT26 score >= 20 was more common in overweight adolescents. Multinomial analysis abolished the relationship between overweight and the use of most drugs, implicating self-esteem, parents' educational level, and friendships as mediators of the association. Within the overweight category, adolescents reporting recent drug use, showed greater frequency of having drug-abusing friends (similar to 80%), and severe problems with parents and school (similar to 30%) compared to overweight adolescents without recent drug use. Conclusion: The frequent association of overweight and substance use and the presence of common underlying social factors, highlights the need for an interdisciplinary approach involving individual-focused treatment models as well as public health, social and environmental changes to reduce food-and substances-related problems.	[Denoth, Francesca; Siciliano, Valeria; Iozzo, Patricia; Fortunato, Loredana; Molinaro, Sabrina] Italian Natl Res Council CNR, Inst Clin Physiol, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Istituto di Neuroscienze (IN-CNR)	Denoth, F (corresponding author), Italian Natl Res Council CNR, Inst Clin Physiol, Pisa, Italy.	molinaro@ifc.cnr.it	Iozzo, P/O-2893-2015; Molinaro, Sabrina/F-5828-2012; Fortunato, Loredana/AAD-3472-2022; Molinaro, Sabrina/B-3710-2013	Iozzo, P/0000-0001-6443-7074; Molinaro, Sabrina/0000-0001-7221-0873; Molinaro, Sabrina/0000-0002-1140-0312	Ministero della Solidarieta Sociale	Ministero della Solidarieta Sociale	The data on which this paper is based are a part of the 2007 ESPAD (R) Italia data funded by "Ministero della Solidarieta Sociale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM SF, 1982, PSYCHOL MED, V12, P625, DOI 10.1017/S0033291700055732; Ahren-Moonga J, 2009, AM J EPIDEMIOL, V170, P566, DOI 10.1093/aje/kwp166; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Calero-Elvira A, 2009, EUR EAT DISORD REV, V17, P243, DOI 10.1002/erv.936; Carr KD, 2007, PHYSIOL BEHAV, V91, P459, DOI 10.1016/j.physbeh.2006.09.021; Casiero Deena, 2006, Cardiol Rev, V14, P227; Desai MN, 2008, J AM COLL HEALTH, V57, P109, DOI 10.3200/JACH.57.1.109-114; Dietz WH, 1998, PEDIATRICS, V101, P518; Domine F, 2009, J ADOLESCENT HEALTH, V44, P111, DOI 10.1016/j.jadohealth.2008.07.019; Dotti A, 1998, Eat Weight Disord, V3, P188; FISHER M, 1991, J ADOLESCENT HEALTH, V12, P377, DOI 10.1016/0197-0070(91)90051-M; FURNHAM A, 1983, PSYCHOL MED, V13, P829, DOI 10.1017/S0033291700051540; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; Haines J, 2006, HEALTH EDUC RES, V21, P770, DOI 10.1093/her/cyl094; Herrero M, 2010, EUR J PSYCHIAT, V24, P9, DOI 10.4321/s0213-61632010000100002; Hibell B., 2009, 2007 ESPAD REPORT SU, P1; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Janssen I, 2004, J ADOLESCENT HEALTH, V35, P360, DOI [10.1016/j.jadohealth.2003.11.095, 10.1016/S1054-139X(04)00058-8]; Jeffery RW, 1996, ADDICT BEHAV, V21, P217, DOI 10.1016/0306-4603(95)00050-X; JOHNSTON L, 2007, NIH PUBLICATION; JOHNSTON LD, 2006, NIH PUBLICATION; Keel PK, 2002, J PSYCHOSOM RES, V53, P1043, DOI 10.1016/S0022-3999(02)00491-9; Khlat M, 2009, SOC SCI MED, V68, P1692, DOI 10.1016/j.socscimed.2009.02.024; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Krahn D, 1992, J Subst Abuse, V4, P341, DOI 10.1016/0899-3289(92)90041-U; Krug I, 2009, PSYCHIAT CLIN NEUROS, V63, P82, DOI 10.1111/j.1440-1819.2008.01908.x; Liu YJ, 2010, J PSYCHOACTIVE DRUGS, V42, P133, DOI 10.1080/02791072.2010.10400686; Mitchell JE, 2006, CURR OPIN PSYCHIATR, V19, P438, DOI 10.1097/01.yco.0000228768.79097.3e; Mitchell James E., 1997, P415; Mulye TP, 2009, J ADOLESCENT HEALTH, V45, P8, DOI 10.1016/j.jadohealth.2009.03.013; Neumark-Sztainer D, 1998, AM J PUBLIC HEALTH, V88, P952, DOI 10.2105/AJPH.88.6.952; Pinto LSNM, 2006, BRAIN RES, V1078, P171, DOI 10.1016/j.brainres.2005.12.092; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Tomotake Masahito, 2002, Journal of Medical Investigation, V49, P87; Trent Maria E., 1999, Current Opinion in Pediatrics, V11, P297, DOI 10.1097/00008480-199908000-00005; Vamosi M, 2010, OBES REV, V11, P177, DOI 10.1111/j.1467-789X.2009.00645.x; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wolfe WL, 2000, CLIN PSYCHOL REV, V20, P617, DOI 10.1016/S0272-7358(99)00009-4	40	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27358	10.1371/journal.pone.0027358	http://dx.doi.org/10.1371/journal.pone.0027358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110632	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400038
J	Kokal, I; Engel, A; Kirschner, S; Keysers, C				Kokal, Idil; Engel, Annerose; Kirschner, Sebastian; Keysers, Christian			Synchronized Drumming Enhances Activity in the Caudate and Facilitates Prosocial Commitment - If the Rhythm Comes Easily	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; NEURAL SYSTEMS; REWARD; TRUST; BRAIN; RESPONSES; LESIONS; MUSIC	Why does chanting, drumming or dancing together make people feel united? Here we investigate the neural mechanisms underlying interpersonal synchrony and its subsequent effects on prosocial behavior among synchronized individuals. We hypothesized that areas of the brain associated with the processing of reward would be active when individuals experience synchrony during drumming, and that these reward signals would increase prosocial behavior toward this synchronous drum partner. 18 female non-musicians were scanned with functional magnetic resonance imaging while they drummed a rhythm, in alternating blocks, with two different experimenters: one drumming in-synchrony and the other out-of-synchrony relative to the participant. In the last scanning part, which served as the experimental manipulation for the following prosocial behavioral test, one of the experimenters drummed with one half of the participants in-synchrony and with the other out-of-synchrony. After scanning, this experimenter "accidentally" dropped eight pencils, and the number of pencils collected by the participants was used as a measure of prosocial commitment. Results revealed that participants who mastered the novel rhythm easily before scanning showed increased activity in the caudate during synchronous drumming. The same area also responded to monetary reward in a localizer task with the same participants. The activity in the caudate during experiencing synchronous drumming also predicted the number of pencils the participants later collected to help the synchronous experimenter of the manipulation run. In addition, participants collected more pencils to help the experimenter when she had drummed in-synchrony than out-of-synchrony during the manipulation run. By showing an overlap in activated areas during synchronized drumming and monetary reward, our findings suggest that interpersonal synchrony is related to the brain's reward system.	[Kokal, Idil; Engel, Annerose; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Kokal, Idil] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kokal, Idil] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Engel, Annerose] Max Planck Inst Human Cognit & Brain Sci, Mus Cognit & Act Grp, Leipzig, Germany; [Kirschner, Sebastian] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Engel, Annerose; Keysers, Christian] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Groningen; Radboud University Nijmegen; Max Planck Society; Max Planck Society; Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kokal, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	c.keysers@nin.knaw.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467	European commission; N.W.O. VIDI	European commission(European CommissionEuropean Commission Joint Research Centre); N.W.O. VIDI(Netherlands Organization for Scientific Research (NWO))	The study was supported by a Marie Curie Excellent Grant of the European commission, and a N.W.O. VIDI grant to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSHEL A, 1988, J MUSIC THER, V25, P145, DOI 10.1093/jmt/25.3.145; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Brown S, 2000, ORIGINS OF MUSIC, P3; Cohen EEA, 2010, BIOL LETTERS, V6, P106, DOI 10.1098/rsbl.2009.0670; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Huron D, 2001, ANN NY ACAD SCI, V930, P43, DOI 10.1111/j.1749-6632.2001.tb05724.x; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Macrae CN, 1998, SOC COGNITION, V16, P400, DOI 10.1521/soco.1998.16.4.400; McNeil W. H., 1995, KEEPING TOGETHER TIM; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Rao SM, 1997, J NEUROSCI, V17, P5528; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; ROEDERER JG, 1984, MUSIC PERCEPT, V1, P350; Saxe R, 2008, NEURON, V58, P164, DOI 10.1016/j.neuron.2008.04.005; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301	37	152	154	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27272	10.1371/journal.pone.0027272	http://dx.doi.org/10.1371/journal.pone.0027272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	855HV	22110623	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400031
J	Lau, HY; Alger, SE; Fishbein, W				Lau, Hiuyan; Alger, Sara E.; Fishbein, William			Relational Memory: A Daytime Nap Facilitates the Abstraction of General Concepts	PLOS ONE			English	Article							DECLARATIVE MEMORY; SLEEP; CONSOLIDATION; HIPPOCAMPUS; EXPERIENCE; WAKING; TIME	It is increasingly evident that sleep strengthens memory. However, it is not clear whether sleep promotes relational memory, resultant of the integration of disparate memory traces into memory networks linked by commonalities. The present study investigates the effect of a daytime nap, immediately after learning or after a delay, on a relational memory task that requires abstraction of general concept from separately learned items. Specifically, participants learned English meanings of Chinese characters with overlapping semantic components called radicals. They were later tested on new characters sharing the same radicals and on explicitly stating the general concepts represented by the radicals. Regardless of whether the nap occurred immediately after learning or after a delay, the nap participants performed better on both tasks. The results suggest that sleep - even as brief as a nap - facilitates the reorganization of discrete memory traces into flexible relational memory networks.	[Lau, Hiuyan; Alger, Sara E.; Fishbein, William] CUNY City Coll, Dept Psychol, New York, NY 10031 USA; [Lau, Hiuyan] NYU, Ctr Excellence Brain Aging, Langone Med Ctr, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); New York University; NYU Langone Medical Center	Lau, HY (corresponding author), CUNY City Coll, Dept Psychol, New York, NY 10031 USA.	hlau@gc.cuny.edu		Alger, Sara/0000-0002-5078-6510	Professional Staff Congress-City University of New York (PSC-CUNY) [614540039]	Professional Staff Congress-City University of New York (PSC-CUNY)	This study is supported by the Professional Staff Congress-City University of New York (PSC-CUNY) Research Award Program grant #614540039. The Professional Staff Congress-City University of New York (PSC-CUNY) grant program is an internal small grant program maintained by the Research Foundation of the City University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012131; Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Jackson D. N., 1998, MULTIDIMENSIONAL APT; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Pace-Schott EF, 2009, SLEEP, V32, P19; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; van der Helm E, 2010, SLEEP, V33, P335, DOI 10.1093/sleep/33.3.335; Vertes RP, 2005, SLEEP, V28, P1228, DOI 10.1093/sleep/28.10.1228; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	24	45	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27139	10.1371/journal.pone.0027139	http://dx.doi.org/10.1371/journal.pone.0027139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110606	Green Published, gold			2022-12-25	WOS:000297555400021
J	Tang, P; Ma, QH; Tang, ZN; Wang, KF; Jiang, J				Tang Peng; Ma Qinghua; Tang Zhenning; Wang Kaifa; Jiang Jun			Long-Term Sphere Culture Cannot Maintain a High Ratio of Cancer Stem Cells: A Mathematical Model and Experiment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; HETEROGENEITY	Acquiring abundant and high-purity cancer stem cells (CSCs) is an important prerequisite for CSC research. At present, researchers usually gain high-purity CSCs through flow cytometry sorting and expand them by short-term sphere culture. However, it is still uncertain whether we can amplify high-purity CSCs through long-term sphere culture. We have proposed a mathematical model using ordinary differential equations to derive the continuous variation of the CSC ratio in long-term sphere culture and estimated the model parameters based on a long-term sphere culture of MCF-7 stem cells. We found that the CSC ratio in long-term sphere culture presented as gradually decreased drift and might be stable at a lower level. Furthermore, we found that fitted model parameters could explain the main growth pattern of CSCs and differentiated cancer cells in long-term sphere culture.	[Tang Peng; Tang Zhenning; Jiang Jun] Third Mil Med Univ, Southwest Hosp, Breast Dis Ctr, Chongqing, Peoples R China; [Ma Qinghua] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China; [Wang Kaifa] Third Mil Med Univ, Dept Med Device & Equipment, Sch Biomed Engn & Med Imaging, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Tang, P (corresponding author), Third Mil Med Univ, Southwest Hosp, Breast Dis Ctr, Chongqing, Peoples R China.	kaifawang@yahoo.com.cn; jcbd@medmail.com.cn			National Natural Science Fund of People's Republic of China [30872517]	National Natural Science Fund of People's Republic of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Natural Science Fund of People's Republic of China (no. 30872517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Cammareri P, 2008, METHOD CELL BIOL, V86, P311, DOI 10.1016/S0091-679X(08)00014-9; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Lim YC, 2011, ORAL ONCOL, V47, P83, DOI 10.1016/j.oraloncology.2010.11.011; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marx J, 2003, SCIENCE, V301, P1308, DOI 10.1126/science.301.5638.1308; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; TANG SY, 2008, DYNAMIC BIOSYSTEMS S, P479; Wang KF, 2011, INTERVIROLOGY, V54, P349, DOI 10.1159/000321454; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; Xue Y.Q., 2007, NUMERICAL SIMULATION; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013	28	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e25518	10.1371/journal.pone.0025518	http://dx.doi.org/10.1371/journal.pone.0025518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110580	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400005
J	Tonelli, RR; Augusto, LD; Castilho, BA; Schenkman, S				Tonelli, Renata R.; Augusto, Leonardo da Silva; Castilho, Beatriz A.; Schenkman, Sergio			Protein Synthesis Attenuation by Phosphorylation of eIF2 alpha Is Required for the Differentiation of Trypanosoma cruzi into Infective Forms	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TRANSLATION INITIATION; GENE-EXPRESSION; MESSENGER-RNAS; IN-VITRO; KINASES; STRESS; GRANULES; REVEALS; PKR	Chagas' disease is a potentially life-threatening illness caused by the unicellular protozoan parasite Trypanosoma cruzi. It is transmitted to humans by triatomine bugs where T. cruzi multiplies and differentiates in the digestive tract. The differentiation of proliferative and non-infective epimastigotes into infective metacyclic trypomastigotes (metacyclogenesis) can be correlated to nutrient exhaustion in the gut of the insect vector. In vitro, metacyclic-trypomastigotes can be obtained when epimastigotes are submitted to nutritional stress suggesting that metacyclogenesis is triggered by nutrient starvation. The molecular mechanism underlying such event is not understood. Here, we investigated the role of one of the key signaling responses elicited by nutritional stress in all other eukaryotes, the inhibition of translation initiation by the phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2 alpha), during the in vitro differentiation of T. cruzi. Monospecific antibodies that recognize the phosphorylated Tc-eIF2 alpha form were generated and used to demonstrate that parasites subjected to nutritional stress show increased levels of Tc-eIF2 alpha phosphorylation. This was accompanied by a drastic inhibition of global translation initiation, as determined by polysomal profiles. A strain of T. cruzi overexpressing a mutant Tc-eIF2 alpha, incapable of being phosphorylated, showed a block on translation initiation, indicating that such a nutritional stress in trypanosomatids induces the conserved translation inhibition response. In addition, Tc-eIF2 alpha phosphorylation is critical for parasite differentiation since the overexpression of the mutant eIF2 alpha in epimastigotes abolished metacyclogenesis. This work defines the role of eIF2 alpha phosphorylation as a key step in T. cruzi differentiation.	[Tonelli, Renata R.; Augusto, Leonardo da Silva; Castilho, Beatriz A.; Schenkman, Sergio] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Tonelli, RR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	sschenkman@unifesp.br	Schenkman, Sergio/A-9227-2013; Castilho, Beatriz A/C-2503-2012; Tonelli, Renata R/H-1334-2012	Schenkman, Sergio/0000-0001-9353-8480; Castilho, Beatriz A/0000-0003-4509-5237; Tonelli, Renata R/0000-0002-1685-9042; da Silva Augusto, Leonardo/0000-0003-0430-8216	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to S.S. and B.A.C. and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), and Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LR, 2010, GENE, V452, P72, DOI 10.1016/j.gene.2009.12.009; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; da Cunha JPC, 2006, MOL BIOCHEM PARASIT, V150, P268, DOI 10.1016/j.molbiopara.2006.08.012; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; da Cunha JPC, 2005, MOL BIOCHEM PARASIT, V140, P75, DOI 10.1016/j.molbiopara.2004.12.007; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Dhaliwal S, 2003, J MOL BIOL, V334, P187, DOI 10.1016/j.jmb.2003.09.045; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; ISOLA ELD, 1986, EXP PARASITOL, V62, P329, DOI 10.1016/0014-4894(86)90039-1; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Mello CB, 1996, EXP PARASITOL, V82, P112, DOI 10.1006/expr.1996.0015; Mohrle JJ, 1997, BIOCHEM J, V328, P677; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Nonato MC, 2002, J BIOL CHEM, V277, P17057, DOI 10.1074/jbc.M111804200; Ramirez MI, 2000, MOL BIOCHEM PARASIT, V111, P235, DOI 10.1016/S0166-6851(00)00309-1; RANGELALDAO R, 1987, MOL BIOCHEM PARASIT, V22, P39, DOI 10.1016/0166-6851(87)90067-3; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Shi HF, 2009, J BIOL CHEM, V284, P36511, DOI 10.1074/jbc.M109.073072; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	33	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27904	10.1371/journal.pone.0027904	http://dx.doi.org/10.1371/journal.pone.0027904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114724	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400138
J	Zudaire, E; Gambardella, L; Kurcz, C; Vermeren, S				Zudaire, Enrique; Gambardella, Laure; Kurcz, Christopher; Vermeren, Sonja			A Computational Tool for Quantitative Analysis of Vascular Networks	PLOS ONE			English	Article							BLOOD-VESSELS; ANGIOGENESIS; PI3K; P110-ALPHA; INHIBITOR; ALLANTOIS; KINASES; MICE	Angiogenesis is the generation of mature vascular networks from pre-existing vessels. Angiogenesis is crucial during the organism' development, for wound healing and for the female reproductive cycle. Several murine experimental systems are well suited for studying developmental and pathological angiogenesis. They include the embryonic hindbrain, the postnatal retina and allantois explants. In these systems vascular networks are visualised by appropriate staining procedures followed by microscopical analysis. Nevertheless, quantitative assessment of angiogenesis is hampered by the lack of readily available, standardized metrics and software analysis tools. Non-automated protocols are being used widely and they are, in general, time - and labour intensive, prone to human error and do not permit computation of complex spatial metrics. We have developed a light-weight, user friendly software, AngioTool, which allows for quick, hands-off and reproducible quantification of vascular networks in microscopic images. AngioTool computes several morphological and spatial parameters including the area covered by a vascular network, the number of vessels, vessel length, vascular density and lacunarity. In addition, AngioTool calculates the so-called "branching index" ( branch points / unit area), providing a measurement of the sprouting activity of a specimen of interest. We have validated AngioTool using images of embryonic murine hindbrains, post-natal retinas and allantois explants. AngioTool is open source and can be downloaded free of charge.	[Zudaire, Enrique] NCI, Angiogenesis Core Facil, Radiat Oncol Branch, NIH, Gaithersburg, MD USA; [Gambardella, Laure; Vermeren, Sonja] Babraham Inst, Inositide Lab, Cambridge, England; [Kurcz, Christopher] Sci Applicat Int Corp Frederick Inc, Adv Biomed Comp Ctr, Informat Syst Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Science Applications International Corporation (SAIC)	Zudaire, E (corresponding author), NCI, Angiogenesis Core Facil, Radiat Oncol Branch, NIH, Gaithersburg, MD USA.	zudairee@mail.nih.gov; sonja.vermeren@babraham.ac.uk	Vermeren, Sonja/AAK-7442-2020	Vermeren, Sonja/0000-0002-8460-0884	Medical Research Council [G0700740]; Biotechnology and Biological Sciences Research Council [BB/C520712]; BBSRC [BB/C520712/1, BBS/E/B/0000M221] Funding Source: UKRI; MRC [G0700740] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520712/1, BBS/E/B/0000M221] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an grant from the Medical Research Council (G0700740; http://www.mrc.ac.uk). SV holds a Biotechnology and Biological Sciences Research Council David Phillips Fellowship (BB/C520712; http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Downs KM, 2001, DEV BIOL, V233, P347, DOI 10.1006/dbio.2001.0227; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gambardella L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001026; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Guidolin D, 2004, LEUKEMIA, V18, P1745, DOI 10.1038/sj.leu.2403526; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kanemura H, 2009, BIOCHEM BIOPH RES CO, V387, P754, DOI 10.1016/j.bbrc.2009.07.108; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kroll J, 2009, AM J PHYSIOL-HEART C, V296, pH893, DOI 10.1152/ajpheart.01038.2008; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Manniesing R, 2006, MED IMAGE ANAL, V10, P815, DOI 10.1016/j.media.2006.06.003; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105	30	489	491	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27385	10.1371/journal.pone.0027385	http://dx.doi.org/10.1371/journal.pone.0027385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110636	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400041
J	Bissett, A; Neu, TR; de Beer, D				Bissett, Andrew; Neu, Thomas R.; de Beer, Dirk			Dissolution of Calcite in the Twilight Zone: Bacterial Control of Dissolution of Sinking Planktonic Carbonates Is Unlikely	PLOS ONE			English	Article							DEGRADATION; MICROSENSOR; CO2	We investigated the ability of bacterial communities to colonize and dissolve two biogenic carbonates (Foraminifera and oyster shells). Bacterial carbonate dissolution in the upper water column is postulated to be driven by metabolic activity of bacteria directly colonising carbonate surfaces and the subsequent development of acidic microenvironments. We employed a combination of microsensor measurements, scanning electron microscopy (SEM), confocal laser scanning microscopy (CLSM) and image analysis and molecular documentation of colonising bacteria to monitor microbial processes and document changes in shell surface topography. Bacterial communities rapidly colonised shell surfaces, forming dense biofilms with extracellular polymeric substance (EPS) deposits. Despite this, we found no evidence of bacterially mediated carbonate dissolution. Dissolution was not indicated by Ca2+ microprofiles, nor was changes in shell surface structure related to the presence of colonizing bacteria. Given the short time (days) settling carbonate material is actually in the twilight zone (500-1000 m), it is highly unlikely that microbial metabolic activity on directly colonised shells plays a significant role in dissolving settling carbonates in the shallow ocean.	[Bissett, Andrew; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Neu, Thomas R.] UFZ Helmholtz Ctr Environm Res, Magdeburg, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Bissett, A (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	Andrew.bissett@csiro.au	Bissett, Andrew/AFR-3887-2022; de Beer, Dirk/L-4840-2013	Bissett, Andrew/0000-0001-7396-1484; de Beer, Dirk/0000-0001-5274-1781; Neu, Thomas/0000-0001-6990-8787	German Research Foundation [DFG-FOR 571]	German Research Foundation(German Research Foundation (DFG))	This project is part of the Research Unit "Geobiology of Organo- and Biofilms" funded by the German Research Foundation (DFG-FOR 571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMANN D, 1987, PFLUG ARCH EUR J PHY, V409, P223, DOI 10.1007/BF00583469; deBeer D, 1997, APPL ENVIRON MICROB, V63, P973, DOI 10.1128/AEM.63.3.973-977.1997; deBeer D, 1997, BIOTECHNOL BIOENG, V53, P151, DOI 10.1002/(SICI)1097-0290(19970120)53:2<151::AID-BIT4>3.0.CO;2-N; DEBEER D, 2000, MAR ECOL-PROG SER, V194, P175; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FREIWALD A, 1995, PALAIOS, V10, P337, DOI 10.2307/3515159; Friis K, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002727; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; GLOVER CP, 1993, J GEOL, V101, P729, DOI 10.1086/648271; Jansen H, 2001, MAR ECOL PROG SER, V221, P199, DOI 10.3354/meps221199; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; MARLIN A, 1999, AQUARIUM FRONTIE MAR; Milliman JD, 1999, DEEP-SEA RES PT I, V46, P1653, DOI 10.1016/S0967-0637(99)00034-5; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/s005310050090; Morse JW, 2002, EARTH-SCI REV, V58, P51, DOI 10.1016/S0012-8252(01)00083-6; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Ploug H, 1999, LIMNOL OCEANOGR, V44, P1949, DOI 10.4319/lo.1999.44.8.1949; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Schiebel R, 2007, DEEP-SEA RES PT II, V54, P676, DOI 10.1016/j.dsr2.2007.01.009; Schoon R, 2010, LIMNOL OCEANOGR, V55, P377, DOI 10.4319/lo.2010.55.1.0377; Staudt C, 2004, BIOTECHNOL BIOENG, V88, P585, DOI 10.1002/bit.20241; Staudt C., 2003, BIOFILMS MED IND ENV, P308; Troy PJ, 1997, AQUAT GEOCHEM, V3, P1, DOI 10.1023/A:1009652821575; TROY PJ, 1995, SURFACE CHEM SOLIDS; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	28	8	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e26404	10.1371/journal.pone.0026404	http://dx.doi.org/10.1371/journal.pone.0026404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102861	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300005
J	Jiang, XQ; Xu, Z; Li, JJ; Shi, YY; Wu, WW; Tao, SH				Jiang, Xiaoqian; Xu, Zhao; Li, Jingjing; Shi, Youyi; Wu, Wenwu; Tao, Shiheng			The Influence of Deleterious Mutations on Adaptation in Asexual Populations	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE SUBSTITUTIONS; BENEFICIAL MUTATIONS; CLONAL INTERFERENCE; NATURAL-SELECTION; MULLERS RATCHET; EVOLUTION; FITNESS; LINKAGE; SEX; CHROMOSOME	We study the dynamics of adaptation in asexual populations that undergo both beneficial and deleterious mutations. In particular, how the deleterious mutations affect the fixation of beneficial mutations was investigated. Using extensive Monte Carlo simulations, we find that in the "strong-selection weak mutation (SSWM)'' regime or in the "clonal interference (CI)'' regime, deleterious mutations rarely influence the distribution of "selection coefficients of the fixed mutations (SCFM)''; while in the "multiple mutations'' regime, the accumulation of deleterious mutations would lead to a decrease in fitness significantly. We conclude that the effects of deleterious mutations on adaptation depend largely on the supply of beneficial mutations. And interestingly, the lowest adaptation rate occurs for a moderate value of selection coefficient of deleterious mutations.	[Jiang, Xiaoqian; Wu, Wenwu; Tao, Shiheng] NW A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [Xu, Zhao; Shi, Youyi] NW A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China; [Li, Jingjing] Shanghai Jiao Tong Univ, Sch Pharmacol, Shanghai 200030, Peoples R China; [Tao, Shiheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Shanghai Jiao Tong University; Northwest A&F University - China	Tao, SH (corresponding author), NW A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn	Wu, Wenwu/AAP-1966-2021; Wu, Wenwu/HDO-7873-2022	Wu, Wenwu/0000-0003-2996-8675; Wu, Wenwu/0000-0003-2996-8675	PhD Programs Foundation of the Ministry of Education of China [20100204110026]	PhD Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	The authors gratefully acknowledge the PhD Programs Foundation of the Ministry of Education of China (20100204110026) in SHT's Lab. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtrog D, 2004, EVOLUTION, V58, P1403; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Barrett RDH, 2006, GENETICS, V174, P2071, DOI 10.1534/genetics.106.062406; Barton NH, 2010, PHILOS T R SOC B, V365, P2559, DOI 10.1098/rstb.2010.0106; Barton NH, 2010, PHILOS T R SOC B, V365, P1281, DOI 10.1098/rstb.2009.0320; BARTON NH, 1995, GENETICS, V140, P821; Campos PRA, 2004, EVOLUTION, V58, P932; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH B, 2009, GENETIC RECOMBINATIO, P177; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Fisher R.A., 1930, GENETICAL THEORY NAT; FISHER RA, 1922, B MATH BIOL, V52, P297; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Gerrish P, 2001, NATURE, V413, P299, DOI 10.1038/35095046; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Hadany L, 2005, J EVOLUTION BIOL, V18, P309, DOI 10.1111/j.1420-9101.2004.00858.x; HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8; HALDANE J, 1927, B MATH BIOL, V52, P209; HARTFIELD M, 2011, EVOLUTION IN PRESS; Jiang XQ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-298; Johnson T, 2002, GENETICS, V162, P395; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; KIMURA M, 1962, GENETICS, V47, P713; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Orr HA, 2000, GENETICS, V155, P961; Orr HA, 2003, GENETICS, V163, P1519; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; PECK JR, 1994, GENETICS, V137, P597; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; RICE WR, 1987, GENETICS, V116, P161; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Wilke CO, 2004, GENETICS, V167, P2045, DOI 10.1534/genetics.104.027136; Zeyl C, 2001, GENETICS, V157, P53	41	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27757	10.1371/journal.pone.0027757	http://dx.doi.org/10.1371/journal.pone.0027757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110756	Green Submitted, gold, Green Published			2022-12-25	WOS:000297554300052
J	Mashalidis, EH; Mukherjee, T; Sledz, P; Matak-Vinkovic, D; Boshoff, H; Abell, C; Barry, CE				Mashalidis, Ellene H.; Mukherjee, Tathagata; Sledz, Pawel; Matak-Vinkovic, Dijana; Boshoff, Helena; Abell, Chris; Barry, Clifton E., III			Rv2607 from Mycobacterium tuberculosis Is a Pyridoxine 5 '-Phosphate Oxidase with Unusual Substrate Specificity	PLOS ONE			English	Article							BRAIN PYRIDOXINE-5-PHOSPHATE OXIDASE; VITAMIN-B6 BIOSYNTHESIS; GENOME SEQUENCE; RABBIT LIVER; PURIFICATION; 5-PHOSPHATE; METABOLISM; INSIGHTS; FMN	Despite intensive effort, the majority of the annotated Mycobacterium tuberculosis genome consists of genes encoding proteins of unknown or poorly understood function. For example, there are seven conserved hypothetical proteins annotated as homologs of pyridoxine 5'-phosphate oxidase (PNPOx), an enzyme that oxidizes pyridoxine 59-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) to form pyridoxal 5'-phosphate (PLP). We have characterized the function of Rv2607 from Mycobacterium tuberculosis H37Rv and shown that it encodes a PNPOx that oxidizes PNP to PLP. The k(cat) and K(M) for this reaction were 0.01 s(-1) and 360 mu M, respectively. Unlike many PNPOx enzymes, Rv2607 does not recognize PMP as a substrate.	[Mashalidis, Ellene H.; Mukherjee, Tathagata; Boshoff, Helena; Barry, Clifton E., III] NIAID, NIH, Bethesda, MD 20892 USA; [Mashalidis, Ellene H.; Sledz, Pawel; Matak-Vinkovic, Dijana; Abell, Chris] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge	Mashalidis, EH (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ca26@cam.ac.uk; clifton_barry@nih.gov	Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Sledz, Pawel/0000-0002-4440-3253	National Institute of Allergy and Infectious Disease, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARGOUDELIS CJ, 1986, J AGR FOOD CHEM, V34, P995, DOI 10.1021/jf00072a016; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; CHOI JD, 1983, J BIOL CHEM, V258, P840; CHOI SY, 1987, J BIOL CHEM, V262, P12013; CHURCHICH JE, 1984, EUR J BIOCHEM, V138, P327, DOI 10.1111/j.1432-1033.1984.tb07918.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Di Salvo M, 1998, PROTEIN EXPRES PURIF, V13, P349, DOI 10.1006/prep.1998.0904; di Salvo ML, 2003, BBA-PROTEINS PROTEOM, V1647, P76, DOI 10.1016/S1570-9639(03)00060-8; Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KAZARINOFF MN, 1975, J BIOL CHEM, V250, P3436; KWOK F, 1980, J BIOL CHEM, V255, P882; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; WADA H, 1961, J BIOL CHEM, V236, P2089; ZHAO GS, 1995, J BACTERIOL, V177, P883, DOI 10.1128/jb.177.4.883-891.1995	26	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27643	10.1371/journal.pone.0027643	http://dx.doi.org/10.1371/journal.pone.0027643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110704	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300043
J	Matsumoto, Y; Tsunekawa, Y; Nomura, T; Suto, F; Matsumata, M; Tsuchiya, S; Osumi, N				Matsumoto, Yoko; Tsunekawa, Yuji; Nomura, Tadashi; Suto, Fumikazu; Matsumata, Miho; Tsuchiya, Shigeru; Osumi, Noriko			Differential Proliferation Rhythm of Neural Progenitor and Oligodendrocyte Precursor Cells in the Young Adult Hippocampus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PDGF ALPHA-RECEPTOR; GLIAL-CELLS; CIRCADIAN VARIATION; TUMOR SUPPRESSION; CEREBRAL-CORTEX; CYCLE PROTEINS; DENTATE GYRUS; WHITE-MATTER; RAT CNS	Oligodendrocyte precursor cells (OPCs) are a unique type of glial cells that function as oligodendrocyte progenitors while constantly proliferating in the normal condition from rodents to humans. However, the functional roles they play in the adult brain are largely unknown. In this study, we focus on the manner of OPC proliferation in the hippocampus of the young adult mice. Here we report that there are oscillatory dynamics in OPC proliferation that differ from neurogenesis in the subgranular zone (SGZ); the former showed S-phase and M-phase peaks in the resting and active periods, respectively, while the latter only exhibited M-phase peak in the active period. There is coincidence between different modes of proliferation and expression of cyclin proteins that are crucial for cell cycle; cyclin D1 is expressed in OPCs, while cyclin D2 is observed in neural stem cells. Similar to neurogenesis, the proliferation of hippocampal OPCs was enhanced by voluntary exercise that leads to an increase in neuronal activity in the hippocampus. These data suggest an intriguing control of OPC proliferation in the hippocampus.	[Matsumoto, Yoko; Tsunekawa, Yuji; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Dev Neurosci, Sendai, Miyagi 980, Japan; [Matsumoto, Yoko; Tsuchiya, Shigeru] Tohoku Univ Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Nomura, Tadashi] Kyoto Prefectural Univ Med, Dept Biol, Kyoto, Japan; [Suto, Fumikazu] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan; [Matsumata, Miho] RIKEN, Brain Sci Inst, Dept Dev Gene Regulat, Wako, Saitama, Japan	Tohoku University; Tohoku University; Kyoto Prefectural University of Medicine; National Center for Neurology & Psychiatry - Japan; RIKEN	Matsumoto, Y (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Dev Neurosci, Sendai, Miyagi 980, Japan.	osumi@med.tohoku.ac.jp	Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20650046]; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST); Miyagi Prefectural Medical Women's Association; Grants-in-Aid for Scientific Research [23650186] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Miyagi Prefectural Medical Women's Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 20650046), Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST), the Global Century Center Of Excellence (COE) Program from MEXT, a Grant-in-Aid for Scientific Research from the Miyagi Prefectural Medical Women's Association, and the Scientific Research Program for Enhancing Systemic Education in Graduate Schools from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; Chen-Goodspeed M, 2007, J BIOL RHYTHM, V22, P291, DOI 10.1177/0748730407303387; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Daumas S, 2009, LEARN MEMORY, V16, P504, DOI 10.1101/lm.1418309; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Frederick TJ, 2004, MOL CELL NEUROSCI, V25, P480, DOI 10.1016/j.mcn.2003.11.015; GAARSKJAER FB, 1986, BRAIN RES REV, V11, P335, DOI 10.1016/0165-0173(86)90004-4; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Ge WP, 2009, P NATL ACAD SCI USA, V106, P328, DOI 10.1073/pnas.0811353106; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Guzman-Marin R, 2007, NEUROSCI LETT, V422, P198, DOI 10.1016/j.neulet.2007.06.022; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mori T, 2009, ACTA HISTOCHEM CYTOC, V42, P1, DOI 10.1267/ahc.08037; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Tamai SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003835; Timsit S, 1999, EUR J NEUROSCI, V11, P263, DOI 10.1046/j.1460-9568.1999.00434.x; Van der Borght K, 2009, HIPPOCAMPUS, V19, P928, DOI 10.1002/hipo.20545; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Witmer AN, 2004, J HISTOCHEM CYTOCHEM, V52, P39, DOI 10.1177/002215540405200105; Yu C, 2000, J NEUROIMMUNOL, V108, P2, DOI 10.1016/S0165-5728(99)00278-7; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zhang SC, 2001, NAT REV NEUROSCI, V2, P840, DOI 10.1038/35097593	50	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27628	10.1371/journal.pone.0027628	http://dx.doi.org/10.1371/journal.pone.0027628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110700	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300040
J	Lallous, N; Legrand, P; McEwen, AG; Ramon-Maiques, S; Samama, JP; Birck, C				Lallous, Nada; Legrand, Pierre; McEwen, Alastair G.; Ramon-Maiques, Santiago; Samama, Jean-Pierre; Birck, Catherine			The PHD Finger of Human UHRF1 Reveals a New Subgroup of Unmethylated Histone H3 Tail Readers	PLOS ONE			English	Article							HEMI-METHYLATED DNA; SRA DOMAIN; STRUCTURAL BASIS; MOLECULAR-BASIS; RECOGNITION; ICBP90; GENE; HETEROCHROMATIN; H3K4ME3; NP95	The human UHRF1 protein (ubiquitin-like containing PHD and RING finger domains 1) has emerged as a potential cancer target due to its implication in cell cycle regulation, maintenance of DNA methylation after replication and heterochromatin formation. UHRF1 functions as an adaptor protein that binds to histones and recruits histone modifying enzymes, like HDAC1 or G9a, which exert their action on chromatin. In this work, we show the binding specificity of the PHD finger of human UHRF1 (huUHRF1-PHD) towards unmodified histone H3 N-terminal tail using native gel electrophoresis and isothermal titration calorimetry. We report the molecular basis of this interaction by determining the crystal structure of huUHRF1-PHD in complex with the histone H3 N-terminal tail. The structure reveals a new mode of histone recognition involving an extra conserved zinc finger preceding the conventional PHD finger region. This additional zinc finger forms part of a large surface cavity that accommodates the side chain of the histone H3 lysine K4 (H3K4) regardless of its methylation state. Mutation of Q330, which specifically interacts with H3K4, to alanine has no effect on the binding, suggesting a loose interaction between huUHRF1-PHD and H3K4. On the other hand, the recognition appears to rely on histone H3R2, which fits snugly into a groove on the protein and makes tight interactions with the conserved aspartates D334 and D337. Indeed, a mutation of the former aspartate disrupts the formation of the complex, while mutating the latter decreases the binding affinity nine-fold.	[Lallous, Nada; McEwen, Alastair G.; Birck, Catherine] Univ Strasbourg, IGBMC, INSERM, U964,CNRS,UMR 7104, Illkirch Graffenstaden, France; [Legrand, Pierre; Samama, Jean-Pierre] Synchrotron SOLEIL, St Aubin, France; [Ramon-Maiques, Santiago] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; SOLEIL Synchrotron; Centro Nacional de Investigaciones Oncologicas (CNIO)	Lallous, N (corresponding author), Univ Strasbourg, IGBMC, INSERM, U964,CNRS,UMR 7104, Illkirch Graffenstaden, France.	nlallous@cnio.es; birck@igbmc.fr	Lallous, Nada/AAP-3827-2021; Ramon-Maiques, Santiago/R-2533-2019; LEGRAND, Pierre/G-7709-2011	Lallous, Nada/0000-0002-8665-8641; LEGRAND, Pierre/0000-0003-2431-2255; McEwen, Alastair G./0000-0003-4484-3512; Ramon-Maiques, Santiago/0000-0001-9674-8088	Centre national de la recherche scientifique; Institut national de la sante et de la recherche medicale; Universite Louis Pasterur (Universite de Strasbourg); European Commission [031220]; French Ministry of Research and synchrotron SOLEIL	Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Louis Pasterur (Universite de Strasbourg); European Commission(European CommissionEuropean Commission Joint Research Centre); French Ministry of Research and synchrotron SOLEIL	This work received financial support from Centre national de la recherche scientifique, Institut national de la sante et de la recherche medicale, Universite Louis Pasterur (Universite de Strasbourg), the European Commission as SPINE2-complexes (contract no. 031220), the French Ministry of Research and synchrotron SOLEIL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; LALLOUS N, 2011, ENCY LIFE SCI ELS, DOI DOI 10.1002/9780470015902.A0023176; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Papait R, 2007, MOL BIOL CELL, V18; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016	39	31	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27599	10.1371/journal.pone.0027599	http://dx.doi.org/10.1371/journal.pone.0027599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096602	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900061
J	Milkereit, R; Rotin, D				Milkereit, Ruth; Rotin, Daniela			A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins	PLOS ONE			English	Article							AMINO-ACID PERMEASE; HEPATOCELLULAR-CARCINOMA; MULTIDRUG-RESISTANCE; TETRATRANSMEMBRANE PROTEIN; INTRACELLULAR TRAFFICKING; SACCHAROMYCES-CEREVISIAE; LYSOSOMES; EXPRESSION; GENE; CANCER	Background: The Lysosome associated protein transmembrane (LAPTM) family is comprised of three members: LAPTM5, LAPTM4a and LAPTM4b, with the latter previously shown to be overexpressed in numerous cancers. While we had demonstrated earlier the requirement of the E3 ubiquitin ligase Nedd4 for LAPTM5 sorting to lysosomes, the regulation of sorting of LAPTM4 proteins is less clear. Methodology/Principal Findings: Here we show that LAPTM4a and LAPTM4b are localized to the lysosome, but unique to LAPTM4b, a fraction of it is present at the plasma membrane and its overexpression induces the formation of actin-based membrane protrusions. We demonstrate that LAPTM4s, like LAPTM5, are able to co-immunoprecipitate with the E3 ubiquitin ligase Nedd4, an interaction that is dependent on LAPTM4 PY motifs and plays a role in membrane sorting. Accordingly, in Nedd4 knockout mouse embryonic fibroblasts (MEFs), LAPTM4a and LAPTM4b show reduced lysosomal localization. Moreover, lack of PY motifs leads to enhanced missorting of LAPTM4b to the plasma membrane instead of the lysosome. Conclusions/Significance: These results suggest that while some requisites of LAPTM5 lysosomal sorting are conserved among LAPTM4 proteins, LAPTM4a and LAPTM4b have also developed distinct sorting requirements.	[Milkereit, Ruth; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Cell Biol Program, Dept Biochem, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Milkereit, R (corresponding author), Univ Toronto, Hosp Sick Children, Cell Biol Program, Dept Biochem, Toronto, ON M5G 1X8, Canada.	drotin@sickkids.ca			Canadian Institute of Health Research (CIHR) [MOP-13494]; Ontario Graduate Scholarship	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the Canadian Institute of Health Research (CIHR, MOP-13494, http://www.cihr-irsc.gc.ca/e/193.html, to DR). RM is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship and Ontario Graduate Scholarship. DR holds a Canada Research Chair (Tier I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Boman AL, 2001, J CELL SCI, V114, P3413; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cabrita MA, 1999, CANCER RES, V59, P4890; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Hayami Y, 2003, LEUKEMIA, V17, P1650, DOI 10.1038/sj.leu.2403026; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hogue DL, 1996, J BIOL CHEM, V271, P9801, DOI 10.1074/jbc.271.16.9801; Hogue DL, 2002, BIOCHEM J, V365, P721, DOI 10.1042/BJ20020205; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu JJ, 2000, CHINESE MED J-PEKING, V113, P881; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Meng FL, 2010, INT J GYNECOL PATHOL, V29, P587, DOI 10.1097/PGP.0b013e3181e0898e; Morris DG, 2005, EUR J ENDOCRINOL, V153, P143, DOI 10.1530/eje.1.01937; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Passey S, 2004, BIOCHEM SOC T, V32, P1115, DOI 10.1042/BST0321115; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Porcelli L, 2009, CURR TOP MED CHEM, V9, P197, DOI 10.2174/156802609787521562; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Steenhuis P, 2010, TRAFFIC, V11, P987, DOI 10.1111/j.1600-0854.2010.01073.x; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; YANG H, 2010, CANC LETT; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; YIN M, 2010, INT J CANC; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	50	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27478	10.1371/journal.pone.0027478	http://dx.doi.org/10.1371/journal.pone.0027478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096579	gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900049
J	Wunderli, W; Meerbach, A; Guengoer, T; Berger, C; Greiner, O; Caduff, R; Trkola, A; Bossart, W; Gerlach, D; Schibler, M; Cordey, S; Mckee, TA; Van Belle, S; Kaiser, L; Tapparel, C				Wunderli, Werner; Meerbach, Astrid; Guengoer, Tayfun; Berger, Christoph; Greiner, Oliver; Caduff, Rosmarie; Trkola, Alexandra; Bossart, Walter; Gerlach, Daniel; Schibler, Manuel; Cordey, Samuel; McKee, Thomas Alexander; Van Belle, Sandra; Kaiser, Laurent; Tapparel, Caroline			Astrovirus Infection in Hospitalized Infants with Severe Combined Immunodeficiency after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; RT-PCR; RECIPIENTS; NOROVIRUS; DNA; GASTROENTERITIS; RHINOVIRUSES; SEQUENCE; DIARRHEA; DISEASE	Infants with severe primary combined immunodeficiency (SCID) and children post-allogeneic hematopoietic stem cell transplantation (HSCT) are extremely susceptible to unusual infections. The lack of generic tools to detect disease-causing viruses among more than 200 potential human viral pathogens represents a major challenge to clinicians and virologists. We investigated retrospectively the causes of a fatal disseminated viral infection with meningoencephalitis in an infant with gamma C-SCID and of chronic gastroenteritis in 2 other infants admitted for HSCT during the same time period. Analysis was undertaken by combining cell culture, electron microscopy and sequence-independent single primer amplification (SISPA) techniques. Caco-2 cells inoculated with fecal samples developed a cytopathic effect and non-enveloped viral particles in infected cells were detected by electron microscopy. SISPA led to the identification of astrovirus as the pathogen. Both sequencing of the capsid gene and the pattern of infection suggested nosocomial transmission from a chronically excreting index case to 2 other patients leading to fatal infection in 1 and to transient disease in the others. Virus-specific, real-time reverse transcription polymerase chain reaction was then performed on different stored samples to assess the extent of infection. Infection was associated with viremia in 2 cases and contributed to death in 1. At autopsy, viral RNA was detected in the brain and different other organs, while immunochemistry confirmed infection of gastrointestinal tissues. This report illustrates the usefulness of the combined use of classical virology procedures and modern molecular tools for the diagnosis of unexpected infections. It illustrates that astrovirus has the potential to cause severe disseminated lethal infection in highly immunocompromised pediatric patients.	[Wunderli, Werner; Meerbach, Astrid; Trkola, Alexandra; Bossart, Walter] Univ Zurich, Div Clin Virol, Zurich, Switzerland; [Wunderli, Werner; Schibler, Manuel; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent; Tapparel, Caroline] Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Wunderli, Werner; Schibler, Manuel; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent; Tapparel, Caroline] Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Guengoer, Tayfun; Berger, Christoph; Greiner, Oliver] Univ Childrens Hosp, Div Immunol & Bone Marrow Transplantat, Zurich, Switzerland; [Caduff, Rosmarie] Univ Zurich Hosp, Div Pathol, CH-8091 Zurich, Switzerland; [Gerlach, Daniel] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Gerlach, Daniel] Univ Geneva, Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Cordey, Samuel] Univ Hosp Geneva, Swiss Natl Reference Ctr Emerging Viruses CRIVE, Geneva, Switzerland; [McKee, Thomas Alexander] Univ Hosp Geneva, Div Pathol, Geneva, Switzerland	University of Zurich; University of Geneva; University of Geneva; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Geneva	Wunderli, W (corresponding author), Univ Zurich, Div Clin Virol, Zurich, Switzerland.	wunderli.werner@virology.uzh.ch; caroline.tapparel@hcuge.ch	Cordey, Samuel/C-9240-2018; Trkola, Alexandra/K-2115-2012; Güngör, Tayfun/ABF-4256-2020	Cordey, Samuel/0000-0002-2684-5680; Trkola, Alexandra/0000-0003-1013-876X; Güngör, Tayfun/0000-0002-3261-1186; McKee, Thomas/0000-0002-2147-3136; Tapparel Vu, Caroline/0000-0002-0411-6567; Gerlach, Daniel/0000-0001-9338-3765; Kaiser, Laurent/0000-0002-0857-2252	SNF [FNS 310030-127159]; Laurent Kaiser [32003B_127160]	SNF; Laurent Kaiser	The study was supported by SNF funding awarded to Caroline Tapparel (FNS 310030-127159) and Laurent Kaiser (32003B_127160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Bagci S, 2008, PEDIATR INFECT DIS J, V27, P347, DOI 10.1097/INF.0b013e318162a17a; Berger C, 2001, J MED VIROL, V64, P505, DOI 10.1002/jmv.1078; Cubitt WD, 1999, J MED VIROL, V57, P313, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;313::AID-JMV16&gt;3.0.CO;2-A; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; de Mezerville MH, 2006, PEDIATR INFECT DIS J, V25, P815, DOI 10.1097/01.inf.0000233542.48267.fd; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Glass RI, 1996, ARCH VIROL, P287; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hohne M, 2004, J MED VIROL, V72, P312, DOI 10.1002/jmv.10573; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; Kronenberg A, 2002, CLIN INFECT DIS, V35, P330, DOI 10.1086/341492; Liakopoulou E, 2005, BONE MARROW TRANSPL, V36, P691, DOI 10.1038/sj.bmt.1705127; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; Pevenstein SR, 1999, J VIROL, V73, P10514, DOI 10.1128/JVI.73.12.10514-10518.1999; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Schorn R, 2010, CLIN INFECT DIS, V51, P307, DOI 10.1086/653939; Sebire NJ, 2004, J CLIN PATHOL, V57, P1001, DOI 10.1136/jcp.2004.017178; Soccal PM, 2010, CLIN INFECT DIS, V51, P163, DOI 10.1086/653529; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Walter JE, 2003, CURR OPIN INFECT DIS, V16, P247, DOI 10.1097/00001432-200306000-00011; Yun ZB, 2000, TRANSPLANTATION, V69, P1733	31	81	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27483	10.1371/journal.pone.0027483	http://dx.doi.org/10.1371/journal.pone.0027483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096580	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000297553900050
J	Estay, SA; Albornoz, AA; Lima, M; Boyce, MS; Stenseth, NC				Estay, Sergio A.; Albornoz, Abraham A.; Lima, Mauricio; Boyce, Mark S.; Stenseth, Nils C.			A Simultaneous Test of Synchrony Causal Factors in Muskrat and Mink Fur Returns at Different Scales across Canada	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; POPULATION-DYNAMICS; SPATIAL SYNCHRONY; PATTERNS; FLUCTUATIONS; MODELS; IMPACT	Background: Synchrony among populations has been attributed to three major hypotheses: dispersal, the Moran effect, and trophic-level interactions. Unfortunately, simultaneous testing of these hypotheses demands complete and detailed data, which are scarce for ecological systems. Methodology/Principal Findings: Hudson's Bay Company data on mink and muskrat fur returns in Canada represent an excellent opportunity to test these hypotheses because of the detailed spatial and temporal data from this predator-prey system. Using structural equation modelling, support for each hypothesis was evaluated at two spatial scales: across Canada and dividing the country into three regions longitudinally. Our results showed that at both scales mink synchrony is a major factor determining muskrat synchrony, supporting the hypothesis of trophic-level interactions, but the influence of winter precipitation synchrony is also important in eastern Canada. Moreover, mink synchrony is influenced principally by winter precipitation synchrony at the level of all Canada (Moran effect), but by distance at regional level, which might suggest some influence of dispersal at this level. Discussion/Significance: Our result is one of the few reports of synchrony mediated by trophic-level interactions, highlighting the importance of evaluation of scale effects in population synchrony studies.	[Estay, Sergio A.] Univ Austral Chile, Inst Ecol & Evoluc, Fac Ciencias, Valdivia, Chile; [Estay, Sergio A.; Albornoz, Abraham A.; Lima, Mauricio] Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [Stenseth, Nils C.] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biol, Oslo, Norway; [Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Universidad Austral de Chile; Pontificia Universidad Catolica de Chile; University of Oslo; University of Alberta	Estay, SA (corresponding author), Univ Austral Chile, Inst Ecol & Evoluc, Fac Ciencias, Valdivia, Chile.	sergio.estay@gmail.com	Lima, Mauricio/F-2722-2013; Stenseth, Nils Chr./G-5212-2016; Boyce, Mark S/A-2620-2014	Lima, Mauricio/0000-0002-3700-2945; Stenseth, Nils Chr./0000-0002-1591-5399; Boyce, Mark S/0000-0001-5811-325X; Estay, Sergio/0000-0002-3797-8964	CONICYT; FONDAP-FONDECYT [1501-0001]; Natural Sciences and Engineering Research Council of Canada	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDAP-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	S.E. and A.A.A. acknowledge the financial support of the CONICYT Doctoral scholarship. S.E., A.A.A. and M. L. acknowledge financial support from FONDAP-FONDECYT grant 1501-0001 (Program 2). M. S. B. is supported by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CAUSE CORRELATION BI; Benton TG, 2001, ECOL LETT, V4, P236, DOI 10.1046/j.1461-0248.2001.00225.x; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; BROWNE MW, 1992, MULTIVAR BEHAV RES, V27, P269, DOI 10.1207/s15327906mbr2702_13; BUTLER L., 1953, CANADIAN JOUR ZOOL, V31, P242, DOI 10.1139/z53-021; Cazelles B, 2001, AM NAT, V157, P670, DOI 10.1086/320624; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Elton CS, 1924, BR J EXP BIOL, V2, P119; Erb J, 2001, OIKOS, V93, P365, DOI 10.1034/j.1600-0706.2001.930302.x; Erb J, 2000, CAN J ZOOL, V78, P1009, DOI 10.1139/cjz-78-6-1009; Errington PL, 1939, ECOLOGY, V20, P168, DOI 10.2307/1930738; Fox J., 2008, SEM STRUCTURAL EQUAT; Greenman JV, 2005, THEOR POPUL BIOL, V68, P217, DOI 10.1016/j.tpb.2005.06.007; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Haydon DT, 2001, P NATL ACAD SCI USA, V98, P13149, DOI 10.1073/pnas.221275198; Holmengen N, 2009, OIKOS, V118, P440, DOI 10.1111/j.1600-0706.2008.16613.x; Hugueny B, 2006, OIKOS, V115, P3, DOI 10.1111/j.2006.0030-1299.14686.x; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Kline RB., 2004, PRINCIPLES PRACTICE, V2nd; Koenig WD, 2002, ECOGRAPHY, V25, P283, DOI 10.1034/j.1600-0587.2002.250304.x; Korpimaki E, 2005, P ROY SOC B-BIOL SCI, V272, P193, DOI 10.1098/rspb.2004.2860; KORPIMAKI E, 1991, OECOLOGIA, V88, P552, DOI 10.1007/BF00317719; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Paradis E, 1999, ECOL LETT, V2, P114, DOI 10.1046/j.1461-0248.1999.22060.x; R. T. eam, 2008, R LANG ENV STAT COMP; Ranta E, 1999, P ROY SOC B-BIOL SCI, V266, P1851, DOI 10.1098/rspb.1999.0856; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; Ranta Esa, 2006, P1; Royama T, 2005, ECOL MONOGR, V75, P277, DOI 10.1890/04-0770; Royama T., 1992, ANAL POPULATION ECOL; Shier CJ, 2009, J MAMMAL, V90, P897, DOI 10.1644/07-MAMM-A-410.1; Swanson BJ, 1999, OIKOS, V86, P265, DOI 10.2307/3546444; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Viljugrein H, 2001, J ANIM ECOL, V70, P671, DOI 10.1046/j.1365-2656.2001.00526.x; Yao QW, 2000, P ROY SOC B-BIOL SCI, V267, P2459, DOI 10.1098/rspb.2000.1306	40	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27766	10.1371/journal.pone.0027766	http://dx.doi.org/10.1371/journal.pone.0027766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102919	Green Submitted, Green Published, gold			2022-12-25	WOS:000297348800041
J	Ho, DK; Tissari, J; Jarvinen, HM; Blom, AM; Meri, S; Jarva, H				Ho, Derek K.; Tissari, Jorma; Jarvinen, Hanna M.; Blom, Anna M.; Meri, Seppo; Jarva, Hanna			Functional Recruitment of Human Complement Inhibitor C4b-Binding Protein to Outer Membrane Protein Rck of Salmonella	PLOS ONE			English	Article							TYPHIMURIUM VIRULENCE PLASMID; COB-BINDING PROTEIN; SERUM RESISTANCE; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; GENE RCK; C4BP; MECHANISM; ENTERICA; IDENTIFICATION	Resistance to complement mediated killing, or serum resistance, is a common trait of pathogenic bacteria. Rck is a 17 kDa outer membrane protein encoded on the virulence plasmid of Salmonella enterica serovars Typhimurium and Enteritidis. When expressed in either E. coli or S. enterica Typhimurium, Rck confers LPS-independent serum resistance as well as the ability to bind to and invade mammalian cells. Having recently shown that Rck binds the inhibitor of the alternative pathway of complement, factor H (fH), we hypothesized that Rck can also bind the inhibitor of the classical and lectin pathways, C4b-binding protein (C4BP). Using flow cytometry and direct binding assays, we demonstrate that E. coli expressing Rck binds C4BP from heat-inactivated serum and by using the purified protein. No binding was detected in the absence of Rck expression. C4BP bound to Rck is functional, as we observed factor I-mediated cleavage of C4b in cofactor assays. In competition assays, binding of radiolabeled C4BP to Rck was reduced by increasing concentrations of unlabeled protein. No effect was observed by increasing heparin or salt concentrations, suggesting mainly non-ionic interactions. Reduced binding of C4BP mutants lacking complement control protein domains (CCPs) 7 or 8 was observed compared to wt C4BP, suggesting that these CCPs are involved in Rck binding. While these findings are restricted to Rck expression in E. coli, these data suggest that C4BP binding may be an additional mechanism of Rck-mediated complement resistance.	[Ho, Derek K.; Tissari, Jorma; Jarvinen, Hanna M.; Meri, Seppo; Jarva, Hanna] Univ Helsinki, Infect Biol Program, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Blom, Anna M.] Lund Univ, Div Med Prot Chem, Dept Lab Med, Malmo, Sweden; [Meri, Seppo; Jarva, Hanna] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland	University of Helsinki; Lund University; University of Helsinki; Helsinki University Central Hospital	Ho, DK (corresponding author), Univ Helsinki, Infect Biol Program, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland.	hanna.jarva@helsinki.fi	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Jarva, Hanna/0000-0002-9154-354X; Meri, Seppo/0000-0001-9142-501X	Academy of Finland; Sigrid Juselius Foundation; Helsinki University Central Hospital; U.S. Student Fulbright Grant	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital; U.S. Student Fulbright Grant	This work was supported by the Academy of Finland (http://www.aka.fi/en-GB/A/), Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), Helsinki University Central Hospital Funds (http://www.hus.fi/default.asp?path=59), and the U.S. Student Fulbright Grant (http://www.iie.org/fulbright). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo P, 1996, J IMMUNOL, V157, P4935; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Blom AM, 2000, J IMMUNOL, V164, P5328, DOI 10.4049/jimmunol.164.10.5328; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Blom AM, 2002, BIOCHEM SOC T, V30, P978, DOI 10.1042/bst0300978; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Cirillo DM, 1996, INFECT IMMUN, V64, P2019, DOI 10.1128/IAI.64.6.2019-2023.1996; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992; HEFFERNAN EJ, 1992, J CLIN INVEST, V90, P953, DOI 10.1172/JCI115972; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; Ho DK, 2010, J IMMUNOL, V185, P1763, DOI 10.4049/jimmunol.1001244; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; JOINER KA, 1982, J EXP MED, V155, P797, DOI 10.1084/jem.155.3.797; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Morgan BP., 1999, COMPLEMENT REGULATOR; Nishio M, 2005, MICROBIOL-SGM, V151, P863, DOI 10.1099/mic.0.27654-0; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; PRAMOONJAGO P, 1992, J IMMUNOL, V148, P827; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Ramu P, 2007, FEBS LETT, V581, P1716, DOI 10.1016/j.febslet.2007.03.049; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	30	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27546	10.1371/journal.pone.0027546	http://dx.doi.org/10.1371/journal.pone.0027546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102907	gold, Green Submitted, Green Published			2022-12-25	WOS:000297348800032
J	Gillibert-Duplantier, J; Duthey, B; Sisirak, V; Salaun, D; Gargi, T; Tredan, O; Finetti, P; Bertucci, F; Birnbaum, D; Bendriss-Vermare, N; Badache, A				Gillibert-Duplantier, J.; Duthey, B.; Sisirak, V.; Salaun, D.; Gargi, T.; Tredan, O.; Finetti, P.; Bertucci, F.; Birnbaum, D.; Bendriss-Vermare, N.; Badache, A.			Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis	ONCOGENE			English	Article						ErbB2/Her2; cell migration; transcriptome; ST2/IL1RL1; metastasis	SOLUBLE ST2 PROTEIN; ERBB SIGNALING NETWORK; ACTIVATED RECEPTOR-2; ACUTE EXACERBATION; RESPONSIVE GENE; IL-1 RECEPTOR; CANCER CELLS; INVASION; INDUCTION; MIGRATION	Overexpression of the ErbB2 receptor tyrosine kinase in breast cancer contributes to tumor development and is associated with poor prognosis. However, the mechanism by which ErbB2 might contribute to metastasis is not well defined. To identify genes that mediate ErbB2-driven cell motility, we performed differential gene expression analysis of ErbB2-expressing migrating breast cancer cells vs mutant ErbB2-expressing non-migrating cells. Among the genes that were specifically induced in migrating cells were known transcriptional targets of ErbB2, such as matrix metalloproteinases, and novel ErbB2 targets. Contribution of selected candidate genes to ErbB2-driven cell motility was tested by small interfering RNA targeting. Knockdown of the soluble form of ST2 (sST2), also called interleukin-1 receptor-like 1, one of the most robustly induced genes, decreased ErbB2-induced cell motility in two different cell lines. In response to ErbB2 activation, sST2 protein expression and secretion were increased. Moreover, recombinant sST2 associated with the plasma membrane and sST2-blocking antibodies reduced ErbB2-induced motility. Interestingly, cells from metastatic breast tumors secreted higher levels of sST2 than primary tumor cells. Finally, sST2 was found at high levels in the serum of metastatic breast cancer patients. Our data suggest that sST2 contributes to breast cancer cell motility and that sST2 secretion is associated with metastasis. Oncogene (2012) 31, 3516-3524; doi:10.1038/onc.2011.525; published online 21 November 2011	[Gillibert-Duplantier, J.; Duthey, B.; Salaun, D.; Finetti, P.; Bertucci, F.; Birnbaum, D.; Badache, A.] Ctr Rech Cancerol Marseille, Inserm U891, Marseille, France; [Gillibert-Duplantier, J.; Duthey, B.; Salaun, D.; Finetti, P.; Bertucci, F.; Birnbaum, D.; Badache, A.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Gillibert-Duplantier, J.; Duthey, B.; Salaun, D.; Bertucci, F.; Birnbaum, D.; Badache, A.] Aix Marseille Univ, Marseille, France; [Sisirak, V.; Bendriss-Vermare, N.] Ctr Rech Cancerol Lyon, Inserm UMR1052, CNRS UMR5286, Lyon, France; [Sisirak, V.; Tredan, O.; Bendriss-Vermare, N.] Ctr Leon Berard, F-69373 Lyon, France; [Sisirak, V.; Bendriss-Vermare, N.] Univ Lyon 1, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Badache, A (corresponding author), Ctr Rech Cancerol Marseille, Inserm U891, Marseille, France.	ali.badache@inserm.fr	Bendriss-Vermare, Nathalie/M-9197-2018; Sisirak, Vanja/O-9393-2016; Tredan, Olivier/N-9794-2017; Sisirak, Vanja/GRJ-7805-2022; Badache, Ali/Q-6098-2017; Sisirak, Vanja/L-7304-2019; Finetti, Pascal/O-8669-2017	Bendriss-Vermare, Nathalie/0000-0002-8771-3585; Sisirak, Vanja/0000-0003-3070-6533; Tredan, Olivier/0000-0001-5881-9383; Badache, Ali/0000-0001-7710-2505; Sisirak, Vanja/0000-0003-3070-6533; Finetti, Pascal/0000-0002-2674-3123	Fondation de France; Association pour la Recherche contre le Cancer; Inserm Avenir Program; Ligue Nationale Contre le Cancer-Label Ligue; INCa [PL-969-017]; Association pour la Recherche sur le Cancer	Fondation de France(Fondation de France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer-Label Ligue; INCa(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank R Marone and N Hynes for support in the preliminary phase of the project, M Lopez and A Goncalves for helpful discussions, and E Tabone and G Clapisson for providing clinical data. This work was supported by Fondation de France, Association pour la Recherche contre le Cancer and Inserm Avenir Program (AB), Ligue Nationale Contre le Cancer-Label Ligue (DB), INCa grant PL-969-017 "Met-Escape" (NB-V) and fellowships from Fondation de France (JG-D and BD) and Association pour la Recherche sur le Cancer (VS).	Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Gayle MA, 1996, J BIOL CHEM, V271, P5784, DOI 10.1074/jbc.271.10.5784; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hijazi MM, 2000, INT J ONCOL, V17, P629; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarry A, 2007, BIOCHEM BIOPH RES CO, V364, P689, DOI 10.1016/j.bbrc.2007.10.073; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kedrin D, 2009, CLIN CANCER RES, V15, P3733, DOI 10.1158/1078-0432.CCR-08-2163; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Mazumdar A, 2001, CANCER RES, V61, P400; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; ROSSLER U, 1995, DEV BIOL, V168, P86, DOI 10.1006/dbio.1995.1063; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Tajima S, 2003, CHEST, V124, P1206, DOI 10.1378/chest.124.4.1206; Tominaga S, 1999, BIOCHEM BIOPH RES CO, V264, P14, DOI 10.1006/bbrc.1999.1469; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; WERENSKIOLD AK, 1989, MOL CELL BIOL, V9, P5207, DOI 10.1128/MCB.9.11.5207; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	47	29	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	30					3516	3524		10.1038/onc.2011.525	http://dx.doi.org/10.1038/onc.2011.525			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22105364	Bronze			2022-12-25	WOS:000306844100004
J	Haglund, E; Danielsson, J; Kadhirvel, S; Lindberg, MO; Logan, DT; Oliveberg, M				Haglund, Ellinor; Danielsson, Jens; Kadhirvel, Saraboji; Lindberg, Magnus O.; Logan, Derek T.; Oliveberg, Mikael			Trimming Down a Protein Structure to Its Bare Foldons SPATIAL ORGANIZATION OF THE COOPERATIVE UNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FOLDING PATHWAYS; TRANSITION-STATE; S6; AGGREGATION; REFINEMENT; MUTATIONS; DYNAMICS; SYSTEM	Folding of the ribosomal protein S6 is a malleable process controlled by two competing, and partly overlapping, folding nuclei. Together, these nuclei extend over most of the S6 structure, except the edge strand beta 2, which is consistently missing in the folding transition states; despite being part of the S6 four-stranded sheet, beta 2 seems not to be part of the cooperative unit of the protein. The question is then whether beta 2 can be removed from the S6 structure without compromising folding cooperativity or native state integrity. To investigate this, we constructed a truncated variant of S6 lacking beta 2, reducing the size of the protein from 96 to 76 residues (S6(Delta beta 2)). The new S6 variant expresses well in Escherichia coli and has a well dispersed heteronuclear single quantum correlation spectrum and a perfectly wild-type-like crystal structure, but with a smaller three-stranded beta-sheet. Moreover, S6(Delta beta 2) displays an archetypical v-shaped chevron plot with decreased slope of the unfolding limb, as expected from a protein with maintained folding cooperativity and reduced size. The results support the notion that foldons, as defined by the structural distribution of the folding nuclei, represent a property-based level of hierarchy in the build-up of larger protein structures and suggest that the role of beta 2 in S6 is mainly in intermolecular binding, consistent with the position of this strand in the ribosomal assembly.	[Haglund, Ellinor; Danielsson, Jens; Lindberg, Magnus O.; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Kadhirvel, Saraboji; Logan, Derek T.] Lund Univ, Dept Biochem & Struct Biol, S-22100 Lund, Sweden	Stockholm University; Lund University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael@dbb.su.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019; Danielsson, Jens/AAG-6915-2021; Kadhirvel, Saraboji/H-4908-2011	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Kadhirvel, Saraboji/0000-0002-4876-4443; Danielsson, Jens/0000-0002-6048-6896	Swedish Research Council (VR) [VR 2009-5580, VR 2006-4387]; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation; Hjarnfonden	Swedish Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation; Hjarnfonden	This work was supported by grants from the Swedish Research Council (VR 2009-5580 (to M. O.) and VR 2006-4387) (to D. T. L.), the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, and Hjarnfonden.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Bystrom R, 2010, J BIOL CHEM, V285, P19544, DOI 10.1074/jbc.M109.086074; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FUSHMAN D, 1994, J BIOMOL STRUCT DYN, V11, P1377, DOI 10.1080/07391102.1994.10508074; Goddard T. D, 2007, SPARKY 3; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Haglund E, 2009, P NATL ACAD SCI USA, V106, P21619, DOI 10.1073/pnas.0907665106; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Ohman A, 2010, PROTEIN SCI, V19, P183, DOI 10.1002/pro.298; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Olofsson M, 2007, J MOL BIOL, V365, P237, DOI 10.1016/j.jmb.2006.09.016; Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Whitford PC, 2008, HFSP J, V2, P61, DOI 10.2976/1.2894846; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517	45	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2731	2738		10.1074/jbc.M111.312447	http://dx.doi.org/10.1074/jbc.M111.312447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117065	Green Published, hybrid			2022-12-25	WOS:000300292300044
J	Bargagna-Mohan, P; Paranthan, RR; Hamza, A; Zhan, CG; Lee, DM; Kim, KB; Lau, DL; Srinivasan, C; Nakayama, K; Nakayama, KI; Herrmann, H; Mohan, R				Bargagna-Mohan, Paola; Paranthan, Riya R.; Hamza, Adel; Zhan, Chang-Guo; Lee, Do-Min; Kim, Kyung Bo; Lau, Daniel L.; Srinivasan, Cidambi; Nakayama, Keiko; Nakayama, Keiichi I.; Herrmann, Harald; Mohan, Royce			Corneal Antifibrotic Switch Identified in Genetic and Pharmacological Deficiency of Vimentin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENT NETWORKS; UBIQUITIN-PROTEASOME PATHWAY; MICE LACKING VIMENTIN; MUSCLE ALPHA-ACTIN; CELL-PROLIFERATION; WITHAFERIN-A; MYOFIBROBLAST DIFFERENTIATION; RETINAL-DETACHMENT; LACERATED CORNEAS	The type III intermediate filaments (IFs) are essential cytoskeletal elements of mechanosignal transduction and serve critical roles in tissue repair. Mice genetically deficient for the IF protein vimentin (Vim(-/-)) have impaired wound healing from deficits in myofibroblast development. We report a surprising finding made in Vim(-/-) mice that corneas are protected from fibrosis and instead promote regenerative healing after traumatic alkali injury. This reparative phenotype in Vim(-/-) corneas is strikingly recapitulated by the pharmacological agent withaferin A (WFA), a small molecule that binds to vimentin and down-regulates its injury-induced expression. Attenuation of corneal fibrosis by WFA is mediated by down-regulation of ubiquitin-conjugating E3 ligase Skp2 and up-regulation of cyclin-dependent kinase inhibitors p27(Kip1) and p21(Cip1). In cell culture models, WFA exerts G(2)/M cell cycle arrest in a p27(Kip1)- and Skp2-dependent manner. Finally, by developing a highly sensitive imaging method to measure corneal opacity, we identify a novel role for desmin overexpression in corneal haze. We demonstrate that desmin down-regulation by WFA via targeting the conserved WFA-ligand binding site shared among type III IFs promotes further improvement of corneal transparency without affecting cyclin-dependent kinase inhibitor levels in Vim(-/-) mice. This dissociates a direct role for desmin in corneal cell proliferation. Taken together, our findings illuminate a previously unappreciated pathogenic role for type III IF overexpression in corneal fibrotic conditions and also validate WFA as a powerful drug lead toward anti-fibrosis therapeutic development.	[Mohan, Royce] Univ Connecticut, Ctr Hlth, Dept Neurosci, Lab Chem Biol & Drug Discovery, Farmington, CT 06030 USA; [Paranthan, Riya R.] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40503 USA; [Hamza, Adel; Zhan, Chang-Guo; Lee, Do-Min; Kim, Kyung Bo] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40503 USA; [Lau, Daniel L.] Univ Kentucky, Dept Comp & Elect Engn, Lexington, KY 40503 USA; [Srinivasan, Cidambi] Univ Kentucky, Dept Stat, Lexington, KY 40503 USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Dev Genet, Sendai, Miyagi 9808575, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Herrmann, Harald] German Canc Res Ctr, Funct Architecture Cell Grp, D-69120 Heidelberg, Germany	University of Connecticut; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Tohoku University; Kyushu University; Helmholtz Association; German Cancer Research Center (DKFZ)	Mohan, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Lab Chem Biol & Drug Discovery, 263 Farmington Ave, Farmington, CT 06030 USA.	Mohan@UCHC.edu	Lau, Daniel L/O-5169-2014	Lau, Daniel L/0000-0003-1377-4622	National Institutes of Health [R01 EY016782, R01 CA131059, R01 DA013930, R01 DA025100, R01 DA021416]; John A. and Florence Mattern Solomon Endowed Chair in vision biology and eye diseases; Fight for Sight, Inc.; Kentucky Science and Engineering Foundation [KSEF-578-RDE-005]; NATIONAL CANCER INSTITUTE [R01CA131059] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013930, R01DA025100, R01DA021416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John A. and Florence Mattern Solomon Endowed Chair in vision biology and eye diseases; Fight for Sight, Inc.; Kentucky Science and Engineering Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY016782 and R01 CA131059 (to R. M.) and R01 DA013930, R01 DA025100, and R01 DA021416 (to C.-G. Z.). This work was also supported in part by the John A. and Florence Mattern Solomon Endowed Chair in vision biology and eye diseases (to R. M.) and funds from Fight for Sight, Inc., and Kentucky Science and Engineering Foundation Grant KSEF-578-RDE-005 (to R. M.).	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Ambati BK, 2003, CORNEA, V22, P465, DOI 10.1097/00003226-200307000-00013; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bond M, 2011, FRONT BIOSCI-LANDMRK, V16, P1517, DOI 10.2741/3802; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Chang HC, 2007, MOL CANCER THER, V6, P1572, DOI 10.1158/1535-7163.MCT-06-0812; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Cook JR, 1999, INVEST OPHTH VIS SCI, V40, P3122; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HOPKINSONWOOLLEY J, 1994, J CELL SCI, V107, P1159; Hu D, 2011, CELL CYCLE, V10, P285, DOI 10.4161/cc.10.2.14517; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; ISHIZAKI M, 1994, EXP EYE RES, V59, P537, DOI 10.1006/exer.1994.1139; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Jiang XG, 2009, MOL CELL BIOL, V29, P5104, DOI 10.1128/MCB.00465-09; Kase S, 2006, CURR EYE RES, V31, P307, DOI 10.1080/02713680600584687; Lacolley P, 2001, CARDIOVASC RES, V51, P178, DOI 10.1016/S0008-6363(01)00278-4; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Mackey DA, 2011, CLIN EXP OPHTHALMOL, V39, P462, DOI 10.1111/j.1442-9071.2010.02487.x; Macsai MS, 2000, CORNEA, V19, P617, DOI 10.1097/00003226-200009000-00007; Maxwell SA, 2011, LEUKEMIA LYMPHOMA, V52, P849, DOI 10.3109/10428194.2010.551793; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MOON RT, 1983, P NATL ACAD SCI-BIOL, V80, P5495, DOI 10.1073/pnas.80.18.5495; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Oshima T, 2006, BRIT J OPHTHALMOL, V90, P218, DOI 10.1136/bjo.2005.077875; Paranthan RR, 2011, MOL VIS, V17, P1901; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; Petroll WM, 2004, INVEST OPHTH VIS SCI, V45, P3466, DOI 10.1167/iovs.04-0361; Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011; Qazi Y, 2010, BRAIN RES BULL, V81, P198, DOI 10.1016/j.brainresbull.2009.05.019; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Saika S, 2005, AM J PATHOL, V166, P1393, DOI 10.1016/S0002-9440(10)62357-7; Saika S, 2005, LAB INVEST, V85, P474, DOI 10.1038/labinvest.3700247; Salomao MQ, 2009, J REFRACT SURG, V25, P459, DOI 10.3928/1081597X-20090422-09; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Scott RS, 2008, AM J PHYSIOL-CELL PH, V295, pC324, DOI 10.1152/ajpcell.90622.2007; SKALLI O, 1992, P NATL ACAD SCI USA, V89, P11959, DOI 10.1073/pnas.89.24.11959; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Stramer BM, 2001, INVEST OPHTH VIS SCI, V42, P1698; Suzuki S, 2007, AM J PATHOL, V171, P473, DOI 10.2353/ajpath.2007.070279; Tandon A, 2010, CURR MOL MED, V10, P565; Taneri S, 2011, J CATARACT REFR SURG, V37, P392, DOI 10.1016/j.jcrs.2010.11.013; Tanter M, 2009, IEEE T MED IMAGING, V28, P1881, DOI 10.1109/TMI.2009.2021471; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Wang F, 2010, INVEST OPHTH VIS SCI, V51, P1475, DOI 10.1167/iovs.09-4363; West-Mays JA, 1999, INVEST OPHTH VIS SCI, V40, P887; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Yoshida K, 2002, INVEST OPHTH VIS SCI, V43, P364; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zieske JD, 2000, PROG RETIN EYE RES, V19, P257, DOI 10.1016/S1350-9462(99)00018-X	89	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					989	1006		10.1074/jbc.M111.297150	http://dx.doi.org/10.1074/jbc.M111.297150			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117063	Green Published, hybrid			2022-12-25	WOS:000299170300017
J	Wei, X; Guo, YH; Shao, CL; Sun, ZK; Zhurina, D; Liu, DW; Liu, W; Zou, DY; Jiang, Z; Wang, XS; Zhao, JL; Shang, W; Li, XL; Liao, XR; Huang, LY; Riedel, CU; Yuan, J				Wei, Xiao; Guo, Yanhong; Shao, Changlin; Sun, Zhongke; Zhurina, Daria; Liu, Dawei; Liu, Wei; Zou, Dayang; Jiang, Zheng; Wang, Xuesong; Zhao, Jiangli; Shang, Wei; Li, Xuelian; Liao, Xiangru; Huang, Liuyu; Riedel, Christian U.; Yuan, Jing			Fructose Uptake in Bifidobacterium longum NCC2705 Is Mediated by an ATP-binding Cassette Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE ABC TRANSPORTER; FECAL MICROBIOTA; PROTEIN; GLUCOSE; EXPRESSION; SEQUENCE; SYSTEMS; MALF	Recently, a putative ATP-binding cassette (ABC) transport system was identified in Bifidobacterium longum NCC2705 that is highly up-regulated during growth on fructose as the sole carbon source. Cloning and expression of the corresponding ORFs (bl0033-0036) result in efficient fructose uptake by bacteria. Sequence analysis reveals high similarity to typical ABC transport systems and suggests that these genes are organized as an operon. Expression of FruE is induced by fructose, ribose, or xylose and is able to bind these sugars with fructose as the preferred substrate. Our data suggest that BL0033-0036 constitute a high affinity fructose-specific ABC transporter of B. longum NCC2705. We thus suggest to rename the coding genes to fruEKFG and the corresponding proteins to FruE (sugar-binding protein), FruK (ATPase subunit), FruF, and FruG (membrane permeases). Furthermore, protein-protein interactions between the components of the transporter complex were determined by GST pulldown and Western blot analysis. This revealed interactions between the membrane subunits FruF and FruG with FruE, which in vivo is located on the external side of the membrane, and with the cytoplasmatic ATPase FruK. This is in line with the proposed model for bacterial ABC sugar transporters.	[Wei, Xiao; Guo, Yanhong; Shao, Changlin; Sun, Zhongke; Liu, Dawei; Liu, Wei; Zou, Dayang; Jiang, Zheng; Wang, Xuesong; Zhao, Jiangli; Li, Xuelian; Huang, Liuyu; Yuan, Jing] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing 100071, Peoples R China; [Sun, Zhongke; Zhurina, Daria; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [Guo, Yanhong; Shao, Changlin; Shang, Wei; Liao, Xiangru] Jiangnan Univ, Sch Biotechnol, Wuxi 214122, Peoples R China	Academy of Military Medical Sciences - China; Ulm University; Jiangnan University	Huang, LY (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, 20 Dongda St, Beijing 100071, Peoples R China.	huangliuyuly@163.com; christian.riedel@uni-ulm.de; yuanjing6216@163.com	Sun, Zhongke/R-2274-2019; Sun, Zhongke/AAF-5743-2020	Sun, Zhongke/0000-0002-9784-9769; Riedel, Christian U./0000-0001-7134-7085	National Natural Science Foundation of China [81071321]; Mega-projects of Science and Technology Research of China [2009ZX10004-205]; National High Technology Research and Development Program of China 863 Program [2007AA02Z118]; German Academic Exchange Service/Federal Ministry of Education and Research [D/09/04778]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-projects of Science and Technology Research of China; National High Technology Research and Development Program of China 863 Program(National High Technology Research and Development Program of China); German Academic Exchange Service/Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by National Natural Science Foundation of China Grant 81071321, Mega-projects of Science and Technology Research of China Grant 2009ZX10004-205, and National High Technology Research and Development Program of China 863 Program Grant 2007AA02Z118.; Supported by German Academic Exchange Service/Federal Ministry of Education and Research Grant D/09/04778. To whom correspondence may be addressed: Inst. of Microbiology and Biotechnology, University of Ulm, D-89069 Ulm, Germany. Tel.: 49-7315024853; Fax: 49-7315022719; E-mail: christian.riedel@uni-ulm.de.	AULKEMEYER P, 1991, MOL MICROBIOL, V5, P2913, DOI 10.1111/j.1365-2958.1991.tb01851.x; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Briczinski EP, 2008, APPL ENVIRON MICROB, V74, P6941, DOI 10.1128/AEM.01280-08; Brigidi P, 2001, RES MICROBIOL, V152, P735, DOI 10.1016/S0923-2508(01)01254-2; Caescu CI, 2004, J BACTERIOL, V186, P6515, DOI 10.1128/JB.186.19.6515-6525.2004; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Ehrle R, 1996, J BACTERIOL, V178, P2255, DOI 10.1128/jb.178.8.2255-2262.1996; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; He T, 2007, J MICROBIOL METH, V69, P364, DOI 10.1016/j.mimet.2007.02.008; HENDERSON PJF, 1992, INT REV CYTOL, V137A, P149; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; KORNBERG HL, 1989, FEMS MICROBIOL LETT, V63, P193, DOI 10.1016/0168-6445(89)90024-7; Lambert A, 2001, J BACTERIOL, V183, P4709, DOI 10.1128/JB.183.16.4709-4717.2001; Liu DW, 2011, PROTEOMICS, V11, P2628, DOI 10.1002/pmic.201100035; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Parche S, 2006, J BACTERIOL, V188, P1260, DOI 10.1128/JB.188.4.1260-1265.2006; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rossi M, 1998, LETT APPL MICROBIOL, V26, P101; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; SAURIN W, 1994, PROTEIN SCI, V3, P325; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P2129, DOI 10.1128/AEM.70.4.2129-2136.2004; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	33	14	22	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					357	367		10.1074/jbc.M111.266213	http://dx.doi.org/10.1074/jbc.M111.266213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102285	hybrid, Green Published			2022-12-25	WOS:000298682400035
J	Permenter, MG; Lewis, JA; Jackson, DA				Permenter, Matthew G.; Lewis, John A.; Jackson, David A.			Exposure to Nickel, Chromium, or Cadmium Causes Distinct Changes in the Gene Expression Patterns of a Rat Liver Derived Cell Line	PLOS ONE			English	Article							DNA-REPAIR; PROTEIN; METAL; TRANSCRIPTION; MODULATION; MECHANISMS; INDUCTION; METABOLISM; ASCORBATE; CYSTEINE	Many heavy metals, including nickel (Ni), cadmium (Cd), and chromium (Cr) are toxic industrial chemicals with an exposure risk in both occupational and environmental settings that may cause harmful outcomes. While these substances are known to produce adverse health effects leading to disease or health problems, the detailed mechanisms remain unclear. To elucidate the processes involved in the toxicity of nickel, cadmium, and chromium at the molecular level and to perform a comparative analysis, H4-II-E-C3 rat liver-derived cell lines were treated with soluble salts of each metal using concentrations derived from viability assays, and gene expression patterns were determined with DNA microarrays. We identified both common and unique biological responses to exposure to the three metals. Nickel, cadmium, chromium all induced oxidative stress with both similar and unique genes and pathways responding to this stress. Although all three metals are known to be genotoxic, evidence for DNA damage in our study only exists in response to chromium. Nickel induced a hypoxic response as well as inducing genes involved in chromatin structure, perhaps by replacing iron in key proteins. Cadmium distinctly perturbed genes related to endoplasmic reticulum stress and invoked the unfolded protein response leading to apoptosis. With these studies, we have completed the first gene expression comparative analysis of nickel, cadmium, and chromium in H4-II-E-C3 cells.	[Permenter, Matthew G.] Excet Inc, Ft Detrick, MD USA; [Lewis, John A.; Jackson, David A.] USA, Ctr Environm Hlth Res, Ft Detrick, MD USA		Permenter, MG (corresponding author), Excet Inc, Ft Detrick, MD USA.	matthew.permenter@us.army.mil	Jackson, David/E-9984-2014		U.S. Army Medical Research and Materiel Command	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The research was sponsored by the U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program, and Matthew Permenter is employed by Excet, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 2005, TOX PROF NICK; Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; BENJAMINI Y, 1995, J ROY STAT SOC, P1351; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Binet F, 2010, BIOCHEM BIOPH RES CO, V391, P18, DOI 10.1016/j.bbrc.2009.10.141; Boyack KW, 2002, J AM SOC INF SCI TEC, V53, P764, DOI 10.1002/asi.10066; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; COHEN MD, 1993, CRIT REV TOXICOL, V23, P255, DOI 10.3109/10408449309105012; Coll JM, 1996, ONCOL RES, V8, P435; Copanaki E, 2007, BBA-MOL CELL RES, V1773, P157, DOI 10.1016/j.bbamcr.2006.10.002; Cui YX, 2009, J BIOL CHEM, V284, P24925, DOI 10.1074/jbc.M109.026609; Dai HQ, 2009, TOXICOL APPL PHARM, V236, P154, DOI 10.1016/j.taap.2008.12.028; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Garrido JL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-231; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hiramatsu N, 2007, FEBS LETT, V581, P2055, DOI 10.1016/j.febslet.2007.04.040; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jiang HY, 2002, J CELL BIOCHEM, V85, P762, DOI 10.1002/jcb.10182; Joshi S, 2005, HUM EXP TOXICOL, V24, P13, DOI 10.1191/0960327105ht493oa; Kaczmarek M, 2007, FREE RADICAL BIO MED, V42, P1246, DOI 10.1016/j.freeradbiomed.2007.01.026; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547; Michels G, 2006, TOXICOLOGY, V225, P173, DOI 10.1016/j.tox.2006.05.014; Mostbock S, 2002, GEN PHYSIOL BIOPHYS, V21, P443; Recalcati S, 2003, HEPATOLOGY, V38, P1159, DOI 10.1053/jhep.2003.50417; Rothnie A, 2008, MOL PHARMACOL, V74, P1630, DOI 10.1124/mol.108.049080; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Shi XL, 1999, J TOXICOL ENV HEAL B, V2, P87, DOI 10.1080/109374099281241; Sidhu A, 2011, BIOCHEM BIOPH RES CO, V404, P963, DOI 10.1016/j.bbrc.2010.12.089; STOHS SJ, 2008, FREE RADICAL BIO MED, V18, P321; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Zhang L, 2011, MOL CELL BIOCHEM, V347, P21, DOI 10.1007/s11010-010-0608-1; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+	46	59	62	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27730	10.1371/journal.pone.0027730	http://dx.doi.org/10.1371/journal.pone.0027730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110744	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400099
J	Waight, JD; Hu, Q; Miller, A; Liu, S; Abrams, SI				Waight, Jeremy D.; Hu, Qiang; Miller, Austin; Liu, Song; Abrams, Scott I.			Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CD8(+) T-CELLS; ACTIVATED GRANULOCYTES; FACTOR-RECEPTOR; CANCER; ANGIOGENESIS; CARCINOMA; EXPRESSION; SUBPOPULATIONS; MOBILIZATION	Myeloid-derived suppressor cells (MDSC) are induced under diverse pathologic conditions, including neoplasia, and suppress innate and adaptive immunity. While the mechanisms by which MDSC mediate immunosuppression are well-characterized, details on how they develop remain less understood. This is complicated further by the fact that MDSC comprise multiple myeloid cell types, namely monocytes and granulocytes, reflecting diverse stages of differentiation and the proportion of these subpopulations vary among different neoplastic models. Thus, it is thought that the type and quantities of inflammatory mediators generated during neoplasia dictate the composition of the resultant MDSC response. Although much interest has been devoted to monocytic MDSC biology, a fundamental gap remains in our understanding of the derivation of granulocytic MDSC. In settings of heightened granulocytic MDSC responses, we hypothesized that inappropriate production of G-CSF is a key initiator of granulocytic MDSC accumulation. We observed abundant amounts of G-CSF in vivo, which correlated with robust granulocytic MDSC responses in multiple tumor models. Using G-CSF loss-and gain-of-function approaches, we demonstrated for the first time that: 1) abrogating G-CSF production significantly diminished granulocytic MDSC accumulation and tumor growth; 2) ectopically over-expressing G-CSF in G-CSF-negative tumors significantly augmented granulocytic MDSC accumulation and tumor growth; and 3) treatment of naive healthy mice with recombinant G-CSF protein elicited granulocytic-like MDSC remarkably similar to those induced under tumor-bearing conditions. Collectively, we demonstrated that tumor-derived G-CSF enhances tumor growth through granulocytic MDSC-dependent mechanisms. These findings provide us with novel insights into MDSC subset development and potentially new biomarkers or targets for cancer therapy.	[Waight, Jeremy D.; Abrams, Scott I.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Hu, Qiang; Miller, Austin; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Waight, JD (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	scott.abrams@roswellpark.org			National Cancer Institute [R01CA140622]; Roswell Park Alliance Foundation; National Institutes of Health (NIH) [T325T32CA085183]; NATIONAL CANCER INSTITUTE [T32CA085183, R01CA140622] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Alliance Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by Grant Number R01CA140622 from the National Cancer Institute (to SIA), an Alliance Developmental Award from the Roswell Park Alliance Foundation (to SIA), and a National Institutes of Health (NIH) training grant T325T32CA085183 (to JDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe F, 2010, CANCER IMMUNOL IMMUN, V59, P47, DOI 10.1007/s00262-009-0719-2; Asano Y, 1997, CANCER RES, V57, P3395; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bharadwaj U, 2007, CANCER RES, V67, P5479, DOI 10.1158/0008-5472.CAN-06-3963; Brimnes MK, 2010, SCAND J IMMUNOL, V72, P540, DOI 10.1111/j.1365-3083.2010.02463.x; Chakraborty A, 2007, UROLOGY, V69, P1210, DOI 10.1016/j.urology.2007.02.035; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Joshita S, 2009, INTERNAL MED, V48, P687, DOI 10.2169/internalmedicine.48.1900; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Kyo S, 2000, GYNECOL ONCOL, V78, P383, DOI 10.1006/gyno.2000.5904; LEES JR, 2011, CURR OPIN IMMUNOL; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; MORALES JK, 2009, BREAST CANC RES TREA; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; PERANZONI E, 2010, CURR OPIN IMMUNOL; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Rutella S, 2005, J IMMUNOL, V175, P7085, DOI 10.4049/jimmunol.175.11.7085; Savarese TM, 2001, CANCER LETT, V162, P105, DOI 10.1016/S0304-3835(00)00623-6; Schmielau J, 2001, CANCER RES, V61, P4756; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Stewart TJ, 2009, J IMMUNOL, V183, P117, DOI 10.4049/jimmunol.0804132; Tadmor T, 2011, BRIT J HAEMATOL, V153, P557, DOI 10.1111/j.1365-2141.2011.08678.x; Talmadge JE, 2011, SEMIN CANCER BIOL, V21, P131, DOI 10.1016/j.semcancer.2010.12.002; TSUKUDA M, 1993, BIOTHERAPY, V6, P183, DOI 10.1007/BF01878079; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	51	176	180	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27690	10.1371/journal.pone.0027690	http://dx.doi.org/10.1371/journal.pone.0027690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110722	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400084
J	Wu, FQ; Zhang, XM; Li, DM; Fu, YF				Wu, Fa-Qiang; Zhang, Xiao-Mei; Li, Dong-Mei; Fu, Yong-Fu			Ectopic Expression Reveals a Conserved PHYB Homolog in Soybean	PLOS ONE			English	Article							ARABIDOPSIS PHYTOCHROME B; GENE-EXPRESSION; RED-LIGHT; FLOWERING TIME; BLUE-LIGHT; PLANTS; FAMILY; IDENTIFICATION; PHOTORECEPTOR; THALIANA	Phytochromes sense red/far-red light and trigger a cascade of physiological responses in plant. Here, a phytochrome B homolog, GmPHYB1, was amplified from the soybean genome, and its expression profiles were obtained for various parts of the plant and at various developmental stages. The gene was ectopically expressed in Arabidopsis thaliana, driven by CaMV 35S promoter, to study the physiological functions of the gene product. The overexpressors of GmPHYB1 behaved similarly to those of AtPHYB, but with some subtle differences with respect to the acceleration of flowering under short day conditions and the growth of the hypocotyl under certain light fluence rate. The results suggested that this soybean PHYB homolog was well conserved both at the level of sequence and physiological function.	[Wu, Fa-Qiang; Zhang, Xiao-Mei; Li, Dong-Mei; Fu, Yong-Fu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wu, FQ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, Beijing 100193, Peoples R China.	fufu19cn@163.com			Transgenic program [2009ZX08009-133B, 2011ZX08009-001, 2011ZX08004-005]; Chinese National Key Basic Research "973'' Program [2010CB125906]	Transgenic program; Chinese National Key Basic Research "973'' Program(National Basic Research Program of China)	This work was partly supported by Transgenic program (Nos 2009ZX08009-133B, 2011ZX08009-001 and 2011ZX08004-005) and the Chinese National Key Basic Research "973'' Program (2010CB125906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-119; Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; BOYLAN M, 1994, PLANT CELL, V6, P449, DOI 10.1105/tpc.6.3.449; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Foyer CH, 1999, SCIENCE, V284, P599, DOI 10.1126/science.284.5414.599; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Franklin KA, 2007, PLANT J, V50, P108, DOI 10.1111/j.1365-313X.2007.03036.x; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Furuya M, 1989, Adv Biophys, V25, P133, DOI 10.1016/0065-227X(89)90006-3; GOLDBLATT P, 1981, CYTOLOGY PHYLOGENY L; Goosey L, 1997, PLANT PHYSIOL, V115, P959, DOI 10.1104/pp.115.3.959; Halliday KJ, 1997, PLANT J, V12, P1079, DOI 10.1046/j.1365-313X.1997.12051079.x; Hauser BA, 1995, PLANT MOL BIOL, V29, P1143, DOI 10.1007/BF00020458; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HEYER A, 1992, PLANT MOL BIOL, V20, P589, DOI 10.1007/BF00046444; Hisamatsu T, 2005, PLANT PHYSIOL, V138, P1106, DOI 10.1104/pp.104.059055; Howe GT, 1998, MOL BIOL EVOL, V15, P160, DOI 10.1093/oxfordjournals.molbev.a025912; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Josse EM, 2008, PLANT CELL ENVIRON, V31, P667, DOI 10.1111/j.1365-3040.2008.01794.x; KAY SA, 1989, PLANT CELL, V1, P351, DOI 10.1105/tpc.1.3.351; KERN R, 1993, PLANT PHYSIOL, V102, P1363, DOI 10.1104/pp.102.4.1363; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kneissl J, 2008, MOL PLANT, V1, P84, DOI 10.1093/mp/ssm010; LAGARIAS JC, 1985, J BIOL CHEM, V260, P2415; Lazarova GI, 1998, PLANT MOL BIOL, V38, P1137, DOI 10.1023/A:1006068305454; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; Mathews S, 2006, MOL ECOL, V15, P3483, DOI 10.1111/j.1365-294X.2006.03051.x; Neff MM, 2000, GENE DEV, V14, P257; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; ROBSON PRH, 1993, PLANT PHYSIOL, V102, P1179, DOI 10.1104/pp.102.4.1179; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Short TW, 1999, PLANT PHYSIOL, V119, P1497, DOI 10.1104/pp.119.4.1497; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Thiele A, 1999, PLANT PHYSIOL, V120, P73, DOI 10.1104/pp.120.1.73; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; WAGNER D, 1991, PLANT CELL, V3, P1275, DOI 10.1105/tpc.3.12.1275; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Weller JL, 2001, PLANT J, V26, P283, DOI 10.1046/j.1365-313X.2001.01027.x; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891	60	14	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27737	10.1371/journal.pone.0027737	http://dx.doi.org/10.1371/journal.pone.0027737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110748	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400102
J	Proepper, C; Steinestel, K; Schmeisser, MJ; Heinrich, J; Steinestel, J; Bockmann, J; Liebau, S; Boeckers, TM				Proepper, Christian; Steinestel, Konrad; Schmeisser, Michael J.; Heinrich, Jutta; Steinestel, Julie; Bockmann, Juergen; Liebau, Stefan; Boeckers, Tobias M.			Heterogeneous Nuclear Ribonucleoprotein K Interacts with Abi-1 at Postsynaptic Sites and Modulates Dendritic Spine Morphology	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; HNRNP-K; CELL-PROLIFERATION; SYNAPSE FORMATION; DOMAIN PROTEINS; NERVOUS-SYSTEM; XENOPUS-LAEVIS; STEM-CELLS; N-WASP; BINDING	Background: Abelson-interacting protein 1 (Abi-1) plays an important role for dendritic branching and synapse formation in the central nervous system. It is localized at the postsynaptic density (PSD) and rapidly translocates to the nucleus upon synaptic stimulation. At PSDs Abi-1 is in a complex with several other proteins including WASP/WAVE or cortactin thereby regulating the actin cytoskeleton via the Arp 2/3 complex. Principal Findings: We identified heterogeneous nuclear ribonucleoprotein K (hnRNPK), a 65 kDa ssDNA/RNA-binding-protein that is involved in multiple intracellular signaling cascades, as a binding partner of Abi-1 at postsynaptic sites. The interaction with the Abi-1 SH3 domain is mediated by the hnRNPK-interaction (KI) domain. We further show that during brain development, hnRNPK expression becomes more and more restricted to granule cells of the cerebellum and hippocampal neurons where it localizes in the cell nucleus as well as in the spine/dendritic compartment. The downregulation of hnRNPK in cultured hippocampal neurons by RNAi results in an enlarged dendritic tree and a significant increase in filopodia formation. This is accompanied by a decrease in the number of mature synapses. Both effects therefore mimic the neuronal morphology after downregulation of Abi-1 mRNA in neurons. Conclusions: Our findings demonstrate a novel interplay between hnRNPK and Abi-1 in the nucleus and at synaptic sites and show obvious similarities regarding both protein knockdown phenotypes. This indicates that hnRNPK and Abi-1 act synergistic in a multiprotein complex that regulates the crucial balance between filopodia formation and synaptic maturation in neurons.	[Proepper, Christian; Steinestel, Konrad; Schmeisser, Michael J.; Heinrich, Jutta; Steinestel, Julie; Bockmann, Juergen; Liebau, Stefan; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; [Steinestel, Konrad] BWK Hosp Ulm, Dept Pathol, Ulm, Germany	Ulm University	Proepper, C (corresponding author), Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany.	stefan.liebau@uni-ulm.de; tobias.boeckers@uni-ulm.de	Heinrich, Joachim/N-1720-2013; Liebau, Stefan/C-3374-2015; Schmeisser, Michael/S-6347-2019	Heinrich, Joachim/0000-0002-9620-1629; Liebau, Stefan/0000-0003-0721-8187; Steinestel, Konrad/0000-0002-6549-9848	Deutsche Forschungsgemeinschaft (DFG) [BO1718/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG, BO1718/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Blanchette AR, 2006, GENE EXPR PATTERNS, V6, P596, DOI 10.1016/j.modgep.2005.11.008; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Charroux B, 1999, MOL CELL BIOL, V19, P7846, DOI 10.1128/mcb.19.11.7846; Courtney KD, 2000, MOL CELL NEUROSCI, V16, P244, DOI 10.1006/mcne.2000.0865; Echarri A, 2004, MOL CELL BIOL, V24, P4979, DOI 10.1128/MCB.24.11.4979-4993.2004; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fenn S, 2007, NUCLEIC ACIDS RES, V35, P2651, DOI 10.1093/nar/gkm139; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hering H, 2003, J NEUROSCI, V23, P11759; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Iwasaki T, 2008, DEV GROWTH DIFFER, V50, P23, DOI 10.1111/j.1440-169x.2007.00974.x; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Liebau S, 2007, STEM CELLS, V25, P1720, DOI 10.1634/stemcells.2006-0823; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; Liebau S, 2009, BIOCHEM BIOPH RES CO, V385, P460, DOI 10.1016/j.bbrc.2009.05.098; Liu YY, 2008, DEVELOPMENT, V135, P3125, DOI [10.1242/dev.066993, 10.1242/dev.022236]; Marcu A, 2001, INT J DEV BIOL, V45, P743; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Messias AC, 2006, J MOL BIOL, V361, P470, DOI 10.1016/j.jmb.2006.06.025; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Thyagarajan A, 2004, J BIOL CHEM, V279, P49680, DOI 10.1074/jbc.M408915200; Thyagarajan A, 2008, BRAIN RES, V1189, P33, DOI 10.1016/j.brainres.2007.11.012; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	48	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27045	10.1371/journal.pone.0027045	http://dx.doi.org/10.1371/journal.pone.0027045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102872	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300007
J	Zhou, L; Ding, H; Zhang, XM; He, MA; Huang, SL; Xu, YJ; Shi, Y; Cui, GL; Cheng, LX; Wang, QK; Hu, FB; Wang, DW; Wu, TC				Zhou, Li; Ding, Hu; Zhang, Xiaomin; He, Meian; Huang, Suli; Xu, Yujun; Shi, Ying; Cui, Guanglin; Cheng, Longxian; Wang, Qing K.; Hu, Frank B.; Wang, Daowen; Wu, Tangchun			Genetic Variants at Newly Identified Lipid Loci Are Associated with Coronary Heart Disease in a Chinese Han Population	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ARTERY-DISEASE; RISK-FACTORS; POLYMORPHISMS; MORTALITY; STROKE	Background: Recent genome-wide association studies (GWAS) have mapped several novel loci influencing blood lipid levels in Caucasians. We sought to explore whether the genetic variants at newly identified lipid-associated loci were associated with CHD susceptibility in a Chinese Han population. Methodology/Principal Findings: We conducted a two-stage case-control study in a Chinese Han population. The first-stage, consisting of 1,376 CHD cases and 1,376 sex and age-frequency matched controls, examined 5 novel lipid-associated single-nucleotide polymorphisms (SNPs) identified from GWAS among Caucasians in relation to CHD risk in Chinese. We then validated significant SNPs in the second-stage, consisting of 1,269 cases and 2,745 controls. We also tested associations between SNPs within the five novel loci and blood lipid levels in 4,121 controls. We identified two novel SNPs (rs599839 in CELSR2-PSRC1-SORT1 and rs16996148 in NCAN-CILP2) that were significantly associated with reduced CHD risk in Chinese (odds ratios (95% confidence intervals) in the dominant model 0.76 (0.61-0.90; P = 0.001), 0.67 (0.57-0.77; P = 3.4 x 10(-8)), respectively). Multiple linear regression analyses using dominant model showed that rs599839 was significantly associated with decreased LDL levels (P = 0.022) and rs16996148 was significantly associated with increased LDL and HDL levels (P = 2.9 x 10(-4) and 0.001, respectively). Conclusions/Significance: We identified two novel SNPs (rs599839 and rs16996148) at newly identified lipid-associated loci that were significantly associated with CHD susceptibility in a Chinese Han population.	[Zhou, Li; Zhang, Xiaomin; He, Meian; Huang, Suli; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Inst Occupat Med, Wuhan 430074, Hubei, Peoples R China; [Zhou, Li; Zhang, Xiaomin; He, Meian; Huang, Suli; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Ding, Hu; Xu, Yujun; Cui, Guanglin; Wang, Daowen] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Hypertens, Wuhan 430074, Hubei, Peoples R China; [Ding, Hu; Xu, Yujun; Cui, Guanglin; Wang, Daowen] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, Wuhan 430074, Hubei, Peoples R China; [Shi, Ying; Cheng, Longxian] Huazhong Univ Sci & Technol, Union Hosp, Dept Cardiol, Wuhan 430074, Hubei, Peoples R China; [Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Hubei, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health	Zhou, L (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Inst Occupat Med, Wuhan 430074, Hubei, Peoples R China.	dwwang@tjh.tjmu.edu.cn; wut@mails.tjmu.edu.cn		Wang, Dao Wen/0000-0002-9774-3980; ding, hu/0000-0002-1814-1552	973 Program [2011CB503806]; National Natural Scientific Foundation of China (NNSFC) [30711120579]; NSFC [81172751]	973 Program(National Basic Research Program of China); National Natural Scientific Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	The present study is partly supported by research funds from 973 Program (2011CB503806), National Natural Scientific Foundation of China (NNSFC 30711120579 to Tangchun Wu) and NSFC 81172751 to Meian He. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Law S W, 1986, Adv Exp Med Biol, V201, P151; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Muendlein A, 2009, ATHEROSCLEROSIS, V206, P494, DOI 10.1016/j.atherosclerosis.2009.02.040; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pollin TI, 2004, ATHEROSCLEROSIS, V173, P89, DOI 10.1016/j.atherosclerosis.2003.11.012; Puavilai G, 1999, DIABETES RES CLIN PR, V44, P21, DOI 10.1016/S0168-8227(99)00008-X; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; SING CF, 1985, AM J HUM GENET, V37, P268; Tai ES, 2009, J LIPID RES, V50, P514, DOI 10.1194/jlr.M800456-JLR200; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065	25	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27481	10.1371/journal.pone.0027481	http://dx.doi.org/10.1371/journal.pone.0027481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110658	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300033
J	Merriam, EB; Lumbard, DC; Viesselmann, C; Ballweg, J; Stevenson, M; Pietila, L; Hu, XD; Dent, EW				Merriam, Elliott B.; Lumbard, Derek C.; Viesselmann, Chris; Ballweg, Jason; Stevenson, Matthew; Pietila, Lauren; Hu, Xindao; Dent, Erik W.			Dynamic Microtubules Promote Synaptic NMDA Receptor-Dependent Spine Enlargement	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; DENDRITIC SPINES; SILENT SYNAPSES; ACTIN DYNAMICS; PLASTICITY; ACTIVATION; PHOSPHORYLATION; LTP; GEF	Most excitatory synaptic terminals in the brain impinge on dendritic spines. We and others have recently shown that dynamic microtubules (MTs) enter spines from the dendritic shaft. However, a direct role for MTs in long-lasting spine plasticity has yet to be demonstrated and it remains unclear whether MT-spine invasions are directly influenced by synaptic activity. Lasting changes in spine morphology and synaptic strength can be triggered by activation of synaptic NMDA receptors (NMDARs) and are associated with learning and memory processes. To determine whether MTs are involved in NMDAR-dependent spine plasticity, we imaged MT dynamics and spine morphology in live mouse hippocampal pyramidal neurons before and after acute activation of synaptic NMDARs. Synaptic NMDAR activation promoted MT-spine invasions and lasting increases in spine size, with invaded spines exhibiting significantly faster and more growth than non-invaded spines. Even individual MT invasions triggered rapid increases in spine size that persisted longer following NMDAR activation. Inhibition of either NMDARs or dynamic MTs blocked NMDAR-dependent spine growth. Together these results demonstrate for the first time that MT-spine invasions are positively regulated by signaling through synaptic NMDARs, and contribute to long-lasting structural changes in targeted spines.	[Merriam, Elliott B.; Hu, Xindao; Dent, Erik W.] Univ Wisconsin, Neurosci Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Lumbard, Derek C.; Viesselmann, Chris; Ballweg, Jason; Stevenson, Matthew; Pietila, Lauren; Dent, Erik W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Merriam, EB (corresponding author), Univ Wisconsin, Neurosci Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA.	ewdent@wisc.edu	Dent, Erik/L-6208-2019	Dent, Erik/0000-0001-8525-7136	NIH [F31-NS071816, T90-DK070079, T01-GM07507, R01-064014]; Dana Foundation; Whitehall Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS071816, R01NS064014] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Whitehall Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH (www.nih.gov) (F31-NS071816, T90-DK070079 and T01-GM07507) to E.B.M., and the Dana Foundation (www.dana.org), Whitehall Foundation (www.whitehall.org) and NIH (R01-064014) to E.W.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Matsuzaki M, 2007, NEUROSCI RES, V57, P1, DOI 10.1016/j.neures.2006.09.017; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Viesselmann C, 2011, JOVE-J VIS EXP, DOI 10.3791/2373; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006	35	61	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27688	10.1371/journal.pone.0027688	http://dx.doi.org/10.1371/journal.pone.0027688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096612	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900071
J	Gonzalez-Quintial, R; Lawson, BR; Scatizzi, JC; Craft, J; Kono, DH; Baccala, R; Theofilopoulos, AN				Gonzalez-Quintial, Rosana; Lawson, Brian R.; Scatizzi, John C.; Craft, Joseph; Kono, Dwight H.; Baccala, Roberto; Theofilopoulos, Argyrios N.			Systemic Autoimmunity and Lymphoproliferation Are Associated with Excess IL-7 and Inhibited by IL-7R alpha Blockade	PLOS ONE			English	Article							NAIVE T-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; MRL-LPR MICE; HOMEOSTATIC PROLIFERATION; INTERLEUKIN-7 RECEPTOR; DOWN-REGULATION; CUTTING EDGE; MURINE LUPUS; IN-VIVO; MEMORY	Lupus is characterized by disturbances in lymphocyte homeostasis, as demonstrated by the marked accumulation of activated/memory T cells. Here, we provide evidence that proliferation of the CD8(+) precursors for the accumulating CD4(-)CD8(-) T cells in MRL-Fas(lpr) lupus-predisposed mice is, in part, driven by commensal antigens. The ensuing lymphadenopathy is associated with increased production of IL-7 due to expansion of fibroblastic reticular cells, the primary source of this cytokine. The excess IL-7 is not, however, consumed by CD4(-)CD8(-) T cells due to permanent down-regulation of IL-7R alpha (CD127), but instead supports proliferation of autoreactive T cells and progression of autoimmunity. Accordingly, IL-7R blockade reduced T cell activation and autoimmune manifestations even when applied at advanced disease stage. These findings indicate that an imbalance favoring production over consumption of IL-7 may contribute to systemic autoimmunity, and correction of this imbalance may be a novel therapeutic approach in lymphoproliferative and autoimmune syndromes.	[Gonzalez-Quintial, Rosana; Lawson, Brian R.; Scatizzi, John C.; Kono, Dwight H.; Baccala, Roberto; Theofilopoulos, Argyrios N.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Craft, Joseph] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Craft, Joseph] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Scripps Research Institute; Yale University; Yale University	Gonzalez-Quintial, R (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	rbaccala@scripps.edu; argyrio@scripps.edu		Baccala, Roberto/0000-0002-3159-8469	Guthy-Jackson Charitable Foundation; National Institutes of Health [AR031203, CA109026]; NATIONAL CANCER INSTITUTE [R01CA109026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR039555, R01AR031203] Funding Source: NIH RePORTER	Guthy-Jackson Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by The Guthy-Jackson Charitable Foundation and by grants from the National Institutes of Health (AR031203, CA109026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 1994, Semin Immunol, V6, P9, DOI 10.1006/smim.1994.1003; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Aranami T, 2004, MICROBIOL IMMUNOL, V48, P477, DOI 10.1111/j.1348-0421.2004.tb03539.x; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Baccala R, 2005, TRENDS IMMUNOL, V26, P5, DOI 10.1016/j.it.2004.11.006; Balomenos D, 1997, J IMMUNOL, V159, P2265; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bristeau-Leprince A, 2008, J IMMUNOL, V181, P440, DOI 10.4049/jimmunol.181.1.440; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Christianson GJ, 1996, J IMMUNOL, V156, P4932; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Crispin JC, 2009, J IMMUNOL, V183, P4675, DOI 10.4049/jimmunol.0901533; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fortner KA, 2005, J IMMUNOL, V175, P4374, DOI 10.4049/jimmunol.175.7.4374; Ge Q, 2001, P NATL ACAD SCI USA, V98, P1728, DOI 10.1073/pnas.98.4.1728; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; KOH DR, 1995, EUR J IMMUNOL, V25, P2558, DOI 10.1002/eji.1830250923; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maldonado MA, 1999, J IMMUNOL, V162, P6322; MALDONADO MA, 1995, J EXP MED, V181, P641, DOI 10.1084/jem.181.2.641; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; MIXTER PF, 1995, J IMMUNOL, V154, P2063; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Peng SL, 1996, J IMMUNOL, V157, P5689; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Stockinger B, 2004, CURR OPIN IMMUNOL, V16, P775, DOI 10.1016/j.coi.2004.09.003; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Theofilopoulos AN, 2001, J CLIN INVEST, V108, P335, DOI 10.1172/JCI12173; ZHANG L, 1995, J IMMUNOL, V155, P3464	56	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27528	10.1371/journal.pone.0027528	http://dx.doi.org/10.1371/journal.pone.0027528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102903	Green Submitted, Green Published, gold			2022-12-25	WOS:000297348800030
J	Shahar, OD; Ram, EVSR; Shimshoni, E; Hareli, S; Meshorer, E; Goldberg, M				Shahar, O. D.; Ram, E. V. S. Raghu; Shimshoni, E.; Hareli, S.; Meshorer, E.; Goldberg, M.			Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells	ONCOGENE			English	Article						DNA double-strand breaks; DNA repair; homologous recombination; genomic stability; ISceI	MAMMALIAN-CELLS; MITOTIC CYCLINS; PATHWAY CHOICE; S-PHASE; END; DEGRADATION; STABILITY; ONSET	DNA double-strand breaks (DSBs), the most hazardous DNA lesions, may result in genomic instability, a hallmark of cancer cells. The main DSB repair pathways are non-homologous end joining (NHEJ) and homologous recombination (HR). In mammalian cells, NHEJ, which can lead to inaccurate repair, predominates. HR repair (HRR) is considered accurate and is restricted to S, G2 and M phases of the cell cycle. Despite its importance, many aspects regarding HRR remain unknown. Here, we developed a novel inducible on/off switch cell system that enables, for the first time, to induce a DSB in a rapid and reversible manner in human cells. By limiting the duration of DSB induction, we found that non-persistent endonuclease-induced DSBs are rarely repaired by HR, whereas persistent DSBs result in the published HRR frequencies (non-significant HR frequency versus frequency of similar to 10%, respectively). We demonstrate that these DSBs are repaired by an accurate repair mechanism, which is distinguished from HRR (most likely, error-free NHEJ). Notably, our data reveal that HRR frequencies of endonuclease-induced DSBs in human cells are >10-fold lower than what was previously estimated by prevailing methods, which resulted in recurrent DSB formation. Our findings suggest a role for HRR mainly in repairing challenging DSBs, in contrast to uncomplicated lesions that are frequently repaired by NHEJ. Preventing HR from repairing DSBs in the complex and repetitive human genome probably has an essential role in maintaining genomic stability. Oncogene (2012) 31, 3495-3504; doi:10.1038/onc.2011.516; published online 21 November 2011	[Shahar, O. D.; Ram, E. V. S. Raghu; Shimshoni, E.; Hareli, S.; Meshorer, E.; Goldberg, M.] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Meshorer, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	meshorer@cc.huji.ac.il; goldbergm@vms.huji.ac.il	Edupuganti, Venkata/AAG-6486-2019; Shahar, Or/ABG-9168-2020	Edupuganti, Venkata/0000-0001-9414-2672; Shahar, Or/0000-0002-5039-8307; Meshorer, Eran/0000-0003-4777-986X; Goldberg, Michal/0000-0001-9397-2383	AFHU; United States Binational Science Foundation [2009286]; Israel Cancer Association; Israel Science Foundation [943/09]; Israel Cancer Research Foundation; Israel Ministry of Health [6007]; European Union [IRG-206872, 238176]; HU; Israel Psychobiology Institute; Lady Davies Fellowship program; Edmond J Safra Foundation	AFHU; United States Binational Science Foundation; Israel Cancer Association; Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Foundation; Israel Ministry of Health; European Union(European Commission); HU; Israel Psychobiology Institute; Lady Davies Fellowship program; Edmond J Safra Foundation	We thank members of our laboratories, Sagiv Shifman and Liran Carmel for discussions, Naomi Melamed-Book for assistance in confocal analyses, Maya Schuldiner and Yifat Cohen for technical help. Stephan P Jackson, Tom Misteli, Amir Eden and Agnes Klochendler-Yeivin for reagents, Ilana Livyatan for critical reading of the manuscript, Evi Soutoglou for discussions and reagents, and the Edmond J Safra Foundation for financial support. MG is supported by the AFHU, The United States Binational Science Foundation (2009286) and the Israel Cancer Association. EM is a Joseph H and Belle R Braun senior lecturer in life sciences and is supported by the Israel Science Foundation (943/09), the Israel Cancer Research Foundation, the Israel Ministry of Health (6007), the European Union (IRG-206872 and 238176), the Internal Applicable Medical Grants of the HU and the Israel Psychobiology Institute. EVSRR is supported by the Lady Davies Fellowship program.	Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Covo S, 2009, NUCLEIC ACIDS RES, V37, P6737, DOI 10.1093/nar/gkp703; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Salpeter SJ, 2011, ENDOCRINOLOGY, V152, P2589, DOI 10.1210/en.2010-1372; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Takashima Y, 2009, ENVIRON MOL MUTAGEN, V50, P815, DOI 10.1002/em.20481; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Villalobos Michael J, 2006, Methods Mol Biol, V314, P109; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Yanez RJ, 1998, GENE THER, V5, P149, DOI 10.1038/sj.gt.3300601; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	29	36	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	30					3495	3504		10.1038/onc.2011.516	http://dx.doi.org/10.1038/onc.2011.516			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22105360				2022-12-25	WOS:000306844100002
J	Damian, M; Marie, J; Leyris, JP; Fehrentz, JA; Verdie, P; Martinez, J; Baneres, JL; Mary, S				Damian, Marjorie; Marie, Jacky; Leyris, Jean-Philippe; Fehrentz, Jean-Alain; Verdie, Pascal; Martinez, Jean; Baneres, Jean-Louis; Mary, Sophie			High Constitutive Activity Is an Intrinsic Feature of Ghrelin Receptor Protein A STUDY WITH A FUNCTIONAL MONOMERIC GHS-R1a RECEPTOR RECONSTITUTED IN LIPID DISCS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HORMONE SECRETAGOGUE RECEPTOR; GPCR DRUG DISCOVERY; COUPLED RECEPTORS; INVERSE AGONISM; ALPHA(1B)-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; MONOMERIC RHODOPSIN; STRUCTURAL INSIGHTS	Despite its central role in signaling and the potential therapeutic applications of inverse agonists, the molecular mechanisms underlying G protein-coupled receptor (GPCR) constitutive activity remain largely to be explored. In this context, ghrelin receptor GHS-R1a is a peculiar receptor in the sense that it displays a strikingly high, physiologically relevant, constitutive activity. To identify the molecular mechanisms responsible for this high constitutive activity, we have reconstituted a purified GHS-R1a monomer in a lipid disc. Using this reconstituted system, we show that the isolated ghrelin receptor per se activates G(q) in the absence of agonist, as assessed through guanosine 5'-O-(thiotriphosphate) binding experiments. The measured constitutive activity is similar in its extent to that observed in heterologous systems and in vivo. This is the first direct evidence for the high constitutive activity of the ghrelin receptor being an intrinsic property of the protein rather than the result of influence of its cellular environment. Moreover, we show that the isolated receptor in lipid discs recruits arrestin-2 in an agonist-dependent manner, whereas it interacts with mu-AP2 in the absence of ligand or in the presence of ghrelin. Of importance, these differences are linked to ligand-specific GHS-R1a conformations, as assessed by intrinsic fluorescence measurements. The distinct ligand requirements for the interaction of purified GHS-R1a with arrestin and AP2 provide a new rationale to the differences in basal and agonist-induced internalization observed in cells.	[Damian, Marjorie; Marie, Jacky; Leyris, Jean-Philippe; Fehrentz, Jean-Alain; Verdie, Pascal; Martinez, Jean; Baneres, Jean-Louis; Mary, Sophie] Univ Montpellier 1 & Montpellier 2, Fac Pharm, IBMM, CNRS UMR 5247, F-34093 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Baneres, JL (corresponding author), Univ Montpellier 1 & Montpellier 2, Fac Pharm, IBMM, CNRS UMR 5247, 15 Ave Charles Flahaut,BP 14491, F-34093 Montpellier 5, France.	jean-louis.baneres@univ-monp1.fr; sophie.mary@univ-montp1.fr	verdie, pascal/AAM-4228-2020; Martinez, Jean/R-9421-2019	Martinez, Jean/0000-0002-9267-4621; Baneres, jean-louis/0000-0001-7078-1285; VERDIe, Pascal/0000-0002-5807-0293	Universities of Montpellier 1 and Montpellier 2; CNRS; Agence Nationale pour la Recherche [PCV08_323163]	Universities of Montpellier 1 and Montpellier 2; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Universities of Montpellier 1 and Montpellier 2, CNRS, and Agence Nationale pour la Recherche Contract PCV08_323163.	Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Arvanitakis L, 1998, TRENDS ENDOCRIN MET, V9, P27, DOI 10.1016/S1043-2760(98)00007-1; Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Dahmane T, 2009, BIOCHEMISTRY-US, V48, P6516, DOI 10.1021/bi801729z; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Floquet N, 2010, J MOL BIOL, V395, P769, DOI 10.1016/j.jmb.2009.09.051; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lau PN, 2009, MOL CELL ENDOCRINOL, V299, P232, DOI 10.1016/j.mce.2008.12.006; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mokrosinski J, 2010, METHOD ENZYMOL, V484, P53, DOI [10.1016/B978-0-12-381298-8.00003-4, 10.1016/S0076-6879(10)84003-0]; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Ratnala VRP, 2009, METHODS MOL BIOL, V552, P67, DOI 10.1007/978-1-60327-317-6_5; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schneider EH, 2010, METHOD ENZYMOL, V485, P527, DOI [10.1016/S0076-6879(10)85028-1, 10.1016/B978-0-12-381296-4.00028-2]; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Stoddart LA, 2010, METHOD ENZYMOL, V484, P569, DOI [10.1016/S0076-6879(10)84028-5, 10.1016/B978-0-12-381298-8.00028-9]; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596	69	106	106	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3630	3641		10.1074/jbc.M111.288324	http://dx.doi.org/10.1074/jbc.M111.288324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22117076	Green Published, hybrid			2022-12-25	WOS:000300410900003
J	Colello, D; Mathew, S; Ward, R; Pumiglia, K; LaFlamme, SE				Colello, Diane; Mathew, Shomita; Ward, Rachel; Pumiglia, Kevin; LaFlamme, Susan E.			Integrins Regulate Microtubule Nucleating Activity of Centrosome through Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (MEK/ERK) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; ANDROGEN RECEPTOR; GAMMA-TUBULIN; PROSTATE-CANCER; PROGESTERONE-RECEPTOR; CYTOPLASMIC DOMAINS; EPITHELIAL-CELLS; TYROSINE KINASE; TALIN BINDING; SRC	Microtubule nucleation is an essential step in the formation of the microtubule cytoskeleton. We recently showed that androgen and Src promote microtubule nucleation and gamma-tubulin accumulation at the centrosome. Here, we explore the mechanisms by which androgen and Src regulate these processes and ask whether integrins play a role. We perturb integrin function by a tyrosine-to-alanine substitution in membrane-proximal NPIY motif in the integrin beta 1 tail and show that this mutant substantially decreases microtubule nucleation and gamma-tubulin accumulation at the centrosome. Because androgen stimulation promotes the interaction of the androgen receptor with Src, resulting in PI3K/AKT and MEK/ERK signaling, we asked whether these pathways are inhibited by the mutant integrin and whether they regulate microtubule nucleation. Our results indicate that the formation of the androgen receptor-Src complex and the activation of downstream pathways are significantly suppressed when cells are adhered by the mutant integrin. Inhibitor studies indicate that microtubule nucleation requires MEK/ERK but not PI3K/AKT signaling. Importantly, the expression of activated RAF-1 is sufficient to rescue microtubule nucleation inhibited by the mutant integrin by promoting the centrosomal accumulation of gamma-tubulin. Our data define a novel paradigm of integrin signaling, where integrins regulate microtubule nucleation by promoting the formation of androgen receptor-Src signaling complexes to activate the MEK/ERK signaling pathway.	[Colello, Diane; Mathew, Shomita; Ward, Rachel; Pumiglia, Kevin; LaFlamme, Susan E.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	LaFlamme, SE (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, 47 New Scotland Ave, Albany, NY 12208 USA.	laflams@mail.amc.edu	Mathew, Shomita/B-3775-2012; MATHEW-STEINER, SHOMITA S/AAE-8041-2022	Mathew-Steiner, Shomita/0000-0002-7730-9140; Pumiglia, Kevin/0000-0003-4655-0334	National Institutes of Health [GM51540]; NATIONAL CANCER INSTITUTE [R01CA081419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51540 (to S. E. L.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Bajaj A, 2010, CANCER RES, V70, P3803, DOI 10.1158/0008-5472.CAN-09-2648; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bodeau AL, 2001, J CELL SCI, V114, P2795; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Colello D, 2010, J CELL SCI, V123, P2093, DOI 10.1242/jcs.057505; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DiDomenico M, 1996, CANCER RES, V56, P4516; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Echarri A, 2006, CELL CYCLE, V5, P2179, DOI 10.4161/cc.5.19.3264; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Harrison RE, 2001, NEOPLASIA, V3, P385, DOI 10.1038/sj.neo.7900180; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2002, ANN NY ACAD SCI, V963, P185; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; SCHMIDT JW, 1992, J CELL BIOL, V116, P1019, DOI 10.1083/jcb.116.4.1019; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takayama Y, 1997, FEBS LETT, V406, P11, DOI 10.1016/S0014-5793(97)00224-X; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	66	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2520	2530		10.1074/jbc.M111.254128	http://dx.doi.org/10.1074/jbc.M111.254128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117069	hybrid, Green Published			2022-12-25	WOS:000300292300026
J	Bernardi, ML; Giangrieco, I; Camardella, L; Ferrara, R; Palazzo, P; Panico, MR; Crescenzo, R; Carratore, V; Zennaro, D; Liso, M; Santoro, M; Zuzzi, S; Tamburrini, M; Ciardiello, MA; Mari, A				Bernardi, Maria Livia; Giangrieco, Ivana; Camardella, Laura; Ferrara, Rosetta; Palazzo, Paola; Panico, Maria Rosaria; Crescenzo, Roberta; Carratore, Vito; Zennaro, Danila; Liso, Marina; Santoro, Mario; Zuzzi, Sara; Tamburrini, Maurizio; Ciardiello, Maria Antonietta; Mari, Adriano			Allergenic Lipid Transfer Proteins from Plant-Derived Foods Do Not Immunologically and Clinically Behave Homogeneously: The Kiwifruit LTP as a Model	PLOS ONE			English	Article							PRU P 3; CROSS-REACTIVITY; PEACH ALLERGEN; IN-VITRO; GASTROINTESTINAL DIGESTION; MOLECULAR CHARACTERIZATION; ARTEMISIA POLLEN; HAZELNUT ALLERGY; ROSACEAE FRUITS; MAJOR ALLERGEN	Background: Food allergy is increasingly common worldwide. Tools for allergy diagnosis measuring IgE improved much since allergenic molecules and microarrays started to be used. IgE response toward allergens belonging to the same group of molecules has not been comprehensively explored using such approach yet. Objective: Using the model of lipid transfer proteins (LTPs) from plants as allergens, including two new structures, we sought to define how heterogeneous is the behavior of homologous proteins. Methods: Two new allergenic LTPs, Act d 10 and Act c 10, have been identified in green (Actinidia deliciosa) and gold (Actinidia chinensis) kiwifruit (KF), respectively, using clinically characterized allergic patients, and their biochemical features comparatively evaluated by means of amino acid sequence alignments. Along with other five LTPs from peach, mulberry, hazelnut, peanut, mugwort, KF LTPs, preliminary tested positive for IgE, have been immobilized on a microarray, used for IgE testing 1,003 allergic subjects. Comparative analysis has been carried out. Results: Alignment of Act d 10 primary structure with the other allergenic LTPs shows amino acid identities to be in a narrow range between 40 and 55%, with a number of substitutions making the sequences quite different from each other. Although peach LTP dominates the IgE immune response in terms of prevalence, epitope recognition driven by sequence heterogeneity has been recorded to be distributed in a wide range of behaviors. KF LTPs IgE positive results were obtained in a patient subset IgE positive for the peach LTP. Anyhow, the negative results on homologous molecules allowed us to reintroduce KF in patients' diet. Conclusion: The biochemical nature of allergenic molecule belonging to a group of homologous ones should not be taken as proof of immunological recognition as well. The availability of panels of homologous molecules to be tested using microarrays is valuable to address the therapeutic intervention.	[Bernardi, Maria Livia; Giangrieco, Ivana; Ferrara, Rosetta; Palazzo, Paola; Crescenzo, Roberta; Zennaro, Danila; Liso, Marina; Santoro, Mario; Zuzzi, Sara; Mari, Adriano] IDI IRCCS, Ctr Mol Allergol, Rome, Italy; [Giangrieco, Ivana; Camardella, Laura; Panico, Maria Rosaria; Crescenzo, Roberta; Carratore, Vito; Tamburrini, Maurizio; Ciardiello, Maria Antonietta] CNR, Inst Prot Biochem, I-80125 Naples, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Bernardi, ML (corresponding author), IDI IRCCS, Ctr Mol Allergol, Rome, Italy.	adriano.mari@idi.it	Santoro, Mario/GVU-5164-2022; Liso, Marina/AAB-3723-2019	Santoro, Mario/0000-0001-6626-9430; CIARDIELLO, MARIA ANTONIETTA/0000-0002-7203-0554; LISO, MARINA/0000-0002-8766-1869	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The study has been funded by the Italian Ministry of Health, Programma Ricerca Corrente 2008-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; Asero R, 2004, ANN ALLERG ASTHMA IM, V92, P268, DOI 10.1016/S1081-1206(10)61559-1; Asero R, 2011, J INVEST ALLERG CLIN, V21, P129; Asero R, 2011, INT ARCH ALLERGY IMM, V155, P149, DOI 10.1159/000318864; Beezhold DH, 2003, ANN ALLERG ASTHMA IM, V90, P439, DOI 10.1016/S1081-1206(10)61830-3; Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; Borges JP, 2008, BIOCHEM BIOPH RES CO, V365, P685, DOI 10.1016/j.bbrc.2007.11.046; Bublin M, 2011, CLIN EXP ALLERGY, V41, P129, DOI 10.1111/j.1365-2222.2010.03619.x; Bublin M, 2008, MOL NUTR FOOD RES, V52, P1130, DOI 10.1002/mnfr.200700167; Cavatorta V, 2010, MOL NUTR FOOD RES, V54, P1452, DOI 10.1002/mnfr.200900552; Cavatorta V, 2009, J MASS SPECTROM, V44, P891, DOI 10.1002/jms.1562; Ciardiello MA, 2010, ALLERGY, V65, P597, DOI 10.1111/j.1398-9995.2009.02277.x; Ciardiello MA, 2008, PROTEINS, V71, P195, DOI 10.1002/prot.21681; Ciardiello MA, 2009, J AGR FOOD CHEM, V57, P1565, DOI 10.1021/jf802966n; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; Egger M, 2010, CURR ALLERGY ASTHM R, V10, P326, DOI 10.1007/s11882-010-0128-9; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Fernandez-Rivas M, 2009, ALLERGY, V64, P876, DOI 10.1111/j.1398-9995.2008.01921.x; Ferreira F, 2004, ALLERGY, V59, P243, DOI 10.1046/j.1398-9995.2003.00407.x; Flinterman AE, 2008, J ALLERGY CLIN IMMUN, V121, P423, DOI 10.1016/j.jaci.2007.10.009; Gadermaier G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024150; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Garcia-Selles FJ, 2002, INT ARCH ALLERGY IMM, V128, P115, DOI 10.1159/000059401; Gonzalez-Mancebo E, 2011, J INVEST ALLERG CLIN, V21, P278; Hansen KS, 2009, J ALLERGY CLIN IMMUN, V123, P1134, DOI 10.1016/j.jaci.2009.02.005; Hartz C, 2007, MOL IMMUNOL, V44, P2820, DOI 10.1016/j.molimm.2007.01.030; Hartz C, 2010, INT ARCH ALLERGY IMM, V153, P335, DOI 10.1159/000316344; Harwanegg Christian, 2007, V385, P145, DOI 10.1007/978-1-59745-426-1_11; Hauser M, 2011, CLIN EXP ALLERGY, V41, P1804, DOI 10.1111/j.1365-2222.2011.03866.x; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Lauer I, 2007, CLIN EXP ALLERGY, V37, P261, DOI 10.1111/j.1365-2222.2007.02653.x; Lauer I, 2009, CLIN EXP ALLERGY, V39, P1427, DOI 10.1111/j.1365-2222.2009.03312.x; Lombardero M, 2004, CLIN EXP ALLERGY, V34, P1415, DOI 10.1111/j.1365-2222.2004.02053.x; Mari A, 2011, CURR OPIN ALLERGY CL, V11, P438, DOI 10.1097/ACI.0b013e32834a41dd; Mari A, 2010, CURR ALLERGY ASTHM R, V10, P357, DOI 10.1007/s11882-010-0132-0; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; Nicolaou N, 2011, J ALLERGY CLIN IMMUN, V127, P684, DOI 10.1016/j.jaci.2010.12.012; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Palacin A, 2010, CLIN EXP ALLERGY, V40, P1422, DOI 10.1111/j.1365-2222.2010.03578.x; Palacin A, 2010, INT ARCH ALLERGY IMM, V152, P178, DOI 10.1159/000265539; Pastorello EA, 2002, J ALLERGY CLIN IMMUN, V110, P310, DOI 10.1067/mai.2002.125830; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2011, MOL IMMUNOL, V48, P600, DOI 10.1016/j.molimm.2010.10.019; Ruiz-Garcia M, 2011, J ALLERGY CLIN IMMUN, V128, P416, DOI 10.1016/j.jaci.2011.03.008; Salcedo G, 2004, CLIN EXP ALLERGY, V34, P1336, DOI 10.1111/j.1365-2222.2004.02018.x; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Scala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024912; Schocker F, 2004, J ALLERGY CLIN IMMUN, V113, P141, DOI 10.1016/j.jaci.2003.09.013; Tordesillas L, 2011, INT ARCH ALLERGY IMM, V156, P291, DOI 10.1159/000323503; Tordesillas L, 2009, MOL IMMUNOL, V47, P534, DOI 10.1016/j.molimm.2009.07.028; Vassilopoulou E, 2007, INT ARCH ALLERGY IMM, V143, P92, DOI 10.1159/000098657; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zoccatelli G, 2010, MOL IMMUNOL, V47, P1561, DOI 10.1016/j.molimm.2010.01.009; Zuidmeer L, 2007, CURR OPIN ALLERGY CL, V7, P269, DOI 10.1097/ACI.0b013e32814a5401	62	56	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27856	10.1371/journal.pone.0027856	http://dx.doi.org/10.1371/journal.pone.0027856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114713	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800041
J	Cozzi-Lepri, A; Prosperi, MCF; Kjaer, J; Dunn, D; Paredes, R; Sabin, CA; Lundgren, JD; Phillips, AN; Pillay, D				Cozzi-Lepri, Alessandro; Prosperi, Mattia C. F.; Kjaer, Jesper; Dunn, David; Paredes, Roger; Sabin, Caroline A.; Lundgren, Jens D.; Phillips, Andrew N.; Pillay, Deenan		EuroSIDA United Kingdom CHIC	Can Linear Regression Modeling Help Clinicians in the Interpretation of Genotypic Resistance Data? An Application to Derive a Lopinavir-Score	PLOS ONE			English	Article							VIROLOGICAL RESPONSE; PROTEASE GENOTYPE; GENETIC BARRIER; MARKOV MODEL; LOPINAVIR/RITONAVIR; PREDICTION; PHENOTYPE; RITONAVIR; IDENTIFICATION; VALIDATION	Background: The question of whether a score for a specific antiretroviral (e. g. lopinavir/r in this analysis) that improves prediction of viral load response given by existing expert-based interpretation systems (IS) could be derived from analyzing the correlation between genotypic data and virological response using statistical methods remains largely unanswered. Methods and Findings: We used the data of the patients from the UK Collaborative HIV Cohort (UK CHIC) Study for whom genotypic data were stored in the UK HIV Drug Resistance Database (UK HDRD) to construct a training/validation dataset of treatment change episodes (TCE). We used the average square error (ASE) on a 10-fold cross-validation and on a test dataset (the EuroSIDA TCE database) to compare the performance of a newly derived lopinavir/r score with that of the 3 most widely used expert-based interpretation rules (ANRS, HIVDB and Rega). Our analysis identified mutations V82A, I54V, K20I and I62V, which were associated with reduced viral response and mutations I15V and V91S which determined lopinavir/r hypersensitivity. All models performed equally well (ASE on test ranging between 1.1 and 1.3, p = 0.34). Conclusions: We fully explored the potential of linear regression to construct a simple predictive model for lopinavir/rbased TCE. Although, the performance of our proposed score was similar to that of already existing IS, previously unrecognized lopinavir/r-associated mutations were identified. The analysis illustrates an approach of validation of expert-based IS that could be used in the future for other antiretrovirals and in other settings outside HIV research.	[Cozzi-Lepri, Alessandro; Sabin, Caroline A.; Phillips, Andrew N.] UCL Med Sch, Dept Infect & Populat Hlth, Div Populat Hlth, London, England; [Cozzi-Lepri, Alessandro] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Prosperi, Mattia C. F.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Emerging Pathogens Inst, Gainesville, FL USA; [Kjaer, Jesper; Lundgren, Jens D.] Univ Copenhagen, Panum Inst, Copenhagen HIV Programme, DK-2200 Copenhagen, Denmark; [Dunn, David] MRC, Clin Trials Unit, London, England; [Paredes, Roger] Hosp Badalona Germans Trias & Pujol, HIV Unit, Barcelona, Spain; [Paredes, Roger] Hosp Badalona Germans Trias & Pujol, IrsiCaixa Retrovirol Lab, Barcelona, Spain; [Lundgren, Jens D.] Copenhagen Univ Hosp, Ctr Viral Dis, Dept Infect Dis, Copenhagen, Denmark; [Pillay, Deenan] UCL, Dept Virol, London, England	University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida; University of Copenhagen; Medical Research Council Clinical Trials Unit; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; University of Copenhagen; University of London; University College London	Cozzi-Lepri, A (corresponding author), UCL Med Sch, Dept Infect & Populat Hlth, Div Populat Hlth, Royal Free Campus, London, England.	aclepri@ccbr.umn.edu	Anderson, Jane/A-1632-2012; Sabin, Caroline/C-2464-2008; Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008	Anderson, Jane/0000-0001-5294-8707; Sabin, Caroline/0000-0001-5173-2760; Phillips, Andrew N/0000-0003-2384-4807; Dunn, David/0000-0003-1836-4446; Lundgren, Jens/0000-0001-8901-7850	Department of Health; Swiss National Science Foundation [108787]; EU [223131]; Bristol-Myers Squibb; Gilead; Pfizer; Tibotec (a division of Janssen-Cilag Ltd); European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; MRC [MC_U122886351, G0900274, MC_EX_G0800814] Funding Source: UKRI; Medical Research Council [MC_U122886351, MC_EX_G0800814, G0900274] Funding Source: researchfish	Department of Health; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Pfizer(Pfizer); Tibotec (a division of Janssen-Cilag Ltd); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The United Kingdom HIV Drug Resistance Database is partly funded by the Department of Health; the views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Additional support is provided by Bristol-Myers Squibb, Gilead, Pfizer, and Tibotec (a division of Janssen-Cilag Ltd). Primary support for EuroSIDA is provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632) and the 7th Framework (FP7/2007-2013, EuroCoord n<SUP>o</SUP> 260694) programmes. Current support also includes unrestricted grants by Gilead, Pfizer, and Merck and Co.; The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). Additional funding provided to Deenan Pillay from the EU FP 7 CHAIN grant (223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ABB PHARM, 2004, LOP RIT KAL US PRESC; Altmann A, 2007, ANTIVIR THER, V12, P169; Assoumou L, 2008, J INFECT DIS, V198, P470, DOI 10.1086/590156; Assoumou L, 2010, J ANTIMICROB CHEMOTH, V65, P752, DOI 10.1093/jac/dkq034; Assoumou L, 2010, AIDS, V24, P365, DOI 10.1097/QAD.0b013e32833338ba; Beerenwinkel N, 2007, BIOSTATISTICS, V8, P53, DOI 10.1093/biostatistics/kxj033; *BHIVA, 2008, BHIVA GUID TREATM HI; Bogojeska J, 2010, BIOINFORMATICS, V26, P2085, DOI 10.1093/bioinformatics/btq361; Buendia P, 2009, BIOINFORMATICS, V25, P2522, DOI 10.1093/bioinformatics/btp466; de Requena DG, 2004, AIDS RES HUM RETROV, V20, P275, DOI 10.1089/088922204322996509; Deforche K, 2008, ANTIVIR THER, V13, P399; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Gianotti N, 2006, J MED VIROL, V78, P1537, DOI 10.1002/jmv.20736; Grant P, 2008, ANTIMICROB AGENTS CH, V52, P4050, DOI 10.1128/AAC.00605-08; Grant RM, 1996, CURR OPIN INFECT DIS, V9, P7, DOI 10.1097/00001432-199602000-00003; Hill A, 2009, HIV MED, V10, P620, DOI 10.1111/j.1468-1293.2009.00734.x; Kempf DJ, 2001, J VIROL, V75, P7462, DOI 10.1128/JVI.75.16.7462-7469.2001; King MS, 2007, ANTIMICROB AGENTS CH, V51, P3067, DOI 10.1128/AAC.00388-07; KIRK O, 1994, EUROSIDA MULTICENTRE; Larder Brendan, 2008, V458, P123; Loutfy MR, 2004, ANTIVIR THER, V9, P595; Maillard A, 2007, J CLIN VIROL, V38, P131, DOI 10.1016/j.jcv.2006.11.011; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Naeger LK, 2006, AIDS, V20, P847, DOI 10.1097/01.aids.0000218548.77457.76; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Parkin NT, 2003, AIDS, V17, P955, DOI 10.1097/00002030-200305020-00003; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013753; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Sabin C, 2004, HIV MED, V5, P115; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vella S, 1995, J ACQ IMMUN DEF SYND, V10, pS20; World Health Organization, 2006, ANT THER HIV INF AD; Zazzi M, 2011, HIV MED, V12, P211, DOI 10.1111/j.1468-1293.2010.00871.x	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e25665	10.1371/journal.pone.0025665	http://dx.doi.org/10.1371/journal.pone.0025665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110581	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400006
J	Kap, M; Smedts, F; Oosterhuis, W; Winther, R; Christensen, N; Reischauer, B; Viertler, C; Groelz, D; Becker, KF; Zatloukal, K; Langer, R; Slotta-Huspenina, J; Bodo, K; de Jong, B; Oelmuller, U; Riegman, P				Kap, Marcel; Smedts, Frank; Oosterhuis, Wolter; Winther, Rosa; Christensen, Nanna; Reischauer, Bilge; Viertler, Christian; Groelz, Daniel; Becker, Karl-Friedrich; Zatloukal, Kurt; Langer, Rupert; Slotta-Huspenina, Julia; Bodo, Koppany; de Jong, Bas; Oelmuller, Uwe; Riegman, Peter			Histological Assessment of PAXgene Tissue Fixation and Stabilization Reagents	PLOS ONE			English	Article							FORMALIN; RNA; FORMALDEHYDE; RECOVERY; QUALITY; DNA	Within SPIDIA, an EC FP7 project aimed to improve pre analytic procedures, the PAXgene Tissue System ( PAXgene), was designed to improve tissue quality for parallel molecular and morphological analysis. Within the SPIDIA project promising results were found in both genomic and proteomic experiments with PAXgene-fixed and paraffin embedded tissue derived biomolecules. But, for this technology to be accepted for use in both clinical and basic research, it is essential that its adequacy for preserving morphology and antigenicity is validated relative to formalin fixation. It is our aim to assess the suitability of PAXgene tissue fixation for ( immuno) histological methods. Normal human tissue specimens (n = 70) were collected and divided into equal parts for fixation either with formalin or PAXgene. Sections of the obtained paraffin-embedded tissue were cut and stained. Morphological aspects of PAXgene-fixed tissue were described and also scored relative to formalin-fixed tissue. Performance of PAXgene-fixed tissue in immunohistochemical and in situ hybridization assays was also assessed relative to the corresponding formalin-fixed tissues. Morphology of PAXgene-fixed paraffin embedded tissue was well preserved and deemed adequate for diagnostics in most cases. Some antigens in PAXgene-fixed and paraffin embedded sections were detectable without the need for antigen retrieval, while others were detected using standard, formalin fixation based, immunohistochemistry protocols. Comparable results were obtained with in situ hybridization and histochemical stains. Basically all assessed histological techniques were found to be applicable to PAXgene-fixed and paraffin embedded tissue. In general results obtained with PAXgene-fixed tissue are comparable to those of formalin-fixed tissue. Compromises made in morphology can be called minor compared to the advantages in the molecular pathology possibilities.	[Kap, Marcel; Smedts, Frank; Oosterhuis, Wolter; de Jong, Bas; Riegman, Peter] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Reischauer, Bilge; Becker, Karl-Friedrich; Langer, Rupert; Slotta-Huspenina, Julia] Tech Univ Munich, Dept Pathol, Munich, Germany; [Winther, Rosa; Christensen, Nanna] Dako, Res & Dev, Glostrup, Denmark; [Viertler, Christian; Zatloukal, Kurt; Bodo, Koppany] Med Univ Graz, Inst Pathol, Graz, Austria; [Groelz, Daniel; Oelmuller, Uwe] Qiagen, Res & Dev, Hilden, Germany	Erasmus University Rotterdam; Erasmus MC; Technical University of Munich; Medical University of Graz; QIAGEN GmbH	Kap, M (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.	m.kap.1@erasmusmc.nl	Langer, Rupert/AAU-1174-2021; Riegman, Peter/GLS-0041-2022; Becker, Karl-Friedrich/D-3636-2015	Langer, Rupert/0000-0001-9491-3609; Becker, Karl-Friedrich/0000-0002-6801-4498	European Union [222916]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement no 222916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgley BM, 2009, J PROTEOME RES, V8, P917, DOI 10.1021/pr800503u; BANCROFT JD, 1990, THEORY PRACTICE HIST, P188; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Benchekroun M, 2004, DIAGN MOL PATHOL, V13, P116, DOI 10.1097/00019606-200406000-00008; Blum F., 1894, ANAT ANZEIGER, V9, P229; Bolt HM, 2010, ARCH TOXICOL, V84, P421, DOI 10.1007/s00204-010-0561-5; BOON ME, 1992, PATHOL RES PRACT, V188, P832, DOI 10.1016/S0344-0338(11)80240-2; Bosetti C, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdm202; DENK H, 1987, VIRCHOWS ARCH A, V410, P295, DOI 10.1007/BF00711286; Ergin B, 2010, J PROTEOME RES, V9, P5188, DOI 10.1021/pr100664e; Gnanapragasam VJ, 2010, BJU INT, V105, P274, DOI 10.1111/j.1464-410X.2009.08665.x; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Huang WY, 2010, CANCER EPIDEM BIOMAR, V19, P973, DOI 10.1158/1055-9965.EPI-10-0091; Kristensen LS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-453; Marcon N, 2009, ANN PATHOL, V29, P460, DOI 10.1016/j.annpat.2009.09.011; MATTHEWS A, 2008, WALL STREET J   0104, pB1; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Oosterhuis JW, 2003, NAT REV CANCER, V3, P73, DOI 10.1038/nrc973; Preusser M, 2008, CLIN NEUROPATHOL, V27, P388; Taylor CR, 2006, BIOTECH HISTOCHEM, V81, P3, DOI 10.1080/10520290600667866; Titford ME, 2005, ARCH PATHOL LAB MED, V129, P502; Vollmer E, 2006, Rom J Morphol Embryol, V47, P15; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261	23	62	80	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27704	10.1371/journal.pone.0027704	http://dx.doi.org/10.1371/journal.pone.0027704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110732	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400090
J	Moldobaeva, A; van Rooijen, N; Wagner, EM				Moldobaeva, Aigul; van Rooijen, Nico; Wagner, Elizabeth M.			Effects of Ischemia on Lung Macrophages	PLOS ONE			English	Article							MOUSE LUNG; ANGIOGENESIS; MONOCYTES; NEOVASCULARIZATION; CIRCULATION; INHIBITION; EXPRESSION; CXCR2; FLOW; RAT	Angiogenesis after pulmonary ischemia is initiated by reactive O(2) species and is dependent on CXC chemokine growth factors, and its magnitude is correlated with the number of lavaged macrophages. After complete obstruction of the left pulmonary artery in mice, the left lung is isolated from the peripheral circulation until 5-7 days later, when a new systemic vasculature invades the lung parenchyma. Consequently, this model offers a unique opportunity to study the differentiation and/or proliferation of monocyte-derived cells within the lung. In this study, we questioned whether macrophage subpopulations were differentially expressed and which subset contributed to growth factor release. We characterized the change in number of all macrophages (MHCII (int), CD11C+), alveolar macrophages (MHCII (int), CD11C+, CD11B-) and mature lung macrophages (MHCII (int), CD11C+, CD11B+) in left lungs from mice immediately (0 h) or 24 h after left pulmonary artery ligation (LPAL). In left lung homogenates, only lung macrophages increased 24 h after LPAL (vs. 0 h; p < 0.05). No changes in proliferation were seen in any subset by PCNA expression (0 h vs. 24 h lungs). When the number of monocytic cells was reduced with clodronate liposomes, systemic blood flow to the left lung 14 days after LPAL decreased by 42% (p < 0.01) compared to vehicle controls. Furthermore, when alveolar macrophages and lung macrophages were sorted and studied in vitro, only lung macrophages secreted the chemokine MIP-2 alpha (ELISA). These data suggest that ischemic stress within the lung contributes to the differentiation of immature monocytes to lung macrophages within the first 24 h after LPAL. Lung macrophages but not alveolar macrophages increase and secrete the proangiogenic chemokine MIP-2 alpha. Overall, an increase in the number of lung macrophages appears to be critical for neovascularization in the lung, since clodronate treatment decreased their number and attenuated functional angiogenesis.	[Moldobaeva, Aigul; van Rooijen, Nico; Wagner, Elizabeth M.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA	Johns Hopkins University	Moldobaeva, A (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	wagnerem@jhmi.edu	Van Rooijen, Nico/Z-1578-2019		National Institutes of Health (NIH) [HL071605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071605] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant HL071605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charan NB, 1997, J APPL PHYSIOL, V82, P284, DOI 10.1152/jappl.1997.82.1.284; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; ELDRIDGE LMA, 2011, AM J PHYSIOL-LUNG C; Endrys J, 1997, HEART, V78, P171, DOI 10.1136/hrt.78.2.171; Fadel E, 1998, AM J RESP CRIT CARE, V157, P1294, DOI 10.1164/ajrccm.157.4.9707063; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Jaramillo M, 2002, J IMMUNOL, V169, P7026, DOI 10.4049/jimmunol.169.12.7026; Karsner HT, 1913, J EXP MED, V18, P507, DOI 10.1084/jem.18.5.507; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; LANDBERG G, 1990, EXP CELL RES, V187, P111, DOI 10.1016/0014-4827(90)90124-S; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005; MICHEL RP, 1990, J APPL PHYSIOL, V69, P1022, DOI 10.1152/jappl.1990.69.3.1022; Mitzner W, 2000, AM J PATHOL, V157, P93, DOI 10.1016/S0002-9440(10)64521-X; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Sanchez J, 2007, J APPL PHYSIOL, V103, P594, DOI 10.1152/japplphysiol.00037.2007; Srisuma S, 2003, AM J RESP CELL MOL, V29, P172, DOI 10.1165/rcmb.2002-0276OC; Sukkar A, 2008, J APPL PHYSIOL, V104, P1470, DOI 10.1152/japplphysiol.00974.2007; Tighe RM, 2011, AM J RESP CELL MOL, V45, P781, DOI 10.1165/rcmb.2010-0471OC; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wagner EM, 2008, AM J PHYSIOL-LUNG C, V294, pL351, DOI 10.1152/ajplung.00369.2007; Wagner EM, 2006, J APPL PHYSIOL, V100, P587, DOI 10.1152/japplphysiol.00029.2005; WEIBEL ER, 1960, CIRC RES, V8, P353, DOI 10.1161/01.RES.8.2.353; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zaslona Z, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-2	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e26716	10.1371/journal.pone.0026716	http://dx.doi.org/10.1371/journal.pone.0026716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110592	Green Published, gold			2022-12-25	WOS:000297555400013
J	Aziz, M; Jacob, A; Matsuda, A; Wu, RQ; Zhou, M; Dong, WF; Yang, WL; Wang, P				Aziz, Monowar; Jacob, Asha; Matsuda, Akihisa; Wu, Rongqian; Zhou, Mian; Dong, Weifeng; Yang, Weng-Lang; Wang, Ping			Pre-Treatment of Recombinant Mouse MFG-E8 Downregulates LPS-Induced TNF-alpha Production in Macrophages via STAT3-Mediated SOCS3 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; FACTOR-FACTOR VIII; APOPTOTIC CELLS; NEGATIVE REGULATION; STAT3; TRANSDUCTION; INFLAMMATION; CLEARANCE; ISCHEMIA; BINDING	Milk fat globule-epidermal growth factor factor 8 (MFG-E8) regulates innate immune function by modulating cellular signaling, which is less understood. Herein, we aimed to investigate the direct anti-inflammatory role of MFG-E8 in macrophages by pre-treatment with recombinant murine MFG-E8 (rmMFG-E8) followed by stimulation with LPS in RAW264.7 cells and in peritoneal macrophages, isolated from wild-type (WT) or MFG-E8(-/-) mice. RAW264.7 cells and mouse peritoneal macrophages treated with rmMFG-E8 significantly downregulated LPS-induced TNF-alpha mRNA by 25% and 24%, and protein levels by 29% and 23%, respectively (P<0.05). Conversely, peritoneal macrophages isolated from MFG-E8(-/-) mice produced 28% higher levels of TNF-alpha, as compared to WT mice when treated with LPS. In in vivo, endotoxemia induced by intraperitoneal injection of LPS (5 mg/kg BW), at 4 h after induction, serum level of TNF-alpha was significantly higher in MFG-E8(-/-) mice (837 pg/mL) than that of WT (570 pg/mL, P<0.05). To elucidate the direct anti-inflammatory effect of MFG-E8, we examined STAT3 and its target gene, SOCS3. Treatment with rmMGF-E8 significantly induced pSTAT3 and SOCS3 in macrophages. Similar results were observed in in vivo treatment of rmMFG-E8 in peritoneal cells and splenic tissues. Pre-treatment with rmMFG-E8 significantly reduced LPS-induced NF-kappa B p65 contents. These data clearly indicated that rmMFG-E8 upregulated SOCS3 which in turn interacted with NF-kappa B p65, facilitating negative regulation of TLR4 signaling for LPS-induced TNF-alpha production. Our findings strongly suggest that MFG-E8 is a direct anti-inflammatory molecule, and that it could be developed as a therapy in attenuating inflammation and tissue injury.	[Aziz, Monowar; Jacob, Asha; Matsuda, Akihisa; Wu, Rongqian; Zhou, Mian; Dong, Weifeng; Yang, Weng-Lang; Wang, Ping] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Aziz, Monowar; Jacob, Asha; Matsuda, Akihisa; Wu, Rongqian; Zhou, Mian; Dong, Weifeng; Yang, Weng-Lang; Wang, Ping] N Shore Univ Hosp, Long Isl Jewish Med Ctr, Manhasset, NY USA; [Jacob, Asha; Wu, Rongqian; Zhou, Mian; Yang, Weng-Lang] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY USA	Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; Northwell Health	Aziz, M (corresponding author), N Shore Univ Hosp, Dept Surg, Manhasset, NY USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021; Wu, Rongqian/I-3614-2012	Wu, Rongqian/0000-0003-0993-4531; Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R01 GM 057468, R33 AI 080536]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI080536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057468] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH) grants, R01 GM 057468 and R33 AI 080536 (to PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Ayala A, 2006, INTENS CARE MED, V32, P637, DOI 10.1007/s00134-006-0150-5; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Behera R, 2010, CARCINOGENESIS, V31, P192, DOI 10.1093/carcin/bgp289; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Butchar JP, 2006, CURR PHARM DESIGN, V12, P4143, DOI 10.2174/138161206778743574; Chogle A, 2011, MOL MED, V17, P502, DOI 10.2119/molmed.2010.00074; Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Finfer S, 2008, NEW ENGL J MED, V358, P188, DOI 10.1056/NEJMe0708098; Friggeri A, 2010, AM J PHYSIOL-CELL PH, V299, pC1267, DOI 10.1152/ajpcell.00152.2010; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Fujimoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/470468; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Komura H, 2009, J IMMUNOL, V182, P581, DOI 10.4049/jimmunol.182.1.581; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Matsuda A, 2011, MOL MED, V17, P126, DOI 10.2119/molmed.2010.00135; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miksa M, 2006, SHOCK, V25, P586, DOI 10.1097/01.shk.0000209533.22941.d0; Miksa M, 2008, INT J MOL MED, V22, P743, DOI 10.3892/ijmm_00000080; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Yamawaki Y, 2010, AM J PHYSIOL-REG I, V298, pR403, DOI 10.1152/ajpregu.00395.2009; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004	49	62	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27685	10.1371/journal.pone.0027685	http://dx.doi.org/10.1371/journal.pone.0027685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22114683	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300042
J	Bjorkstrom, NK; Svensson, A; Malmberg, KJ; Eriksson, K; Ljunggren, HG				Bjorkstrom, Niklas K.; Svensson, Alexandra; Malmberg, Karl-Johan; Eriksson, Kristina; Ljunggren, Hans-Gustaf			Characterization of Natural Killer Cell Phenotype and Function during Recurrent Human HSV-2 Infection	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; SIMPLEX-VIRUS TYPE-2; HUMAN NK CELLS; FLOW-CYTOMETRY; SUBSET; REPERTOIRE; EDUCATION; RECEPTOR; KIR	Human natural killer (NK) cell differentiation, characterized by a loss of NKG2A in parallel with the acquisition of NKG2C, KIRs, and CD57 is stimulated by a number of virus infections, including infection with human cytomegalovirus (CMV), hantavirus, chikungunya virus, and HIV-1. Here, we addressed if HSV-2 infection in a similar way drives NK cell differentiation towards an NKG2A(-)NKG2C(+)KIR(+)CD57(+) phenotype. In contrast to infection with CMV, hantavirus, chikungunya virus, and HIV-1, recurrent HSV-2 infection did not yield an accumulation of highly differentiated NK cells in human peripheral blood. This outcome indicates that human HSV-2 infection has no significant imprinting effect on the human NK cell repertoire.	[Bjorkstrom, Niklas K.; Malmberg, Karl-Johan; Ljunggren, Hans-Gustaf] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Svensson, Alexandra; Eriksson, Kristina] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Bjorkstrom, NK (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden.	niklas.bjorkstrom@ki.se	Björkström, Niklas/N-2919-2017	Björkström, Niklas/0000-0002-0967-076X; Malmberg, Karl-Johan/0000-0002-8718-9373	Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Society; Karolinska Institutet; Karolinska University Hospital	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet)	This work was supported by grants from the Swedish Foundation for Strategic Research, the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institutet, and the Karolinska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bjorkstrom NK, 2010, METHODS MOL BIOL, V612, P353, DOI 10.1007/978-1-60761-362-6_24; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Chan T, 2011, J REPROD IMMUNOL, V88, P210, DOI 10.1016/j.jri.2011.01.001; Gorander S, 2003, J CLIN MICROBIOL, V41, P3681, DOI 10.1128/JCM.41.8.3681-3686.2003; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665	19	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27664	10.1371/journal.pone.0027664	http://dx.doi.org/10.1371/journal.pone.0027664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110712	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300041
J	Andersson, P; Pluim, JPW; Siero, JCW; Klein, S; Viergever, MA; Ramsey, NF				Andersson, Patrik; Pluim, Josien P. W.; Siero, Jeroen C. W.; Klein, Stefan; Viergever, Max A.; Ramsey, Nick F.			Real-Time Decoding of Brain Responses to Visuospatial Attention Using 7T fMRI	PLOS ONE			English	Article							COMPUTER INTERFACE BCI; FUNCTIONAL MRI; VISUAL-CORTEX; SPATIAL ATTENTION; CORTICAL CONTROL; BOLD SIGNAL; COMMUNICATION; FIELD; EEG; MODULATION	Brain-Computer interface technologies mean to create new communication channels between our mind and our environment, independent of the motor system, by detecting and classifying self regulation of local brain activity. BCIs can provide patients with severe paralysis a means to communicate and to live more independent lives. There has been a growing interest in using invasive recordings for BCI to improve the signal quality. This also potentially gives access to new control strategies previously inaccessible by non-invasive methods. However, before surgery, the best implantation site needs to be determined. The blood-oxygen-level dependent signal changes measured with fMRI have been shown to agree well spatially with those found with invasive electrodes, and are the best option for pre-surgical localization. We show, using real-time fMRI at 7T, that eye movement-independent visuospatial attention can be used as a reliable control strategy for BCIs. At this field strength even subtle signal changes can be detected in single trials thanks to the high contrast-to-noise ratio. A group of healthy subjects were instructed to move their attention between three (two peripheral and one central) spatial target regions while keeping their gaze fixated at the center. The activated regions were first located and thereafter the subjects were given real-time feedback based on the activity in these regions. All subjects managed to regulate local brain areas without training, which suggests that visuospatial attention is a promising new target for intracranial BCI. ECoG data recorded from one epilepsy patient showed that local changes in gamma-power can be used to separate the three classes.	[Andersson, Patrik; Pluim, Josien P. W.; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Siero, Jeroen C. W.; Ramsey, Nick F.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Div Neurosci, Utrecht, Netherlands; [Klein, Stefan] ErasmusMC, Dept Radiol & Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Andersson, P (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	patrik@isi.uu.nl	Viergever, Max A/J-1215-2014; Siero, Jeroen Cornelis Willem/I-4841-2019	Siero, Jeroen Cornelis Willem/0000-0001-5079-2868; Klein, Stefan/0000-0003-4449-6784; ramsey, nick/0000-0002-7136-259X	Dutch Technology Foundation STW; Applied Science Division of Netherlands Organisation for Scientific Research; Ministry of Economic Affairs; University of Utrecht [UGT7685]; BrainGain	Dutch Technology Foundation STW(Technologiestichting STW); Applied Science Division of Netherlands Organisation for Scientific Research; Ministry of Economic Affairs; University of Utrecht; BrainGain	This work was supported by the Dutch Technology Foundation STW [to NR]; the Applied Science Division of Netherlands Organisation for Scientific Research [to NR]; the Technology Program of the Ministry of Economic Affairs [to NR]; the University of Utrecht [UGT7685 to NR] and the BrainGain Smart Mix Programme [to JS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026007; Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Allison BZ, 2010, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-1-84996-272-8_3; Bagarinao E, 2003, NEUROIMAGE, V19, P422, DOI 10.1016/S1053-8119(03)00081-8; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brefczynski-Lewis JA, 2009, J COGNITIVE NEUROSCI, V21, P1447, DOI 10.1162/jocn.2009.21005; Datta R, 2009, VISION RES, V49, P1037, DOI 10.1016/j.visres.2009.01.014; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Graimann B, 2004, IEEE T BIO-MED ENG, V51, P954, DOI 10.1109/TBME.2004.826671; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Heinemann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005560; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Kalcher J, 1996, MED BIOL ENG COMPUT, V34, P382, DOI 10.1007/BF02520010; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kelly SP, 2005, I IEEE EMBS C NEUR E, P667; Kelly SP, 2005, IEEE T BIO-MED ENG, V52, P1588, DOI 10.1109/TBME.2005.851510; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Koch VM, 2003, J VIS, V3; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Lopez-Gordo MA, 2011, CLIN NEUROPHYSIOL, V122, P128, DOI 10.1016/j.clinph.2010.05.021; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; MOENCH T, 2008, SPIE, V6916; Muller NG, 2008, NEUROIMAGE, V40, P818, DOI 10.1016/j.neuroimage.2007.11.060; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Pessoa L, 2003, J NEUROSCI, V23, P3990; Popescu F, 2008, IEEE INTELL SYST, V23, P78; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ramsey NF, 2006, IEEE T NEUR SYS REH, V14, P214, DOI 10.1109/TNSRE.2006.875582; Sanchez JC, 2008, J NEUROSCI METH, V167, P63, DOI 10.1016/j.jneumeth.2007.04.019; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shenoy P, 2008, IEEE T BIO-MED ENG, V55, P273, DOI 10.1109/TBME.2007.903528; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Sitaram R, 2008, IEEE SIGNAL PROC MAG, V25, P95, DOI 10.1109/MSP2007.910456; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; van Gerven M, 2009, NEURAL NETWORKS, V22, P1271, DOI 10.1016/j.neunet.2009.06.004; Vansteensel M.J., HUM BRAIN M IN PRESS; Vansteensel MJ, 2010, ANN NEUROL, V67, P809, DOI 10.1002/ana.21985; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe	63	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27638	10.1371/journal.pone.0027638	http://dx.doi.org/10.1371/journal.pone.0027638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110702	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300041
J	Fablet, R; Pecquerie, L; de Pontual, H; Hoie, H; Millner, R; Mosegaard, H; Kooijman, SALM				Fablet, Ronan; Pecquerie, Laure; de Pontual, Helene; Hoie, Hans; Millner, Richard; Mosegaard, Henrik; Kooijman, Sebastiaan A. L. M.			Shedding Light on Fish Otolith Biomineralization Using a Bioenergetic Approach	PLOS ONE			English	Article							COD GADUS-MORHUA; NORTHEAST ARCTIC COD; GROWTH; TEMPERATURE; AGE; ASSUMPTIONS; VALIDATION; ACCRETION; CHEMISTRY; MODEL	Otoliths are biocalcified bodies connected to the sensory system in the inner ears of fish. Their layered, biorhythm-following formation provides individual records of the age, the individual history and the natural environment of extinct and living fish species. Such data are critical for ecosystem and fisheries monitoring. They however often lack validation and the poor understanding of biomineralization mechanisms has led to striking examples of misinterpretations and subsequent erroneous conclusions in fish ecology and fisheries management. Here we develop and validate a numerical model of otolith biomineralization. Based on a general bioenergetic theory, it disentangles the complex interplay between metabolic and temperature effects on biomineralization. This model resolves controversial issues and explains poorly understood observations of otolith formation. It represents a unique simulation tool to improve otolith interpretation and applications, and, beyond, to address the effects of both climate change and ocean acidification on other biomineralizing organisms such as corals and bivalves.	[Fablet, Ronan] TELECOM Bretagne, Inst TELECOM, Lab STICC, Brest, France; [Pecquerie, Laure] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [de Pontual, Helene] IFREMER, Dept Fisheries Sci & Technol, Plouzane, France; [Hoie, Hans] Univ Bergen, Dept Biol, Bergen, Norway; [Hoie, Hans] Inst Marine Res, N-5024 Bergen, Norway; [Millner, Richard] CEFAS, Lowestoft, Suffolk, England; [Mosegaard, Henrik] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Kooijman, Sebastiaan A. L. M.] Vrije Univ Amsterdam, Dept Theoret Biol, Amsterdam, Netherlands	IMT - Institut Mines-Telecom; IMT Atlantique; Universite de Bretagne Occidentale; University of California System; University of California Santa Barbara; Ifremer; University of Bergen; Institute of Marine Research - Norway; Centre for Environment Fisheries & Aquaculture Science; Technical University of Denmark; Vrije Universiteit Amsterdam	Fablet, R (corresponding author), TELECOM Bretagne, Inst TELECOM, Lab STICC, Brest, France.	ronan.fablet@telecom-bretagne.eu	Pecquerie, Laure/L-9918-2017; fablet, ronan/L-5574-2019; Pecquerie, Laure/B-2176-2012	Pecquerie, Laure/0000-0002-2973-1056; fablet, ronan/0000-0002-6462-423X; Pecquerie, Laure/0000-0002-2973-1056; Kooijman, Sebastiaan A. L. M./0000-0002-5767-0027; de Pontual, Helene/0000-0001-5813-4042; Mosegaard, Henrik/0000-0001-7045-9456	National Science Foundation (NSF) [EF-0742521, DEB-0717259]; ANR	National Science Foundation (NSF)(National Science Foundation (NSF)); ANR(French National Research Agency (ANR))	This study was partially funded by National Science Foundation (NSF) grants EF-0742521 and DEB-0717259 to L.P. and ANR grant OTOCAL to R.F. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand Denis, 2007, P291, DOI 10.1002/9783527619443.ch17; Andrews AH, 2009, CAN J FISH AQUAT SCI, V66, P1130, DOI 10.1139/F09-059; BEAMISH RJ, 1996, RECENT DEV FISH OTOL, P545; BECKMAN DW, 1996, RECENT DEV FISH OTOL, P27; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Cardoso JFMF, 2006, J SEA RES, V56, P125, DOI 10.1016/j.seares.2006.05.001; Carpenter SJ, 2003, NATURE, V423, P70, DOI 10.1038/nature01575; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; de Pontual H, 2006, ICES J MAR SCI, V63, P1674, DOI 10.1016/j.icesjms.2006.07.007; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Fablet R, 2008, COMPUT VIS IMAGE UND, V111, P295, DOI 10.1016/j.cviu.2007.12.005; Godo OR, 2000, FISH RES, V48, P127, DOI 10.1016/S0165-7836(00)00177-6; Hoie H, 2008, J APPL ICHTHYOL, V24, P138, DOI 10.1111/j.1439-0426.2007.01014.x; Hoie H, 2009, FISH RES, V96, P319, DOI 10.1016/j.fishres.2008.12.007; Hussy K, 2004, CAN J FISH AQUAT SCI, V61, P1021, DOI [10.1139/f04-038, 10.1139/F04-038]; Hussy K, 2004, CAN J FISH AQUAT SCI, V61, P1012, DOI [10.1139/f04-037, 10.1139/F04-037]; *IBACS, 2006, QQLRT200101610 IBACS; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; MILLNER RS, 2010, MARINE BIOL; MOSEGAARD H, 1987, DAILY GROWTH RATES O, P221; Muller EB, 2009, J THEOR BIOL, V259, P44, DOI 10.1016/j.jtbi.2009.03.004; Neat FC, 2008, J FISH BIOL, V73, P2527, DOI 10.1111/j.1095-8649.2008.02107.x; Pilling GM, 2007, J FISH BIOL, V70, P584, DOI 10.1111/j.1095-8649.2007.01331.x; Romanek CS, 1996, COMP BIOCHEM PHYS A, V114, P71, DOI 10.1016/0300-9629(95)02094-2; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Schirripa MJ, 1997, ECOL MODEL, V102, P209, DOI 10.1016/S0304-3800(97)00057-4; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; VANDERVEER H, 2010, PHILOS T ROYAL SOC B; Wright PJ, 2001, J FISH BIOL, V59, P657, DOI 10.1111/j.1095-8649.2001.tb02369.x; Yaragina NA, 2000, ICES J MAR SCI, V57, P42, DOI 10.1006/jmsc.1999.0493	33	58	58	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27055	10.1371/journal.pone.0027055	http://dx.doi.org/10.1371/journal.pone.0027055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110601	Green Published, gold			2022-12-25	WOS:000297554300012
J	Petkovits, T; Nagy, LG; Hoffmann, K; Wagner, L; Nyilasi, I; Griebel, T; Schnabelrauch, D; Vogel, H; Voigt, K; Vagvolgyi, C; Papp, T				Petkovits, Tamas; Nagy, Laszlo G.; Hoffmann, Kerstin; Wagner, Lysett; Nyilasi, Ildiko; Griebel, Thasso; Schnabelrauch, Domenica; Vogel, Heiko; Voigt, Kerstin; Vagvoelgyi, Csaba; Papp, Tamas			Data Partitions, Bayesian Analysis and Phylogeny of the Zygomycetous Fungal Family Mortierellaceae, Inferred from Nuclear Ribosomal DNA Sequences	PLOS ONE			English	Article							GENUS; INFERENCE; SELECTION; ZYGOMYCOTA; MUCORALES; MRBAYES; MODELS; ACID	Although the fungal order Mortierellales constitutes one of the largest classical groups of Zygomycota, its phylogeny is poorly understood and no modern taxonomic revision is currently available. In the present study, 90 type and reference strains were used to infer a comprehensive phylogeny of Mortierellales from the sequence data of the complete ITS region and the LSU and SSU genes with a special attention to the monophyly of the genus Mortierella. Out of 15 alternative partitioning strategies compared on the basis of Bayes factors, the one with the highest number of partitions was found optimal (with mixture models yielding the best likelihood and tree length values), implying a higher complexity of evolutionary patterns in the ribosomal genes than generally recognized. Modeling the ITS1, 5.8S, and ITS2, loci separately improved model fit significantly as compared to treating all as one and the same partition. Further, within-partition mixture models suggests that not only the SSU, LSU and ITS regions evolve under qualitatively and/or quantitatively different constraints, but that significant heterogeneity can be found within these loci also. The phylogenetic analysis indicated that the genus Mortierella is paraphyletic with respect to the genera Dissophora, Gamsiella and Lobosporangium and the resulting phylogeny contradict previous, morphology-based sectional classification of Mortierella. Based on tree structure and phenotypic traits, we recognize 12 major clades, for which we attempt to summarize phenotypic similarities. M. longicollis is closely related to the outgroup taxon Rhizopus oryzae, suggesting that it belongs to the Mucorales. Our results demonstrate that traits used in previous classifications of the Mortierellales are highly homoplastic and that the Mortierellales is in a need of a reclassification, where new, phylogenetically informative phenotypic traits should be identified, with molecular phylogenies playing a decisive role.	[Petkovits, Tamas; Nagy, Laszlo G.; Nyilasi, Ildiko; Vagvoelgyi, Csaba; Papp, Tamas] Univ Szeged, Dept Microbiol, Fac Sci & Informat, Szeged, Hungary; [Hoffmann, Kerstin; Wagner, Lysett; Voigt, Kerstin] Univ Jena, Dept Microbiol & Mol Biol, Sch Biol & Pharm, Inst Microbiol, Jena, Germany; [Hoffmann, Kerstin; Wagner, Lysett; Voigt, Kerstin] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Mol & Appl Microbiol, Jena, Germany; [Griebel, Thasso] Univ Jena, Dept Bioinformat, Sch Math & Informat, Inst Informat, Jena, Germany; [Schnabelrauch, Domenica; Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	Szeged University; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Max Planck Society	Petkovits, T (corresponding author), Univ Szeged, Dept Microbiol, Fac Sci & Informat, Szeged, Hungary.	pappt@bio.u-szeged.hu	Voigt, Kerstin/AAA-9021-2019; Vagvolgyi, Csaba/L-8497-2018; Tamás, Papp/L-8272-2018; Nyilasi, Ildikó/L-8288-2018	Vagvolgyi, Csaba/0000-0003-0009-7773; Nyilasi, Ildikó/0000-0001-7457-067X; Wagner, Lysett/0000-0003-3335-3913; Papp, Tamas/0000-0001-8211-5431	German and Hungarian Research Foundations [DFG Vo 772/9-1, OTKA NN75255]	German and Hungarian Research Foundations	This research was supported by an international cooperation grant of the German and Hungarian Research Foundations (DFG Vo 772/9-1 and OTKA NN75255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS RE, 1966, MYCOLOGIA, V58, P805, DOI 10.2307/3756856; BENJAMIN R K, 1978, Aliso, V9, P157; Benny GL, 2004, MYCOLOGIA, V96, P143, DOI 10.2307/3761995; Borchsenius F, 2010, FASTGAP 1 0 8 SOFTWA; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Castoe TA, 2004, SYST BIOL, V53, P448, DOI 10.1080/10635150490445797; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; CHESTERS CHAS. G. C., 1933, TRANS BRITISH MYCOL SOC, V18, P199; CHIEN CY, 1974, MYCOLOGIA, V66, P114, DOI 10.2307/3758460; Coemans E., 1863, B ACAD R SCI BELG CL, V2, P536; Degawa Yousuke, 1997, Mycoscience, V38, P387, DOI 10.1007/BF02461677; Ekman S, 2011, SYST BIOL, DOI [10.1093/sysbio/syr022, DOI 10.1093/SYSBIO/SVR022]; EMBREE RW, 1967, B TORREY BOT CLUB, V94, P464, DOI 10.2307/2483563; Fan Y, 2011, MOL BIOL EVOL, V28, P523, DOI 10.1093/molbev/msq224; Felsenstein J., 2004, INFERRING PHYLOGENIE, P664; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Fischer A, 1892, KRYPTOGAMEN FLORA DE, VIV; Gams W., 1977, PERSOONIA, V9, P381; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Higashiyama K, 2002, BIOTECHNOL BIOPROCES, P7; HOFFMANN K, 2009, CURRENT ADV MOL MYCO, P263; Holland HL, 2001, NAT PROD REP, V18, P171, DOI 10.1039/b002681f; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Khalabuda TV, 1968, SYSTEMICA FAMILIAE M, P121; Kwasna H, 2006, MYCOL RES 5, V110; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Linnemann G, 1941, MUCORINEEN GATTUNG M, P72; MALLOCH D, 1967, MYCOLOGIA, V59, P326, DOI 10.2307/3756806; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; Meyer W, 2003, MYCOL RES, V107, P339, DOI 10.1017/S0953756203007226; Nagy LG, 2011, NEW PHYTOL, V191, P789, DOI 10.1111/j.1469-8137.2011.03707.x; Nagy LG, 2011, SYST BIOL, V60, P303, DOI 10.1093/sysbio/syr005; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Donnell K, 2001, MYCOLOGIA, V93, P286, DOI 10.2307/3761650; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2006, BAYESPHYLOGENIES 1 0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2008, TRACER 1 4 1 SOFTWAR; Rannala B, 2002, SYST BIOL, V51, P754, DOI 10.1080/10635150290102429; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Schipper MAA, 2003, MYCOLOGY S, V16, P67; Schroter J, 1893, NATURLICHEN PFLANZ 1, P119; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SHINMEN Y, 1989, APPL MICROBIOL BIOT, V31, P11, DOI 10.1007/BF00252518; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Staden R, 2000, Methods Mol Biol, V132, P115; Stamatakis A, 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thaxter R, 1914, BOT GAZ, V58, P0353, DOI 10.1086/331416; Thompson JD, 2002, BIOINFORMATICS, P231; Trytek M, 2005, BIOTECHNOL LETT, V27, P149, DOI 10.1007/s10529-004-7347-x; Voigt K, 1999, J CLIN MICROBIOL, V37, P3957, DOI 10.1128/JCM.37.12.3957-3964.1999; Voigt K, 2001, GENE, V270, P113, DOI 10.1016/S0378-1119(01)00464-4; Watanabe T, 2001, MYCOL RES, V105, P506, DOI 10.1017/S0953756201003859; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Zycha H, 1969, BESCHREIBUNG ALLER G	69	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27507	10.1371/journal.pone.0027507	http://dx.doi.org/10.1371/journal.pone.0027507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102902	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800029
J	Jedlicka, JA; Greenberg, R; Letourneau, DK				Jedlicka, Julie A.; Greenberg, Russell; Letourneau, Deborah K.			Avian Conservation Practices Strengthen Ecosystem Services in California Vineyards	PLOS ONE			English	Article							REDUCE CATERPILLAR DAMAGE; APPLE ORCHARDS; COFFEE FARMS; GREAT TITS; SUN COFFEE; PREDATORS; BIRDS; PEST; BIODIVERSITY; SHADE	Insectivorous Western Bluebirds (Sialia mexicana) occupy vineyard nest boxes established by California winegrape growers who want to encourage avian conservation. Experimentally, the provision of available nest sites serves as an alternative to exclosure methods for isolating the potential ecosystem services provided by foraging birds. We compared the abundance and species richness of avian foragers and removal rates of sentinel prey in treatments with songbird nest boxes and controls without nest boxes. The average species richness of avian insectivores increased by over 50 percent compared to controls. Insectivorous bird density nearly quadrupled, primarily due to a tenfold increase in Western Bluebird abundance. In contrast, there was no significant difference in the abundance of omnivorous or granivorous bird species some of which opportunistically forage on grapes. In a sentinel prey experiment, 2.4 times more live beet armyworms (Spodoptera exigua) were removed in the nest box treatment than in the control. As an estimate of the maximum foraging services provided by insectivorous birds, we found that larval removal rates measured immediately below occupied boxes averaged 3.5 times greater than in the control. Consequently the presence of Western Bluebirds in vineyard nest boxes strengthened ecosystem services to winegrape growers, illustrating a benefit of agroecological conservation practices. Predator addition and sentinel prey experiments lack some disadvantages of predator exclusion experiments and were robust methodologies for detecting ecosystem services.	[Jedlicka, Julie A.; Letourneau, Deborah K.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Greenberg, Russell] Smithsonian Conservat Biol Inst, Migratory Bird Ctr, Washington, DC USA	University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Jedlicka, JA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	julie.jedlicka@gmail.com		Jedlicka, Julie/0000-0003-4691-445X	The Organic Farming Research Foundation; Animal Behavior Society; Wilson Ornithological Society; Smithsonian Migratory Bird Center; Annie's Sustainable Agriculture Graduate Scholarship; Environmental Studies Department at University of California Santa Cruz	The Organic Farming Research Foundation; Animal Behavior Society; Wilson Ornithological Society; Smithsonian Migratory Bird Center(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Annie's Sustainable Agriculture Graduate Scholarship; Environmental Studies Department at University of California Santa Cruz	Funding for this research was provided by: The Organic Farming Research Foundation (http://ofrf.org); Animal Behavior Society (http://animalbehaviorsociety.org); Wilson Ornithological Society (http://www.wilsonsociety.org); Smithsonian Migratory Bird Center (http://nationalzoo.si.edu/scbi/migratorybirds/default.cfm); Annie's Sustainable Agriculture Graduate Scholarship (http://www.annies.com/sustainable_agriculture_scholarship); and the Environmental Studies Department at University of California Santa Cruz (http://envs.ucsc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Bird Conservancy, 2007, TOP 20 MOST THREAT B; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Borkhataria RR, 2006, ECOL APPL, V16, P696, DOI 10.1890/1051-0761(2006)016[0696:AEOVPO]2.0.CO;2; Brown CR, 1992, VIOLET GREEN SWALLOW; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; California Department of Food and Agriculture, 2011, CAL AGR RES DIR 2010; California Department of Food and Agriculture, 2010, CAL AGR PROD STAT 20; California Partners in Flight, 2002, VERS 2 0 OAK WOODL B; Chang GC, 2004, BIOL CONTROL, V31, P453, DOI 10.1016/j.biocontrol.2004.07.009; Cornell Lab of Ornithology, 2008, NESTWATCH; Cossentine JE, 2008, EUR J ENTOMOL, V105, P241, DOI 10.14411/eje.2008.034; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Danne A, 2010, ENVIRON ENTOMOL, V39, P970, DOI 10.1603/EN09144; Dickinson JL, 1996, ANIM BEHAV, V52, P981, DOI 10.1006/anbe.1996.0246; Ehler LE, 2007, BIOCONTROL, V52, P323, DOI 10.1007/s10526-006-9023-7; Englund G, 1997, ECOLOGY, V78, P2316; Evenden M.D., 1995, FOR CONSERV HIST, V39, P172, DOI DOI 10.2307/3983958; Fiehler CM, 2006, WILSON J ORNITHOL, V118, P552, DOI 10.1676/05-066.1; GRADWOHL J, 1982, ECOLOGY, V63, P581, DOI 10.2307/1938974; Greenberg R, 1997, CONSERV BIOL, V11, P448, DOI 10.1046/j.1523-1739.1997.95464.x; Guinan J. A., 2008, W BLUEBIRD SIALIA ME; Hagler JR, 2006, ANN APPL BIOL, V149, P153, DOI 10.1111/j.1744-7348.2006.00076.x; Heaton E., 2000, California Agriculture, V54, P12, DOI 10.3733/ca.v054n03p12; Heaton E., 2008, U CALIFORNIA AGR NAT; Holmes R.T, 1990, STUD AVIAN BIOL, V13, P6; Jacobson SK, 2003, CONSERV BIOL, V17, P595, DOI 10.1046/j.1523-1739.2003.01472.x; Johnson MD, 2010, ANIM CONSERV, V13, P140, DOI 10.1111/j.1469-1795.2009.00310.x; Kellermann JL, 2008, CONSERV BIOL, V22, P1177, DOI 10.1111/j.1523-1739.2008.00968.x; Kirk David A., 1996, Current Ornithology, V13, P175; Koball D, 2010, COMMUNICATION   0120; KOPTUR S, 1984, ECOLOGY, V65, P1787, DOI 10.2307/1937775; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; LETOURNEAU DK, 1983, OECOLOGIA, V60, P122, DOI 10.1007/BF00379331; Martin AC., 1951, AM WILDLIFE PLANTS G; Merenlender A. M., 1998, U CALIFORNIA DIVISIO, V21577; Middleton AL, 1998, CHIPPING SPARROW SPI; MOCK PJ, 1991, CONDOR, V93, P598, DOI 10.2307/1368192; MOCK PJ, 1991, AUK, V108, P34; Mols CMM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000202; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; North American Bluebird Society, 2008, E W BLUEB NESTB; Pearce S, 2006, J APPL ECOL, V43, P128, DOI 10.1111/j.1365-2664.2005.01118.x; Perfecto I, 2004, ECOLOGY, V85, P2677, DOI 10.1890/03-3145; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Prasifka JR, 2006, ENVIRON ENTOMOL, V35, P1423, DOI 10.1603/0046-225X(2006)35[1423:EOLMOP]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ralph CJ, 1993, HDB FIELD METHODS MO; Raynolds LT, 2004, WORLD DEV, V32, P725, DOI 10.1016/j.worlddev.2003.11.008; Stange Christian, 2003, Vogelwelt, V124, P25; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Toops C, 1994, BLUEBIRDS FOREVER; University of California Agriculture and Natural Resources, 1992, U CAL AGR NAT RES PU, V3343; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Walker KR, 2004, ENVIRON ENTOMOL, V33, P1327, DOI 10.1603/0046-225X-33.5.1327; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Winkler D. W., 2011, TREE SWALLOW TACHYCI	58	79	81	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27347	10.1371/journal.pone.0027347	http://dx.doi.org/10.1371/journal.pone.0027347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096555	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800046
J	Ohmi, K; Zhao, HZ; Neufeld, EF				Ohmi, Kazuhiro; Zhao, Hui-Zhi; Neufeld, Elizabeth F.			Defects in the Medial Entorhinal Cortex and Dentate Gyrus in the Mouse Model of Sanfilippo Syndrome Type B	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS IIIB MICE; ALPHA-N-ACETYLGLUCOSAMINIDASE; HEPARAN-SULFATE PROTEOGLYCANS; MITOCHONDRIAL ATP SYNTHASE; LYSOSOMAL STORAGE DISEASE; GENE DELIVERY; MPS IIIB; NEUROLOGICAL DISEASE; ALZHEIMERS-DISEASE; MURINE MODEL	Sanfilippo syndrome type B (MPS IIIB) is characterized by profound mental retardation in childhood, dementia and death in late adolescence; it is caused by deficiency of alpha-N-acetylglucosaminidase and resulting lysosomal storage of heparan sulfate. A mouse model, generated by homologous recombination of the Naglu gene, was used to study pathological changes in the brain. We found earlier that neurons in the medial entorhinal cortex (MEC) and the dentate gyrus showed a number of secondary defects, including the presence of hyperphosphorylated tau (Ptau) detected with antibodies raised against Ptau in Alzheimer disease brain. By further use of immunohistochemistry, we now show staining in neurons of the same area for beta amyloid, extending the resemblance to Alzheimer disease. Ptau inclusions in the dentate gyrus of MPS IIIB mice were reduced in number when the mice were administered LiCl, a specific inhibitor of Gsk3 beta. Additional proteins found elevated in MEC include proteins involved in autophagy and the heparan sulfate proteoglycans, glypicans 1 and 5, the latter closely related to the primary defect. The level of secondary accumulations was associated with elevation of glypican, as seen by comparing brains of mice at different ages or with different mucopolysaccharide storage diseases. The MEC of an MPS IIIA mouse had the same intense immunostaining for glypican 1 and other markers as MPS IIIB, while MEC of MPS I and MPS II mice had weak staining, and MEC of an MPS VI mouse had no staining at all for the same proteins. A considerable amount of glypican was found in MEC of MPS IIIB mice outside of lysosomes. We propose that it is the extralysosomal glypican that would be harmful to neurons, because its heparan sulfate branches could potentiate the formation of Ptau and beta amyloid aggregates, which would be toxic as well as difficult to degrade.	[Ohmi, Kazuhiro; Zhao, Hui-Zhi; Neufeld, Elizabeth F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ohmi, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	eneufeld@mednet.ucla.edu			National Institutes of Health [NS022376]; Children's Medical Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Research Foundation	The work was funded by a grant from the National Institutes of Health (NS022376) and a grant from the Children's Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; [Anonymous], 2006, ALL MOUS BRAIN ATL; Arrasate M, 1997, AM J PATHOL, V151, P1115; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Di Domenico C, 2009, AM J MED GENET A, V149A, P1209, DOI 10.1002/ajmg.a.32861; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Fu H, 2007, GENE THER, V14, P1065, DOI 10.1038/sj.gt.3302961; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Fu HY, 2010, J GENE MED, V12, P624, DOI 10.1002/jgm.1480; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Killedar S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-39; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Li XH, 2005, J NEUROCHEM, V92, P701, DOI 10.1111/j.1471-4159.2004.02898.x; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; McCarty DM, 2009, GENE THER, V16, P1340, DOI 10.1038/gt.2009.85; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Vitry S, 2010, AM J PATHOL, V177, P2984, DOI 10.2353/ajpath.2010.100447; WANG QM, 1994, J BIOL CHEM, V269, P14566; Yu WH, 2000, MOL GENET METAB, V71, P573, DOI 10.1006/mgme.2000.3095; Zheng Y, 2004, MOL GENET METAB, V82, P286, DOI 10.1016/j.ymgme.2004.06.004	43	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27461	10.1371/journal.pone.0027461	http://dx.doi.org/10.1371/journal.pone.0027461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096577	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800054
J	Steirer, LM; Moe, GR				Steirer, Lindsay M.; Moe, Gregory R.			An Antibody to De-N-Acetyl Sialic Acid Containing-Polysialic Acid Identifies an Intracellular Antigen and Induces Apoptosis in Human Cancer Cell Lines	PLOS ONE			English	Article							GROUP-B POLYSACCHARIDE; GROWTH-FACTOR RECEPTOR; MENINGITIDIS GROUP-B; HUMAN-MELANOMA CELLS; ADHESION MOLECULE; MONOCLONAL-ANTIBODIES; GD3 GANGLIOSIDE; LUNG-CANCER; EXPRESSION; NEUROBLASTOMA	Polysialic acid (PSA), an alpha 2,8-linked homopolymer of N-acetylneuraminic acid (Neu5Ac), is developmentally regulated and its expression is thought to be restricted to a few tissues in adults. Recently, we showed that two human pathogens expressed a derivative of PSA containing de-N-acetyl sialic acid residues (NeuPSA). Here we show that an epitope identified by the anti-NeuPSA monoclonal antibody, SEAM 3 (SEAM 3-reactive antigen or S3RA), is expressed in human melanomas, and also intracellularly in a human melanoma cell line (SK-MEL-28), a human T cell leukemia cell line (Jurkat), and two neuroblastoma cell lines (CHP-134 and SH-SY5Y). SEAM 3 binding induced apoptosis in the four cell lines tested. The unusual intracellular distribution of S3RA was similar to that described for the PSA polysialyltransferases, STX and PST, which are also expressed in the four cell lines used here. Interestingly, suppression of PST mRNA expression by transfection of SK-MEL-28 cells with PST-specific short interfering RNA (siRNA) resulted in decreased SEAM 3 binding. The results suggest further studies of the utility of antibodies such as SEAM 3 as therapeutic agents for certain malignancies.	[Steirer, Lindsay M.; Moe, Gregory R.] CHORI, Ctr Canc, Oakland, CA USA; [Moe, Gregory R.] CHORI, Immunobiol & Vaccine Dev, Oakland, CA USA	Children's Hospital Oakland Research Institute; Children's Hospital Oakland Research Institute	Steirer, LM (corresponding author), CHORI, Ctr Canc, Oakland, CA USA.	gmoe@chori.org			NIH NIAID [AI064314]; NIH NCRR [CO6 RR-16226, S10RR025472]; Children's Hospital Branches, Inc.; NIH NHLBI [T-32 5T32DK078514-09]; Swim Across America San Francisco Bay Area; Jennifer Leigh Wells Family; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064314, R56AI064314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK078514] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital Branches, Inc.; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swim Across America San Francisco Bay Area; Jennifer Leigh Wells Family; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by NIH NIAID grant number AI064314 (www.niaid.nih.gov/Pages/default.aspx), NIH NCRR grant numbers CO6 RR-16226 and S10RR025472 (www.ncrr.nih.gov), Children's Hospital Branches, Inc. (www.childrenshospitalbranches.org), NIH NHLBI T-32 5T32DK078514-09 (grants.nih.gov/training/nrsa.htm), Swim Across America San Francisco Bay Area (www.swimacrossamerica.org), and the Jennifer Leigh Wells Family (www.moonlight4meningitis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2002, IEEE T MED IMAGING, V21, P296, DOI 10.1109/TMI.2002.1000254; Amoureux MC, BMC CANC, V10, P91; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRODIN T, 1985, BIOCHIM BIOPHYS ACTA, V837, P349, DOI 10.1016/0005-2760(85)90059-1; Chammas R, 1999, CANCER RES, V59, P1337; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Debarbieux S, 2009, ACTA DERMATOVENER CR, V17, P209; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Flitter BA, 2010, VACCINE, V28, P5967, DOI 10.1016/j.vaccine.2010.06.119; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gluer S, 1998, PEDIATR RES, V43, P145, DOI 10.1203/00006450-199801000-00022; Granoff DM, 1998, J IMMUNOL, V160, P5028; HANAI N, 1987, BIOCHEM BIOPH RES CO, V147, P127, DOI 10.1016/S0006-291X(87)80096-7; HANAI N, 1988, J BIOL CHEM, V263, P6296; Iovannisci DM, 2010, J EUKARYOT MICROBIOL, V57, P405, DOI 10.1111/j.1550-7408.2010.00496.x; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kang Y, 2006, GLYCOBIOLOGY, V16, P375, DOI 10.1093/glycob/cwj087; Korja M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-57; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; MANDRELL RE, 1982, J IMMUNOL, V129, P2172; MANZI AE, 1990, J BIOL CHEM, V265, P13091; Moe GR, 2006, MOL IMMUNOL, V43, P1424, DOI 10.1016/j.molimm.2005.07.033; Moe GR, 2005, INFECT IMMUN, V73, P2123, DOI 10.1128/IAI.73.4.2123-2128.2005; Moe GR, 2009, J IMMUNOL, V182, P6610, DOI 10.4049/jimmunol.0803677; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Petridis AK, 2009, ACTA NEUROCHIR, V151, P601, DOI 10.1007/s00701-009-0324-3; Popa I, 2007, GLYCOBIOLOGY, V17, P367, DOI 10.1093/glycob/cwm006; ROTH J, 1988, AM J PATHOL, V133, P227; Ruan ST, 1999, J NEUROCHEM, V72, P514, DOI 10.1046/j.1471-4159.1999.0720514.x; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Seidenfaden R, 2001, J NEUROBIOL, V46, P11, DOI 10.1002/1097-4695(200101)46:1<11::AID-NEU2>3.0.CO;2-#; SJOBERG ER, 1995, J BIOL CHEM, V270, P2921, DOI 10.1074/jbc.270.7.2921; Sonnenburg JL, 2002, J BIOL CHEM, V277, P17502, DOI 10.1074/jbc.M110867200; Tanaka F, 2000, CANCER RES, V60, P3072; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZHOU QG, 1994, J BIOL CHEM, V269, P1959; ZUBER C, 1992, J BIOL CHEM, V267, P9965	44	4	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27249	10.1371/journal.pone.0027249	http://dx.doi.org/10.1371/journal.pone.0027249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096542	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800039
J	Schneider, K; Peyraud, R; Kiefer, P; Christen, P; Delmotte, N; Massou, S; Portais, JC; Vorholt, JA				Schneider, Kathrin; Peyraud, Remi; Kiefer, Patrick; Christen, Philipp; Delmotte, Nathanael; Massou, Stephane; Portais, Jean-Charles; Vorholt, Julia A.			The Ethylmalonyl-CoA Pathway Is Used in Place of the Glyoxylate Cycle by Methylobacterium extorquens AM1 during Growth on Acetate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; METHYLENE TETRAHYDROMETHANOPTERIN DEHYDROGENASE; METABOLIC FLUX ANALYSIS; MASS-SPECTROMETRY; NONMETHYLOTROPHIC CONDITIONS; CORYNEBACTERIUM-GLUTAMICUM; RHODOBACTER-SPHAEROIDES; FORMATE DEHYDROGENASE; ESCHERICHIA-COLI; CARBON-SOURCES	Acetyl-CoA assimilation was extensively studied in organisms harboring the glyoxylate cycle. In this study, we analyzed the metabolism of the facultative methylotroph Methylobacterium extorquens AM1, which lacks isocitrate lyase, the key enzyme in the glyoxylate cycle, during growth on acetate. MS/MS-based proteomic analysis revealed that the protein repertoire of M. extorquens AM1 grown on acetate is similar to that of cells grown on methanol and includes enzymes of the ethylmalonyl-CoA (EMC) pathway that were recently shown to operate during growth on methanol. Dynamic C-13 labeling experiments indicate the presence of distinct entry points for acetate: the EMC pathway and the TCA cycle. C-13 steady-state metabolic flux analysis showed that oxidation of acetyl-CoA occurs predominantly via the TCA cycle and that assimilation occurs via the EMC pathway. Furthermore, acetyl-CoA condenses with the EMC pathway product glyoxylate, resulting in malate formation. The latter, also formed by the TCA cycle, is converted to phosphoglycerate by a reaction sequence that is reversed with respect to the serine cycle. Thus, the results obtained in this study reveal the utilization of common pathways during the growth of M. extorquens AM1 on C1 and C2 compounds, but with a major redirection of flux within the central metabolism. Furthermore, our results indicate that the metabolic flux distribution is highly complex in this model methylotroph during growth on acetate and is fundamentally different from organisms using the glyoxylate cycle.	[Schneider, Kathrin; Peyraud, Remi; Kiefer, Patrick; Christen, Philipp; Delmotte, Nathanael; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Massou, Stephane; Portais, Jean-Charles] Univ Toulouse 2, Inst Natl Sci Appl, Inst Natl Polytech Toulouse, Lab Ingn Syst Biol & Proc,Univ Toulouse, F-31077 Toulouse, France; [Massou, Stephane; Portais, Jean-Charles] INRA, UMR792, F-31400 Toulouse, France; [Massou, Stephane; Portais, Jean-Charles] CNRS, UMR5504, F-31400 Toulouse, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Vorholt, JA (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	vorholt@micro.biol.ethz.ch	Kiefer, Patrick/G-5138-2010; Delmotte, Nathanael/G-7531-2016; Peyraud, Rémi/G-5226-2010; Vorholt, Julia/K-3514-2016	Peyraud, Rémi/0000-0002-7580-042X; Vorholt, Julia/0000-0002-6011-4910; Christen, Philipp/0000-0002-3139-2874; Portais, Jean-Charles/0000-0002-3480-0933	ETH Zurich [ETH-0909-2]	ETH Zurich(ETH Zurich)	This work was supported by ETH Zurich Grant ETH-0909-2.	Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x; ALBERS H, 1976, ARCH MICROBIOL, V111, P45, DOI 10.1007/BF00446548; Anthony C., 1982, BIOCH METHYLOTROPHS; Anthony Christopher, 2011, Science Progress, V94, P109, DOI 10.3184/003685011X13044430633960; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; GOTTSCHAL JC, 1980, ARCH MICROBIOL, V126, P33, DOI 10.1007/BF00421888; Hagemeier CH, 2000, EUR J BIOCHEM, V267, P3762, DOI 10.1046/j.1432-1327.2000.01413.x; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; HARDER W, 1971, BIOCHEM J, V121, P753, DOI 10.1042/bj1210753; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Kleijn RJ, 2005, FEBS J, V272, P4970, DOI 10.1111/j.1742-4658.2005.04907.x; KORNBERG HL, 1957, BIOCHIM BIOPHYS ACTA, V24, P651, DOI 10.1016/0006-3002(57)90268-8; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Laukel M, 2003, EUR J BIOCHEM, V270, P325, DOI 10.1046/j.1432-1033.2003.03391.x; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Massou S, 2007, PHYTOCHEMISTRY, V68, P2330, DOI 10.1016/j.phytochem.2007.03.011; Massou S, 2007, METAB ENG, V9, P252, DOI 10.1016/j.ymben.2007.03.001; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Vorholt JA, 1998, J BACTERIOL, V180, P5351, DOI 10.1128/JB.180.20.5351-5356.1998; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; WALSH K, 1984, J BIOL CHEM, V259, P9646; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	44	59	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					757	766		10.1074/jbc.M111.305219	http://dx.doi.org/10.1074/jbc.M111.305219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105076	Green Published, hybrid			2022-12-25	WOS:000298682400073
J	Musiime, S; Muhairwe, F; Rutagengwa, A; Mutimura, E; Anastos, K; Hoover, DR; Shi, QH; Munyazesa, E; Emile, I; Uwineza, A; Cowan, E				Musiime, Stephenson; Muhairwe, Fred; Rutagengwa, Alfred; Mutimura, Eugene; Anastos, Kathryn; Hoover, Donald R.; Shi Qiuhu; Munyazesa, Elizaphane; Emile, Ivan; Uwineza, Annette; Cowan, Ethan			Adherence to Highly Active Antiretroviral Treatment in HIV-Infected Rwandan Women	PLOS ONE			English	Article							MULTICENTER AIDS COHORT; SUB-SAHARAN AFRICA; THERAPY; DETERMINANTS	Background: Scale-up of highly active antiretroviral treatment therapy (HAART) programs in Rwanda has been highly successful but data on adherence is limited. We examined HAART adherence in a large cohort of HIV+ Rwandan women. Methods: The Rwanda Women's Interassociation Study Assessment (RWISA) was a prospective cohort study that assessed effectiveness and toxicity of ART. We analyzed patient data 1263 months after HAART initiation to determine adherence rates in HIV+ women who had initiated HAART. Results: Of the 710 HIV+ women at baseline, 490 (87.2%) initiated HAART. Of these, 6 (1.2%) died within 12 months, 15 others (3.0%) discontinued the study and 80 others (19.0%) remained in RWISA but did not have a post-HAART initiation visit that fell within the 1263 month time points leaving 389 subjects for analysis. Of these 389, 15 women stopped their medications without being advised to do so by their doctors. Of the remaining 374 persons who reported current HAART use 354 completed the adherence assessment. All women, 354/354, reported 100% adherence to HAART at the post-HAART visit. The high self-reported level of adherence is supported by changes in laboratory measures that are influenced by HAART. The median (interquartile range) CD4 cell count measured within 6 months prior to HAART initiation was 185 (128, 253) compared to 264 (182, 380) cells/mm(3) at the post-HAART visit. Similarly, the median (interquartile range) MCV within 6 months prior to HAART initiation was 88 (83, 93) fL compared to 104 (98, 110) fL at the 1263 month visit. Conclusion: Self-reported adherence to antiretroviral treatment 1263 months after initiating therapy was 100% in this cohort of HIV-infected Rwandan women. Future studies should explore country-specific factors that may be contributing to high levels of adherence to HAART in this population.	[Musiime, Stephenson] King Faisal Hosp, Kigali, Rwanda; [Rutagengwa, Alfred; Uwineza, Annette] Natl Univ Rwanda, Fac Med, Huye, Rwanda; [Mutimura, Eugene] Womens Equ Access Care & Treatment WE ACTx, Kigali, Rwanda; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [Cowan, Ethan] Albert Einstein Coll Med, Dept Emergency Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Shi Qiuhu] New York Med Coll, Sch Hlth Sci & Practice, Valhalla, NY 10595 USA; [Munyazesa, Elizaphane] Natl Reference Lab, Kigali, Rwanda; [Emile, Ivan] Kigali Hlth Inst, Rwanda Biomed Ctr, Kigali, Rwanda	University of Rwanda; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; New York Medical College; Rwanda Biomedical Center	Musiime, S (corresponding author), King Faisal Hosp, Kigali, Rwanda.	smusiime9@gmail.com	UWINEZA, Annette/I-3984-2016	UWINEZA, Annette/0000-0003-1749-0395	Fogarty International Center, NIH [D43-TW001403]; National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS); National Institute of Allergy and Infectious [UO1-AI-35004]; Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center; National Institutes of Health (NIH) [AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; Chicago WIHS [U01-AI-34993]; National Institute of Allergy and Infectious Diseases [5 K23 AI078755-03]; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI134993, U01AI034993, P30AI051519, U01AI096299, K23AI078755, U01AI035004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615] Funding Source: NIH RePORTER	Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS); National Institute of Allergy and Infectious(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago WIHS; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors acknowledge support from the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403). This study was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious (UO1-AI-35004). The study was also supported in part by the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615), and the Chicago WIHS (U01-AI-34993). Dr. Cowan is supported by a Career Development Award from the National Institute of Allergy and Infectious Diseases (5 K23 AI078755-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Anastos K, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-34; [Anonymous], 2008, 2008 REPORT GLOBAL A; Bastard M, 2011, JAIDS-J ACQ IMM DEF, V57, P55, DOI 10.1097/QAI.0b013e318211b43b; Buclin T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018578; Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Demeester R, 2005, JAIDS-J ACQ IMM DEF, V40, P113, DOI 10.1097/01.qai.0000176590.68430.59; Do NT, 2010, AIDS RES HUM RETROV, V26, P685, DOI 10.1089/aid.2009.0222; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; HOOVER DR, 1992, J ACQ IMMUN DEF SYND, V5, P794; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kleeberger CA, 2001, J ACQ IMMUN DEF SYND, V26, P82, DOI 10.1097/00126334-200101010-00012; Lazo M, 2007, CLIN INFECT DIS, V45, P1377, DOI 10.1086/522762; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; *MIN HLTH, 2009, GUID PROV COMPR PERS; Pandolfi F, 1998, CLIN EXP IMMUNOL, V111, P564; Romanelli F, 2002, AIDS PATIENT CARE ST, V16, P405, DOI 10.1089/108729102760330245; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Stubbs BA, 2009, AIDS CARE, V21, P1412, DOI 10.1080/09540120902814395; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006	29	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27832	10.1371/journal.pone.0027832	http://dx.doi.org/10.1371/journal.pone.0027832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HZ	22114706	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800039
J	van der Helm, E; Gujar, N; Nishida, M; Walker, MP				van der Helm, Els; Gujar, Ninad; Nishida, Masaki; Walker, Matthew P.			Sleep-Dependent Facilitation of Episodic Memory Details	PLOS ONE			English	Article							SLOW-WAVE SLEEP; EYE-MOVEMENT SLEEP; DECLARATIVE MEMORY; SPINDLE ACTIVITY; HIPPOCAMPAL RIPPLES; RECOGNITION MEMORY; PERIRHINAL CORTEX; PREFRONTAL CORTEX; CONSOLIDATION; ITEM	While a role for sleep in declarative memory processing is established, the qualitative nature of this consolidation benefit, and the physiological mechanisms mediating it, remain debated. Here, we investigate the impact of sleep physiology on characteristics of episodic memory using an item- (memory elements) and context- (contextual details associated with those elements) learning paradigm; the latter being especially dependent on the hippocampus. Following back-to-back encoding of two word lists, each associated with a different context, participants were assigned to either a Nap-group, who obtained a 120-min nap, or a No Nap-group. Six hours post-encoding, participants performed a recognition test involving item-memory and context- memory judgments. In contrast to item- memory, which demonstrated no between-group differences, a significant benefit in context- memory developed in the Nap-group, the extent of which correlated both with the amount of stage-2 NREM sleep and frontal fast sleep-spindles. Furthermore, a difference was observed on the basis of word-list order, with the sleep benefit and associated physiological correlations being selective for the second word-list, learned last (most proximal to sleep). These findings suggest that sleep may preferentially benefit contextual (hippocampal-dependent) aspects of memory, supported by sleep-spindle oscillations, and that the temporal order of initial learning differentially determines subsequent offline consolidation.	[van der Helm, Els; Gujar, Ninad; Nishida, Masaki; Walker, Matthew P.] Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [van der Helm, Els; Gujar, Ninad; Nishida, Masaki; Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Nishida, Masaki] Tokyo Med & Dent Univ, Sect Psychiat & Behav Sci, Bunkyo Ku, Tokyo, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tokyo Medical & Dental University (TMDU)	van der Helm, E (corresponding author), Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, 3210 Tolman Hall, Berkeley, CA 94720 USA.	mpwalker@berkeley.edu	Nishida, Masaki/O-7439-2018	Nishida, Masaki/0000-0003-2661-4425	National Institutes of Health, National Institute of Aging [RO1AG031164]; NATIONAL INSTITUTE ON AGING [R01AG031164] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health, National Institute of Aging RO1AG031164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY A, 1979, PSYCHOL GEDACHTNISSE; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Brown RM, 2007, NAT NEUROSCI, V10, P148, DOI 10.1038/nn1836; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cansino S, 2008, COGN AFFECT BEHAV NE, V8, P85, DOI 10.3758/CABN.8.1.85; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Clemens Z, 2006, NEUROSCI LETT, V403, P52, DOI 10.1016/j.neulet.2006.04.035; Cohen NJ, 1997, MEMORY, V5, P131, DOI 10.1080/741941149; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dinges DF, 1997, SLEEP, V20, P267; Dinges DF., 1991, SLEEP SLEEPINESS PER, P97; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drosopoulos S, 2007, J EXP PSYCHOL GEN, V136, P169, DOI 10.1037/0096-3445.136.2.169; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Ekstrom AD, 2007, LEARN MEMORY, V14, P645, DOI 10.1101/lm.575107; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Fogel SM, 2009, BRAIN RES BULL, V79, P445, DOI 10.1016/j.brainresbull.2009.03.002; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Graham R, 2001, CAN J EXP PSYCHOL, V55, P154, DOI 10.1037/h0087362; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Knoblauch V, 2003, CLIN NEUROPHYSIOL, V114, P2258, DOI 10.1016/S1388-2457(03)00238-4; Macmillan N. A., 1991, DETECTION THEORY USE; MANDER BA, CURR BIOL, V21, pR183; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; Miller G, 2007, SCIENCE, V315, P1360, DOI 10.1126/science.315.5817.1360; Milner CE, 2006, BIOL PSYCHOL, V73, P141, DOI 10.1016/j.biopsycho.2006.01.015; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Morin A, 2008, SLEEP, V31, P1149; Muller G.E., 1900, EXPT BEITRAGE LEHRE; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; OPITZ B, BRAIN COGN, V73, P110; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rauchs G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002949; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Ross RS, 2008, J COGNITIVE NEUROSCI, V20, P432, DOI 10.1162/jocn.2008.20.3.432; SALETIN JM, CEREB CORTEX; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Simons JS, 2005, J NEUROPHYSIOL, V94, P813, DOI 10.1152/jn.01200.2004; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Starns JJ, 2008, PSYCHON B REV, V15, P309, DOI 10.3758/PBR.15.2.309; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tamaki M, 2008, SLEEP, V31, P204, DOI 10.1093/sleep/31.2.204; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Uncapher MR, 2006, NEURON, V52, P547, DOI 10.1016/j.neuron.2006.08.011; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Walker MP, 2009, J CLIN SLEEP MED, V5, pS20; WALKER MP, NAT REV NEUROSCI, V11, P218; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; Zsofia C, 2011, EUR J NEUROSCI, V33, P511, DOI 10.1111/j.1460-9568.2010.07505.x	81	96	96	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27421	10.1371/journal.pone.0027421	http://dx.doi.org/10.1371/journal.pone.0027421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HZ	22114672	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800020
J	Chung-Delgado, K; Revilla-Montag, A; Guillen-Bravo, S; Velez-Segovia, E; Soria-Montoya, A; Nunez-Garbin, A; Silva-Caso, W; Bernabe-Ortiz, A				Chung-Delgado, Kocfa; Revilla-Montag, Alejandro; Guillen-Bravo, Sonia; Velez-Segovia, Eduardo; Soria-Montoya, Andrea; Nunez-Garbin, Alexandra; Silva-Caso, Wilmer; Bernabe-Ortiz, Antonio			Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru	PLOS ONE			English	Article							DRUG-INTERACTIONS; HEPATOTOXICITY; TUBERCULOSIS	Background: Long-term exposure to anti-tuberculosis medication increases risk of adverse drug reactions and toxicity. The objective of this investigation was to determine factors associated with anti-tuberculosis adverse drug reactions in Lima, Peru, with special emphasis on MDR-TB medication, HIV infection, diabetes, age and tobacco use. Methodology and Results: A case-control study was performed using information from Peruvian TB Programme. A case was defined as having reported an anti-TB adverse drug reaction during 2005-2010 with appropriate notification on clinical records. Controls were defined as not having reported a side effect, receiving anti-TB therapy during the same time that the case had appeared. Crude, and age-and sex-adjusted models were calculated using odds ratios (OR) and 95% confidence intervals (95% CI). A multivariable model was created to look for independent factors associated with side effect from anti-TB therapy. A total of 720 patients (144 cases and 576 controls) were analyzed. In our multivariable model, age, especially those over 40 years (OR = 3.93; 95% CI: 1.65-9.35), overweight/obesity (OR = 2.13; 95% CI: 1.17-3.89), anemia (OR = 2.10; IC95%: 1.13-3.92), MDR-TB medication (OR = 11.1; 95% CI: 6.29-19.6), and smoking (OR = 2.00; 95% CI: 1.03-3.87) were independently associated with adverse drug reactions. Conclusions: Old age, anemia, MDR-TB medication, overweight/obesity status, and smoking history are independent risk factors associated with anti-tuberculosis adverse drug reactions. Patients with these risk factors should be monitored during the anti-TB therapy. A comprehensive clinical history and additional medical exams, including hematocrit and HIV-ELISA, might be useful to identify these patients.	[Chung-Delgado, Kocfa; Revilla-Montag, Alejandro; Guillen-Bravo, Sonia; Velez-Segovia, Eduardo; Soria-Montoya, Andrea; Nunez-Garbin, Alexandra; Silva-Caso, Wilmer; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru; [Chung-Delgado, Kocfa; Revilla-Montag, Alejandro; Guillen-Bravo, Sonia; Velez-Segovia, Eduardo; Soria-Montoya, Andrea; Nunez-Garbin, Alexandra; Silva-Caso, Wilmer] Univ Peruana Ciencias Aplicadas SOCIEMUPC, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana de Ciencias Aplicadas (UPC)	Chung-Delgado, K (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru.	kocfachung@gmail.com	Silva, Wilmer Gianfranco/D-2699-2018	Silva, Wilmer Gianfranco/0000-0003-1086-8084; Chung-Delgado, Kocfa/0000-0003-1962-9434; Bernabe-Ortiz, Antonio/0000-0002-6834-1376				Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 1968, NUTR AN; Arbex MA, 2010, J BRAS PNEUMOL, V36, P626, DOI 10.1590/S1806-37132010000500016; Arbex MA, 2010, J BRAS PNEUMOL, V36, P641, DOI 10.1590/S1806-37132010000500017; Bernabe Ortiz Antonio, 2007, Rev Med Hered, V18, P179; Boldu J, 2007, AN SIST SANIT NAVAR, V30, P99; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Chang KC, 2008, AM J RESP CRIT CARE, V177, P1391, DOI 10.1164/rccm.200802-355OC; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; El Gharbi Leila, 2006, Tunis Med, V84, P487; FARGA V, 2009, REV CHIL ENFERM RESP, V25, P43; Fernandez-Villar A, 2003, CLIN INFECT DIS, V36, P293, DOI 10.1086/345906; Forget EJ, 2006, EXPERT OPIN DRUG SAF, V5, P231, DOI 10.1517/14740338.5.2.231; GEISELER PJ, 1985, AM REV RESPIR DIS, V131, P944; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; HERRERA S, 2005, ENFERM TORAX, V49, P181; Joseph P, 2011, INDIAN J MED RES, V133, P529; Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Marra F, 2007, INT J TUBERC LUNG D, V11, P868; *MIN SAL, 2008, INF GEST SIT TUB PER; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Ormerod LP, 1996, TUBERCLE LUNG DIS, V77, P37, DOI 10.1016/S0962-8479(96)90073-8; REIDENBERG MM, 1977, CLIN PHARMACOL THER, V22, P729; RIEDER HL, 2002, INTERVENTIONS TUBERC; Singla R, 2010, INDIAN J MED RES, V132, P81; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; *USAID, 2009, TUB PROF, P1; Vilarica AS, 2010, REV PORT PNEUMOL, V16, P431, DOI 10.1016/S0873-2159(15)30040-4; *WHO, 2010, GLOB TURB CONTR 2010; *WHO, 2011, NUTR BOD MASS IND BM; Xia Yin-Yin, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P419; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2008, RESPIROLOGY, V13, P21, DOI 10.1111/j.1440-1843.2007.01180.x; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x	37	44	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27610	10.1371/journal.pone.0027610	http://dx.doi.org/10.1371/journal.pone.0027610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110689	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400069
J	Stevenson, NJ; Murphy, AG; Bourke, NM; Keogh, CA; Hegarty, JE; O'Farrelly, C				Stevenson, Nigel J.; Murphy, Alison G.; Bourke, Nollaig M.; Keogh, Catherine A.; Hegarty, John E.; O'Farrelly, Cliona			Ribavirin Enhances IFN-alpha Signalling and MxA Expression: A Novel Immune Modulation Mechanism during Treatment of HCV	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SMOOTH ENDOPLASMIC-RETICULUM; ANTIVIRAL ACTIVITY; INITIAL TREATMENT; INTERFERON-ALPHA; GENE-EXPRESSION; INFLUENZA-VIRUS; PROTEIN; RNA; REPLICATION	The nucleoside analogue Ribavirin significantly increases patient response to IFN-alpha treatment of HCV, by directly inhibiting viral replication. Recent studies indicate that Ribavirin also regulates immunity and we propose that Ribavirin enhances specific interferon sensitive gene (ISG) expression by amplifying the IFN-alpha-JAK/STAT pathway. We found that IFN-alpha-induced STAT1 and STAT3 phosphorylation was increased in hepatocytes co-treated with Ribavirin and IFN-alpha, compared to IFN-alpha alone. Ribavirin specifically enhanced IFN-alpha induced mRNA and protein of the anti-viral mediator MxA, which co-localised with HCV core protein. These novel findings indicate for the first time that Ribavirin, in addition to its viral incorporation, also enhances IFN-alpha-JAK/STAT signalling, leading to a novel MxA-mediated immuno-modulatory mechanism that may enhance IFN-alpha anti-viral activity against HCV.	[Stevenson, Nigel J.; Murphy, Alison G.; Bourke, Nollaig M.; Keogh, Catherine A.; O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Hegarty, John E.] St Vincents Univ Hosp, Natl Liver Transplant Unit, Dublin 4, Ireland	Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital	Stevenson, NJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	N.Stevenson@tcd.ie	Bourke, Nollaig/AAE-7279-2019; Stevenson, Nigel/X-5412-2018; Bourke, Nollaig M/A-9840-2017	Bourke, Nollaig/0000-0003-4313-6859; Stevenson, Nigel/0000-0002-6966-9314; Bourke, Nollaig M/0000-0003-4313-6859	Irish Health Research Board	Irish Health Research Board	This study was funded by the Irish Health Research Board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; DIBISCEGLIE AM, 1995, ANN INTERN MED, V123, P897, DOI 10.7326/0003-4819-123-12-199512150-00001; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Frese M, 2001, J GEN VIROL, V82, P723, DOI 10.1099/0022-1317-82-4-723; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; MacQuillan GC, 2002, J MED VIROL, V68, P197, DOI 10.1002/jmv.10182; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 1999, SEMIN LIVER DIS, V19, P57; Ning Q, 1998, J IMMUNOL, V160, P3487; REICHARD O, 1991, LANCET, V337, P1058, DOI 10.1016/0140-6736(91)91707-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	29	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27866	10.1371/journal.pone.0027866	http://dx.doi.org/10.1371/journal.pone.0027866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114715	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400132
J	Yin, DT; Wang, QE; Chen, L; Liu, MY; Han, CH; Yan, QT; Shen, RL; He, G; Duan, WR; Li, JJ; Wani, A; Gao, JX				Yin, De-Tao; Wang, Qien; Chen, Li; Liu, Meng-Yao; Han, Chunhua; Yan, Qingtao; Shen, Rulong; He, Gang; Duan, Wenrui; Li, Jian-Jian; Wani, Altaf; Gao, Jian-Xin			Germline Stem Cell Gene PIWIL2 Mediates DNA Repair through Relaxation of Chromatin	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; INTERACTING RNAS PIRNAS; DOUBLE-STRAND BREAKS; DAMAGE RESPONSE; HISTONE ACETYLATION; ANTICANCER BARRIER; PROTEIN PIWIL2; PAZ DOMAIN; FAMILY; MILI	DNA damage response (DDR) is an intrinsic barrier of cell to tumorigenesis initiated by genotoxic agents. However, the mechanisms underlying the DDR are not completely understood despite of extensive investigation. Recently, we have reported that ectopic expression of germline stem cell gene PIWIL2 is associated with tumor stem cell development, although the underlying mechanisms are largely unknown. Here we show that PIWIL2 is required for the repair of DNA-damage induced by various types of genotoxic agents. Upon ultraviolet (UV) irradiation, silenced PIWIL2 gene in normal human fibroblasts was transiently activated after treatment with UV light. This activation was associated with DNA repair, because Piwil2-deficienct mouse embryonic fibroblasts (mili(-/-) MEFs) were defective in cyclobutane pyrimidine dimers (CPD) repair after UV treatment. As a result, the UV-treated mili(-/-) MEFs were more susceptible to apoptosis, as characterized by increased levels of DNA damage-associated apoptotic proteins, such as active caspase-3, cleaved Poly (ADP-ribose) polymerase (PARP) and Bik. The impaired DNA repair in the mili(-/-) MEFs was associated with the reductions of histone H3 acetylation and chromatin relaxation, although the DDR pathway downstream chromatin relaxation appeared not to be directly affected by Piwil2. Moreover, guanine-guanine (Pt-[GG]) and double strand break (DSB) repair were also defective in the mili(-/-) MEFs treated by genotoxic chemicals Cisplatin and ionizing radiation (IR), respectively. The results indicate that Piwil2 can mediate DNA repair through an axis of Piwil2 -> histone acetylation -> chromatin relaxation upstream DDR pathways. The findings reveal a new role for Piwil2 in DNA repair and suggest that Piwil2 may act as a gatekeeper against DNA damage-mediated tumorigenesis.	[Yin, De-Tao; Chen, Li; Yan, Qingtao; Shen, Rulong; He, Gang; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Liu, Meng-Yao; Gao, Jian-Xin] Shanghai Jiao Tong Univ, Lab Tumorigenesis & Immun, Clin Stem Cell Res Ctr, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Wang, Qien; Han, Chunhua; Wani, Altaf] Ohio State Univ, Dept Radiol, Med Ctr, Columbus, OH 43210 USA; [Duan, Wenrui; Wani, Altaf; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yin, De-Tao] Zhengzhou Univ, Dept Gen Surg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Li, Jian-Jian] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA	University System of Ohio; Ohio State University; Shanghai Jiao Tong University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Zhengzhou University; University of California System; University of California Davis	Yin, DT (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	jianxingao@sjtu.edu.cn	Shen, Rulong/E-4079-2011	duan, wenrui/0000-0001-6512-7350; Li, Jian Jian/0000-0003-3694-9675	OSU Medical College; OSUCCC; American Cancer society [IRG-112367]; OSU; China Scholarship Council; NCI [CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER	OSU Medical College; OSUCCC; American Cancer society(American Cancer Society); OSU; China Scholarship Council(China Scholarship Council); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Strategy Initiative Grant (SIG) 2006/2007 (OSU Medical College; JXG); Immunology Program Award 2008 (OSUCCC; JXG); American Cancer society IRG-112367 (JXG); Davis/Bremer Medical Research Grant (OSU; RH and JXG); Department Start-up funding (GH); Chinese scholarship (China Scholarship Council (DTY); and Grant CA93413 (NCI; AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; DEALMODOVAR JMR, 1994, RADIAT RES, V138, pS93, DOI 10.2307/3578771; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Downey M, 2006, NAT CELL BIOL, V8, P9, DOI 10.1038/ncb0106-9; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gao JX, 2009, DRUG DISCOV TODAY DI, V6, P5; Gao JX, 2011, FIELD CANCERIZATION, P26; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; He G, 2010, AM J TRANSL RES, V2, P156; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kuo WHW, 2007, EXP CELL RES, V313, P1628, DOI 10.1016/j.yexcr.2007.02.010; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; MYAKISHEV MV, 1995, USE PERCHLORATE PREC; OGAWA Y, 1995, J BIOL CHEM, V270, P9272, DOI 10.1074/jbc.270.16.9272; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; REEDIJK J, 1985, PHARM WEEKBLAD, V7, P173, DOI 10.1007/BF02307573; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Shen RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001652; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; THOMAS DC, 1989, J BIOL CHEM, V264, P18005; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; van Gijssel HE, 2007, MUTAGENESIS, V22, P49, DOI 10.1093/mutage/gel050; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	66	40	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27154	10.1371/journal.pone.0027154	http://dx.doi.org/10.1371/journal.pone.0027154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110608	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400023
J	Zhang, L; Reidy, SP; Bogachev, O; Hall, BK; Majdalawieh, A; Ro, HS				Zhang, Lei; Reidy, Shannon P.; Bogachev, Oleg; Hall, Brian K.; Majdalawieh, Amin; Ro, Hyo-Sung			Lactation Defect with Impaired Secretory Activation in AEBP1-Null Mice	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; ENHANCER-BINDING PROTEIN-1; BREAST-CANCER DEVELOPMENT; EXTRACELLULAR-MATRIX; TRANSCRIPTIONAL REPRESSOR; HOST MICROENVIRONMENT; EPITHELIAL-CELLS; KEY STAGES; EXPRESSION; MACROPHAGES	Adipocyte enhancer binding protein 1 (AEBP1) is a multifunctional protein that negatively regulates the tumor suppressor PTEN and I kappa B alpha, the inhibitor of NF-kappa B, through protein-protein interaction, thereby promoting cell survival and inflammation. Mice homozygous for a disrupted AEBP1 gene developed to term but showed defects in growth after birth. AEBP1(-/-) females display lactation defect, which results in the death of 100% of the litters nursed by AEBP1(-/-) dams. Mammary gland development during pregnancy appears normal in AEBP1(-/-) dams; however these mice exhibit expansion of the luminal space and the appearance of large cytoplasmic lipid droplets (CLDs) in the mammary epithelial cells at late pregnancy and parturition, which is a clear sign of failed secretory activation, and accumulation of milk proteins in the mammary gland, presumably reflecting milk stasis following failed secretory activation. Eventually, AEBP1(-/-) mammary gland rapidly undergoes involution at postpartum. Stromal restoration of AEBP1 expression by transplanting wild-type bone marrow (BM) cells is sufficient to rescue the mammary gland defect. Our studies suggest that AEBP1 is critical in the maintenance of normal tissue architecture and function of the mammary gland tissue and controls stromal-epithelial crosstalk in mammary gland development.	[Zhang, Lei; Reidy, Shannon P.; Bogachev, Oleg; Ro, Hyo-Sung] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Majdalawieh, Amin] Amer Univ Sharjah, Fac Arts & Sci, Dept Biol Chem & Environm Sci, Sharjah, U Arab Emirates	Dalhousie University; Dalhousie University; American University of Sharjah	Zhang, L (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	hsro@dal.ca	Majdalawieh, Amin/AAZ-9349-2020	Majdalawieh, Amin/0000-0002-0240-1057; Ro, Hyo-Sung/0000-0003-4411-0386	Canadian Institute of Health Research [MOP-57675]; Canadian Breast Cancer Research Alliance [019454]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance	This work was supported by grant from the Canadian Institute of Health Research (MOP-57675) and Canadian Breast Cancer Research Alliance (019454) to H. S. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bogachev O, 2011, MOL MED, V17, P1056, DOI 10.2119/molmed.2011.00141; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; CUNHA GR, 2000, METHODS MAMMARY GLAN, P289; DEOME KB, 1959, CANCER RES, V19, P515; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Gorbenko O, 2004, EXP ONCOL, V26, P15; Gouon-Evans V, 2002, BREAST CANCER RES, V4, P155, DOI 10.1186/bcr441; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; Haslam SZ, 2003, BREAST CANCER RES, V5, P208, DOI 10.1186/bcr615; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Ho MY, 1997, MOL CELL ENDOCRINOL, V136, P15, DOI 10.1016/S0303-7207(97)00208-6; HOWLETT AR, 1993, EPITHELIAL CELL BIOL, V2, P79; Hutt JA, 2000, J BIOL CHEM, V275, P29123, DOI 10.1074/jbc.M004476200; Karim RZ, 2009, PATHOLOGY, V41, P105, DOI 10.1080/00313020802579342; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Layne MD, 2001, MOL CELL BIOL, V21, P5256, DOI 10.1128/MCB.21.15.5256-5261.2001; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Li G, 2002, DEVELOPMENT, V129, P4159; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lyons PJ, 2005, BIOCHEMISTRY-US, V44, P926, DOI 10.1021/bi0480178; Majdalawieh A, 2006, P NATL ACAD SCI USA, V103, P2346, DOI 10.1073/pnas.0508139103; Majdalawieh A, 2007, MOL BIOL CELL, V18, P930, DOI 10.1091/mbc.E06-03-0217; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Majdalawieh A, 2009, INT J BIOCHEM CELL B, V41, P1518, DOI 10.1016/j.biocel.2009.01.003; Nguyen DA, 2001, J ENDOCRINOL, V170, P347, DOI 10.1677/joe.0.1700347; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Palmer CA, 2003, TRANSGENIC RES, V12, P283, DOI 10.1023/A:1023398926763; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Ro HS, 2001, GENE, V280, P123, DOI 10.1016/S0378-1119(01)00771-5; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Shekhar MPV, 2003, BREAST CANCER RES, V5, P130, DOI 10.1186/bcr580; STINNAKRE MG, 1994, P NATL ACAD SCI USA, V91, P6544, DOI 10.1073/pnas.91.14.6544; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wagner Kay-Uwe, 1997, Genes and Function, V1, P233; Watkin H, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-6; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Young LJT, 2000, METHODS MAMMARY GLAN, P67; Zhang L, 2005, MOL MED, V11, P39, DOI 10.2119/2005-00021.Ro	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27795	10.1371/journal.pone.0027795	http://dx.doi.org/10.1371/journal.pone.0027795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114697	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400115
J	Liu, J; Ding, X; Tang, J; Cao, YD; Hu, P; Zhou, F; Shan, XL; Cai, XF; Chen, QM; Ling, N; Zhang, BQ; Bi, Y; Chen, K; Ren, H; Huang, AL; He, TC; Tang, N				Liu, Jiao; Ding, Xiong; Tang, Jia; Cao, Youde; Hu, Peng; Zhou, Fan; Shan, Xiaoliang; Cai, Xuefei; Chen, Qingmei; Ling, Ning; Zhang, Bingqiang; Bi, Yang; Chen, Ke; Ren, Hong; Huang, Ailong; He, Tong-Chuan; Tang, Ni			Enhancement of Canonical Wnt/beta-Catenin Signaling Activity by HCV Core Protein Promotes Cell Growth of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							UP-REGULATION; ACTIVATION; DIFFERENTIATION; FIBROBLASTS; EXPRESSION; GSK-3-BETA; MUTATIONS; PATHWAY; INSULIN; TARGET	Background: The Hepatitis C virus (HCV) core protein has been implicated as a potential oncogene or a cofactor in HCV-related hepatocellular carcinoma (HCC), but the underlying mechanisms are unknown. Overactivation of the Wnt/beta-catenin signaling is a major factor in oncogenesis of HCC. However, the pathogenesis of HCV core-associated Wnt/beta-catenin activation remains to be further characterized. Therefore, we attempted to determine whether HCV core protein plays an important role in regulating Wnt/b-catenin signaling in HCC cells. Methodology: Wnt/b-catenin signaling activity was investigated in core-expressing hepatoma cells. Protein and gene expression were examined by Western blot, immunofluorescence staining, RT-qPCR, and reporter assay. Principal Findings: HCV core protein significantly enhances Tcf-dependent transcriptional activity induced by Wnt3A in HCC cell lines. Additionally, core protein increases and stabilizes b-catenin levels in hepatoma cell line Huh7 through inactivation of GSK-3 beta, which contributes to the up-regulation of downstream target genes, such as c-Myc, cyclin D1, WISP2 and CTGF. Also, core protein increases cell proliferation rate and promotes Wnt3A-induced tumor growth in the xenograft tumor model of human HCC. Conclusions/Significance: HCV core protein enhances Wnt/b-catenin signaling activity, hence playing an important role in HCV-associated carcinogenesis.	[Liu, Jiao; Ding, Xiong; Tang, Jia; Hu, Peng; Zhou, Fan; Shan, Xiaoliang; Cai, Xuefei; Chen, Qingmei; Ling, Ning; Chen, Ke; Ren, Hong; Huang, Ailong; Tang, Ni] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Liu, Jiao; Ding, Xiong; Tang, Jia; Hu, Peng; Zhou, Fan; Shan, Xiaoliang; Cai, Xuefei; Chen, Qingmei; Ling, Ning; Chen, Ke; Ren, Hong; Huang, Ailong; Tang, Ni] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chinese Minist Educ, Chongqing, Peoples R China; [Cao, Youde] Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China; [Zhang, Bingqiang] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Bi, Yang; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Chongqing, Peoples R China; [He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Chicago; University of Chicago Medical Center	Liu, J (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China.	nitang809@163.com			China National Natural Science Foundation [30972586, 30972584]; Natural Science Foundation CQ CSTC [CQ CSTC (2009BA5036]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0872]; Major National ST program [2008ZX10001-016, 2008ZX10002-006]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation CQ CSTC(National Natural Science Foundation of China (NSFC)Natural Science Foundation Project of CQ CSTC); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Major National ST program	This work was supported in part by research grants from China National Natural Science Foundation (#30972586, NT; #30972584, PH), Natural Science Foundation Project of CQ CSTC (2009BA5036, NT), Natural Science Foundation Project of CQMU (NT), Program for Changjiang Scholars and Innovative Research Team in University (#IRT0872, HR) and Major National S&T program (2008ZX10001-016, ALH; 2008ZX10002-006, HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; BUENDIA MA, 1992, ADV CANCER RES, V59, P167, DOI 10.1016/S0065-230X(08)60306-1; Castro-Garza J, 2007, J MED MICROBIOL, V56, P733, DOI 10.1099/jmm.0.46915-0; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Clarke B, 1997, J GEN VIROL, V78, P2397, DOI 10.1099/0022-1317-78-10-2397; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Delhem N, 2001, ONCOGENE, V20, P5836, DOI 10.1038/sj.onc.1204744; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; DILMAN R, 1998, J VIRAL HEPATITIS, V5, P285; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Fukutomi T, 2005, HEPATOLOGY, V41, P1096, DOI 10.1002/hep.20668; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Juan G, 2001, METHOD CELL BIOL, V63, P343; Kato T, 2003, CANCER SCI, V94, P679, DOI 10.1111/j.1349-7006.2003.tb01502.x; Lai MMC, 2000, CURR TOP MICROBIOL, V242, P117; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Liu J, 2011, ARCH VIROL, V156, P1013, DOI 10.1007/s00705-011-0943-x; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Otsuka M, 2000, J BIOL CHEM, V275, P34122, DOI 10.1074/jbc.M000578200; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Ray RB, 1996, J VIROL, V70, P4438, DOI 10.1128/JVI.70.7.4438-4443.1996; Tanaka S, 2003, HEPATOLOGY, V37, P1122, DOI 10.1053/jhep.2003.50187; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsuchihara K, 1999, VIROLOGY, V258, P100, DOI 10.1006/viro.1999.9694; Wei W, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-76; Xu LF, 2000, GENE DEV, V14, P585; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	45	45	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27496	10.1371/journal.pone.0027496	http://dx.doi.org/10.1371/journal.pone.0027496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110662	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300025
J	Palus, S; Schur, R; Akashi, YJ; Bockmeyer, B; Datta, R; Halem, H; Dong, J; Culler, MD; Adams, V; Anker, SD; Springer, J				Palus, Sandra; Schur, Robert; Akashi, Yoshihiro J.; Bockmeyer, Barbara; Datta, Rakesh; Halem, Heather; Dong, Jesse; Culler, Michael D.; Adams, Volker; Anker, Stefan D.; Springer, Jochen			Ghrelin and Its Analogues, BIM-28131 and BIM-28125, Improve Body Weight and Regulate the Expression of MuRF-1 and MAFbx in a Rat Heart Failure Model	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; FOOD-INTAKE; CACHEXIA; RESISTANCE; PROGNOSIS; MORTALITY; THERAPY; LIGASES; LEPTIN; FAT	Cardiac cachexia is a serious complication of chronic heart failure with a prevalence of 10-16% and poor prognosis. There are no current therapy options for cardiac cachexia. Ghrelin is the natural ligand for the GHS-1a-receptor and a potential target for conditions associated with cachexia. Ghrelin has been shown to increase weight in several species. The GHS-1a-receptor is not only found in the brain, but also in other tissues, including the myocardium. Human clinical trials with native ghrelin in cardiac cachexia demonstrated increases in appetite, weight and cardiac output. Methods: Human ghrelin or one of two analogues BIM-28125 and BIM-28131 (also known as RM-131) were tested at 50 nmole/kg/d and 500 nmole/kg/d versus placebo in a ratmodel of heart failure (myocardial infarction). Animals (SD-rats, approx. 225 g at surgery) received diuretics from day 14 and compounds from day 28 for 4 weeks using osmotic pumps. Weight was monitored and body composition analysed (NMR-scanning). Cardiac function was assessed by echocardiography and hemodynamics. Results: Animals with MI gained less weight compared to sham rats until start of the therapy (311 g vs 324 g, p = 0.0129). Animals treated with BIM-28131 at 50 nmole/kg/d or all compounds at 500 nmole/kg/d displayed stronger weight gain compared to placebo and sham (all p < 0.001). Before treatment, body composition was similar in all groups (average: 36 g fat, 248 g lean). Placebo-treated rats gained no fat, but only lean mass. The active compounds induced both fat and lean mass gain, but to a different extent. The fat-to-muscle-ratio of tissue gain was 0.9 +/- 0.07 for BIM-28131 at 50 nmole/kg/d, whereas at 500 nmole/kg/d it was 0.76 +/- 0.07 for BIM-28131, 0.68 +/- 0.12 for BIM-28125, and 0.48 +/- 0.05 for ghrelin. MuRF-1 and MAFbx were differentially regulated by treatment. Conclusion: Ghrelin is a very promising treatment option for cardiac cachexia, with the analogue BIM-28131 (RM-131) being the most effective compound.	[Palus, Sandra; Akashi, Yoshihiro J.; Bockmeyer, Barbara; Anker, Stefan D.; Springer, Jochen] Charite, Dept Cardiol, Appl Cachexia Res, Berlin, Germany; [Palus, Sandra; Akashi, Yoshihiro J.; Bockmeyer, Barbara; Springer, Jochen] Charite, Ctr Cardiovasc Res, Berlin, Germany; [Schur, Robert; Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, Dept Cardiol, Leipzig, Germany; [Datta, Rakesh; Halem, Heather; Dong, Jesse; Culler, Michael D.] IPSEN, Milford, MA USA; [Anker, Stefan D.] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy; [Springer, Jochen] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heart Center Leipzig GMBH; Leipzig University; Ipsen; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of East Anglia	Palus, S (corresponding author), Charite, Dept Cardiol, Appl Cachexia Res, Berlin, Germany.	jochen.springer@charite.de	Akashi, Yoshihiro/J-8312-2019; Akashi, Yoshihiro J/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326; Akashi, Yoshihiro J/0000-0001-7670-7326; Culler, Michael D./0000-0001-5168-8739	IPSEN Pharmaceuticals	IPSEN Pharmaceuticals(Ipsen)	This study was funded by IPSEN Pharmaceuticals through the employment of authors Rakesh Datta, Heather Halem, Jesse Dong and Michael D. Culler, who contributed to all aspects of the study.	Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Akashi YJ, 2009, INT J CARDIOL, V137, P267, DOI 10.1016/j.ijcard.2008.06.094; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Anker SD, 2001, J AM COLL CARDIOL, V38, P443, DOI 10.1016/S0735-1097(01)01385-7; Attaix D, 2001, CURR OPIN CLIN NUTR, V4, P45, DOI 10.1097/00075197-200101000-00009; Balasubramaniam A, 2006, PEPTIDES, V27, P1624, DOI 10.1016/j.peptides.2006.02.005; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Bertrand ME, 2004, CURR MED RES OPIN, V20, P1559, DOI 10.1185/030079904X4185; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Cicoira M, 2003, J CARD FAIL, V9, P219, DOI 10.1054/jcaf.2003.23; Davos CH, 2003, J CARD FAIL, V9, P29, DOI 10.1054/jcaf.2003.4; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Krum H, 2005, EUR HEART J, V26, P2154, DOI 10.1093/eurheartj/ehi409; Lavie CJ, 2003, AM J CARDIOL, V91, P891, DOI 10.1016/S0002-9149(03)00031-6; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nogueiras R., 2006, CNS & Neurological Disorders-Drug Targets, V5, P335, DOI 10.2174/187152706777452227; Schulze PC, 2003, BASIC RES CARDIOL, V98, P267, DOI 10.1007/s00395-003-0411-1; Sheriff S, 2009, PEPTIDES, V30, P1909, DOI 10.1016/j.peptides.2009.06.029; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Springer J, 2006, CURR OPIN CARDIOL, V21, P229, DOI 10.1097/01.hco.0000221585.94490.09; TIMO D, 2010, J CACHEXIA SARCOPENI, V1, P159; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Toshinai K, 2007, MECH AGEING DEV, V128, P182, DOI 10.1016/j.mad.2006.10.001; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6	32	42	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e26865	10.1371/journal.pone.0026865	http://dx.doi.org/10.1371/journal.pone.0026865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102869	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300006
J	van den Berg, CHBS; Grady, BPX; Schinkel, J; van de Laar, T; Molenkamp, R; van Houdt, R; Coutinho, RA; van Baarle, D; Prins, M				van den Berg, Charlotte H. B. S.; Grady, Bart P. X.; Schinkel, Janke; van de Laar, Thijs; Molenkamp, Richard; van Houdt, Robin; Coutinho, Roel A.; van Baarle, Debbie; Prins, Maria			Female Sex and IL28B, a Synergism for Spontaneous Viral Clearance in Hepatitis C Virus (HCV) Seroconverters from a Community-Based Cohort	PLOS ONE			English	Article							SINGLE-SOURCE OUTBREAK; INJECTION-DRUG USERS; GENETIC-VARIATION; INTERFERON-ALPHA; NATURAL-HISTORY; INFECTION; GENOTYPE; DISEASE; PERSISTENCE; PREVALENCE	Background & Aims: Since acute hepatitis C virus (HCV) infection is often asymptomatic, it is difficult to examine the rate and determinants of spontaneous clearance. Consequently, these studies are subject to bias, which can potentially lead to biased rates of viral clearance and risk estimates. We evaluated determinants of spontaneous HCV clearance among HCV seroconverters identified in a unique community-based cohort. Methods: Subjects were 106 drug users with documented dates of HCV seroconversion from the Amsterdam Cohort Study. Logistic regression was used to examine sociodemographic, behavioral, clinical, viral and host determinants, measured around acute infection, of HCV clearance. Results: The spontaneous viral clearance rate was 33.0% (95% confidence interval (CI) 24.2-42.8). In univariate analyses female sex and fever were significantly associated with spontaneous clearance. The favorable genotypes for rs12979860 (CC) and rs8099917 (TT) were associated with spontaneous clearance, although borderline significant. In multivariate analysis, females with the favorable genotype for rs12979860 (CC) had an increased odds to spontaneously clear HCV infection (adjustedOR 6.62, 95% 2.69-26.13), whereas females with the unfavorable genotype were as likely as men with the favorable and unfavorable genotype to clear HCV. Chronic Hepatitis B infection and absence of HIV coinfection around HCV seroconversion also favor HCV clearance. Conclusions: This study shows that co-infection with HIV and HBV and genetic variation in the IL28B region play an important role in spontaneous clearance of HCV. Our findings suggest a possible synergistic interaction between female sex and IL28B in spontaneous clearance of HCV.	[van den Berg, Charlotte H. B. S.; Grady, Bart P. X.; Prins, Maria] Ctr Infect & Immun Amsterdam CINIMA, Publ Hlth Serv, Dept Res, Amsterdam, Netherlands; [van den Berg, Charlotte H. B. S.; Prins, Maria] Univ Amsterdam, Acad Med Ctr, CINIMA, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Schinkel, Janke; Molenkamp, Richard] Univ Amsterdam, Acad Med Ctr, CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van de Laar, Thijs; van Houdt, Robin] Publ Hlth Serv, Publ Hlth Lab, Amsterdam, Netherlands; [van de Laar, Thijs] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [van Houdt, Robin; Coutinho, Roel A.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands	Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van den Berg, CHBS (corresponding author), Ctr Infect & Immun Amsterdam CINIMA, Publ Hlth Serv, Dept Res, Amsterdam, Netherlands.	bgrady@ggd.amsterdam.nl	Grady, Bart/F-3410-2013; Schinkel, Janke/I-3099-2012	Schinkel, Janke/0000-0002-1112-0644	Netherlands National Institute for Public Health and the Environment	Netherlands National Institute for Public Health and the Environment	The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment. Website: http://www.amsterdamcohort studies.org/. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; BROOKMEYER R, 1987, AM J EPIDEMIOL, V126, P14, DOI 10.1093/oxfordjournals.aje.a114646; CLAUSEN LN, 2010, J VIRAL HEPAT; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Danta M, 2008, CURR PHARM DESIGN, V14, P1690, DOI 10.2174/138161208784746761; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; EYSTER ME, 1994, BLOOD, V84, P1020; FALETTI E, 2011, CLIN IMMUNOLOGY; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; GRADY B, 2011, CLIN GASTROENTEROL H; Grebely J, 2007, CAN J GASTROENTEROL, V21, P447, DOI 10.1155/2007/796325; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Jauncey M, 2004, J INFECT DIS, V190, P1270, DOI 10.1086/423943; Kamal SM, 2008, AM J GASTROENTEROL, V103, P1283, DOI 10.1111/j.1572-0241.2008.01825.x; Keating S, 2005, IRISH J MED SCI, V174, P37, DOI 10.1007/BF03168517; Langendam MW, 1999, INT J EPIDEMIOL, V28, P514, DOI 10.1093/ije/28.3.514; Larghi A, 2002, HEPATOLOGY, V36, P993, DOI 10.1053/jhep.2002.36129; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Melendez-Morales L, 2007, AIDS, V21, P1631, DOI 10.1097/QAD.0b013e32826fb6d9; Memon MI, 2002, J VIRAL HEPATITIS, V9, P84, DOI 10.1046/j.1365-2893.2002.00329.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Morsica G, 2009, INFECTION, V37, P445, DOI 10.1007/s15010-008-8194-9; Operskalski EA, 2008, J CLIN VIROL, V41, P255, DOI 10.1016/j.jcv.2007.08.021; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Poynard T, 2002, COCHRANE DB SYST REV; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rosen HR, 2002, HEPATOLOGY, V35, P190, DOI 10.1053/jhep.2002.30293; Ruys TA, 2008, J VIRAL HEPATITIS, V15, P409, DOI 10.1111/j.1365-2893.2007.00963.x; Sagnelli E, 2009, HEPATOLOGY, V49, P1090, DOI 10.1002/hep.22794; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; VANDENHOEK JAR, 1988, AIDS, V2, P55, DOI 10.1097/00002030-198802000-00010; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Wiese M, 2000, HEPATOLOGY, V32, P91, DOI 10.1053/jhep.2000.8169; ZURSCHULZE WJ, 2005, J IMMUNOL, V175, P3603	49	72	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27555	10.1371/journal.pone.0027555	http://dx.doi.org/10.1371/journal.pone.0027555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110669	gold, Green Published			2022-12-25	WOS:000297555300029
J	Kulkarni, V; Khadilkar, RJ; Srivathsa, MS; Inamdar, MS				Kulkarni, Vani; Khadilkar, Rohan J.; Srivathsa, M. S.; Inamdar, Maneesha S.			Asrij Maintains the Stem Cell Niche and Controls Differentiation during Drosophila Lymph Gland Hematopoiesis	PLOS ONE			English	Article							POSTEMBRYONIC PERICARDIAL CELLS; TRANSCRIPTION FACTORS; SIGNALING CENTER; GENE-EXPRESSION; OVARIAN-CANCER; NOTCH; MELANOGASTER; HEMOCYTES; BLOOD; ACTIVATION	Several signaling pathways control blood cell (hemocyte) development in the Drosophila lymph gland. Mechanisms that modulate and integrate these signals are poorly understood. Here we report that mutation in a conserved endocytic protein Asrij affects signal transmission and causes aberrant lymph gland hematopoiesis. Mammalian Asrij (Ociad1) is expressed in stem cells of the blood vascular system and is implicated in several cancers. We found that Drosophila Asrij is a pan-hemocyte marker and localizes to a subset of endocytic vesicles. Loss of asrij causes hyperproliferation of lymph gland lobes coupled with increased hemocyte differentiation, thereby depleting the pool of quiescent hemocyte precursors. This corelates with fewer Col+ cells in the hematopoietic stem cell niche of asrij mutants. Asrij null mutants also show excess specification of crystal cells that express the RUNX factor Lozenge (Lz), a target of Notch signaling. Asrij mutant lymph glands show increased N in sorting endosomes suggesting aberrant trafficking. In vitro assays also show impaired traffic of fluorescent probes in asrij null hemocytes. Taken together our data suggest a role for Asrij in causing increased Notch signaling thereby affecting hemocyte differentiation. Thus, conserved endocytic functions may control blood cell progenitor quiescence and differentiation.	[Kulkarni, Vani; Khadilkar, Rohan J.; Srivathsa, M. S.; Inamdar, Maneesha S.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Kulkarni, V (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India.	inamdar@jncasr.ac.in	Khadilkar, Rohan/AAV-5384-2020; Magadi, Srivathsa/GQA-4381-2022	Khadilkar, Rohan/0000-0002-7297-2736; Magadi, Srivathsa/0000-0002-7926-5970; INAMDAR, MANEESHA/0000-0002-8243-2821	Department of Science and Technology, Government of India; Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, Government of India and the Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; ARAI H, 1987, BRAIN RES, V418, P164, DOI 10.1016/0006-8993(87)90974-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Das D, 2008, GENE EXPR PATTERNS, V8, P199, DOI 10.1016/j.gep.2007.10.008; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Grigorian M, 2011, DEV GENES EVOL, V221, P121, DOI 10.1007/s00427-011-0364-6; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Hayes SA, 2001, DEVELOPMENT, V128, P1193; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Inamdar MS, 2003, DEV GENES EVOL, V213, P134, DOI 10.1007/s00427-003-0305-0; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jundt F, 2008, LEUKEMIA, V22, P1587, DOI 10.1038/leu.2008.101; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Minakhina S, 2007, DEVELOPMENT, V134, P2387, DOI 10.1242/dev.003616; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Mukhopadhyay A, 2003, DEV DYNAM, V227, P578, DOI 10.1002/dvdy.10332; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; RIZKI TM, 1981, J HERED, V72, P78, DOI 10.1093/oxfordjournals.jhered.a109457; Rothwell WF, 2000, CURR TOP DEV BIOL, V49, P409; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sengupta S, 2008, GYNECOL ONCOL, V109, P226, DOI 10.1016/j.ygyno.2007.12.024; Shen CY, 2002, LUNG CANCER, V38, P235, DOI 10.1016/S0169-5002(02)00300-8; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wang CY, 2010, MOL CANCER THER, V9, P1709, DOI 10.1158/1535-7163.MCT-09-1024; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	63	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27667	10.1371/journal.pone.0027667	http://dx.doi.org/10.1371/journal.pone.0027667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110713	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300046
J	Cardoso, FC; Roddick, JS; Groves, P; Doolan, DL				Cardoso, Fernanda C.; Roddick, Joanne S.; Groves, Penny; Doolan, Denise L.			Evaluation of Approaches to Identify the Targets of Cellular Immunity on a Proteome-Wide Scale	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; T-CELLS; BORRELIA-BURGDORFERI; VACCINE CANDIDATES; EXPRESSION SYSTEM; DNA VACCINE; GENOME; GENERATION; INFECTION	Background: Vaccine development against malaria and other complex diseases remains a challenge for the scientific community. The recent elucidation of the genome, proteome and transcriptome of many of these complex pathogens provides the basis for rational vaccine design by identifying, on a proteome-wide scale, novel target antigens that are recognized by T cells and antibodies from exposed individuals. However, there is currently no algorithm to effectively identify important target antigens from genome sequence data; this is especially challenging for T cell targets. Furthermore, for some of these pathogens, such as Plasmodium, protein expression using conventional platforms has been problematic but cell-free in vitro transcription translation (IVTT) strategies have recently proved successful. Herein, we report a novel approach for proteome-wide scale identification of the antigenic targets of T cell responses using IVTT products. Principal Findings: We conducted a series of in vitro and in vivo experiments using IVTT proteins either unpurified, absorbed to carboxylated polybeads, or affinity purified through nickel resin or magnetic beads. In vitro studies in humans using CMV, EBV, and Influenza A virus proteins showed antigen-specific cytokine production in ELIspot and Cytometric Bead Array assays with cells stimulated with purified or unpurified IVTT antigens. In vitro and in vivo studies in mice immunized with the Plasmodium yoelii circumsporozoite DNA vaccine with or without IVTT protein boost showed antigen-specific cytokine production using purified IVTT antigens only. Overall, the nickel resin method of IVTT antigen purification proved optimal in both human and murine systems. Conclusions: This work provides proof of concept for the potential of high-throughput approaches to identify T cell targets of complex parasitic, viral or bacterial pathogens from genomic sequence data, for rational vaccine development against emerging and re-emerging diseases that pose a threat to public health.	[Cardoso, Fernanda C.; Roddick, Joanne S.; Groves, Penny; Doolan, Denise L.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Cardoso, FC (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	Denise.Doolan@qimr.edu.au	Cardoso, Fernanda C/J-7147-2013; Doolan, Denise L/F-1969-2015	Cardoso, Fernanda C/0000-0002-0068-9974; Doolan, Denise/0000-0001-7354-8817	National Health and Medical Research Council, Australia; Pfizer Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia(PfizerPfizer Australia)	This work was supported by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Angela Trieu and Ms Kathy Buttigieg for constructing the preliminary version of the expression vector pIVEX HisHA, and Dr Simon Apte for assistance with the flow cytometry. We also thank Dr Rajiv Khanna, Dr Stephen Turner and Dr Richard Webby for providing the DNA templates for viral antigens. The human volunteers who provided the PBMC specimens are gratefully acknowledged. DLD is supported by a Pfizer Australia Senior Research Fellowship.	Aguiar JC, 2004, GENOME RES, V14, P2076, DOI 10.1101/gr.2416604; Angenendt P, 2004, ANAL CHEM, V76, P1844, DOI 10.1021/ac035114i; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; ARRAND JR, 1981, NUCLEIC ACIDS RES, V9, P2999, DOI 10.1093/nar/9.13.2999; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doi N, 2002, GENOME RES, V12, P487, DOI 10.1101/gr.218802; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Dower WJ, 2002, CURR OPIN CHEM BIOL, V6, P390, DOI 10.1016/S1367-5931(02)00332-0; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Franke ED, 1997, J IMMUNOL, V159, P3424; Goldszmid RS, 2010, CURR OPIN IMMUNOL, V22, P118, DOI 10.1016/j.coi.2010.01.017; He MY, 2008, NEW BIOTECHNOL, V25, P126, DOI 10.1016/j.nbt.2008.08.004; He MY, 2003, J IMMUNOL METHODS, V274, P265, DOI 10.1016/S0022-1759(02)00521-5; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Jing L, 2008, J VIROL, V82, P7120, DOI 10.1128/JVI.00453-08; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; King RW, 1997, SCIENCE, V277, P973, DOI 10.1126/science.277.5328.973; LAL AA, 1987, J BIOL CHEM, V262, P2937; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; Luke CJ, 1997, J INFECT DIS, V175, P91, DOI 10.1093/infdis/175.1.91; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Morita EH, 2003, PROTEIN SCI, V12, P1216, DOI 10.1110/ps.0241203; Neuman BW, 2004, J VIROL, V78, P5891, DOI 10.1128/JVI.78.11.5891-5899.2004; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ramachandiran V, 2000, FEBS LETT, V482, P185, DOI 10.1016/S0014-5793(00)02017-2; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; RUGER B, 1987, J VIROL, V61, P446; Scheerlinck JPY, 2006, VACCINE, V24, P1124, DOI 10.1016/j.vaccine.2005.09.009; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Tabuchi I, 2003, BIOCHEM BIOPH RES CO, V305, P1, DOI 10.1016/S0006-291X(03)00686-7; Takai K, 2010, CURR PHARM BIOTECHNO, V11, P272, DOI 10.2174/138920110791111933; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tsuboi T, 2010, ACTA TROP, V114, P171, DOI 10.1016/j.actatropica.2009.10.024; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vigil A, 2010, PROTEOMICS, V10, P2259, DOI 10.1002/pmic.201000064; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zhao Li, 2010, Journal of Structural and Functional Genomics, V11, P201, DOI 10.1007/s10969-010-9093-8; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	57	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27666	10.1371/journal.pone.0027666	http://dx.doi.org/10.1371/journal.pone.0027666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096610	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900069
J	Konar, A; Shah, N; Singh, R; Saxena, N; Kaul, SC; Wadhwa, R; Thakur, MK				Konar, Arpita; Shah, Navjot; Singh, Rumani; Saxena, Nishant; Kaul, Sunil C.; Wadhwa, Renu; Thakur, Mahendra K.			Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; INDUCED AMNESIA; BACOPA-MONNIERA; GENE-EXPRESSION; BDNF GENE; MEMORY; RECEPTORS; GROWTH; INVOLVEMENT; PROMOTERS	Background: Scopolamine is a well-known cholinergic antagonist that causes amnesia in human and animal models. Scopolamine-induced amnesia in rodent models has been widely used to understand the molecular, biochemical, behavioral changes, and to delineate therapeutic targets of memory impairment. Although this has been linked to the decrease in central cholinergic neuronal activity following the blockade of muscarinic receptors, the underlying molecular and cellular mechanism(s) particularly the effect on neuroplasticity remains elusive. In the present study, we have investigated (i) the effects of scopolamine on the molecules involved in neuronal and glial plasticity both in vivo and in vitro and (ii) their recovery by alcoholic extract of Ashwagandha leaves (i-Extract). Methodology/Principal Findings: As a drug model, scopolamine hydrobromide was administered intraperitoneally to mice and its effect on the brain function was determined by molecular analyses. The results showed that the scopolamine caused downregulation of the expression of BDNF and GFAP in dose and time dependent manner, and these effects were markedly attenuated in response to i-Extract treatment. Similar to our observations in animal model system, we found that the scopolamine induced cytotoxicity in IMR32 neuronal and C6 glioma cells. It was associated with downregulation of neuronal cell markers NF-H, MAP2, PSD-95, GAP-43 and glial cell marker GFAP and with upregulation of DNA damage- gamma H2AX and oxidative stress-ROS markers. Furthermore, these molecules showed recovery when cells were treated with i-Extract or its purified component, withanone. Conclusion: Our study suggested that besides cholinergic blockade, scopolamine-induced memory loss may be associated with oxidative stress and Ashwagandha i-Extract, and withanone may serve as potential preventive and therapeutic agents for neurodegenerative disorders and hence warrant further molecular analyses.	[Konar, Arpita; Thakur, Mahendra K.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India; [Shah, Navjot; Singh, Rumani; Saxena, Nishant; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Banaras Hindu University (BHU); National Institute of Advanced Industrial Science & Technology (AIST)	Konar, A (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	renu-wadhwa@aist.go.jp; mkt_bhu@yahoo.com	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Konar, Arpita/0000-0002-1761-1065	Council of Scientific and Industrial Research (CSIR), India; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Honjo International Scholarship Foundation, Japan; Department of Science and Technology [SR/SO/HS-54/2008]; Indian Council of Medical Research, Government of India [3/6/2004-BMS]; AIST (Japan)	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Honjo International Scholarship Foundation, Japan; Department of Science and Technology(Department of Science & Technology (India)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); AIST (Japan)	A. Konar is a recipient of Junior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), India. N. Shah and R. Singh are supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) scholarships, Japan. N. Saxena is supported by Honjo International Scholarship Foundation, Japan. The work was supported by grants from the Department of Science and Technology (SR/SO/HS-54/2008) and Indian Council of Medical Research (3/6/2004-BMS), Government of India to M. K. Thakur, and from AIST (Japan) to S.C. Kaul and R. Wadhwa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinav Kanwal, 2010, Pharmacology and Pharmacy, V1, P1, DOI 10.4103/0976-500X.64527; Acosta JI, 2009, HORM BEHAV, V55, P454, DOI 10.1016/j.yhbeh.2008.11.008; Agrawal R, 2009, INDIAN J PHARMACOL, V41, P192, DOI 10.4103/0253-7613.56072; Ahmed T, 2009, PHARMACOL BIOCHEM BE, V91, P554, DOI 10.1016/j.pbb.2008.09.010; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Albrecht C, 2000, J BIOL CHEM, V275, P28929, DOI 10.1074/jbc.M003053200; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; BERZAGHI MD, 1993, J NEUROSCI, V13, P3818; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; BLOKLAND A, 2005, SCOPOLAMINE REV, V1; Brouillette J, 2007, J NEUROCHEM, V102, P1978, DOI 10.1111/j.1471-4159.2007.04666.x; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Cho WS, 2010, HUM MOL GENET, V19, P3169, DOI 10.1093/hmg/ddq227; Choudhary MI, 2004, CHEM PHARM BULL, V52, P1358, DOI 10.1248/cpb.52.1358; Das A, 2002, PHARMACOL BIOCHEM BE, V73, P893, DOI 10.1016/S0091-3057(02)00940-1; Drozdov OL, 2003, NEUROPHYSIOLOGY+, V35, P98, DOI 10.1023/A:1026060607740; French SJ, 1999, MOL BRAIN RES, V67, P124, DOI 10.1016/S0169-328X(99)00048-0; Garzon D, 2002, J NEUROCHEM, V82, P1058, DOI 10.1046/j.1471-4159.2002.01030.x; GILBEA FJ, 2010, HIPPOCAMPUS; Guizzetti M, 2003, NEUROSCIENCE, V120, P941, DOI 10.1016/S0306-4522(03)00401-9; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Hung CH, 2004, NEUROSCI LETT, V364, P63, DOI 10.1016/j.neulet.2004.02.074; KOKAIA Z, 1994, EUR J NEUROSCI, V6, P587, DOI 10.1111/j.1460-9568.1994.tb00303.x; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kurosinski P, 2002, ARCH NEUROL-CHICAGO, V59, P1524, DOI 10.1001/archneur.59.10.1524; Lee B, 2010, J PHARM PHARMACOL, V62, P263, DOI 10.1211/jpp.62.02.0015; Lee JH, 2010, J PHARM PHARMACOL, V62, P1, DOI [10.1211/jpp.62.01.0001, 10.1211/jpp/62.01.0001]; Lee YB, 2004, J NUTR, V134, P1827, DOI 10.1093/jn/134.7.1827; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Nathanson NM, 2000, P NATL ACAD SCI USA, V97, P6245, DOI 10.1073/pnas.97.12.6245; Power JM, 2002, J NEUROSCI, V22, P3454; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Saraf MK, 2008, NEUROSCIENCE, V155, P476, DOI 10.1016/j.neuroscience.2008.05.043; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; SILVA AL, 2009, PSYCHOPHARMACOLOGY, V202, P165; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tohda C, 2009, BRIT J PHARMACOL, V157, P1427, DOI 10.1111/j.1476-5381.2009.00313.x; VanDeMark KL, 2009, ALCOHOL CLIN EXP RES, V33, P1945, DOI 10.1111/j.1530-0277.2009.01032.x; VANDERWOLF CH, 1991, BEHAV BRAIN RES, V44, P217, DOI 10.1016/S0166-4328(05)80027-0; Wakabayashi T, 1999, BIOTECHNIQUES, V26, P302, DOI 10.2144/99262st04; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Yamada K, 2003, J PHARMACOL SCI, V91, P267	50	111	111	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27265	10.1371/journal.pone.0027265	http://dx.doi.org/10.1371/journal.pone.0027265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096544	Green Submitted, gold, Green Published			2022-12-25	WOS:000297553900028
J	Shu, XH; Li, H; Sun, XX; Wang, Q; Sun, Z; Wu, ML; Chen, XY; Li, C; Kong, QY; Liu, J				Shu, Xiao-Hong; Li, Hong; Sun, Xiao-Xin; Wang, Qian; Sun, Zheng; Wu, Mo-Li; Chen, Xiao-Yan; Li, Chong; Kong, Qing-You; Liu, Jia			Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies	PLOS ONE			English	Article							STAT3; EXPRESSION; APOPTOSIS; GROWTH; SULFOTRANSFERASE; BIOAVAILABILITY; LOCALIZATION; BRAIN; 1A1	Background: Trans-resveratrol rather than its biotransformed monosulfate metabolite exerts anti-medulloblastoma effects by suppressing STAT3 activation. Nevertheless, its effects on human glioblastoma cells are variable due to certain unknown reason(s). Methodology/Principal Findings: Citing resveratrol-sensitive UW228-3 medulloblastoma cell line and primarily cultured rat brain cells/PBCs as controls, the effect of resveratrol on LN-18 human glioblastoma cells and its relevance with metabolic pattern(s), brain-associated sulfotransferase/SULT expression and the statuses of STAT3 signaling and protein inhibitor of activated STAT3 (PIAS3) were elucidated by multiple experimental approaches. Meanwhile, the expression patterns of three SULTs (SULT1A1, 1C2 and 4A1) in human glioblastoma tumors were profiled immunohistochemically. The results revealed that 100 mu M resveratrol-treated LN-18 generated the same metabolites as UW228-3 cells, while additional metabolite in molecular weight of 403.0992 in negative ion mode was found in PBCs. Neither growth arrest nor apoptosis was found in resveratrol-treated LN-18 and PBC cells. Upon resveratrol treatment, the levels of SULT1A1, 1C2 and 4A1 expression in LN-18 cells were more up-regulated than that expressed in UW228-3 cells and close to the levels in PBCs. Immunohistochemical staining showed that 42.0%, 27.1% and 19.6% of 149 glioblastoma cases produced similar SULT1A1, 1C2 and 4A1 levels as that of tumor-surrounding tissues. Unlike the situation in UW228-3 cells, STAT3 signaling remained activated and its protein inhibitor PIAS3 was restricted in the cytosol of resveratrol-treated LN-18 cells. No nuclear translocation of STAT3 and PIAS3 was observed in resveratrol-treated PBCs. Treatment with STAT3 chemical inhibitor, AG490, committed majority of LN-18 and UW228-3 cells but not PBCs to apoptosis within 48 hours. Conclusions/Significance: LN-18 glioblastoma cells are insensitive to resveratrol due to the more inducible brain-associated SULT expression, insufficiency of resveratrol to suppress activated STAT3 signaling and the lack of PIAS3 nuclear translocation. The findings from PBCs suggest that an effective anticancer dose of resveratrol exerts little side effect on normal brain cells.	[Shu, Xiao-Hong; Li, Hong; Sun, Xiao-Xin; Wang, Qian; Sun, Zheng; Wu, Mo-Li; Chen, Xiao-Yan; Li, Chong; Kong, Qing-You; Liu, Jia] Dalian Med Univ, Liaoning Lab Canc Genet & Epigenet, Dept Cell Biol, Dalian, Peoples R China; [Shu, Xiao-Hong] Dalian Med Univ, Dept Med Chem, Coll Pharm, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Shu, XH (corresponding author), Dalian Med Univ, Liaoning Lab Canc Genet & Epigenet, Dept Cell Biol, Dalian, Peoples R China.	jialiudl@yahoo.com.cn	Shu, Xiaohong/J-1920-2019	Shu, Xiaohong/0000-0003-0299-1963	National Natural Science Foundation of China [30670946, 30971038, 81072063]; China Postdoctoral Science Foundation [20100481217]; Liaoning Department of Education [20060193, 2007-7-26, 2008T028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Liaoning Department of Education	This work was supported by the grants from National Natural Science Foundation of China (No. 30670946, 30971038 and 81072063), China Postdoctoral Science Foundation (No. 20100481217) and Liaoning Department of Education for key laboratory (20060193) and for the creative research team (2007-7-26 and 2008T028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bastianetto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012935; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Birner P, 2010, J NEURO-ONCOL, V100, P339, DOI 10.1007/s11060-010-0195-8; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Gagliano N, 2010, ANTI-CANCER DRUG, V21, P140, DOI 10.1097/CAD.0b013e32833498f1; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Keles GE, 1995, ONCOL RES, V7, P493; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; LI H, 1993, CANCER RES, V53, P5345; Liyou NE, 2003, J HISTOCHEM CYTOCHEM, V51, P1655, DOI 10.1177/002215540305101209; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Murias M, 2008, CANCER LETT, V261, P172, DOI 10.1016/j.canlet.2007.11.008; Ogata Y, 2006, NEOPLASIA, V8, P817, DOI 10.1593/neo.06409; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Urpi-Sarda M, 2007, CLIN CHEM, V53, P292, DOI 10.1373/clinchem.2006.071936; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang DG, 2005, J CHROMATOGR B, V829, P97, DOI 10.1016/j.jchromb.2005.09.040; Wang QA, 2003, NEUROSCI LETT, V351, P83, DOI 10.1016/j.neulet.2003.07.002; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Yang F, 2008, MOL CANCER THER, V7, P3519, DOI 10.1158/1535-7163.MCT-08-0138; Yang YP, 2012, J CELL PHYSIOL, V227, P976, DOI 10.1002/jcp.22806; Yu LJ, 2008, NEOPLASIA, V10, P736, DOI 10.1593/neo.08304	35	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27484	10.1371/journal.pone.0027484	http://dx.doi.org/10.1371/journal.pone.0027484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096581	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900051
J	Zhang, F; Xu, X; Zhou, B; He, ZS; Zhai, QW				Zhang, Fang; Xu, Xiang; Zhou, Ben; He, Zhishui; Zhai, Qiwei			Gene Expression Profile Change and Associated Physiological and Pathological Effects in Mouse Liver Induced by Fasting and Refeeding	PLOS ONE			English	Article							HEPATIC GLUCONEOGENESIS; PRENATAL EXPOSURE; RNA-SEQ; DISEASE; ALPHA; SCHIZOPHRENIA; RESTRICTION; GLUCOKINASE; PREVENTION; STARVATION	Food availability regulates basal metabolism and progression of many diseases, and liver plays an important role in these processes. The effects of food availability on digital gene expression profile, physiological and pathological functions in liver are yet to be further elucidated. In this study, we applied high-throughput sequencing technology to detect digital gene expression profile of mouse liver in fed, fasted and refed states. Totally 12162 genes were detected, and 2305 genes were significantly regulated by food availability. Biological process and pathway analysis showed that fasting mainly affected lipid and carboxylic acid metabolic processes in liver. Moreover, the genes regulated by fasting and refeeding in liver were mainly enriched in lipid metabolic process or fatty acid metabolism. Network analysis demonstrated that fasting mainly regulated Drug Metabolism, Small Molecule Biochemistry and Endocrine System Development and Function, and the networks including Lipid Metabolism, Small Molecule Biochemistry and Gene Expression were affected by refeeding. In addition, FunDo analysis showed that liver cancer and diabetes mellitus were most likely to be affected by food availability. This study provides the digital gene expression profile of mouse liver regulated by food availability, and demonstrates the main biological processes, pathways, gene networks and potential hepatic diseases regulated by fasting and refeeding. These results show that food availability mainly regulates hepatic lipid metabolism and is highly correlated with liver-related diseases including liver cancer and diabetes.	[Zhang, Fang; Xu, Xiang; Zhou, Ben; He, Zhishui; Zhai, Qiwei] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, F (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn	Zhou, Ben/R-9844-2019; Zhou, Ben/G-1850-2017; Zhou, Ben/AAB-5808-2020	Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zhang, Fang/0000-0002-7000-554X; Zhai, Qiwei/0000-0002-9617-7403	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002]; National Basic Research Program of China (973 Program) [2009CB918403, 2007CB914501]; Program of Shanghai Subject Chief Scientist [11XD1405800]; Director Foundation of Institute for Nutritional Sciences [20090101]; SA-SIBS Scholarship; China Postdoctoral Science Foundation [20100480641, 20090450743]; Shanghai Postdoctoral Scientific Program [11R21417400, 09R21416800]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2011KIP511, 2009KIP512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of Shanghai Subject Chief Scientist; Director Foundation of Institute for Nutritional Sciences; SA-SIBS Scholarship; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Scientific Program; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from National Natural Science Foundation of China (30825009, 30970619, 31030022 and 81021002), National Basic Research Program of China (973 Program, 2009CB918403 and 2007CB914501), Program of Shanghai Subject Chief Scientist (11XD1405800), Director Foundation of Institute for Nutritional Sciences (20090101), SA-SIBS Scholarship Program, China Postdoctoral Science Foundation (20100480641 and 20090450743), Shanghai Postdoctoral Scientific Program (11R21417400 and 09R21416800) and the Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2011KIP511 and 2009KIP512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARES K, 1994, CANCER RES, V54, P2303; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berk PD, 1999, HEPATOLOGY, V29, P1607, DOI 10.1002/hep.510290538; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Fidelis P, 1914, EXP BIOL MED MAYWOOD, V235, P1365; Flatt T, 2009, NATURE, V462, P989, DOI 10.1038/462989a; FRENCH SA, 1994, INT J OBESITY, V18, P145; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnstone AM, 2007, OBES REV, V8, P211, DOI 10.1111/j.1467-789X.2006.00266.x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; KEYS A, 1950, SCIENCE, V112, P371; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Marinella MA, 2003, NUTR REV, V61, P320, DOI 10.1301/nr.2003.sept.320-323; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Mehanna H, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-4; MEZEY E, 1978, GASTROENTEROLOGY, V74, P770; Mody N, 2008, AM J PHYSIOL-ENDOC M, V294, pE785, DOI 10.1152/ajpendo.00521.2007; Murakami Y, 2005, DRUG METAB DISPOS, V33, P1845, DOI 10.1124/dmd.105.005264; Orman MA, 2010, BIOTECHNOL BIOENG, V107, P825, DOI 10.1002/bit.22878; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Phillips C, 2006, CURR OPIN CARDIOL, V21, P185, DOI 10.1097/01.hco.0000221579.25878.11; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Quigley R, 2009, NEPHRON PHYSIOL, V113, pP23, DOI 10.1159/000235774; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Robson Anthony A., 2009, Nutrition and Health (Bicester), V20, P135; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Somsak L, 2003, CURR PHARM DESIGN, V9, P1177, DOI 10.2174/1381612033454919; Spielbauer B, 2005, MOL NUTR FOOD RES, V49, P908, DOI 10.1002/mnfr.200500033; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Swanson KS, 2008, J ANIM PHYSIOL AN N, V92, P246, DOI 10.1111/j.1439-0396.2007.00737.x; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Team RDC, 2010, R LANG ENV STAT COMP; TORRES NV, 1990, MOL CELL BIOCHEM, V93, P21; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yeh CS, 2006, CANCER LETT, V233, P297, DOI 10.1016/j.canlet.2005.03.050; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	54	43	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27553	10.1371/journal.pone.0027553	http://dx.doi.org/10.1371/journal.pone.0027553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096593	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800060
J	Woo, MG; Xue, K; Liu, JY; McBride, H; Tsang, BK				Woo, Michael G.; Xue, Kai; Liu, Jiayin; McBride, Heidi; Tsang, Benjamin K.			Calpain-mediated Processing of p53-associated Parkin-like Cytoplasmic Protein (PARC) Affects Chemosensitivity of Human Ovarian Cancer Cells by Promoting p53 Subcellular Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; X-LINKED INHIBITOR; TUMOR-SUPPRESSOR; DOWN-REGULATION; ACTIVATION; CLEAVAGE; AKT; BAX; PHOSPHORYLATION; EXPRESSION	Resistance to cisplatin (CDDP)-based therapy is a major hurdle to the successful treatment of human ovarian cancer (OVCA), and the chemoresistant phenotype in OVCA cells is associated with Akt-attenuated p53-mediated apoptosis. Proapoptotic functions of p53 involve both transcription-dependent and -independent signaling pathways, and dysfunctional localization and/or inactivation of p53 contribute to the development of chemoresistance. PARC is a cytoplasmic protein regulating p53 subcellular localization and subsequent function. Little is known about the molecular mechanisms regulating PARC. Although PARC contains putative caspase-3 cleavage sites, and CDDP is known to induce the activation of caspases and calpains and induce proteasomal degradation of anti-apoptotic proteins, if and how PARC is regulated by CDDP in OVCA are unknown. Here, we present evidence that CDDP promotes calpain-mediated PARC down-regulation, mitochondrial and nuclear p53 accumulation, and apoptosis in chemosensitive but not resistant OVCA cells. Inhibition of Akt is required to sensitize chemoresistant cells to CDDP in a p53-dependent manner, an effect enhanced by PARC down-regulation. CDDP-induced PARC down-regulation is reversible by inhibition of calpain but not of caspases or the 26 S proteasome. Furthermore, in vitro experiments confirm the ability of calpain in mediating Ca2+-dependent PARC down-regulation. The role Ca2+ in PARC down-regulation was further confirmed as ionomycin-induced PARC down-regulation in both chemosensitive and chemoresistant ovarian cancer cells. The data presented here implicate the regulation of p53 subcellular localization and apoptosis by PARC as a contributing factor in CDDP resistance in OVCA cells and Ca2+/calpain in PARC post-translational processing and chemosensitivity.	[Woo, Michael G.; Xue, Kai; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada; [Woo, Michael G.; Xue, Kai; Tsang, Benjamin K.] Univ Ottawa, Reprod Biol Unit, Ottawa, ON K1Y 4E9, Canada; [Woo, Michael G.; Xue, Kai; Tsang, Benjamin K.] Univ Ottawa, Div Gynecol Oncol, Dept Obstet & Gynecol, Ottawa, ON K1Y 4E9, Canada; [Woo, Michael G.; McBride, Heidi; Tsang, Benjamin K.] Univ Ottawa, Div Gynecol Oncol, Dept Cellular & Mol Med, Ottawa, ON K1Y 4E9, Canada; [Xue, Kai; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Xue, Kai; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Tsang, Benjamin K.] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151921, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Nanjing Medical University; Nanjing Medical University; Seoul National University (SNU)	Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	btsang@ohri.ca	McBride, Heidi M./ABD-5774-2021	McBride, Heidi M./0000-0003-4666-2280; Tsang, Benjamin K./0000-0003-1213-3946	Canadian Institute of Health Research [MOP-15691]; World Class University; National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10056]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); World Class University; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Canadian Institute of Health Research Grant MOP-15691 and World Class University Program, National Research Foundation of Korea, supported by Ministry of Education, Science and Technology Grant R31-10056.	AAGAARDTILLERY KM, 1995, J IMMUNOL, V155, P3297; Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; ANDREWS PA, 1992, CANCER RES, V52, P1895; Asselin E, 2001, CANCER RES, V61, P1862; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; BAST RC, 1974, NEW ENGL J MED, V290, P1413, DOI 10.1056/NEJM197406202902506; BAST RC, 1974, NEW ENGL J MED, V290, P1458, DOI 10.1056/NEJM197406272902605; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; BUICK RN, 1985, CANCER RES, V45, P3668; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Grusch M, 2002, CELL DEATH DIFFER, V9, P169, DOI 10.1038/sj.cdd.4400937; HAVRILESKY LJ, 1995, OBSTET GYNECOL, V85, P1007, DOI 10.1016/0029-7844(95)00058-Y; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hu LM, 2002, CANCER RES, V62, P1087; Jang JS, 1999, ONCOGENE, V18, P1789, DOI 10.1038/sj.onc.1202497; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Liu L, 2008, INT J CANCER, V122, P2210, DOI 10.1002/ijc.23378; Liu L, 2009, INT J CANCER, V125, P2757, DOI 10.1002/ijc.24626; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLTHOFF CFM, 1991, INT J CANCER, V47, P72, DOI 10.1002/ijc.2910470114; Mulhall JP, 2010, BJU INT, V106, P1706, DOI 10.1111/j.1464-410X.2010.09754.x; Mullen P, 2004, METH MOLEC MED, V88, P171; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Sasaki H, 2000, CANCER RES, V60, P5659; Sato K, 2004, J BIOCHEM, V136, P777, DOI 10.1093/jb/mvh187; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Skaar JR, 2005, MOL CELL BIOL, V25, P5579, DOI 10.1128/mcb.25.13.5579-5589.2005; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Splettstoesser F, 2007, BRIT J PHARMACOL, V151, P1176, DOI 10.1038/sj.bjp.0707335; Takamure M, 2005, MUSCLE NERVE, V32, P303, DOI 10.1002/mus.20362; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; Vitali R, 2008, BIOCHEM BIOPH RES CO, V368, P350, DOI 10.1016/j.bbrc.2008.01.093; Wolf JK, 1999, GYNECOL ONCOL, V75, P261, DOI 10.1006/gyno.1999.5565; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu GX, 2006, MOL CANCER RES, V4, P235, DOI 10.1158/1541-7786.MCR-05-0174; Yan XJ, 2006, GYNECOL ONCOL, V102, P348, DOI 10.1016/j.ygyno.2005.12.033; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200	58	34	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3963	3975		10.1074/jbc.M111.314765	http://dx.doi.org/10.1074/jbc.M111.314765			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22117079	hybrid, Green Published			2022-12-25	WOS:000300410900031
J	Sasser, T; Qiu, QS; Karunakaran, S; Padolina, M; Reyes, A; Flood, B; Smith, S; Gonzales, C; Fratti, RA				Sasser, Terry; Qiu, Quan-Sheng; Karunakaran, Surya; Padolina, Mark; Reyes, Anna; Flood, Blake; Smith, Sheena; Gonzales, Chad; Fratti, Rutilio A.			Yeast Lipin 1 Orthologue Pah1p Regulates Vacuole Homeostasis and Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDATE PHOSPHATASE; SNARE COMPLEX; GTPASE YPT7P; DOCKING; HOMOLOG; PROTEIN; DIACYLGLYCEROL; HOPS	Vacuole homotypic fusion requires a group of regulatory lipids that includes diacylglycerol, a fusogenic lipid that is produced through multiple metabolic pathways including the dephosphorylation of phosphatidic acid (PA). Here we examined the relationship between membrane fusion and PA phosphatase activity. Pah1p is the single yeast homologue of the Lipin family of PA phosphatases. Deletion of PAH1 was sufficient to cause marked vacuole fragmentation and abolish vacuole fusion. The function of Pah1p solely depended on its phosphatase activity as complementation studies showed that wild type Pah1p restored fusion, whereas the phosphatase dead mutant Pah1p(D398E) had no effect. We discovered that the lack of PA phosphatase activity blocked fusion by inhibiting the binding of SNAREs to Sec18p, an N-ethylmaleimide-sensitive factor homologue responsible for priming inactive cis-SNARE complexes. In addition, pah1 Delta vacuoles were devoid of the late endosome/vacuolar Rab Ypt7p, the phosphatidylinositol 3-kinase Vps34p, and Vps39p, a subunit of the HOPS (homotypic fusion and vacuole protein sorting) tethering complex, all of which are required for vacuole fusion. The lack of Vps34p resulted in the absence of phosphatidylinositol 3-phosphate, a lipid required for SNARE activity and vacuole fusion. These findings demonstrate that Pah1p and PA phosphatase activity are critical for vacuole homeostasis and fusion.	[Sasser, Terry; Qiu, Quan-Sheng; Karunakaran, Surya; Padolina, Mark; Reyes, Anna; Flood, Blake; Smith, Sheena; Gonzales, Chad; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,B-4,600 S Mathews Ave, Urbana, IL 61801 USA.	rfratti@illinois.edu	Smith, Sheena N./AAB-8850-2019	Smith, Sheena N./0000-0002-2162-7107	March of Dimes Birth Defects Foundation [5-FY09-117]; University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101132] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by March of Dimes Birth Defects Foundation Basil O'Connor Starter Scholar Research Award Grant 5-FY09-117 (to R.A.F.) and startup funds provided by the University of Illinois at Urbana-Champaign (to R.A.F.).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Coluccio A, 2004, GENETICS, V166, P89, DOI 10.1534/genetics.166.1.89; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES EW, 1982, GENETICS, V102, P665; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Koulov AV, 2003, CELL DEATH DIFFER, V10, P1357, DOI 10.1038/sj.cdd.4401315; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loos RJF, 2007, OBESITY, V15, P2723, DOI 10.1038/oby.2007.324; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mizogami M, 2010, EUR J ANAESTH, V27, P829, DOI 10.1097/EJA.0b013e32833bf5e4; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; PAPPU AS, 1983, NEUROCHEM RES, V8, P1565, DOI 10.1007/BF00964158; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Reese C, 2005, J CELL BIOL, V171, P981, DOI 10.1083/jcb.200510018; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Slessareva JE, 2006, SCIENCE, V314, P1412, DOI 10.1126/science.1134041; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Trotter PJ, 2000, TRAFFIC, V1, P425, DOI 10.1034/j.1600-0854.2000.010507.x; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu H, 2010, J BIOL CHEM, V285, P39359, DOI 10.1074/jbc.M110.183111; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97	77	64	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2221	2236		10.1074/jbc.M111.317420	http://dx.doi.org/10.1074/jbc.M111.317420			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22121197	Green Published, hybrid			2022-12-25	WOS:000299321000060
J	Dong, GF; Callegari, EA; Gloeckner, CJ; Ueffing, M; Wang, HM				Dong, Gaofeng; Callegari, Eduardo A.; Gloeckner, Christian J.; Ueffing, Marius; Wang, Hongmin			Prothymosin-alpha Interacts with Mutant Huntingtin and Suppresses Its Cytotoxicity in Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; NEURONAL DEATH; DISEASE; TOXICITY; NECROSIS; TRANSCRIPTION; CONFORMATION; PATHOGENESIS; AGGREGATION; UBIQUILIN	Huntington disease (HD), a fatal neurodegenerative disorder, is caused by a lengthening of the polyglutamine tract in the huntingtin (Htt) protein. Despite considerable effort, thus far there is no cure or treatment available for the disorder. Using the approach of tandem affinity purification we recently discovered that prothymosin-alpha (ProT alpha), a small highly acidic protein, interacts with mutant Htt (mHtt). This was confirmed by co-immunoprecipitation and a glutathione S-transferase (GST) pull-down assay. Overexpression of ProT alpha remarkably reduced mHtt-induced cytotoxicity in both non-neuronal and neuronal cell models expressing N-terminal mHtt fragments, whereas knockdown of ProT alpha expression in the cells enhanced mHtt-caused cell death. Deletion of the central acidic domain of ProT alpha abolished not only its interaction with mHtt but also its protective effect on mHtt-caused cytotoxicity. Additionally, overexpression of ProT alpha inhibited caspase-3 activation but enhanced aggregation of mHtt. Furthermore, when added to cultured cells expressing mHtt, the purified recombinant ProT alpha protein not only entered the cells but it also significantly suppressed the mHtt-caused cytotoxicity. Taken together, these data suggest that ProT alpha might be a novel therapeutic target for treating HD and other polyglutamine expansion disorders.	[Dong, Gaofeng; Callegari, Eduardo A.; Wang, Hongmin] Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA; [Gloeckner, Christian J.; Ueffing, Marius] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Prot Sci, D-85764 Neuherberg, Germany; [Gloeckner, Christian J.; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Med Proteome Ctr, D-72076 Tubingen, Germany	University of South Dakota; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wang, HM (corresponding author), Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, 414 E Clark St, Vermillion, SD 57069 USA.	Hongmin.Wang@usd.edu	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944	Sanford School of Medicine, University of South Dakota; South Dakota Board of Regents; University of South Dakota; NIH [P20 RR 015567]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103443] Funding Source: NIH RePORTER	Sanford School of Medicine, University of South Dakota; South Dakota Board of Regents; University of South Dakota; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Start-up Funds from the Sanford School of Medicine, University of South Dakota (to H. W.), a Competitive Research Grant Award of the South Dakota Board of Regents (to H. W.), and a New Faculty Development Award of the University of South Dakota (to H. W.).; We thank Dr. Robin Miskimins for critical reading of the manuscript; Drs. Marian DiFiglia, Shihua Li, and Xiao-Jiang Li for providing huntingtin constructs; Dr. Mervyn J. Monteiro for providing the stable cell lines expressing GFP-tagged Htt-exon-1; Justine Ferguson and Dr. Dong Zhang for assistance in cell death analysis; Dr. Khosrow Rezvani for assistance in measuring pixel density of Western blot bands; and Drs. Joyce Keifer and Fran Day at the South Dakota Imaging Core Facility (supported by NIH P20 RR 015567, which is designated as a Center of Biomedical Research Excellence [COBRE] to Dr. Joyce Keifer) for help in fluorescence microscopy.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; BATES G, 2002, HUNTINGTONS DIS; Covelo G, 2006, J BIOCHEM, V140, P627, DOI 10.1093/jb/mvj197; Dong G, 2011, CELL MOL NEUROBIOL, V31, P737, DOI 10.1007/s10571-011-9679-0; Fujita R, 2007, CELL DEATH DIFFER, V14, P1839, DOI 10.1038/sj.cdd.4402189; Fujita R, 2009, CELL DEATH DIFFER, V16, P349, DOI 10.1038/cdd.2008.159; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Hannappel E, 2003, VITAM HORM, V66, P257, DOI 10.1016/S0083-6729(03)01007-0; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karetsou Z, 2002, EMBO REP, V3, P361, DOI 10.1093/embo-reports/kvf071; Letsas KP, 2006, NEOPLASMA, V53, P92; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; Mosoian A, 2006, J VIROL, V80, P9200, DOI 10.1128/JVI.00589-06; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sukhacheva EA, 2002, J IMMUNOL METHODS, V266, P185, DOI 10.1016/S0022-1759(02)00098-4; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang HM, 2007, BIOCHEM BIOPH RES CO, V360, P423, DOI 10.1016/j.bbrc.2007.06.097; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440	33	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1279	1289		10.1074/jbc.M111.294280	http://dx.doi.org/10.1074/jbc.M111.294280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110140	Green Published, hybrid			2022-12-25	WOS:000299170300044
J	Palazuelos, J; Ortega, Z; Diaz-Alonso, J; Guzman, M; Galve-Roperh, I				Palazuelos, Javier; Ortega, Zaira; Diaz-Alonso, Javier; Guzman, Manuel; Galve-Roperh, Ismael			CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; ENDOCANNABINOID SYSTEM; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE; POSTNATAL BRAIN; ADULT BRAIN; NEUROGENESIS; EXPRESSION; MIGRATION	The endocannabinoid system is known to regulate neural progenitor (NP) cell proliferation and neurogenesis. In particular, CB2 cannabinoid receptors have been shown to promote NP proliferation. As CB2 receptors are not expressed in differentiated neurons, CB2-selective agonists are promising candidates to manipulate NP proliferation and indirectly neurogenesis by overcoming the undesired psychoactive effects of neuronal CB1 cannabinoid receptor activation. Here, by using NP cells, brain organotypic cultures, and in vivo animal models, we investigated the signal transduction mechanism involved in CB2 receptor-induced NP cell proliferation and neurogenesis. Exposure of hippocampal HiB5 NP cells to the CB2 receptor-selective agonist HU-308 led to the activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin complex 1 (mTORC1) pathway, which, by inhibiting its downstream target p27Kip1, induced NP proliferation. Experiments conducted with the CB2 receptor-selective antagonist SR144528, inhibitors of the PI3K/Akt/mTORC1 axis, and CB2 receptor transient-transfection vector further supported that CB2 receptors control NP cell proliferation via activation of mTORC1 signaling. Likewise, CB2 receptor engagement induced cell proliferation in an mTORC1-dependent manner both in embryonic cortical slices and in adult hippocampal NPs. Thus, HU-308 increased ribosomal protein S6 phosphorylation and 5-bromo-2'-deoxyuridine incorporation in wild-type but not CB2 receptor-deficient NPs of the mouse subgranular zone. Moreover, adult hippocampal NP proliferation induced by HU-308 and excitotoxicity was blocked by the mTORC1 inhibitor rapamycin. Altogether, these findings provide a mechanism of action and a rationale for the use of nonpsychotomimetic CB2 receptor-selective ligands as a novel strategy for the control of NP cell proliferation and neurogenesis.	[Galve-Roperh, Ismael] Univ Complutense, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; Univ Complutense, Inst Ramon y Cajal Invest Sanitaria, E-28040 Madrid, Spain; Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain	CIBERNED; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	Galve-Roperh, I (corresponding author), Univ Complutense, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain.	igr@quim.ucm.es	PALAZUELOS, JAVIER/AAD-7313-2020; PALAZUELOS, JAVIER/D-1211-2013; Alonso, Javier Diaz/ABH-6002-2020; Galve-Roperh, Ismael/AAG-2369-2020; Llorente, Zaira Ortega/F-8847-2016	PALAZUELOS, JAVIER/0000-0002-0409-1398; Llorente, Zaira Ortega/0000-0001-9445-0421; Galve-Roperh, Ismael/0000-0003-3501-2434; Guzman, Manuel/0000-0001-7475-118X	Ministerio de Ciencia e Innovacion [PLE2009-0117, SAF2009-08403]; Comunidad de Madrid-Universidad Complutense de Madrid [S-SAL-2006/261, 950344]; Fondo de Investigaciones Sanitarias	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid-Universidad Complutense de Madrid(Comunidad de Madrid); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by Ministerio de Ciencia e Innovacion Grants PLE2009-0117 (to I. G.-R.) and SAF2009-08403 (to M. G.) and Comunidad de Madrid-Universidad Complutense de Madrid Grants S-SAL-2006/261 and 950344 (to M. G. and I. G.-R.).; Supported by Fondo de Investigaciones Sanitarias.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Arevalo-Martin A, 2007, EUR J NEUROSCI, V26, P1548, DOI 10.1111/j.1460-9568.2007.05782.x; Auvin S, 2010, NEUROBIOL DIS, V40, P303, DOI 10.1016/j.nbd.2010.06.004; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Gomez O, 2011, BRIT J PHARMACOL, V163, P1520, DOI 10.1111/j.1476-5381.2011.01414.x; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; Kokaia M, 2011, EUR J NEUROSCI, V33, P1133, DOI 10.1111/j.1460-9568.2011.07612.x; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Malagelada C, 2011, J NEUROSCI, V31, P3186, DOI 10.1523/JNEUROSCI.4011-10.2011; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Qiu JH, 2009, STEM CELLS, V27, P920, DOI 10.1002/stem.1; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Trazzi S, 2010, J BIOL CHEM, V285, P10098, DOI 10.1074/jbc.M109.043711; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020; Zurolo E, 2010, NEUROSCIENCE, V170, P28, DOI 10.1016/j.neuroscience.2010.07.004	49	111	113	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1198	1209		10.1074/jbc.M111.291294	http://dx.doi.org/10.1074/jbc.M111.291294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102284	Green Published, hybrid			2022-12-25	WOS:000299170300035
J	Cunha, C; Giovannini, G; Pierini, A; Bell, AS; Sorci, G; Riuzzi, F; Donato, R; Rodrigues, F; Velardi, A; Aversa, F; Romani, L; Carvalho, A				Cunha, Cristina; Giovannini, Gloria; Pierini, Antonio; Bell, Alain S.; Sorci, Guglielmo; Riuzzi, Francesca; Donato, Rosario; Rodrigues, Fernando; Velardi, Andrea; Aversa, Franco; Romani, Luigina; Carvalho, Agostinho			Genetically-Determined Hyperfunction of the S100B/RAGE Axis Is a Risk Factor for Aspergillosis in Stem Cell Transplant Recipients	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; S100 PROTEINS; FUNGAL-INFECTIONS; RECEPTOR; RAGE; DISEASE; POLYMORPHISMS; IMMUNE; INFLAMMATION; RESPONSES	Invasive aspergillosis (IA) is a major threat to the successful outcome of hematopoietic stem cell transplantation (HSCT), although individual risk varies considerably. Recent evidence has established a pivotal role for a danger sensing mechanism implicating the S100B/receptor for advanced glycation end products (RAGE) axis in antifungal immunity. The association of selected genetic variants in the S100B/RAGE axis with susceptibility to IA was investigated in 223 consecutive patients undergoing HSCT. Furthermore, studies addressing the functional consequences of these variants were performed. Susceptibility to IA was significantly associated with two distinct polymorphisms in RAGE (-374T/A) and S100B (+427C/T) genes, the relative contribution of each depended on their presence in both transplantation counterparts [ patient SNP(RAGE), adjusted hazard ratio (HR), 1.97; P = 0.042 and donor SNP(RAGE), HR, 2.03; P = 0.047] or in donors (SNP(S100B), HR, 3.15; P = 7.8e(-4)) only, respectively. Functional assays demonstrated a gain-of-function phenotype of both variants, as shown by the enhanced expression of inflammatory cytokines in RAGE polymorphic cells and increased S100B secretion in vitro and in vivo in the presence of the S100B polymorphism. These findings point to a relevant role of the danger sensing signaling in human antifungal immunity and highlight a possible contribution of a genetically-determined hyperfunction of the S100B/RAGE axis to susceptibility to IA in the HSCT setting.	[Cunha, Cristina; Giovannini, Gloria; Romani, Luigina; Carvalho, Agostinho] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Pierini, Antonio; Bell, Alain S.; Velardi, Andrea; Aversa, Franco] Univ Perugia, Div Hematol & Clin Immunol, Dept Clin & Expt Med, I-06100 Perugia, Italy; [Sorci, Guglielmo; Riuzzi, Francesca; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, Anat Sect, I-06100 Perugia, Italy; [Rodrigues, Fernando; Carvalho, Agostinho] Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal; [Rodrigues, Fernando; Carvalho, Agostinho] 3Bs PT Govt Associate Lab, Life & Hlth Sci Res Inst, Braga, Portugal	University of Perugia; University of Perugia; University of Perugia; Universidade do Minho	Cunha, C (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	aacarvalho2008@gmail.com	Cunha, Cristina/D-2687-2009; Cunha, Cristina/AAH-9951-2021; Romani, Luigina/O-9987-2018; Pierini, Antonio/K-6650-2016; Donato, Rosario/I-3943-2019; Carvalho, Agostinho/D-2667-2009; Rodrigues, Fernando/A-3123-2011; Rodrigues, Fernando/T-5299-2018	Cunha, Cristina/0000-0002-6002-5782; Cunha, Cristina/0000-0002-6002-5782; Carvalho, Agostinho/0000-0001-8935-8030; Rodrigues, Fernando/0000-0001-8436-9398; Riuzzi, Francesca/0000-0001-7908-3379; Romani, Luigina/0000-0002-1356-525X; Aversa, Franco/0000-0002-8871-6817; Sorci, Guglielmo/0000-0002-1973-9679; PIERINI, ANTONIO/0000-0003-3518-0665	Specific Targeted Research Projects [FP7-HEALTH-2010-single-stage, 260338, FP7-HEALTH-2009-single-stage 037899]; Fondazione per la Ricerca sulla Fibrosi Cistica (FFC) [21/2010]; Fondazione Cassa di Risparmio di Perugia [2009.020.0021]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/65962/2009, SFRH/BPD/46292/2008]	Specific Targeted Research Projects; Fondazione per la Ricerca sulla Fibrosi Cistica (FFC); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Specific Targeted Research Projects "ALLFUN" (FP7-HEALTH-2010-single-stage, contract number 260338) and "SYBARIS" (FP7-HEALTH-2009-single-stage contract number 037899), by the Fondazione per la Ricerca sulla Fibrosi Cistica (FFC#21/2010) and by the Fondazione Cassa di Risparmio di Perugia (2009.020.0021). CC and AC were financially supported by fellowships from Fundacao para a Ciencia e Tecnologia, Portugal (contracts SFRH/BD/65962/2009 and SFRH/BPD/46292/2008, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; BRETT J, 1993, AM J PATHOL, V143, P1699; Carvalho A, 2007, MOL CELL PROBE, V21, P316, DOI 10.1016/j.mcp.2007.03.005; Carvalho A, 2009, EXP HEMATOL, V37, P1022, DOI 10.1016/j.exphem.2009.06.004; Chai LYA, 2010, IMMUNOLOGY, V130, P46, DOI 10.1111/j.1365-2567.2009.03211.x; CIESLA M, 2011, ANAL BIOANAL CHEM; Cunha C, 2011, MED MYCOL, V49, pS137, DOI 10.3109/13693786.2010.508797; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; Daborg J, 2010, J NEURAL TRANSM, V117, P861, DOI 10.1007/s00702-010-0437-0; Dabritz J, 2011, AM J PHYSIOL-GASTR L, V300, pG823, DOI 10.1152/ajpgi.00115.2010; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Gaens KHJ, 2008, ANN NY ACAD SCI, V1126, P162, DOI 10.1196/annals.1433.013; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Girmenia C, 2009, CLIN INFECT DIS, V49, P1226, DOI 10.1086/605665; Gu HJ, 2008, CLIN CANCER RES, V14, P3627, DOI 10.1158/1078-0432.CCR-07-4808; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hohoff C, 2010, AM J MED GENET B, V153B, P291, DOI 10.1002/ajmg.b.30950; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ito T., 2010, INT J CANC; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; LI K, 2011, MULT SCLER; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Park S.J., 2011, J BIOL CHEM; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	45	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27962	10.1371/journal.pone.0027962	http://dx.doi.org/10.1371/journal.pone.0027962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114731	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555800046
J	el Jundi, B; Pfeiffer, K; Homberg, U				el Jundi, Basil; Pfeiffer, Keram; Homberg, Uwe			A Distinct Layer of the Medulla Integrates Sky Compass Signals in the Brain of an Insect	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; POLARIZATION-SENSITIVE INTERNEURONS; ANTERIOR OPTIC TUBERCLE; DORSAL RIM AREA; CENTRAL COMPLEX; NEURAL MECHANISMS; COMPOUND EYE; SUN COMPASS; NEURONS; LIGHT	Mass migration of desert locusts is a common phenomenon in North Africa and the Middle East but how these insects navigate is still poorly understood. Laboratory studies suggest that locusts are able to exploit the sky polarization pattern as a navigational cue. Like other insects locusts detect polarized light through a specialized dorsal rim area (DRA) of the eye. Polarization signals are transmitted through the optic lobe to the anterior optic tubercle (AOTu) and, finally, to the central complex in the brain. Whereas neurons of the AOTu integrate sky polarization and chromatic cues in a daytime dependent manner, the central complex holds a topographic representation of azimuthal directions suggesting a role as an internal sky compass. To understand further the integration of sky compass cues we studied polarization-sensitive (POL) neurons in the medulla that may be intercalated between DRA photoreceptors and AOTu neurons. Five types of POL-neuron were characterized and four of these in multiple recordings. All neurons had wide arborizations in medulla layer 4 and most, additionally, in the dorsal rim area of the medulla and in the accessory medulla, the presumed circadian clock. The neurons showed type-specific orientational tuning to zenithal polarized light and azimuth tuning to unpolarized green and UV light spots. In contrast to neurons of the AOTu, we found no evidence for color opponency and daytime dependent adjustment of sky compass signals. Therefore, medulla layer 4 is a distinct stage in the integration of sky compass signals that precedes the time-compensated integration of celestial cues in the AOTu.	[el Jundi, Basil; Homberg, Uwe] Univ Marburg, Dept Biol, Marburg, Germany; [Pfeiffer, Keram] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	Philipps University Marburg; Dalhousie University	el Jundi, B (corresponding author), Univ Marburg, Dept Biol, Marburg, Germany.	homberg@biologie.uni-marburg.de	Homberg, Uwe/AFH-8214-2022; Pfeiffer, Keram/AAQ-1812-2020; Jundi, Basil el/AAM-8308-2021	Homberg, Uwe/0000-0002-8229-7236; el Jundi, Basil/0000-0002-4539-6681; Pfeiffer, Keram/0000-0001-5348-2304; el Jundi, Basil/0000-0002-3044-0432	Deutsche Forschungsgemeinschaft [HO 950/16-2, HO 950/20-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants HO 950/16-2 and HO 950/20-1. The funders had no role in study design, data collection and analysis, decision to publish, pr preparation of the manuscript.	Batschelet E., 1981, CIRCULAR STAT BIOL, P371; BRINES ML, 1982, J EXP BIOL, V96, P69; CLEMENTS AN, 1974, J EXP BIOL, V60, P673; COEMANS MAJM, 1994, VISION RES, V34, P1461, DOI 10.1016/0042-6989(94)90148-1; Eggers A., 1993, SENSORY SYSTEMS ARTH, P101; el Jundi B, 2010, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.021.2009; el Jundi B, 2010, J INSECT PHYSIOL, V56, P971, DOI 10.1016/j.jinsphys.2010.05.011; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; Frost BJ, 2006, CURR OPIN NEUROBIOL, V16, P481, DOI 10.1016/j.conb.2006.06.005; Heinze S, 2008, J COMP NEUROL, V511, P454, DOI 10.1002/cne.21842; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Heinze S, 2009, J NEUROSCI, V29, P11783, DOI 10.1523/JNEUROSCI.1870-09.2009; Helfrich-Forster C, 2004, J COMP PHYSIOL A, V190, P601, DOI 10.1007/s00359-004-0527-2; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Homberg U, 2004, NATURWISSENSCHAFTEN, V91, P199, DOI 10.1007/s00114-004-0525-9; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771; Homberg U, 2002, ARTHROPOD STRUCT DEV, V30, P271, DOI 10.1016/S1467-8039(02)00010-5; Homberg U, 1997, J COMP NEUROL, V386, P329; HOMBERG U, 1991, CELL TISSUE RES, V266, P343, DOI 10.1007/BF00318190; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; HORVATH G, 1995, J THEOR BIOL, V175, P27, DOI 10.1006/jtbi.1995.0118; Kinoshita M, 2007, J EXP BIOL, V210, P1350, DOI 10.1242/jeb.02744; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 1996, J EXP BIOL, V199, P1467; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; Labhart T, 2001, J EXP BIOL, V204, P2423; LABHART T, 1988, NATURE, V331, P435, DOI 10.1038/331435a0; Labhart Thomas, 1993, P158; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; PETZOLD J, 2001, THESIS U ZURICH; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; Pfeiffer K, 2007, CURR BIOL, V17, P960, DOI 10.1016/j.cub.2007.04.059; Pfeiffer K, 2011, J NEUROPHYSIOL, V105, P28, DOI 10.1152/jn.00480.2010; ROSSEL S, 1984, J COMP PHYSIOL, V155, P605, DOI 10.1007/BF00610846; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; Shashar N, 2005, BIOL LETTERS, V1, P472, DOI 10.1098/rsbl.2005.0334; Shiga S, 2007, PHOTOCHEM PHOTOBIOL, V83, P76, DOI 10.1562/2006-03-31-IR-863; Struu J. W., 1871, PHILOS MAG, V41, P274, DOI DOI 10.1080/14786447108640479; Suhai B, 2004, J OPT SOC AM A, V21, P1669, DOI 10.1364/JOSAA.21.001669; Trager U, 2011, J NEUROSCI, V31, P2238, DOI 10.1523/JNEUROSCI.3624-10.2011; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; WEHNER R, 1984, ANNU REV ENTOMOL, V29, P277, DOI 10.1146/annurev.en.29.010184.001425; Wehner R, 2006, INVERTEBRATE VISION, P291; WENDT B, 1992, J COMP NEUROL, V321, P387, DOI 10.1002/cne.903210307	47	37	38	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27855	10.1371/journal.pone.0027855	http://dx.doi.org/10.1371/journal.pone.0027855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114712	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400130
J	Sabatier, R; Finetti, P; Adelaide, J; Guille, A; Borg, JP; Chaffanet, M; Lane, L; Birnbaum, D; Bertucci, F				Sabatier, Renaud; Finetti, Pascal; Adelaide, Jose; Guille, Arnaud; Borg, Jean-Paul; Chaffanet, Max; Lane, Lydie; Birnbaum, Daniel; Bertucci, Francois			Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer	PLOS ONE			English	Article							ESOPHAGEAL CANCER; EXPRESSION; HYPERMETHYLATION; PROLIFERATION; GROWTH; BASAL	Introduction: ECRG4/C2ORF40 is a potential tumor suppressor gene (TSG) recently identified in esophageal carcinoma. Its expression, gene copy number and prognostic value have never been explored in breast cancer. Methods: Using DNA microarray and array-based comparative genomic hybridization (aCGH), we examined ECRG4 mRNA expression and copy number alterations in 353 invasive breast cancer samples and normal breast (NB) samples. A meta-analysis was done on a large public retrospective gene expression dataset (n = 1,387) in search of correlations between ECRG4 expression and histo-clinical features including survival. Results: ECRG4 was underexpressed in 94.3% of cancers when compared to NB. aCGH data revealed ECRG4 loss in 18% of tumors, suggesting that DNA loss is not the main mechanism of underexpression. Meta-analysis showed that ECRG4 expression was significantly higher in tumors displaying earlier stage, smaller size, negative axillary lymph node status, lower grade, and normal-like subtype. Higher expression was also associated with disease-free survival (DFS; HR = 0.84 [0.76-0.92], p = 0.0002) and overall survival (OS; HR = 0.72 [0.63-0.83], p = 5.0E-06). In multivariate analysis including the other histoclinical prognostic features, ECRG4 expression remained the only prognostic factor for DFS and OS. Conclusions: Our data suggest that ECRG4 is a candidate TSG in breast cancer, the expression of which may help improve the prognostication. If functional analyses confirm this TSG role, restoring ECRG4 expression in the tumor may represent a promising therapeutic approach.	[Sabatier, Renaud; Finetti, Pascal; Adelaide, Jose; Guille, Arnaud; Chaffanet, Max; Birnbaum, Daniel; Bertucci, Francois] INSERM, UMR891, Ctr Rech Cancerol Marseille, Dept Mol Oncol, Marseille, France; [Sabatier, Renaud; Bertucci, Francois] Inst Paoli Calmettes Marseille, Ctr Rech Cancerol Marseille, Dept Med Oncol, Marseille, France; [Borg, Jean-Paul; Bertucci, Francois] Univ Mediterranee, Marseille, France; [Borg, Jean-Paul] INSERM, U891, Ctr Rech Cancerol Marseille, Dept Polar Cellulaire Signalisat & Canc, Marseille, France; [Lane, Lydie] SIB, Geneva, Switzerland; [Lane, Lydie] Univ Geneva, Dept Human Prot Sci, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Swiss Institute of Bioinformatics; University of Geneva	Sabatier, R (corresponding author), INSERM, UMR891, Ctr Rech Cancerol Marseille, Dept Mol Oncol, Marseille, France.	bertuccif@marseille.fnclcc.fr	Lane, Lydie/AAQ-4896-2021; ADELAIDE, José JA/O-4390-2017; Sabatier, Renaud/K-5816-2017; Guille, Arnaud/GZG-1785-2022; CHAFFANET, Max/AAU-5743-2020; Borg, Jean-Paul/AAX-8096-2020; Finetti, Pascal/O-8669-2017	Lane, Lydie/0000-0002-9818-3030; ADELAIDE, José JA/0000-0003-4364-9857; Sabatier, Renaud/0000-0002-5821-682X; Guille, Arnaud/0000-0001-5747-562X; Borg, Jean-Paul/0000-0001-8418-3382; CHAFFANET, Max/0000-0002-2344-1488; Finetti, Pascal/0000-0002-2674-3123; Bertucci, Francois/0000-0002-0157-0959	Institut National du Cancer; Ligue Nationale contre le Cancer	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	The work is supported by Institut National du Cancer and Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gotze S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-447; Goncalves A, 2011, BREAST CANCER RES TR, V127, P273, DOI 10.1007/s10549-010-1199-y; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; *ING, ING PATHW AN V8 0 26; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kujuro Y, 2010, P NATL ACAD SCI USA, V107, P8259, DOI 10.1073/pnas.0911446107; Li LW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-52; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Li W, 2010, J EXP CLIN CANC RES, V29, P1, DOI 10.1186/1756-9966-29-89; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Mori Y, 2007, ONCOL REP, V18, P981; Ozawa A, 2011, MOL ENDOCRINOL, V25, P776, DOI 10.1210/me.2010-0389; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Su Tao, 1998, Zhonghua Zhongliu Zazhi, V20, P254; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van der Auwera I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-97; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174	28	106	108	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27656	10.1371/journal.pone.0027656	http://dx.doi.org/10.1371/journal.pone.0027656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110708	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400078
J	Narmadha, G; Muneswararao, K; Rajesh, A; Yenugu, S				Narmadha, Ganapathy; Muneswararao, Katakam; Rajesh, Angireddy; Yenugu, Suresh			Characterization of a Novel Lysozyme-Like 4 Gene in the Rat	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; ANTIBACTERIAL ACTIVITY; TESTIS FLUID; PROTEIN; EXPRESSION; EVOLUTION; PEPTIDES; CYSTATIN; CLONING; SYSTEM	Lysozyme-like proteins (LYZLs) belong to the class of c-type lysozymes and are not well characterized in many species including the rat. In this study, using in silico and molecular biology techniques, we report the identification, cloning and characterization of rat Lyzl4 gene and also determine the expression pattern of Lyzl1, Lyzl3 and Lyzl6. The rat Lyzl genes were found to be distributed on three chromosomes and all of them retained the characteristic eight cysteine signature of c-type lysozyme. Homology modeling of rat LYZL4 indicated that its structure is similar to that of the mouse SLLP1. In the male reproductive tract of rat, Lyzl gene expression was confined to the testis. Lyzl1 and Lyzl4 were found to be expressed in tissues beyond the male reproductive tract, whereas Lyzl3 and Lyzl6 were not. Lyzl expression in the developing (10-60 day old) rats was androgen dependent in the testis. Immunodetection using antibodies against rat LYZL4 revealed the presence of LYZL4 protein in the germinal layer of the testes and on the sperm tail. Recombinant LYZL4 did not exhibit antibacterial, muramidase and isopeptidase activities characteristic to c-type lysozyme. To the best of our knowledge, for the first time we report the characterization of Lyzl genes in the rat. Results of our study indicate that rat LYZL proteins may have an important role in male reproductive tract function.	[Narmadha, Ganapathy; Muneswararao, Katakam; Rajesh, Angireddy; Yenugu, Suresh] Univ Hyderabad, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Narmadha, G (corresponding author), Univ Hyderabad, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	ysnaidu@yahoo.com	Angireddy, Rajesh/GMX-3147-2022; Yenugu, Suresh/Y-7661-2019	Angireddy, Rajesh/0000-0002-9215-2209; Yenugu, Suresh/0000-0002-5431-2267				Blankenvoorde MFJ, 1998, BIOL CHEM, V379, P1371; CHAREST NJ, 1989, ENDOCRINOLOGY, V125, P942, DOI 10.1210/endo-125-2-942; CORNWALL GA, 1995, J ANDROL, V16, P379; DAUTIGNY A, 1991, J MOL EVOL, V32, P187, DOI 10.1007/BF02515392; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Hall SH, 2002, J ANDROL, V23, P585; Hamil Katherine G, 2003, Reprod Biol Endocrinol, V1, P112, DOI 10.1186/1477-7827-1-112; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Hamil KG, 2002, ENDOCRINOLOGY, V143, P2787, DOI 10.1210/en.143.7.2787; HARRIS ME, 1974, ENDOCRINOLOGY, V95, P701, DOI 10.1210/endo-95-3-701; HARRIS ME, 1981, EXPERIENTIA, V37, P426, DOI 10.1007/BF01959901; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Hinton BT, 1998, J REPROD FERTIL, P47; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; Ito Y, 1999, EUR J BIOCHEM, V259, P456, DOI 10.1046/j.1432-1327.1999.00064.x; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Jolles P., 1996, LYSOZYMES MODEL ENZY; Joskova R, 2009, DEV COMP IMMUNOL, V33, P932, DOI 10.1016/j.dci.2009.03.002; Liu Q, 2001, ENDOCRINOLOGY, V142, P4529, DOI 10.1210/en.142.10.4529; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; NAYFEH SN, 1966, ENDOCRINOLOGY, V78, P1041, DOI 10.1210/endo-78-5-1041; Rodriguez CM, 2001, REPRODUCTION, V122, P41, DOI 10.1530/reprod/122.1.41; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Takeshita K, 2003, CELL MOL LIFE SCI, V60, P1944, DOI 10.1007/s00018-003-3082-z; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Yenugu S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-7; Yenugu S, 2004, ENDOCRINOLOGY, V145, P3165, DOI 10.1210/en.2003-1698; Yenugu S, 2003, BIOCHEM J, V372, P473, DOI 10.1042/BJ20020225; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	30	13	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27659	10.1371/journal.pone.0027659	http://dx.doi.org/10.1371/journal.pone.0027659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110709	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300040
J	Mittal, P; Karthikeyan, S; Chakraborti, PK				Mittal, Payal; Karthikeyan, Subramanian; Chakraborti, Pradip K.			Amino Acids Involved in Polyphosphate Synthesis and Its Mobilization Are Distinct in Polyphosphate Kinase-1 from Mycobacterium tuberculosis	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; PHOSPHOTRANSFER; METABOLISM; MOTILITIES; SUBUNIT; ASSAY; PPK2	Background: In bacteria polyphosphates (poly-P) are involved in cellular metabolism and development especially during stress. The enzyme, principally involved in polyphosphate biosynthesis and its mobilization leading to generation of NTPs, is known as polyphosphate kinase (PPK). Principal Findings: Among two genes of polyphosphate kinases present in Mycobacterium tuberculosis, we cloned and expressed PPK1 in Escherichia coli as histidine-tagged protein. This similar to 86 kDa protein is capable of autophosphorylation and synthesis of poly-P as well as NTP. Among 22 conserved histidine residues, we found only His-491 is autophosphorylated and crucial for any enzymatic activity. Substitution of His-510 caused mPPK1 protein deficient but not defective in autophosphorylation, thereby contrary to earlier reports negating any role of this residue in the process. However, mutation of His-510 with either Ala or Gln affected ATP or poly-P synthesis depending on the substitution; while such effects were severe with H510A but mild with H510Q. Furthermore, mPPK1 also renders auxiliary nucleotide diphosphate kinase function by synthesizing virtually all NTPs/dNTPs from their cognate NDPs/dNDPs by utilizing poly-P as the phosphate donor albeit with varied efficiency. To assess the influence of other catalytic domain residues of mPPK1 towards its functionality, we designed mutations based on E. coli PPK1 crystal structure since it owes 68% amino acid sequence similarity with mPPK1. Interestingly, our results revealed that mutations in mPPK1 affecting poly-P synthesis always affected its ATP synthesizing ability; however, the reverse may not be true. Conclusions/Significance: We conclude that amino acid residues involved in poly-P and ATP synthesizing activities of mPPK1 are distinct. Considering conserved nature of PPK1, it seems our observations have broader implications and not solely restricted to M. tuberculosis only. A	[Mittal, Payal; Karthikeyan, Subramanian; Chakraborti, Pradip K.] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Mittal, P (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh, India.	pradip@imtech.res.in	Karthikeyan, Subramanian/F-8808-2010		Council of Scientific and Industrial Research, India [NWP-0038]; University Grants Commission, New Delhi, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was financially supported by Council of Scientific and Industrial Research, India as a part of a network research program NWP-0038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to Dr. Haider H. Dar for critical reading of this manuscript. We gratefully acknowledge excellent technical assistance provided by Mr. J. Prasad during the course of this study. Senior Research Fellowship to one of us (PM) from the University Grants Commission, New Delhi, India, is gratefully acknowledged.	AHN KH, 1990, J BIOL CHEM, V265, P11734; [Anonymous], 2004, BIOCH INORGANIC POLY; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Ayraud S, 2005, FEMS MICROBIOL LETT, V243, P45, DOI 10.1016/j.femsle.2004.11.040; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Cheng YY, 2009, J MICROBIOL BIOTECHN, V19, P1527, DOI 10.4014/jmb.0903.03030; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; Chouayekh H, 2002, MOL MICROBIOL, V43, P919, DOI 10.1046/j.1365-2958.2002.02557.x; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Dar HH, 2010, BIOCHEM J, V430, P539, DOI 10.1042/BJ20100026; DELANO WL, 2002, PYMOL MOL GRAPHICS; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gounaris K, 2001, INFECT IMMUN, V69, P3658, DOI 10.1128/IAI.69.6.3658-3662.2001; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Korn-berg A, 2008, MICROBE, V3, P119; KORNBERG A, 1956, BIOCHIM BIOPHYS ACTA, V20, P215, DOI 10.1016/0006-3002(56)90280-3; Kumble KD, 1996, P NATL ACAD SCI USA, V93, P14391, DOI 10.1073/pnas.93.25.14391; Kuroda A, 1997, P NATL ACAD SCI USA, V94, P439, DOI 10.1073/pnas.94.2.439; Mullan A, 2002, MICROB ECOL, V44, P69, DOI 10.1007/s00248-002-3004-x; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; Nesmeyanova MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P309; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Ogawa N, 2000, J BACTERIOL, V182, P6687, DOI 10.1128/JB.182.23.6687-6693.2000; Parish T, 1998, METH MOL B, V101, P1, DOI 10.1385/0-89603-471-2:1; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Sambrook J, 2001, MOL CLONING LAB MANU; Sarin J, 2001, J BIOL CHEM, V276, P44590, DOI 10.1074/jbc.M105401200; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Shum KT, 2011, BIOCHEMISTRY-US, V50, P3261, DOI 10.1021/bi2001455; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Sureka K, 2009, MOL MICROBIOL, V74, P1187, DOI 10.1111/j.1365-2958.2009.06925.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Tzeng CM, 2000, J BIOL CHEM, V275, P3977, DOI 10.1074/jbc.275.6.3977; Varela C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-7; WOOD HG, 1988, ANNU REV BIOCHEM, V57, P235, DOI 10.1146/annurev.bi.57.070188.001315; Zhang HY, 2002, P NATL ACAD SCI USA, V99, P16678, DOI 10.1073/pnas.262655199; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	47	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27398	10.1371/journal.pone.0027398	http://dx.doi.org/10.1371/journal.pone.0027398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110640	Green Submitted, Green Published, gold			2022-12-25	WOS:000297554300026
J	Huang, R; Jaritz, M; Guenzl, P; Vlatkovic, I; Sommer, A; Tamir, IM; Marks, H; Klampfl, T; Kralovics, R; Stunnenberg, HG; Barlow, DP; Pauler, FM				Huang, Ru; Jaritz, Markus; Guenzl, Philipp; Vlatkovic, Irena; Sommer, Andreas; Tamir, Ido M.; Marks, Hendrik; Klampfl, Thorsten; Kralovics, Robert; Stunnenberg, Hendrik G.; Barlow, Denise P.; Pauler, Florian M.			An RNA-Seq Strategy to Detect the Complete Coding and Non-Coding Transcriptome Including Full-Length Imprinted Macro ncRNAs	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME; SHOWS; IGF2R; BIAS; BIOGENESIS; RESOLUTION; MICRORNAS; LANDSCAPE; CELLS	Imprinted macro non-protein-coding (nc) RNAs are cis-repressor transcripts that silence multiple genes in at least three imprinted gene clusters in the mouse genome. Similar macro or long ncRNAs are abundant in the mammalian genome. Here we present the full coding and non-coding transcriptome of two mouse tissues: differentiated ES cells and fetal head using an optimized RNA-Seq strategy. The data produced is highly reproducible in different sequencing locations and is able to detect the full length of imprinted macro ncRNAs such as Airn and Kcnq1ot1, whose length ranges between 80-118 kb. Transcripts show a more uniform read coverage when RNA is fragmented with RNA hydrolysis compared with cDNA fragmentation by shearing. Irrespective of the fragmentation method, all coding and non-coding transcripts longer than 8 kb show a gradual loss of sequencing tags towards the 39 end. Comparisons to published RNA-Seq datasets show that the strategy presented here is more efficient in detecting known functional imprinted macro ncRNAs and also indicate that standardization of RNA preparation protocols would increase the comparability of the transcriptome between different RNA-Seq datasets.	[Huang, Ru; Guenzl, Philipp; Vlatkovic, Irena; Klampfl, Thorsten; Kralovics, Robert; Barlow, Denise P.; Pauler, Florian M.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Jaritz, Markus; Sommer, Andreas; Tamir, Ido M.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Marks, Hendrik; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NCMLS, NL-6525 ED Nijmegen, Netherlands	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Radboud University Nijmegen	Huang, R (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	dbarlow@cemm.oeaw.ac.at; fpauler@cemm.oeaw.ac.at	Stunnenberg, Hendrik G./D-6875-2012; Marks, Hendrik/E-2801-2012	Stunnenberg, Hendrik G./0000-0002-0066-1576; Marks, Hendrik/0000-0002-4198-3731; Klampfl, Thorsten/0000-0002-6666-9773; Kralovics, Robert/0000-0002-6997-8539; Vlatkovic, Irena/0000-0001-8745-4299; Sommer, Andreas/0000-0003-0456-1940; Jaritz, Markus/0000-0002-9326-2047	EU [LSHGCt-2005-018883]; GEN-AU III Epigenetic Regulation Of Cell Fate Decisions [GZ200.141/1-VI/12009]	EU(European Commission); GEN-AU III Epigenetic Regulation Of Cell Fate Decisions	EU Framework Program 6 Integrated Project 'HEROIC' LSHGCt-2005-018883 http://www.heroic-ip.eu/. GEN-AU III Epigenetic Regulation Of Cell Fate Decisions GZ200.141/1-VI/12009 http://www.gen-au.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauler FM, 2005, GENOME RES, V15, P1379, DOI 10.1101/gr.3783805; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232	41	73	75	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27288	10.1371/journal.pone.0027288	http://dx.doi.org/10.1371/journal.pone.0027288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102886	Green Submitted, Green Published, gold			2022-12-25	WOS:000297348800021
J	Rzymski, T; Petry, A; Kracun, D; Riess, F; Pike, L; Harris, AL; Gorlach, A				Rzymski, T.; Petry, A.; Kracun, D.; Riess, F.; Pike, L.; Harris, A. L.; Goerlach, A.			The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress	ONCOGENE			English	Article						ADAM17/TACE; hypoxia; ER stress; unfolded protein response; TNF alpha receptor; cancer	TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; ALPHA-CONVERTING-ENZYME; NF-KAPPA-B; UP-REGULATED EXPRESSION; ISOLATED LIMB PERFUSION; SOLUBLE RECEPTORS; TNF-ALPHA; SIGNALING PATHWAYS; PROGNOSTIC-FACTORS	The family of ADAM (a disintegrin and metalloproteinase) proteins has been implicated in tumor initiation and progression. ADAM17/tumor necrosis factor-alpha (TNF alpha)-converting enzyme (TACE) has been initially recognized to release TNF alpha as well as its receptors (TNFRs) from the membrane. ADAM17, TNF alpha and TNFR have been found upregulated in cancer patients, although the underlying mechanisms remain largely unknown. As hypoxia is a hallmark of cancer that can lead to severe stress conditions accumulating in endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), we investigated the role of these stress conditions in the regulation of ADAM17 and release of TNFR1. We found that severe hypoxia induced ADAM17 expression and activity. Although hypoxia-inducible factor 1 alpha (HIF1 alpha) was important to maintain basal ADAM17 mRNA levels during moderate hypoxia, it was not sufficient to induce ADAM17 levels under severe hypoxia. Instead, we found that ADAM17 induction by severe hypoxia can be mimicked by ER stressors such as Thapsigargin and occurs as a consequence of the activation of the PERK/eIF2 alpha/ATF4 and activating transcription factor 6 (ATF6) arms of UPR in several tumor cell lines. ADAM17 expression was also increased in xenografts displaying ER stress because of treatment with the vascular endothelial growth factor (VEGF) inhibitory antibody Bevacizumab. Additionally, severe hypoxia and ER stress activated ADAM17 and ectodomain shedding of TNFR1 involving mitogen-activated protein (MAP) kinases and reactive oxygen species (ROS). Collectively, these results show that ADAM17 is a novel UPR-regulated gene in response to severe hypoxia and ER stress, which is actively involved in the release of TNFR1 under these conditions. These data provide a novel link between severe hypoxic stress conditions and inflammation in the tumor environment. Oncogene (2012) 31, 3621-3634; doi:10.1038/onc.2011.522; published online 21 November 2011	[Rzymski, T.; Petry, A.; Kracun, D.; Riess, F.; Goerlach, A.] Tech Univ Munich, German Heart Ctr Munich, D-80636 Munich, Bavaria, Germany; [Pike, L.; Harris, A. L.] John Radcliffe Hosp, Weatherall Inst Mol Med, Univ Dept Med Oncol, Mol Oncol Labs, Oxford OX3 9DU, England	German Heart Centre Munich; Technical University of Munich; University of Oxford	Gorlach, A (corresponding author), Tech Univ Munich, German Heart Ctr Munich, Lazarettstr 36, D-80636 Munich, Bavaria, Germany.	goerlach@dhm.mhn.de	Gorlach, Agnes/B-3494-2013; Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409	EU 7th FP Metoxia [222471]; Fondation Leducq; DFG [GO709/4-4]	EU 7th FP Metoxia; Fondation Leducq(Leducq Foundation); DFG(German Research Foundation (DFG))	We thank Merel Gijsen, Francesca Buffa and Ji-Liang Li for help with tumor sample preparation, bioinformatics and xenograft work. This work was supported by EU 7th FP 222471 Metoxia, DFG GO709/4-4 and Fondation Leducq.	ADERKA D, 1991, CANCER RES, V51, P5602; AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arsenault D, 2012, J CELL PHYSIOL, V227, P789, DOI 10.1002/jcp.22792; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Burton Elizabeth R, 2009, J Biol, V8, P85, DOI 10.1186/jbiol189; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Coleman ML, 2007, ESSAYS BIOCHEM, V43, P1; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1, DOI 10.1111/j.1600-0609.1995.tb01618.x; Eggermont AMM, 2003, LANCET ONCOL, V4, P429, DOI 10.1016/S1470-2045(03)01141-0; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; FEINBERG B, 1988, J CLIN ONCOL, V6, P1328, DOI 10.1200/JCO.1988.6.8.1328; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fraker DL, 1996, J CLIN ONCOL, V14, P479, DOI 10.1200/JCO.1996.14.2.479; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HELLER RA, 1990, P NATL ACAD SCI USA, V87, P6151, DOI 10.1073/pnas.87.16.6151; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kornfeld JW, 2011, BRIT J CANCER, V104, P138, DOI 10.1038/sj.bjc.6606017; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; LANGKOPF F, 1994, LANCET, V344, P57, DOI 10.1016/S0140-6736(94)91078-2; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCulloch DR, 2000, MOL CELL ENDOCRINOL, V167, P11, DOI 10.1016/S0303-7207(00)00305-1; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mujcic H, 2009, RADIOTHER ONCOL, V92, P450, DOI 10.1016/j.radonc.2009.08.017; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; REIBNEGGER G, 1994, LANCET, V344, P681, DOI 10.1016/S0140-6736(94)92115-6; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rzymski T, 2008, ONCOGENE, V27, P4532, DOI 10.1038/onc.2008.100; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Rzymski T, 2007, CLIN CANCER RES, V13, P2537, DOI 10.1158/1078-0432.CCR-06-2126; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Vahdat AM, 2010, LEUKEMIA, V24, P51, DOI 10.1038/leu.2009.230; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Viac J, 1996, EUR J CANCER, V32A, P447, DOI 10.1016/0959-8049(95)00541-2; Waetzig GH, 2004, FASEB J, V18, P91, DOI 10.1096/fj.04-2073fje; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yoshimura T, 2002, J INFECT DIS, V185, P332, DOI 10.1086/338191; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang ZL, 2001, FASEB J, V15, P303; Zheng X, 2009, CANCER BIOL THER, V8, P1045, DOI 10.4161/cbt.8.11.8539	83	54	56	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	31					3621	3634		10.1038/onc.2011.522	http://dx.doi.org/10.1038/onc.2011.522			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22105359				2022-12-25	WOS:000307245600005
J	Marathe, N; Rangaswami, H; Zhuang, SH; Boss, GR; Pilz, RB				Marathe, Nisha; Rangaswami, Hema; Zhuang, Shunhui; Boss, Gerry R.; Pilz, Renate B.			Pro-survival Effects of 17 beta-Estradiol on Osteocytes Are Mediated by Nitric Oxide/cGMP via Differential Actions of cGMP-dependent Protein Kinases I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP; INDUCED APOPTOSIS; OXIDATIVE STRESS; POSTMENOPAUSAL WOMEN; BONE-FORMATION; BH3 DOMAIN; ESTROGEN; ALPHA; BAD; PHOSPHORYLATION	Estrogens promote bone health in part by increasing osteocyte survival, an effect that requires activation of the protein kinases Akt and ERK1/2, but the molecular mechanisms involved are only partly understood. Because estrogens increase nitric oxide (NO) synthesis and NO can have anti-apoptotic effects, we examined the role of NO/cGMP signaling in estrogen regulation of osteocyte survival. Etoposide-induced death of MLO-Y4 osteocyte-like cells, assessed by trypan blue staining, caspase-3 cleavage, and TUNEL assays, was completely prevented when cells were pre-treated with 17 beta-estradiol. This protective effect was mimicked when cells were pre-treated with a membrane-permeable cGMP analog and blocked by pharmacological inhibitors of NO synthase, soluble guanylate cyclase, or cGMP-dependent protein kinases (PKGs), supporting a requirement for NO/cGMP/PKG signaling downstream of 17 beta-estradiol. siRNA-mediated knockdown and viral reconstitution of individual PKG isoforms demonstrated that the anti-apoptotic effects of estradiol and cGMP were mediated by PKG I alpha and PKG II. Akt and ERK1/2 activation by 17 beta-estradiol required PKG II, and cGMP mimicked the effects of estradiol on Akt and ERK, including induction of ERK nuclear translocation. cGMP induced BAD phosphorylation on several sites, and experiments with phosphorylation-deficient BAD mutants demonstrated that the anti-apoptotic effects of cGMP and 17 beta-estradiol required BAD phosphorylation on Ser(136) and Ser(155); these sites were targeted by Akt and PKG I, respectively, and regulate BAD interaction with Bcl-2. In conclusion, 17 beta-estradiol protects osteocytes against apoptosis by activating the NO/cGMP/PKG cascade; PKG II is required for estradiol-induced activation of ERK and Akt, and PKG I alpha contributes to pro-survival signaling by directly phosphorylating BAD.	Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; Univ Calif San Diego, Ctr Canc, San Diego, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Progam, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300];  [T32-HL007261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR051300 (to R. B. P.) and Training Grant T32-HL007261 (to N. M.).	Alexaki VI, 2006, J STEROID BIOCHEM, V98, P97, DOI 10.1016/j.jsbmb.2005.08.017; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Armour KE, 1998, ENDOCRINOLOGY, V139, P799, DOI 10.1210/en.139.2.799; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chae HJ, 2006, CLIN CHIM ACTA, V365, P270, DOI 10.1016/j.cca.2005.09.011; Chen JR, 2005, J BIOL CHEM, V280, P4632, DOI 10.1074/jbc.M411530200; Cherney A, 2003, AM J PHYSIOL-REG I, V285, pR842, DOI 10.1152/ajpregu.00035.2003; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; Grassi F, 2006, ENDOCRINOLOGY, V147, P4392, DOI 10.1210/en.2006-0334; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Hukkanen M, 2003, BONE, V32, P142, DOI 10.1016/S8756-3282(02)00955-9; Jamal SA, 2004, J BONE MINER RES, V19, P1512, DOI 10.1359/JBMR.040716; Jamal SA, 2011, JAMA-J AM MED ASSOC, V305, P800, DOI 10.1001/jama.2011.176; Johlfs MG, 2010, NEUROCHEM INT, V56, P546, DOI 10.1016/j.neuint.2009.12.017; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Koga M, 2004, BIOCHEM BIOPH RES CO, V324, P321, DOI 10.1016/j.bbrc.2004.09.060; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; O'Shaughnessy MC, 2000, BIOCHEM BIOPH RES CO, V277, P604, DOI 10.1006/bbrc.2000.3714; Parker JD, 2004, J CLIN INVEST, V113, P352, DOI 10.1172/JCI200421003; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Samuels A, 2001, BONE, V29, P24, DOI 10.1016/S8756-3282(01)00471-9; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Soh JW, 2000, CLIN CANCER RES, V6, P4136; Stratton RC, 2010, J BIOL CHEM, V285, P27201, DOI 10.1074/jbc.M110.103630; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tan SD, 2006, J DENT RES, V85, P905, DOI 10.1177/154405910608501006; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wimalawansa SJ, 1996, BONE, V18, P301, DOI 10.1016/8756-3282(96)00005-1; Wimalawansa SJ, 2007, ANN NY ACAD SCI, V1117, P283, DOI 10.1196/annals.1402.066; Wong JC, 2011, J CELL BIOCHEM, V112, P829, DOI 10.1002/jcb.22981; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200	54	64	69	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					978	988		10.1074/jbc.M111.294959	http://dx.doi.org/10.1074/jbc.M111.294959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117068	Green Published, hybrid			2022-12-25	WOS:000299170300016
J	Lindgren, J; Everhart, MJ; Caldwell, MW				Lindgren, Johan; Everhart, Michael J.; Caldwell, Michael W.			Three-Dimensionally Preserved Integument Reveals Hydrodynamic Adaptations in the Extinct Marine Lizard Ectenosaurus (Reptilia, Mosasauridae)	PLOS ONE			English	Article							SOFT-TISSUE PRESERVATION; CARCHARODON-CARCHARIAS; FUNCTIONAL-MORPHOLOGY; WHITE SHARK; SKIN; ICHTHYOSAUR; SQUAMATA; ANATOMY; DOLPHIN; FIBERS	The physical properties of water and the environment it presents to its inhabitants provide stringent constraints and selection pressures affecting aquatic adaptation and evolution. Mosasaurs (a group of secondarily aquatic reptiles that occupied a broad array of predatory niches in the Cretaceous marine ecosystems about 98-65 million years ago) have traditionally been considered as anguilliform locomotors capable only of generating short bursts of speed during brief ambush pursuits. Here we report on an exceptionally preserved, long-snouted mosasaur (Ectenosaurus clidastoides) from the Santonian (Upper Cretaceous) part of the Smoky Hill Chalk Member of the Niobrara Formation in western Kansas, USA, that contains phosphatized remains of the integument displaying both depth and structure. The small, ovoid neck and/or anterior trunk scales exhibit a longitudinal central keel, and are obliquely arrayed into an alternating pattern where neighboring scales overlap one another. Supportive sculpturing in the form of two parallel, longitudinal ridges on the inner scale surface and a complex system of multiple, superimposed layers of straight, cross-woven helical fiber bundles in the underlying dermis, may have served to minimize surface deformation and frictional drag during locomotion. Additional parallel fiber bundles oriented at acute angles to the long axis of the animal presumably provided stiffness in the lateral plane. These features suggest that the anterior torso of Ectenosaurus was held somewhat rigid during swimming, thereby limiting propulsive movements to the posterior body and tail.	[Lindgren, Johan] Lund Univ, Dept Earth & Ecosyst Sci, Lund, Sweden; [Everhart, Michael J.] Ft Hays State Univ, Sternberg Museum Nat Hist, Hays, KS 67601 USA; [Caldwell, Michael W.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Caldwell, Michael W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Lund University; University of Alberta; University of Alberta	Lindgren, J (corresponding author), Lund Univ, Dept Earth & Ecosyst Sci, Lund, Sweden.	johan.lindgren@geol.lu.se	Caldwell, Michael/A-2622-2014	Caldwell, Michael/0000-0002-2377-3925	Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences	This research was supported by grants from the Swedish Research Council, the Crafoord Foundation and the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff JE, 2000, J BIOMECH, V33, P645, DOI 10.1016/S0021-9290(00)00018-X; BREDER C. M., 1926, ZOOLOGICA, V4, P159; Caldwell MW, 2004, J VERTEBR PALEONTOL, V24, P980, DOI 10.1671/0272-4634(2004)024[0980:SPIAMY]2.0.CO;2; CALDWELL MW, 2012, B SOC GEOL IN PRESS; Camp C. I., 1942, Memoirs of the University of California, V13, P1; Dortangs RW, 2002, GEOL MIJNBOUW-N J G, V81, P1; Everhart M. J., 2005, OCEANS KANSAS NATURA; Feduccia A, 2005, J MORPHOL, V266, P125, DOI 10.1002/jmor.10382; Gauthier J, 2008, J HERPETOL, V42, P708, DOI 10.1670/07-047R2.1; HEBRANK MR, 1986, BIOL BULL, V171, P236, DOI 10.2307/1541920; Hutchinson DA, 2004, J MORPHOL, V260, P247, DOI 10.1002/jmor.10219; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Konishi T, 2011, J VERTEBR PALEONTOL, V31, P754, DOI 10.1080/02724634.2011.579023; Lillywhite HB, 2009, J EXP BIOL, V212, P1921, DOI 10.1242/jeb.028704; Lindgren J, 2007, LETHAIA, V40, P153, DOI 10.1111/j.1502-3931.2007.00009.x; Lindgren J, 2011, PALEOBIOLOGY, V37, P445, DOI 10.1666/09023.1; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Lindgren J, 2009, BIOL LETTERS, V5, P528, DOI 10.1098/rsbl.2009.0097; Lindgren J, 2008, J VERTEBR PALEONTOL, V28, P1043, DOI 10.1671/0272-4634-28.4.1043; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P563, DOI 10.1007/s00114-003-0483-7; Lingham-Soliar T, 2001, LETHAIA, V34, P287, DOI 10.1080/002411601753293042; Lingham-Soliar T, 1999, P ROY SOC B-BIOL SCI, V266, P2367, DOI 10.1098/rspb.1999.0933; Lingham-Soliar T, 2005, J MORPHOL, V264, P233, DOI 10.1002/jmor.10328; Lingham-Soliar T, 2005, J MORPHOL, V263, P1, DOI 10.1002/jmor.10207; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2007, NATURWISSENSCHAFTEN, V94, P65, DOI 10.1007/s00114-006-0160-8; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263; Pabst DA, 1996, J ZOOL, V238, P35, DOI 10.1111/j.1469-7998.1996.tb05378.x; Pabst DA, 2000, AM ZOOL, V40, P146, DOI 10.1668/0003-1569(2000)040[0146:TBADCO]2.0.CO;2; Polcyn MJ, 2005, NETH J GEOSCI, V84, P321, DOI 10.1017/S0016774600021107; RUSSELL DA, 1967, SYSTEMATICS, V23, P1; Schweitzer MH, 2011, ANNU REV EARTH PL SC, V39, P187, DOI 10.1146/annurev-earth-040610-133502; Sherbrooke WC, 2007, ZOOMORPHOLOGY, V126, P89, DOI 10.1007/s00435-007-0031-7; Smith KT, 2008, J VERTEBR PALEONTOL, V28, P85, DOI 10.1671/0272-4634(2008)28[85:ANASAW]2.0.CO;2; SNOW FH, 1878, T KANSAS ACAD SCI, V6, P54, DOI DOI 10.2307/3623557; Sues, 2007, EVOLUTIONARY TRANSIT, P253; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Williston S. W, 1898, U GEOLOGICAL SURVEY, V4, P81; WILLISTON SW, 1897, KANSAS U Q, V4, P99	40	14	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27343	10.1371/journal.pone.0027343	http://dx.doi.org/10.1371/journal.pone.0027343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110629	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400036
J	Long, EF				Long, Elisa F.			HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; SEXUAL TRANSMISSION; RISK BEHAVIOR; DRUG-USERS; VIRAL LOAD; INFECTION; RNA; POPULATION; DIAGNOSIS	Background: At least 10% of the 56,000 annual new HIV infections in the United States are caused by individuals with acute HIV infection (AHI). It unknown whether the health benefits and costs of routine nucleic acid amplification testing (NAAT) are justified, given the availability of newer fourth-generation immunoassay tests. Methods: Using a dynamic HIV transmission model instantiated with U. S. epidemiologic, demographic, and behavioral data, I estimated the number of acute infections identified, HIV infections prevented, quality-adjusted life years (QALYs) gained, and the cost-effectiveness of alternative screening strategies. I varied the target population (everyone aged 15-64, injection drug users [IDUs] and men who have sex with men [MSM], or MSM only), screening frequency (annually, or every six months), and test(s) utilized (fourth-generation immunoassay only, or immunoassay followed by pooled NAAT). Results: Annual immunoassay testing of MSM reduces incidence by 9.5% and costs <$10,000 per QALY gained. Adding pooled NAAT identifies 410 AHI per year, prevents 9.6% of new cases, costs $ 92,000 per QALY gained, and remains <$ 100,000 per QALY gained in settings where undiagnosed HIV prevalence exceeds 4%. Screening IDUs and MSM annually with fourth-generation immunoassay reduces incidence by 13% with cost-effectiveness <$ 10,000 per QALY gained. Increasing the screening frequency to every six months reduces incidence by 11% (MSM only) or 16% (MSM and IDUs) and costs <$ 20,000 per QALY gained. Conclusions: Pooled NAAT testing every 12 months of MSM and IDUs in the United States prevents a modest number of infections, but may be cost-effective given sufficiently high HIV prevalence levels. However, testing via fourth-generation immunoassay every six months prevents a greater number of infections, is more economically efficient, and may obviate the benefits of acute HIV screening via NAAT.	Yale Univ, Sch Management, New Haven, CT 06520 USA	Yale University	Long, EF (corresponding author), Yale Univ, Sch Management, New Haven, CT 06520 USA.	elisa.long@yale.edu	Long, Elisa/AFQ-5915-2022					Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2010, HIV AIDS US; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; CensusScope, 2000, US AG DISTR; Centers for Disease Control and Prevention, 2010, HIV AIDS GAY BIS MEN; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Coco A, 2005, ANN FAM MED, V3, P391, DOI 10.1370/afm.375; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; *CTR MED MED SERV, 2009, MED FEE SCHED; Elbeik T, 2000, J CLIN MICROBIOL, V38, P1113, DOI 10.1128/JCM.38.3.1113-1120.2000; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Gold MR, 1996, COST EFFECTIVENESS H; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; HALL HI, 2008, United States JAMA, V300, P520; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; HOLLINGSWORTH TD, 2006, 13 C RETR OPP INF; Hutchinson AB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000342; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Patel P, 2010, ARCH INTERN MED, V170, P66, DOI 10.1001/archinternmed.2009.445; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Priddy FH, 2007, JAIDS-J ACQ IMM DEF, V44, P196, DOI 10.1097/01.qai.0000254323.86897.36; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sherlock M, 2007, SEX TRANSM DIS, V34, P314, DOI 10.1097/01.olq.0000263262.00273.9c; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; *UNAIDS, 2010, REP GLOB AIDS EP; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Westreich DJ, 2008, J CLIN MICROBIOL, V46, P1785, DOI 10.1128/JCM.00787-07	49	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27625	10.1371/journal.pone.0027625	http://dx.doi.org/10.1371/journal.pone.0027625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110698	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400074
J	Serghides, L; Kim, H; Lu, ZY; Kain, DC; Miller, C; Francis, RC; Liles, WC; Zapol, WM; Kain, KC				Serghides, Lena; Kim, Hani; Lu, Ziyue; Kain, Dylan C.; Miller, Chris; Francis, Roland C.; Liles, W. Conrad; Zapol, Warren M.; Kain, Kevin C.			Inhaled Nitric Oxide Reduces Endothelial Activation and Parasite Accumulation in the Brain, and Enhances Survival in Experimental Cerebral Malaria	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; PLASMODIUM-FALCIPARUM MALARIA; UNCOMPLICATED MALARIA; MYOCARDIAL-ISCHEMIA; ADJUNCTIVE THERAPY; LEUKOCYTE ADHESION; AFRICAN CHILDREN; CARBON-MONOXIDE; SODIUM-NITRITE; SERUM-LEVELS	The host immune response contributes to the onset and progression of severe malaria syndromes, such as cerebral malaria. Adjunctive immunomodulatory strategies for severe malaria may improve clinical outcome beyond that achievable with artemisinin-based therapy alone. Here, we report that prophylaxis with inhaled nitric oxide significantly reduced systemic inflammation (lower TNF, IFN gamma and MCP-1 in peripheral blood) and endothelial activation (decreased sICAM-1 and vWF, and increased angiopoeitin-1 levels in peripheral blood) in an experimental cerebral malaria model. Mice that received inhaled nitric oxide starting prior to infection had reduced parasitized erythrocyte accumulation in the brain, decreased brain expression of ICAM-1, and preserved vascular integrity compared to control mice. Inhaled nitric oxide administered in combination with artesunate, starting as late as 5.5 days post-infection, improved survival over treatment with artesunate alone (70% survival in the artesunate only vs. 100% survival in the artesunate plus iNO group, p = 0.03). These data support the clinical investigation of inhaled nitric oxide as a novel adjunctive therapy in patients with severe malaria.	[Serghides, Lena; Kim, Hani; Lu, Ziyue; Kain, Dylan C.; Liles, W. Conrad; Kain, Kevin C.] Toronto Gen Hosp, Dept Med, McLaughlin Rotman Ctr Global Hlth,Div Infect Dis, SA Rotman Labs,Trop Dis Unit,Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Serghides, Lena; Kim, Hani; Lu, Ziyue; Kain, Dylan C.; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Toronto, ON, Canada; [Miller, Chris] Univ British Columbia, Fac Med, Dept Resp Med, Vancouver, BC, Canada; [Francis, Roland C.; Zapol, Warren M.] Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of British Columbia; Harvard University; Massachusetts General Hospital	Serghides, L (corresponding author), Toronto Gen Hosp, Dept Med, McLaughlin Rotman Ctr Global Hlth,Div Infect Dis, SA Rotman Labs,Trop Dis Unit,Univ Hlth Network, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.on.ca	Serghides, Lena/C-7968-2018	Serghides, Lena/0000-0002-2817-6134; Kain, Dylan/0000-0001-5890-2742; Francis, Roland Chike Eluaka/0000-0003-1958-9364; Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research [MOP-13721, 244701]; Canada Research Chair; Ontario HIV Treatment Network [287]; Defense Advanced Research Projects Agency [58217-LS-DRP]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario HIV Treatment Network; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the Canadian Institutes of Health Research MOP-13721 and 244701 [KCK], Canada Research Chair [KCK, WCL], an Ontario HIV Treatment Network Junior Investigator Salary Award 287 [LS], and a Defense Advanced Research Projects Agency grant 58217-LS-DRP [KCK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Barrington KJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000509.pub3; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; Bloch KD, 2007, CARDIOVASC RES, V75, P339, DOI 10.1016/j.cardiores.2007.04.014; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 1999, J INFECT DIS, V180, P1742, DOI 10.1086/315078; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Cabrales P, 2011, J INFECT DIS, V203, P1454, DOI 10.1093/infdis/jir058; Carvalho LJM, 2010, TRENDS PARASITOL, V26, P271, DOI 10.1016/j.pt.2010.03.001; Cauwels A, 2009, J EXP MED, V206, P2915, DOI 10.1084/jem.20091236; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; CONROY AL, 2011, CRIT CARE M IN PRESS; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Faiz MA, 2005, LANCET, V366, P717; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Finer NN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000399.pub2; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; HASEGAWA AT, 1965, RADIAT RES, V24, P636, DOI 10.2307/3571882; HAWKES M, 2011, MED HYPOTHESES; Hawkes M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-176; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hobbs MR, 2002, LANCET, V360, P1468, DOI 10.1016/S0140-6736(02)11474-7; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Jennings VM, 1998, INFECT IMMUN, V66, P5972, DOI 10.1128/IAI.66.12.5972-5979.1998; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; John CC, 2008, CYTOKINE, V41, P204, DOI 10.1016/j.cyto.2007.12.008; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; John CC, 2010, EXPERT REV ANTI-INFE, V8, P997, DOI [10.1586/eri.10.90, 10.1586/ERI.10.90]; Jung KH, 2006, STROKE, V37, P2744, DOI 10.1161/01.STR.0000245116.40163.1c; Kawai S, 2003, J VET MED SCI, V65, P629, DOI 10.1292/jvms.65.629; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Lamb Tracey J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010581; Langhorne J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-23; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Li J, 2003, J INVEST MED, V51, P128, DOI 10.1136/jim-51-03-15; Liu XS, 2007, J AM COLL CARDIOL, V50, P808, DOI 10.1016/j.jacc.2007.04.069; LOOAREESUWAN S, 1991, ACTA TROP, V48, P263, DOI 10.1016/0001-706X(91)90014-B; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Nagasaka Y, 2008, ANESTHESIOLOGY, V109, P675, DOI 10.1097/ALN.0b013e318186316e; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; REST JR, 1982, T ROY SOC TROP MED H, V76, P410, DOI 10.1016/0035-9203(82)90203-6; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Sokol J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002787; Stevenson MM, 2010, TRENDS PARASITOL, V26, P274, DOI 10.1016/j.pt.2010.03.008; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heijden M, 2009, EXPERT OPIN THER TAR, V13, P39, DOI 10.1517/14728220802626256 ; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; WENISCH C, 1994, CLIN IMMUNOL IMMUNOP, V71, P344, DOI 10.1006/clin.1994.1096; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; White VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004317; WILLIMANN K, 1995, J EXP MED, V182, P643, DOI 10.1084/jem.182.3.643; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Zacharek A, 2006, NEUROSCI LETT, V404, P28, DOI 10.1016/j.neulet.2006.05.027; Zanini GM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-66	91	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27714	10.1371/journal.pone.0027714	http://dx.doi.org/10.1371/journal.pone.0027714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110737	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400094
J	Ledberg, A; Robbe, D				Ledberg, Anders; Robbe, David			Locomotion-Related Oscillatory Body Movements at 6-12 Hz Modulate the Hippocampal Theta Rhythm	PLOS ONE			English	Article							SPATIAL PERIODICITY; PATH-INTEGRATION; PLACE CELLS; RAT; PHASE; MEMORY; SPEED; HEAD; COORDINATION; STIMULATION	The hippocampal theta rhythm is required for accurate navigation and spatial memory but its relation to the dynamics of locomotion is poorly understood. We used miniature accelerometers to quantify with high temporal and spatial resolution the oscillatory movements associated with running in rats. Simultaneously, we recorded local field potentials in the CA1 area of the hippocampus. We report that when rats run their heads display prominent vertical oscillations with frequencies in the same range as the hippocampal theta rhythm (i.e., 6-12 Hz). In our behavioral set-up, rats run mainly with speeds between 50 and 100 cm/s. In this range of speeds, both the amplitude and frequency of the "theta" head oscillations were increasing functions of running speed, demonstrating that the head oscillations are part of the locomotion dynamics. We found evidence that these rhythmical locomotor dynamics interact with the neuronal activity in the hippocampus. The amplitude of the hippocampal theta rhythm depended on the relative phase shift with the head oscillations, being maximal when the two signals were in phase. Despite similarity in frequency, the head movements and LFP oscillations only displayed weak phase and frequency locking. Our results are consistent with that neurons in the CA1 region receive inputs that are phase locked to the head acceleration signal and that these inputs are integrated with the ongoing theta rhythm.	[Ledberg, Anders] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain; [Robbe, David] IDIBAPS, Dept Syst Neurosci, Barcelona, Spain	Pompeu Fabra University; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Ledberg, A (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain.	anders.ledberg@upf.edu; davidrobbe@gmail.com	robbe, david/O-5439-2016	robbe, david/0000-0002-9450-0553; Ledberg, Anders/0000-0003-3827-8721	Ministerio de Ciencia e Innovacion [BFU2008-03946]; Marie Curie International Reintegration Grant [IRG230976]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Marie Curie International Reintegration Grant(European Commission)	This work was funded by a national grant from the Ministerio de Ciencia e Innovacion (BFU2008-03946, to D.R.) and a Marie Curie International Reintegration Grant (IRG230976 to D.R.). A.L. and D.R. were supported by Ramon-Y-Cajal fellowships from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JH, 1978, EXP BRAIN RES, V32, P491; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berg RW, 2006, J NEUROSCI, V26, P6518, DOI 10.1523/JNEUROSCI.0190-06.2006; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; BUNO W, 1977, PHYSIOL BEHAV, V19, P615, DOI 10.1016/0031-9384(77)90035-X; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Gillis GB, 2001, J EXP BIOL, V204, P2717; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; HORII A, 1994, J NEUROPHYSIOL, V72, P605, DOI 10.1152/jn.1994.72.2.605; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; LOUIE AW, 1976, EXP BRAIN RES, V24, P447; MAREY M, 1873, J ANAT PHYSL, V9, P42; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; Mitra P., 2007, OBSERVED BRAIN DYNAM; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pikovsky A., 2001, SYNCHRONIZATION UNIV; POZZO T, 1990, EXP BRAIN RES, V82, P97; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; Schmidt A, 2010, J EXP BIOL, V213, P3615, DOI 10.1242/jeb.045278; SEMBA K, 1978, ELECTROEN CLIN NEURO, V44, P61, DOI 10.1016/0013-4694(78)90105-0; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Smith PF, 1997, HIPPOCAMPUS, V7, P465, DOI 10.1002/(SICI)1098-1063(1997)7:5<465::AID-HIPO3>3.0.CO;2-G; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Venkatraman S, 2010, J NEUROPHYSIOL, V104, P569, DOI 10.1152/jn.00121.2010; Webb AA, 2011, JOVE-J VIS EXP, DOI 10.3791/2138; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	42	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27575	10.1371/journal.pone.0027575	http://dx.doi.org/10.1371/journal.pone.0027575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102910	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300030
J	Levy, R; Biran, A; Poirier, F; Raz, A; Kloog, Y				Levy, Ran; Biran, Anat; Poirier, Francoise; Raz, Avraham; Kloog, Yoel			Galectin-3 Mediates Cross-Talk between K-Ras and Let-7c Tumor Suppressor microRNA	PLOS ONE			English	Article							H-RAS; CANCER; BINDING; ACTIVATION; PHOSPHORYLATION; SURVIVAL; SITE; EXPRESSION; REGION; SIGNAL	Background: Galectin-3 (Gal-3) and active (GTP-bound) K-Ras contribute to the malignant phenotype of many human tumors by increasing the rate of cell proliferation, survival, and migration. These Gal-3-mediated effects result from a selective binding to K-Ras. GTP, causing increased nanoclustering in the cell membrane and leading to robust Ras signaling. Regulation of the interactions between Gal-3 and active K-Ras is not fully understood. Methods and Findings: To gain a better understanding of what regulates the critical interactions between these two proteins, we examined the role of Gal-3 in the regulation of K-Ras by using Gal-3-knockout mouse embryonic-fibroblasts (Gal-3(-/-) MEFs) and/or Gal-3/Gal-1 double-knockout MEFs. We found that knockout of Gal-3 induced strong downregulation (similar to 60%) of K-Ras and K-Ras. GTP. The downregulation was somewhat more marked in the double-knockout MEFs, in which we also detected robust inhibition(similar to 50%) of ERK and Akt activation. These additional effects are probably attributable to inhibition of the weak interactions of K-Ras. GTP with Gal-1. Re-expression of Gal-3 reversed the phenotype of the Gal-3(-/-) MEFs and dramatically reduced the disappearance of K-Ras in the presence of cycloheximide to the levels seen in wild-type MEFs. Furthermore, phosphorylation of Gal-3 by casein kinase-1 (CK-1) induced translocation of Gal-3 from the nucleus to the cytoplasm and the plasma membrane, leading to K-Ras stabilization accompanied by downregulation of the tumor suppressor miRNA let-7c, known to negatively control K-Ras transcription. Conclusions: Our results suggest a novel cross-talk between Gal-3-mediated downregulation of let 7c microRNA (which in turn negatively regulates K-Ras transcription) and elucidates the association among Gal-3 let-7c and K-Ras transcription/translation, cellular compartmentalization and activity.	[Levy, Ran; Biran, Anat; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Poirier, Francoise] Univ Paris Diderot, CNRS, Inst Jacques Monod Inst, Paris 13, France; [Raz, Avraham] Wayne State Univ, Sch Med, Dept Pathol & Oncol, Karmanos Canc Inst, Detroit, MI USA	Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Barbara Ann Karmanos Cancer Institute; Wayne State University	Levy, R (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	kloog@post.tau.ac.il			Israel Science Foundation [912/06]; NIH [R37CA46120]; Prajs-Drimmer Institute for The Development of Anti-degenerative Drugs; NATIONAL CANCER INSTITUTE [R37CA046120] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prajs-Drimmer Institute for The Development of Anti-degenerative Drugs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by The Israel Science Foundation 912/06 (Y.K.), by NIH R37CA46120 (A. R.), and by the Prajs-Drimmer Institute for The Development of Anti-degenerative Drugs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; BOS JL, 1989, CANCER RES, V49, P4682; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Colnot C, 1996, BIOCHEM SOC T, V24, P141, DOI 10.1042/bst0240141; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; COX AD, 1994, J BIOL CHEM, V269, P19203; Der CJ, 2007, CELL, V129, P855, DOI 10.1016/j.cell.2007.05.031; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Graziano F, 2010, PHARMACOGENOMICS J, V10, P458, DOI 10.1038/tpj.2010.9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HUFLEJT ME, 1993, J BIOL CHEM, V268, P26712; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Levy R, 2010, MOL CANCER THER, V9, P2208, DOI 10.1158/1535-7163.MCT-10-0262; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; MAZUREK N, 2000, J BIOL CHEM; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Nakahara S, 2006, METHOD ENZYMOL, V417, P273, DOI 10.1016/S0076-6879(06)17019-6; Nelson HH, 2010, LUNG CANCER, V69, P51, DOI 10.1016/j.lungcan.2009.09.008; Niv H, 1999, J BIOL CHEM, V274, P1606, DOI 10.1074/jbc.274.3.1606; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rosseland CM, 2008, J CELL PHYSIOL, V215, P818, DOI 10.1002/jcp.21367; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; SHAPIRA S, 2006, CELL DEATH DIFFER; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Yan J, 2009, ONCOGENE, V28, P973, DOI 10.1038/onc.2008.435; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	42	29	30	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27490	10.1371/journal.pone.0027490	http://dx.doi.org/10.1371/journal.pone.0027490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102901	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555300024
J	Barto, EK; Hilker, M; Muller, F; Mohney, BK; Weidenhamer, JD; Rillig, MC				Barto, E. Kathryn; Hilker, Monika; Mueller, Frank; Mohney, Brian K.; Weidenhamer, Jeffrey D.; Rillig, Matthias C.			The Fungal Fast Lane: Common Mycorrhizal Networks Extend Bioactive Zones of Allelochemicals in Soils	PLOS ONE			English	Article							INVASION; COMMUNITIES; ALLELOPATHY; INTERFERENCE; CHEMISTRY; WATER	Allelopathy, a phenomenon where compounds produced by one plant limit the growth of surrounding plants, is a controversially discussed factor in plant-plant interactions with great significance for plant community structure. Common mycorrhizal networks (CMNs) form belowground networks that interconnect multiple plant species; yet these networks are typically ignored in studies of allelopathy. We tested the hypothesis that CMNs facilitate transport of allelochemicals from supplier to target plants, thereby affecting allelopathic interactions. We analyzed accumulation of a model allelopathic substance, the herbicide imazamox, and two allelopathic thiophenes released from Tagetes tenuifolia roots, by diffusion through soil and CMNs. We also conducted bioassays to determine how the accumulated substances affected plant growth. All compounds accumulated to greater levels in target soils with CMNs as opposed to soils without CMNs. This increased accumulation was associated with reduced growth of target plants in soils with CMNs. Our results show that CMNs support transfer of allelochemicals from supplier to target plants and thus lead to allelochemical accumulation at levels that could not be reached by diffusion through soil alone. We conclude that CMNs expand the bioactive zones of allelochemicals in natural environments, with significant implications for interspecies chemical interactions in plant communities.	[Barto, E. Kathryn; Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, D-1000 Berlin, Germany; [Hilker, Monika; Mueller, Frank] Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, D-1000 Berlin, Germany; [Mohney, Brian K.; Weidenhamer, Jeffrey D.] Ashland Univ, Dept Chem Geol & Phys, Ashland, OH USA	Free University of Berlin; Free University of Berlin; Ashland University	Barto, EK (corresponding author), Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, D-1000 Berlin, Germany.	barto@zedat.fu-berlin.de	Morris, Kathryn/I-4701-2014; Rillig, Matthias C./AAE-6980-2019; Rillig, Matthias C./B-3675-2009	Morris, Kathryn/0000-0003-3548-444X; Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853				Allen MF, 1996, MYCOL RES, V100, P769, DOI 10.1016/S0953-7562(96)80021-9; Allen MF, 2007, VADOSE ZONE J, V6, P291, DOI 10.2136/vzj2006.0068; Auge RM, 2001, PLANT SOIL, V230, P87, DOI 10.1023/A:1004891210871; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Barto EK, 2010, SOIL BIOL BIOCHEM, V42, P2316, DOI 10.1016/j.soilbio.2010.09.008; Barto EK, 2009, CHEMOSPHERE, V76, P71, DOI 10.1016/j.chemosphere.2009.02.020; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; Blum U, 2004, ALLELOPATHY: CHEMISTRY AND MODE OF ACTION OF ALLELOCHEMICALS, P57; BLUME HP, 2000, HDB BODENUNTERSUCHUN; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Duke SO, 2010, ALLELOPATHY J, V25, P17; Giovannetti M, 2004, NEW PHYTOL, V164, P175, DOI 10.1111/j.1469-8137.2004.01145.x; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Gyuricza V, 2010, ENVIRON MICROBIOL, V12, P2180, DOI 10.1111/j.1462-2920.2009.02118.x; Hillel, 1998, ENV SOIL PHYS, P771; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2005, J PLANT INTERACT, V1, P69, DOI 10.1080/17429140600622535; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson D, 2001, NEW PHYTOL, V152, P555, DOI 10.1046/j.0028-646X.2001.00273.x; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Macias FA, 2007, PHYTOCHEMISTRY, V68, P2917, DOI 10.1016/j.phytochem.2007.10.010; Mohney BK, 2009, J CHEM ECOL, V35, P1279, DOI 10.1007/s10886-009-9711-8; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; Nakano-Hylander A, 2007, SOIL BIOL BIOCHEM, V39, P1450, DOI 10.1016/j.soilbio.2006.12.031; Querejeta JI, 2003, OECOLOGIA, V134, P55, DOI 10.1007/s00442-002-1078-2; R Core Team, 2022, R LANG ENV STAT COMP; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Scarponi L, 2001, ITAL J FOOD SCI, V13, P213; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Schmidt SK, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P339; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Song Yuan Yuan, 2010, PLoS One, V5, pe13324, DOI 10.1371/journal.pone.0013324; Stampe ED, 2003, OIKOS, V100, P362, DOI 10.1034/j.1600-0706.2003.12006.x; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Tate R.L., 2021, SOIL MICROBIOLOGY; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Thorn R. G., 2007, SOIL MICROBIOLOGY EC, P145; Toljander JF, 2006, FEMS MICROBIOL LETT, V254, P34, DOI 10.1111/j.1574-6968.2005.00003.x; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; VISCHETTI C, 2001, FRESEN ENVIRON BULL, V10, P207; Weidenhamer JD, 2004, J CHEM ECOL, V30, P1067, DOI 10.1023/B:JOEC.0000028468.97851.7a; Weidenhamer JD, 2009, PLANT SOIL, V322, P177, DOI 10.1007/s11104-009-9905-4; Wolfe BE, 2008, J ECOL, V96, P777, DOI 10.1111/j.1365-2745.2008.01389.x	48	102	115	5	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27195	10.1371/journal.pone.0027195	http://dx.doi.org/10.1371/journal.pone.0027195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110615	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300017
J	Heins, RA; Choi, JH; Sohka, T; Ostermeier, M				Heins, Richard A.; Choi, Jay H.; Sohka, Takayuki; Ostermeier, Marc			In Vitro Recombination of Non-Homologous Genes Can Result in Gene Fusions that Confer a Switching Phenotype to Cells	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; BETA-LACTAMASE; STABILITY; FLUORESCENCE; CREATION; SERINE; VIVO	Regulation of protein activity is central to the complexity of life. The ability to regulate protein activity through exogenously added molecules has biotechnological/biomedical applications and offers tools for basic science. Such regulation can be achieved by establishing a means to modulate the specific activity of the protein (i.e. allostery). An alternative strategy for intracellular regulation of protein activity is to control the amount of protein through effects on its production, accumulation, and degradation. We have previously demonstrated that the non-homologous recombination of the genes encoding maltose binding protein (MBP) and TEM1 beta-lactamase (BLA) can result in fusion proteins in which beta-lactamase enzyme activity is allosterically regulated by maltose. Here, through use of a two-tiered genetic selection scheme, we demonstrate that such recombination can result in genes that confer maltose-dependent resistance to beta-lactam even though they do not encode allosteric enzymes. These 'phenotypic switch' genes encode fusion proteins whose accumulation is a result of a specific interaction with maltose. Phenotypic switches represent an important class of proteins for basic science and biotechnological applications in vivo.	[Heins, Richard A.; Choi, Jay H.; Sohka, Takayuki; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University	Heins, RA (corresponding author), Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; Defense Threat Reduction Agency [HDTRA1-09-1-0016]; Asahi Kasei Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Asahi Kasei Corporation(Asahi Kasei Corporation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; the Defense Threat Reduction Agency [HDTRA1-09-1-0016]; and a gift from Asahi Kasei Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by a gift from Asahi Kasei Corporation. There are currently pending patents, but no other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	BETTON JM, 1994, EMBO J, V13, P1226, DOI 10.1002/j.1460-2075.1994.tb06372.x; Coombs GS, 1998, J BIOL CHEM, V273, P4323, DOI 10.1074/jbc.273.8.4323; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Goldsmith M, 2007, PROTEIN ENG DES SEL, V20, P315, DOI 10.1093/protein/gzm026; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guntas G, 2004, CHEM BIOL, V11, P1483, DOI 10.1016/j.chembiol.2004.08.020; Guntas G, 2004, J MOL BIOL, V336, P263, DOI 10.1016/j.jmb.2003.12.016; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; MARTINEAU P, 1990, J MOL BIOL, V214, P337, DOI 10.1016/0022-2836(90)90165-I; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Ostermeier M, 2009, CURR OPIN STRUC BIOL, V19, P442, DOI 10.1016/j.sbi.2009.04.007; Pace C N, 1986, Methods Enzymol, V131, P266; RAIBAUD O, 1980, J BACTERIOL, V143, P761, DOI 10.1128/JB.143.2.761-771.1980; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Rosgen J, 2005, BIOPHYS J, V89, P2988, DOI [10.1529/biophysj.105.067330, 10.1529/biophsyj.105.067330]; SIGAL IS, 1984, J BIOL CHEM, V259, P5327; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; VANHOVE M, 1995, BIOCHEM J, V308, P859, DOI 10.1042/bj3080859; Wright CM, 2011, P NATL ACAD SCI USA, V108, P16206, DOI 10.1073/pnas.1102803108	22	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27302	10.1371/journal.pone.0027302	http://dx.doi.org/10.1371/journal.pone.0027302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096548	gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900030
J	Newman, JD; Muntner, P; Shimbo, D; Davidson, KW; Shaffer, JA; Edmondson, D				Newman, Jonathan D.; Muntner, Paul; Shimbo, Daichi; Davidson, Karina W.; Shaffer, Jonathan A.; Edmondson, Donald			Post-Traumatic Stress Disorder (PTSD) Symptoms Predict Delay to Hospital in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PREHOSPITAL DELAY; HEART-DISEASE; COPING STRATEGIES; SEEK TREATMENT; CARE; TIME; DEPRESSION; MANAGEMENT; CARDIOLOGY	Background: Increased delay to hospital presentation with acute coronary syndrome (ACS) is associated with poor outcomes. While demographic factors associated with this delay have been well described, scarce data are available on the role of modifiable factors, such as psychosocial disorders, on pre-hospital delay. Patients with symptoms of post-traumatic stress disorder (PTSD) often avoid stressful situations and may delay presenting for care when they experience cardiac symptoms. It is unknown, however, whether PTSD symptoms negatively impact the time to presentation during an ACS. Methods: We assessed the relationship between PTSD symptoms and pre-hospital delay in 241 adults with an ACS in the ongoing Prescription Use, Lifestyle, Stress Evaluation (PULSE) study. Results: Overall, 66% of patients were male; 40% were Hispanic or Latino. The mean age was 61.9 +/- 11.6 years old. PTSD symptoms were present in 17.8% of patients. Pre-hospital delay was longer for patients with PTSD symptoms compared to those without [geometric mean: 25.8 hours (95% CI 13.8 - 44.8) vs. 10.7 hours (95% CI 8.3 - 13.8)]; P = 0.005. After multivariable adjustment for age, sex, ethnicity, depression, left ventricular ejection fraction and history of myocardial infarction, the mean pre-hospital delay was 173% (95% CI: 36% -450%) longer for patients with versus without PTSD symptoms. Conclusion: Among patients presenting with an ACS, PTSD symptoms were independently associated with longer pre-hospital delays. Future studies of pre-hospital delay should examine the mechanisms underlying this association.	[Newman, Jonathan D.; Shimbo, Daichi; Davidson, Karina W.; Shaffer, Jonathan A.; Edmondson, Donald] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Columbia University; University of Alabama System; University of Alabama Birmingham	Newman, JD (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.	kd2124@columbia.edu	Edmondson, Donald/G-7486-2016; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Shaffer, Jonathan A/B-2783-2013	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Edmondson, Donald/0000-0002-4518-8196; Newman, Jonathan/0000-0001-6855-7305	National Heart, Lung, and Blood Institute [HL-088117, HL-091099, HL-076857, HL-47540, HL-101663, HL-098037, HL-083056, HL-084438, HL-84034, T32 HL007854-15]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024156]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL076857, P01HL047540, P01HL088117, T32HL007854, R01HL083056, RC2HL101663, R01HL091099, R01HL114924, R01HL084438, K24HL084034, R01HL098037] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL-088117, HL-091099, HL-076857, HL-47540, HL-101663, HL-098037, HL-083056, HL-084438, HL-84034 and T32 HL007854-15 from the National Heart, Lung, and Blood Institute. The project described was also supported by Grant Number UL1 RR024156 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research, and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AHMADI N, 2011, AM J CARDIO IN PRESS; Amir M, 1997, PERS INDIV DIFFER, V23, P399, DOI 10.1016/S0191-8869(97)80005-0; Beck A, 1979, COGNITIVE THERAPY DE; Bedi US, 2007, J NATL MED ASSOC, V99, P642; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Bunde J, 2006, PSYCHOSOM MED, V68, P51, DOI 10.1097/01.psy.0000195724.58085.f0; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chang CM, 2003, J NERV MENT DIS, V191, P391, DOI 10.1097/01.NMD.0000071588.73571.3D; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Dracup K, 1997, HEART LUNG, V26, P253, DOI 10.1016/S0147-9563(97)90082-0; Dracup K, 2009, CIRC-CARDIOVASC QUAL, V2, P144, DOI 10.1161/CIRCOUTCOMES.109.855635; Dracup K, 2009, CIRC-CARDIOVASC QUAL, V2, P524, DOI 10.1161/CIRCOUTCOMES.109.852608; Elhai JD, 2008, DEPRESS ANXIETY, V25, P737, DOI 10.1002/da.20318; Figueredo VM, 2009, AM J MED, V122, P704, DOI 10.1016/j.amjmed.2009.05.001; First M. B., 2002, STRUCTURED CLIN INTE; Franklin CL, 2002, PSYCHOL ASSESSMENT, V14, P467, DOI 10.1037//1040-3590.14.4.467; Goldberg RJ, 2002, AM J CARDIOL, V89, P791, DOI 10.1016/S0002-9149(02)02186-0; King KB, 2007, HEART LUNG, V36, P235, DOI 10.1016/j.hrtlng.2006.08.008; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Nguyen HL, 2010, CIRC-CARDIOVASC QUAL, V3, P82, DOI 10.1161/CIRCOUTCOMES.109.884361; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Shemesh E, 2004, PSYCHOSOM MED, V66, P521, DOI 10.1097/01.psy.0000126199.05189.86; Smolderen KG, 2010, JAMA-J AM MED ASSOC, V303, P1392, DOI 10.1001/jama.2010.409; Strik JJMH, 2003, J AM COLL CARDIOL, V42, P1801, DOI 10.1016/j.jacc.2003.07.007; Sullivan MD, 2009, CIRC-CARDIOVASC QUAL, V2, P148, DOI 10.1161/CIRCOUTCOMES.108.825471; Ting HH, 2008, ARCH INTERN MED, V168, P959, DOI 10.1001/archinte.168.9.959; Ting HH, 2010, ARCH INTERN MED, V170, P1834, DOI 10.1001/archinternmed.2010.385; Valentiner DP, 1996, J ABNORM PSYCHOL, V105, P455, DOI 10.1037/0021-843X.105.3.455; Walczewska J, 2011, EUR HEART J, V32, P730, DOI 10.1093/eurheartj/ehq354; Walsh JC, 2004, J PSYCHOSOM RES, V56, P67, DOI 10.1016/S0022-3999(03)00082-5	33	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27640	10.1371/journal.pone.0027640	http://dx.doi.org/10.1371/journal.pone.0027640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096608	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900067
J	Van Haastert, PJM				Van Haastert, Peter J. M.			Amoeboid Cells Use Protrusions for Walking, Gliding and Swimming	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; DICTYOSTELIUM-AMEBAS; MIGRATION; PSEUDOPOD; MOVEMENT; ADHESION; ABSENCE; PROPULSION; GRADIENTS; POLARITY	Amoeboid cells crawl using pseudopods, which are convex extensions of the cell surface. In many laboratory experiments, cells move on a smooth substrate, but in the wild cells may experience obstacles of other cells or dead material, or may even move in liquid. To understand how cells cope with heterogeneous environments we have investigated the pseudopod life cycle of wild type and mutant cells moving on a substrate and when suspended in liquid. We show that the same pseudopod cycle can provide three types of movement that we address as walking, gliding and swimming. In walking, the extending pseudopod will adhere firmly to the substrate, which allows cells to generate forces to bypass obstacles. Mutant cells with compromised adhesion can move much faster than wild type cells on a smooth substrate ( gliding), but cannot move effectively against obstacles that provide resistance. In a liquid, when swimming, the extending pseudopods convert to side-bumps that move rapidly to the rear of the cells. Calculations suggest that these bumps provide sufficient drag force to mediate the observed forward swimming of the cell.	Univ Groningen, Dept Cell Biochem, Groningen, Netherlands	University of Groningen	Van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Groningen, Netherlands.	P.J.M.van.haastert@rug.nl						Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Bae AJ, 2010, P NATL ACAD SCI USA, V107, pE165, DOI 10.1073/pnas.1011900107; Bahat A, 2006, MOL CELL ENDOCRINOL, V252, P115, DOI 10.1016/j.mce.2006.03.027; Barry NP, 2010, P NATL ACAD SCI USA, V107, P11376, DOI 10.1073/pnas.1006327107; Bosgraaf L., 2009, CELL ADHES MIGR, V4, P1; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Dusenbery D. B., 2009, LIVING MICRO SCALE U; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; FRANCK C, 2006, PLOS ONE, V6; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fukui Y, 1997, CELL MOTIL CYTOSKEL, V36, P339; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Iwadate Y, 2008, J CELL SCI, V121, P1314, DOI 10.1242/jcs.021576; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kortholt A, 2006, J BIOL CHEM, V281, P23367, DOI 10.1074/jbc.M600804200; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Provenzano PP, 2009, TRENDS CELL BIOL, V19, P638, DOI 10.1016/j.tcb.2009.08.009; Stone HA, 1996, PHYS REV LETT, V77, P4102, DOI 10.1103/PhysRevLett.77.4102; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; Van Haastert PJM, 2009, HFSP J, V3, P282, DOI 10.2976/1.3185725; Weber I, 2006, EUR J CELL BIOL, V85, P915, DOI 10.1016/j.ejcb.2006.05.002; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; WINET H, 1976, J EXP BIOL, V64, P283; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	33	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27532	10.1371/journal.pone.0027532	http://dx.doi.org/10.1371/journal.pone.0027532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096590	Green Published, gold			2022-12-25	WOS:000297350800058
J	Yoon, S; Woo, SU; Kang, JH; Kim, K; Shin, HJ; Gwak, HS; Park, S; Chwae, YJ				Yoon, S.; Woo, S. U.; Kang, J. H.; Kim, K.; Shin, H-J; Gwak, H-S; Park, S.; Chwae, Y-J			NF-kappa B and STAT3 cooperatively induce IL6 in starved cancer cells	ONCOGENE			English	Article						cancer; ER stress; IL6; NF-kappa B; STAT3	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ACTIVATES TRANSCRIPTION; INDUCED AUTOPHAGY; NADPH OXIDASE; PATHWAY; BINDING; SURVIVAL; INHIBITION; MECHANISMS	A number of genes involved in tumorigenesis have been known to be controlled by signal transducer and activator of transcription 3 (STAT3) and NF-kappa B, either synergistically or individually. In starved cancer cells, we found that NF-kappa B was activated through endoplasmic reticulum stress signals, which depend on reactive oxygen species, cytosolic calcium and preserved translation of NF-kappa B p65 subunit, but independent of I kappa B alpha serine phosphorylation, thereby resulting in IL6 induction. STAT3 was required for proper induction of IL6 by NF-kappa B. They existed as identical nuclear complexes in proximal IL6 promoters, and STAT3 had critical roles in binding to IL6 promoters as well as nuclear retention of NF-kappa B. The conditioned media from starved cancer cells contained various secretory factors, such as IL6, IL9, VWF (von Willebrand factor), FREM1 (FRAS1 related extracellular matrix 1), SAA1 (serum amyloid A1), SDK1 (sidekick homolog 1) and ADAM12 (ADAM metallopeptidase domain 12), induced by NF-kappa B and STAT3 and promoted clonogenic capacities of cancer cells, and proliferation and migration of human umbilical vein endothelial cells. These results suggest novel survival strategies of cancer cells by which two oncogenic transcriptional factors, NF-kappa B and STAT3, are activated simultaneously by an intrinsic mechanism during stressful conditions of cancer cells, and they cooperatively induce various survival factors. Oncogene (2012) 31, 3467-3481; doi:10.1038/onc.2011.517; published online 21 November 2011	[Yoon, S.; Woo, S. U.; Kang, J. H.; Kim, K.; Shin, H-J; Park, S.; Chwae, Y-J] Ajou Univ, Sch Med, Dept Microbiol, Suwon 443721, Gyeonggi Do, South Korea; [Gwak, H-S] Natl Canc Ctr Korea, Neurooncol Clin, Koyang, South Korea	Ajou University; National Cancer Center - Korea (NCC)	Chwae, YJ (corresponding author), Ajou Univ, Sch Med, Dept Microbiol, San 5 Woncheon Dong, Suwon 443721, Gyeonggi Do, South Korea.	ponggo67@ajou.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0005804, 2009-0076174, 2011-0089971]; Korea Science and Engineering Foundation (KOSEF) through the Chronic Inflammatory Disease Research Center (CIDRC) [R13-2003-019]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation (KOSEF) through the Chronic Inflammatory Disease Research Center (CIDRC)(Korea Science and Engineering Foundation)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2011-0005804, No. 2009-0076174, and No. 2011-0089971), and a Korea Science and Engineering Foundation (KOSEF) Grant (R13-2003-019) through the Chronic Inflammatory Disease Research Center (CIDRC). We are grateful to Mogam Biotechnology Research Institute (Yongin, Korea) for providing us with HUVEC and U87MG cell lines. We are very thankful to Professor Kyung-Sup Kim (Yonsei University College of Medicine, Seoul, Korea) and Professor Woon Ki Baek for critical reading and proofreading of the manuscript.	Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; Bosco N, 2010, CANCER GENET CYTOGEN, V202, P47, DOI 10.1016/j.cancergencyto.2010.06.008; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Frank David A, 2003, Cancer Treat Res, V115, P267; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Gil-Bazo I, 2003, Rev Med Univ Navarra, V47, P22; Gloire G, 2006, ONCOGENE, V25, P5485, DOI 10.1038/sj.onc.1209542; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jacobsen J, 2009, CURR PHARM DESIGN, V15, P2300, DOI 10.2174/138161209788682389; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mattarollo SR, 2010, NAT IMMUNOL, V11, P981, DOI 10.1038/ni1110-981; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Shang J, 2004, BIOCHEMISTRY-US, V43, P9576, DOI 10.1021/bi049358o; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Souza V, 2009, TOXICOL LETT, V187, P180, DOI 10.1016/j.toxlet.2009.02.021; Vales LD, 2002, J BIOL CHEM, V277, P42438, DOI 10.1074/jbc.M207363200; Wu TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-160; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang XR, 2009, INT J CANCER, V125, P2912, DOI 10.1002/ijc.24622; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Ye JP, 1996, MOL CELL BIOL, V16, P4744; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	47	98	100	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	29					3467	3481		10.1038/onc.2011.517	http://dx.doi.org/10.1038/onc.2011.517			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	976FN	22105366				2022-12-25	WOS:000306566400007
J	Abudu, A; Wang, XJ; Dang, Y; Zhou, T; Xiang, SH; Zheng, YH				Abudu, Aierken; Wang, Xiaojun; Dang, Ying; Zhou, Tao; Xiang, Shi-Hua; Zheng, Yong-Hui			Identification of Molecular Determinants from Moloney Leukemia Virus 10 Homolog (MOV10) Protein for Virion Packaging and Anti-HIV-1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EDITING ENZYME APOBEC3G; HIV-1 VIRIONS; STRESS GRANULES; RNA HELICASES; VIF; REPLICATION; GAG; DOMAIN; DEGRADATION; EXPRESSION	Discovery of novel antiretroviral mechanism is essential for the design of innovative antiretroviral therapy. Recently, we and others reported that ectopic expression of Moloney leukemia virus 10 (MOV10) protein strongly inhibits retrovirus replication. MOV10, a putative RNA helicase, can be packaged into HIV-1 virions by binding to the nucleocapsid (NC) region of Gag and inhibit viral replication at a postentry step. Here, we report critical determinants for MOV10 virion packaging and antiviral activity. MOV10 has 1,003 amino acids and seven helicase motifs. We found that MOV10 packaging requires the NC basic linker, and Gag binds to the N-terminal amino acids 261-305 region of MOV10. Our predicted MOV10 three-dimensional structure model indicates that the Gag binding region is located in a structurally exposed domain, which spans amino acids 93-305 and is Cys-His-rich. Simultaneous mutation of residues Cys-188, Cys-195, His-199, His-201, and His-202 in this domain significantly compromised MOV10 anti-HIV-1 activity. Notably, although MOV10-Gag interaction is required, it is not sufficient for MOV10 packaging, which also requires its C-terminal all but one of seven helicase motifs. Moreover, we have mapped the minimal MOV10 antiviral region to amino acids 99-949, indicating that nearly all MOV10 residues are required for its antiviral activity. Mutations of residues Cys-947, Pro-948, and Phe-949 at the C terminus of this region completely disrupted MOV10 anti-HIV-1 activity. Taken together, we have identified two critical MOV10 packaging determinants and eight other critical residues for anti-HIV-1 activity. These results provide a molecular basis for further understanding the MOV10 antiretroviral mechanism.	[Abudu, Aierken; Wang, Xiaojun; Dang, Ying; Zhou, Tao; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Wang, Xiaojun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Xiang, Shi-Hua] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68583 USA	Michigan State University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Nebraska System; University of Nebraska Lincoln	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zhou, Tao/B-5757-2017; Zheng, Yong-Hui/AAP-4492-2021	Zhou, Tao/0000-0002-3648-9923; Zheng, Yong-Hui/0000-0002-1098-7385; Wang, Xiaojun/0000-0003-4521-4099	National Institutes of Health [AI063944, AI080225]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI080225, R01AI063944, R56AI063944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063944 and AI080225 (to Y.-H. Z).	Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Heise CT, 2007, BIOCHEMISTRY-US, V46, P1612, DOI 10.1021/bi062174k; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	32	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1220	1228		10.1074/jbc.M111.309831	http://dx.doi.org/10.1074/jbc.M111.309831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22105071	Green Published, hybrid			2022-12-25	WOS:000299170300037
J	Martinez, V; Ingwers, M; Smith, J; Glushka, J; Yang, T; Bar-Peled, M				Martinez, Viviana; Ingwers, Miles; Smith, James; Glushka, John; Yang, Ting; Bar-Peled, Maor			Biosynthesis of UDP-4-keto-6-deoxyglucose and UDP-rhamnose in Pathogenic Fungi Magnaporthe grisea and Botryotinia fuckeliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSE; HERICIUM-ERINACEUS; FRUITING BODIES; CELL-WALLS; COMPONENTS; SUGAR; EXOPOLYSACCHARIDE; 4,6-DEHYDRATASE; COLLETOTRICHUM; IDENTIFICATION	There is increasing evidence that in several fungi, rhamnose-containing glycans are involved in processes that affect hostpathogen interactions, including adhesion, recognition, virulence, and biofilm formation. Nevertheless, little is known about the pathways for the synthesis of these glycans. We show that rhamnose is present in glycans isolated from the rice pathogen Magnaporthe grisea and from the plant pathogen Botryotinia fuckeliana. We also provide evidence that these fungi produce UDP-rhamnose. This is in contrast to bacteria where dTDP-rhamnose is the activated form of this sugar. In bacteria, formation of dTDP-rhamnose requires three enzymes. Here, we demonstrate that in fungi only two genes are required for UDP-Rha synthesis. The first gene encodes a UDP-glucose-4,6-dehydratase that converts UDP-glucose to UDP-4-keto-6-deoxyglucose. The product was shown by time-resolved H-1 NMR spectroscopy to exist in solution predominantly as a hydrated form along with minor amounts of a keto form. The second gene encodes a bifunctional UDP-4-keto-6-deoxyglucose-3,5-epimerase/-4-reductase that converts UDP-4-keto-6-deoxyglucose to UDP-rhamnose. Sugar composition analysis and gene expression studies at different stages of growth indicate that the synthesis of rhamnose-containing glycans is under tissue-specific regulation. Together, our results provide new insight into the formation of rhamnose-containing glycans during the fungal life cycle. The role of these glycans in the interactions between fungal pathogens and their hosts is discussed. Knowledge of the metabolic pathways involved in the formation of rhamnose-containing glycans may facilitate the development of drugs to combat fungal diseases in humans, as to the best of our knowledge mammals do not make these types of glycans.	[Martinez, Viviana; Smith, James; Glushka, John; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Ingwers, Miles; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Yang, Ting] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			National Science Foundation [IOB-0453664]; BioEnergy Science Center (Office of Biological and Environmental Research in the Department of Energy Office of Science) [DE-PS02-06ER64304]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); BioEnergy Science Center (Office of Biological and Environmental Research in the Department of Energy Office of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation Grant IOB-0453664 (to M. B.-P.) and by BioEnergy Science Center Grant DE-PS02-06ER64304 (supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science).	Ahrazem O, 2002, MYCOL RES, V106, P1187, DOI 10.1017/S0953756202006482; Allard STM, 2002, STRUCTURE, V10, P81, DOI 10.1016/S0969-2126(01)00694-3; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; DeVicente JI, 1996, FUNGAL GENET BIOL, V20, P115, DOI 10.1006/fgbi.1996.0026; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong SL, 2010, J BACTERIOL, V192, P5053, DOI 10.1128/JB.00568-10; Epstein L, 2006, BIOLOGICAL ADHESIVES, P41, DOI 10.1007/978-3-540-31049-5_3; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GORIN PAJ, 1970, CARBOHYD RES, V13, P339, DOI 10.1016/S0008-6215(00)80591-1; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Harki E, 2006, FOOD CHEM, V99, P394, DOI 10.1016/j.foodchem.2005.08.030; Hegeman AD, 2002, BIOCHEMISTRY-US, V41, P2797, DOI 10.1021/bi011748c; Jia LM, 2004, CARBOHYD RES, V339, P2667, DOI [10.1016/j.carres.2004.07.027, 10.1016/j.carrres.2004.07.027]; Lal P, 2010, J APPL MICROBIOL, V109, P128, DOI 10.1111/j.1365-2672.2009.04634.x; Ma YF, 2002, J BACTERIOL, V184, P3392, DOI 10.1128/JB.184.12.3392-3395.2002; MacFarlane H. H., 1968, REV APPL MYCOLOGY PL, V1-40, P1922; Molinaro A, 2002, CARBOHYD RES, V337, P1707, DOI 10.1016/S0008-6215(02)00283-5; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Pettolino F, 2009, FEBS J, V276, P4122, DOI 10.1111/j.1742-4658.2009.07086.x; RAMADOSS CS, 1985, J AGR FOOD CHEM, V33, P728, DOI 10.1021/jf00064a041; RIZZA V, 1969, J GEN MICROBIOL, V58, P307, DOI 10.1099/00221287-58-3-307; Ruiz-Baca E, 2009, MED MYCOL, V47, P185, DOI 10.1080/13693780802165789; Soares RMD, 1995, MYCOPATHOLOGIA, V132, P71, DOI 10.1007/BF01103778; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200; Wu SC, 1997, MOL PLANT MICROBE IN, V10, P700, DOI 10.1094/MPMI.1997.10.6.700; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zeigler R. S., 1994, CAB INT PUBLICATION; Zhang AQ, 2006, CARBOHYD RES, V341, P645, DOI 10.1016/j.carres.2005.11.038	38	40	43	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					879	892		10.1074/jbc.M111.287367	http://dx.doi.org/10.1074/jbc.M111.287367			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102281	hybrid, Green Published			2022-12-25	WOS:000299170300007
J	Beites, T; Pires, SDS; Santos, CL; Osorio, H; Moradas-Ferreira, P; Mendes, MV				Beites, Tiago; Pires, Silvia D. S.; Santos, Catarina L.; Osorio, Hugo; Moradas-Ferreira, Pedro; Mendes, Marta V.			Crosstalk between ROS Homeostasis and Secondary Metabolism in S. natalensis ATCC 27448: Modulation of Pimaricin Production by Intracellular ROS	PLOS ONE			English	Article							CONTAINING SUPEROXIDE-DISMUTASE; ALKYL HYDROPEROXIDE REDUCTASE; POLYENE MACROLIDE PIMARICIN; POSITIVE REGULATOR; ESCHERICHIA-COLI; STREPTOMYCES-CLAVULIGERUS; ENHANCED BIOSYNTHESIS; TRANSCRIPTION FACTOR; CLAVULANIC ACID; GENE DISRUPTION	Streptomyces secondary metabolism is strongly affected by oxygen availability. The increased culture aeration enhances pimaricin production in S. natalensis, however the excess of O-2 consumption can lead to an intracellular ROS imbalance that is harmful to the cell. The adaptive physiological response of S. natalensis upon the addition of exogenous H2O2 suggested that the modulation of the intracellular ROS levels, through the activation of the H2O2 inducible catalase during the late exponential growth phase, can alter the production of pimaricin. With the construction of defective mutants on the H2O2 related enzymes SodF, AhpCD and KatA1, an effective and enduring modulation of intracellular ROS was achieved. Characterization of the knock-out strains revealed different behaviours regarding pimaricin production: whilst the superoxide dismutase defective mutant presented low levels of pimaricin production compared to the wild-type, the mutants defective on the H2O2-detoxifying enzymes displayed a pimaricin overproducer phenotype. Using physiological and molecular approaches we report a crosstalk between oxidative stress and secondary metabolism regulatory networks. Our results reveal that the redox-based regulation network triggered by an imbalance of the intracellular ROS homeostasis is also able to modulate the biosynthesis of pimaricin in S. natalensis.	[Beites, Tiago; Pires, Silvia D. S.; Santos, Catarina L.; Moradas-Ferreira, Pedro; Mendes, Marta V.] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Beites, Tiago] Univ Porto, Dept Biol, Fac Ciencias FCUP, P-4100 Oporto, Portugal; [Pires, Silvia D. S.; Moradas-Ferreira, Pedro] Univ Porto, ICBAS Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Osorio, Hugo] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Beites, T (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mvm@ibmc.up.pt	Mendes, Marta Vaz/A-8541-2008; MORADAS-FERREIRA, PEDRO/E-6357-2012; Osorio, Hugo/A-7847-2012; Beites, Tiago/AAD-7394-2021; Beites, Tiago/J-9970-2013; Santos, Catarina/D-2275-2012	Mendes, Marta Vaz/0000-0002-6105-522X; MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Osorio, Hugo/0000-0002-6362-8255; Beites, Tiago/0000-0002-7366-2107; Lopes dos Santos, Catarina/0000-0002-4273-1077; Pires, Silvia/0000-0003-3478-5769	FCT - Fundacao para a Ciencia e Tecnologia [PTDC/BIO/64682/2006, SFRH/BD/40100/2007, SFRH/BPD/62978/2009, SFRH/BD/66367/2009]; European Regional Development Fund [FCOMP-01-0124-FEDER-007080]; Programa Ciencia; POPH QREN Tipologia; MCTES	FCT - Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Regional Development Fund(European Commission); Programa Ciencia(Spanish Government); POPH QREN Tipologia; MCTES	This work was co-funded by the FCT - Fundacao para a Ciencia e Tecnologia (PTDC/BIO/64682/2006) and the European Regional Development Fund (FCOMP-01-0124-FEDER-007080). MVM and HO were supported by "Programa Ciencia 2007" sponsored by POPH QREN Tipologia 4.2 Promocao do Emprego Cientifico program and co-financed by the European Social Fund and Portuguese national funds from the MCTES. TB, CLS and SP were supported, respectively, by the FCT fellowships SFRH/BD/40100/2007, SFRH/BPD/62978/2009 and SFRH/BD/66367/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 2000, CHEM BIOL, V7, P895, DOI 10.1016/S1074-5521(00)00038-7; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BEERS RF, 1952, J BIOL CHEM, V195, P133; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho YH, 1997, J BACTERIOL, V179, P4049, DOI 10.1128/jb.179.12.4049-4052.1997; Cho YH, 2000, MOL MICROBIOL, V35, P150, DOI 10.1046/j.1365-2958.2000.01685.x; Chung HJ, 1999, GENE, V231, P87, DOI 10.1016/S0378-1119(99)00088-8; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; CONYERS SM, 1991, ANAL BIOCHEM, V192, P207, DOI 10.1016/0003-2697(91)90208-B; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; El-Enshasy HA, 2000, J BASIC MICROB, V40, P333, DOI 10.1002/1521-4028(200012)40:5/6<333::AID-JOBM333>3.0.CO;2-Q; Enriquez LL, 2006, FEMS MICROBIOL LETT, V257, P312, DOI 10.1111/j.1574-6968.2006.00189.x; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gromova I., 2006, CELL BIOL LAB HDB, P219, DOI DOI 10.1016/B978-012164730-8/50212-4; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hahn JS, 2000, J BIOL CHEM, V275, P38254, DOI 10.1074/jbc.M006079200; Hahn JS, 2002, J BACTERIOL, V184, P5214, DOI 10.1128/JB.184.19.5214-5222.2002; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; KANTH BK, 2010, MICROBIOL RES; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim EJ, 1998, J BACTERIOL, V180, P2014, DOI 10.1128/JB.180.8.2014-2020.1998; Kim EJ, 1996, EUR J BIOCHEM, V241, P178, DOI 10.1111/j.1432-1033.1996.0178t.x; KIM HP, 1994, MICROBIOL-SGM, V140, P3391, DOI 10.1099/13500872-140-12-3391; Kim JS, 2000, BBA-GENE STRUCT EXPR, V1493, P200, DOI 10.1016/S0167-4781(00)00178-0; Kwon HJ, 1998, APPL MICROBIOL BIOT, V49, P77, DOI 10.1007/s002530051140; Kwon HJ, 1999, APPL MICROBIOL BIOT, V53, P57, DOI 10.1007/s002530051614; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Martin JF, 2009, METHOD ENZYMOL, V459, P215, DOI 10.1016/S0076-6879(09)04610-2; Mendes MV, 2007, CHEM BIOL, V14, P279, DOI 10.1016/j.chembiol.2007.01.010; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Mongkolsuk S, 2000, J BACTERIOL, V182, P6845, DOI 10.1128/JB.182.23.6845-6849.2000; Nieselt K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-10; Nystrom T, 1999, CURR OPIN MICROBIOL, V2, P214, DOI 10.1016/S1369-5274(99)80037-X; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sambrook J, 2001, MOL CLONING LAB MANU; Santos-Aberturas J, 2011, J BIOL CHEM, V286, P9150, DOI 10.1074/jbc.M110.182428; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Song SK, 2006, J MICROBIOL BIOTECHN, V16, P1690; STALLINGS WC, 1985, J BIOL CHEM, V260, P6424; STEINMAN HM, 1985, J BACTERIOL, V162, P1255, DOI 10.1128/JB.162.3.1255-1260.1985; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; STRUYK A. P., 1958, Antibiot. Ann. 1957-1958, P878; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; te Welscher YM, 2010, ANTIMICROB AGENTS CH, V54, P2618, DOI 10.1128/AAC.01794-09; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; WALKER GE, 1995, MICROBIOL-SGM, V141, P1377, DOI 10.1099/13500872-141-6-1377; YEGNESWARAN PK, 1991, BIOTECHNOL PROGR, V7, P246, DOI 10.1021/bp00009a008; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zou PJ, 1999, MICROBIOL-SGM, V145, P549, DOI 10.1099/13500872-145-3-549	67	29	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27472	10.1371/journal.pone.0027472	http://dx.doi.org/10.1371/journal.pone.0027472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114674	Green Published, gold			2022-12-25	WOS:000297555800022
J	Caruso, A; Rudolphi, J; Rydin, H				Caruso, Alexandro; Rudolphi, Jorgen; Rydin, Hakan			Positive Edge Effects on Forest-Interior Cryptogams in Clear-Cuts	PLOS ONE			English	Article							FRAGMENTED LANDSCAPES; OCCUPANCY DYNAMICS; EPIPHYTIC LICHEN; BOREAL FOREST; GROWTH; HABITATS; MATRIX; PLANT; BRYOPHYTES; MANAGEMENT	Biological edge effects are often assessed in high quality focal habitats that are negatively influenced by human-modified low quality matrix habitats. A deeper understanding of the possibilities for positive edge effects in matrix habitats bordering focal habitats (e.g. spillover effects) is, however, essential for enhancing landscape-level resilience to human alterations. We surveyed epixylic (dead wood inhabiting) forest-interior cryptogams (lichens, bryophytes, and fungi) associated with mature old-growth forests in 30 young managed Swedish boreal forest stands bordering a mature forest of high conservation value. In each young stand we registered species occurrences on coarse dead wood in transects 0-50 m from the border between stand types. We quantified the effect of distance from the mature forest on the occurrence of forest-interior species in the young stands, while accounting for local environment and propagule sources. For comparison we also surveyed epixylic open-habitat (associated with open forests) and generalist cryptogams. Species composition of epixylic cryptogams in young stands differed with distance from the mature forest: the frequency of occurrence of forest-interior species decreased with increasing distance whereas it increased for open-habitat species. Generalists were unaffected by distance. Epixylic, boreal forest-interior cryptogams do occur in matrix habitats such as clear-cuts. In addition, they are associated with the matrix edge because of a favourable microclimate closer to the mature forest on southern matrix edges. Retention and creation of dead wood in clear-cuts along the edges to focal habitats is a feasible way to enhance the long-term persistence of epixylic habitat specialists in fragmented landscapes. The proposed management measures should be performed in the whole stand as it matures, since microclimatic edge effects diminish as the matrix habitat matures. We argue that management that aims to increase habitat quality in matrix habitats bordering focal habitats should increase the probability of long-term persistence of habitat specialists.	[Caruso, Alexandro; Rudolphi, Jorgen] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Rydin, Hakan] Uppsala Univ, Dept Plant Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Caruso, A (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	alexandro.caruso@slu.se	Sjögren, Jörgen/GXG-8007-2022; Rudolphi, Jörgen/C-9363-2013	Sjögren, Jörgen/0000-0002-0538-8265; Rudolphi, Jörgen/0000-0002-0538-8265	Swedish Energy Agency (Energimyndigheten); Swedish Research Council Formas; Swedish University of Agricultural Sciences	Swedish Energy Agency (Energimyndigheten)(Swedish Energy Agency); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish University of Agricultural Sciences	The study was supported by The Swedish Energy Agency (Energimyndigheten), the Swedish Research Council Formas (www.formas.se), and the Swedish University of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1995, GLOBAL BIODIVERSITY; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; Brady MJ, 2009, LANDSCAPE ECOL, V24, P879, DOI 10.1007/s10980-009-9372-6; Brudvig LA, 2009, P NATL ACAD SCI USA, V106, P9328, DOI 10.1073/pnas.0809658106; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; CHEN JQ, 1993, AGR FOREST METEOROL, V63, P219, DOI 10.1016/0168-1923(93)90061-L; Driscoll DA, 2005, ECOL ENTOMOL, V30, P8, DOI 10.1111/j.0307-6946.2005.00666.x; Edman M, 2004, ECOL APPL, V14, P893, DOI 10.1890/03-5103; Esseen PA, 1998, CONSERV BIOL, V12, P1307, DOI 10.1046/j.1523-1739.1998.97346.x; ESSEEN PA, 1992, BOREAL FORESTS FOCAL; Fonseca CR, 2007, RESTOR ECOL, V15, P613, DOI 10.1111/j.1526-100X.2007.00273.x; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; GILBERT O., 2000, LICHENS NEW NATURALI; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Hylander K, 2009, ECOLOGY, V90, P160, DOI 10.1890/08-0042.1; Kivisto L, 2000, LICHENOLOGIST, V32, P387, DOI 10.1006/lich.2000.0282; Lindo Z, 2010, ECOSYSTEMS, V13, P612, DOI 10.1007/s10021-010-9336-3; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; McCune B., 2011, PC ORD MULTIVARIATE; Moen J, 2003, CONSERV BIOL, V17, P380, DOI 10.1046/j.1523-1739.2003.00406.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nitare J., 2005, SIGNALARTER INDIKATO; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Pharo EJ, 2007, BIOL CONSERV, V135, P315, DOI 10.1016/j.biocon.2006.10.016; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Reino L, 2009, BIOL CONSERV, V142, P824, DOI 10.1016/j.biocon.2008.12.011; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rudolphi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018639; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; Schmalholz M, 2011, ECOGRAPHY, V34, P637, DOI 10.1111/j.1600-0587.2010.06652.x; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Siitonen P, 2005, CONSERV BIOL, V19, P250, DOI 10.1111/j.1523-1739.2005.00232.x; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Sju┬rs H., 1999, ACTA PHYTOGEOGRAPHIC, V84, P5; SOKAL RR, 1981, BIOMETRICS; Timonen J, 2010, SCAND J FOREST RES, V25, P309, DOI 10.1080/02827581.2010.497160; Watling JI, 2010, LANDSCAPE ECOL, V25, P69, DOI 10.1007/s10980-009-9416-y; Webster J.W., 1995, FUNGAL ECOL	44	21	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27936	10.1371/journal.pone.0027936	http://dx.doi.org/10.1371/journal.pone.0027936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114728	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800045
J	Moriishi, T; Maruyama, Z; Fukuyama, R; Ito, M; Miyazaki, T; Kitaura, H; Ohnishi, H; Furuichi, T; Kawai, Y; Masuyama, R; Komori, H; Takada, K; Kawaguchi, H; Komori, T				Moriishi, Takeshi; Maruyama, Zenjiro; Fukuyama, Ryo; Ito, Masako; Miyazaki, Toshihiro; Kitaura, Hideki; Ohnishi, Hidetake; Furuichi, Tatsuya; Kawai, Yosuke; Masuyama, Ritsuko; Komori, Hisato; Takada, Kenji; Kawaguchi, Hiroshi; Komori, Toshihisa			Overexpression of Bcl2 in Osteoblasts Inhibits Osteoblast Differentiation and Induces Osteocyte Apoptosis	PLOS ONE			English	Article							CELL-CYCLE ENTRY; BONE-FORMATION; PROGNOSTIC MARKER; DNA-DAMAGE; IN-VIVO; EXPRESSION; ESTROGEN; P53; BISPHOSPHONATES; GLUCOCORTICOIDS	Bcl2 subfamily proteins, including Bcl2 and Bcl-X-L, inhibit apoptosis. As osteoblast apoptosis is in part responsible for osteoporosis in sex steroid deficiency, glucocorticoid excess, and aging, bone loss might be inhibited by the upregulation of Bcl2; however, the effects of Bcl2 overexpression on osteoblast differentiation and bone development and maintenance have not been fully investigated. To investigate these issues, we established two lines of osteoblast-specific BCL2 transgenic mice. In BCL2 transgenic mice, bone volume was increased at 6 weeks of age but not at 10 weeks of age compared with wild-type mice. The numbers of osteoblasts and osteocytes increased, but osteoid thickness and the bone formation rate were reduced in BCL2 transgenic mice with high expression at 10 weeks of age. The number of BrdU-positive cells was increased but that of TUNEL-positive cells was unaltered at 2 and 6 weeks of age. Osteoblast differentiation was inhibited, as shown by reduced Col1a1 and osteocalcin expression. Osteoblast differentiation of calvarial cells from BCL2 transgenic mice also fell in vitro. Overexpression of BCL2 in primary osteoblasts had no effect on osteoclastogenesis in co-culture with bone marrow cells. Unexpectedly, overexpression of BCL2 in osteoblasts eventually caused osteocyte apoptosis. Osteocytes, which had a reduced number of processes, gradually died with apoptotic structural alterations and the expression of apoptosis-related molecules, and dead osteocytes accumulated in cortical bone. These findings indicate that overexpression of BCL2 in osteoblasts inhibits osteoblast differentiation, reduces osteocyte processes, and causes osteocyte apoptosis.	[Moriishi, Takeshi; Maruyama, Zenjiro; Miyazaki, Toshihiro; Ohnishi, Hidetake; Furuichi, Tatsuya; Kawai, Yosuke; Masuyama, Ritsuko; Komori, Hisato; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Maruyama, Zenjiro; Kawaguchi, Hiroshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Tokyo, Japan; [Ito, Masako] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Radiat Biol, Nagasaki 852, Japan; [Fukuyama, Ryo] Hiroshima Int Univ, Pharmacol Lab, Kure, Japan; [Kitaura, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Div Orthodont & Biomed Engn, Nagasaki 852, Japan; [Ohnishi, Hidetake; Takada, Kenji] Osaka Univ, Dept Orthodont & Dentofacial Orthoped, Fac Dent, Osaka, Japan; [Kawai, Yosuke] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan; [Kitaura, Hideki] Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Sendai, Miyagi 980, Japan; [Furuichi, Tatsuya] Jikei Univ, Lab Anim Facil, Sch Med, Res Ctr Med Sci, Tokyo, Japan	Nagasaki University; University of Tokyo; Nagasaki University; Nagasaki University; Osaka University; Nagasaki University; Tohoku University; Jikei University	Moriishi, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan.	komorit@nagasaki-u.ac.jp	Kitaura, Hideki/U-7277-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology; Ground-based Research Program for Space Utilization	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ground-based Research Program for Space Utilization	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the "Ground-based Research Program for Space Utilization" promoted by the Japan Space Forum, the Nakatomi Foundation, and the President's Discretionary Fund of Nagasaki University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN EJ, 2002, PRINCIPLES BONE BIOL, V1, P59; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; EJIRI S, 1982, ARCH HISTOL JAPON, V45, P399, DOI 10.1679/aohc.45.399; EVAN FL, 1999, J IMMUNOL, V162, P5374; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; GERALD P, 1996, P NATL ACAD SCI USA, V93, P9545; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; GONDO Y, 1994, BIOCHEM BIOPH RES CO, V202, P830, DOI 10.1006/bbrc.1994.2005; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kusuzaki K, 2000, BONE, V27, P655, DOI 10.1016/S8756-3282(00)00383-5; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Limana F, 2002, P NATL ACAD SCI USA, V99, P6257, DOI 10.1073/pnas.092672899; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Martin RB, 2000, BONE, V26, P71, DOI 10.1016/S8756-3282(99)00242-2; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Odgren PR, 2002, PRINCIPLES BONE BIOL, P3, DOI DOI 10.1016/B978-012098652-1.50103-7; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Stanislaus D, 2000, BONE, V27, P209, DOI 10.1016/S8756-3282(00)00309-4; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; WANG Y, 2011, BONE IN PRESS; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang W, 2007, CALCIFIED TISSUE INT, V80, P111, DOI 10.1007/s00223-006-0168-2; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	50	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27487	10.1371/journal.pone.0027487	http://dx.doi.org/10.1371/journal.pone.0027487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114675	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800023
J	Thomas, S; Thirumalapura, NR; Crocquet-Valdes, PA; Luxon, BA; Walker, DH				Thomas, Sunil; Thirumalapura, Nagaraja R.; Crocquet-Valdes, Patricia A.; Luxon, Bruce A.; Walker, David H.			Structure-Based Vaccines Provide Protection in a Mouse Model of Ehrlichiosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ANIMAL-MODEL; ANTIGENIC PROTEIN; IFN-GAMMA; SCID MICE; TNF-ALPHA; I-TASSER; T-CELLS; CHAFFEENSIS; IMMUNITY	Background: Recent advances in bioinformatics have made it possible to predict the B cell and T cell epitopes of antigenic proteins. This has led to design of peptide based vaccines that are more specific, safe, and easy to produce. The obligately intracellular gram negative bacteria Ehrlichia cause ehrlichioses in humans and animals. As yet there are no vaccines to protect against Ehrlichia infection. Methodology/Principal Findings: We applied the principle of structural vaccinology to design peptides to the epitopes of Ehrlichia muris outer membrane P28-19 (OMP-1/P28) and Ehrlichia Heat shock protein 60 (Hsp60/GroEL) antigenic proteins. Both P28-19 and Ehrlichia Hsp60 peptides reacted with polyclonal antibodies against E. canis and E. chaffeensis and could be used as a diagnostic tool for ehrlichiosis. In addition, we demonstrated that mice vaccinated with Ehrlichia P28-19 and Hsp60 peptides and later challenged with E. muris were protected against the pathogen. Conclusions/Significance: Our results demonstrate the power of structural vaccines and could be a new strategy in the development of vaccines to provide protection against pathogenic microorganisms.	[Thomas, Sunil; Thirumalapura, Nagaraja R.; Crocquet-Valdes, Patricia A.; Walker, David H.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Thomas, Sunil; Walker, David H.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Luxon, Bruce A.] Univ Texas Med Branch, Inst Human Infect & Immun, Inst Translat Sci, Dept Biochem & Mol Biol, Galveston, TX USA; [Walker, David H.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thomas, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	suntom2@gmail.com; dwalker@utmb.edu	Luxon, Bruce A/C-9140-2012	Thomas, Sunil/0000-0003-4780-8851	National Institute of Allergy and Infectious Diseases [AI31431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031431, R21AI031431] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant AI31431 from the National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2011, VIRUS RES, V155, P240, DOI 10.1016/j.virusres.2010.10.014; Bansal A, 2010, MOL CELL BIOCHEM, V337, P213, DOI 10.1007/s11010-009-0301-4; Barh D, 2010, BIOINFORMATION, V5, P77, DOI 10.6026/97320630005077; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Bitsaktsis C, 2007, INFECT IMMUN, V75, P4933, DOI 10.1128/IAI.00705-07; Croft NP, 2011, EXPERT REV VACCINES, V10, P211, DOI 10.1586/ERV.10.161; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Fairlie-Clarke KJ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-6; Feng HM, 2004, INFECT IMMUN, V72, P966, DOI 10.1128/IAI.72.2.966-971.2004; Galdiero M, 1997, INFECT IMMUN, V65, P699, DOI 10.1128/IAI.65.2.699-707.1997; Gollub RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002120; HARBOE M, 1991, CLIN EXP IMMUNOL, V86, P2; Ismail N, 2006, INFECT IMMUN, V74, P1846, DOI 10.1128/IAI.74.3.1846-1856.2006; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; KARPATHY SE, 2010, 24 M ASR; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Kumagai Y, 2008, J BACTERIOL, V190, P3597, DOI 10.1128/JB.02017-07; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li JSY, 2002, J IMMUNOL, V169, P1419, DOI 10.4049/jimmunol.169.3.1419; Li JSY, 2001, J IMMUNOL, V166, P1855; McBride JW, 2010, EXPERT REV VACCINES, V9, P1071, DOI [10.1586/erv.10.93, 10.1586/ERV.10.93]; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; Nandi B, 2007, INFECT IMMUN, V75, P5453, DOI 10.1128/IAI.00713-07; Noah CE, 2010, INFECT IMMUN, V78, P1797, DOI 10.1128/IAI.01135-09; Noll A, 1996, CLIN EXP IMMUNOL, V105, P231, DOI 10.1046/j.1365-2249.1996.d01-758.x; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Ohashi N, 1998, INFECT IMMUN, V66, P132, DOI 10.1128/IAI.66.1.132-139.1998; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Roberts WK, 2002, BLOOD, V99, P3748, DOI 10.1182/blood.V99.10.3748; ROWLANDS DJ, 1992, FEMS MICROBIOL LETT, V100, P479; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Sinha K, 2010, MOL IMMUNOL, V48, P264, DOI 10.1016/j.molimm.2010.08.001; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Telford Iii Sam R, 2011, Open Microbiol J, V5, P18, DOI 10.2174/1874285801105010018; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; Thomas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015775; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; VANREGENMORTEL MHV, 1986, TRENDS BIOCHEM SCI, V11, P36, DOI 10.1016/0968-0004(86)90230-6; Walker David H, 2004, Trans Am Clin Climatol Assoc, V115, P375; Walker DH, 2005, ARCH VIROL, P147; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Woo PCY, 2001, CLIN DIAGN LAB IMMUN, V8, P832, DOI 10.1128/CDLI.8.4.832-836.2001; Zhang JZ, 2004, INFECT IMMUN, V72, P4336, DOI 10.1128/IAI.72.8.4336-4343.2004; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	52	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27981	10.1371/journal.pone.0027981	http://dx.doi.org/10.1371/journal.pone.0027981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114733	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800048
J	Geier, F; Fengos, G; Iber, D				Geier, Florian; Fengos, Georgios; Iber, Dagmar			A Computational Analysis of the Dynamic Roles of Talin, Dok1, and PIPKI for Integrin Activation	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; STRUCTURAL BASIS; AFFINITY MODULATION; BINDING; PHOSPHORYLATION; LOCALIZATION; ADHESION; SYSTEMS; MUSCLE; DOMAIN	Integrin signaling regulates cell migration and plays a pivotal role in developmental processes and cancer metastasis. Integrin signaling has been studied extensively and much data is available on pathway components and interactions. Yet the data is fragmented and an integrated model is missing. We use a rule-based modeling approach to integrate available data and test biological hypotheses regarding the role of talin, Dok1 and PIPKI in integrin activation. The detailed biochemical characterization of integrin signaling provides us with measured values for most of the kinetics parameters. However, measurements are not fully accurate and the cellular concentrations of signaling proteins are largely unknown and expected to vary substantially across different cellular conditions. By sampling model behaviors over the physiologically realistic parameter range we find that the model exhibits only two different qualitative behaviors and these depend mainly on the relative protein concentrations, which offers a powerful point of control to the cell. Our study highlights the necessity to characterize model behavior not for a single parameter optimum, but to identify parameter sets that characterize different signaling modes.	[Geier, Florian; Fengos, Georgios; Iber, Dagmar] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Geier, F (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	dagmar.iber@bsse.ethz.ch	Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035	SystemsX.ch, the Swiss Initiative for Systems Biology;  [51RT-0-126008 (InfectX)]	SystemsX.ch, the Swiss Initiative for Systems Biology; 	The project was financially supported by grants 51RT-0-126008 (InfectX) and an iPhD grant from SystemsX.ch, the Swiss Initiative for Systems Biology (www.systemsx.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Geier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024808; Giudici ML, 2006, FEBS LETT, V580, P6933, DOI 10.1016/j.febslet.2006.11.052; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; GOLDMANN WH, 1995, FEBS LETT, V368, P516, DOI 10.1016/0014-5793(95)00678-3; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Iber D, 2006, B MATH BIOL, V68, P945, DOI 10.1007/s11538-005-9049-5; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nag A, 2010, J IMMUNOL, V185, P3268, DOI 10.4049/jimmunol.1000326; NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PAOLO GD, 2002, NATURE, V420, P85; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vitte J, 2004, BIOPHYS J, V86, P4059, DOI 10.1529/biophysj.103.038778; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	43	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e24808	10.1371/journal.pone.0024808	http://dx.doi.org/10.1371/journal.pone.0024808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110576	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000297555400003
J	Gill, PS; Calvert, M; Davis, R; Davies, MK; Freemantle, N; Lip, GYH				Gill, Paramjit S.; Calvert, Melanie; Davis, Russell; Davies, Michael K.; Freemantle, Nick; Lip, Gregory Y. H.			Prevalence of Heart Failure and Atrial Fibrillation in Minority Ethnic Subjects: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)	PLOS ONE			English	Article							VENTRICULAR SYSTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; ACUTE ADMISSIONS; WHITE PATIENTS; RISK-FACTORS; DISEASE; POPULATION; PROGNOSIS; PARTICIPATION; EPIDEMIOLOGY	Background: Limited data exists on the prevalence of heart failure amongst minority groups in the UK. To document the community prevalence and severity of left ventricular systolic dysfunction, heart failure, and atrial fibrillation, amongst the South Asian and Black African -Caribbean groups in the UK. Methods s and Results: We conducted a cross-sectional study recruiting from September 2006 to July 2009 from 20 primary care centres in Birmingham, UK. 10,902 eligible subjects invited, 5,408 participated (49.6%) and 5,354 had complete data (49.1%). Subjects had median age 58.2 years (interquartile range 51.0 to 70.0), and 2544 (47.5%) were male. Of these, 1933 (36.3%) had BMI > 30 kg/m(2), 1,563 (29.2%) had diabetes, 2676 (50.0%) had hypertension, 307 (5.7%) had a history of myocardial infarction, and 104 (1.9%) had history of arrhythmia. Overall, 59 (1.1%) had an Ejection Fraction <40%, and of these 40 (0.75%) were NYHA class >= 2; 51 subjects (0.95%) had atrial fibrillation. Of the remaining 19 patients with an EF < 40%, only 4 patients were treated with furosemide. A further 54 subjects had heart failure with preserved ejection fraction. Conclusions: This is the largest study of the prevalence of left ventricular systolic dysfunction, heart failure and atrial fibrillation in under-researched minority communities in the UK. The prevalence of heart failure in these minority communities appears comparable to that of the general population but less than anticipated given the high rates of cardiovascular disease in these groups. Heart failure continues to be a major cause of morbidity in all ethnic groups and preventive strategies need to be identified and implemented.	[Gill, Paramjit S.; Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England; [Davis, Russell; Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Davies, Michael K.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Freemantle, Nick] UCL, London, England	University of Birmingham; University of Birmingham; University of Birmingham; University of London; University College London	Gill, PS (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	p.s.gill@bham.ac.uk	Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; Freemantle, Nick/0000-0001-5807-5740	British Heart Foundation [PG/05/036]; Heart of Birmingham Teaching Primary Care Trust; Primary Care Research Network-Central England	British Heart Foundation(British Heart Foundation); Heart of Birmingham Teaching Primary Care Trust; Primary Care Research Network-Central England	This work was supported by the British Heart Foundation (PG/05/036), Heart of Birmingham Teaching Primary Care Trust, and through the National Health Service R&D support funding (Primary Care Research Network-Central England). Primary Care Clinical Sciences is a member of the NIHR National School for Primary Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Blackledge HM, 2003, BRIT MED J, V327, P526, DOI 10.1136/bmj.327.7414.526; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Fischbacher CM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-142; Galasko GIW, 2005, HEART, V91, P595, DOI 10.1136/hrt.2003.029959; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gill PS, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-47; GILL PS, 2007, HLTH CARE NEEDS ASSE, P227; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Liew R, 2006, HEART, V92, P1030, DOI 10.1136/hrt.2005.078634; Lip GYH, 1998, INT J CARDIOL, V65, P187, DOI 10.1016/S0167-5273(98)00125-9; Lip GYH, 1997, INT J CLIN PRACT, V51, P223; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Maeder MT, 2009, J AM COLL CARDIOL, V53, P905, DOI 10.1016/j.jacc.2008.12.007; Matthews JNS, 1996, BRIT MED J, V313, P862; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Millett C, 2005, PUBLIC HEALTH, V119, P632, DOI 10.1016/j.puhe.2004.09.004; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Murray J, 2010, FAM PRACT, V27, P430, DOI 10.1093/fampra/cmq030; Newton JD, 2005, HEART, V91, P1545, DOI 10.1136/hrt.2004.057935; *NICE, 2010, NICE CLIN GUID, V108; Peterson E, 2009, NEW ENGL J MED, V360, P1172, DOI 10.1056/NEJMp0810121; Ramakrishnan S, 2009, NATL MED J INDIA, V22, P72; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Scarborough P, 2010, ETHNIC DIFFERENCES C; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Sosin MD, 2004, EUR J HEART FAIL, V6, P831, DOI 10.1016/j.ejheart.2003.11.019; Sosin MD, 2004, EUR J HEART FAIL, V6, P669, DOI 10.1016/j.ejheart.2003.11.016; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Temple R, 2007, ANN INTERN MED, V146, P57, DOI 10.7326/0003-4819-146-1-200701020-00010; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; Yancy CW, 2011, J AM COLL CARDIOL, V57, P245, DOI 10.1016/j.jacc.2010.09.027	40	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e26710	10.1371/journal.pone.0026710	http://dx.doi.org/10.1371/journal.pone.0026710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110591	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400012
J	Parrott, FR; Mwafulirwa, C; Ngwira, B; Nkhwazi, S; Floyd, S; Houben, RMGJ; Glynn, JR; Crampin, AC; French, N				Parrott, Fiona R.; Mwafulirwa, Charles; Ngwira, Bagrey; Nkhwazi, Sothini; Floyd, Sian; Houben, Rein M. G. J.; Glynn, Judith R.; Crampin, Amelia C.; French, Neil			Combining Qualitative and Quantitative Evidence to Determine Factors Leading to Late Presentation for Antiretroviral Therapy in Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RURAL DISTRICT; HIV; GENDER; MORTALITY; ACCEPTANCE; RETENTION; HIV/AIDS; OUTCOMES; ACCESS	Background: Treatment seeking delays among people living with HIV have adverse consequences for outcome. Gender differences in treatment outcomes have been observed in sub-Saharan Africa. Objective: To better understand antiretroviral treatment (ART) seeking behaviour in HIV-infected adults in rural Malawi. Methods: Qualitative interviews with male and female participants in an ART cohort study at a treatment site in rural northern Malawi triangulated with analysis of baseline clinical and demographic data for 365 individuals attending sequentially for ART screening between January 2008 and September 2009. Results: 43% of the cohort presented with late stage HIV disease classified as WHO stage 3/4. Respondents reported that women's frequency of testing, health awareness and commitment to children led to earlier ART uptake and that men's commitment to wider social networks of influence, masculine ideals of strength, and success with sexual and marital partners led them to refuse treatment until they were sick. Quantitative analysis of the screening cohort provided supporting evidence for these expressed views. Overall, male gender (adjusted OR 2.3, 95% CI1.3-3.9) and never being married (adjusted OR 4.1, 95% CI1.5-11.5) were risk factors for late presentation, whereas having >= 3 dependent children was associated with earlier presentation (adjusted OR 0.31, 95% CI0.15-0.63), compared to those with no dependent children. Conclusion: Gender-specific barriers and facilitators operate throughout the whole process of seeking care. Further efforts to enrol men into care earlier should focus on the masculine characteristics that they value, and the risks to these of severe health decline. Our results emphasise the value of exploring as well as identifying behavioural correlates of late presentation.	[Parrott, Fiona R.; Ngwira, Bagrey; Floyd, Sian; Houben, Rein M. G. J.; Glynn, Judith R.; Crampin, Amelia C.; French, Neil] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Mwafulirwa, Charles; Nkhwazi, Sothini] Karonga Prevent Study, Chilumba, Malawi; [Parrott, Fiona R.] Univ Amsterdam, AISSR, Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; University of Amsterdam	Parrott, FR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	f.r.parrott@uva.nl		French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330; Houben, Fiona/0000-0002-5630-3516	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded through a Wellcome Trust Programme Grant awarded to the Karonga Prevention Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK D, 2004, 53 CSSR; Bila B, 2009, SOC SCI MED, V69, P854, DOI 10.1016/j.socscimed.2009.05.035; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Colebunders R, 2005, CLIN INFECT DIS, V41, P386, DOI 10.1086/431490; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; DUBE A, 2009, INDEPTH FERTILITY MO; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fitzgerald M, 2010, AIDS CARE, V22, P355, DOI 10.1080/09540120903111536; Floyd S, 2008, TROP MED INT HEALTH, V13, P520, DOI 10.1111/j.1365-3156.2008.02030.x; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015334; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; HEMMINGS J, 2007, THESIS CTR POPULATIO; Hirsch JS, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000298099.48990.99; Inhorn MC, 2001, SOC SCI MED, V53, P553, DOI 10.1016/S0277-9536(00)00360-9; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; LIBAMBA E, 2006, SUPERVISION, V84, P320; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Marston M, 2009, SEX TRANSM INFECT, V85, pI64, DOI 10.1136/sti.2008.034249; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; Morse JM, 2010, SAGE HDB MIXED METHO, P339; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Nattrass N, 2008, FEM ECON, V14, P19, DOI 10.1080/13545700802266452; Nyanzi-Wakholi B, 2009, AIDS CARE, V21, P903, DOI 10.1080/09540120802657498; Obermeyer CM, 2009, SOC SCI MED, V69, P877, DOI 10.1016/j.socscimed.2009.07.003; Reniers G, 2008, DEMOGRAPHY, V45, P417, DOI 10.1353/dem.0.0002; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Smith DJ, 2010, SOC SCI MED, V71, P345, DOI 10.1016/j.socscimed.2010.04.006; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	37	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27917	10.1371/journal.pone.0027917	http://dx.doi.org/10.1371/journal.pone.0027917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22114727	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000297555400141
J	Rumeu, B; Caujape-Castells, J; Blanco-Pastor, JL; Jaen-Molina, R; Nogales, M; Elias, RB; Vargas, P				Rumeu, Beatriz; Caujape-Castells, Juli; Luis Blanco-Pastor, Jose; Jaen-Molina, Ruth; Nogales, Manuel; Elias, Rui B.; Vargas, Pablo			The Colonization History of Juniperus brevifolia (Cupressaceae) in the Azores Islands	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; MULTIPLE COLONIZATIONS; MITOCHONDRIAL-DNA; NONCODING REGIONS; GENE FLOW; CHLOROPLAST; EVOLUTION; BIOGEOGRAPHY; PHYLOGEOGRAPHY; INHERITANCE	Background: A central aim of island biogeography is to understand the colonization history of insular species using current distributions, fossil records and genetic diversity. Here, we analyze five plastid DNA regions of the endangered Juniperus brevifolia, which is endemic to the Azores archipelago. Methodology/Principal Findings: The phylogeny of the section Juniperus and the phylogeographic analyses of J. brevifolia based on the coalescence theory of allele (plastid) diversity suggest that: (1) a single introduction event likely occurred from Europe; (2) genetic diversification and inter-island dispersal postdated the emergence of the oldest island (Santa Maria, 8.12 Ma); (3) the genetic differentiation found in populations on the islands with higher age and smaller distance to the continent is significantly higher than that on the younger, more remote ones; (4) the high number of haplotypes observed (16), and the widespread distribution of the most frequent and ancestral ones across the archipelago, are indicating early diversification, demographic expansion, and recurrent dispersal. In contrast, restriction of six of the seven derived haplotypes to single islands is construed as reflecting significant isolation time prior to colonization. Conclusions/Significance: Our phylogeographic reconstruction points to the sequence of island emergence as the key factor to explain the distribution of plastid DNA variation. The reproductive traits of this juniper species (anemophily, ornithochory, multi-seeded cones), together with its broad ecological range, appear to be largely responsible for recurrent inter-island colonization of ancestral haplotypes. In contrast, certain delay in colonization of new haplotypes may reflect intraspecific habitat competition on islands where this juniper was already present.	[Rumeu, Beatriz; Nogales, Manuel] IPNA CSIC, Isl Ecol & Evolut Res Grp, Tenerife, Canary Islands, Spain; [Caujape-Castells, Juli; Jaen-Molina, Ruth] Unidad Asociada CSIC, Jardin Bot Canario Viera y Clavijo, Dept Mol Biodivers, Las Palmas Gran Canaria, Spain; [Caujape-Castells, Juli; Jaen-Molina, Ruth] Unidad Asociada CSIC, Jardin Bot Canario Viera y Clavijo, DNA Bank, Las Palmas Gran Canaria, Spain; [Elias, Rui B.] Univ Acores, Dept Ciencias Agr, Grp Biodiversidade Acores CITA A, Angra Do Heroismo, Azores, Portugal; [Luis Blanco-Pastor, Jose] CSIC, Real Jardin Bot, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidade dos Acores; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Rumeu, B (corresponding author), IPNA CSIC, Isl Ecol & Evolut Res Grp, Tenerife, Canary Islands, Spain.	brumeu@ipna.csic.es	Rumeu, Beatriz/ABF-6936-2020; Caujapé-Castells, Juli/J-8938-2015; Nogales, Manuel/I-9831-2014; Elias, Rui Bento/B-9055-2018; Blanco-Pastor, José Luis/R-2075-2018	Rumeu, Beatriz/0000-0002-9017-5466; Caujapé-Castells, Juli/0000-0003-0600-1496; Nogales, Manuel/0000-0002-5327-3104; Elias, Rui Bento/0000-0003-2397-2438; Blanco-Pastor, José Luis/0000-0002-7708-1342	Spanish National Research Council; Spanish Ministry of Science and Innovation [CGL2010-18759, PI2007/053]; Canary Island Government; European Union; The Organismo Autonomo de Parques Nacionales [051/2010]	Spanish National Research Council; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Canary Island Government; European Union(European Commission); The Organismo Autonomo de Parques Nacionales	B. Rumeu and J.L. Blanco-Pastor were funded by a Spanish National Research Council grant mu(CSIC: JAE-PRE; http://www.csic.es/web/guest/programajae). This contribution is framed within the projects CGL2010-18759 and PI2007/053 and financed by the Spanish Ministry of Science and Innovation (http://www.micinn.es), and the Canary Island Government (http://www.gobcan.es), respectively, both of which were partially funded by the European Union. The Organismo Autonomo de Parques Nacionales (http://www.mma.es/secciones/el_ministerio/organismos/oapn/) also financed part of this work (project 051/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2011, JUNIPERS WORLD GENUS; Adams RP, 2009, PHYTOLOGIA, V91, P160; Adams RP, 2010, PHYTOLOGIA, V92, P44; AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Allan GJ, 2004, MOL PHYLOGENET EVOL, V32, P123, DOI 10.1016/j.ympev.2003.11.018; Andrade C, 2008, HOLOCENE, V18, P745, DOI 10.1177/0959683608091794; Andrus N, 2004, TAXON, V53, P333, DOI 10.2307/4135612; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Borges PAV, 1999, BIOL J LINN SOC, V66, P373, DOI 10.1111/j.1095-8312.1999.tb01897.x; BURROWS FM, 1975, NEW PHYTOL, V75, P389, DOI 10.1111/j.1469-8137.1975.tb01403.x; C?lix M., 2018, EUROPEAN RED LIST SA; Cardoso P, 2010, J BIOGEOGR, V37, P1034, DOI 10.1111/j.1365-2699.2009.02264.x; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carine MA, 2010, J BIOGEOGR, V37, P77, DOI 10.1111/j.1365-2699.2009.02181.x; CARLQUIST SH, 1965, ISLAND LIFE NATURAL, P451; Caujape-Castells J., 2011, The biology of island floras, P284; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darwin C., 1877, DIFFERENT FORMS FLOW; DIAS E, 2007, ACORES MADEIRA FLORE, P362; Diaz-Perez A, 2008, SYST BIOL, V57, P732, DOI 10.1080/10635150802302450; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elias RB, 2004, J VEG SCI, V15, P331, DOI 10.1111/j.1654-1103.2004.tb02269.x; ELIAS RB, 2007, THESIS AZORES U ANGR; Elias RB, 2009, PLANT ECOL, V200, P179, DOI 10.1007/s11258-008-9442-x; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ferreira RC, 2011, EUR J FOREST RES, V130, P181, DOI 10.1007/s10342-010-0420-1; Fiz O, 2002, MOL PHYLOGENET EVOL, V25, P157, DOI 10.1016/S1055-7903(02)00228-2; FRANCA Z, 2003, GEOLOGIA ACORES PERS, P11; Garcia D, 2001, J VEG SCI, V12, P839, DOI 10.2307/3236872; Garcia-Verdugo C, 2010, EVOLUTION, V64, P3525, DOI 10.1111/j.1558-5646.2010.01091.x; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gussarova G, 2008, MOL PHYLOGENET EVOL, V48, P444, DOI 10.1016/j.ympev.2008.05.002; Hamilton MB, 1999, MOL ECOL, V8, P521; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hipkins V. D., 1994, Forest Genetics, V1, P179; Hudson RR, 2000, GENETICS, V155, P2011; Hwang LiHoung, 2000, Taiwan Journal of Forest Science, V15, P229; JORDANO P, 1993, VEGETATIO, V108, P85; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIVINGSTON RB, 1972, ECOLOGY, V53, P1141, DOI 10.2307/1935427; MANTEL N, 1967, CANCER RES, V27, P209; Mao KS, 2010, NEW PHYTOL, V188, P254, DOI 10.1111/j.1469-8137.2010.03351.x; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; MARTINS AMF, 1993, B MUSEU MUNICIPAL S, V2, P181; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Molero J, 2002, PLANT SYST EVOL, V231, P109, DOI 10.1007/s006060200014; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; NEALE DB, 1991, CAN J FOREST RES, V21, P717, DOI 10.1139/x91-100; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; PALMER JD, 1988, ANN MO BOT GARD, V75, P1180, DOI 10.2307/2399279; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell EA, 2002, SYST BOT, V27, P768; Provan J, 2008, CONSERV GENET, V9, P1521, DOI 10.1007/s10592-007-9484-y; Rambaut A, 2014, TRACER V1 6; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; Rumeu B, 2011, PLANT ECOL, V212, P911, DOI 10.1007/s11258-010-9875-x; Rumeu B, 2009, EUR J FOREST RES, V128, P567, DOI 10.1007/s10342-009-0304-4; Salgado A.M, 2011, BIOSENSORS ENV APPL, P1; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schaefer H, 2011, J BIOGEOGR, V38, P1345, DOI 10.1111/j.1365-2699.2011.02494.x; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Schirone B, 2010, BIODIVERS CONSERV, V19, P1547, DOI 10.1007/s10531-010-9786-0; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Sima A, 2004, EARTH PLANET SC LETT, V222, P741, DOI 10.1016/j.epsl.2004.03.026; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Swenson U, 2003, TAXON, V52, P533, DOI 10.2307/3647452; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TEMPLETON AR, 1992, GENETICS, V132, P619; Vargas P, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P297, DOI 10.1007/1-4020-4904-8_11; Walker G.P.L., 1973, GEOL RUNDSCH, V62, P431, DOI [10.1007/BF01840108, DOI 10.1007/BF01840108]; WHITTAKER RJ, ISLAND BIOGEOGRAPHY; ZAMORA R, 1990, Alauda, V58, P67; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x	87	32	35	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27697	10.1371/journal.pone.0027697	http://dx.doi.org/10.1371/journal.pone.0027697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110727	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400088
J	Tchilian, EZ; Ronan, EO; de Lara, C; Lee, LN; Franken, KLMC; Vordermeier, MH; Ottenhoff, THM; Beverley, PCL				Tchilian, Elma Z.; Ronan, Edward O.; de Lara, Catherine; Lee, Lian Ni; Franken, Kees L. M. C.; Vordermeier, Martin H.; Ottenhoff, Tom H. M.; Beverley, Peter C. L.			Simultaneous Immunization against Tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; VACCINIA VIRUS ANKARA; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; MUCOSAL IMMUNIZATION; AEROSOL CHALLENGE; RHESUS MACAQUES; MICE	Background: BCG, the only licensed vaccine against tuberculosis, provides some protection against disseminated disease in infants but has little effect on prevention of adult pulmonary disease. Newer parenteral immunization prime boost regimes may provide improved protection in experimental animal models but are unproven in man so that there remains a need for new and improved immunization strategies. Methods and Findings: Mice were immunized parenterally, intranasally or simultaneously by both routes with BCG or recombinant mycobacterial antigens plus appropriate adjuvants. They were challenged with Mycobacterium tuberculosis (Mtb) and the kinetics of Mtb growth in the lungs measured. We show that simultaneous immunization (SIM) of mice by the intranasal and parenteral routes is highly effective in increasing protection over parenteral BCG administration alone. Intranasal immunization induces local pulmonary immunity capable of inhibiting the growth of Mtb in the early phase (the first week) of infection, while parenteral immunization has a later effect on Mtb growth. Importantly, these two effects are additive and do not depend on priming and boosting the immune response. The best SIM regimes reduce lung Mtb load by up to 2 logs more than BCG given by either route alone. Conclusions: These data establish SIM as a novel and highly effective immunization strategy for Mtb that could be carried out at a single clinic visit. The efficacy of SIM does not depend on priming and boosting an immune response, but SIM is complementary to prime boost strategies and might be combined with them.	[Tchilian, Elma Z.; Ronan, Edward O.; de Lara, Catherine; Lee, Lian Ni; Beverley, Peter C. L.] Univ Oxford, Oxford, England; [Franken, Kees L. M. C.; Ottenhoff, Tom H. M.] Leiden Univ Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Vordermeier, Martin H.] Vet Labs Agcy, TB Immunol Grp, Weybridge, Surrey, England	University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Veterinary Laboratories Agency	Tchilian, EZ (corresponding author), Univ Oxford, Oxford, England.	elma.tchilian@ndm.ox.ac.uk	Franken, Kees/ABA-7095-2021; Tchilian, Elma Z/Q-5976-2017; Vordermeier, H Martin/C-6936-2011	Franken, Kees/0000-0002-4747-6060; Tchilian, Elma Z/0000-0002-4869-5118; Beverley, Peter/0000-0003-0481-2180; Lee, Lian Ni/0000-0003-3915-3015	United Kingdom Medical Research Council [G0701235]; EU [FP7]; MRC [G0701235] Funding Source: UKRI; Medical Research Council [G0701235] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by United Kingdom Medical Research Council grant number G0701235. TO is funded by EU FP7 project NEWTBVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Garcia-Contreras L, 2008, P NATL ACAD SCI USA, V105, P4656, DOI 10.1073/pnas.0800043105; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Jeyanathan M, 2010, AM J RESP CRIT CARE, V181, P862, DOI 10.1164/rccm.200910-1583OC; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213; Mollenkopf HJ, 2004, J INFECT DIS, V190, P588, DOI 10.1086/422394; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Ronan EO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008235; ROSENTHAL S R, 1968, Journal of Asthma Research, V5, P309, DOI 10.3109/02770906809100348; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Song KM, 2010, P NATL ACAD SCI USA, V107, P22213, DOI 10.1073/pnas.1015536108; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009	35	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27477	10.1371/journal.pone.0027477	http://dx.doi.org/10.1371/journal.pone.0027477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110657	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400049
J	Xue, Y; Li, L; Zhang, D; Wu, KJ; Chen, YL; Zeng, J; Wang, XY; He, DL				Xue, Yan; Li, Lei; Zhang, Dong; Wu, Kaijie; Chen, Yule; Zeng, Jin; Wang, Xinyang; He, Dalin			Twisted Epithelial-to-Mesenchymal Transition Promotes Progression of Surviving Bladder Cancer T24 Cells with hTERT-Dysfunction	PLOS ONE			English	Article							IMMORTAL HUMAN-CELLS; TELOMERE MAINTENANCE; MAMMALIAN-CELLS; TUMOR-CELLS; HOMOLOGOUS RECOMBINATION; EXPRESSION; SENESCENCE; P53; REPAIR; LINES	Background: Human cancer cells maintain telomeres to protect cells from senescence through telomerase activity (TA) or alternative lengthening of telomeres (ALT) in different cell types. Moreover, cellular senescence can be bypassed by Epithelial-to-mesenchymal transition (EMT) during cancer progression in diverse solid tumors. However, it has not been elucidated the characteristics of telomere maintenance and progression ability after long-term culture in bladder cancer T24 cells with hTERT dysfunction. Methodology/Principal Findings: In this study, by using a dominant negative mutant human telomerase reverse transcriptase (hTERT) vector to inhibit TA in bladder cancer T24 cells, we observed the appearance of long phenotype of telomere length and the ALT-associated PML body (APB) complex after the 27(th) passage, indicating the occurrence of ALT-like pathway in surviving T24/DN868A cells with telomerase inhibition. Meanwhile, telomerase inhibition resulted in significant EMT as shown by change in cellular morphology concomitant with variation of EMT markers. Consistently, the surviving T24/DN868A cells showed increased progression ability in vitro and in vivo. In addition, we found Twist was activated to mediate EMT in surviving T24/DN868A samples. Conclusions/Significance: Taken together, our findings indicate that bladder cancer T24 cells may undergo the telomerase-to-ALT-like conversion and promote cancer progression at advanced stages through promoting EMT, thus providing novel possible insight into the mechanism of resistance to telomerase inhibitors in cancer treatment.	[Xue, Yan; Li, Lei; Zhang, Dong; Wu, Kaijie; Chen, Yule; Zeng, Jin; Wang, Xinyang; He, Dalin] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Xue, Y (corresponding author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China.	dalinhexjtu@163.com	Zeng, Jin/F-9744-2013		National Natural Science Foundation of China (NSFC) [30772163]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the program of The National Natural Science Foundation of China (NSFC NO. 30772163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bacchetti S, 1996, CANCER SURV, V28, P197; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Bertrand P, 1997, ONCOGENE, V14, P1117, DOI 10.1038/sj.onc.1200931; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chen W, 2010, CANCER SCI, V101, P1769, DOI 10.1111/j.1349-7006.2010.01611.x; Colitz CMH, 2009, MOL VIS, V15, P2259; Costa A, 2006, CANCER RES, V66, P8918, DOI 10.1158/0008-5472.CAN-06-0273; D'Alcontres MS, 2007, J CELL BIOL, V179, P855, DOI 10.1083/jcb.200703020; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Delhommeau FO, 2002, ONCOGENE, V21, P8262, DOI 10.1038/sj.onc.1206054; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Fondrevelle ME, 2009, UROL ONCOL-SEMIN ORI, V27, P268, DOI 10.1016/j.urolonc.2007.12.012; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; He DL, 1997, CANCER RES, V57, P1868; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jackson P, 2002, UROL ONCOL, V7, P99, DOI 10.1016/S1078-1439(01)00175-2; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kumakura S, 2005, CANCER RES, V65, P2778, DOI 10.1158/0008-5472.CAN-04-1819; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Li L, 2006, CANCER LETT, V236, P259, DOI 10.1016/j.canlet.2005.05.034; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Mialhe A, 2000, J UROLOGY, V164, P826, DOI 10.1016/S0022-5347(05)67322-3; Neumann AA, 2002, NAT REV CANCER, V2, P879, DOI 10.1038/nrc929; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Razak ZRA, 2004, MOL CELL BIOL, V24, P5967, DOI 10.1128/MCB.24.13.5967-5977.2004; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smit MA, 2008, CANCER CELL, V14, P5, DOI 10.1016/j.ccr.2008.06.012; Smit MA, 2010, AGING-US, V2, P735, DOI 10.18632/aging.100209; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Thykjaer T, 2001, BRIT J CANCER, V85, P568, DOI 10.1054/bjoc.2001.1949; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhu GD, 2007, PROSTATE, V67, P674, DOI 10.1002/pros.20563	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27748	10.1371/journal.pone.0027748	http://dx.doi.org/10.1371/journal.pone.0027748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110753	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555300051
J	Fischer, R; Maier, O; Siegemund, M; Wajant, H; Scheurich, P; Pfizenmaier, K				Fischer, Roman; Maier, Olaf; Siegemund, Martin; Wajant, Harald; Scheurich, Peter; Pfizenmaier, Klaus			A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GLUTAMATE-INDUCED EXCITOTOXICITY; SINGLE-CHAIN TNF; KAPPA-B PATHWAY; PARKINSONS-DISEASE; SIGNALING COMPLEX; ACTIVATION; APOPTOSIS; DOPAMINE; LIGAND	Tumor necrosis factor (TNF) plays a dual role in neurodegenerative diseases. Whereas TNF receptor (TNFR) 1 is predominantly associated with neurodegeneration, TNFR2 is involved in tissue regeneration and neuroprotection. Accordingly, the availability of TNFR2-selective agonists could allow the development of new therapeutic treatments of neurodegenerative diseases. We constructed a soluble, human TNFR2 agonist (TNC-scTNF(R2)) by genetic fusion of the trimerization domain of tenascin C to a TNFR2-selective single-chain TNF molecule, which is comprised of three TNF domains connected by short peptide linkers. TNC-scTNFR2 specifically activated TNFR2 and possessed membrane-TNF mimetic activity, resulting in TNFR2 signaling complex formation and activation of downstream signaling pathways. Protection from neurodegeneration was assessed using the human dopaminergic neuronal cell line LUHMES. First we show that TNC-scTNF(R2) interfered with cell death pathways subsequent to H2O2 exposure. Protection from cell death was dependent on TNFR2 activation of the PI3K-PKB/Akt pathway, evident from restoration of H2O2 sensitivity in the presence of PI3K inhibitor LY294002. Second, in an in vitro model of Parkinson disease, TNC-scTNFR(2) rescues neurons after induction of cell death by 6-OHDA. Since TNFR2 is not only promoting anti-apoptotic responses but also plays an important role in tissue regeneration, activation of TNFR2 signaling by TNC-scTNF(R2) appears a promising strategy to ameliorate neurodegenerative processes.	[Fischer, Roman; Maier, Olaf; Siegemund, Martin; Scheurich, Peter; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany	University of Stuttgart; University of Wurzburg	Fischer, R (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany.	roman.fischer@izi.uni-stuttgart.de	Wajant, Harald/A-3020-2017; Fischer, Roman/AAA-9695-2021; Fischer, Roman/M-8045-2017	Wajant, Harald/0000-0002-2005-3949; Fischer, Roman/0000-0001-7927-604X; Fischer, Roman/0000-0001-7927-604X; Siegemund, Martin/0000-0003-4088-6734	European Community [LSHM-CT-2005-018637]	European Community(European Commission)	This work was supported by a grant from European Community Sixth Framework Programme, Project NeuroproMiSe, contract # LSHM-CT-2005-018637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Bergman H, 2002, MOVEMENT DISORD, V17, pS28, DOI 10.1002/mds.10140; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boschert V, 2010, CELL SIGNAL, V22, P1088, DOI 10.1016/j.cellsig.2010.02.011; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fischer R, 2011, CELL SIGNAL, V23, P161, DOI 10.1016/j.cellsig.2010.08.016; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Gary DS, 2001, J NEUROCHEM, V76, P1485, DOI 10.1046/j.1471-4159.2001.00173.x; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Jordan J, 2004, J NEUROCHEM, V89, P124, DOI 10.1046/j.1471-4159.2003.02299.x; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; Krippner-Heidenreich A, 2008, J IMMUNOL, V180, P8176, DOI 10.4049/jimmunol.180.12.8176; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Lotharius J, 1999, J NEUROSCI, V19, P1284; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Pfizenmaier K, 2011, ADV EXP MED BIOL, V691, P487, DOI 10.1007/978-1-4419-6612-4_50; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; RICHARDSON JS, 1993, ANN NY ACAD SCI, V695, P73, DOI 10.1111/j.1749-6632.1993.tb23031.x; RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O; Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027; SCHOLZ D, 2011, J NEUROCHEM; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WALLACH D, 1991, AGENT ACTION SUPPL, V35, P51; WHITTEMORE ER, 1994, NEUROREPORT, V5, P1485, DOI 10.1097/00001756-199407000-00019; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004	44	79	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27621	10.1371/journal.pone.0027621	http://dx.doi.org/10.1371/journal.pone.0027621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110694	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300039
J	Ahmad, S; Nichols, DP; Strand, M; Rancourt, RC; Randell, SH; White, CW; Ahmad, A				Ahmad, Shama; Nichols, David P.; Strand, Matthew; Rancourt, Raymond C.; Randell, Scott H.; White, Carl W.; Ahmad, Aftab			SERCA2 Regulates Non-CF and CF Airway Epithelial Cell Response to Ozone	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; INTRACELLULAR CALCIUM; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; RETICULUM CA2+; KAPPA-B; ACTIVATION; EXPRESSION; INFECTION	Calcium mobilization can regulate a wide range of essential functions of respiratory epithelium, including ion transport, ciliary beat frequency, and secretion of mucus, all of which are modified in cystic fibrosis (CF). SERCA2, an important controller of calcium signaling, is deficient in CF epithelium. We conducted this study to determine whether SERCA2 deficiency can modulate airway epithelial responses to environmental oxidants such as ozone. This could contribute to the pathogenesis of pulmonary exacerbations, which are important and frequent clinical events in CF. To address this, we used air-liquid interface (ALI) cultures of non-CF and CF cell lines, as well as differentiated cultures of cells derived from non-CF and CF patients. We found that ozone exposure caused enhanced membrane damage, mitochondrial dysfunction and apoptotic cell death in CF airway epithelial cell lines relative to non-CF. Ozone exposure caused increased proinflammatory cytokine production in CF airway epithelial cell lines. Elevated proinflammatory cytokine production also was observed in shRNA-mediated SERCA2 knockdown cells. Overexpression of SERCA2 reversed ozone-induced proinflammatory cytokine production. Ozone-induced proinflammatory cytokine production was NF-kappa B-dependent. In a stable NF-kappa B reporter cell line, SERCA2 inhibition and knockdown both upregulated cytomix-induced NF-kappa B activity, indicating importance of SERCA2 in modulating NF-kappa B activity. In this system, increased NF-kappa B activity was also accompanied by increased IL-8 production. Ozone also induced NF-kappa B activity and IL-8 release, an effect that was greater in SERCA2-silenced NF-kappa B-reporter cells. SERCA2 overexpression reversed cytomix-induced increased IL-8 release and total nuclear p65 in CFTR-deficient (16HBE-AS) cells. These studies suggest that SERCA2 is an important regulator of the proinflammatory response of airway epithelial cells and could be a potential therapeutic target.	[Ahmad, Shama; Nichols, David P.; Rancourt, Raymond C.; White, Carl W.; Ahmad, Aftab] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Strand, Matthew] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Randell, Scott H.] Univ N Carolina, Dept Med, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA	National Jewish Health; National Jewish Health; University of North Carolina; University of North Carolina Chapel Hill	Ahmad, S (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO USA.	ahmads@njhealth.org	ahmad, shama/GNH-1803-2022; Strand, Matt/AAU-3762-2021; Ahmad, Aftab/ABC-2734-2020	ahmad, shama/0000-0003-1049-5054; Strand, Matt/0000-0002-9083-5989; Ahmad, Aftab/0000-0003-0686-0987; Nichols, David/0000-0001-8611-7960	National Institute of Environmental Health Sciences (NIEHS), NIH [R01-ES014448]; Max and Yetta Karasik Family Foundation [R01-HL080322]; CF Foundation [RDP CORE C: R026-R02]; National Center for Research Resources (NCRR) [K12 KL2RR025779]; American Heart Association [0830418N]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025779] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014448] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Max and Yetta Karasik Family Foundation; CF Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01-ES014448 from the National Institute of Environmental Health Sciences (NIEHS), NIH, and by the Max and Yetta Karasik Family Foundation (CWW), R01-HL080322 and CF Foundation Resources Development Program Grant RDP CORE C: R026-R02 (SR). SA is supported by K12 KL2RR025779 from the National Center for Research Resources (NCRR). AA is supported by the Scientist Development Grant award (0830418N) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2006, FREE RADICAL BIO MED, V40, P1108, DOI 10.1016/j.freeradbiomed.2005.10.045; Ahmad S, 2005, FREE RADICAL BIO MED, V39, P213, DOI 10.1016/j.freeradbiomed.2005.03.009; Ahmad S, 2004, J BIOL CHEM, V279, P16317, DOI 10.1074/jbc.M313890200; Ahmad S, 2001, AM J PHYSIOL-LUNG C, V280, pL779, DOI 10.1152/ajplung.2001.280.4.L779; Ahmad S, 2009, AM J RESP CRIT CARE, V179, P816, DOI 10.1164/rccm.200807-1104OC; Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Bosson J, 2003, CLIN EXP ALLERGY, V33, P777, DOI 10.1046/j.1365-2222.2003.01662.x; Cebo C, 2001, J BIOL CHEM, V276, P5685, DOI 10.1074/jbc.M008662200; Cho HY, 2000, AM J RESP CRIT CARE, V162, P629, DOI 10.1164/ajrccm.162.2.9811078; Ciarlet M, 2001, J VIROL, V75, P11834, DOI 10.1128/JVI.75.23.11834-11850.2001; Damera G, 2009, AM J PHYSIOL-LUNG C, V296, pL674, DOI 10.1152/ajplung.90585.2008; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gilliland FD, 2009, PEDIATRICS, V123, pS168, DOI 10.1542/peds.2008-2233G; Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC; HARKEMA JR, 1993, AM J PATHOL, V143, P857; HARKEMA JR, 1993, TOXICOL LETT, V68, P251, DOI 10.1016/0378-4274(93)90136-L; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Larsen ST, 2010, J TOXICOL ENV HEAL A, V73, P738, DOI 10.1080/15287391003614034; Lattanzio FA, 2005, CARDIOVASC TOXICOL, V5, P377, DOI 10.1385/CT:5:4:377; LIN H, 1989, AM J RESP CELL MOL, V1, P41, DOI 10.1165/ajrcmb/1.1.41; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; Meehan S, 1997, AM J PHYSIOL-CELL PH, V273, pC2030, DOI 10.1152/ajpcell.1997.273.6.C2030; Nichols DP, 2009, AM J PHYSIOL-LUNG C, V297, pL828, DOI 10.1152/ajplung.00171.2009; Oslund KL, 2008, AM J RESP CELL MOL, V39, P279, DOI 10.1165/rcmb.2008-0009OC; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Qu F, 2009, CHEM-BIOL INTERACT, V179, P219, DOI 10.1016/j.cbi.2008.10.059; Rabinovitch N, 2006, AM J RESP CRIT CARE, V173, P1098, DOI 10.1164/rccm.200509-1393OC; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Reid DW, 2007, RESPIROLOGY, V12, P63, DOI 10.1111/j.1440-1843.2006.00962.x; Ribeiro Carla Maria Pedrosa, 2006, Drugs R D, V7, P17, DOI 10.2165/00126839-200607010-00002; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Rusznak C, 1996, EUR RESPIR J, V9, P2298, DOI 10.1183/09031936.96.09112298; Sathishkumar K, 2009, FREE RADICAL BIO MED, V47, P548, DOI 10.1016/j.freeradbiomed.2009.05.020; Spannhake EW, 2002, ENVIRON HEALTH PERSP, V110, P665, DOI 10.1289/ehp.02110665; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Thompson DC, 1998, AM J PHYSIOL-LUNG C, V274, pL922, DOI 10.1152/ajplung.1998.274.6.L922; Uhlson C, 2002, CHEM RES TOXICOL, V15, P896, DOI 10.1021/tx010183i; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Wagner JG, 2003, TOXICOL SCI, V74, P437, DOI 10.1093/toxsci/kfg120; Warburg O, 1942, BIOCHEM Z, V310, P384; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005	53	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27451	10.1371/journal.pone.0027451	http://dx.doi.org/10.1371/journal.pone.0027451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096575	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900046
J	Gupta, S; Kruger, WD				Gupta, Sapna; Kruger, Warren D.			Cystathionine Beta-Synthase Deficiency Causes Fat Loss in Mice	PLOS ONE			English	Article							HISTONE H3 METHYLTRANSFERASE; STEAROYL-COA DESATURASE-1; N-ACETYLCYSTEINE; KINETIC MECHANISM; SEBACEOUS GLANDS; BODY-COMPOSITION; GENE-EXPRESSION; HOMOCYSTEINE; CYSTEINE; MOUSE	Cystathionine beta synthase (CBS) is the rate-limiting enzyme responsible for the de novo synthesis of cysteine. Patients with CBS deficiency have greatly elevated plasma total homocysteine (tHcy), decreased levels of plasma total cysteine (tCys), and often a marfanoid appearance characterized by thinness and low body-mass index (BMI). Here, we characterize the growth and body mass characteristics of CBS deficient TgI278T Cbs(-/-) mice and show that these animals have significantly decreased fat mass and tCys compared to heterozygous sibling mice. The decrease in fat mass is accompanied by a 34% decrease in liver glutathione (GSH) along with a significant decrease in liver mRNA and protein for the critical fat biosynthesizing enzyme Stearoyl CoA desaturase-1 (Scd-1). Because plasma tCys has been positively associated with fat mass in humans, we tested the hypothesis that decreased tCys in TgI278T Cbs(-/-) mice was the cause of the lean phenotype by placing the animals on water supplemented with N-acetyl cysteine (NAC) from birth to 240 days of age. Although NAC treatment in TgI278T Cbs(-/-) mice caused significant increase in serum tCys and liver GSH, there was no increase in body fat content or in liver Scd-1 levels. Our results show that lack of CBS activity causes loss of fat mass, and that this effect appears to be independent of low serum tCys.	[Gupta, Sapna; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Gupta, S (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018; kruger, warren/A-6407-2008	kruger, warren/0000-0002-4990-3695	National Institutes of Health [HL50299, CA06927]; Hempling Foundation for homocystinuria research; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hempling Foundation for homocystinuria research; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants HL50299 and CA06927 from the National Institutes of Health, The Hempling Foundation for homocystinuria research, and an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; BRENTON D P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P277; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Dauletbaev N, 2009, EUR J MED RES, V14, P352; De Rosa SC, 2000, EUR J CLIN INVEST, V30, P915, DOI 10.1046/j.1365-2362.2000.00736.x; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Elshorbagy AK, 2009, BONE, V44, P954, DOI 10.1016/j.bone.2008.12.018; Flynn J, 1998, BIOCHEMISTRY-US, V37, P15162, DOI 10.1021/bi9810609; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; GIBSON JB, 1964, J CLIN PATHOL, V17, P427, DOI 10.1136/jcp.17.4.427; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; HANSEN NCG, 1994, RESP MED, V88, P531, DOI 10.1016/S0954-6111(05)80337-3; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; LEE HW, 1977, BIOCHEMISTRY-US, V16, P78, DOI 10.1021/bi00620a013; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; MUDD SH, 1985, AM J HUM GENET, V37, P1; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Robert K, 2004, ANAT REC PART A, V280A, P1072, DOI 10.1002/ar.a.20082; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; SOUZA GA, 2008, EVID-BASED COMPL ALT; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446	32	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27598	10.1371/journal.pone.0027598	http://dx.doi.org/10.1371/journal.pone.0027598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096601	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900060
J	Wang, P; Zhu, F; Konstantopoulos, K				Wang, Pu; Zhu, Fei; Konstantopoulos, Konstantinos			Interleukin-6 Synthesis in Human Chondrocytes Is Regulated via the Antagonistic Actions of Prostaglandin (PG)E-2 and 15-deoxy-Delta(12,14)-PGJ(2)	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HUMAN ARTICULAR CHONDROCYTES; INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; SYNOVIAL-FLUID; PPAR-GAMMA; CROSS-TALK; KINASE; IL-6; E-2	Background: Elevated levels of interleukin-6 (IL-6), prostaglandin (PG)E-2, PGD(2) and its dehydration end product 15-deoxy-Delta(12,14) -PGJ(2) (15d-PGJ(2)) have been detected in joint synovial fluids from patients with rheumatoid arthritis (RA). PGE(2) directly stimulates IL-6 production in human articular chondrocytes. However, the effects of PGD(2) and 15d-PGJ(2) in the absence or presence of PGE(2) on IL-6 synthesis in human chondrocytes have yet to be determined. It is believed that dysregulated overproduction of IL-6 is responsible for the systemic inflammatory manifestations and abnormal laboratory findings in RA patients. Methodology/Principal Findings: Using the T/C-28a2 chondrocyte cell line as a model system, we report that exogenous PGE(2) and PGD(2)/15d-PGJ(2) exert antagonistic effects on IL-6 synthesis in human T/C-28a2 chondrocytes. Using a synthesis of sophisticated molecular biology techniques, we determined that PGE(2) stimulates Toll-like receptor 4 (TLR4) synthesis, which is in turn responsible for the activation of the ERK1/2, PI3K/Akt and PKA/CREB pathways that phosphorylate the NF-kappa B p65 subunit leading to NF-kappa B activation. Binding of the activated NF-kappa B p65 subunit to IL-6 promoter induces IL-6 synthesis in human T/C28a2 chondrocytes. PGD(2) or 15d-PGJ(2) concurrently downregulates TLR4 and upregulates caveolin-1, which in turn inhibit the PGE(2)-dependent ERK1/2, PI3-K and PKA activation, and ultimately with NF-kappa B-dependent IL-6 synthesis in chondrocytes. Conclusions/Significance: We have delineated the signaling cascade by which PGE(2) and PGD(2)/15d-PGJ(2) exert opposing effects on IL-6 synthesis in human chondrocytes. Elucidation of the molecular pathway of IL-6 synthesis and secretion by chondrocytes will provide insights for developing strategies to reduce inflammation and pain in RA patients.	[Wang, Pu; Zhu, Fei; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wang, P (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	konstant@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health NIAMS [RO1 AR053358]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by the National Institutes of Health NIAMS Grant RO1 AR053358. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Blom MAA, 1997, BRAIN RES, V777, P210, DOI 10.1016/S0006-8993(97)01204-3; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Chearwae W, 2008, J CLIN IMMUNOL, V28, P558, DOI 10.1007/s10875-008-9202-7; EGG D, 1984, Z RHEUMATOL, V43, P89; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Eun CS, 2006, DIGEST DIS SCI, V51, P693, DOI 10.1007/s10620-006-3193-0; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Hardy MM, 2002, ARTHRITIS RHEUM, V46, P1789, DOI 10.1002/art.10356; He Q, 2010, AM J PHYSIOL-HEART C, V298, pH136, DOI 10.1152/ajpheart.00251.2009; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Inoue K, 2005, CLIN EXP PHARMACOL P, V32, P230, DOI 10.1111/j.1440-1681.2005.04175.x; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Li X, 2009, ARTHRITIS RHEUM-US, V60, P513, DOI 10.1002/art.24258; Lowe GN, 1996, ENDOCRINOLOGY, V137, P2208, DOI 10.1210/en.137.6.2208; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Miller C, 1998, J CELL BIOCHEM, V69, P392, DOI 10.1002/(SICI)1097-4644(19980615)69:4<392::AID-JCB2>3.3.CO;2-Z; Muller G, 1999, CELL MOL LIFE SCI, V56, P945, DOI 10.1007/s000180050485; Noguchi K, 2002, J PERIODONTAL RES, V37, P29, DOI 10.1034/j.1600-0765.2002.00641.x; Ohnuma Kei, 2006, Mod Rheumatol, V16, P3; OKEEFE RJ, 1992, J BONE MINER RES, V7, P397; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Qian YG, 2009, J CANCER RES CLIN, V135, P379, DOI 10.1007/s00432-008-0478-z; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Relic B, 2004, J BIOL CHEM, V279, P22399, DOI 10.1074/jbc.M314118200; Ruiz PA, 2004, J BIOL CHEM, V279, P36103, DOI 10.1074/jbc.M405032200; Shan ZZ, 2004, J BIOL CHEM, V279, P37939, DOI 10.1074/jbc.M402424200; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Takaoka Y, 1999, J BIOCHEM-TOKYO, V126, P553, DOI 10.1093/oxfordjournals.jbchem.a022485; Tetlow LC, 2006, INFLAMM RES, V55, pS73, DOI 10.1007/s00011-005-0049-6; Thieringer R, 2000, J IMMUNOL, V164, P1046, DOI 10.4049/jimmunol.164.2.1046; TRANG LE, 1977, SCAND J RHEUMATOL, V6, P151, DOI 10.3109/03009747709095440; Tsubouchi Y, 2000, BIOCHEM BIOPH RES CO, V270, P400, DOI 10.1006/bbrc.2000.2436; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P677, DOI 10.1016/j.biocel.2007.10.007; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zhang FP, 2010, J NEUROIMMUNOL, V218, P36, DOI 10.1016/j.jneuroim.2009.10.016; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13; Zhu F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015174	54	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27630	10.1371/journal.pone.0027630	http://dx.doi.org/10.1371/journal.pone.0027630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096605	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900064
J	Carballo-Dieguez, A; Balan, I; Marone, R; Pando, MA; Dolezal, C; Barreda, V; Leu, CS; Avila, MM				Carballo-Dieguez, Alex; Balan, Ivan; Marone, Ruben; Pando, Maria A.; Dolezal, Curtis; Barreda, Victoria; Leu, Cheng-Shiun; Mercedes Avila, Maria			Use of Respondent Driven Sampling (RDS) Generates a Very Diverse Sample of Men Who Have Sex with Men (MSM) in Buenos Aires, Argentina	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; LATINO MEN; RISK-FACTORS; HIV RISK; POPULATIONS; PREVALENCE; BEHAVIOR	Background: Prior research focusing on men who have sex with men (MSM) conducted in Buenos Aires, Argentina, used convenience samples that included mainly gay identified men. To increase MSM sample representativeness, we used Respondent Driven Sampling (RDS) for the first time in Argentina. Using RDS, under certain specified conditions, the observed estimates for the percentage of the population with a specific trait are asymptotically unbiased. We describe, the diversity of the recruited sample, from the point of view of sexual orientation, and contrast the different subgroups in terms of their HIV sexual risk behavior. Methodology: 500 MSM were recruited using RDS. Behavioral data were collected through face-to-face interviews and Web-based CASI. Conclusion: In contrast with prior studies, RDS generated a very diverse sample of MSM from a sexual identity perspective. Only 24.5% of participants identified as gay; 36.2% identified as bisexual, 21.9% as heterosexual, and 17.4% were grouped as "other.'' Gay and non-gay identified MSM differed significantly in their sexual behavior, the former having higher numbers of partners, more frequent sexual contacts and less frequency of condom use. One third of the men (gay, 3%; bisexual, 34%, heterosexual, 51%; other, 49%) reported having had sex with men, women and transvestites in the two months prior to the interview. This population requires further study and, potentially, HIV prevention strategies tailored to such diversity of partnerships. Our results highlight the potential effectiveness of using RDS to reach non-gay identified MSM. They also present lessons learned in the implementation of RDS to recruit MSM concerning both the importance and limitations of formative work, the need to tailor incentives to circumstances of the less affluent potential participants, the need to prevent masking, and the challenge of assessing network size.	[Carballo-Dieguez, Alex; Balan, Ivan; Dolezal, Curtis; Leu, Cheng-Shiun] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; [Carballo-Dieguez, Alex; Balan, Ivan; Dolezal, Curtis; Leu, Cheng-Shiun] Columbia Univ, New York, NY USA; [Marone, Ruben; Barreda, Victoria] Nexo Asociac Civil, Buenos Aires, DF, Argentina; [Pando, Maria A.; Mercedes Avila, Maria] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina	New York State Psychiatry Institute; Columbia University; University of Buenos Aires	Carballo-Dieguez, A (corresponding author), New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA.	ac72@columbia.edu			US National Institute of Mental Health (NIMH) [R01-MH073410]; NIMH [P30-MH43520]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520, R01MH073410] Funding Source: NIH RePORTER	US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported with funds from the US National Institute of Mental Health (NIMH) to the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University (R01-MH073410; Principal Investigator: Alex Carballo-Dieguez, Ph.D.). Additional funds came from a grant from NIMH to the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University (P30-MH43520; Principal Investigator: Anke A. Ehrhardt, Ph.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the NIH.	Barreda V, 2010, SEX SALUD SOC, V6, P41; Bozicevic I, 2009, AIDS BEHAV, V13, P303, DOI 10.1007/s10461-008-9436-7; Carrier Joseph, 1995, OTROS INTIMACY HOMOS; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; COLEMAN E, 1987, J HOMOSEXUAL, V14, P9, DOI 10.1300/J082v14n01_02; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McCormick TH, 2010, J AM STAT ASSOC, V105, P59, DOI 10.1198/jasa.2009.ap08518; Mimiaga MJ, 2010, DRUG ALCOHOL DEPEN, V110, P30, DOI 10.1016/j.drugalcdep.2010.01.017; Munoz-Laboy M, 2007, AM J PUBLIC HEALTH, V97, P1102, DOI 10.2105/AJPH.2005.078345; Pando MD, 2003, INT J EPIDEMIOL, V32, P735, DOI 10.1093/ije/dyg104; Parker R, 1999, Cult Health Sex, V1, P201, DOI 10.1080/136910599300978; Parker R, 1991, BODIES PLEASURES PAS; Reisner SL, 2009, AIDS CARE, V21, P1481, DOI 10.1080/09540120902893258; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; SPSS Inc, 2009, PASW STAT; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Vignoles M, 2006, JAIDS-J ACQ IMM DEF, V42, P494, DOI 10.1097/01.qai.0000221678.06822.8b; Volz E, 2008, J OFF STAT, V24, P79; Yeka W, 2006, J URBAN HEALTH, V83, pI60, DOI 10.1007/s11524-006-9103-0; Zellner JA, 2009, AM J PUBLIC HEALTH, V99, P125, DOI 10.2105/AJPH.2007.129809	30	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27447	10.1371/journal.pone.0027447	http://dx.doi.org/10.1371/journal.pone.0027447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HQ	22102896	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800025
J	Blas, MM; Alva, IE; Cabello, R; Carcamo, C; Kurth, AE				Blas, Magaly M.; Alva, Isaac E.; Cabello, Robinson; Carcamo, Cesar; Kurth, Ann E.			Risk Behaviors and Reasons for not Getting Tested for HIV among Men Who Have Sex with Men: An Online Survey in Peru	PLOS ONE			English	Article							INTERNET USE; ASSOCIATION	Background: Men who have sex with men (MSM) account for the greatest burden of the HIV epidemic in Peru. Given that MSM are frequent users of the Internet, understanding the risk behaviors and the reasons for not getting tested among MSM who surf the Internet may improve the tailoring of future online behavioral interventions. Methods: From October 2007 to April 2008, we conducted an online survey among users of seven Peruvian gay websites. Results: We received 1,481 surveys, 1,301 of which were included in the analysis. The median age of the participants was 22.5 years (range 12 - 71), 67% were homosexual, and the remainder was bisexual. Of survey respondents, 49.4% had never been tested for HIV and only 11.3% were contacted in-person during the last year by peer health educators from the Peruvian Ministry of Health and NGOs. Additionally, 50.8% had unprotected anal or vaginal sex at last intercourse, and a significant percentage reported a condom broken (22.1%), slipped (16.4%) or sexual intercourse initiated without wearing a condom (39.1%). The most common reasons for not getting tested for HIV among high-risk MSM were "I fear the consequences of a positive test result" (n = 55, 34.4%), and "I don't know where I can get tested" (n = 50, 31.3%). Conclusions: A small percentage of Peruvian MSM who answered our online survey, were reached by traditional peer-based education programs. Given that among high-risk MSM, fear of a positive test result and lack of awareness of places where to get tested are the most important reasons for not taking an HIV test, Internet interventions aimed at motivating HIV testing should work to reduce fear of testing and increase awareness of places that offer free HIV testing services to MSM.	[Blas, Magaly M.; Alva, Isaac E.; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol HIV & STD Unit, Lima, Peru; [Kurth, Ann E.] Univ Washington, Sch Nursing, Dept Global Hlth, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol HIV & STD Unit, Lima, Peru.	magalyblas@gmail.com	Oliveira, Claudia DL/G-8618-2011; Kurth, Ann E/A-1615-2013		University of Washington; Fogarty International Center/National Institutes of Health (FIC/NIH) [5D43TW007551]; QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH [D43TW008438-0109]; FIC/NIH [R01TW008398]; FOGARTY INTERNATIONAL CENTER [D43TW008438, D43TW007551, R01TW008398] Funding Source: NIH RePORTER	University of Washington(University of Washington); Fogarty International Center/National Institutes of Health (FIC/NIH); QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH; FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by The University of Washington AMAUTA Global Informatics Research and Training Program, a Fogarty International Center/National Institutes of Health (FIC/NIH) funded grant (5D43TW007551); QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH funded grant (D43TW008438-0109); and, by a grant from the FIC/NIH (R01TW008398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EP FACT SHEET HIV AI; Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Curioso WH, 2007, PLOS MED, V4, P248, DOI [10.1371/journal.pmed.0040011, 10.1371/jourmal.pmed.0040011]; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Green EC, 2006, J HEALTH COMMUN, V11, P245, DOI 10.1080/10810730600613807; Kalichman SC, 2002, AIDS EDUC PREV, V14, P51, DOI 10.1521/aeap.14.1.51.24335; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Mikolajczak J, 2006, AIDS BEHAV, V10, P431, DOI 10.1007/s10461-006-9068-8; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Peruvian Ministry of Health, 2006, AN SIT EP VIH SIDA P; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Slavin S, 2007, AIDS CARE, V19, P130, DOI 10.1080/09540120600866473; UNAIDS, 2007, UNAIDS POL BRIEF HIV; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Zhang D, 2007, SEX TRANSM INFECT, V83, P571, DOI 10.1136/sti.2007.026138	17	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27334	10.1371/journal.pone.0027334	http://dx.doi.org/10.1371/journal.pone.0027334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852II	22096551	gold, Green Submitted, Green Published			2022-12-25	WOS:000297350800043
J	Li, X; Cheung, KF; Ma, X; Tian, L; Zhao, J; Go, MYY; Shen, B; Cheng, ASL; Ying, J; Tao, Q; Sung, JJY; Kung, HF; Yu, J				Li, X.; Cheung, K. F.; Ma, X.; Tian, L.; Zhao, J.; Go, M. Y. Y.; Shen, B.; Cheng, A. S. L.; Ying, J.; Tao, Q.; Sung, J. J. Y.; Kung, H-F; Yu, J.			Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients	ONCOGENE			English	Article						paired box gene 5; gastric cancer; tumor suppressor gene; epigenetic alteration; prognosis	TRANSCRIPTION FACTOR BSAP; HEPATOCYTE GROWTH-FACTOR; CPG ISLAND METHYLATION; DOWN-REGULATION; BREAST-CANCER; MATRIX METALLOPROTEINASES; MET PROTOONCOGENE; CELL-DEVELOPMENT; B-LYMPHOPOIESIS; LUNG-CANCER	Using genome-wide methylation screening, we identified that paired box gene 5 (PAX5) is involved in human cancer development. However, the function of PAX5 in gastric cancer (GC) development is largely unclear. We analyzed its epigenetic inactivation, biological functions and clinical application in GC. PAX5 was silenced in seven out of eight GC cell lines. A significant downregulation was also detected in paired gastric tumors compared with adjacent non-cancerous tissues. The downregulation of PAX5 was closely linked to the promoter hypermethylation status and could be restored with demethylation treatment. Ectopic expression of PAX5 in silenced GC cell lines (AGS and BGC823) inhibited colony formation and cell viability, arrested cell cycle, induced apoptosis, suppressed cell migration and invasion and repressed tumorigenicity in nude mice. Consistent with the induction of apoptosis by PAX5 in vitro, terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling (TUNEL) staining showed significantly enhanced apoptotic cells in PAX5-expressed tumors compared with the vector control tumors. On the other hand, knockdown of PAX5 by PAX5-short hairpin RNA increased the cell viability and proliferation. The anti-tumorigenic function of PAX5 was revealed to be mediated by upregulating downstream targets of tumor protein 53 (p53), p21, BCL2-associated X protein, metastasis suppressor 1 and tissue inhibitors of metalloproteinase 1, and downregulating BCL2, cyclin D1, mesenchymal-epithelial transition factor (MET) and matrix metalloproteinase 1. Immunoprecipitation assay demonstrated that PAX5 directly bound to the promoters of p53 and MET. Moreover, PAX5 hypermethylation was detected in 77% (144 of 187) of primary GCs compared with 10.5% (2/19) of normal gastric tissues (P<0.0001). GC patients with PAX5 methylation had a significant poor survival compared with the unmethylated cases as demonstrated by Cox regression model and log-rank test. In conclusion, PAX5 is a novel functional tumor suppressor in gastric carcinogenesis. Detection of methylated PAX5 can be utilized as an independent prognostic factor in GC. Oncogene (2012) 31, 3419-3430; doi:10.1038/onc.2011.511; published online 21 November 2011	[Li, X.; Cheung, K. F.; Ma, X.; Zhao, J.; Go, M. Y. Y.; Shen, B.; Cheng, A. S. L.; Sung, J. J. Y.; Yu, J.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; [Li, X.; Cheung, K. F.; Ma, X.; Zhao, J.; Go, M. Y. Y.; Shen, B.; Cheng, A. S. L.; Sung, J. J. Y.; Yu, J.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Ma, X.] Hebei Med Univ, Hosp 1, Dept Neurol, Shijiazhuang, Peoples R China; [Tian, L.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Shen, B.] Guangzhou First Municipal Peoples Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Ying, J.; Tao, Q.] Chinese Univ Hong Kong, Canc Epigenet Lab, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Kung, H-F] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Hebei Medical University; Chinese University of Hong Kong; South China University of Technology; Chinese University of Hong Kong; Chinese University of Hong Kong	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Shatin, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Sung, Joseph J. Y./R-3203-2018; Li, Xiao-xing/B-9114-2008; Yu, Jun/D-8569-2015; Tao, Qian/T-4743-2018; Cheng, Alfred SL/C-3327-2014; Tian, Linwei/A-9736-2009	Sung, Joseph J. Y./0000-0003-3125-5199; Li, Xiao-xing/0000-0001-8791-7505; Yu, Jun/0000-0001-5008-2153; Tao, Qian/0000-0001-5383-4808; Cheng, Alfred SL/0000-0003-2345-6951; Tian, Linwei/0000-0002-4739-1534; Tian, Linwei/0000-0003-2240-8886	National Basic Research Program of China (973 Program) [2010CB529305]; Hong Kong General Research Fund [473008]; RFCID [11100022, 10090942]; CUHK Group Research Scheme [3110043]; Scheme C	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Hong Kong General Research Fund; RFCID; CUHK Group Research Scheme; Scheme C	This study was supported by research grants of National Basic Research Program of China (973 Program, 2010CB529305), Hong Kong General Research Fund (473008), RFCID (11100022, 10090942), CUHK Group Research Scheme (3110043) and Scheme C.	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Carotta S, 2006, CELL CYCLE, V5, P2452, DOI 10.4161/cc.5.21.3396; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GIORDANO S, 1993, P NATL ACAD SCI USA, V90, P649, DOI 10.1073/pnas.90.2.649; HALDAR S, 1994, CANCER RES, V54, P2095; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kang GH, 2003, AM J PATHOL, V163, P1551, DOI 10.1016/S0002-9440(10)63511-0; Kang GH, 2003, LAB INVEST, V83, P519, DOI 10.1097/01.LAB.0000064704.53132.65; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; KISHIMOTO Y, 1992, CANCER RES, V52, P4799; Kovac CR, 2000, J BIOL CHEM, V275, P16752, DOI 10.1074/jbc.M001551200; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kubetzko FBB, 2004, CARCINOGENESIS, V25, P1839, DOI 10.1093/carcin/bgh190; Lazzi S, 2009, HUM PATHOL, V40, P1252, DOI 10.1016/j.humpath.2009.01.007; Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232; Lee JH, 2004, ONCOGENE, V23, P4646, DOI 10.1038/sj.onc.1207588; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Levine A J, 1989, Princess Takamatsu Symp, V20, P221; Liu WL, 2011, HEPATOLOGY, V53, P843, DOI 10.1002/hep.24124; MALKIN D, 1994, CANCER RES, V54, P2077; Meza JL, 2006, J CLIN ONCOL, V24, P3844, DOI 10.1200/JCO.2005.05.3801; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P709, DOI 10.1136/jcp.2006.039917; MIYASHITA T, 1995, CELL, V80, P293; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang Y, 2007, CANCER INVEST, V25, P79, DOI 10.1080/07357900701205457; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu J, 2010, GASTROENTEROLOGY, V138, P694, DOI 10.1053/j.gastro.2009.09.058; ZWOLLO P, 1994, J BIOL CHEM, V269, P15310	49	57	60	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	29					3419	3430		10.1038/onc.2011.511	http://dx.doi.org/10.1038/onc.2011.511			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	976FN	22105368				2022-12-25	WOS:000306566400003
J	Reed, SA; Sandesara, PB; Senf, SM; Judge, AR				Reed, Sarah A.; Sandesara, Pooja B.; Senf, Sarah M.; Judge, Andrew R.			Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy	FASEB JOURNAL			English	Article						cancer; sepsis; satellite cells; myostatin; protein synthesis	MOUSE SKELETAL-MUSCLE; NF-KAPPA-B; CANCER CACHEXIA; GENE-EXPRESSION; WEIGHT-LOSS; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; SATELLITE CELLS; MESSENGER-RNA; SEPSIS	Cachexia is characterized by inexorable muscle wasting that significantly affects patient prognosis and increases mortality. Therefore, understanding the molecular basis of this muscle wasting is of significant importance. Recent work showed that components of the forkhead box O (FoxO) pathway are increased in skeletal muscle during cachexia. In the current study, we tested the physiological significance of FoxO activation in the progression of muscle atrophy associated with cachexia. FoxO-DNA binding dependent transcription was blocked in the muscles of mice through injection of a dominant negative (DN) FoxO expression plasmid prior to inoculation with Lewis lung carcinoma cells or the induction of sepsis. Expression of DN FoxO inhibited the increased mRNA levels of atrogin-1, MuRF1, cathepsin L, and/or Bnip3 and inhibited muscle fiber atrophy during cancer cachexia and sepsis. Interestingly, during control conditions, expression of DN FoxO decreased myostatin expression, increased MyoD expression and satellite cell proliferation, and induced fiber hypertrophy, which required de novo protein synthesis. Collectively, these data show that FoxO-DNA binding-dependent transcription is necessary for normal muscle fiber atrophy during cancer cachexia and sepsis, and further suggest that basal levels of FoxO play an important role during normal conditions to depress satellite cell activation and limit muscle growth.-Reed, S. A., Sandesara, P. B., Senf, S. F., Judge, A. R. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J. 26, 987-1000 (2012). www.fasebj.org	[Reed, Sarah A.; Sandesara, Pooja B.; Judge, Andrew R.] Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA; [Senf, Sarah M.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Judge, AR (corresponding author), Univ Florida, Dept Phys Therapy, 101 S Newell Dr, Gainesville, FL 32611 USA.	arjudge@phhp.ufl.edu		Judge, Sarah/0000-0002-3974-0247; Reed, Sarah A/0000-0002-9961-6280	Bankhead Coley Cancer Research Program [09BN-09]; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases [R03AR056418, R01AR060209]; U.S. National Institute of Child Health and Human Development [T32-HD-043730]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR056418, R01AR060209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Bankhead Coley Cancer Research Program; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Bankhead Coley Cancer Research Program grant 09BN-09, and U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R03AR056418 and R01AR060209 (to A.R.J.). S. M. S. is supported by U.S. National Institute of Child Health and Human Development grant T32-HD-043730.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; COSTELLI P, 1993, J CLIN INVEST, V92, P2783, DOI 10.1172/JCI116897; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fareed MU, 2006, AM J PHYSIOL-REG I, V290, pR1589, DOI 10.1152/ajpregu.00668.2005; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fortunati N, 2007, ONCOL REP, V18, P1521; Frost RA, 2007, AM J PHYSIOL-ENDOC M, V292, pE501, DOI 10.1152/ajpendo.00359.2006; HALLANGERAS M, 1990, SURGERY, V108, P460; HARVEY KB, 1979, CANCER, V43, P2065, DOI 10.1002/1097-0142(197905)43:5+<2065::AID-CNCR2820430714>3.0.CO;2-1; Hasselgren PO, 2005, INT J BIOCHEM CELL B, V37, P2156, DOI 10.1016/j.biocel.2005.01.017; HASSELGREN PO, 1989, METABOLISM, V38, P634, DOI 10.1016/0026-0495(89)90100-5; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Krzystek-Korpacka M, 2007, CLIN BIOCHEM, V40, P1353, DOI 10.1016/j.clinbiochem.2007.07.013; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Lipina C, 2010, FEBS LETT, V584, P2403, DOI 10.1016/j.febslet.2010.04.039; Liu CM, 2007, CANCER GENE THER, V14, P945, DOI 10.1038/sj.cgt.7701091; Llovera M, 1996, BIOCHEM BIOPH RES CO, V221, P653, DOI 10.1006/bbrc.1996.0651; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MATTHYS P, 1991, EUR J CANCER, V27, P182, DOI 10.1016/0277-5379(91)90483-T; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Menconi MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE533, DOI 10.1152/ajpendo.00596.2009; Minnaard R, 2005, MUSCLE NERVE, V31, P339, DOI 10.1002/mus.20268; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Murton AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006945; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915; Penner CG, 2001, BIOCHEM BIOPH RES CO, V281, P1331, DOI 10.1006/bbrc.2001.4497; Penner G, 2002, AM J PHYSIOL-REG I, V282, pR439, DOI 10.1152/ajpregu.00512.2001; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; Poylin V, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/317851; Reed SA, 2011, BIOCHEM BIOPH RES CO, V405, P491, DOI 10.1016/j.bbrc.2011.01.059; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Schertzer Jonathan D., 2008, V433, P115, DOI 10.1007/978-1-59745-237-3_7; Schmitt TL, 2007, J MOL MED, V85, P647, DOI 10.1007/s00109-007-0177-2; Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; VAUGHAN GM, 1982, J TRAUMA, V22, P263, DOI 10.1097/00005373-198204000-00001; Vigano A, 2000, ARCH INTERN MED, V160, P861, DOI 10.1001/archinte.160.6.861; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang AYM, 2004, J AM SOC NEPHROL, V15, P3134, DOI 10.1097/01.ASN.0000144206.29951.B2; Welle S, 2011, AM J PHYSIOL-ENDOC M, V300, pE993, DOI 10.1152/ajpendo.00509.2010; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yamazaki Y, 2010, BIOCHEM J, V427, P171, DOI 10.1042/BJ20091346; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	78	140	146	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					987	1000		10.1096/fj.11-189977	http://dx.doi.org/10.1096/fj.11-189977			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22102632	Green Published			2022-12-25	WOS:000300949300004
J	Uluisik, I; Kaya, A; Fomenko, DE; Karakaya, HC; Carlson, BA; Gladyshev, VN; Koc, A				Uluisik, Irem; Kaya, Alaattin; Fomenko, Dmitri E.; Karakaya, Huseyin C.; Carlson, Bradley A.; Gladyshev, Vadim N.; Koc, Ahmet			Boron Stress Activates the General Amino Acid Control Mechanism and Inhibits Protein Synthesis	PLOS ONE			English	Article							TRANSFER-RNA-BINDING; QUORUM-SENSING SIGNAL; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; TRANSLATIONAL REGULATION; OXIDATIVE STRESS; MAMMALIAN-CELLS; DIETARY BORON; YEAST; GCN4	Boron is an essential micronutrient for plants, and it is beneficial for animals. However, at high concentrations boron is toxic to cells although the mechanism of this toxicity is not known. Atr1 has recently been identified as a boron efflux pump whose expression is upregulated in response to boron treatment. Here, we found that the expression of ATR1 is associated with expression of genes involved in amino acid biosynthesis. These mechanisms are strictly controlled by the transcription factor Gcn4 in response to boron treatment. Further analyses have shown that boron impaired protein synthesis by promoting phosphorylation of eIF2 alpha in a Gcn2 kinase dependent manner. The uncharged tRNA binding domain (HisRS) of Gcn2 is necessary for the phosphorylation of eIF2 alpha in the presence of boron. We postulate that boron exerts its toxic effect through activation of the general amino acid control system and inhibition of protein synthesis. Since the general amino acid control pathway is conserved among eukaryotes, this mechanism of boron toxicity may be of general importance.	[Uluisik, Irem; Kaya, Alaattin; Karakaya, Huseyin C.; Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Kaya, Alaattin; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA; [Kaya, Alaattin; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Fomenko, Dmitri E.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Carlson, Bradley A.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Izmir Institute of Technology; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Uluisik, I (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.	ahmetkoc@iyte.edu.tr	Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013; KOÇ, AHMET/ABI-3322-2020	Kaya, Alaattin/0000-0002-6132-5197; KOÇ, AHMET/0000-0003-3484-2137; Karakaya, Huseyin Caglar/0000-0003-2914-7594; Gladyshev, Vadim/0000-0002-0372-7016	TUBITAK [104T213, 110T917]; TUBA-GEBIP	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBA-GEBIP(Turkish Academy of Sciences)	This work was supported by TUBITAK Grant No. 104T213, 110T917 and TUBA-GEBIP grant to (A.Koc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolanos L, 2004, PLANT PHYSIOL BIOCH, V42, P907, DOI 10.1016/j.plaphy.2004.11.002; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Coleman ST, 1997, J BIOL CHEM, V272, P23224, DOI 10.1074/jbc.272.37.23224; Cui Y, 2004, ONCOL REP, V11, P887; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Goldbach HE, 2007, J PLANT NUTR SOIL SC, V170, P39, DOI 10.1002/jpln.200625161; Gonzalez-Fontes A, 2008, PLANT SIGNAL BEHAV, V3, P24, DOI 10.4161/psb.3.1.4812; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; Herzog B, 2011, J MOL BIOL, V405, P909, DOI 10.1016/j.jmb.2010.11.033; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Kaya A, 2009, MOL CELL BIOL, V29, P3665, DOI 10.1128/MCB.01646-08; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Mahabir S, 2008, AM J EPIDEMIOL, V167, P1070, DOI 10.1093/aje/kwn021; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nielsen FH, 1997, PLANT SOIL, V193, P199, DOI 10.1023/A:1004276311956; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Rowe RI, 1998, FASEB J, V12, pA205; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; TAVERNARAKIS N, 1995, MOL GEN GENET, V247, P571, DOI 10.1007/BF00290348; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Uluisik I, 2011, GENOMICS, V97, P106, DOI 10.1016/j.ygeno.2010.10.006; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WARINGTON K, 1923, EFFECT BORIC ACID BO; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106	43	37	39	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27772	10.1371/journal.pone.0027772	http://dx.doi.org/10.1371/journal.pone.0027772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114689	Green Published, gold			2022-12-25	WOS:000297555800033
J	Hengenius, JB; Gribskov, M; Rundell, AE; Fowlkes, CC; Umulis, DM				Hengenius, James B.; Gribskov, Michael; Rundell, Ann E.; Fowlkes, Charless C.; Umulis, David M.			Analysis of Gap Gene Regulation in a 3D Organism-Scale Model of the Drosophila melanogaster Embryo	PLOS ONE			English	Article							LARVAL CUTICLE; ZYGOTIC LOCI; POSITIONAL INFORMATION; PARAMETER-ESTIMATION; MORPHOGEN GRADIENT; PATTERN-FORMATION; BICOID PROTEIN; HUNCHBACK; SEGMENTATION; EXPRESSION	The axial bodyplan of Drosophila melanogaster is determined during a process called morphogenesis. Shortly after fertilization, maternal bicoid mRNA is translated into Bicoid (Bcd). This protein establishes a spatially graded morphogen distribution along the anterior-posterior (AP) axis of the embryo. Bcd initiates AP axis determination by triggering expression of gap genes that subsequently regulate each other's expression to form a precisely controlled spatial distribution of gene products. Reaction-diffusion models of gap gene expression on a 1D domain have previously been used to infer complex genetic regulatory network (GRN) interactions by optimizing model parameters with respect to 1D gap gene expression data. Here we construct a finite element reaction-diffusion model with a realistic 3D geometry fit to full 3D gap gene expression data. Though gap gene products exhibit dorsal-ventral asymmetries, we discover that previously inferred gap GRNs yield qualitatively correct AP distributions on the 3D domain only when DV-symmetric initial conditions are employed. Model patterning loses qualitative agreement with experimental data when we incorporate a realistic DV-asymmetric distribution of Bcd. Further, we find that geometry alone is insufficient to account for DV-asymmetries in the final gap gene distribution. Additional GRN optimization confirms that the 3D model remains sensitive to GRN parameter perturbations. Finally, we find that incorporation of 3D data in simulation and optimization does not constrain the search space or improve optimization results.	[Hengenius, James B.; Gribskov, Michael] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Rundell, Ann E.] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA; [Fowlkes, Charless C.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Umulis, David M.] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Irvine; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hengenius, JB (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	dumulis@purdue.edu	Gribskov, Michael/AAH-5905-2021; Rundell, Ann/P-1822-2014; Umulis, David/AAB-1312-2021	Gribskov, Michael/0000-0002-1718-0242; Fowlkes, Charless/0000-0002-2990-1780; Hengenius, James/0000-0003-0662-5282	National Institutes of Health (NIH) [5T32GM008296-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008296] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (NIH) Biophysics Training Grant (5T32GM008296-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM M, 1987, DEVELOPMENT, V101, P1; Alves F, 2006, J THEOR BIOL, V241, P342, DOI 10.1016/j.jtbi.2005.11.034; ANDERSON KV, 1987, TRENDS GENET, V3, P91, DOI 10.1016/0168-9525(87)90191-0; [Anonymous], COMSOL MULT 3 5A; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Ashyraliyev M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-83; Bieler J, 2011, BIOPHYS J, V101, P287, DOI 10.1016/j.bpj.2011.05.060; BRONNER G, 1991, MECH DEVELOP, P205; CAPOVILLA M, 1992, DEVELOPMENT, V114, P99; CARROLL SB, 1987, DEVELOPMENT, V99, P327; COUNCE SJ, 1961, ANNU REV ENTOMOL, V6, P295, DOI 10.1146/annurev.en.06.010161.001455; Deng JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010275; DRIEVER W, 1989, NATURE, V342, P149, DOI 10.1038/342149a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; ELDON ED, 1991, DEVELOPMENT, V111, P367; Fomekong-Nanfack Y, 2007, BIOINFORMATICS, V23, P3356, DOI 10.1093/bioinformatics/btm433; Fomekong-Nanfack Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-94; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Grimm O, 2010, DEVELOPMENT, V137, P2857, DOI 10.1242/dev.052589; Gursky VV, 2004, PHYSICA D, V197, P286, DOI 10.1016/j.physd.2004.07.003; HARDING K, 1988, EMBO J, V7, P205, DOI 10.1002/j.1460-2075.1988.tb02801.x; HE F, 2010, BIOPHYS J, P697; HULSKAMP M, 1994, GENETICS, V138, P125; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; JAEGER J, 2007, MECH DEVELOP, P108; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Jaeger J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.85; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; Keranen SVE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r124; Kopp A, 1999, DEVELOPMENT, V126, P3495; KRAUT R, 1991, DEVELOPMENT, V111, P611; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; MANU SS, 2009, PLOS BIOL, P591; *MATHW, MATLAB R2009A; Munteanu A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000226; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; PERKINS T, 2006, PLOS COMPUTATIONAL B, P417; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; Sample C, 2010, P NATL ACAD SCI USA, V107, P10092, DOI 10.1073/pnas.1001139107; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STJOHNSTON D, 1992, CELL, V68, P201; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Ulmulis DM, 2010, DEV CELL, V18, P260, DOI 10.1016/j.devcel.2010.01.006; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; Vakulenko S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168102; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; WAGNER A, 2008, P ROYAL SOC B, P91; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158	72	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e26797	10.1371/journal.pone.0026797	http://dx.doi.org/10.1371/journal.pone.0026797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110594	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400014
J	Mondal, HA; Chakraborti, D; Majumder, P; Roy, P; Roy, A; Bhattacharya, SG; Das, S				Mondal, Hossain Ali; Chakraborti, Dipankar; Majumder, Pralay; Roy, Pampa; Roy, Amit; Bhattacharya, Swati Gupta; Das, Sampa			Allergenicity Assessment of Allium sativum Leaf Agglutinin, a Potential Candidate Protein for Developing Sap Sucking Insect Resistant Food Crops	PLOS ONE			English	Article							GALANTHUS-NIVALIS AGGLUTININ; IN-VITRO; LECTIN; BINDING; EXPRESSION; ASAL; DIGESTIBILITY; PREDICTION; RECEPTORS; SEQUENCE	Background: Mannose-binding Allium sativum leaf agglutinin (ASAL) is highly antinutritional and toxic to various phloemfeeding hemipteran insects. ASAL has been expressed in a number of agriculturally important crops to develop resistance against those insects. Awareness of the safety aspect of ASAL is absolutely essential for developing ASAL transgenic plants. Methodology/Principal Findings: Following the guidelines framed by the Food and Agriculture Organization/World Health Organization, the source of the gene, its sequence homology with potent allergens, clinical tests on mammalian systems, and the pepsin resistance and thermostability of the protein were considered to address the issue. No significant homology to the ASAL sequence was detected when compared to known allergenic proteins. The ELISA of blood sera collected from known allergy patients also failed to show significant evidence of cross-reactivity. In vitro and in vivo assays both indicated the digestibility of ASAL in the presence of pepsin in a minimum time period. Conclusions/Significance: With these experiments, we concluded that ASAL does not possess any apparent features of an allergen. This is the first report regarding the monitoring of the allergenicity of any mannose-binding monocot lectin having insecticidal efficacy against hemipteran insects.	[Mondal, Hossain Ali; Chakraborti, Dipankar; Majumder, Pralay; Roy, Pampa; Roy, Amit; Bhattacharya, Swati Gupta; Das, Sampa] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Chakraborti, Dipankar] St Xaviers Coll, Post Grad Dept Biotechnol, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; St. Xavier's College Kolkata	Mondal, HA (corresponding author), Bose Inst, Div Plant Biol, Kolkata, W Bengal, India.	sampa@bic.boseinst.ernet.in	Roy, Amit/X-7485-2019; Roy, Amit/N-4761-2015	Roy, Amit/0000-0003-3237-3525; Roy, Amit/0000-0003-3237-3525; HA, Mondal/0000-0001-5181-0300	Swiss Agency for Development & Cooperation, Government of Switzerland; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Swiss Agency for Development & Cooperation, Government of Switzerland; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by the following: 1. Swiss Agency for Development & Cooperation, Government of Switzerland and the Department of Biotechnology, Government of India under the Indo-Swiss Collaboration in Biotechnology. 2. Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; Chakraborti D, 2008, PLANT CELL REP, V27, P1623, DOI 10.1007/s00299-008-0585-y; Chakraborti D, 2009, TRANSGENIC RES, V18, P529, DOI 10.1007/s11248-009-9242-7; Chakraborty P, 2005, ALLERGY, V60, P920, DOI 10.1111/j.1398-9995.2005.00634.x; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Clement F, 2010, INT IMMUNOPHARMACOL, V10, P1161, DOI 10.1016/j.intimp.2010.06.022; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; Dutta I, 2005, PLANT SCI, V169, P996, DOI 10.1016/j.plantsci.2005.05.016; Dutta I, 2005, PLANT BIOTECHNOL J, V3, P601, DOI 10.1111/j.1467-7652.2005.00151.x; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; FAO/WHO, 2001, EV ALL GEN MOD FOODS; Fiers MWEJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-133; Fitches E, 2001, J INSECT PHYSIOL, V47, P777, DOI 10.1016/S0022-1910(01)00068-3; Foissac X, 2000, J INSECT PHYSIOL, V46, P573, DOI 10.1016/S0022-1910(99)00143-2; FU TJ, 2000, J AGR FOOD CHEM, V50, P7154; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Fuchs RL, 1996, FOOD TECHNOL-CHICAGO, V50, P83; Gatehouse A, 1995, LECTINS BIOMEDICAL P, P29; GATEHOUSE AMR, 1993, PHILOS T R SOC B, V342, P279, DOI 10.1098/rstb.1993.0158; Haas H, 1999, EUR J IMMUNOL, V29, P918, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;918::AID-IMMU918&gt;3.0.CO;2-T; Hansen KS, 2003, ALLERGY, V58, P132, DOI 10.1034/j.1398-9995.2003.23959.x; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861; Huby RDJ, 2000, TOXICOL SCI, V55, P235, DOI 10.1093/toxsci/55.2.235; Kanrar S, 2002, PLANT CELL REP, V20, P976, DOI 10.1007/s00299-001-0422-z; Kordas K, 2000, J PHYSIOL-PARIS, V94, P31, DOI 10.1016/S0928-4257(99)00106-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Majumder P, 2004, GLYCOCONJUGATE J, V20, P525, DOI 10.1023/B:GLYC.0000043288.72051.7c; Majumder P, 2005, J AGR FOOD CHEM, V53, P6725, DOI 10.1021/jf051155z; Maynard F, 1997, INT ARCH ALLERGY IMM, V113, P478, DOI 10.1159/000237625; Metcalfe DD, 1996, CRIT REV FOOD SCI, V36, pS165, DOI 10.1080/10408399609527763; Momma K, 1999, BIOSCI BIOTECH BIOCH, V63, P314, DOI 10.1271/bbb.63.314; Noteborn HPJM, 1995, ACS SYM SER, V605, P134; Park JJ, 2007, NEUROSCI LETT, V411, P87, DOI 10.1016/j.neulet.2006.10.046; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Perez-Pimiento AJ, 1999, ALLERGY, V54, P626, DOI 10.1034/j.1398-9995.1999.00806.x; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Pusztai A, 1996, J NUTR BIOCHEM, V7, P677, DOI 10.1016/S0955-2863(96)00131-3; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Rouge P, 2010, MOL IMMUNOL, V47, P2359, DOI 10.1016/j.molimm.2010.05.006; Roy A, 2008, J PLANT INTERACT, V3, P157, DOI 10.1080/17429140701754195; Saha P, 2007, PLANTA, V226, P429, DOI 10.1007/s00425-007-0493-3; Stadler MB, 2003, FASEB J, V17, P1141, DOI 10.1096/fj.02-1052fje; TAYLOR SL, 1987, ANN ALLERGY, V59, P93	47	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27716	10.1371/journal.pone.0027716	http://dx.doi.org/10.1371/journal.pone.0027716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110739	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400096
J	Holliday, IE; Longe, OA; Thai, NJ; Hancock, PJB; Tovee, MJ				Holliday, Ian E.; Longe, Olivia A.; Thai, N. Jade; Hancock, Peter J. B.; Tovee, Martin J.			BMI Not WHR Modulates BOLD fMRI Responses in a Sub-Cortical Reward Network When Participants Judge the Attractiveness of Human Female Bodies	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST-HIP RATIO; PHYSICAL ATTRACTIVENESS; FUNCTIONAL MRI; FACIAL ATTRACTIVENESS; UNIPOLAR DEPRESSION; EATING-DISORDERS; HUMAN BRAIN; PREFERENCES; SHAPE	In perceptual terms, the human body is a complex 3d shape which has to be interpreted by the observer to judge its attractiveness. Both body mass and shape have been suggested as strong predictors of female attractiveness. Normally body mass and shape co-vary, and it is difficult to differentiate their separate effects. A recent study suggested that altering body mass does not modulate activity in the reward mechanisms of the brain, but shape does. However, using computer generated female body-shaped greyscale images, based on a Principal Component Analysis of female bodies, we were able to construct images which covary with real female body mass (indexed with BMI) and not with body shape (indexed with WHR), and vice versa. Twelve observers (6 male and 6 female) rated these images for attractiveness during an fMRI study. The attractiveness ratings were correlated with changes in BMI and not WHR. Our primary fMRI results demonstrated that in addition to activation in higher visual areas (such as the extrastriate body area), changing BMI also modulated activity in the caudate nucleus, and other parts of the brain reward system. This shows that BMI, not WHR, modulates reward mechanisms in the brain and we infer that this may have important implications for judgements of ideal body size in eating disordered individuals.	[Holliday, Ian E.; Longe, Olivia A.; Thai, N. Jade] Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England; [Hancock, Peter J. B.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Tovee, Martin J.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Aston University; University of Stirling; Newcastle University - UK	Holliday, IE (corresponding author), Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England.	m.j.tovee@ncl.ac.uk	Hancock, Peter J.B./A-4633-2009	Hancock, Peter J.B./0000-0001-6025-7068; Tovee, Martin/0000-0001-9642-4462; Thai, Ngoc Jade/0000-0001-6125-7326	Wellcome Trust; Lord Dowding Fund	Wellcome Trust(Wellcome TrustEuropean Commission); Lord Dowding Fund	This work was supported by The Wellcome Trust (http://www.wellcome.ac.uk/) and The Lord Dowding Fund (http://www.ldf.org.uk/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; BAXTER LR, 1985, ARCH GEN PSYCHIAT, V42, P441; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; BUSS DM, SOCIOBIOLOGY PSYCHOL, P335; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; Cornelissen PL, 2009, J THEOR BIOL, V256, P343, DOI 10.1016/j.jtbi.2008.09.041; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Fan JT, 2007, PERCEPT MOTOR SKILL, V105, P117, DOI 10.2466/PMS.105.1.117-132; Fan JT, 2004, P ROY SOC B-BIOL SCI, V271, P347, DOI 10.1098/rspb.2003.2613; FRISCH RE, 1988, SCI AM, V258, P88, DOI 10.1038/scientificamerican0388-88; George H. R., 2008, J EVOLUTIONARY PSYCH, V6, P207, DOI DOI 10.1556/JEP.6.2008.3.4; GEORGE HR, 2011, BRIT J PSYCHOL, DOI DOI 10.1348/000712610X524291; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Lake JK, 1997, INT J OBESITY, V21, P432, DOI 10.1038/sj.ijo.0800424; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Pawlowski B, 2008, EVOL HUM BEHAV, V29, P19, DOI 10.1016/j.evolhumbehav.2007.07.003; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Penton-Voak IS, 2003, J COMP PSYCHOL, V117, P264, DOI 10.1037/0735-7036.117.3.264; Platek SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009042; Polivy J, 2002, ANNU REV PSYCHOL, V53, P187, DOI 10.1146/annurev.psych.53.100901.135103; Puhl R.M., 2001, PSYCHOL EVOLUTION GE, V3, P27, DOI [DOI 10.1080/14616660110049573, https://doi.org/10.1080/14616660110049573]; REID RL, 1987, FERTIL STERIL, V48, P905; Rilling JK, 2009, EVOL HUM BEHAV, V30, P21, DOI 10.1016/j.evolhumbehav.2008.08.007; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Smith FG, 2009, PERS INDIV DIFFER, V47, P476, DOI 10.1016/j.paid.2009.04.022; Smith KL, 2007, VIS COGN, V15, P927, DOI 10.1080/13506280601029515; Smith KL, 2007, EVOL HUM BEHAV, V28, P48, DOI 10.1016/j.evolhumbehav.2006.05.007; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Streeter SA, 2003, EVOL HUM BEHAV, V24, P88, DOI 10.1016/S1090-5138(02)00121-6; Swami V, 2006, EUR J PERSONALITY, V20, P69, DOI 10.1002/per.568; Swami V, 2007, BODY IMAGE, V4, P219, DOI 10.1016/j.bodyim.2007.01.002; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 2012, EVOL HUM BEHAV, V33, P85, DOI 10.1016/j.evolhumbehav.2011.05.008; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1999, NATURE, V399, P215, DOI 10.1038/20345; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Tovee MJ, 2000, P ROY SOC B-BIOL SCI, V267, P1987, DOI 10.1098/rspb.2000.1240; Tovee MJ, 2003, BRIT J PSYCHOL, V94, P501, DOI 10.1348/000712603322503060; Tovee MJ, 2002, P ROY SOC B-BIOL SCI, V269, P2205, DOI 10.1098/rspb.2002.2133; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; *UK DEP HLTH, 2008, HLTH SURV ENGL 2008; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Wang JX, 2000, BRIT MED J, V321, P1320, DOI 10.1136/bmj.321.7272.1320; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; World Medical Association, 2008, WMA DECL HELS ETH PR	64	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27255	10.1371/journal.pone.0027255	http://dx.doi.org/10.1371/journal.pone.0027255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102883	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000297555300013
J	Incoronato, M; Urso, L; Portela, A; Laukkanen, MO; Soini, Y; Quintavalle, C; Keller, S; Esteller, M; Condorelli, G				Incoronato, Mariarosaria; Urso, Loredana; Portela, Ana; Laukkanen, Mikko O.; Soini, Ylermi; Quintavalle, Cristina; Keller, Simona; Esteller, Manel; Condorelli, Gerolama			Epigenetic Regulation of miR-212 Expression in Lung Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; TRAIL RESISTANCE; DNA METHYLATION; TRICHOSTATIN-A; INHIBITOR; APOPTOSIS; GROWTH	Many studies have shown that microRNA expression in cancer may be regulated by epigenetic events. Recently, we found that in lung cancer miR-212 was strongly down-regulated. However, mechanisms involved in the regulation of miR-212 expression are unknown. Therefore, we addressed this point by investigating the molecular mechanisms of miR-212 silencing in lung cancer. We identified histone modifications rather than DNA hypermethylation as epigenetic events that regulate miR-212 levels in NSCLC. Moreover, we found that miR-212 silencing in vivo is closely associated with the severity of the disease.	[Incoronato, Mariarosaria; Urso, Loredana; Laukkanen, Mikko O.] Fdn IRCCS SDN, Naples, Italy; [Portela, Ana; Esteller, Manel] Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona 08908, Catalonia, Spain; [Soini, Ylermi] Univ Eastern Finland, Canc Ctr Eastern Finland, Sch Med, Dept Pathol & Forens Med,Inst Clin Med Pathol & F, Kuopio, Finland; [Quintavalle, Cristina; Keller, Simona; Condorelli, Gerolama] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Keller, Simona] CEINGE Biotecnol Avanzate, Naples Oncogen Ctr, Naples, Italy; [Condorelli, Gerolama] CNR, IEOS, I-80125 Naples, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Fac Sci Biotecnol, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Eastern Finland; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Incoronato, M (corresponding author), Fdn IRCCS SDN, Naples, Italy.	gecondor@unina.it	Quintavalle, Cristina/AHH-9379-2022; Condorelli, Gerolama/AAC-3472-2022; Urso, Loredana/J-9438-2018; Esteller, Manel/L-5956-2014; Incoronato, Mariarosaria/K-8727-2016; Urso, Loredana/AAG-1187-2021; Incoronato, Mariarosaria/AAA-7541-2021; Laukkanen, Mikko/K-5868-2016	Condorelli, Gerolama/0000-0003-0177-8829; Urso, Loredana/0000-0001-9805-7686; Esteller, Manel/0000-0003-4490-6093; Incoronato, Mariarosaria/0000-0001-7019-0581; Urso, Loredana/0000-0001-9805-7686; Incoronato, Mariarosaria/0000-0001-7019-0581; Portela, Anna/0000-0003-2184-2584; Laukkanen, Mikko/0000-0002-1004-7131	Fondazione IRCCS SDN; Associazione Italiana Ricerca sul cancro (AIRC) [10620]; MERIT [RBNE08E8CZ_002]	Fondazione IRCCS SDN; Associazione Italiana Ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); MERIT	This work was partially supported by funds from: Fondazione IRCCS SDN www.sdn-napoli.it, 5x1000 to Istituto di Ricerca Diagnostica e Nucleare Fondazione IRCCS SDN, Associazione Italiana Ricerca sul cancro (AIRC) (grant n.ro 10620)www.airc.it and MERIT (RBNE08E8CZ_002)www.miur.it to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Esteller M, 2005, CURR OPIN ONCOL, V17, P55, DOI 10.1097/01.cco.0000147383.04709.10; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005; Hatakeyama H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012702; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li XQ, 2010, BRIT J HAEMATOL, V148, P69, DOI 10.1111/j.1365-2141.2009.07920.x; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; MELO SA, 2010, FEBS LETT; Navarro A, 2011, J SURG ONCOL, V103, P411, DOI 10.1002/jso.21847; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Park JK, 2011, BIOCHEM BIOPH RES CO, V406, P518, DOI 10.1016/j.bbrc.2011.02.065; Platta CS, 2007, J SURG RES, V142, P219, DOI 10.1016/j.jss.2006.12.555; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Woo HJ, 2007, EXP MOL PATHOL, V82, P77, DOI 10.1016/j.yexmp.2006.02.004; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zanca C, 2008, J CELL MOL MED, V12, P2416, DOI 10.1111/j.1582-4934.2008.00283.x; Zhang ZP, 2010, INT J BIOCHEM CELL B, V42, P367, DOI 10.1016/j.biocel.2009.11.023	38	60	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27722	10.1371/journal.pone.0027722	http://dx.doi.org/10.1371/journal.pone.0027722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110741	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300048
J	Steidl, S; Miller, AD; Blaha, CD; Yeomans, JS				Steidl, Stephan; Miller, Anthony D.; Blaha, Charles D.; Yeomans, John S.			M-5 Muscarinic Receptors Mediate Striatal Dopamine Activation by Ventral Tegmental Morphine and Pedunculopontine Stimulation in Mice	PLOS ONE			English	Article							NUCLEUS-LESIONED RATS; SUBSTANTIA-NIGRA; CHOLINERGIC STIMULATION; GLUTAMATE RECEPTORS; EXCITOTOXIC LESIONS; D-AMPHETAMINE; NEURONS; AREA; EFFLUX; ACETYLCHOLINE	Opiates, like other addictive drugs, elevate forebrain dopamine levels and are thought to do so mainly by inhibiting GABA neurons near the ventral tegmental area (VTA), in turn leading to a disinhibition of dopamine neurons. However, cholinergic inputs from the laterodorsal (LDT) and pedunculopontine (PPT) tegmental nucleus to the VTA and substantia nigra (SN) importantly contribute, as either LDT or PPT lesions strongly attenuate morphine-induced forebrain dopamine elevations. Pharmacological blockade of muscarinic acetylcholine receptors in the VTA or SN has similar effects. M-5 muscarinic receptors are the only muscarinic receptor subtype associated with VTA and SN dopamine neurons. Here we tested the contribution of M-5 muscarinic receptors to morphine-induced dopamine elevations by measuring nucleus accumbens dopamine efflux in response to intra-VTA morphine infusion using in vivo chronoamperometry. Intra-VTA morphine increased nucleus accumbens dopamine efflux in urethane-anesthetized wildtype mice starting at 10 min after infusion. These increases were absent in M-5 knockout mice and were similarly blocked by pre-treatment with VTA scopolamine in wildtype mice. Furthermore, in wildtype mice electrical stimulation of the PPT evoked an initial, short-lasting increase in striatal dopamine efflux, followed 5 min later by a second prolonged increase in dopamine efflux. In M-5 knockout mice, or following systemic pre-treatment with scopolamine in wildtype mice, the prolonged increase in striatal dopamine efflux was absent. The time course of increased accumbal dopamine efflux in wildtype mice following VTA morphine was consistent with both the prolonged M-5-mediated excitation of striatal dopamine efflux following PPT electrical stimulation and accumbal dopamine efflux following LDT electrical stimulation. Therefore, M-5 receptors appear critical for prolonged PPT excitation of dopamine efflux and for dopamine efflux induced by intra-VTA morphine.	[Steidl, Stephan; Yeomans, John S.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Miller, Anthony D.; Blaha, Charles D.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Steidl, Stephan; Yeomans, John S.] Univ Toronto, Ctr Biol Timing & Cognit, Toronto, ON, Canada	University of Toronto; University of Memphis; University of Toronto	Steidl, S (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Res Branch, NIH, Baltimore, MD USA.	ssteidl@nida.nih.gov		Blaha, Charles/0000-0001-5155-1505	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Canadian Institutes of Health Research (CIHR) grant to JSY and a Natural Sciences and Engineering Research Council of Canada Graduate Scholar doctoral scholarship (NSERC CGS-D) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile AS, 2002, P NATL ACAD SCI USA, V99, P11452, DOI 10.1073/pnas.162371899; BECHARA A, 1992, BEHAV NEUROSCI, V106, P798, DOI 10.1037/0735-7044.106.5.798; Blaha CD, 1996, BEHAV PHARMACOL, V7, P675; BLAHA CD, 1991, J ELECTROANAL CHEM, V310, P317, DOI 10.1016/0022-0728(91)85270-Y; Blaha CD, 1996, J NEUROSCI, V16, P714; BLAHA CD, 1993, J NEUROSCI, V13, P1035; DAVID V, 1994, BEHAV BRAIN RES, V65, P205, DOI 10.1016/0166-4328(94)90106-6; FERRARIDILEO G, 1994, MOL PHARMACOL, V46, P1028; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; Forster GL, 2002, NEUROSCIENCE, V114, P817, DOI 10.1016/S0306-4522(02)00365-2; Forster GL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0001.2002; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kohlmeier KA, 2010, NEUROSCIENCE, V171, P812, DOI 10.1016/j.neuroscience.2010.09.034; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Lecca S, 2011, NEUROPSYCHOPHARMACOL, V36, P589, DOI 10.1038/npp.2010.190; LEONE P, 1991, PHARMACOL BIOCHEM BE, V39, P469, DOI 10.1016/0091-3057(91)90210-S; MATTHEWS RT, 1984, NEUROSCIENCE, V11, P617, DOI 10.1016/0306-4522(84)90048-4; Miller AD, 2005, NEUROSCIENCE, V136, P531, DOI 10.1016/j.neuroscience.2005.08.035; Miller AD, 2002, NEUROSCIENCE, V111, P351, DOI 10.1016/S0306-4522(01)00595-4; MILLER AD, 2005, MIDBRAIN MUSCARINIC; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Olmstead MC, 1998, J NEUROSCI, V18, P5035; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Rezayof A, 2007, EUR J PHARMACOL, V562, P92, DOI 10.1016/j.ejphar.2007.01.081; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; STEIDL S, 2008, J PHARMACOL EXP THER, V328, P1; STERIADE M, 1990, J NEUROSCI, V10, P2541; Takakusaki K, 1997, NEUROSCIENCE, V79, P1089, DOI 10.1016/S0306-4522(97)00019-5; Takeuchi J, 2002, PHARMACOL BIOCHEM BE, V72, P117, DOI 10.1016/S0091-3057(01)00725-0; VILARO MT, 1990, NEUROSCI LETT, V114, P154, DOI 10.1016/0304-3940(90)90064-G; WEINER DM, 1990, P NATL ACAD SCI USA, V87, P7050, DOI 10.1073/pnas.87.18.7050; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Yeomans J, 2001, LIFE SCI, V68, P2449, DOI 10.1016/S0024-3205(01)01038-4; YEOMANS JS, 1988, BRAIN RES, V450, P86, DOI 10.1016/0006-8993(88)91547-8	38	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27538	10.1371/journal.pone.0027538	http://dx.doi.org/10.1371/journal.pone.0027538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102904	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555300027
J	Hendrikx, LH; Ozturk, K; de Rond, LGH; de Greeff, SC; Sanders, EAM; Berbers, GAM; Buisman, AM				Hendrikx, Lotte H.; Ozturk, Kemal; de Rond, Lia G. H.; de Greeff, Sabine C.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.; Buisman, Anne-Marie			Serum IgA Responses against Pertussis Proteins in Infected and Dutch wP or aP Vaccinated Children: An Additional Role in Pertussis Diagnostics	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; IMMUNOGLOBULIN-A; FILAMENTOUS HEMAGGLUTININ; DISEASE BURDEN; IMMUNITY; PROTECTION; ANTIBODIES; IMMUNIZATION; IMMUNOGENICITY; HOUSEHOLD	Background: Whooping cough is a respiratory disease caused by Bordetella pertussis, which induces mucosal IgA antibodies that appear to be relevant in protection. Serum IgA responses are measured after pertussis infection and might provide an additional role in pertussis diagnostics. However, the possible interfering role for pertussis vaccinations in the induction of serum IgA antibodies is largely unknown. Methods/Principal Findings: We compared serum IgA responses in healthy vaccinated children between 1 and 10 years of age with those in children who despite vaccinations recently were infected with Bordetella pertussis. All children have been vaccinated at 2, 3, 4 and 11 months of age with either the Dutch whole-cell pertussis (wP) vaccine or an acellular pertussis (aP) vaccine and additionally received an aP booster vaccination at 4 years of age. Serum IgA responses to pertussis toxin (PT), filamentous heamagglutinin (FHA) and pertactin (Prn) were measured with a fluorescent multiplex bead-based immuno-assay. An ELISPOT-assay was used for the detection of IgA-memory B-cells specific to these antigens. Serum IgA levels to all pertussis vaccine antigens were significantly higher in infected children compared with healthy children. High correlations between anti-PT, anti-FHA or anti-Prn IgA and IgG levels were found in infected children and to some degree in wP primed children, but not at all in aP primed children. Highest numbers of IgA-pertussis-specific memory B-cells were observed after infection and generally comparable numbers were found after wP and aP vaccination. Conclusions: This study provides new insight in the diagnostic role for serum IgA responses against PT in vaccinated children. Since aP vaccines induce high serum IgG levels that interfere with pertussis diagnostics, serum IgA-PT levels will provide an additional diagnostic role. High levels of serum IgA for PT proved specific for recent pertussis infection with reasonable sensitivity, whereas the role for IgA levels against FHA and Prn in diagnosing pertussis remains controversial.	[Hendrikx, Lotte H.; Ozturk, Kemal; de Rond, Lia G. H.; de Greeff, Sabine C.; Berbers, Guy A. M.; Buisman, Anne-Marie] Natl Inst Publ Hlth & Environm, Ctr Infect Dis & Control CIb, NL-3720 BA Bilthoven, Netherlands; [Hendrikx, Lotte H.] Spaarne Hosp Hoofddorp, Res Ctr Linnaeus Inst, Hoofddorp, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Spaarne Hospital; Utrecht University; Utrecht University Medical Center	Hendrikx, LH (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis & Control CIb, NL-3720 BA Bilthoven, Netherlands.	Lotte.Hendrikx@rivm.nl			Dutch government	Dutch government	This study is funded by the Dutch government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonhoeffer J, 2005, INFECTION, V33, P13, DOI 10.1007/s15010-005-4004-9; BRANDTZAEG P, 1995, AM J RESP CRIT CARE, V151, P2081, DOI 10.1164/ajrccm.151.6.7767561; Brandtzaeg P, 2007, ANN NY ACAD SCI, V1098, P288, DOI 10.1196/annals.1384.012; Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102; Buisman AM, 2008, J INFECT DIS, V197, P698, DOI 10.1086/527487; CHERRY JD, 1995, CLIN INFECT DIS, V20, P1271, DOI 10.1093/clinids/20.5.1271; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; DEEN JL, 1995, CLIN INFECT DIS, V21, P1211, DOI 10.1093/clinids/21.5.1211; Feunou PF, 2010, VACCINE, V28, P7047, DOI 10.1016/j.vaccine.2010.08.017; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Gonzalez R, 2005, J MED VIROL, V76, P608, DOI 10.1002/jmv.20404; GUISO N, 2010, EUR J CLIN MICROBIOL; Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7; Heininger U, 2004, CLIN INFECT DIS, V38, P591, DOI 10.1086/381439; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Hendrikx LH, 2011, VACCINE, V29, P1431, DOI 10.1016/j.vaccine.2010.12.033; Hendrikx LH, 2009, VACCINE, V27, P6530, DOI 10.1016/j.vaccine.2009.08.052; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; ISACSON J, 1995, PEDIATR INFECT DIS J, V14, P517, DOI 10.1097/00006454-199506000-00009; Knuf M, 2006, VACCINE, V24, P2043, DOI 10.1016/j.vaccine.2005.11.024; Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035; Littmann M, 2008, VACCINE, V26, P2344, DOI 10.1016/j.vaccine.2008.02.065; NAGEL J, 1983, J MED MICROBIOL, V16, P417, DOI 10.1099/00222615-16-4-417; NOVOTNY P, 1991, DEV BIOLOGICALS, V73, P267; Parton R, 1999, BIOLOGICALS, V27, P71, DOI 10.1006/biol.1999.0182; Poynten IM, 2002, EPIDEMIOL INFECT, V128, P161, DOI 10.1017/S0950268801006598; THOMAS MG, 1989, J INFECT DIS, V160, P838, DOI 10.1093/infdis/160.5.838; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; von Linstow ML, 2010, EUR J PEDIATR, V169, P1119, DOI 10.1007/s00431-010-1192-9; Wolfe DN, 2007, INFECT IMMUN, V75, P4416, DOI 10.1128/IAI.00412-07; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; ZACKRISSON G, 1990, J CLIN MICROBIOL, V28, P1502, DOI 10.1128/JCM.28.7.1502-1505.1990	35	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27681	10.1371/journal.pone.0027681	http://dx.doi.org/10.1371/journal.pone.0027681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110718	gold, Green Submitted, Green Published			2022-12-25	WOS:000297554300047
J	Sumie, S; Kawaguchi, T; Kuromatsu, R; Takata, A; Nakano, M; Satani, M; Yamada, S; Niizeki, T; Torimura, T; Sata, M				Sumie, Shuji; Kawaguchi, Takumi; Kuromatsu, Ryoko; Takata, Akio; Nakano, Masahito; Satani, Manabu; Yamada, Shingo; Niizeki, Takashi; Torimura, Takuji; Sata, Michio			Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; CIRCULATING ADIPONECTIN; SERUM ADIPONECTIN; PLASMA ADIPONECTIN; COLORECTAL-CANCER; LIVER-CIRRHOSIS; RISK-FACTORS; OBESITY	Background: Adiponectin is shown to be inversely associated with development and progression of various cancers. We evaluated whether adiponectin level was associated with the prevalence and histological grade of hepatocellular carcinoma (HCC), and liver fibrosis in patients with hepatitis C virus (HCV) infection. Methods: A case-control study was conducted on 97 HCC patients (cases) and 97 patients (controls) matched for sex, Child-Pugh grade and platelet count in patients with HCV infection. The serum total and high molecular weight (HMW) adiponectin levels were measured by enzyme-linked immunosorbent assays and examined in their association with the prevalence of HCC. In addition, the relationship between these adiponectin levels and body mass index (BMI), progression of liver fibrosis, and histological grade of HCC was also evaluated. Liver fibrosis was assessed using the aspartate aminotransferase to platelet ratio index (APRI). Results: There were no significant differences in the serum total and HMW adiponectin levels between cases and controls. Moreover, there were no inverse associations between serum total and HMW adiponectin levels and BMI in both cases and controls. On the other hand, serum total and HMW adiponectin levels are positively correlated with APRI in both cases (r = 0.491, P<0.001 and r = 0.485, P<0.001, respectively) and controls (r = 0.482, P<0.001 and r = 0.476, P<0.001, respectively). Interestingly, lower serum total (OR 11.76, 95% CI: 2.97-46.66 [P<0.001]) and HMW (OR 10.24, CI: 2.80-37.40 [P<0.001] adiponectin levels were independent risk factors of worse histological grade of HCC. Conclusions: Our results suggested that serum total and HMW adiponectin levels were predictors of liver fibrosis, but not prevalence of HCC in patients with HCV infection. Moreover, low these adiponectin levels were significantly associated with worse histological grades.	[Sumie, Shuji; Kawaguchi, Takumi; Kuromatsu, Ryoko; Takata, Akio; Nakano, Masahito; Satani, Manabu; Yamada, Shingo; Niizeki, Takashi; Sata, Michio] Kurume Univ, Sch Med, Div Gastroenterol, Dept Med, Kurume, Fukuoka 830, Japan; [Kawaguchi, Takumi; Sata, Michio] Kurume Univ, Sch Med, Dept Digest Dis Informat & Res, Kurume, Fukuoka 830, Japan; [Torimura, Takuji] Kurume Univ, Liver Canc Res Div, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Sumie, S (corresponding author), Kurume Univ, Sch Med, Div Gastroenterol, Dept Med, Kurume, Fukuoka 830, Japan.	sumie_shyuuji@kurume-u.ac.jp		Nakano, Masahito/0000-0002-3375-180X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790874]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22790874). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Barresi V, 2009, PATHOLOGY, V41, P533, DOI 10.1080/00313020903071553; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Dal Maso L, 2004, J CLIN ENDOCR METAB, V89, P1160, DOI 10.1210/jc.2003-031716; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; HIMENO H, 1994, J PATHOL, V174, P217, DOI 10.1002/path.1711740311; Hui CK, 2007, J HEPATOL, V47, P191, DOI 10.1016/j.jhep.2007.02.023; Ishikawa M, 2005, CLIN CANCER RES, V11, P466; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Jonsson JR, 2008, HEPATOLOGY, V48, P80, DOI 10.1002/hep.22311; Kaser S, 2005, J INTERN MED, V258, P274, DOI 10.1111/j.1365-2796.2005.01543.x; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kojiro M, 2005, BEST PRACT RES CL GA, V19, P39, DOI 10.1016/j.bpg.2004.10.007; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu CJ, 2005, J HEPATOL, V43, P235, DOI 10.1016/j.jhep.2005.02.044; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Miyazaki T, 2005, BIOCHEM BIOPH RES CO, V333, P79, DOI 10.1016/j.bbrc.2005.05.076; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Monto A, 2002, HEPATOLOGY, V36, P729, DOI 10.1053/jhep.2002.35064; NAKASHIMA O, 1995, HEPATOLOGY, V22, P101, DOI 10.1002/hep.1840220116; Nkontchou G, 2010, J HEPATOL, V53, P827, DOI 10.1016/j.jhep.2010.04.035; Ohki T, 2008, CLIN GASTROENTEROL H, V6, P459, DOI 10.1016/j.cgh.2008.02.012; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; SAXENA NK, 2010, GASTROENTEROLOGY; Seker M, 2010, MED ONCOL, V27, P1319, DOI 10.1007/s12032-009-9382-x; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wayne JD, 2002, ANN SURG, V235, P722, DOI 10.1097/00000658-200205000-00015; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Zografos TA, 2008, AM J GASTROENTEROL, V103, P605, DOI 10.1111/j.1572-0241.2007.01729.x	41	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e26840	10.1371/journal.pone.0026840	http://dx.doi.org/10.1371/journal.pone.0026840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110596	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300008
J	Kang, SM; Yoon, JW; Ahn, HY; Kim, SY; Lee, KH; Shin, H; Choi, SH; Park, KS; Jang, HC; Lim, S				Kang, Seon Mee; Yoon, Ji Won; Ahn, Hwa Young; Kim, So Yeon; Lee, Kyoung Ho; Shin, Hayley; Choi, Sung Hee; Park, Kyong Soo; Jang, Hak Chul; Lim, Soo			Android Fat Depot Is More Closely Associated with Metabolic Syndrome than Abdominal Visceral Fat in Elderly People	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; X-RAY ABSORPTIOMETRY; BODY-MASS INDEX; ADIPOSE-TISSUE; INSULIN-RESISTANCE; RISK; COMPARTMENTS; MORTALITY; OBESITY; WOMEN	Background: Fat accumulation in android compartments may confer increased metabolic risk. The incremental utility of measuring regional fat deposition in association with metabolic syndrome (MS) has not been well described particularly in an elderly population. Methods and Findings: As part of the Korean Longitudinal Study on Health and Aging, which is a community-based cohort study of people aged more than 65 years, subjects (287 male, 75.9 +/- 8.6 years and 278 female, 76.0 +/- 8.8 years) with regional body composition data using Dual energy X-ray absorptiometry for android/gynoid area, computed tomography for visceral/subcutaneous adipose tissue (VAT/SAT), and cardiometabolic markers including adiponectin and high-sensitivity CRP were enrolled. We investigated the relationship between regional body composition and MS in multivariate regression models. Mean VAT and SAT area was 131.4 +/- 65.5 cm(2) and 126.9 +/- 55.2 cm(2) in men (P = 0.045) and 120.0 +/- 46.7 cm(2) and 211.8 +/- 65.9 cm(2) in women (P<0.01). Mean android and gynoid fat amount was 1.8 +/- 0.8 kg and 2.5 +/- 0.8 kg in men and 2.0 +/- 0.6 kg and 3.3 +/- 0.8 kg in women, respectively (both P<0.01). VAT area and android fat amount was strongly correlated with most metabolic risk factors compared to SAT or gynoid fat. Furthermore, android fat amount was significantly associated with clustering of MS components after adjustment for multiple parameters including age, gender, adiponectin, hsCRP, a surrogate marker of insulin resistance, whole body fat mass and VAT area. Conclusions: Our findings are consistent with the hypothesized role of android fat as a pathogenic fat depot in the MS. Measurement of android fat may provide a more complete understanding of metabolic risk associated with variations in fat distribution.	[Kang, Seon Mee; Yoon, Ji Won; Ahn, Hwa Young; Choi, Sung Hee; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Dept Internal Med, Coll Med, Songnam, South Korea; [Kang, Seon Mee; Yoon, Ji Won; Ahn, Hwa Young; Kim, So Yeon; Lee, Kyoung Ho; Choi, Sung Hee; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Kim, So Yeon; Lee, Kyoung Ho] Seoul Natl Univ, Dept Radiol, Coll Med, Songnam, South Korea; [Shin, Hayley] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Seoul National University (SNU)	Kang, SM (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Songnam, South Korea.	limsoo@snu.ac.kr	Jang, Hak Chul/D-9637-2012; Choi, Sung-hee/J-5689-2012; Park, Kyong Soo/C-2265-2008; Lim, Soo/AAU-8107-2020; Lee, Kyoung Ho/J-5570-2012; KIM, SEONG YEON/E-4164-2012	Jang, Hak Chul/0000-0002-4188-6536; Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; CHOI, SUNG HEE/0000-0003-0740-8116; Lee, Kyoung Ho/0000-0001-6045-765X	Ministry of Science and Technology [2006-2005410]; Seoul R&BD Program, Republic of Korea [10526]; Seoul National University Bundang Hospital; Korean Diabetes Association	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Seoul R&BD Program, Republic of Korea(Seoul RBD program); Seoul National University Bundang Hospital; Korean Diabetes Association	This work was supported by the Ministry of Science and Technology (2006-2005410), Seoul R&BD Program, Republic of Korea (10526), Seoul National University Bundang Hospital to S. Lim, and Korean Diabetes Association grant (2006) to S.H. Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aucouturier J, 2009, ARCH PEDIAT ADOL MED, V163, P826, DOI 10.1001/archpediatrics.2009.148; Austen W G, 1975, Circulation, V51, P5; Berends AL, 2009, BJOG-INT J OBSTET GY, V116, P442, DOI 10.1111/j.1471-0528.2008.02044.x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres Jean-Pierre, 2007, Crit Pathw Cardiol, V6, P51, DOI 10.1097/HPC.0b013e318057d4c9; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2011, J AM COLL CARDIOL, V57, P1887, DOI 10.1016/j.jacc.2010.10.063; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kim SK, 2010, INT J OBESITY, V34, P105, DOI 10.1038/ijo.2009.210; LIM S, 2009, OBESITY SILVER SPRIN, V18, P826, DOI DOI 10.1038/OBY.2009.232; Lim S, 2009, OBESITY, V17, P188, DOI 10.1038/oby.2008.486; Lim S, 2011, OBESITY, V19, P631, DOI 10.1038/oby.2010.167; Lim S, 2009, ATHEROSCLEROSIS, V205, P156, DOI 10.1016/j.atherosclerosis.2008.10.041; Lohman M, 2009, METABOLISM, V58, P1663, DOI 10.1016/j.metabol.2009.05.023; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Niederauer CM, 2006, J NUTR HEALTH AGING, V10, P154; Oka R, 2010, OBESITY, V18, P153, DOI 10.1038/oby.2009.180; Oliveira A, 2010, INT J OBESITY, V34, P733, DOI 10.1038/ijo.2009.281; Park YW, 2002, INT J OBESITY, V26, P978, DOI 10.1038/sj.ijo.0801982; Pi-Sunyer FX, 2004, NUTR REV, V62, pS120, DOI 10.1111/j.1753-4887.2004.tb00081.x; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rhee EJ, 2011, DIABETES METAB J, V35, P138, DOI 10.4093/dmj.2011.35.2.138; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; TREUTH MS, 1995, AM J CLIN NUTR, V62, P527, DOI 10.1093/ajcn/62.3.527; VANGAAL LF, 1989, J AM COLL NUTR, V8, P504; Wang J, 2000, ANN NY ACAD SCI, V904, P317; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Yudkin JS, 2005, LANCET, V365, P1817, DOI 10.1016/S0140-6736(05)66585-3; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	41	118	120	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27694	10.1371/journal.pone.0027694	http://dx.doi.org/10.1371/journal.pone.0027694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096613	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900072
J	Zhang, XP; Yuan, QX; Tang, W; Gu, JY; Osei, K; Wang, J				Zhang, Xiaoping; Yuan, Qingxin; Tang, Wei; Gu, Jingyu; Osei, Kwame; Wang, Jie			Substrate-Favored Lysosomal and Proteasomal Pathways Participate in the Normal Balance Control of Insulin Precursor Maturation and Disposal in beta-Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PANCREATIC-ISLETS; AMYLOID POLYPEPTIDE; PROTEIN-DEGRADATION; ALPHA-SYNUCLEIN; QUALITY-CONTROL; AUTOPHAGY; PROINSULIN; GENE; TRANSLOCATION	Our recent studies have uncovered that aggregation-prone proinsulin preserves a low relative folding rate and maintains a homeostatic balance of natively and non-natively folded states (i.e., proinsulin homeostasis, PIHO) in beta-cells as a result of the integration of maturation and disposal processes. Control of precursor maturation and disposal is thus an early regulative mechanism in the insulin production of beta-cells. Herein, we show pathways involved in the disposal of endogenous proinsulin at the early secretory pathway. We conducted metabolic-labeling, immunoblotting, and immunohistochemistry studies to examine the effects of selective proteasome and lysosome or autophagy inhibitors on the kinetics of proinsulin and control proteins in various post-translational courses. Our metabolic-labeling studies found that the main lysosomal and ancillary proteasomal pathways participate in the heavy clearance of insulin precursor in mouse islets/beta-cells cultured at the mimic physiological glucose concentrations. Further immunoblotting and immunohistochemistry studies in cloned beta-cells validated that among secretory proteins, insulin precursor is heavily and preferentially removed. The rapid disposal of a large amount of insulin precursor after translation is achieved mainly through lysosomal autophagy and the subsequent basal disposals are carried out by both lysosomal and proteasomal pathways within a 30 to 60-minute post-translational process. The findings provide the first clear demonstration that lysosomal and proteasomal pathways both play roles in the normal maintenance of PIHO for insulin production, and defined the physiological participation of lysosomal autophagy in the protein quality control at the early secretory pathway of pancreatic beta-cells.	[Zhang, Xiaoping; Yuan, Qingxin; Tang, Wei; Gu, Jingyu; Osei, Kwame; Wang, Jie] Ohio State Univ, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zhang, XP (corresponding author), Ohio State Univ, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA.	jie.wang2@osumc.edu			Ohio State University	Ohio State University(Ohio State University)	This work was supported by the start-up fund and the Manuel Tzagournis Medical Research Award from the Ohio State University (to J.W.). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT SG, 1979, J BIOL CHEM, V254, P3483; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; ESKRIDGE EM, 1983, J BIOL CHEM, V258, P1487; Franklin JL, 1998, J CELL BIOL, V142, P1313, DOI 10.1083/jcb.142.5.1313; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; KULIAWAT R, 1994, J CELL BIOL, V126, P77, DOI 10.1083/jcb.126.1.77; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; MANCHESTER KL, 1969, NATURE, V221, P188, DOI 10.1038/221188a0; Marzban L, 2006, DIABETES, V55, P2192, DOI 10.2337/db05-1566; NAGAMATSU S, 1991, J BIOL CHEM, V266, P13737; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OKUN MM, 1990, J BIOL CHEM, V265, P7478; ORCI L, 1993, P NATL ACAD SCI USA, V90, P11089, DOI 10.1073/pnas.90.23.11089; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PATZELT C, 1978, P NATL ACAD SCI USA, V75, P1260, DOI 10.1073/pnas.75.3.1260; Perry CN, 2009, METHOD ENZYMOL, V453, P325, DOI 10.1016/S0076-6879(08)04016-0; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; STEINER DF, 1968, P NATL ACAD SCI USA, V60, P622, DOI 10.1073/pnas.60.2.622; STEINER DF, 2001, ENDOCRINOLOGY, P667; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019446; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005	46	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27647	10.1371/journal.pone.0027647	http://dx.doi.org/10.1371/journal.pone.0027647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102916	gold, Green Published, Green Submitted			2022-12-25	WOS:000297348800038
J	Baquedano, E; Garcia-Caceres, C; Diz-Chaves, Y; Lagunas, N; Calmarza-Font, I; Azcoitia, I; Garcia-Segura, LM; Argente, J; Chowen, JA; Frago, LM				Baquedano, Eva; Garcia-Caceres, Cristina; Diz-Chaves, Yolanda; Lagunas, Natalia; Calmarza-Font, Isabel; Azcoitia, Inigo; Garcia-Segura, Luis M.; Argente, Jesus; Chowen, Julie A.; Frago, Laura M.			Prenatal Stress Induces Long-Term Effects in Cell Turnover in the Hippocampus-Hypothalamus-Pituitary Axis in Adult Male Rats	PLOS ONE			English	Article							REPEATED RESTRAINT STRESS; CALPASTATIN EXPRESSION; NEURONAL APOPTOSIS; ADRENAL AXIS; CALPAIN; NEUROGENESIS; ACTIVATION; CASPASE; CLEAVAGE; BEHAVIOR	Subchronic gestational stress leads to permanent modifications in the hippocampus-hypothalamus-pituitary-adrenal axis of offspring probably due to the increase in circulating glucocorticoids known to affect prenatal programming. The aim of this study was to investigate whether cell turnover is affected in the hippocampus-hypothalamus-pituitary axis by subchronic prenatal stress and the intracellular mechanisms involved. Restraint stress was performed in pregnant rats during the last week of gestation (45 minutes; 3 times/day). Only male offspring were used for this study and were sacrificed at 6 months of age. In prenatally stressed adults a decrease in markers of cell death and proliferation was observed in the hippocampus, hypothalamus and pituitary. This was associated with an increase in insulin-like growth factor-I mRNA levels, phosphorylation of CREB and calpastatin levels and inhibition of calpain -2 and caspase -8 activation. Levels of the antiapoptotic protein Bcl-2 were increased and levels of the pro-apoptotic factor p53 were reduced. In conclusion, prenatal restraint stress induces a long-term decrease in cell turnover in the hippocampus-hypothalamus-pituitary axis that might be at least partly mediated by an autocrine-paracrine IGF-I effect. These changes could condition the response of this axis to future physiological and pathophysiological situations.	[Baquedano, Eva; Garcia-Caceres, Cristina; Argente, Jesus; Chowen, Julie A.; Frago, Laura M.] Univ Autonoma Madrid, Dept Pediat, Hosp Infantil Univ Nino Jesus, Madrid, Spain; [Baquedano, Eva; Garcia-Caceres, Cristina; Argente, Jesus; Chowen, Julie A.; Frago, Laura M.] Inst Salud Carlos III, Inst Invest Sanitaria Princesa, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Diz-Chaves, Yolanda; Lagunas, Natalia; Calmarza-Font, Isabel; Garcia-Segura, Luis M.] CSIC, Inst Cajal, Lab Neuroact Steroids, E-28002 Madrid, Spain; [Azcoitia, Inigo] Univ Complutense Madrid, Dept Cellular Biol, Sch Biol, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Complutense University of Madrid	Baquedano, E (corresponding author), Univ Autonoma Madrid, Dept Pediat, Hosp Infantil Univ Nino Jesus, Madrid, Spain.	laura.frago@uam.es	Argente, Jesús/K-1167-2014; Frago, Laura M/B-9661-2012; Baquedano, Eva/E-8798-2013; Argente, Jesús/M-5226-2019; Diz-Chaves, Yolanda/L-5039-2019; Azcoitia, Iñigo/A-6208-2011; Lagunas, Natalia/G-8092-2016; García-Cáceres, Cristina/O-6601-2016; Garcia-Segura, Luis M/U-3711-2017; Diz-Chaves, Yolanda/F-4763-2016; Chowen, Julie/C-8979-2011	Argente, Jesús/0000-0001-5826-0276; Frago, Laura M/0000-0002-5927-9240; Baquedano, Eva/0000-0002-3934-2134; Argente, Jesús/0000-0001-5826-0276; Diz-Chaves, Yolanda/0000-0001-5365-7178; Azcoitia, Iñigo/0000-0002-5791-9144; Lagunas, Natalia/0000-0003-4847-9578; García-Cáceres, Cristina/0000-0001-6376-9448; Garcia-Segura, Luis M/0000-0002-2450-2916; Diz-Chaves, Yolanda/0000-0001-5365-7178; Chowen, Julie/0000-0002-4770-2291	Ministerio de Ciencia e Innovacion [BFU2008-02950 C03-1, C03-2, C03-3]; Universidad Autonoma de Madrid-Comunidad de Madrid [CCG2008-UAM/SAL4451]; Fondo de Investigacion Sanitaria [PI070182]; CIBER de Fisiopatologia de Obesidad y Nutricion (CIBEROBN) Instituto de Salud Carlos III; Fundacion de Endocrinologia y Nutricion; Ministerio de Educacion y Ciencia; Consejeria de Sanidad y Consumo de la Comunidad de Madrid	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad Autonoma de Madrid-Comunidad de Madrid; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBER de Fisiopatologia de Obesidad y Nutricion (CIBEROBN) Instituto de Salud Carlos III; Fundacion de Endocrinologia y Nutricion; Ministerio de Educacion y Ciencia(Spanish Government); Consejeria de Sanidad y Consumo de la Comunidad de Madrid	Funding for this study was provided by grants from Ministerio de Ciencia e Innovacion (BFU2008-02950 C03-1, C03-2 and C03-3), Universidad Autonoma de Madrid-Comunidad de Madrid (CCG2008-UAM/SAL4451), Fondo de Investigacion Sanitaria (PI070182), CIBER de Fisiopatologia de Obesidad y Nutricion (CIBEROBN) Instituto de Salud Carlos III and Fundacion de Endocrinologia y Nutricion. EB and CG-C are supported by predoctoral fellowships from the Ministerio de Educacion y Ciencia and JAC is supported by the biomedical investigation program of the Consejeria de Sanidad y Consumo de la Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroba AI, 2006, J ENDOCRINOL, V191, P55, DOI 10.1677/joe.1.06908; Arroba AI, 2009, EUR J NEUROSCI, V30, P975, DOI 10.1111/j.1460-9568.2009.06902.x; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Brunson KL, 2001, P NATL ACAD SCI USA, V98, P8856, DOI 10.1073/pnas.151224898; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; Chistyakova OV, 2008, J EVOL BIOCHEM PHYS+, V44, P1, DOI 10.1134/S0022093008010015; Cong M, 1998, BBA-GENE STRUCT EXPR, V1443, P186, DOI 10.1016/S0167-4781(98)00203-6; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Das A, 2008, J NEUROSCI RES, V86, P2992, DOI 10.1002/jnr.21737; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fujioka T, 1999, NEUROSCIENCE, V92, P1079, DOI 10.1016/S0306-4522(99)00073-1; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P1525, DOI 10.1016/j.psyneuen.2010.05.006; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P403, DOI 10.1016/j.psyneuen.2009.08.001; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonzalez-Parra S, 2000, J ENDOCRINOL, V164, P265, DOI 10.1677/joe.0.1640265; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hamada H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004795; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hayashi A, 1998, INT J DEV NEUROSCI, V16, P209, DOI 10.1016/S0736-5748(98)00028-8; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Kar P, 2010, ARCH BIOCHEM BIOPHYS, V495, P1, DOI 10.1016/j.abb.2009.12.020; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Koehl M, 1999, J NEUROBIOL, V40, P302, DOI 10.1002/(SICI)1097-4695(19990905)40:3<302::AID-NEU3>3.0.CO;2-7; Kwon MS, 2006, NEUROSCIENCE, V142, P1281, DOI 10.1016/j.neuroscience.2006.07.027; Kwon MS, 2007, J NEUROCHEM, V103, P1530, DOI 10.1111/j.1471-4159.2007.04865.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; Levine S, 2002, NEUROTOX RES, V4, DOI 10.1080/10298420290030569; Li YZ, 2009, EXP NEUROL, V220, P316, DOI 10.1016/j.expneurol.2009.09.004; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Liu Y, 2008, ENDOCRINOLOGY, V149, P3512, DOI 10.1210/en.2008-0052; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Maccari S, 2003, NEUROSCI BIOBEHAV R, V27, P119, DOI 10.1016/S0149-7634(03)00014-9; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Mairesse J, 2007, PSYCHONEUROENDOCRINO, V32, P765, DOI 10.1016/j.psyneuen.2007.03.013; Mandyam CD, 2008, DEV NEUROBIOL, V68, P575, DOI 10.1002/dneu.20600; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McEwen BS, 2000, PROG BRAIN RES, V122, P25; McGinnis KM, 2003, NEUROCHEM INT, V42, P517, DOI 10.1016/S0197-0186(02)00078-5; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murphy RC, 2001, FEBS LETT, V497, P73, DOI 10.1016/S0014-5793(01)02440-1; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Piechaczyk M, 2000, METH MOL B, V144, P297; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; SCHULER M, 2001, BIOCHEM, P684; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Vaisid T, 2009, INT J BIOCHEM CELL B, V41, P2450, DOI 10.1016/j.biocel.2009.07.010; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WARD IL, 1980, SCIENCE, V207, P328, DOI 10.1126/science.7188648; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wingrave JM, 2004, J NEUROTRAUM, V21, P1240, DOI 10.1089/0897715041953894; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Zhang LX, 2002, DEV BRAIN RES, V133, P1, DOI 10.1016/S0926-6410(01)00118-5; Zheng WH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-51	73	24	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27549	10.1371/journal.pone.0027549	http://dx.doi.org/10.1371/journal.pone.0027549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096592	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800059
J	Hognas, G; Tuomi, S; Veltel, S; Mattila, E; Murumagi, A; Edgren, H; Kallioniemi, O; Ivaska, J				Hognas, G.; Tuomi, S.; Veltel, S.; Mattila, E.; Murumagi, A.; Edgren, H.; Kallioniemi, O.; Ivaska, J.			Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo	ONCOGENE			English	Article						integrin traffic; cytokinesis; aneuploidy; cancer	MAMMALIAN-CELLS; CHROMOSOMAL INSTABILITY; TUMORIGENESIS; MICE; CANCER; P53; ENDOCYTOSIS; PROGRESSION; INVASION; MUTATION	Aneuploidy is frequently detected in solid tumors but the mechanisms regulating the generation of aneuploidy and their relevance in cancer initiation remain under debate and are incompletely characterized. Spatial and temporal regulation of integrin traffic is critical for cell migration and cytokinesis. Impaired integrin endocytosis, because of the loss of Rab21 small GTPase or mutations in the integrin beta-subunit cytoplasmic tail, induces failure of cytokinesis in vitro. Here, we describe that repeatedly failed cytokinesis, because of impaired traffic, is sufficient to trigger the generation of aneuploid cells, which display characteristics of oncogenic transformation in vitro and are tumorigenic in vivo. Furthermore, in an in vivo mouse xenograft model, non-transformed cells with impaired integrin traffic formed tumors with a long latency. More detailed investigation of these tumors revealed that the tumor cells were aneuploid. Therefore, abnormal integrin traffic was linked with generation of aneuploidy and cell transformation also in vivo. In human prostate and ovarian cancer samples, downregulation of Rab21 correlates with increased malignancy. Loss-of-function experiments demonstrate that long-term depletion of Rab21 is sufficient to induce chromosome number aberrations in normal human epithelial cells. These data are the first to demonstrate that impaired integrin traffic is sufficient to induce conversion of non-transformed cells to tumorigenic cells in vitro and in vivo. Oncogene (2012) 31, 3597-3606; doi:10.1038/onc.2011.527; published online 28 November 2011	[Hognas, G.; Tuomi, S.; Veltel, S.; Mattila, E.; Ivaska, J.] Univ Turku, VTT Tech Res Ctr Finland, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Murumagi, A.; Edgren, H.; Kallioniemi, O.] Univ Helsinki, Inst Mol Med, FIMM, Helsinki, Finland; [Ivaska, J.] Univ Turku, Dept Biochem & Food Chem, FIN-20520 Turku, Finland	University of Turku; VTT Technical Research Center Finland; University of Helsinki; University of Turku	Ivaska, J (corresponding author), Univ Turku, VTT Tech Res Ctr Finland, Turku Ctr Biotechnol, FIN-20520 Turku, Finland.	Johanna.ivaska@vtt.fi	Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Ivaska, Johanna/0000-0002-6295-6556; Veltel, Stefan/0000-0002-4925-3776	ERC starting grant; Academy of Finland; Finnish Cancer Organizations; Sigrid Juselius Foundation; Turku Graduate School for Biomedical Sciences; VTT Medical Biotechnology; EMBO LTF; Alexander von Humboldt foundation	ERC starting grant(European Research Council (ERC)); Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Graduate School for Biomedical Sciences; VTT Medical Biotechnology; EMBO LTF(European Molecular Biology Organization (EMBO)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	We thank Dr M Karin for DNA constructs; H Marttila, J Siivonen and L Lahtinen for excellent technical assistance. I Ahonen is thanked for help with the statistical analysis. This research has been supported by ERC starting grant, Academy of Finland, Finnish Cancer Organizations and Sigrid Juselius Foundation. GH is supported by Turku Graduate School for Biomedical Sciences, ST by VTT Medical Biotechnology and SV is supported by EMBO LTF and Alexander von Humboldt foundation. The Central Animal Laboratory of the University of Turku is acknowledged for the animal experiments.	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BENZEEV A, 1981, CELL, V26, P107, DOI 10.1016/0092-8674(81)90038-6; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Thullberg M, 2007, P NATL ACAD SCI USA, V104, P20338, DOI 10.1073/pnas.0706609105; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	35	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	31					3597	3606		10.1038/onc.2011.527	http://dx.doi.org/10.1038/onc.2011.527			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22120710	Green Published, hybrid			2022-12-25	WOS:000307245600003
J	Wang, H; Huang, ZB; Huang, LS; Niu, SN; Rao, XR; Xu, J; Kong, H; Yang, JZ; Yang, C; Wu, DH; Li, SH; Li, XJ; Liu, TH; Sheng, GQ				Wang, Hao; Huang, Zhenbo; Huang, Liansha; Niu, Shaona; Rao, Xiurong; Xu, Jing; Kong, Hui; Yang, Jianzhong; Yang, Chuan; Wu, Donghai; Li, Shihua; Li, Xiao-Jiang; Liu, Tonghua; Sheng, Guoqing			Hypothalamic Ahi1 Mediates Feeding Behavior through Interaction with 5-HT2C Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING HORMONE; NEUROPEPTIDE-Y CONCENTRATIONS; JOUBERT-SYNDROME; BODY-WEIGHT; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; MELANOCORTIN RECEPTORS; OLANZAPINE TREATMENT; ENERGY-BALANCE; GENE-MUTATIONS	It is indicated that there are important molecules interacting with brain nervous systems to regulate feeding and energy balance by influencing the signaling pathways of these systems, but relatively few of the critical players have been identified. In the present study, we provide the evidence for the role of Abelson helper integration site 1 (Ahi1) protein as a mediator of feeding behavior through interaction with serotonin receptor 2C (5-HT2CR), known for its critical role in feeding and appetite control. First, we demonstrated the co-localization and interaction between hypothalamic Ahi1 and 5-HT2CR. Ahi1 promoted the degradation of 5-HT2CR through the lysosomal pathway. Then, we investigated the effects of fasting on the expression of hypothalamic Ahi1 and 5-HT2CR. Fasting resulted in an increased Ahi1 expression and a concomitant decreased expression of 5-HT2CR. Knockdown of hypothalamic Ahi1 led to a concomitant increased expression of 5-HT2CR and a decrease of food intake and body weight. Last, we found that Ahi1 could regulate the expression of neuropeptide Y and proopiomelanocortin. Taken together, our results indicate that Ahi1 mediates feeding behavior by interacting with 5-HT2CR to modulate the serotonin signaling pathway.	[Huang, Liansha; Liu, Tonghua] Beijing Univ Chinese Med, Dept Sci & Technol, Beijing 100029, Peoples R China; [Wang, Hao; Huang, Zhenbo; Rao, Xiurong; Xu, Jing; Kong, Hui; Wu, Donghai; Sheng, Guoqing] Chinese Acad Sci, CAS Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Niu, Shaona] Linyi Peoples Hosp, Dept Endocrinol, Linyi 276003, Peoples R China; [Yang, Jianzhong] Red Cross Hosp Yunnan Prov, Kunming 650030, Peoples R China; [Yang, Chuan] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Guangzhou 510020, Guangdong, Peoples R China; [Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Beijing University of Chinese Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Sun Yat Sen University; Emory University	Liu, TH (corresponding author), Beijing Univ Chinese Med, Dept Sci & Technol, Beijing 100029, Peoples R China.	thliu@vip.163.com; shenggibh@gmail.com			National Institutes of Health [NS036232]; National Natural Science Foundation of China (NSFC) [30700213, 30811120429]; Guangdong Natural Science Foundation (GDSF) [07007215]; "973" Projects [2007CB947804, 2010CB945503]; International Traditional Chinese Medicine Program for Cooperation in Science and Technology (ISCP) [2011DFA30920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153, R01AG019206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation (GDSF); "973" Projects(National Basic Research Program of China); International Traditional Chinese Medicine Program for Cooperation in Science and Technology (ISCP); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NS036232 (to X.-J. L). This work was also supported by National Natural Science Foundation of China (NSFC) Grants 30700213 and 30811120429, Guangdong Natural Science Foundation (GDSF) Grant 07007215, and "973" Projects 2007CB947804 and 2010CB945503 (to G. S.) and by International Traditional Chinese Medicine Program for Cooperation in Science and Technology (ISCP) Grant 2011DFA30920 (to T. L.).	ADAN RAH, 1994, MOL PHARMACOL, V46, P1182; Ascher-Svanum H, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-3; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; BROWN CM, 1995, PHARMACOL BIOCHEM BE, V51, P641, DOI 10.1016/0091-3057(94)00431-H; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Currie PJ, 1999, NEUROREPORT, V10, P3033, DOI 10.1097/00001756-199909290-00029; De Vry J, 2000, NEUROSCI BIOBEHAV R, V24, P341, DOI 10.1016/S0149-7634(99)00083-4; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; DRYDEN S, 1993, PEPTIDES, V14, P791, DOI 10.1016/0196-9781(93)90115-W; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Garfield AS, 2009, J PHYSIOL-LONDON, V587, P49, DOI 10.1113/jphysiol.2008.164152; GOODALL E, 1988, BRIT J PSYCHIAT, V153, P208, DOI 10.1192/bjp.153.2.208; Han SB, 2009, BIOCHEM BIOPH RES CO, V390, P535, DOI 10.1016/j.bbrc.2009.09.133; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; Hsiao SH, 2006, NEUROSCI LETT, V394, P256, DOI 10.1016/j.neulet.2005.10.054; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; JESPERSEN S, 1973, J PHARM PHARMACOL, V25, P49, DOI 10.1111/j.2042-7158.1973.tb09114.x; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; KENNETT GA, 1989, EUR J PHARMACOL, V164, P445, DOI 10.1016/0014-2999(89)90252-5; Kinon BJ, 2001, J CLIN PSYCHIAT, V62, P92, DOI 10.4088/JCP.v62n0204; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kring SII, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006696; L'ltalien GJ, 2007, J CLIN PSYCHIAT, V68, P1510, DOI 10.4088/JCP.v68n1006; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Lordanidou M, 2008, PHARMACOGENET GENOM, V18, P153, DOI 10.1097/FPC.0b013e3282f4ae93; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nasrallah H, 2003, PSYCHONEUROENDOCRINO, V28, P83, DOI 10.1016/S0306-4530(02)00114-2; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; NASRALLAH HA, 2004, J CLIN PSYCHOPHARM, V24, P7, DOI DOI 10.1097/01.JCP.0000142282.62336.E9; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Niu SN, 2011, FEBS LETT, V585, P85, DOI 10.1016/j.febslet.2010.11.059; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PINDER RM, 1975, DRUGS, V10, P241, DOI 10.2165/00003495-197510040-00001; POIRIER Y, 1988, J VIROL, V62, P3985, DOI 10.1128/JVI.62.11.3985-3992.1988; Prior MJ, 2010, METABOLISM, V59, P1057, DOI 10.1016/j.metabol.2009.11.002; ROGERS P, 1991, PEPTIDES, V12, P251, DOI 10.1016/0196-9781(91)90007-C; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Scheepers FE, 2001, J CLIN PSYCHOPHARM, V21, P575, DOI 10.1097/00004714-200112000-00006; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; SHORPOSNER G, 1986, BRAIN RES BULL, V17, P663, DOI 10.1016/0361-9230(86)90198-X; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; SWANDULLA D, 1990, J NEUROPHYSIOL, V64, P715, DOI 10.1152/jn.1990.64.3.715; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Vezzosi D, 2007, EUR J ENDOCRINOL, V156, P21, DOI 10.1530/eje.1.02324; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P274, DOI 10.1007/s00213-002-1378-6; Vickers SP, 2000, BRIT J PHARMACOL, V130, P1305, DOI 10.1038/sj.bjp.0703443; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	64	11	12	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2237	2246		10.1074/jbc.M111.277871	http://dx.doi.org/10.1074/jbc.M111.277871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123816	Green Published, hybrid			2022-12-25	WOS:000299321000061
J	Birtwistle, MR; von Kriegsheim, A; Kida, K; Schwarz, JP; Anderson, KI; Kolch, W				Birtwistle, Marc R.; von Kriegsheim, Alexander; Kida, Katarzyna; Schwarz, Juliane P.; Anderson, Kurt I.; Kolch, Walter			Linear Approaches to Intramolecular Forster Resonance Energy Transfer Probe Measurements for Quantitative Modeling	PLOS ONE			English	Article							YELLOW FLUORESCENT PROTEIN; X-LINKED-INHIBITOR; APOPTOSIS-PROTEIN; CELL; DYNAMICS; ACTIVATION; RECEPTOR; PHOSPHORYLATION; EXECUTION	Numerous unimolecular, genetically-encoded Forster Resonance Energy Transfer (FRET) probes for monitoring biochemical activities in live cells have been developed over the past decade. As these probes allow for collection of high frequency, spatially resolved data on signaling events in live cells and tissues, they are an attractive technology for obtaining data to develop quantitative, mathematical models of spatiotemporal signaling dynamics. However, to be useful for such purposes the observed FRET from such probes should be related to a biological quantity of interest through a defined mathematical relationship, which is straightforward when this relationship is linear, and can be difficult otherwise. First, we show that only in rare circumstances is the observed FRET linearly proportional to a biochemical activity. Therefore in most cases FRET measurements should only be compared either to explicitly modeled probes or to concentrations of products of the biochemical activity, but not to activities themselves. Importantly, we find that FRET measured by standard intensity-based, ratiometric methods is inherently non-linear with respect to the fraction of probes undergoing FRET. Alternatively, we find that quantifying FRET either via (1) fluorescence lifetime imaging (FLIM) or (2) ratiometric methods where the donor emission intensity is divided by the directly-excited acceptor emission intensity (denoted R(alt)) is linear with respect to the fraction of probes undergoing FRET. This linearity property allows one to calculate the fraction of active probes based on the FRET measurement. Thus, our results suggest that either FLIM or ratiometric methods based on R(alt) are the preferred techniques for obtaining quantitative data from FRET probe experiments for mathematical modeling purposes.	[Birtwistle, Marc R.; von Kriegsheim, Alexander; Kida, Katarzyna; Kolch, Walter] Univ Coll Dublin, Belfield, Ireland; [Birtwistle, Marc R.] Georgia Hlth Sci Univ, Canc Res Ctr, Augusta, GA USA; [Schwarz, Juliane P.; Anderson, Kurt I.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University College Dublin; University System of Georgia; Augusta University; Beatson Institute	Birtwistle, MR (corresponding author), Univ Coll Dublin, Belfield, Ireland.	marc.birtwistle@gmail.com	Kolch, Walter/ABF-2102-2021; von Kriegsheim, Alex/C-2371-2016; Admin, SBI/HGB-2738-2022	von Kriegsheim, Alex/0000-0002-4952-8573; Kolch, Walter/0000-0001-5777-5016; Birtwistle, Marc/0000-0002-0341-0705; Anderson, Kurt/0000-0002-9324-9598	Science Foundation Ireland [06/CE/B1129]; Marie Curie International Incoming Fellowship [36758]; European Molecular Biology Organization [ALTF 815-2010]; Cancer Research UK [15565] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie International Incoming Fellowship(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	This work was supported by Science Foundation Ireland under Grant No. 06/CE/B1129. MRB acknowledges a Marie Curie International Incoming Fellowship (36758) and an European Molecular Biology Organization long-term fellowship (ALTF 815-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Huber HJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-9; Kumagai Y, 2011, ANAL BIOCHEM, V413, P192, DOI 10.1016/j.ab.2011.02.021; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Offterdinger M, 2004, J BIOL CHEM, V279, P36972, DOI 10.1074/jbc.M405830200; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	26	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27823	10.1371/journal.pone.0027823	http://dx.doi.org/10.1371/journal.pone.0027823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114702	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400122
J	Noor, NM; Steer, DL; Wheaton, BJ; Ek, CJ; Truettner, JS; Dietrich, WD; Dziegielewska, KM; Richardson, SJ; Smith, AI; VandeBerg, JL; Saunders, NR				Noor, Natassya M.; Steer, David L.; Wheaton, Benjamin J.; Ek, C. Joakim; Truettner, Jessie S.; Dietrich, W. Dalton; Dziegielewska, Katarzyna M.; Richardson, Samantha J.; Smith, A. Ian; VandeBerg, John L.; Saunders, Norman R.			Age-Dependent Changes in the Proteome Following Complete Spinal Cord Transection in a Postnatal South American Opossum (Monodelphis domestica)	PLOS ONE			English	Article							GENE-EXPRESSION; SUPRASPINAL AXONS; INDUCED APOPTOSIS; BINDING PROTEINS; ACTIN DYNAMICS; BASIC-PROTEIN; RAT-BRAIN; REGENERATION; INJURY; UBIQUITIN	Recovery from severe spinal injury in adults is limited, compared to immature animals who demonstrate some capacity for repair. Using laboratory opossums (Monodelphis domestica), the aim was to compare proteomic responses to injury at two ages: one when there is axonal growth across the lesion and substantial behavioural recovery and one when no axonal growth occurs. Anaesthetized pups at postnatal day (P) 7 or P28 were subjected to complete transection of the spinal cord at thoracic level T10. Cords were collected 1 or 7 days after injury and from age-matched controls. Proteins were separated based on isoelectric point and subunit molecular weight; those whose expression levels changed following injury were identified by densitometry and analysed by mass spectrometry. Fifty-six unique proteins were identified as differentially regulated in response to spinal transection at both ages combined. More than 50% were cytoplasmic and 70% belonged to families of proteins with characteristic binding properties. Proteins were assigned to groups by biological function including regulation (40%), metabolism (26%), inflammation (19%) and structure (15%). More changes were detected at one than seven days after injury at both ages. Seven identified proteins: 14-3-3 epsilon, 14-3-3 gamma, cofilin, alpha enolase, heart fatty acid binding protein (FABP3), brain fatty acid binding protein (FABP7) and ubiquitin demonstrated age-related differential expression and were analysed by qRT-PCR. Changes in mRNA levels for FABP3 at P7+1day and ubiquitin at P28+1day were statistically significant. Immunocytochemical staining showed differences in ubiquitin localization in younger compared to older cords and an increase in oligodendrocyte and neuroglia immunostaining following injury at P28. Western blot analysis supported proteomic results for ubiquitin and 14-3-3 proteins. Data obtained at the two ages demonstrated changes in response to injury, compared to controls, that were different for different functional protein classes. Some may provide targets for novel drug or gene therapies.	[Noor, Natassya M.; Wheaton, Benjamin J.; Ek, C. Joakim; Dziegielewska, Katarzyna M.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Steer, David L.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Truettner, Jessie S.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Richardson, Samantha J.] RMIT Univ, Sch Med Sci, Bundoora, Vic, Australia; [Richardson, Samantha J.] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic, Australia; [VandeBerg, John L.] Texas Biomed Res Inst, San Antonio, TX USA	University of Melbourne; Monash University; University of Miami; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Texas Biomedical Research Institute	Noor, NM (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Smith, Ian/0000-0002-4143-2892; Richardson, Samantha/0000-0002-1708-9430; Saunders, Norman/0000-0001-6660-7639; Wheaton, Benjamin/0000-0003-0619-4777	Victorian Neurotrauma Initiative [DPO49]; Robert J. Kleberg; Helen C. Kleberg Foundation (United States of America)	Victorian Neurotrauma Initiative; Robert J. Kleberg; Helen C. Kleberg Foundation (United States of America)	This study was supported by grants from the Victorian Neurotrauma Initiative (Project DPO49) and the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (United States of America). For more information about this research fund, go to http://www.tac.vic.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rub M, 2010, DRUG DISCOV TODAY, V15, P436, DOI 10.1016/j.drudis.2010.03.008; Adori C, 2006, J HISTOCHEM CYTOCHEM, V54, P263, DOI 10.1369/jhc.5B6752.2005; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Antes I, 2003, BIOPHYS J, V85, P695, DOI 10.1016/S0006-3495(03)74513-5; Birkenfeld J, 2003, BIOCHEM J, V369, P45, DOI 10.1042/BJ20021152; Boneva NB, 2010, NEUROSCI RES, V68, P94, DOI 10.1016/j.neures.2010.07.2028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Craveiro LM, 2008, EUR J NEUROSCI, V28, P1808, DOI 10.1111/j.1460-9568.2008.06473.x; Dai RY, 2010, FOLIA BIOL-PRAGUE, V56, P37; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Farlow DN, 2000, J CELL BIOCHEM, V80, P171; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Flann S, 1997, NEUROSCIENCE, V81, P173, DOI 10.1016/S0306-4522(97)00196-6; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; GHOORAY GT, 1993, DEV BRAIN RES, V72, P67, DOI 10.1016/0165-3806(93)90160-C; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; GRENELL RG, 1955, J CELL COMPAR PHYSL, V46, P143, DOI 10.1002/jcp.1030460108; HARTMAN BK, 1982, P NATL ACAD SCI-BIOL, V79, P4217, DOI 10.1073/pnas.79.13.4217; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; KALMUTZ SE, 1962, NATURE, V193, P851, DOI 10.1038/193851a0; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Krzyminska S, 2010, MICROB PATHOGENESIS, V49, P83, DOI 10.1016/j.micpath.2010.04.003; KUBO K, 1995, ANAL BIOCHEM, V225, P351, DOI 10.1006/abio.1995.1167; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lane M, 2007, EUR J NEUROSCI, P25; Leblond H, 1997, J COMP NEUROL, V386, P203; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Lopez-Meraz ML, 2010, EPILEPSIA, V51, P56, DOI 10.1111/j.1528-1167.2010.02611.x; LOWRY OH, 1964, J BIOL CHEM, V239, P31; MACKLIN WB, 1985, DEV NEUROSCI-BASEL, V7, P170, DOI 10.1159/000112285; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Mazur AJ, 2010, EUR J CELL BIOL, V89, P402, DOI 10.1016/j.ejcb.2009.10.017; MCCARTY RE, 1992, J EXP BIOL, V172, P431; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Michaelsen K, 2010, P NATL ACAD SCI USA, V107, P15780, DOI 10.1073/pnas.1004406107; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Mladinic M, 2005, CELL MOL NEUROBIOL, V25, P407, DOI 10.1007/s10571-005-3150-z; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Mortazavi MM, 2011, CHILD NERV SYST, V27, P237, DOI 10.1007/s00381-010-1312-x; Nielson JL, 2010, J NEUROSCI, V30, P11516, DOI 10.1523/JNEUROSCI.1433-10.2010; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; QIN YQ, 1993, DEV BRAIN RES, V75, P75, DOI 10.1016/0165-3806(93)90067-K; RABILLOUD T, 1992, ELECTROPHORESIS, V13, P429, DOI 10.1002/elps.1150130190; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; SAMPLES NK, 1986, AM J REPROD IMMUNOL, V11, P94; SANTAMARIA L, 1993, HISTOCHEMISTRY, V100, P131, DOI 10.1007/BF00572899; Satoh J, 2004, AM J PATHOL, V165, P577, DOI 10.1016/S0002-9440(10)63322-6; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; SPAMER C, 1977, HISTOCHEMISTRY, V52, P201, DOI 10.1007/BF00495857; STOLP HB, 2002, P AUST NEUROSCI SOC, V13, P79; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Takada M, 2010, LIFE SCI, V86, P499, DOI 10.1016/j.lfs.2010.02.010; Umahara T, 2009, BRAIN RES, V1253, P15, DOI 10.1016/j.brainres.2008.11.065; VARGA ZM, 1995, P NATL ACAD SCI USA, V92, P10959, DOI 10.1073/pnas.92.24.10959; Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036; WANG X, 1996, J COMP NEUROL, V371; Wang XM, 1998, J COMP NEUROL, V398, P83; Wang XM, 1998, EXP NEUROL, V151, P50, DOI 10.1006/exnr.1998.6795; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	78	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27465	10.1371/journal.pone.0027465	http://dx.doi.org/10.1371/journal.pone.0027465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110655	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400048
J	Poisbleau, M; Demongin, L; Parenteau, C; Eens, M				Poisbleau, Maud; Demongin, Laurent; Parenteau, Charline; Eens, Marcel			Intra-Clutch Ratio of Yolk Progesterone Level Changes with Laying Date in Rockhopper Penguins: A Strategy to Influence Brood Reduction?	PLOS ONE			English	Article							EUDYPTES-CHRYSOCOME-CHRYSOCOME; EGG-SIZE; HATCHING ASYNCHRONY; STEROID-HORMONES; ENVIRONMENTAL-CONDITIONS; APTENODYTES PATAGONICUS; EUROPEAN STARLINGS; MATERNAL HORMONES; MACARONI PENGUINS; ADELIE PENGUIN	Hatching asynchrony in avian species generally leads to a size hierarchy among siblings, favouring the first-hatched chicks. Maternally deposited hormones affect the embryo and chick's physiology and behaviour. It has been observed that progesterone, a hormone present at higher levels than other steroid hormones in egg yolks, is negatively related to body mass in embryos, chicks and adults. A differential within-clutch progesterone deposition could therefore be linked to the size hierarchy between siblings and to the resulting brood reduction. We tested whether yolk progesterone levels differed between eggs according to future parental ability to feed the entire clutch in wild rockhopper penguins Eudyptes chrysocome. This species presents a unique reversed egg-size dimorphism and hatching asynchrony, with the larger second-laid egg (B-egg) hatching before the smaller first-laid egg (A-egg). Yolk progesterone levels increased only slightly with female body mass at laying. However, intra-clutch ratios were not related to female body mass. On the other hand, yolk progesterone levels increased significantly with the date of laying onset for A-eggs while they decreased for B-eggs. Early clutches therefore had proportionally more progesterone in the B-egg compared to the A-egg while late clutches had proportionally less progesterone in the B-egg. We propose that females could strategically regulate yolk progesterone deposition within clutches according to the expected food availability during chick growth, an adaptive strategy to adjust brood reduction to conditions. We also discuss these results, relating to yolk progesterone, in the broader context of other yolk steroids.	[Poisbleau, Maud; Demongin, Laurent; Eens, Marcel] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Parenteau, Charline] Ctr Natl Rech Sci, Ctr Etud Biol Chize, Villiers En Bois, France	University of Antwerp; Centre National de la Recherche Scientifique (CNRS)	Poisbleau, M (corresponding author), Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium.	maud.poisbleau@ua.ac.be	Poisbleau, Maud/B-9968-2014; Eens, Marcel/AAC-8466-2020	Poisbleau, Maud/0000-0002-0729-3251; 	University of Antwerp; FWO-Flanders [1.2.619.10.N.00, 1.5.020.11.N.00]	University of Antwerp; FWO-Flanders(FWO)	Financial support was provided by the University of Antwerp and FWO-Flanders (Application numbers 1.2.619.10.N.00 and 1.5.020.11.N.00) to ME and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; ASTHEIMER LB, 1985, CONDOR, V87, P256, DOI 10.2307/1366891; BAHR JM, 1983, BIOL REPROD, V29, P326, DOI 10.1095/biolreprod29.2.326; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Blas J, 2010, GEN COMP ENDOCR, V168, P22, DOI 10.1016/j.ygcen.2010.03.020; Camacho-Arroyo I, 2003, COMP BIOCHEM PHYS A, V136, P447, DOI 10.1016/S1095-6433(03)00204-6; Charrassin JB, 2002, ECOL LETT, V5, P317, DOI 10.1046/j.1461-0248.2002.00341.x; CHEREL Y, 1994, PHYSIOL ZOOL, V67, P1154, DOI 10.1086/physzool.67.5.30163887; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Crossin GT, 2010, AM NAT, V176, P357, DOI 10.1086/655223; Demongin L, 2010, POLAR BIOL, V33, P469, DOI 10.1007/s00300-009-0722-2; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; GASC JM, 1991, ANAT EMBRYOL, V183, P415; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Gochfeld M., 1980, P207; GRAU CR, 1982, CONDOR, V84, P172, DOI 10.2307/1367663; Groothuis TGG, 2005, ANN NY ACAD SCI, V1046, P168, DOI 10.1196/annals.1343.014; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Gwynn A. M., 1953, ANARE REP          B, V1, P1; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lamey T.C., 1990, P399; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Lipar JL, 1999, AUK, V116, P231, DOI 10.2307/4089471; Lipar JL, 2001, J AVIAN BIOL, V32, P231, DOI 10.1111/j.0908-8857.2001.320305.x; Love OP, 2009, GEN COMP ENDOCR, V163, P169, DOI 10.1016/j.ygcen.2008.10.001; MAUGET R, 1994, GEN COMP ENDOCR, V93, P36, DOI 10.1006/gcen.1994.1005; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mock D. W., 1997, EVOLUTION SIBLING RI; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; OCONNOR RJ, 1978, ANIM BEHAV, V26, P79, DOI 10.1016/0003-3472(78)90008-8; Paitz RT, 2011, P ROY SOC B-BIOL SCI, V278, P99, DOI 10.1098/rspb.2010.0813; Poisbleau M, 2011, GEN COMP ENDOCR, V170, P622, DOI 10.1016/j.ygcen.2010.11.027; Poisbleau M, 2009, GEN COMP ENDOCR, V162, P139, DOI 10.1016/j.ygcen.2009.03.022; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2011, BIOL LETTERS, V7, P605, DOI 10.1098/rsbl.2010.1134; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Poisbleau M, 2009, HORM BEHAV, V55, P500, DOI 10.1016/j.yhbeh.2009.02.002; QUILLFELDT P, 2011, ENDOCRINOLOGY, V173, P11; Reed ET, 2003, ECOLOGY, V84, P219, DOI 10.1890/0012-9658(2003)084[0219:AAECAR]2.0.CO;2; RENDEN JA, 1980, POULTRY SCI, V59, P2559, DOI 10.3382/ps.0592559; RHYMER JM, 1992, J EVOLUTION BIOL, V5, P289, DOI 10.1046/j.1420-9101.1992.5020289.x; Royle NJ, 2005, P ROY SOC B-BIOL SCI, V272, P1917, DOI 10.1098/rspb.2005.3190; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SEDINGER JS, 1995, ECOLOGY, V76, P2404, DOI 10.2307/2265816; Shine R, 1999, OECOLOGIA, V119, P1, DOI 10.1007/s004420050754; SLAGSVOLD T, 1984, AUK, V101, P685, DOI 10.2307/4086895; STOKLAND JN, 1988, AUK, V105, P308, DOI 10.2307/4087495; Tarlow EM, 2001, HORM BEHAV, V40, P14, DOI 10.1006/hbeh.2001.1661; Warham J., 1975, P189; Williams T.D., 1995, PENGUINS; WILLIAMS TD, 1989, OIKOS, V55, P19, DOI 10.2307/3565867; Wittenberger J.F., 1985, Avian Biology, V8, P1; ZACH R, 1982, AUK, V99, P695	61	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27765	10.1371/journal.pone.0027765	http://dx.doi.org/10.1371/journal.pone.0027765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110758	Green Published, gold			2022-12-25	WOS:000297555400110
J	Zhang, XJ; Zhao, C; Huang, C; Duan, H; Huan, P; Liu, CZ; Zhang, XY; Zhang, Y; Li, FH; Zhang, HB; Xiang, JH				Zhang, Xiaojun; Zhao, Cui; Huang, Chao; Duan, Hu; Huan, Pin; Liu, Chengzhang; Zhang, Xiuying; Zhang, Yang; Li, Fuhua; Zhang, Hong-Bin; Xiang, Jianhai			A BAC-Based Physical Map of Zhikong Scallop (Chlamys farreri Jones et Preston)	PLOS ONE			English	Article							CHROMOSOMAL LOCALIZATION; FINGERPRINT ANALYSIS; GENOME; CONSTRUCTION; GENERATION; CLONES; IDENTIFICATION; GENE	Zhikong scallop (Chlamys farreri) is one of the most economically important aquaculture species in China. Physical maps are crucial tools for genome sequencing, gene mapping and cloning, genetic improvement and selective breeding. In this study, we have developed a genome-wide, BAC-based physical map for the species. A total of 81,408 clones from two BAC libraries of the scallop were fingerprinted using an ABI 3130xl Genetic Analyzer and a fingerprinting kit developed in our laboratory. After data processing, 63,641 (similar to 5.8x genome coverage) fingerprints were validated and used in the physical map assembly. A total of 3,696 contigs were assembled for the physical map. Each contig contained an average of 10.0 clones, with an average physical size of 490 kb. The combined total physical size of all contigs was 1.81 Gb, equivalent to approximately 1.5 fold of the scallop haploid genome. A total of 10,587 BAC end sequences (BESs) and 167 markers were integrated into the physical map. We evaluated the physical map by overgo hybridization, BAC-FISH (fluorescence in situ hybridization), contig BAC pool screening and source BAC library screening. The results have provided evidence of the high reliability of the contig physical map. This is the first physical map in mollusc; therefore, it provides an important platform for advanced research of genomics and genetics, and mapping of genes and QTL of economical importance, thus facilitating the genetic improvement and selective breeding of the scallop and other marine molluscs.	[Zhang, Xiaojun; Zhao, Cui; Huang, Chao; Duan, Hu; Huan, Pin; Liu, Chengzhang; Zhang, Xiuying; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhao, Cui; Huang, Chao; Duan, Hu; Zhang, Xiuying] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, Yang; Zhang, Hong-Bin] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Texas A&M University System; Texas A&M University College Station	Zhang, XJ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	jhxiang@qdio.ac.cn	xiang, jianhai/A-4767-2012; Zhang, Yang/A-5460-2011	xiang, jianhai/0000-0001-5395-7787; 	National Natural Science Foundation of China [30730071, 3094225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the Programs of National Natural Science Foundation of China (No. 30730071, No. 3094225) website: http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Jie, 2008, Zhongguo Haiyang Daxue Xuebao, V38, P78; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Huan Pin, 2009, Marine Sciences (Beijing), V33, P10; Huan P, 2010, GENET MOL BIOL, V33, P36, DOI 10.1590/S1415-47572010005000015; Huan Pin, 2009, Yichuan, V31, P1241, DOI 10.3724/SP.J.1005.2009.01241; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Li L, 2005, AQUACULTURE, V245, P63, DOI 10.1016/j.aquaculture.2004.12.015; Lorenz S, 2010, ANIM GENET, V41, P48, DOI 10.1111/j.1365-2052.2009.01963.x; NELSON W, 2009, NUCLEIC ACIDS RES, V37, P1; Ng SHS, 2005, GENOMICS, V86, P396, DOI 10.1016/j.ygeno.2005.06.001; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; Quiniou SMA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-40; Ren CW, 2003, GENOME RES, V13, P2754, DOI 10.1101/gr.1499303; SAMBROOK J, 2001, MOL CLONING LAB MANU; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; Wang LL, 2005, AQUAC RES, V36, P643, DOI 10.1111/j.1365-2109.2005.01268.x; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wu CC, 2004, GENOME RES, V14, P319, DOI 10.1101/gr.1405004; Wu CC, 2005, HANDBOOK OF PLANT GENOME MAPPING: GENETIC AND PHYSICAL MAPPING, P257, DOI 10.1002/3527603514.ch11; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xiao H, 2005, AQUACULTURE, V250, P602, DOI 10.1016/j.aquaculture.2005.05.002; XU P, 2007, AQUACULTURE GENOME T, P261; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Xu ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni037; Xu ZY, 2004, GENOMICS, V84, P941, DOI 10.1016/j.ygeno.2004.08.014; Zhan A, 2009, ANIM GENET, V40, P821, DOI 10.1111/j.1365-2052.2009.01920.x; Zhang LL, 2007, MAR BIOTECHNOL, V9, P606, DOI 10.1007/s10126-007-9014-4; Zhang X, 2006, MOL PLANT MICROBE IN, V19, P1302, DOI 10.1094/MPMI-19-1302; Zhang Y, 2008, MAR BIOTECHNOL, V10, P358, DOI 10.1007/s10126-007-9071-8; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8	33	17	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27612	10.1371/journal.pone.0027612	http://dx.doi.org/10.1371/journal.pone.0027612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110691	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400071
J	Tilahun, ME; Kwan, A; Natarajan, K; Quinn, M; Tilahun, AY; Xie, C; Margulies, DH; Osborne, BA; Goldsby, RA; Rajagopalan, G				Tilahun, Mulualem E.; Kwan, Alan; Natarajan, Kannan; Quinn, Megan; Tilahun, Ashenafi Y.; Xie, Chen; Margulies, David H.; Osborne, Barbara A.; Goldsby, Richard A.; Rajagopalan, Govindarajan			Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEB	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; II TRANSGENIC MICE; T-CELL-ACTIVATION; BACTERIAL SUPERANTIGENS; INTRAVENOUS IMMUNOGLOBULIN; STAPHYLOCOCCAL ENTEROTOXINS; RECEPTOR MIMICS; TOXOID VACCINES; STATINS; STIMULATION	Staphylococcal enterotoxin B (SEB) is one of a family of toxins secreted by Staphylococcus aureus that act as superantigens, activating a large fraction of the T-cell population and inducing production of high levels of inflammatory cytokines that can cause toxic shock syndrome (TSS) and death. Extracellular engagement of the TCR of T-cells and class II MHC of antigen presenting cells by SEB triggers the activation of many intracellular signaling processes. We engineered chimeric antibodies to block the extracellular engagement of cellular receptors by SEB and used a statin to inhibit intracellular signaling. Chimeric human-mouse antibodies directed against different neutralizing epitopes of SEB synergistically inhibited its activation of human T-cells in vitro. In the in vivo model of lethal toxic shock syndrome (TSS) in HLA-DR3 transgenic mice, two of these antibodies conferred significant partial protection when administered individually, but offered complete protection in a synergistic manner when given together. Similarly, in vivo, lovastatin alone conferred only partial protection from TSS similar to single anti-SEB antibodies. However, used in combination with one chimeric neutralizing anti-SEB antibody, lovastatin provided complete protection against lethal TSS in HLA-DR3 transgenic mice. These experiments demonstrate that in vivo protection against lethal doses of SEB can be achieved by a statin of proven clinical safety and chimeric human-mouse antibodies, agents now widely used and known to be of low immunogenicity in human hosts.	[Tilahun, Mulualem E.; Kwan, Alan; Quinn, Megan; Xie, Chen; Goldsby, Richard A.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Tilahun, Mulualem E.; Osborne, Barbara A.; Goldsby, Richard A.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Tilahun, Ashenafi Y.; Rajagopalan, Govindarajan] Mayo Clin, Coll Med, Dept Immunol, Rochester, MA USA; [Natarajan, Kannan; Margulies, David H.] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	Amherst College; University of Massachusetts System; University of Massachusetts Amherst; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tilahun, ME (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	ragoldsby@amherst.edu; Rajagopalan.Govindarajan@mayo.edu		Margulies, David/0000-0001-8530-7375; Xie, Chen/0000-0003-4738-2117; Kwan, Alan/0000-0002-4393-1011	NIH [AI057652, AI076944, AI068741]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057652, R01AI068741, R15AI076944, ZIAAI000622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI057652, AI076944, and AI068741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Arad G, 2004, IMMUNOL LETT, V91, P141, DOI 10.1016/j.imlet.2003.11.003; Arad G, 2001, J LEUKOCYTE BIOL, V69, P921; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Bergdoll M.S., 1983, STAPHYLOCOCCI STAPHY, V2, P559; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; Boles JW, 2003, CLIN IMMUNOL, V108, P51, DOI 10.1016/S1521-6616(03)00066-4; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Fehr T, 2004, ATHEROSCLEROSIS, V175, P83, DOI 10.1016/j.atherosclerosis.2004.02.016; FISCHER H, 1992, J IMMUNOL, V148, P1993; Fogerty MD, 2010, J TRAUMA, V69, P99, DOI 10.1097/TA.0b013e3181df61b1; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hong-Geller E, 2004, J BIOL CHEM, V279, P5676, DOI 10.1074/jbc.M309388200; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; JUPIN C, 1988, J EXP MED, V167, P752, DOI 10.1084/jem.167.3.752; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Larkin EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013253; Lehnert NM, 2001, BIOCHEMISTRY-US, V40, P4222, DOI 10.1021/bi002172e; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Lowell GH, 1996, INFECT IMMUN, V64, P1706, DOI 10.1128/IAI.64.5.1706-1713.1996; Lowell GH, 1996, INFECT IMMUN, V64, P4686, DOI 10.1128/IAI.64.11.4686-4693.1996; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Mollhoff M, 2005, J MOL RECOGNIT, V18, P73, DOI 10.1002/jmr.684; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rajagopalan G, 2004, INFECT IMMUN, V72, P6733, DOI 10.1128/IAI.72.11.6733-6737.2004; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Roy CJ, 2005, INFECT IMMUN, V73, P2452, DOI 10.1128/IAI.73.4.2452-2460.2005; Rusnak JM, 2004, EMERG INFECT DIS, V10, P1544, DOI 10.3201/eid1009.040250; SCHLIEVERT PM, 1993, J INFECT DIS, V167, P997, DOI 10.1093/infdis/167.5.997; Silversides Jonathan A, 2010, Curr Infect Dis Rep, V12, P392, DOI 10.1007/s11908-010-0119-y; Stiles BG, 2001, INFECT IMMUN, V69, P2031, DOI 10.1128/IAI.69.4.2031-2036.2001; Taneja V, 1999, IMMUNOL REV, V169, P67, DOI 10.1111/j.1600-065X.1999.tb01307.x; Taneja V, 2001, NAT IMMUNOL, V2, P781, DOI 10.1038/ni0901-781; Tilahun AY, 2011, AM J PATHOL, V178, P2760, DOI 10.1016/j.ajpath.2011.02.033; Tilahun AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016764; Tilahun AY, 2010, MOL THER, V18, P1143, DOI 10.1038/mt.2010.53; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Ulrich RG, 1998, VACCINE, V16, P1857, DOI 10.1016/S0264-410X(98)00176-5; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407; Visvanathan K, 2001, INFECT IMMUN, V69, P875, DOI 10.1128/IAI.69.2.875-884.2001; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	57	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27203	10.1371/journal.pone.0027203	http://dx.doi.org/10.1371/journal.pone.0027203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102880	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300012
J	Achonu, C; Rosella, L; Gubbay, JB; Deeks, S; Rebbapragada, A; Mazzulli, T; Willison, D; Foisy, J; McGeer, A; Johnson, I; LaFreniere, M; Johnson, C; Willmore, J; Yue, C; Crowcroft, NS				Achonu, Camille; Rosella, Laura; Gubbay, Jonathan B.; Deeks, Shelley; Rebbapragada, Anu; Mazzulli, Tony; Willison, Don; Foisy, Julie; McGeer, Allison; Johnson, Ian; LaFreniere, Marie; Johnson, Caitlin; Willmore, Jacqueline; Yue, Carmen; Crowcroft, Natasha S.			Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009-May 2010	PLOS ONE			English	Article							INFECTION; VIRUS; 1ST	Background: We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza season. Methods: Residual serum specimens from five time points (between 01/2009 and 05/2010) and samples from two time points from a prospectively recruited cohort were included. The distribution of risk factors was explored in multivariate adjusted analyses using logistic regression among the cohort. Antibody levels were measured by hemagglutination inhibition (HAI) and microneutralization (MN) assays. Results: Residual sera from 3375 patients and 1024 prospectively recruited cohort participants were analyzed. Prepandemic seroprevalence ranged from 2%-12% across age groups. Overall seropositivity ranged from 10%-19% post-first wave and 32%-41% by the end of the 2009/10 influenza season. Seroprevalence and risk factors differed between MN and HAI assays, particularly in older age groups and between waves. Following the H1N1 vaccination program, higher GMT were noted among vaccinated individuals. Overall, 20-30% of the population was estimated to be infected. Conclusions: Combining population sources of sera across five time points with prospectively collected epidemiological information yielded a complete description of the evolution of pH1N1 infection.	[Achonu, Camille; Rosella, Laura; Deeks, Shelley; Willison, Don; Foisy, Julie; Johnson, Ian; LaFreniere, Marie; Johnson, Caitlin; Crowcroft, Natasha S.] Publ Hlth Ontario, Dept Surveillance & Epidemiol, Toronto, ON, Canada; [Gubbay, Jonathan B.; Rebbapragada, Anu; Mazzulli, Tony] Publ Hlth Ontario, Publ Hlth Labs, Toronto, ON, Canada; [Willmore, Jacqueline] Ottawa Publ Hlth, Nepean, ON, Canada; [Yue, Carmen] Toronto Publ Hlth, Toronto, ON, Canada; [Rosella, Laura; Deeks, Shelley; McGeer, Allison; Johnson, Ian; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gubbay, Jonathan B.; Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [McGeer, Allison] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Achonu, C (corresponding author), Publ Hlth Ontario, Dept Surveillance & Epidemiol, Toronto, ON, Canada.	natasha.crowcroft@oahpp.ca	McGeer, Allison/AAB-6885-2020; Gubbay, Jonathan/Q-8580-2019; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; Gubbay, Jonathan/0000-0003-0026-3786; mcgeer, allison/0000-0001-5647-6137	Ministry of Health and Long Term Care, Ontario, Canada; Public Health Agency of Canada; GlaxoSmithKline Inc.; Hoffman-La Roche Ltd	Ministry of Health and Long Term Care, Ontario, Canada(Ministry of Health and Long-Term Care, Ontario); Public Health Agency of Canada; GlaxoSmithKline Inc.(GlaxoSmithKline); Hoffman-La Roche Ltd	This work was supported by the Ministry of Health and Long Term Care, Ontario, Canada, and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; None of the authors has any conflict of interest to declare. Dr Gubbay has received research grants from GlaxoSmithKline Inc. and Hoffman-La Roche Ltd to study antiviral resistance in influenza, however, this is not relevant to this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	A-Asmary S, 2007, INT J INFECT DIS, V11, P268, DOI 10.1016/j.ijid.2006.04.008; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; FOISY J, 2011, HLTH REPORTS, P3; FOISY J, 2011, AM J EPIDEMIOL S11, V173, pS1, DOI DOI 10.1093/AJE/KWR181; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Kelly H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021828; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; McCullers JA, 2010, CLIN INFECT DIS, V50, P1487, DOI 10.1086/652441; McVernon J, 2010, EUROSURVEILLANCE, V15, P7; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *ONT AG HLTH PROT, 2010, ONT AG HLTH PROT PRO; *ONT MIN HLTH LONG, 2009, WKLY EPIDEMIOL REC, V84, P485; *ONT MIN HLTH LONG, 2010, ONT INFL B SURV WEEK; *ONT MIN HLTH LONG, 2007, POP EST 2007 INTELLI; Ontario Ministry of Health and Long Term Care, 2010, H1N1 PAND ONT FAR RE; Papenburg J, 2011, CLIN VACCINE IMMUNOL, V18, P520, DOI 10.1128/CVI.00449-10; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; ROSS T, 2010, PLOS CURR INFLUENZA; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Tian LL, 2011, PREV MED, V52, P71, DOI 10.1016/j.ypmed.2010.10.006; Troko J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-16; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; WAGAR LE, 2011, PLOS ONE UNPUB; World Health Organization, 2002, WHO MAN AN INFL DIAG; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	35	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e26427	10.1371/journal.pone.0026427	http://dx.doi.org/10.1371/journal.pone.0026427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110586	gold, Green Submitted, Green Published			2022-12-25	WOS:000297554300005
J	Davis, MM; Alvarez, FJ; Ryman, K; Holm, AA; Ljungdahl, PO; Engstrom, Y				Davis, Monica M.; Alvarez, Francisco J.; Ryman, Kicki; Holm, Asa A.; Ljungdahl, Per O.; Engstrom, Ylva			Wild-Type Drosophila melanogaster as a Model Host to Analyze Nitrogen Source Dependent Virulence of Candida albicans	PLOS ONE			English	Article							RECEPTOR-ACTIVATED PROTEOLYSIS; EXTRACELLULAR AMINO-ACIDS; HUMAN FUNGAL PATHOGENS; TRANSCRIPTION FACTOR; IMMUNE-RESPONSE; ENDOPROTEOLYTIC ACTIVATION; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CELL-LINE; YEAST	The fungal pathogen Candida albicans is a common cause of opportunistic infections in humans. We report that wild-type Drosophila melanogaster (OrR) flies are susceptible to virulent C. albicans infections and have established experimental conditions that enable OrR flies to serve as model hosts for studying C. albicans virulence. After injection into the thorax, wild-type C. albicans cells disseminate and invade tissues throughout the fly, leading to lethality. Similar to results obtained monitoring systemic infections in mice, well-characterized cph1 Delta efg1 Delta and csh3 Delta fungal mutants exhibit attenuated virulence in flies. Using the OrR fly host model, we assessed the virulence of C. albicans strains individually lacking functional components of the SPS sensing pathway. In response to extracellular amino acids, the plasma membrane localized SPS-sensor (Ssy1, Ptr3, and Ssy5) activates two transcription factors (Stp1 and Stp2) to differentially control two distinct modes of nitrogen acquisition (host protein catabolism and amino acid uptake, respectively). Our results indicate that a functional SPS-sensor and Stp1 controlled genes required for host protein catabolism and utilization, including the major secreted aspartyl protease SAP2, are required to establish virulent infections. By contrast, Stp2, which activates genes required for amino acid uptake, is dispensable for virulence. These results indicate that nutrient availability within infected hosts directly influences C. albicans virulence.	[Davis, Monica M.; Holm, Asa A.; Engstrom, Ylva] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden; [Alvarez, Francisco J.; Ryman, Kicki; Ljungdahl, Per O.] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Davis, MM (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden.	per.ljungdahl@wgi.su.se; ylva.engstrom@molbio.su.se	Ljungdahl, Per O/M-5258-2013; Alvarez, Francisco Javier/B-8763-2018	Ljungdahl, Per O/0000-0002-6625-3540; Alvarez, Francisco Javier/0000-0003-1632-1792; Engstrom, Ylva/0000-0002-8731-4613	Swedish Research Council [2007-3894, 2008-725]; Swedish Cancer Society [08-0288]; European Union [MRTN-CT-2004-512481-CanTRAIN]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); European Union(European Commission)	This work was supported by the Swedish Research Council (2007-3894; 2008-725) (http://www.vr.se); The Swedish Cancer Society (08-0288) (http://www.cancerfonden.se); The European Union (MRTN-CT-2004-512481-CanTRAIN) (http://ec.europa.eu/research/fp6/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200592; Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Brega E, 2004, EUKARYOT CELL, V3, P135, DOI 10.1128/EC.3.1.135-143.2004; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chamilos G, 2006, J INFECT DIS, V193, P1014, DOI 10.1086/500950; Chamilos G, 2009, J INFECT DIS, V200, P152, DOI 10.1086/599363; CHEN J, P NATL ACAD SCI US, V107, P20774; Colina AR, 1996, INFECT IMMUN, V64, P4514, DOI 10.1128/IAI.64.11.4514-4519.1996; Dabas N, 2008, MOL MICROBIOL, V69, P586, DOI 10.1111/j.1365-2958.2008.06297.x; De Bernardis F, 2002, INFECT IMMUN, V70, P2725, DOI 10.1128/IAI.70.5.2725-2729.2002; Dimarcq JL, 1997, INSECT BIOCHEM MOLEC, V27, P877, DOI 10.1016/S0965-1748(97)00072-6; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Gateff E., 1980, INVERTEBRATE SYSTEMS, P517; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Hermann P., 2001, Acta Microbiologica et Immunologica Hungarica, V48, P479, DOI 10.1556/AMicr.48.2001.3-4.15; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Kibbler CC, 2003, J HOSP INFECT, V54, P18, DOI 10.1016/S0195-6701(03)00085-9; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Korting HC, 1999, ANTIMICROB AGENTS CH, V43, P2038, DOI 10.1128/AAC.43.8.2038; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levitin A, 2007, EUKARYOT CELL, V6, P658, DOI 10.1128/EC.00346-06; LIONAKIS MS, 2011, J INNATE IMMUN; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Martinez P, 2004, MOL MICROBIOL, V51, P371, DOI 10.1046/j.1365-2958.2003.03845.x; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Morschhauser J, 1997, FEMS MICROBIOL LETT, V153, P349, DOI 10.1016/S0378-1097(97)00273-5; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Okado K, 2009, BIOCHEM BIOPH RES CO, V379, P6, DOI 10.1016/j.bbrc.2008.11.097; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; PIYANKARAGE SC, 2009, AMINO ACIDS; Rahman D, 2007, MICROBES INFECT, V9, P615, DOI 10.1016/j.micinf.2007.01.012; Ress C, 2000, TISSUE CELL, V32, P464, DOI 10.1016/S0040-8166(00)80003-8; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; ROSETTO M, 1995, BIOCHEM BIOPH RES CO, V209, P111, DOI 10.1006/bbrc.1995.1477; Rozell B, 2006, CURR DRUG TARGETS, V7, P483, DOI 10.2174/138945006776359449; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Sallah S, 2001, CANCER-AM CANCER SOC, V92, P1349, DOI 10.1002/1097-0142(20010915)92:6<1349::AID-CNCR1457>3.0.CO;2-E; Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIDDIQUI AH, 1988, MOL CELL BIOL, V8, P4634, DOI 10.1128/MCB.8.11.4634; Soll DR, 2002, ACTA TROP, V81, P101, DOI 10.1016/S0001-706X(01)00200-5; Staib P, 2008, ANTIMICROB AGENTS CH, V52, P146, DOI 10.1128/AAC.01072-07; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Vilanova M, 2004, IMMUNOLOGY, V111, P334, DOI 10.1111/j.1365-2567.2004.01819.x; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Yang YL, 2009, MYCOL RES, V113, P388, DOI 10.1016/j.mycres.2008.11.016	66	26	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27434	10.1371/journal.pone.0027434	http://dx.doi.org/10.1371/journal.pone.0027434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110651	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300032
J	Weise, LD; Panfilov, AV				Weise, Louis D.; Panfilov, Alexander V.			New Mechanism of Spiral Wave Initiation in a Reaction-Diffusion-Mechanics System	PLOS ONE			English	Article							CRITICAL CURVATURE PHENOMENON; ISOLATED CARDIAC-MUSCLE; EXCITATION; PROPAGATION; VENTRICLE; CHANNELS; HEART; MODEL	Spiral wave initiation in the heart muscle is a mechanism for the onset of dangerous cardiac arrhythmias. A standard protocol for spiral wave initiation is the application of a stimulus in the refractory tail of a propagating excitation wave, a region that we call the "classical vulnerable zone." Previous studies of vulnerability to spiral wave initiation did not take the influence of deformation into account, which has been shown to have a substantial effect on the excitation process of cardiomyocytes via the mechano-electrical feedback phenomenon. In this work we study the effect of deformation on the vulnerability of excitable media in a discrete reaction-diffusion-mechanics (dRDM) model. The dRDM model combines FitzHugh-Nagumo type equations for cardiac excitation with a discrete mechanical description of a finite-elastic isotropic material (Seth material) to model cardiac excitation-contraction coupling and stretch activated depolarizing current. We show that deformation alters the "classical," and forms a new vulnerable zone at longer coupling intervals. This mechanically caused vulnerable zone results in a new mechanism of spiral wave initiation, where unidirectional conduction block and rotation directions of the consequently initiated spiral waves are opposite compared to the mechanism of spiral wave initiation due to the "classical vulnerable zone." We show that this new mechanism of spiral wave initiation can naturally occur in situations that involve wave fronts with curvature, and discuss its relation to supernormal excitability of cardiac tissue. The concept of mechanically induced vulnerability may lead to a better understanding about the onset of dangerous heart arrhythmias via mechano-electrical feedback.	[Weise, Louis D.] Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands; [Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium	Utrecht University; Ghent University	Weise, LD (corresponding author), Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands.	L.D.Weise@uu.nl	Panfilov, Alexander/G-8459-2016	Panfilov, Alexander/0000-0003-2643-642X	Netherlands Organization for Scientific Research (NWO) of the research Council for Physical Sciences (EW) [613.000.604]	Netherlands Organization for Scientific Research (NWO) of the research Council for Physical Sciences (EW)(Netherlands Organization for Scientific Research (NWO))	LDW is funded by the Netherlands Organization for Scientific Research (http://www.nwo.nl) (NWO Grant No. 613.000.604) of the research Council for Physical Sciences (EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev RR, 1996, CHAOS SOLITON FRACT, V7, P293, DOI 10.1016/0960-0779(95)00089-5; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; CABO C, 1994, CIRC RES, V75, P1014, DOI 10.1161/01.RES.75.6.1014; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Gerisch G., 1965, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V156, P127, DOI 10.1007/BF00573870; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoff HE, 1938, AM J PHYSIOL, V124, P591, DOI 10.1152/ajplegacy.1938.124.3.591; Hu H, 1997, J MOL CELL CARDIOL, V29, P1511, DOI 10.1006/jmcc.1997.0392; IMBIHL R, 1995, CHEM REV, V95, P697, DOI 10.1021/cr00035a012; Kamkin A, 2003, PROG BIOPHYS MOL BIO, V82, P111, DOI 10.1016/S0079-6107(03)00009-9; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.258104; PANFILOV AV, 1982, BIOFIZIKA+, V27, P886; PERTSOV AM, 1983, BIOFIZIKA+, V28, P100; STARMER CF, 1993, BIOPHYS J, V65, P1775, DOI 10.1016/S0006-3495(93)81233-5; VANDAM RT, 1956, CIRC RES, V4, P196, DOI 10.1161/01.RES.4.2.196; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; WIENER N, 1946, Arch Inst Cardiol Mex, V16, P205; Winfree A.T., 1987, TIME BREAKS 3 DIMENS; WINFREE AT, 1989, J THEOR BIOL, V138, P353, DOI 10.1016/S0022-5193(89)80200-0; WINFREE AT, 1984, NATURE, V311, P611, DOI 10.1038/311611a0; Yoshida R, 1996, J AM CHEM SOC, V118, P5134, DOI 10.1021/ja9602511; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; Zhang YH, 2000, J PHYSIOL-LONDON, V523, P607, DOI 10.1111/j.1469-7793.2000.00607.x	30	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27264	10.1371/journal.pone.0027264	http://dx.doi.org/10.1371/journal.pone.0027264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22114667	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300020
J	Olsson, MG; Allhorn, M; Larsson, J; Cederlund, M; Lundqvist, K; Schmidtchen, A; Sorensen, OE; Morgelin, M; Akerstrom, B				Olsson, Magnus G.; Allhorn, Maria; Larsson, Jorgen; Cederlund, Martin; Lundqvist, Katarina; Schmidtchen, Artur; Sorensen, Ole E.; Morgelin, Matthias; Akerstrom, Bo			Up-Regulation of A1M/alpha(1)-Microglobulin in Skin by Heme and Reactive Oxygen Species Gives Protection from Oxidative Damage	PLOS ONE			English	Article							MONOCLONAL ANTI-ALPHA-1-MICROGLOBULIN ANTIBODIES; LIPOCALIN ALPHA(1)-MICROGLOBULIN; STRESS; ALPHA-1-MICROGLOBULIN; HEMOGLOBIN; ANTIOXIDANTS; PURIFICATION; MECHANISMS; REDUCTION; COMPLEXES	During bleeding the skin is subjected to oxidative insults from free heme and radicals, generated from extracellular hemoglobin. The lipocalin alpha(1)-microglobulin (A1M) was recently shown to have reductase properties, reducing heme-proteins and other substrates, and to scavenge heme and radicals. We investigated the expression and localization of A1M in skin and the possible role of A1M in the protection of skin tissue from damage induced by heme and reactive oxygen species. Skin explants, keratinocyte cultures and purified collagen I were exposed to heme, reactive oxygen species, and/or A1M and investigated by biochemical methods and electron microscopy. The results demonstrate that A1M is localized ubiquitously in the dermal and epidermal layers, and that the A1M-gene is expressed in keratinocytes and up-regulated after exposure to heme and reactive oxygen species. A1M inhibited the heme-and reactive oxygen species-induced ultrastructural damage, up-regulation of antioxidation and cell cycle regulatory genes, and protein carbonyl formation in skin and keratinocytes. Finally, A1M bound to purified collagen I (K-d = 0.96 x 10(-6) M) and could inhibit and repair the destruction of collagen fibrils by heme and reactive oxygen species. The results suggest that A1M may have a physiological role in protection of skin cells and matrix against oxidative damage following bleeding.	[Olsson, Magnus G.; Allhorn, Maria; Larsson, Jorgen; Cederlund, Martin; Sorensen, Ole E.; Morgelin, Matthias; Akerstrom, Bo] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden; [Lundqvist, Katarina; Schmidtchen, Artur] Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, Lund, Sweden	Lund University; Lund University	Olsson, MG (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden.	magnus_g.olsson@med.lu.se	Schmidtchen, Artur/F-9507-2015; Gram, Magnus/AAM-4825-2021	Gram, Magnus/0000-0002-5880-2925	Swedish Research Council [7144, 7480]; government funds for clinical research (ALF); Royal Physiographic Society in Lund; Foundations of Greta and Johan Kock and Alfred Osterlund; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Blood and Defence Network; Lund University; Magnus Bergvalls foundation; Swedish Society for Medical Research; Preelumina AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); government funds for clinical research (ALF); Royal Physiographic Society in Lund; Foundations of Greta and Johan Kock and Alfred Osterlund; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Blood and Defence Network; Lund University; Magnus Bergvalls foundation; Swedish Society for Medical Research; Preelumina AB(HOGANAS ABStatisticon AB)	This work was funded by grants from the Swedish Research Council (7144 and 7480), government funds for clinical research (ALF) to Lund University and Lund University Hospital, the Royal Physiographic Society in Lund, the Foundations of Greta and Johan Kock and Alfred Osterlund, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Blood and Defence Network, Lund University, Magnus Bergvalls foundation, the Swedish Society for Medical Research and Preelumina AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1990, TRENDS BIOCHEM SCI, V15, P240, DOI 10.1016/0968-0004(90)90037-C; AKERSTROM B, 1985, EUR J BIOCHEM, V146, P353; Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Akerstrom Bo, 2006, P1; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; APPLEGATE LA, 1991, CANCER RES, V51, P974; BABIKERMOHAMED H, 1991, SCAND J IMMUNOL, V34, P655, DOI 10.1111/j.1365-3083.1991.tb01589.x; Berggard T, 1997, EUR J BIOCHEM, V245, P676, DOI 10.1111/j.1432-1033.1997.00676.x; BJORCK L, 1977, SCAND J IMMUNOL, V6, P1063; BOUIC P, 1985, BRIT J DERMATOL, V112, P35, DOI 10.1111/j.1365-2133.1985.tb02288.x; Bunn H., 1992, HEMOGLOBIN; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; DEMARS DD, 1989, CLIN CHEM, V35, P766; Faivre B, 1998, ARTIF CELL BLOOD SUB, V26, P17, DOI 10.3109/10731199809118943; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Konopacka M, 1998, MUTAT RES-GEN TOX EN, V417, P85, DOI 10.1016/S1383-5718(98)00095-3; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson J, 2004, ARCH BIOCHEM BIOPHYS, V432, P196, DOI 10.1016/j.abb.2004.09.021; Larsson J, 2001, J LAB CLIN MED, V137, P165, DOI 10.1067/mlc.2001.112957; Li YX, 2010, J AGR FOOD CHEM, V58, P578, DOI 10.1021/jf902811j; Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; NILSON B, 1987, J IMMUNOL METHODS, V99, P39, DOI 10.1016/0022-1759(87)90029-9; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Olsson MG, 2010, RADIAT RES, V174, P590, DOI 10.1667/RR2213.1; Orciani M, 2010, FREE RADICAL BIO MED, V49, P830, DOI 10.1016/j.freeradbiomed.2010.06.007; Packer L, 2002, SKIN PHARMACOL APPL, V15, P282, DOI 10.1159/000064531; PLESNER T, 1975, SCAND J CLIN LAB INV, V35, P729, DOI 10.3109/00365517509095804; Ray Gibanananda, 2002, Indian Journal of Experimental Biology, V40, P1213; ROTH J, 1986, J MICROSC-OXFORD, V143, P125, DOI 10.1111/j.1365-2818.1986.tb02771.x; Santin M, 1999, SCAND J IMMUNOL, V50, P289; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; TEJLER L, 1978, BIOCHIM BIOPHYS ACTA, V542, P506, DOI 10.1016/0304-4165(78)90380-X; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; Ushakova T, 1999, FREE RADICAL BIO MED, V26, P887, DOI 10.1016/S0891-5849(98)00281-0; VINCENT C, 1987, EUR J BIOCHEM, V165, P699, DOI 10.1111/j.1432-1033.1987.tb11497.x	42	48	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27505	10.1371/journal.pone.0027505	http://dx.doi.org/10.1371/journal.pone.0027505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096585	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900054
J	Shin, DM; Lee, CH; Morse, HC				Shin, Dong-Mi; Lee, Chang-Hoon; Morse, Herbert C., III			IRF8 Governs Expression of Genes Involved in Innate and Adaptive Immunity in Human and Mouse Germinal Center B Cells	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; INTERFERON REGULATORY FACTOR-8; LEUKEMIA-LIKE SYNDROME; TRANSCRIPTION FACTORS; DENDRITIC CELLS; IN-VIVO; TARGET GENES; FACTOR PU.1; ACTIVATION; FAMILY	IRF8 (Interferon Regulatory Factor 8) is a transcription factor expressed throughout B cell differentiation except for mature plasma cells. Previous studies showed it is part of the transcriptional network governing B cell specification and commitment in the bone marrow, regulates the distribution of mature B cells into the splenic follicular and marginal zone compartments, and is expressed at highest levels in germinal center (GC) B cells. Here, we investigated the transcriptional programs and signaling pathways affected by IRF8 in human and mouse GC B cells as defined by ChIP-chip analyses and transcriptional profiling. We show that IRF8 binds a large number of genes by targeting two distinct motifs, half of which are also targeted by PU.1. Over 70% of the binding sites localized to proximal and distal promoter regions with similar to 25% being intragenic. There was significant enrichment among targeted genes for those involved in innate and adaptive immunity with over 30% previously defined as interferon stimulated genes. We also showed that IRF8 target genes contributes to multiple aspects of the biology of mature B cells including critical components of the molecular crosstalk among GC B cells, T follicular helper cells, and follicular dendritic cells.	[Shin, Dong-Mi; Lee, Chang-Hoon; Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shin, DM (corresponding author), NIAID, Immunopathol Lab, NIH, Rockville, MD USA.	hmorse@niaid.nih.gov		Morse, Herbert/0000-0002-9331-3705	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001024, ZIAAI001057, ZIAAI000858] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeKoter RP, 2010, J IMMUNOL, V185, P7374, DOI 10.4049/jimmunol.1001413; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Hartley JW, 2000, LAB INVEST, V80, P159, DOI 10.1038/labinvest.3780020; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; MARECKI S, 2000, BIOCHEMISTRY-US, V33, P127; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Nelson N, 1996, J IMMUNOL, V156, P3711; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poovassery JS, 2009, J IMMUNOL, V183, P2974, DOI 10.4049/jimmunol.0900495; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sharf R, 1997, J BIOL CHEM, V272, P9785; Shin DM, 2008, CANCER RES, V68, P9202, DOI 10.1158/0008-5472.CAN-07-6555; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weigelt K, 2008, BIOTECHNIQUES, V45, P131, DOI 10.2144/000112819; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhou JX, 2009, J IMMUNOL, V183, P3188, DOI 10.4049/jimmunol.0803693	51	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27384	10.1371/journal.pone.0027384	http://dx.doi.org/10.1371/journal.pone.0027384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096565	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900039
J	Vanschoenwinkel, B; Mergeay, J; Pinceel, T; Waterkeyn, A; Vandewaerde, H; Seaman, M; Brendonck, L				Vanschoenwinkel, Bram; Mergeay, Joachim; Pinceel, Tom; Waterkeyn, Aline; Vandewaerde, Hanne; Seaman, Maitland; Brendonck, Luc			Long Distance Dispersal of Zooplankton Endemic to Isolated Mountaintops - an Example of an Ecological Process Operating on an Evolutionary Time Scale	PLOS ONE			English	Article							WATER ROCK POOLS; POPULATION-GROWTH; GENE FLOW; BRANCHIOPODA; DIVERSITY; PHYLOGEOGRAPHY; INSELBERGS; CRUSTACEA; DAPHNIA; SIZE	Recent findings suggest a convergence of time scales between ecological and evolutionary processes which is usually explained in terms of rapid micro evolution resulting in evolution on ecological time scales. A similar convergence, however, can also emerge when slow ecological processes take place on evolutionary time scales. A good example of such a slow ecological process is the colonization of remote aquatic habitats by passively dispersed zooplankton. Using variation at the protein coding mitochondrial COI gene, we investigated the balance between mutation and migration as drivers of genetic diversity in two Branchipodopsis fairy shrimp species (Crustacea, Anostraca) endemic to remote temporary rock pool clusters at the summit of isolated mountaintops in central South Africa. We showed that both species colonized the region almost simultaneously c. 0.8 My ago, but exhibit contrasting patterns of regional genetic diversity and demographic history. The haplotype network of the common B. cf. wolfi showed clear evidence of 11 long distance dispersal events (up to 140 km) with five haplotypes that are shared among distant inselbergs, as well as some more spatially isolated derivates. Similar patterns were not observed for B. drakensbergensis presumably since this rarer species experienced a genetic bottleneck. We conclude that the observed genetic patterns reflect rare historic colonization events rather than frequent ongoing gene flow. Moreover, the high regional haplotype diversity combined with a high degree of haplotype endemicity indicates that evolutionary- (mutation) and ecological (migration) processes in this system operate on similar time scales.	[Vanschoenwinkel, Bram; Mergeay, Joachim; Pinceel, Tom; Waterkeyn, Aline; Vandewaerde, Hanne; Brendonck, Luc] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Geraardsbergen, Belgium; [Seaman, Maitland] Univ Free State, Ctr Environm Management, Bloemfontein, South Africa	KU Leuven; Research Institute for Nature & Forest; University of the Free State	Vanschoenwinkel, B (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium.	bram.vanschoenwinkel@bio.kuleuven.be	Mergeay, Joachim/E-7670-2011; Vanschoenwinkel, Bram/I-9021-2019	Mergeay, Joachim/0000-0002-6504-0551; Vanschoenwinkel, Bram/0000-0002-8973-6297; Brendonck, Luc/0000-0001-5383-1420	Research Foundation, Flanders (FWO) [G.0118.03]	Research Foundation, Flanders (FWO)(FWO)	BV currently holds a postdoctoral fellowship with the Research Foundation, Flanders (FWO). This research was financially supported by project G.0118.03 of the FWO (Research Foundation, Flanders, http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2004, ZOOL J LINN SOC-LOND, V140, P171, DOI 10.1111/j.1096-3642.2003.00089.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BASKIN JM, 1988, J BIOGEOGR, V15, P829, DOI 10.2307/2845343; Beladjal L, 2009, J CRUSTACEAN BIOL, V29, P266, DOI 10.1651/08-3059R.1; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Bohonak AJ, 1998, CAN J ZOOL, V76, P2049, DOI 10.1139/cjz-76-11-2049; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bohonak AJ, 1999, HEREDITY, V82, P451, DOI 10.1038/sj.hdy.6885050; Bohonak AJ, 1999, LIMNOL OCEANOGR, V44, P487, DOI 10.4319/lo.1999.44.3.0487; Brendonck L, 2000, OECOLOGIA, V123, P506, DOI 10.1007/s004420000344; Brendonck L., 2000, African Journal of Aquatic Science, V25, P98, DOI 10.2989/160859100780177668; Brendonck L, 1997, J CRUSTACEAN BIOL, V17, P111, DOI 10.2307/1549468; Brendonck L, 2000, CRUSTACEAN ISS, V12, P109; Brendonck L, 2010, LIMNETICA, V29, P25; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Burke A, 2003, BIODIVERS CONSERV, V12, P469, DOI 10.1023/A:1022491723262; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper SJB, 2007, MOL ECOL, V16, P1533, DOI 10.1111/j.1365-294X.2007.03261.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hall AM, 2006, GEOGR ANN A, V88A, P135, DOI 10.1111/j.0435-3676.2006.00290.x; Hall T.A., 1999, BIOEDIT USER FRIENDL; Hamer M. L., 1996, Annals of the South African Museum, V104, P311; Hamer ML, 1998, HYDROBIOLOGIA, V384, P151, DOI 10.1023/A:1003251428494; Hulsmans A, 2007, LIMNOL OCEANOGR, V52, P676, DOI 10.4319/lo.2007.52.2.0676; Irwin D, 1992, FIELD GUIDE NATAL DR; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jocque M, 2010, FRESHWATER BIOL, V55, P1587, DOI 10.1111/j.1365-2427.2010.02402.x; Ketmaier V, 2005, J ZOOL, V266, P401, DOI 10.1017/S0952836905007041; Ketmaier V, 2003, J ZOOL SYST EVOL RES, V41, P276, DOI 10.1046/j.1439-0469.2003.00222.x; Macneale KH, 2005, FRESHWATER BIOL, V50, P1117, DOI 10.1111/j.1365-2427.2005.01387.x; MANTEL N, 1967, CANCER RES, V27, P209; Mergeay J, 2008, MOL ECOL, V17, P1789, DOI 10.1111/j.1365-294X.2007.03679.x; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Munoz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011932; Nathan R, 2008, SCIENCE, V322, P375; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Panov Vadim E., 2007, Monographiae Biologicae, V84, P187; Porembski S, 2000, PLANT ECOL, V151, P19, DOI 10.1023/A:1026565817218; Ray N., 2001, INTERNET ARCHAEOL, V11; Riddoch BJ, 1994, P GEN EV AQ ORG C, P96; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozen S., 2008, BIOINFORMATICS METHO, V132, P1064; Sanchez MI, 2007, MAR BIOL, V151, P1407, DOI 10.1007/s00227-006-0577-9; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2; Van de Meutter F, 2008, BIOL LETTERS, V4, P494, DOI 10.1098/rsbl.2008.0323; Van Doorslaer W, 2007, GLOBAL CHANGE BIOL, V13, P878, DOI 10.1111/j.1365-2486.2007.01317.x; Vandergast AG, 2009, MOL ECOL RESOUR, V9, P767, DOI 10.1111/j.1755-0998.2009.02522.x; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Vanschoenwinkel B, 2010, AQUAT ECOL, V44, P771, DOI 10.1007/s10452-010-9315-y; Vanschoenwinkel B, 2009, FRESHWATER BIOL, V54, P1487, DOI 10.1111/j.1365-2427.2009.02198.x; Willis B, 1934, ANN ASSOC AM GEOGR, V24, P123, DOI 10.2307/2560659; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161	67	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26730	10.1371/journal.pone.0026730	http://dx.doi.org/10.1371/journal.pone.0026730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102865	Green Published, gold			2022-12-25	WOS:000297348800009
J	Ambrose, C; Wasteneys, GO				Ambrose, Chris; Wasteneys, Geoffrey O.			Cell Edges Accumulate Gamma Tubulin Complex Components and Nucleate Microtubules following Cytokinesis in Arabidopsis thaliana	PLOS ONE			English	Article							ROOT-TIP CELLS; ADIANTUM-CAPILLUS-VENERIS; CORTICAL MICROTUBULES; PLANT-CELLS; NITELLA-TASMANICA; BRAIN TUBULIN; GUARD-CELLS; ORGANIZATION; ARRAYS; SITES	Microtubules emanate from distinct organizing centers in fungal and animal cells. In plant cells, by contrast, microtubules initiate from dispersed sites in the cell cortex, where they then self-organize into parallel arrays. Previous ultrastructural evidence suggested that cell edges participate in microtubule nucleation but so far there has been no direct evidence for this. Here we use live imaging to show that components of the gamma tubulin nucleation complex (GCP2 and GCP3) localize at distinct sites along the outer periclinal edge of newly formed crosswalls, and that microtubules grow predominantly away from these edges. These data confirm a role for cell edges in microtubule nucleation, and suggest that an asymmetric distribution of microtubule nucleation factors contributes to cortical microtubule organization in plants, in a manner more similar to other kingdoms than previously thought.	[Ambrose, Chris; Wasteneys, Geoffrey O.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Ambrose, C (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	geoffrey.wasteneys@ubc.ca	Wasteneys, Geoffrey/AGQ-5388-2022	Wasteneys, Geoffrey/0000-0002-8746-7994	Natural Science and Engineering Research Council of Canada [298264-2009]; Canadian Institutes of Health Research [MOP-86675]; UBC Bioimaging Facility	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UBC Bioimaging Facility	This research was funded by a Natural Science and Engineering Research Council of Canada Discovery Grant (298264-2009) and a Canadian Institutes of Health Research Operating grant (MOP-86675) and the UBC Bioimaging Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2008, MOL BIOL CELL, V19, P4730, DOI 10.1091/mbc.E08-06-0665; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; CLEARY AL, 1988, CAN J BOT, V66, P2353, DOI 10.1139/b88-320; FALCONER MM, 1988, PROTOPLASMA, V144, P46, DOI 10.1007/BF01320279; GALATIS B, 1980, J CELL SCI, V45, P211; GALATIS B, 1983, PROTOPLASMA, V115, P176, DOI 10.1007/BF01279808; GUNNING BES, 1980, EUR J CELL BIOL, V23, P53; GUNNING BES, 1978, PLANTA, V143, P161, DOI 10.1007/BF00387788; Kotzer AM, 2006, CAN J BOT, V84, P594, DOI 10.1139/B06-023; MCDONALD AR, 1993, PLANTA, V191, P357, DOI 10.1007/BF00195693; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; Panteris E, 2005, NEW PHYTOL, V167, P721, DOI 10.1111/j.1469-8137.2005.01464.x; PANTERIS E, 1991, PROTOPLASMA, V165, P173, DOI 10.1007/BF01322288; Pastuglia M, 2006, PLANT CELL, V18, P1412, DOI 10.1105/tpc.105.039644; Schmit AC, 2002, INT REV CYTOL, V220, P257; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; WASTENEYS GO, 1989, CELL BIOL INT REP, V13, P513; WASTENEYS GO, 1993, CELL MOTIL CYTOSKEL, V24, P205, DOI 10.1002/cm.970240308; WASTENEYS GO, 1989, J CELL SCI, V93, P705; Wasteneys GO, 2002, J CELL SCI, V115, P1345; WASTENEYS GO, 1993, BOT ACTA, V106, P136, DOI 10.1111/j.1438-8677.1993.tb00349.x	27	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27423	10.1371/journal.pone.0027423	http://dx.doi.org/10.1371/journal.pone.0027423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22110647	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800052
J	Ge, L; Smail, M; Meng, WX; Shyr, Y; Ye, F; Fan, KH; Li, XH; Zhou, HM; Bhowmick, NA				Ge, Lin; Smail, Matthew; Meng, Wenxia; Shyr, Yu; Ye, Fei; Fan, Kang-Hsien; Li, Xiaohong; Zhou, Hong-Mei; Bhowmick, Neil A.			Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; POOR-PROGNOSIS; GROWTH-CONTROL; HIPPO PATHWAY; YAP; CANCER; DELTA-NP63-ALPHA; OVEREXPRESSION; INHIBITION; DROSOPHILA	Introduction: Yes-associated protein (YAP) is considered an oncogene found amplified in multiple tumors, including head and neck squamous cell carcinoma (HNSCC). However, the role for YAP expression in HNSCC is not understood. Based on the central role of YAP in the hippo pathway, we tested if YAP was associated with the stage of HNSCC progression and metastatic potential. Methods: To determine the expression of YAP in human benign and HNSCC tissue specimens, immunohistochemical analyses were performed in whole tissue samples and tissue microarrays. The expression of YAP in tissues of microarray was first associated with clinic-pathologic factors and results verified in samples from whole tissue sections. To investigate the role of YAP and p63 in regulating HNSCC epithelial to mesenchymal transition, epithelial and mesenchymal markers were assayed in Fadu and SCC-25 cells, HNSCC cells with endogenously elevated YAP expression and siRNA-mediated expression knockdown. Results: Analysis of human HNSCC tissues suggested YAP expression was elevated in tumors compared to benign tissues and specifically localized at the tumor invasive front (p value <0.05). But, indexed YAP expression was lower with greater tumor grade (p value = 0.02). In contrast, p63 expression was primarily elevated in high-grade tumors. Interestingly, both YAP and p63 was strongly expressed at the tumor invasive front and in metastatic HNSCC. Strikingly, we demonstrated YAP expression in the primary HNSCC tumor was associated with nodal metastasis in univariate analysis (p value = 0.02). However, the knockdown of YAP in Fadu and SCC-25 cell lines was not associated with changes in epithelial to mesenchymal transdifferentiation or p63 expression. Conclusion: Together, YAP expression, in combination with p63 can facilitate identification of HNSCC tumors from hyperplastic and benign tissues and the metastatic function of YAP in HNSCC may not be a result of epithelia to mesenchymal transdifferentiation.	[Ge, Lin; Meng, Wenxia] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Smail, Matthew; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Shyr, Yu; Ye, Fei; Fan, Kang-Hsien] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Li, Xiaohong] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA; [Zhou, Hong-Mei] Sichuan Univ, Dept Oral Med, W China Hosp Stomatol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Cedars Sinai Medical Center; Vanderbilt University; Vanderbilt University; Sichuan University	Ge, L (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China.	acomnet@126.com; bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989; Fan, Kang-hsien/0000-0003-0121-3959; , Xiaohong/0000-0001-5074-193X; Zhou, Hongmei/0000-0003-2985-3536	National Natural Science Foundation of China [30872873]; Ministry of Education of China [20070610067]; State Scholarship Fund of China [2008624092]; National Cancer Institute/National Institute of Health [RO1 CA108646]; NATIONAL CANCER INSTITUTE [R01CA108646] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); State Scholarship Fund of China; National Cancer Institute/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Natural Science Foundation of China (No. 30872873 to H-MZ), the Doctoral Fund of the Ministry of Education of China (No. 20070610067 to H-MZ), and the State Scholarship Fund of China (No. 2008624092 to LG). It was also supported by the National Cancer Institute/National Institute of Health grant (RO1 CA108646 to NAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; BALDWIN C, 2005, CANCER RES, V65, P7; CAMARGO FD, 2007, CURRENT BIOL; Chatterjee A, 2010, CELL CYCLE, V9, P162, DOI 10.4161/cc.9.1.10321; Da CL, 2009, WORLD J GASTROENTERO, V15, P4055, DOI 10.3748/wjg.15.4055; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Lo Muzio L, 2005, HUM PATHOL, V36, P187, DOI 10.1016/j.humpath.2004.12.003; Martinez-Ferrer M, 2008, AM J PATHOL, V172, P59, DOI 10.2353/ajpath.2008.070529; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; NYLANDER K, 2002, J PATHOLOGY; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; Roperch JP, 2008, CANCER RES, V68, P8231, DOI 10.1158/0008-5472.CAN-08-1483; SNIJDERS AM, 2005, ONCOGENE; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Tomlins SA, 2006, CANCER CELL, V10, P2, DOI 10.1016/j.ccr.2006.06.013; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	28	63	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27529	10.1371/journal.pone.0027529	http://dx.doi.org/10.1371/journal.pone.0027529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096589	Green Submitted, gold, Green Published			2022-12-25	WOS:000297350800057
J	Namba, T; Tanaka, KI; Hoshino, T; Azuma, A; Mizushima, T				Namba, Takushi; Tanaka, Ken-Ichiro; Hoshino, Tatsuya; Azuma, Arata; Mizushima, Tohru			Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis	PLOS ONE			English	Article							CELL LUNG-CANCER; INDUCED GASTRIC-LESIONS; HEAT-SHOCK FACTOR-1; GENETIC-EVIDENCE; PROTECTIVE ROLE; MUCOSAL CELLS; DISEASE; ZD1839; EGFR; INDOMETHACIN	Drug-induced interstitial lung disease (ILD), particularly pulmonary fibrosis, is of serious clinical concern. Gefitinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), is beneficial as a drug for treating non-small cell lung cancer; however, this drug induces ILD and the molecular mechanisms underpinning this condition remain unclear. We recently reported that expression of heat shock protein 70 (HSP70) protects against bleomycin-induced pulmonary fibrosis, an animal model of pulmonary fibrosis. In this study, we have examined the effects of drugs known to induce ILD clinically on the expression of HSP70 in cultured lung epithelial cells and have found that gefitinib has a suppressive effect. Results of a luciferase reporter assay, pulse-labelling analysis of protein and experiments using an inhibitor of translation or transcription suggest that gefitinib suppresses the expression of HSP70 at the level of translation. Furthermore, the results of experiments with siRNA for Dicer1, an enzyme responsible for synthesis of microRNA, and real-time RT-PCR analysis suggest that some microRNAs are involved in the gefitinib-induced translational inhibition of HSP70. Mutations in the EGFR affect the concentration of gefitinib required for suppressing the expression of HSP70. These results suggest that gefitinib suppresses the translation of HSP70 through an EGFR-and microRNA-mediated mechanism. In vivo, while oral administration of gefitinib suppressed the pulmonary expression of HSP70 and exacerbated bleomycin-induced pulmonary fibrosis in wild-type mice, these effects were not as distinct in transgenic mice expressing HSP70. Furthermore, oral co-administration of geranylgeranylacetone (GGA), an inducer of HSP70, suppressed gefitinib-induced exacerbation of bleomycin-induced pulmonary fibrosis. Taken together, these findings suggest that gefitinib-induced exacerbation of bleomycin-induced pulmonary fibrosis is mediated by suppression of pulmonary expression of HSP70 and that an inducer of HSP70 expression, such as GGA, may be therapeutically beneficial for the treatment of gefitinib-induced pulmonary fibrosis.	[Namba, Takushi; Tanaka, Ken-Ichiro; Hoshino, Tatsuya; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto, Japan; [Azuma, Arata] Nippon Med Sch, Dept Internal Med, Div Resp Infect & Oncol, Tokyo 113, Japan; [Mizushima, Tohru] Keio Univ, Fac Pharm, Dept Analyt Chem, Tokyo, Japan	Kumamoto University; Nippon Medical School; Keio University	Namba, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto, Japan.	mizu@gpo.kumamoto-u.ac.jp		Azuma, Arata/0000-0003-0506-9966; Tanaka, Ken-ichiro/0000-0003-1893-0751	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid of Scientific Research from the Ministry of Health, Labour, and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/), and Grants-in-Aid of the Japan Science and Technology Agency (http://www.jst.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Blackledge G, 2004, BRIT J CANCER, V90, P566, DOI 10.1038/sj.bjc.6601550; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camus P, 2004, RESPIRATION, V71, P301, DOI 10.1159/000079633; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Flieder DB, 2004, CLIN CHEST MED, V25, P37, DOI 10.1016/S0272-5231(03)00138-2; Fujibayashi Takayoshi, 2009, BMC Pulm Med, V9, P45, DOI 10.1186/1471-2466-9-45; Fumeaux T, 2001, INTENS CARE MED, V27, P1868, DOI 10.1007/s00134-001-1150-0; Gridelli C, 2007, ONCOLOGIST, V12, P840, DOI 10.1634/theoncologist.12-7-840; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kataoka K, 2006, RESP MED, V100, P698, DOI 10.1016/j.rmed.2005.07.015; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li J, 2006, JNCI-J NATL CANCER I, V98, P1714, DOI 10.1093/jnci/djj466; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Miyata H, 2006, INT J ONCOL, V28, P915; Moon DO, 2007, ACTA PHARMACOL SIN, V28, P1205, DOI 10.1111/j.1745-7254.2007.00615.x; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Namba T, 2010, CELL DEATH DIFFER, V17, P1882, DOI 10.1038/cdd.2010.64; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Ono M, 2004, MOL CANCER THER, V3, P465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Suzuki H, 2003, CANCER RES, V63, P5054; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tomisato W, 2000, DIGEST DIS SCI, V45, P1674, DOI 10.1023/A:1005597902470; Van Schaeybroeck S, 2006, MOL CANCER THER, V5, P1154, DOI 10.1158/1535-7163.MCT-05-0446; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007	51	33	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27296	10.1371/journal.pone.0027296	http://dx.doi.org/10.1371/journal.pone.0027296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096546	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800041
J	Paget, JA; Restall, IJ; Daneshmand, M; Mersereau, JA; Simard, MA; Parolin, DAE; Lavictoire, SJ; Amin, MS; Islam, S; Lorimer, IAJ				Paget, J. A.; Restall, I. J.; Daneshmand, M.; Mersereau, J. A.; Simard, M. A.; Parolin, D. A. E.; Lavictoire, S. J.; Amin, M. S.; Islam, S.; Lorimer, I. A. J.			Repression of cancer cell senescence by PKC iota	ONCOGENE			English	Article						atypical protein kinase-C; PIK3CA; breast cancer; glioblastoma; senescence; aurora kinase	KINASE-C-IOTA; SUPPRESSES TUMOR-GROWTH; BREAST-CANCER; IN-VIVO; PIK3CA MUTATIONS; CYCLE ARREST; AURORA-A; PROTEIN; ONCOGENE; PHOSPHORYLATION	Senescence is an irreversible growth arrest phenotype adopted by cells that has a key role in protecting organisms from cancer. There is now considerable interest in therapeutic strategies that reactivate this process to control the growth of cancer cells. Protein kinase-C iota (PKC iota) is a member of the atypical PKC family and an important downstream mediator in the phosphoinositide-3-kinase (PI-3-kinase) pathway. PKC iota expression was found to be upregulated in a subset of breast cancers and breast cancer cell lines. Activation of the PI-3-kinase pathway by introduction of mutant, oncogenic PIK3CA into breast mammary epithelial cells increased both the expression and activation of PKC iota. In breast cancer cells lines overexpressing PKC iota, depletion of PKC iota increased the number of senescent cells, as assessed by senescence-associated beta-galactosidase, morphology and bromodeoxyuridine incorporation. This phenomenon was not restricted to breast cancer cells, as it was also seen in glioblastoma cells in which PKC iota is activated by loss of PTEN. Senescence occurred in the absence of a detectable DNA-damage response, was dependent on p21 and was enhanced by the aurora kinase inhibitor VX-680, suggesting that senescence is triggered by defects in mitosis. Depletion of PKCi had no effect on senescence in normal mammary epithelial cell lines. We conclude that PKC iota is overexpressed in a subset of cancers where it functions to suppress premature senescence. This function appears to be restricted to cancer cells and inhibition of PKC iota may therefore be an effective way to selectively activate premature senescence in cancer cells. Oncogene (2012) 31, 3584-3596; doi:10.1038/onc.2011.524; published online 28 November 2011	[Lorimer, I. A. J.] Ottawa Hosp, Reg Canc Ctr, Ctr Canc Therapeut, Res Inst, Ottawa, ON K1H 8L6, Canada; [Paget, J. A.; Restall, I. J.; Lorimer, I. A. J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Amin, M. S.; Islam, S.] Ottawa Hosp, Dept Pathol, Ottawa, ON K1H 8L6, Canada; [Lorimer, I. A. J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Lorimer, IAJ (corresponding author), Ottawa Hosp, Reg Canc Ctr, Ctr Canc Therapeut, Res Inst, 3rd Floor,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	ilorimer@ohri.ca		Simard, Manon/0000-0001-5363-1699	Canadian Institutes of Health Research; Ottawa Regional Cancer Foundation; Canadian Institutes of Health Research Banting; Best MSc Scholarship; Ontario Graduate Scholarship in Science and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation; Canadian Institutes of Health Research Banting(Canadian Institutes of Health Research (CIHR)); Best MSc Scholarship; Ontario Graduate Scholarship in Science and Technology	This work was supported by grants from the Canadian Institutes of Health Research and the Ottawa Regional Cancer Foundation (to IAJL). JP was supported by a Canadian Institutes of Health Research Banting and Best MSc Scholarship. IR is supported by an Ontario Graduate Scholarship in Science and Technology. We thank Sharon Rowan and Mara Coiciu for their work on the initial characterization of PKC iota activation in breast cancer cells.	Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baldwin RM, 2008, ONCOGENE, V27, P3587, DOI 10.1038/sj.onc.1211027; Baldwin RM, 2006, ONCOGENE, V25, P2909, DOI 10.1038/sj.onc.1209312; Baldwin RM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-233; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; HERMAN JG, 1995, CANCER RES, V55, P4525; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lorimer IAJ, 2000, J IMMUNOL METHODS, V237, P147, DOI 10.1016/S0022-1759(99)00219-7; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; OConnor PM, 1997, CANCER RES, V57, P4285; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	51	25	26	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	31					3584	3596		10.1038/onc.2011.524	http://dx.doi.org/10.1038/onc.2011.524			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22120720				2022-12-25	WOS:000307245600002
J	Bjorkman, M; Ostling, P; Harma, V; Virtanen, J; Mpindi, JP; Rantala, J; Mirtti, T; Vesterinen, T; Lundin, M; Sankila, A; Rannikko, A; Kaivanto, E; Kohonen, P; Kallioniemi, O; Nees, M				Bjorkman, M.; Ostling, P.; Harma, V.; Virtanen, J.; Mpindi, J-P; Rantala, J.; Mirtti, T.; Vesterinen, T.; Lundin, M.; Sankila, A.; Rannikko, A.; Kaivanto, E.; Kohonen, P.; Kallioniemi, O.; Nees, M.			Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion	ONCOGENE			English	Article						prostate cancer; epigenetics; histone demethylase; migration; invasion; PHF8	LINKED MENTAL-RETARDATION; ANDROGEN-RECEPTOR; GLOBAL LEVELS; PREDICT RISK; PHD FINGERS; GENE; LYSINE-4; METHYLATION; H3; TRANSCRIPTION	Our understanding of key epigenetic regulators involved in specific biological processes and cancers is still incomplete, despite great progress in genome-wide studies of the epigenome. Here, we carried out a systematic, genome-wide analysis of the functional significance of 615 epigenetic proteins in prostate cancer (PrCa) cells. We used the high-content cell-spot microarray technology and siRNA silencing of PrCa cell lines for functional screening of cell proliferation, survival, androgen receptor (AR) expression, histone methylation and acetylation. Our study highlights subsets of epigenetic enzymes influencing different cancer cell phenotypes. Plant homeo domain (PHD) finger proteins have a key role in cell survival and histone methylation, whereas histone deacetylases were primarily involved in regulating AR expression. In contrast, JumonjiC-domain (JmjC) containing histone lysine demethylases (KDMs) mainly had an impact on cell proliferation. Our results show that the KDMs JARID1B, PHF8, KDM3A, KDM3B and KDM4A were highly expressed in clinical PrCa samples. The PHD-finger protein 8 (PHF8), a transcriptional coactivator with both PHD- and JmjC-domains, was moderately to strongly expressed in 80% of clinical PrCa samples, whereas 76% of normal and benign samples were negative or only showed weak PHF8 expression. Strong PHF8 expression correlated significantly with high Gleason grade and was borderline significant for poor prognosis. The results of functional PHF8 knockdown implicate a role in cell migration and invasion, as shown by cell motility and 3-D invasion assays. Our study suggests that various cellular phenotypes are regulated by distinct subsets of epigenetic enzymes. Proteins interpreting and modifying histone methylation, such as JmjC-domain and particularly PHD-finger proteins like PHF8, are activated in subsets of PrCa's and promote cancer relevant phenotypes. Oncogene (2012) 31, 3444-3456; doi:10.1038/onc.2011.512; published online 28 November 2011	[Bjorkman, M.; Ostling, P.; Harma, V.; Virtanen, J.; Mpindi, J-P; Rantala, J.; Kaivanto, E.; Kohonen, P.; Kallioniemi, O.; Nees, M.] VTT Tech Res Ctr Finland, FI-20520 Turku, Varsinais Suomi, Finland; [Bjorkman, M.; Ostling, P.; Harma, V.; Virtanen, J.; Mpindi, J-P; Rantala, J.; Kaivanto, E.; Kohonen, P.; Kallioniemi, O.; Nees, M.] Univ Turku, Ctr Biotechnol, FI-20520 Turku, Varsinais Suomi, Finland; [Bjorkman, M.; Ostling, P.; Harma, V.; Virtanen, J.; Mpindi, J-P; Rantala, J.; Kaivanto, E.; Kohonen, P.; Kallioniemi, O.; Nees, M.] Abo Akad Univ, FI-20520 Turku, Varsinais Suomi, Finland; [Ostling, P.; Mpindi, J-P; Mirtti, T.; Vesterinen, T.; Lundin, M.; Sankila, A.; Kallioniemi, O.] Univ Helsinki, FIMM, Helsinki, Finland; [Rannikko, A.] Univ Helsinki, Dept Urol, HUSLAB, Helsinki, Finland	VTT Technical Research Center Finland; University of Turku; Abo Akademi University; University of Helsinki; University of Helsinki	Nees, M (corresponding author), VTT Tech Res Ctr Finland, FI-20520 Turku, Varsinais Suomi, Finland.	matthias.nees@vtt.fi	Rannikko, Antti/ABB-8453-2020; Kohonen, Pekka/F-9596-2011; Nees, Matthias/AAT-5577-2020; Kallioniemi, Olli P/H-5111-2011; Vesterinen, Tiina J/O-8922-2016; Nees, Matthias/W-6596-2018	Rannikko, Antti/0000-0002-4261-3484; Kohonen, Pekka/0000-0002-7845-3611; Kallioniemi, Olli P/0000-0002-3231-0332; Nees, Matthias/0000-0002-9034-301X; Ostling, Paivi/0000-0001-5501-466X; Vesterinen, Tiina/0000-0003-2997-0337; Harma, Ville/0000-0001-5767-5226; Mirtti, Tuomas/0000-0003-0455-9891; Rantala, Juha/0000-0002-4999-5585	Academy of Finland [111456]; EU-EPITRON [LSHC-CT-2005-518417]; Marie Curie Canceromics [MEXT-CT-2003-2728]; Cancer Organizations Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); EU-EPITRON(European Commission); Marie Curie Canceromics(European Commission); Cancer Organizations Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	We thank Professor Tony Kouzarides from The Gurdon Institute, University of Cambridge for valuable suggestions and insights in constructing the epigenetic siRNA library. We thank Daniela Kleine-Kohlbrecher and Professor Kristian Helin from Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Denmark, for insightful discussions, sharing unpublished results and PHF8 over expression construct. We thank Arho Virkki and Elmar Bucher for assistance with gene expression data normalization. This study was supported by grants from Academy of Finland (grant Nr. 111456 to MN, VH), EU-EPITRON (contract # LSHC-CT-2005-518417 to MB, OK), Marie Curie Canceromics (MEXT-CT-2003-2728 to OK), Cancer Organizations Finland and Sigrid Juselius Foundation (JPM, JR).	Abbott A, 2010, NATURE, V463, P596, DOI 10.1038/463596b; Abidi FE, 2007, CLIN GENET, V72, P19, DOI 10.1111/j.1399-0004.2007.00817.x; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bianco-Miotto T, 2010, CANCER EPIDEM BIOMAR, V19, P2611, DOI 10.1158/1055-9965.EPI-10-0555; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bjorkman M, 2008, INT J CANCER, V123, P2774, DOI 10.1002/ijc.23885; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ellinger J, 2010, PROSTATE, V70, P61, DOI 10.1002/pros.21038; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Flamand V, 2010, J CANCER RES CLIN, V136, P1761, DOI 10.1007/s00432-010-0835-6; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Holst CR, 2003, CANCER RES, V63, P1596; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Qiao Y, 2008, CLIN GENET, V74, P134, DOI 10.1111/j.1399-0004.2008.01028.x; Rantala JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-162; Rantala JK, 2010, NEOPLASIA, V12, P877, DOI 10.1593/neo.10548; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wolf SS, 2007, ARCH BIOCHEM BIOPHYS, V460, P56, DOI 10.1016/j.abb.2007.01.017; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	58	80	84	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	29					3444	3456		10.1038/onc.2011.512	http://dx.doi.org/10.1038/onc.2011.512			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	976FN	22120715				2022-12-25	WOS:000306566400005
J	Beisang, D; Rattenbacher, B; Vlasova-St Louis, IA; Bohjanen, PR				Beisang, Daniel; Rattenbacher, Bernd; Vlasova-St Louis, Irina A.; Bohjanen, Paul R.			Regulation of CUG-binding Protein 1 (CUGBP1) Binding to Target Transcripts upon T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; GU-RICH ELEMENTS; GENE-EXPRESSION; INCREASES TRANSLATION; COORDINATE REGULATION; MYOTONIC-DYSTROPHY; BETA; IL-2; ABNORMALITIES; STABILITY	The RNA-binding protein, CUG-binding protein 1 (CUGBP1), regulates gene expression at the levels of alternative splicing, mRNA degradation, and translation. We used RNA immunoprecipitation followed by microarray analysis to identify the cytoplasmic mRNA targets of CUGBP1 in resting and activated primary human T cells and found that CUGBP1 targets were highly enriched for the presence of GU-rich elements (GREs) in their 3'-untranslated regions. The number of CUGBP1 target transcripts decreased dramatically following T cell activation as a result of activation-dependent phosphorylation of CUGBP1 and decreased ability of CUGBP1 to bind to GRE-containing RNA. A large percentage of CUGBP1 target transcripts exhibited rapid and transient up-regulation, and a smaller percentage exhibited transient down-regulation following T cell activation. Many of the transiently up-regulated CUGBP1 target transcripts encode important regulatory proteins necessary for transition from a quiescent state to a state of cellular activation and proliferation. Overall, our results show that CUGBP1 binding to certain GRE-containing target transcripts decreased following T cell activation through activation-dependent phosphorylation of CUGBP1.	[Beisang, Daniel; Rattenbacher, Bernd; Vlasova-St Louis, Irina A.; Bohjanen, Paul R.] Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Beisang, Daniel; Rattenbacher, Bernd; Vlasova-St Louis, Irina A.; Bohjanen, Paul R.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bohjanen, Paul R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bohjanen, PR (corresponding author), Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, 3-214 MTRF,2001 6th St SE, Minneapolis, MN 55455 USA.	Bohja001@umn.edu	Bohjanen, Paul/B-2329-2015; Louis, Vlasova-St./ABC-1933-2020; Louis, Irina Vlasova-St/B-1254-2009	Bohjanen, Paul/0000-0002-2772-3597; Louis, Irina Vlasova-St/0000-0003-0795-4723; Rattenbacher, Bernd/0000-0003-1435-0100	National Institutes of Health [AIO57484, AIO72068, 3T32GM8244-24S1]; Swiss National Science Foundation; Lymphoma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI096925, R01AI072068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lymphoma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AIO57484 and AIO72068 (to P. R. B.).; Supported by National Institutes of Health Medical Scientist Training Program Grant 3T32GM8244-24S1.; Supported by a postdoctoral fellowship from the Swiss National Science Foundation. Present address: Dept. of Clinical Research, Institute of internal medicine, University of Bern, 3010 Bern, Switzerland.; Supported by a fellowship from the Lymphoma Research Foundation.	Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Choi WT, 2007, CANCER GENET CYTOGEN, V177, P108, DOI 10.1016/j.cancergencyto.2007.07.002; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Han J, 2005, NUCLEIC ACIDS RES, V33, P2769, DOI 10.1093/nar/gki561; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Liu X, 2001, Pac Symp Biocomput, P127; Merup M, 1998, MED ONCOL, V15, P79, DOI 10.1007/BF02989584; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pearson PL, 1998, J INTERN MED, V243, P413; Raghavan A, 2004, GENOMICS, V84, P1002, DOI 10.1016/j.ygeno.2004.08.007; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Vlasova IA, 2005, GENOMICS, V86, P159, DOI 10.1016/j.ygeno.2005.04.013; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Vlasova-St Louis I, 2011, CURR OPIN GENET DEV, V21, P444, DOI 10.1016/j.gde.2011.03.002; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976; Whistler T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-496; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200	38	42	43	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					950	960		10.1074/jbc.M111.291658	http://dx.doi.org/10.1074/jbc.M111.291658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117072	Green Published, hybrid			2022-12-25	WOS:000299170300013
J	Wu, YL; Sommers, JA; Khan, I; de Winter, JP; Brosh, RM				Wu, Yuliang; Sommers, Joshua A.; Khan, Irfan; de Winter, Johan P.; Brosh, Robert M., Jr.			Biochemical Characterization of Warsaw Breakage Syndrome Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA SUBSTRATE-SPECIFICITY; GENOMIC STABILITY; FANCONI-ANEMIA; G-QUADRUPLEX; HOLLIDAY JUNCTIONS; PAPILLOMAVIRUS E2; REPLICATION FORKS; ESCHERICHIA-COLI; BREAST-CANCER	Mutations in the human ChlR1 gene are associated with a unique genetic disorder known as Warsaw breakage syndrome characterized by cellular defects in sister chromatid cohesion and hypersensitivity to agents that induce replication stress. A role of ChlR1 helicase in sister chromatid cohesion was first evidenced by studies of the yeast homolog Chl1p; however, its cellular functions in DNA metabolism are not well understood. We carefully examined the DNA substrate specificity of purified recombinant human ChlR1 protein and the biochemical effect of a patient-derived mutation, a deletion of a single lysine (K897del) in the extreme C terminus of ChlR1. The K897del clinical mutation abrogated ChlR1 helicase activity on forked duplex or D-loop DNA substrates by perturbing its DNA binding and DNA-dependent ATPase activity. Wild-type ChlR1 required a minimal 5' single-stranded DNA tail of 15 nucleotides to efficiently unwind a simple duplex DNA substrate. The additional presence of a 3' single-stranded DNA tail as short as five nucleotides dramatically increased ChlR1 helicase activity, demonstrating the preference of the enzyme for forked duplex structures. ChlR1 unwound G-quadruplex (G4) DNA with a strong preference for a two-stranded antiparallel G4 (G2') substrate and was only marginally active on a four-stranded parallel G4 structure. The marked difference in ChlR1 helicase activity on the G4 substrates, reflected by increased binding to the G2' substrate, distinguishes ChlR1 from the sequence-related FANCJ helicase mutated in Fanconi anemia. The biochemical results are discussed in light of the known cellular defects associated with ChlR1 deficiency.	[Wu, Yuliang; Sommers, Joshua A.; Khan, Irfan; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [de Winter, Johan P.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020		National Institutes of Health of the NIA; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING [ZIAAG000753, ZIAAG000752, ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health of the NIA; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIA (to R. M. B.). This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Feeney KM, 2011, VIROLOGY, V414, P1, DOI 10.1016/j.virol.2011.03.015; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Nakagawa T, 2002, J BIOL CHEM, V277, P28019, DOI 10.1074/jbc.M204165200; Ozsoy AZ, 2003, NUCLEIC ACIDS RES, V31, P1554, DOI 10.1093/nar/gkg243; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Schultze P, 1999, NUCLEIC ACIDS RES, V27, P3018, DOI 10.1093/nar/27.15.3018; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	44	73	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1007	1021		10.1074/jbc.M111.276022	http://dx.doi.org/10.1074/jbc.M111.276022			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102414	Green Published, hybrid			2022-12-25	WOS:000299170300018
J	Lee, HS; Lee, JC; Lee, IK; Moon, HB; Chang, YS; Jacobs, DR; Lee, DH				Lee, Hae-Sook; Lee, Je-Chul; Lee, In-Kyu; Moon, Hyo-Bang; Chang, Yoon-Seok; Jacobs, David R., Jr.; Lee, Duk-Hee			Associations among Organochlorine Pesticides, Methanobacteriales, and Obesity in Korean Women	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; HUMAN GUT MICROBIOTA; SERUM CONCENTRATIONS; METABOLIC SYNDROME; ADIPOSE-TISSUE; WEIGHT-LOSS; INTESTINAL METHANOGENESIS; NONDIABETIC ADULTS; TOXIC POLLUTANTS; NATIONAL-HEALTH	Background: Although Methanobacteriales in the gut has recently been linked to obesity, no study has examined the hypothesis that waist circumference, a marker of visceral obesity, are positively associated with Methanobacteriales in the general population. Since Methanobacteriales increase in a petroleum-contaminated environment to biodegrade petroleum as one way of autopurification, we also hypothesized that high body burden of highly lipophilic petroleum-based chemicals like organochlorine pesticides (OCPs) is associated with higher levels of Methanobacteriales in the gut. Methodology/Principal Findings: Among 83 Korean women who visited a community health service center for a routine health checkup, quantitative real-time PCR (qPCR) based on 16S rDNA was used to quantify Methanobacteriales in feces. Nine OCPs were measured in both serum and feces of 16 subjects. Methanobacteriales were detected in 32.5% (27/83 women). Both BMI and waist circumference among women with Methanobacteriales were significantly higher than in women without Methanobacteriales (P = 0.04 and P = 0.01, respectively). Also, Methanobacteriales levels in feces were positively associated with BMI and waist circumference (r = +0.23 and P = 0.03 for both). Furthermore, there were significant correlations between feces Methanobacteriales levels and serum concentrations of most OCPs, including with cis-nonachlor (r = +0.53, P < 0.05), oxychlordane (r = +0.46, P < 0.1), and trans-nonachlor (r = +0.43, P < 0.1). Despite high correlations of serum and feces concentrations of most OCPs, feces OCP concentrations were not clearly associated with feces Methanobacteriales levels. Conclusion/Significance: In this cross-sectional study, the levels of Methanobacteriales in the human gut were associated with higher body weight and waist circumference. In addition, serum OCP concentrations were positively correlated with levels of Methanobacteriales. There may be a meaningful link among body burden of OCP, Methanobacteriales in the gut, and obesity in the general population.	[Lee, Hae-Sook] Kyungpook Natl Univ, Dept Publ Hlth, Grad Sch, Taegu, South Korea; [Lee, Je-Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Endocrinol, Taegu, South Korea; [Moon, Hyo-Bang] Hanyang Univ, Coll Sci & Technol, Dept Environm Marine Sci, Ansan, South Korea; [Chang, Yoon-Seok] POSTECH, Sch Environm Sci & Engn, Pohang, South Korea; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Hanyang University; Pohang University of Science & Technology (POSTECH); University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Kyungpook National University	Lee, HS (corresponding author), Kyungpook Natl Univ, Dept Publ Hlth, Grad Sch, Taegu, South Korea.	lee_dh@knu.ac.kr	Moon, Hyo-Bang/M-7676-2017; Lee, In-Kyu/AAR-6374-2021	Moon, Hyo-Bang/0000-0001-6618-2036; Jacobs, David/0000-0002-7232-0543; Chang, Yoon-Seok/0000-0002-0623-2932	National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0004692]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (no. 2011-0004692). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Atlas R M, 1988, Basic Life Sci, V45, P211; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Chevrier J, 2000, INT J OBESITY, V24, P1272, DOI 10.1038/sj.ijo.0801380; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Florin THJ, 2000, AM J GASTROENTEROL, V95, P2872, DOI 10.1016/S0002-9270(00)01111-4; Gray ND, 2010, ADV APPL MICROBIOL, V72, P137, DOI 10.1016/S0065-2164(10)72005-0; HACKSTEIN JHP, 1995, DEUT TIERARZTL WOCH, V102, P152; HUDSON MJ, 1993, SCAND J GASTROENTERO, V28, P993, DOI 10.3109/00365529309098298; Hue O, 2006, OBES SURG, V16, P1145, DOI 10.1381/096089206778392356; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lim JS, 2011, INT J OBESITY, V35, P744, DOI 10.1038/ijo.2010.188; Lim JS, 2008, DIABETES CARE, V31, P1802, DOI 10.2337/dc08-0850; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Rozman K, 1985, Arch Toxicol Suppl, V8, P87; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; SEGAL I, 1988, GUT, V29, P608, DOI 10.1136/gut.29.5.608; Stellman SD, 1998, CANCER EPIDEM BIOMAR, V7, P489; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wajchenberg BL, 2009, ARQ BRAS ENDOCRINOL, V53, P145, DOI 10.1590/S0004-27302009000200005; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	32	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27773	10.1371/journal.pone.0027773	http://dx.doi.org/10.1371/journal.pone.0027773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114690	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800034
J	Thomas, SK; Iravatham, CC; Moni, BH; Kumar, A; Archana, BV; Majid, M; Priyadarshini, Y; Rani, PS; Valluri, V; Hasnain, SE; Ahmed, N				Thomas, Shirly K.; Iravatham, Chitra C.; Moni, Bottu Heleena; Kumar, Ashutosh; Archana, Bandaru V.; Majid, Mohammad; Priyadarshini, Yerra; Rani, Pittu Sandhya; Valluri, Vijayalakshmi; Hasnain, Seyed E.; Ahmed, Niyaz			Modern and Ancestral Genotypes of Mycobacterium tuberculosis from Andhra Pradesh, India	PLOS ONE			English	Article							STRAIN DIFFERENTIATION; EPIDEMIOLOGY; PREDOMINANCE; COMPLEX; DIVERSITY; BACTERIA; LINEAGES; DELHI	Traditionally, the distribution of the Mycobacterium tuberculosis genotypes in India has been characterized by widespread prevalence of ancestral lineages (TbD1+ strains and variants) in the south and the modern forms (TbD1(-) CAS and variants) predominating in the north of India. The pattern was, however, not clearly known in the south-central region such as Hyderabad and the rest of the state of Andhra Pradesh where the prevalence of both tuberculosis (TB) and human immunodeficiency virus (HIV) infection is one of the highest in the country; this area has been the hotspot of TB vaccine trials. Spoligotyping of 101 clinical isolates obtained from Hyderabad and rural Andhra Pradesh confirmed the occurrence of major genogroups such as the ancestral (or the TbD1+ type or the East African Indian (EAI) type), the Central Asian (CAS) or Delhi type and the Beijing lineage in Andhra Pradesh. Sixty five different spoligotype patterns were observed for the isolates included in this study; these were further analyzed based on specific genetic signatures/mutations. It was found that the major genogroups, CAS and "ancestral,'' were almost equally prevalent in our collection but followed a north-south compartmentalization as was also reported previously. However, we observed a significant presence of MANU lineage in south Andhra Pradesh, which was earlier reported to be overwhelmingly present in Mumbai. This study portrays genotypic diversity of M. tuberculosis from the Indian state of Andhra Pradesh and provides a much needed snapshot of the strain diversity that will be helpful in devising effective TB control programs in this part of the world.	[Thomas, Shirly K.; Archana, Bandaru V.; Hasnain, Seyed E.; Ahmed, Niyaz] Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Iravatham, Chitra C.; Valluri, Vijayalakshmi] Bhagwan Mahavir Hosp & Res Ctr, AC Guards, Hyderabad, Andhra Pradesh, India; [Moni, Bottu Heleena; Kumar, Ashutosh; Majid, Mohammad; Priyadarshini, Yerra; Rani, Pittu Sandhya; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Pathogen Biol Lab, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Valluri, Vijayalakshmi] Blue Peter Res Ctr Lepra India, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Technol, Sch Biol Sci, New Delhi, India; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia	University of Hyderabad; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Universiti Malaya	Thomas, SK (corresponding author), Inst Life Sci, Univ Hyderabad Campus, Hyderabad, Andhra Pradesh, India.	niyazSL@uohyd.ernet.in	Ahmed, Niyaz/D-2589-2010	Ahmed, Niyaz/0000-0001-6425-7583; Hasnain, Seyed/0000-0002-2967-0791; Heleena Moni, Bottu/0000-0003-3280-5180	Department of Biotechnology of the Indian Government [BT/01/CoE/07/02]; Indian Council of Medical Research	Department of Biotechnology of the Indian Government; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was funded under the Centre of Excellence Program of the Department of Biotechnology of the Indian Government (Ref. BT/01/CoE/07/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our sincere thanks are due to the late K. J. R. Murthy. We are thankful for the guidance and support provided by V. M. Katoch, Director General, Indian Council of Medical Research, as well as technical assistance provided by Pragya Sharma, National JALMA Institute of Leprosy and other Mycobacterial Diseases, Agra, India. This work represents part of the doctoral research of Chitra Iravatham. We are thankful to our collaborators for providing genomic DNA of mycobacterial isolates and Aparna Srikantam for suggestions. We would like to extend special thanks to Christa Ewers for help with the use of Bionumerics (R) program.	Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed N, 2011, TUBERCULOSIS, V91, P407, DOI 10.1016/j.tube.2011.03.006; Ahmed N, 2009, INFECT GENET EVOL, V9, P142, DOI 10.1016/j.meegid.2008.10.001; Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chatterjee A, 2010, J CLIN MICROBIOL, V48, P3593, DOI 10.1128/JCM.00430-10; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Helal ZH, 2009, J CLIN MICROBIOL, V47, P2794, DOI 10.1128/JCM.00360-09; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; Tuberculosis Research Centre (now National Institute for Research in Tuberculosis) Chennai, 2010, STAND OP PROC MYC LA; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003	22	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27584	10.1371/journal.pone.0027584	http://dx.doi.org/10.1371/journal.pone.0027584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114678	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800026
J	Garrels, W; Holler, S; Taylor, U; Herrmann, D; Struckmann, C; Klein, S; Barg-Kues, B; Nowak-Imialek, M; Ehling, C; Rath, D; Ivics, Z; Niemann, H; Kues, WA				Garrels, Wiebke; Holler, Stephanie; Taylor, Ulrike; Herrmann, Doris; Struckmann, Christina; Klein, Sabine; Barg-Kues, Brigitte; Nowak-Imialek, Monika; Ehling, Christine; Rath, Detlef; Ivics, Zoltan; Niemann, Heiner; Kues, Wilfried A.			Genotype-Independent Transmission of Transgenic Fluorophore Protein by Boar Spermatozoa	PLOS ONE			English	Article							SLEEPING-BEAUTY; FARM-ANIMALS; MESSENGER-RNA; TRANSPOSON; EXPRESSION; CELLS; PIGS; IDENTIFICATION; TRANSCRIPTS; STRATEGIES	Recently, we generated transposon-transgenic boars (Sus scrofa), which carry three monomeric copies of a fluorophore marker gene. Amazingly, a ubiquitous fluorophore expression in somatic, as well as in germ cells was found. Here, we characterized the prominent fluorophore load in mature spermatozoa of these animals. Sperm samples were analyzed for general fertility parameters, sorted according to X and Y chromosome-bearing sperm fractions, assessed for potential detrimental effects of the reporter, and used for inseminations into estrous sows. Independent of their genotype, all spermatozoa were uniformly fluorescent with a subcellular compartmentalization of the fluorophore protein in postacrosomal sheath, mid piece and tail. Transmission of the fluorophore protein to fertilized oocytes was shown by confocal microscopic analysis of zygotes. The monomeric copies of the transgene segregated during meiosis, rendering a certain fraction of the spermatozoa non-transgenic (about 10% based on analysis of 74 F1 offspring). The genotype-independent transmission of the fluorophore protein by spermatozoa to oocytes represents a non-genetic contribution to the mammalian embryo.	[Garrels, Wiebke; Holler, Stephanie; Taylor, Ulrike; Herrmann, Doris; Struckmann, Christina; Klein, Sabine; Barg-Kues, Brigitte; Nowak-Imialek, Monika; Ehling, Christine; Rath, Detlef; Niemann, Heiner; Kues, Wilfried A.] Friedrich Loeffler Inst, Mariensee, Germany; [Ivics, Zoltan] Max Delbruck Ctr Mol Med, Berlin, Germany	Friedrich Loeffler Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Garrels, W (corresponding author), Friedrich Loeffler Inst, Mariensee, Germany.	wilfried.kues@fli.bund.de	Kues, Wilfried/AAX-2466-2020; Nowak-Imialek, Monika/AAD-3441-2019; Kues, Wilfried/D-9232-2011; Klein, Sabine/J-5325-2019	Nowak-Imialek, Monika/0000-0003-1243-5282; Kues, Wilfried/0000-0002-0850-8103; Klein, Sabine/0000-0001-7408-8445	Deutsche Forschungsgemeinschaft (DFG) [KU-1586/2-1, IV21/6-1, SPP1313]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support by the Deutsche Forschungsgemeinschaft (DFG) via KU-1586/2-1, IV21/6-1, and SPP1313 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Bryla M, 2010, ANIM REPROD SCI, V118, P77, DOI 10.1016/j.anireprosci.2009.06.008; CALDWELL KA, 1991, P NATL ACAD SCI USA, V88, P2407, DOI 10.1073/pnas.88.6.2407; Carlson DF, 2011, TRANSGENIC RES, V20, P1125, DOI 10.1007/s11248-010-9481-7; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; DYM M, 1971, BIOL REPROD, V4, P195, DOI 10.1093/biolreprod/4.2.195; Foxcroft GR, 2008, THERIOGENOLOGY, V70, P1324, DOI 10.1016/j.theriogenology.2008.07.015; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Gilbert I, 2007, REPRODUCTION, V133, P1073, DOI 10.1530/REP-06-0292; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Habermann FA, 2007, THERIOGENOLOGY, V68, pS116, DOI 10.1016/j.theriogenology.2007.05.055; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Huang ZY, 2000, FEBS LETT, V487, P248, DOI 10.1016/S0014-5793(00)02271-7; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Iqbal K, 2011, BIOL REPROD, V84, P723, DOI 10.1095/biolreprod.110.087205; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; JOHNSON L, 1991, BIOL REPROD, V44, P284, DOI 10.1095/biolreprod44.2.284; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Koga A, 2008, DEV DYNAM, V237, P2466, DOI 10.1002/dvdy.21688; Kramer JA, 1997, MOL HUM REPROD, V3, P473, DOI 10.1093/molehr/3.6.473; Kues WA, 2010, REPROD DOMEST ANIM, V45, P25, DOI 10.1111/j.1439-0531.2010.01663.x; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009; Kues Wilfried A., 2002, Cloning and Stem Cells, V4, P231, DOI 10.1089/15362300260339511; Kues WA, 2010, TRANSGENIC RES, V19, P336; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; Martin JS, 2009, BIOCHEM SOC T, V37, P830, DOI 10.1042/BST0370830; Martin-DeLeon PA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-32; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Niemann H, 2007, REPROD FERT DEVELOP, V19, P762, DOI 10.1071/RD07040; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Oko R, 2009, J REPROD IMMUNOL, V83, P2, DOI 10.1016/j.jri.2009.05.008; Peng KC, 2010, FISH SHELLFISH IMMUN, V28, P905, DOI 10.1016/j.fsi.2010.02.003; Roy A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1342, DOI 10.1039/c0pp00141d; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Sinzelle L, 2006, TRANSGENIC RES, V15, P751, DOI 10.1007/s11248-006-9014-6; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trzcinska M, 2009, THERIOGENOLOGY, V72, P1141, DOI 10.1016/j.theriogenology.2009.07.010; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; Wykes SM, 1997, MOL HUM REPROD, V3, P15, DOI 10.1093/molehr/3.1.15; Yamauchi Y, 2011, ASIAN J ANDROL, V13, P31, DOI 10.1038/aja.2010.75; Yang CC, 2009, ANIM REPROD SCI, V113, P143, DOI 10.1016/j.anireprosci.2008.08.012; Zhao YX, 2006, HUM REPROD, V21, P1583, DOI 10.1093/humrep/del027; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	62	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27563	10.1371/journal.pone.0027563	http://dx.doi.org/10.1371/journal.pone.0027563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110672	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400055
J	Gong, IY; Schwarz, UI; Crown, N; Dresser, GK; Lazo-Langner, A; Zou, GY; Roden, DM; Stein, CM; Rodger, M; Wells, PS; Kim, RB; Tirona, RG				Gong, Inna Y.; Schwarz, Ute I.; Crown, Natalie; Dresser, George K.; Lazo-Langner, Alejandro; Zou, GuangYong; Roden, Dan M.; Stein, C. Michael; Rodger, Marc; Wells, Philip S.; Kim, Richard B.; Tirona, Rommel G.			Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation	PLOS ONE			English	Article							VITAMIN-K; VENOUS THROMBOEMBOLISM; MAJOR HEMORRHAGE; S-WARFARIN; CYP2C9; DRUG; POLYMORPHISMS; ASSOCIATION; METABOLISM; REDUCTASE	Variable warfarin response during treatment initiation poses a significant challenge to providing optimal anticoagulation therapy. We investigated the determinants of initial warfarin response in a cohort of 167 patients. During the first nine days of treatment with pharmacogenetics-guided dosing, S-warfarin plasma levels and international normalized ratio were obtained to serve as inputs to a pharmacokinetic-pharmacodynamic (PK-PD) model. Individual PK (S-warfarin clearance) and PD (I-max) parameter values were estimated. Regression analysis demonstrated that CYP2C9 genotype, kidney function, and gender were independent determinants of S-warfarin clearance. The values for I-max were dependent on VKORC1 and CYP4F2 genotypes, vitamin K status (as measured by plasma concentrations of proteins induced by vitamin K absence, PIVKA-II) and weight. Importantly, indication for warfarin was a major independent determinant of I-max during initiation, where PD sensitivity was greater in atrial fibrillation than venous thromboembolism. To demonstrate the utility of the global PK-PD model, we compared the predicted initial anticoagulation responses with previously established warfarin dosing algorithms. These insights and modeling approaches have application to personalized warfarin therapy.	[Gong, Inna Y.; Schwarz, Ute I.; Kim, Richard B.; Tirona, Rommel G.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada; [Gong, Inna Y.; Schwarz, Ute I.; Crown, Natalie; Dresser, George K.; Kim, Richard B.; Tirona, Rommel G.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Div Clin Pharmacol, London, ON, Canada; [Lazo-Langner, Alejandro] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Div Hematol, London, ON, Canada; [Lazo-Langner, Alejandro; Zou, GuangYong] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Roden, Dan M.; Stein, C. Michael] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Roden, Dan M.; Stein, C. Michael] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Div Clin Pharmacol, Nashville, TN 37232 USA; [Rodger, Marc; Wells, Philip S.] Univ Ottawa, Dept Med, Ottawa Hlth Res Inst, Ottawa, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Vanderbilt University; Vanderbilt University; University of Ottawa; Ottawa Hospital Research Institute	Gong, IY (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada.	rommel.tirona@schulich.uwo.ca	Dresser, George/G-3291-2011; Schwarz, Ute/G-2845-2011; Lazo-Langner, Alejandro/E-6993-2011; Roden, Dan/ABD-5412-2021; Kim, Richard/D-6971-2011; Zou, Guangyong/K-6408-2013; Lazo-Langner, Alejandro/G-3318-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Kim, Richard/0000-0001-8148-1632; Zou, Guangyong/0000-0001-5773-4185; Lazo-Langner, Alejandro/0000-0001-6869-8431; Rodger, Marc/0000-0001-8166-3487	Drug Innovation Fund; Ontario Graduate Scholarship; Canadian Institutes of Health Research Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056693] Funding Source: NIH RePORTER	Drug Innovation Fund; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research Canada(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the Drug Innovation Fund established by the Ontario Ministry of Health and Long-Term Care. Inna Gong is a recipient of an Ontario Graduate Scholarship and Canadian Institutes of Health Research Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Borgiani P, 2009, PHARMACOGENOMICS, V10, P261, DOI 10.2217/14622416.10.2.261; Cain D, 1997, J BIOL CHEM, V272, P29068, DOI 10.1074/jbc.272.46.29068; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Cao YG, 2007, EUR J PHARM SCI, V30, P175, DOI 10.1016/j.ejps.2006.10.009; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P112, DOI 10.3177/jnsv.55.112; Cushman M, 2001, BRIT J HAEMATOL, V112, P572, DOI 10.1046/j.1365-2141.2001.02635.x; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; FASCO MJ, 1982, J BIOL CHEM, V257, P4894; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Garcia D, 2005, CHEST, V127, P2049, DOI 10.1378/chest.127.6.2049; GARCIA DA, 2010, THROMB HAEMOST, V104; Gong IY, 2011, BLOOD, V118, P3163, DOI 10.1182/blood-2011-03-345173; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Hamberg AK, 2007, CLIN PHARMACOL THER, V81, P529, DOI 10.1038/sj.clpt.6100084; Herman D, 2005, PHARMACOGENOMICS J, V5, P193, DOI 10.1038/sj.tpj.6500308; Ho RH, 2006, GASTROENTEROLOGY, V130, P1793, DOI 10.1053/j.gastro.2006.02.034; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; Juurlink DN, 2007, CAN MED ASSOC J, V177, P369, DOI 10.1503/cmaj.070946; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; KARLSON B, 1986, ACTA MED SCAND, V220, P347; KERIN NZ, 1988, ARCH INTERN MED, V148, P1779, DOI 10.1001/archinte.148.8.1779; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Kovacs MJ, 2003, ANN INTERN MED, V138, P714, DOI 10.7326/0003-4819-138-9-200305060-00007; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; Lazo-Langner A, 2009, J THROMB HAEMOST, V7, P1276, DOI 10.1111/j.1538-7836.2009.03483.x; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy G, 2003, J PHARM SCI, V92, P985, DOI 10.1002/jps.10345; Limdi NA, 2010, AM J KIDNEY DIS, V56, P823, DOI 10.1053/j.ajkd.2010.05.023; Limdi NA, 2009, J AM SOC NEPHROL, V20, P912, DOI 10.1681/ASN.2008070802; Linder MW, 2009, CLIN CHEM, V55, P1861, DOI 10.1373/clinchem.2009.125898; Loebstein R, 2001, CLIN PHARMACOL THER, V70, P159, DOI 10.1067/mcp.2001.117444; MCDONALD MG, 2009, MOL PHARM; McMahan DA, 1998, J GEN INTERN MED, V13, P311, DOI 10.1046/j.1525-1497.1998.00096.x; NELSON E, 1961, J PHARM SCI, V50, P181, DOI 10.1002/jps.2600500302; OREILLY RA, 1963, J CLIN INVEST, V42, P1542, DOI 10.1172/JCI104839; PEDERSEN FM, 1991, J INTERN MED, V229, P517, DOI 10.1111/j.1365-2796.1991.tb00388.x; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Sanoski CA, 2002, CHEST, V121, P19, DOI 10.1378/chest.121.1.19; Schelleman H, 2008, CLIN PHARMACOL THER, V84, P581, DOI 10.1038/clpt.2008.150; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; Takahashi H, 2000, CLIN PHARMACOL THER, V68, P541, DOI 10.1067/mcp.2000.110977; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; WAGNER JG, 1971, J PHARM SCI, V60, P666, DOI 10.1002/jps.2600600503; Wells PS, 2009, BLOOD COAGUL FIBRIN, V20, P403, DOI 10.1097/MBC.0b013e32832b184d; Willey VJ, 2004, CLIN THER, V26, P1149, DOI 10.1016/S0149-2918(04)90187-7; WYNNE H, 1995, BRIT J CLIN PHARMACO, V40, P203; Yuan HY, 2005, HUM MOL GENET, V14, P1745, DOI 10.1093/hmg/ddi180	55	61	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27808	10.1371/journal.pone.0027808	http://dx.doi.org/10.1371/journal.pone.0027808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114699	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400118
J	Gong, T; Hartmann, N; Kohane, IS; Brinkmann, V; Staedtler, F; Letzkus, M; Bongiovanni, S; Szustakowski, JD				Gong, Ting; Hartmann, Nicole; Kohane, Isaac S.; Brinkmann, Volker; Staedtler, Frank; Letzkus, Martin; Bongiovanni, Sandrine; Szustakowski, Joseph D.			Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; DISSECTION; PATTERNS; FTY720	Large-scale molecular profiling technologies have assisted the identification of disease biomarkers and facilitated the basic understanding of cellular processes. However, samples collected from human subjects in clinical trials possess a level of complexity, arising from multiple cell types, that can obfuscate the analysis of data derived from them. Failure to identify, quantify, and incorporate sources of heterogeneity into an analysis can have widespread and detrimental effects on subsequent statistical studies. We describe an approach that builds upon a linear latent variable model, in which expression levels from mixed cell populations are modeled as the weighted average of expression from different cell types. We solve these equations using quadratic programming, which efficiently identifies the globally optimal solution while preserving non-negativity of the fraction of the cells. We applied our method to various existing platforms to estimate proportions of different pure cell or tissue types and gene expression profilings of distinct phenotypes, with a focus on complex samples collected in clinical trials. We tested our methods on several well controlled benchmark data sets with known mixing fractions of pure cell or tissue types and mRNA expression profiling data from samples collected in a clinical trial. Accurate agreement between predicted and actual mixing fractions was observed. In addition, our method was able to predict mixing fractions for more than ten species of circulating cells and to provide accurate estimates for relatively rare cell types (<10% total population). Furthermore, accurate changes in leukocyte trafficking associated with Fingolomid (FTY720) treatment were identified that were consistent with previous results generated by both cell counts and flow cytometry. These data suggest that our method can solve one of the open questions regarding the analysis of complex transcriptional data: namely, how to identify the optimal mixing fractions in a given experiment.	[Gong, Ting; Szustakowski, Joseph D.] Novartis Inst BioMed Res, Cambridge, MA USA; [Brinkmann, Volker] Novartis Inst BioMed Res, Dept Autoimmun Transplantat & Inflammat, Basel, Switzerland; [Kohane, Isaac S.] Harvard Univ, Childrens Hosp, Med Ctr, Sch Med, Boston, MA 02115 USA	Novartis; Novartis; Harvard University; Boston Children's Hospital; Harvard Medical School	Gong, T (corresponding author), Novartis Inst BioMed Res, Cambridge, MA USA.	ting.gong@novartis.com	Kohane, Isaac Kohane/K-3716-2012; Szustakowski, Joseph/HGB-2712-2022	Kohane, Isaac Kohane/0000-0003-2192-5160; Szustakowski, Joseph/0000-0001-7900-3973	Novartis Institutes for Biomedical Research; NIBR Education Office	Novartis Institutes for Biomedical Research; NIBR Education Office	Novartis Institutes for Biomedical Research funded the current study. Novartis employees (TG, NH, VB, FS, ML, SB, JS) and IK from Harvard planned, designed, conducted and analyzed, interpreted experiments described in the study. Novartis employees (TG, NH, VB, FS and JS) and IK from Harvard also took part in preparation and review of the manuscript.; The authors thank E. Luesink, M. Schumacher, N. R. Nirmala, for their critical discussions of this work; P. Burtin, and B. Nuesslein-Hildesheim for reviewing the manuscript. T. G. thanks the NIBR Education Office for their support via a Presidential Postdoctoral Fellowship. The authors thank the reviewers for the constructive feedback.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; [Anonymous], INT C HARM TECHN REQ; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Clarke J, 2010, BIOINFORMATICS, V26, P1043, DOI 10.1093/bioinformatics/btq097; Coleman WB, 2009, MOLECULAR PATHOLOGY: THE MOLECULAR BASIS OF HUMAN DISEASE, P1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erkkila T, 2010, BIOINFORMATICS, V26, P2571, DOI 10.1093/bioinformatics/btq406; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; LAWSON CL, SOLVING LEAST SQUARE, P1; Liebermeister W, 2002, BIOINFORMATICS, V18, P51, DOI 10.1093/bioinformatics/18.1.51; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mellick AS, 2002, INT J CANCER, V100, P172, DOI 10.1002/ijc.10451; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Quon G, 2009, BIOINFORMATICS, V25, P2882, DOI 10.1093/bioinformatics/btp378; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Tureci O, 2003, FASEB J, V17, P376, DOI 10.1096/fj.02-0478com; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; World Medical Association, 2002, J Postgrad Med, V48, P206	30	84	86	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27156	10.1371/journal.pone.0027156	http://dx.doi.org/10.1371/journal.pone.0027156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110609	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400024
J	Lian, LY; Pandalaneni, SR; Patel, P; Mccue, HV; Haynes, LP; Burgoyne, RD				Lian, Lu-Yun; Pandalaneni, Sravan R.; Patel, Pryank; McCue, Hannah V.; Haynes, Lee P.; Burgoyne, Robert D.			Characterisation of the Interaction of the C-Terminus of the Dopamine D2 Receptor with Neuronal Calcium Sensor-1	PLOS ONE			English	Article							CA2+ SIGNAL-TRANSDUCTION; ADRENAL CHROMAFFIN CELLS; BINDING-PROTEINS; CONFORMATIONAL-CHANGES; THERAPEUTIC LEVELS; SYNAPTIC EFFICACY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PC12 CELLS; NCS-1	NCS-1 is a member of the neuronal calcium sensor (NCS) family of EF-hand Ca2+ binding proteins which has been implicated in several physiological functions including regulation of neurotransmitter release, membrane traffic, voltage gated Ca2+ channels, neuronal development, synaptic plasticity, and learning. NCS-1 binds to the dopamine D2 receptor, potentially affecting its internalisation and controlling dopamine D2 receptor surface expression. The D2 receptor binds NCS-1via a short 16-residue cytoplasmic C-terminal tail. We have used NMR and fluorescence spectroscopy to characterise the interactions between the NCS-1/Ca2+ and D2 peptide. The data show that NCS-1 binds D2 peptide with a K-d of similar to 14.3 mu M and stoichiometry of peptide binding to NCS-1 of 2.1. NMR chemical shift mapping confirms that D2 peptide binds to the large, solvent-exposed hydrophobic groove, on one face of the NCS-1 molecule, with residues affected by the presence of the peptide spanning both the N and C-terminal portions of the protein. The NMR and mutagenesis data further show that movement of the C-terminal helix 11 of NCS-1 to fully expose the hydrophobic groove is important for D2 peptide binding. Molecular docking using restraints derived from the NMR chemical shift data, together with the experimentally-derived stoichiometry, produced a model of the complex between NCS-1 and the dopamine receptor, in which two molecules of the receptor are able to simultaneously bind to the NCS-1 monomer.	[Lian, Lu-Yun; Pandalaneni, Sravan R.; Patel, Pryank] Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England; [McCue, Hannah V.; Haynes, Lee P.; Burgoyne, Robert D.] Univ Liverpool, Physiol Lab, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Lian, LY (corresponding author), Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England.	Lu-Yun.Lian@liv.ac.uk; burgoyne@liv.ac.uk	Burgoyne, Robert D/P-6641-2019; Burgoyne, Robert/C-6706-2008	Burgoyne, Robert D/0000-0002-9219-0387; Burgoyne, Robert/0000-0002-9219-0387; McCue, Hannah/0000-0001-5237-3261	University of Liverpool; Wellcome Trust [086391, 083848]	University of Liverpool; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by The University of Liverpool (studentship support to SRP), the Wellcome Trust Grant Ref: 086391 (http://www.wellcome.ac.uk/), and a Wellcome Trust prize PhD studentship awarded to HVM (Grant Ref: 083848). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; COX JA, 1994, J BIOL CHEM, V269, P32807; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Dason JS, 2009, J CELL SCI, V122, P4109, DOI 10.1242/jcs.055095; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Handley MTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010534; Haynes LP, 2007, TRAFFIC, V8, P1080, DOI 10.1111/j.1600-0854.2007.00594.x; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kabbani N, 2006, NEUROREPORT, V17, P299, DOI 10.1097/01.wnr.0000199460.24412.04; Kabbani N, 2002, J NEUROSCI, V22, P8476; Kragelund BB, 2000, J BIOMOL NMR, V16, P85, DOI 10.1023/A:1008383002568; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; McCue HV, 2010, CSH PERSPECT BIOL; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; SEEMAN P, 1992, NEUROPSYCHOPHARMACOL, V7, P261; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; Woll MP, 2011, BIOCHEMISTRY-US, V50, P8780, DOI 10.1021/bi200637e; Xu XZ, 2011, PROTEINS, V79, P1910, DOI 10.1002/prot.23014; ZERNII E, 2011, BIOCH J	51	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27779	10.1371/journal.pone.0027779	http://dx.doi.org/10.1371/journal.pone.0027779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114693	gold, Green Published			2022-12-25	WOS:000297555400112
J	Wertheim, JO; Pond, SLK; Little, SJ; De Gruttola, V				Wertheim, Joel O.; Pond, Sergei L. Kosakovsky; Little, Susan J.; De Gruttola, Victor			Using HIV Transmission Networks to Investigate Community Effects in HIV Prevention Trials	PLOS ONE			English	Article							MALE CIRCUMCISION; PHYLOGENETIC RECONSTRUCTION; INFECTION; IDENTIFICATION; THAILAND; MEN	Effective population screening of HIV and prevention of HIV transmission are only part of the global fight against AIDS. Community-level effects, for example those aimed at thwarting future transmission, are potential outcomes of treatment and may be important in stemming the epidemic. However, current clinical trial designs are incapable of detecting a reduction in future transmission due to treatment. We took advantage of the fact that HIV is an evolving pathogen whose transmission network can be reconstructed using genetic sequence information to address this shortcoming. Here, we use an HIV transmission network inferred from recently infected men who have sex with men (MSM) in San Diego, California. We developed and tested a network-based statistic for measuring treatment effects using simulated clinical trials on our inferred transmission network. We explored the statistical power of this network-based statistic against conventional efficacy measures and find that when future transmission is reduced, the potential for increased statistical power can be realized. Furthermore, our simulations demonstrate that the network statistic is able to detect community-level effects (e. g., reduction in onward transmission) of HIV treatment in a clinical trial setting. This study demonstrates the potential utility of a network-based statistical metric when investigating HIV treatment options as a method to reduce onward transmission in a clinical trial setting.	[Wertheim, Joel O.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Pond, Sergei L. Kosakovsky; Little, Susan J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [De Gruttola, Victor] Harvard Univ, Dept Biostat, Cambridge, MA 02138 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University	Wertheim, JO (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	jwertheim@ucsd.edu	Pond, Sergei LK/G-9830-2012; Little, Susan/AAA-6116-2019	Pond, Sergei LK/0000-0003-4817-4029; 	California HIV Research Program (CHRP) [RN07-SD-702]; NIAID [AI5116401];  [NIH-AI07384];  [NIH-AI047745];  [NIH-DA012065];  [NIH-AI43638];  [AI074621]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI106039, P01AI074621, T32AI007384, R01AI047745, R37AI051164, R01AI051164, U01AI043638, R56AI047745, R21AI047745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012065] Funding Source: NIH RePORTER	California HIV Research Program (CHRP); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH-AI07384 (JOW), NIH-AI047745 (SLKP), NIH-DA012065 (SJL), NIH-AI43638 and AI074621 (SLKP and SJL), California HIV Research Program (CHRP) RN07-SD-702, and NIAID AI5116401 (VGD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 6 INT AIDS SOC C HIV; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bon I, 2010, J CLIN VIROL, V48, P212, DOI 10.1016/j.jcv.2010.03.021; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Lemey P, 2005, AIDS, V19, P1649, DOI 10.1097/01.aids.0000187904.02261.1a; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Manhart LE, 2005, J INFECT DIS, V191, pS7, DOI 10.1086/425275; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Paraskevis D, 2004, J MOL EVOL, V59, P709, DOI 10.1007/s00239-004-2651-6; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81	24	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27775	10.1371/journal.pone.0027775	http://dx.doi.org/10.1371/journal.pone.0027775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114692	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400111
J	Yan, JQ; Zhou, B; Taheri, S; Shi, HL				Yan, Jingqi; Zhou, Bo; Taheri, Saeid; Shi, Honglian			Differential Effects of HIF-1 Inhibition by YC-1 on the Overall Outcome and Blood-Brain Barrier Damage in a Rat Model of Ischemic Stroke	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; FOCAL CEREBRAL-ISCHEMIA; HIF-1-ALPHA ACCUMULATION; INCREASED EXPRESSION; VEGF EXPRESSION; TARGETING HIF-1; NEONATAL-RAT; HYPOXIA; CELLS	Hypoxia-inducible factor 1 (HIF-1) is a master regulator of cellular adaptation to hypoxia and has been suggested as a potent therapeutic target in cerebral ischemia. Here we show in an ischemic stroke model of rats that inhibiting HIF-1 and its downstream genes by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) significantly increases mortality and enlarges infarct volume evaluated by MRI and histological staining. Interestingly, the HIF-1 inhibition remarkably ameliorates ischemia-induced blood-brain barrier (BBB) disruption determined by Evans blue leakage although it does not affect brain edema. The result demonstrates that HIF-1 inhibition has differential effects on ischemic outcomes and BBB permeability. It indicates that HIF-1 may have different functions in different brain cells. Further analyses show that ischemia upregulates HIF-1 and its downstream genes erythropoietin (EPO), vascular endothelial growth factor (VEGF), and glucose transporter (Glut) in neurons and brain endothelial cells and that YC-1 inhibits their expression. We postulate that HIF-1-induced VEGF increases BBB permeability while certain other proteins coded by HIF-1's downstream genes such as epo and glut provide neuroprotection in an ischemic brain. The results indicate that YC-1 lacks the potential as a cerebral ischemic treatment although it confers certain protection to the cerebral vascular system.	[Yan, Jingqi; Zhou, Bo; Shi, Honglian] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Taheri, Saeid] Univ S Carolina, Dept Neurol, Columbia, SC 29208 USA	University of Kansas; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Yan, JQ (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA.	hshi@ku.edu		yan, Jingqi/0000-0002-7024-6423	National Institutes of Health [R01NS058807]; Kansas University Center for Research from the University of Kansas; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas University Center for Research from the University of Kansas; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by a grant from the National Institutes of Health (R01NS058807) and a Kansas University Center for Research startup fund from the University of Kansas. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bamforth SD, 1999, J CELL SCI, V112, P1879; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Bernaudin M, 2002, J BIOL CHEM, V277, P39728, DOI 10.1074/jbc.M204619200; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Halterman MW, 1999, EXP NEUROL, V159, P65, DOI 10.1006/exnr.1999.7160; Heiland S, 1999, ROFO-FORTSCHR RONTG, V171, P3, DOI 10.1055/s-1999-9889; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Hsiao G, 2004, BIOCHEM PHARMACOL, V67, P1411, DOI 10.1016/j.bcp.2003.12.010; Huber JD, 2006, AM J PHYSIOL-HEART C, V291, pH2660, DOI 10.1152/ajpheart.00489.2006; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kim HL, 2006, INT J ONCOL, V29, P255; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Lawrence MS, 1996, J CEREBR BLOOD F MET, V16, P181, DOI 10.1097/00004647-199603000-00001; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Liu Y, 2009, J RADIAT RES, V50, P233, DOI 10.1269/jrr.08112; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nickel EA, 2009, SHOCK, V31, P354, DOI 10.1097/SHK.0b013e3181862fdd; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pichiule P, 2003, ADV EXP MED BIOL, V530, P611; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520, DOI 10.1097/00004647-200205000-00003; Ralph GS, 2004, J CEREBR BLOOD F MET, V24, P245, DOI 10.1097/01.WCB.0000110532.48786.46; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; TAKAGI K, 1994, STROKE, V25, P481, DOI 10.1161/01.STR.25.2.481; Teng CM, 1997, EUR J PHARMACOL, V320, P161, DOI 10.1016/S0014-2999(96)00911-9; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Yang XF, 2011, CELL MOL NEUROBIOL, V31, P303, DOI 10.1007/s10571-010-9622-9; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Yeo EJ, 2004, BIOCHEM PHARMACOL, V68, P1061, DOI 10.1016/j.bcp.2004.02.040; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zaman K, 1999, J NEUROSCI, V19, P9821	54	55	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27798	10.1371/journal.pone.0027798	http://dx.doi.org/10.1371/journal.pone.0027798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110762	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400116
J	Avila-Rios, S; Garcia-Morales, C; Garrido-Rodriguez, D; Ormsby, CE; Hernandez-Juan, R; Andrade-Villanueva, J; Gonzalez-Hernandez, LA; Torres-Escobar, I; Navarro-Alvarez, S; Reyes-Teran, G				Avila-Rios, Santiago; Garcia-Morales, Claudia; Garrido-Rodriguez, Daniela; Ormsby, Christopher E.; Hernandez-Juan, Ramon; Andrade-Villanueva, Jaime; Gonzalez-Hernandez, Luz A.; Torres-Escobar, Indiana; Navarro-Alvarez, Samuel; Reyes-Teran, Gustavo		Mexican HIV Mol Epidemiology Proje	National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; UNITED-KINGDOM; TYPE-1; SURVEILLANCE; MUTATIONS; SUBTYPES; RECOMBINANTS; INFECTION; STRATEGY	Background: Transmitted drug resistance (TDR) remains an important concern for the management of HIV infection, especially in countries that have recently scaled-up antiretroviral treatment (ART) access. Methodology/Principal Findings: We designed a study to assess HIV diversity and transmitted drug resistance (TDR) prevalence and trends in Mexico. 1655 ART-naive patients from 12 Mexican states were enrolled from 2005 to 2010. TDR was assessed from plasma HIV pol sequences using Stanford scores and the WHO TDR surveillance mutation list. TDR prevalence fluctuations over back-projected dates of infection were tested. HIV subtype B was highly prevalent in Mexico (99.9%). TDR prevalence (Stanford score > 15) in the country for the study period was 7.4% (95% CI, 6.2: 8.8) and 6.8% (95% CI, 5.7: 8.2) based on the WHO TDR surveillance mutation list. NRTI TDR was the highest (4.2%), followed by NNRTI (2.5%) and PI (1.7%) TDR. Increasing trends for NNRTI (p = 0.0456) and PI (p = 0.0061) major TDR mutations were observed at the national level. Clustering of viruses containing minor TDR mutations was observed with some apparent transmission pairs and geographical effects. Conclusions: TDR prevalence in Mexico remains at the intermediate level and is slightly lower than that observed in industrialized countries. Whether regional variations in TDR trends are associated with differences in antiretroviral drug usage/ART efficacy or with local features of viral evolution remains to be further addressed.	[Avila-Rios, Santiago; Garcia-Morales, Claudia; Garrido-Rodriguez, Daniela; Ormsby, Christopher E.; Hernandez-Juan, Ramon; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Respiratorias, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Andrade-Villanueva, Jaime; Gonzalez-Hernandez, Luz A.] Hosp Civil Guadalajara Fray Antonio Alcalde, Unidad VIH SIDA, Guadalajara, Jalisco, Mexico; [Andrade-Villanueva, Jaime; Gonzalez-Hernandez, Luz A.] Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Torres-Escobar, Indiana] Hosp Gen Puebla, Puebla, Mexico; [Torres-Escobar, Indiana] Benemerita Univ Autonoma Puebla, Fac Med, Puebla, Mexico; [Navarro-Alvarez, Samuel] Hosp Gen Tijuana, Tijuana, Baja California, Mexico	Universidad de Guadalajara; Benemerita Universidad Autonoma de Puebla	Avila-Rios, S (corresponding author), Inst Nacl Enfermedades Respiratorias, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X	Mexican Government (Comision de Equidad y Genero de la H. Camara de Diputados); Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF) [PIRIVE09-18]; Fundacion Mexico Vivo	Mexican Government (Comision de Equidad y Genero de la H. Camara de Diputados); Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF); Fundacion Mexico Vivo	This work was supported by grants from the Mexican Government (Comision de Equidad y Genero de la H. Camara de Diputados), Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, PIRIVE09-18) (http://www.icyt.df.gob.mx/) and Fundacion Mexico Vivo (http://www.mexicovivo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Bautista-Arredondo S, 2008, SALUD PUBLICA MEXICO, V50, pS437; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertognolio S, 2008, ANTIVIR THER, V13, P49; *BIOAF, 2006, REGA HIV 1 2 AUT SUB; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; CALLEGARO A, 2011, INFECT GENET EVOL; Calva JJ, 2009, 25 ANOS SIDA MEXICO, P333; *CENSIDA, 2010, B SALVAR; *CENSIDA, 2010, PAN EP VIH SIDA MEX; Centro Nacional para la Prevencion y Control del SIDA (CENSIDA), 2009, VIH SIDA MEX 2009; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Eyzaguirre L, 2007, AIDS RES HUM RETROV, V23, P331, DOI 10.1089/aid.2006.0166; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Green H, 2008, JAIDS-J ACQ IMM DEF, V49, P196, DOI 10.1097/QAI.0b013e318185725f; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Jayaraman GC, 2006, JAIDS-J ACQ IMM DEF, V42, P86, DOI 10.1097/01.qai.0000196666.16616.fe; *LANL, 2011, LOS AL HIV DAT RIP H; *LANL, 2010, LOS AL HIV DAT HIV S; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Payne BAI, 2008, J ANTIMICROB CHEMOTH, V62, P464, DOI 10.1093/jac/dkn228; PYNE MT, 2009, ANAL HIV SUBTYPE PRE; Rivera-Morales LG, 2001, AIDS RES HUM RETROV, V17, P87, DOI 10.1089/088922201750056825; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2008, ANTIVIR THER, V13, P59; *STANF U, 2006, STANF HIV DRUG RES D; *STANF U, 2006, HIV DRUG RES DAT; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; Vazquez-Valls E, 2010, AIDS RES HUM RETROV, V26, P777, DOI 10.1089/aid.2009.0195; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS; Wong KH, 2010, AIDS RES HUM RETROV, V26, P1079, DOI 10.1089/aid.2009.0272; 2007, AIDS, V21, P1035	41	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27812	10.1371/journal.pone.0027812	http://dx.doi.org/10.1371/journal.pone.0027812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110765	gold, Green Published			2022-12-25	WOS:000297555300054
J	Ito, SY; Hansen, ME; Heiland, R; Lumsdaine, A; Litke, AM; Beggs, JM				Ito, Shinya; Hansen, Michael E.; Heiland, Randy; Lumsdaine, Andrew; Litke, Alan M.; Beggs, John M.			Extending Transfer Entropy Improves Identification of Effective Connectivity in a Spiking Cortical Network Model	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NEURONAL AVALANCHES; NEURAL INFORMATION; GRANGER CAUSALITY; CROSS-CORRELATION; ACTIVITY PATTERNS; DYNAMICS; BRAIN; TOPOLOGY; BURSTS	Transfer entropy (TE) is an information-theoretic measure which has received recent attention in neuroscience for its potential to identify effective connectivity between neurons. Calculating TE for large ensembles of spiking neurons is computationally intensive, and has caused most investigators to probe neural interactions at only a single time delay and at a message length of only a single time bin. This is problematic, as synaptic delays between cortical neurons, for example, range from one to tens of milliseconds. In addition, neurons produce bursts of spikes spanning multiple time bins. To address these issues, here we introduce a free software package that allows TE to be measured at multiple delays and message lengths. To assess performance, we applied these extensions of TE to a spiking cortical network model (Izhikevich, 2006) with known connectivity and a range of synaptic delays. For comparison, we also investigated single-delay TE, at a message length of one bin (D1TE), and cross-correlation (CC) methods. We found that D1TE could identify 36% of true connections when evaluated at a false positive rate of 1%. For extended versions of TE, this dramatically improved to 73% of true connections. In addition, the connections correctly identified by extended versions of TE accounted for 85% of the total synaptic weight in the network. Cross correlation methods generally performed more poorly than extended TE, but were useful when data length was short. A computational performance analysis demonstrated that the algorithm for extended TE, when used on currently available desktop computers, could extract effective connectivity from 1 hr recordings containing 200 neurons in similar to 5 min. We conclude that extending TE to multiple delays and message lengths improves its ability to assess effective connectivity between spiking neurons. These extensions to TE soon could become practical tools for experimentalists who record hundreds of spiking neurons.	[Ito, Shinya; Beggs, John M.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Hansen, Michael E.; Heiland, Randy; Lumsdaine, Andrew] Indiana Univ, Sch Informat, Comp Sci Grp, Bloomington, IN 47405 USA; [Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Beggs, John M.] Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington	Ito, SY (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	itos@indiana.edu		Heiland, Randy/0000-0002-7440-2905; Lumsdaine, Andrew/0000-0002-9153-6622	National Science Foundation (NSF) [0904912, IIS-0904413]; Direct For Computer & Info Scie & Enginr [0904413] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Funding was provided by National Science Foundation (NSF) 0904912 to JMB and AML, and NSF IIS-0904413 to AML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arnhold J, 1999, PHYSICA D, V134, P419, DOI 10.1016/S0167-2789(99)00140-2; Astolfi L, 2006, IEEE T BIO-MED ENG, V53, P1802, DOI 10.1109/TBME.2006.873692; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Berdondini L, 2009, J NEUROSCI METH, V177, P386, DOI 10.1016/j.jneumeth.2008.10.032; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bhattacharya S, 2006, NEUROIMAGE, V30, P794, DOI 10.1016/j.neuroimage.2005.10.019; Blinder Pablo, 2005, Natural Computing, V4, P339, DOI 10.1007/s11047-005-3667-6; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Callaway EM, 2002, CURR OPIN NEUROBIOL, V12, P587, DOI 10.1016/S0959-4388(02)00364-1; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Eichler M, 2006, BIOL CYBERN, V94, P469, DOI 10.1007/s00422-006-0062-z; ELDAWLATLY S, 2007, C P IEEE ENG MED BIO, P1445; Eldawlatly S, 2009, NEURAL COMPUT, V21, P450, DOI 10.1162/neco.2008.09-07-606; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feldmann U, 2004, INT J BIFURCAT CHAOS, V14, P505, DOI 10.1142/S0218127404009314; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gandolfo M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056001; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Granger C. W. J., 1986, FORECASTING EC TIME, DOI 10.1016/B978-0-12-295183-1.50013-3; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Guo SX, 2008, J NEUROSCI METH, V172, P79, DOI 10.1016/j.jneumeth.2008.04.011; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hulata Eyal, 2005, Natural Computing, V4, P363, DOI 10.1007/s11047-005-3668-5; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Juergens E, 1997, BIOL CYBERN, V76, P217, DOI 10.1007/s004220050334; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kiemel T, 1998, J COMPUT NEUROSCI, V5, P267, DOI 10.1023/A:1008835011799; Kramer G., 1998, DIRECTED INFORM CHAN, DOI [10.3929/ethz-a-001988524, DOI 10.3929/ETHZ-A-001988524]; Latham PE, 2000, J NEUROPHYSIOL, V83, P828, DOI 10.1152/jn.2000.83.2.828; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LIST B, 2002, WHY OPTIMIZE EFFICIE; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lungarella M, 2005, NEUROINFORMATICS, V3, P243, DOI 10.1385/NI:3:3:243; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Maccione Alessandro, 2010, Front Neuroeng, V3, P4, DOI 10.3389/fneng.2010.00004; MAEDA E, 1995, J NEUROSCI, V15, P6834; MASSEY JL, 1990, CAUSALITY FEEDBACK D, P303; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Napoletani D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026103; Nichols JM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046217; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Overbey LA, 2009, J SOUND VIB, V322, P438, DOI 10.1016/j.jsv.2008.11.025; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Patnaik D, 2008, SCI PROGRAMMING-NETH, V16, P49, DOI [10.1155/2008/324626, 10.3233/SPR-2008-0242]; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tateno T, 1999, BIOL CYBERN, V80, P45, DOI 10.1007/s004220050503; Teramae JN, 2007, J COMPUT NEUROSCI, V22, P301, DOI 10.1007/s10827-006-0014-6; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P752, DOI 10.1152/jn.1987.58.4.752; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiener N., 1956, THEORY PREDICTION; Zhuang JC, 2008, NEUROIMAGE, V42, P799, DOI 10.1016/j.neuroimage.2008.05.036	93	132	132	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27431	10.1371/journal.pone.0027431	http://dx.doi.org/10.1371/journal.pone.0027431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102894	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555300020
J	He, SS; Wang, F; Yang, LJ; Guo, CY; Wan, R; Ke, AW; Xu, L; Hu, GY; Xu, XF; Shen, J; Wang, XP				He, ShanShan; Wang, Feng; Yang, LiJuan; Guo, ChuanYong; Wan, Rong; Ke, AiWu; Xu, Ling; Hu, GuoYong; Xu, XuanFu; Shen, Jie; Wang, XingPeng			Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer	PLOS ONE			English	Article							DNA METHYLTRANSFERASES 3A; MESSENGER-RNA EXPRESSION; CHROMOSOMAL INSTABILITY; SIGNALING PATHWAY; METHYLATION; HEDGEHOG; 3B; HYPOMETHYLATION; ACTIVATION; PROMOTER	Background and Aims: GLI1, as an indispensable transcriptional factor of Hedgehog signaling pathway, plays an important role in the development of pancreatic cancer (PC). DNA methyltransferases (DNMTs) mediate the methylation of quantity of tumor-related genes. Our study aimed to explore the relationship between GLI1 and DNMTs. Methods: Expressions of GLI1 and DNMTs were detected in tumor and adjacent normal tissues of PC patients by immunohistochemistry (IHC). PANC-1 cells were treated by cyclopamine and GLI1-siRNA, while BxPC-3 cells were transfected with overexpression-GLI1 lentiviral vector. Then GLI1 and DNMTs expression were analyzed by qRT-PCR and western blot (WB). Then we took chromatin immunoprecipitation (ChIP) to demonstrate GLI1 bind to DNMT1. Finally, nested MSP was taken to valuate the methylation levels of APC and hMLH1, when GLI1 expression altered. Results: IHC result suggested the expressions of GLI1, DNMT1 and DNMT3a in PC tissues were all higher than those in adjacent normal tissues (p < 0.05). After GLI1 expression repressed by cyclopamine in mRNA and protein level (down-regulation 88.1 +/- 2.2%, 86.4 +/- 2.2%, respectively), DNMT1 and DNMT3a mRNA and protein level decreased by 91.6% +/- 2.2% and 83.8 +/- 4.8%, 87.4 +/- 2.7% and 84.4 +/- 1.3%, respectively. When further knocked down the expression of GLI1 by siRNA (mRNA decreased by 88.6 +/- 2.1%, protein decreased by 63.5 +/- 4.5%), DNMT1 and DNMT3a mRNA decreased by 80.9 +/- 2.3% and 78.6 +/- 3.8% and protein decreased by 64.8 +/- 2.8% and 67.5 +/- 5.6%, respectively. Over-expression of GLI1 by GLI1 gene transfection (mRNA increased by 655.5685.9%, and protein increased by 272.3614.4%.), DNMT1 and DNMT3a mRNA and protein increased by 293.0 +/- 14.8% and 578.3 +/- 58.5%, 143.5 +/- 17.4% and 214.0 +/- 18.9%, respectively. ChIP assays showed GLI1 protein bound to DNMT1 but not to DNMT3a. Results of nested MSP demonstrated GLI1 expression affected the DNA methylation level of APC but not hMLH1 in PC. Conclusion: DNMT1 and DNMT3a are regulated by GLI1 in PC, and DNMT1 is its direct target gene.	[He, ShanShan; Wang, Feng; Yang, LiJuan; Guo, ChuanYong; Wan, Rong; Ke, AiWu; Xu, Ling; Hu, GuoYong; Xu, XuanFu; Shen, Jie] Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Yang, LiJuan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Gastroenterol, Shanghai 200030, Peoples R China	Tongji University; Shanghai Jiao Tong University	He, SS (corresponding author), Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	wangxingpeng@hotmail.com	He, Shanshan/P-5691-2014	wang, feng/0000-0003-4068-3339; Guo, Chuanyong/0000-0002-6527-4673; Ke, Ai-Wu/0000-0002-7964-6909	National Natural Science Foundation of China [81072005, 81172312]; Shanghai Science and Technology Committee [08411963000, 09JC1412200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	National Natural Science Foundation of China (81072005, 81172312) and Shanghai Science and Technology Committee (08411963000, 09JC1412200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston AT, 2005, J BIOL CHEM, V280, P18302, DOI 10.1074/jbc.M501675200; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gao J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-28; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; House MG, 2003, CARCINOGENESIS, V24, P193, DOI 10.1093/carcin/24.2.193; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Oghamian S, 2011, CARCINOGENESIS, V32, P829, DOI 10.1093/carcin/bgr039; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Robertson KD, 2000, NUCLEIC ACIDS RES, V28, P2108, DOI 10.1093/nar/28.10.2108; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018434; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392	32	53	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27684	10.1371/journal.pone.0027684	http://dx.doi.org/10.1371/journal.pone.0027684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110720	Green Submitted, Green Published, gold			2022-12-25	WOS:000297554300048
J	Sarma, NJ; Buford, TD; Haley, T; Barbara-Haley, K; Santangelo, GM; Willis, KA				Sarma, Nayan J.; Buford, Thomas D.; Haley, Terry; Barbara-Haley, Kellie; Santangelo, George M.; Willis, Kristine A.			The Nuclear Pore Complex Mediates Binding of the Mig1 Repressor to Target Promoters	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CHROMATIN-STRUCTURE; SUC2 GENE; REVERSE RECRUITMENT; REMODELING COMPLEX; GLUCOSE REPRESSOR	All eukaryotic cells alter their transcriptional program in response to the sugar glucose. In Saccharomyces cerevisiae, the best-studied downstream effector of this response is the glucose-regulated repressor Mig1. We show here that nuclear pore complexes also contribute to glucose-regulated gene expression. NPCs participate in glucose-responsive repression by physically interacting with Mig1 and mediating its function independently of nucleocytoplasmic transport. Surprisingly, despite its abundant presence in the nucleus of glucose-grown nup120 Delta or nup133 Delta cells, Mig1 has lost its ability to interact with target promoters. The glucose repression defect in the absence of these nuclear pore components therefore appears to result from the failure of Mig1 to access its consensus recognition sites in genomic DNA. We propose that the NPC contributes to both repression and activation at the level of transcription.	[Sarma, Nayan J.; Buford, Thomas D.; Haley, Terry; Barbara-Haley, Kellie; Santangelo, George M.; Willis, Kristine A.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Sarma, NJ (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	kaw85@georgetown.edu	Georgieva, Elena/C-2588-2012		National Institutes of Health [GM83309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM83309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Barbara KE, 2007, MOL GENET GENOMICS, V277, P171, DOI 10.1007/s00438-006-0182-0; Boukaba A, 2004, J BIOL CHEM, V279, P7678, DOI 10.1074/jbc.M310849200; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; CARLSON M, 1981, GENETICS, V98, P25; CELENZA JL, 1984, MOL CELL BIOL, V4, P49, DOI 10.1128/MCB.4.1.49; Deminoff SJ, 2001, GENETICS, V158, P133; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; DEVLIN C, 1991, MOL CELL BIOL, V11, P3642, DOI 10.1128/MCB.11.7.3642; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Finlan LE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-222; Fleming AB, 2007, NUCLEIC ACIDS RES, V35, P5520, DOI 10.1093/nar/gkm573; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Gao HH, 2003, J BIOL CHEM, V278, P25331, DOI 10.1074/jbc.M301607200; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; GIESMAN D, 1991, MOL CELL BIOL, V11, P1069, DOI 10.1128/MCB.11.2.1069; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kipper J, 2002, METHOD ENZYMOL, V351, P394; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leff T, 2003, BIOCHEM SOC T, V31, P224; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Lopez MC, 2000, J BACTERIOL, V182, P4970, DOI 10.1128/JB.182.17.4970-4978.2000; Lutfiyya LL, 1996, MOL CELL BIOL, V16, P4790; Lutfiyya LL, 1998, GENETICS, V150, P1377; MATALLANA E, 1992, MOL GEN GENET, V231, P395, DOI 10.1007/BF00292708; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; NEIGEBORN L, 1987, MOL CELL BIOL, V7, P672, DOI 10.1128/MCB.7.2.672; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; PTASHNE M, 1984, NATURE, V308, P753, DOI 10.1038/308753c0; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sarma NJ, 2007, GENETICS, V175, P1127, DOI 10.1534/genetics.106.068932; Sasaki H, 2005, YEAST, V22, P111, DOI 10.1002/yea.1198; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Titus LC, 2010, MOL BIOL CELL, V21, P1072, DOI 10.1091/mbc.E09-07-0615; TORNOW J, 1993, EMBO J, V12, P2431, DOI 10.1002/j.1460-2075.1993.tb05897.x; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; TRAVERS A, 1983, NATURE, V303, P755, DOI 10.1038/303755a0; Turkel S, 2003, MOL GENET GENOMICS, V268, P825, DOI 10.1007/s00438-003-0808-4; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wu L, 1997, NUCLEIC ACIDS RES, V25, P4230, DOI 10.1093/nar/25.21.4230; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	64	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27117	10.1371/journal.pone.0027117	http://dx.doi.org/10.1371/journal.pone.0027117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110603	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300013
J	Witso, E; Tapia, G; Cinek, O; Pociot, FM; Stene, LC; Ronningen, KS				Witso, Elisabet; Tapia, German; Cinek, Ondrej; Pociot, Flemming Michael; Stene, Lars C.; Ronningen, Kjersti S.			Polymorphisms in the Innate Immune IFIH1 Gene, Frequency of Enterovirus in Monthly Fecal Samples during Infancy, and Islet Autoimmunity	PLOS ONE			English	Article							BETA-CELL AUTOIMMUNITY; BLOOD MONONUCLEAR-CELLS; FUNCTION MUTATIONS; RISK-FACTOR; RIG-I; TYPE-1; INFECTIONS; RNA; ASSOCIATION; CHILDREN	Interferon induced with helicase C domain 1 (IFIH1) senses and initiates antiviral activity against enteroviruses. Genetic variants of IFIH1, one common and four rare SNPs have been associated with lower risk for type 1 diabetes. Our aim was to test whether these type 1 diabetes-associated IFIH1 polymorphisms are associated with the occurrence of enterovirus infection in the gut of healthy children, or influence the lack of association between gut enterovirus infection and islet autoimmunity. After testing of 46,939 Norwegian newborns, 421 children carrying the high risk genotype for type 1 diabetes (HLA-DR4-DQ8/DR3-DQ2) as well as 375 children without this genotype were included for monthly fecal collections from 3 to 35 months of age, and genotyped for the IFIH1 polymorphisms. A total of 7,793 fecal samples were tested for presence of enterovirus RNA using real time reverse transcriptase PCR. We found no association with frequency of enterovirus in the gut for the common IFIH1 polymorphism rs1990760, or either of the rare variants of rs35744605, rs35667974, rs35337543, while the enterovirus prevalence marginally differed in samples from the 8 carriers of a rare allele of rs35732034 (26.1%, 18/69 samples) as compared to wild-type homozygotes (12.4%, 955/7724 samples); odds ratio 2.5, p = 0.06. The association was stronger when infections were restricted to those with high viral loads (odds ratio 3.3, 95% CI 1.3-8.4, p = 0.01). The lack of association between enterovirus frequency and islet autoimmunity reported in our previous study was not materially influenced by the IFIH1 SNPs. We conclude that the type 1 diabetes-associated IFIH1 polymorphisms have no, or only minor influence on the occurrence, quantity or duration of enterovirus infection in the gut. Its effect on the risk of diabetes is likely to lie elsewhere in the pathogenic process than in the modification of gut infection.	[Witso, Elisabet; Tapia, German; Stene, Lars C.] Norwegian Inst Publ Hlth, Oslo, Norway; [Cinek, Ondrej] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Pociot, Flemming Michael] Glostrup Res Inst, Glostrup, Denmark; [Ronningen, Kjersti S.] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway	Norwegian Institute of Public Health (NIPH); Charles University Prague; University of Oslo; National Hospital Norway	Witso, E (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	elisabet.witso@gmail.com	Tapia, German/AAS-8467-2020; Cinek, Ondrej/AAF-6664-2020	Tapia, German/0000-0002-1770-1183; Cinek, Ondrej/0000-0002-0526-8714; Pociot, Flemming/0000-0003-3274-5448	Norwegian Organization for Health and Rehabilitation [2008/0182]; Ministry of Education of the Czech Republic [MSM0021620814]; Ministry of Health of the Czech Republic [IGA MZ 11465-5]; Research Council of Norway [135893/330, 155300/320, 156477/730, 166515/V50]; Norwegian Diabetes Association; Sigurd K. Thoresen's Legacy	Norwegian Organization for Health and Rehabilitation; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Research Council of Norway(Research Council of Norway); Norwegian Diabetes Association; Sigurd K. Thoresen's Legacy	This study and the MIDIA project were funded by the Norwegian Organization for Health and Rehabilitation (2008/0182), the Ministry of Education of the Czech Republic (grant MSM0021620814) and the Ministry of Health of the Czech Republic (IGA MZ 11465-5), the Research Council of Norway (grants 135893/330, 155300/320, 156477/730, and 166515/V50), the Norwegian Diabetes Association and Sigurd K. Thoresen's Legacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT JC, 2009, NAT GENET; BODIAN D, 1955, SCIENCE, V122, P105, DOI 10.1126/science.122.3159.105; Chistiakov DA, 2010, HUM IMMUNOL, V71, P1128, DOI 10.1016/j.humimm.2010.08.005; Chistiakov DA, 2010, VIRAL IMMUNOL, V23, P3, DOI 10.1089/vim.2009.0071; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Fuchtenbusch M, 2001, J AUTOIMMUN, V17, P333, DOI 10.1006/jaut.2001.0550; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Graves PM, 2003, DIABETES RES CLIN PR, V59, P51, DOI 10.1016/S0168-8227(02)00198-5; Huhn MH, 2010, VIROLOGY, V401, P42, DOI 10.1016/j.virol.2010.02.010; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kemball CC, 2010, FUTURE MICROBIOL, V5, P1329, DOI 10.2217/FMB.10.101; Klinker MW, 2010, IMMUNOGENETICS, V62, P101, DOI 10.1007/s00251-009-0417-4; Lonnrot M, 2000, J MED VIROL, V61, P214, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;214::AID-JMV7&gt;3.0.CO;2-9; Minor Philip D., 1997, P555; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Ouzilou L, 2002, J GEN VIROL, V83, P2177, DOI 10.1099/0022-1317-83-9-2177; Pallansch M., 2007, FIELDS VIROLOGY, P839; Qu HQ, 2008, DIABETOLOGIA, V51, P473, DOI 10.1007/s00125-007-0895-6; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Roivainen M, 2006, INT J BIOCHEM CELL B, V38, P721, DOI 10.1016/j.biocel.2005.08.019; Sadeharju K, 2003, CLIN EXP IMMUNOL, V132, P271, DOI 10.1046/j.1365-2249.2003.02147.x; Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260; Salminen KK, 2004, DIABETIC MED, V21, P156, DOI 10.1111/j.1464-5491.2004.01097.x; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stene LC, 2007, J AUTOIMMUN, V29, P44, DOI 10.1016/j.jaut.2007.04.003; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tapia G, 2011, DIABETES CARE, V34, P151, DOI 10.2337/dc10-1413; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Winkler C, 2011, DIABETES, V60, P685, DOI 10.2337/db10-1269; Witso E, 2006, J CLIN MICROBIOL, V44, P4095, DOI 10.1128/JCM.00653-06	39	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27781	10.1371/journal.pone.0027781	http://dx.doi.org/10.1371/journal.pone.0027781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110759	gold, Green Published, Green Submitted			2022-12-25	WOS:000297554300053
J	Zhang, ZY; Teruya, K; Eto, H; Shirahata, S				Zhang, Zhongyuan; Teruya, Kiichiro; Eto, Hiroshi; Shirahata, Sanetaka			Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated Pathways	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; BREAST-CANCER CELLS; N-TERMINAL KINASE; DOWN-REGULATION; DEATH; ERK; ANTITUMOR; INVOLVEMENT; MODULATION; INHIBITION	Background: Fucoidan extract (FE), an enzymatically digested compound with a low molecular weight, is extracted from brown seaweed. As a natural compound with various actions, FE is attractive, especially in Asian countries, for improving the therapeutic efficacy and safety of cancer treatment. The present study was carried out to investigate the anti-tumor properties of FE in human carcinoma cells and further examine the underlying mechanisms of its activities. Methodology/Principal Finding: FE inhibits the growth of MCF-7, MDA-MB-231, HeLa, and HT1080 cells. FE-mediated apoptosis in MCF-7 cancer cells is accompanied by DNA fragmentation, nuclear condensation, and phosphatidylserine exposure. FE induces mitochondrial membrane permeabilization (MMP) through loss of mitochondrial membrane potential (Delta Psi m) and regulation of the expression of Bcl-2 family members. Release of apoptosis-inducing factor (AIF) and cytochrome c precedes MMP. AIF release causes DNA fragmentation, the final stage of apoptosis, via a caspase-independent mitochondrial pathway. Additionally, FE was found to induce phosphorylation of c-Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK) 1/2, and apoptosis was found to be attenuated by inhibition of JNK. Furthermore, FE-mediated apoptosis was found to involve the generation of reactive oxygen species (ROS), which are responsible for the decrease of Delta Psi m and phosphorylation of JNK, p38, and ERK1/2 kinases. Conclusions/Significance: These data suggest that FE activates a caspase-independent apoptotic pathway in MCF-7 cancer cells through activation of ROS-mediated MAP kinases and regulation of the Bcl-2 family protein-mediated mitochondrial pathway. They also provide evidence that FE deserves further investigation as a natural anticancer and cancer preventive agent.	[Zhang, Zhongyuan; Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan; [Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Eto, Hiroshi] Daiichi Sangyo Co Ltd, Osaka, Japan	Kyushu University; Kyushu University; Daiichi Sankyo Company Limited	Zhang, ZY (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan.	kteruya@grt.kyushu-u.ac.jp			Daiichi Sangyo Co., Ltd.	Daiichi Sangyo Co., Ltd.(Daiichi Sankyo Company Limited)	This work was supported by Daiichi Sangyo Co., Ltd. Hiroshi Eto is an employee of Daiichi Sangyo Co., Ltd. and contributed analysis tools to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Athukorala Y, 2009, J APPL PHYCOL, V21, P307, DOI 10.1007/s10811-008-9368-7; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; COOMBE DR, 1987, INT J CANCER, V39, P82, DOI 10.1002/ijc.2910390115; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Egawa-Takata T, 2010, CANCER SCI, V101, P2171, DOI 10.1111/j.1349-7006.2010.01670.x; Engles JM, 2006, J NUCL MED, V47, P603; Ham YM, 2003, J BIOL CHEM, V278, P50330, DOI 10.1074/jbc.M302997200; Haneji K, 2005, NUTR CANCER, V52, P189, DOI 10.1207/s15327914nc5202_9; Harmon AW, 2004, BREAST CANCER RES TR, V85, P103, DOI 10.1023/B:BREA.0000025397.56192.e2; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Hyun JH, 2009, BIOL PHARM BULL, V32, P1760, DOI 10.1248/bpb.32.1760; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jin JO, 2010, MOL CARCINOGEN, V49, P771, DOI 10.1002/mc.20654; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Maruyama H, 2006, PLANTA MED, V72, P1415, DOI 10.1055/s-2006-951703; Moley KH, 2000, APOPTOSIS, V5, P99, DOI 10.1023/A:1009697908332; Nagamine T, 2009, NUTR CANCER, V61, P340, DOI 10.1080/01635580802567133; Nishimoto SJ, 2004, J INT SOC LIFE INFO, V22, P497; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Parreno M, 2008, CANCER RES, V68, P6313, DOI 10.1158/0008-5472.CAN-08-1054; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Shrivastava A, 2006, J BIOL CHEM, V281, P19762, DOI 10.1074/jbc.M600746200; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Takada E, 2001, J IMMUNOL, V166, P1641, DOI 10.4049/jimmunol.166.3.1641; TAKADA M, 2007, 5 ANN M JAP SOC MED; Tokita Y, 2010, BIOSCI BIOTECH BIOCH, V74, P350, DOI 10.1271/bbb.90705; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015; Wang XD, 2001, GENE DEV, V15, P2922; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamasaki-Miyamoto Y, 2009, J AGR FOOD CHEM, V57, P8677, DOI 10.1021/jf9010406; Ye J, 2005, CYTOTECHNOLOGY, V47, P117, DOI 10.1007/s10616-005-3761-8	60	82	86	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27441	10.1371/journal.pone.0027441	http://dx.doi.org/10.1371/journal.pone.0027441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096572	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900044
J	Dehmer, JJ; Garrison, AP; Speck, KE; Dekaney, CM; Van Landeghem, L; Sun, XF; Henning, SJ; Helmrath, MA				Dehmer, Jeffrey J.; Garrison, Aaron P.; Speck, Karen E.; Dekaney, Christopher M.; Van Landeghem, Laurianne; Sun, Xiaofei; Henning, Susan J.; Helmrath, Michael A.			Expansion of Intestinal Epithelial Stem Cells during Murine Development	PLOS ONE			English	Article							CRYPT FISSION; POSTNATAL-DEVELOPMENT; MOUSE; POPULATION; BOWEL; MICE; HYPERPLASIA; EXPRESSION; RESECTION; MARKER	Murine small intestinal crypt development is initiated during the first postnatal week. Soon after formation, overall increases in the number of crypts occurs through a bifurcating process called crypt fission, which is believed to be driven by developmental increases in the number of intestinal stem cells (ISCs). Recent evidence suggests that a heterogeneous population of ISCs exists within the adult intestine. Actively cycling ISCs are labeled by Lgr5, Ascl2 and Olfm4; whereas slowly cycling or quiescent ISC are marked by Bmi1 and mTert. The goal of this study was to correlate the expression of these markers with indirect measures of ISC expansion during development, including quantification of crypt fission and side population (SP) sorting. Significant changes were observed in the percent of crypt fission and SP cells consistent with ISC expansion between postnatal day 14 and 21. Quantitative real-time polymerase chain reaction (RT-PCR) for the various ISC marker mRNAs demonstrated divergent patterns of expression. mTert surged earliest, during the first week of life as crypts are initially being formed, whereas Lgr5 and Bmi1 peaked on day 14. Olfm4 and Ascl2 had variable expression patterns. To assess the number and location of Lgr5-expressing cells during this period, histologic sections from intestines of Lgr5-EGFP mice were subjected to quantitative analysis. There was attenuated Lgr5-EGFP expression at birth and through the first week of life. Once crypts were formed, the overall number and percent of Lgr5-EGFP positive cells per crypt remain stable throughout development and into adulthood. These data were supported by Lgr5 in situ hybridization in wild-type mice. We conclude that heterogeneous populations of ISCs are expanding as measured by SP sorting and mRNA expression at distinct developmental time points.	[Helmrath, Michael A.] Cincinnati Childrens Hosp Med Ctr, Dept Surg, Cincinnati, OH USA; [Sun, Xiaofei] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH USA; [Henning, Susan J.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Dehmer, JJ (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA.	michael.helmrath@cchmc.org	, Histology Research Core Facility/ABF-6317-2021; Van Landeghem, Laurianne/K-2430-2015; Van+Landeghem, Laurianne/AAG-7334-2019	Van+Landeghem, Laurianne/0000-0001-7408-3521; Dekaney, Christopher/0000-0002-3252-1199	National Institutes of Health [T32-GM008450, R01-DK083325, P30 DK034987, U01-DK085547]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083325, U01DK085547, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants T32-GM008450 (JJD, APG, KES), R01-DK083325 (MAH), P30 DK034987 (SJH, MAH), and U01-DK085547 (SJH, MAH). The latter grant is part of the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bianchi A, 2009, SEMIN PEDIATR SURG, V18, P249, DOI 10.1053/j.sempedsurg.2009.07.010; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; CAIRNIE AB, 1975, CELL TISSUE KINET, V8, P189, DOI 10.1111/j.1365-2184.1975.tb01219.x; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; Cummins AG, 2008, J PEDIATR GASTR NUTR, V47, P153, DOI 10.1097/MPG.0b013e3181604d27; Cummins AG, 2006, DIGEST DIS SCI, V51, P718, DOI 10.1007/s10620-006-3197-9; Dekaney CM, 2007, AM J PHYSIOL-GASTR L, V293, pG1013, DOI 10.1152/ajpgi.00218.2007; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; Garrison AP, 2009, J PEDIATR GASTR NUTR, V49, P2, DOI 10.1097/MPG.0b013e3181ad3021; Gulati AS, 2008, AM J PHYSIOL-GASTR L, V294, pG286, DOI 10.1152/ajpgi.00416.2007; HERBST JJ, 1969, PEDIATR RES, V3, P27, DOI 10.1203/00006450-196901000-00004; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Longshore SW, 2009, J PEDIATR SURG, V44, P1065, DOI 10.1016/j.jpedsurg.2009.02.034; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Potten CS, 2002, J CELL SCI, V115, P2381; Reinisch C, 2006, HISTOL HISTOPATHOL, V21, P1143, DOI 10.14670/HH-21.1143; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; TOTAFURNO J, 1987, BIOPHYS J, V52, P279, DOI 10.1016/S0006-3495(87)83215-0; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VanDussen KL, 2010, GASTROENTEROLOGY, V138, pS116; Wright NA, 2000, INT J EXP PATHOL, V81, P117, DOI 10.1046/j.1365-2613.2000.00146.x	32	60	61	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27070	10.1371/journal.pone.0027070	http://dx.doi.org/10.1371/journal.pone.0027070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102874	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800015
J	Li, JF; Bush, J; Xiong, Y; Li, L; McCormack, M				Li, Jian-Feng; Bush, Jenifer; Xiong, Yan; Li, Lei; McCormack, Matthew			Large-Scale Protein-Protein Interaction Analysis in Arabidopsis Mesophyll Protoplasts by Split Firefly Luciferase Complementation	PLOS ONE			English	Article							AUXIN RESPONSE; REGULATED PROTEIN; CIRCADIAN CLOCK; GENE-EXPRESSION; AUX/IAA PROTEIN; BIOLUMINESCENCE; ASSAY; ARF; DNA; IDENTIFICATION	Protein-protein interactions (PPIs) constitute the regulatory network that coordinates diverse cellular functions. There are growing needs in plant research for creating protein interaction maps behind complex cellular processes and at a systems biology level. However, only a few approaches have been successfully used for large-scale surveys of PPIs in plants, each having advantages and disadvantages. Here we present split firefly luciferase complementation (SFLC) as a highly sensitive and noninvasive technique for in planta PPI investigation. In this assay, the separate halves of a firefly luciferase can come into close proximity and transiently restore its catalytic activity only when their fusion partners, namely the two proteins of interest, interact with each other. This assay was conferred with quantitativeness and high throughput potential when the Arabidopsis mesophyll protoplast system and a microplate luminometer were employed for protein expression and luciferase measurement, respectively. Using the SFLC assay, we could monitor the dynamics of rapamycin-induced and ascomycin-disrupted interaction between Arabidopsis FRB and human FKBP proteins in a near real-time manner. As a proof of concept for large-scale PPI survey, we further applied the SFLC assay to testing 132 binary PPIs among 8 auxin response factors (ARFs) and 12 Aux/IAA proteins from Arabidopsis. Our results demonstrated that the SFLC assay is ideal for in vivo quantitative PPI analysis in plant cells and is particularly powerful for large-scale binary PPI screens.	[Li, Jian-Feng; Xiong, Yan; Li, Lei; McCormack, Matthew] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Li, Jian-Feng; Bush, Jenifer; Xiong, Yan; Li, Lei; McCormack, Matthew] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Li, JF (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	jli@molbio.mgh.harvard.edu	Li, Lei/F-9826-2015		Massachusetts General Hospital; National Institutes of Health [GM070567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567] Funding Source: NIH RePORTER	Massachusetts General Hospital(General Electric); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Massachusetts General Hospital postdoctoral fellowship for medical discovery awarded to Dr. Li, and the National Institutes of Health grant GM070567 to Dr. Sheen (Massachusetts General Hospital, United States of America). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Boruc J, 2010, PLANT SIGNAL BEHAV, V5, P1276, DOI 10.4161/psb.5.10.13037; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Faraco M, 2011, PLANT PHYSIOL, V156, P474, DOI 10.1104/pp.111.173708; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fukaki H, 2005, PLANT J, V44, P382, DOI 10.1111/j.1365-313X.2005.02537.x; Gehl C, 2011, PLANT J, V67, P542, DOI 10.1111/j.1365-313X.2011.04607.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Kim JY, 2010, J BIOL CHEM, V285, P23307, DOI 10.1074/jbc.M110.105981; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Porter JR, 2008, J AM CHEM SOC, V130, P6488, DOI 10.1021/ja7114579; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Rose A, 2004, PLANT PHYSIOL, V134, P927, DOI 10.1104/pp.103.035626; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Weijers D, 2004, CURR OPIN PLANT BIOL, V7, P687, DOI 10.1016/j.pbi.2004.09.006; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YX, 2010, CURR GENOMICS, V11, P40, DOI 10.2174/138920210790218016	50	43	59	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27364	10.1371/journal.pone.0027364	http://dx.doi.org/10.1371/journal.pone.0027364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096563	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800050
J	Zaritsky, A; Natan, S; Horev, J; Hecht, I; Wolf, L; Ben-Jacob, E; Tsarfaty, I				Zaritsky, Assaf; Natan, Sari; Horev, Judith; Hecht, Inbal; Wolf, Lior; Ben-Jacob, Eshel; Tsarfaty, Ilan			Cell Motility Dynamics: A Novel Segmentation Algorithm to Quantify Multi-Cellular Bright Field Microscopy Images	PLOS ONE			English	Article							GROWTH FACTOR/SCATTER FACTOR; IN-VITRO; MIGRATION; SCATTERING; EPITHELIUM; MONOLAYER; SOFTWARE; TEXTURE; TUMOR; MODEL	Confocal microscopy analysis of fluorescence and morphology is becoming the standard tool in cell biology and molecular imaging. Accurate quantification algorithms are required to enhance the understanding of different biological phenomena. We present a novel approach based on image-segmentation of multi-cellular regions in bright field images demonstrating enhanced quantitative analyses and better understanding of cell motility. We present MultiCellSeg, a segmentation algorithm to separate between multi-cellular and background regions for bright field images, which is based on classification of local patches within an image: a cascade of Support Vector Machines (SVMs) is applied using basic image features. Post processing includes additional classification and graph-cut segmentation to reclassify erroneous regions and refine the segmentation. This approach leads to a parameter-free and robust algorithm. Comparison to an alternative algorithm on wound healing assay images demonstrates its superiority. The proposed approach was used to evaluate common cell migration models such as wound healing and scatter assay. It was applied to quantify the acceleration effect of Hepatocyte growth factor/scatter factor (HGF/SF) on healing rate in a time lapse confocal microscopy wound healing assay and demonstrated that the healing rate is linear in both treated and untreated cells, and that HGF/SF accelerates the healing rate by approximately two-fold. A novel fully automated, accurate, zero-parameters method to classify and score scatter-assay images was developed and demonstrated that multi-cellular texture is an excellent descriptor to measure HGF/SF-induced cell scattering. We show that exploitation of textural information from differential interference contrast (DIC) images on the multi-cellular level can prove beneficial for the analyses of wound healing and scatter assays. The proposed approach is generic and can be used alone or alongside traditional fluorescence single-cell processing to perform objective, accurate quantitative analyses for various biological applications.	[Natan, Sari; Horev, Judith; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Hecht, Inbal; Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Zaritsky, Assaf; Wolf, Lior] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Zaritsky, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ilants@post.tau.ac.il		Zaritsky, Assaf/0000-0002-1477-5478; Tsarfaty, Ilan/0000-0002-5230-7093; Natan, Sari/0000-0001-9419-3808	Breast Cancer Research Foundation; Federico Foundation	Breast Cancer Research Foundation; Federico Foundation	This work was supported in part by research grants from the Breast Cancer Research Foundation and the Federico Foundation Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali R, 2008, ADV PHASE BASED SEGM, P181; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Candes E, 2006, MULTISCALE MODEL SIM, V5, P861, DOI 10.1137/05064182X; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; FU YX, 1990, CANCER RES, V50, P227; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Geback T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-75; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kort EJ, 2003, CYTOM PART A, V51A, P119, DOI 10.1002/cyto.a.10010; Korzynska A, 2007, PATTERN ANAL APPL, V10, P301, DOI 10.1007/s10044-007-0069-7; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lampugnani MG, 1999, METH MOL B, V96, P177; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Placidi Giuseppe, 2003, Stud Health Technol Inform, V95, P164; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Qin JF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-9; Selinummi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007497; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Skopin MD, 2009, PHOTODERMATOL PHOTO, V25, P75, DOI 10.1111/j.1600-0781.2009.00406.x; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Topman G, 2011, MED ENG PHYS; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I; Zordan MD, 2011, CYTOM PART A, V79A, P227, DOI 10.1002/cyto.a.21029	32	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27593	10.1371/journal.pone.0027593	http://dx.doi.org/10.1371/journal.pone.0027593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096600	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800065
J	Tailler, M; Senovilla, L; Lainey, E; Thepot, S; Metivier, D; Sebert, M; Baud, V; Billot, K; Fenaux, P; Galluzzi, L; Boehrer, S; Kroemer, G; Kepp, O				Tailler, M.; Senovilla, L.; Lainey, E.; Thepot, S.; Metivier, D.; Sebert, M.; Baud, V.; Billot, K.; Fenaux, P.; Galluzzi, L.; Boehrer, S.; Kroemer, G.; Kepp, O.			Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia	ONCOGENE			English	Article						apoptosis; necrosis; myeloblasts; HL-60; HCS	CELL-DEATH; CARDIAC-GLYCOSIDES; MITOCHONDRIAL ALTERATIONS; CANCER-CELLS; DIFFERENTIATION; APOPTOSIS; ASSAYS; INHIBITION; EXPRESSION; GUIDELINES	Despite recent progress in the treatment of acute myeloid leukemia (AML), the prognosis of this rather heterogeneous disease remains poor and novel chemotherapeutics that specifically target leukemic cells must be developed. To address this need at the preclinical level, we implemented a high content imaging-based screen for the identification of small agents that induce AML cell death in vitro. Among a panel of 1040 Food and Drug Administration-approved agents, we identified pyrithione zinc (PZ) and ouabain (OUA) as potential antileukemic compounds. Both PZ and OUA efficiently induced cell death associated with apoptotic chromatin condensation and inhibition of nuclear factor-kappa B survival signaling, leading to reduced expression of antiapoptotic proteins, in several AML cell lines. PZ- and OUA-induced cell death was associated with the permeabilization of the outer mitochondrial membrane and led to the release of cytochrome c followed by caspase activation. Both PZ and OUA exerted significant anticancer effects in vivo, on human AML cells xenografts as well as ex vivo, on CD34(+) (but not CD34(-)) malignant myeloblasts from AML patients. Altogether, our results suggest that PZ and OUA may exhibit antileukemic effects by inducing the apoptotic demise of AML cells. Oncogene (2012) 31, 3536-3546; doi:10.1038/onc.2011.521; published online 21 November 2011	[Kroemer, G.] Inst Gustave Roussy, INSERM, PR1, U848, F-94805 Villejuif, Val De Marne, France; [Tailler, M.; Senovilla, L.; Lainey, E.; Thepot, S.; Metivier, D.; Sebert, M.; Fenaux, P.; Galluzzi, L.; Boehrer, S.; Kepp, O.] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Thepot, S.; Sebert, M.; Fenaux, P.; Boehrer, S.] Univ Paris 13, AP HP, Hop Avicenne, Serv Hematol Clin, Bobigny, France; [Baud, V.; Billot, K.] INSERM, Inst Cochin, U1016, Paris, France; [Baud, V.; Billot, K.] CNRS, UMR8104, Paris, France; [Baud, V.; Billot, K.; Kroemer, G.] Univ Paris 05, Paris, France; [Kroemer, G.] Ctr Rech Cordeliers, Paris, France; [Kroemer, G.] Hop Europe Georges Pompidou, AP HP, Pole Biol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, PR1, U848, 114 Rue Edouard Vaillant, F-94805 Villejuif, Val De Marne, France.	kroemer@orange.fr; oliver.kepp@igr.fr	KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAH-3286-2021; Kepp, Oliver/N-2763-2017; Galluzzi, Lorenzo/AAG-6432-2019; Senovilla, Laura/AAX-5599-2021; Baud, Veronique/F-7699-2013; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/K-2709-2012; Kepp, Oliver/GPX-8627-2022; THEPOT, Sylvain/L-3078-2015; Baud, Veronique/AAL-3950-2020; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; Kepp, Oliver/0000-0002-6081-9558; Baud, Veronique/0000-0002-4090-718X; Galluzzi, Lorenzo/0000-0003-2257-8500; Baud, Veronique/0000-0002-4090-718X; Senovilla, Laura/0000-0001-6887-2436; thepot, sylvain/0000-0003-3492-2778	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR); European Commission; Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Canceropole Ile-de-France; Fondation Bettencourt-Schueller; LabEx Onco-Immunology; Agence Nationale pour la Recherche; Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Universite Paris Descartes; Ligue Nationale contre le Cancer; Apo-Sys	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; LabEx Onco-Immunology; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Universite Paris Descartes; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Apo-Sys(European CommissionEuropean Commission Joint Research Centre)	This work is supported by grants to GK from the Ligue Nationale contre le Cancer (Equipes labellisee), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Canceropole Ile-de-France, Fondation Bettencourt-Schueller and the LabEx Onco-Immunology; to VB from Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole and Universite Paris Descartes. MT is supported by the Ligue Nationale contre le Cancer. LG is funded by Apo-Sys; KB is supported by Agence Nationale pour la Recherche.	Bielawski K, 2006, BIOL PHARM BULL, V29, P1493, DOI 10.1248/bpb.29.1493; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chan G, 2007, BLOOD, V110, P1079, DOI 10.1182/blood-2007-01-069856; Edwards Bruce S., 2009, V486, P151, DOI 10.1007/978-1-60327-545-3_11; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hallbook H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015718; Hoffmann J, 2008, CANCER RES, V68, P5301, DOI 10.1158/0008-5472.CAN-08-0237; Juncker T, 2011, BIOCHEM PHARMACOL, V81, P13, DOI 10.1016/j.bcp.2010.08.025; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Lamore SD, 2011, BIOMETALS, V24, P875, DOI 10.1007/s10534-011-9441-6; Lamore SD, 2010, CELL STRESS CHAPERON, V15, P309, DOI 10.1007/s12192-009-0145-6; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Perne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008292; Rouge TD, 2007, CANCER RES, V67, P6253, DOI 10.1158/0008-5472.CAN-07-0538; Smits ELJ, 2011, CANCER IMMUNOL IMMUN, V60, P757, DOI 10.1007/s00262-011-1022-6; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Vitale I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001337; Wald DN, 2008, CANCER RES, V68, P4369, DOI 10.1158/0008-5472.CAN-07-6559; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Yin W, 2009, BIOCHEM PHARMACOL, V78, P191, DOI 10.1016/j.bcp.2009.03.025; ZHANG LS, 1992, CANCER RES, V52, P4634	34	47	48	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	30					3536	3546		10.1038/onc.2011.521	http://dx.doi.org/10.1038/onc.2011.521			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22105358				2022-12-25	WOS:000306844100006
J	Nordmann, A; Wixler, L; Boergeling, Y; Wixler, V; Ludwig, S				Nordmann, Alexandra; Wixler, Ludmilla; Boergeling, Yvonne; Wixler, Viktor; Ludwig, Stephan			A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication	FASEB JOURNAL			English	Article						cellular innate immune response; interferon; large GTPases	INFLUENZA-A VIRUS; VESICULAR STOMATITIS-VIRUS; NUCLEOTIDE-BINDING; INTERFERON-GAMMA; GTPASE; ACTIVATION; EXPRESSION; FAMILY; PROLIFERATION; INDUCTION	Guanylate-binding proteins (GBPs) belong to the family of large GTPases that are induced in response to interferons. GBPs contain an N-terminal globular GTPase domain and a C-terminal alpha-helical regulatory domain that are connected by a short middle domain. Antiviral activity against vesicular stomatitis virus and encephalomyocarditis virus has been shown for hGBP-1; however, no anti-influenza virus properties for GBPs have been described to date. Here we show that hGBP-1 and hGBP-3 possess anti-influenza viral activity. Furthermore, we have identified a novel splice variant of hGBP-3, named hGBP-3 Delta C, with a largely modified C-terminal alpha-helical domain. While all three GBP isoforms were up-regulated on influenza virus infection, hGBP-3 Delta C showed the most prominent antiviral activity in epithelial cells. Mutational analysis of hGBPs revealed that the globular domain is the principal antiviral effector domain, and GTP-binding, but not hydrolysis, is necessary for antiviral action. Furthermore, we showed that hGBP-3 Delta C strongly represses the activity of the viral polymerase complex, which results in decreased synthesis of viral vRNA, cRNA, mRNA, and viral proteins, as well.-Nordmann, A., Wixler, L., Boergeling, Y., Wixler, V., Ludwig, S. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 26, 1290-1300 (2012). www.fasebj.org	[Nordmann, Alexandra; Wixler, Ludmilla; Boergeling, Yvonne; Wixler, Viktor; Ludwig, Stephan] Univ Munster, IMV, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany	University of Munster	Ludwig, S (corresponding author), Univ Munster, IMV, Ctr Mol Biol Inflammat ZMBE, Von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Deutsche Forschungsgemeinschaft [DFG Lu477/13-1]; International Max Planck Research School (IMPRS) International Graduate School Muenster (Muenster, Germany); German Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School (IMPRS) International Graduate School Muenster (Muenster, Germany); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (grant DFG Lu477/13-1) and the Graduate Program Cell Dynamics and Disease (CEDAD)-International Max Planck Research School (IMPRS) International Graduate School Muenster (Muenster, Germany). The Institute of Molecular Virology Muenster is a member of the Flu Research Net, a nationwide research network on zoonotic influenza sponsored by the German Ministry of Education and Research (BMBF).	Abdullah N, 2009, J MOL BIOL, V386, P690, DOI 10.1016/j.jmb.2008.12.060; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dudek SE, 2010, J VIROL, V84, P9439, DOI 10.1128/JVI.00533-10; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Fellenberg F, 2004, J INVEST DERMATOL, V122, P1510, DOI 10.1111/j.0022-202X.2004.22613.x; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; Vopel T, 2010, J MOL BIOL, V400, P63, DOI 10.1016/j.jmb.2010.04.053; Wehner M, 2010, FEBS J, V277, P1597, DOI 10.1111/j.1742-4658.2010.07586.x	32	67	72	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1290	1300		10.1096/fj.11-189886	http://dx.doi.org/10.1096/fj.11-189886			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22106366				2022-12-25	WOS:000300949300031
J	Chung, SM; Miller, JT; Johnson, BC; Hughes, SH; Le Grice, SFJ				Chung, Suhman; Miller, Jennifer T.; Johnson, Barry C.; Hughes, Stephen H.; Le Grice, Stuart F. J.			Mutagenesis of Human Immunodeficiency Virus Reverse Transcriptase p51 Subunit Defines Residues Contributing to Vinylogous Urea Inhibition of Ribonuclease H Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV RNASE-H; WILD-TYPE; POSITIONAL ADAPTABILITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DRUG-RESISTANCE; DNA-POLYMERASE; NUCLEIC-ACID; TYPE-1; DESIGN	The vinylogous urea, NSC727447, was proposed to allosterically inhibit ribonucleaseH(RNase H) activity of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) by interacting with the thumb subdomain of its non-catalytic p51 subunit. Proximity of the p51 thumb to the p66 RNase H domain implied that inhibitor binding altered active site geometry, whereas protein footprinting suggested a contribution from alpha-helix I residues Cys-280 and Lys-281. To more thoroughly characterize the vinylogous urea binding site, horizontal alanine scanning mutagenesis between p51 residues Lys-275 and Thr-286 (comprising alpha-helix I and portions of the neighboring alpha H/alpha I and alpha I/alpha J connecting loops) was combined with a limited vertical scan of Cys-280. A contribution from Cys-280 was strengthened by our observation that all substitutions at this position rendered selectively mutated, reconstituted p66/p51 heterodimers similar to 45-fold less sensitive to inhibition. An similar to 19-fold reduced IC50 for p51 mutant T286A coupled with a 2-8-fold increased IC50 when intervening residues were substituted supports our original proposal of p51 alpha-helix I as the vinylogous urea binding site. In contrast to these allosteric inhibitors, mutant enzymes retained equivalent sensitivity to the natural product alpha-hydroxytropolone inhibitor manicol, which x-ray crystallography has demonstrated functions by chelating divalent metal at the p66 RNase H active site. Finally, reduced DNA strand-transfer activity together with increased vinylogous urea sensitivity of p66/p51 heterodimers containing short p51 C-terminal deletions suggests an additional role for the p51 C terminus in nucleic acid binding that is compromised by inhibitor binding.	[Chung, Suhman; Miller, Jennifer T.; Johnson, Barry C.; Hughes, Stephen H.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Le Grice, SFJ (corresponding author), Bldg 535,Rm 312,1050 Boyles St, Frederick, MD 21702 USA.	legrices@mail.nih.gov		Johnson, Barry/0000-0001-9482-2248	National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010481, ZIABC010494] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; Chung SM, 2011, J MED CHEM, V54, P4462, DOI 10.1021/jm2000757; Chung SM, 2010, ANTIMICROB AGENTS CH, V54, P3913, DOI 10.1128/AAC.00434-10; Cullen MD, 2009, J MED CHEM, V52, P6467, DOI 10.1021/jm901167t; Das K, 2005, PROG BIOPHYS MOL BIO, V88, P209, DOI 10.1016/j.pbiomolbio.2004.07.001; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Ghosh M, 1997, BIOCHEMISTRY-US, V36, P5758, DOI 10.1021/bi963045e; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; HERMANN T, 1994, NUCLEIC ACIDS RES, V22, P4625, DOI 10.1093/nar/22.22.4625; Hermann T, 1996, EUR J BIOCHEM, V242, P98, DOI 10.1111/j.1432-1033.1996.0098r.x; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Hsiou Y, 1998, J MOL BIOL, V284, P313, DOI 10.1006/jmbi.1998.2171; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JACQUES PS, 1994, J BIOL CHEM, V269, P1388; Janssen PAJ, 2005, J MED CHEM, V48, P1901, DOI 10.1021/jm040840e; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Kirschberg TA, 2009, J MED CHEM, V52, P5781, DOI 10.1021/jm900597q; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; Lansdon EB, 2011, ANTIMICROB AGENTS CH, V55, P2905, DOI 10.1128/AAC.01594-10; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Ohishi M, 2007, VIROLOGY, V362, P131, DOI 10.1016/j.virol.2006.12.030; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; Sahlberg Christer, 2008, Anti-Infective Agents in Medicinal Chemistry, V7, P101, DOI 10.2174/187152108783954597; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sevilya Z, 2003, J MOL BIOL, V327, P19, DOI 10.1016/S0022-2836(03)00052-4; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; Sluis-Cremer N, 2000, BIOCHEMISTRY-US, V39, P1427, DOI 10.1021/bi991682+; Sluis-Cremer N, 2006, J MED CHEM, V49, P4834, DOI 10.1021/jm0604575; Srivastava S, 2006, CURR PHARM DESIGN, V12, P1879, DOI 10.2174/138161206776873590; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039	44	18	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4066	4075		10.1074/jbc.M111.314781	http://dx.doi.org/10.1074/jbc.M111.314781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22105069	hybrid, Green Published			2022-12-25	WOS:000300410900040
J	Gu, YZ; Barry, J; McDougel, R; Terman, D; Gu, C				Gu, Yuanzheng; Barry, Joshua; McDougel, Robert; Terman, David; Gu, Chen			Alternative Splicing Regulates Kv3.1 Polarized Targeting to Adjust Maximal Spiking Frequency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENT; GATED POTASSIUM CHANNELS; K+ CHANNELS; A-TYPE; AUDITORY NEURONS; RAT-BRAIN; GABAERGIC INTERNEURONS; DEVELOPMENTAL-CHANGES; HIPPOCAMPAL-NEURONS; DISTINCT ROLES	Synaptic inputs received at dendrites are converted into digital outputs encoded by action potentials generated at the axon initial segment in most neurons. Here, we report that alternative splicing regulates polarized targeting of Kv3.1 voltage-gated potassium (Kv) channels to adjust the input-output relationship. The spiking frequency of cultured hippocampal neurons correlated with the level of endogenous Kv3 channels. Expression of axonal Kv3.1b, the longer form of Kv3.1 splice variants, effectively converted slow-spiking young neurons to fast-spiking ones; this was not the case for Kv1.2 or Kv4.2 channel constructs. Despite having identical biophysical properties as Kv3.1b, dendritic Kv3.1a was significantly less effective at increasing the maximal firing frequency. This suggests a possible role of channel targeting in regulating spiking frequency. Mutagenesis studies suggest the electrostatic repulsion between the Kv3.1b N/C termini, created by its C-terminal splice domain, unmasks the Kv3.1b axonal targeting motif. Kv3.1b axonal targeting increased the maximal spiking frequency in response to prolonged depolarization. This finding was further supported by the results of local application of channel blockers and computer simulations. Taken together, our studies have demonstrated that alternative splicing controls neuronal firing rates by regulating the polarized targeting of Kv3.1 channels.	[Gu, Yuanzheng; Gu, Chen] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Gu, Yuanzheng; Gu, Chen] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Barry, Joshua; Gu, Chen] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [McDougel, Robert; Terman, David] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University	Gu, C (corresponding author), 182 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	gu.49@osu.edu	Gu, Chen/E-3163-2011		National Institutes of Health [R01NS062720]; NINDS; National Science Foundation [DMS-1022627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1022627] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS062720 from the NINDS (to C. G.) and National Science Foundation Grant DMS-1022627 (to D. T.). All animal experiments have been conducted in accordance with the National Institutes of Health Animal Use Guidelines.	Atzori M, 2000, NAT NEUROSCI, V3, P791, DOI 10.1038/77693; BACCAGLINI PI, 1977, J PHYSIOL-LONDON, V271, P93, DOI 10.1113/jphysiol.1977.sp011992; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Brooke RE, 2004, NEUROSCIENCE, V126, P1001, DOI 10.1016/j.neuroscience.2004.03.051; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Chow A, 1999, J NEUROSCI, V19, P9332; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cooper EC, 1998, J NEUROSCI, V18, P965; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Golomb D, 2007, PLOS COMPUT BIOL, V3, P1498, DOI 10.1371/journal.pcbi.0030156; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009; Guan DX, 2011, J NEUROPHYSIOL, V105, P2976, DOI 10.1152/jn.00758.2010; Gurantz D, 1996, J NEUROSCI, V16, P3287; HARRIS GL, 1988, NEURON, V1, P739, DOI 10.1016/0896-6273(88)90172-9; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; HWANG PM, 1993, NEUROSCIENCE, V55, P613, DOI 10.1016/0306-4522(93)90427-H; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Martina M, 2003, J NEUROSCI, V23, P5698; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Nakamura Y, 2007, J PHYSIOL-LONDON, V581, P1101, DOI 10.1113/jphysiol.2007.128702; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Parameshwaran S, 2001, J NEUROSCI, V21, P485, DOI 10.1523/JNEUROSCI.21-02-00485.2001; PERNEY TM, 1992, J NEUROPHYSIOL, V68, P756, DOI 10.1152/jn.1992.68.3.756; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Rasband M, 1998, J NEUROSCI, V18, P36; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; von Hehn CAA, 2004, J NEUROSCI, V24, P1936, DOI 10.1523/JNEUROSCI.4554-03.2004; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007	62	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1755	1769		10.1074/jbc.M111.299305	http://dx.doi.org/10.1074/jbc.M111.299305			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22105078	Green Published, hybrid			2022-12-25	WOS:000299321000018
J	Knorzer, P; Silakov, A; Foster, CE; Armstrong, FA; Lubitz, W; Happe, T				Knoerzer, Philipp; Silakov, Alexey; Foster, Carina E.; Armstrong, Fraser A.; Lubitz, Wolfgang; Happe, Thomas			Importance of the Protein Framework for Catalytic Activity of [FeFe]-Hydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-ONLY HYDROGENASE; DENSITY-FUNCTIONAL CALCULATIONS; ALGA CHLAMYDOMONAS-REINHARDTII; AMINO-ACID-SEQUENCE; H-CLUSTER; DESULFOVIBRIO-DESULFURICANS; CLOSTRIDIUM-ACETOBUTYLICUM; ELECTRONIC-STRUCTURE; LIGHT SENSITIVITY; EVOLUTIONARY CONSERVATION	The active center (H-cluster) of [FeFe]-hydrogenases is embedded into a hydrophobic pocket within the protein. We analyzed several amino acids, located in the vicinity of this niche, by site-directed mutagenesis of the [FeFe]-hydrogenases from Clostridium pasteurianum (CpI) and Chlamydomonas reinhardtii (CrHydA1). These amino acids are highly conserved and predicted to be involved in H-cluster coordination. Characterization of two hydrogenase variants confirmed this hypothesis. The exchange of residues CrHydA1Met(415) and CrHydA1Lys(228) resulted in inactive proteins, which, according to EPR and FTIR analyses, contain no intact H-cluster. However, [FeFe]-hydrogenases in which CpIMet(353) (CrHydA1Met(223)) and CpICys(299) (CrHydA1Cys(169)) were exchanged to leucine and serine, respectively, showed a structurally intact H-cluster with catalytic activity either absent (CpIC299S) or strongly diminished (CpIM353L). In the case of CrHydA1C169S, the H-cluster was trapped in an inactive state exhibiting g values and vibrational frequencies that resembled the H-trans state of DdH from Desulfovibrio desulfuricans. This cysteine residue, interacting with the bridge head nitrogen of the di(methyl) amine ligand, seems therefore to represent an essential contribution of the immediate protein environment to the reaction mechanism. Exchanging methionine CpIM353 (CrHydA1M(223)) to leucine led to a strong decrease in turnover without affecting the K-m value of the electron donor. We suggest that this methionine constitutes a "fine-tuning" element of hydrogenase activity.	[Knoerzer, Philipp; Happe, Thomas] Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44780 Bochum, Germany; [Silakov, Alexey; Lubitz, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Foster, Carina E.; Armstrong, Fraser A.] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England	Ruhr University Bochum; Max Planck Society; University of Oxford	Happe, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, Univ Str 150, D-44780 Bochum, Germany.	thomas.happe@rub.de	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253; Happe, Thomas/0000-0003-1206-5234	EU; Bundesministerium fur Bildung und Forschung (BMBF) [Bio-H2]; Volkswagen (VW) foundation [LigH2t]	EU(European Commission); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Volkswagen (VW) foundation(Volkswagen)	Supported by the EU-SOLAR-H2 program, the Bundesministerium fur Bildung und Forschung (BMBF) (Bio-H2), and the Volkswagen (VW) foundation (LigH2t). To whom correspondence should be addressed: Ruhr Universitat Bochum, Lehrstuhl fur Biochemie der Pflanzen, AG Photobiotechnologie, Univesitatsstrasse 150, 44780 Bochum, Germany. Tel.: 49-234-32-27026; Fax: 49-234-32-14322; E-mail: thomas.happe@rub.de.	ADAMS MWW, 1984, J BIOL CHEM, V259, P7045; Albracht SPJ, 2006, J BIOL INORG CHEM, V11, P88, DOI 10.1007/s00775-005-0039-8; Apfel UP, 2009, J INORG BIOCHEM, V103, P1236, DOI 10.1016/j.jinorgbio.2009.07.005; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barton BE, 2010, CURR OPIN BIOTECH, V21, P292, DOI 10.1016/j.copbio.2010.03.003; Barton BE, 2008, J AM CHEM SOC, V130, P16834, DOI 10.1021/ja8057666; Bennett B, 2000, BIOCHEMISTRY-US, V39, P7455, DOI 10.1021/bi992583z; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Bingham S. A., 2011, INT J HYDRO IN PRESS; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruschi M, 2002, INORG CHEM, V41, P1421, DOI 10.1021/ic010770r; Bruschi M, 2003, INORG CHEM, V42, P4773, DOI 10.1021/ic0262132; Bruschi M, 2009, ANGEW CHEM INT EDIT, V48, P3503, DOI 10.1002/anie.200900494; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Cammack R., 2001, HYDROGEN FUEL LEARNI; Cao ZX, 2001, J AM CHEM SOC, V123, P3734, DOI 10.1021/ja000116v; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Cohen RO, 2004, BIOCHEMISTRY-US, V43, P4741, DOI 10.1021/bi035633f; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Erdem OF, 2011, ANGEW CHEM INT EDIT, V50, P1439, DOI 10.1002/anie.201006244; Fan HJ, 2001, J AM CHEM SOC, V123, P3828, DOI 10.1021/ja004120i; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Gao WM, 2010, CHEM-EUR J, V16, P2537, DOI 10.1002/chem.200902278; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Greco C, 2007, INORG CHEM, V46, P5911, DOI 10.1021/ic062320a; Greco C, 2007, INORG CHEM, V46, P7256, DOI 10.1021/ic701051h; Green KN, 2009, DALTON T, P4344, DOI 10.1039/b823152d; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hiromoto T, 2009, ANGEW CHEM INT EDIT, V48, P6457, DOI 10.1002/anie.200902695; Ibrahim S, 2010, CHEM COMMUN, V46, P8189, DOI 10.1039/c0cc02962a; Jablonskyte A, 2010, DALTON T, V39, P3026, DOI 10.1039/b923191a; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Karle IL, 1999, J MOL STRUCT, V474, P103, DOI 10.1016/S0022-2860(98)00564-X; King P., 2004, U.S. Patent, Patent No. [7,501,270 B2, 7501270]; Krassen H, 2011, PHYS CHEM CHEM PHYS, V13, P47, DOI 10.1039/c0cp0M63k; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Liu ZP, 2002, J AM CHEM SOC, V124, P5175, DOI 10.1021/ja0118690; Liu ZP, 2002, J CHEM PHYS, V117, P8177, DOI 10.1063/1.1519252; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PATIL DS, 1988, J BIOL CHEM, V263, P18732; Pereira AS, 2001, J AM CHEM SOC, V123, P2771, DOI 10.1021/ja003176+; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Popescu CV, 1999, J AM CHEM SOC, V121, P7877, DOI 10.1021/ja991243y; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; SCHWARTZ RM, 1978, ATLAS PROTEIN SEQ S3, V5, P345; Schweiger A., 2001, PRINCIPLES PULSE ELE; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Silakov A, 2007, J AM CHEM SOC, V129, P11447, DOI 10.1021/ja072592s; Silakov A, 2011, EUR J INORG CHEM, P1056, DOI 10.1002/ejic.201001080; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Singleton ML, 2011, INORG CHEM, V50, P5015, DOI 10.1021/ic200272x; Singleton ML, 2010, J AM CHEM SOC, V132, P8870, DOI 10.1021/ja103774j; SOUCAILLE P, 2006, Patent No. 2006066997; Stripp S, 2009, BIOCHEMISTRY-US, V48, P5042, DOI 10.1021/bi900010b; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Tye JW, 2006, INORG CHEM, V45, P1552, DOI 10.1021/ic051231f; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Wait AF, 2011, J AM CHEM SOC, V133, P1282, DOI 10.1021/ja110103p; WIESENBORN DP, 1988, APPL ENVIRON MICROB, V54, P2717, DOI 10.1128/AEM.54.11.2717-2722.1988; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou TJ, 2005, INORG CHEM, V44, P4941, DOI 10.1021/ic0484699; Zhou TJ, 2004, INORG CHEM, V43, P923, DOI 10.1021/ic0342301	82	111	112	1	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1489	1499		10.1074/jbc.M111.305797	http://dx.doi.org/10.1074/jbc.M111.305797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110126	Green Published, hybrid			2022-12-25	WOS:000299170300062
J	Zhang, XT; Morrissey, C; Sun, SH; Ketchandji, M; Nelson, PS; True, LD; Vakar-Lopez, F; Vessella, RL; Plymate, SR				Zhang, Xiaotun; Morrissey, Colm; Sun, Shihua; Ketchandji, Melanie; Nelson, Peter S.; True, Lawrence D.; Vakar-Lopez, Funda; Vessella, Robert L.; Plymate, Stephen R.			Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases	PLOS ONE			English	Article							GROWTH-FACTOR-I; GENE-EXPRESSION; PROGRESSION; STEROIDOGENESIS; TESTOSTERONE; ACTIVATION; MECHANISMS; INDUCTION; SIGNAL; BONE	Background: Although androgens are depleted in castration resistant prostate cancer (CRPC), metastases still express nuclear androgen receptor (AR) and androgen regulated genes. We recently reported that C-terminal truncated constitutively active AR splice variants contribute to CRPC development. Since specific antibodies detecting all C-terminal truncated AR variants are not available, our aim was to develop an approach to assess the prevalence and function of AR variants in prostate cancer (PCa). Methodology/Principal Findings: Using 2 antibodies against different regions of AR protein (N- or C-terminus), we successfully showed the existence of AR variant in the LuCaP 86.2 xenograft. To evaluate the prevalence of AR variants in human PCa tissue, we used this method on tissue microarrays including 50 primary PCa and 162 metastatic CRPC tissues. RT-PCR was used to confirm AR variants. We observed a significant decrease in nuclear C-terminal AR staining in CRPC but no difference between N- and C-terminal AR nuclear staining in primary PCa. The expression of the AR regulated proteins PSA and PSMA were marginally affected by the decrease in C-terminal staining in CRPC samples. These data suggest that there is an increase in the prevalence of AR variants in CRPC based on our ability to differentiate nuclear AR expression using N- and C-terminal AR antibodies. These findings were validated using RT-PCR. Importantly, the loss of C-terminal immunoreactivity and the identification of AR variants were different depending on the site of metastasis in the same patient. Conclusions: We successfully developed a novel immunohistochemical approach which was used to ascertain the prevalence of AR variants in a large number of primary PCa and metastatic CRPC. Our results showed a snapshot of overall high frequency of C-terminal truncated AR splice variants and site specific AR loss in CRPC, which could have utility in stratifying patients for AR targeted therapeutics.	[Zhang, Xiaotun; Morrissey, Colm; Ketchandji, Melanie; Vessella, Robert L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Sun, Shihua; Nelson, Peter S.; Plymate, Stephen R.] Univ Washington, Dept Med, Seattle, WA USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [True, Lawrence D.; Vakar-Lopez, Funda] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Vessella, Robert L.; Plymate, Stephen R.] Dept Vet Affairs Med Ctr, GRECC & Res Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Zhang, XT (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	splymate@u.washington.edu			PO1 National Institutes of Health [PO1CA085859]; Pacific Northwest Prostate Cancer SPORE [P50CA097186]; Prostate Cancer Foundation; Richard M. Lucas Foundation; VA Puget Sound Health Care System, Seattle, Washington; NATIONAL CANCER INSTITUTE [P01CA085859, P50CA097186] Funding Source: NIH RePORTER	PO1 National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; Richard M. Lucas Foundation; VA Puget Sound Health Care System, Seattle, Washington; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is based upon work supported in part by a PO1 National Institutes of Health grant (PO1CA085859), the Pacific Northwest Prostate Cancer SPORE grant (P50CA097186), the Prostate Cancer Foundation and the Richard M. Lucas Foundation. CM received a career development award from the Pacific Northwest Prostate Cancer SPORE grant (P50CA097186). This research is the result of work supported by resources from the VA Puget Sound Health Care System, Seattle, Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2007, MOL CELL ENDOCRINOL, V270, P50, DOI 10.1016/j.mce.2007.02.006; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; CULIG Z, 1994, CANCER RES, V54, P5474; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Galsky MD, 2005, J CLIN ONCOL, V23, P4823, DOI 10.1200/JCO.2005.92.001; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jagla M, 2007, ENDOCRINOLOGY, V148, P4334, DOI 10.1210/en.2007-0446; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Morrissey C, 2010, PROSTATE, V70, P412, DOI 10.1002/pros.21075; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Putz T, 1999, CANCER RES, V59, P227; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Sadar MD, 2000, CANCER RES, V60, P5825; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang XT, 2009, PROSTATE, V69, P727, DOI 10.1002/pros.20920; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	38	159	175	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27970	10.1371/journal.pone.0027970	http://dx.doi.org/10.1371/journal.pone.0027970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114732	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800047
J	Cascioferro, A; Daleke, MH; Ventura, M; Dona, V; Delogu, G; Palu, G; Bitter, W; Manganelli, R				Cascioferro, Alessandro; Daleke, Maria H.; Ventura, Marcello; Dona, Valentina; Delogu, Giovanni; Palu, Giorgio; Bitter, Wilbert; Manganelli, Riccardo			Functional Dissection of the PE Domain Responsible for Translocation of PE_PGRS33 across the Mycobacterial Cell Wall	PLOS ONE			English	Article							PGRS PROTEINS; VII SECRETION; TUBERCULOSIS; SURFACE; EXPRESSION; PPE; IMMUNOGENICITY; LOCALIZATION; PURIFICATION; NECROSIS	PE are peculiar exported mycobacterial proteins over-represented in pathogenic mycobacterial species. They are characterized by an N-terminal domain of about 110 amino acids (PE domain) which has been demonstrated to be responsible for their export and localization. In this paper, we characterize the PE domain of PE_PGRS33 (PERv1818c), one of the best characterized PE proteins. We constructed several mutated proteins in which portions of the PE domain were deleted or subjected to defined mutations. These proteins were expressed in different mycobacterial species and their localization was characterized. We confirmed that the PE domain is essential for PE_PGRS33 surface localization, and demonstrated that a PE domain lacking its first 30 amino acids loses its function. However, single amino acid substitutions in two regions extremely well conserved within the N-terminal domain of all PE proteins had some effect on the stability of PE_PGRS33, but not on its localization. Using Mycobacterium marinum we could show that the type VII secretion system ESX-5 is essential for PE_PGRS33 export. Moreover, in M. marinum, but not in Mycobacterium bovis BCG and in Mycobacterium tuberculosis, the PE domain of PE_PGRS33 is processed and secreted into the culture medium when expressed in the absence of the PGRS domain. Finally, using chimeric proteins in which different portions of the PERv1818c domain were fused to the N-terminus of the green fluorescent protein, we could hypothesize that the first 30 amino acids of the PE domain contain a sequence that allows protein translocation.	[Cascioferro, Alessandro; Ventura, Marcello; Dona, Valentina; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Daleke, Maria H.; Bitter, Wilbert] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Daleke, Maria H.; Bitter, Wilbert] Vrije Univ Amsterdam, Dept Mol Microbiol, Amsterdam, Netherlands; [Delogu, Giovanni] Catholic Univ Sacred Hearth, Inst Microbiol, Rome, Italy	University of Padua; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cascioferro, A (corresponding author), Inst Pasteur, Integrated Mycobacterial Pathogen Unit, Paris, France.	riccardo.manganelli@unipd.it	Delogu, Giovanni/I-3701-2012; Manganelli, Riccardo/A-7361-2009; Bitter, Wilbert/ABG-3726-2020; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; Cascioferro, Alessandro/E-3445-2017	Delogu, Giovanni/0000-0003-0182-8267; Manganelli, Riccardo/0000-0003-0940-7336; Bitter, Wilbert/0000-0001-8347-6511; Cascioferro, Alessandro/0000-0001-7751-7348	European Community [201762]; Ministero dell'Universita e della Ricerca Scientifica (MIUR) [2008Y8RZTF]	European Community(European Commission); Ministero dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no201762 and by Ministero dell'Universita e della Ricerca Scientifica (MIUR), Progetti di Interesse Nazionale (PRIN) 2008 ( code number 2008Y8RZTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Song H, 2008, TUBERCULOSIS EDINB; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Talarico S, 2005, J CLIN MICROBIOL, V43, P4954, DOI 10.1128/JCM.43.10.4954-4960.2005	31	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27713	10.1371/journal.pone.0027713	http://dx.doi.org/10.1371/journal.pone.0027713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110736	Green Published, gold			2022-12-25	WOS:000297555400093
J	Leroy, F; Mangin, JF; Rousseau, F; Glasel, H; Hertz-Pannier, L; Dubois, J; Dehaene-Lambertz, G				Leroy, Francois; Mangin, Jean-Francois; Rousseau, Francois; Glasel, Herve; Hertz-Pannier, L.; Dubois, Jessica; Dehaene-Lambertz, Ghislaine			Atlas-Free Surface Reconstruction of the Cortical Grey-White Interface in Infants	PLOS ONE			English	Article							AUTOMATIC SEGMENTATION; CEREBRAL ASYMMETRY; MR-IMAGES; BRAIN; MYELINATION	Background: The segmentation of the cortical interface between grey and white matter in magnetic resonance images (MRI) is highly challenging during the first post-natal year. First, the heterogeneous brain maturation creates important intensity fluctuations across regions. Second, the cortical ribbon is highly folded creating complex shapes. Finally, the low tissue contrast and partial volume effects hamper cortex edge detection in parts of the brain. Methods and Findings: We present an atlas-free method for segmenting the grey-white matter interface of infant brains in T2-weighted (T2w) images. We used a broad characterization of tissue using features based not only on local contrast but also on geometric properties. Furthermore, inaccuracies in localization were reduced by the convergence of two evolving surfaces located on each side of the inner cortical surface. Our method has been applied to eleven brains of one-to four-month-old infants. Both quantitative validations against manual segmentations and sulcal landmarks demonstrated good performance for infants younger than two months old. Inaccuracies in surface reconstruction increased with age in specific brain regions where the tissue contrast decreased with maturation, such as in the central region. Conclusions: We presented a new segmentation method which achieved good to very good performance at the grey-white matter interface depending on the infant age. This method should reduce manual intervention and could be applied to pathological brains since it does not require any brain atlas.	[Leroy, Francois; Glasel, Herve; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Leroy, Francois; Mangin, Jean-Francois; Glasel, Herve; Hertz-Pannier, L.; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] CEA, DSV, I2BM, Neurospin Ctr, Gif Sur Yvette, France; [Leroy, Francois; Glasel, Herve; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] Univ Paris 11, Orsay, France; [Leroy, Francois; Mangin, Jean-Francois; Glasel, Herve; Hertz-Pannier, L.; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] IFR49, Paris, France; [Rousseau, Francois] Univ Strasbourg, LSIIT, UMR 7005, CNRS, Illkirch Graffenstaden, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Leroy, F (corresponding author), INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	francois.leroy@cea.fr	Mangin, Jean-Francois/AAI-8983-2020; rousseau, francois/B-3338-2008; Dubois, Jessica/P-2461-2014; Dehaene, Ghislaine/O-3633-2017	rousseau, francois/0000-0001-9837-7487; Dubois, Jessica/0000-0003-4865-8111; Dehaene, Ghislaine/0000-0003-2221-9081; Leroy, Francois/0000-0002-5439-1516; Hertz-Pannier, Lucie/0000-0003-4952-7009	McDonnell Foundation; La Fondation Motrice; ANR; ENP; Fondation Fyssen	McDonnell Foundation; La Fondation Motrice; ANR(French National Research Agency (ANR)); ENP; Fondation Fyssen	The McDonnell Foundation (http://www.jsmf.org/), La Fondation Motrice (http://www.lafondationmotrice.org), ANR (http://www.agence-nationale-recherche.fr/), ENP (http://www.paris-neuroscience.fr), and Fondation Fyssen (http://www.fondation-fyssen.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Cointepas Y, 2001, NEUROIMAGE, V13, pS98; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; FORTIER MFA, 1999, SURVEY WORK ROAD EXT; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Glasel H, 2011, NEUROIMAGE, V58, P716, DOI 10.1016/j.neuroimage.2011.06.016; GUI L, 2011, 2011 IEEE INT S BIOM; Habas PA, 2010, HUM BRAIN MAPP, V31, P1348, DOI 10.1002/hbm.20935; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Leroy F, 2011, J NEUROSCI, V31, P1500, DOI 10.1523/JNEUROSCI.4141-10.2011; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; McKinney CM, 2008, CLEFT PALATE-CRAN J, V45, P208, DOI 10.1597/06-227.1; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Rousseau F, 2006, ACAD RADIOL, V13, P1072, DOI 10.1016/j.acra.2006.05.003; Serra J., 1982, IMAGE ANAL MATH MORP; SHI F, 2010, HUMAN BRAIN MAPPING; Shi F, 2010, LECT NOTES COMPUT SC, V6326, P42; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Song Z, 2007, LECT NOTES COMPUT SC, V4791, P883; THIRION JP, 1995, COMPUT VIS IMAGE UND, V61, P190, DOI 10.1006/cviu.1995.1015; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; WANG L, 2011, NEUROIMAGE; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yu X., 2010, PLOS ONE, V5	27	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27128	10.1371/journal.pone.0027128	http://dx.doi.org/10.1371/journal.pone.0027128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110604	Green Published, gold			2022-12-25	WOS:000297555400019
J	Nagode, DA; Tang, AH; Karson, MA; Klugmann, M; Alger, BE				Nagode, Daniel A.; Tang, Ai-Hui; Karson, Miranda A.; Klugmann, Matthias; Alger, Bradley E.			Optogenetic Release of ACh Induces Rhythmic Bursts of Perisomatic IPSCs in Hippocampus	PLOS ONE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; GABAERGIC INTERNEURONS; CHOLINERGIC INDUCTION; PYRAMIDAL CELLS; INHIBITORY INTERNEURONS; CANNABINOID RECEPTORS; SYNAPTIC-TRANSMISSION; THETA OSCILLATIONS; RAT HIPPOCAMPUS; GABA RELEASE	Acetylcholine (ACh) influences a vast array of phenomena in cortical systems. It alters many ionic conductances and neuronal firing behavior, often by regulating membrane potential oscillations in populations of cells. Synaptic inhibition has crucial roles in many forms of oscillation, and cholinergic mechanisms regulate both oscillations and synaptic inhibition. In vitro investigations using bath-application of cholinergic receptor agonists, or bulk tissue electrical stimulation to release endogenous ACh, have led to insights into cholinergic function, but questions remain because of the relative lack of selectivity of these forms of stimulation. To investigate the effects of selective release of ACh on interneurons and oscillations, we used an optogenetic approach in which the light-sensitive non-selective cation channel, Channelrhodopsin2 (ChR2), was virally delivered to cholinergic projection neurons in the medial septum/diagonal band of Broca (MS/DBB) of adult mice expressing Cre-recombinase under the control of the choline-acetyltransferase (ChAT) promoter. Acute hippocampal slices obtained from these animals weeks later revealed ChR2 expression in cholinergic axons. Brief trains of blue light pulses delivered to untreated slices initiated bursts of ACh-evoked, inhibitory post-synaptic currents (L-IPSCs) in CA1 pyramidal cells that lasted for 10's of seconds after the light stimulation ceased. L-IPSC occurred more reliably in slices treated with eserine and a very low concentration of 4-AP, which were therefore used in most experiments. The rhythmic, L-IPSCs were driven primarily by muscarinic ACh receptors (mAChRs), and could be suppressed by endocannabinoid release from pyramidal cells. Finally, low-frequency oscillations (LFOs) of local field potentials (LFPs) were significantly cross-correlated with the L-IPSCs, and reversal of the LFPs near s. pyramidale confirmed that the LFPs were driven by perisomatic inhibition. This optogenetic approach may be a useful complementary technique in future investigations of endogenous ACh effects.	[Nagode, Daniel A.; Tang, Ai-Hui; Karson, Miranda A.; Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Nagode, Daniel A.; Alger, Bradley E.] Univ Maryland, Grad Program Life Sci, Program Mol Med, Baltimore, MD 21201 USA; [Tang, Ai-Hui; Karson, Miranda A.; Alger, Bradley E.] Univ Maryland, Grad Program Life Sci, Program Neurosci, Baltimore, MD 21201 USA; [Klugmann, Matthias] Univ New S Wales, Translat Neurosci Facil, Sydney, NSW, Australia	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of New South Wales Sydney	Nagode, DA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	balgerlab@gmail.com	Tang, Ai-Hui/D-4311-2009; Nagode, Daniel/AAF-1547-2021	Tang, Ai-Hui/0000-0003-3715-6714; 	National Institutes of Health [RO1 MH077277, RO1 DA014625]; NRSA [1 F31 NS074880-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health RO1 MH077277 and RO1 DA014625 to B. E. A. and NRSA 1 F31 NS074880-01 to D.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger BE, 2002, PROG NEUROBIOL, V68, P247; Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BELL KA, 2011, NEUROPHARMACOLOG AUG; Biro AA, 2006, J NEUROSCI, V26, P12487, DOI 10.1523/JNEUROSCI.3106-06.2006; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Chapman CA, 1999, J NEUROSCI, V19, P8637; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; Cobb SR, 1999, J PHYSIOL-LONDON, V518, P131, DOI 10.1111/j.1469-7793.1999.0131r.x; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Drake CT, 1999, BRAIN RES, V849, P203, DOI 10.1016/S0006-8993(99)01910-1; Ellender TJ, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00026; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Hull C, 2009, J NEUROSCI, V29, P8991, DOI 10.1523/JNEUROSCI.5717-08.2009; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Karson MA, 2008, NEUROPHARMACOLOGY, V54, P117, DOI 10.1016/j.neuropharm.2007.06.023; Karson MA, 2009, J NEUROSCI, V29, P4140, DOI 10.1523/JNEUROSCI.5264-08.2009; Katona I, 1999, J NEUROSCI, V19, P4544; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Martin LA, 1999, NEUROSCIENCE, V92, P61, DOI 10.1016/S0306-4522(98)00745-3; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oren I, 2010, J PHYSIOL-LONDON, V588, P785, DOI 10.1113/jphysiol.2009.180851; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1992, J NEUROSCI, V12, P4122; Reich CG, 2005, J NEUROPHYSIOL, V94, P4290, DOI 10.1152/jn.00480.2005; Szabo GG, 2010, EUR J NEUROSCI, V31, P2234, DOI 10.1111/j.1460-9568.2010.07292.x; Tang AH, 2011, J NEUROSCI, V31, P13546, DOI 10.1523/JNEUROSCI.2781-11.2011; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Vizi ES, 1999, BRAIN RES REV, V30, P219, DOI 10.1016/S0165-0173(99)00016-8; Vizi ES, 1998, HIPPOCAMPUS, V8, P566, DOI 10.1002/(SICI)1098-1063(1998)8:6<566::AID-HIPO2>3.0.CO;2-W; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Widmer H, 2006, HIPPOCAMPUS, V16, P617, DOI 10.1002/hipo.20191; Williams JH, 1997, J NEUROPHYSIOL, V78, P2631, DOI 10.1152/jn.1997.78.5.2631; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	51	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27691	10.1371/journal.pone.0027691	http://dx.doi.org/10.1371/journal.pone.0027691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110723	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400085
J	Chougule, MB; Patel, A; Sachdeva, P; Jackson, T; Singh, M				Chougule, Mahavir B.; Patel, Apurva; Sachdeva, Pratik; Jackson, Tanise; Singh, Mandip			Enhanced Anticancer Activity of Gemcitabine in Combination with Noscapine via Antiangiogenic and Apoptotic Pathway against Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; PANCREATIC-CANCER; PACLITAXEL; SP1; ANGIOGENESIS; PROTEIN; AGENT; PHARMACOKINETICS; PROLIFERATION; CHEMOTHERAPY	Background: The aim of this investigation was to evaluate the anticancer activity of Noscapine (Nos) and Gemcitabine (Gem) combination (NGC) against non-small cell lung cancer (NSCLC) and to elucidate the underlying mechanism of action. Methods: Isobolographic method was used to calculate combination index values from cytotoxicity data. In vitro antiangiogenic and apoptotic activity of Nos, Gem and NGC was evaluated. For in vivo studies, female athymic Nu/nu mice were xenografted with H460 tumors and the efficacy of Nos, Gem, or NGC was determined. Protein expressions by immunohistochemical staining were evaluated in harvested tumor tissues. Results: The CI values (<0.59) were suggestive of synergistic behavior between Nos and Gem. NGC treatment showed significantly inhibited tube formation and increased percentage of apoptotic cells. NGC, Gem and Nos treatment reduced tumor volume by 82.9 +/- 4.5 percent, 39.4 +/- 5.8 percent and 34.2 +/- 5.7 percent respectively. Specifically, NGC treatment decreased expression cell survival proteins; VEGF, CD31 staining and microvessel density and enhanced DNA fragmentation and cleaved caspase 3 levels compared to single agent treated and control groups. Conclusion: Nos potentiated the anticancer activity of Gem in an additive to synergistic manner against lung cancer via antiangiogenic and apoptotic pathways. These findings suggest potential benefit for use of NGC chemotherapy for treatment of lung cancer.	[Chougule, Mahavir B.] Univ Hawaii, Dept Pharmaceut Sci, Coll Pharm, Hilo, HI 96720 USA; [Patel, Apurva; Sachdeva, Pratik; Jackson, Tanise; Singh, Mandip] Florida A&M Univ, Dept Pharmaceut Sci, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	University of Hawaii System; University Hawaii Hilo; State University System of Florida; Florida A&M University	Chougule, MB (corresponding author), Univ Hawaii, Dept Pharmaceut Sci, Coll Pharm, Hilo, HI 96720 USA.	mandip.sachdeva@gmail.com			Research Centers in Minority Institutions (RCMI) [G12RR03020-11]; National Institute of General Medical Sciences/Minority Biomedical Research Support (NIGMS/MBRS), National Institutes of Health (NIH) [5S06GM008111-36]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER	Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences/Minority Biomedical Research Support (NIGMS/MBRS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by a Research Centers in Minority Institutions (RCMI) award (G12RR03020-11) and a National Institute of General Medical Sciences/Minority Biomedical Research Support (NIGMS/MBRS) award (5S06GM008111-36) from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Chougule M, 2011, LUNG CANCER, V71, P271, DOI 10.1016/j.lungcan.2010.06.002; Chougule MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017733; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; Denlinger CE, 2004, ANN THORAC SURG, V78, P1207, DOI 10.1016/j.athoracsur.2004.04.029; Dougherty DW, 2010, CURR HEMATOL MALIG R, V5, P148, DOI 10.1007/s11899-010-0054-x; Douillard JY, 2002, LUNG CANCER, V38, pS21, DOI 10.1016/S0169-5002(02)00168-X; Eichhorn ME, 2010, INT J CANCER, V126, P1235, DOI 10.1002/ijc.24846; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giovannetti E, 2005, BRIT J CANCER, V92, P681, DOI 10.1038/sj.bjc.6602382; Guo QQ, 2009, TUMORI J, V95, P796, DOI 10.1177/030089160909500624; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Heidari N, 2007, ANTI-CANCER DRUG, V18, P1139, DOI 10.1097/CAD.0b013e3282eea257; Hiser L, 2008, LEUKEMIA LYMPHOMA, V49, P1603, DOI 10.1080/10428190802213480; Hosoi Y, 2004, INT J ONCOL, V25, P461; Ichite N, 2009, CLIN CANCER RES, V15, P543, DOI 10.1158/1078-0432.CCR-08-1558; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Kelner MJ, 2008, INVEST NEW DRUG, V26, P407, DOI 10.1007/s10637-008-9113-8; Klastersky J, 1997, Rev Med Brux, V18, P328; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Laquente B, 2008, MOL CANCER THER, V7, P638, DOI 10.1158/1535-7163.MCT-07-2122; Liu D, 2009, MOL CANCER THER, V8, P980, DOI 10.1158/1535-7163.MCT-08-0901; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; Lou Z, 2005, CANCER RES, V65, P1007; Markman M, 2003, SUPPORT CARE CANCER, V11, P144, DOI 10.1007/s00520-002-0405-9; Menendez JA, 2001, EUR J CANCER, V37, P402, DOI 10.1016/S0959-8049(00)00408-1; Newcomb EW, 2008, INT J RADIAT ONCOL, V71, P1477, DOI 10.1016/j.ijrobp.2008.04.020; Papineni S, 2009, CARCINOGENESIS, V30, P1193, DOI 10.1093/carcin/bgp092; Schniewind Bodo, 2006, J Carcinog, V5, P25, DOI 10.1186/1477-3163-5-25; Sheth S, 2010, AM J HEALTH-SYST PH, V67, pS9, DOI 10.2146/ajhp090457; Tolis C, 1999, EUR J CANCER, V35, P796, DOI 10.1016/S0959-8049(98)00425-0; van Zuylen L, 2001, INVEST NEW DRUG, V19, P125, DOI 10.1023/A:1010618632738; Wakelee H, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-90003-1; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Xu GP, 2001, J CLIN ENDOCR METAB, V86, P1769, DOI 10.1210/jc.86.4.1769; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zupi G, 2005, CANCER BIOL THER, V4, P866, DOI 10.4161/cbt.4.8.1895	48	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27394	10.1371/journal.pone.0027394	http://dx.doi.org/10.1371/journal.pone.0027394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102891	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555300017
J	Pepin, D; Shao, ZQ; Huppe, G; Wakefield, A; Chu, CW; Sharif, Z; Vanderhyden, BC				Pepin, David; Shao, Zhong-Qi; Huppe, Genevieve; Wakefield, Andrea; Chu, Chee-Wui; Sharif, Zahra; Vanderhyden, Barbara C.			Kallikreins 5, 6 and 10 Differentially Alter Pathophysiology and Overall Survival in an Ovarian Cancer Xenograft Model	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTORS; HUMAN TISSUE KALLIKREINS; ZYME/PROTEASE M/NEUROSIN; SERINE-PROTEASE; CELL-LINES; IMMUNOFLUOROMETRIC ASSAY; SUBSTRATE-SPECIFICITY; PROSTATE ANTIGEN; SERUM BIOMARKER; KININ SYSTEM	Human tissue kallikreins (KLKs) are members of a multigene family of serine proteases aberrantly expressed in many cancer types. In ovarian cancer, 12 KLKs are upregulated, and of those KLK5, 6 and 10 have been the focus of investigations into new diagnostic and prognostic biomarkers. However, little is known about the contributions of KLK5, 6 and 10 to ovarian cancer pathophysiology. In this study, a panel of 13 human ovarian cancer cell lines was screened by ELISA for secretion of KLK5, 6, 8, 10, 13, and 14. The ES-2 cell line, devoid of these kallikreins, was transfected with expression vectors of KLK5, 6 and 10 individually or in pairs. Co-expression of KLK5, 6 and 10 was correlated with lessened aggressivity of ovarian cancer cell lines as defined by reduced colony formation in soft agar and tumorigenicity in nude mice. ES-2 clones overexpressing KLK5, 10/5, 10/6, 5/6 made significantly fewer colonies in soft agar. When compared to control mice, survival of mice injected with ES-2 clones overexpressing KLK10, 10/5, 10/6, 5/6 was significantly longer, while KLK6 was shorter. All groups displaying a survival advantage also differed quantitatively and qualitatively in their presentation of ascites, with both a reduced incidence of ascites and an absence of cellular aggregates within those ascites. The survival advantage conferred by KLK10 overexpression could be recapitulated with the exogenous administration of a recombinant KLK10. In conclusion, these findings indicate that KLK5, 6 and 10 may modulate the progression of ovarian cancer, and interact together to alter tumour pathophysiology. Furthermore, results support the putative role of KLK10 as a tumour suppressor and suggest it may hold therapeutic potential in ovarian cancer.	[Pepin, David; Sharif, Zahra; Vanderhyden, Barbara C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Pepin, David; Sharif, Zahra; Vanderhyden, Barbara C.] Ottawa Hlth Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Shao, Zhong-Qi; Huppe, Genevieve; Wakefield, Andrea; Chu, Chee-Wui] Ibex Pharmaceut Inc, Montreal, PQ, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Pepin, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	bvanderhyden@ohri.ca			Ontario Graduate Scholarship in Science and Technology; IBEX Pharmaceuticals, Inc.	Ontario Graduate Scholarship in Science and Technology; IBEX Pharmaceuticals, Inc.	This work was supported in part by a scholarship from the Ontario Graduate Scholarship in Science and Technology to D. Pepin. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Principal funding for the research was provided by IBEX Pharmaceuticals, Inc., which employed some of the authors who contributed to the design of the studies and the collection and analysis of data. No additional external funding was received for this study.	Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Bandiera E, 2009, INT J GYNECOL CANCER, V19, P1015, DOI 10.1111/IGC.0b013e3181ab597f; Bayes A, 2004, BIOL CHEM, V385, P517, DOI 10.1515/BC.2004.061; BERCHUCK A, 1992, AM J OBSTET GYNECOL, V166, P676, DOI 10.1016/0002-9378(92)91697-9; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2003, CANCER RES, V63, P9032; BUICK RN, 1985, CANCER RES, V45, P3668; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Cassim B, 2002, PHARMACOL THERAPEUT, V94, P1, DOI 10.1016/S0163-7258(02)00166-3; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Colman RW, 1998, CLIN REV ALLERG IMMU, V16, P365, DOI 10.1007/BF02737657; Colman RW, 1999, IMMUNOPHARMACOLOGY, V43, P103, DOI 10.1016/S0162-3109(99)00068-5; Damas J, 2004, DIABETES-METAB RES, V20, P288, DOI 10.1002/dmrr.489; Diamandis EP, 2000, CLIN BIOCHEM, V33, P369, DOI 10.1016/S0009-9120(00)00145-4; Diamandis EP, 2003, TUMOR BIOL, V24, P299, DOI 10.1159/000076462; Diamandis EP, 2000, CLIN BIOCHEM, V33, P579, DOI 10.1016/S0009-9120(00)00182-X; Dorn J, 2011, ANN ONCOL, V22, P1783, DOI 10.1093/annonc/mdq701; Dorn J, 2007, CLIN CANCER RES, V13, P1742, DOI 10.1158/1078-0432.CCR-06-2482; Ghosh MC, 2004, TUMOR BIOL, V25, P193, DOI 10.1159/000081102; Goyal J, 1998, CANCER RES, V58, P4782; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Huang W, 2008, WORLD J GASTROENTERO, V14, P5810, DOI 10.3748/wjg.14.5810; Kapadia C, 2003, CLIN CHEM, V49, P77, DOI 10.1373/49.1.77; Kim H, 2001, BRIT J CANCER, V84, P643, DOI 10.1054/bjoc.2000.1649; Kishi T, 2003, CLIN CHEM, V49, P87, DOI 10.1373/49.1.87; Koh SCL, 2011, ARCH GYNECOL OBSTET, V284, P183, DOI 10.1007/s00404-010-1605-z; KURIYAMA M, 1980, CANCER RES, V40, P4568; Langdon SP, 2000, METH MOLEC MED, V39, P155; LAU DHM, 1991, CANCER RES, V51, P5181; Liu XL, 1996, CANCER RES, V56, P3371; LOUIE KG, 1985, CANCER RES, V45, P2110; Luo LY, 2006, TUMOR BIOL, V27, P227, DOI 10.1159/000094693; Luo LY, 2003, CLIN CHIM ACTA, V337, P115, DOI 10.1016/j.cccn.2003.07.008; Luo LY, 2003, CANCER RES, V63, P807; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Luo LY, 2001, CLIN CHEM, V47, P237; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; MALDEN LT, 1986, Q J MED, V58, P221; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; MOLTHOFF CFM, 1991, INT J CANCER, V47, P72, DOI 10.1002/ijc.2910470114; Ni X, 2004, BRIT J CANCER, V91, P725, DOI 10.1038/sj.bjc.6602041; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Oikonomopoulou K, 2006, BIOL CHEM, V387, P677, DOI 10.1515/BC.2006.086; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; Paliouras M, 2006, BIOL CHEM, V387, P643, DOI 10.1515/BC.2006.083; PAPSIDERO LD, 1980, CANCER RES, V40, P2428; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Sherer DM, 2000, GYNECOL OBSTET INVES, V50, P217, DOI 10.1159/000010320; Shih LM, 2007, GYNECOL ONCOL, V105, P501, DOI 10.1016/j.ygyno.2007.01.018; Sidiropoulos M, 2005, TUMOR BIOL, V26, P324, DOI 10.1159/000089290; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109; White NMA, 2009, BRIT J CANCER, V101, P1107, DOI 10.1038/sj.bjc.6605280; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; YOUNG CYF, 1995, J ANDROL, V16, P97; Yousef GM, 2005, ADV CLIN CHEM, V39, P11, DOI 10.1016/S0065-2423(04)39002-5; Yousef GM, 1999, GENOMICS, V62, P251, DOI 10.1006/geno.1999.6012; Yousef GM, 2003, CANCER RES, V63, P3958; Yousef GM, 2003, CLIN CHIM ACTA, V329, P1, DOI 10.1016/S0009-8981(03)00004-4	64	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e26075	10.1371/journal.pone.0026075	http://dx.doi.org/10.1371/journal.pone.0026075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102857	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300002
J	van Leenders, GJLH; Sookhlall, R; Teubel, WJ; de Ridder, CMA; Reneman, S; Sacchetti, A; Vissers, KJ; van Weerden, W; Jenster, G				van Leenders, Geert J. L. H.; Sookhlall, Rajesh; Teubel, Wilma J.; de Ridder, Corrina M. A.; Reneman, Suzanne; Sacchetti, Andrea; Vissers, Kees J.; van Weerden, Wytske; Jenster, Guido			Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INITIATING CELLS; BETA-CATENIN; PROSPECTIVE IDENTIFICATION; FACTOR/SCATTER FACTOR; SIGNALING PATHWAYS; INTERMEDIATE CELLS; E-CADHERIN; IN-VITRO	Prostate cancer consists of secretory cells and a population of immature cells. The function of immature cells and their mutual relation with secretory cells are still poorly understood. Immature cells either have a hierarchical relation to secretory cells (stem cell model) or represent an inducible population emerging upon appropriate stimulation of differentiated cells. Hepatocyte Growth Factor (HGF) receptor c-MET is specifically expressed in immature prostate cells. Our objective is to determine the role of immature cells in prostate cancer by analysis of the HGF/c-MET pathway. Gene-expression profiling of DU145 prostate cancer cells stimulated with HGF revealed induction of a molecular signature associated with stem cells, characterized by up-regulation of CD49b, CD49f, CD44 and SOX9, and down-regulation of CD24 ('stem-like signature'). We confirmed the acquisition of a stem-like phenotype by quantitative PCR, FACS analysis and Western blotting. Further, HGF led to activation of the stem cell related Notch pathway by up-regulation of its ligands Jagged-1 and Delta-like 4. Small molecules SU11274 and PHA665752 targeting c-MET activity were both able to block the molecular and biologic effects of HGF. Knock-down of c-MET by shRNA infection resulted in significant reduction and delay of orthotopic tumour-formation in male NMRI mice. Immunohistochemical analysis in prostatectomies revealed significant enrichment of c-MET positive cells at the invasive front, and demonstrated co-expression of c-MET with stem-like markers CD49b and CD49f. In conclusion, activation of c-MET in prostate cancer cells induced a stem-like phenotype, indicating a dynamic relation between differentiated and stem-like cells in this malignancy. Its mediation of efficient tumour-formation in vivo and predominant receptor expression at the invasive front implicate that c-MET regulates tumour infiltration in surrounding tissues putatively by acquisition of a stem-like phenotype.	[van Leenders, Geert J. L. H.; Sookhlall, Rajesh; Sacchetti, Andrea; Vissers, Kees J.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Teubel, Wilma J.; de Ridder, Corrina M. A.; Reneman, Suzanne; van Weerden, Wytske; Jenster, Guido] Erasmus MC, Dept Urol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Leenders, GJLH (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	g.vanleenders@erasmusmc.nl	Sacchetti, Andrea/H-8763-2019		Netherlands Organisation for Health Research and Development (ZonMW) [907-00-138]; Foundation for Scientific Urological Research (SUWO); Foundation Adessium; Foundation Zabawas, The Netherlands	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Foundation for Scientific Urological Research (SUWO); Foundation Adessium; Foundation Zabawas, The Netherlands(Netherlands Government)	The Netherlands Organisation for Health Research and Development (ZonMW; grant 907-00-138; personal grant to Dr. van Leenders; http://www.zonmw.nl/); Foundation for Scientific Urological Research (SUWO); Foundation Adessium; Foundation Zabawas, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christensen JG, 2003, CANCER RES, V63, P7345; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; Davies G, 2001, CLIN CANCER RES, V7, P3289; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fujiuchi Y, 2003, ONCOL REP, V10, P1001; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Grey BR, 2009, BJU INT, V103, P856, DOI 10.1111/j.1464-410X.2008.08250.x; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hiscox S, 1999, ANTICANCER RES, V19, P509; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; MORTON RA, 1993, CANCER RES, V53, P3585; Nishimura K, 1998, Int J Urol, V5, P276, DOI 10.1111/j.1442-2042.1998.tb00603.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Sattler M, 2003, CANCER RES, V63, P5462; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suzuki H, 2008, ANTICANCER RES, V28, P1821; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; van Leenders G, 2002, PROSTATE, V51, P98, DOI 10.1002/pros.10073; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; van Leenders GJLH, 2003, CRIT REV ONCOL HEMAT, V46, pS3, DOI 10.1016/S1040-8428(03)00059-3; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Veldhoven A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-192; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Zhang YW, 2005, ONCOGENE, V24, P101, DOI 10.1038/sj.onc.1208181	50	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e26753	10.1371/journal.pone.0026753	http://dx.doi.org/10.1371/journal.pone.0026753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110593	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300007
J	Kummer, S; Jeruschke, S; Wegerich, LV; Peters, A; Lehmann, P; Seibt, A; Mueller, F; Koleganova, N; Halbenz, E; Schmitt, CP; Bettendorf, M; Mayatepek, E; Gross-Weissmann, ML; Oh, J				Kummer, Sebastian; Jeruschke, Stefanie; Wegerich, Lara Vanessa; Peters, Andrea; Lehmann, Petra; Seibt, Annette; Mueller, Friederike; Koleganova, Nadezda; Halbenz, Elisabeth; Schmitt, Claus Peter; Bettendorf, Markus; Mayatepek, Ertan; Gross-Weissmann, Marie-Luise; Oh, Jun			Estrogen Receptor Alpha Expression in Podocytes Mediates Protection against Apoptosis In-Vitro and In-Vivo	PLOS ONE			English	Article							RENAL-DISEASE; NULL MICE; ER-ALPHA; GLOMERULOSCLEROSIS; PROGRESSION; RATS; GENDER; GROWTH; INJURY; BETA	Context/Objective: Epidemiological studies have demonstrated that women have a significantly better prognosis in chronic renal diseases compared to men. This suggests critical influences of gender hormones on glomerular structure and function. We examined potential direct protective effects of estradiol on podocytes. Methods: Expression of estrogen receptor alpha (ER alpha) was examined in podocytes in vitro and in vivo. Receptor localization was shown using Western blot of separated nuclear and cytoplasmatic protein fractions. Podocytes were treated with Puromycin aminonucleoside (PAN, apoptosis induction), estradiol, or both in combination. Apoptotic cells were detected with Hoechst nuclear staining and Annexin-FITC flow cytometry. To visualize mitochondrial membrane potential depolarization as an indicator for apoptosis, cells were stained with tetramethyl rhodamine methylester (TMRM). Estradiol-induced phosphorylation of ERK1/2 and p38 MAPK was examined by Western blot. Glomeruli of ER alpha knock-out mice and wild-type controls were analysed by histomorphometry and immunohistochemistry. Results: ER alpha was consistently expressed in human and murine podocytes. Estradiol stimulated ER alpha protein expression, reduced PAN-induced apoptosis in vitro by 26.5 +/- 24.6% or 56.6 +/- 5.9% (flow cytometry or Hoechst-staining, respectively; both p<0.05), and restored PAN-induced mitochondrial membrane potential depolarization. Estradiol enhanced ERK1/2 phosphorylation. In ER alpha knockout mice, podocyte number was reduced compared to controls (female/male: 80/86 vs. 132/135 podocytes per glomerulus, p<0.05). Podocyte volume was enhanced in ER alpha knockout mice (female/male: 429/371 mm(3) vs. 264/223 mm(3) in controls, p<0.05). Tgf beta 1 and collagen type IV expression were increased in knockout mice, indicating glomerular damage. Conclusions: Podocytes express ER alpha, whose activation leads to a significant protection against experimentally induced apoptosis. Possible underlying mechanisms include stabilization of mitochondrial membrane potential and activation of MAPK signalling. Characteristic morphological changes indicating glomerulopathy in ER alpha knock-out mice support the in vivo relevance of the ER alpha for podocyte viability and function. Thus, our findings provide a novel model for the protective influence of female gender on chronic glomerular diseases.	[Kummer, Sebastian; Jeruschke, Stefanie; Wegerich, Lara Vanessa; Peters, Andrea; Seibt, Annette; Mayatepek, Ertan; Oh, Jun] Univ Childrens Hosp Duesseldorf, Dept Gen Pediat & Neonatol, Dusseldorf, Germany; [Jeruschke, Stefanie] Univ Duisburg Essen, Essen, Germany; [Lehmann, Petra; Koleganova, Nadezda; Gross-Weissmann, Marie-Luise] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Bettendorf, Markus] Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, Heidelberg, Germany; [Schmitt, Claus Peter] Univ Childrens Hosp, Div Pediat Nephrol, Heidelberg, Germany; [Mueller, Friederike; Halbenz, Elisabeth; Oh, Jun] Univ Med Ctr, Dept Pediat Nephrol, Hamburg, Germany	University of Duisburg Essen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kummer, S (corresponding author), Univ Childrens Hosp Duesseldorf, Dept Gen Pediat & Neonatol, Dusseldorf, Germany.	Sebastian.Kummer@med.uni-duesseldorf.de	Gross, Wolfgang Ludwig WG/C-8733-2011; Oh, Jun/K-4039-2013		Peter-Stiftung fur die Nierenwissenschaft; Forschungskommission der Medizinischen Fakultat; Heinrich-Heine-University, Duesseldorf	Peter-Stiftung fur die Nierenwissenschaft; Forschungskommission der Medizinischen Fakultat; Heinrich-Heine-University, Duesseldorf	This work was supported by a grant from the "Peter-Stiftung fur die Nierenwissenschaft" (http://www.peter-stiftung.de) to S.K., and by a grant from the "Forschungskommission der Medizinischen Fakultat", Heinrich-Heine-University, Duesseldorf (http://medfak.uniklinikum-duessedorf.de/deutsch/MedizinischeFakultt/Dekanat/Kommissionen/Forschungskommission/page.html) to J.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2008, KIDNEY INT, V74, P370, DOI 10.1038/ki.2008.205; Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Amann K, 2001, KIDNEY INT, V60, P1309, DOI 10.1046/j.1523-1755.2001.00936.x; Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x; Aulmann S, 2006, J CLIN PATHOL, V59, P424, DOI 10.1136/jcp.2005.029264; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Boland R, 2008, STEROIDS, V73, P859, DOI 10.1016/j.steroids.2007.12.027; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Doublier S, 2011, KIDNEY INT, V79, P404, DOI 10.1038/ki.2010.398; Dupont S, 2000, DEVELOPMENT, V127, P4277; ELEMA JD, 1975, LAB INVEST, V33, P554; Elliot SJ, 2007, KIDNEY INT, V72, P464, DOI 10.1038/sj.ki.5002328; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; GILBOA N, 1987, LIFE SCI, V41, P1629, DOI 10.1016/0024-3205(87)90731-4; Gross ML, 2004, J AM SOC NEPHROL, V15, P348, DOI 10.1097/01.ASN.0000105993.63023.D8; Guo GJ, 2001, AM J PHYSIOL-RENAL, V280, pF777, DOI 10.1152/ajprenal.2001.280.5.F777; HAJDU A, 1971, EXPERIENTIA, V27, P956, DOI 10.1007/BF02135771; Inokuchi S, 1996, KIDNEY INT, V50, P1278, DOI 10.1038/ki.1996.439; IRZYNIEC T, 1992, AM J HYPERTENS, V5, P437, DOI 10.1093/ajh/5.7.437; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Koh PO, 2007, NEUROSCI LETT, V412, P68, DOI 10.1016/j.neulet.2006.10.060; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; KUMMER S, 2011, PEDIAT NEPHROLOGY; Lovegrove AS, 2004, AM J PHYSIOL-RENAL, V287, pF586, DOI 10.1152/ajprenal.00414.2003; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Meng XM, 2011, LIFE SCI, V88, P178, DOI 10.1016/j.lfs.2010.11.008; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Nielsen CB, 2004, VIRCHOWS ARCH, V444, P561, DOI 10.1007/s00428-004-1006-4; NITSCH W, 1955, Ther Ggw, V94, P364; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schopick EL, 2009, NEPHROL DIAL TRANSPL, V24, P3739, DOI 10.1093/ndt/gfp321; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Silbiger SR, 2003, ADV RENAL REPLACE TH, V10, P3, DOI 10.1053/jarr.2003.50001; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Sun JH, 2006, AM J PHYSIOL-RENAL, V290, pF319, DOI 10.1152/ajprenal.00271.2005; THOMAS D, 1995, J BIOL CHEM, V270, P28924, DOI 10.1074/jbc.270.48.28924; Tofovic SP, 2002, J AM SOC NEPHROL, V13, P2737, DOI 10.1097/01.ASN.0000031804.77546.F5; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang ZG, 2004, STEROIDS, V69, P523, DOI 10.1016/j.steroids.2004.05.012	49	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27457	10.1371/journal.pone.0027457	http://dx.doi.org/10.1371/journal.pone.0027457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096576	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900047
J	Meijaard, E; Buchori, D; Hadiprakarsa, Y; Utami-Atmoko, SS; Nurcahyo, A; Tjiu, A; Prasetyo, D; Nardiyono; Christie, L; Ancrenaz, M; Abadi, F; Antoni, ING; Armayadi, D; Dinato, A; Ella; Gumelar, P; Indrawan, TP; Kussaritano; Munajat, C; Priyono, CWP; Purwanto, Y; Puspitasari, D; Putra, MSW; Rahmat, A; Ramadani, H; Sammy, J; Siswanto, D; Syamsuri, M; Andayani, N; Wu, HH; Wells, JA; Mengersen, K				Meijaard, Erik; Buchori, Damayanti; Hadiprakarsa, Yokyok; Utami-Atmoko, Sri Suci; Nurcahyo, Anton; Tjiu, Albertus; Prasetyo, Didik; Nardiyono; Christie, Lenny; Ancrenaz, Marc; Abadi, Firman; Antoni, I. Nyoman Gede; Armayadi, Dedy; Dinato, Adi; Ella; Gumelar, Pajar; Indrawan, Tito P.; Kussaritano; Munajat, Cecep; Priyono, C. Wawan Puji; Purwanto, Yadi; Puspitasari, Dewi; Putra, M. Syukur Wahyu; Rahmat, Abdi; Ramadani, Harri; Sammy, Jim; Siswanto, Dedi; Syamsuri, Muhammad; Andayani, Noviar; Wu, Huanhuan; Wells, Jessie Anne; Mengersen, Kerrie			Quantifying Killing of Orangutans and Human-Orangutan Conflict in Kalimantan, Indonesia	PLOS ONE			English	Article							PONGO-ABELII; CONSERVATION; ATTITUDES; PRIMATES; SUMATRA	Human-orangutan conflict and hunting are thought to pose a serious threat to orangutan existence in Kalimantan, the Indonesian part of Borneo. No data existed prior to the present study to substantiate these threats. We investigated the rates, spatial distribution and causes of conflict and hunting through an interview-based survey in the orangutan's range in Kalimantan, Indonesia. Between April 2008 and September 2009, we interviewed 6983 respondents in 687 villages to obtain socio-economic information, assess knowledge of local wildlife in general and orangutan encounters specifically, and to query respondents about their knowledge on orangutan conflicts and killing, and relevant laws. This survey revealed estimated killing rates of between 750 and 1800 animals killed in the last year, and between 1950 and 3100 animals killed per year on average within the lifetime of the survey respondents. These killing rates are higher than previously thought and are high enough to pose a serious threat to the continued existence of orangutans in Kalimantan. Importantly, the study contributes to our understanding of the spatial variation in threats, and the underlying causes of those threats, which can be used to facilitate the development of targeted conservation management.	[Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik; Wells, Jessie Anne] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Buchori, Damayanti; Hadiprakarsa, Yokyok; Nardiyono] Nat Conservancy Indonesia Forest Program, Jakarta, Indonesia; [Buchori, Damayanti; Hadiprakarsa, Yokyok; Nardiyono] Nat Conservancy Indonesia Forest Program, Bogor, Indonesia; [Buchori, Damayanti] Inst Pertanian Bogor, Dept Plant Protect, Fac Agr, Bogor, Indonesia; [Hadiprakarsa, Yokyok; Utami-Atmoko, Sri Suci; Tjiu, Albertus; Prasetyo, Didik; Nardiyono; Christie, Lenny; Andayani, Noviar] Indonesian Assoc Primatologists PERHAPPI, Bogor, Indonesia; [Utami-Atmoko, Sri Suci] Univ Nas, Fac Biol, Jakarta, Indonesia; [Nurcahyo, Anton; Ella] Borneo Orangutan Survival Fdn, Orangutan Reintroduct Program Cent Kalimantan, Palangkaraya, Indonesia; [Tjiu, Albertus; Puspitasari, Dewi] World Wide Fund Nat Indonesia, Pontianak, Indonesia; [Ancrenaz, Marc] Kinabatangan Orang Utan Conservat Project, Sandakan, Sabah, Malaysia; [Abadi, Firman] Borneo Ecol & Biodivers Conservat Inst BEBSiC, Samarinda, Indonesia; [Antoni, I. Nyoman Gede] Friends Natl Pk Fdn FNFP, Kumai, Indonesia; [Armayadi, Dedy] People Resources & Conservat Fdn PRCF, Pontianak, Indonesia; [Dinato, Adi] SuaR Inst, Nanga Pinoh, Indonesia; [Gumelar, Pajar] BIOMA Fdn, Samarinda, Indonesia; [Indrawan, Tito P.] Gunung Palung Orangutan Conservat Program, Ketapang, Indonesia; [Kussaritano] Mitra Lingkungan Hidup KalTeng, Palangkaraya, Indonesia; [Munajat, Cecep] Orangutan Fdn Int, Pangkalanbun, Indonesia; [Priyono, C. Wawan Puji] Yayasan Dian Tama, Pontianak, Indonesia; [Purwanto, Yadi] Simpur Hutan, Pontianak, Indonesia; [Putra, M. Syukur Wahyu] Yayasan Titian, Pontianak, Indonesia; [Rahmat, Abdi] Yayasan Perhimpunan TeROPONG, Palangkaraya, Indonesia; [Ramadani, Harri] Sylva Indonesia PC UNTAN, Pontianak, Indonesia; [Sammy, Jim] Yayasan Riak Bumi, Pontianak, Indonesia; [Siswanto, Dedi] Yayasan Cakrawala Indonesia, Palangkaraya, Indonesia; [Syamsuri, Muhammad] Forum Komunikasi Kader Konservasi Indonesia FK3I, Pontianak, Indonesia; [Andayani, Noviar] Wildlife Conservat Soc, Bogor, Indonesia; [Wu, Huanhuan; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia	People & Nature Consulting International; University of Queensland; Australian National University; Bogor Agricultural University; Universitas Nasional Pionir Perubahan; Wildlife Conservation Society - Indonesia; Queensland University of Technology (QUT)	Meijaard, E (corresponding author), People & Nat Consulting Int, Jakarta, Indonesia.	emeijaard@gmail.com	Meijaard, Erik/A-2687-2016; Buchori, Damayanti/L-5878-2017; Mengersen, Kerrie/AHC-4096-2022; Wells, Jessie A/F-7318-2010	Meijaard, Erik/0000-0001-8685-3685; Buchori, Damayanti/0000-0002-2843-0737; Wells, Jessie A/0000-0002-3555-5108; Hadiprakarsa, Yokyok/0000-0001-5186-6742; Prasetyo, Didik/0000-0001-5486-2624; utami, sri/0000-0002-5138-242X; Mengersen, Kerrie/0000-0001-8625-9168; Andayani, Noviar/0000-0002-1888-193X	Adopt-an-Acre program; United States Agency for International Development (USAID); Directorate of Forest Protection and Nature Conservation of the Indonesian Ministry of Forestry	Adopt-an-Acre program; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Directorate of Forest Protection and Nature Conservation of the Indonesian Ministry of Forestry	The Adopt-an-Acre program and the United States Agency for International Development (USAID) provided funding and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Peter Kareiva and Robert Lalasz for their help in writing and structuring this manuscript, three anonymous reviewers for providing detailed and constructive input for improving our manuscript, the Directorate of Forest Protection and Nature Conservation of the Indonesian Ministry of Forestry for supporting our study, and the Association of Indonesian Primatologists (PERHAPPI) for coordinating the studies. We are most grateful to our many respondents for taking the time to discuss with us their views on conservation in Kalimantan.	Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Beaman J, 2005, J WILDLIFE MANAGE, V69, P967, DOI 10.2193/0022-541X(2005)069[0967:CPIHRO]2.0.CO;2; C?lix M., 2018, EUROPEAN RED LIST SA; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020962; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Hartter J, 2011, J NAT CONSERV, V19, P79, DOI 10.1016/j.jnc.2010.06.005; Hockings K., 2009, BEST PRACTICE GUIDEL; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Husson Simon J., 2009, P77; Leadley P.W., 2010, CBD TECHNICAL SERIES, V50; Marshall Andrew J., 2009, P311; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; *MIN AGR REP IND, 2010, MAP DISTR OIL PALM P; *MIN FOR REP IND, 2010, MAP DISTR IUPHHK HA; NETER J, 1964, J AM STAT ASSOC, V59, P18, DOI 10.2307/2282857; Nijman V, 2010, INT J PEST MANAGE, V56, P153, DOI 10.1080/09670870903248850; NURCAHYO A, 2009, FOREST SC NEWS, V5, P8; Rijksen HD, 1999, OUR VANISHING RELATI; Singleton I., 2004, ORANGUTAN POPULATION; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; Wich SA, 2003, ORYX, V37, P49, DOI 10.1017/S0030605303000115; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X	30	90	92	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27491	10.1371/journal.pone.0027491	http://dx.doi.org/10.1371/journal.pone.0027491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096582	Green Published, gold			2022-12-25	WOS:000297553900052
J	Sun, L; Wang, CC				Sun, Lu; Wang, Ching C.			The Structural Basis of Localizing Polo-Like Kinase to the Flagellum Attachment Zone in Trypanosoma brucei	PLOS ONE			English	Article							BOX DOMAIN; CELL-DIVISION; SUBCELLULAR-LOCALIZATION; CYTOKINESIS; PLK1; BINDING; PHOSPHORYLATION; DUPLICATION; SEGREGATION; SUBSTRATE	The polo-like kinase in the deep branching eukaryote Trypanosoma brucei (TbPlk) has many unique features. Unlike all the other polo-like kinases known to associate with the nucleus and controlling both mitosis and cytokinesis, TbPlk localizes to the flagellum attachment zone (FAZ) and regulates only cytokinesis in T. brucei. TbPlk was, however, previously found capable of complementing all the multiple Plk (Cdc5) functions in Saccharomyces cerevisiae, indicating that it has acquired all the functions of Cdc5. In the present study, Cdc5 tagged with an enhanced yellow fluorescence protein (EYFP) localized exclusively in the FAZ of T. brucei, suggesting that the unusual localization and limited function of TbPlk are probably attributed to the particular environment in T. brucei cells. Structural basis for the FAZ localization of TbPlk was further investigated with TbPlk and TbPlk mutants tagged with EYFP and expressed in T. brucei. The results indicated that a kinase-inactive mutant N169A and a TbPlk mutant with the entire kinase domain (KD) deleted both localized to the FAZ. Substantial association with FAZ was also maintained when one of the two polo-boxes (PB1 or 2) or the linker region between them was deleted from TbPlk. But a deletion of both polo-boxes led to a complete exclusion of the protein from FAZ. All the deletion mutants retained the kinase activity, further indicating that the TbPlk kinase function does not play a role for FAZ localization. The two polo boxes in TbPlk are most likely instrumental in localizing the protein to FAZ through potential interactions with certain FAZ structural component(s). A putative cryptic bipartite nuclear targeting signal was identified in TbPlk, which was capable of directing TbPlk into the nucleus when either the kinase activity was lost or the PB1 was deleted from the protein.	[Sun, Lu; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sun, L (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			National Institutes of Health [AI21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 grants AI21786 to CCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Graham TM, 1998, GENE, V207, P71, DOI 10.1016/S0378-1119(97)00606-9; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Liao CZ, 2010, ACS MED CHEM LETT, V1, P110, DOI 10.1021/ml100020e; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma S, 2003, MOL CANCER RES, V1, P376; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Park CJ, 2008, EUKARYOT CELL, V7, P444, DOI 10.1128/EC.00283-07; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27303	10.1371/journal.pone.0027303	http://dx.doi.org/10.1371/journal.pone.0027303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096549	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900031
J	Li, Z; Stevens, DL; Hamilton, SM; Parimon, T; Ma, YS; Kearns, AM; Ellis, RW; Bryant, AE				Li, Zhi; Stevens, Dennis L.; Hamilton, Stephanie M.; Parimon, Tanyalak; Ma, Yongsheng; Kearns, Angela M.; Ellis, Richard W.; Bryant, Amy E.			Fatal S. aureus Hemorrhagic Pneumonia: Genetic Analysis of a Unique Clinical Isolate Producing both PVL and TSST-1	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT STAPHYLOCOCCUS-AUREUS; SHOCK-SYNDROME TOXIN-1; PATHOGENICITY ISLAND; BACTERIOPHAGE-LAMBDA; GENOME; PHAGE; EXPRESSION; SEQUENCE; STRAINS	In 2008, an unusual strain of methicillin-sensitive Staphylococcus aureus (MSSA68111), producing both Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1), was isolated from a fatal case of necrotizing pneumonia. Because PVL/TSST-1 co-production in S. aureus is rare, we characterized the molecular organization of these toxin genes in strain 68111. MSSA68111 carries the PVL genes within a novel temperate prophage we call Phi PVLv68111 that is most similar, though not identical, to phage Phi PVL - a phage type that is relatively rare worldwide. The TSST-1 gene (tst) in MSSA68111 is carried on a unique staphylococcal pathogenicity island (SaPI) we call SaPI68111. Features of SaPI68111 suggest it likely arose through multiple major recombination events with other known SaPIs. Both Phi PVLv68111 and SaPI68111 are fully mobilizable and therefore transmissible to other strains. Taken together, these findings suggest that hypervirulent S. aureus have the potential to emerge worldwide.	[Li, Zhi; Stevens, Dennis L.; Hamilton, Stephanie M.; Parimon, Tanyalak; Ma, Yongsheng; Bryant, Amy E.] Vet Affairs Med Ctr, Boise, ID USA; [Stevens, Dennis L.; Parimon, Tanyalak; Bryant, Amy E.] Univ Washington, Sch Med, Seattle, WA USA; [Ma, Yongsheng] Idaho State Univ, Pocatello, ID 83209 USA; [Kearns, Angela M.] Hlth Protect Agcy, Microbiol Serv Div, London, England; [Ellis, Richard W.] S Tyneside NHS Fdn Trust, Dept Microbiol, S Shields, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; Idaho; Idaho State University; Health Protection Agency	Li, Z (corresponding author), Vet Affairs Med Ctr, Boise, ID USA.	lizhi_lily@hotmail.com	Parimon, Tanyalak/AAH-6864-2021		United States Department of Veterans Affairs, Research and Development Service; VA Medical Center, Boise, ID; St. Luke's Mountain States Tumor and Medical Research Institute, Boise, ID	United States Department of Veterans Affairs, Research and Development Service(US Department of Veterans Affairs); VA Medical Center, Boise, ID; St. Luke's Mountain States Tumor and Medical Research Institute, Boise, ID	This work was supported, in part, by grants from the United States Department of Veterans Affairs, Research and Development Service, Biomedical Laboratory Research Program, VA Medical Center, Boise, ID (DLS and AEB) and from St. Luke's Mountain States Tumor and Medical Research Institute, Boise, ID (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; DEBOER ML, 1994, J INFECT DIS, V170, P818, DOI 10.1093/infdis/170.4.818; DELBRUCK M, 1945, J BACTERIOL, V50, P151; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; FAIRWEATHER N, 1983, INFECT IMMUN, V41, P1112, DOI 10.1128/IAI.41.3.1112-1117.1983; FINCKBARBANCON V, 1991, RES MICROBIOL, V142, P75, DOI 10.1016/0923-2508(91)90099-V; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Fraser J, 2000, MOL MED TODAY, V6, P125, DOI 10.1016/S1357-4310(99)01657-3; Galkin VE, 2009, J MOL BIOL, V385, P779, DOI 10.1016/j.jmb.2008.10.081; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Hallin M, 2007, J ANTIMICROB CHEMOTH, V59, P465, DOI 10.1093/jac/dkl535; Hamilton SM, 2007, CLIN INFECT DIS, V45, P1550, DOI 10.1086/523581; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P1960, DOI 10.1271/bbb.61.1960; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kearns AM, 2008, INT S STAPH STAPH IN; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LI BH, 1993, MOL GEN GENET, V240, P450, DOI 10.1007/BF00280400; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Mushtaq F, 2008, ACTA PAEDIATR, V97, P985, DOI 10.1111/j.1651-2227.2008.00797.x; Nagao M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-52; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; O'Hara FP, 2008, J INFECT DIS, V197, P187, DOI 10.1086/524684; PARMA DH, 1992, GENE DEV, V6, P497, DOI 10.1101/gad.6.3.497; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Ruimy R, 2009, J BACTERIOL, V191, P5577, DOI 10.1128/JB.00493-09; SEE RH, 1992, INFECT IMMUN, V60, P2612, DOI 10.1128/IAI.60.7.2612-2618.1992; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Ubeda C, 2003, MOL MICROBIOL, V49, P193, DOI 10.1046/j.1365-2958.2003.03577.x; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wirtz C, 2009, MICROBIOL-SGM, V155, P3491, DOI 10.1099/mic.0.032466-0	49	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27246	10.1371/journal.pone.0027246	http://dx.doi.org/10.1371/journal.pone.0027246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22110621	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000036
J	Sethi, MK; Buettner, FFR; Ashikov, A; Krylov, VB; Takeuchi, H; Nifantiev, NE; Haltiwanger, RS; Gerardy-Schahn, R; Bakker, H				Sethi, Maya K.; Buettner, Falk F. R.; Ashikov, Angel; Krylov, Vadim B.; Takeuchi, Hideyuki; Nifantiev, Nikolay E.; Haltiwanger, Robert S.; Gerardy-Schahn, Rita; Bakker, Hans			Molecular Cloning of a Xylosyltransferase That Transfers the Second Xylose to O-Glucosylated Epidermal Growth Factor Repeats of Notch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE DOMAIN; CELL LINE HEPG2; FACTOR-IX; EXTRACELLULAR DOMAIN; MAMMALIAN NOTCH; SERINE RESIDUE; MODIFIES NOTCH; MOUSE NOTCH1; FACTOR-VII; FRINGE	The extracellular domain of Notch contains epidermal growth factor (EGF) repeats that are extensively modified with different O-linked glycans. O-Fucosylation is essential for receptor function, and elongation with N-acetylglucosamine, catalyzed by members of the Fringe family, modulates Notch activity. Only recently, genes encoding enzymes involved in the O-glucosylation pathway have been cloned. In the Drosophila mutant rumi, characterized by a mutation in the protein O-glucosyltransferase, Notch signaling is impaired in a temperature-dependent manner, and a mouse knock-out leads to embryonic lethality. We have previously identified two human genes, GXYLT1 and GXYLT2, encoding glucoside xylosyltransferases responsible for the transfer of xylose to O-linked glucose. The identity of the enzyme further elongating the glycan to generate the final trisaccharide xylose-xylose-glucose, however, remained unknown. Here, we describe that the human gene C3ORF21 encodes a UDP-xylose: alpha-xyloside alpha 1,3-xylosyl-transferase, acting on xylose-alpha 1,3-glucose beta 1-containing acceptor structures. We have, therefore, renamed it XXYLT1 (xyloside xylosyltransferase 1). XXYLT1 cannot act on a synthetic acceptor containing an alpha-linked xylose alone, but requires the presence of the underlying glucose. Activity on Notch EGF repeats was proven by in vitro xylosylation of a mouse Notch1 fragment recombinantly produced in Sf9 insect cells, a bacterially expressed EGF repeat from mouse Notch2 modified in vitro by Rumi and Gxylt2 and in vivo by co-expression of the enzyme with the Notch1 fragment. The enzyme was shown to be a typical type II membrane-bound glycosyltransferase localized in the endoplasmic reticulum.	[Sethi, Maya K.; Buettner, Falk F. R.; Ashikov, Angel; Gerardy-Schahn, Rita; Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany; [Krylov, Vadim B.; Nifantiev, Nikolay E.] Russian Acad Sci, Lab Glycoconjugate Chem, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Hannover Medical School; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bakker, H (corresponding author), Hannover Med Sch, Dept Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/A-1787-2017; Takeuchi, Hideyuki/AAZ-9210-2020; Ashikov, Angel/N-7714-2015; Nifantiev, Nikolay E/O-6579-2015; Krylov, Vadim B./AAE-9936-2022; Bakker, Hans/AAA-1623-2020; Krylov, Vadim B./AES-8666-2022	Bakker, Hans/0000-0002-1364-9154; Ashikov, Angel/0000-0001-9679-7955; Nifantiev, Nikolay E/0000-0002-0727-4050; Krylov, Vadim B./0000-0001-9477-4610; Bakker, Hans/0000-0002-1364-9154; Krylov, Vadim B./0000-0001-9477-4610	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); National Institutes of Health [GM61126]; National Science Foundation Research Coordination Networks [0090281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research Coordination Networks(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and by National Institutes of Health Grant GM61126 (to R. S. H.).; UDP-Xyl isolation by the CarboSource Services at the Complex Carbohydrate Research Center, University of Georgia, Athens GA, was supported in part by National Science Foundation Research Coordination Networks Grant 0090281.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krylov V, 2007, SYNTHESIS-STUTTGART, P3147, DOI 10.1055/s-2007-990784; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; OKA C, 1995, DEVELOPMENT, V121, P3291; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Omichi K, 1997, EUR J BIOCHEM, V245, P143, DOI 10.1111/j.1432-1033.1997.00143.x; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Rana NA, 2010, GLYCOBIOLOGY, V20, P1486; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173	46	55	57	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2739	2748		10.1074/jbc.M111.302406	http://dx.doi.org/10.1074/jbc.M111.302406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117070	Green Published, hybrid			2022-12-25	WOS:000300292300045
J	Malmstrom, J; Karlsson, C; Nordenfelt, P; Ossola, R; Weisser, H; Quandt, A; Hansson, K; Aebersold, R; Malmstrom, L; Bjorck, L				Malmstrom, Johan; Karlsson, Christofer; Nordenfelt, Pontus; Ossola, Reto; Weisser, Hendrik; Quandt, Andreas; Hansson, Karin; Aebersold, Ruedi; Malmstroem, Lars; Bjorck, Lars			Streptococcus pyogenes in Human Plasma ADAPTIVE MECHANISMS ANALYZED BY MASS SPECTROMETRY-BASED PROTEOMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HUMAN-SERUM-ALBUMIN; STATISTICAL-MODEL; ABSOLUTE PROTEIN; BINDING; SURFACE; IDENTIFICATIONS; QUANTIFICATION; M1-PROTEIN; FIBRINOGEN	Streptococcus pyogenes is a major bacterial pathogen and a potent inducer of inflammation causing plasma leakage at the site of infection. A combination of label-free quantitative mass spectrometry-based proteomics strategies were used to measure how the intracellular proteome homeostasis of S. pyogenes is influenced by the presence of human plasma, identifying and quantifying 842 proteins. In plasma the bacterium modifies its production of 213 proteins, and the most pronounced change was the complete down-regulation of proteins required for fatty acid biosynthesis. Fatty acids are transported by albumin (HSA) in plasma. S. pyogenes expresses HSA-binding surface proteins, and HSA carrying fatty acids reduced the amount of fatty acid biosynthesis proteins to the same extent as plasma. The results clarify the function of HSA-binding proteins in S. pyogenes and underline the power of the quantitative mass spectrometry strategy used here to investigate bacterial adaptation to a given environment.	[Malmstrom, Johan; Karlsson, Christofer; Nordenfelt, Pontus; Hansson, Karin] Lund Univ, Dept Immunotechnol, SE-22100 Lund, Sweden; [Karlsson, Christofer; Nordenfelt, Pontus; Bjorck, Lars] Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden; [Ossola, Reto; Weisser, Hendrik; Quandt, Andreas; Aebersold, Ruedi; Malmstroem, Lars] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Weisser, Hendrik] Univ Zurich, Life Sci Zurich Ph D Program Syst Biol Complex Di, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Lund University; Lund University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Malmstrom, J (corresponding author), BMC, D13, SE-22184 Lund, Sweden.	Johan.Malmstrom@immun.lth.se	Nordenfelt, Pontus/H-5310-2019; Malmström, Lars/R-4991-2019; Malmström, Johan A/B-7660-2009	Nordenfelt, Pontus/0000-0002-9481-9951; Malmström, Lars/0000-0001-9885-9312; Malmström, Johan A/0000-0002-2889-7169	Swedish Research Council [2008-3356, 7480]; Crafoord Foundation; Swedish Foundation for Swedish Research [FFL4]; Swedish Government; Hansa Medical AB; Foundation of Johan; Foundation of Greta Kock; Foundation of Alfred Osterlund; Foundation of Torsten and Ragnar Soderberg; SystemsX.ch, the Swiss initiative for systems biology	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Swedish Foundation for Swedish Research; Swedish Government; Hansa Medical AB; Foundation of Johan; Foundation of Greta Kock; Foundation of Alfred Osterlund; Foundation of Torsten and Ragnar Soderberg; SystemsX.ch, the Swiss initiative for systems biology	Supported by Swedish Research Council Project 2008-3356, the Crafoord Foundation, and the Swedish Foundation for Swedish Research (FFL4). To whom correspondence should be addressed: BMC, D13, SE-221 84 Lund, Sweden. Tel.: 4646-2220830; Fax: 4646-2224200; E-mail: Johan.Malmstrom@immun.lth.se.; Supported by Swedish Research Council Project 7480, the Swedish Government Funds for Clinical Research (ALF), Hansa Medical AB, and the Foundations of Johan and Greta Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg.; Supported by SystemsX.ch, the Swiss initiative for systems biology.	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; deChateau M, 1996, P NATL ACAD SCI USA, V93, P8490, DOI 10.1073/pnas.93.16.8490; DECHATEAU M, 1994, J BIOL CHEM, V269, P12147; deChateau M, 1996, J BIOL CHEM, V271, P26609, DOI 10.1074/jbc.271.43.26609; Egesten A, 2011, J BIOL CHEM, V286, P2469, DOI 10.1074/jbc.M110.148171; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Gubbe K, 1997, BIOCHEMISTRY-US, V36, P8107, DOI 10.1021/bi962991s; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hong K, 2007, CURR MICROBIOL, V55, P427, DOI 10.1007/s00284-007-9012-9; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kihlberg BM, 1995, MICROB PATHOGENESIS, V19, P299, DOI 10.1016/S0882-4010(96)80003-9; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; KRONVALL G, 1979, INFECT IMMUN, V25, P1; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oehmcke S, 2010, CLIN CHIM ACTA, V411, P1172, DOI 10.1016/j.cca.2010.04.032; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; RETNONINGRUM DS, 1994, INFECT IMMUN, V62, P2387, DOI 10.1128/IAI.62.6.2387-2394.1994; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; Schujman GE, 2005, CURR OPIN MICROBIOL, V8, P149, DOI 10.1016/j.mib.2005.02.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tillett WS, 1934, B JOHNS HOPKINS HOSP, V54, P145; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	52	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1415	1425		10.1074/jbc.M111.267674	http://dx.doi.org/10.1074/jbc.M111.267674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117078	hybrid, Green Published			2022-12-25	WOS:000299170300055
J	Armas, C; Pugnaire, FI				Armas, Cristina; Ignacio Pugnaire, Francisco			Plant Neighbour Identity Matters to Belowground Interactions under Controlled Conditions	PLOS ONE			English	Article							ROOT COMPETITION; COMMUNITIES; PERFORMANCE; ALLELOPATHY; PLASTICITY; MOLECULES; NETWORKS; TRAGEDY; ECOLOGY; COMMONS	Background: Root competition is an almost ubiquitous feature of plant communities with profound effects on their structure and composition. Far beyond the traditional view that plants interact mainly through resource depletion (exploitation competition), roots are known to be able to interact with their environment using a large variety of mechanisms that may inhibit or enhance access of other roots to the resource or affect plant growth (contest interactions). However, an extensive analysis on how these contest root interactions may affect species interaction abilities is almost lacking. Methodology/Principal Findings: In a common garden experiment with ten perennial plant species we forced pairs of plants of the same or different species to overlap their roots and analyzed how belowground contest interactions affected plant performance, biomass allocation patterns, and competitive abilities under abundant resource supply. Our results showed that net interaction outcome ranged from negative to positive, affecting total plant mass and allocation patterns. A species could be a strong competitor against one species, weaker against another one, and even facilitator to a third species. This leads to sets of species where competitive hierarchies may be clear but also to groups where such rankings are not, suggesting that intransitive root interactions may be crucial for species coexistence. Conclusions/Significance: The outcome of belowground contest interactions is strongly dependent on neighbours' identity. In natural plant communities this conditional outcome may hypothetically help species to interact in non-hierarchical and intransitive networks, which in turn might promote coexistence.	[Armas, Cristina; Ignacio Pugnaire, Francisco] CSIC, Grp Ecol Func, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Armas, C (corresponding author), CSIC, Grp Ecol Func, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain.	cris@eeza.csic.es	Armas, Cristina/A-1128-2012; Pugnaire, Francisco I./A-7150-2008	Armas, Cristina/0000-0003-0356-8075; Pugnaire, Francisco I./0000-0002-1227-6827	Spanish Ministry of Science and Innovation [CGL2007-63718, CGL2010-17081]; Junta de Andalucia environmental department	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia environmental department(Junta de Andalucia)	This work was funded by the Spanish Ministry of Science and Innovation (grants CGL2007-63718, CGL2010-17081, http://www.micinn.es/ or http://www.micinn.es/portal/site/MICINN/menuitem.abd9b51cad64425c8674c210a14041a0/? vgnextoid=d9581f4368aef110VgnVCM1000001034e20aRCRD&lang_choosen=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Ragan M. Callaway and Sara Hortal for providing constructive criticism of earlier versions of the manuscript. We thank the Junta de Andalucia environmental department for its support and the supply of plants.	Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; ARMAS C, 2011, OECOLOGIA IN PRESS; Ayres E, 2007, FUNCT ECOL, V21, P256, DOI 10.1111/j.1365-2435.2006.01227.x; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Biedrzycki ML, 2009, J EXP BOT, V60, P1533, DOI 10.1093/jxb/erp105; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BRUNO JF, 2003, EVOLUTION, V18, P119; Cahill JF, 2003, J ECOL, V91, P532, DOI 10.1046/j.1365-2745.2003.00792.x; Callaway Ragan M., 2007, V68, P317, DOI 10.1007/978-3-540-36832-8_14; Callaway RM, 1998, OIKOS, V82, P202, DOI 10.2307/3546931; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Castillo P, 2002, J NEMATOL, V34, P146; De Kroon H., 2003, VVolume 168, P215; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; Egerton-Warburton LM, 2007, J EXP BOT, V58, P1473, DOI 10.1093/jxb/erm009; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Flores HE, 1999, TRENDS PLANT SCI, V4, P220, DOI 10.1016/S1360-1385(99)01411-9; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Hauggaard-Nielsen H, 2005, PLANT SOIL, V274, P237, DOI 10.1007/s11104-004-1305-1; Hess L, 2007, J ECOL, V95, P241, DOI 10.1111/j.1365-2745.2006.01204.x; Hodge A, 2009, PLANT CELL ENVIRON, V32, P628, DOI 10.1111/j.1365-3040.2008.01891.x; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Keddy P, 2002, J VEG SCI, V13, P5, DOI 10.1111/j.1654-1103.2002.tb02018.x; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Montgomery RA, 2010, ECOLOGY, V91, P3641, DOI 10.1890/09-1663.1; Murphy GP, 2007, J ECOL, V95, P261, DOI 10.1111/j.1365-2745.2007.01217.x; Novoplansky A, 2001, J VEG SCI, V12, P199, DOI 10.2307/3236604; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Prieto I, 2011, PERSPECT PLANT ECOL, V13, P181, DOI 10.1016/j.ppees.2011.05.002; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Reynolds HL, 1996, PLANT SOIL, V185, P75, DOI 10.1007/BF02257566; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Semchenko M, 2007, J ECOL, V95, P252, DOI 10.1111/j.1365-2745.2007.01210.x; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Sun ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015418; Thrall PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023545; Tilman D., 1982, Monographs in Population Biology, pi; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Zhang Q, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012380, 10.1371/journal.pone.0011063]	44	25	28	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27791	10.1371/journal.pone.0027791	http://dx.doi.org/10.1371/journal.pone.0027791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114696	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800036
J	Castilho-Martins, EA; da Silva, MFL; dos Santos, MG; Muxel, SM; Floeter-Winter, LM				Castilho-Martins, Emerson A.; Laranjeira da Silva, Maria Fernanda; dos Santos, Marcos G.; Muxel, Sandra M.; Floeter-Winter, Lucile M.			Axenic Leishmania amazonensis Promastigotes Sense both the External and Internal Arginine Pool Distinctly Regulating the Two Transporter-Coding Genes	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; NITRIC-OXIDE PRODUCTION; ACTIVATED MACROPHAGES; IN-VIVO; DONOVANI AMASTIGOTES; PARASITIC INFECTIONS; EXPRESSION; ARGINASE; METABOLISM; STAGE	Leishmania (L.) amazonensis uses arginine to synthesize polyamines to support its growth and survival. Here we describe the presence of two gene copies, arranged in tandem, that code for the arginine transporter. Both copies show similar Open Reading Frames (ORFs), which are 93% similar to the L. (L.) donovani AAP3 gene, but their 59 and 39 UTR's have distinct regions. According to quantitative RT-PCR, the 5.1 AAP3 mRNA amount was increased more than 3 times that of the 4.7 AAP3 mRNA along the promastigote growth curve. Nutrient deprivation for 4 hours and then supplemented or not with arginine (400 mu M) resulted in similar 4.7 AAP3 mRNA copy-numbers compared to the starved and control parasites. Conversely, the 5.1 AAP3 mRNA copy-numbers increased in the starved parasites but not in ones supplemented with arginine (p < 0.05). These results correlate with increases in amino acid uptake. Both Meta1 and arginase mRNAs remained constant with or without supplementation. The same starvation experiment was performed using a L. (L.) amazonensis null knockout for arginase (arg(-)) and two other mutants containing the arginase ORF with (arg(-)/ARG) or without the glycosomal addressing signal (arg(-)/arg Delta SKL). The arg(-) and the arg(-)/arg Delta SKL mutants did not show the same behavior as the wild-type (WT) parasite or the arg(-)/ARG mutant. This can be an indicative that the internal pool of arginine is also important for controlling transporter expression and function. By inhibiting mRNA transcription or/and mRNA maturation, we showed that the 5.1 AAP3 mRNA did not decay after 180 min, but the 4.7 AAP3 mRNA presented a half-life decay of 32.6 +/- 2 5.0 min. In conclusion, parasites can regulate amino acid uptake by increasing the amount of transporter-coding mRNA, possibly by regulating the mRNA half-life in an environment where the amino acid is not present or is in low amounts.	[Castilho-Martins, Emerson A.; Laranjeira da Silva, Maria Fernanda; dos Santos, Marcos G.; Muxel, Sandra M.; Floeter-Winter, Lucile M.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Castilho-Martins, EA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	lucile@ib.usp.br	Floeter-Winter, Lucile Maria/AAE-7629-2019; Muxel, Sandra/F-7464-2012; Laranjeira-Silva, Maria Fernanda/H-9056-2012; Castilho-Martins, Emerson Augusto/I-2094-2014; Floeter-Winter, Lucile Maria/K-2618-2012; Santos, Marcos/E-1993-2013	Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Laranjeira-Silva, Maria Fernanda/0000-0002-7128-6208; Castilho-Martins, Emerson Augusto/0000-0003-0542-4294; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman M, 2004, BIOCHEM BIOPH RES CO, V325, P353, DOI 10.1016/j.bbrc.2004.09.212; Archer S, 2008, METHOD ENZYMOL, V448, P359, DOI 10.1016/S0076-6879(08)02618-9; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; BOGLE RG, 1992, BIOCHEM J, V284, P15, DOI 10.1042/bj2840015; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; CAMARGO EP, 1978, EXP PARASITOL, V46, P141, DOI 10.1016/0014-4894(78)90125-X; Closs EI, 2000, MOL PHARMACOL, V57, P68; CLOSS EI, 1993, J BIOL CHEM, V268, P20796; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; dos Santos MG, 2011, MEM I OSWALDO CRUZ, V106, P190, DOI 10.1590/S0074-02762011000200012; dos Santos MG, 2009, MOL BIOCHEM PARASIT, V163, P107, DOI 10.1016/j.molbiopara.2008.11.001; Evans TG, 1996, AM J TROP MED HYG, V54, P486, DOI 10.4269/ajtmh.1996.54.486; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FLINN HM, 1992, NUCLEIC ACIDS RES, V20, P755, DOI 10.1093/nar/20.4.755; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Geraldo MV, 2005, FEMS MICROBIOL LETT, V242, P275, DOI 10.1016/j.femsle.2004.11.030; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; GREEN SJ, 1990, J IMMUNOL, V144, P278; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; Liew FY, 1999, IMMUNOL LETT, V65, P101, DOI 10.1016/S0165-2478(98)00131-X; LIEW FY, 1990, J IMMUNOL, V144, P4794; Liew FY, 1997, PHILOS T R SOC B, V352, P1311, DOI 10.1098/rstb.1997.0115; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; MUKHOPADHYAY R, 1995, INT J BIOCHEM CELL B, V27, P947, DOI 10.1016/1357-2725(95)00053-R; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; MURRAY HW, 1983, J CLIN INVEST, V72, P32, DOI 10.1172/JCI110972; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; MURRAY HW, 1982, J IMMUNOL, V129, P351; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; ROACH TIA, 1991, INFECT IMMUN, V59, P3935, DOI 10.1128/IAI.59.11.3935-3944.1991; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; Sambrook J, 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Uliana SRB, 1999, EXP PARASITOL, V92, P183, DOI 10.1006/expr.1999.4410; ULIANA SRB, 1991, EXP PARASITOL, V72, P157, DOI 10.1016/0014-4894(91)90133-H; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yeramian A, 2006, EUR J IMMUNOL, V36, P1516, DOI 10.1002/eji.200535694; YOSHIDA N, 1978, J BACTERIOL, V136, P1184, DOI 10.1128/JB.136.3.1184-1186.1978; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	48	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27818	10.1371/journal.pone.0027818	http://dx.doi.org/10.1371/journal.pone.0027818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114701	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400121
J	Chen, YC; Zheng, JH; Zheng, FC; Wang, JZ; Zhang, YM; Gao, FF; Huang, ZQ; Shi, GG				Chen, Yicun; Zheng, Jinhong; Zheng, Fuchun; Wang, Jinzhi; Zhang, Yanmei; Gao, Fenfei; Huang, Zhanqin; Shi, Ganggang			Design, Synthesis, and Pharmacological Evaluation of Haloperidol Derivatives as Novel Potent Calcium Channel Blockers with Vasodilator Activity	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CELL-PROLIFERATION; PRIMARY CULTURE; NITRIC-OXIDE; EXPRESSION; MECHANISM; CONTRACTION; ARRHYTHMIAS; ANTAGONISTS; INHIBITION	Several haloperidol derivatives with a piperidine scaffold that was decorated at the nitrogen atom with different alkyl, benzyl, or substituted benzyl moieties were synthesized at our laboratory to establish a library of compounds with vasodilator activity. Compounds were screened for vasodilatory activity on isolated thoracic aorta rings from rats, and their quantitative structure-activity relationships (QSAR) were examined. Based on the result of QSAR, N-4-tert-butyl benzyl haloperidol chloride (16c) was synthesized and showed the most potent vasodilatory activity of all designed compounds. 16c dose-dependently inhibited the contraction caused by the influx of extracellular Ca(2+) in isolated thoracic aorta rings from rats. It concentration-dependently attenuated the calcium channel current and extracellular Ca(2+) influx, without affecting the intracellular Ca(2+) mobilization, in vascular smooth muscle cells from rats. 16c, possessing the N-4-tert-butyl benzyl piperidine structure, as a novel calcium antagonist, may be effective as a calcium channel blocker in cardiovascular disease.	[Chen, Yicun; Zhang, Yanmei; Gao, Fenfei; Huang, Zhanqin; Shi, Ganggang] Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Guangdong, Peoples R China; [Zheng, Jinhong; Wang, Jinzhi] Shantou Univ, Coll Med, Dept Chem, Shantou, Guangdong, Peoples R China; [Zheng, Fuchun] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Pharm, Shantou, Guangdong, Peoples R China; [Shi, Ganggang] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Cardiovasc Dis, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Chen, YC (corresponding author), Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Guangdong, Peoples R China.	ggshi@stu.edu.cn	Gao, Fenfei/S-5331-2019	Gao, Fenfei/0000-0003-4144-8891	National Natural Science Foundation of China [30973922, 30472028]; National and GuangDong province Natural Science Foundation of China [U0932005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National and GuangDong province Natural Science Foundation of China	This work was supported by a grant from the National Natural Science Foundation of China (No. 30973922, 30472028), and the United Fund of the National and GuangDong province Natural Science Foundation of China (No. U0932005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki O, 2008, EUR J PHARMACOL, V584, P424, DOI 10.1016/j.ejphar.2008.02.001; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Best JM, 2010, AM J PHYSIOL-HEART C, V298, pH3, DOI 10.1152/ajpheart.01044.2009; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; BLOCK LH, 1989, P NATL ACAD SCI USA, V86, P2388, DOI 10.1073/pnas.86.7.2388; Breschi MC, 2006, J MED CHEM, V49, P2628, DOI 10.1021/jm0600186; CAMPBELL JH, 1989, ARTERIOSCLEROSIS, V9, P633, DOI 10.1161/01.ATV.9.5.633; Chan ECH, 2000, J CARDIOVASC PHARM, V35, P326, DOI 10.1097/00005344-200002000-00023; Chen YC, 2009, CELL PHYSIOL BIOCHEM, V23, P295, DOI 10.1159/000218176; DEARDEN JC, 1997, J PHARM PHARM S, V31, P45; Escobales N, 1996, J HYPERTENS, V14, P115; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; GOLLASCH M, 1991, P NATL ACAD SCI USA, V88, P10262, DOI 10.1073/pnas.88.22.10262; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansch C., 1995, EXPLORING QSAR HYDRO; Hansch C., 1995, J AM CHEM SOC; Hansch C, 1979, SUBSTITUENT CONSTANT; Hulsman N, 2007, J MED CHEM, V50, P2424, DOI 10.1021/jm061371e; Izumi H, 1996, GEN PHARMACOL, V27, P985, DOI 10.1016/0306-3623(95)02139-6; JANIS RA, 1983, J MED CHEM, V26, P775, DOI 10.1021/jm00360a001; Kiselev KV, 2008, MOL BIOL+, V42, P243, DOI 10.1134/S0026893308020106; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Lyles-Eggleston M, 2004, J MED CHEM, V47, P497, DOI 10.1021/jm0301033; MINTA A, 1989, J BIOL CHEM, V264, P8171; NG LL, 1994, CIRC RES, V74, P173, DOI 10.1161/01.RES.74.2.173; OPIE L H, 1987, Cardiovascular Drugs and Therapy, V1, P411, DOI 10.1007/BF02209083; Orallo F, 1996, PHARMACOL THERAPEUT, V69, P153, DOI 10.1016/0163-7258(95)02042-X; POLSTER P, 1990, J PHARMACOL EXP THER, V255, P593; SAIDA K, 1983, CIRC RES, V52, P137, DOI 10.1161/01.RES.52.2.137; Shi G., 1998, CHIN PHARM J, V09, P529; Shi GG, 2001, ACTA PHARMACOL SIN, V22, P837; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SPEDDING M, 1992, CARDIOVASC DRUG THER, V6, P35, DOI 10.1007/BF00050915; TOWART R, 1982, BRIT J PHARMACOL, V75, P150; Unno T, 2003, BRIT J PHARMACOL, V139, P337, DOI 10.1038/sj.bjp.0705267; Verma RP, 2008, J PHARM SCI-US, V97, P88, DOI 10.1002/jps.21087; Wajima T, 2004, PHARMACOLOGY, V70, P68, DOI 10.1159/000074670; XIONG ZL, 1995, J MOL CELL CARDIOL, V27, P75, DOI 10.1016/S0022-2828(08)80009-0; Yoshida J, 2003, EUR J PHARMACOL, V472, P23, DOI 10.1016/S0014-2999(03)01831-4; [郑锦鸿 Zheng Jinhong], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P947	41	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27673	10.1371/journal.pone.0027673	http://dx.doi.org/10.1371/journal.pone.0027673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110716	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400081
J	Grenier, L; Robaire, B; Hales, BF				Grenier, Lisanne; Robaire, Bernard; Hales, Barbara F.			Paternal Cyclophosphamide Exposure Induces the Formation of Functional Micronuclei during the First Zygotic Division	PLOS ONE			English	Article							PREIMPLANTATION RAT EMBRYO; MOUSE 2-CELL EMBRYOS; SPERM CHROMATIN; TESTICULAR CANCER; DNA-DAMAGE; DEVELOPMENTAL ABILITY; CHROMOSOMAL MOSAICISM; BLASTOCYST STAGE; CHILDHOOD-CANCER; INTEGRITY	Paternal exposures to cancer chemotherapeutics or environmental chemicals may have adverse effects on progeny outcome that are manifested in the preimplantation embryo. The objectives of this study were to determine the impact of paternal exposure to cyclophosphamide, an anticancer alkylating agent, on the formation, chromatin origin and function of micronuclei in cleavage stage rat embryos. Male Sprague-Dawley rats were gavaged with saline or cyclophosphamide (6 mg/kg/day) for 4 weeks and mated to naturally cycling females to collect pronuclear zygotes and 2 to 8 cell embryos. Micronuclear chromatin structure was characterized using confocal microscopy to detect immunoreactivities for H3K9me3, a marker for maternal chromatin, and lamin B, a nuclear membrane marker. DNA synthesis was monitored using EdU (5-ethynyl-2'-deoxyuridine) incorporation. Fertilization by cyclophosphamide-exposed spermatozoa led to a dramatic elevation in micronuclei in cleavage stage embryos (control embryos: 1% to 5%; embryos sired by treated males: 70%). The formation of micronuclei occurred during the first zygotic division and was associated with a subsequent developmental delay. The absence of H3K9me3 indicated that these micronuclei were of paternal origin. The micronuclei had incomplete peri-nuclear and peri-nucleolar lamin B1 membrane formation but incorporated EdU into DNA to the same extent as the main nucleus. The formation of micronuclei in response to the presence of a damaged paternal genome may play a role in increasing the rate of embryo loss that is associated with the use of assisted reproductive technologies, parenthood among cancer survivors, and paternal aging.	[Grenier, Lisanne; Robaire, Bernard; Hales, Barbara F.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Grenier, L (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	Bernard.robaire@mcgill.ca			Canadian Institutes of Health Research [MOP-79254]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by grant MOP-79254 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WW, 2010, INT J HYG ENVIR HEAL, V213, P32, DOI 10.1016/j.ijheh.2009.09.002; Barton TS, 2005, P NATL ACAD SCI USA, V102, P7865, DOI 10.1073/pnas.0501200102; Bielanska M, 2002, HUM REPROD, V17, P413, DOI 10.1093/humrep/17.2.413; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Codrington AM, 2004, J ANDROL, V25, P657; Colvin OM, 1999, CURR PHARM DESIGN, V5, P555; Delbes G, 2007, J ANDROL, V28, P241, DOI 10.2164/jandrol.106.001487; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fiserova J, 2010, BIOCHEM SOC T, V38, P829, DOI 10.1042/BST0380829; Green DM, 2010, J CLIN ONCOL, V28, P332, DOI 10.1200/JCO.2009.24.9037; Grenier L, 2010, BIOL REPROD, V83, P195, DOI 10.1095/biolreprod.109.083345; Harrouk W, 2000, MUTAT RES-DNA REPAIR, V461, P229, DOI 10.1016/S0921-8777(00)00053-7; Harrouk W, 2000, BIOL REPROD, V63, P74, DOI 10.1095/biolreprod63.1.74; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Huyhe E, 2007, EUR UROL, V51, P621, DOI 10.1016/j.eururo.2006.08.024; KELLY SM, 1994, BIOL REPROD, V50, P55, DOI 10.1095/biolreprod50.1.55; KELLY SM, 1992, TERATOLOGY, V45, P313, DOI 10.1002/tera.1420450310; Kirsch-Volders M, 2011, ARCH TOXICOL, V85, P873, DOI 10.1007/s00204-011-0691-4; Marchetti F, 2009, TOXICOL SCI, V107, P194, DOI 10.1093/toxsci/kfn209; Mozdarani H, 2009, REPRODUCTION, V137, P35, DOI 10.1530/REP-08-0073; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Nygren KG, 2011, FERTIL STERIL, V95, P2209, DOI 10.1016/j.fertnstert.2011.03.058; O'Flaherty C, 2008, HUM REPROD, V23, P1044, DOI 10.1093/humrep/den081; O'Flaherty C, 2010, FERTIL STERIL, V94, P1374, DOI 10.1016/j.fertnstert.2009.05.068; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Sandalinas M, 2001, HUM REPROD, V16, P1954, DOI 10.1093/humrep/16.9.1954; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; SARTORE RC, 2011, PLOS ONE IN PRESS; Stahl O, 2011, JNCI-J NATL CANCER I, V103, P398, DOI 10.1093/jnci/djq550; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Thomson AB, 2002, LANCET, V360, P361, DOI 10.1016/S0140-6736(02)09606-X; Tian Y, 2003, REPROD TOXICOL, V17, P401, DOI 10.1016/S0890-6238(03)00039-X; Titenko-Holland N, 1998, ENVIRON MOL MUTAGEN, V31, P206, DOI 10.1002/(SICI)1098-2280(1998)31:3<206::AID-EM2>3.0.CO;2-I; Toyoshima M, 2009, J RADIAT RES, V50, P11, DOI 10.1269/jrr.08099; TRASLER JM, 1986, BIOL REPROD, V34, P275, DOI 10.1095/biolreprod34.2.275; TRASLER JM, 1985, NATURE, V316, P144, DOI 10.1038/316144a0; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021557; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yukawa M, 2007, BIOCHEM BIOPH RES CO, V358, P578, DOI 10.1016/j.bbrc.2007.04.162; Zini A, 2011, SYST BIOL REPROD MED, V57, P78, DOI 10.3109/19396368.2010.515704	42	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27600	10.1371/journal.pone.0027600	http://dx.doi.org/10.1371/journal.pone.0027600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110683	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400065
J	Watabe-Rudolph, M; Begus-Nahrmann, Y; Lechel, A; Rolyan, H; Scheithauer, MO; Rettinger, G; Thal, DR; Rudolph, KL				Watabe-Rudolph, Masami; Begus-Nahrmann, Yvonne; Lechel, Andre; Rolyan, Harshvardhan; Scheithauer, Marc-Oliver; Rettinger, Gerhard; Thal, Dietmar Rudolf; Rudolph, Karl Lenhard			Telomere Shortening Impairs Regeneration of the Olfactory Epithelium in Response to Injury but Not Under Homeostatic Conditions	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; TERMINAL TRANSFERASE; STEM-CELLS; LIFE-SPAN; RIBONUCLEOPROTEIN; NEUROGENESIS; DYNAMICS; MAMMALS; SYSTEM; CANCER	Atrophy of the olfactory epithelium (OE) associated with impaired olfaction and dry nose represents one of the most common phenotypes of human aging. Impairment in regeneration of a functional olfactory epithelium can also occur in response to injury due to infection or nasal surgery. These complications occur more frequently in aged patients. Although age is the most unifying risk factor for atrophic changes and functional decline of the olfactory epithelium, little is known about molecular mechanisms that could influence maintenance and repair of the olfactory epithelium. Here, we analyzed the influence of telomere shortening (a basic mechanism of cellular aging) on homeostasis and regenerative reserve in response to chemical induced injury of the OE in late generation telomere knockout mice (G3 mTerc(-/-)) with short telomeres compared to wild type mice (mTerc(+/+)) with long telomeres. The study revealed no significant influence of telomere shortening on homeostatic maintenance of the OE during mouse aging. In contrast, the regenerative response to chemical induced injury of the OE was significantly impaired in G3 mTerc(-/-) mice compared to mTerc(+/+) mice. Seven days after chemical induced damage, G3 mTerc(-/-) mice exhibited significantly enlarged areas of persisting atrophy compared to mTerc(+/+) mice (p = 0.031). Telomere dysfunction was associated with impairments in cell proliferation in the regenerating epithelium. Deletion of the cell cycle inhibitor, Cdkn1a (p21) rescued defects in OE regeneration in telomere dysfunctional mice. Together, these data indicate that telomere shortening impairs the regenerative capacity of the OE by impairing cell cycle progression in a p21-dependent manner. These findings could be relevant for the impairment in OE function in elderly people.	[Watabe-Rudolph, Masami; Scheithauer, Marc-Oliver; Rettinger, Gerhard] Univ Ulm, Dept Otorhinolaryngol, Ulm, Germany; [Begus-Nahrmann, Yvonne; Lechel, Andre; Rolyan, Harshvardhan; Rudolph, Karl Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, Ulm, Germany; [Begus-Nahrmann, Yvonne; Lechel, Andre; Rolyan, Harshvardhan; Rudolph, Karl Lenhard] Univ Ulm, Inst Mol Med, Ulm, Germany; [Thal, Dietmar Rudolf] Univ Ulm, Dept Pathol, Ulm, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University; Ulm University	Watabe-Rudolph, M (corresponding author), Univ Ulm, Dept Otorhinolaryngol, Ulm, Germany.	Lenhard.Rudolph@uni-ulm.de	Thal, Dietmar R/O-7483-2018; Lechel, André/AAQ-2041-2021; Rolyan, Harshvardhan/G-2461-2017	Thal, Dietmar R/0000-0002-1036-1075; Lechel, André/0000-0003-0221-6959; Rolyan, Harshvardhan/0000-0001-8967-9627; Rudolph, Karl Lenhard/0000-0002-4839-2862	DFG [KFO142, 167, Ru745-11]	DFG(German Research Foundation (DFG))	This work was supported by the DFG (KFO142 and 167, Ru745-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELORENZO AJ, 1957, J BIOPHYS BIOCHEM CY, V3, P839, DOI 10.1083/jcb.3.6.839; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Doty R L, 1979, Am J Otolaryngol, V1, P57, DOI 10.1016/S0196-0709(79)80010-1; DOTY RL, 1991, PSYCHOPHYSICAL ANATO, V640, P20; Feng YR, 1999, PATHOBIOLOGY, V67, P34, DOI 10.1159/000028048; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Jenkin A, 2000, GYNECOL ENDOCRINOL, V14, P65, DOI 10.3109/09513590009167663; Kondo K, 2010, J COMP NEUROL, V518, P1962, DOI 10.1002/cne.22316; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LEVEY MS, 1991, J NEUROSCI, V11, P3556; MATULIONIS DH, 1975, AM J ANAT, V142, P67, DOI 10.1002/aja.1001420106; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Min YG, 2003, LARYNGOSCOPE, V113, P2157, DOI 10.1097/00005537-200312000-00020; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shay JW, 2004, NAT GENET, V36, P437, DOI 10.1038/ng0504-437; Sundermann EE, 2008, HORM BEHAV, V54, P528, DOI 10.1016/j.yhbeh.2008.05.007; Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533; Vaziri H, 1999, ONCOGENE, V18, P7676, DOI 10.1038/sj.onc.1203016; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Welge-Lussen A, 2009, B-ENT, P129; WYSOCKI CJ, 1993, CRIT REV FOOD SCI, V33, P63, DOI 10.1080/10408399309527613	36	23	24	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27801	10.1371/journal.pone.0027801	http://dx.doi.org/10.1371/journal.pone.0027801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110763	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400117
J	Crevel, I; Crevel, G; Gostan, T; de Renty, C; Coulon, V; Cotterill, S				Crevel, Isabelle; Crevel, Gilles; Gostan, Thierry; de Renty, Christelle; Coulon, Vincent; Cotterill, Sue			Decreased MCM2-6 in Drosophila S2 Cells Does Not Generate Significant DNA Damage or Cause a Marked Increase in Sensitivity to Replication Interference	PLOS ONE			English	Article							DORMANT ORIGINS; EXCESS MCM2-7; PROTEINS; STRESS; GENOME; MELANOGASTER; COMPLEXES; CHROMATIN; HELICASE; PHASE	A reduction in the level of some MCM proteins in human cancer cells (MCM5 in U20S cells or MCM3 in Hela cells) causes a rapid increase in the level of DNA damage under normal conditions of cell proliferation and a loss of viability when the cells are subjected to replication interference. Here we show that Drosophila S2 cells do not appear to show the same degree of sensitivity to MCM2-6 reduction. Under normal cell growth conditions a reduction of >95% in the levels of MCM3, 5, and 6 causes no significant short term alteration in the parameters of DNA replication or increase in DNA damage. MCM depleted cells challenged with HU do show a decrease in the density of replication forks compared to cells with normal levels of MCM proteins, but this produces no consistent change in the levels of DNA damage observed. In contrast a comparable reduction of MCM7 levels has marked effects on viability, replication parameters and DNA damage in the absence of HU treatment.	[Crevel, Isabelle; Crevel, Gilles; Cotterill, Sue] St Georges Univ London, Dept Basic Med Sci, London, England; [Gostan, Thierry; de Renty, Christelle; Coulon, Vincent] Univ Montpellier 1, Montpellier, France; [Gostan, Thierry; de Renty, Christelle; Coulon, Vincent] Univ Montpellier 2, Montpellier, France; [Gostan, Thierry; de Renty, Christelle; Coulon, Vincent] CNRS, Inst Mol Genet, DNA Combing Facil, UMR 5535, Montpellier, France	St Georges University London; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Crevel, I (corresponding author), St Georges Univ London, Dept Basic Med Sci, London, England.	s.cotterill@sgul.ac.uk	Coulon, Vincent/B-2437-2009; Coulon, Vincent/AFF-7934-2022	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755	Medical Research Council (UK) [G0601107]; MRC [G0601107] Funding Source: UKRI; Medical Research Council [G0601107] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grant number G0601107 from the Medical Research Council (UK) (http://www.mrc.ac.uk/index.htm) to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; Crevel G, 2001, NUCLEIC ACIDS RES, V29, P4834, DOI 10.1093/nar/29.23.4834; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Dorn ES, 2009, NUCLEIC ACIDS RES, V37, P60, DOI 10.1093/nar/gkn912; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 2003, EUR J BIOCHEM, V270, P1089, DOI 10.1046/j.1432-1033.2003.03440.x; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lei M, 1996, MOL CELL BIOL, V16, P5081; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; MARTON RF, 1994, FEBS LETT, V342, P139, DOI 10.1016/0014-5793(94)80488-5; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27101	10.1371/journal.pone.0027101	http://dx.doi.org/10.1371/journal.pone.0027101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102875	Green Published, Green Accepted, gold			2022-12-25	WOS:000297555300009
J	Gao, Y; Zhao, JT; Zu, YG; Fu, YJ; Wang, W; Luo, M; Efferth, T				Gao, Yuan; Zhao, Jin Tong; Zu, Yuan Gang; Fu, Yu Jie; Wang, Wei; Luo, Meng; Efferth, Thomas			Characterization of Five Fungal Endophytes Producing Cajaninstilbene Acid Isolated from Pigeon Pea [Cajanus cajan (L.) Millsp.]	PLOS ONE			English	Article							EXTRACTS; FUSARIUM; CYLINDROCARPON; CONSTITUENTS; DISEASE; GINSENG; YEASTS; LEAVES; ABIES	Five fungal endophytes (K4, K5, K6, K9, K14) producing Cajaninstilbene acid (CSA, 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid) were isolated from the roots of pigeon pea [Cajanus cajan (L.) Millsp.]. CSA is responsible for the prominent pharmacological activities in pigeon pea. The amount of CSA in culture solution varied among the five fungal endophytes. K4 produced the highest levels of CSA (1037.13 mu g/L) among the endophytes tested after incubation for five days. Both morphological characteristics and molecular methods were used for species identification of fungal endophytes. The five endophytic isolates were characterized by analyzing the internal transcribed spacer (ITS) rRNA and beta-tubulin genes. The K4, K5, K9 and K14 strains isolated from pigeon pea roots were found to be closely related to the species Fusarium oxysporum. K6 was identified as Neonectria macrodidym. The present study is the first report on the isolation and identification of fungal endophytes producing CSA in pigeon pea. The study also provides a scientific base for large scale production of CSA.	[Gao, Yuan; Zhao, Jin Tong; Zu, Yuan Gang; Fu, Yu Jie; Wang, Wei; Luo, Meng] NE Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin, Peoples R China; [Gao, Yuan; Zhao, Jin Tong; Zu, Yuan Gang; Fu, Yu Jie; Wang, Wei; Luo, Meng] NE Forestry Univ, Minist Educ, Engn Res Ctr Forest Biopreparat, Harbin, Peoples R China; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, Mainz, Germany	Northeast Forestry University - China; Northeast Forestry University - China; Johannes Gutenberg University of Mainz	Gao, Y (corresponding author), NE Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin, Peoples R China.	yujie_fu2002@yahoo.com	Luo, Meng/D-6950-2013	Efferth, Thomas/0000-0002-3096-3292	Agricultural Science and Technology Achievements Transformation Fund Program [2009GB23600514]; Special Fund of Forestry Industrial Research for Public Welfare of China [201004040]; Heilongjiang Province Science Foundation for Excellent Youths [JC200704]; Chinese Ministry of Education [MS2010DBLY031]; Key Program for Science and Technology Development of Harbin [2009AA3BS083]	Agricultural Science and Technology Achievements Transformation Fund Program; Special Fund of Forestry Industrial Research for Public Welfare of China; Heilongjiang Province Science Foundation for Excellent Youths; Chinese Ministry of Education(Ministry of Education, China); Key Program for Science and Technology Development of Harbin	Agricultural Science and Technology Achievements Transformation Fund Program (2009GB23600514), Special Fund of Forestry Industrial Research for Public Welfare of China (201004040), Heilongjiang Province Science Foundation for Excellent Youths (JC200704), Project for Distinguished Teacher Abroad, Chinese Ministry of Education (MS2010DBLY031) and the Key Program for Science and Technology Development of Harbin (2009AA3BS083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Bigelis R, 2006, J IND MICROBIOL BIOT, V33, P815, DOI 10.1007/s10295-006-0126-z; BOOTH C., 1971, The genus Fusarium.; BOOTH C, 1959, MYCOL PAP, V73, P1; Brayford D, 2004, MYCOLOGIA, V96, P572, DOI 10.2307/3762176; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; COOKSEY CJ, 1982, PHYTOCHEMISTRY, V21, P2935, DOI 10.1016/0031-9422(80)85072-2; Duker-Eshun G, 2004, PHYTOTHER RES, V18, P128, DOI 10.1002/ptr.1375; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu YJ, 2008, J SEP SCI, V31, P268, DOI 10.1002/jssc.200700312; Fu YJ, 2006, J CHROMATOGR A, V1137, P145, DOI 10.1016/j.chroma.2006.08.067; Fujita K, 2004, PLANT SCI, V166, P641, DOI 10.1016/j.plantsci.2003.10.032; Germaine K, 2004, FEMS MICROBIOL ECOL, V48, P109, DOI 10.1016/j.femsec.2003.12.009; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hua X, 2010, J PHARMACEUT BIOMED, V52, P273, DOI 10.1016/j.jpba.2010.01.004; Kong Y, 2009, FOOD CHEM, V117, P152, DOI 10.1016/j.foodchem.2009.03.091; LI WK, 2005, CHIN J NAT MED, V4, P193; Liu W, 2010, FOOD CHEM, V121, P732, DOI 10.1016/j.foodchem.2010.01.023; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; MORTON JF, 1976, HORTSCIENCE, V11, P11; Nel B, 2006, PLANT PATHOL, V55, P207, DOI 10.1111/j.1365-3059.2006.01343.x; Nelson P., 1983, FUSARIUM SPECIES ILL; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; OUELLETTE G. B., 1966, PLANT DIS REPORT, V50, P722; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; POLAND WSW, 2007, PHYTOCHEMISTRY, V68, P886; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rossman AY, 1999, STUD MYCOL, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuels G. J., 1993, Sydowia, V45, P55; SCHULTZ ME, 1990, PLANT DIS, V74, P178, DOI 10.1094/PD-74-0178; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; SEBASTIEN A, 2008, PHYSL MOL PLANT P, V73, P9; Seifert KA, 2003, PHYTOPATHOLOGY, V93, P1533, DOI 10.1094/PHYTO.2003.93.12.1533; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2002, CRIT REV BIOTECHNOL, V22, P315, DOI 10.1080/07388550290789531; Sun S. M., 1995, CHIN TRADIT HERB DRU, V26, P147; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Tang Y., 1999, J GUANGZHOU U TRADIT, V16, P302; Vasiliauskas R, 2004, BIOL CONTROL, V31, P405, DOI 10.1016/j.biocontrol.2004.05.006; Vasiliauskas R, 1996, EUR J FOREST PATHOL, V26, P285; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang Y, 2005, FUNGAL DIVERS, V20, P235; White T., 1990, PCR PROTOCOLS GUIDE, P315; Windels C. E., 1992, METHODS RES SOILBORN, P115; Wu N, 2009, MOLECULES, V14, P1032, DOI 10.3390/molecules14031032; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Xu LL, 2009, PHYTOMEDICINE, V16, P609, DOI 10.1016/j.phymed.2009.03.014; Zheng Yuan-yuan, 2007, Yaoxue Xuebao, V42, P562; Zu YG, 2006, CHROMATOGRAPHIA, V63, P499, DOI 10.1365/s10337-006-0784-z	55	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27589	10.1371/journal.pone.0027589	http://dx.doi.org/10.1371/journal.pone.0027589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102911	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555300032
J	Xue, HJ; Li, WZ; Nie, RE; Yang, XK				Xue, Huai-Jun; Li, Wen-Zhu; Nie, Rui-E; Yang, Xing-Ke			Recent Speciation in Three Closely Related Sympatric Specialists: Inferences Using Multi-Locus Sequence, Post-Mating Isolation and Endosymbiont Data	PLOS ONE			English	Article							HOST RACE FORMATION; REPRODUCTIVE ISOLATION; CYTOPLASMIC INCOMPATIBILITY; NEODIPRION HYMENOPTERA; BEETLES COLEOPTERA; BAYESIAN-INFERENCE; ALTICA COLEOPTERA; GENETIC-ANALYSIS; INVASIVE PLANT; PEA APHIDS	Shifting between unrelated host plants is relatively rare for phytophagous insects, and distinct host specificity may play crucial roles in reproductive isolation. However, the isolation status and the relationship between parental divergence and post-mating isolation among closely related sympatric specialists are still poorly understood. Here, multi-locus sequence were used to estimate the relationship among three host plant-specific closely related flea beetles, Altica cirsicola, A. fragariae and A. viridicyanea (abbreviated as AC, AF and AV respectively). The tree topologies were inconsistent using different gene or different combinations of gene fragments. The relationship of AF+(AC+AV) was supported, however, by both gene tree and species tree based on concatenated data. Post-mating reproductive data on the results of crossing these three species are best interpreted in the light of a well established phylogeny. Nuclear-induced but not Wolbachia-induced unidirectional cytoplasmic incompatibility, which was detected in AC-AF and AF-AV but not in AC-AV, may also suggest more close genetic affinity between AC and AV. Prevalence of Wolbachia in these three beetles, and the endosymbiont in most individuals of AV and AC sharing a same wsp haplotype may give another evidence of AF+(AC+AV). Our study also suggested that these three flea beetles diverged in a relative short time (0.94 My), which may be the result of shifting between unrelated host plants and distinct host specificity. Incomplete post-mating isolation while almost complete lineage sorting indicated that effective pre-mating isolation among these three species should have evolved.	[Xue, Huai-Jun; Li, Wen-Zhu; Nie, Rui-E; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Nie, Rui-E] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xue, HJ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn	Xue, Huai-Jun/G-8541-2011		National Natural Science Foundation of China [31071951, 3010300101]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences	This study was supported by grants from National Natural Science Foundation of China (No. 31071951, 3010300101) and a grant from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (No. O529YX5105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Borer M, 2010, MOL PHYLOGENET EVOL, V57, P703, DOI 10.1016/j.ympev.2010.08.017; Bull V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-11; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dasmahapatra KK, 2007, BIOL LETTERS, V3, P660, DOI 10.1098/rsbl.2007.0401; Deering MD, 2002, J ETHOL, V20, P25, DOI 10.1007/s10164-002-0050-2; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Farrell BD, 2004, EVOLUTION, V58, P1984; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hirai Y, 2006, ENTOMOL EXP APPL, V118, P129, DOI 10.1111/j.1570-7458.2006.00365.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Ikonen A, 2003, ENTOMOL EXP APPL, V108, P179, DOI 10.1046/j.1570-7458.2003.00079.x; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Jenkins TM, 2007, MOL PHYLOGENET EVOL, V42, P612, DOI 10.1016/j.ympev.2006.11.024; Jenkins TM, 2009, ANN ENTOMOL SOC AM, V102, P386, DOI 10.1603/008.102.0306; Jiggins CD, 2006, EVOLUTION, V60, P1454, DOI 10.1111/j.0014-3820.2006.tb01224.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; KATAKURA H, 1989, EVOLUTION, V43, P1045, DOI 10.1111/j.1558-5646.1989.tb02549.x; Keese MC, 1998, J EVOLUTION BIOL, V11, P403, DOI 10.1007/s000360050096; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kobayashi N, 2011, J ZOOL SYST EVOL RES, V49, P16, DOI 10.1111/j.1439-0469.2010.00581.x; Koehncke A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004425; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; Linnen CR, 2008, MOL PHYLOGENET EVOL, V48, P240, DOI 10.1016/j.ympev.2008.03.021; Linnen CR, 2010, P ROY SOC B-BIOL SCI, V277, P3131, DOI 10.1098/rspb.2010.0577; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; Marcade I, 1999, HEREDITY, V83, P71, DOI 10.1038/sj.hdy.6885380; Matsubayashi KW, 2011, J EVOLUTION BIOL, V24, P1421, DOI 10.1111/j.1420-9101.2011.02274.x; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Mercader RJ, 2009, OECOLOGIA, V158, P651, DOI 10.1007/s00442-008-1177-9; Michel-Salzat A, 2001, HEREDITY, V87, P428, DOI 10.1046/j.1365-2540.2001.00920.x; Mitter C., 1991, P35; Normark BB, 1999, P ROY SOC B-BIOL SCI, V266, P2253, DOI 10.1098/rspb.1999.0916; Ohshima I, 2008, BIOL J LINN SOC, V93, P135, DOI 10.1111/j.1095-8312.2007.00949.x; Ording GJ, 2010, OECOLOGIA, V162, P523, DOI 10.1007/s00442-009-1493-8; Perlman SJ, 2008, GENETICS, V178, P1003, DOI 10.1534/genetics.107.083071; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2010, TRACER 1 5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Ruhl MW, 2010, MOL PHYLOGENET EVOL, V54, P664, DOI 10.1016/j.ympev.2009.07.036; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Schwarz D, 2007, EVOLUTION, V61, P245, DOI 10.1111/j.1558-5646.2007.00027.x; Scriber JM, 2008, ENTOMOL EXP APPL, V128, P230, DOI 10.1111/j.1570-7458.2008.00691.x; Scriber JM, 2011, INSECT SCI, V18, P121, DOI 10.1111/j.1744-7917.2010.01367.x; Scriber JM, 2010, INSECT SCI, V17, P471, DOI 10.1111/j.1744-7917.2010.01357.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Telschow A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000701; Ueno H, 2003, J EVOLUTION BIOL, V16, P883, DOI 10.1046/j.1420-9101.2003.00604.x; Vandenberg N. J., 1996, HDB PALEARCTIC FLEA, V1; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Wang Shu-Yong, 2005, Chinese Bulletin of Entomology, V42, P385; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Xue HJ, 2009, J EVOLUTION BIOL, V22, P2258, DOI 10.1111/j.1420-9101.2009.01841.x; Xue HJ, 2009, ECOL ENTOMOL, V34, P74, DOI 10.1111/j.1365-2311.2008.01042.x; Yu P.Y., 1996, EC INSECT FAUNA CHIN; Zhai Zong-Zhao, 2007, Acta Zootaxonomica Sinica, V32, P137; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	76	17	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27834	10.1371/journal.pone.0027834	http://dx.doi.org/10.1371/journal.pone.0027834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110767	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555300055
J	Prigione, A; Hossini, AM; Lichtner, B; Serin, A; Fauler, B; Megges, M; Lurz, R; Lehrach, H; Makrantonaki, E; Zouboulis, CC; Adjaye, J				Prigione, Alessandro; Hossini, Amir M.; Lichtner, Bjoern; Serin, Akdes; Fauler, Beatrix; Megges, Matthias; Lurz, Rudi; Lehrach, Hans; Makrantonaki, Eugenia; Zouboulis, Christos C.; Adjaye, James			Mitochondrial-Associated Cell Death Mechanisms Are Reset to an Embryonic-Like State in Aged Donor-Derived iPS Cells Harboring Chromosomal Aberrations	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; STRESS PATHWAY; X-INACTIVATION; APOPTOSIS; FIBROBLASTS; MUTATIONS; DYNAMICS; CANCER	Somatic cells reprogrammed into induced pluripotent stem cells (iPSCs) acquire features of human embryonic stem cells (hESCs) and thus represent a promising source for cellular therapy of debilitating diseases, such as age-related disorders. However, reprogrammed cell lines have been found to harbor various genomic alterations. In addition, we recently discovered that the mitochondrial DNA of human fibroblasts also undergoes random mutational events upon reprogramming. Aged somatic cells might possess high susceptibility to nuclear and mitochondrial genome instability. Hence, concerns over the oncogenic potential of reprogrammed cells due to the lack of genomic integrity may hinder the applicability of iPSC-based therapies for age-associated conditions. Here, we investigated whether aged reprogrammed cells harboring chromosomal abnormalities show resistance to apoptotic cell death or mitochondrial-associated oxidative stress, both hallmarks of cancer transformation. Four iPSC lines were generated from dermal fibroblasts derived from an 84-year-old woman, representing the oldest human donor so far reprogrammed to pluripotency. Despite the presence of karyotype aberrations, all aged-iPSCs were able to differentiate into neurons, re-establish telomerase activity, and reconfigure mitochondrial ultra-structure and functionality to a hESC-like state. Importantly, aged-iPSCs exhibited high sensitivity to drug-induced apoptosis and low levels of oxidative stress and DNA damage, in a similar fashion as iPSCs derived from young donors and hESCs. Thus, the occurrence of chromosomal abnormalities within aged reprogrammed cells might not be sufficient to over-ride the cellular surveillance machinery and induce malignant transformation through the alteration of mitochondrial-associated cell death. Taken together, we unveiled that cellular reprogramming is capable of reversing aging-related features in somatic cells from a very old subject, despite the presence of genomic alterations. Nevertheless, we believe it will be essential to develop reprogramming protocols capable of safeguarding the integrity of the genome of aged somatic cells, before employing iPSC-based therapy for age-associated disorders.	[Prigione, Alessandro; Lichtner, Bjoern; Megges, Matthias; Lehrach, Hans; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Hossini, Amir M.; Makrantonaki, Eugenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol, Dessau, Germany; [Hossini, Amir M.; Makrantonaki, Eugenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Venereol, Dessau, Germany; [Hossini, Amir M.; Makrantonaki, Eugenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Allergol & Immunol, Dessau, Germany; [Serin, Akdes] Max Planck Inst Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Fauler, Beatrix; Lurz, Rudi] Max Planck Inst Mol Genet, Electron Microscopy Grp, Berlin, Germany; [Makrantonaki, Eugenia] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Adjaye, James] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	Max Planck Society; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; King Saud University	Prigione, A (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany.	adjaye@molgen.mpg.de	Prigione, Alessandro/ABA-1584-2021; Zouboulis, Christos C./I-4493-2013; Makrantonaki, Evgenia/G-1769-2010; Alessandro, Prigione/B-2959-2013	Zouboulis, Christos C./0000-0003-1646-2608; Makrantonaki, Evgenia/0000-0001-8522-2128; Alessandro, Prigione/0000-0001-9457-1952	BMBF (Federal Ministry of Education and Research) [01GN0807]; Max Planck Society	BMBF (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by BMBF (Federal Ministry of Education and Research) (01GN0807) and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Boulting GL, 2011, NAT BIOTECHNOL; Fecker LF, 2002, J INVEST DERMATOL, V118, P1019, DOI 10.1046/j.1523-1747.2002.01744.x; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hussein D, 2011, NEURO-ONCOLOGY, V13, P70, DOI 10.1093/neuonc/noq144; JOZEFCZUK J, 2011, STEM CELLS DEV; Kadaja M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000397; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; LIU GH, 2011, NATURE; Makrantonaki E, 2006, AGING CELL, V5, P331, DOI 10.1111/j.1474-9726.2006.00223.x; Marion RM, 2010, CURR OPIN GENET DEV, V20, P190, DOI 10.1016/j.gde.2010.01.005; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905; PASI CE, 2011, CELL DEATH DIFFER; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Prigione A, 2007, AGING CELL, V6, P619, DOI 10.1111/j.1474-9726.2007.00323.x; Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; RAMOSMEJIA V, 2011, STEM CELLS DEV; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wang MH, 2007, NEUROSCI RES, V59, P40, DOI 10.1016/j.neures.2007.05.010; WANG Y, 2010, STEM CELL REV; Wang Y, 2011, STEM CELL REV REP, V7, P331, DOI 10.1007/s12015-010-9209-3; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeuschner D, 2010, STEM CELLS DEV, V19, P615, DOI 10.1089/scd.2009.0159; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	53	82	85	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27352	10.1371/journal.pone.0027352	http://dx.doi.org/10.1371/journal.pone.0027352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110631	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000297554300022
J	Rizza, SA; Challagundla, KB; Natesampillai, S; Bren, GD; Sykora, J; Walczak, H; Badley, AD				Rizza, Stacey A.; Challagundla, Kishore B.; Natesampillai, Sekar; Bren, Gary D.; Sykora, Jaromir; Walczak, Henning; Badley, Andrew D.			TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INDUCED APOPTOSIS; MEDIATED APOPTOSIS; LIVER FIBROSIS; PROTEIN; INFECTION; DEATH; HIV; CELLS; ACTIVATION	The mechanism by which HIV and HCV cooperatively accelerate hepatocyte damage is not clearly understood; however, each virus affects the TRAIL: TRAIL-receptor system. We, therefore, questioned whether the independent effects of HCV and HIV combine to synergistically result in TRAIL dependent hepatocyte killing. We describe that Huh7 hepatocytes treated with HIV gp120 results in both increase TRAIL-R2 expression and an acquired sensitivity to TRAIL mediated killing. Moreover HCV infection and HCV core expression alone in Huh7 cells upregulates TRAIL. Co-incubation of HIV gp120 primed hepatocytes with HCV core expressing hepatocytes results in the selective death of the HIV gp120 primed hepatocytes that is selectively blocked by TRAIL-R2-Fc fusion protein. Liver biopsies from HIV mono-infected patients have increased TRAIL-R2; biopsies from HCV infected patients have increased TRAIL, while co-infected liver biopsies have increased PARP cleavage within hepatocytes indicating enhanced apoptosis. These findings suggest a pathogenic model to understand why HIV/HCV co-infection accelerates liver injury.	[Rizza, Stacey A.; Challagundla, Kishore B.; Natesampillai, Sekar; Bren, Gary D.; Sykora, Jaromir; Walczak, Henning; Badley, Andrew D.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA	Mayo Clinic	Rizza, SA (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014; Walczak, Henning/AAV-2214-2020; Challagundla, Kishore B./H-8189-2019	Walczak, Henning/0000-0002-6312-4591; Challagundla, Kishore B./0000-0001-8654-7717; Badley, Andrew/0000-0001-7796-7680	National Institutes of Health (NIH) [R01 AI62261, R21DK 77575-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077575] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Andrew Badley is supported by a grant from the National Institutes of Health (NIH) (R01 AI62261). Dr. Stacey Rizza's work was supported by a grant from the NIH (R21DK 77575-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUTA N, 2011, INTERVIROLOGY; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Balasubramanian A, 2005, CLIN INFECT DIS, V41, pS32, DOI 10.1086/429493; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2000, CELL DEATH DIFFER, V7, P504, DOI 10.1038/sj.cdd.4400669; Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Berg CP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-213; Bird GLA, 1995, J VIRAL HEPATITIS, V2, P261, DOI 10.1111/j.1365-2893.1995.tb00039.x; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Cummins NW, 2010, J INFECT DIS, V201, P1273, DOI 10.1086/651434; EYSTER ME, 1994, BLOOD, V84, P1020; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Ghany MG, 1996, DIGEST DIS SCI, V41, P1265, DOI 10.1007/BF02088247; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Guo LR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265105; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Jang JY, 2011, J HEPATOL, V54, P612, DOI 10.1016/j.jhep.2010.07.042; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Laskus T, 2004, BLOOD, V103, P3854, DOI 10.1182/blood-2003-08-2923; LEFKOWITCH JH, 1994, DIGEST DIS, V12, P321, DOI 10.1159/000171468; Liang XH, 2007, APOPTOSIS, V12, P1827, DOI 10.1007/s10495-007-0114-4; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Macias J, 2005, J INFECT DIS, V192, P1566, DOI 10.1086/491736; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Martin-Carbonero L, 2004, CLIN INFECT DIS, V38, P128, DOI 10.1086/380130; Mohd-Ismail NK, 2009, J VIROL, V83, P9993, DOI 10.1128/JVI.00509-09; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; Schneider-Jakob S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.66; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Winslow Dean L, 2006, AIDS Alert, V21, P142; Woitas RP, 1999, AIDS, V13, P1313, DOI 10.1097/00002030-199907300-00007; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27171	10.1371/journal.pone.0027171	http://dx.doi.org/10.1371/journal.pone.0027171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110611	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300014
J	Kim, J; Dabiri, S; Seeley, ES				Kim, Jinah; Dabiri, Salma; Seeley, E. Scott			Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma	PLOS ONE			English	Article							HISTOPATHOLOGIC DIAGNOSIS; MELANOCYTIC LESIONS; CELLS; CANCER; IMMUNOREACTIVITY; MICROTUBULES; DISCORDANCE; EPITHELIA; FAMILIES; BENIGN	Cutaneous melanoma is a lethal malignancy that arises spontaneously or via in situ precursor neoplasms. While melanoma in situ and locally invasive malignant melanoma can be cured surgically, these lesions can sometimes be difficult to distinguish from melanocytic nevi. Thus, the identification of histolopathologic or molecular features that distinguish these biologically distinct lesions would represent an important advance. To this end, we determined the abundance of melanocytic primary cilia in a series of 62 cases composed of typical cutaneous melanocytic nevi, melanoma in situ, invasive melanoma, and metastatic melanoma. Primary cilia are sensory organelles that modulate developmental and adaptive signaling and notably, are substantially depleted from the neoplastic epithelium of pancreatic carcinoma at a stage equivalent to melanoma in situ. In this series, we find that while nearly all melanocytes in 22 melanocytic nevi possessed a primary cilium, a near-complete loss of this organelle was observed in 16 cases of melanoma in situ, in 16 unequivocal primary invasive melanomas, and in 8 metastatic tumors, each associated with a cutaneous primary lesion. These findings suggest that the primary cilium may be used to segregate cutaneous invasive melanoma and melanoma in situ from melanocytic nevi. Moreover, they place the loss of an organelle known to regulate oncogenic signaling at an early stage of melanoma development.	[Kim, Jinah; Dabiri, Salma; Seeley, E. Scott] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Kim, Jinah] Stanford Univ, Med Ctr, Dept Dermatol, Stanford, CA 94305 USA	Stanford University; Stanford University	Kim, J (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	seeley@stanford.edu			Stanford Department of Pathology	Stanford Department of Pathology	This study was supported by funding made available by the Stanford Department of Pathology (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bartsch DK, 2010, CLIN GENET, V77, P333, DOI 10.1111/j.1399-0004.2009.01352.x; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; DAVIES H, 2002, MUTATIONS BRAF; de Snoo FA, 2008, CLIN CANCER RES, V14, P7151, DOI 10.1158/1078-0432.CCR-08-0403; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; HAN YGG, 2009, NAT MED; Li LXL, 2000, AM J DERMATOPATH, V22, P489, DOI 10.1097/00000372-200012000-00002; Lodha S, 2008, J CUTAN PATHOL, V35, P349, DOI 10.1111/j.1600-0560.2007.00970.x; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nasr MR, 2008, AM J DERMATOPATH, V30, P117, DOI 10.1097/DAD.0b013e3181624054; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Ramos-Herberth FI, 2010, J CUTAN PATHOL, V37, P944, DOI 10.1111/j.1600-0560.2010.01568.x; ROTH KE, 1988, J CELL SCI, V89, P457; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seeley ES, 2009, METHOD CELL BIOL, V94, P299, DOI 10.1016/S0091-679X(08)94015-2; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; SHIDA T, 2010, P NATL ACAD SCI US; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; WARFVINGE K, 1988, CELL TISSUE RES, V251, P237, DOI 10.1007/BF00215830; Warfvinge K, 1995, ACTA DERM-VENEREOL, V75, P446; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; WONG SY, 2009, NAT MED	28	63	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27410	10.1371/journal.pone.0027410	http://dx.doi.org/10.1371/journal.pone.0027410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096570	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900042
J	Almeida, JAS; Faneca, H; Carvalho, RA; Marques, EF; Pais, AACC				Almeida, Joao A. S.; Faneca, Henrique; Carvalho, Rui A.; Marques, Eduardo F.; Pais, Alberto A. C. C.			Dicationic Alkylammonium Bromide Gemini Surfactants. Membrane Perturbation and Skin Irritation	PLOS ONE			English	Article							EPITHELIAL-LIKE CELLS; TERM TISSUE-CULTURE; NCTC STRAIN 2544; CATIONIC GEMINI; PHASE-BEHAVIOR; IN-VITRO; CHOLESTEROL; TRANSFECTION; BILAYERS; ASSOCIATION	Dicationic alkylammonium bromide gemini surfactants represent a class of amphiphiles potentially effective as skin permeation enhancers. However, only a limited number of studies has been dedicated to the evaluation of the respective cytotoxicity, and none directed to skin irritation endpoints. Supported on a cell viability study, the cytotoxicity of gemini surfactants of variable tail and spacer length was assessed. For this purpose, keratinocyte cells from human skin (NCTC 2544 cell line), frequently used as a model for skin irritation, were employed. The impact of the different gemini surfactants on the permeability and morphology of model vesicles was additionally investigated by measuring the leakage of calcein fluorescent dye and analyzing the NMR spectra of P-31, respectively. Detail on the interaction of gemini molecules with model membranes was also provided by a systematic differential scanning calorimetry (DSC) and molecular dynamics (MD) simulation. An irreversible impact on the viability of the NCTC 2544 cell line was observed for gemini concentrations higher than 25 mM, while no cytotoxicity was found for any of the surfactants in a concentration range up to 10 mM. A higher cytotoxicity was also found for gemini surfactants presenting longer spacer and shorter tails. The same trend was obtained in the calorimetric and permeability studies, with the gemini of longest spacer promoting the highest degree of membrane destabilization. Additional structural and dynamical characterization of the various systems, obtained by P-31 NMR and MD, provide some insight on the relationship between the architecture of gemini surfactants and the respective perturbation mechanism.	[Almeida, Joao A. S.; Pais, Alberto A. C. C.] Univ Coimbra, Dept Chem, Coimbra, Portugal; [Faneca, Henrique; Carvalho, Rui A.] Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cellular Biol, Coimbra, Portugal; [Marques, Eduardo F.] Univ Porto, Dept Chem & Biochem, Ctr Invest Quim, P-4100 Oporto, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto	Almeida, JAS (corresponding author), Univ Coimbra, Dept Chem, Coimbra, Portugal.	jasalmeida@qui.uc.pt	Faneca, Henrique M/L-2425-2018; Carvalho, Rui A/A-6661-2010; Marques, Eduardo F./A-8081-2012	Faneca, Henrique M/0000-0001-5554-7829; Carvalho, Rui A/0000-0003-1820-0353; Marques, Eduardo F./0000-0002-3892-9216; Almeida, Joao/0000-0002-7084-882X; Pais, Alberto/0000-0002-6725-6460	FCT, Portugal [PTDC/QUI-QUI/101442/2008, SFRH/BD/31064/2006]	FCT, Portugal(Portuguese Foundation for Science and Technology)	Funding through project no. PTDC/QUI-QUI/101442/2008 (COMPETE:FCOMP-01-0124-FEDER-010831) assigned by FCT, Portugal. PhD grant SFRH/BD/31064/2006 assigned by FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JAS, 2011, PHYS CHEM CHEM PHYS, V13, P13772, DOI 10.1039/c1cp20477g; Almeida JAS, 2010, PHYS CHEM CHEM PHYS, V12, P14462, DOI 10.1039/c0cp00950d; Bai GY, 2001, J PHYS CHEM B, V105, P3105, DOI 10.1021/jp0043017; Bangham A.D., 1974, METHODS MEMBRANE BIO, P1, DOI [DOI 10.1007/978-1-4615-7422-4_1, 10.1007/978-1-4615-7422-4_1]; Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bombelli C, 2005, J MED CHEM, V48, P4882, DOI 10.1021/jm050182d; Burrows HD, 2007, J PHYS CHEM B, V111, P4401, DOI 10.1021/jp070100s; Cardoso AMS, 2011, BBA-BIOMEMBRANES, V1808, P341, DOI 10.1016/j.bbamem.2010.09.026; Courrier HM, 2003, BIOMATERIALS, V24, P689, DOI 10.1016/S0142-9612(02)00407-6; Dasgupta A, 2007, J PHYS CHEM B, V111, P8502, DOI 10.1021/jp068571m; Dubnickova M, 2000, ACTA BIOCHIM POL, V47, P651; El Maghraby GMM, 2004, INT J PHARMACEUT, V276, P143, DOI 10.1016/j.ijpharm.2004.02.024; ESTEP TN, 1978, BIOCHEMISTRY-US, V17, P1984, DOI 10.1021/bi00603a029; Faneca H, 2004, J GENE MED, V6, P681, DOI 10.1002/jgm.550; Fisicaro E, 2005, BBA-GEN SUBJECTS, V1722, P224, DOI 10.1016/j.bbagen.2004.12.013; Fiske CH, 1925, J BIOL CHEM, V66, P375; Hait SK, 2002, CURR SCI INDIA, V82, P1101; Heerklotz H, 2008, Q REV BIOPHYS, V41, P205, DOI 10.1017/S0033583508004721; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hofsass C, 2003, BIOPHYS J, V84, P2192, DOI 10.1016/S0006-3495(03)75025-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inacio AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019850; Jadhav V, 2008, BIOMACROMOLECULES, V9, P1852, DOI 10.1021/bm8000765; Karmakar S, 2005, J PHYS-CONDENS MAT, V17, pS1177, DOI 10.1088/0953-8984/17/14/006; Kozak M, 2007, J THERM ANAL CALORIM, V88, P395, DOI 10.1007/s10973-006-8061-9; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8; MABREY S, 1978, BIOCHEMISTRY-US, V17, P2464, DOI 10.1021/bi00605a034; Maitani Y, 2008, INT J PHARM, V356, P69, DOI 10.1016/j.ijpharm.2007.12.033; Martinez V, 2006, TOXICOL LETT, V164, P259, DOI 10.1016/j.toxlet.2006.01.005; McIntosh TJ, 2003, BIOPHYS J, V85, P1675, DOI 10.1016/S0006-3495(03)74597-4; MCMULLEN TPW, 1995, BBA-BIOMEMBRANES, V1234, P90, DOI 10.1016/0005-2736(94)00266-R; MCMULLEN TPW, 1993, BIOCHEMISTRY-US, V32, P516, DOI 10.1021/bi00053a016; Menger FM, 2001, J AM CHEM SOC, V123, P875, DOI 10.1021/ja0033178; Menger FM, 2000, ANGEW CHEM INT EDIT, V39, P1907; Menger FM, 2000, LANGMUIR, V16, P9095, DOI 10.1021/la0003692; MENGER FM, 1993, J AM CHEM SOC, V115, P10083, DOI 10.1021/ja00075a025; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Mouritsen OG, 2005, FRONT COLLECT, P91; NEUFAHRT A, 1978, ARCH DERMATOL RES, V261, P27, DOI 10.1007/BF00455372; NEUFAHRT A, 1976, ARCH DERMATOL RES, V256, P255, DOI 10.1007/BF00572490; Nilsson M, 2006, LANGMUIR, V22, P8663, DOI 10.1021/la061220e; Nomura K, 2005, BIOPHYS J, V89, P4067, DOI 10.1529/biophysj.105.070292; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Paolino D, 2007, BIOMED MICRODEVICES, V9, P421, DOI 10.1007/s10544-007-9046-6; Pasenkiewicz-Gierula M, 2000, BIOPHYS J, V78, P1376, DOI 10.1016/S0006-3495(00)76691-4; Perkins MA, 1999, TOXICOL SCI, V48, P218, DOI 10.1093/toxsci/48.2.218; POTT T, 1995, BIOPHYS J, V68, P965, DOI 10.1016/S0006-3495(95)80272-9; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Sanchez L, 2006, TOXICOL LETT, V167, P40, DOI 10.1016/j.toxlet.2006.08.006; Sanchez L, 2006, TOXICOL LETT, V161, P53, DOI 10.1016/j.toxlet.2005.07.015; Sanchez L, 2004, PHARM RES-DORDR, V21, P1637, DOI 10.1023/B:PHAM.0000041459.63362.6f; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10676, DOI 10.1021/bi00499a015; Sikiric M, 2002, J COLLOID INTERF SCI, V250, P221, DOI 10.1006/jcis.2002.8304; Silvander M, 2003, CHEM PHYS LIPIDS, V126, P77, DOI 10.1016/S0009-3084(03)00094-X; Subedi RK, 2010, ARCH PHARM RES, V33, P339, DOI 10.1007/s12272-010-0301-7; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vattulainen I, 2005, HDB THEORETICAL COMP, P1; Videira RA, 1999, CHEM PHYS LIPIDS, V97, P139, DOI 10.1016/S0009-3084(98)00105-4; Vieira OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002913; Ward RK, 1998, TOXICOL IN VITRO, V12, P163, DOI 10.1016/S0887-2333(97)00098-2	63	37	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26965	10.1371/journal.pone.0026965	http://dx.doi.org/10.1371/journal.pone.0026965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102870	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800013
J	Amato, R; Miele, G; Monticelli, A; Cocozza, S				Amato, Roberto; Miele, Gennaro; Monticelli, Antonella; Cocozza, Sergio			Signs of Selective Pressure on Genetic Variants Affecting Human Height	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; DISRUPTIVE SELECTION; NATURAL-SELECTION; ADAPTATION; EVOLUTION; PATHWAYS; SWEEPS; GENOME; MEN	Many decades of scientific investigation have proved the role of selective pressure in Homo Sapiens at least at the level of individual genes or loci. Nevertheless, there are examples of polygenic traits that are bound to be under selection, but studies devoted to apply population genetics methods to unveil such occurrence are still lacking. Stature provides a relevant example of well-studied polygenic trait for which is now available a genome-wide association study which has identified the genes involved in this trait, and which is known to be under selection. We studied the behavior of F-ST in a simulated toy model to detect population differentiation on a generic polygenic phenotype under selection. The simulations showed that the set of alleles involved in the trait has a higher mean FST value than those undergoing genetic drift only. In view of this we looked for an increase in the mean FST value of the 180 variants associated to human height. For this set of alleles we found F-ST to be significantly higher than the genomic background (p = 0.0356). On the basis of a statistical analysis we excluded that the increase was just due to the presence of outliers. We also proved as marginal the role played by local adaptation phenomena, even on different phenotypes in linkage disequilibrium with genetic variants involved in height. The increase of F-ST for the set of alleles involved in a polygenic trait seems to provide an example of symmetry breaking phenomenon concerning the population differentiation. The splitting in the allele frequencies would be driven by the initial conditions in the population dynamics which are stochastically modified by events like drift, bottlenecks, etc, and other stochastic events like the born of new mutations.	[Amato, Roberto; Miele, Gennaro; Cocozza, Sergio] Univ Salerno, Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy; [Amato, Roberto; Miele, Gennaro] Univ Naples Federico II, Dipartimento Sci Fis, Naples, Italy; [Amato, Roberto; Miele, Gennaro] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Monticelli, Antonella] CNR Napoli, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Cocozza, Sergio] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol L Calif, Naples, Italy	University of Naples Federico II; University of Salerno; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Amato, R (corresponding author), Univ Salerno, Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy.	roamato@na.infn.it	Miele, Gennaro/AAG-6782-2020; Miele, Gennaro/F-3628-2010; Cocozza, Sergio/F-6488-2010	Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578; Amato, Roberto/0000-0001-8633-9221	Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples	Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples	R.A. is a recipient of a fellowship by Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sayama H, 2000, PHYS REV E, V62, P7065, DOI 10.1103/PhysRevE.62.7065; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; Van Doorn GS, 2006, EVOLUTION, V60, P2226, DOI 10.1554/06-291.1	15	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27588	10.1371/journal.pone.0027588	http://dx.doi.org/10.1371/journal.pone.0027588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096598	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800063
J	Porter, MY; Routledge, KE; Radford, SE; Hewitt, EW				Porter, Morwenna Y.; Routledge, Katy E.; Radford, Sheena E.; Hewitt, Eric W.			Characterization of the Response of Primary Cells Relevant to Dialysis-Related Amyloidosis to beta(2)-Microglobulin Monomer and Fibrils	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; NEUTRAL PH; IN-VITRO; OSTEOCLAST DIFFERENTIATION; CHRONIC-HEMODIALYSIS; BETA-2-MICROGLOBULIN; MACROPHAGES; PROTEIN; COLLAGEN; PATHOGENESIS	The formation of insoluble amyloid fibrils is associated with an array of devastating human diseases. Dialysis-related amyloidosis (DRA) is a severe complication of hemodialysis that results in the progressive destruction of the bones and joints. Elevated concentrations of beta(2)-microglobulin (beta(2)m) in the serum of subjects on hemodialysis promote the formation of amyloid fibrils in the osteoarticular tissues, but the cellular basis for the destruction of these tissues in DRA is poorly understood. In this study we performed a systematic analysis of the interaction of monomeric and fibrillar beta(2)m with primary human cells of the types present in the synovial joints of subjects with DRA. Building upon observations that macrophages infiltrate beta(2)m amyloid deposits in vivo we demonstrate that monocytes, the precursors of macrophages, cannot degrade beta(2)m fibrils, and that both monomeric beta(2)m and fibrillar beta(2)m are cytotoxic to these cells. beta(2)m fibrils also impair the formation of bone resorbing osteoclasts from monocytes and reduce the viability of osteoblasts, the cell type that produces bone. As a consequence, we predict that beta(2)m amyloid will disrupt the remodelling of the bone, which is critical for the maintenance of this tissue. Moreover, we show that beta(2)m fibrils reduce the viability of chondrocytes, rationalizing the loss of cartilage in DRA. Together, our observations demonstrate that beta(2)m cytotoxicity has multiple cellular targets in the osteoarticular tissues and is likely to be a key factor in the bone and joint destruction characteristic of DRA.	[Porter, Morwenna Y.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Porter, MY (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	e.w.hewitt@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Hewitt, Eric/0000-0002-6238-6303	Yorkshire Kidney Research Fund	Yorkshire Kidney Research Fund	This work was funded by the Yorkshire Kidney Research Fund (http://www.ykrf.co.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGILES A, 1994, NEPHROL DIAL TRANSPL, V9, P662, DOI 10.1093/ndt/9.6.662; Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Corlin DB, 2005, CLIN CHEM, V51, P1177, DOI 10.1373/clinchem.2005.049544; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; de Koning EJP, 1998, AMYLOID, V5, P247, DOI 10.3109/13506129809007297; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Drueke TB, 2009, SEMIN DIALYSIS, V22, P378, DOI 10.1111/j.1525-139X.2009.00584.x; EFSTRATIADIS T, 1985, ENZYME, V34, P140, DOI 10.1159/000469376; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Floege J, 1996, NEPHRON, V72, P9, DOI 10.1159/000188801; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gargar C, 1999, KIDNEY INT, V55, P1983, DOI 10.1046/j.1523-1755.1999.00430.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Giorgetti S, 2009, NEPHROL DIAL TRANSPL, V24, P1176, DOI 10.1093/ndt/gfn623; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GOREVIC PD, 1985, J CLIN INVEST, V76, P2425, DOI 10.1172/JCI112257; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; INOUE H, 1995, NEPHROL DIAL TRANSPL, V10, P2077; Inoue S, 1997, KIDNEY INT, V52, P1543, DOI 10.1038/ki.1997.484; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazama JJ, 2006, J BONE MINER METAB, V24, P182, DOI 10.1007/s00774-005-0669-5; Kazama JJ, 2001, AM J KIDNEY DIS, V38, pS156, DOI 10.1053/ajkd.2001.27427; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Malluche HH, 2011, J BONE MINER RES, V26, P1368, DOI 10.1002/jbmr.309; Menaa C, 2008, KIDNEY INT, V73, P1275, DOI 10.1038/ki.2008.100; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; NISHI S, 1990, NEPHRON, V56, P357, DOI 10.1159/000186175; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ohashi K, 2001, PATHOL INT, V51, P1, DOI 10.1046/j.1440-1827.2001.01156.x; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Schonland SO, 2008, HAEMATOLOGICA, V93, P955, DOI 10.3324/haematol.12497; Shiraishi M, 1997, SCAND J RHEUMATOL, V26, P61, DOI 10.3109/03009749709065667; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	59	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27353	10.1371/journal.pone.0027353	http://dx.doi.org/10.1371/journal.pone.0027353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096558	Green Published, gold			2022-12-25	WOS:000297350800048
J	Schack, VR; Holm, R; Vilsen, B				Schack, Vivien Rodacker; Holm, Rikke; Vilsen, Bente			Inhibition of Phosphorylation of Na+,K+-ATPase by Mutations Causing Familial Hemiplegic Migraine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET DYSTONIA-PARKINSONISM; TRANSMEMBRANE SEGMENT M1; ATPASE GENE ATP1A2; CRYSTAL-STRUCTURE; K+-ATPASE; FUNCTIONAL CONSEQUENCES; ALTERNATING HEMIPLEGIA; NA+ INTERACTION; NA,K-ATPASE; PUMP	The neurological disorder familial hemiplegic migraine type II (FHM2) is caused by mutations in the alpha 2-isoform of the Na+, K+-ATPase. We have studied the partial reaction steps of the Na+, K+-pump cycle in nine FHM2 mutants retaining overall activity at a level still compatible with cell growth. Although it is believed that the pathophysiology of FHM2 results from reduced extracellular K+ clearance and/or changes in Na+ gradient-dependent transport processes in neuroglia, a reduced affinity for K+ or Na+ is not a general finding with the FHM2 mutants. Six of the FHM2 mutations markedly affect the maximal rate of phosphorylation from ATP leading to inhibition by intracellular K+, thereby likely compromising pump function under physiological conditions. In mutants R593W, V628M, and M731T, the defective phosphorylation is caused by local perturbations within the Rossmann fold, possibly interfering with the bending of the P-domain during phosphoryl transfer. In mutants V138A, T345A, and R834Q, long range effects reaching from as far away as the M2 transmembrane helix perturb the function of the catalytic site. Mutant E700K exhibits a reduced rate of E2P dephosphorylation without effect on phosphorylation from ATP. An extremely reduced vanadate affinity of this mutant indicates that the slow dephosphorylation reflects a destabilization of the phosphoryl transition state. This seems to be caused by insertion of the lysine between two other positively charged residues of the Rossmann fold. In mutants R202Q and T263M, effects on the A-domain structure are responsible for a reduced rate of the E1P to E2P transition.	[Schack, Vivien Rodacker; Holm, Rikke; Vilsen, Bente] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	Aarhus University	Vilsen, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk		Vilsen, Bente/0000-0002-4727-9382	Danish Medical Research Council; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat); Lundbeck Foundation; Lundbeck Foundation [R48-2009-4638] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat)(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), and the Lundbeck Foundation.	Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Castro MJ, 2008, CLIN GENET, V73, P37, DOI 10.1111/j.1399-0004.2007.00918.x; Castro MJ, 2007, J HUM GENET, V52, P990, DOI 10.1007/s10038-007-0205-7; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Fedosova NU, 2003, BIOCHEMISTRY-US, V42, P3536, DOI 10.1021/bi0268302; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; JORGENSEN PL, 1991, SOC GEN PHY, V46, P189; Kaunisto MA, 2004, NEUROGENETICS, V5, P141, DOI 10.1007/s10048-004-0178-z; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Patchornik G, 2000, P NATL ACAD SCI USA, V97, P11954, DOI 10.1073/pnas.220332897; Pierelli F, 2006, CEPHALALGIA, V26, P324, DOI 10.1111/j.1468-2982.2006.01002.x; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Skou J. C, 1991, SODIUM PUMP RECENT D, P317; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Todt U, 2005, HUM MUTAT, V26, P315, DOI 10.1002/humu.20229; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vanmolkot KRJ, 2007, EUR J HUM GENET, V15, P884, DOI 10.1038/sj.ejhg.5201841; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Vilsen B, 1999, BIOCHEMISTRY-US, V38, P11389, DOI 10.1021/bi990951t; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; YODA A, 1987, J BIOL CHEM, V262, P110; YODA S, 1987, J BIOL CHEM, V262, P103	45	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2191	2202		10.1074/jbc.M111.323022	http://dx.doi.org/10.1074/jbc.M111.323022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117059	hybrid, Green Published			2022-12-25	WOS:000299321000058
J	Thompson, JA; Marzahn, MR; O'Donnell, M; Bloom, LB				Thompson, Jennifer A.; Marzahn, Melissa R.; O'Donnell, Mike; Bloom, Linda B.			Replication Factor C Is a More Effective Proliferating Cell Nuclear Antigen (PCNA) Opener than the Checkpoint Clamp Loader, Rad24-RFC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; BETA-SLIDING CLAMP; ESCHERICHIA-COLI; ENERGY-TRANSFER; COMPLEX; MECHANISM; DELTA; ATP; DYNAMICS; MACHINE	Clamp loaders from all domains of life load clamps onto DNA. The clamp tethers DNA polymerases to DNA to increase the processivity of synthesis as well as the efficiency of replication. Here, we investigated proliferating cell nuclear antigen (PCNA) binding and opening by the Saccharomyces cerevisiae clamp loader, replication factor C (RFC), and the DNA damage checkpoint clamp loader, Rad24-RFC, using two separate fluorescence intensity-based assays. Analysis of PCNA opening by RFC revealed a two-step reaction in which RFC binds PCNA before opening PCNA rather than capturing clamps that have transiently and spontaneously opened in solution. The affinity of RFC for PCNA is about an order of magnitude lower in the absence of ATP than in its presence. The affinity of Rad24-RFC for PCNA in the presence of ATP is about an order magnitude weaker than that of RFC for PCNA, similar to the RFC-PCNA interaction in the absence of ATP. Importantly, fewer open clamp loader-clamp complexes are formed when PCNA is bound by Rad24-RFC than when bound by RFC.	[Thompson, Jennifer A.; Marzahn, Melissa R.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA; [O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA	State University System of Florida; University of Florida; Rockefeller University; Howard Hughes Medical Institute	Bloom, LB (corresponding author), 1600 SW Archer Rd,JHMHC Rm R3-234, Gainesville, FL 32601 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM082849, GM038839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM082849, R37GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082849 (to L. B. B.) and GM038839 (to M. O. D.).	Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bloom LB, 2009, DNA REPAIR, V8, P570, DOI 10.1016/j.dnarep.2008.12.014; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Indiani C, 2003, J BIOL CHEM, V278, P40272, DOI 10.1074/jbc.M305828200; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, J BIOL CHEM, V279, P20921, DOI 10.1074/jbc.M400898200; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Navadgi-Patil VM, 2011, BIOCHEM SOC T, V39, P600, DOI 10.1042/BST0390600; Paschall CO, 2011, J BIOL CHEM, V286, P42704, DOI 10.1074/jbc.M111.268169; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	32	26	28	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2203	2209		10.1074/jbc.C111.318899	http://dx.doi.org/10.1074/jbc.C111.318899			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22115746	hybrid, Green Published			2022-12-25	WOS:000299321000059
J	Wooldridge, L; Ekeruche-Makinde, J; van den Berg, HA; Skowera, A; Miles, JJ; Tan, MP; Dolton, G; Clement, M; Llewellyn-Lacey, S; Price, DA; Peakman, M; Sewell, AK				Wooldridge, Linda; Ekeruche-Makinde, Julia; van den Berg, Hugo A.; Skowera, Anna; Miles, John J.; Tan, Mai Ping; Dolton, Garry; Clement, Mathew; Llewellyn-Lacey, Sian; Price, David A.; Peakman, Mark; Sewell, Andrew K.			A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; CROSS-REACTIVITY; MOLECULAR MIMICRY; ALLORECOGNITION; ALLOREACTIVITY; SPECIFICITY; REPERTOIRE; ACTIVATION; LIGANDS	The T cell receptor (TCR) orchestrates immune responses by binding to foreign peptides presented at the cell surface in the context of major histocompatibility complex (MHC) molecules. Effective immunity requires that all possible foreign peptide MHC molecules are recognized or risks leaving holes in immune coverage that pathogens could quickly evolve to exploit. It is unclear how a limited pool of <10(8) human TCRs can successfully provide immunity to the vast array of possible different peptides that could be produced from 20 proteogenic amino acids and presented by self-MHC molecules (>10(15) distinct peptide-MHCs). One possibility is that T cell immunity incorporates an extremely high level of receptor degeneracy, enabling each TCR to recognize multiple peptides. However, the extent of such TCR degeneracy has never been fully quantified. Here, we perform a comprehensive experimental and mathematical analysis to reveal that a single patient-derived autoimmune CD8(+) T cell clone of pathogenic relevance in human type I diabetes recognizes >one million distinct decamer peptides in the context of a single MHC class I molecule. A large number of peptides that acted as substantially better agonists than the wild-type "index" preproinsulin-derived peptide (ALWGPDPAAA) were identified. The RQFGPDFPTI peptide (sampled from >10(8) peptides) was >100-fold more potent than the index peptide despite differing from this sequence at 7 of 10 positions. Quantification of this previously unappreciated high level of CD8(+) T cell cross-reactivity represents an important step toward understanding the system requirements for adaptive immunity and highlights the enormous potential of TCR degeneracy to be the causative factor in autoimmune disease.	[Wooldridge, Linda; Ekeruche-Makinde, Julia; Miles, John J.; Tan, Mai Ping; Dolton, Garry; Clement, Mathew; Llewellyn-Lacey, Sian; Price, David A.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [van den Berg, Hugo A.] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Skowera, Anna; Peakman, Mark] Kings Coll London, Dept Immunobiol, London SE1 9RT, England; [Skowera, Anna; Peakman, Mark] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London SE1 9RT, England	Cardiff University; University of Warwick; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	sewellak@cardiff.ac.uk	Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022; Price, David A/C-7876-2013	Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Price, David A/0000-0001-9416-2737; Peakman, Mark/0000-0003-3328-3513; Wooldridge, Linda/0000-0002-6213-347X; Makinde, Julia/0000-0002-9906-7437; van den Berg, Hugo/0000-0002-8230-6227	Biotechnology and Biological Sciences Research Council [BB/H001085/1]; United Kingdom Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Wellcome Trust [WT079848MA]; Juvenile Diabetes Research Foundation [7-2005-877, 1-2007-1803, 17-2009-806]; Welsh Office of Research and Development; BBSRC [BB/H001085/1] Funding Source: UKRI; MRC [G0501963] Funding Source: UKRI; Medical Research Council [G0501963, MR/J006742/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Welsh Office of Research and Development; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council Grant BB/H001085/1 and the United Kingdom Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London (to A. S. and M. P.).; Supported by Wellcome Trust Clinical Intermediate Fellow Grant WT079848MA.; Supported by Juvenile Diabetes Research Foundation Grants 7-2005-877, 1-2007-1803, or 17-2009-806.; Supported by a Welsh Office of Research and Development translational fellowship.	Archbold JK, 2008, MOL IMMUNOL, V45, P583, DOI 10.1016/j.molimm.2006.05.018; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BHARDWAJ V, 1993, J IMMUNOL, V151, P5000; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hiemstra HS, 2000, CURR OPIN IMMUNOL, V12, P80, DOI 10.1016/S0952-7915(99)00054-0; Ishizuka J, 2009, J IMMUNOL, V183, P4337, DOI 10.4049/jimmunol.0901607; Kan-Mitchell J, 2006, J IMMUNOL, V176, P6690, DOI 10.4049/jimmunol.176.11.6690; Karlin S., 1974, 1 COURSE STOCHASTIC, P495; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kissler S, 2002, J AUTOIMMUN, V19, P183, DOI 10.1006/jaut.2002.0614; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nino-Vasquez JJ, 2004, MOL IMMUNOL, V40, P1063, DOI 10.1016/j.molimm.2003.11.005; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Van Den Berg HA, 2001, J THEOR BIOL, V209, P465, DOI 10.1006/jtbi.2001.2281; van den Berg HA, 2007, IMMUNOL REV, V216, P81; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; WRAITH DC, 1992, J IMMUNOL, V149, P3765; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8	33	269	278	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1168	1177		10.1074/jbc.M111.289488	http://dx.doi.org/10.1074/jbc.M111.289488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102287	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000299170300032
J	Lujan, AM; Macia, MD; Yang, L; Molin, S; Oliver, A; Smania, AM				Lujan, Adela M.; Macia, Maria D.; Yang, Liang; Molin, Soren; Oliver, Antonio; Smania, Andrea M.			Evolution and Adaptation in Pseudomonas aeruginosa Biofilms Driven by Mismatch Repair System-Deficient Mutators	PLOS ONE			English	Article							CHRONIC PULMONARY INFECTION; CYSTIC-FIBROSIS PATIENTS; SMALL-COLONY VARIANTS; HIGH MUTATION-RATES; GENETIC ADAPTATION; MUCOID CONVERSION; PHYSIOLOGICAL HETEROGENEITY; EXPERIMENTAL POPULATIONS; RESISTANCE DEVELOPMENT; ANTIBIOTIC-RESISTANCE	Pseudomonas aeruginosa is an important opportunistic pathogen causing chronic airway infections, especially in cystic fibrosis (CF) patients. The majority of the CF patients acquire P. aeruginosa during early childhood, and most of them develop chronic infections resulting in severe lung disease, which are rarely eradicated despite intensive antibiotic therapy. Current knowledge indicates that three major adaptive strategies, biofilm development, phenotypic diversification, and mutator phenotypes [driven by a defective mismatch repair system (MRS)], play important roles in P. aeruginosa chronic infections, but the relationship between these strategies is still poorly understood. We have used the flow-cell biofilm model system to investigate the impact of the mutS associated mutator phenotype on development, dynamics, diversification and adaptation of P. aeruginosa biofilms. Through competition experiments we demonstrate for the first time that P. aeruginosa MRS-deficient mutators had enhanced adaptability over wild-type strains when grown in structured biofilms but not as planktonic cells. This advantage was associated with enhanced micro-colony development and increased rates of phenotypic diversification, evidenced by biofilm architecture features and by a wider range and proportion of morphotypic colony variants, respectively. Additionally, morphotypic variants generated in mutator biofilms showed increased competitiveness, providing further evidence for mutator-driven adaptive evolution in the biofilm mode of growth. This work helps to understand the basis for the specific high proportion and role of mutators in chronic infections, where P. aeruginosa develops in biofilm communities.	[Lujan, Adela M.; Smania, Andrea M.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Macia, Maria D.; Oliver, Antonio] Hosp Son Espases, Inst Univ Invest Ciencias Salud IUNICS, Microbiol Serv, Palma De Mallorca, Spain; [Macia, Maria D.; Oliver, Antonio] Hosp Son Espases, Inst Univ Invest Ciencias Salud IUNICS, Unidad Invest, Palma De Mallorca, Spain; [Yang, Liang; Molin, Soren] Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Hospital Universitari Son Espases; Universitat de les Illes Balears; Hospital Universitari Son Espases; Universitat de les Illes Balears; Technical University of Denmark	Lujan, AM (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	antonio.oliver@ssib.es; asmania@mail.fcq.unc.edu.ar	Oliver, Antonio/E-4048-2012; Smania, Andrea/AAG-1105-2022; Yang, Liang/C-8487-2011; Lujan, Adela M/K-6707-2015; Oliver, Antonio/V-5541-2019; Smania, Andrea/AFK-2800-2022	Oliver, Antonio/0000-0001-9327-1894; Yang, Liang/0000-0002-2362-0128; Oliver, Antonio/0000-0001-9327-1894; Lujan, Adela Maria/0000-0002-0365-6828; Molin, Soren/0000-0002-7973-2639; Smania, Andrea/0000-0002-6527-7719; Macia, Maria Dolores/0000-0001-5038-1356	Agencia Nacional de Promocion Cientifica y Tecnoloogica (ANPCYT) [PICT-2007-00687]; Secretaria de Ciencia y Tecnica (SECYT-UNC) [05/C486]; REIPI [C03/14, RD06/0008, PS09/00033]	Agencia Nacional de Promocion Cientifica y Tecnoloogica (ANPCYT)(ANPCyT); Secretaria de Ciencia y Tecnica (SECYT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); REIPI	Agencia Nacional de Promocion Cientifica y Tecnoloogica (ANPCYT) Grant PICT-2007-00687 (http://www.agencia.gov.ar/), and Secretaria de Ciencia y Tecnica (SECYT-UNC) Grant 05/C486 (http://www.secyt.unc.edu.ar/). Ministerio de Ciencia e Innovacion of Spain and the Instituto de Salud Carlos III, through the Spanish Network for the Research in Infectious Diseases. Grants REIPI C03/14, RD06/0008 and PS09/00033 (http://www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Feliziani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012669; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Funchain P, 2001, J BACTERIOL, V183, P3737, DOI 10.1128/JB.183.12.3737-3741.2001; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Gutierrez O, 2004, ANTIMICROB AGENTS CH, V48, P3573, DOI 10.1128/AAC.48.9.3573-3575.2004; Hansen SK, 2007, J BACTERIOL, V189, P4932, DOI 10.1128/JB.00041-07; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; HARRISON F, PLOS ONE, V6; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Koh KS, 2007, J BACTERIOL, V189, P119, DOI 10.1128/JB.00930-06; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lujan AM, 2007, MICROBIOL-SGM, V153, P225, DOI 10.1099/mic.0.29021-0; Macia MD, 2011, ANTIMICROB AGENTS CH, V55, P5230, DOI 10.1128/AAC.00617-11; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Meier P, 2005, J BACTERIOL, V187, P143, DOI 10.1128/JB.187.1.143-154.2005; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Moyano AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008203; Mulet X, 2009, ANTIMICROB AGENTS CH, V53, P1552, DOI 10.1128/AAC.01264-08; NAGAKI M, 1992, CHEST, V102, P1464, DOI 10.1378/chest.102.5.1464; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Pezza RJ, 2002, BIOCHEM J, V361, P87, DOI 10.1042/0264-6021:3610087; Plasencia V, 2007, ANTIMICROB AGENTS CH, V51, P2574, DOI 10.1128/AAC.00174-07; Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0; RACEY A, EVOLUTION, V64, P515; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Smania AM, 2004, MICROBIOL-SGM, V150, P1327, DOI 10.1099/mic.0.26751-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Spiers AJ, 2002, GENETICS, V161, P33; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Valle J, 2007, J BACTERIOL, V189, P2886, DOI 10.1128/JB.01767-06; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	76	39	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27842	10.1371/journal.pone.0027842	http://dx.doi.org/10.1371/journal.pone.0027842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114708	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800040
J	Jakubik, J; Janickova, H; Randakova, A; El-Fakahany, EE; Dolezal, V				Jakubik, Jan; Janickova, Helena; Randakova, Alena; El-Fakahany, Esam E.; Dolezal, Vladimir			Subtype Differences in Pre-Coupling of Muscarinic Acetylcholine Receptors	PLOS ONE			English	Article							G-PROTEIN ACTIVATION; BINDING-PROPERTIES; AGONIST EFFICACY; M-2 RECEPTORS; LIVING CELLS; KINETICS; STATE; G(S)	Based on the kinetics of interaction between a receptor and G-protein, a myriad of possibilities may result. Two extreme cases are represented by: 1/Collision coupling, where an agonist binds to the free receptor and then the agonist-receptor complex "collides'' with the free G-protein. 2/Pre-coupling, where stable receptor/G-protein complexes exist in the absence of agonist. Pre-coupling plays an important role in the kinetics of signal transduction. Odd-numbered muscarinic acetylcholine receptors preferentially couple to G(q/11), while even-numbered receptors prefer coupling to G(i/o). We analyzed the coupling status of the various subtypes of muscarinic receptors with preferential and non-preferential G-proteins. The magnitude of receptor-G-protein coupling was determined by the proportion of receptors existing in the agonist high-affinity binding conformation. Antibodies directed against the C-terminus of the alpha-subunits of the individual G-proteins were used to interfere with receptor-G-protein coupling. Effects of mutations and expression level on receptor-G-protein coupling were also investigated. Tested agonists displayed biphasic competition curves with the antagonist [(3)H]-N-methylscopolamine. Antibodies directed against the C-terminus of the alpha-subunits of the preferential G-protein decreased the proportion of high-affinity sites, and mutations at the receptor-G-protein interface abolished agonist high-affinity binding. In contrast, mutations that prevent receptor activation had no effect. Expression level of preferential G-proteins had no effect on pre-coupling to non-preferential G-proteins. Our data show that all subtypes of muscarinic receptors pre-couple with their preferential classes of G-proteins, but only M(1) and M(3) receptors also pre-couple with non-preferential G(i/o) G-proteins. Pre-coupling is not dependent on agonist efficacy nor on receptor activation. The ultimate mode of coupling is therefore dictated by a combination of the receptor subtype and the class of G-protein.	[Jakubik, Jan; Janickova, Helena; Randakova, Alena; Dolezal, Vladimir] Acad Sci Czech Republic, Inst Physiol, Dept Neurochem, Vvi, Prague, Czech Republic; [El-Fakahany, Esam E.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Jakubik, J (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Neurochem, Vvi, Prague, Czech Republic.	jakubik@biomed.cas.cz	Janickova, Helena/Q-7211-2017; Janickova, Helena/G-7748-2014; Jakubik, Jan/B-7461-2012; Dolezal, Vladimir/A-8732-2008; Randáková, Alena/K-3445-2017	Janickova, Helena/0000-0003-0310-7893; Jakubik, Jan/0000-0002-1737-1487; Dolezal, Vladimir/0000-0003-3412-256X; Randáková, Alena/0000-0002-8403-6494	Academy of Sciences of the Czech Republic [AV0Z 50110509]; Grant Agency of the Czech Republic [305/09/0681]; Grant Agency of the Czech Academy of Sciences [IAA500110703]; Ministry of Education, Youth and Sports of the Czech Republic [LC554]; National Institutes of Health [NS25743]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025743] Funding Source: NIH RePORTER	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Academy of Sciences of the Czech Republic [Project AV0Z 50110509], the Grant Agency of the Czech Republic [Grant 305/09/0681], the Grant Agency of the Czech Academy of Sciences [Grant IAA500110703], the Ministry of Education, Youth and Sports of the Czech Republic [Grant LC554], and National Institutes of Health [Grant NS25743]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Jakubik J, 1996, P NATL ACAD SCI USA, V93, P8705, DOI 10.1073/pnas.93.16.8705; Jakubik J, 2011, BRIT J PHARMACOL, V162, P1029, DOI 10.1111/j.1476-5381.2010.01081.x; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Kukkonen JP, 2001, TRENDS PHARMACOL SCI, V22, P616, DOI 10.1016/S0165-6147(00)01864-2; Lachance M, 1999, CELL SIGNAL, V11, P523, DOI 10.1016/S0898-6568(99)00024-8; Michal P, 2007, J PHARMACOL EXP THER, V320, P607, DOI 10.1124/jpet.106.114314; Michal P, 2009, EUR J PHARMACOL, V606, P50, DOI 10.1016/j.ejphar.2009.01.028; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; OKUMA Y, 1992, J BIOL CHEM, V267, P14826; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Sykes DA, 2009, MOL PHARMACOL, V76, P543, DOI 10.1124/mol.108.054452; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27732	10.1371/journal.pone.0027732	http://dx.doi.org/10.1371/journal.pone.0027732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110745	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400100
J	Mainguy, V; Provencher, S; Maltais, F; Malenfant, S; Saey, D				Mainguy, Vincent; Provencher, Steeve; Maltais, Francois; Malenfant, Simon; Saey, Didier			Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							6-MINUTE WALK TEST; QUALITY-OF-LIFE; MUSCLE DYSFUNCTION; EXERCISE; SURVIVAL; COPD	Background: In pulmonary arterial hypertension (PAH), the six-minute walk test (6MWT) is believed to be representative of patient's daily life physical activities (DLPA). Whether DLPA are decreased in PAH and whether the 6MWT is representative of patient's DLPA remain unknown. Methods: 15 patients with idiopathic PAH (IPAH) and 10 patients with PAH associated with limited systemic sclerosis (PAH-SSc) were matched with 15 healthy control subjects and 10 patients with limited systemic sclerosis without PAH. Each subject completed a 6MWT. The mean number of daily steps and the mean energy expenditure and duration of physical activities >3 METs were assessed with a physical activity monitor for seven consecutive days and used as markers of DLPA. Results: The mean number of daily steps and the mean daily energy expenditure and duration of physical activities >3 METs were all reduced in PAH patients compared to their controls (all p<0.05). The mean number of daily steps correlated with the 6MWT distance for both IPAH and PAH-SSc patients (r = 0.76, p<0.01 and r = 0.85, p<0.01), respectively. Conclusion: DLPA are decreased in PAH and correlate with the 6MWT distance. Functional exercise capacity may thus be a useful surrogate of DLPA in PAH.	[Mainguy, Vincent; Provencher, Steeve; Maltais, Francois; Malenfant, Simon; Saey, Didier] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Mainguy, V (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Didier.Saey@rea.ulaval.ca	Malenfant, Simon/AAQ-5587-2020; Saey, Didier/F-7963-2014	Malenfant, Simon/0000-0002-3911-3702	Reseau en Sante Respiratoire du Fonds de Recherche en Sante du Quebec; Groupe de Recherche en Sante Respiratoire de l'Universite Laval (GESER)	Reseau en Sante Respiratoire du Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Groupe de Recherche en Sante Respiratoire de l'Universite Laval (GESER)	This project was supported by the Reseau en Sante Respiratoire du Fonds de Recherche en Sante du Quebec and the Groupe de Recherche en Sante Respiratoire de l'Universite Laval (GESER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer R, 2007, RESP MED, V101, P2366, DOI 10.1016/j.rmed.2007.06.014; Chemla D, 2002, EUR RESPIR J, V20, P1314, DOI 10.1183/09031936.02.00068002; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Man FS, 2009, EUR RESPIR J, V34, P669, DOI 10.1183/09031936.00027909; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; Langer D, 2009, J HEART LUNG TRANSPL, V28, P572, DOI 10.1016/j.healun.2009.03.007; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; LIGHT RW, 1985, CHEST, V87, P35, DOI 10.1378/chest.87.1.35; Mainguy V, 2010, J CARDIOPULM REHABIL, V30, P319, DOI 10.1097/HCR.0b013e3181d6f962; Mainguy V, 2010, THORAX, V65, P113, DOI 10.1136/thx.2009.117168; McKenna S, 2006, QUAL LIFE RES, V15, P103, DOI 10.1007/s11136-005-3513-4; McLaughlin VV, 2009, J AM COLL CARDIOL, V54, pS97, DOI 10.1016/j.jacc.2009.04.007; McLaughlin VV, 2009, CIRCULATION; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Patel Sanjay A, 2007, COPD, V4, P107, DOI 10.1080/15412550701246658; Pitta F, 2006, EUR RESPIR J, V27, P1040, DOI 10.1183/09031936.06.00064105; Provencher S, 2006, EUR RESPIR J, V27, P114, DOI 10.1183/09031936.06.00042705; Provencher S, 2006, EUR RESPIR J, V28, P1073, DOI 10.1183/09031936.00120506; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Steele BG, 2000, CHEST, V117, P1359, DOI 10.1378/chest.117.5.1359; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; WEAVER TE, 1992, NURS RES, V41, P286; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A	34	65	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27993	10.1371/journal.pone.0027993	http://dx.doi.org/10.1371/journal.pone.0027993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110770	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400144
J	Pereira, CS; Teixeira, J; Figueiredo, P; Xavier, J; Castro, SL; Brattico, E				Pereira, Carlos Silva; Teixeira, Joao; Figueiredo, Patricia; Xavier, Joao; Castro, Sao Luis; Brattico, Elvira			Music and Emotions in the Brain: Familiarity Matters	PLOS ONE			English	Article							NEURAL BASIS; TIME-COURSE; RESPONSES; ROBUST; HAPPY; SAD; OPTIMIZATION; REGISTRATION; ANTICIPATION; RECOGNITION	The importance of music in our daily life has given rise to an increased number of studies addressing the brain regions involved in its appreciation. Some of these studies controlled only for the familiarity of the stimuli, while others relied on pleasantness ratings, and others still on musical preferences. With a listening test and a functional magnetic resonance imaging (fMRI) experiment, we wished to clarify the role of familiarity in the brain correlates of music appreciation by controlling, in the same study, for both familiarity and musical preferences. First, we conducted a listening test, in which participants rated the familiarity and liking of song excerpts from the pop/rock repertoire, allowing us to select a personalized set of stimuli per subject. Then, we used a passive listening paradigm in fMRI to study music appreciation in a naturalistic condition with increased ecological value. Brain activation data revealed that broad emotion-related limbic and paralimbic regions as well as the reward circuitry were significantly more active for familiar relative to unfamiliar music. Smaller regions in the cingulate cortex and frontal lobe, including the motor cortex and Broca's area, were found to be more active in response to liked music when compared to disliked one. Hence, familiarity seems to be a crucial factor in making the listeners emotionally engaged with music, as revealed by fMRI data.	[Pereira, Carlos Silva] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, P-4100 Oporto, Portugal; [Teixeira, Joao; Xavier, Joao] Hosp Geral Santo Antonio, Dept Neuroradiol, Oporto, Portugal; [Figueiredo, Patricia] Inst Super Tecn, Lisbon & Bioengn Dept, Inst Syst & Robot, Lisbon, Portugal; [Castro, Sao Luis] Univ Porto, Fac Psychol & Educ Sci, P-4100 Oporto, Portugal; [Brattico, Elvira] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Brattico, Elvira] Univ Jyvaskyla, Ctr Excellence Interdisciplinary Mus Res, Jyvaskyla, Finland	Universidade do Porto; Universidade de Coimbra; Universidade de Lisboa; Instituto Superior Tecnico; Universidade do Porto; University of Helsinki; University of Jyvaskyla	Pereira, CS (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cb10014@icbas.up.pt	Figueiredo, Patricia/A-1194-2013; Castro, Sao Luis/E-5518-2017; Brattico, Elvira/M-1455-2019	Figueiredo, Patricia/0000-0002-0743-0869; Castro, Sao Luis/0000-0002-1487-3596; Brattico, Elvira/0000-0003-0676-6464	Portuguese Ministry of Science, Technology and Higher Education [SFRH/BD/27414/2006]; Academy of Finland [1133673]; University of Helsinki	Portuguese Ministry of Science, Technology and Higher Education(Portuguese Foundation for Science and Technology); Academy of Finland(Academy of Finland); University of Helsinki	The following institutions contributed to the financing of this study: the Portuguese Foundation for Science and Technology (FCT) from the Portuguese Ministry of Science, Technology and Higher Education (http://alfa.fct.mctes.pt/index.phtml.en), which contributed to the doctoral fellowship (reference SFRH/BD/27414/2006) attributed to CSP, the Academy of Finland (http://www.aka.fi/eng) (project number 1133673), and University of Helsinki (http://www.helsinki.fi/university/), which contributed financial support to the CSP and EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachorik JP, 2009, MUSIC PERCEPT, V26, P355, DOI 10.1525/MP.2009.26.4.355; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Berns GS, 2010, NEUROIMAGE, V49, P2687, DOI 10.1016/j.neuroimage.2009.10.070; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BRATTICO E, PSYCHOL AES IN PRESS; Brattico E, 2006, BRAIN RES, V1117, P162, DOI 10.1016/j.brainres.2006.08.023; Brattico E, 2009, ANN NY ACAD SCI, V1169, P308, DOI 10.1111/j.1749-6632.2009.04843.x; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Dalla Bella S, 2001, COGNITION, V80, pB1, DOI 10.1016/S0010-0277(00)00136-0; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Ekman P., 1999, HDB COGNITION EMOTIO, P45, DOI [10.1017/S0140525X0800349X, DOI 10.1002/0470013494.CH3, 10.1002/0470013494.ch3]; Gabrielsson A., 2010, HDB MUSIC EMOTION TH, P547; Griffiths TD, 2001, ANN NY ACAD SCI, V930, P133, DOI 10.1111/j.1749-6632.2001.tb05729.x; Halpern AR, 2001, ANN NY ACAD SCI, V930, P179, DOI 10.1111/j.1749-6632.2001.tb05733.x; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Huron D., 2010, HDB MUSIC EMOTION TH, P575, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0021; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Janata P, 2009, CEREB CORTEX, V19, P2579, DOI 10.1093/cercor/bhp008; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Juslin P.N., 2010, SERIES AFFECTIVE SCI, P605, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0022; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Kirk U, 2009, BRAIN COGNITION, V69, P306, DOI 10.1016/j.bandc.2008.08.004; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Leaver AM, 2009, J NEUROSCI, V29, P2477, DOI 10.1523/JNEUROSCI.4921-08.2009; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer M, 1903, AM J PSYCHOL, V14, P456; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Peretz I, 1998, MEM COGNITION, V26, P884, DOI 10.3758/BF03201171; Peretz I., 2010, HDB MUSIC EMOTION TH, P99, DOI [DOI 10.1093/ACPROF:OSO/9780199230143.003.0005, DOI 10.1093/ACPROF:OSO/9780199230143.001.0001]; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Plailly J, 2007, CEREB CORTEX, V17, P2650, DOI 10.1093/cercor/bhl173; Rauschecker JP, 2011, HEARING RES, V271, P16, DOI 10.1016/j.heares.2010.09.001; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Samson F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00241; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Satoh M, 2006, AM J NEURORADIOL, V27, P1101; Schellenberg EG, 2008, COGNITION EMOTION, V22, P218, DOI 10.1080/02699930701350753; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; SLOBODA J. A., 2010, HDB MUSIC EMOTION TH, P493, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0018; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zysset S, 2003, NEUROSCI LETT, V335, P183, DOI 10.1016/S0304-3940(02)01196-5; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	60	171	179	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27241	10.1371/journal.pone.0027241	http://dx.doi.org/10.1371/journal.pone.0027241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	855HV	22110619	Green Published, gold			2022-12-25	WOS:000297555400029
J	Kaluzhny, D; Ilyinsky, N; Shchekotikhin, A; Sinkevich, Y; Tsvetkov, PO; Tsvetkov, V; Veselovsky, A; Livshits, M; Borisova, O; Shtil, A; Shchyolkina, A				Kaluzhny, Dmitry; Ilyinsky, Nikolay; Shchekotikhin, Andrei; Sinkevich, Yuri; Tsvetkov, Philipp O.; Tsvetkov, Vladimir; Veselovsky, Alexander; Livshits, Mikhail; Borisova, Olga; Shtil, Alexander; Shchyolkina, Anna			Disordering of Human Telomeric G-Quadruplex with Novel Antiproliferative Anthrathiophenedione	PLOS ONE			English	Article							DNA; INHIBITION; ANTHRACENE-9,10-DIONES; BINDING; AGENTS	Linear heteroareneanthracenediones have been shown to interfere with DNA functions, thereby causing death of human tumor cells and their drug resistant counterparts. Here we report the interaction of our novel antiproliferative agent 4,11-bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione with telomeric DNA structures studied by isothermal titration calorimetry, circular dichroism and UV absorption spectroscopy. New compound demonstrated a high affinity (K-ass similar to 10(6) M-1) for human telomeric antiparallel quadruplex d(TTAGGG)(4) and duplex d(TTAGGG)(4):d(CCCTAA)(4). Importantly, a similar to 100-fold higher affinity was determined for the ligand binding to an unordered oligonucleotide d(TTAGGG TTAGAG TTAGGG TTAGGG unable to form quadruplex structures. Moreover, in the presence of Na+ the compound caused dramatic conformational perturbation of the telomeric G-quadruplex, namely, almost complete disordering of G-quartets. Disorganization of a portion of G-quartets in the presence of K+ was also detected. Molecular dynamics simulations were performed to illustrate how the binding of one molecule of the ligand might disrupt the G-quartet adjacent to the diagonal loop of telomeric G-quadruplex. Our results provide evidence for a non-trivial mode of alteration of G-quadruplex structure by tentative antiproliferative drugs.	[Kaluzhny, Dmitry; Tsvetkov, Philipp O.; Livshits, Mikhail; Borisova, Olga; Shchyolkina, Anna] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia; [Ilyinsky, Nikolay] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Shchekotikhin, Andrei] Russian Acad Med Sci, Gause Inst New Antibiot, Moscow, Russia; [Sinkevich, Yuri] Mendeleyev Univ Chem Technol, Moscow, Russia; [Tsvetkov, Vladimir; Veselovsky, Alexander] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow, Russia; [Shtil, Alexander] Russian Acad Med Sci, Blokhin Canc Ctr, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Moscow Institute of Physics & Technology; Russian Academy of Medical Sciences; Russian Academy of Sciences; Gause Institute of New Antibiotics; Mendeleev University of Chemical Technology of Russia; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Kaluzhny, D (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia.	uzhny@mail.ru	Veselovsky, Alexander V./I-3556-2012; Shtil, Alexander A./K-1568-2017; Livshits, Mikhail/P-6744-2015; Shchekotikhin, Andrey/K-6082-2015; Tsvetkov, Vladimir B/L-9399-2013; Ilyinsky, Nikolay S/G-5402-2012; Shchyolkina, Anna/AAB-8268-2021; Kaluzhny, Dmitry N/G-7256-2014	Veselovsky, Alexander V./0000-0001-6362-7757; Shtil, Alexander A./0000-0001-6469-0221; Livshits, Mikhail/0000-0001-8027-2273; Tsvetkov, Vladimir B/0000-0003-0494-3332; Ilyinsky, Nikolay/0000-0002-8812-5849; Kaluzhny, Dmitry/0000-0001-7090-3334; Shchekotikhin, Andrey/0000-0002-6595-0811	Russian Foundation for Basic Research [11-04-00385-a]; Russian Academy of Science	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Science(Russian Academy of Sciences)	This study was supported by the Russian Foundation for Basic Research (grant 11-04-00385-a) and the Molecular and Cellular Biology Program of the Russian Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBANDJE M, 1992, J MED CHEM, V35, P1418, DOI 10.1021/jm00086a010; Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chaires JB, 2010, FEBS J, V277, P1098, DOI 10.1111/j.1742-4658.2009.07462.x; Fornier MN, 2011, SEMIN ONCOL, V38, pS3, DOI 10.1053/j.seminoncol.2011.04.003; FOX KR, 1995, P NATL ACAD SCI USA, V92, P7887, DOI 10.1073/pnas.92.17.7887; Gray DM, 2008, CHIRALITY, V20, P431, DOI 10.1002/chir.20455; Gray RD, 2008, NUCLEIC ACIDS RES, V36, P4191, DOI 10.1093/nar/gkn379; Hajihassan Z, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-31; Haq I, 1996, J AM CHEM SOC, V118, P10693, DOI 10.1021/ja961907t; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Jiang WL, 2011, BIOANALYSIS, V3, P333, DOI [10.4155/bio.10.204, 10.4155/BIO.10.204]; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; NOVAK RF, 1988, BIOACTIVE MOL; Ofran Y, 2011, CURR OPIN HEMATOL, V18, P83, DOI 10.1097/MOH.0b013e32834399d9; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; PANOUSIS C, 1994, NUCLEIC ACIDS RES, V22, P1342, DOI 10.1093/nar/22.8.1342; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Perry PJ, 1998, J MED CHEM, V41, P3253, DOI 10.1021/jm9801105; Perry PJ, 1998, J MED CHEM, V41, P4873, DOI 10.1021/jm981067o; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Shchekotikhin AE, 2009, BIOORGAN MED CHEM, V17, P1861, DOI 10.1016/j.bmc.2009.01.047; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Tomasko M, 2009, BIOCHIMIE, V91, P171, DOI 10.1016/j.biochi.2008.07.012; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0	30	34	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27151	10.1371/journal.pone.0027151	http://dx.doi.org/10.1371/journal.pone.0027151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22102877	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555300010
J	Garbe, Y; Maletzki, C; Linnebacher, M				Garbe, Yvette; Maletzki, Claudia; Linnebacher, Michael			An MSI Tumor Specific Frameshift Mutation in a Coding Microsatellite of MSH3 Encodes for HLA-A0201-Restricted CD8(+) Cytotoxic T Cell Epitopes	PLOS ONE			English	Article							COLORECTAL-CANCER; INFILTRATING LYMPHOCYTES; INSTABILITY; IDENTIFICATION; RII	Background: Microsatellite instability (MSI) resulting from inactivation of the DNA mismatch repair system (MMR) characterizes a highly immunological subtype of colorectal carcinomas. Those tumors express multiple frameshift-mutated proteins which present a unique pool of tumor-specific antigens. The DNA MMR protein MSH3 is frequently mutated in MSI+ colorectal tumors, thus making it an attractive candidate for T cell-based immunotherapies. Methodology/Principal Findings: FSP-specific CD8(+) T cells were generated from a healthy donor using reverse immunology. Those T cells specifically recognized T2 cells sensitized with the respective peptides. Specific recognition and killing of MSI+ colorectal carcinoma cells harbouring the mutated reading frame was observed. The results obtained with T cell bulk cultures could be reproduced with T cell clones obtained from the same cultures. Blocking experiments (using antibodies and cold target inhibition) confirmed peptide as well as HLA-A0201-specificity. Conclusions: We identified two novel HLA-A0201-restricted cytotoxic T cell epitopes derived from a (-1) frameshift mutation of a coding A(8) tract within the MSH3 gene. These were (386)-FLLALWECSL (FSP18) and (387)-LLALWECSL (FSP19) as well as (403)-IVSRTLLLV (FSP23) and (402)-LIVSRTLLLV (FSP31), respectively. These results suggest that MSH3(-1) represents another promising MSI+-induced target antigen. By identifying two distinct epitopes within MSH3(-1), the sustained immunogenicity of the frameshift mutated sequence was confirmed. Our data therefore encourage further exploitation of MSH3 as a piece for peptide-based vaccines either for therapeutic or -even more important- preventive purposes.	[Garbe, Yvette] Natl Ctr Radiat Res Oncol, Dresden, Germany; [Maletzki, Claudia; Linnebacher, Michael] Univ Rostock, Div Mol Oncol & Immunotherapy, Dept Gen Surg, Rostock, Germany	Technische Universitat Dresden; University of Rostock	Garbe, Y (corresponding author), Natl Ctr Radiat Res Oncol, Dresden, Germany.	michael.linnebacher@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402				Damia G, 2010, CURR DRUG TARGETS, V11, P1317, DOI 10.2174/1389450111007011317; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Drescher KM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/170432; Duraturo F, 2011, INT J CANCER, V129, P1643, DOI 10.1002/ijc.25824; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Linnebacher M, 2001, INT J CANCER, V93, P6, DOI 10.1002/ijc.1298; Linnebacher M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/841451; Meijer TWH, 2009, HISTOPATHOLOGY, V55, P414, DOI 10.1111/j.1365-2559.2009.03403.x; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Reuschenbach M, 2010, FAM CANCER, V9, P173, DOI 10.1007/s10689-009-9307-z; Ripberger E, 2003, J CLIN IMMUNOL, V23, P415, DOI 10.1023/A:1025329819121; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Saeterdal I, 2001, CANCER IMMUNOL IMMUN, V50, P469, DOI 10.1007/s002620100222; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Schwitalle Yvette, 2004, Cancer Immun, V4, P14; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Tougeron D, 2009, MODERN PATHOL, V22, P1186, DOI 10.1038/modpathol.2009.80; Williams DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016012; Woerner SM, 2001, INT J CANCER, V93, P12, DOI 10.1002/ijc.1299; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303	22	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e26517	10.1371/journal.pone.0026517	http://dx.doi.org/10.1371/journal.pone.0026517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110587	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300006
J	Xu, L; Pallikkuth, S; Hou, ZJ; Mignery, GA; Robia, SL; Han, RZ				Xu, Li; Pallikkuth, Sandeep; Hou, Zhanjia; Mignery, Gregory A.; Robia, Seth L.; Han, Renzhi			Dysferlin Forms a Dimer Mediated by the C2 Domains and the Transmembrane Domain In Vitro and in Living Cells	PLOS ONE			English	Article							FLUORESCENCE FLUCTUATION SPECTROSCOPY; DEFICIENT MUSCULAR-DYSTROPHY; RESONANCE ENERGY-TRANSFER; MEMBRANE REPAIR; PHOSPHOLAMBAN OLIGOMERIZATION; REGULATORY COMPLEX; PLASMA-MEMBRANE; PROTEIN; OTOFERLIN; MUTATION	Dysferlin was previously identified as a key player in muscle membrane repair and its deficiency leads to the development of muscular dystrophy and cardiomyopathy. However, little is known about the oligomerization of this protein in the plasma membrane. Here we report for the first time that dysferlin forms a dimer in vitro and in living adult skeletal muscle fibers isolated from mice. Endogenous dysferlin from rabbit skeletal muscle exists primarily as a similar to 460 kDa species in detergent-solubilized muscle homogenate, as shown by sucrose gradient fractionation, gel filtration and cross-linking assays. Fluorescent protein (YFP) labeled human dysferlin forms a dimer in vitro, as demonstrated by fluorescence correlation spectroscopy (FCS) and photon counting histogram (PCH) analyses. Dysferlin also dimerizes in living cells, as probed by fluorescence resonance energy transfer (FRET). Domain mapping FRET experiments showed that dysferlin dimerization is mediated by its transmembrane domain and by multiple C2 domains. However, C2A did not significantly contribute to dimerization; notably, this is the only C2 domain in dysferlin known to engage in a Ca-dependent interaction with cell membranes. Taken together, the data suggest that Ca-insensitive C2 domains mediate high affinity self-association of dysferlin in a parallel homodimer, leaving the Ca-sensitive C2A domain free to interact with membranes.	[Xu, Li; Pallikkuth, Sandeep; Hou, Zhanjia; Mignery, Gregory A.; Robia, Seth L.; Han, Renzhi] Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Med Ctr, Maywood, IL 60153 USA	Loyola University Chicago	Xu, L (corresponding author), Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.	renhan@lumc.edu	xu, li/M-1661-2015	Han, Renzhi/0000-0002-8202-9186	American Heart Association [10SDG4140138]; Muscular Dystrophy Association [MDA171667]; National Institute of Health [HL092321, EB006061]; McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research support was provided by the American Heart Association Scientist Development Award 10SDG4140138 (to RH), Muscular Dystrophy Association research grant MDA171667 (to RH), National Institute of Health grants HL092321 and EB006061 (to SLR). Support for the Department of Cell and Molecular Physiology Multiphoton Imaging Facility was provided by the McCormick Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 1997, J CELL SCI, V110, P1073; Al-Soufi W, 2005, J AM CHEM SOC, V127, P8775, DOI 10.1021/ja0508976; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; CHASE TH, 2009, AM J PATHOL; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; DiFranco M, 2009, J VIS EXP; DiFranco M, 2007, J GEN PHYSIOL, V130, P581, DOI 10.1085/jgp.200709831; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Guan R, 2007, BIOCHEMISTRY-US, V46, P8988, DOI 10.1021/bi700698a; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Han RZ, 2006, CELL CALCIUM, V40, P299, DOI 10.1016/j.ceca.2006.04.016; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kuru Satoshi, 2004, Rinsho Shinkeigaku, V44, P375; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lu J, 2006, PLOS BIOL, V4, P1159, DOI 10.1371/journal.pbio.0040192; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; WENZEL K, 2007, J MOL MED; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	47	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27884	10.1371/journal.pone.0027884	http://dx.doi.org/10.1371/journal.pone.0027884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110769	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300056
J	Zhong, YA; Shtineman-Kotler, A; Nguyen, L; Iliadi, KG; Boulianne, GL; Rotin, D				Zhong, Yunan; Shtineman-Kotler, Alina; Leo Nguyen; Iliadi, Konstantin G.; Boulianne, Gabrielle L.; Rotin, Daniela			A Splice Isoform of DNedd4, DNedd4-Long, Negatively Regulates Neuromuscular Synaptogenesis and Viability in Drosophila	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; UBIQUITIN LIGASE NEDD4-1; C2 DOMAIN; PY MOTIF; LIDDLES-SYNDROME; GENE; EXPRESSION; COMMISSURELESS; GROWTH; ENAC	Background: Neuromuscular (NM) synaptogenesis is a tightly regulated process. We previously showed that in flies, Drosophila Nedd4 (dNedd4/dNedd4S) is required for proper NM synaptogenesis by promoting endocytosis of commissureless from the muscle surface, a pre-requisite step for muscle innervation. DNedd4 is an E3 ubiquitin ligase comprised of a C2-WW(x3)-Hect domain architecture, which includes several splice isoforms, the most prominent ones are dNedd4-short (dNedd4S) and dNedd4-long (dNedd4Lo). Methodology/Principal Findings: We show here that while dNedd4S is essential for NM synaptogenesis, the dNedd4Lo isoform inhibits this process and causes lethality. Our results reveal that unlike dNedd4S, dNedd4Lo cannot rescue the lethality of dNedd4 null (DNedd4(T121FS)) flies. Moreover, overexpression of UAS-dNedd4Lo specifically in wildtype muscles leads to NM synaptogenesis defects, impaired locomotion and larval lethality. These negative effects of dNedd4Lo are ameliorated by deletion of two regions (N-terminus and Middle region) unique to this isoform, and by inactivating the catalytic activity of dNedd4Lo, suggesting that these unique regions, as well as catalytic activity, are responsible for the inhibitory effects of dNedd4Lo on synaptogenesis. In accord with these findings, we demonstrate by sqRT-PCR an increase in dNedd4S expression relative to the expression of dNedd4Lo during embryonic stages when synaptogenesis takes place. Conclusion/Significance: Our studies demonstrate that splice isoforms of the same dNedd4 gene can lead to opposite effects on NM synaptogenesis.	[Zhong, Yunan; Shtineman-Kotler, Alina; Leo Nguyen; Rotin, Daniela] Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Iliadi, Konstantin G.; Boulianne, Gabrielle L.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Zhong, Yunan; Shtineman-Kotler, Alina; Leo Nguyen; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Iliadi, Konstantin G.; Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Zhong, YA (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	drotin@sickkids.ca		Zhong, Yunan/0000-0001-9008-5893	Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN 342051-07]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Science and Engineering Research Council of Canada (NSERC, RGPIN 342051-07 to DR and GLB). DR and GLB each hold a Canada Research Chair (CRC, Tier I). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Beumer K, 2002, DEVELOPMENT, V129, P3381; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Guo YQ, 2000, J CELL SCI, V113, P3499; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; KESHISHIAN H, 1993, TRENDS NEUROSCI, V16, P278, DOI 10.1016/0166-2236(93)90182-L; Knight D, 2007, DEV NEUROBIOL, V67, P1598, DOI 10.1002/dneu.20532; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Wang Y, 2010, DEV BIOL, V342, P1, DOI 10.1016/j.ydbio.2010.03.005; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wolf B, 1998, DEVELOPMENT, V125, P3853; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Zaffran S, 1997, DEVELOPMENT, V124, P2087	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27007	10.1371/journal.pone.0027007	http://dx.doi.org/10.1371/journal.pone.0027007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110599	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300010
J	Dai, Q; Li, LH; Liu, XQ; Yao, YH; Zhao, FK; Zhang, M				Dai, Qi; Li, Lihua; Liu, Xiaoqing; Yao, Yuhua; Zhao, Fukun; Zhang, Michael			Integrating Overlapping Structures and Background Information of Words Significantly Improves Biological Sequence Comparison	PLOS ONE			English	Article							HEPATITIS-E VIRUS; PHYLOGENETIC ANALYSIS; PROTEIN SEQUENCES; REGULATORY SEQUENCES; STATISTICAL MEASURES; ALIGNMENT; DISTANCE; GENOME; GENE; DATABASE	Word-based models have achieved promising results in sequence comparison. However, as the important statistical properties of words in biological sequence, how to use the overlapping structures and background information of the words to improve sequence comparison is still a problem. This paper proposed a new statistical method that integrates the overlapping structures and the background information of the words in biological sequences. To assess the effectiveness of this integration for sequence comparison, two sets of evaluation experiments were taken to test the proposed model. The first one, performed via receiver operating curve analysis, is the application of proposed method in discrimination between functionally related regulatory sequences and unrelated sequences, intron and exon. The second experiment is to evaluate the performance of the proposed method with f-measure for clustering Hepatitis E virus genotypes. It was demonstrated that the proposed method integrating the overlapping structures and the background information of words significantly improves biological sequence comparison and outperforms the existing models.	[Dai, Qi; Yao, Yuhua; Zhao, Fukun] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Lihua] Hangzhou Dianzi Univ, Inst Biomed Engn & Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Liu, Xiaoqing] Hangzhou Dianzi Univ, Sch Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Zhejiang Sci-Tech University; Hangzhou Dianzi University; Hangzhou Dianzi University; Cold Spring Harbor Laboratory	Dai, Q (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	daiailiu2004@yahoo.com.cn			National Natural Science Foundation of China [61170316, 61001214, 61003191]; Zhejiang Provincial Natural Science Foundation of China [60788101, Y2100930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work is supported by the National Natural Science Foundation of China (61170316, 61001214, 61003191), National Distinguished Young Research Scientist Award (60788101), and a research grant (Y2100930) from Zhejiang Provincial Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2007, PLOS COMPUT BIOL, V3, P73, DOI 10.1371/journal.pcbi.0030003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apostolico A, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-13; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cannarozzi G, 2007, PLOS COMPUT BIOL, V3, P9, DOI 10.1371/journal.pcbi.0030002; Chao K.M., 2008, SEQUENCE COMP THEORY, V7; Dai Q, 2008, BIOINFORMATICS, V24, P2296, DOI 10.1093/bioinformatics/btn436; Dixon RJ, 2007, BIOINFORMATICS, V23, P150, DOI 10.1093/bioinformatics/btl575; Durbin R., 1998, BIOL SEQUENCE ANAL P; Egan J.P., 1975, SIGNAL DETECTION THE; Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FICHANT G, 1987, COMPUT APPL BIOSCI, V3, P287; Gallo SM, 2006, BIOINFORMATICS, V22, P381, DOI 10.1093/bioinformatics/bti794; Green RE, 2002, P IEEE, V90, P1834, DOI 10.1109/JPROC.2002.805303; Guigo R, 1999, GENETIV DATABASE; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hao Bailin, 2004, J Bioinform Comput Biol, V2, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang R, 2008, PHYSICA A, V387, P4223, DOI 10.1016/j.physa.2008.02.076; Jiang R, 2008, INT J DATA MIN BIOIN, V2, P15, DOI 10.1504/IJDMB.2008.016754; Kantorovitz MR, 2007, BIOINFORMATICS, V23, pI249, DOI 10.1093/bioinformatics/btm211; Komatsu K, 2001, PLANTA MED, V67, P461, DOI 10.1055/s-2001-15821; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Li M, 2001, BIOINFORMATICS, V17, P149, DOI 10.1093/bioinformatics/17.2.149; Lippert RA, 2002, P NATL ACAD SCI USA, V99, P13980, DOI 10.1073/pnas.202468099; Liu LH, 2009, VIROLOGY, V385, P351, DOI 10.1016/j.virol.2008.12.004; Liu ZH, 2008, BIOCHEM BIOPH RES CO, V368, P223, DOI 10.1016/j.bbrc.2008.01.070; Livak F, 2003, IMMUNOGENETICS, V55, P307, DOI 10.1007/s00251-003-0577-6; Lu GQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S15; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mitrophanov AY, 2005, J APPL PROBAB, V42, P1003, DOI 10.1239/jap/1134587812; Mitrophanov AY, 2005, J APPL PROBAB, V42, P632, DOI 10.1239/jap/1127322017; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Olvera A, 2010, VET J, V184, P130, DOI 10.1016/j.tvjl.2009.02.015; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Pham TD, 2004, BIOINFORMATICS, V20, P3455, DOI 10.1093/bioinformatics/bth426; Pham TD, 2007, PATTERN RECOGN, V40, P516, DOI 10.1016/j.patcog.2006.02.026; Pipenbacher P, 2002, BIOINFORMATICS, V18, pS182, DOI 10.1093/bioinformatics/18.suppl_2.S182; Reinert G, 2000, J COMPUT BIOL, V7, P1, DOI 10.1089/10665270050081360; Rijsbergen C.J., 1979, INFORM RETIREVAL; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Robin S, 1999, J APPL PROBAB, V36, P179, DOI 10.1017/S0021900200016958; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schbath S, 1997, J COMPUT BIOL, V4, P189, DOI 10.1089/cmb.1997.4.189; Sinha S, 2007, PLOS COMPUT BIOL, V3, P2175, DOI 10.1371/journal.pcbi.0030216; Smith AA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000116; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stuart GW, 2002, BIOINFORMATICS, V18, P100, DOI 10.1093/bioinformatics/18.1.100; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; van Helden J, 2004, BIOINFORMATICS, V20, P399, DOI 10.1093/bioinformatics/btg425; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Waterman M.S., 1995, INTRO COMPUTATIONAL; Wu TJ, 1997, BIOMETRICS, V53, P1431, DOI 10.2307/2533509; Wu TJ, 2001, BIOMETRICS, V57, P441, DOI 10.1111/j.0006-341X.2001.00441.x; Wu Xiaomeng, 2006, Int J Bioinform Res Appl, V2, P219; Wu YH, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061916; Xia HY, 2008, VIRUS GENES, V37, P39, DOI 10.1007/s11262-008-0246-9	61	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26779	10.1371/journal.pone.0026779	http://dx.doi.org/10.1371/journal.pone.0026779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102867	Green Published, gold			2022-12-25	WOS:000297348800011
J	Ladenburger, EM; Plattner, H				Ladenburger, Eva-Maria; Plattner, Helmut			Calcium-Release Channels in Paramecium. Genomic Expansion, Differential Positioning and Partial Transcriptional Elimination	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MUSCLE SARCOPLASMIC-RETICULUM; MEMBRANE-PROTEIN TOPOLOGY; RYANODINE RECEPTOR; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; MOLECULAR DETERMINANTS; CONTRACTILE VACUOLE; SEQUENCE ALIGNMENT; PLASMA-MEMBRANE	The release of Ca2+ from internal stores is a major source of signal Ca2+ in almost all cell types. The internal Ca2+ pools are activated via two main families of intracellular Ca2+-release channels, the ryanodine and the inositol 1,4,5-trisphosphate (InsP(3)) receptors. Among multicellular organisms these channel types are ubiquitous, whereas in most unicellular eukaryotes the identification of orthologs is impaired probably due to evolutionary sequence divergence. However, the ciliated protozoan Paramecium allowed us to prognosticate six groups, with a total of 34 genes, encoding proteins with characteristics typical of InsP(3) and ryanodine receptors by BLAST search of the Paramecium database. We here report that these Ca2+-release channels may display all or only some of the characteristics of canonical InsP(3) and ryanodine receptors. In all cases, prediction methods indicate the presence of six trans-membrane regions in the C-terminal domains, thus corresponding to canonical InsP(3) receptors, while a sequence homologous to the InsP(3)-binding domain is present only in some types. Only two types have been analyzed in detail previously. We now show, by using antibodies and eventually by green fluorescent protein labeling, that the members of all six groups localize to distinct organelles known to participate in vesicle trafficking and, thus, may provide Ca2+ for local membrane-membrane interactions. Whole genome duplication can explain radiation within the six groups. Comparative and evolutionary evaluation suggests derivation from a common ancestor of canonical InsP(3) and ryanodine receptors. With one group we could ascertain, to our knowledge for the first time, aberrant splicing in one thoroughly analyzed Paramecium gene. This yields truncated forms and, thus, may indicate a way to pseudogene formation. No comparable analysis is available for any other, free-living or parasitic/pathogenic protozoan.	[Ladenburger, Eva-Maria; Plattner, Helmut] Univ Konstanz, Dept Biol, Constance, Germany	University of Konstanz	Ladenburger, EM (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	Eva.Ladenburger@uni-konstanz.de			Deutsche Forschungsgemeinschaft DFG [PL 78/22, TR-SFB11]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft DFG (www.dfg.de) by grants to Helmut Plattner including PL 78/22 and project C4 of TR-SFB11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R.D., 1988, P4; Allen RD, 2000, BIOESSAYS, V22, P1035; ALLEN RD, 1992, J CELL SCI, V101, P449; Allen RD, 2000, INT REV CYTOL, V198, P277; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439, DOI 10.1093/nar/gkl777; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Beisson J, 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5365, DOI 10.1101/PDB.PR0T5365]; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bootman MD, 2009, J CELL SCI, V122, P2337, DOI 10.1242/jcs.028100; Bright LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001155; CHANG DC, 1995, J CELL BIOL, V131, P1539, DOI 10.1083/jcb.131.6.1539; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dillon P J, 1993, Methods Mol Biol, V15, P263, DOI 10.1385/0-89603-244-2:263; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Dulhunty AF, 2003, CLIN EXP PHARMACOL P, V30, P713, DOI 10.1046/j.1440-1681.2003.03904.x; Erxleben C, 1997, J CELL BIOL, V136, P597, DOI 10.1083/jcb.136.3.597; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Flotenmeyer M, 1999, EUR J CELL BIOL, V78, P67; Galiano M, 2004, CELL CALCIUM, V36, P359, DOI 10.1016/j.ceca.2004.02.004; Gogendeau D, 2008, J CELL SCI, V121, P65, DOI 10.1242/jcs.019414; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Hardt M, 2000, EUR J CELL BIOL, V79, P642, DOI 10.1078/0171-9335-00087; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Hauser K, 2000, MOL MICROBIOL, V37, P773, DOI 10.1046/j.1365-2958.2000.02038.x; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Ishida N, 2001, J EUKARYOT MICROBIOL, V48, P640, DOI 10.1111/j.1550-7408.2001.tb00203.x; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; KANESHIRO ES, 1979, J PROTOZOOL, V26, P147, DOI 10.1111/j.1550-7408.1979.tb02754.x; Kissmehl R, 2002, J CELL SCI, V115, P3935, DOI 10.1242/jcs.00079; Kissmehl R, 2007, TRAFFIC, V8, P523, DOI 10.1111/j.1600-0854.2007.00544.x; KNOLL G, 1991, J CELL BIOL, V113, P1295, DOI 10.1083/jcb.113.6.1295; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Ladenburger EM, 2009, MOL CELL BIOL, V29, P3605, DOI 10.1128/MCB.01592-08; Lindmark IM, 2002, BBA-MOL CELL RES, V1590, P159, DOI 10.1016/S0167-4889(02)00209-4; LOIRAND G, 1991, J PHYSIOL-LONDON, V437, P461, DOI 10.1113/jphysiol.1991.sp018606; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; Machemer H., 1988, P185; McCarron JG, 2008, J BIOL CHEM, V283, P7206, DOI 10.1074/jbc.M708923200; Meur G, 2007, J BIOL CHEM, V282, P23096, DOI 10.1074/jbc.M702457200; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; Mohamed I, 2003, CELL CALCIUM, V34, P87, DOI 10.1016/S0143-4160(03)00025-3; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Nagata T, 2004, MOL BIOL EVOL, V21, P1855, DOI 10.1093/molbev/msh197; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NELSON DL, 1995, METHOD CELL BIOL, V47, P17, DOI 10.1016/S0091-679X(08)60785-2; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Pantazaka E, 2011, J BIOL CHEM; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Plattner H, 2001, INT REV CYTOL, V201, P115, DOI 10.1016/S0074-7696(01)01003-8; Plattner H, 2003, INT REV CYTOL, V232, P185, DOI 10.1016/S0074-7696(03)32005-4; Plattner H, 2010, INT REV CEL MOL BIO, V280, P79, DOI 10.1016/S1937-6448(10)80003-6; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Prajer M, 1997, J CELL SCI, V110, P529; Ramoino P, 2000, J PHOTOCH PHOTOBIO B, V54, P35, DOI 10.1016/S1011-1344(99)00153-0; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; RUSSELL CB, 1994, NUCLEIC ACIDS RES, V22, P1221, DOI 10.1093/nar/22.7.1221; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Schilde C, 2006, TRAFFIC, V7, P440, DOI 10.1111/j.1600-0854.2006.00397.x; Schilde C, 2010, EUKARYOT CELL, V9, P288, DOI 10.1128/EC.00220-09; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Sehring IM, 2007, J CELL SCI, V120, P177, DOI 10.1242/jcs.03313; Shah PK, 2001, PROTEIN ENG, V14, P867, DOI 10.1093/protein/14.11.867; Solovyova N, 2003, PFLUG ARCH EUR J PHY, V446, P447, DOI 10.1007/s00424-003-1094-z; Sonneborn TM, 1974, HDB GENETICS, V11, P469; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sperling L, 2002, EUKARYOT CELL, V1, P341, DOI 10.1128/EC.1.3.341-352.2002; Srikanth S, 2004, FEBS LETT, V575, P95, DOI 10.1016/j.febslet.2004.08.042; STELLY N, 1991, J CELL BIOL, V113, P103, DOI 10.1083/jcb.113.1.103; Stock C, 2002, EUR J CELL BIOL, V81, P505, DOI 10.1078/0171-9335-00272; Sutko JL, 1997, PHARMACOL REV, V49, P53; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; TAYLOR CW, 1995, J MEMBRANE BIOL, V145, P109; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 1998, TRENDS PHARMACOL SCI, V19, P370, DOI 10.1016/S0165-6147(98)01243-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Vinet AF, 2008, J IMMUNOL, V181, P5289, DOI 10.4049/jimmunol.181.8.5289; Wassmer T, 2006, MOL BIOL CELL, V17, P917, DOI 10.1091/mbc.E05-06-0511; Wehner M, 2003, CELL CALCIUM, V34, P163, DOI 10.1016/S0143-4160(03)00072-1; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Wirsel SGR, 2004, EUR J PLANT PATHOL, V110, P767, DOI 10.1007/s10658-004-0608-7; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zagulski M, 2004, CURR BIOL, V14, P1397, DOI 10.1016/j.cub.2004.07.029; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	105	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27111	10.1371/journal.pone.0027111	http://dx.doi.org/10.1371/journal.pone.0027111			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102876	Green Submitted, gold, Green Published			2022-12-25	WOS:000297348800016
J	Pan, WJ; Chen, CW; Chu, YW				Pan, Wei-Jie; Chen, Chi-Wei; Chu, Yen-Wei			siPRED: Predicting siRNA Efficacy Using Various Characteristic Methods	PLOS ONE			English	Article							RNA INTERFERENCE; DESIGN; SEQUENCES; EFFICIENT; MODEL; SELECTION; DUPLEXES; REGRESSION; ANTISENSE; NETWORK	Small interfering RNA (siRNA) has been used widely to induce gene silencing in cells. To predict the efficacy of an siRNA with respect to inhibition of its target mRNA, we developed a two layer system, siPRED, which is based on various characteristic methods in the first layer and fusion mechanisms in the second layer. Characteristic methods were constructed by support vector regression from three categories of characteristics, namely sequence, features, and rules. Fusion mechanisms considered combinations of characteristic methods in different categories and were implemented by support vector regression and neural networks to yield integrated methods. In siPRED, the prediction of siRNA efficacy through integrated methods was better than through any method that utilized only a single method. Moreover, the weighting of each characteristic method in the context of integrated methods was established by genetic algorithms so that the effect of each characteristic method could be revealed. Using a validation dataset, siPRED performed better than other predictive systems that used the scoring method, neural networks, or linear regression. Finally, siPRED can be improved to achieve a correlation coefficient of 0.777 when the threshold of the whole stacking energy is >=-34.6 kcal/mol. siPRED is freely available on the web at http://predictor.nchu.edu.tw/siPRED.	[Pan, Wei-Jie; Chen, Chi-Wei; Chu, Yen-Wei] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Pan, WJ (corresponding author), Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan.	ywchu@nchu.edu.tw	Chu, Yen-Wei/AAJ-4508-2020	Chu, Yen-Wei/0000-0002-5525-4011; Chen, Chi-Wei/0000-0002-5799-9017	National Science Council (NSC) [99-2221-E-005-099, 100-2221-E-005-073]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work was supporting by National Science Council (NSC) 99-2221-E-005-099 and 100-2221-E-005-073 (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ge GT, 2005, BIOCHEM BIOPH RES CO, V336, P723, DOI 10.1016/j.bbrc.2005.08.147; Gong WM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-516; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Holen T, 2006, RNA, V12, P1620, DOI 10.1261/rna.81006; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jiang P, 2007, COMPUT METH PROG BIO, V87, P230, DOI 10.1016/j.cmpb.2007.06.001; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Muhonen P, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-8; Peek AS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-182; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOINFORMATICS, V20, P3055, DOI 10.1093/bioinformatics/bth364; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Takasaki S, 2004, CELL CYCLE, V3, P790; Takasaki S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S22; Takasaki S, 2006, COMPUT BIOL CHEM, V30, P169, DOI 10.1016/j.compbiolchem.2006.02.003; Takasaki S, 2009, COMPUT BIOL CHEM, V33, P368, DOI 10.1016/j.compbiolchem.2009.07.009; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	32	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27602	10.1371/journal.pone.0027602	http://dx.doi.org/10.1371/journal.pone.0027602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102913	gold, Green Submitted, Green Published			2022-12-25	WOS:000297348800036
J	Wanka, C; Brucker, DP; Bahr, O; Ronellenfitsch, M; Weller, M; Steinbach, JP; Rieger, J				Wanka, C.; Brucker, D. P.; Baehr, O.; Ronellenfitsch, M.; Weller, M.; Steinbach, J. P.; Rieger, J.			Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death	ONCOGENE			English	Article						p53; SCO2; hypoxia; glioma; respiration	ENERGY-METABOLISM; P53; GENE; ANTIANGIOGENESIS; EXPRESSION; STRATEGIES; EVOLUTION; PATHWAYS; ARREST; SCO2	P53 has an important role in the processing of starvation signals. P53-dependent molecular mediators of the Warburg effect reduce glucose consumption and promote mitochondrial function. We therefore hypothesized that the retention of wild-type p53 characteristic of primary glioblastomas limits metabolic demands induced by deregulated signal transduction in the presence of hypoxia and nutrient depletion. Here we report that short hairpin RNA-mediated gene suppression of wild-type p53 or ectopic expression of mutant temperature-sensitive dominant-negative p53(V135A) increased glucose consumption and lactate production, decreased oxygen consumption and enhanced hypoxia-induced cell death in p53 wild-type human glioblastoma cells. Similarly, genetic knockout of p53 in HCT116 colon carcinoma cells resulted in reduced respiration and hypersensitivity towards hypoxia-induced cell death. Further, wild-type p53 gene silencing reduced the expression of synthesis of cytochrome c oxidase 2 (SCO2), an effector necessary for respiratory chain function. An SCO2 transgene reverted the metabolic phenotype and restored resistance towards hypoxia in p53-depleted and p53 mutant glioma cells in a rotenone-sensitive manner, demonstrating that this effect was dependent on intact oxidative phosphorylation. Supplementation with methyl-pyruvate, a mitochondrial substrate, rescued p53 wild-type but not p53 mutant cells from hypoxic cell death, demonstrating a p53-mediated selective aptitude to metabolize mitochondrial substrates. Further, SCO2 gene silencing in p53 wild-type glioma cells sensitized these cells towards hypoxia. Finally, lentiviral gene suppression of SCO2 significantly enhanced tumor necrosis in a subcutaneous HCT116 xenograft tumor model, compatible with impaired energy metabolism in these cells. These findings demonstrate that glioma and colon cancer cells with p53 wild-type status can skew the Warburg effect and thereby reduce their vulnerability towards tumor hypoxia in an SCO2-dependent manner. Targeting SCO2 may therefore represent a valuable strategy to enhance sensitivity towards hypoxia and may complement strategies targeting glucose metabolism. Oncogene (2012) 31, 3764-3776; doi:10.1038/onc.2011.530; published online 28 November 2011	[Wanka, C.; Brucker, D. P.; Baehr, O.; Ronellenfitsch, M.; Steinbach, J. P.; Rieger, J.] Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60528 Frankfurt, Germany; [Wanka, C.; Brucker, D. P.; Steinbach, J. P.] Univ Tubingen Hosp, Dept Neurol, Tubingen, Germany; [Weller, M.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	Goethe University Frankfurt; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital	Rieger, J (corresponding author), Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	johannes.rieger@med.uni-frankfurt.de	Ronellenfitsch, Michael/AAW-8201-2020	Ronellenfitsch, Michael/0000-0002-1402-6290; Weller, Michael/0000-0002-1748-174X; Brucker, Daniel Peer/0000-0002-1808-5917; Rieger, Johannes/0000-0002-7918-1777	Deutsche Forschungsgemeinschaft [GRK 1302/1]; Hertie foundation; Dr Senckenberg foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie foundation; Dr Senckenberg foundation	We thank P Hwang for providing the SCO2 expression plasmid and B Vogelstein for the HCT116 p53<SUP>+/+</SUP> and p53<SUP>-/-</SUP> cell lines. This work was supported by The Deutsche Forschungsgemeinschaft (GRK 1302/1). The Dr Senckenberg Institute of Neurooncology is supported by the Hertie foundation and the Dr Senckenberg foundation. JPS is 'Hertie Professor for Neurooncology'.	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Barnes K, 2002, J CELL SCI, V115, P2433; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bhonde MR, 2006, ONCOGENE, V25, P165, DOI 10.1038/sj.onc.1209017; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Choe G, 2003, CANCER RES, V63, P2742; Corcoran CA, 2006, CANCER BIOL THER, V5, P1610, DOI 10.4161/cbt.5.12.3617; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Ehrmann J, 1995, Cesk Patol, V31, P87; FULTS D, 1992, CANCER RES, V52, P674; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlieb E, 2009, NATURE, V461, P44, DOI 10.1038/461044a; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jansen M, 2004, BRAIN RES REV, V45, P143, DOI 10.1016/j.brainresrev.2004.03.001; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim E, 2009, BIOCHEM PHARMACOL, V77, P11, DOI 10.1016/j.bcp.2008.08.030; Kondoh H, 2005, CANCER RES, V65, P177; KOPPER L, 1975, CANCER RES, V35, P2704; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Naumann U, 1998, ONCOGENE, V17, P1567, DOI 10.1038/sj.onc.1202071; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Puduvalli VK, 2000, J NEURO-ONCOL, V50, P189, DOI 10.1023/A:1006469830739; Rieger J, 2010, J NEURO-ONCOL, V99, P49, DOI 10.1007/s11060-009-0098-8; RYAN JJ, 1993, MOL CELL BIOL, V13, P711, DOI 10.1128/MCB.13.1.711; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; VAN MEIR EG, 1994, CANCER RES, V54, P649; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wischhusen J, 2004, CELL DEATH DIFFER, V11, P1150, DOI 10.1038/sj.cdd.4401477; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Zhao Y, 2009, J ZHEJIANG UNIV-SC B, V10, P404, DOI 10.1631/jzus.B0820293	52	40	41	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	33					3764	3776		10.1038/onc.2011.530	http://dx.doi.org/10.1038/onc.2011.530			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22120717	Green Accepted			2022-12-25	WOS:000307924900003
J	Moon, MJ; Kim, HY; Park, S; Kim, DK; Cho, EB; Park, CR; You, DJ; Hwang, JI; Kim, K; Choe, H; Seong, JY				Moon, Mi Jin; Kim, Hee Young; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Park, Cho Rong; You, Dong-Joo; Hwang, Jong-Ik; Kim, Kyungjin; Choe, Han; Seong, Jae Young			Evolutionarily Conserved Residues at Glucagon-like Peptide-1 (GLP-1) Receptor Core Confer Ligand-induced Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULINOTROPIC POLYPEPTIDE GIP; GASTRIC-INHIBITORY POLYPEPTIDE; TERMINAL EXTRACELLULAR DOMAIN; PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; CRITICAL DETERMINANTS; PARATHYROID-HORMONE; CHIMERIC RECEPTORS; SECRETIN RECEPTOR; AGONIST BINDING	Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) play important roles in insulin secretion through their receptors, GLP1R and GIPR. Although GLP-1 and GIP are attractive candidates for treatment of type 2 diabetes and obesity, little is known regarding the molecular interaction of these peptides with the heptahelical core domain of their receptors. These core domains are important not only for specific ligand binding but also for ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R/GIPR, we determined that evolutionarily conserved amino acid residues such as Ile(196) at transmembrane helix 2, Leu(232) and Met(233) at extracellular loop 1, and Asn(302) at extracellular loop 2 of GLP1R are responsible for interaction with ligand and receptor activation. Application of chimeric GLP-1/GIP peptides together with molecular modeling suggests that His(1) of GLP-1 interacts with Asn(302) of GLP1R and that Thr(7) of GLP-1 has close contact with a binding pocket formed by Ile(196), Leu(232), and Met(233) of GLP1R. This study may provide critical clues for the development of peptide and/or nonpeptide agonists acting at GLP1R.	[Choe, Han] Univ Ulsan, Dept Physiol, Coll Med, Seoul 138736, South Korea; [Choe, Han] Univ Ulsan, Biomed Inst Technol, Coll Med, Seoul 138736, South Korea; [Moon, Mi Jin; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Park, Cho Rong; You, Dong-Joo; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Kim, Hee Young] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	University of Ulsan; University of Ulsan; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Choe, H (corresponding author), Univ Ulsan, Dept Physiol, Coll Med, Seoul 138736, South Korea.	hchoe@amc.seoul.kr; jyseong@korea.ac.kr	choe, han/A-5679-2010; Seong, Jae Young/A-5794-2012	choe, han/0000-0003-4604-647X; Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	Brain Research Center of the 21st Century Frontier Research Program [2011K00277, 2011K000279]; National Research Foundation of Korea [2011-0019205]; Ministry of Education, Science and Technology	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grants 2011K00277 and 2011K000279 from the Brain Research Center of the 21st Century Frontier Research Program and Grant 2011-0019205 from the Brain Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; BROWN JC, 1981, PEPTIDES, V2, P241, DOI 10.1016/0196-9781(81)90038-3; BROWN JC, 1971, CAN J BIOCHEM CELL B, V49, P867, DOI 10.1139/o71-122; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Gallwitz B, 1996, REGUL PEPTIDES, V63, P17, DOI 10.1016/0167-0115(96)00019-5; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Hinke SA, 2003, BIOL CHEM, V384, P403, DOI 10.1515/BC.2003.046; Hinke SA, 2002, BIOCHEM BIOPH RES CO, V291, P1302, DOI 10.1006/bbrc.2002.6607; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; Hjorth SA, 1996, ACTA PHYSIOL SCAND, V157, P343, DOI 10.1046/j.1365-201X.1996.37259000.x; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Moon MJ, 2010, MOL CELLS, V30, P149, DOI 10.1007/s10059-010-0100-5; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3873	3884		10.1074/jbc.M111.276808	http://dx.doi.org/10.1074/jbc.M111.276808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22105074	hybrid, Green Published			2022-12-25	WOS:000300410900024
J	Barsotti, AM; Beckerman, R; Laptenko, O; Huppi, K; Caplen, NJ; Prives, C				Barsotti, Anthony M.; Beckerman, Rachel; Laptenko, Oleg; Huppi, Konrad; Caplen, Natasha J.; Prives, Carol			p53-dependent Induction of PVT1 and miR-1204	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; WILD-TYPE P53; P53-MEDIATED APOPTOSIS; C-MYC; GENE-EXPRESSION; NONCODING RNA; BREAST-CANCER; G(2) ARREST; DNA-DAMAGE; STEM-CELLS	p53 is a tumor suppressor protein that acts as a transcription factor to regulate (either positively or negatively) a plethora of downstream target genes. Although its ability to induce protein coding genes is well documented, recent studies have implicated p53 in the regulation of non-coding RNAs, including both microRNAs (e.g. miR-34a) and long non-coding RNAs (e.g. lincRNA-p21). We have identified the non-protein coding locus PVT1 as a p53-inducible target gene. PVT1, a very large (>300 kb) locus located downstream of c-myc on chromosome 8q24, produces a wide variety of spliced non-coding RNAs as well as a cluster of six annotated microRNAs: miR-1204, miR-1205, miR-1206, miR-1207-5p, miR-1207-3p, and miR-1208. Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), and luciferase assays reveal that p53 binds and activates a canonical response element within the vicinity of miR-1204. Consistently, we demonstrate the p53-dependent induction of endogenous PVT1 transcripts and consequent upregulation of mature miR-1204. Finally, we have shown that ectopic expression of miR-1204 leads to increased p53 levels and causes cell death in a partially p53-dependent manner.	[Barsotti, Anthony M.; Beckerman, Rachel; Laptenko, Oleg; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Huppi, Konrad; Caplen, Natasha J.] NCI, Gene Silencing Sect, Genet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	clp3@columbia.edu	Caplen, Natasha J/H-2768-2016	Caplen, Natasha J/0000-0002-0001-9460	National Institutes of Health [CA77742]; (Center for Cancer Research, NCI) of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010612, R01CA077742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); (Center for Cancer Research, NCI) of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA77742 and the Intramural Research Program (Center for Cancer Research, NCI) of the National Institutes of Health.	ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; Barsotti AM, 2010, CELL, V142, P358, DOI 10.1016/j.cell.2010.07.029; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; BORG A, 1992, INT J CANCER, V51, P687, DOI 10.1002/ijc.2910510504; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; HARPER JW, 1993, CELL, V75, P805; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Janicke RU, 2007, CELL CYCLE, V6, P407; Kamath A, 2008, CANCER GENET CYTOGEN, V183, P117, DOI 10.1016/j.cancergencyto.2008.02.011; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; PALUMBO AP, 1990, CANCER RES, V50, P6478; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; SHAULSKY G, 1991, P NATL ACAD SCI USA, V88, P8982, DOI 10.1073/pnas.88.20.8982; Sheikh MS, 2000, LEUKEMIA, V14, P1509, DOI 10.1038/sj.leu.2401865; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; You L, 2011, BIOCHEM BIOPH RES CO, V407, P1, DOI 10.1016/j.bbrc.2011.02.027; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zilfou JT, 2005, CELL, V123, P545, DOI 10.1016/j.cell.2005.11.003	55	143	153	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2509	2519		10.1074/jbc.M111.322875	http://dx.doi.org/10.1074/jbc.M111.322875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22110125	Green Published, hybrid			2022-12-25	WOS:000300292300025
J	Buler, M; Aatsinki, SM; Skoumal, R; Komka, Z; Toth, M; Kerkela, R; Georgiadi, A; Kersten, S; Hakkola, J				Buler, Marcin; Aatsinki, Sanna-Mari; Skoumal, Reka; Komka, Zsolt; Toth, Miklos; Kerkela, Risto; Georgiadi, Anastasia; Kersten, Sander; Hakkola, Jukka			Energy-sensing Factors Coactivator Peroxisome Proliferator-activated Receptor gamma Coactivator 1-alpha (PGC-1 alpha) and AMP-activated Protein Kinase Control Expression of Inflammatory Mediators in Liver INDUCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; CALORIC RESTRICTION; METABOLIC SYNDROME; DIABETES-MELLITUS; NUCLEAR RECEPTORS; HUMAN OBESITY	Obesity and insulin resistance are associated with chronic, low grade inflammation. Moreover, regulation of energy metabolism and immunity are highly integrated. We hypothesized that energy-sensitive coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and AMP-activated protein kinase (AMPK) may modulate inflammatory gene expression in liver. Microarray analysis revealed that PGC-1 alpha up-regulated expression of several cytokines and cytokine receptors, including interleukin 15 receptor alpha (IL15R alpha) and, even more importantly, anti-inflammatory interleukin 1 receptor antagonist (IL1Rn). Overexpression of PGC-1 alpha and induction of PGC-1 alpha by fasting, physical exercise, glucagon, or cAMP was associated with increased IL1Rn mRNA and protein expression in hepatocytes. Knockdown of PGC-1 alpha by siRNA down-regulated cAMP-induced expression of IL1Rn in mouse hepatocytes. Furthermore, knockdown of peroxisome proliferator-activated receptor alpha (PPAR alpha) attenuated IL1Rn induction by PGC-1 alpha. Overexpression of PGC-1 alpha, at least partially through IL1Rn, suppressed interleukin 1 beta-induced expression of acute phase proteins, C-reactive protein, and haptoglobin. Fasting and exercise also induced IL15R alpha expression, whereas glucagon and cAMP resulted in reduction in IL15R alpha mRNA levels. Finally, AMPK activator metformin and adenoviral overexpression of AMPK up-regulated IL1Rn and down-regulated IL15R alpha in primary hepatocytes. We conclude that PGC-1 alpha and AMPK alter inflammatory gene expression in liver and thus integrate energy homeostasis and inflammation. Induction of IL1Rn by PGC-1 alpha and AMPK may be involved in the beneficial effects of exercise and caloric restriction and putative anti-inflammatory effects of metformin.	[Buler, Marcin; Aatsinki, Sanna-Mari; Skoumal, Reka; Kerkela, Risto; Hakkola, Jukka] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu 90014, Finland; [Skoumal, Reka; Komka, Zsolt; Toth, Miklos] Semmelweis Univ, Dept Hlth Sci & Sports Med, Fac Phys Educ & Sport Sci, H-1085 Budapest, Hungary; [Georgiadi, Anastasia; Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, NL-6703 HD Wageningen, Netherlands	University of Oulu; Semmelweis University; University of Physical Education; Wageningen University & Research	Hakkola, J (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, POB 5000,Aapistie 5B, Oulu 90014, Finland.	jukka.hakkola@oulu.fi	Buler, Marcin/J-8871-2012; Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; Hakkola, Jukka/0000-0001-5048-4363	European Union; Academy of Finland [110591]; Sigrid Juselius Foundation; National Development Agency of Hungary [TAMOP 4.2.2-08/01/KMR-2008-004]	European Union(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Development Agency of Hungary	This work was supported by grants from the European Union (Marie Curie RTN NucSys), the Academy of Finland (Contract 110591), the Sigrid Juselius Foundation, and the National Development Agency of Hungary (Grant TAMOP 4.2.2-08/01/KMR-2008-004).	Arpiainen S, 2008, TOXICOL APPL PHARM, V232, P135, DOI 10.1016/j.taap.2008.06.001; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulcao C, 2007, AM J CARDIOVASC DRUG, V7, P219, DOI 10.2165/00129784-200707030-00007; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Souza AT, 2006, NUCLEIC ACIDS RES, V34, P4486, DOI 10.1093/nar/gkl609; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; Gaillard S, 2006, MOL CELL, V24, P797, DOI 10.1016/j.molcel.2006.10.012; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang W, 2010, ARTERIOSCL THROM VAS, V30, P1542, DOI 10.1161/ATVBAHA.109.191189; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Im SS, 2011, J BIOL CHEM, V286, P1157, DOI 10.1074/jbc.M110.157875; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kuczynski S, 2005, DIABETES RES CLIN PR, V69, P231, DOI 10.1016/j.diabres.2005.02.007; Lamacchia C, 2010, J IMMUNOL, V185, P2516, DOI 10.4049/jimmunol.1000872; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lukic ML, 2003, J AUTOIMMUN, V21, P239, DOI 10.1016/S0896-8411(03)00115-X; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Nielsen AR, 2007, J PHYSIOL-LONDON, V584, P305, DOI 10.1113/jphysiol.2007.139618; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Ranhotra HS, 2010, INDIAN J BIOCHEM BIO, V47, P272; Riechman SE, 2004, J APPL PHYSIOL, V97, P2214, DOI 10.1152/japplphysiol.00491.2004; Ruchatz H, 1998, J IMMUNOL, V160, P5654; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Smith XG, 2000, J IMMUNOL, V165, P3444, DOI 10.4049/jimmunol.165.6.3444; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; STEINKASSERER A, 1992, FEBS LETT, V310, P60, DOI 10.1016/0014-5793(92)81146-D; Stienstra R, 2007, J HEPATOL, V46, P869, DOI 10.1016/j.jhep.2006.11.019; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	54	39	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1847	1860		10.1074/jbc.M111.302356	http://dx.doi.org/10.1074/jbc.M111.302356			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117073	Green Published, hybrid			2022-12-25	WOS:000299321000026
J	Lee, SG; Kim, Y; Alpert, TD; Nagata, A; Jez, JM				Lee, Soon Goo; Kim, Youngchang; Alpert, Tara D.; Nagata, Akina; Jez, Joseph M.			Structure and Reaction Mechanism of Phosphoethanolamine Methyltransferase from the Malaria Parasite Plasmodium falciparum AN ANTIPARASITIC DRUG TARGET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE N-METHYLTRANSFERASE; GUANIDINOACETATE METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; METHYL TRANSFER; PATHWAY; MODEL; INHIBITORS	In the malarial parasite Plasmodium falciparum, a multifunctional phosphoethanolamine methyltransferase (PfPMT) catalyzes the methylation of phosphoethanolamine (pEA) to phosphocholine for membrane biogenesis. This pathway is also found in plant and nematodes, but PMT from these organisms use multiple methyltransferase domains for the S-adenosylmethionine (AdoMet) reactions. Because PfPMT is essential for normal growth and survival of Plasmodium and is not found in humans, it is an antiparasitic target. Here we describe the 1.55 angstrom resolution crystal structure of PfPMT in complex with AdoMet by single-wavelength anomalous dispersion phasing. In addition, 1.19-1.52 angstrom resolution structures of PfPMT with pEA (substrate), phosphocholine (product), sinefungin (inhibitor), and both pEA and S-adenosylhomocysteine bound were determined. These structures suggest that domain rearrangements occur upon ligand binding and provide insight on active site architecture defining the AdoMet and phosphobase binding sites. Functional characterization of 27 site-directed mutants identifies critical active site residues and suggests that Tyr-19 and His-132 form a catalytic dyad. Kinetic analysis, isothermal titration calorimetry, and protein crystallography of the Y19F and H132A mutants suggest a reaction mechanism for the PMT. Not only are Tyr-19 and His-132 required for phosphobase methylation, but they also form a "catalytic" latch that locks ligands in the active site and orders the site for catalysis. This study provides the first insight on this antiparasitic target enzyme essential for survival of the malaria parasite; however, further studies of the multidomain PMT from plants and nematodes are needed to understand the evolutionary division of metabolic function in the phosphobase pathway of these organisms.	[Lee, Soon Goo; Alpert, Tara D.; Nagata, Akina; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kim, Youngchang] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Nagata, Akina] Knox Coll, Dept Biol, Galesburg, IL 61401 USA	Washington University (WUSTL); United States Department of Energy (DOE); Argonne National Laboratory	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu		Lee, Soon Goo/0000-0002-1541-8587; Kim, Youngchang/0000-0002-1610-4889	Washington University; Knox College Howard Hughes Medical Institute (HHMI)-SURF; University of Chicago for the United States Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097119] Funding Source: NIH RePORTER	Washington University; Knox College Howard Hughes Medical Institute (HHMI)-SURF; University of Chicago for the United States Department of Energy Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from Washington University and the Washington University Summer Undergraduate Research Fellowship Program (to T.D.A.) and from the Knox College Howard Hughes Medical Institute (HHMI)-SURF Program (to A.N.).; Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the United States Department of Energy Office of Biological and Environmental Research (Grant DE-AC02-06CH11357).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Calas M, 2000, J MED CHEM, V43, P505, DOI 10.1021/jm9911027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jez J.M., 2007, CURR ENZYM INHIB, V3, P133, DOI [10.2174/157340807780598378, DOI 10.2174/157340807780598378]; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Komoto J, 2004, BIOCHEMISTRY-US, V43, P14385, DOI 10.1021/bi0486785; Komoto J, 2002, J MOL BIOL, V320, P223, DOI 10.1016/S0022-2836(02)00448-5; Lee Soon Goo, 2011, Curr Chem Biol, V5, P183, DOI 10.2174/2212796811105030183; Lee SG, 2011, J BIOL CHEM, V286, P38060, DOI 10.1074/jbc.M111.290619; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soriano A, 2006, BIOCHEMISTRY-US, V45, P14917, DOI 10.1021/bi061319k; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Velichkova P, 2006, J PHYS CHEM B, V110, P16, DOI 10.1021/jp055120d; Velichkova P, 2005, J PHYS CHEM B, V109, P8216, DOI 10.1021/jp0443254; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; *WHO EXP COMM MAL, 2000, WHO TECHN REP SER, V892; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Wu Q, 2005, J MED CHEM, V48, P7243, DOI 10.1021/jm050568o	39	38	40	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1426	1434		10.1074/jbc.M111.315267	http://dx.doi.org/10.1074/jbc.M111.315267			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117061	hybrid, Green Published			2022-12-25	WOS:000299170300056
J	Ma, LJ; Liu, Y; El-Achkar, TM; Wu, XR				Ma, Lijie; Liu, Yan; El-Achkar, Tarek M.; Wu, Xue-Ru			Molecular and Cellular Effects of Tamm-Horsfall Protein Mutations and Their Rescue by Chemical Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE HYPERURICEMIC NEPHROPATHY; 1-FIMBRIATED ESCHERICHIA-COLI; CHRONIC KIDNEY-DISEASE; ENDOPLASMIC-RETICULUM; PHARMACOLOGICAL CHAPERONES; UROMODULIN DISORDERS; ANCHORED COUNTERPART; STONE FORMATION; DEFENSE FACTOR; UMOD GENE	Correct folding of a nascent polypeptide in the lumen of the endoplasmic reticulum (ER) into a three-dimensional conformation is a crucial step in the stability, intracellular trafficking, and targeting to the final destination of a protein. By transiently and stably expressing human-relevant mutants of Tamm-Horsfall protein in polarized Madin-Darby canine kidney cells, we show here that a cysteine-altering mutation in the evolutionally conserved cysteine-rich domain had more severe defects in ER exit and surface translocation and triggered more apoptosis than a cysteine-altering mutation outside the domain. Both mutants were able to specifically bind and trap the wild-type Tamm-Horsfall protein (THP) and prevent it from exiting the ER and translocating to the cell surface. This explains at least partly why in patients with THP-associated diseases there is a marked urinary reduction of both the mutant and the wild-type THP. Exposure of mutant-expressing cells to low temperature (30 degrees C), osmolytes (glycerol, trimethylamine N-oxide, and dimethyl sulfoxide), and the Ca2+-ATP inhibitor thapsigargin only slightly relieved ER retention and increased surface targeting of the mutants. In contrast, sodium 4-phenylbutyrate and probenecid, the latter a uricosuric drug used clinically to treat gout, markedly reduced ER retention of the mutants and increased their surface translocation and secretion into the culture media. The rescue of the THP mutants was associated with the restoration of the level and subcellular localization of cytosolic chaperone HSP70. Our results reveal intricate mechanistic details that may underlie THP-associated diseases and suggest that novel therapeutics enhancing the refolding of THP mutants may be of important value in therapy.	[Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA; [Ma, Lijie; Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [El-Achkar, Tarek M.] St Louis Univ, Div Nephrol, St Louis, MO 63108 USA; [El-Achkar, Tarek M.] St Louis Vet Affairs Med Ctr, St Louis, MO 63108 USA	New York University; New York University; Saint Louis University	Wu, XR (corresponding author), NYU, Sch Med, Dept Urol, Vet Affairs Med Ctr Manhattan, 423 E23 St,Rm 18064 S, New York, NY 10010 USA.	xue-ru.wu@med.nyu.edu		Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health [DK56903]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56903.	Allen S, 2001, BIOCHEM BIOPH RES CO, V280, P448, DOI 10.1006/bbrc.2000.4139; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bleyer AJ, 2006, ADV CHRONIC KIDNEY D, V13, P124, DOI 10.1053/j.ackd.2006.01.008; Bleyer AJ, 2004, KIDNEY INT, V66, P974, DOI 10.1111/j.1523-1755.2004.00845.x; Bleyer AJ, 2010, SEMIN NEPHROL, V30, P366, DOI 10.1016/j.semnephrol.2010.06.003; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Buckland PR, 2004, HUM MOL GENET, V13, pR255, DOI 10.1093/hmg/ddh227; Cameron JS, 2005, SEMIN NEPHROL, V25, P9, DOI 10.1016/j.semnephrol.2004.09.003; Cavallone D, 2004, J BIOL CHEM, V279, P216, DOI 10.1074/jbc.M308821200; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Chung Y, 2008, AM J MED SCI, V335, P219, DOI 10.1097/MAJ.0b013e31815acb10; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Devuyst O, 2005, NEPHROL DIAL TRANSPL, V20, P1290, DOI 10.1093/ndt/gfh851; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; Fukuoka SI, 2001, BIOCHEM BIOPH RES CO, V289, P1044, DOI 10.1006/bbrc.2001.6112; Gong B, 2009, MOL VIS, V15, P2829; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lens XM, 2005, AM J KIDNEY DIS, V46, P52, DOI 10.1053/j.ajkd.2005.04.003; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Nasr SH, 2008, KIDNEY INT, V73, P971, DOI 10.1038/sj.ki.5002679; Ohashi T, 2003, HISTOCHEM CELL BIOL, V119, P257, DOI 10.1007/s00418-003-0511-x; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; Puig JG, 2006, NUCLEOS NUCLEOT NUCL, V25, P1295, DOI 10.1080/15257770600894766; Raffi HS, 2009, J UROLOGY, V181, P2332, DOI 10.1016/j.juro.2009.01.014; Raffi HS, 2005, AM J NEPHROL, V25, P570, DOI 10.1159/000088990; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rezende-Lima W, 2004, KIDNEY INT, V66, P558, DOI 10.1111/j.1523-1755.2004.00774.x; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Sedor JR, 2010, J AM SOC NEPHROL, V21, P204, DOI 10.1681/ASN.2009121283; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Yang HR, 2004, FEBS LETT, V578, P236, DOI 10.1016/j.febslet.2004.10.092; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077	62	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1290	1305		10.1074/jbc.M111.283036	http://dx.doi.org/10.1074/jbc.M111.283036			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117067	Green Published, hybrid			2022-12-25	WOS:000299170300045
J	Alam, H; Gangadaran, P; Bhate, AV; Chaukar, DA; Sawant, SS; Tiwari, R; Bobade, J; Kannan, S; D'cruz, AK; Kane, S; Vaidya, MM				Alam, Hunain; Gangadaran, Prakash; Bhate, Amruta V.; Chaukar, Devendra A.; Sawant, Sharada S.; Tiwari, Richa; Bobade, Jyoti; Kannan, Sadhana; D'cruz, Anil K.; Kane, Shubhada; Vaidya, Milind M.			Loss of Keratin 8 Phosphorylation Leads to Increased Tumor Progression and Correlates with Clinico-Pathological Parameters of OSCC Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SIMPLE EPITHELIAL KERATINS; LYMPH-NODE METASTASIS; INTERMEDIATE-FILAMENTS; CULTURED-CELLS; EXPRESSION; DISEASE; MIGRATION; INVASION; TISSUES	Background: Keratins are cytoplasmic intermediate filament proteins expressed in tissue specific and differentiation dependent manner. Keratins 8 and 18 (K8 and K18) are predominantly expressed in simple epithelial tissues and perform both mechanical and regulatory functions. Aberrant expression of K8 and K18 is associated with neoplastic progression, invasion and poor prognosis in human oral squamous cell carcinomas (OSCCs). K8 and K18 undergo several post-translational modifications including phosphorylation, which are known to regulate their functions in various cellular processes. Although, K8 and K18 phosphorylation is known to regulate cell cycle, cell growth and apoptosis, its significance in cell migration and/or neoplastic progression is largely unknown. In the present study we have investigated the role of K8 phosphorylation in cell migration and/or neoplastic progression in OSCC. Methodology and Principal Findings: To understand the role of K8 phosphorylation in neoplastic progression of OSCC, shRNA-resistant K8 phospho-mutants of Ser73 and Ser431 were overexpressed in K8-knockdown human AW13516 cells (derived from SCC of tongue; generated previously). Wound healing assays and tumor growth in NOD-SCID mice were performed to analyze the cell motility and tumorigenicity respectively in overexpressed clones. The overexpressed K8 phospho-mutants clones showed significant increase in cell migration and tumorigenicity as compared with K8 wild type clones. Furthermore, loss of K8 Ser73 and Ser431 phosphorylation was also observed in human OSCC tissues analyzed by immunohistochemistry, where their dephosphorylation significantly correlated with size, lymph node metastasis and stage of the tumor. Conclusion and Significance: Our results provide first evidence of a potential role of K8 phosphorylation in cell migration and/or tumorigenicity in OSCC. Moreover, correlation studies of K8 dephosphorylation with clinico-pathological parameters of OSCC patients also suggest its possible use in prognostication of human OSCC.	[Alam, Hunain; Gangadaran, Prakash; Bhate, Amruta V.; Tiwari, Richa; Bobade, Jyoti; Vaidya, Milind M.] TMC, ACTREC, CRI, Kharghar, Navi Mumbai, India; [Chaukar, Devendra A.; D'cruz, Anil K.] Tata Mem Hosp, Surg Oncol Head & Neck Unit, Bombay 400012, Maharashtra, India; [Kannan, Sadhana] TMC, ACTREC, CRC, Epidemiol & Clin Trials Unit, Kharghar, Navi Mumbai, India; [Kane, Shubhada] Tata Mem Hosp, Dept Pathol, Bombay 400012, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Centre (TMC); Tata Memorial Hospital	Alam, H (corresponding author), TMC, ACTREC, CRI, Kharghar, Navi Mumbai, India.	mvaidya@actrec.gov.in	Gangadaran, Prakash/AAV-3102-2021; Bhate, Amruta/AAR-2679-2021; Alam, Hunain/H-2984-2019	Bhate, Amruta/0000-0002-8570-2372; Alam, Hunain/0000-0002-6183-3677; Gangadaran, Prakash/0000-0002-0658-4604	Department of Biotechnology (DBT); Council for Scientific and Industrial Research (CSIR), India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology (DBT). Hunain Alam was supported by fellowships from the Council for Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM H, 2011, J CELL SCI; ALAM H, 2011, MOL BIOL CE IN PRESS; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Ferlito A, 2003, ORAL ONCOL, V39, P429, DOI 10.1016/S1368-8375(03)00010-1; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Hassan NMM, 2011, ASIAN PAC J CANCER P, V12, P947; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; Lo WL, 2003, J ORAL MAXIL SURG, V61, P751, DOI 10.1016/S0278-2391(03)00149-6; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mizuuchi E, 2009, INT J CANCER, V124, P1802, DOI 10.1002/ijc.24111; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; NELSON WG, 1983, J CELL BIOL, V97, P244, DOI 10.1083/jcb.97.1.244; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; SCHAAFSMA HE, 1993, J PATHOL, V170, P77, DOI 10.1002/path.1711700113; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shingaki S, 2003, AM J SURG, V185, P278, DOI 10.1016/S0002-9610(02)01378-8; Tao GZ, 2006, J CELL SCI, V119, P1425, DOI 10.1242/jcs.02861; TATAKE RJ, 1990, J CANCER RES CLIN, V116, P179, DOI 10.1007/BF01612674; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Toivola DM, 1997, J CELL SCI, V110, P23; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Woolgar JA, 2003, ORAL ONCOL, V39, P130, DOI 10.1016/S1368-8375(02)00030-1; Woolgar JA, 2006, ORAL ONCOL, V42, P229, DOI 10.1016/j.oraloncology.2005.05.008; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002	45	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27767	10.1371/journal.pone.0027767	http://dx.doi.org/10.1371/journal.pone.0027767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114688	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555800032
J	Burgess, A; Ayala-Grosso, CA; Ganguly, M; Jordao, JF; Aubert, I; Hynynen, K				Burgess, Alison; Ayala-Grosso, Carlos A.; Ganguly, Milan; Jordao, Jessica F.; Aubert, Isabelle; Hynynen, Kullervo			Targeted Delivery of Neural Stem Cells to the Brain Using MRI-Guided Focused Ultrasound to Disrupt the Blood-Brain Barrier	PLOS ONE			English	Article							LONG-TERM SURVIVAL; DOPAMINERGIC GRAFTS; MOTOR FUNCTION; MIGRATION; PROSPECTS; THERAPY; NEURONS; MODEL	Stem cell therapy is a promising strategy to treat neurodegenerative diseases, traumatic brain injury, and stroke. For stem cells to progress towards clinical use, the risks associated with invasive intracranial surgery used to deliver the cells to the brain, needs to be reduced. Here, we show that MRI-guided focused ultrasound (MRIgFUS) is a novel method for non-invasive delivery of stem cells from the blood to the brain by opening the blood brain barrier (BBB) in specific brain regions. We used MRI guidance to target the ultrasound beam thereby delivering the iron-labeled, green fluorescent protein (GFP)-expressing neural stem cells specifically to the striatum and the hippocampus of the rat brain. Detection of cellular iron using MRI established that the cells crossed the BBB to enter the brain. After sacrifice, 24 hours later, immunohistochemical analysis confirmed the presence of GFP-positive cells in the targeted brain regions. We determined that the neural stem cells expressed common stem cell markers (nestin and polysialic acid) suggesting they survived after transplantation with MRIgFUS. Furthermore, delivered stem cells expressed doublecortin in vivo indicating the stem cells were capable of differentiating into neurons. Together, we demonstrate that transient opening of the BBB with MRIgFUS is sufficient for transplantation of stem cells from the blood to targeted brain structures. These results suggest that MRIgFUS may be an effective alternative to invasive intracranial surgery for stem cell transplantation.	[Burgess, Alison; Ayala-Grosso, Carlos A.; Ganguly, Milan; Jordao, Jessica F.; Aubert, Isabelle; Hynynen, Kullervo] Sunnybrook Res Inst, Toronto, ON, Canada; [Ayala-Grosso, Carlos A.] Inst Venezolano Invest Cient, Ctr Med Expt, Lab Patol Celular & Mol, Caracas, Venezuela; [Jordao, Jessica F.; Aubert, Isabelle; Hynynen, Kullervo] Univ Toronto, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Venezuelan Institute Science Research; University of Toronto	Burgess, A (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	aburgess@sri.utoronto.ca	Aubert, Isabelle/AAG-4001-2019; Ayala-Grosso, Carlos/ABD-5221-2020	Aubert, Isabelle/0000-0001-5163-9961; Ayala-Grosso, Carlos/0000-0003-3079-1109	National Institute of Biomedical Imaging And Bioengineering of the National Institutes of Health [EB003268, EB009032]; Canadian Institutes for Health Research; Alzheimer's Association; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003268, R01EB009032] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging And Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Support for this work was provided by the grants EB003268 and EB009032 from the National Institute of Biomedical Imaging And Bioengineering of the National Institutes of Health (Kullervo Hynynen), and grants from the Canadian Institutes for Health Research and the Alzheimer's Association (Isabelle Aubert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 2004, CURR PHARM BIOTECHNO, V5, P567; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Chuang CS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-9; Danielyan L, 2011, REJUV RES, V14, P3, DOI 10.1089/rej.2010.1130; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Matsushita T, 2011, NEUROSCI LETT, V502, P41, DOI 10.1016/j.neulet.2011.07.021; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; O'Reilly MA, 2011, ULTRASOUND MED BIOL, V37, P587, DOI 10.1016/j.ultrasmedbio.2011.01.008; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; SEYFRIED DM, 2008, BRAIN RES, V11, P1224; SINDEN JD, 1992, CURR OPIN NEUROL NEU, V5, P902; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wenning GK, 1997, ANN NEUROL, V42, P95, DOI 10.1002/ana.410420115; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006	26	181	187	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27877	10.1371/journal.pone.0027877	http://dx.doi.org/10.1371/journal.pone.0027877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114718	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400133
J	Ker, DFE; Weiss, LE; Junkers, SN; Chen, M; Yin, ZZ; Sandbothe, MF; Huh, SI; Eom, S; Bise, R; Osuna-Highley, E; Kanade, T; Campbell, PG				Ker, Dai Fei Elmer; Weiss, Lee E.; Junkers, Silvina N.; Chen, Mei; Yin, Zhaozheng; Sandbothe, Michael F.; Huh, Seung-il; Eom, Sungeun; Bise, Ryoma; Osuna-Highley, Elvira; Kanade, Takeo; Campbell, Phil G.			An Engineered Approach to Stem Cell Culture: Automating the Decision Process for Real-Time Adaptive Subculture of Stem Cells	PLOS ONE			English	Article							REGENERATIVE MEDICINE; DIFFERENTIATION; GROWTH	Current cell culture practices are dependent upon human operators and remain laborious and highly subjective, resulting in large variations and inconsistent outcomes, especially when using visual assessments of cell confluency to determine the appropriate time to subculture cells. Although efforts to automate cell culture with robotic systems are underway, the majority of such systems still require human intervention to determine when to subculture. Thus, it is necessary to accurately and objectively determine the appropriate time for cell passaging. Optimal stem cell culturing that maintains cell pluripotency while maximizing cell yields will be especially important for efficient, cost-effective stem cell-based therapies. Toward this goal we developed a real-time computer vision-based system that monitors the degree of cell confluency with a precision of 0.791 +/- 0.031 and recall of 0.559 +/- 0.043. The system consists of an automated phase-contrast time-lapse microscope and a server. Multiple dishes are sequentially imaged and the data is uploaded to the server that performs computer vision processing, predicts when cells will exceed a pre-defined threshold for optimal cell confluency, and provides a Web-based interface for remote cell culture monitoring. Human operators are also notified via text messaging and e-mail 4 hours prior to reaching this threshold and immediately upon reaching this threshold. This system was successfully used to direct the expansion of a paradigm stem cell population, C2C12 cells. Computer-directed and human-directed control subcultures required 3 serial cultures to achieve the theoretical target cell yield of 50 million C2C12 cells and showed no difference for myogenic and osteogenic differentiation. This automated vision-based system has potential as a tool toward adaptive real-time control of subculturing, cell culture optimization and quality assurance/quality control, and it could be integrated with current and developing robotic cell cultures systems to achieve complete automation.	[Ker, Dai Fei Elmer; Campbell, Phil G.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Campbell, Phil G.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Sandbothe, Michael F.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Ker, Dai Fei Elmer; Weiss, Lee E.; Osuna-Highley, Elvira; Kanade, Takeo; Campbell, Phil G.] Carnegie Mellon Univ, Inst Complex Engn Syst, Pittsburgh, PA 15213 USA; [Weiss, Lee E.; Junkers, Silvina N.; Yin, Zhaozheng; Sandbothe, Michael F.; Huh, Seung-il; Eom, Sungeun] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Chen, Mei] Intel Labs, Pittsburgh, PA USA; [Bise, Ryoma] Dai Nippon Printing, Tokyo, Japan	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Intel Corporation; Dai Nippon Printing Co. Ltd.	Ker, DFE (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	pcampbel@cs.cmu.edu	Ker, Dai Fei Elmer/R-5959-2018	Ker, Dai Fei Elmer/0000-0003-3434-8390	National Institutes of Health [RO1EB004343, RO1EB007369]; Pennsylvania Infrastructure Technology Alliance (PITA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007369, R01EB004343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Infrastructure Technology Alliance (PITA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants RO1EB004343 and RO1EB007369 as well as funding from the Pennsylvania Infrastructure Technology Alliance (PITA). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Archer R, 2005, NAT BIOTECHNOL, V23, P1353, DOI 10.1038/nbt1105-1353; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; *BSI, 2006, 83 BSI; FDA, 1997, PROP APPR REG CELL T; *FDA, 2007, GUID IND REG HUM CEL; Huh S, 2011, IEEE T MED IMAGING, V30, P586, DOI 10.1109/TMI.2010.2089384; Ivanovic Zoran, 2010, World J Stem Cells, V2, P18, DOI 10.4252/wjsc.v2.i2.18; Kato R, 2010, TISSUE ENG PART C-ME, V16, P947, DOI [10.1089/ten.tec.2009.0305, 10.1089/ten.TEC.2009.0305]; Ker EDF, 2011, BIOMATERIALS, V32, P3413, DOI 10.1016/j.biomaterials.2011.01.036; Kino-oka M, 2000, BIOTECHNOL BIOENG, V67, P234, DOI 10.1002/(SICI)1097-0290(20000120)67:2<234::AID-BIT13>3.3.CO;2-8; Kino-Oka M, 2009, TISSUE ENG PART C-ME, V15, P717, DOI [10.1089/ten.tec.2008.0429, 10.1089/ten.TEC.2008.0429]; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Lindgren K, 2009, CYTOTECHNOLOGY, V59, P1, DOI 10.1007/s10616-009-9187-y; Liu Y, 2010, J TISSUE ENG REGEN M, V4, P45, DOI 10.1002/term.217; Mason C, 2007, TISSUE ENG, V13, P301, DOI 10.1089/ten.2006.0177; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Miller ED, 2009, COMB CHEM HIGH T SCR, V12, P604, DOI 10.2174/138620709788681907; Murphy D B, 2001, FUNDAMENTALS LIGHT M; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520; Qin J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013014; Saha K, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13144; SHARMA S, 2011, BIOTECHNOL J; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; Thomas RJ, 2009, BIOTECHNOL BIOENG, V102, P1636, DOI 10.1002/bit.22187; Thomas RJ, 2007, CYTOTECHNOLOGY, V55, P31, DOI 10.1007/s10616-007-9091-2; TRIDGELL A, 1999, UNDERSTANDING OPTICS; Veraitch FS, 2008, BIOTECHNOL BIOENG, V99, P1216, DOI 10.1002/bit.21673; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; YIN Z, 2011, 33 ANN INT C IEEE EN; Yin ZZ, 2010, LECT NOTES COMPUT SC, V6361, P209	33	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27672	10.1371/journal.pone.0027672	http://dx.doi.org/10.1371/journal.pone.0027672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110715	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555400080
J	Chutiwitoonchai, N; Hiyoshi, M; Mwimanzi, P; Ueno, T; Adachi, A; Ode, H; Sato, H; Fackler, OT; Okada, S; Suzu, S				Chutiwitoonchai, Nopporn; Hiyoshi, Masateru; Mwimanzi, Philip; Ueno, Takamasa; Adachi, Akio; Ode, Hirotaka; Sato, Hironori; Fackler, Oliver T.; Okada, Seiji; Suzu, Shinya			The Identification of a Small Molecule Compound That Reduces HIV-1 Nef-Mediated Viral Infectivity Enhancement	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-PROTEIN INTERACTION; M-CSF RECEPTOR; DOWN-REGULATION; CONFORMATIONAL ENERGIES; TYROSINE KINASE; HCK; ACTIVATION; REPLICATION; SURFACE	Nef is a multifunctional HIV-1 protein that accelerates progression to AIDS, and enhances the infectivity of progeny viruses through a mechanism that is not yet understood. Here, we show that the small molecule compound 2c reduces Nef-mediated viral infectivity enhancement. When added to viral producer cells, 2c did not affect the efficiency of viral production itself. However, the infectivity of the viruses produced in the presence of 2c was significantly lower than that of control viruses. Importantly, an inhibitory effect was observed with Nef(+) wild-type viruses, but not with viruses produced in the absence of Nef or in the presence of proline-rich PxxP motif-disrupted Nef, both of which displayed significantly reduced intrinsic infectivity. Meanwhile, the overexpression of the SH3 domain of the tyrosine kinase Hck, which binds to a PxxP motif in Nef, also reduced viral infectivity. Importantly, 2c inhibited Hck SH3-Nef binding, which was more marked when Nef was pre-incubated with 2c prior to its incubation with Hck, indicating that both Hck SH3 and 2c directly bind to Nef and that their binding sites overlap. These results imply that both 2c and the Hck SH3 domain inhibit the interaction of Nef with an unidentified host protein and thereby reduce Nef-mediated infectivity enhancement. The first inhibitory compound 2c is therefore a valuable chemical probe for revealing the underlying molecular mechanism by which Nef enhances the infectivity of HIV-1.	[Chutiwitoonchai, Nopporn; Hiyoshi, Masateru; Mwimanzi, Philip; Ueno, Takamasa; Okada, Seiji; Suzu, Shinya] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Adachi, Akio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Microbiol, Tokushima 770, Japan; [Ode, Hirotaka; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Fackler, Oliver T.] Univ Heidelberg, Dept Infect Dis, Heidelberg, Germany	Kumamoto University; Tokushima University; National Institute of Infectious Diseases (NIID); Ruprecht Karls University Heidelberg	Chutiwitoonchai, N (corresponding author), Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan.	ssuzu06@kumamoto-u.ac.jp	Okada, Seiji/F-5785-2013; Ueno, Takamasa/AAW-9491-2020; Ueno, Takamasa/F-5788-2013; Suzu, Shinya/F-5786-2013	Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Suzu, Shinya/0000-0003-2531-4770; Ode, Hirotaka/0000-0001-8624-2382; Hiyoshi, Masateru/0000-0002-1127-562X; Adachi, Akio/0000-0003-1674-332X; Fackler, Oliver Till/0000-0003-2982-4209	Global COE program "Global Education and Research Center Aiming at the control of AIDS"	Global COE program "Global Education and Research Center Aiming at the control of AIDS"	This research was supported by the grant from the Global COE program "Global Education and Research Center Aiming at the control of AIDS", launched as a project commissioned by the Ministry of Education, Science, Sports, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Akari H, 1999, J GEN VIROL, V80, P2945, DOI 10.1099/0022-1317-80-11-2945; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Bouchet J, 2011, BLOOD, V117, P3559, DOI 10.1182/blood-2010-07-296749; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GOLDSMITH MA, 1995, NEF J VIROL, V69, P4112; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; HALLER C, 2011, EUR J CELL IN PRESS; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hassan R, 2009, J CELL PHYSIOL, V221, P458, DOI 10.1002/jcp.21878; Hiyoshi M, 2008, BLOOD, V111, P243, DOI 10.1182/blood-2007-04-086017; Jere A, 2010, MICROBES INFECT, V12, P65, DOI 10.1016/j.micinf.2009.09.009; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Laguette N, 2009, J VIROL, V83, P1093, DOI 10.1128/JVI.01633-08; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Olszewski A, 2004, P NATL ACAD SCI USA, V101, P14079, DOI 10.1073/pnas.0406040101; Oneyama C, 2003, CHEM BIOL, V10, P443, DOI 10.1016/S1074-5521(03)00101-7; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Rauch S, 2008, J VIROL, V82, P2918, DOI 10.1128/JVI.02185-07; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schindler M, 2007, J VIROL, V81, P13005, DOI 10.1128/JVI.01436-07; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Singh RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008364; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Suzu S, 2005, BLOOD, V105, P3230, DOI 10.1182/blood-2004-06-2084; Tokunaga K, 1998, J VIROL, V72, P6257, DOI 10.1128/JVI.72.7.6257-6259.1998; Verollet C, 2010, J IMMUNOL, V184, P7030, DOI 10.4049/jimmunol.0903345; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005	55	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27696	10.1371/journal.pone.0027696	http://dx.doi.org/10.1371/journal.pone.0027696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110726	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300043
J	Bagaitkar, J; Daep, CA; Patel, CK; Renaud, DE; Demuth, DR; Scott, DA				Bagaitkar, Juhi; Daep, Carlo A.; Patel, Carol K.; Renaud, Diane E.; Demuth, Donald R.; Scott, David A.			Tobacco Smoke Augments Porphyromonas gingivalis - Streptococcus gordonii Biofilm Formation	PLOS ONE			English	Article							ALVEOLAR BONE LOSS; PERIODONTAL-DISEASE; CIGARETTE-SMOKING; CREVICULAR FLUID; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FIMBRIAL PROTEINS; RISK INDICATORS; SSPB PROTEIN; IN-VITRO; COTININE	Smoking is responsible for the majority of periodontitis cases in the US and smokers are more susceptible than non-smokers to infection by the periodontal pathogen Porphyromonas gingivalis. P. gingivalis colonization of the oral cavity is dependent upon its interaction with other plaque bacteria, including Streptococcus gordonii. Microarray analysis suggested that exposure of P. gingivalis to cigarette smoke extract (CSE) increased the expression of the major fimbrial antigen (FimA), but not the minor fimbrial antigen (Mfa1). Therefore, we hypothesized that CSE promotes P. gingivalis-S. gordonii biofilm formation in a FimA-dependent manner. FimA total protein and cell surface expression were increased upon exposure to CSE whereas Mfa1 was unaffected. CSE exposure did not induce P. gingivalis auto-aggregation but did promote dual species biofilm formation, monitored by microcolony numbers and depth (both, p<0.05). Interestingly, P. gingivalis biofilms grown in the presence of CSE exhibited a lower pro-inflammatory capacity (TNF-alpha, IL-6) than control biofilms (both, p<0.01). CSE-exposed P. gingivalis bound more strongly to immobilized rGAPDH, the cognate FimA ligand on S. gordonii, than control biofilms (p<0.001) and did so in a dose-dependent manner. Nevertheless, a peptide representing the Mfa1 binding site on S. gordonii, SspB, completely inhibited dual species biofilm formation. Thus, CSE likely augments P. gingivalis biofilm formation by increasing FimA avidity which, in turn, supports initial interspecies interactions and promotes subsequent high affinity Mfa1-SspB interactions driving biofilm growth. CSE induction of P. gingivalis biofilms of limited pro-inflammatory potential may explain the increased persistence of this pathogen in smokers. These findings may also be relevant to other biofilm-induced infectious diseases and conditions.	[Bagaitkar, Juhi; Daep, Carlo A.; Demuth, Donald R.; Scott, David A.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Patel, Carol K.; Renaud, Diane E.; Demuth, Donald R.; Scott, David A.] Univ Louisville, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Bagaitkar, J (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	dascot07@louisville.edu	Scott, David/GYU-8656-2022	Scott, David A./0000-0003-1007-2756	National Institutes of Health [R01DE019826]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by a National Institutes of Health award to DAS (R01DE019826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGAITKAR J, 2008, TOBACCO INDUCED DIS, V4; Bagaitkar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009323; Bagaitkar J, 2009, ENVIRON MICROBIOL, V11, P1242, DOI 10.1111/j.1462-2920.2008.01852.x; Brown LJ, 2002, PERIODONTOL 2000, V29, P223, DOI 10.1034/j.1600-0757.2002.290111.x; Chen X, 2001, J CLIN PERIODONTOL, V28, P331, DOI 10.1034/j.1600-051x.2001.028004331.x; Christopher AB, 2010, MICROBIOL-SGM, V156, P3469, DOI 10.1099/mic.0.042671-0; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; Cogo K, 2008, CAN J MICROBIOL, V54, P501, DOI [10.1139/W08-032, 10.1139/w08-032]; Cogo K, 2009, ARCH ORAL BIOL, V54, P1061, DOI 10.1016/j.archoralbio.2009.08.001; DAEP CA, 2008, INFECT IMMUN; DAEP CA, 2008, INFECT IMMUNITY; Daep CA, 2006, INFECT IMMUN, V74, P5756, DOI 10.1128/IAI.00813-06; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Demuth DR, 2001, INFECT IMMUN, V69, P5736, DOI 10.1128/IAI.69.9.5736-5741.2001; DEMUTH DR, 1988, INFECT IMMUN, V56, P2484, DOI 10.1128/IAI.56.9.2484-2490.1988; Eggert FM, 2001, J PERIODONTOL, V72, P1210, DOI 10.1902/jop.2000.72.9.1210; Fraser HS, 2001, J DENT RES, V80, P1643, DOI 10.1177/00220345010800070901; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; GROSSI SG, 1995, J PERIODONTOL, V66, P23, DOI 10.1902/jop.1995.66.1.23; GUGGENHEIM B, 2009, NATURE IMMU IN PRESS; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P377, DOI 10.1034/j.1600-051x.2001.028005377.x; Hashimoto M, 2003, FEMS MICROBIOL LETT, V226, P267, DOI 10.1016/S0378-1097(03)00615-3; Hongo H, 2007, J PERIODONTAL RES, V42, P114, DOI 10.1111/j.1600-0765.2006.00922.x; Hritz M, 1996, INFECT IMMUN, V64, P2724, DOI 10.1128/IAI.64.7.2724-2729.1996; Johnson GK, 2007, PERIODONTOL 2000, V44, P178, DOI 10.1111/j.1600-0757.2007.00212.x; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; Khlgatian M, 2002, INFECT IMMUN, V70, P257, DOI 10.1128/IAI.70.1.257-267.2002; Koh EM, 2011, MICROBIOL IMMUNOL, V55, P199, DOI 10.1111/j.1348-0421.2011.00305.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Maeda K, 2004, INFECT IMMUN, V72, P1341, DOI 10.1128/IAI.72.3.1341-1348.2004; Marsh P D, 1994, Adv Dent Res, V8, P263; MCGUIRE JR, 1989, J PERIODONTOL, V60, P176, DOI 10.1902/jop.1989.60.4.176; McGuire Michael K., 1996, Journal of Periodontology, V67, P666; Nagata H, 2009, INFECT IMMUN, V77, P5130, DOI 10.1128/IAI.00439-09; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Pierce DL, 2009, INFECT IMMUN, V77, P3294, DOI 10.1128/IAI.00262-09; Rapala-Kozik M, 2011, INFECT IMMUN, V79, P797, DOI 10.1128/IAI.00966-10; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Scott DA, 2001, J CLIN PERIODONTOL, V28, P715, DOI 10.1034/j.1600-051X.2001.280801.x; Shin EA, 2009, MOL BIOTECHNOL, V43, P138, DOI 10.1007/s12033-009-9181-9; Shoji M, 2010, CAN J MICROBIOL, V56, P959, DOI [10.1139/W10-084, 10.1139/w10-084]; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Yu F, 2011, J CLIN PERIODONTOL, V38, P334, DOI 10.1111/j.1600-051X.2010.01700.x; Zambon JJ, 1996, J PERIODONTOL, V67, P1050, DOI 10.1902/jop.1996.67.10s.1050; Zhang W, 2011, J PERIODONTOL, V82, P909, DOI 10.1902/jop.2010.100501	49	54	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27386	10.1371/journal.pone.0027386	http://dx.doi.org/10.1371/journal.pone.0027386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110637	Green Published, gold, Green Submitted			2022-12-25	WOS:000297554300024
J	Shin, YC; Tang, SJ; Chen, JH; Liao, PH; Chang, SC				Shin, Yung-Cheng; Tang, Siao-Jing; Chen, Jou-Han; Liao, Pei-Han; Chang, Shih-Chung			The Molecular Determinants of NEDD8 Specific Recognition by Human SENP8	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; DENEDDYLATING ENZYME; CONJUGATING ENZYMES; CRYSTAL-STRUCTURE; DUAL-SPECIFICITY; C-TERMINUS; IDENTIFICATION; DEN1; PATHWAY; COMPLEX	Although neuronal-precursor-cell-expressed developmentally downregulated protein-8 (NEDD8) and ubiquitin share the highest level of sequence identity and structural similarity among several known ubiquitin-like proteins, their conjugation to a protein leads to distinct biological consequences. In the study, we first identified the NEDD8 protein of Chlamydomonas reinhardtii (CrNEDD8) and discovered that CrNEDD8 is fused at the C-terminus of a ubiquitin moiety (CrUb) in a head-to-tail arrangement. This CrUb-CrNEDD8 protein was termed CrRUB1 (related to ubiquitin 1) by analogy with a similar protein in Arabidopsis thaliana (AtRUB1). Since there is high sequence identity in comparison to the corresponding human proteins (97% for ubiquitin and 84% for NEDD8), a His-CrRUB1-glutathione S-transferase (GST) fusion construct was adopted as the alternative substrate to characterize the specificity of NEDD8-specific peptidase SENP8 for CrNEDD8. The data showed that SENP8 only cleaved the peptide bond beyond the di-glycine motif of CrNEDD8 and His-RUB1 was subsequently generated, confirming that SENP8 has exquisite specificity for CrNEDD8 but not CrUb. To further determine the basis of this specificity, site-directed mutagenesis at earlier reported putative molecular determinants of NEDD8 specific recognition by SENP8 was performed. We found that a single N51E mutation of CrNEDD8 completely inhibited its hydrolysis by SENP8. Conversely, a single E51N mutation of CrUb enabled this ubiquitin mutant to undergo hydrolysis by SENP8, revealing that a single residue difference at the position 51 contributes substantially to the substrate selectivity of SENP8. Moreover, the E51N/R72A double mutant of the CrUb subdomain can further increase the efficiency of cleavage by SENP8, indicating that the residue at position 72 is also important in substrate recognition. The E51N or R72A mutation of CrUb also inhibited the hydrolysis of CrUb by ubiquitin-specific peptidase USP2. However, USP2 cannot cleave the N51E/A72R double mutant of the CrNEDD8 subdomain, suggesting that USP2 requires additional recognition sites.	[Shin, Yung-Cheng; Tang, Siao-Jing; Chen, Jou-Han; Liao, Pei-Han; Chang, Shih-Chung] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University	Shin, YC (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	shihchung@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	CHANG, SHIH-CHUNG/0000-0002-5015-8178	Frontier and Innovative Research of National Taiwan University [99R70442]; National Science Council of the Republic of China [NSC96-2311-B-002-024-MY3]	Frontier and Innovative Research of National Taiwan University(National Taiwan University); National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the Frontier and Innovative Research of National Taiwan University (99R70442) and from the National Science Council of the Republic of China (NSC96-2311-B-002-024-MY3) to S.-C.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Linghu B, 2002, EUKARYOT CELL, V1, P491, DOI 10.1128/EC.1.3.491-494.2002; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rao-Naik C, 1998, J BIOL CHEM, V273, P34976, DOI 10.1074/jbc.273.52.34976; Reverter D, 2005, J MOL BIOL, V345, P141, DOI 10.1016/j.jmb.2004.10.022; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Shin YC, 2010, PLANTA, V232, P649, DOI 10.1007/s00425-010-1204-z; Souphron J, 2008, BIOCHEMISTRY-US, V47, P8961, DOI 10.1021/bi800604c; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Zhou LH, 2005, BIOCHEM J, V389, P307, DOI 10.1042/BJ20041991	40	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27742	10.1371/journal.pone.0027742	http://dx.doi.org/10.1371/journal.pone.0027742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110750	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300050
J	Matzdorff, AC; Arnold, G; Salama, A; Ostermann, H; Eberle, S; Hummler, S				Matzdorff, Axel C.; Arnold, Gabriele; Salama, Abdulgabar; Ostermann, Helmut; Eberle, Sonja; Hummler, Simone			Advances in ITP - Therapy and Quality of Life - A Patient Survey	PLOS ONE			English	Article							IMMUNE-THROMBOCYTOPENIC-PURPURA; NATURAL-HISTORY; DOUBLE-BLIND; ADULTS; SPLENECTOMY; MANAGEMENT; PREVALENCE; HEMORRHAGE; EFFICACY; CHILDREN	Background: Current guidelines recommend glucocorticoids and splenectomy as standard 1(st) and 2(nd) line treatments for chronic immune thrombocytopenia (ITP). We sought to find out how German ITP-patients are treated with respect to these guidelines. Methods: Members of a patient support association >= 18 years with a self-reported history of chronic ITP. 12 months were surveyed with a web-based questionnaire. Results: 122 questionnaires were evaluated. 70% of patients had chronic ITP for more than 5 years and 20% an average platelet count of <= 30.10(9)/L. 41% of the patients reported haematomas or petechiae more than once or twice and up to 12 times or more per year and 17% oropharyngeal and nasal bleeds. 11% had been admitted to hospital during the last 12 months. 88% had received or currently receive glucocorticoids, 27% were splenectomised. IVIG had been given to 55%, rituximab to 22%, anti-D to 12%, ciclosporin to 7%, while complementary and alternative medical treatments had been used by 36%. 50 women responded to questions concerning pregnancy. 14 (28%) had been advised not to become pregnant. 23 reported pregnancies and 10 (44%) required treatment for their ITP during pregnancy. Conclusion: Glucocorticoids are the most common therapy for chronic ITP but complementary and alternative treatments already come second and less than M of patients are splenectomised. This and the frequent use of complementary medicines suggests patients' dissatisfaction with conventional approaches. Many patients receive off-label therapies. There is a major need for adequate counselling and care for pregnant ITP-patients.	[Matzdorff, Axel C.] Caritasklin St Theresia, Dept Haematol, Saarbrucken, Germany; [Arnold, Gabriele] ITP Self Support Grp, Giessen, Germany; [Salama, Abdulgabar] Charite Univ Med Berlin, Inst Transfus Med, Berlin, Germany; [Ostermann, Helmut] Univ Munich Grosshadern Campus, Dept Haematol, Munich, Germany; [Eberle, Sonja] GlaxoSmithKline, Dept Biostat & Epidemiol, Munich, Germany; [Hummler, Simone] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Hummler, Simone] German Canc Res Ctr, D-6900 Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; GlaxoSmithKline; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Matzdorff, AC (corresponding author), Caritasklin St Theresia, Dept Haematol, Saarbrucken, Germany.	a.matzdorff@caritasklinik.de			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The set up of the web-based questionnaire was funded by GlaxoSmithKline (the content of the questionnaire was based on clinical literature, expert opinion and patients' experience). Sonja Eberle (employee at GlaxoSmithKline) was involved in the data analysis process. No other external funding was received.	ALEDORT LML, 2006, BLOOD, V108; BAILI LKM, 2009, BLOOD, V114; Berti D, 2008, CLIN THER, V30, P1540, DOI 10.1016/j.clinthera.2008.08.005; Buchanan GR, 2002, J PEDIATR-US, V141, P683, DOI 10.1067/mpd.2002.128547; Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Cohen YC, 2000, ARCH INTERN MED, V160, P1630, DOI 10.1001/archinte.160.11.1630; Djulbegovic B, 2001, BLOOD, V98, P2282, DOI 10.1182/blood.V98.7.2282; Feudjo-Tepie MA, 2008, J THROMB HAEMOST, V6, P711, DOI 10.1111/j.1538-7836.2008.02911.x; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; LACEY JV, 1977, SEMIN THROMB HEMOST, V3, P160; Love N, 2009, J CLIN ONCOL, V27; Mathias SD, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-13; Matzdorff A, 2007, EUR J HAEMATOL, V78, P381, DOI 10.1111/j.1600-0609.2007.00829.x; Matzdorff A, 2010, ONKOLOGIE, V33, P2, DOI 10.1159/000290758; McMillan R, 2004, BLOOD, V104, P956, DOI 10.1182/blood-2003-11-3908; Neunert CE, 2008, BLOOD, V112, P4003, DOI 10.1182/blood-2008-03-138487; Neylon AJ, 2003, BRIT J HAEMATOL, V122, P966, DOI 10.1046/j.1365-2141.2003.04547.x; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Psaila B, 2009, BLOOD, V114, P4777, DOI 10.1182/blood-2009-04-215525; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; Snyder CF, 2008, CURR MED RES OPIN, V24, P2767, DOI 10.1185/03007990802377461 ; STASI R, 1995, AM J MED, V98, P436, DOI 10.1016/S0002-9343(99)80342-8; Tarantino MD, 2010, CURR MED RES OPIN, V26, P319, DOI 10.1185/03007990903451298; Vesely SK, 2004, ANN INTERN MED, V140, P112, DOI 10.7326/0003-4819-140-3-200402030-00012	30	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27350	10.1371/journal.pone.0027350	http://dx.doi.org/10.1371/journal.pone.0027350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096556	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900034
J	Pedro, L; Banos, RC; Aznar, S; Madrid, C; Balsalobre, C; Juarez, A				Pedro, Laura; Banos, Rosa C.; Aznar, Sonia; Madrid, Cristina; Balsalobre, Carlos; Juarez, Antonio			Antibiotics Shaping Bacterial Genome: Deletion of an IS91 Flanked Virulence Determinant upon Exposure to Subinhibitory Antibiotic Concentrations	PLOS ONE			English	Article							PROMOTES HORIZONTAL DISSEMINATION; INSERTION-SEQUENCE IS91; ESCHERICHIA-COLI; H-NS; PATHOGENICITY ISLAND; GENES; MODULATION; PLASMID; PROTEINS; HHA	The nucleoid-associated proteins Hha and YdgT repress the expression of the toxin a-hemolysin. An Escherichia coli mutant lacking these proteins overexpresses the toxin a-hemolysin encoded in the multicopy recombinant plasmid pANN202-312R. Unexpectedly, we could observe that this mutant generated clones that no further produced hemolysin (Hly(-)). Generation of Hly(-) clones was dependent upon the presence in the culture medium of the antibiotic kanamycin (km), a marker of the hha allele (hha::Tn5). Detailed analysis of different Hly(-) clones evidenced that recombination between partial IS91 sequences that flank the hly operon had occurred. A fluctuation test evidenced that the presence of km in the culture medium was underlying the generation of these clones. A decrease of the km concentration from 25 mg/l to 12.5 mg/l abolished the appearance of Hly(-) derivatives. We considered as a working hypothesis that, when producing high levels of the toxin (combination of the hha ydgT mutations with the presence of the multicopy hemolytic plasmid pANN202-312R), the concentration of km of 25 mg/l resulted subinhibitory and stimulated the recombination between adjacent IS91 flanking sequences. To further test this hypothesis, we analyzed the effect of subinhibitory km concentrations in the wild type E. coli strain MG1655 harboring the parental low copy number plasmid pHly152. At a km concentration of 5 mg/l, subinhibitory for strain MG1655 (pHly152), generation of Hly(-) clones could be readily detected. Similar results were also obtained when, instead of km, ampicillin was used. IS91 is flanking several virulence determinants in different enteric bacterial pathogenic strains from E. coli and Shigella. The results presented here evidence that stress generated by exposure to subinhibitory antibiotic concentrations may result in rearrangements of the bacterial genome. Whereas some of these rearrangements may be deleterious, others may generate genotypes with increased virulence, which may resume infection.	[Pedro, Laura; Banos, Rosa C.; Juarez, Antonio] Inst Bioengn Catalunya, Barcelona, Spain; [Aznar, Sonia; Madrid, Cristina; Balsalobre, Carlos; Juarez, Antonio] Univ Barcelona, Dept Microbiol, Fac Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona	Pedro, L (corresponding author), Inst Bioengn Catalunya, Parc Cient Barcelona, Barcelona, Spain.	ajuarez@ub.edu	Balsalobre, Carlos/E-4213-2016; Madrid, Cristina/K-2939-2017	Balsalobre, Carlos/0000-0002-4147-219X; Madrid, Cristina/0000-0002-5861-3980; Juarez, Antonio/0000-0002-5027-8778	Spanish MICINN [Bio2010-15683, BFU2010-21836-C02-01, CSD2008-00013]; Generalitat de Catalunya [2009SGR1352]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by funds from the Spanish MICINN-FEDER (Bio2010-15683, BFU2010-21836-C02-01 and CSD2008-00013) and the Generalitat de Catalunya (2009SGR1352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; BACHMANN BJ, 1987, ESCHERICHIA COLI SAL; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bernales I, 1999, MOL MICROBIOL, V33, P223, DOI 10.1046/j.1365-2958.1999.01432.x; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Couce A, 2009, FEMS MICROBIOL REV, V33, P531, DOI 10.1111/j.1574-6976.2009.00165.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; DIAZAROCA E, 1984, MOL GEN GENET, V193, P493, DOI 10.1007/BF00382089; Dozois CM, 1999, VET RES, V30, P157; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Garcillan-Barcia MP, 2002, FEMS MICROBIOL ECOL, V42, P303, DOI 10.1111/j.1574-6941.2002.tb01020.x; GARCILLANBARCIA.MP, 2002, MOBILE DNA, V2; GODESSART N, 1988, J GEN MICROBIOL, V134, P2779; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hacker J, 1999, PATHOGENICITY ISLAND; Hastings PJ, 2007, CRIT REV BIOCHEM MOL, V42, P271, DOI 10.1080/10409230701507757; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; HENGGEARONIS R, 1992, MOL MICROBIOL, V6, P1877, DOI 10.1111/j.1365-2958.1992.tb01360.x; KNAPP S, 1984, J BACTERIOL, V159, P1027, DOI 10.1128/JB.159.3.1027-1033.1984; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lombardo MJ, 2004, GENETICS, V166, P669, DOI 10.1534/genetics.166.2.669; Lopez E, 2007, MOL MICROBIOL, V64, P83, DOI 10.1111/j.1365-2958.2007.05642.x; Lopez E, 2009, ANTIMICROB AGENTS CH, V53, P3411, DOI 10.1128/AAC.00358-09; Luria SE, 1943, GENETICS, V28, P491; Madrid C, 2002, J BACTERIOL, V184, P5058, DOI 10.1128/JB.184.18.5058-5066.2002; Madrid C, 2007, MOL MICROBIOL, V63, P7, DOI 10.1111/j.1365-2958.2006.05497.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; NOEGEL A, 1981, J BACTERIOL, V145, P233, DOI 10.1128/JB.145.1.233-247.1981; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Schlor S, 2000, APPL ENVIRON MICROB, V66, P352, DOI 10.1128/AEM.66.1.352-358.2000; Shapiro JA, 2009, GENETICS, V183, P1205, DOI 10.1534/genetics.109.110007; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Turner SA, 2001, J BACTERIOL, V183, P5535, DOI 10.1128/JB.183.19.5535-5543.2001; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8; Yim G, 2006, J BACTERIOL, V188, P7988, DOI 10.1128/JB.00791-06; ZABALA JC, 1984, MOL GEN GENET, V197, P90, DOI 10.1007/BF00327927; ZABALA JC, 1982, J BACTERIOL, V151, P472, DOI 10.1128/JB.151.1.472-476.1982; Zaghloul L, 2007, FEMS MICROBIOL LETT, V277, P197, DOI 10.1111/j.1574-6968.2007.00957.x	51	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27606	10.1371/journal.pone.0027606	http://dx.doi.org/10.1371/journal.pone.0027606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096603	Green Published, gold			2022-12-25	WOS:000297553900062
J	Zhang, R; Zheng, LQ; Sun, ZQ; Zhang, XG; Li, J; Hu, DY; Sun, YX				Zhang, Rui; Zheng, Liqiang; Sun, Zhaoqing; Zhang, Xingang; Li, Jue; Hu, Dayi; Sun, Yingxian			Decreased Glomerular Filtration Rate Is Associated with Mortality and Cardiovascular Events in Patients with Hypertension: A Prospective Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; RISK-FACTOR; RENAL-INSUFFICIENCY; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; DYSFUNCTION; DEATH; ALBUMINURIA; POPULATION	Background: Few studies reported the associations between decreased glomerular filtration rate (GFR) and mortality, coronary heart disease (CHD), and stroke in hypertensive patients. We aim to assess the associations between GFR and mortality, CHD, and stroke in hypertensive patients and to evaluate whether low GFR can improve the prediction of these outcomes in addition to conventional cardiovascular risk factors. Methods and Findings: This is an observational prospective study and 3,711 eligible hypertensive patients aged >= 5 years from rural areas of China were used for the present analysis. The associations between eGFR and outcomes, followed by a median of 4.9 years, were evaluated using Cox proportional hazards models adjusting for other potential confounders. Low eGFR was independently associated with risk of all-cause mortality, cardiovascular mortality, and incident stroke [multivariable adjusted hazard ratios (95% confidence intervals) for eGFR,60 ml/min/1.73 m(2) relative to eGFR >= 90 ml/min/1.73 m(2) were 1.824 (1.047-3.365), 2.371 (1.109-5.068), and 2.493 (1.193-5.212), respectively]. We found no independent association between eGFR and the risk of CHD. For 4-year all-cause and cardiovascular mortality, integrated discrimination improvement (IDI) was positive when eGFR were added to traditional risk factors (1.51%, P = 0.016, and 1.99%, P = 0.017, respectively). For stroke and CHD events, net reclassification improvements (NRI) were 5.9% (P = 0.012) and 1.8% (P = 0.083) for eGFR, respectively. Conclusions: We have established an inversely independent association between eGFR and all-cause mortality, cardiovascular mortality, and stroke in hypertensive patients in rural areas of China. Further, addition of eGFR significantly improved the prediction of 4-year mortality and stroke over and above that of conventional risk factors. We recommend that eGFR be incorporated into prognostic assessment for patients with hypertension in rural areas of China. Limitations: We did not have sufficient information on atrial fibrillation to control for the potential covariate. These associations should be further confirmed in future.	[Zhang, Rui] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zheng, Liqiang] China Med Univ, Shengjing Hosp, Library, Shenyang, Peoples R China; [Sun, Zhaoqing] China Med Univ, Shengjing Hosp, Dept Cardiol, Shenyang, Peoples R China; [Zhang, Xingang; Sun, Yingxian] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Shenyang, Peoples R China; [Li, Jue; Hu, Dayi] Tongji Univ, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China	Peking University; China Medical University; China Medical University; China Medical University; Tongji University	Sun, YX (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Cardiol, 155 Nanjing N St, Shenyang 110001, Peoples R China.	sunyingxian12@yahoo.com.cn			Key Technology Research and Development Program of Liaoning Province [2003225003]	Key Technology Research and Development Program of Liaoning Province	This study was supported by grants from the Key Technology Research and Development Program of Liaoning Province (2003225003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax L, 2008, ATHEROSCLEROSIS, V200, P184, DOI 10.1016/j.atherosclerosis.2007.12.006; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Bouchi R, 2010, HYPERTENS RES, V33, P1298, DOI 10.1038/hr.2010.170; Bouchi R, 2009, HYPERTENS RES, V32, P381, DOI 10.1038/hr.2009.30; Brugts JJ, 2005, ARCH INTERN MED, V165, P2659, DOI 10.1001/archinte.165.22.2659; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; *DEP HLTH HUM SERV, 1989, INT CLASS DIS CLIN M; Ford I, 2009, PLOS MED, V6, P76, DOI 10.1371/journal.pmed.1000016; Fox CS, 2004, KIDNEY INT, V66, P2017, DOI 10.1111/j.1523-1755.2004.00973.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; McCullough PA, 2000, J AM COLL CARDIOL, V36, P679, DOI 10.1016/S0735-1097(00)00774-9; *NAT I ALC AB ALC, 2000, 10 SPEC REP US C ALC, V24, P5; Ovbiagele B, 2008, ARCH NEUROL-CHICAGO, V65, P934, DOI 10.1001/archneur.65.7.934; Rahman M, 2006, ANN INTERN MED, V144, P172, DOI 10.7326/0003-4819-144-3-200602070-00005; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; Viazzi F, 2010, J HYPERTENS, V28, P848, DOI 10.1097/HJH.0b013e328336ed09; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007; Zheng LQ, 2008, STROKE, V39, P1932, DOI 10.1161/STROKEAHA.107.510677	30	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27359	10.1371/journal.pone.0027359	http://dx.doi.org/10.1371/journal.pone.0027359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096561	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900037
J	Geng, W; Ng, KTP; Sun, CKW; Yau, WL; Liu, XB; Cheng, Q; Poon, RTP; Lo, CM; Man, K; Fan, ST				Geng, Wei; Ng, Kevin T. P.; Sun, Chris K. W.; Yau, Wing Lung; Liu, Xiao Bing; Cheng, Qiao; Poon, Ronnie T. P.; Lo, Chung Mau; Man, Kwan; Fan, Sheung Tat			The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; BREAST-CANCER CELL; LUNG-CANCER; TARGETED THERAPY; PROSTATE-CANCER; GROWTH-FACTOR; CHEMOTHERAPY; EXPRESSION; PATHWAY; PROLIFERATION	Aims: We previously demonstrated Proline rich tyrosine kinase 2 (Pyk2) plays important roles in regulating tumor progression, migration and invasion in hepatocellular carcinoma (HCC). In this study, we aimed to examine the role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in HCC and to explore its underlying molecular mechanism. Methodology/Principal Findings: Stable transfectants either overexpressing or suppressing Pyk2 were established in different HCC cell lines. MTT, colony formation and Annexin-V assays were employed to examine their in vitro responses to cisplatin. Xenograft ectopic and orthotopic nude mice models were generated to investigate the in vivo responses of them to cisplatin treatment. cDNA microarray was performed to identify Pyk2-induced genes which were further validated by quantitative real-time RT-PCR using clinical HCC samples. In vitro functional study demonstrated that Pyk2-overexpressing HCC transfectants exhibited relatively lower cytotoxicity, higher colony-forming ability and lower apoptosis to cisplatin compared with the control transfectants. Moreover, Pyk2 overexpressing HCC transfectants had a higher survival rate under cisplatin treatment by up-regulation of AKT phosphorylation. In vivo xenograft nude mice model demonstrated that Pyk2-overexpressing transfectants developed higher tolerance to cisplatin treatment together with less tumor necrosis and apoptosis. cDNA microarray analysis revealed that there were more than 4,000 genes differentially expressed upon overexpression of Pyk2. Several upregulated genes were found to be involved in drug resistance and invasion in cancers. Among them, the expression profiles of MDR1, GAGE1, STAT1 and MAP7 were significantly associated with the expression of Pyk2 in clinical HCC samples. Conclusions: Our results may suggest a new evidence of Pyk2 on promoting cisplatin resistance of HCC cells through preventing cell apoptosis, activation of AKT pathway and upregulation of drug resistant genes.	[Geng, Wei; Ng, Kevin T. P.; Sun, Chris K. W.; Yau, Wing Lung; Liu, Xiao Bing; Cheng, Qiao; Poon, Ronnie T. P.; Lo, Chung Mau; Man, Kwan; Fan, Sheung Tat] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Geng, W (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	kwanman@hkucc.hku.hk	NG, Kevin Tak-Pan/J-1510-2018	NG, Kevin Tak-Pan/0000-0001-9822-1335	Research Grant Council Hong Kong [7574/06M, HKU5/CRF/08]	Research Grant Council Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (7574/06M) and Collaborative Research Fund (HKU5/CRF/08) of the Research Grant Council Hong Kong. http://www.ugc.edu.hk/eng/ugc/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, MOL MECH HEPATOCELLU; Asechi H, 2010, INT J ONCOL, V37, P89, DOI 10.3892/ijo_00000656; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bagi CM, 2009, CANCER BIOL THER, V8, P856, DOI 10.4161/cbt.8.9.8246; Behmoaram E, 2008, AM J PATHOL, V173, P1540, DOI 10.2353/ajpath.2008.080292; Chou YY, 1997, J GASTROEN HEPATOL, V12, P569, DOI 10.1111/j.1440-1746.1997.tb00487.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503, DOI 10.14670/HH-24.503; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Inamura K, 2005, BBA-MOL CELL RES, V1745, P401, DOI 10.1016/j.bbamcr.2005.06.003; JANIK P, 1975, CANCER RES, V35, P3698; Johnson-Holiday C, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-46; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Kasuga C, 2008, J NEUROS-PEDIATR, V1, P305, DOI 10.3171/PED/2008/1/4/305; Kawano Y, 2009, EJSO-EUR J SURG ONC, V35, P174, DOI 10.1016/j.ejso.2008.01.027; Kerr SH, 2009, CANCER LETT, V286, P114, DOI 10.1016/j.canlet.2009.07.001; Langer R, 2004, VERH DEUT G, V88, P207; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luo Guorong, 2002, Cancer Immun, V2, P11; Man K, 2005, AM J TRANSPLANT, V5, P40, DOI 10.1111/j.1600-6143.2004.00642.x; Man K, 2010, ANN SURG, V251, P1154, DOI 10.1097/SLA.0b013e3181d96e3d; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Minemura M, 1999, INT J ONCOL, V15, P559; Okusaka Takuji, 2004, Gan To Kagaku Ryoho, V31, P2122; Pan JH, 2009, RESPIRATION, V78, P49, DOI 10.1159/000158454; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Picascia A, 2002, MOL CELL ENDOCRINOL, V186, P81, DOI 10.1016/S0303-7207(01)00667-0; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Shen X, 2010, CELL MOL LIFE SCI; Shiraga K, 2001, J GASTROEN HEPATOL, V16, P460, DOI 10.1046/j.1440-1746.2001.02457.x; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spangenberg HC, 2009, TARGETED THERAPY HEP; Stanzione R, 2001, LAB INVEST, V81, P51, DOI 10.1038/labinvest.3780211; Sun CK, 2007, BRIT J CANCER, V97, P50, DOI 10.1038/sj.bjc.6603827; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Sun CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018878; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Tsurutani J, 2005, CANCER RES, V65, P8423, DOI 10.1158/0008-5472.CAN-05-0058; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yau T, 2009, LIVER INT, V29, P10, DOI 10.1111/j.1478-3231.2008.01916.x; Zhang SY, 2008, LUNG CANCER, V62, P295, DOI 10.1016/j.lungcan.2008.05.008; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422	50	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27362	10.1371/journal.pone.0027362	http://dx.doi.org/10.1371/journal.pone.0027362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096562	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800049
J	Bonnomet, A; Syne, L; Brysse, A; Feyereisen, E; Thompson, EW; Noel, A; Foidart, JM; Birembaut, P; Polette, M; Gilles, C				Bonnomet, A.; Syne, L.; Brysse, A.; Feyereisen, E.; Thompson, E. W.; Noel, A.; Foidart, J-M; Birembaut, P.; Polette, M.; Gilles, C.			A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer	ONCOGENE			English	Article						EMT; circulating tumor cells; metastases; vimentin; MDA-MB-468	GROWTH-FACTOR RECEPTOR-2; GENE-EXPRESSION; STEM-CELL; CARCINOMA CELLS; E-CADHERIN; BASAL; SNAIL; PHENOTYPE; INVASION; SUBTYPE	Epithelial-to-mesenchymal transition (EMT) processes endow epithelial cells with enhanced migratory/invasive properties and are therefore likely to contribute to tumor invasion and metastatic spread. Because of the difficulty in following EMT processes in human tumors, we have developed and characterized an animal model with transplantable human breast tumor cells (MDA-MB-468) uniquely showing spontaneous EMT events to occur. Using vimentin as a marker of EMT, heterogeneity was revealed in the primary MDA-MB-468 xenografts with vimentin-negative and vimentin-positive areas, as also observed on clinical human invasive breast tumor specimens. Reverse transcriptase-PCR after microdissection of these populations from the xenografts revealed EMT traits in the vimentin-positive zones characterized by enhanced 'mesenchymal gene' expression (Snail, Slug and fibroblast-specific protein-1) and diminished expression of epithelial molecules (E-cadherin, ZO-3 and JAM-A). Circulating tumor cells (CTCs) were detected in the blood as soon as 8 days after s.c. injection, and lung metastases developed in all animals injected as examined by in vivo imaging analyses and histology. High levels of vimentin RNA were detected in CTCs by reverse transcriptase-quantitative PCR as well as, to a lesser extent, Snail and Slug RNA. Von Willebrand Factor/vimentin double immunostainings further showed that tumor cells in vascular tumoral emboli all expressed vimentin. Tumoral emboli in the lungs also expressed vimentin whereas macrometastases displayed heterogenous vimentin expression, as seen in the primary xenografts. In conclusion, our data uniquely demonstrate in an in vivo context that EMT occurs in the primary tumors, and associates with an enhanced ability to intravasate and generate CTCs. They further suggest that mesenchymal-to-epithelial phenomena occur in secondary organs, facilitating the metastatic growth. Oncogene (2012) 31, 3741-3753; doi:10.1038/onc.2011.540; published online 28 November 2011	[Bonnomet, A.; Syne, L.; Brysse, A.; Feyereisen, E.; Noel, A.; Foidart, J-M; Gilles, C.] Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, B-4000 Liege, Belgium; [Thompson, E. W.] St Vincents Inst, Melbourne, Vic, Australia; [Thompson, E. W.] Univ Melbourne, St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia; [Bonnomet, A.; Birembaut, P.; Polette, M.] INSERM, Unite U903, Lab Pol Bouin, Reims, France	University of Liege; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gilles, C (corresponding author), Univ Liege, CHU Sart Tilman, Lab Tumor & Dev Biol, B-4000 Liege, Belgium.	cgilles@ulg.ac.be	Thompson, Erik W/A-1425-2009; BIREMBAUT, Philippe/P-5210-2016; POLETTE, Myriam/P-5147-2016; Thompson, Erik/GPK-2067-2022	Thompson, Erik W/0000-0002-9723-4924; Thompson, Erik/0000-0002-9723-4924; BONNOMET, Arnaud/0000-0002-4933-3338; Noel, Agnes/0000-0002-7670-6179; POLETTE, Myriam/0000-0001-8173-3246	Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS, Belgium); Foundation against Cancer (foundation of public interest, Belgium); C.G.R.I.-F.N.R.S.-INSERM Cooperation; Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Region Champagne-Ardenne; Ligue Contre le Cancer; Lions Club of Soissons; Un Euro contre le Cancer; Fond National pour la Sante ACI INCa (Canceropole Grand-Est project); US. Army Medical Research and Materiel Command [BC0213201, BC084667]; Victorian Breast Cancer Research Consortium, Cancer Council Victoria [509295]; National Breast Cancer Foundation (Australia); National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Foundation against Cancer (foundation of public interest, Belgium); C.G.R.I.-F.N.R.S.-INSERM Cooperation(Fonds de la Recherche Scientifique - FNRS); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Region Champagne-Ardenne(Region Grand-Est); Ligue Contre le Cancer(Ligue nationale contre le cancer); Lions Club of Soissons; Un Euro contre le Cancer; Fond National pour la Sante ACI INCa (Canceropole Grand-Est project)(Region Grand-Est); US. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Victorian Breast Cancer Research Consortium, Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Breast Cancer Foundation (Australia); National Breast Cancer Foundation	The research effort associated with this article was funded in part by the Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS, Belgium), the Foundation against Cancer (foundation of public interest, Belgium), the 'C.G.R.I.-F.N.R.S.-INSERM Cooperation', the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the 'Region Champagne-Ardenne', the 'Ligue Contre le Cancer', the Lions Club of Soissons, Un Euro contre le Cancer and the Fond National pour la Sante ACI 2004-2010 INCa (Canceropole Grand-Est project), the US. Army Medical Research and Materiel Command (BC0213201 and BC084667), the Victorian Breast Cancer Research Consortium, Cancer Council Victoria (#509295), the National Breast Cancer Foundation (Australia). CG is a Senior Research Associate from the F.R.S.-FNRS (Belgium). AB is supported by the 'Region Champagne-Ardenne'. We thank Nathalie Lefin and Benoit Brouwers for their technical assistance.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chen XD, 2008, J MOL HISTOL, V39, P283, DOI 10.1007/s10735-008-9164-3; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mego M, 2011, INT J CANC; NOEL A, 1993, BRIT J CANCER, V68, P909, DOI 10.1038/bjc.1993.453; Oltean S, 2006, P NATL ACAD SCI USA, V103, P14116, DOI 10.1073/pnas.0603090103; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Xue CS, 2003, CANCER RES, V63, P3386; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang A, 2008, ANTICANCER RES, V28, P621	40	145	151	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	33					3741	3753		10.1038/onc.2011.540	http://dx.doi.org/10.1038/onc.2011.540			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22120722	Green Submitted			2022-12-25	WOS:000307924900001
J	Li, X; Gilkes, D; Li, B; Cheng, Q; Pernazza, D; Lawrence, H; Lawrence, N; Chen, J				Li, X.; Gilkes, D.; Li, B.; Cheng, Q.; Pernazza, D.; Lawrence, H.; Lawrence, N.; Chen, J.			Abnormal MDMX degradation in tumor cells due to ARF deficiency	ONCOGENE			English	Article						MDM2; MDMX; ARF; p53; ubiquitination; nutlin	AUTOREGULATORY FEEDBACK LOOP; SMALL-MOLECULE INHIBITORS; DNA-DAMAGE; EMBRYONIC LETHALITY; P53 ACTIVATION; IN-VIVO; MDM2-DEFICIENT MICE; ACIDIC DOMAIN; RING DOMAIN; UBIQUITINATION	MDMX is a heterodimeric partner of MDM2 and a critical regulator of p53. The MDMX level is generally elevated in tumors with wild-type p53 and contributes to p53 inactivation. MDMX degradation is controlled in part by MDM2-mediated ubiquitination. Here, we show that MDMX turnover is highly responsive to changes in MDM2 level in non-transformed cells, but not in tumor cells. We found that loss of alternate reading frame (ARF) expression, which occurs in most tumors with wild-type p53, significantly reduces MDMX sensitivity to MDM2. Restoration of ARF expression in tumor cells enables MDM2 to degrade MDMX in a dose-dependent manner. ARF binds to MDM2 and stimulates a second-site interaction between the central region of MDM2 and MDMX, and thus increases MDMX-MDM2 binding and MDMX ubiquitination. These results reveal an important abnormality in the p53-regulatory pathway as a consequence of ARF deficiency. Loss of ARF during tumor development not only prevents p53 stabilization by proliferative stress but also causes accumulation of MDMX that compromises p53 activity. This phenomenon may reduce the clinical efficacy of MDM2-specific inhibitors by preventing MDMX downregulation. Oncogene (2012) 31, 3721-3732; doi:10.1038/onc.2011.534; published online 28 November 2011	[Li, X.; Gilkes, D.; Li, B.; Cheng, Q.; Chen, J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Li, X.] Tianjin Med Univ, Dept Head & Neck Tumor, Canc Inst & Hosp, Tianjin, Peoples R China; [Pernazza, D.; Lawrence, H.; Lawrence, N.] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University; H Lee Moffitt Cancer Center & Research Institute	Chen, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, MRC3057A,12902 Magnolia Dr, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	Li, Baozong/ABD-4742-2020; Gilkes, Daniele M/AAI-8133-2020; li, baozong/K-4176-2012	Gilkes, Daniele M/0000-0003-3984-9338; 	National Institutes of Health [CA141244, CA109636, CA118210]; NATIONAL CANCER INSTITUTE [R01CA109636, R01CA141244, P01CA118210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Dawn Quelle for NARF6 cells and Dr Yanping Zhang for ARF-null MEF. This work was supported in part by grants from the National Institutes of Health (CA141244, CA109636 and CA118210).	Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Cross B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228981; Dang JJ, 2002, CANCER RES, V62, P1222; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LUNA RMD, 1995, NATURE, V378, P203; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Millard M, 2011, CURR PHARM DESIGN, V17, P536, DOI 10.2174/138161211795222649; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Ramos YFM, 2001, CANCER RES, V61, P1839; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Sivakolundu SG, 2008, J MOL BIOL, V384, P240, DOI 10.1016/j.jmb.2008.09.019; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wang XQ, 2001, FEBS LETT, V490, P202, DOI 10.1016/S0014-5793(01)02124-X; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xia MX, 2008, CELL CYCLE, V7, P1604, DOI 10.4161/cc.7.11.5929; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	54	23	24	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	32					3721	3732		10.1038/onc.2011.534	http://dx.doi.org/10.1038/onc.2011.534			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22120712	Green Accepted			2022-12-25	WOS:000307653800006
J	Jo, SH; Ren, RB				Jo, Seung-Hee; Ren, Ruibao			IRF-4 Suppresses BCR/ABL Transformation of Myeloid Cells in a DNA Binding-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-4; CHRONIC MYELOGENOUS LEUKEMIA; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; BCR-ABL; PRE-B; INTESTINAL TUMORIGENESIS; MULTIPLE-MYELOMA; EXPRESSION; GENE	Interferon regulatory factor 4 (IRF-4) is essential for B and T cell development and immune response regulation, and has both nuclear and cytoplasmic functions. IRF-4 was originally identified as a proto-oncogene resulting from a t(6; 14) chromosomal translocation in multiple myeloma and its expression was shown to be essential for multiple myeloma cell survival. However, we have previously shown that IRF-4 functions as a tumor suppressor in the myeloid lineage and in early stages of B cell development. In this study, we found that IRF-4 suppresses BCR/ABL transformation of myeloid cells. To gain insight into the molecular pathways that mediate IRF-4 tumor suppressor function, we performed a structure-function analysis of IRF-4 as a suppressor of BCR/ABL transformation. We found that the DNA binding domain deletion mutant of IRF-4, which is localized only in the cytoplasm, is still able to inhibit BCR/ABL transformation of myeloid cells. IRF-4 also functions as a tumor suppressor in bone marrow cells deficient in MyD88, an IRF-4-interacting protein found in the cytoplasm. However, IRF-4 tumor suppressor activity is lost in IRF association domain (IAD) deletion mutants. These results demonstrate that IRF-4 suppresses BCR/ABL transformation by a novel cytoplasmic function involving its IAD domain.	[Ren, Ruibao] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Ren, Ruibao] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Ren, RB (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	ren@brandeis.edu			National Institutes of Health [R01HL083515]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported, in whole or in part, by National Institutes of Health Grant R01HL083515 (to R. R.).	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Coligan J.E., 1996, CURRENT PROTOCOLS IM; Gross AW, 1999, MOL CELL BIOL, V19, P6918; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Ito M, 2002, JPN J CANCER RES, V93, P685, DOI 10.1111/j.1349-7006.2002.tb01307.x; Jo SH, 2010, BLOOD, V116, P2759, DOI 10.1182/blood-2009-07-234559; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Klein F, 2005, J IMMUNOL, V174, P367, DOI 10.4049/jimmunol.174.1.367; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ortmann CA, 2005, NUCLEIC ACIDS RES, V33, P6895, DOI 10.1093/nar/gki1001; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71	42	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1770	1778		10.1074/jbc.M111.289728	http://dx.doi.org/10.1074/jbc.M111.289728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22110133	Green Published, hybrid			2022-12-25	WOS:000299321000019
J	Jager, R; Russwurm, C; Schwede, F; Genieser, HG; Koesling, D; Russwurm, M				Jaeger, Ronald; Russwurm, Corina; Schwede, Frank; Genieser, Hans-Gottfried; Koesling, Doris; Russwurm, Michael			Activation of PDE10 and PDE11 Phosphodiesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; GAF DOMAINS; SPLICE VARIANTS; HUMAN TISSUES; GENE FAMILY; CGMP; CAMP; 11A; LOCALIZATION; CLONING	The most recently identified cyclic nucleotide phosphodiesterases, PDE10 and PDE11, contain a tandem of so-called GAF domains in their N-terminal regulatory regions. In PDE2 and PDE5, the GAF domains mediate cGMP stimulation; however, their function in PDE10 and PDE11 remains controversial. Although the GAF domains of PDE10 mediate cAMP-induced stimulation of chimeric adenylyl cyclases, cAMP binding did not stimulate the PDE10 holoenzyme. Comparable data about cGMP and the PDE11 GAF domains exist. Here, we identified synthetic ligands for the GAF domains of PDE10 and PDE11 to reduce interference of the GAF ligand with the catalytic reaction of PDE. With these ligands, GAF-mediated stimulation of the PDE10 and PDE11 holoenzymes is demonstrated for the first time. Furthermore, PDE10 is shown to be activated by cAMP, which paradoxically results in potent competitive inhibition of cGMP turnover by cAMP. PDE11, albeit susceptible to GAF-dependent stimulation, is not activated by the native cyclic nucleotides cAMP and cGMP. In summary, PDE11 can be stimulated by GAF domain ligands, but its native ligand remains to be identified, and PDE10 is the only PDE activated by cAMP.	[Jaeger, Ronald; Russwurm, Corina; Koesling, Doris; Russwurm, Michael] Ruhr Univ Bochum, Inst Pharmakol & Toxikol, Fak Med, D-44780 Bochum, Germany; [Schwede, Frank; Genieser, Hans-Gottfried] BIOLOG Life Sci Inst, D-28071 Bremen, Germany	Ruhr University Bochum	Russwurm, M (corresponding author), Ruhr Univ Bochum, Inst Pharmakol & Toxikol, Fak Med, MA N1, D-44780 Bochum, Germany.	michael.russwurm@ruhr-uni-bochum.de		Genieser, Hans-Gottfried/0000-0002-4904-5790	Deutsche Forschungsgemeinschaft [Ko1157]; Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty (KOFFER)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty (KOFFER)	This work was supported by Deutsche Forschungsgemeinschaft Grant Ko1157 and the Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty (KOFFER). H. G. G. is the chief executive officer and F. S. is the head of research and development of BIOLOG Life Science Institute, which sells cyclic nucleotide analogues for research purposes.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; BEAVO JA, 1971, J BIOL CHEM, V246, P3841; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; D'Andrea MR, 2005, J HISTOCHEM CYTOCHEM, V53, P895, DOI 10.1369/jhc.5A6625.2005; Fawcett L, 2000, P NATL ACAD SCI USA, V97, P3702, DOI 10.1073/pnas.050585197; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Hetman JM, 2000, P NATL ACAD SCI USA, V97, P12891, DOI 10.1073/pnas.200355397; HURLEY JH, 2003, SCI STKE, pPE1; Jager R, 2010, BRIT J PHARMACOL, V161, P1645, DOI 10.1111/j.1476-5381.2010.00977.x; Kelly MP, 2010, P NATL ACAD SCI USA, V107, P8457, DOI 10.1073/pnas.1000730107; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Loughney K, 2005, INT J IMPOT RES, V17, P320, DOI 10.1038/sj.ijir.3901317; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; O'Connor V, 2004, J BIOL CHEM, V279, P15841, DOI 10.1074/jbc.M312500200; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Russwurm M, 2007, BIOCHEM J, V407, P69, DOI 10.1042/BJ20070348; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Schultz Joachim E., 2009, V191, P93, DOI 10.1007/978-3-540-68964-5_6; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Wang HC, 2007, P NATL ACAD SCI USA, V104, P5782, DOI 10.1073/pnas.0700279104; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200; Yuasa K, 2001, EUR J BIOCHEM, V268, P4440, DOI 10.1046/j.1432-1327.2001.02366.x; Yuasa K, 2001, EUR J BIOCHEM, V268, P168, DOI 10.1046/j.1432-1327.2001.01866.x; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	39	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1210	1219		10.1074/jbc.M111.263806	http://dx.doi.org/10.1074/jbc.M111.263806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22105073	hybrid, Green Published			2022-12-25	WOS:000299170300036
J	Rajpal, G; Schuiki, I; Liu, M; Volchuk, A; Arvan, P				Rajpal, Gautam; Schuiki, Irmgard; Liu, Ming; Volchuk, Allen; Arvan, Peter			Action of Protein Disulfide Isomerase on Proinsulin Exit from Endoplasmic Reticulum of Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE ACTIVITIES; INSULIN; REDUCTASE; STRESS	For insulin synthesis, the proinsulin precursor is translated at the endoplasmic reticulum (ER), folds to include its three native disulfide bonds, and is exported to secretory granules for processing and secretion. Protein disulfide isomerase (PDI) has long been assumed to assist proinsulin in this process. Herein we have examined the effect of PDI knockdown (PDI-KD) in beta-cells. The data establish that upon PDI-KD, oxidation of proinsulin to form native disulfide bonds is unimpaired and in fact enhanced. This is accompanied by improved proinsulin exit from the ER and increased total insulin secretion, with no evidence of ER stress. We provide evidence for direct physical interaction between PDI and proinsulin in the ER of pancreatic beta-cells, in a manner requiring the catalytic activity of PDI. In beta-cells after PDI-KD, enhanced export is selective for proinsulin over other secretory proteins, but the same effect is observed for recombinant proinsulin trafficking upon PDI-KD in heterologous cells. We hypothesize that PDI exhibits unfoldase activity for proinsulin, increasing retention of proinsulin within the ER of pancreatic beta-cells.	[Rajpal, Gautam; Liu, Ming; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48105 USA; [Rajpal, Gautam; Liu, Ming; Arvan, Peter] Univ Michigan, Cellular & Mol Biol Program, Med Ctr, Ann Arbor, MI 48105 USA; [Schuiki, Irmgard; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON M5G 2M9, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5112 Brehm Ctr,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu			National Institutes of Health [R01-DK48280]; Canadian Institutes of Health Research [MOP-86641]; Rackham Graduate School; Cell and Molecular Biology Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rackham Graduate School; Cell and Molecular Biology Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK48280 (to P. A.). This work was also supported by Canadian Institutes of Health Research Grant MOP-86641 (to A. V.).; Supported by grants from the Rackham Graduate School and the Cell and Molecular Biology Training Program.	Ahmed M, 2005, J PROTEOME RES, V4, P931, DOI 10.1021/pr050024a; Cras-Meneur C, 2004, DIABETOLOGIA, V47, P284, DOI 10.1007/s00125-003-1300-8; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Honjo Y, 2010, BRAIN RES, V1349, P90, DOI 10.1016/j.brainres.2010.06.016; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; Khoo C, 2011, ENDOCRINOLOGY, V152, P2599, DOI 10.1210/en.2010-1420; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; PUIG A, 1994, J BIOL CHEM, V269, P19128; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; TANG JG, 1988, BIOCHEM J, V255, P451, DOI 10.1042/bj2550451; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wang CC, 1998, BIOCHEMISTRY-MOSCOW+, V63, P407; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	24	45	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					43	47		10.1074/jbc.C111.279927	http://dx.doi.org/10.1074/jbc.C111.279927			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105075	hybrid, Green Published			2022-12-25	WOS:000298682400007
J	Su, DS; Zhao, YX; Wang, BL; Xu, H; Li, W; Chen, J; Wang, XR				Su, Diansan; Zhao, Yanxing; Wang, Beilei; Xu, Huan; Li, Wen; Chen, Jie; Wang, Xiangrui			Isoflurane-Induced Spatial Memory Impairment in Mice is Prevented by the Acetylcholinesterase Inhibitor Donepezil	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; NITROUS OXIDE ANESTHESIA; AMYLOID PROTEIN-LEVELS; GENERAL-ANESTHESIA; ANTICHOLINERGIC PROPERTIES; NEUROCOGNITIVE FUNCTION; NONCARDIAC SURGERY; AGED RATS; PERFORMANCE; DRUGS	Although many studies have shown that isoflurane exposure impairs spatial memory in aged animals, there are no clinical treatments available to prevent this memory deficit. The anticholinergic properties of volatile anesthetics are a biologically plausible cause of cognitive dysfunction in elderly subjects. We hypothesized that pretreatment with the acetylcholinesterase inhibitor donepezil, which has been approved by the Food and Drug Administration (FDA) for the treatment of Alzheimer's disease, prevents isoflurane-induced spatial memory impairment in aged mice. In present study, eighteen-month-old mice were administered donepezil (5 mg/kg) or an equal volume of saline by oral gavage with a feeding needle for four weeks. Then the mice were exposed to isoflurane (1.2%) for six hours. Two weeks later, mice were subjected to the Morris water maze to examine the impairment of spatial memory after exposure to isoflurane. After the behavioral test, the mice were sacrificed, and the protein expression level of acetylcholinesterase (AChE), choline acetylase (ChAT) and alpha 7 nicotinic receptor (alpha 7-nAChR) were measured in the brain. Each group consisted of 12 mice. We found that isoflurane exposure for six hours impaired the spatial memory of the mice. Compared with the control group, isoflurane exposure dramatically decreased the protein level of ChAT, but not AChE or a7-nAChR. Donepezil prevented isoflurane-induced spatial memory impairments and increased ChAT levels, which were downregulated by isoflurane. In conclusions, pretreatment with the AChE inhibitor donepezil prevented isoflurane-induced spatial memory impairment in aged mice. The mechanism was associated with the upregulation of ChAT, which was decreased by isoflurane.	[Su, Diansan; Zhao, Yanxing; Wang, Beilei; Xu, Huan; Li, Wen; Chen, Jie; Wang, Xiangrui] Shanghai Jiao Tong Univ, Dept Anesthesiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Su, DS (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China.	Wangxr2010@yahoo.com	su, diansan/AAA-5057-2022		Health Bureau of Shanghai [2006Y027]; Educational Bureau of Shanghai [08YZ36]; Shanghai Municipal Natural Science Foundation [08ZR1413700]; Shanghai Science and Technology Development Funds [09QA1403800]; National Natural Science Foundation of China [30801069]	Health Bureau of Shanghai; Educational Bureau of Shanghai; Shanghai Municipal Natural Science Foundation; Shanghai Science and Technology Development Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Health Bureau of Shanghai (No. 2006Y027), the Educational Bureau of Shanghai (No. 08YZ36), the Shanghai Municipal Natural Science Foundation (No. 08ZR1413700), Shanghai Science and Technology Development Funds (No. 09QA1403800) and the National Natural Science Foundation of China (No. 30801069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildstrom H, 2000, ACTA ANAESTH SCAND, V44, P1246, DOI 10.1034/j.1399-6576.2000.441010.x; Betourne A, 2009, NEUROPHARMACOLOGY, V56, P615, DOI 10.1016/j.neuropharm.2008.11.001; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Butterfield NN, 2004, ANESTH ANALG, V98, P1305, DOI 10.1213/01.ANE.0000108484.91089.13; Cancelli I, 2008, J CLIN PSYCHOPHARM, V28, P654, DOI 10.1097/JCP.0b013e31818ce849; Cao YJ, 2008, CLIN PHARMACOL THER, V83, P422, DOI 10.1038/sj.clpt.6100303; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Ewald AJ, 2011, COLD SPRING HARB PRO; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Grasshoff C, 2007, TOXICOLOGY, V229, P206, DOI 10.1016/j.tox.2006.10.017; Gulur P, 2006, BEST PRACT RES-CLIN, V20, P249, DOI 10.1016/j.bpa.2005.10.002; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Haydar SN, 2009, BIOORGAN MED CHEM, V17, P5247, DOI 10.1016/j.bmc.2009.05.040; Jackson SN, 2008, EUR J PHARMACOL, V582, P42, DOI 10.1016/j.ejphar.2007.12.023; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Lechevallier-Michel N, 2005, BRIT J CLIN PHARMACO, V59, P143, DOI 10.1111/j.1365-2125.2004.02232.x; Lee JH, 2007, BRAIN RES, V1185, P246, DOI 10.1016/j.brainres.2007.09.016; Lewis MC, 2007, MED HYPOTHESES, V68, P484, DOI 10.1016/j.mehy.2006.08.030; Magnusson KR, 1998, MECH AGEING DEV, V104, P227, DOI 10.1016/S0047-6374(98)00076-1; Magnusson KR, 2001, NEUROBIOL AGING, V22, P613, DOI 10.1016/S0197-4580(00)00258-X; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Rajesh RV, 2009, BIOCHIMIE, V91, P1087, DOI 10.1016/j.biochi.2009.07.004; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Ray P G, 1992, J Geriatr Psychiatry Neurol, V5, P72; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Sprague JE, 2003, PHYSIOL BEHAV, V79, P281, DOI 10.1016/S0031-9384(03)00092-1; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Su D, 2011, ACTA ANAESTH SCAND, V55, P468, DOI 10.1111/j.1399-6576.2010.02385.x; Szczesny G, 2004, LAB ANIM-UK, V38, P64, DOI 10.1258/00236770460734416; Takada-Takatori Y, 2008, EUR J PHARMACOL, V590, P150, DOI 10.1016/j.ejphar.2008.06.027; Valentim AM, 2008, J AM ASSOC LAB ANIM, V47, P16; WILLIAMSRUSSO P, 1995, JAMA-J AM MED ASSOC, V274, P44, DOI 10.1001/jama.274.1.44; Yang KC, 2009, ACTA PHARMACOL SIN, V30, P740, DOI 10.1038/aps.2009.63; Zhen Y, 2009, ANESTHESIOLOGY, V111, P741, DOI 10.1097/ALN.0b013e3181b27fd4; Zivin M, 2008, PSYCHIAT DANUB, V20, P168; ZUCKER J, 1991, ANESTH ANALG, V72, P790	42	37	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27632	10.1371/journal.pone.0027632	http://dx.doi.org/10.1371/journal.pone.0027632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114680	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800028
J	Diman, NYSG; Remacle, S; Bertrand, N; Picard, JJ; Zaffran, S; Rezsohazy, R				Diman, Nata Y. S. -G.; Remacle, Sophie; Bertrand, Nicolas; Picard, Jacques J.; Zaffran, Stephane; Rezsohazy, Rene			A Retinoic Acid Responsive Hoxa3 Transgene Expressed in Embryonic Pharyngeal Endoderm, Cardiac Neural Crest and a Subdomain of the Second Heart Field	PLOS ONE			English	Article							OUTFLOW TRACT DEVELOPMENT; MYOCARDIUM DERIVES; ARTERIAL POLE; CELL LINEAGES; MOUSE; DIFFERENTIATION; GENES; MICE; MORPHOGENESIS; HINDBRAIN	A transgenic mouse line harbouring a beta-galacdosidase reporter gene controlled by the proximal 2 kb promoter of Hoxa3 was previously generated to investigate the regulatory cues governing Hoxa3 expression in the mouse. Examination of transgenic embryos from embryonic day (E) 8.0 to E15.5 revealed regionally restricted reporter activity in the developing heart. Indeed, transgene expression specifically delineated cells from three distinct lineages: a subpopulation of the second heart field contributing to outflow tract myocardium, the cardiac neural crest cells and the pharyngeal endoderm. Manipulation of the Retinoic Acid (RA) signaling pathway showed that RA is required for correct expression of the transgene. Therefore, this transgenic line may serve as a cardiosensor line of particular interest for further analysis of outflow tract development.	[Diman, Nata Y. S. -G.; Remacle, Sophie; Rezsohazy, Rene] Catholic Univ Louvain, Inst Life Sci, Mol & Cellular Anim Embryol Grp, B-1348 Louvain, Belgium; [Bertrand, Nicolas; Zaffran, Stephane] Aix Marseille Univ, UMR910, Marseille, France; [Bertrand, Nicolas; Zaffran, Stephane] INSERM, UMR S910, F-13258 Marseille, France; [Picard, Jacques J.] Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium	Universite Catholique Louvain; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite Catholique Louvain	Diman, NYSG (corresponding author), Cornell Univ, Mol Cardiol Lab, Greenberg Cardiol Div, Dept Med,Weill Med Coll, New York, NY 10021 USA.	stephane.zaffran@univmed.fr; rene.rezsohazy@uclouvain.be	Zaffran, Stéphane/S-7454-2019; Zaffran, Stéphane/I-2955-2016	Zaffran, Stéphane/0000-0002-0811-418X; Zaffran, Stéphane/0000-0002-0811-418X	Universite catholique de Louvain; Agence Nationale de la Recherche [ANR-07-MRAR-003]; Association Francaise contre les Myopathies; Ivory Coast government	Universite catholique de Louvain; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ivory Coast government	This work was supported by the "Fonds Speciaux de Recherche" of the Universite catholique de Louvain (to RR), the "Agence Nationale de la Recherche" (ANR-07-MRAR-003), (to SZ) and the "Association Francaise contre les Myopathies" (to SZ). NYSGD held a fellowship of the "Direction de l'orientation et des bourses" from the Ivory Coast government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bertrand N, 2011, DEV BIOL, V353, P266, DOI 10.1016/j.ydbio.2011.02.029; Brewer S, 2002, MECH DEVELOP, V110, P139, DOI 10.1016/S0925-4773(01)00579-2; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Diman NYSG, 2004, DEV BRAIN RES, V150, P211, DOI 10.1016/j.devbrainres.2004.03.013; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dolle P, 2010, DEV DYNAM, V239, P3260, DOI 10.1002/dvdy.22479; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Galli D, 2008, DEVELOPMENT, V135, P1157, DOI 10.1242/dev.014563; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddeeris MM, 2007, DEVELOPMENT, V134, P1593, DOI 10.1242/dev.02824; Graham A, 2001, J ANAT, V199, P133, DOI 10.1017/S0021878201008159; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jiang XB, 2002, MECH DEVELOP, V117, P115, DOI 10.1016/S0925-4773(02)00206-X; Kameda Y, 2003, CELL TISSUE RES, V311, P343, DOI 10.1007/s00441-002-0681-1; Kameda Y, 2002, DEV BIOL, V247, P197, DOI 10.1006/dbio.2002.0689; Kameda Y, 2009, CELL TISSUE RES, V336, P165, DOI 10.1007/s00441-009-0760-7; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kruithof BPT, 2003, ANAT REC PART A, V271A, P303, DOI 10.1002/ar.a.10033; Le Douarin NM, 1999, NEURAL CREST, V2; Li J, 2000, GENESIS, V26, P162, DOI 10.1002/(SICI)1526-968X(200002)26:2<162::AID-GENE21>3.0.CO;2-R; Lin SC, 2010, P NATL ACAD SCI USA, V107, P9234, DOI 10.1073/pnas.0910430107; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Manzanares M, 1999, DEVELOPMENT, V126, P759; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mic FA, 2002, DEVELOPMENT, V129, P2271; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mulder GB, 2000, TERATOLOGY, V62, P214, DOI 10.1002/1096-9926(200010)62:4<214::AID-TERA7>3.0.CO;2-N; Mulder GB, 1998, TERATOLOGY, V58, P263, DOI 10.1002/(SICI)1096-9926(199812)58:6<263::AID-TERA8>3.3.CO;2-1; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Waldo KL, 1999, DEV BIOL, V208, P307, DOI 10.1006/dbio.1999.9219; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Waxman JS, 2009, DEV DYNAM, V238, P1207, DOI 10.1002/dvdy.21951; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yelbuz TM, 2003, DEV DYNAM, V228, P152, DOI 10.1002/dvdy.10364; Yelbuz TM, 2002, CIRCULATION, V106, P504, DOI 10.1161/01.CIR.0000023044.44974.8A; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zhang J, 2010, CIRC RES, V107, P1209, DOI 10.1161/CIRCRESAHA.110.225318	62	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27624	10.1371/journal.pone.0027624	http://dx.doi.org/10.1371/journal.pone.0027624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110697	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400073
J	Hietanen, JK; Nummenmaa, L				Hietanen, Jari K.; Nummenmaa, Lauri			The Naked Truth: The Face and Body Sensitive N170 Response Is Enhanced for Nude Bodies	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; SPATIAL ATTENTION; VISUAL-CORTEX; ELECTROPHYSIOLOGICAL EVIDENCE; EMOTIONAL EXPRESSIONS; GENDER-DIFFERENCES; FACIAL EXPRESSION; SEX-DIFFERENCES; STIMULUS SIZE; PERCEPTION	Recent event-related potential studies have shown that the occipitotemporal N170 component - best known for its sensitivity to faces - is also sensitive to perception of human bodies. Considering that in the timescale of evolution clothing is a relatively new invention that hides the bodily features relevant for sexual selection and arousal, we investigated whether the early N170 brain response would be enhanced to nude over clothed bodies. In two experiments, we measured N170 responses to nude bodies, bodies wearing swimsuits, clothed bodies, faces, and control stimuli (cars). We found that the N170 amplitude was larger to opposite and same-sex nude vs. clothed bodies. Moreover, the N170 amplitude increased linearly as the amount of clothing decreased from full clothing via swimsuits to nude bodies. Strikingly, the N170 response to nude bodies was even greater than that to faces, and the N170 amplitude to bodies was independent of whether the face of the bodies was visible or not. All human stimuli evoked greater N170 responses than did the control stimulus. Autonomic measurements and self-evaluations showed that nude bodies were affectively more arousing compared to the other stimulus categories. We conclude that the early visual processing of human bodies is sensitive to the visibility of the sex-related features of human bodies and that the visual processing of other people's nude bodies is enhanced in the brain. This enhancement is likely to reflect affective arousal elicited by nude bodies. Such facilitated visual processing of other people's nude bodies is possibly beneficial in identifying potential mating partners and competitors, and for triggering sexual behavior.	[Hietanen, Jari K.] Univ Tampere, Human Informat Proc Lab, Sch Social Sci & Humanities, FIN-33101 Tampere, Finland; [Nummenmaa, Lauri] Aalto Univ Sch Sci & Technol, Brain Res Unit, Low Temp Lab, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ Sch Sci & Technol, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland	Tampere University; Aalto University; Aalto University; University of Turku	Hietanen, JK (corresponding author), Univ Tampere, Human Informat Proc Lab, Sch Social Sci & Humanities, FIN-33101 Tampere, Finland.	jari.hietanen@uta.fi	Nummenmaa, Lauri/G-6910-2012	Nummenmaa, Lauri/0000-0002-2497-9757	Academy of Finland [130272, 121031]; Aalto University	Academy of Finland(Academy of Finland); Aalto University	This work was supported by the Academy of Finland grants #130272 to J.K.H and #121031 to L.N. and the AivoAALTO Grant from the Aalto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, ARCH SEX BEHAV, V38, P434, DOI 10.1007/s10508-008-9429-7; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Arnow BA, 2009, NEUROSCIENCE, V158, P484, DOI 10.1016/j.neuroscience.2008.09.044; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boothroyd LG, 2008, EVOL HUM BEHAV, V29, P211, DOI 10.1016/j.evolhumbehav.2007.12.009; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BUHLER M, 2010, BEH BRAIN FUNCT, V4, P30; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Carlson JM, 2010, BRAIN COGNITION, V73, P20, DOI 10.1016/j.bandc.2010.01.007; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Codispoti M, 2007, PSYCHOPHYSIOLOGY, V44, P680, DOI 10.1111/j.1469-8986.2007.00545.x; Conty L, 2007, NEUROPSYCHOLOGIA, V45, P3024, DOI 10.1016/j.neuropsychologia.2007.05.017; Costa M, 2003, BIOL PSYCHOL, V63, P129, DOI 10.1016/S0301-0511(03)00054-1; COSTELL RM, 1972, SCIENCE, V177, P718, DOI 10.1126/science.177.4050.718; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; Crist RE, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.010.2007; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Furey ML, 2006, P NATL ACAD SCI USA, V103, P1065, DOI 10.1073/pnas.0510124103; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Gliga T, 2005, J COGNITIVE NEUROSCI, V17, P1328, DOI 10.1162/0898929055002481; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; HOWARD RC, 1994, BIOL PSYCHOL, V38, P169, DOI 10.1016/0301-0511(94)90037-X; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacques C, 2006, J VISION, V6, P154, DOI 10.1167/6.2.6; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Kvavadze E, 2009, SCIENCE, V325, P1359, DOI 10.1126/science.1175404; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Lindsey DT, 2010, PSYCHOL SCI, V21, P1208, DOI 10.1177/0956797610379861; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Minnebusch DA, 2009, J COGNITIVE NEUROSCI, V21, P865, DOI 10.1162/jocn.2009.21074; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Mohamed TN, 2009, NEUROREPORT, V20, P782, DOI 10.1097/WNR.0b013e32832b7e24; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Ponkanen LM, 2011, SOC COGN AFFECT NEUR, V6, P486, DOI 10.1093/scan/nsq068; Pourtois G, 2007, NEUROPSYCHOLOGIA, V45, P2621, DOI 10.1016/j.neuropsychologia.2007.04.005; Quinsey VL, 1996, ETHOL SOCIOBIOL, V17, P341, DOI 10.1016/S0162-3095(96)00060-X; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Sabatinelli D, 2004, NEUROREPORT, V15, P1109, DOI 10.1097/00001756-200405190-00005; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Sell R.L., 1996, J GAY LESBIAN BISEXU, V1, P295, DOI 10.1007/BF03372244; Sreenivasan KK, 2009, ATTEN PERCEPT PSYCHO, V71, P837, DOI 10.3758/APP.71.4.837; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Sun YT, 2010, BRAIN RES, V1327, P69, DOI 10.1016/j.brainres.2010.02.013; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; van Heijnsbergen CCRJ, 2007, BRAIN RES, V1186, P233, DOI 10.1016/j.brainres.2007.09.093; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Walen S. R., 1987, THEORIES HUMAN SEXUA, P335; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	79	44	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e24408	10.1371/journal.pone.0024408	http://dx.doi.org/10.1371/journal.pone.0024408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110574	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400001
J	Seizl, M; Hartmann, H; Hoeg, F; Kurth, F; Martin, DE; Soding, J; Cramer, P				Seizl, Martin; Hartmann, Holger; Hoeg, Friederike; Kurth, Fabian; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick			A Conserved GA Element in TATA-Less RNA Polymerase II Promoters	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; TRANSCRIPTION INITIATION; CORE PROMOTER; DNA-SEQUENCES; TBP BINDING; IN-VIVO; YEAST; COMPLEX; GENE	Initiation of RNA polymerase (Pol) II transcription requires assembly of the pre-initiation complex (PIC) at the promoter. In the classical view, PIC assembly starts with binding of the TATA box-binding protein (TBP) to the TATA box. However, a TATA box occurs in only 15% of promoters in the yeast Saccharomyces cerevisiae, posing the question how most yeast promoters nucleate PIC assembly. Here we show that one third of all yeast promoters contain a novel conserved DNA element, the GA element (GAE), that generally does not co-occur with the TATA box. The distance of the GAE to the transcription start site (TSS) resembles the distance of the TATA box to the TSS. The TATA-less TMT1 core promoter contains a GAE, recruits TBP, and supports formation of a TBP-TFIIB-DNA-complex. Mutation of the promoter region surrounding the GAE abolishes transcription in vivo and in vitro. A 32-nucleotide promoter region containing the GAE can functionally substitute for the TATA box in a TATA-containing promoter. This identifies the GAE as a conserved promoter element in TATA-less promoters.	[Seizl, Martin] Univ Munich, Dept Biochem, CIPSM, Munich, Germany; Univ Munich, Gene Ctr, CIPSM, Munich, Germany	University of Munich; University of Munich	Seizl, M (corresponding author), Univ Munich, Dept Biochem, CIPSM, Munich, Germany.	soeding@lmb.uni-muenchen.de; cramer@lmb.uni-muenchen.de	Söding, Johannes/A-3341-2013	Söding, Johannes/0000-0001-9642-8244	Deutsche Forschungsgemeinschaft [SFB646], TR5, FOR1068]; European Molecular Biology Organization (EMBO); Boehringer Ingelheim Fonds; Elite Network of Bavaria; LMUinnovativ project Bioimaging Network (BIN); European Research Council; LMUexcellent research professorship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Elite Network of Bavaria; LMUinnovativ project Bioimaging Network (BIN); European Research Council(European Research Council (ERC)European Commission); LMUexcellent research professorship	This work was supported by grants of Deutsche Forschungsgemeinschaft (SFB646, TR5, FOR1068, NIM); the European Molecular Biology Organization (EMBO); the Boehringer Ingelheim Fonds to MS, the Elite Network of Bavaria to MS and FH; the LMUinnovativ project Bioimaging Network (BIN), an Advanced Investigator Grant of the European Research Council, and an LMUexcellent research professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Burley SK, 1996, CURR OPIN STRUC BIOL, V6, P69, DOI 10.1016/S0959-440X(96)80097-2; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Faiger H, 2006, NUCLEIC ACIDS RES, V34, P104, DOI 10.1093/nar/gkj414; GRAHAM IR, 1994, MOL MICROBIOL, V12, P931, DOI 10.1111/j.1365-2958.1994.tb01081.x; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lariviere L, 2008, GENE DEV, V22, P872, DOI 10.1101/gad.465108; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Moreira JMA, 2002, J BIOL CHEM, V277, P3202, DOI 10.1074/jbc.M108962200; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741; THIRYBLAISE LM, 1990, MOL GEN GENET, V223, P474, DOI 10.1007/BF00264456; Tsukihashi Y, 2000, MOL CELL BIOL, V20, P2385, DOI 10.1128/MCB.20.7.2385-2399.2000; Wu R, 2010, GENOME RES, V20, P473, DOI 10.1101/gr.103226.109; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	35	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27595	10.1371/journal.pone.0027595	http://dx.doi.org/10.1371/journal.pone.0027595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110682	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400064
J	Sun, L; Pan, A; Yu, ZJ; Li, HX; Shi, AZ; Yu, DX; Zhang, G; Zong, G; Liu, Y; Lin, X				Sun, Liang; Pan, An; Yu, Zhijie; Li, Huaixing; Shi, Aizhen; Yu, Danxia; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu			Snoring, Inflammatory Markers, Adipokines and Metabolic Syndrome in Apparently Healthy Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; VASCULAR RISK-FACTORS; SLEEP-APNEA; INSULIN-RESISTANCE; BLOOD-PRESSURE; SERUM LEPTIN; OBESITY; ASSOCIATION; DISEASE; GLUCOSE	Objective: Chronic low-grade inflammation and adipokines dysregulation are linked to mechanisms underscoring the pathogenesis of obesity-related metabolic disorders. Little is known about roles of these cytokines on the association between snoring and metabolic syndrome (MetS). We aimed to investigate whether a cluster of cytokines are related to snoring frequency and its association with MetS in apparently healthy Chinese. Methods: Current analyses used a population-based sample including 1059 Shanghai residents aged 35-54 years. Self-reported snoring frequency was classified as never, occasionally and regularly. Fasting plasma glucose, lipid profile, insulin, C-reactive protein, interleukin-6, interleukin-18, lipopolysaccharide binding protein, high-molecular-weight adiponectin and leptin were measured. MetS was defined by the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian-Americans. Results: Overweight/obese subjects had significantly higher prevalence of regular snorers than their normal-weight counterparts (34.8% vs. 11.5%, P< 0.001). Regular snoring was associated with unfavorable profile of inflammatory markers and adipokines. However, those associations were abolished after adjustment for body mass index (BMI) or waist circumference. The MetS risk (multivariate-adjusted odds ratio 5.41, 95% confidence interval 3.72-7.88) was substantially higher in regular snorers compared with non-snorers. Controlling for BMI remarkably attenuated the association (2.03, 1.26-3.26), while adjusting for inflammatory markers and adipokines showed little effects. Conclusion: Frequent snoring was associated with an elevated MetS risk independent of lifestyle factors, adiposity, inflammatory markers and adipokines in apparently healthy Chinese. Whether snoring pattern is an economic and noinvasive indicator for screening high-risk persons needs to be addressed prospectively.	[Sun, Liang; Yu, Zhijie; Li, Huaixing; Yu, Danxia; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Pan, An] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Yu, Zhijie] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Shanghai, Peoples R China; [Shi, Aizhen] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk; Shanghai Center for Disease Control & Prevention	Sun, L (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Pan, An/C-5572-2011; Zong, Geng/ABG-6946-2021	Pan, An/0000-0002-1089-7945; Yu, Danxia/0000-0002-1710-9382	National Natural Science Foundation of China [30930081, 81021002]; Ministry of Science and Technology of China [2011CB504002, 2008DFA31960]; Chinese Academy of Sciences [KSCX2-EW-R-10]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]; China Postdoctoral Science Foundation [20110490751]; Novo Nordisk A/S	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Novo Nordisk A/S(Novo Nordisk)	This study was supported by the National Natural Science Foundation of China (30930081 and 81021002), the Ministry of Science and Technology of China (2011CB504002 and 2008DFA31960), the Chinese Academy of Sciences (KSCX2-EW-R-10), the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006), the China Postdoctoral Science Foundation (grant number 20110490751) and the Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763; Dixon JB, 2001, ARCH INTERN MED, V161, P102, DOI 10.1001/archinte.161.1.102; Elmasry A, 2000, J INTERN MED, V248, P13, DOI 10.1046/j.1365-2796.2000.00683.x; Franks PW, 2005, OBES RES, V13, P1476, DOI 10.1038/oby.2005.178; GAINER JL, 1987, ATHEROSCLEROSIS, V68, P263, DOI 10.1016/0021-9150(87)90206-1; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Grunstein RR, 2007, SLEEP, V30, P703, DOI 10.1093/sleep/30.6.703; GRUNSTEIN RR, 1989, J CLIN ENDOCR METAB, V68, P352, DOI 10.1210/jcem-68-2-352; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; Ip MSM, 2000, CHEST, V118, P580, DOI 10.1378/chest.118.3.580; Janszky I, 2008, SLEEP, V31, P801, DOI 10.1093/sleep/31.6.801; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kapsimalis F, 2008, LUNG, V186, P209, DOI 10.1007/s00408-008-9082-x; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; Lao XQ, 2010, RESP MED, V104, P1750, DOI 10.1016/j.rmed.2010.06.003; Makino S, 2006, CLIN ENDOCRINOL, V64, P12, DOI 10.1111/j.1365-2265.2005.02407.x; MARRONE O, 1993, CHEST, V103, P722, DOI 10.1378/chest.103.3.722; MARSHALL S, 1991, FASEB J, V5, P3031, DOI 10.1096/fasebj.5.15.1743436; McNicholas WT, 2009, AM J RESP CRIT CARE, V180, P692, DOI 10.1164/rccm.200903-0347PP; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Piliar G, 2008, DIABETES CARE, V31, pS303, DOI 10.2337/dc08-s272; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Schafer H, 2002, CHEST, V122, P829, DOI 10.1378/chest.122.3.829; SERIES F, 1990, J APPL PHYSIOL, V68, P2159, DOI 10.1152/jappl.1990.68.5.2159; Shin C, 2005, AM J RESP CRIT CARE, V171, P287, DOI 10.1164/rccm.200407-906OC; Sun LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018104; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Taheri S, 2007, SLEEP, V30, P991, DOI 10.1093/sleep/30.8.991; TELAKIVI T, 1987, ACTA NEUROL SCAND, V76, P69, DOI 10.1111/j.1600-0404.1987.tb03547.x; Thomas GN, 2006, SLEEP, V29, P896, DOI 10.1093/sleep/29.7.896; Troxel WM, 2010, SLEEP, V33, P1633, DOI 10.1093/sleep/33.12.1633; ULUKAVAK CT, 2005, RESPIRATION, V72, P395; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Williams CJ, 2007, DIABETES CARE, V30, P1233, DOI 10.2337/dc06-2107; Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	43	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27515	10.1371/journal.pone.0027515	http://dx.doi.org/10.1371/journal.pone.0027515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110665	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400052
J	Sun, YX; Wang, ZG; Zhang, YF; Sundell, J				Sun, Yuexia; Wang, Zhigang; Zhang, Yufeng; Sundell, Jan			In China, Students in Crowded Dormitories with a Low Ventilation Rate Have More Common Colds: Evidence for Airborne Transmission	PLOS ONE			English	Article							VIRAL RESPIRATORY-INFECTIONS; RHINOVIRUS COLDS; COLLEGE-STUDENTS; RISK; ASSOCIATIONS; DAMPNESS; HOME; AIR; ALLERGY; SPREAD	Objective: To test whether the incidence of common colds among college students in China is associated with ventilation rates and crowdedness in dormitories. Methods: In Phase I of the study, a cross-sectional study, 3712 students living in 1569 dorm rooms in 13 buildings responded to a questionnaire about incidence and duration of common colds in the previous 12 months. In Phase II, air temperature, relative humidity and CO(2) concentration were measured for 24 hours in 238 dorm rooms in 13 buildings, during both summer and winter. Out-to indoor air flow rates at night were calculated based on measured CO(2) concentrations. Results: In Phase I, 10% of college students reported an incidence of more than 6 common colds in the previous 12 months, and 15% reported that each infection usually lasted for more than 2 weeks. Students in 6-person dorm rooms were about 2 times as likely to have an incidence of common colds >= 6 times per year and a duration >= 2 weeks, compared to students in 3-person rooms. In Phase II, 90% of the measured dorm rooms had an out-to indoor air flow rate less than the Chinese standard of 8.3 L/s per person during the heating season. There was a dose-response relationship between out-to indoor air flow rate per person in dorm rooms and the proportion of occupants with annual common cold infections >= 6 times. A mean ventilation rate of 5 L/(s.person) in dorm buildings was associated with 5% of self reported common cold >= 6 times, compared to 35% at 1 L/(s.person). Conclusion: Crowded dormitories with low out-to indoor airflow rates are associated with more respiratory infections among college students.	[Sun, Yuexia; Zhang, Yufeng] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China; [Sun, Yuexia] Penn State Univ, Architecture Engn Dept, State Coll, PA USA; [Wang, Zhigang] Tianjin Municipal Engn Design & Res Inst, Tianjin, Peoples R China; [Sundell, Jan] Chongqing Univ, Fac Urban Construct & Environm Engn, Chongqing 630044, Peoples R China; [Sundell, Jan] Tsinghua Univ, Sch Architecture, Beijing 100084, Peoples R China	Tianjin University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Chongqing University; Tsinghua University	Sun, YX (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.	yxiasun@gmail.com	Zhang, Yufeng/GZL-1973-2022; Sundell, Jan H/B-2857-2012					ASHRAE, 1999, 621999 ASHRAE; Barker J, 2001, J APPL MICROBIOL, V91, P7, DOI 10.1046/j.1365-2672.2001.01364.x; Bertino JS, 2002, AM J MED, V112, p42S; BRUNDAGE JF, 1988, JAMA-J AM MED ASSOC, V259, P2108, DOI 10.1001/jama.259.14.2108; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; DICK EC, 1987, J INFECT DIS, V156, P442, DOI 10.1093/infdis/156.3.442; Drinka PJ, 1996, J AM GERIATR SOC, V44, P910, DOI 10.1111/j.1532-5415.1996.tb01859.x; *GB T, 2002, 188832002 GBT NAT EN; Goldmann DA, 2000, PEDIATR INFECT DIS J, V19, pS97, DOI 10.1097/00006454-200010001-00002; GWALTNEY MJ, 1978, AM J EPIDEMIOL, V107, P357; HAYDEN FG, 1988, ANTIMICROB AGENTS CH, V32, P224, DOI 10.1128/AAC.32.2.224; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; JENNINGS LC, 1987, EUR J EPIDEMIOL, V3, P327, DOI 10.1007/BF00145641; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Menzies D, 2000, ANN INTERN MED, V133, P779, DOI 10.7326/0003-4819-133-10-200011210-00010; Milton DK, 2000, INDOOR AIR, V10, P212, DOI 10.1034/j.1600-0668.2000.010004212.x; Myatt TA, 2004, AM J RESP CRIT CARE, V169, P1187, DOI 10.1164/rccm.200306-760OC; Pirhonen I, 1996, EUR RESPIR J, V9, P2618, DOI 10.1183/09031936.96.09122618; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Shendell DG, 2004, INDOOR AIR, V14, P333, DOI 10.1111/j.1600-0668.2004.00251.x; STAVOVA P, 2004, THESIS TU DENMARK; Sun Y, 2011, INDOOR AIR, V21, P277, DOI 10.1111/j.1600-0668.2010.00699.x; Sun Y, 2009, INDOOR AIR, V19, P174, DOI 10.1111/j.1600-0668.2008.00577.x; SUN Y, 2009, P 11 INT ROOMVENT C, P364; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	30	46	48	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27140	10.1371/journal.pone.0027140	http://dx.doi.org/10.1371/journal.pone.0027140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110607	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555400022
J	Wang, J; Shete, S				Wang, Jian; Shete, Sanjay			Testing Hardy-Weinberg Proportions in a Frequency-Matched Case-Control Genetic Association Study	PLOS ONE			English	Article							LUNG-CANCER; UNITED-STATES; SMOKING; EQUILIBRIUM; DISEASE; LOCUS	In case-control genetic association studies, cases are subjects with the disease and controls are subjects without the disease. At the time of case-control data collection, information about secondary phenotypes is also collected. In addition to studies of primary diseases, there has been some interest in studying genetic variants associated with secondary phenotypes. In genetic association studies, the deviation from Hardy-Weinberg proportion (HWP) of each genetic marker is assessed as an initial quality check to identify questionable genotypes. Generally, HWP tests are performed based on the controls for the primary disease or secondary phenotype. However, when the disease or phenotype of interest is common, the controls do not represent the general population. Therefore, using only controls for testing HWP can result in a highly inflated type I error rate for the disease-and/or phenotype-associated variants. Recently, two approaches, the likelihood ratio test (LRT) approach and the mixture HWP (mHWP) exact test were proposed for testing HWP in samples from case-control studies. Here, we show that these two approaches result in inflated type I error rates and could lead to the removal from further analysis of potential causal genetic variants associated with the primary disease and/or secondary phenotype when the study of primary disease is frequency-matched on the secondary phenotype. Therefore, we proposed alternative approaches, which extend the LRT and mHWP approaches, for assessing HWP that account for frequency matching. The goal was to maintain more (possible causative) single-nucleotide polymorphisms in the sample for further analysis. Our simulation results showed that both extended approaches could control type I error probabilities. We also applied the proposed approaches to test HWP for SNPs from a genome-wide association study of lung cancer that was frequency-matched on smoking status and found that the proposed approaches can keep more genetic variants for association studies.	[Wang, Jian; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	sshete@mdanderson.org	Wang, Jian/A-3276-2013		National Institutes of Health [1R01CA131324]; University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; NIH [R01CA55769, U19CA148127, R01CA121197]; NATIONAL CANCER INSTITUTE [R01CA121197, U19CA148127, R01CA131324, R01CA055769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant 1R01CA131324 and by a faculty fellowship from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment. This study makes use of lung cancer data obtained through NIH grants R01CA55769, U19CA148127, and R01CA121197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Cheng Dong, 2005, Nutr Metab (Lond), V2, P29, DOI 10.1186/1743-7075-2-29; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; FMINSEARCHCON DJ, MATLAB CENTRAL FILE; Li MY, 2008, GENET EPIDEMIOL, V32, P589, DOI 10.1002/gepi.20335; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Rothman K., 1998, MODERN EPIDEMIOLOGY; VILLENEUVE PJ, 1994, CAN J PUBLIC HEALTH, V85, P385; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wang J, 2010, HUM HERED, V69, P212, DOI 10.1159/000289597; Weir BS, 1996, GENETIC DATA ANAL; Yu C, 2009, GENET EPIDEMIOL, V33, P275, DOI 10.1002/gepi.20381	13	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27642	10.1371/journal.pone.0027642	http://dx.doi.org/10.1371/journal.pone.0027642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110703	Green Published, Green Submitted, gold			2022-12-25	WOS:000297554300042
J	Hewlett, L; Zupancic, G; Mashanov, G; Knipe, L; Ogden, D; Hannah, MJ; Carter, T				Hewlett, Lindsay; Zupancic, Gregor; Mashanov, Gregory; Knipe, Laura; Ogden, David; Hannah, Matthew J.; Carter, Tom			Temperature-Dependence of Weibel-Palade Body Exocytosis and Cell Surface Dispersal of von Willebrand Factor and Its Propolypeptide	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; VONWILLEBRAND-FACTOR; BODIES; RELEASE; PROTEIN; SECRETION; MOLECULES; MECHANISM; STORAGE	Background: Weibel-Palade bodies (WPB) are endothelial cell (EC) specific secretory organelles containing Von Willebrand factor (VWF). The temperature-dependence of Ca2+-driven WPB exocytosis is not known, although indirect evidence suggests that WPB exocytosis may occur at very low temperatures. Here we quantitatively analyse the temperature-dependence of Ca2+-driven WPB exocytosis and release of secreted VWF from the cell surface of ECs using fluorescence microscopy of cultured human ECs containing fluorescent WPBs. Principal Findings: Ca2+-driven WPB exocytosis occurred at all temperatures studied (7-37 degrees C). The kinetics and extent of WPB exocytosis were strongly temperature-dependent: Delays in exocytosis increased from 0.92 s at 37 degrees C to 134.2 s at 7 degrees C, the maximum rate of WPB fusion decreased from 10.0 +/- 2.2 s(-1) (37 degrees C) to 0.80 +/- 0.14 s(-1) (7 degrees C) and the fractional extent of degranulation of WPBs in each cell from 67 +/- 3% (37 degrees C) to 3.6 +/- 1.3% (7 degrees C). A discrepancy was found between the reduction in Ca2+-driven VWF secretion and WPB exocytosis at reduced temperature; at 17 degrees C VWF secretion was reduced by 95% but WPB exocytosis by 75-80%. This discrepancy arises because VWF dispersal from sites of WPB exocytosis is largely prevented at low temperature. In contrast VWF-propolypeptide (proregion) dispersal from WPBs, although slowed, was complete within 60-120 s. Novel antibodies to the cleaved and processed proregion were characterised and used to show that secreted proregion more accurately reports the secretion of WPBs at sub-physiological temperatures than assay of VWF itself. Conclusions: We report the first quantitative analysis of the temperature-dependence of WPB exocytosis. We provide evidence; by comparison of biochemical data for VWF or proregion secretion with direct analysis of WPB exocytosis at reduced temperature, that proregion is a more reliable marker for WPB exocytosis at reduced temperature, where VWF-EC adhesion is increased.	[Hewlett, Lindsay; Mashanov, Gregory; Knipe, Laura; Hannah, Matthew J.; Carter, Tom] Med Res Councils Natl Inst Med Res, Div Phys Biochem, London, England; [Zupancic, Gregor] Univ Ljubljana, Dept Biol, Ljubljana, Slovenia; [Ogden, David] Univ Paris 05, Brain Physiol Lab, Paris, France	MRC National Institute for Medical Research; University of Ljubljana; UDICE-French Research Universities; Universite Paris Cite	Hewlett, L (corresponding author), Med Res Councils Natl Inst Med Res, Div Phys Biochem, London, England.	tcarter@nimr.mrc.ac.uk	Carter, Tom/E-5035-2016	Carter, Tom/0000-0002-6248-7278	United Kingdom Medical Research Council [U117573808, U117570589]; MRC [MC_U117573808] Funding Source: UKRI; Medical Research Council [U117512659, MC_U117573808] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the United Kingdom Medical Research Council (reference codes U117573808 and U117570589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Babich V, 2009, J BIOL CHEM, V284, P12459, DOI 10.1074/jbc.M809235200; Berriman JA, 2009, P NATL ACAD SCI USA, V106, P17407, DOI 10.1073/pnas.0902977106; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; BONFANTI R, 1989, BLOOD, V73, P1109; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; CROWE JH, 1989, CRYOBIOLOGY, V26, P76, DOI 10.1016/0011-2240(89)90035-7; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; FREARSON JA, 1995, BIOCHEM J, V309, P473, DOI 10.1042/bj3090473; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; Hannah MJ, 2003, J CELL SCI, V116, P3939, DOI 10.1242/jcs.00711; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kiskin NI, 2010, J CELL SCI, V123, P2964, DOI 10.1242/jcs.073593; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; REINDERS JH, 1984, BIOCHIM BIOPHYS ACTA, V804, P361, DOI 10.1016/0167-4889(84)90140-X; ROARKE MC, 1989, EUR J CELL BIOL, V48, P337; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217	23	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27314	10.1371/journal.pone.0027314	http://dx.doi.org/10.1371/journal.pone.0027314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096550	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900032
J	Le Port, A; Watier, L; Cottrell, G; Ouedraogo, S; Dechavanne, C; Pierrat, C; Rachas, A; Bouscaillou, J; Bouraima, A; Massougbodji, A; Fayomi, B; Thiebaut, A; Chandre, F; Migot-Nabias, F; Martin-Prevel, Y; Garcia, A; Cot, M				Le Port, Agnes; Watier, Laurence; Cottrell, Gilles; Ouedraogo, Smaila; Dechavanne, Celia; Pierrat, Charlotte; Rachas, Antoine; Bouscaillou, Julie; Bouraima, Aziz; Massougbodji, Achille; Fayomi, Benjamin; Thiebaut, Anne; Chandre, Fabrice; Migot-Nabias, Florence; Martin-Prevel, Yves; Garcia, Andre; Cot, Michel			Infections in Infants during the First 12 Months of Life: Role of Placental Malaria and Environmental Factors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; GAMBIAN CHILDREN; TRANSMISSION; VARIABILITY; MORBIDITY; DISTRICT; VECTORS; ALLELES; RISK	Background: The association between placental malaria (PM) and first peripheral parasitaemias in early infancy was assessed in Tori Bossito, a rural area of Benin with a careful attention on transmission factors at an individual level. Methodology: Statistical analysis was performed on 550 infants followed weekly from birth to 12 months. Malaria transmission was assessed by anopheles human landing catches every 6 weeks in 36 sampling houses and season defined by rainfall. Each child was located by GPS and assigned to the closest anopheles sampling house. Data were analysed by survival Cox models, stratified on the possession of insecticide-treated mosquito nets (ITNs) at enrolment. Principal Findings: Among infants sleeping in a house with an ITN, PM was found to be highly associated to first malaria infections, after adjusting on season, number of anopheles, antenatal care (ANC) visits and maternal severe anaemia. Infants born from a malaria infected placenta had a 2.13 fold increased risk to present a first malaria infection than those born from a non infected placenta ([1.24-3.67], p<0.01) when sleeping in a house with an ITN. The risk to present a first malaria infection was increased by 3.2 to 6.5, according to the level of anopheles exposure (moderate or high levels, compared to the absence of anopheles). Conclusions: First malaria infections in early childhood can be attributed simultaneously to both PM and high levels of exposure to infected anopheles. Protective measures as Intermittent Preventive Treatment during pregnancy (IPTp) and ITNs, targeted on both mothers and infants should be reinforced, as well as the research on new drugs and insecticides. In parallel, investigations on placental malaria have to be strengthened to better understand the mechanisms involved, and thus to protect adequately the infants high risk group.	[Le Port, Agnes; Dechavanne, Celia; Pierrat, Charlotte; Rachas, Antoine; Bouscaillou, Julie; Migot-Nabias, Florence; Garcia, Andre; Cot, Michel] IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Le Port, Agnes; Cottrell, Gilles; Ouedraogo, Smaila; Dechavanne, Celia; Pierrat, Charlotte; Rachas, Antoine; Bouscaillou, Julie; Migot-Nabias, Florence; Garcia, Andre; Cot, Michel] Univ Paris 05, Fac Pharm, Paris, France; [Watier, Laurence; Thiebaut, Anne] INSERM, U657, Garches, France; [Watier, Laurence; Thiebaut, Anne] UVSQ, EA4499, Garches, France; [Watier, Laurence; Thiebaut, Anne] Inst Pasteur, PhEMI, Garches, France; [Cottrell, Gilles; Ouedraogo, Smaila] IRD, Mere & Enfant Face Infect Trop UMR216, Cotonou, Benin; [Bouraima, Aziz; Fayomi, Benjamin] ISBA, Cotonou, Benin; [Massougbodji, Achille] FSS, Cotonou, Benin; [Chandre, Fabrice] IRD, Caracterisat & Controle Populat Vecteurs UR016, Montpellier, France; [Martin-Prevel, Yves] IRD, Prevent Malnutr & Pathol Associees NUTRIPASS UMR2, Montpellier, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Le Port, A (corresponding author), IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France.	agnesleport@yahoo.fr	Garcia, Andre/S-2959-2016; , Watier/K-8213-2013; Cot, Michel/E-7633-2011; Chandre, Fabrice/Q-3429-2019; Thiébaut, Anne C.M./O-1788-2018; Garcia, Andre/ABA-1820-2020; Martin-Prevel, Yves/E-7637-2011	Garcia, Andre/0000-0002-1808-472X; , Watier/0000-0002-4057-1102; Cot, Michel/0000-0003-3014-4294; Chandre, Fabrice/0000-0002-1994-9705; Thiébaut, Anne C.M./0000-0003-2651-2795; Garcia, Andre/0000-0002-1808-472X; Martin-Prevel, Yves/0000-0002-4689-7867; Migot-Nabias, Florence/0000-0001-9982-594X; Dechavanne, Celia/0000-0001-8439-9976; Cottrell, Gilles/0000-0002-7964-8963; Le Port, Agnes/0000-0002-8337-6569	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche (ANR); Ministere de la Recherche et des Technologies, France; Fondation de France; Fondation Merieux	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de la Recherche et des Technologies, France; Fondation de France(Fondation de France); Fondation Merieux	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche (ANR); Ministere de la Recherche et des Technologies, France; Fondation de France; Fondation Merieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; [Anonymous], 2004, COCHRANE DB SYST REV; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Cairns M, 2009, CLIN INFECT DIS, V48, P497, DOI 10.1086/596548; Cano J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-21; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; *INSAE, 2007, ANN STAT SAN 2006; Jafari-Guemouri S, 2005, J CLIN MICROBIOL, V43, P2980, DOI 10.1128/JCM.43.6.2980-2983.2005; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2005, J CLIN MICROBIOL, V43, P3630, DOI 10.1128/JCM.43.8.3630-3635.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Mwangoka GW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-117; RANTALA AM, MALAR J, V9, P269; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8; Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2; *WHO, 2000, AB DECL PLAN ACT; World Health Organization, 1995, PHYS STAT US INT ANT; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	25	55	55	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27516	10.1371/journal.pone.0027516	http://dx.doi.org/10.1371/journal.pone.0027516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096588	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900056
J	Lowman, DW; West, LJ; Bearden, DW; Wempe, MF; Power, TD; Ensley, HE; Haynes, K; Williams, DL; Kruppa, MD				Lowman, Douglas W.; West, Lara J.; Bearden, Daniel W.; Wempe, Michael F.; Power, Trevor D.; Ensley, Harry E.; Haynes, Ken; Williams, David L.; Kruppa, Michael D.			New Insights into the Structure of (1 -> 3,1 -> 6)-beta-D-Glucan Side Chains in the Candida glabrata Cell Wall	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHODS; SACCHAROMYCES-CEREVISIAE; NMR-SPECTROSCOPY; SENSITIVITY IMPROVEMENT; CROSS-LINKING; GLUCANS; (1->3)-BETA-D-GLUCAN; CHITIN	beta-glucan is a (1 -> 3)-beta-linked glucose polymer with (1 -> 6)-beta-linked side chains and a major component of fungal cell walls. beta-glucans provide structural integrity to the fungal cell wall. The nature of the (1-6)-beta-linked side chain structure of fungal (1 -> 3,1 -> 6)-beta-D-glucans has been very difficult to elucidate. Herein, we report the first detailed structural characterization of the (1 -> 6)-beta-linked side chains of Candida glabrata using high-field NMR. The (1 -> 6)-beta-linked side chains have an average length of 4 to 5 repeat units spaced every 21 repeat units along the (1 -> 3)-linked polymer backbone. Computer modeling suggests that the side chains have a bent curve structure that allows for a flexible interconnection with parallel (1 -> 3)-beta-D-glucan polymers, and/or as a point of attachment for proteins. Based on these observations we propose new approaches to how (1 -> 6)-beta-linked side chains interconnect with neighboring glucan polymers in a manner that maximizes fungal cell wall strength, while also allowing for flexibility, or plasticity.	[Lowman, Douglas W.; Williams, David L.] E Tennessee State Univ, Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Lowman, Douglas W.] AppRidge Int LLC, Jonesborough, TN USA; [West, Lara J.; Haynes, Ken] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Bearden, Daniel W.] Natl Inst Stand & Technol, Hollings Marine Lab, Div Analyt Chem, Charleston, SC USA; [Wempe, Michael F.] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA; [Power, Trevor D.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA; [Ensley, Harry E.] Tulane Univ, Dept Chem, New Orleans, LA 70118 USA; [Kruppa, Michael D.] E Tennessee State Univ, Dept Microbiol, Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University; Imperial College London; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Texas System; University of Texas Medical Branch Galveston; Tulane University; East Tennessee State University	Lowman, DW (corresponding author), E Tennessee State Univ, Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA.	KRUPPA@mail.etsu.edu	Kruppa, Michael D/B-6052-2009	Kruppa, Michael D/0000-0002-1747-2333; Bearden, Daniel/0000-0003-0330-8513	National Institutes of Health [R01 GM53552, R01 GM83016]; Hollings Marine Laboratory NMR Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083016] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/10331] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Marine Laboratory NMR Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in part, by National Institutes of Health grants R01 GM53552 and R01 GM83016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, AppRidge International, LLC, did have a role in the data analysis and preparation of the manuscript.; We acknowledge the support of the Hollings Marine Laboratory NMR Facility for this work.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Ancian B, 1997, J MAGN RESON, V125, P348, DOI 10.1006/jmre.1997.1112; [Anonymous], JMOL OPEN SOURCE JAV; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BAX A, 1985, J MAGN RESON, V65, P335; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Cabib E, 2009, EUKARYOT CELL, V8, P1626, DOI 10.1128/EC.00228-09; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; Clavaud C, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P387; COLLINS JB, 1976, J CHEM PHYS, V64, P5142, DOI 10.1063/1.432189; De Nobel Hans, 1994, Trends in Cell Biology, V4, P42, DOI 10.1016/0962-8924(94)90003-5; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; ENSLEY HE, 1994, CARBOHYD RES, V258, P307, DOI 10.1016/0008-6215(94)84098-9; *GAUSS, 2004, GAUSS 03 REV C 02 CO; HEHRE WJ, 1969, J CHEM PHYS, V51, P2657, DOI 10.1063/1.1672392; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kamran M, 2004, EUKARYOT CELL, V3, P546, DOI 10.1128/EC.3.2.546-552.2004; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim YT, 2000, CARBOHYD RES, V328, P331, DOI 10.1016/S0008-6215(00)00105-1; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kruppa MD, 2009, CARBOHYD RES, V344, P2474, DOI 10.1016/j.carres.2009.09.029; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; Monteiro MA, 2000, CARBOHYD RES, V329, P121, DOI 10.1016/S0008-6215(00)00148-8; Mueller Antje, 1997, Carbohydrate Research, V299, P203; NORWOOD NJ, 1990, J MAGN RESON, V87, P488; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Shaw AA, 1996, J MAGN RESON SER A, V120, P110, DOI 10.1006/jmra.1996.0105; Storseth TR, 2006, CARBOHYD RES, V341, P2108, DOI 10.1016/j.carres.2006.05.005; Sugawara T, 2004, CARBOHYD RES, V339, P2255, DOI 10.1016/j.carres.2004.05.033; Tada R, 2009, CARBOHYD RES, V344, P400, DOI 10.1016/j.carres.2008.11.005; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; WEST LJ, 2009, GLYCOSYLATION VIRULE; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; Yiannikouris A, 2006, BIOMACROMOLECULES, V7, P1147, DOI 10.1021/bm050968t	38	44	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27614	10.1371/journal.pone.0027614	http://dx.doi.org/10.1371/journal.pone.0027614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096604	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900063
J	Zhou, Y; Ng, DMW; Seto, WH; Ip, DKM; Kwok, HKH; Ma, ESK; Ng, S; Lau, LLH; Peiris, JSM; Cowling, BJ				Zhou, Ying; Ng, Diane M. W.; Seto, Wing-Hong; Ip, Dennis K. M.; Kwok, Henry K. H.; Ma, Edward S. K.; Ng, Sophia; Lau, Lincoln L. H.; Peiris, J. S. Malik; Cowling, Benjamin J.			Seroprevalence of Pandemic H1N1 Antibody among Health Care Workers in Hong Kong Following Receipt of Monovalent 2009 H1N1 Influenza Vaccine	PLOS ONE			English	Article							VIRUS; IMMUNOGENICITY; INFECTION; RESPONSES; COVERAGE; INFANTS	Background: Healthcare workers in many countries are recommended to receive influenza vaccine to protect themselves as well as patients. A monovalent H1N1 vaccine became available in Hong Kong in December 2009 and around 10% of local healthcare workers had received the vaccine by February 2010. Methods: We conducted a cross-sectional study of the prevalence of antibody to pandemic (H1N1) 2009 among HCWs in Hong Kong in February-March 2010 following the first pandemic wave and the pH1N1 vaccination campaign. In this study we focus on the subset of healthcare workers who reported receipt of non-adjuvanted monovalent 2009 H1N1 vaccine (Panenza, Sanofi Pasteur). Sera collected from HCWs were tested for antibody against the pH1N1 virus by hemagglutination inhibition (HI) and viral neutralization (VN) assays. Results: We enrolled 703 HCWs. Among 104 HCWs who reported receipt of pH1N1 vaccine, 54% (95% confidence interval (CI): 44%-63%) had antibody titer >= 1:40 by HI and 42% (95% CI: 33%-52%) had antibody titer >= 1:40 by VN. The proportion of HCWs with antibody titer >= 1:40 by HI and VN significantly decreased with age, and the proportion with antibody titer >= 1:40 by VN was marginally significantly lower among HCWs who reported prior receipt of 2007-08 seasonal influenza vaccine (odds ratio: 0.43; 95% CI: 0.19-1.00). After adjustment for age, the effect of prior seasonal vaccine receipt was not statistically significant. Conclusions: Our findings suggest that monovalent H1N1 vaccine may have had suboptimal immunogenicity in HCWs in Hong Kong. Larger studies are required to confirm whether influenza vaccine maintains high efficacy and effectiveness in HCWs.	[Zhou, Ying; Ng, Diane M. W.; Ip, Dennis K. M.; Ng, Sophia; Lau, Lincoln L. H.; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Seto, Wing-Hong; Kwok, Henry K. H.] Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Ma, Edward S. K.; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Zhou, Y (corresponding author), Univ Hong Kong, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Ng, Sophia/AAA-1461-2019; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Ng, Sophia/0000-0001-7817-7744; Zhou, Ying/0000-0002-6859-8702; Seto, Wing Hong/0000-0002-1139-9200; Ip, Dennis Kai Ming/0000-0003-3592-8709	Hong Kong University Grants Committee [AoE/M-12/06]; MedImmune Inc.; Roche	Hong Kong University Grants Committee; MedImmune Inc.(AstraZenecaMedimmune); Roche(Roche Holding)	This work has received financial support from the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funding body was not involved in the collection, analysis, and interpretation of data, the writing of the article, or the decision to submit it for publication.; BJC has received research funding from MedImmune Inc., a manufacturer of influenza vaccines. DKMI has received research funding from Roche. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors report no other potential conflicts of interest.	ALKHAYATT R, 1984, J HYG-CAMBRIDGE, V93, P301, DOI 10.1017/S0022172400064834; Brydak LB, 2003, J CLIN IMMUNOL, V23, P214, DOI 10.1023/A:1023314029788; Bull AL, 2007, MED J AUSTRALIA, V186, P185, DOI 10.5694/j.1326-5377.2007.tb00858.x; Chan KH, 2011, CLIN VACCINE IMMUNOL, V18, P867, DOI 10.1128/CVI.00555-10; Choi YS, 2011, CLIN VACCINE IMMUNOL, V18, P1519, DOI 10.1128/CVI.05053-11; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Juanes JR, 2007, VACCINE, V25, P201, DOI 10.1016/j.vaccine.2005.10.057; Department of Health The Government of Hong Kong SAR China, 2010, STAT HUM SWIN INFL V; Department of Health The Government of Hong Kong SAR China, 2009, STAT HUM SWIN INFL V; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Helms CM, 2008, YES BMJ, V337, pa2142; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Igari H, 2010, MICROBIOL IMMUNOL, V54, P618, DOI 10.1111/j.1348-0421.2010.00254.x; Iorio AM, 2007, GERONTOLOGY, V53, P411, DOI 10.1159/000110579; Isaacs David, 2008, BMJ, V337, pa2140, DOI 10.1136/bmj.a2140; Kunzel W, 1996, VACCINE, V14, P1108, DOI 10.1016/0264-410X(96)00061-8; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Liu W, 2010, CLIN INFECT DIS, V51, P1028, DOI 10.1086/656588; Maltezou HC, 2008, VACCINE, V26, P1408, DOI 10.1016/j.vaccine.2008.01.049; Ng S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-230; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; Seto WH, 2011, CLIN INFECT DIS, V53, P280, DOI 10.1093/cid/cir375; Shroufi A, 2009, PUBLIC HEALTH, V123, P645, DOI 10.1016/j.puhe.2009.09.014; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Song JY, 2006, INFECT CONT HOSP EP, V27, P612, DOI 10.1086/504503; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tilburt JC, 2008, VACCINE, V26, pD27, DOI 10.1016/j.vaccine.2008.07.068; Uno S, 2011, MICROBIOL IMMUNOL, V55, P783, DOI 10.1111/j.1348-0421.2011.00381.x; Van der Vliet D, 2010, HUM VACCIN, V6, P34; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Wu JA, 2011, VACCINE, V29, P1009, DOI 10.1016/j.vaccine.2010.11.058; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Zhou Y, 2011, J HOSP INFECT, V78, P308, DOI 10.1016/j.jhin.2011.02.017; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27169	10.1371/journal.pone.0027169	http://dx.doi.org/10.1371/journal.pone.0027169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102878	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800017
J	Wang, Y; Pivonka, P; Buenzli, PR; Smith, DW; Dunstan, CR				Wang, Yan; Pivonka, Peter; Buenzli, Pascal R.; Smith, David W.; Dunstan, Colin R.			Computational Modeling of Interactions between Multiple Myeloma and the Bone Microenvironment	PLOS ONE			English	Article							KAPPA-B LIGAND; SERUM OSTEOPROTEGERIN LEVELS; MARROW STROMAL CELLS; RECEPTOR ACTIVATOR; BIOCHEMICAL MARKERS; OSTEOLYTIC LESIONS; MATHEMATICAL-MODEL; GROWTH-FACTOR; STEM-CELL; DISEASE	Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It has been postulated that positive feedback loops in the interactions between MM cells and the bone microenvironment form reinforcing 'vicious cycles', resulting in more bone resorption and MM cell population growth in the bone microenvironment. Despite many identified MM-bone interactions, the combined effect of these interactions and their relative importance are unknown. In this paper, we develop a computational model of MM-bone interactions and clarify whether the intercellular signaling mechanisms implemented in this model appropriately drive MM disease progression. This new computational model is based on the previous bone remodeling model of Pivonka et al. [1], and explicitly considers IL-6 and MM-BMSC (bone marrow stromal cell) adhesion related pathways, leading to formation of two positive feedback cycles in this model. The progression of MM disease is simulated numerically, from normal bone physiology to a well established MM disease state. Our simulations are consistent with known behaviors and data reported for both normal bone physiology and for MM disease. The model results suggest that the two positive feedback cycles identified for this model are sufficient to jointly drive the MM disease progression. Furthermore, quantitative analysis performed on the two positive feedback cycles clarifies the relative importance of the two positive feedback cycles, and identifies the dominant processes that govern the behavior of the two positive feedback cycles. Using our proposed quantitative criteria, we identify which of the positive feedback cycles in this model may be considered to be 'vicious cycles'. Finally, key points at which to block the positive feedback cycles in MM-bone interactions are identified, suggesting potential drug targets.	[Wang, Yan] Univ Melbourne, Sch Engn, Dept Infrastruct Engn, Melbourne, Vic, Australia; [Pivonka, Peter; Buenzli, Pascal R.; Smith, David W.] Univ Western Australia, Fac Engn Comp & Math, Perth, WA 6009, Australia; [Dunstan, Colin R.] Univ Sydney, Dept Biomed Engn, Sch Engn, Sydney, NSW 2006, Australia	University of Melbourne; University of Western Australia; University of Sydney	Wang, Y (corresponding author), Univ Melbourne, Sch Engn, Dept Infrastruct Engn, Melbourne, Vic, Australia.	wangyan00@tsinghua.org.cn; david.smith@uwa.edu.au	Smith, David W/H-5856-2014; Pivonka, Peter/AAL-1053-2021; Dunstan, Colin/G-6214-2013	Smith, David W/0000-0003-4864-0288; Dunstan, Colin/0000-0001-7586-4071; Pivonka, Peter/0000-0001-9183-530X; Buenzli, Pascal/0000-0003-3962-5393	Australian Research Council (ARC) [DP0879466]	Australian Research Council (ARC)(Australian Research Council)	This study was supported by the Australian Research Council (ARC, http://www.arc.gov.au/), in the framework of the project Bone Regulation - Cell Interaction to Disease (DP0879466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Abe M, 2009, J BONE MINER METAB, V27, P16, DOI 10.1007/s00774-008-0012-z; Abildgaard N, 2000, EUR J HAEMATOL, V64, P121, DOI 10.1034/j.1600-0609.2000.90074.x; Alexandrakis MG, 2003, AM J HEMATOL, V72, P229, DOI 10.1002/ajh.10304; Alexandrakis MG, 2002, CLIN CHIM ACTA, V325, P51, DOI 10.1016/S0009-8981(02)00246-2; Ayati BP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-28; BATAILLE R, 1992, INT J CLIN LAB RES, V21, P283, DOI 10.1007/BF02591662; BELCH AR, 1991, J CLIN ONCOL, V9, P1397, DOI 10.1200/JCO.1991.9.8.1397; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bruno B, 2005, LEUKEMIA, V19, P1729, DOI 10.1038/sj.leu.2403905; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Cheng X, 2003, JBC; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Choi SJ, 2000, BLOOD, V96, P671; Corso A, 2004, LEUKEMIA, V18, P1555, DOI 10.1038/sj.leu.2403429; Cowin S, 2001, BONE MECH HDB, V2nd, DOI DOI 10.1201/B14263; CRISTY M, 1981, PHYS MED BIOL, V26, P389, DOI 10.1088/0031-9155/26/3/003; Diamond T, 1997, BRIT J HAEMATOL, V97, P641, DOI 10.1046/j.1365-2141.1997.1042920.x; Dingli D, 2009, CANC GENE THER; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Fan X, 2004, ENDOCRINOLOGY, V145, P751, DOI 10.1210/en.2003-0726; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Goranova-Marinova V, 2007, HAEMATOLOGICA, V92, P1000, DOI 10.3324/haematol.10943; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Heider U, 2005, BIOCHEM BIOPH RES CO, V338, P687, DOI 10.1016/j.bbrc.2005.09.146; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Ideta AM, 2008, J NONLINEAR SCI, V18, P593, DOI 10.1007/s00332-008-9031-0; Jakob C, 2002, EUR J HAEMATOL, V69, P37, DOI 10.1034/j.1600-0609.2002.00505.x; Kawasaki K, 1997, ENDOCRINOLOGY, V138, P4959, DOI 10.1210/en.138.11.4959; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kunzmann V, 2000, BLOOD, V96, P384; KYLE RA, 1975, NEW ENGL J MED, V293, P1334, DOI 10.1056/NEJM197512252932602; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lauta VM, 2001, CYTOKINE, V16, P79, DOI 10.1006/cyto.2001.0982; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lipton A, 2002, CLIN CANCER RES, V8, P2306; Liu XH, 2005, ENDOCRINOLOGY, V146, P1991, DOI 10.1210/en.2004-1167; Malpas JS, 2004, MYELOMA BIOL MANAGEM; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mitsiades CS, 2007, J CELL BIOCHEM, V101, P950, DOI 10.1002/jcb.21213; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Muraglia A, 2000, J CELL SCI, V113, P1161; Nau KC, 2008, AM FAM PHYSICIAN, V78, P853; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021; Politou M, 2004, BRIT J HAEMATOL, V126, P686, DOI 10.1111/j.1365-2141.2004.05092.x; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Raitakari M, 2000, BRIT J HAEMATOL, V110, P203, DOI 10.1046/j.1365-2141.2000.02131.x; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; SALMON SE, 1970, J CLIN INVEST, V49, P1114, DOI 10.1172/JCI106327; Schmitt CP, 1998, J AM SOC NEPHROL, V9, P1832; Scholten JD, 1997, J BIOL CHEM, V272, P18077, DOI 10.1074/jbc.272.29.18077; Seidel C, 2001, BLOOD, V98, P2269, DOI 10.1182/blood.V98.7.2269; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Silbermann R, 2010, CURR CLIN ONCOL, P1, DOI 10.1007/978-1-60761-554-5_1; Standal T, 2002, BLOOD, V100, P3002, DOI 10.1182/blood-2002-04-1190; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Teoh G, 1997, HEMATOL ONCOL CLIN N, V11, P27, DOI 10.1016/S0889-8588(05)70413-5; Terpos E, 2007, LEUKEMIA, V21, P1875, DOI 10.1038/sj.leu.2404843; Terpos E, 2005, ANN ONCOL, V16, P1223, DOI 10.1093/annonc/mdi235; Terpos E, 2003, BRIT J HAEMATOL, V123, P106, DOI 10.1046/j.1365-2141.2003.04561.x; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; Terpos E, 2006, BRIT J HAEMATOL, V135, P688, DOI 10.1111/j.1365-2141.2006.06356.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Urashima M, 1996, BLOOD, V87, P1928; Vanderkerken K, 2003, CANCER RES, V63, P287; vanZaanen HCT, 1996, J CLIN INVEST, V98, P1441, DOI 10.1172/JCI118932; WAKEFIELD LM, 1990, J CLIN INVEST, V86, P1976, DOI 10.1172/JCI114932; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wong PKK, 2003, ARTHRITIS RHEUM-US, V48, P1177, DOI 10.1002/art.10943; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yeh HS, 2006, EUR J CANCER, V42, P1554, DOI 10.1016/j.ejca.2005.11.035; ZHANG XG, 1994, BLOOD, V83, P3654; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3	90	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27494	10.1371/journal.pone.0027494	http://dx.doi.org/10.1371/journal.pone.0027494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22110661	Green Published, gold			2022-12-25	WOS:000297349700052
J	Mao, L; Ding, J; Perdue, A; Yang, L; Zha, Y; Ren, M; Huang, S; Cui, H; Ding, HF				Mao, L.; Ding, J.; Perdue, A.; Yang, L.; Zha, Y.; Ren, M.; Huang, S.; Cui, H.; Ding, H-F			Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression	ONCOGENE			English	Article						BMI1; cyclin E1; FBXW7; MYCN; neuroblastoma	CELL SELF-RENEWAL; GENE-EXPRESSION; STEM-CELLS; N-MYC; SENESCENCE; DIFFERENTIATION; INHIBITION; APOPTOSIS; GROWTH; IDENTIFICATION	The Polycomb transcription repressor BMI1 is highly expressed in human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neuroblastoma cell lines. The molecular basis of BMI1 action in neuroblastoma cells is not well understood. Here we report that BMI1 has a critical role in stabilizing cyclin E1 by repressing the expression of FBXW7, a substrate-recognition subunit of the SCF E3 ubiquitin ligase that targets cyclin E1 for degradation. BMI1 binds to the FBXW7 locus in vivo and represses its mRNA expression. Overexpression of cyclin E1 or abrogation of FBXW7 induction rescues the cell-death phenotype of BMI1 knockdown. Moreover, MYCN, an oncoprotein in the pathogenesis of high-risk neuroblastomas, is able to counteract the death-inducing effect of BMI1 knockdown by activating CCNE1 transcription. We further show that high cyclin E1 expression is associated with Stage 4 neuroblastomas and poor prognosis in patients. These findings suggest a molecular mechanism for the oncogenic activity of BMI1 and MYCN in neuroblastoma pathogenesis and progression by maintaining cyclin E1 levels. Oncogene (2012) 31, 3785-3795; doi:10.1038/onc.2011.536; published online 28 November 2011	[Cui, H.] Southwest Univ, State Key Lab Silkworm Funct Genome Biol, Inst Sericulture & Syst Biol, Chongqing 400716, Peoples R China; [Mao, L.; Ding, J.; Perdue, A.; Yang, L.; Zha, Y.; Ren, M.; Ding, H-F] Georgia Hlth Sci Univ, Ctr Canc, Dept Pathol, Augusta, GA 30912 USA; [Mao, L.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Peoples R China; [Zha, Y.] Three Gorges Univ, Coll Med, Hosp Yichang 1, Dept Neurol, Yichang, Peoples R China; [Huang, S.] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	Southwest University - China; University System of Georgia; Augusta University; Huazhong University of Science & Technology; China Three Gorges University; University System of Georgia; Augusta University	Cui, H (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, 2 Tianshenqiao, Chongqing 400716, Peoples R China.	hcui@swu.edu.cn; hding@georgiahealth.edu		Ding, Han-Fei/0000-0001-5702-3439	NIH [CA124982]; Georgia Cancer Coalition Distinguished Scholar Award [H-FD]; National Basic Research Program of China [2012cb114603]; National Science Foundation of China [NSFC 81101905]; NATIONAL CANCER INSTITUTE [R01CA124982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Distinguished Scholar Award; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Q Du for pKMyc-cyclinE1, G Hannon and J Silva for shRNAmir Tet-Off, R Mulligan for pHDM-G and pMD.MLVogp, W Wei for pBabe-puro-p14<SUP>ARF</SUP> and J Khan for gene expression data sets from the Oncogenomics Database. This work was supported by the NIH grant CA124982 and a Georgia Cancer Coalition Distinguished Scholar Award (H-FD), and a grant from the National Basic Research Program of China (No. 2012cb114603) to HC. LM was supported in part by a grant from the National Science Foundation of China (NSFC 81101905).	Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chen QR, 2008, GENOMICS, V92, P195, DOI 10.1016/j.ygeno.2008.05.014; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Cui HJ, 2005, J BIOL CHEM, V280, P9474, DOI 10.1074/jbc.M410450200; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Ferrari-Toninelli G, 2010, NEURO-ONCOLOGY, V12, P1231, DOI 10.1093/neuonc/noq101; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Onoyama I, 2008, CELL CYCLE, V7, P3307, DOI 10.4161/cc.7.21.6931; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000	51	17	18	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	33					3785	3795		10.1038/onc.2011.536	http://dx.doi.org/10.1038/onc.2011.536			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22120721	Green Accepted			2022-12-25	WOS:000307924900005
J	Pessemesse, L; Schlernitzauer, A; Sar, C; Levin, J; Grandemange, S; Seyer, P; Favier, FB; Kaminski, S; Cabello, G; Wrutniak-Cabello, C; Casas, F				Pessemesse, Laurence; Schlernitzauer, Audrey; Sar, Chamroeun; Levin, Jonathan; Grandemange, Stephanie; Seyer, Pascal; Favier, Francois B.; Kaminski, Sandra; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois			Depletion of the p43 mitochondrial T3 receptor in mice affects skeletal muscle development and activity	FASEB JOURNAL			English	Article						metabolism; thyroid hormone	REGULATES MYOBLAST DIFFERENTIATION; MYOSIN ISOFORM EXPRESSION; HEAVY-CHAIN ISOFORMS; RESPIRATORY-CHAIN; PROTEIN-SYNTHESIS; OVEREXPRESSION; EXERCISE; SOLEUS; RNA	In vertebrates, skeletal muscle myofibers display different contractile and metabolic properties associated with different mitochondrial content and activity. We have previously identified a mitochondrial triiodothyronine receptor (p43) regulating mitochondrial transcription and mitochondrial biogenesis. When overexpressed in skeletal muscle, it increases mitochondrial DNA content, stimulates mitochondrial respiration, and induces a shift in the metabolic and contractile features of muscle fibers toward a slower and more oxidative phenotype. Here we show that a p43 depletion in mice decreases mitochondrial DNA replication and respiratory chain activity in skeletal muscle in association with the induction of a more glycolytic muscle phenotype and a decrease of capillary density. In addition, p43(-/-) mice displayed a significant increase in muscle mass relative to control animals and had an improved ability to use lipids. Our findings establish that the p43 mitochondrial receptor strongly affects muscle mass and the metabolic and contractile features of myofibers and provides evidence that this receptor mediates, in part, the influence of thyroid hormone in skeletal muscle.-Pessemesse, L., Schlernitzauer, A., Sar, C., Levin, J., Grandemange, S., Seyer, P., Favier, F. B., Kaminski, S., Cabello, G., Wrutniak-Cabello, C., Casas, F. Depletion of the p43 mitochondrial T3 receptor in mice affects skeletal muscle development and activity. FASEB J. 26, 748-756 (2012). www.fasebj.org	[Pessemesse, Laurence; Schlernitzauer, Audrey; Levin, Jonathan; Grandemange, Stephanie; Seyer, Pascal; Favier, Francois B.; Kaminski, Sandra; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] INRA, UMR 866 Dynam Musculaire & Metab, Unite Mixte Rech, F-34060 Montpellier, France; [Pessemesse, Laurence; Schlernitzauer, Audrey; Sar, Chamroeun; Levin, Jonathan; Grandemange, Stephanie; Seyer, Pascal; Favier, Francois B.; Kaminski, Sandra; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier I, Montpellier, France; [Pessemesse, Laurence; Schlernitzauer, Audrey; Sar, Chamroeun; Levin, Jonathan; Grandemange, Stephanie; Seyer, Pascal; Favier, Francois B.; Kaminski, Sandra; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier 2, F-34060 Montpellier, France; [Sar, Chamroeun] INSERM, Hopital St Eloi 80, Inst Neurosci Montpellier, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Casas, F (corresponding author), INRA, UMR 866 Dynam Musculaire & Metab, Unite Mixte Rech, 2 Pl Viala, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Grandemange, Stéphanie/G-7928-2015; Kaminski, Sandra/AAM-6134-2021; Levin, Jonathan/N-3189-2018	Francois, Casas/0000-0002-5535-8195; Favier, Francois/0000-0002-9084-4797	Institut National de la Recherche Agronomique; Agence Nationale de la Recherche (ANR MitHyCal); Association Francaise contre les Myopathies	Institut National de la Recherche Agronomique; Agence Nationale de la Recherche (ANR MitHyCal)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The authors thank the animal staff for animal care. The authors thank Chantal Cazevieille (Clinical Research Imaging Centre, Montpellier, France) for technical assistance and interpreting data concerning ultrastructural evaluation. This work was supported by grants from the Institut National de la Recherche Agronomique, Agence Nationale de la Recherche (ANR MitHyCal), and Association Francaise contre les Myopathies.	AUSONI S, 1990, J NEUROSCI, V10, P153; Blanchet E, 2012, FASEB J, V26, P40, DOI 10.1096/fj.11-186841; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; BUTLERBROWNE GS, 1984, FEBS LETT, V166, P71, DOI 10.1016/0014-5793(84)80047-2; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005631; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; ENGLAND JM, 1978, J MOL BIOL, V119, P455, DOI 10.1016/0022-2836(78)90226-7; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; KING DB, 1987, J EXP ZOOL, P291; LANSMAN RA, 1975, J MOL BIOL, V99, P777, DOI 10.1016/S0022-2836(75)80184-7; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; MATHIEUCOSTELLO O, 1991, AM J PHYSIOL, V261, pH1617, DOI 10.1152/ajpheart.1991.261.5.H1617; MCDONALD KS, 1992, J APPL PHYSIOL, V73, P1135, DOI 10.1152/jappl.1992.73.3.1135; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; SUGIE H, 1985, MUSCLE NERVE, V8, P654, DOI 10.1002/mus.880080805; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wharton DC., 1967, METHOD ENZYMOL, P245; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Yu FS, 2000, AM J PHYSIOL-REG I, V278, pR1545, DOI 10.1152/ajpregu.2000.278.6.R1545; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	33	40	40	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					748	756		10.1096/fj.11-195933	http://dx.doi.org/10.1096/fj.11-195933			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22109994	Green Submitted			2022-12-25	WOS:000300485700026
J	Walseth, TF; Lin-Moshier, Y; Jain, P; Ruas, M; Parrington, J; Galione, A; Marchant, JS; Slama, JT				Walseth, Timothy F.; Lin-Moshier, Yaping; Jain, Pooja; Ruas, Margarida; Parrington, John; Galione, Antony; Marchant, Jonathan S.; Slama, James T.			Photoaffinity Labeling of High Affinity Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-Binding Proteins in Sea Urchin Egg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAADP-SENSITIVE CA2+; 2-PORE CHANNELS; CALCIUM-RELEASE; MOBILIZES CALCIUM; INACTIVATION; RECEPTORS	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a messenger that regulates calcium release from intracellular acidic stores. Recent studies have identified two-pore channels (TPCs) as endolysosomal channels that are regulated by NAADP; however, the nature of the NAADP receptor binding site is unknown. To further study NAADP binding sites, we have synthesized and characterized [P-32-5-azido] nicotinic acid adenine dinucleotide phosphate ([P-32-5N(3)] NAADP) as a photoaffinity probe. Photolysis of sea urchin egg homogenates preincubated with [P-32-5N(3)] NAADP resulted in specific labeling of 45-, 40-, and 30-kDa proteins, which was prevented by inclusion of nanomolar concentrations of unlabeled NAADP or 5N(3)-NAADP, but not by micromolar concentrations of structurally related nucleotides such as NAD, nicotinic acid adenine dinucleotide, nicotinamide mononucleotide, nicotinic acid, or nicotinamide. [P-32-5N(3)]NAADP binding was saturable and displayed high affinity (K-d similar to 10 nM) in both binding and photolabeling experiments. [P-32-5N(3)]NAADP photolabeling was irreversible in a high K+ buffer, a hallmark feature of NAADP binding in the egg system. The proteins photolabeled by [P-32-5N(3)]NAADP have molecular masses smaller than the sea urchin TPCs, and antibodies to TPCs do not detect any immunoreactivity that comigrates with either the 45-kDa or the 40-kDa photolabeled proteins. Interestingly, antibodies to TPC1 and TPC3 were able to immunoprecipitate a small fraction of the 45- and 40-kDa photolabeled proteins, suggesting that these proteins associate with TPCs. These data suggest that high affinity NAADP binding sites are distinct from TPCs.	[Walseth, Timothy F.; Lin-Moshier, Yaping; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Jain, Pooja; Slama, James T.] Univ Toledo, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Ruas, Margarida; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Toledo; University of Oxford	Walseth, TF (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	walse001@umn.edu	Walseth, Timothy F/F-9518-2010; MARCHANT, Jonathan/B-8051-2009; Marchant, Jonathan/Q-5484-2019	Walseth, Timothy F/0000-0003-2558-7859; MARCHANT, Jonathan/0000-0001-6592-0877; Marchant, Jonathan/0000-0001-6592-0877; Galione, Antony/0000-0002-4132-7646; Ruas, Margarida/0000-0002-4872-7618	National Institutes of Health [GM088790]; University of Minnesota Academic Health Center [2101.95]; Wellcome Trust; University of Minnesota Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Wellcome Trust(Wellcome TrustEuropean Commission); University of Minnesota Graduate School(University of Minnesota System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088790 (to J. S. M.). This work was also supported by University of Minnesota Academic Health Center Seed Grant 2101.95 (to T. F. W.) and a Wellcome Trust Programme Grant (to A. G. and J. P.).; Supported by a doctoral dissertation fellowship from the University of Minnesota Graduate School.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Evans AM, 2010, ADV EXP MED BIOL, V661, P57, DOI 10.1007/978-1-60761-500-2_4; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Robinette D, 2006, EXPERT REV PROTEOMIC, V3, P399, DOI 10.1586/14789450.3.4.399; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zhu Michael X., 2010, Communicative & Integrative Biology, V3, P12; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	31	87	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2308	2315		10.1074/jbc.M111.306563	http://dx.doi.org/10.1074/jbc.M111.306563			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117077	hybrid, Green Published			2022-12-25	WOS:000300292300007
J	Hu, LN; Gocke, AR; Knapp, E; Rosenzweig, JM; Grishkan, IV; Baxi, EG; Zhang, H; Margolick, JB; Whartenby, KA; Calabresi, PA				Hu, Lina; Gocke, Anne R.; Knapp, Edward; Rosenzweig, Jason M.; Grishkan, Inna V.; Baxi, Emily G.; Zhang, Hao; Margolick, Joseph B.; Whartenby, Katharine A.; Calabresi, Peter A.			Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21(cip1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; INDUCTION; P27(KIP1); SMAD; SUPPRESSION; CURRENTS	The maintenance of T cell memory is critical for the development of rapid recall responses to pathogens, but may also have the undesired side effect of clonal expansion of T effector memory (T-EM) cells in chronic autoimmune diseases. The mechanisms by which lineage differentiation of T cells is controlled have been investigated, but are not completely understood. Our previous work demonstrated a role of the voltage-gated potassium channel Kv1.3 in effector T cell function in autoimmune disease. In the present study, we have identified a mechanism by which Kv1.3 regulates the conversion of T central memory cells (T-CM) into T-EM. Using a lentiviral-dominant negative approach, we show that loss of function of Kv1.3 mediates reversion of T-EM into T-CM, via a delay in cell cycle progression at the G2/M stage. The inhibition of Kv1.3 signaling caused an up-regulation of SMAD3 phosphorylation and induction of nuclear p21(cip1) with resulting suppression of Cdk1 and cyclin B1. These data highlight a novel role for Kv1.3 in T cell differentiation and memory responses, and provide further support for the therapeutic potential of Kv1.3 specific channel blockers in T-EM-mediated autoimmune diseases.	[Hu, Lina; Gocke, Anne R.; Knapp, Edward; Rosenzweig, Jason M.; Grishkan, Inna V.; Baxi, Emily G.; Whartenby, Katharine A.; Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Calabresi, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St, Baltimore, MD 21287 USA.	Calabresi@jhmi.edu	Calabresi, Peter A./AAF-2288-2019		National Institutes of Health [R01NS041435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS041435 (to P. A. C.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Calabresi PA, 2003, J NEUROIMMUNOL, V139, P58, DOI 10.1016/S0165-5728(03)00127-9; CONE CD, 1976, SCIENCE, V192, P155, DOI 10.1126/science.56781; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Gerlach C, 2011, ANN NY ACAD SCI, V1217, P139, DOI 10.1111/j.1749-6632.2010.05830.x; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Koni PA, 2003, J BIOL CHEM, V278, P39443, DOI 10.1074/jbc.M304879200; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rudd CE, 2006, NAT IMMUNOL, V7, P1130, DOI 10.1038/ni1106-1130; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Wolfraim LA, 2005, J IMMUNOL, V174, P2481, DOI 10.4049/jimmunol.174.5.2481; Wolfraim LA, 2004, J IMMUNOL, V173, P3093, DOI 10.4049/jimmunol.173.5.3093; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zimmerman CM, 1998, J BIOL CHEM, V273, P677, DOI 10.1074/jbc.273.2.677	27	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1261	1268		10.1074/jbc.M111.296798	http://dx.doi.org/10.1074/jbc.M111.296798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110135	Green Published, hybrid			2022-12-25	WOS:000299170300042
J	Jin, F; Claessens, F; Fondell, JD				Jin, Feng; Claessens, Frank; Fondell, Joseph D.			Regulation of Androgen Receptor-dependent Transcription by Coactivator MED1 Is Mediated through a Newly Discovered Noncanonical Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROSTATE-CANCER CELLS; NUCLEAR RECEPTOR; LIGAND-BINDING; CONSTITUTIVE ACTIVATION; HORMONE-RECEPTORS; COREGULATORY ROLE; GENE-EXPRESSION; TERMINAL DOMAIN; LXXLL MOTIFS	Nuclear receptor (NR) activation by cognate ligand generally involves allosteric realignment of C-terminal alpha-helices thus generating a binding surface for coactivators containing canonical LXXLL alpha-helical motifs. The androgen receptor (AR) is uncommon among NRs in that ligand triggers an intramolecular interaction between its N- and C-terminal domains (termed the N/C interaction) and that coactivators can alternatively bind to surfaces in the AR N-terminal or hinge regions. The evolutionary conserved Mediator complex plays a key coregulatory role in steroid hormone-dependent transcription and is chiefly targeted to NRs via the LXXLL-containing MED1 subunit. Whereas MED1 has been demonstrated to serve as a key transcriptional coactivator for AR, the mechanisms by which AR recruits MED1 have remained unclear. Here we show that MED1 binds to a distinct AR N-terminal region termed transactivation unit-1 (Tau-1) via two newly discovered noncanonical alpha-helical motifs located between MED1 residues 505 and 537. Neither of the two MED1 LXXLL motifs is required for AR binding, whereas loss of the intramolecular AR N/C interaction decreases MED1 binding. We further demonstrate that mitogen-activated protein kinase phosphorylation of MED1 enhances the AR-MED1 interaction in prostate cancer cells. In sum, our findings reveal a novel AR-coactivator binding mechanism that may have clinical implications for AR activity in prostate cancer.	[Jin, Feng; Fondell, Joseph D.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Claessens, Frank] Catholic Univ Louvain, Dept Mol Cell Biol, Mol Endocrinol Lab, B-3000 Louvain, Belgium	Rutgers State University New Brunswick; Rutgers State University Medical Center; Universite Catholique Louvain	Fondell, JD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 683 Hoes Lane,Room 164, Piscataway, NJ 08854 USA.	fondeljd@umdnj.edu	Claessens, Frank/M-8565-2016	Claessens, Frank/0000-0002-8676-7709	United States Department of Defense [W81XWH-10-1-0227]	United States Department of Defense(United States Department of Defense)	This work was supported by a United States Department of Defense Prostate Cancer Research Program Award W81XWH-10-1-0227 (to J. D. F.).	Alen P, 1999, MOL CELL BIOL, V19, P6085; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Bakin RE, 2003, CANCER RES, V63, P1981; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bright RK, 1997, CANCER RES, V57, P995; Callewaert L, 2006, CANCER RES, V66, P543, DOI 10.1158/0008-5472.CAN-05-2389; Callewaert L, 2003, J BIOL CHEM, V278, P8212, DOI 10.1074/jbc.M210744200; CELIS L, 1993, MOL CELL ENDOCRINOL, V94, P165, DOI 10.1016/0303-7207(93)90165-G; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gioeli D, 1999, CANCER RES, V59, P279; Glass CK, 2000, GENE DEV, V14, P121; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Knuesel MT, 2011, TRANSCR-AUSTIN, V2, P28, DOI 10.4161/trns.2.1.13950; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lee JE, 2005, J BIOL CHEM, V280, P8819, DOI 10.1074/jbc.M413184200; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Vijayvargia R, 2007, CANCER RES, V67, P4034, DOI 10.1158/0008-5472.CAN-06-3039; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zhu X, 1999, MOL CELL ENDOCRINOL, V152, P199, DOI 10.1016/S0303-7207(99)00031-3	56	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					858	870		10.1074/jbc.M111.304519	http://dx.doi.org/10.1074/jbc.M111.304519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102282	hybrid, Green Published			2022-12-25	WOS:000299170300005
J	Dominguez, JM; Fuertes, A; Orozco, L; del Monte-Millan, M; Delgado, E; Medina, M				Manuel Dominguez, Juan; Fuertes, Ana; Orozco, Leyre; del Monte-Millan, Maria; Delgado, Elena; Medina, Miguel			Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3 beta by Tideglusib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GSK-3 INHIBITORS; KINASE INHIBITORS; PROTEIN; TAU; PHOSPHORYLATION; BINDING; GLYCOGEN-SYNTHASE-KINASE-3-BETA; ASSOCIATION; MECHANISM	Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy. Sustained oral administration of the compound to a variety of animal models decreases Tau hyperphosphorylation, lowers brain amyloid plaque load, improves learning and memory, and prevents neuronal loss. We report here that tideglusib inhibits GSK-3 beta irreversibly, as demonstrated by the lack of recovery in enzyme function after the unbound drug has been removed from the reaction medium and the fact that its dissociation rate constant is non-significantly different from zero. Such irreversibility may explain the non-competitive inhibition pattern with respect to ATP shown by tideglusib and perhaps other structurally related compounds. The replacement of Cys-199 by an Ala residue in the enzyme seems to increase the dissociation rate, although the drug retains its inhibitory activity with decreased potency and long residence time. In addition, tideglusib failed to inhibit a series of kinases that contain a Cys homologous to Cys-199 in their active site, suggesting that its inhibition of GSK-3 beta obeys to a specific mechanism and is not a consequence of nonspecific reactivity. Results obtained with [S-35]tideglusib do not support unequivocally the existence of a covalent bond between the drug and GSK-3 beta. The irreversibility of the inhibition and the very low protein turnover rate observed for the enzyme are particularly relevant from a pharmacological perspective and could have significant implications on its therapeutic potential.	[Manuel Dominguez, Juan; Fuertes, Ana; Orozco, Leyre; del Monte-Millan, Maria; Delgado, Elena; Medina, Miguel] Noscira SA, Tres Cantos 28760, Spain		Dominguez, JM (corresponding author), Noscira SA, Ave Ind 52, Tres Cantos 28760, Spain.	jmdominguez@noscira.com; mmedina@noscira.com	Medina, Miguel/I-7135-2019; Medina, Miguel/J-1642-2019; Dominguez, Juan Manuel/I-9993-2019; Medina, Miguel/H-5676-2012	Dominguez, Juan Manuel/0000-0001-9472-6969; Medina, Miguel/0000-0002-7016-5340	European Commission [223276]; CDTI [IDI-20110884]	European Commission(European CommissionEuropean Commission Joint Research Centre); CDTI	This work was supported by European Commission Grant EU-FP7 (Neuro. GSK3, Project 223276) and CDTI Grant IDI-20110884. All of the authors are employees of Noscira, the owner of tideglusib.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cook P. F., 2007, ENZYME KINETICS MECH; COPELAND RA, 1994, P NATL ACAD SCI USA, V91, P11202, DOI 10.1073/pnas.91.23.11202; Copeland RA, 2000, ENZYMES PRACTICAL IN, P318, DOI 10.1002/0471220639.ch10; Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, V3rd, P113; del Ser T., 2010, ALZHEIMERS DEMENT, V6, pS147, DOI DOI 10.1016/J.JALZ.2010.05.455; Fersht A., 1999, STRUCTURE MECH PROTE; Gentles RG, 2009, ANNU REP MED CHEM, V44, P3, DOI 10.1016/S0065-7743(09)04401-7; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kluter S, 2010, CHEMBIOCHEM, V11, P2557, DOI 10.1002/cbic.201000352; Kwok JBJ, 2008, ANN NEUROL, V64, P446, DOI 10.1002/ana.21476; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Marcinkeviciene J, 2001, J BIOL CHEM, V276, P23790, DOI 10.1074/jbc.M101896200; Martinez A, 2005, J MED CHEM, V48, P7103, DOI 10.1021/jm040895g; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Mateo I, 2006, DEMENT GERIATR COGN, V21, P228, DOI 10.1159/000091044; Mateo I, 2009, ACTA NEUROL SCAND, V120, P130, DOI 10.1111/j.1600-0404.2008.01128.x; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Medina M, 2011, ALZHEIMER'S DISEASE PATHOGENESIS - CORE CONCEPTS, SHIFTING PARADIGMS AND THERAPEUTIC TARGETS, P197; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Moreno H, 2009, P NATL ACAD SCI USA, V106, P5901, DOI 10.1073/pnas.0900944106; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Schaffer BAJ, 2008, ARCH NEUROL-CHICAGO, V65, P1368, DOI 10.1001/archneur.65.10.1368; Schirmer A, 2006, P NATL ACAD SCI USA, V103, P4234, DOI 10.1073/pnas.0600445103; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhao A, 1999, J ANTIBIOT, V52, P1086, DOI 10.7164/antibiotics.52.1086; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	57	161	166	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					893	904		10.1074/jbc.M111.306472	http://dx.doi.org/10.1074/jbc.M111.306472			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102280	Green Published, hybrid			2022-12-25	WOS:000299170300008
J	Chi, LJ; Saarela, U; Railo, A; Prunskaite-Hyyrylainen, R; Skovorodkin, I; Anthony, S; Katsu, K; Liu, Y; Shan, JD; Salgueiro, AM; Belo, JA; Davies, J; Yokouchi, Y; Vainio, SJ				Chi, Lijun; Saarela, Ulla; Railo, Antti; Prunskaite-Hyyrylainen, Renata; Skovorodkin, Ilya; Anthony, Shelagh; Katsu, Kenjiro; Liu, Yu; Shan, Jingdong; Salgueiro, Ana Marisa; Belo, Jose Antonio; Davies, Jamie; Yokouchi, Yuji; Vainio, Seppo J.			A Secreted BMP Antagonist, Cer1, Fine Tunes the Spatial Organization of the Ureteric Bud Tree during Mouse Kidney Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; RENAL BRANCHING MORPHOGENESIS; METANEPHRIC MESENCHYME; EPITHELIAL TRANSFORMATION; CERBERUS-LIKE; EXPRESSION; GENE; SIGNALS; REGULATOR; PATHWAYS	The epithelial ureteric bud is critical for mammalian kidney development as it generates the ureter and the collecting duct system that induces nephrogenesis in dicrete locations in the kidney mesenchyme during its emergence. We show that a secreted Bmp antagonist Cerberus homologue (Cer1) fine tunes the organization of the ureteric tree during organogenesis in the mouse embryo. Both enhanced ureteric expression of Cer1 and Cer1 knock out enlarge kidney size, and these changes are associated with an altered three-dimensional structure of the ureteric tree as revealed by optical projection tomography. Enhanced Cer1 expression changes the ureteric bud branching programme so that more trifid and lateral branches rather than bifid ones develop, as seen in time-lapse organ culture. These changes may be the reasons for the modified spatial arrangement of the ureteric tree in the kidneys of Cer1+ embryos. Cer1 gain of function is associated with moderately elevated expression of Gdnf and Wnt11, which is also induced in the case of Cer1 deficiency, where Bmp4 expression is reduced, indicating the dependence of Bmp expression on Cer1. Cer1 binds at least Bmp2/4 and antagonizes Bmp signalling in cell culture. In line with this, supplementation of Bmp4 restored the ureteric bud tip number, which was reduced by Cer1+ to bring it closer to the normal, consistent with models suggesting that Bmp signalling inhibits ureteric bud development. Genetic reduction of Wnt11 inhibited the Cer1-stimulated kidney development, but Cer1 did not influence Wnt11 signalling in cell culture, although it did inhibit the Wnt3a-induced canonical Top Flash reporter to some extent. We conclude that Cer1 fine tunes the spatial organization of the ureteric tree by coordinating the activities of the growth-promoting ureteric bud signals Gndf and Wnt11 via Bmp-mediated antagonism and to some degree via the canonical Wnt signalling involved in branching.	[Chi, Lijun; Saarela, Ulla; Railo, Antti; Prunskaite-Hyyrylainen, Renata; Skovorodkin, Ilya; Shan, Jingdong; Vainio, Seppo J.] Univ Oulu, Bioctr Oulu, Ctr Cell Matrix Res,Inst Biomed Oulu, Lab Dev Biol,Dept Med Biochem & Mol Biol, Oulu, Finland; [Anthony, Shelagh; Davies, Jamie] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Katsu, Kenjiro; Yokouchi, Yuji] Kumamoto Univ, Div Pattern Format, Dept Organogenesis, Inst Mol Embryol & Genet, Kumamoto, Japan; [Liu, Yu] Texas A&M Hlth Sci Ctr, Ctr Dev & Dis, Inst Biosci & Technol, Houston, TX USA; [Salgueiro, Ana Marisa; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Algarve, Portugal; [Salgueiro, Ana Marisa; Belo, Jose Antonio] Univ Algarve, IBB, Ctr Biomed Mol & Estrutural, Faro, Portugal	University of Oulu; University of Edinburgh; Kumamoto University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Universidade do Algarve; Universidade do Algarve	Chi, LJ (corresponding author), Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.	seppo.vainio@oulu.fi	Liu, Yu/F-2802-2015; Belo, José A. A/F-4444-2012; Saarela, Ulla/GRF-3712-2022; Davies, Jamie/AAE-7111-2019; Skovorodkin, Ilya/AAJ-1780-2020; Salgueiro, Ana Marisa/F-8601-2014	Liu, Yu/0000-0002-1282-4897; Belo, José A. A/0000-0001-7384-0949; Davies, Jamie/0000-0001-6660-4032; Skovorodkin, Ilya/0000-0003-1182-1130; Salgueiro, Ana Marisa/0000-0002-9694-1029; Vainio, Seppo/0000-0001-9319-3566; Prunskaite-Hyyrylainen, Renata/0000-0001-5453-2983	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Organizations; UK Medical Research Council; European Union [LSHG-CT-2004-005085, HEALTH-F5-2008-223007]; Grants-in-Aid for Scientific Research [22590176] Funding Source: KAKEN	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The project was supported financially by grants from the Academy of Finland Centre of Excellence Programme 2012-2017, the Sigrid Juselius Foundation, the Finnish Cancer Organizations, the UK Medical Research Council, the European Union (EuReGene, LSHG-CT-2004-005085; HEALTH-F5-2008-223007 STAR-T REK and F. C. T. and IBB/CBME, LA to J.A. Belo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Belo JA, 2000, GENESIS, V26, P265, DOI 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.3.CO;2-W; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; BERTRAM JF, 1992, CELL TISSUE RES, V270, P37, DOI 10.1007/BF00381877; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Chi LJ, 2006, ENDOCRINOLOGY, V147, P3777, DOI 10.1210/en.2006-0299; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Costantini F, 2010, ORGANOGENESIS, V6, P252, DOI 10.4161/org.6.4.12680; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Godin RE, 1998, DEVELOPMENT, V125, P3473; Godin RE, 1999, INT J DEV BIOL, V43, P405; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019370; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Gupta IR, 1999, J BIOL CHEM, V274, P26305, DOI 10.1074/jbc.274.37.26305; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hartwg S, 2005, MECH DEVELOP, V122, P928, DOI 10.1016/j.mod.2005.03.007; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Hu MC, 2003, DEVELOPMENT, V130, P2753, DOI 10.1242/dev.00478; Ikeya M, 2010, DEV BIOL, V337, P405, DOI 10.1016/j.ydbio.2009.11.013; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Karner CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010418; Kiefer SM, 2010, DEVELOPMENT, V137, P3099, DOI 10.1242/dev.037812; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kispert A, 1996, DEVELOPMENT, V122, P3627; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kuschert S, 2001, DEV BIOL, V229, P128, DOI 10.1006/dbio.2000.9971; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Kuure S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001176; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Lin YF, 2001, DEVELOPMENT, V128, P1573; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Martinez G, 2002, INT J DEV BIOL, V46, P525; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Munne PM, 2010, EVOL DEV, V12, P383, DOI 10.1111/j.1525-142X.2010.00425.x; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Oxburgh L, 2005, DEV BIOL, V286, P637, DOI 10.1016/j.ydbio.2005.08.024; OXBURGH L, 2011, PEDIAT NEPHROL  0304, V4; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Perala N, 2011, DIFFERENTIATION, V81, P81, DOI 10.1016/j.diff.2010.10.001; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Piscione TD, 1997, AM J PHYSIOL-RENAL, V273, pF961, DOI 10.1152/ajprenal.1997.273.6.F961; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010; REGINENSI A, 2011, HUM MOL GENET   0106; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sainio K, 1997, DEVELOPMENT, V124, P4077; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shawlot W, 2000, GENESIS, V26, P253, DOI 10.1002/(SICI)1526-968X(200004)26:4<253::AID-GENE60>3.3.CO;2-4; Short KM, 2010, KIDNEY INT, V77, P1132, DOI 10.1038/ki.2010.42; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; VALERIUS MT, 2002, MECH DEVELOP, V12, P219; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075	82	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27676	10.1371/journal.pone.0027676	http://dx.doi.org/10.1371/journal.pone.0027676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114682	Green Published, gold			2022-12-25	WOS:000297555800030
J	Foury, F; Szczepanowska, K				Foury, Francoise; Szczepanowska, Karolina			Antimutator Alleles of Yeast DNA Polymerase Gamma Modulate the Balance between DNA Synthesis and Excision	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; MISMATCH REPAIR; MUTATIONS; REPLICATION; SUBUNIT; GENE; IDENTIFICATION; HELICASE; CLONING; REGION	Mutations in mitochondrial DNA (mtDNA) are an important cause of disease and perhaps aging in human. DNA polymerase gamma (pol gamma), the unique replicase inside mitochondria, plays a key role in the fidelity of mtDNA replication through selection of the correct nucleotide and 3'-5' exonuclease proofreading. For the first time, we have isolated and characterized antimutator alleles in the yeast pol gamma (Mip1). These mip1 mutations, localised in the 3'-5' exonuclease and polymerase domains, elicit a 2-15 fold decrease in the frequency of mtDNA point mutations in an msh1-1 strain which is partially deficient in mtDNA mismatch-repair. In vitro experiments show that in all mutants the balance between DNA synthesis and exonucleolysis is shifted towards excision when compared to wild-type, suggesting that in vivo more opportunity is given to the editing function for removing the replicative errors. This results in partial compensation for the mismatch-repair defects and a decrease in mtDNA point mutation rate. However, in all mutants but one the antimutator trait is lost in the wild-type MSH1 background. Accordingly, the polymerases of selected mutants show reduced oligonucleotide primed M13 ssDNA synthesis and to a lesser extent DNA binding affinity, suggesting that in mismatch-repair proficient cells efficient DNA synthesis is required to reach optimal accuracy. In contrast, the Mip1-A256T polymerase, which displays wild-type like DNA synthesis activity, increases mtDNA replication fidelity in both MSH1 and msh1-1 backgrounds. Altogether, our data show that accuracy of wild-type Mip1 is probably not optimal and can be improved by specific (often conservative) amino acid substitutions that define a pol gamma area including a loop of the palm subdomain, two residues near the ExoII motif and an exonuclease helix-coil-helix module in close vicinity to the polymerase domain. These elements modulate in a subtle manner the balance between DNA polymerization and excision.	[Foury, Francoise; Szczepanowska, Karolina] Catholic Univ Louvain, Inst Sci Vie, B-3000 Louvain, Belgium	Universite Catholique Louvain	Foury, F (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-3000 Louvain, Belgium.	francoise.foury@uclouvain.be	Szczepanowska, Karolina/ABC-1404-2020	Szczepanowska, Karolina/0000-0003-4689-2350	'Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture' (Belgium); Belgian National Fund for Scientific Research; Association Francaise contre les 34 Myopathies; Interuniversity Attraction Poles Program-Belgian Science Policy	'Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture' (Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Association Francaise contre les 34 Myopathies; Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office)	KS was supported by a fellowship from the 'Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture' (Belgium). This work was supported by grants from the Belgian National Fund for Scientific Research, the Association Francaise contre les 34 Myopathies and the Interuniversity Attraction Poles Program-Belgian Science Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACKER J, 1985, CURR GENET, V10, P7, DOI 10.1007/BF00418487; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; CHI NW, 1994, J BIOL CHEM, V269, P29984; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1039; Foury F, 2004, CELL MOL LIFE SCI, V61, P2799, DOI 10.1007/s00018-004-4220-y; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; FOURY F, 1989, J BIOL CHEM, V264, P20552; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; REENAN RAG, 1992, GENETICS, V132, P963; Reha-Krantz LJ, 1998, GENETICS, V148, P1551; REHAKRANTZ LJ, 1989, J VIROL, V63, P4762, DOI 10.1128/JVI.63.11.4762-4766.1989; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Wu P, 1998, BIOCHEMISTRY-US, V37, P14748, DOI 10.1021/bi980835a; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344; ZASSENHAUS HP, 1988, NUCLEIC ACIDS RES, V16, P3283, DOI 10.1093/nar/16.8.3283; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012	41	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27847	10.1371/journal.pone.0027847	http://dx.doi.org/10.1371/journal.pone.0027847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114710	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400128
J	Rincon-Gonzalez, L; Buneo, CA; Tillery, SIH				Rincon-Gonzalez, Liliana; Buneo, Christopher A.; Tillery, Stephen I. Helms			The Proprioceptive Map of the Arm Is Systematic and Stable, but Idiosyncratic	PLOS ONE			English	Article							CORIOLIS-FORCE PERTURBATIONS; UPPER-LIMB ASYMMETRIES; LIGHT TOUCH; FINGERTIP CONTACT; VISUAL RESPONSES; MOTOR ADAPTATION; POSITION; HAND; SPACE; REPRESENTATION	Visual and somatosensory signals participate together in providing an estimate of the hand's spatial location. While the ability of subjects to identify the spatial location of their hand based on visual and proprioceptive signals has previously been characterized, relatively few studies have examined in detail the spatial structure of the proprioceptive map of the arm. Here, we reconstructed and analyzed the spatial structure of the estimation errors that resulted when subjects reported the location of their unseen hand across a 2D horizontal workspace. Hand position estimation was mapped under four conditions: with and without tactile feedback, and with the right and left hands. In the task, we moved each subject's hand to one of 100 targets in the workspace while their eyes were closed. Then, we either a) applied tactile stimulation to the fingertip by allowing the index finger to touch the target or b) as a control, hovered the fingertip 2 cm above the target. After returning the hand to a neutral position, subjects opened their eyes to verbally report where their fingertip had been. We measured and analyzed both the direction and magnitude of the resulting estimation errors. Tactile feedback reduced the magnitude of these estimation errors, but did not change their overall structure. In addition, the spatial structure of these errors was idiosyncratic: each subject had a unique pattern of errors that was stable between hands and over time. Finally, we found that at the population level the magnitude of the estimation errors had a characteristic distribution over the workspace: errors were smallest closer to the body. The stability of estimation errors across conditions and time suggests the brain constructs a proprioceptive map that is reliable, even if it is not necessarily accurate. The idiosyncrasy across subjects emphasizes that each individual constructs a map that is unique to their own experiences.	[Rincon-Gonzalez, Liliana] Arizona State Univ, Grad Program Biomed Engn, Sch Biol & Hlth Syst Engn, Tempe, AZ 85069 USA; Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Rincon-Gonzalez, L (corresponding author), Arizona State Univ, Grad Program Biomed Engn, Sch Biol & Hlth Syst Engn, Tempe, AZ 85069 USA.	Steve.HelmsTillery@asu.edu		Rincon-Gonzalez, Liliana/0000-0002-5565-9609	National Institutes of Health (NIH) [R01-NS063372]; National Science Foundation (NSF); NSF Alliance for Graduate Education and Professiorate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063372] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Alliance for Graduate Education and Professiorate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by National Institutes of Health (NIH) Grant R01-NS063372 (SHT), the National Science Foundation (NSF) Bridge to the Doctorate (LRG) and the NSF Alliance for Graduate Education and Professiorate program (LRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Azanon E, 2007, EXP BRAIN RES, V182, P537, DOI 10.1007/s00221-007-1011-3; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; Bagesteiro LB, 2006, EXP BRAIN RES, V171, P358, DOI 10.1007/s00221-005-0272-y; Balslev D, 2005, CEREB CORTEX, V15, P166, DOI 10.1093/cercor/bhh119; Balslev D, 2007, J VISION, V7, DOI 10.1167/7.5.12; Berens P., 2009, J STAT SOFTWARE, V31; Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Brown LE, 2003, EXP BRAIN RES, V153, P266, DOI 10.1007/s00221-003-1601-7; Buneo CA, 2011, J NEUROSCI METH, V197, P109, DOI 10.1016/j.jneumeth.2011.02.008; DARLING WG, 1993, EXP BRAIN RES, V93, P534; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; Dickstein R, 2005, SOMATOSENS MOT RES, V22, P319, DOI 10.1080/08990220500420640; DIZIO P, 1995, J NEUROPHYSIOL, V74, P1787, DOI 10.1152/jn.1995.74.4.1787; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Goble DJ, 2007, EXP BRAIN RES, V180, P693, DOI 10.1007/s00221-007-0890-7; Goble DJ, 2009, EXP BRAIN RES, V197, P403, DOI 10.1007/s00221-009-1922-2; Goble DJ, 2006, EXP BRAIN RES, V168, P307, DOI 10.1007/s00221-005-0280-y; Graziano MSA, 2004, EXP BRAIN RES, V155, P30, DOI 10.1007/s00221-003-1701-4; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 1998, EXP BRAIN RES, V118, P373, DOI 10.1007/s002210050291; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Haggard P, 2006, EXP BRAIN RES, V172, P94, DOI 10.1007/s00221-005-0311-8; JEKA JJ, 1995, EXP BRAIN RES, V103, P267; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Kappers AML, 2003, ACTA PSYCHOL, V114, P131, DOI 10.1016/S0001-6918(03)00063-5; Kennett S, 2002, PERCEPT PSYCHOPHYS, V64, P1083, DOI 10.3758/BF03194758; Kouzaki M, 2008, EXP BRAIN RES, V188, P153, DOI 10.1007/s00221-008-1426-5; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lackner JR, 2000, TRENDS COGN SCI, V4, P279, DOI 10.1016/S1364-6613(00)01493-5; Lackner JR, 2000, J NEUROPHYSIOL, V84, P2217, DOI 10.1152/jn.2000.84.5.2217; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Overvliet KE, 2011, EXP BRAIN RES, V208, P245, DOI 10.1007/s00221-010-2475-0; Rabin E, 2004, J APPL PHYSIOL, V96, P1555, DOI 10.1152/japplphysiol.01085.2003; Rabin E, 2008, J NEUROPHYSIOL, V99, P595, DOI 10.1152/jn.00504.2007; Rao AK, 2001, EXP BRAIN RES, V138, P438, DOI 10.1007/s002210100717; RINCONGONZALEZ L, 2011, IEEE T NEUR IN PRESS; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Sainburg RL, 2005, EXERC SPORT SCI REV, V33, P206, DOI 10.1097/00003677-200510000-00010; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Spence C, 2004, J PHYSIOL-PARIS, V98, P171, DOI 10.1016/j.jphysparis.2004.03.008; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; TILLERY SIH, 1994, NEUROREPORT, V6, P177; TILLERY SIH, 1991, J NEUROSCI, V11, P770; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van den Dobbelsteen JJ, 2004, J NEUROPHYSIOL, V92, P416, DOI 10.1152/jn.00764.2003; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wang JS, 2007, EXP BRAIN RES, V178, P565, DOI 10.1007/s00221-007-0936-x; WANN JP, 1992, EXP BRAIN RES, V91, P162; Warren JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018073; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Wong JD, 2011, J NEUROPHYSIOL, V105, P2512, DOI 10.1152/jn.00949.2010; Yamamoto S, 2001, NAT NEUROSCI, V4, P979, DOI 10.1038/nn721	70	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e25214	10.1371/journal.pone.0025214	http://dx.doi.org/10.1371/journal.pone.0025214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110578	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400004
J	Llorens-Martin, M; Lopez-Domenech, G; Soriano, E; Avila, J				Llorens-Martin, Maria; Lopez-Domenech, Guillermo; Soriano, Eduardo; Avila, Jesus			GSK3 beta Is Involved in the Relief of Mitochondria Pausing in a Tau-Dependent Manner	PLOS ONE			English	Article							FAST AXONAL-TRANSPORT; CONDITIONAL TRANSGENIC MICE; SYNTHASE KINASE 3-BETA; AMYLOID-BETA; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; INDUCED DEFECTS; KINESIN; PROTEIN; PHOSPHORYLATION	Mitochondrial trafficking deficits have been implicated in the pathogenesis of several neurological diseases, including Alzheimer's disease (AD). The Ser/Thre kinase GSK3 beta is believed to play a fundamental role in AD pathogenesis. Given that GSK3 beta substrates include Tau protein, here we studied the impact of GSK3 beta on mitochondrial trafficking and its dependence on Tau protein. Overexpression of GSK3 beta in neurons resulted in an increase in motile mitochondria, whereas a decrease in the activity of this kinase produced an increase in mitochondria pausing. These effects were dependent on Tau proteins, as Tau (-/-) neurons did not respond to distinct GSK3 beta levels. Furthermore, differences in GSK3 beta expression did not affect other parameters like mitochondria velocity or mitochondria run length. We conclude that GSK3 beta activity regulates mitochondrial axonal trafficking largely in a Tau-dependent manner.	[Llorens-Martin, Maria; Avila, Jesus] Ctr Biol Mol Severo Ochoa, Dept Mol Neurobiol, Madrid, Spain; [Lopez-Domenech, Guillermo; Soriano, Eduardo; Avila, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Lopez-Domenech, Guillermo; Soriano, Eduardo] Inst Res Biomed, Barcelona, Spain; [Lopez-Domenech, Guillermo; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Llorens-Martin, M (corresponding author), Ctr Biol Mol Severo Ochoa, Dept Mol Neurobiol, Madrid, Spain.	javila@cbm.uam.es	Avila, Jesus/I-2610-2015; Soriano, Eduardo/AAB-3216-2019; López Doménech, Guillermo López Doménech/X-6075-2018; Llorens-Martin, Maria/R-4613-2017	Avila, Jesus/0000-0002-6288-0571; Soriano, Eduardo/0000-0002-3204-9285; López Doménech, Guillermo López Doménech/0000-0002-3114-2082; Llorens-Martin, Maria/0000-0001-9129-5198	Spanish Ministry of Health [SAF 2006-02424, BFU-2008-03980]; Comunidad de Madrid [SAL/0202/2006]; Fundacion M. Botin; Fundacion Caixa Catalunya Obra Social; Fundacion R. Areces	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion M. Botin; Fundacion Caixa Catalunya Obra Social; Fundacion R. Areces(Instituto de Salud Carlos III)	This study was funded by grants from the Spanish Ministry of Health (SAF 2006-02424, BFU-2008-03980), the Comunidad de Madrid (SAL/0202/2006), the Fundacion M. Botin, the Fundacion Caixa Catalunya Obra Social, and an institutional grant from the Fundacion R. Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; AVILA J, 1994, CELL BIOL INT, V18, P309, DOI 10.1006/cbir.1994.1079; Berciano J, 2011, NAT REV NEUROL, V7, P305, DOI 10.1038/nrneurol.2011.72; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DIAZNIDO J, 1988, J CELL BIOL, V106, P2057, DOI 10.1083/jcb.106.6.2057; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; Hiruma H, 2003, J NEUROSCI, V23, P8967; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; KANAAN NM, 2011, NEUROBIOL AGING; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MACKEY S, 1981, BIOPHYS J, V36, P455, DOI 10.1016/S0006-3495(81)84745-5; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Mandell JW, 1996, J NEUROSCI, V16, P5727; Morel M, 2010, NEUROSCIENCE, V167, P1044, DOI 10.1016/j.neuroscience.2010.02.077; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; ULLOA L, 1993, EMBO J, V12, P1633, DOI 10.1002/j.1460-2075.1993.tb05808.x; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zhang LH, 2011, INTEGRATION, V44, P1, DOI 10.1016/j.vlsi.2010.09.003	46	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27686	10.1371/journal.pone.0027686	http://dx.doi.org/10.1371/journal.pone.0027686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110721	gold, Green Published, Green Submitted			2022-12-25	WOS:000297554300049
J	Ruuskanen, S; Siitari, H; Eeva, T; Belskii, E; Jarvinen, A; Kerimov, A; Krams, I; Moreno, J; Morosinotto, C; Mand, R; Mostl, E; Orell, M; Qvarnstrom, A; Salminen, JP; Slater, F; Tilgar, V; Visser, ME; Winkel, W; Zang, H; Laaksonen, T				Ruuskanen, Suvi; Siitari, Heli; Eeva, Tapio; Belskii, Eugen; Jarvinen, Antero; Kerimov, Anvar; Krams, Indrikis; Moreno, Juan; Morosinotto, Chiara; Maend, Raivo; Moestl, Erich; Orell, Markku; Qvarnstrom, Anna; Salminen, Juha-Pekka; Slater, Fred; Tilgar, Vallo; Visser, Marcel E.; Winkel, Wolfgang; Zang, Herwig; Laaksonen, Toni			Geographical Variation in Egg Mass and Egg Content in a Passerine Bird	PLOS ONE			English	Article							TIT PARUS-MAJOR; YOLK STEROID-LEVELS; BARN SWALLOW EGGS; PIED FLYCATCHER; CLUTCH-SIZE; LATITUDINAL VARIATION; OFFSPRING PHENOTYPE; FICEDULA-ALBICOLLIS; MATERNAL TRANSFER; PARENTAL QUALITY	Reproductive, phenotypic and life-history traits in many animal and plant taxa show geographic variation, indicating spatial variation in selection regimes. Maternal deposition to avian eggs, such as hormones, antibodies and antioxidants, critically affect development of the offspring, with long-lasting effects on the phenotype and fitness. Little is however known about large-scale geographical patterns of variation in maternal deposition to eggs. We studied geographical variation in egg components of a passerine bird, the pied flycatcher (Ficedula hypoleuca), by collecting samples from 16 populations and measuring egg and yolk mass, albumen lysozyme activity, yolk immunoglobulins, yolk androgens and yolk total carotenoids. We found significant variation among populations in most egg components, but ca. 90% of the variation was among individuals within populations. Population however explained 40% of the variation in carotenoid levels. In contrast to our hypothesis, we found geographical trends only in carotenoids, but not in any of the other egg components. Our results thus suggest high within-population variation and leave little scope for local adaptation and genetic differentiation in deposition of different egg components. The role of these maternally-derived resources in evolutionary change should be further investigated.	[Ruuskanen, Suvi; Eeva, Tapio; Morosinotto, Chiara; Laaksonen, Toni] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Siitari, Heli] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Belskii, Eugen] Russian Acad Sci, Inst Plant & Anim Ecol, Ekaterinburg, Russia; [Jarvinen, Antero] Univ Helsinki, Fac Biol & Environm Sci, Helsinki, Finland; [Kerimov, Anvar] Moscow MV Lomonosov State Univ, Zvenigorod Biol Stn, Moscow, Russia; [Krams, Indrikis] Daugavpils Univ, Inst Systemat Biol, Daugavpils, Latvia; [Moreno, Juan] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Maend, Raivo; Tilgar, Vallo] Univ Tartu, Dept Zool, EE-50090 Tartu, Estonia; [Moestl, Erich] Univ Vet Med, Vienna, Austria; [Orell, Markku] Univ Oulu, Dept Biol, Oulu, Finland; [Qvarnstrom, Anna] Uppsala Univ, Dept Anim Ecol, Uppsala, Sweden; [Salminen, Juha-Pekka] Univ Turku, Lab Organ Chem & Chem Biol, Turku, Finland; [Slater, Fred] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Visser, Marcel E.] Netherlands Inst Ecol, Wageningen, Netherlands; [Winkel, Wolfgang] Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany; [Laaksonen, Toni] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	University of Turku; University of Jyvaskyla; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Helsinki; Lomonosov Moscow State University; University of Daugavpils; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Tartu; University of Veterinary Medicine Vienna; University of Oulu; Uppsala University; University of Turku; Cardiff University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Helsinki	Ruuskanen, S (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	suvi.ruuskanen@utu.fi	Salminen, Juha-Pekka/N-3313-2017; Kerimov, Anvar/ABF-5776-2021; Laaksonen, Toni/B-4241-2014; Slater, Fred/A-4340-2010; Moreno, Juan/AAB-1307-2019; Eeva, Tapio/V-8922-2018; Belskii, Eugen A/J-7976-2018; Krams, Indrikis/B-5788-2017; Morosinotto, Chiara/AAK-5266-2020; Visser, Marcel E/A-9151-2009; Ruuskanen, Suvi/A-1790-2013	Salminen, Juha-Pekka/0000-0002-2912-7094; Laaksonen, Toni/0000-0001-9035-7131; Slater, Fred/0000-0002-9504-3606; Moreno, Juan/0000-0003-1508-7295; Eeva, Tapio/0000-0002-0395-1536; Belskii, Eugen A/0000-0002-7570-2555; Krams, Indrikis/0000-0001-7150-4108; Visser, Marcel E/0000-0002-1456-1939; Ruuskanen, Suvi/0000-0001-5582-9455; Qvarnstrom, Anna/0000-0002-1178-4053; Morosinotto, Chiara/0000-0002-9172-894X	Turku University Foundation; Finnish Cultural Foundation [381]; Emil Aaltonen Foundation	Turku University Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Emil Aaltonen Foundation	This study was financially supported by Turku University Foundation, Finnish Cultural Foundation 381 (grants to S.R.) and Emil Aaltonen Foundation (a grant to T.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo RBR, 1996, EVOLUTION, V50, P2338, DOI [10.2307/2410702, 10.1111/j.1558-5646.1996.tb03621.x]; Badyaev AV, 2006, J EVOLUTION BIOL, V19, P1044, DOI 10.1111/j.1420-9101.2006.01106.x; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Bernardo J, 1996, AM ZOOL, V36, P216; Bernardo J, 1996, AM ZOOL, V36, P83; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; BORTOLOTTI R, 2000, P ROY SOC LOND B BIO, V267, P1433; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Bourgault P, 2007, CAN J ZOOL, V85, P71, DOI 10.1139/Z06-189; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; Cucco M, 2006, CAN J ZOOL, V84, P72, DOI 10.1139/Z05-179; Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014; D'Alba L, 2010, BEHAV ECOL SOCIOBIOL, V64, P1037, DOI 10.1007/s00265-010-0919-y; Eeva T, 2002, ECOGRAPHY, V25, P705, DOI 10.1034/j.1600-0587.2002.250606.x; Eeva T, 2011, OECOLOGIA, V165, P277, DOI 10.1007/s00442-010-1772-4; Encabo SI, 2002, IBIS, V144, P623, DOI 10.1046/j.1474-919X.2002.00099.x; Endler J.A., 1977, Monographs in Population Biology, pi; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; GODFRAY HCJ, 1991, ANNU REV ECOL SYST, V22, P409, DOI 10.1146/annurev.es.22.110191.002205; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hahn DC, 2005, J AVIAN BIOL, V36, P40, DOI 10.1111/j.0908-8857.2005.03040.x; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; Hargitai R, 2006, COMP BIOCHEM PHYS B, V143, P145, DOI 10.1016/j.cbpb.2005.11.001; Hargitai R, 2009, BEHAV ECOL SOCIOBIOL, V63, P869, DOI 10.1007/s00265-009-0727-4; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Hirschenhauser K, 1999, GEN COMP ENDOCR, V114, P67, DOI 10.1006/gcen.1998.7236; Horak P, 1995, ORNIS FENNICA, V72, P97; Horak Peeter, 2002, Avian Science, V2, P123; HOYT DF, 1979, AUK, V96, P73; Isaksson C, 2008, PHYSIOL BIOCHEM ZOOL, V81, P112, DOI 10.1086/522650; JARVINEN A, 1989, IBIS, V131, P572, DOI 10.1111/j.1474-919X.1989.tb04792.x; JARVINEN A, 1983, ORNIS SCAND, V14, P253, DOI 10.2307/3676313; JARVINEN A, 1989, OIKOS, V54, P331, DOI 10.2307/3565294; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jokinen EI, 2003, FISH SHELLFISH IMMUN, V15, P159, DOI 10.1016/S1050-4648(02)00155-9; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; KLOMP H, 1970, ARDEA, V58, P1; Laaksonen T, 2011, BEHAV ECOL SOCIOBIOL, V65, P257, DOI 10.1007/s00265-010-1034-9; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Laugen AT, 2002, BIOL J LINN SOC, V76, P61, DOI 10.1046/j.1095-8312.2002.00048.x; Lehtonen PK, 2009, MOL ECOL, V18, P4463, DOI 10.1111/j.1365-294X.2009.04364.x; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Lundberg A, 1992, PIED FLYCATCHER; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Michl G, 2005, BEHAV ECOL, V16, P383, DOI 10.1093/beheco/ari002; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; OJANEN M, 1983, ANN ZOOL FENN, V20, P57; OJANEN M, 1983, THESIS U OULU; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; PARRY RM, 1965, P SOC EXP BIOL MED, V119, P384; PARTALI V, 1987, COMP BIOCHEM PHYS B, V87, P885, DOI 10.1016/0305-0491(87)90408-1; Patten MA, 2007, J AVIAN BIOL, V38, P637, DOI 10.1111/j.2007.0908-8857.04203.x; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasanen K, 2005, OECOLOGIA, V142, P546, DOI 10.1007/s00442-004-1762-5; Roff Derek A., 1992; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; ROWE JW, 1994, OECOLOGIA, V99, P35, DOI 10.1007/BF00317081; Safran RJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P427, DOI 10.1007/s00265-007-0470-7; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Sanz JJ, 1997, IBIS, V139, P107, DOI 10.1111/j.1474-919X.1997.tb04509.x; Sanz JJ, 1999, IBIS, V141, P100; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SHINE R, 2003, P ROY SOC LOND B BIO, V1519, P995; Sillanpaa S, 2009, ACTA OECOL, V35, P805, DOI 10.1016/j.actao.2009.08.006; SLAGSVOLD T, 1975, Norwegian Journal of Zoology, V23, P213; SLATKIN M, 1973, GENETICS, V75, P733; Stearns S.C., 1992, pi; Tobler M, 2007, OECOLOGIA, V151, P731, DOI 10.1007/s00442-006-0610-1; Torok J, 2007, BEHAV ECOL SOCIOBIOL, V61, P541, DOI 10.1007/s00265-006-0282-1; Tschirren B, 2009, AM NAT, V174, P557, DOI 10.1086/605379; VANBALEN JH, 1973, ARDEA, V61, P1; Williams TD, 1996, PHYSIOL ZOOL, V69, P1255, DOI 10.1086/physzool.69.5.30164256; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2	88	25	25	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e25360	10.1371/journal.pone.0025360	http://dx.doi.org/10.1371/journal.pone.0025360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110579	Green Published, gold, Green Accepted			2022-12-25	WOS:000297554300002
J	Tra, T; Gong, L; Kao, LP; Li, XL; Grandela, C; Devenish, RJ; Wolvetang, E; Prescott, M				Thien Tra; Gong, Lan; Kao, Lin-Pin; Li, Xue-Lei; Grandela, Catarina; Devenish, Rodney J.; Wolvetang, Ernst; Prescott, Mark			Autophagy in Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; SELF-RENEWAL; GROWTH; DIFFERENTIATION; LINES; MTOR; PROLIFERATION; FIBROBLASTS; SURVIVAL; YEAST	Autophagy (macroautophagy) is a degradative process that involves the sequestration of cytosolic material including organelles into double membrane vesicles termed autophagosomes for delivery to the lysosome. Autophagy is essential for preimplantation development of mouse embryos and cavitation of embryoid bodies. The precise roles of autophagy during early human embryonic development, remain however largely uncharacterized. Since human embryonic stem cells constitute a unique model system to study early human embryogenesis we investigated the occurrence of autophagy in human embryonic stem cells. We have, using lentiviral transduction, established multiple human embryonic stem cell lines that stably express GFP-LC3, a fluorescent marker for the autophagosome. Each cell line displays both a normal karyotype and pluripotency as indicated by the presence of cell types representative of the three germlayers in derived teratomas. GFP expression and labelling of autophagosomes is retained after differentiation. Baseline levels of autophagy detected in cultured undifferentiated hESC were increased or decreased in the presence of rapamycin and wortmannin, respectively. Interestingly, autophagy was upregulated in hESCs induced to undergo differentiation by treatment with type I TGF-beta receptor inhibitor SB431542 or removal of MEF secreted maintenance factors. In conclusion we have established hESCs capable of reporting macroautophagy and identify a novel link between autophagy and early differentiation events in hESC.	[Thien Tra; Gong, Lan; Li, Xue-Lei; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Gong, Lan; Devenish, Rodney J.] Monash Univ, ARC Ctr Excellence Struct & Funct Genom, Clayton, Vic, Australia; [Kao, Lin-Pin; Wolvetang, Ernst] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Grandela, Catarina] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	Monash University; Monash University; University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam	Tra, T (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	E.wolvetang@uq.edu.au; Mark.prescott@monash.au	Gong, Lan/O-7886-2019; Wolvetang, Ernst jurgen/D-6644-2017; kao, Betty/M-5480-2017; Wolvetang, Ernst J/J-7602-2013; Gong, Lan/J-6368-2016	Gong, Lan/0000-0003-3136-1565; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Gong, Lan/0000-0003-3136-1565	Australian Stem Cell Centre [PO90]; Stemcore tissue culture facility of the ASCC	Australian Stem Cell Centre; Stemcore tissue culture facility of the ASCC	This study was funded by the Australian Stem Cell Centre Grant no PO90 (URL:www.stemcellcentre.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Stemcore tissue culture facility of the ASCC.	Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Basiji DA, 2007, CLIN LAB MED, V27, P653, DOI 10.1016/j.cll.2007.05.008; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; Easley CA, 2010, CELL REPROGRAM, V12, P263, DOI 10.1089/cell.2010.0011; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hannan NRF, 2009, CLONING STEM CELLS, V11, P427, DOI 10.1089/clo.2009.0024; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	29	57	60	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27485	10.1371/journal.pone.0027485	http://dx.doi.org/10.1371/journal.pone.0027485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110659	gold, Green Published, Green Submitted			2022-12-25	WOS:000297554300034
J	Clark, CR; Coull, B; Berkman, LF; Buring, JE; Ridker, PM				Clark, Cheryl R.; Coull, Brent; Berkman, Lisa F.; Buring, Julie E.; Ridker, Paul M.			Geographic Variation in Cardiovascular Inflammation among Healthy Women in the Women's Health Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OLDER POPULATIONS; STROKE INCIDENCE; HEART-DISEASE; RISK; US; ATHEROSCLEROSIS; PREVENTION; PREDICTION; MORTALITY	Background: Geographic variation in traditional cardiovascular disease (CVD) risk factors has been observed among women in the US. It is not known whether state-level variation in cardiovascular inflammation exists or could be explained by traditional clinical risk factors and behavioral lifestyle factors. Methods and Results: We used multilevel linear regression to estimate state-level variation in inflammatory biomarker patterns adjusted for clinical and lifestyle characteristics among 26,029 women free of CVD. Participants derived from the Women's Health Study, a national cohort of healthy middle-aged and older women. Inflammatory biomarker patterns (plasma levels of high-sensitivity C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1), and fibrinogen) were compared to state-level patterns of traditional CVD risk factors and global risk scores. We found that all three inflammatory biomarkers exhibited significant state-level variation including hsCRP (lowest vs. highest state median 1.3 mg/L vs. 2.7 mg/L, unadjusted random effect estimate 1(st) to 99(th) percentile range for log hsCRP 0.52, p<.001), sICAM-1 (325 ng/ml vs. 366ng/ml, unadjusted random effect estimate 1(st) to 99(th) percentile range 0.44, p<.001), and fibrinogen (322 mg/dL vs. 367 mg/dL, unadjusted random effect estimate 1(st) to 99(th) percentile range 0.41, p=.001). Neither demographic, clinical or lifestyle characteristics explained away state-level effects in biomarker patterns. Southern and Appalachian states (Arkansas, West Virginia) had the highest inflammatory biomarker values. Regional geographic patterns of traditional CVD risk factors and risk scores did not completely overlap with biomarkers of inflammation. Conclusions: There is state-level geographic variation in inflammatory biomarkers among otherwise healthy women that cannot be completely attributed to traditional clinical risk factors or lifestyle characteristics. Future research should aim to identify additional factors that may explain geographic variation in biomarkers of inflammation among healthy women.	[Clark, Cheryl R.] Harvard Univ, Sch Med, Div Gen Med & Primary Care, Brigham & Womens Faulkner Hosp Program, Boston, MA 02215 USA; [Clark, Cheryl R.] Brigham & Womens Hosp, Ctr Community Hlth & Hlth Equ, Boston, MA 02115 USA; [Coull, Brent] Harvard Univ, Sch Med, Dept Biostat, Boston, MA USA; [Berkman, Lisa F.] Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA 02115 USA; [Berkman, Lisa F.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Clark, CR (corresponding author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Brigham & Womens Faulkner Hosp Program, Boston, MA 02215 USA.	crclark@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health; Robert Wood Johnson Foundation; National Institutes of Aging [K08 AG 032357]; Robert Wood Johnson Foundation Health Society [53572]; National Cancer Institute [CA047988]; National Heart, Lung, and Blood Institute [HL080467, HL043851, HL099355]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099355, R01HL080467, R01HL043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation Health Society(Robert Wood Johnson Foundation (RWJF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors gratefully acknowledge the funding support of the National Institutes of Health and the Robert Wood Johnson Foundation. This research was supported with funding from the National Institutes of Aging (K08 AG 032357), and the Robert Wood Johnson Foundation Health & Society Scholars program (53572). The Women's Health Study is supported with funding from the National Cancer Institute (CA047988) and the National Heart, Lung, and Blood Institute (HL080467, HL043851, HL099355). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cushman M, 2009, CLIN CHEM, V55, P1627, DOI 10.1373/clinchem.2008.122093; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; El-Saed A, 2006, STROKE, V37, P1980, DOI 10.1161/01.STR.0000231454.77745.d9; El-Saed A, 2006, STROKE, V37, P1975, DOI 10.1161/01.STR.0000231453.98473.67; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Glymour MM, 2007, STROKE, V38, P2415, DOI 10.1161/STROKEAHA.107.482059; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Gregg EW, 2010, JAMA-J AM MED ASSOC, V303, P933; Howard G, 2009, PREV MED, V49, P129, DOI 10.1016/j.ypmed.2009.03.004; Hwang SJ, 1997, CIRCULATION, V96, P4219; Jarvie JL, 2011, J WOMENS HEALTH, V20, P11, DOI 10.1089/jwh.2010.2036; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Subramanian S. V., 2003, Neighborhoods and health, P65; Taylor HA, 2002, AM J PUBLIC HEALTH, V92, P548, DOI 10.2105/AJPH.92.4.548	25	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27468	10.1371/journal.pone.0027468	http://dx.doi.org/10.1371/journal.pone.0027468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102899	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800027
J	Kadonosono, T; Kuchimaru, T; Yamada, S; Takahashi, Y; Murakami, A; Tani, T; Watanabe, H; Tanaka, T; Hirota, K; Inoue, M; Tsukamoto, T; Toyoda, T; Urano, K; Machida, K; Eto, T; Ogura, T; Tsutsumi, H; Ito, M; Hiraoka, M; Kondoh, G; Kizaka-Kondoh, S				Kadonosono, Tetsuya; Kuchimaru, Takahiro; Yamada, Shuichi; Takahashi, Yumi; Murakami, Atsushi; Tani, Taeko; Watanabe, Hitomi; Tanaka, Tomoharu; Hirota, Kiichi; Inoue, Masahiro; Tsukamoto, Tetsuya; Toyoda, Takeshi; Urano, Koji; Machida, Kazuhiko; Eto, Tomoo; Ogura, Tomoyuki; Tsutsumi, Hideki; Ito, Mamoru; Hiraoka, Masahiro; Kondoh, Gen; Kizaka-Kondoh, Shinae			Detection of the Onset of Ischemia and Carcinogenesis by Hypoxia-Inducible Transcription Factor-Based In Vivo Bioluminescence Imaging	PLOS ONE			English	Article							HA-RAS GENE; GROWTH-FACTOR EXPRESSION; TRANSGENIC MICE; FACTOR 1-ALPHA; MOUSE MODEL; PROTEIN; CANCER; HIF-1-ALPHA; MECHANISM; CELLS	An animal model for the early detection of common fatal diseases such as ischemic diseases and cancer is desirable for the development of new drugs and treatment strategies. Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that regulates oxygen homeostasis and plays key roles in a number of diseases, including cancer. Here, we established transgenic (Tg) mice that carry HRE/ODD-luciferase (HOL) gene, which generates bioluminescence in an HIF-1-dependent manner and was successfully used in this study to monitor HIF-1 activity in ischemic tissues. To monitor carcinogenesis in vivo, we mated HOL mice with rasH2 Tg mice, which are highly sensitive to carcinogens and are used for short-term carcinogenicity assessments. After rasH2-HOL Tg mice were treated with N-methyl-N-nitrosourea, bioluminescence was detected noninvasively as early as 9 weeks in tissues that contained papillomas and malignant lesions. These results suggest that the Tg mouse lines we established hold significant potential for monitoring the early onset of both ischemia and carcinogenesis and that these lines will be useful for screening chemicals for carcinogenic potential.	[Kadonosono, Tetsuya; Kuchimaru, Takahiro; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa, Japan; [Yamada, Shuichi] Akita Univ, Anim Res Lab, Biosci Res & Educ Ctr, Akita 010, Japan; [Takahashi, Yumi; Murakami, Atsushi; Tani, Taeko; Hiraoka, Masahiro] Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Watanabe, Hitomi; Kondoh, Gen] Inst Frontier Med Sci, Lab Anim Expt Regenerat, Kyoto, Japan; [Tanaka, Tomoharu; Hirota, Kiichi] Kyoto Univ, Dept Anesthesia, Sakyo Ku, Kyoto, Japan; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, Osaka, Japan; [Tsukamoto, Tetsuya; Toyoda, Takeshi] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Nagoya, Aichi 464, Japan; [Urano, Koji; Machida, Kazuhiko; Eto, Tomoo; Ogura, Tomoyuki; Tsutsumi, Hideki; Ito, Mamoru] Cent Inst Expt Anim, Miyamae Ku, Kawasaki, Kanagawa, Japan	Tokyo Institute of Technology; Akita University; Kyoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Aichi Cancer Center	Kadonosono, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan.	skondoh@bio.titech.ac.jp	Tsukamoto, Tetsuya/ABD-4397-2020; Kuchimaru, Takahiro/B-9269-2015; Kondoh, Shinae/C-6937-2015; Kadonosono, Tetsuya/D-4651-2019; Kondoh, Shinae/AAF-8745-2020; Hirota, Kiichi/E-9181-2010	Tsukamoto, Tetsuya/0000-0002-7502-8724; Kuchimaru, Takahiro/0000-0002-5355-3165; Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782; Hirota, Kiichi/0000-0003-1110-0827	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22112009, 22700935] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Dame C, 1998, BLOOD, V92, P3218, DOI 10.1182/blood.V92.9.3218; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2006, FEBS LETT, V580, P5718, DOI 10.1016/j.febslet.2006.09.025; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kimura M, 2008, BIOCHEM J, V411, P97, DOI 10.1042/BJ20070824; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Long GG, 2010, TOXICOL PATHOL, V38, P43, DOI 10.1177/0192623309354107; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; MacDonald J, 2004, TOXICOL SCI, V77, P188, DOI 10.1093/toxsci/kfh037; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; SAITOH A, 1990, ONCOGENE, V5, P1195; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Storer RD, 2010, TOXICOL PATHOL, V38, P51, DOI 10.1177/0192623309351718; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamamoto S, 1996, CARCINOGENESIS, V17, P2455, DOI 10.1093/carcin/17.11.2455; Yamamoto S, 1998, ENVIRON HEALTH PERSP, V106, P57, DOI 10.2307/3433912; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	35	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e26640	10.1371/journal.pone.0026640	http://dx.doi.org/10.1371/journal.pone.0026640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102864	Green Submitted, Green Published, gold			2022-12-25	WOS:000297348800008
J	Lu, J; Hamze, Z; Bonnavion, R; Herath, N; Pouponnot, C; Assade, F; Fontaniere, S; Bertolino, P; Cordier-Bussat, M; Zhang, CX				Lu, J.; Hamze, Z.; Bonnavion, R.; Herath, N.; Pouponnot, C.; Assade, F.; Fontaniere, S.; Bertolino, P.; Cordier-Bussat, M.; Zhang, C. X.			Reexpression of oncoprotein MafB in proliferative beta-cells and Men1 insulinomas in mouse	ONCOGENE			English	Article						Maf; MafB; Men1; pancreatic beta-cells; proliferation; insulinoma	ENDOCRINE NEOPLASIA TYPE-1; MULTIPLE-MYELOMA; C-MAF; MICE; GENE; EXPRESSION; OVEREXPRESSION; REVEALS; TRANSLOCATION; SECRETION	MafB, a member of the large Maf transcription factor family, is essential for the embryonic and terminal differentiation of pancreatic alpha- and beta-cells. However, the role of MafB in the control of adult islet-cell proliferation remains unknown. Considering its oncogenic potential in several other tissues, we investigated the possible alteration of its expression in adult mouse beta-cells under different conditions of proliferation. We found that MafB, in general silenced in these cells, was reexpressed in similar to 30% of adaptive beta-cells both in gestational female mice and in mice fed with a high-fat diet. Importantly, reactivated MafB expression was also observed in the early beta-cell lesions and insulinomas that developed in beta-cell specific Men1 mutant mice, appearing in >80% of beta-cells in hyperplasic or dysplastic islets from the mutant mice > 4 months of age. Moreover, MafB expression could be induced by glucose stimulation in INS-1 rat insulinoma cells. The induction was further reinforced following Men1 knockdown by siRNA. Furthermore, MafB overexpression in cultured beta TC3 cells enhanced cell foci formation both in culture medium and on soft agar, accompanied with the increased expression of Cyclin B1 and D2. Conversely, MafB downregulation by siRNA transfection reduced BrdU incorporation in INS-1E cells. Taken together, our data reveal that Men1 inactivation leads to MafB reexpression in mouse beta-cells in vivo, and provides evidence that deregulated ectopic MafB expression may have a hitherto unknown role in adult beta-cell proliferation and Men1-related tumorigenesis. Oncogene (2012) 31, 3647-3654; doi:10.1038/onc.2011.538; published online 28 November 2011	[Zhang, C. X.] CNRS 5286, INSERM, U1052, Lyon Canc Res Ctr CRCL, F-69008 Lyon, France; [Lu, J.; Hamze, Z.; Bonnavion, R.; Assade, F.; Fontaniere, S.; Bertolino, P.; Cordier-Bussat, M.; Zhang, C. X.] CNRS, UMR5286, Lyon, France; [Lu, J.; Hamze, Z.; Bonnavion, R.; Assade, F.; Fontaniere, S.; Bertolino, P.; Cordier-Bussat, M.; Zhang, C. X.] Univ Lyon, Lyon, France; [Herath, N.; Pouponnot, C.] CNRS, UMR 3347, Inst Curie, INSERM,U1021, F-91405 Orsay, France; [Lu, J.; Zhang, C. X.] Ruijin Hosp, Sinofrench Life Sci & Genom Ctr, E Inst Shanghai, Shanghai, Peoples R China; [Lu, J.] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai 200030, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, CX (corresponding author), CNRS 5286, INSERM, U1052, Lyon Canc Res Ctr CRCL, 28 Rue Laennec, F-69008 Lyon, France.	chang.zhang@lyon.unicancer.fr	ZHANG, Chang Xian/G-2905-2013; Bertolino, philippe/D-4072-2018; Cordier-Bussat, Martine/G-4019-2014; Bertolino, philippe/M-8977-2019	Bertolino, philippe/0000-0001-8064-8269; Bertolino, philippe/0000-0001-8064-8269; Zhang, Chang Xian/0000-0002-5443-8951; Bonnavion, Remy/0000-0002-7389-4282	Association pour la Recherche contre le Cancer (ARC), France; Ligue contre le Cancer du Rhone and de la Loire; MIRA program of Region Rhone-Alpes; National Science Foundation of China [NSFC30900700, 81170719, 30800537]; Science and Technology Commission of Shanghai Municipality [10140902900]; PhD-fellowship from ARC; Shanghai Pujiang Program [10PJ1408900]; Shanghai New Excellent Youth Program [XYQ2011009]	Association pour la Recherche contre le Cancer (ARC), France(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer du Rhone and de la Loire; MIRA program of Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); PhD-fellowship from ARC(Australian Research Council); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai New Excellent Youth Program	We are grateful to Denis Ressnikoff for expert assistance of confocal microscopy, Jean-Michel Vicat and Martin Donnadieu for the maintenance of the mouse colonies, Dr Fabienne Rajas for help in high fat diet experiments, Pr. Jacques Philippe for Arx antibody, Dr Pierre Maechler for providing INS-1E line to M Cordier-Bussat. This study was supported by the Association pour la Recherche contre le Cancer (ARC), France, the Ligue contre le Cancer du Rhone and de la Loire, the MIRA program of Region Rhone-Alpes, National Science Foundation of China (NSFC30900700, 81170719, 30800537), and Science and Technology Commission of Shanghai Municipality (10140902900). J Lu and Z Hamze were the recipients of PhD-fellowship from ARC. J Lu was also the recipient of Shanghai Pujiang Program (10PJ1408900) and Shanghai New Excellent Youth Program (XYQ2011009).	Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, CANCER RES, V63, P4836; Chesi M, 1998, BLOOD, V91, P4457, DOI 10.1182/blood.V91.12.4457.412k48_4457_4463; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fontaniere S, 2006, ENDOCR-RELAT CANCER, V13, P1223, DOI 10.1677/erc.1.01294; Fontaniere S, 2008, J ENDOCRINOL, V199, P287, DOI 10.1677/JOE-08-0289; Huang K, 2000, GENE, V242, P419, DOI 10.1016/S0378-1119(99)00500-4; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Hussein N, 2007, EUR J CANCER, V43, P402, DOI 10.1016/j.ejca.2006.08.038; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Loffler KA, 2007, INT J CANCER, V120, P259, DOI 10.1002/ijc.22288; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Morito N, 2006, CANCER RES, V66, P812, DOI 10.1158/0008-5472.CAN-05-2154; Morito N, 2011, CANCER RES, V71, P339, DOI 10.1158/0008-5472.CAN-10-1057; Mould AW, 2007, INT J CANCER, V121, P776, DOI 10.1002/ijc.22734; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Nishizawa M, 2003, ONCOGENE, V22, P7882, DOI 10.1038/sj.onc.1206526; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Pouponnot C, 2006, ONCOGENE, V25, P1299, DOI 10.1038/sj.onc.1209171; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; Xavier GD, 2010, BIOCHEM BIOPH RES CO, V402, P252, DOI 10.1016/j.bbrc.2010.10.010; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	33	26	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	31					3647	3654		10.1038/onc.2011.538	http://dx.doi.org/10.1038/onc.2011.538			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22120711				2022-12-25	WOS:000307245600007
J	Senapati, S; Gnanapragassam, VS; Moniaux, N; Momi, N; Batra, SK				Senapati, S.; Gnanapragassam, V. S.; Moniaux, N.; Momi, N.; Batra, S. K.			Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells	ONCOGENE			English	Article						MUC4; pancreatic cancer; metastasis; NIDO domain; MUC4 domains	MUC4 EXPRESSION; ADENOCARCINOMA; EVOLUTION; DIAGNOSIS; BINDING	MUC4 is a large transmembrane type I glycoprotein that is overexpressed in pancreatic cancer (P =C) and has been shown to be associated with its progression and metastasis. However, the exact cellular and molecular mechanism(s) through which MUC4 promotes metastasis of PC cells has been sparsely studied. Here we showed that the nidogen-like (NIDO) domain of MUC4, which is similar to the G1-domain present in the nidogen or entactin (an extracellular matrix protein), contributes to the protein-protein interaction property of MUC4. By this interaction, MUC4 promotes breaching of basement membrane (BM) integrity, and spreading of cancer cells. These observations are corroborated with the data from our study using an engineered MUC4 protein without the NIDO domain, which was ectopically expressed in the MiaPaCa PC cells, lacking endogenous MUC4 and nidogen protein. The in vitro studies demonstrated an enhanced invasiveness of MiaPaCa cells expressing MUC4 (MiaPaCa-MUC4) compared with vector-transfected cells (MiaPaCa-Vec; P = 0.003) or cells expressing MUC4 without the NIDO domain (MiaPaCa-MUC4-NIDOD; P = 0.03). However, the absence of NIDO-domain has no significant role on cell growth and motility (P = 0.93). In the in vivo studies, all the mice orthotopically implanted with MiPaCa-MUC4 cells developed metastasis to the liver as compared with MiaPaCa-Vec or the MiaPaCaMUC4- NIDOD group, hence, supporting our in vitro observations. Additionally, a reduced binding (P = 0.0004) of MiaPaCa-MUC4-NIDOD cells to the fibulin-2 coated plates compared with MiaPaCa-MUC4 cells indicated a possible interaction between the MUC4-NIDO domain and fibulin-2, a nidogen-interacting protein. Furthermore, in PC tissue samples, MUC4 colocalized with the fibulin-2 present in the BM. Altogether, our findings demonstrate that the MUC4-NIDO domain significantly contributes to the MUC4-mediated metastasis of PC cells. This may be partly due to the interaction between the MUC4-NIDO domain and fibulin-2. Oncogene (2012) 31, 3346-3356; doi: 10.1038/onc.2011.505; published online 21 November 2011	[Batra, S. K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	sbatra@unmc.edu	Moniaux, Nicolas/Y-3243-2018	Moniaux, Nicolas/0000-0001-9718-1386; Senapati, Shantibhusan/0000-0001-7108-8255	National Institutes of Health [CA78590, CA111294, CA127297, CA133774, CA131944]; NATIONAL CANCER INSTITUTE [R01CA133774, P50CA127297, R01CA078590, R01CA131944, U01CA111294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from National Institutes of Health (CA78590, CA111294, CA127297, CA133774 and CA131944). We thank Ms Kristi L Berger for editing the manuscript. We acknowledge the invaluable technical support from Mr Erik Moore and Kavita Mallya. We also thank Janice A Tayor and James R Talaska of the confocal laser scanning microscope core facility at the UNMC, for their support.	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; DiMagno EP, 1999, GASTROENTEROLOGY, V117, P1464, DOI 10.1016/S0016-5085(99)70298-2; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Ma C, 2008, COLD SPRING HARB PRO, P5034; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Moniaux N, 2007, BRIT J CANCER, V97, P345, DOI 10.1038/sj.bjc.6603868; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Piscaglia F, 2009, CELL TISSUE RES, V337, P449, DOI 10.1007/s00441-009-0823-9; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Senapati S, 2008, BRIT J CANCER, V99, P949, DOI 10.1038/sj.bjc.6604632; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Singh AP, 2007, ONCOGENE, V26, P30, DOI 10.1038/sj.onc.1209764; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Ulazzi L, 2011, MOL CANCER, V6, P17; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	30	39	39	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	28					3346	3356		10.1038/onc.2011.505	http://dx.doi.org/10.1038/onc.2011.505			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	973NT	22105367	Green Accepted			2022-12-25	WOS:000306367600004
J	Tang, WJ; Yang, F; Li, Y; de Crombrugghe, B; Jiao, HL; Xiao, GZ; Zhang, C				Tang, Wanjin; Yang, Fan; Li, Yang; de Crombrugghe, Benoit; Jiao, Hongli; Xiao, Guozhi; Zhang, Chi			Transcriptional Regulation of Vascular Endothelial Growth Factor (VEGF) by Osteoblast-specific Transcription Factor Osterix (Osx) in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RECEPTOR-MEDIATED TRANSCRIPTION; BONE-FORMATION; SKELETAL DEVELOPMENT; MULTIPLE ROLES; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; OSTEOGENESIS; PROTEIN	Osterix (Osx) is an osteoblast-specific transcription factor required for bone formation and osteoblast differentiation. The critical step in bone formation is to replace the avascular cartilage template with vascularized bone. Osteogenesis and angiogenesis are associated with each other, sharing some essential regulators. Vascular endothelial growth factor (VEGF) is involved in both angiogenesis and osteogenesis. Transcriptional regulation of VEGF expression is not well known in osteoblasts. In this study, quantitative real-time RT-PCR results revealed that VEGF expression was downregulated in Osx-null calvarial cells and that osteoblast marker osteocalcin expression was absent. Overexpression of Osx in stable C2C12 mesenchymal cells using a Tet-off system resulted in up-regulation of both osteocalcin and VEGF expression. The inhibition of Osx by siRNA led to repression of VEGF expression in osteoblasts. These results suggest that Osx controls VEGF expression. Transfection assays demonstrated that Osx activated VEGF promoter activity. A series of VEGF promoter deletion mutants were examined and the minimal Osx-responsive region was defined to the proximal 140-bp region of the VEGF promoter. Additional point mutants were used to identify two GC-rich regions that were responsible for VEGF promoter activation by Osx. Gel shift assay showed that Osx bound to the VEGF promoter sequence directly. Chromatin immunoprecipitation assays indicated that endogenous Osx associated with the native VEGF promoter in primary osteoblasts. Moreover, immunohistochemistry staining showed decreased VEGF protein levels in the tibiae of Osx conditional knock-out mice. We provide the first evidence that Osx controlled VEGF expression, suggesting a potential role of Osx in coordinating osteogenesis and angiogenesis.	[Tang, Wanjin; Yang, Fan; Li, Yang; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75219 USA; [de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Dallas, TX 77030 USA; [Jiao, Hongli; Xiao, Guozhi] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, 2222 Welborn St, Dallas, TX 75219 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012	Jiao, Hongli/0000-0001-8005-8496	National Institutes of Health [AR059647, DK072230]; Arthritis Foundation; Texas Scottish Rite Hospital for Children [RAP01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072, R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Texas Scottish Rite Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR059647 and DK072230 (to G. X.), a research grant from the Arthritis Foundation to the Bone Research Laboratory (to C. Z.), and Texas Scottish Rite Hospital for Children Grant RAP01 (to C. Z.).	COOLBAUGH CC, 1952, AM J PHYSIOL, V169, P26, DOI 10.1152/ajplegacy.1952.169.1.26; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	23	57	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1671	1678		10.1074/jbc.M111.288472	http://dx.doi.org/10.1074/jbc.M111.288472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22110141	hybrid, Green Published			2022-12-25	WOS:000299321000010
J	Villadangos, AF; Fu, HL; Gil, JA; Messens, J; Rosen, BP; Mateos, LM				Villadangos, Almudena F.; Fu, Hsueh-Liang; Gil, Jose A.; Messens, Joris; Rosen, Barry P.; Mateos, Luis M.			Efflux Permease CgAcr3-1 of Corynebacterium glutamicum Is an Arsenite-specific Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-TRANSLOCATING ATPASE; ESCHERICHIA-COLI; ARSA ATPASE; ALKALIPHILUS-METALLIREDIGENS; SACCHAROMYCES-CEREVISIAE; MEMBRANE SUBUNIT; RESISTANCE; GENES; TRANSPORTER; PROTEIN	Resistance to arsenite (As(III)) by cells is generally accomplished by arsenite efflux permeases from Acr3 or ArsB unrelated families. We analyzed the function of three Acr3 proteins from Corynebacterium glutamicum, CgAcr3-1, CgAcr3-2, and CgAcr3-3. CgAcr3-1 conferred the highest level of As(III) resistance and accumulation in vivo. CgAcr3-1 was also the most active when everted membranes vesicles from Escherichia coli or C. glutamicum mutants were assayed for efflux with different energy sources. As(III) and antimonite (Sb(III)) resistance and accumulation studies using E. coli or C. glutamicum arsenite permease mutants clearly show that CgAcr3-1 is specific for As(III). In everted membrane vesicles expressing CgAcr3-1, dissipation of either the membrane potential or the pH gradient of the proton motive force did not prevent As(III) uptake, whereas dissipation of both components eliminated uptake. Further, a mutagenesis study of CgAcr3-1 suggested that a conserved cysteine and glutamate are involved in active transport. Therefore, we propose that CgAcr3-1 is an antiporter that catalyzes arsenite-proton exchange with residues Cys(129) and Glu(305) involved in efflux.	[Rosen, Barry P.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33099 USA; [Villadangos, Almudena F.; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Fac Biol Ambientales, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain; [Fu, Hsueh-Liang] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Messens, Joris] Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium	State University System of Florida; Florida International University; Universidad de Leon; Wayne State University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Rosen, BP (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33099 USA.	brosen@fiu.edu; luis.mateos@unileon.es	Gil, José A./L-1800-2019; Gil, Jose A./C-3902-2009; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Messens, Joris/AAH-3008-2020	Gil, José A./0000-0002-5069-2637; Gil, Jose A./0000-0002-5069-2637; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Messens, Joris/0000-0002-2128-8264; Rosen, Barry P./0000-0002-5230-4271	National Institutes of Health [GM55425]; Spanish Ministerio de Ciencia e Innovacion [BIO2008-00519]; Junta de Castilla y Leon [LE028A10-2]; Vrije Universiteit Brussel, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055425, R37GM055425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Vrije Universiteit Brussel, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55425 (to B. P. R.). This work was also supported by Spanish Ministerio de Ciencia e Innovacion Grant BIO2008-00519 (to J. A. G.), Junta de Castilla y Leon Grant LE028A10-2 (to L. M. M.), and by a Horizontale Onderzoeksactie grant of the Vrije Universiteit Brussel, Belgium (to J. M.).	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; CHEN CM, 1986, J BIOL CHEM, V261, P5030; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DEY S, 1994, J BIOL CHEM, V269, P25442; FernandezGonzalez C, 1996, APPL MICROBIOL BIOT, V46, P554, DOI 10.1007/s002530050860; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Fu HL, 2010, FEBS LETT, V584, P3089, DOI 10.1016/j.febslet.2010.05.044; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Indriolo E, 2010, PLANT CELL, V22, P2045, DOI 10.1105/tpc.109.069773; Kuroda M, 1997, J BIOL CHEM, V272, P326; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Lievremont D, 2009, BIOCHIMIE, V91, P1229, DOI 10.1016/j.biochi.2009.06.016; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Maciaszczyk E, 2004, FEMS YEAST RES, V4, P821, DOI 10.1016/j.femsyr.2004.03.002; Maciaszczyk-Dziubinska E, 2011, BBA-BIOMEMBRANES, V1808, P1855, DOI 10.1016/j.bbamem.2011.03.014; Maciaszczyk-Dziubinska E, 2010, BBA-BIOMEMBRANES, V1798, P2170, DOI 10.1016/j.bbamem.2010.07.017; Mansour NM, 2007, FEBS J, V274, P612, DOI 10.1111/j.1742-4658.2006.05627.x; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; Mateos LM, 2006, INT MICROBIOL, V9, P207; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; NAKAMURA T, 1986, J BIOL CHEM, V261, P678; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Rosen BP, 2010, ADV EXP MED BIOL, V679, P47; Ruan X, 2006, J BIOL CHEM, V281, P9925, DOI 10.1074/jbc.M600125200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; TISA LS, 1990, J BIOL CHEM, V265, P190; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; WU JH, 1992, J BIOL CHEM, V267, P12570; Xia XB, 2008, MOL MEMBR BIOL, V25, P691, DOI 10.1080/09687680802535930; Yang JB, 2011, MOL MICROBIOL, V79, P872, DOI 10.1111/j.1365-2958.2010.07494.x	37	27	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					723	735		10.1074/jbc.M111.263335	http://dx.doi.org/10.1074/jbc.M111.263335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102279	Green Published, hybrid			2022-12-25	WOS:000298682400070
J	Acharya, A; Hans, CP; Koenig, SN; Nichols, HA; Galindo, CL; Garner, HR; Merrill, WH; Hinton, RB; Garg, V				Acharya, Asha; Hans, Chetan P.; Koenig, Sara N.; Nichols, Haley A.; Galindo, Cristi L.; Garner, Harold R.; Merrill, Walter H.; Hinton, Robert B.; Garg, Vidu			Inhibitory Role of Notch1 in Calcific Aortic Valve Disease	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HEART-VALVE; SOX9; PATHWAY; CARTILAGE; EXPRESSION; MUTATIONS; ORGANIZATION; MECHANISMS; PROTEINS	Aortic valve calcification is the most common form of valvular heart disease, but the mechanisms of calcific aortic valve disease (CAVD) are unknown. NOTCH1 mutations are associated with aortic valve malformations and adult-onset calcification in families with inherited disease. The Notch signaling pathway is critical for multiple cell differentiation processes, but its role in the development of CAVD is not well understood. The aim of this study was to investigate the molecular changes that occur with inhibition of Notch signaling in the aortic valve. Notch signaling pathway members are expressed in adult aortic valve cusps, and examination of diseased human aortic valves revealed decreased expression of NOTCH1 in areas of calcium deposition. To identify downstream mediators of Notch1, we examined gene expression changes that occur with chemical inhibition of Notch signaling in rat aortic valve interstitial cells (AVICs). We found significant downregulation of Sox9 along with several cartilage-specific genes that were direct targets of the transcription factor, Sox9. Loss of Sox9 expression has been published to be associated with aortic valve calcification. Utilizing an in vitro porcine aortic valve calcification model system, inhibition of Notch activity resulted in accelerated calcification while stimulation of Notch signaling attenuated the calcific process. Finally, the addition of Sox9 was able to prevent the calcification of porcine AVICs that occurs with Notch inhibition. In conclusion, loss of Notch signaling contributes to aortic valve calcification via a Sox9-dependent mechanism.	[Acharya, Asha; Nichols, Haley A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Acharya, Asha] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Galindo, Cristi L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hans, Chetan P.; Koenig, Sara N.; Garg, Vidu] Ohio State Univ, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA; [Hans, Chetan P.; Koenig, Sara N.; Garg, Vidu] Ohio State Univ, Ctr Heart, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Hans, Chetan P.; Koenig, Sara N.; Garg, Vidu] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Garner, Harold R.] Virginia Tech Blacksburg, Virginia Bioinformat Inst, Blacksburg, VA USA; [Merrill, Walter H.] Univ Cincinnati, Div Cardiothorac Surg, Cincinnati, OH USA; [Hinton, Robert B.] Cincinnati Childrens Hosp, Med Ctr, Div Cardiol, Cincinnati, OH USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Virginia Polytechnic Institute & State University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Acharya, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	vidu.garg@nationwidechildrens.org	Koenig, Sara/AAN-4417-2020; Garg, Vidu/E-3101-2011; Hans, Chetan/C-5490-2012; Garg, Vidu/D-8240-2012	Koenig, Sara/0000-0002-5416-8621; Garg, Vidu/0000-0002-3778-5927	NIH/NIAID [U54 AI057156]; American Heart Association-Texas; NIH; NIH/NHLBI [K23 HL085122, R01 HL088965]; Children's Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL085122, R01HL088965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association-Texas(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant (U54 AI057156) to C. L. G and H. R. G. from NIH/NIAID. A. A. is supported by an American Heart Association-Texas affiliate postdoctoral fellowship, C. L. G. is supported by an NIH cardiology fellowship, R. B. H. is supported by a grant from NIH/NHLBI (K23 HL085122), and V. G. is supported by grants from the NIH/NHLBI (R01 HL088965) and Children's Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Akhtar S, 1999, CARDIOVASC PATHOL, V8, P191, DOI 10.1016/S1054-8807(99)00004-6; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; AMSTRONG EJ, 2004, CIRC RES, V95, P459; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; ENGIN F, 2006, NAT MED, V14, P299; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2006, CURR OPIN CARDIOL, V21, P180, DOI 10.1097/01.hco.0000221578.18254.70; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Ishizeki K, 1999, J ANAT, V194, P265, DOI 10.1046/j.1469-7580.1999.19420265.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Mathieu P, 2005, J HEART VALVE DIS, V14, P353; McBride KL, 2011, HEART, V97, P1193, DOI 10.1136/hrt.2011.222489; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Mjaatvedt CH, 2005, ANAT REC PART A, V285A, P748, DOI 10.1002/ar.a.20210; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Mohler ER, 1999, J HEART VALVE DIS, V8, P254; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nigam V, 2009, J MOL CELL CARDIOL, V47, P828, DOI 10.1016/j.yjmcc.2009.08.008; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Nus M, 2011, ARTERIOSCL THROM VAS, V31, P1580, DOI 10.1161/ATVBAHA.111.227561; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rajamannan NM, 2007, NAT CLIN PRACT CARD, V4, P254, DOI 10.1038/ncpcardio0827; Rajamannan NM, 2005, CIRCULATION, V111, P3296, DOI 10.1161/CIRCULATIONAHA.104.473165; ROGER VL, 2010, CIRCULATION, V123; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shelton JM, 2000, J LIPID RES, V41, P532; THUBRIKAR MJ, 1986, AM J CARDIOL, V58, P304, DOI 10.1016/0002-9149(86)90067-6; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Wirrig EE, 2011, J MOL CELL CARDIOL, V50, P561, DOI 10.1016/j.yjmcc.2010.12.005; Yoshioka M, 2006, NAT MED, V12, P1151, DOI 10.1038/nm1476	44	81	84	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27743	10.1371/journal.pone.0027743	http://dx.doi.org/10.1371/journal.pone.0027743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110751	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400104
J	Garbeva, P; Tyc, O; Remus-Emsermann, MNP; van der Wal, A; Vos, M; Silby, M; de Boer, W				Garbeva, Paolina; Tyc, Olaf; Remus-Emsermann, Mitja N. P.; van der Wal, Annemieke; Vos, Michiel; Silby, Mark; de Boer, Wietse			No Apparent Costs for Facultative Antibiotic Production by the Soil Bacterium Pseudomonas fluorescens Pf0-1	PLOS ONE			English	Article							FITNESS COST; RESISTANCE; COMPETITION; GROWTH; SALMONELLA; EVOLUTION; VIRULENCE	Background: Many soil-inhabiting bacteria are known to produce secondary metabolites that can suppress microorganisms production of antimicrobial compounds is expected to incur fitness costs for the producing bacteria. Such costs form the basis for models on the co-existence of antibiotic-producing and non-antibiotic producing strains. However, so far studies quantifying the costs of antibiotic production by bacteria are scarce. The current study reports on possible costs, for antibiotic production by Pseudomonas fluorescens Pf0-1, a soil bacterium that is induced to produce a broad-spectrum antibiotic when it is confronted with non-related bacterial competitors or supernatants of their cultures. Methodology and Principal Findings: We measured the possible cost of antibiotic production for Pseudomonas fluorescens Pf0-1 by monitoring changes in growth rate with and without induction of antibiotic production by supernatant of a bacterial competitor, namely Pedobacter sp.. Experiments were performed in liquid as well as on semi-solid media under nutrient-limited conditions that are expected to most clearly reveal fitness costs. Our results did not reveal any significant costs for production of antibiotics by Pseudomonas fluorescens Pf0-1. Comparison of growth rates of the antibiotic-producing wild-type cells with those of non-antibiotic producing mutants did not reveal costs of antibiotic production either. Significance: Based on our findings we propose that the facultative production of antibiotics might not be selected to mitigate metabolic costs, but instead might be advantageous because it limits the risk of competitors evolving resistance, or even the risk of competitors feeding on the compounds produced.	[Garbeva, Paolina; Tyc, Olaf; Remus-Emsermann, Mitja N. P.; van der Wal, Annemieke; Vos, Michiel; de Boer, Wietse] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Silby, Mark] Univ Massachusetts Dartmouth, Dept Biol, N Dartmouth, MA USA; [Silby, Mark] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Massachusetts System; University Massachusetts Dartmouth; Tufts University	Garbeva, P (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	p.garbeva@nioo.knaw.nl	Tyc, Olaf/AAQ-1262-2021; de Boer, Wietse/C-2737-2011; Remus-Emsermann, Mitja NP/R-3776-2016; van der Wal, Annemieke/F-7411-2012; Garbeva, Paolina/C-3727-2011	Tyc, Olaf/0000-0001-9949-0975; de Boer, Wietse/0000-0002-5380-2993; Remus-Emsermann, Mitja NP/0000-0002-6378-9526; van der Wal, Annemieke/0000-0003-0261-1203; Garbeva, Paolina/0000-0002-2359-5719; Silby, Mark/0000-0002-3092-8008	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work is financed by The Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Anderl JN, 2003, ANTIMICROB AGENTS CH, V47, P1251, DOI 10.1128/AAC.47.4.1251-1256.2003; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 2003, CURR OPIN MICROBIOL, V6, P452, DOI 10.1016/j.mib.2003.09.001; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P4455, DOI 10.1128/AAC.49.11.4455-4464.2005; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Czaran T, 2007, BEHAV ECOL, V18, P866, DOI 10.1093/beheco/arm061; Czaran TL, 2003, P ROY SOC B-BIOL SCI, V270, P1373, DOI 10.1098/rspb.2003.2338; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; de Boer W, 2007, FEMS MICROBIOL ECOL, V59, P177, DOI 10.1111/j.1574-6941.2006.00197.x; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Garbeva P, 2009, MICROB ECOL, V58, P36, DOI 10.1007/s00248-009-9502-3; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hsu SB, 1997, CHEM ENG SCI, V52, P23, DOI 10.1016/S0009-2509(96)00385-5; Kanai K, 2004, MICROBIOL IMMUNOL, V48, P977, DOI 10.1111/j.1348-0421.2004.tb03628.x; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kugelberg E, 2005, J ANTIMICROB CHEMOTH, V55, P22, DOI 10.1093/jac/dkh505; Ott EM, 2001, J APPL MICROBIOL, V91, P54, DOI 10.1046/j.1365-2672.2001.01334.x; Raaijmakers JM, 1999, PHYTOPATHOLOGY, V89, P470, DOI 10.1094/PHYTO.1999.89.6.470; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; REINHARD F, 2011, MICROBIOLOGY HYDROCA; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; Vos M, 2009, CURR BIOL, V19, P1763, DOI 10.1016/j.cub.2009.08.061; Workentine ML, 2010, ENVIRON MICROBIOL, V12, P1565, DOI 10.1111/j.1462-2920.2010.02185.x; Zhang QJ, 2006, MICROBES INFECT, V8, P1972, DOI 10.1016/j.micinf.2005.12.031	38	28	28	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27266	10.1371/journal.pone.0027266	http://dx.doi.org/10.1371/journal.pone.0027266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110622	Green Published, gold			2022-12-25	WOS:000297555400030
J	Geangu, E; Hauf, P; Bhardwaj, R; Bentz, W				Geangu, Elena; Hauf, Petra; Bhardwaj, Rishi; Bentz, Wolfram			Infant Pupil Diameter Changes in Response to Others' Positive and Negative Emotions	PLOS ONE			English	Article							INHIBITED LIGHT REFLEX; FACIAL EXPRESSIONS; DEVELOPMENTAL-CHANGES; NEURAL MECHANISMS; CRY; DISCRIMINATION; INFORMATION; DISTRESS; SIZE; 7-MONTH-OLD	It has been suggested that infants resonate emotionally to others' positive and negative affect displays, and that these responses become stronger towards emotions with negative valence around the age of 12-months. In this study we measured 6- and 12-month-old infants' changes in pupil diameter when presented with the image and sound of peers experiencing happiness, distress and an emotionally neutral state. For all participants the perception of another's distress triggered larger pupil diameters. Perceiving other's happiness also induced larger pupil diameters but for shorter time intervals. Importantly, we also found evidence for an asymmetry in autonomous arousal towards positive versus negative emotional displays. Larger pupil sizes for another's distress compared to another's happiness were recorded shortly after stimulus onset for the older infants, and in a later time window for the 6-month-olds. These findings suggest that arousal responses for negative as well as for positive emotions are present in the second half of the first postnatal year. Importantly, an asymmetry with stronger responses for negative emotions seems to be already present at this age.	[Geangu, Elena; Bhardwaj, Rishi] Univ Durham, Dept Psychol, Sci Labs, Durham DH1 3LE, England; [Geangu, Elena] Romanian Acad Sci, Dept Psychosocial Res, Cluj Napoca, Romania; [Hauf, Petra] St Francis Xavier Univ, Dept Psychol, Antigonish, NS B2G 1C0, Canada; [Bentz, Wolfram] Univ Lisbon, Fac Ciencias, Ctr Algebra, Lisbon, Portugal	Durham University; Romanian Academy of Sciences; Saint Francis Xavier University - Canada; Universidade de Lisboa	Geangu, E (corresponding author), Univ Durham, Dept Psychol, Sci Labs, Durham DH1 3LE, England.	elena.geangu@unimib.it	Geangu, Elena/N-7861-2015; Bhardwaj, Rishi/AAQ-4074-2020	Geangu, Elena/0000-0002-0398-8398; Bhardwaj, Rishi/0000-0003-0932-6931; Bentz, Wolfram/0000-0003-0002-1277	Canada Research Chair Program; NSERC [322013]; CFI [203229]	Canada Research Chair Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation)	This research was supported by the Canada Research Chair Program, by NSERC (322013) and CFI (203229) grants to PH, and by a NSERC Research Capacity Development Grant to EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin DA, 1996, CHILD DEV, V67, P1915, DOI 10.1111/j.1467-8624.1996.tb01835.x; Barbur J.L., 2004, VISUAL NEUROSCIENCES, P641; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323, 10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323]; Beatty J, 2000, HDB PSYCHOPHYSIOLOGY, Vsecond; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Bitsios P, 1998, PSYCHOPHARMACOLOGY, V135, P93, DOI 10.1007/s002130050489; Bitsios P, 2002, INT J PSYCHOPHYSIOL, V43, P177, DOI 10.1016/S0167-8760(01)00173-8; Blair RJR, 2011, EMOT REV, V3, P109, DOI 10.1177/1754073910384157; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Camras LA, 2010, EMOT REV, V2, P120, DOI 10.1177/1754073909352529; Cappella J. N., 1993, J LANG SOC PSYCHOL, V12, P13, DOI DOI 10.1177/0261927X93121002; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Dondi M, 1999, DEV PSYCHOL, V35, P418, DOI 10.1037/0012-1649.35.2.418; Eisenberg N., 1991, HDB MORAL BEHAV DEV, P63; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Field T, 2007, INFANT BEHAV DEV, V30, P431, DOI 10.1016/j.infbeh.2006.12.011; FITZGERALD HE, 1968, J EXP CHILD PSYCHOL, V6, P470, DOI 10.1016/0022-0965(68)90127-6; FRITH CD, 1981, PERS INDIV DIFFER, V2, P119, DOI 10.1016/0191-8869(81)90006-4; Geangu E, 2011, SOC DEV, V20, P450, DOI 10.1111/j.1467-9507.2010.00596.x; Geangu E, 2010, INFANT BEHAV DEV, V33, P279, DOI 10.1016/j.infbeh.2010.03.004; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Green JA, 1995, EARLY DEV PARENTING, V4, P161, DOI 10.1002/edp.2430040403; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; Grossmann T, 2007, BRAIN COGNITION, V64, P30, DOI 10.1016/j.bandc.2006.10.002; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Gustafson G., 2000, CRYING SIGN SYMPTOM, P8; HAVILAND JM, 1987, DEV PSYCHOL, V23, P97, DOI 10.1037/0012-1649.23.1.97; HAY DF, 1981, CHILD DEV, V52, P1071, DOI 10.1111/j.1467-8624.1981.tb03151.x; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; HORNIK R, 1987, CHILD DEV, V58, P937, DOI 10.2307/1130534; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Legerstee M, 1998, CHILD DEV, V69, P37, DOI 10.2307/1132068; Light SN, 2009, CHILD DEV, V80, P1210, DOI 10.1111/j.1467-8624.2009.01326.x; Lipps Theodor., 1907, PSYCHOL UNTERSUCHUNG, V1, P694; Lowenstein O, 1962, EYE MUSCULAR MECH, V3; LUDEMANN PM, 1991, CHILD DEV, V62, P55, DOI 10.2307/1130704; MacLachlan C, 2002, OPHTHAL PHYSL OPT, V22, P175, DOI 10.1046/j.1475-1313.2002.00023.x; MARTIN GB, 1982, DEV PSYCHOL, V18, P3, DOI 10.1037/0012-1649.18.1.3; Messinger DS, 2001, DEV PSYCHOL, V37, P642, DOI 10.1037/0012-1649.37.5.642; Mumme DL, 1996, CHILD DEV, V67, P3219, DOI 10.1111/j.1467-8624.1996.tb01910.x; Mumme DL, 2003, CHILD DEV, V74, P221, DOI 10.1111/1467-8624.00532; NELSON CA, 1979, CHILD DEV, V50, P1239, DOI 10.1111/j.1467-8624.1979.tb02493.x; NELSON CA, 1985, CHILD DEV, V56, P58, DOI 10.2307/1130173; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; PROVINE RR, 1991, ETHOLOGY, V89, P115; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ross MD, 2009, CURR BIOL, V19, P1106, DOI 10.1016/j.cub.2009.05.028; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Scherer K.R., 1981, SPEECH EVALUATION PS, P189; Serrano JM, 1995, INFANT BEHAV DEV, V18, P477, DOI 10.1016/0163-6383(95)90036-5; Siegle GJ, 2003, COGNITIVE THER RES, V27, P365, DOI 10.1023/A:1023974602357; Silk JS, 2007, AM J PSYCHIAT, V164, P1873, DOI 10.1176/appi.ajp.2007.06111816; SIMNER ML, 1971, DEV PSYCHOL, V5, P136, DOI 10.1037/h0031066; STEINHAUER SR, 1992, ANN NY ACAD SCI, V658, P182, DOI 10.1111/j.1749-6632.1992.tb22845.x; Sullivan MW, 2003, INFANT YOUNG CHILD, V16, P120, DOI 10.1097/00001163-200304000-00005; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; WALKERANDREWS AS, 1991, INFANT BEHAV DEV, V14, P131, DOI 10.1016/0163-6383(91)90001-9; Wermke K, 2002, MED ENG PHYS, V24, P501, DOI 10.1016/S1350-4533(02)00061-9	69	76	77	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27132	10.1371/journal.pone.0027132	http://dx.doi.org/10.1371/journal.pone.0027132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HV	22110605	Green Accepted, Green Published, gold			2022-12-25	WOS:000297555400020
J	Mohangoo, AD; Buitendijk, SE; Szamotulska, K; Chalmers, J; Irgens, LM; Bolumar, F; Nijhuis, JG; Zeitlin, J				Mohangoo, Ashna D.; Buitendijk, Simone E.; Szamotulska, Katarzyna; Chalmers, Jim; Irgens, Lorentz M.; Bolumar, Francisco; Nijhuis, Jan G.; Zeitlin, Jennifer		Euro-Peristat Sci Comm	Gestational Age Patterns of Fetal and Neonatal Mortality in Europe: Results from the Euro-Peristat Project	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; EVALUATING PERINATAL HEALTH; LOW-BIRTH-WEIGHT; IMPACT; TERMINATION; RATES; INDICATORS; PREGNANCY; CARE; ANOMALIES	Background: The first European Perinatal Health Report showed wide variability between European countries in fetal (2.6-9.1%) and neonatal (1.6-5.7%) mortality rates in 2004. We investigated gestational age patterns of fetal and neonatal mortality to improve our understanding of the differences between countries with low and high mortality. Methodology/Principal Findings: Data on 29 countries/regions participating in the Euro-Peristat project were analyzed. Most European countries had no limits for the registration of live births, but substantial variations in limits for registration of stillbirths before 28 weeks of gestation existed. Country rankings changed markedly after excluding deaths most likely to be affected by registration differences (22-23 weeks for neonatal mortality and 22-27 weeks for fetal mortality). Countries with high fetal mortality >= 28 weeks had on average higher proportions of fetal deaths at and near term (>= 37 weeks), while proportions of fetal deaths at earlier gestational ages (28-31 and 32-36 weeks) were higher in low fetal mortality countries. Countries with high neonatal mortality rates >= 24 weeks, all new member states of the European Union, had high gestational age-specific neonatal mortality rates for all gestational-age subgroups; they also had high fetal mortality, as well as high early and late neonatal mortality. In contrast, other countries with similar levels of neonatal mortality had varying levels of fetal mortality, and among these countries early and late neonatal mortality were negatively correlated. Conclusions: For valid European comparisons, all countries should register births and deaths from at least 22 weeks of gestation and should be able to distinguish late terminations of pregnancy from stillbirths. After excluding deaths most likely to be influenced by existing registration differences, important variations in both levels and patterns of fetal and neonatal mortality rates were found. These disparities raise questions for future research about the effectiveness of medical policies and care in European countries.	[Mohangoo, Ashna D.; Buitendijk, Simone E.] TNO Netherlands Org Appl Sci Res, Dept Child Hlth, Leiden, Netherlands; [Szamotulska, Katarzyna] Natl Res Inst Mother & Child, Dept Epidemiol, Warsaw, Poland; [Chalmers, Jim] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Irgens, Lorentz M.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Leiden, Netherlands; [Bolumar, Francisco] Univ Alcala, Dept Publ Hlth Sci, Madrid, Spain; [Nijhuis, Jan G.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Zeitlin, Jennifer] INSERM, UMRS 953, Epidemiol Res Unit Perinatal & Womens & Childrens, Paris, France; [Zeitlin, Jennifer] Univ Paris 06, UPMC, Paris, France	Netherlands Organization Applied Science Research; NHS National Services Scotland; University of Bergen; Universidad de Alcala; Maastricht University; Maastricht University Medical Centre (MUMC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mohangoo, AD (corresponding author), TNO Netherlands Org Appl Sci Res, Dept Child Hlth, Leiden, Netherlands.	ashna.mohangoo@tno.nl	Sakkeus, Luule/E-9558-2010; Zeitlin, Jennifer/G-4973-2017; Correia, Sofia/AAD-6210-2020; Blondel, Beatrice/G-5011-2017	Sakkeus, Luule/0000-0003-3785-183X; Zeitlin, Jennifer/0000-0002-9568-2969; Correia, Sofia/0000-0002-9361-1999; breart, gerard/0000-0003-3142-9128; Hukkelhoven, Chantal/0000-0002-0015-1883; Hindori-Mohangoo, Ashna/0000-0003-2364-2893; Gissler, Mika/0000-0001-8254-7525; Szamotulska, Katarzyna/0000-0003-1045-7584; Francisco, Bolumar Montrull/0000-0001-8007-3231	European Commission (DG-SANCO) [2003131]	European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre)	The results from this study are based on data from the Euro-Peristat project, a European project for monitoring and evaluating perinatal outcomes on the European level. The Euro-Peristat project was co-financed by the European Commission (DG-SANCO), grant number 2003131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Blondel A, 2002, BJOG-INT J OBSTET GY, V109, P718; Boyd PA, 2008, BJOG-INT J OBSTET GY, V115, P689, DOI 10.1111/j.1471-0528.2008.01700.x; Cole TJ, 2011, ANN HUM BIOL, V38, P7, DOI 10.3109/03014460.2011.544139; de Leeuw R, 2000, J PEDIATR-US, V137, P608, DOI 10.1067/mpd.2000.109144; DIRENZO GC, 1992, EUR J OBSTET GYN R B, V45, P81, DOI 10.1016/0028-2243(92)90221-J; *EUROPERISTAT PROJ, 2008, BETT STAT BETT HLTH; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Garne E, 2010, BJOG-INT J OBSTET GY, V117, P660, DOI 10.1111/j.1471-0528.2010.02531.x; GATT M, 2011, COMMUNICATION; GISSLER M, 1994, PAEDIATR PERINAT EP, V8, P391, DOI 10.1111/j.1365-3016.1994.tb00478.x; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Graafmans WC, 2001, BRIT J OBSTET GYNAEC, V108, P1237, DOI 10.1111/j.1471-0528.2001.00291.x; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Kollee LAA, 2009, BJOG-INT J OBSTET GY, V116, P1481, DOI 10.1111/j.1471-0528.2009.02235.x; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Lack N, 2003, EUR J OBSTET GYN R B, V111, pS33, DOI 10.1016/j.ejogrb.2003.09.004; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lorenz JM, 2001, SEMIN PERINATOL, V25, P348, DOI 10.1053/sper.2001.27164; Papiernik E, 2008, BJOG-INT J OBSTET GY, V115, P361, DOI 10.1111/j.1471-0528.2007.01611.x; SACHS BP, 1995, OBSTET GYNECOL, V85, P941, DOI 10.1016/0029-7844(95)00056-W; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; van der Pal-de Bruin KM, 2002, PRENATAL DIAG, V22, P966, DOI 10.1002/pd.442; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Verhagen AAE, 2010, J PEDIATR-US, V156, P33, DOI 10.1016/j.jpeds.2009.07.019; VERLOOVEVANHORICK SP, 1986, LANCET, V1, P55; Wingate MS, 2007, ANN EPIDEMIOL, V17, P425, DOI 10.1016/j.annepidem.2007.01.035; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; World Health Organization, 1992, INT STAT CLASS DIS R; Zeitlin J, 2007, BJOG-INT J OBSTET GY, V114, P1097, DOI 10.1111/j.1471-0528.2007.01328.x; Zeitlin J, 2003, EUR J OBSTET GYN R B, V111, pS1, DOI 10.1016/j.ejogrb.2003.09.001; Zeitlin J, 2003, EUR J OBSTET GYN R B, V111, pS5, DOI 10.1016/j.ejogrb.2003.09.002; Zeitlin J, 2003, EUR J PUBLIC HEALTH, V13, P29, DOI 10.1093/eurpub/13.suppl_1.29; Zeitlin J, 2008, PEDIATRICS, V121, pE936, DOI 10.1542/peds.2007-1620; Zeitlin J, 2009, J EPIDEMIOL COMMUN H, V63, P681, DOI 10.1136/jech.2009.087296; Zimbeck M, 2009, EUR J OBSTET GYN R B, V146, P149, DOI 10.1016/j.ejogrb.2009.07.017	40	53	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e24727	10.1371/journal.pone.0024727	http://dx.doi.org/10.1371/journal.pone.0024727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110575	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400002
J	Stein, P; Weber, M; Prufer, S; Schmid, B; Schmitt, E; Probst, HC; Waisman, A; Langguth, P; Schild, H; Radsak, MP				Stein, Pamela; Weber, Michael; Pruefer, Steve; Schmid, Beate; Schmitt, Edgar; Probst, Hans-Christian; Waisman, Ari; Langguth, Peter; Schild, Hansjoerg; Radsak, Markus P.			Regulatory T Cells and IL-10 Independently Counterregulate Cytotoxic T Lymphocyte Responses Induced by Transcutaneous Immunization	PLOS ONE			English	Article							IMMUNOMODULATORS IMIQUIMOD; MEDIATED SUPPRESSION; CYTOKINE INDUCTION; MICE; SKIN; IMMUNOTHERAPY; INHIBITION; TOLERANCE; DEPLETION; IMMUNITY	Background: The imidazoquinoline derivate imiquimod induces inflammatory responses and protection against transplanted tumors when applied to the skin in combination with a cognate peptide epitope (transcutaneous immunization, TCI). Here we investigated the role of regulatory T cells (T-reg) and the suppressive cytokine IL-10 in restricting TCI-induced cytotoxic T lymphocyte (CTL) responses. Methodology/Principal Findings: TCI was performed with an ointment containing the TLR7 agonist imiquimod and a CTL epitope was applied to the depilated back skin of C57BL/6 mice. Using specific antibodies and FoxP3-diphteria toxin receptor transgenic (DEREG) mice, we interrogated inhibiting factors after TCI: by depleting FoxP3(+) regulatory T cells we found that specific CTL-responses were greatly enhanced. Beyond this, in IL-10 deficient (IL-10(-/-)) mice or after blocking of IL-10 signalling with an IL-10 receptor specific antibody, the TCI induced CTL response is greatly enhanced indicating an important role for this cytokine in TCI. However, by transfer of T-reg in IL-10(-/-) mice and the use of B cell deficient JHT(-/-) mice, we can exclude T-reg and B cells as source of IL-10 in the setting of TCI. Conclusion/Significance: We identify T-reg and IL-10 as two important and independently acting suppressors of CTL-responses induced by transcutaneous immunization. Advanced vaccination strategies inhibiting T-reg function and IL-10 release may lead the development of effective vaccination protocols aiming at the induction of T cell responses suitable for the prophylaxis or treatment of persistent infections or tumors.	[Stein, Pamela; Weber, Michael; Pruefer, Steve; Schmid, Beate; Schmitt, Edgar; Probst, Hans-Christian; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Immunol, Mainz, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Mol Med, Mainz, Germany; [Langguth, Peter] Johannes Gutenberg Univ Mainz, Dept Biopharmaceut & Pharmaceut Technol, Mainz, Germany; [Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Dept Med 3, Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Stein, P (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Inst Immunol, Mainz, Germany.	radsak@uni-mainz.de	Waisman, Ari/C-7383-2015; Radsak, Markus P/L-3651-2013	Waisman, Ari/0000-0003-4304-8234; Radsak, Markus P/0000-0002-3991-5721; PROBST, Hans Christian/0000-0002-7926-0651	Deutsche Forschungsgemeinschaft [KFO183 TP7]; University Medical Center Mainz;  [TR52 TPA1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Center Mainz; 	This project was supported by Deutsche Forschungsgemeinschaft grants KFO183 TP7 (H.S. and M.P.R.), University Medical Center Mainz (MAIFOR Program to M.P.R.) and TR52 TPA1 (E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bopp T, 2009, J IMMUNOL, V182, P4017, DOI 10.4049/jimmunol.0803310; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chacon-Salinas R, 2011, J IMMUNOL, V186, P25, DOI 10.4049/jimmunol.1001657; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; GIBSON SJ, 1995, J INTERF CYTOK RES, V15, P537, DOI 10.1089/jir.1995.15.537; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Itoh T, 2005, J IMMUNOTHER, V28, P430, DOI 10.1097/01.cji.0000171289.78495.b0; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Partidos CD, 2004, VACCINE, V22, P2385, DOI 10.1016/j.vaccine.2003.11.063; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; REITER MJ, 1994, J LEUKOCYTE BIOL, V55, P234, DOI 10.1002/jlb.55.2.234; RIVAS JM, 1992, J IMMUNOL, V149, P3865; Schwarz A, 2000, J IMMUNOL, V165, P1824, DOI 10.4049/jimmunol.165.4.1824; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shreedhar VK, 1998, J IMMUNOL, V161, P1327; SIDKY YA, 1992, CANCER RES, V52, P3528; Stein P, 2011, J INVEST DERMATOL, V131, P211, DOI 10.1038/jid.2010.254; Stoitzner P, 2008, J IMMUNOL, V180, P1991, DOI 10.4049/jimmunol.180.3.1991; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; TESTERMAN TL, 1995, J LEUKOCYTE BIOL, V58, P365, DOI 10.1002/jlb.58.3.365; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Warger T, 2007, CLIN REV ALLERG IMMU, V32, P57, DOI 10.1007/s12016-007-0020-0; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; WITT PL, 1993, CANCER RES, V53, P5176; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	37	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27911	10.1371/journal.pone.0027911	http://dx.doi.org/10.1371/journal.pone.0027911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114725	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400139
J	Tan, GG; Lou, ZY; Liao, WT; Zhu, ZY; Dong, X; Zhang, W; Li, WH; Chai, YF				Tan, Guangguo; Lou, Ziyang; Liao, Wenting; Zhu, Zhenyu; Dong, Xin; Zhang, Wei; Li, Wuhong; Chai, Yifeng			Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application	PLOS ONE			English	Article							ENERGY-METABOLISM; MASS-SPECTROMETRY; INDUCED APOPTOSIS; CARDIAC MYOCYTES; ANTHRACYCLINE ANTIBIOTICS; ANTICANCER DRUG; SYSTEMS BIOLOGY; L-CARNITINE; HPLC-MS; ADRIAMYCIN	Background: Doxorubicin (DOX) is one of the most potent antitumor agents available; however, its clinical use is limited because of the risk of severe cardiotoxicity. Though numerous studies have ascribed DOX cardiomyopathy to specific cellular pathways, the precise mechanism remains obscure. Sini decoction (SND) is a well-known formula of Traditional Chinese Medicine (TCM) and is considered as efficient agents against DOX-induced cardiomyopathy. However, its action mechanisms are not well known due to its complex components. Methodology/Principal Findings: A tissue-targeted metabonomic method using gas chromatography-mass spectrometry was developed to characterize the metabolic profile of DOX-induced cardiomyopathy in mice. With Elastic Net for classification and selection of biomarkers, twenty-four metabolites corresponding to DOX-induced cardiomyopathy were screened out, primarily involving glycolysis, lipid metabolism, citrate cycle, and some amino acids metabolism. With these altered metabolic pathways as possible drug targets, we systematically analyzed the protective effect of TCM SND, which showed that SND administration could provide satisfactory effect on DOX-induced cardiomyopathy through partially regulating the perturbed metabolic pathways. Conclusions/Significance: The results of the present study not only gave rise to a systematic view of the development of DOX-induced cardiomyopathy but also provided the theoretical basis to prevent or modify expected damage.	[Tan, Guangguo; Lou, Ziyang; Liao, Wenting; Zhu, Zhenyu; Dong, Xin; Zhang, Wei; Li, Wuhong; Chai, Yifeng] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Tan, Guangguo; Liao, Wenting; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng] Shanghai Key Lab Pharmaceut Metabolite Res, Shanghai, Peoples R China	Naval Medical University	Tan, GG (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	yfchai@smmu.edu.cn			National Natural Science Fund of China [30873196]; Project of Modernization of Traditional Chinese Medicine of Shanghai [09dZ1975100]; Doctoral Innovation Foundation of Second Military Medical University	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Project of Modernization of Traditional Chinese Medicine of Shanghai; Doctoral Innovation Foundation of Second Military Medical University	The work was supported by the National Natural Science Fund of China (No. 30873196) and the Project of Modernization of Traditional Chinese Medicine of Shanghai (No. 09dZ1975100) as well as the Doctoral Innovation Foundation of Second Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelAleem S, 1997, J MOL CELL CARDIOL, V29, P789, DOI 10.1006/jmcc.1996.0323; Andrieu-Abadie N, 1999, FASEB J, V13, P1501, DOI 10.1096/fasebj.13.12.1501; Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; BOOSER DJ, 1994, DRUGS, V47, P223, DOI 10.2165/00003495-199447020-00002; Bordoni A, 1999, BBA-MOL CELL BIOL L, V1440, P100, DOI 10.1016/S1388-1981(99)00113-4; Carvalho RA, 2010, TOXICOLOGY, V270, P92, DOI 10.1016/j.tox.2010.01.019; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; Gnanapragasam A, 2007, MOL CELL BIOCHEM, V294, P55, DOI 10.1007/s11010-006-9245-0; GOORMAGHTIGH E, 1982, BIOCHEM BIOPH RES CO, V104, P314, DOI 10.1016/0006-291X(82)91976-3; Hong YM, 2002, PEDIATR RES, V51, P249, DOI 10.1203/00006450-200202000-00020; Jin Minghua, 2003, Zhong Yao Cai, V26, P71; Karagiannis TC, 2010, AGING-US, V2, P659, DOI 10.18632/aging.100203; Kawasaki N, 1996, INT J CARDIOL, V55, P217, DOI 10.1016/0167-5273(96)02672-1; Konorev EA, 2002, FREE RADICAL BIO MED, V33, P988, DOI 10.1016/S0891-5849(02)00989-9; Kumar SN, 2011, J PROTEOMICS, V74, P683, DOI 10.1016/j.jprot.2011.02.013; Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF; McNulty PH, 2000, METABOLISM, V49, P1365, DOI 10.1053/meta.2000.9510; MYERS CE, 1977, SCIENCE, V197, P165, DOI 10.1126/science.877547; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Park JC, 2009, J TOXICOL ENV HEAL A, V72, P374, DOI 10.1080/15287390802647195; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Ronen SM, 1999, BRIT J CANCER, V80, P1035, DOI 10.1038/sj.bjc.6690459; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sack MN, 2010, AGING-US, V2, P754, DOI 10.18632/aging.100238; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; SINGAL PK, 1987, J MOL CELL CARDIOL, V19, P817, DOI 10.1016/S0022-2828(87)80392-9; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SOLEM LE, 1994, TOXICOL APPL PHARM, V129, P214, DOI 10.1006/taap.1994.1246; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Todorova VK, 2010, J NUTR, V140, P44, DOI 10.3945/jn.109.113415; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Verpoorte R, 2005, J ETHNOPHARMACOL, V100, P53, DOI 10.1016/j.jep.2005.05.033; WAKASUGI S, 1993, J NUCL MED, V34, P1529; Wang JS, 2009, METABOLOMICS, V5, P407, DOI 10.1007/s11306-009-0165-3; Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624; Wolf MB, 2006, BBA-GEN SUBJECTS, V1760, P267, DOI 10.1016/j.bbagen.2005.10.012; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu W K, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P744; Zhao Dan-Yang, 2008, Zhong Yao Cai, V31, P1681; Zhao Ming-qi, 2009, Zhong Yao Cai, V32, P1860; Zhou SY, 2001, CANCER RES, V61, P771; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	47	51	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27683	10.1371/journal.pone.0027683	http://dx.doi.org/10.1371/journal.pone.0027683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110719	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555400083
J	Wehner, J; Antunes, PM; Powell, JR; Caruso, T; Rillig, MC				Wehner, Jeannine; Antunes, Pedro M.; Powell, Jeff R.; Caruso, Tancredi; Rillig, Matthias C.			Indigenous Arbuscular Mycorrhizal Fungal Assemblages Protect Grassland Host Plants from Pathogens	PLOS ONE			English	Article							DIVERSITY; BIODIVERSITY; MECHANISMS; ECOLOGY; ROOTS	Plant roots can establish associations with neutral, beneficial and pathogenic groups of soil organisms. Although it has been recognized from the study of individual isolates that these associations are individually important for plant growth, little is known about interactions of whole assemblages of beneficial and pathogenic microorganisms associating with plants. We investigated the influence of an interaction between local arbuscular mycorrhizal (AM) fungal and pathogenic/saprobic microbial assemblages on the growth of two different plant species from semi-arid grasslands in NE Germany (Mallnow near Berlin). In a greenhouse experiment each plant species was grown for six months in either sterile soil or in sterile soil with one of three different treatments: 1) an AM fungal spore fraction isolated from field soil from Mallnow; 2) a soil pathogen/saprobe fraction consisting of a microbial community prepared with field soil from Mallnow and; 3) the combined AM fungal and pathogen/saprobe fractions. While both plant species grew significantly larger in the presence of AM fungi, they responded negatively to the pathogen/saprobe treatment. For both plant species, we found evidence of pathogen protection effects provided by the AM fungal assemblages. These results indicate that interactions between assemblages of beneficial and pathogenic microorganisms can influence the growth of host plants, but that the magnitude of these effects is plant species-specific.	[Wehner, Jeannine; Caruso, Tancredi; Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, D-1000 Berlin, Germany; [Antunes, Pedro M.] Algoma Univ, Dept Biol, Sault Ste Marie, ON, Canada; [Powell, Jeff R.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Free University of Berlin; Algoma University; Western Sydney University	Wehner, J (corresponding author), Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, D-1000 Berlin, Germany.	matthias.rillig@fu-berlin.de	Powell, Jeff R/A-5076-2010; Caruso, Tancredi/H-1103-2012; Madeira Antunes, Pedro/C-2949-2008; Rillig, Matthias C./AAE-6980-2019; Rillig, Matthias C./B-3675-2009	Powell, Jeff R/0000-0003-1091-2452; Caruso, Tancredi/0000-0002-3607-9609; Madeira Antunes, Pedro/0000-0003-3596-6983; Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853	Dahlem Center of Plant Sciences at FU Berlin; EU	Dahlem Center of Plant Sciences at FU Berlin; EU(European Commission)	This study was partly supported by a grant from the Dahlem Center of Plant Sciences at FU Berlin to MCR. and by an EU Marie-Curie Reintegration grant to PMA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2008, INT J FOOD MICROBIOL, V126, P172, DOI 10.1016/j.ijfoodmicro.2008.05.036; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; AzconAguilar C, 1996, MYCORRHIZA, V6, P457, DOI 10.1007/s005720050147; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Borowicz VA, 2001, ECOLOGY, V82, P3057; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; CLAPP JP, 1995, NEW PHYTOL, V130, P259, DOI 10.1111/j.1469-8137.1995.tb03047.x; CONWAY KE, 1985, PLANT DIS, V69, P393, DOI 10.1094/PD-69-393; *DEUTSCH WETT, 2010, MEAN ANN CLIM DAT 19; Filion M, 1999, NEW PHYTOL, V141, P525, DOI 10.1046/j.1469-8137.1999.00366.x; Filion M, 2003, PHYTOPATHOLOGY, V93, P229, DOI 10.1094/PHYTO.2003.93.2.229; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Hensen I., 1997, Feddes Repertorium, V108, P425; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; Newsham KK, 1995, J ECOL, V83, P991, DOI 10.2307/2261180; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; R Core Team, 2022, R LANG ENV STAT COMP; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Schwarz D, 2003, SCI HORTIC-AMSTERDAM, V97, P109, DOI 10.1016/S0304-4238(02)00143-7; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Stein C, 2009, OECOLOGIA, V159, P191, DOI 10.1007/s00442-008-1192-x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Vandemark GEJ, 2010, J PHYTOPATHOL, V158, P117, DOI 10.1111/j.1439-0434.2009.01583.x; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Westover KM, 2001, ECOLOGY, V82, P3285, DOI 10.1890/0012-9658(2001)082[3285:MOPSCR]2.0.CO;2	35	29	30	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27381	10.1371/journal.pone.0027381	http://dx.doi.org/10.1371/journal.pone.0027381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110635	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400040
J	Bosis, E; Salomon, D; Sessa, G				Bosis, Eran; Salomon, Dor; Sessa, Guido			A Simple Yeast-Based Strategy to Identify Host Cellular Processes Targeted by Bacterial Effector Proteins	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; KINASE-ACTIVITY; III EFFECTORS; IDENTIFICATION; SYSTEM; FAMILY; COMMON	Bacterial effector proteins, which are delivered into the host cell via the type III secretion system, play a key role in the pathogenicity of Gram-negative bacteria by modulating various host cellular processes to the benefit of the pathogen. To identify cellular processes targeted by bacterial effectors, we developed a simple strategy that uses an array of yeast deletion strains fitted into a single 96-well plate. The array is unique in that it was optimized computationally such that despite the small number of deletion strains, it covers the majority of genes in the yeast synthetic lethal interaction network. The deletion strains in the array are screened for hypersensitivity to the expression of a bacterial effector of interest. The hypersensitive deletion strains are then analyzed for their synthetic lethal interactions to identify potential targets of the bacterial effector. We describe the identification, using this approach, of a cellular process targeted by the Xanthomonas campestris type III effector XopE2. Interestingly, we discover that XopE2 affects the yeast cell wall and the endoplasmic reticulum stress response. More generally, the use of a single 96-well plate makes the screening process accessible to any laboratory and facilitates the analysis of a large number of bacterial effectors in a short period of time. It therefore provides a promising platform for studying the functions and cellular targets of bacterial effectors and other virulence proteins.	[Bosis, Eran; Salomon, Dor; Sessa, Guido] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	Tel Aviv University	Bosis, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	guidos@post.tau.ac.il		Salomon, Dor/0000-0002-2009-9453	Israel Science Foundation (ISF) [326/10]	Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by a research grant from the Israel Science Foundation (ISF; grant no. 326/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bosis E, 2008, BIOCHEMISTRY-US, V47, P10970, DOI 10.1021/bi801545d; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; HONG Z, 1994, MOL CELL BIOL, V14, P1017, DOI 10.1128/MCB.14.2.1017; Iha H, 1998, BIOTECHNIQUES, V25, P936, DOI 10.2144/98256bm01; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Krysan Damian J, 2009, Commun Integr Biol, V2, P233; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lopez-Garcia B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-289; Lussier M, 1997, GENETICS, V147, P435; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Moscovitch D, 2004, BIOPHYS J, V87, P47, DOI 10.1529/biophysj.104.039925; Munkvold KR, 2008, MOL PLANT MICROBE IN, V21, P490, DOI 10.1094/MPMI-21-4-0490; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Reynolds A, 2001, CURR PROTOC MOL BIOL; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salomon D, 2010, JOVE-J VIS EXP, DOI [10.3791/1865, DOI 10.3791/1865]; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Salomon D, 2009, J BIOL CHEM, V284, P15289, DOI 10.1074/jbc.M809724200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Spear E, 2001, TRAFFIC, V2, P515, DOI 10.1034/j.1600-0854.2001.20801.x; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Valdivia RH, 2004, EUKARYOT CELL, V3, P827, DOI 10.1128/EC.3.4.827-834.2004; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034	51	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27698	10.1371/journal.pone.0027698	http://dx.doi.org/10.1371/journal.pone.0027698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110728	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555300044
J	Hoffman, C; Park, SH; Daley, E; Emson, C; Louten, J; Sisco, M; Malefyt, RD; Grunig, G				Hoffman, Carol; Park, Sung-Hyun; Daley, Eleen; Emson, Claire; Louten, Jennifer; Sisco, Maureen; Malefyt, Rene de Waal; Grunig, Gabriele			Interleukin-19: A Constituent of the Regulome That Controls Antigen Presenting Cells in the Lungs and Airway Responses to Microbial Products	PLOS ONE			English	Article							DENDRITIC CELLS; CYTOKINE PRODUCTION; EPITHELIAL-CELLS; TH2 CYTOKINES; IL-10 FAMILY; IFN-GAMMA; TNF-ALPHA; T-CELLS; EXPRESSION; RECEPTOR	Background: Interleukin (IL)-19 has been reported to enhance chronic inflammatory diseases such as asthma but the in vivo mechanism is incompletely understood. Because IL-19 is produced by and regulates cells of the monocyte lineage, our studies focused on in vivo responses of CD11c positive (CD11c+) alveolar macrophages and lung dendritic cells. Methodology/Principal Findings: IL-19-deficient (IL-19-/-) mice were studied at baseline (naive) and following intranasal challenge with microbial products, or recombinant cytokines. Naive IL-19-/- mixed background mice had a decreased percentage of CD11c+ cells in the bronchoalveolar-lavage (BAL) due to the deficiency in IL-19 and a trait inherited from the 129-mouse strain. BAL CD11c+ cells from fully backcrossed IL-19-/- BALB/c or C57BL/6 mice expressed significantly less Major Histocompatibility Complex class II (MHCII) in response to intranasal administration of lipopolysaccharide, Aspergillus antigen, or IL-13, a pro-allergic cytokine. Neurogenic-locus-notch-homolog-protein-2 (Notch2) expression by lung monocytes, the precursors of BAL CD11c+ cells, was dysregulated: extracellular Notch2 was significantly decreased, transmembrane/intracellular Notch2 was significantly increased in IL-19-/- mice relative to wild type. Instillation of recombinant IL-19 increased extracellular Notch2 expression and dendritic cells cultured from bone marrow cells in the presence of IL-19 showed upregulated extracellular Notch2. The CD205 positive subset among the CD11c+ cells was 3-5-fold decreased in the airways and lungs of naive IL-19-/- mice relative to wild type. Airway inflammation and histological changes in the lungs were ameliorated in IL-19-/- mice challenged with Aspergillus antigen that induces T lymphocyte-dependent allergic inflammation but not in IL-19-/- mice challenged with lipopolysaccharide or IL-13. Conclusions/Significance: Because MHCII is the molecular platform that displays peptides to T lymphocytes and Notch2 determines cell fate decisions, our studies suggest that endogenous IL-19 is a constituent of the regulome that controls both processes in vivo.	[Hoffman, Carol; Park, Sung-Hyun; Sisco, Maureen; Grunig, Gabriele] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Daley, Eleen] St Lukes Roosevelt Hosp, Dept Pathol, New York, NY 10025 USA; [Emson, Claire; Louten, Jennifer; Malefyt, Rene de Waal] Merck Res Labs, Palo Alto, CA USA; [Grunig, Gabriele] NYU, Sch Med, Dept Med, Div Pulm Med, New York, NY USA	New York University; Mount Sinai St. Luke's; Mount Sinai West; Merck & Company; New York University	Hoffman, C (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.	gabriele.grunig@nyumc.org		Louten, Jennifer/0000-0002-4568-187X; de Waal Malefyt, Rene/0000-0002-2663-383X	National Institutes of Health [1R21HL092370-01, 1R01 HL095764-01]; American Heart Association [0230348N, 0855943D]; Flight Attendant Medical Research Institute; American Lung Association of the City of New York; Stony Wold-Herbert Fund, New York; Speaker's Fund for Biomedical Research from the City of New York; NIEHS Center [5P30ES00260-47]; Cancer Center Support Grant (CCSG) [5P30CA016087-31]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092370, R01HL095764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Flight Attendant Medical Research Institute; American Lung Association of the City of New York; Stony Wold-Herbert Fund, New York; Speaker's Fund for Biomedical Research from the City of New York; NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was funded in part by the National Institutes of Health 1R21HL092370-01, 1R01 HL095764-01; American Heart Association: national and Founders affiliates (0230348N, 0855943D); Flight Attendant Medical Research Institute; American Lung Association of the City of New York; Stony Wold-Herbert Fund, New York; Speaker's Fund for Biomedical Research from the City of New York (to GG). The NIEHS Center Grant 5P30ES00260-47 and the Cancer Center Support Grant (CCSG) 5P30CA016087-31 provided Core Facility support. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck Research Laboratories provided support through the employment of authors RdWM, CE and JL, who contributed IL-19 deficient mice and who were updated on the studies, and included in discussions on the design of the experiments, data analysis and editing of the manuscript.	Alanara T, 2010, SCAND J RHEUMATOL, V39, P118, DOI 10.3109/03009740903170823; Azuma YT, 2011, J PHARMACOL SCI, V115, P105, DOI 10.1254/jphs.10R02CR; AZUMA YT, 2009, INFLAMM BOWEL DIS; Bettaccini AA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-20; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chang CS, 2003, J BIOL CHEM, V278, P3308, DOI 10.1074/jbc.M208602200; CUNEO AA, 2010, J MOL CELL CARDIOL; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Hsing CH, 2007, NEPHROL DIAL TRANSPL, V22, P2230, DOI 10.1093/ndt/gfm179; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016; Hummelshoj L, 2006, SCAND J IMMUNOL, V64, P40, DOI 10.1111/j.1365-3083.2006.01773.x; Hung LY, 2009, J IMMUNOL, V182; Jain S, 2011, ARTERIOSCL THROM VAS, V31, P167, DOI 10.1161/ATVBAHA.110.214916; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kingo K, 2007, BRIT J DERMATOL, V156, P646, DOI 10.1111/j.1365-2133.2006.07731.x; Koks S, 2005, GENES IMMUN, V6, P407, DOI 10.1038/sj.gene.6364216; Koks S, 2004, GENES IMMUN, V5, P662, DOI 10.1038/sj.gene.6364141; Lambrecht BN, 1999, AM J RESP CELL MOL, V20, P1165, DOI 10.1165/ajrcmb.20.6.3484; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sabat R, 2007, EXPERT OPIN THER TAR, V11, P601, DOI 10.1517/14728222.11.5.601; Sakata-Yanagimoto M, 2008, P NATL ACAD SCI USA, V105, P7839, DOI 10.1073/pnas.0801074105; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; Ten Berge B, 2009, J IMMUNOL METHODS, V351, P13, DOI 10.1016/j.jim.2009.09.009; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; van Rijt LS, 2002, BLOOD, V100, P3663, DOI 10.1182/blood-2002-03-0673; Wahl C, 2009, J IMMUNOL, V182, P802, DOI 10.4049/jimmunol.182.2.802; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zhong HY, 2006, AM J RESP CELL MOL, V35, P587, DOI 10.1165/rcmb.2005-0476OC; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	58	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2011	6	11							e27629	10.1371/journal.pone.0027629	http://dx.doi.org/10.1371/journal.pone.0027629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HU	22110701	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555300038
J	Tang, SX; Zhao, JQ; Setty, MKHG; Devadas, K; Gaddam, D; Viswanath, R; Wood, O; Zhang, PH; Hewlett, IK				Tang, Shixing; Zhao, Jiangqin; Setty, Mohan Kumar Haleyur Giri; Devadas, Krishnakumar; Gaddam, Durga; Viswanath, Ragupathy; Wood, Owen; Zhang, Panhe; Hewlett, Indira K.			Absence of Detectable XMRV and Other MLV-Related Viruses in Healthy Blood Donors in the United States	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; MOUSE DNA; LEUKEMIA; CELLS; PREVALENCE; CONTAMINATION; SEQUENCES; FAILURE	Background: Preliminary studies in chronic fatigue syndrome (CFS) patients and XMRV infected animals demonstrated plasma viremia and infection of blood cells with XMRV, indicating the potential risk for transfusion transmission. XMRV and MLV-related virus gene sequences have also been detected in 4-6% of healthy individuals including blood donors in the U.S. These results imply that millions of persons in the U.S. may be carrying the nucleic acid sequences of XMRV and/or MLV-related viruses, which is a serious public health and blood safety concern. Methodology/Principal Findings: To gain evidence of XMRV or MLV-related virus infection in the U.S. blood donors, 110 plasma samples and 71 PBMC samples from blood donors at the NIH blood bank were screened for XMRV and MLV-related virus infection. We employed highly sensitive assays, including nested PCR and real-time PCR, as well as co-culture of plasma with highly sensitive indicator DERSE cells. Using these assays, none of the samples were positive for XMRV or MLV-related virus. Conclusions/Significance: Our results are consistent with those from several other studies, and demonstrate the absence of XMRV or MLV-related viruses in the U.S. blood donors that we studied.	[Tang, Shixing; Zhao, Jiangqin; Setty, Mohan Kumar Haleyur Giri; Devadas, Krishnakumar; Gaddam, Durga; Viswanath, Ragupathy; Wood, Owen; Zhang, Panhe; Hewlett, Indira K.] US FDA, Mol Virol Lab, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Tang, SX (corresponding author), US FDA, Mol Virol Lab, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	tangshixing@hotmail.com; Indira.hewlett@fda.hhs.gov	Haleyur Giri Setty, Mohan Kumar/F-5841-2014	Haleyur Giri Setty, Mohan Kumar/0000-0001-6423-1420; VISWANATH, R/0000-0002-5376-0834; Zhao, Jiangqin/0000-0003-4672-0735	Center for Biologics Evaluation and Research (CBER)	Center for Biologics Evaluation and Research (CBER)	This work was supported in part by a Critical Path grant from The Center for Biologics Evaluation and Research (CBER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FURUTA RA, 2009, PREVALENCE XENOTROPI; GAO K, 2010, 2010 INT C EM INF DI; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Kim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010255; Klein HG, 2011, TRANSFUSION, V51, P654, DOI 10.1111/j.1537-2995.2010.03012.x; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; LEE K, 2010, 1 INT WORKSH XMRV; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; PAPROTKA T, 2011, 18 C RETR OPP INF, P105; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tang SX, 2011, TRANSFUSION, V51, P463, DOI 10.1111/j.1537-2995.2010.02932.x; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27391	10.1371/journal.pone.0027391	http://dx.doi.org/10.1371/journal.pone.0027391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110639	gold, Green Submitted, Green Published			2022-12-25	WOS:000297554300025
J	Dickerson, JE; Zhu, A; Robertson, DL; Hentges, KE				Dickerson, Jonathan E.; Zhu, Ana; Robertson, David L.; Hentges, Kathryn E.			Defining the Role of Essential Genes in Human Disease	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; OF-FUNCTION MUTATIONS; GENOME DATABASE MGD; HOUSEKEEPING GENES; NETWORK PROPERTIES; MOUSE; IDENTIFICATION; MALFORMATIONS; TUMORIGENESIS; CYTOSCAPE	A greater understanding of the causes of human disease can come from identifying characteristics that are specific to disease genes. However, a full understanding of the contribution of essential genes to human disease is lacking, due to the premise that these genes tend to cause developmental abnormalities rather than adult disease. We tested the hypothesis that human orthologs of mouse essential genes are associated with a variety of human diseases, rather than only those related to miscarriage and birth defects. We segregated human disease genes according to whether the knockout phenotype of their mouse ortholog was lethal or viable, defining those with orthologs producing lethal knockouts as essential disease genes. We show that the human orthologs of mouse essential genes are associated with a wide spectrum of diseases affecting diverse physiological systems. Notably, human disease genes with essential mouse orthologs are over-represented among disease genes associated with cancer, suggesting links between adult cellular abnormalities and developmental functions. The proteins encoded by essential genes are highly connected in protein-protein interaction networks, which we find correlates with an over-representation of nuclear proteins amongst essential disease genes. Disease genes associated with essential orthologs also are more likely than those with non-essential orthologs to contribute to disease through an autosomal dominant inheritance pattern, suggesting that these diseases may actually result from semi-dominant mutant alleles. Overall, we have described attributes found in disease genes according to the essentiality status of their mouse orthologs. These findings demonstrate that disease genes do occupy highly connected positions in protein-protein interaction networks, and that due to the complexity of disease-associated alleles, essential genes cannot be ignored as candidates for causing diverse human diseases.	[Dickerson, Jonathan E.; Zhu, Ana; Robertson, David L.; Hentges, Kathryn E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Dickerson, JE (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	kathryn.hentges@manchester.ac.uk		Chen, Wei-Hua/0000-0003-2168-6147; Hentges, Kathryn/0000-0001-8917-3765	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	AZ, DLR, and KEH had no external funding sources for this study. JED was supported by a Wellcome Trust studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; DICKERSON JE, 2011, MOL BIOL EVOL; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Furney SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn482; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Karkera JD, 2007, AM J HUM GENET, V81, P987, DOI 10.1086/522890; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Kondrashov FA, 2004, NUCLEIC ACIDS RES, V32, P1731, DOI 10.1093/nar/gkh330; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; McKusick V.A., 1998, MENDELIAN INHERITANC; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; R Development Core Team, 2009, R FDN STAT COMP; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith NGC, 2003, GENE, V318, P169, DOI 10.1016/S0378-1119(03)00772-8; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vaiserman A, 2011, EXP GERONTOL, V46, P189, DOI 10.1016/j.exger.2010.08.031; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Veugelers M, 2000, HUM MOL GENET, V9, P1321, DOI 10.1093/hmg/9.9.1321; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	53	62	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27368	10.1371/journal.pone.0027368	http://dx.doi.org/10.1371/journal.pone.0027368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096564	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000297553900038
J	Herrmann, R; Lee, B; Arshavsky, VY				Herrmann, Rolf; Lee, Bowa; Arshavsky, Vadim Y.			RGS9 Knockout Causes a Short Delay in Light Responses of ON-Bipolar Cells	PLOS ONE			English	Article							GTPASE ACCELERATING PROTEIN; MOUSE RETINA; MEMBRANE ANCHOR; MICE LACKING; PHOTORECEPTOR CELLS; ROD PHOTORECEPTORS; RHODOPSIN KINASE; RECEPTOR MGLUR6; DEP DOMAIN; RECOVERIN	RGS9 and R9AP are components of the photoreceptor-specific GTPase activating complex responsible for rapid inactivation of the G protein, transducin, in the course of photoresponse recovery from excitation. The amount of this complex in photoreceptors is strictly dependent on the expression level of R9AP; consequently, the knockouts of either RGS9 or R9AP cause comparable delays in photoresponse recovery. While RGS9 is believed to be present only in rods and cones, R9AP is also expressed in dendritic tips of ON-bipolar cells, which receive synaptic inputs from photoreceptors. Recent studies demonstrated that knockouts of R9AP and its binding partner in ON-bipolar cells, RGS11, cause a small delay in ON-bipolar cell light responses manifested as a delayed onset of electroretinography b-waves. This led the authors to suggest that R9AP and RGS11 participate in regulating the kinetics of light responses in these cells. Here we report the surprising finding that a nearly identical b-wave delay is observed in RGS9 knockout mice. Given the exclusive localization of RGS9 in photoreceptors, this result argues for a presynaptic origin of the b-wave delay in this case and perhaps in the case of the R9AP knockout as well, since R9AP is expressed in both photoreceptors and ON-bipolar cells. We also conducted a detailed analysis of the b-wave rising phase kinetics in both knockout animal types and found that, despite a delayed b-wave onset, the slope of the light response is unaffected or increased, dependent on the light stimulus intensity. This result is inconsistent with a slowdown of response propagation in ON-bipolar cells caused by the R9AP knockout, further arguing against the postsynaptic nature of the delayed b-wave phenotype in RGS9 and R9AP knockout mice.	[Herrmann, Rolf; Lee, Bowa; Arshavsky, Vadim Y.] Duke Univ, Albert Eye Res Inst, Durham, NC 27710 USA	Duke University	Herrmann, R (corresponding author), Duke Univ, Albert Eye Res Inst, Durham, NC 27710 USA.	vadim.arshavsky@duke.edu			National Institutes of Health (NIH) [EY12859, EY5722]; NATIONAL EYE INSTITUTE [P30EY005722, R01EY012859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grant EY12859 (VYA) and the NIH Core Grant for Vision Research EY5722 to Duke University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; BIRCH DG, 1995, INVEST OPHTH VIS SCI, V36, P1603; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2008, J NEUROSCI, V28, P10443, DOI 10.1523/JNEUROSCI.3282-08.2008; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Jeffrey BG, 2010, VISUAL NEUROSCI, V27, P9, DOI 10.1017/S0952523809990319; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Lyubarsky A, 2001, MOL VIS, V7, P71; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nawy S, 1999, J NEUROSCI, V19, P2938; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Robson JG, 2003, J PHYSIOL-LONDON, V547, P509, DOI 10.1113/jphysiol.2002.030304; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Rodieck R.W., 1998, 1 STEPS SEEING; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Strissel KJ, 2005, J BIOL CHEM, V280, P29250, DOI 10.1074/jbc.M501789200; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; Ueda Y, 1997, J NEUROSCI, V17, P3014; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	57	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27573	10.1371/journal.pone.0027573	http://dx.doi.org/10.1371/journal.pone.0027573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096596	gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900059
J	Xu, G; Ahn, J; Chang, S; Eguchi, M; Ogier, A; Han, S; Park, Y; Shim, C; Jang, YS; Yang, B; Xu, AM; Wang, Y; Sweeney, G				Xu, Guoxiong; Ahn, JinHee; Chang, SoYoung; Eguchi, Megumi; Ogier, Arnaud; Han, SungJun; Park, YoungSam; Shim, ChiYoung; Jang, YangSoo; Yang, Bo; Xu, Aimin; Wang, Yu; Sweeney, Gary			Lipocalin-2 Induces Cardiomyocyte Apoptosis by Increasing Intracellular Iron Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC HEART-FAILURE; NEUTROPHIL-GELATINASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; DOWN-REGULATION; CELLS; OBESITY; NGAL	Our objective was to determine whether lipocalin-2 (Lcn2) regulates cardiomyocyte apoptosis, the mechanisms involved, and the functional significance. Emerging evidence suggests that Lcn2 is a proinflammatory adipokine associated with insulin resistance and obesity-related complications, such as heart failure. Here, we used both primary neonatal rat cardiomyocytes and H9c2 cells and demonstrated for the first time that Lcn2 directly induced cardiomyocyte apoptosis, an important component of cardiac remodeling leading to heart failure. This was shown by detection of DNA fragmentation using TUNEL assay, phosphatidylserine exposure using flow cytometry to detect annexin V-positive cells, caspase-3 activity using enzymatic assay and immunofluorescence, and Western blotting for the detection of cleaved caspase-3. We also observed that Lcn2 caused translocation of the proapoptotic protein Bax to mitochondria and disruption of mitochondrial membrane potential. Using transient transfection of GFP-Bax, we confirmed that Lcn2 induced co-localization of Bax with MitoTracker (R) dye. Importantly, we used the fluorescent probe Phen Green SK to demonstrate an increase in intracellular iron in response to Lcn2, and depleting intracellular iron using an iron chelator prevented Lcn2-induced cardiomyocyte apoptosis. Administration of recombinant Lcn2 to mice for 14 days increased cardiomyocyte apoptosis as well as an acute inflammatory response with compensatory changes in cardiac functional parameters. In conclusion, Lcn2-induced cardiomyocyte apoptosis is of physiological significance and occurs via a mechanism involving elevated intracellular iron levels and Bax translocation.	[Shim, ChiYoung; Jang, YangSoo] Yonsei Univ, Coll Med, Dept Cardiol, Seoul 120752, South Korea; [Yang, Bo; Xu, Aimin; Wang, Yu] Univ Hong Kong, Dept Pharmacol, Pokfulam, Hong Kong, Peoples R China; [Eguchi, Megumi; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Xu, Guoxiong; Ahn, JinHee; Eguchi, Megumi; Sweeney, Gary] Inst Pasteur Korea, Diabet Grp, Songnam 463400, Gyeonggi, South Korea; [Ogier, Arnaud] Inst Pasteur Korea, Toxic Grp, Songnam 463400, Gyeonggi, South Korea; [Park, YoungSam; Shim, ChiYoung] Inst Pasteur Korea, Drug Biol Grp, Songnam 463400, Gyeonggi, South Korea	Yonsei University; Yonsei University Health System; University of Hong Kong; York University - Canada; Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea	Sweeney, G (corresponding author), Inst Pasteur Korea, 696 Sampyung dong, Songnam 463400, Gyeonggi, South Korea.	gary@ip-korea.org	Xu, Aimin/D-3291-2013; Shim, Chi Young/AAK-1057-2021; Han, Sung-Jun/B-9547-2012	Xu, Aimin/0000-0002-0668-033X; Shim, Chi Young/0000-0002-6136-0136; Jang, Yangsoo/0000-0002-2169-3112; Chang, So Young/0000-0002-6390-6462; wang, yu/0000-0001-8697-2940	National Research Foundation of Korea [2010-0012009]; Research Grants Council of Hong Kong [HKU 2/07C, 4/HKU/10C]	National Research Foundation of Korea(National Research Foundation of Korea); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Research Foundation of Korea Grant 2010-0012009 (to G. S.) and by Collaborative Research Fund HKU 2/07C and 4/HKU/10C from the Research Grants Council of Hong Kong (to A.X. and Y.W.).	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; Artham Surya M, 2008, J Cardiometab Syndr, V3, P155, DOI 10.1111/j.1559-4572.2008.00001.x; Arvapalli RK, 2010, CARDIOVASC TOXICOL, V10, P108, DOI 10.1007/s12012-010-9068-9; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Bong JJ, 2004, MOL CELLS, V17, P29; Borgna-Pignatti C, 2006, BLOOD, V107, P3733, DOI 10.1182/blood-2005-07-2933; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goswami T, 2002, BIOCHEM CELL BIOL, V80, P679, DOI 10.1139/O02-159; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jang Y., 2011, CLIN EXP PH IN PRESS; Kahn E, 2010, INT J NANOMED, V5, P185; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Kooncumchoo P, 2006, J MOL NEUROSCI, V28, P125, DOI 10.1385/JMN:28:2:125; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oudit GY, 2004, CIRCULATION, V109, P1877, DOI 10.1161/01.CIR.0000124229.40424.80; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Schwartz N, 2007, ANN NY ACAD SCI, V1109, P265, DOI 10.1196/annals.1398.032; Shin E, 2009, J CELL PHYSIOL, V221, P490, DOI 10.1002/jcp.21883; Spagnuolo RD, 2011, BRIT J PHARMACOL, V163, P299, DOI 10.1111/j.1476-5381.2011.01208.x; Takemura G, 2004, PHARMACOL THERAPEUT, V104, P1, DOI 10.1016/j.pharmthera.2004.07.005; Trivedi PS, 2008, CURR HYPERTENS REP, V10, P454, DOI 10.1007/s11906-008-0085-z; van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432; VelezPardo C, 1997, PHARMACOL TOXICOL, V80, P76, DOI 10.1111/j.1600-0773.1997.tb00287.x; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961; Wang YL, 2011, J PHARMACOL EXP THER, V336, P56, DOI 10.1124/jpet.110.172668; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Whittaker P, 1996, TOXICOL PATHOL, V24, P558, DOI 10.1177/019262339602400504; Xu GX, 2006, MOL CANCER RES, V4, P235, DOI 10.1158/1541-7786.MCR-05-0174; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; Zheng LT, 2009, J NEUROCHEM, V111, P1238, DOI 10.1111/j.1471-4159.2009.06410.x	57	91	94	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4808	4817		10.1074/jbc.M111.275719	http://dx.doi.org/10.1074/jbc.M111.275719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22117066	Green Published, hybrid			2022-12-25	WOS:000300608500042
J	Brown, DB; Forsberg, LS; Kannenberg, EL; Carlson, RW				Brown, Dusty B.; Forsberg, L. Scott; Kannenberg, Elmar L.; Carlson, Russell W.			Characterization of Galacturonosyl Transferase Genes rgtA, rgtB, rgtC, rgtD, and rgtE Responsible for Lipopolysaccharide Synthesis in Nitrogen-fixing Endosymbiont Rhizobium leguminosarum LIPOPOLYSACCHARIDE CORE AND LIPID GALACTURONOSYL RESIDUES CONFER MEMBRANE STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION CLONING; ACID; MUTANT; BIOSYNTHESIS; SALMONELLA; GENERATION; STRAINS	Rhizobium lipopolysaccharide (LPS) contains four terminally linked galacturonic acid (GalA) residues; one attached to the lipid A and three attached to the core oligosaccharide moiety. Attachment of the GalA residues requires the lipid donor dodecaprenyl-phosphate GalA (Dod-P-GalA), which is synthesized by the GalA transferase RgtE reported here. The galacturonosyl transferases RgtA, -B, and -C utilize Dod-P-GalA to attach GalAs on the LPS core region, and RgtD attaches GalA to the lipid A 4' position. As reported here, the functions of the rgtD and rgtE genes were determined via insertion mutagenesis and structural characterization of the mutant lipid A. The rgtE(-) mutant lacked Dod-P-GalA as determined by mass spectrometry of total lipid extracts and the inability of rgtE(-) mutant membranes to provide the substrate for heterologously expressed RgtA activity. In addition, we created single mutations in each of the rgtA, -B, -C, -D, and -E genes to study the biological function of the GalA residues. The structures of the core oligosaccharide region from each of the rgt mutants were elucidated by glycosyl linkage analysis. Each mutant was assayed for its sensitivity to sodium deoxycholate and to the antimicrobial cationic peptide, polymyxin B (PmxB). The rgt mutants were more sensitive than the parent strain to deoxycholate by varying degrees. However, the rgtA, -B, and -C mutants were more resistant to PmxB, whereas the rgtD and E mutants were less resistant in comparison to the parent strain.	[Brown, Dusty B.; Forsberg, L. Scott; Kannenberg, Elmar L.; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu			National Institutes of Health [GM39583]; Department of Energy [DE-FG-02-93ER20097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM39583 (to R. W. C.). This work was also supported by Department of Energy Grant DE-FG-02-93ER20097 (to the Complex Carbohydrate Research Center). This work is in partial fulfillment for the Ph.D. degree of D. B. B.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Brown DB, 2011, J BACTERIOL, V193, P4766, DOI 10.1128/JB.00392-11; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cointe D, 1998, CARBOHYD RES, V311, P51, DOI 10.1016/S0008-6215(98)00196-7; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; Forsberg LS, 2003, J BIOL CHEM, V278, P51347, DOI 10.1074/jbc.M309016200; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; Haag AF, 2009, J BACTERIOL, V191, P4681, DOI 10.1128/JB.00318-09; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12865, DOI 10.1074/jbc.M513864200; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12879, DOI 10.1074/jbc.M513865200; Karbarz MJ, 2009, J BIOL CHEM, V284, P414, DOI 10.1074/jbc.M808390200; KITTELBERGER R, 1993, J BIOCHEM BIOPH METH, V26, P81, DOI 10.1016/0165-022X(93)90024-I; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; PHADNIS SH, 1987, J BIOSCIENCE, V12, P131, DOI 10.1007/BF02702964; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12120, DOI 10.1074/jbc.M300379200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; RYAN JM, 1974, ARCH BIOCHEM BIOPHYS, V162, P530, DOI 10.1016/0003-9861(74)90213-6; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Song F, 2009, BIOCHEMISTRY-US, V48, P1173, DOI 10.1021/bi802212t; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Vedam V, 2004, MOL PLANT MICROBE IN, V17, P283, DOI 10.1094/MPMI.2004.17.3.283; WANG TL, 1982, PLANTA, V155, P345, DOI 10.1007/BF00429463; Wang XY, 2009, BIOCHEMISTRY-US, V48, P1162, DOI 10.1021/bi802211k; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; YORK WS, 1986, METHOD ENZYMOL, V118, P3	38	7	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					935	949		10.1074/jbc.M111.311571	http://dx.doi.org/10.1074/jbc.M111.311571			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110131	Green Published, hybrid			2022-12-25	WOS:000299170300012
J	Yu, ED; Girardi, E; Wang, J; Mac, TT; Yu, KOA; Van Calenbergh, S; Porcelli, SA; Zajonc, DM				Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Thien-Thi Mac; Yu, Karl O. A.; Van Calenbergh, Serge; Porcelli, Steven A.; Zajonc, Dirk M.			Structural Basis for the Recognition of C20:2-alpha GalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-GALACTOSYLCERAMIDE; RECOMBINANT ANTIBODIES; NKT CELLS; CD1D; GLYCOLIPIDS; ANTIGENS; COMPLEX; MODEL; SPECIFICITY; RESPONSES	Natural killer T (NKT) cells express a semi-invariant V alpha 14T cell receptor (TCR) and recognize structurally diverse antigens presented by the antigen-presenting molecule CD1d that range from phosphoglycerolipids to alpha- and beta-anomeric glycosphingolipids, as well as microbial alpha-glycosyl diacylglycerolipids. Recently developed antibodies that are specific for the complex of the prototypical invariant NKT (iNKT) cell antigen alpha GalCer (KRN7000) bound to mouse CD1d have become valuable tools in elucidating the mechanism of antigen loading and presentation. Here, we report the 3.1 angstrom resolution crystal structure of the Fab of one of these antibodies, L363, bound to mCD1d complexed with the alpha GalCer analog C20:2, revealing that L363 is an iNKT TCR-like antibody that binds CD1d-presented alpha GalCer in a manner similar to the TCR. The structure reveals that L363 depends on both the L and H chains for binding to the glycolipid-mCD1d complex, although only the L chain is involved in contacts with the glycolipid antigen. The H chain of L363 features residue Trp-104, which mimics the TCR CDR3 alpha residue Leu-99, which is crucial for CD1d binding. We characterized the antigen-specificity of L363 toward several different glycolipids, demonstrating that whereas the TCR can induce structural changes in both antigen and CD1d to recognize disparate lipid antigens, the antibody L363 can only induce the F' roof formation in CD1d but fails to reorient the glycolipid headgroup necessary for binding. In summary, L363 is a powerful tool to study mechanism of iNKT cell activation for structural analogs of KRN7000, and our study can aid in the design of antibodies with altered antigen specificity.	[Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Thien-Thi Mac; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Yu, Karl O. A.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Van Calenbergh, Serge] Univ Ghent, Med Chem Lab, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Yeshiva University; Albert Einstein College of Medicine; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@liai.org	Van Calenbergh, Serge/A-3167-2008; Girardi, Enrico/L-4033-2014; Yu, Karl/ABC-4547-2020; Girardi, Enrico/AAD-2260-2020; Wang, Jing/L-5095-2013; Yu, Dawen/AAE-6444-2019	Van Calenbergh, Serge/0000-0002-4201-1264; Girardi, Enrico/0000-0003-3508-2723; Girardi, Enrico/0000-0003-3508-2723; Yu, Dawen/0000-0002-3970-3753	National Institutes of Health [AI074952, AI45889]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074952, R01AI045889, R56AI074952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI074952 (to D. M. Z.) and AI45889 (to S. A. P.). This work was also supported by an investigator award from the Cancer Research Institute (to D. M. Z.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Cohen CJ, 2003, J MOL RECOGNIT, V16, P324, DOI 10.1002/jmr.640; Dahan R, 2011, EUR J IMMUNOL, V41, P1465, DOI 10.1002/eji.201041241; Denkberg G, 2008, EUR J IMMUNOL, V38, P829, DOI 10.1002/eji.200737518; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii SI, 2006, P NATL ACAD SCI USA, V103, P11252, DOI 10.1073/pnas.0604812103; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Trappeniers M, 2008, J AM CHEM SOC, V130, P16468, DOI 10.1021/ja8064182; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	50	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1269	1278		10.1074/jbc.M111.308783	http://dx.doi.org/10.1074/jbc.M111.308783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110136	Green Published, hybrid			2022-12-25	WOS:000299170300043
J	Xia, F; Dohi, T; Martin, NM; Raskett, CM; Liu, Q; Altieri, DC				Xia, Fang; Dohi, Takehiko; Martin, Nina M.; Raskett, Christopher M.; Liu, Qin; Altieri, Dario C.			Essential Role of the Small GTPase Ran in Postnatal Pancreatic Islet Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PDX1; BETA-CELLS; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; BINDING PROTEINS; MITOTIC SPINDLE; EXPRESSION; MICE; APOPTOSIS; MAINTENANCE	The small GTPase Ran orchestrates pleiotropic cellular responses of nucleo-cytoplasmic shuttling, mitosis and subcellular trafficking, but whether deregulation of these pathways contributes to disease pathogenesis has remained elusive. Here, we generated transgenic mice expressing wild type (WT) Ran, loss-of-function Ran T24N mutant or constitutively active Ran G19V mutant in pancreatic islet beta cells under the control of the rat insulin promoter. Embryonic pancreas and islet development, including emergence of insulin(+) beta cells, was indistinguishable in control or transgenic mice. However, by one month after birth, transgenic mice expressing any of the three Ran variants exhibited overt diabetes, with hyperglycemia, reduced insulin production, and nearly complete loss of islet number and islet mass, in vivo. Deregulated Ran signaling in transgenic mice, adenoviral over-expression of WT or mutant Ran in isolated islets, or short hairpin RNA (shRNA) silencing of endogenous Ran in model insulinoma INS-1 cells, all resulted in decreased expression of the pancreatic and duodenal homeobox transcription factor, PDX-1, and reduced b cell proliferation, in vivo. These data demonstrate that a finely-tuned balance of Ran GTPase signaling is essential for postnatal pancreatic islet development and glucose homeostasis, in vivo.	[Xia, Fang; Dohi, Takehiko; Martin, Nina M.; Raskett, Christopher M.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA USA; [Xia, Fang; Raskett, Christopher M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Liu, Qin] Wistar Inst Anat & Biol, Ctr Computat & Syst Biol, Philadelphia, PA 19104 USA	The Wistar Institute; University of Massachusetts System; University of Massachusetts Worcester; The Wistar Institute	Xia, F (corresponding author), Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA USA.	daltieri@wistar.org		Martin, Nina/0000-0002-3361-7037	National Institutes of Health [CA78810, CA140043, CA118005, HL54131]; NATIONAL CANCER INSTITUTE [R01CA118005, R01CA078810, P01CA140043] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants CA78810, CA140043, CA118005 and HL54131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Dohi T, 2006, EMBO REP, V7, P438, DOI 10.1038/sj.embor.7400640; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; EFRAT S, 1990, MOL CELL BIOL, V10, P1779, DOI 10.1128/MCB.10.4.1779; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Giubettini M, 2011, J CELL SCI, V124, P113, DOI 10.1242/jcs.075457; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; Greiner TU, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-2; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hager JH, 1999, ANN NY ACAD SCI, V887, P150, DOI 10.1111/j.1749-6632.1999.tb07929.x; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kowluru A, 2002, BIOCHEM PHARMACOL, V63, P1027, DOI 10.1016/S0006-2952(02)00849-3; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Offield MF, 1996, DEVELOPMENT, V122, P983; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Papaconstantinou AD, 2006, INT J CANCER, V118, P17, DOI 10.1002/ijc.21247; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; SEGEV N, 2011, Dev Biol, V22, P33; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e27879	10.1371/journal.pone.0027879	http://dx.doi.org/10.1371/journal.pone.0027879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22114719	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555800044
J	Feng, Y; Chen, Z; Liu, SL				Feng, Ye; Chen, Zhe; Liu, Shu-Lin			Gene Decay in Shigella as an Incipient Stage of Host-Adaptation	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; MOLECULAR EVOLUTIONARY HISTORY; COMPLETE GENOME SEQUENCE; DYNAMICS; PATHOGENICITY; DIVERSITY; VIRULENCE; INSIGHTS; MODEL; INDEX	Background: Many facultative bacterial pathogens have undergone extensive gene decay processes, possibly due to lack of selection pressure during evolutionary conversion from free-living to intracellular lifestyle. Shigella, the causative agents of human shigellosis, have arisen from different E. coli-like ancestors independently by convergent paths. As these bacteria all have lost large numbers of genes by mutation or deletion, they can be used as ideal models for systematically studying the process of gene function loss in different bacteria living under similar selection pressures. Methodologies/Principal Findings: We compared the sequenced Shigella genomes and re-defined decayed genes (pseudogenes plus deleted genes) in these bacteria. Altogether, 85 genes are commonly decayed in the five analyzed Shigella strains and 1456 genes are decayed in at least one Shigella strain. Genes coding for carbon utilization, cell motility, transporter or membrane proteins are prone to be inactivated. Decayed genes tend to concentrate in certain operons rather than distribute averagely across the whole genome. Genes in the decayed operon accumulated more non-synonymous mutations than the rest genes and meanwhile have lower expression levels. Conclusions: Different Shigella lineages underwent convergent gene decay processes, and inactivation of one gene would lead to a lesser selection pressure for the other genes in the same operon. The pool of superfluous genes for Shigella may contain at least two thousand genes and the gene decay processes may still continue in Shigella until a minimum genome harboring only essential genes is reached.	[Feng, Ye; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China; [Chen, Zhe] Zhejiang Hosp Tradit Chinese Med, Natl Clin Res Base, Hangzhou, Peoples R China; [Liu, Shu-Lin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; Zhejiang Chinese Medical University; Peking University; University of Calgary	Feng, Y (corresponding author), Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China.	slliu@ucalgary.ca		RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	Harbin Medical University; National Natural Science Foundation of China [NSFC30870098, 30970119, 81030029]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20092307110001]	Harbin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by a grant from Harbin Medical University, grants of National Natural Science Foundation of China (NSFC30870098, 30970119, 81030029) and Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP, 20092307110001) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Hershberg R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r164; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Nie H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-173; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Ochman H, 2005, P NATL ACAD SCI USA, V102, P11959, DOI 10.1073/pnas.0505863102; Peng JP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-218; Peng JP, 2009, INFECT GENET EVOL, V9, P147, DOI 10.1016/j.meegid.2008.10.003; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Scully LR, 2006, CURR GENET, V50, P335, DOI 10.1007/s00294-006-0089-7; Serres MH, 2004, NUCLEIC ACIDS RES, V32, pD300, DOI 10.1093/nar/gkh087; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	32	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27754	10.1371/journal.pone.0027754	http://dx.doi.org/10.1371/journal.pone.0027754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110755	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400105
J	Murai, K; Philpott, A; Jones, PH				Murai, Kasumi; Philpott, Anna; Jones, Philip H.			Hes6 Is Required for the Neurogenic Activity of Neurogenin and NeuroD	PLOS ONE			English	Article							CRANIAL SENSORY GANGLIA; LOOP-HELIX FACTORS; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; MESODERM INDUCTION; XENOPUS-EMBRYOS; NERVOUS-SYSTEM; NOTCH ACTIVITY; EARLY RESPONSE; EXPRESSION	In the embryonic neural plate, a subset of precursor cells with neurogenic potential differentiates into neurons. This process of primary neurogenesis requires both the specification of cells for neural differentiation, regulated by Notch signaling, and the activity of neurogenic transcription factors such as neurogenin and NeuroD which drive the program of neural gene expression. Here we study the role of Hes6, a member of the hairy enhancer of split family of transcription factors, in primary neurogenesis in Xenopus embryos. Hes6 is an atypical Hes gene in that it is not regulated by Notch signaling and promotes neural differentiation in mouse cell culture models. We show that depletion of Xenopus Hes6 (Xhes6) by morpholino antisense oligonucleotides results in a failure of neural differentiation, a phenotype rescued by both wild type Xhes6 and a Xhes6 mutant unable to bind DNA. However, an Xhes6 mutant that lacks the ability to bind Groucho/TLE transcriptional co-regulators is only partly able to rescue the phenotype. Further analysis reveals that Xhes6 is essential for the induction of neurons by both neurogenin and NeuroD, acting via at least two distinct mechanisms, the inhibition of antineurogenic Xhairy proteins and by interaction with Groucho/TLE family proteins. We conclude Xhes6 is essential for neurogenesis in vivo, acting via multiple mechanisms to relieve inhibition of proneural transcription factor activity within the neural plate.	[Murai, Kasumi; Jones, Philip H.] Addenbrookes Hosp, Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 2QB, England; [Philpott, Anna] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Hutchison MRC Res Ctr, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Murai, K (corresponding author), Addenbrookes Hosp, Hutchison MRC Res Ctr, MRC Canc Cell Unit, Hills Rd, Cambridge CB2 2QB, England.	phj20@hutchison-mrc.cam.ac.uk	Jones, Philip/D-2464-2009	Jones, Philip/0000-0002-5904-795X; Philpott, Anna/0000-0003-3789-2463	United Kingdom Medical Research [G0700758]; MRC [MC_U105370181, G0700758] Funding Source: UKRI; Medical Research Council [G0700758, MC_U105370181] Funding Source: researchfish	United Kingdom Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a United Kingdom Medical Research Grant-in-aid and Grant no. G0700758. (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Bae SK, 2000, DEVELOPMENT, V127, P2933; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Cossins J, 2002, DEVELOPMENT, V129, P2195; Cui YZ, 2005, DEV GROWTH DIFFER, V47, P609; Davis RL, 2001, DEV CELL, V1, P553, DOI 10.1016/S1534-5807(01)00054-5; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; HARTENSTEIN V, 1989, NEURON, V3, P399, DOI 10.1016/0896-6273(89)90200-6; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Molenaar M, 2000, MECH DEVELOP, V91, P311, DOI 10.1016/S0925-4773(99)00259-2; Mural K, 2007, DEV BIOL, V312, P61, DOI 10.1016/j.ydbio.2007.09.011; Nieber F, 2009, DEV DYNAM, V238, P451, DOI 10.1002/dvdy.21845; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Perez SE, 1999, DEVELOPMENT, V126, P1715; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Vilas-Boas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015459; Vosper JMD, 2007, BIOCHEM J, V407, P277, DOI 10.1042/BJ20070064	39	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27880	10.1371/journal.pone.0027880	http://dx.doi.org/10.1371/journal.pone.0027880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22114720	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555400134
J	Vikebo, FB; Adlandsvik, B; Albretsen, J; Sundby, S; Stenevik, EK; Huse, G; Svendsen, E; Kristiansen, T; Eriksen, E				Vikebo, Frode B.; Adlandsvik, Bjorn; Albretsen, Jon; Sundby, Svein; Stenevik, Erling Kare; Huse, Geir; Svendsen, Einar; Kristiansen, Trond; Eriksen, Elena			Real-Time Ichthyoplankton Drift in Northeast Arctic Cod and Norwegian Spring-Spawning Herring	PLOS ONE			English	Article							BARENTS SEA; LARVAE; CLIMATE; GROWTH; RECRUITMENT; POPULATIONS; DISPERSAL; PREDATION; ABUNDANCE; ECOSYSTEM	Background: Individual-based biophysical larval models, initialized and parameterized by observations, enable numerical investigations of various factors regulating survival of young fish until they recruit into the adult population. Exponentially decreasing numbers in Northeast Arctic cod and Norwegian Spring Spawning herring early changes emphasizes the importance of early life history, when Ichthyoplankton exhibit pelagic free drift. However, while most studies are concerned with past recruitment variability it is also important to establish real-time predictions of Ichthyoplankton distributions due to the increasing human activity in fish habitats and the need for distribution predictions that could potentially improve field coverage of Ichthyoplankton. Methodology/Principal Findings: A system has been developed for operational simulation of Ichthyoplankton distributions. We have coupled a two-day ocean forecasts from the Norwegian Meteorological Institute with an individual-based ichthyoplankton model for Northeast Arctic cod and Norwegian Spring Spawning herring producing daily updated maps of ichthyoplankton distributions. Recent years observed spawning distribution and intensity have been used as input to the model system. The system has been running in an operational mode since 2008. Surveys are expensive and distributions of early stages are therefore only covered once or twice a year. Comparison between model and observations are therefore limited in time. However, the observed and simulated distributions of juvenile fish tend to agree well during early fall. Area-overlap between modeled and observed juveniles September 1(st) range from 61 to 73%, and 61 to 71% when weighted by concentrations. Conclusions/Significance: The model system may be used to evaluate the design of ongoing surveys, to quantify the overlap with harmful substances in the ocean after accidental spills, as well as management planning of particular risky operations at sea. The modeled distributions are already utilized during research surveys to estimate coverage success of sampled biota and immediately after spills from ships at sea.	[Vikebo, Frode B.; Adlandsvik, Bjorn; Albretsen, Jon; Sundby, Svein; Stenevik, Erling Kare; Huse, Geir; Svendsen, Einar; Kristiansen, Trond; Eriksen, Elena] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway	Vikebo, FB (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	frovik@imr.no	Ådlandsvik, Bjørn/AAD-6421-2019; Albretsen, Jon/AAM-9001-2020; Huse, Geir/AAY-2341-2021	Albretsen, Jon/0000-0001-5863-2439; Sundby, Svein/0000-0002-0815-9740; Kristiansen, Trond/0000-0001-6121-297X				ADLANDSVIK B, 1994, ICES MAR SC, V198, P379; Albretsen J, 2010, OCEAN DYNAM, V60, P933, DOI 10.1007/s10236-010-0296-0; [Anonymous], 1980, ANN BIOL CONSEIL INT, V37, P259; Blumberg A.F., 1987, 3 DIMENSIONAL COASTA, P1, DOI [10.1029/co004p0001, DOI 10.1029/CO004P0001]; BOITSOV VD, 1996, BARENTS SEA COD BIOL; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dingsor GE, 2005, FISH RES, V72, P205, DOI 10.1016/j.fishres.2004.11.001; Ellertsen B., 1984, Flodevigen Rapportserie, V1, P453; Engedahl H, 1998, J MARINE SYST, V14, P1, DOI 10.1016/S0924-7963(98)00004-9; ENGEDAHL H, 5 NORW MET I; Eriksen Elena, 2009, Open Fish Science Journal, V2, P6; FERREIRA A, MARINE BIOL IN PRESS; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; Garrison LP, 2000, MAR ECOL PROG SER, V204, P243, DOI 10.3354/meps204243; GODO OR, 1993, ICES MAR SC, V196, P196; HACKETT B, 1994, TELLUS A, V46, P113, DOI 10.1034/j.1600-0870.1994.t01-1-00003.x; Hansen C, 2009, J MARINE SYST, V75, P236, DOI 10.1016/j.jmarsys.2008.10.004; Hjort J., 1914, RAPPORTS PROCES VERB, V19, P1; Hylen A., 1995, PRECISION RELEVANCE, P146; *ICES, 2011, ACOM, V15, P624; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Kristiansen T, 2009, BEHAV ECOL, V20, P490, DOI 10.1093/beheco/arp023; LACASCE JH, 52007 NORW MET I; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; MAKHOTIN V, 2001, TYPES FREQUENCY MALF; Myksvoll MS, 2011, MAR COAST FISH, V3, P279, DOI 10.1080/19425120.2011.595258; North EW, 2009, 295 ICES, P111; Opdal AF, 2011, MAR ECOL PROG SER, V439, P255, DOI 10.3354/meps09335; Pepin P, 2012, FISH RES, V117, P137, DOI 10.1016/j.fishres.2011.07.004; ROED LP, 42004 NORW MET I; Slotte A, 2001, HERRING EXPECTATIONS, P255; Stenevik EK, 1996, SARSIA, V80, P285, DOI 10.1080/00364827.1996.10413602; STENEVIK EK, J MARINE SY IN PRESS; Sundby S, 1997, SCI MAR, V61, P159; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Svendsen E, 2007, DEEP-SEA RES PT II, V54, P2810, DOI 10.1016/j.dsr2.2007.07.033; Thygesen UH, 2007, MAR ECOL PROG SER, V347, P145, DOI 10.3354/meps06975; VIKEBO F, 2007, ECOLOGY, V347, P207; Vikebo FB, 2010, ICES J MAR SCI, V67, P1948, DOI 10.1093/icesjms/fsq084; Westgard T., 2010, GIS SPATIAL ANAL FIS, V4, P417	43	24	24	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27367	10.1371/journal.pone.0027367	http://dx.doi.org/10.1371/journal.pone.0027367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110633	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400039
J	Sparks, FT; Lehmann, H; Hernandez, K; Sutherland, RJ				Sparks, Fraser T.; Lehmann, Hugo; Hernandez, Khadaryna; Sutherland, Robert J.			Suppression of Neurotoxic Lesion-Induced Seizure Activity: Evidence for a Permanent Role for the Hippocampus in Contextual Memory	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; REMOTE SPATIAL MEMORY; GRADED RETROGRADE-AMNESIA; LONG-TERM-MEMORY; DORSAL HIPPOCAMPUS; RATS; FEAR; CONSOLIDATION; ANTEROGRADE; CORTEX	Damage to the hippocampus (HPC) using the excitotoxin N-methyl-D-aspartate (NMDA) can cause retrograde amnesia for contextual fear memory. This amnesia is typically attributed to loss of cells in the HPC. However, NMDA is also known to cause intense neuronal discharge (seizure activity) during the hours that follow its injection. These seizures may have detrimental effects on retrieval of memories. Here we evaluate the possibility that retrograde amnesia is due to NMDA-induced seizure activity or cell damage per se. To assess the effects of NMDA induced activity on contextual memory, we developed a lesion technique that utilizes the neurotoxic effects of NMDA while at the same time suppressing possible associated seizure activity. NMDA and tetrodotoxin (TTX), a sodium channel blocker, are simultaneously infused into the rat HPC, resulting in extensive bilateral damage to the HPC. TTX, co-infused with NMDA, suppresses propagation of seizure activity. Rats received pairings of a novel context with foot shock, after which they received NMDA-induced, TTX+NMDA-induced, or no damage to the HPC at a recent (24 hours) or remote (5 weeks) time point. After recovery, the rats were placed into the shock context and freezing was scored as an index of fear memory. Rats with an intact HPC exhibited robust memory for the aversive context at both time points, whereas rats that received NMDA or NMDA+TTX lesions showed a significant reduction in learned fear of equal magnitude at both the recent and remote time points. Therefore, it is unlikely that observed retrograde amnesia in contextual fear conditioning are due to disruption of non-HPC networks by propagated seizure activity. Moreover, the memory deficit observed at both time points offers additional evidence supporting the proposition that the HPC has a continuing role in maintaining contextual memories.	[Sparks, Fraser T.; Hernandez, Khadaryna; Sutherland, Robert J.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Lehmann, Hugo] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada	University of Lethbridge; Trent University	Sparks, FT (corresponding author), Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	robert.sutherland@uleth.ca	Lehmann, Hugo/J-8304-2012	Sparks, Fraser/0000-0002-4716-5246	NIMH [MH61460]; Alberta Heritage Foundation for Medical Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061460] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding sources supporting this work: -NIMH Grant MH61460 -Alberta Heritage Foundation for Medical Research The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasser MM, 2007, EUR J NEUROSCI, V26, P1254, DOI 10.1111/j.1460-9568.2007.05753.x; Anagnostaras SG, 2002, HIPPOCAMPUS, V12, P561, DOI 10.1002/hipo.10071; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; BARAN H, 1985, EUR J PHARMACOL, V113, P263, DOI 10.1016/0014-2999(85)90744-7; BERDICHEVSKY E, 1983, NEUROSCI LETT, V36, P75, DOI 10.1016/0304-3940(83)90489-5; BOLHUIS JJ, 1994, Q J EXP PSYCHOL-B, V47, P129; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn127; Butler CR, 2007, ANN NEUROL, V61, P587, DOI 10.1002/ana.21111; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Epp J, 2008, LEARN MEMORY, V15, P214, DOI 10.1101/lm.788008; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gaskin S, 2003, HIPPOCAMPUS, V13, P962, DOI 10.1002/hipo.10154; Genkova-Papazova MG, 2001, EUR NEUROPSYCHOPHARM, V11, P91, DOI 10.1016/S0924-977X(00)00120-6; GENKOVAPAPAZOVA MG, 1995, EUR NEUROPSYCHOPHARM, V5, P53, DOI 10.1016/0924-977X(94)00134-W; GRIFFITHS T, 1983, TEMPORAL LOBE EPILEP, P331; Hornberger M, 2010, J CLIN NEUROSCI, V17, P1319, DOI 10.1016/j.jocn.2010.03.005; JARRARD L, 1993, NEUROBIOLOGY APPL NE, V19; KESNER RP, 1968, EXP NEUROL, V21, P58, DOI 10.1016/0014-4886(68)90034-4; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lehmann H, 2006, HIPPOCAMPUS, V16, P379, DOI 10.1002/hipo.20159; Lehmann H, 2010, NEUROSCIENCE, V167, P974, DOI 10.1016/j.neuroscience.2010.03.005; Lehmann H., 2011, CURRENT OPINION NEUR, V21, P1; LEHMANN H, 2009, NEUR M PLANN ONL; LEHMANN H, 2007, NEUROSCIENCE, V25, P1278; Lehmann H, 2007, EXP BRAIN RES, V180, P755, DOI 10.1007/s00221-007-0895-2; Lehmann H, 2009, LEARN MEMORY, V16, P417, DOI 10.1101/lm.1385409; Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Meeter M, 2004, PSYCHOL BULL, V130, P843, DOI 10.1037/0033-2909.130.6.843; Milton F, 2010, BRAIN, V133, P1368, DOI 10.1093/brain/awq055; Mumby DG, 1999, BEHAV BRAIN RES, V106, P97, DOI 10.1016/S0166-4328(99)00097-2; Olney J.W., 1978, KAINIC ACID TOOL NEU, P95; Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; RETZ KC, 1984, NEUROPHARMACOLOGY, V23, P89, DOI 10.1016/0028-3908(84)90222-3; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; SIDEROFF S, 1975, PHYSIOL BEHAV, V18, P577; SPARKS F, 2009, EUR M PLANN ONL; SPERK G, 1985, BRAIN RES, V338, P289, DOI 10.1016/0006-8993(85)90159-3; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SUTHERLAND R, 2010, NEUROPSYCHO IN PRESS; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Sutherland RJ, 2006, CAN J EXP PSYCHOL, V60, P166, DOI 10.1037/cjep20060016; Takehara K, 2003, J NEUROSCI, V23, P9897; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Winocur G, 2001, HIPPOCAMPUS, V11, P18, DOI 10.1002/1098-1063(2001)11:1<18::AID-HIPO1016>3.0.CO;2-5; Winocur G, 2009, LEARN MEMORY, V16, P722, DOI 10.1101/lm.1447209; ZACZEK R, 1982, NEUROPHARMACOLOGY, V21, P15, DOI 10.1016/0028-3908(82)90205-2	59	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2011	6	11							e27426	10.1371/journal.pone.0027426	http://dx.doi.org/10.1371/journal.pone.0027426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HK	22110648	gold, Green Submitted, Green Published			2022-12-25	WOS:000297554300031
J	Sanguinetti-Scheck, JI; Pedraja, EF; Cilleruelo, E; Migliaro, A; Aguilera, P; Caputi, AA; Budelli, R				Ignacio Sanguinetti-Scheck, Juan; Federico Pedraja, Eduardo; Cilleruelo, Esteban; Migliaro, Adriana; Aguilera, Pedro; Ariel Caputi, Angel; Budelli, Ruben			Fish Geometry and Electric Organ Discharge Determine Functional Organization of the Electrosensory Epithelium	PLOS ONE			English	Article							GYMNOTUS-CARAPO; GNATHONEMUS-PETERSII; WAVE-FORM; APTERONOTUS-LEPTORHYNCHUS; ACTIVE ELECTROLOCATION; OBJECTS; IMAGE; ELECTRORECEPTION; DISTANCE; PERCEPTION	Active electroreception in Gymnotus omarorum is a sensory modality that perceives the changes that nearby objects cause in a self generated electric field. The field is emitted as repetitive stereotyped pulses that stimulate skin electroreceptors. Differently from mormyriformes electric fish, gymnotiformes have an electric organ distributed along a large portion of the body, which fires sequentially. As a consequence shape and amplitude of both, the electric field generated and the image of objects, change during the electric pulse. To study how G. omarorum constructs a perceptual representation, we developed a computational model that allows the determination of the self-generated field and the electric image. We verify and use the model as a tool to explore image formation in diverse experimental circumstances. We show how the electric images of objects change in shape as a function of time and position, relative to the fish's body. We propose a theoretical framework about the organization of the different perceptive tasks made by electroreception: 1) At the head region, where the electrosensory mosaic presents an electric fovea, the field polarizing nearby objects is coherent and collimated. This favors the high resolution sampling of images of small objects and perception of electric color. Besides, the high sensitivity of the fovea allows the detection and tracking of large faraway objects in rostral regions. 2) In the trunk and tail region a multiplicity of sources illuminate different regions of the object, allowing the characterization of the shape and position of a large object. In this region, electroreceptors are of a unique type and capacitive detection should be based in the pattern of the afferents response. 3) Far from the fish, active electroreception is not possible but the collimated field is suitable to be used for electrocommunication and detection of large objects at the sides and caudally.	[Ignacio Sanguinetti-Scheck, Juan; Federico Pedraja, Eduardo; Migliaro, Adriana; Budelli, Ruben] Univ Republica, Dept Biol Celular & Mol, Fac Ciencias, Montevideo, Uruguay; [Cilleruelo, Esteban; Aguilera, Pedro; Ariel Caputi, Angel] Inst Invest Biol Clemente Estable, Dept Neurociencias Integrat, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Sanguinetti-Scheck, JI (corresponding author), Univ Republica, Dept Biol Celular & Mol, Fac Ciencias, Montevideo, Uruguay.	rbudelli@gmail.com	Pedraja, Federico/GMX-0979-2022	Sanguinetti-Scheck, Juan Ignacio/0000-0002-2511-208X	European Union; CSIC (Universidad de la Republica Oriental del Uruguay); Dinacyt (Uruguay)	European Union(European Commission); CSIC (Universidad de la Republica Oriental del Uruguay); Dinacyt (Uruguay)	We received grants from the 7th Frame Program of the European Union (to Ruben Budelli and Angel Caputi) as a part of ANGELS project (http://www.theangelsproject.eu), CSIC (Universidad de la Republica Oriental del Uruguay, to Ruben Budelli) and the Dinacyt (Uruguay, to Ruben Budelli). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; ASSAD C, 1997, ELECT FIELD MAPS BOU; Babineau D, 2007, PLOS COMPUT BIOL, V3, P402, DOI 10.1371/journal.pcbi.0030038; Babineau D, 2006, J EXP BIOL, V209, P3636, DOI 10.1242/jeb.02403; Budelli R, 2000, J EXP BIOL, V203, P481; Budelli R, 2002, J PHYSIOLOGY-PARIS, V96, P421, DOI 10.1016/S0928-4257(03)00020-2; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; CAPUTI A, 1993, J COMP PHYSIOL A, V173, P227; CAPUTI A, 1994, BRAIN BEHAV EVOLUT, V44, P166, DOI 10.1159/000113588; Caputi AA, 2006, J COMP PHYSIOL A, V192, P587, DOI 10.1007/s00359-006-0100-2; Caputi AA, 1998, J EXP BIOL, V201, P2115; Caputi AA, 2008, J PHYSIOL-PARIS, V102, P256, DOI 10.1016/j.jphysparis.2008.10.005; Castello ME, 2000, J EXP BIOL, V203, P3279; Einthoven W, 1912, LANCET, V1, P853; HEILIGENBERG W, 1973, J COMP PHYSL, V87; Hopkins CD, 1995, CURR OPIN NEUROBIOL, V5, P769, DOI 10.1016/0959-4388(95)80105-7; LISSMANN HW, 1958, J EXP BIOL, V35, P457; Migliaro A, 2005, PLOS COMPUT BIOL, V1, P123, DOI 10.1371/journal.pcbi.0010016; PEREIRA AC, INTERDISCIP SCI, V2, P291; Rasnow B, 1996, J COMP PHYSIOL A, V178, P383; RASNOW B, 1993, J COMP PHYSIOL A, V172, P481, DOI 10.1007/BF00213530; Rasnow B, 1996, J COMP PHYSIOL A, V178, P397; Rodriguez-Cattaneo A, 2009, J EXP BIOL, V212, P3478, DOI 10.1242/jeb.033217; Rother D, 2003, BIOSYSTEMS, V71, P169, DOI 10.1016/S0303-2647(03)00124-2; von der Emde G, 2004, J PHYSIOLOGY-PARIS, V98, P67, DOI 10.1016/j.jphysparis.2004.03.013; von der Emde G, 2002, J PHYSIOLOGY-PARIS, V96, P431, DOI 10.1016/S0928-4257(03)00021-4; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; von der Emde G, 2007, J EXP BIOL, V210, P3082, DOI 10.1242/jeb.005694; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576; WATSON D, 1979, J COMP PHYSIOL, V134, P191, DOI 10.1007/BF00610394	30	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27470	10.1371/journal.pone.0027470	http://dx.doi.org/10.1371/journal.pone.0027470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096578	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900048
J	Le Marechal, C; Seyffert, N; Jardin, J; Hernandez, D; Jan, G; Rault, L; Azevedo, V; Francois, P; Schrenzel, J; van de Guchte, M; Even, S; Berkova, N; Thiery, R; Fitzgerald, JR; Vautor, E; Le Loir, Y				Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Hernandez, David; Jan, Gwenael; Rault, Lucie; Azevedo, Vasco; Francois, Patrice; Schrenzel, Jacques; van de Guchte, Maarten; Even, Sergine; Berkova, Nadia; Thiery, Richard; Fitzgerald, J. Ross; Vautor, Eric; Le Loir, Yves			Molecular Basis of Virulence in Staphylococcus aureus Mastitis	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; HORIZONTAL GENE-TRANSFER; ANTIBODY-RESPONSE; STAPHOPAIN-B; ALPHA-TOXINS; BETA-TOXINS; METHICILLIN; IDENTIFICATION; EXPRESSION; COMMUNITY	Background: S. aureus is one of the main pathogens involved in ruminant mastitis worldwide. The severity of staphylococcal infection is highly variable, ranging from subclinical to gangrenous mastitis. This work represents an in-depth characterization of S. aureus mastitis isolates to identify bacterial factors involved in severity of mastitis infection. Methodology/Principal Findings: We employed genomic, transcriptomic and proteomic approaches to comprehensively compare two clonally related S. aureus strains that reproducibly induce severe (strain O11) and milder (strain O46) mastitis in ewes. Variation in the content of mobile genetic elements, iron acquisition and metabolism, transcriptional regulation and exoprotein production was observed. In particular, O11 produced relatively high levels of exoproteins, including toxins and proteases known to be important in virulence. A characteristic we observed in other S. aureus strains isolated from clinical mastitis cases. Conclusions/Significance: Our data are consistent with a dose-dependant role of some staphylococcal factors in the hypervirulence of strains isolated from severemastitis. Mobile genetic elements, transcriptional regulators, exoproteins and iron acquisition pathways constitute good targets for further research to define the underlying mechanisms of mastitis severity.	[Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Jan, Gwenael; Rault, Lucie; Even, Sergine; Berkova, Nadia; Le Loir, Yves] INRA, UMR1253, F-35042 Rennes, France; [Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Jan, Gwenael; Rault, Lucie; Even, Sergine; Berkova, Nadia; Le Loir, Yves] I CEuf, Rennes, France; [Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Jan, Gwenael; Rault, Lucie; Even, Sergine; Berkova, Nadia; Le Loir, Yves] AGROCAMPUS OUEST, UMR1253, Rennes, France; [Le Marechal, Caroline; Thiery, Richard; Vautor, Eric] ANSES, Lab Sophia Antipolis, Unite Pathol Ruminants, Sophia Antipolis, France; [Seyffert, Nubia; Azevedo, Vasco] Univ Fed Minas Gerais UFMG, Inst Ciencias Biol ICB, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Hernandez, David; Francois, Patrice; Schrenzel, Jacques] Univ Geneva Hosp HUG, Genom Res Lab, Infect Dis Serv, Geneva, Switzerland; [van de Guchte, Maarten] INRA, MICALIS, UMR1319, Jouy En Josas, France; [Fitzgerald, J. Ross] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Fitzgerald, J. Ross] Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland	INRAE; Institut Agro; Agrocampus Ouest; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sophia-Antipolis; Universidade Federal de Minas Gerais; University of Geneva; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Le Marechal, C (corresponding author), INRA, UMR1253, F-35042 Rennes, France.	Yves.LeLoir@rennes.inra.fr	Schrenzel, Jacques/P-8525-2017; Jan, Gwenael/K-6767-2014; LE LOIR, Yves/AAD-1879-2021; Schrenzel, Jacques/AAC-5685-2021; Seyffert, Nubia/N-6410-2014; JARDIN, Julien/A-3241-2012; Azevedo, Vasco A.C/F-4315-2011; francois, patrice/AAL-5583-2020; Azevedo, Vasco/B-1556-2019; Thiery, Richard/GRR-1496-2022	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Seyffert, Nubia/0000-0002-2193-6508; JARDIN, Julien/0000-0003-0520-9391; Azevedo, Vasco A.C/0000-0002-4775-2280; Azevedo, Vasco/0000-0002-4775-2280; francois, patrice/0000-0002-0540-750X; Le Loir, Yves/0000-0002-0355-1065; Berkova, Nadia/0000-0001-6246-5549; Thiery, Richard/0000-0003-2049-918X	Biotechnology and Biological Sciences Research Council [BB/D521222/1] Funding Source: Medline; BBSRC [BB/D521222/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ADLAM C, 1977, INFECT IMMUN, V17, P250, DOI 10.1128/IAI.17.2.250-256.1977; Attia AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000802; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diarra MS, 2002, J DAIRY SCI, V85, P2141, DOI 10.3168/jds.S0022-0302(02)74292-6; Dorrell N, 2005, CURR OPIN MICROBIOL, V8, P620, DOI 10.1016/j.mib.2005.08.012; Dumas E, 2008, APPL ENVIRON MICROB, V74, P7399, DOI 10.1128/AEM.00594-08; Duquenne M, 2010, APPL ENVIRON MICROB, V76, P1367, DOI 10.1128/AEM.01736-09; Even S, 2010, INT J FOOD MICROBIOL, V139, P87, DOI 10.1016/j.ijfoodmicro.2010.02.019; Even S, 2009, APPL ENVIRON MICROB, V75, P4459, DOI 10.1128/AEM.02388-08; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Goji N, 2004, VET MICROBIOL, V99, P269, DOI 10.1016/j.vetmic.2003.12.009; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Grumann D, 2008, J IMMUNOL, V181, P5054, DOI 10.4049/jimmunol.181.7.5054; Guinane CM, 2008, J INFECT DIS, V197, P205, DOI 10.1086/524689; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Halasa T, 2009, LIVEST SCI, V124, P295, DOI 10.1016/j.livsci.2009.02.019; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; JETT M, 1990, INFECT IMMUN, V58, P3494, DOI 10.1128/IAI.58.11.3494-3499.1990; JONES TO, 1986, VET REC, V119, P435, DOI 10.1136/vr.119.17.435; JONSSON P, 1985, INFECT IMMUN, V49, P765, DOI 10.1128/IAI.49.3.765-769.1985; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le Marechal C, 2009, J MICROBIOL METH, V79, P131, DOI 10.1016/j.mimet.2009.08.017; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Le Marechal C, 2011, J BACTERIOL, V193, P2353, DOI 10.1128/JB.00045-11; Le Marechal C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-35; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; LELOIR Y, 1994, J BACTERIOL, V176, P5135, DOI 10.1128/jb.176.16.5135-5139.1994; Lorenz U, 2000, FEMS IMMUNOL MED MIC, V29, P145, DOI 10.1111/j.1574-695X.2000.tb01517.x; MATSUNAGA T, 1993, J VET MED SCI, V55, P297, DOI 10.1292/jvms.55.297; Nickerson NN, 2007, J BIOL CHEM, V282, P34129, DOI 10.1074/jbc.M705672200; Nimmo GR, 2006, MED J AUSTRALIA, V184, P384, DOI 10.5694/j.1326-5377.2006.tb00287.x; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Oscarsson J, 2006, INT J MED MICROBIOL, V296, P365, DOI 10.1016/j.ijmm.2006.02.019; Park SA, 2006, PROTEOMICS, V6, P1319, DOI 10.1002/pmic.200500293; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Rainard P, 2007, VET RES, V38, P685, DOI 10.1051/vetres:2007026; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Shevchenko Anna, 2003, Methods Mol Biol, V211, P221; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smagur J, 2009, J INNATE IMMUN, V1, P98, DOI 10.1159/000181014; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Stenz L, 2008, FEMS MICROBIOL LETT, V287, P149, DOI 10.1111/j.1574-6968.2008.01316.x; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; Trivier D, 1996, FEMS MICROBIOL LETT, V141, P117, DOI 10.1111/j.1574-6968.1996.tb08373.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vautor E, 2003, VET MICROBIOL, V96, P69, DOI 10.1016/S0378-1135(03)00207-4; Vautor E, 2009, VET MICROBIOL, V133, P105, DOI 10.1016/j.vetmic.2008.06.006; Vautor E, 2009, VET RES, V40, DOI 10.1051/vetres/2009039; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; WARD PD, 1979, J COMP PATHOL, V89, P169, DOI 10.1016/0021-9975(79)90056-2; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313; Zollner TM, 2000, CLIN EXP ALLERGY, V30, P994	72	55	56	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27354	10.1371/journal.pone.0027354	http://dx.doi.org/10.1371/journal.pone.0027354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096559	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900035
J	Xiong, H; Capurso, D; Sen, S; Segal, MR				Xiong, Hao; Capurso, Daniel; Sen, Saunak; Segal, Mark R.			Sequence-Based Classification Using Discriminatory Motif Feature Selection	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; REGULATORY SITES; PROTEIN; IDENTIFICATION; TRANSCRIPTION; DISCOVERY; DNA; DICTIONARY; PREDICTION; CHROMATIN	Most existing methods for sequence-based classification use exhaustive feature generation, employing, for example, all k-mer patterns. The motivation behind such (enumerative) approaches is to minimize the potential for overlooking important features. However, there are shortcomings to this strategy. First, practical constraints limit the scope of exhaustive feature generation to patterns of length <= k, such that potentially important, longer (>k) predictors are not considered. Second, features so generated exhibit strong dependencies, which can complicate understanding of derived classification rules. Third, and most importantly, numerous irrelevant features are created. These concerns can compromise prediction and interpretation. While remedies have been proposed, they tend to be problem-specific and not broadly applicable. Here, we develop a generally applicable methodology, and an attendant software pipeline, that is predicated on discriminatory motif finding. In addition to the traditional training and validation partitions, our framework entails a third level of data partitioning, a discovery partition. A discriminatory motif finder is used on sequences and associated class labels in the discovery partition to yield a (small) set of features. These features are then used as inputs to a classifier in the training partition. Finally, performance assessment occurs on the validation partition. Important attributes of our approach are its modularity (any discriminatory motif finder and any classifier can be deployed) and its universality (all data, including sequences that are unaligned and/or of unequal length, can be accommodated). We illustrate our approach on two nucleosome occupancy datasets and a protein solubility dataset, previously analyzed using enumerative feature generation. Our method achieves excellent performance results, with and without optimization of classifier tuning parameters. A Python pipeline implementing the approach is available at http://www.epibiostat.ucsf.edu/biostat/sen/dmfs/.	[Xiong, Hao; Sen, Saunak; Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Capurso, Daniel] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Xiong, H (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	hao@biostat.ucsf.edu			National Institutes of Health [GM078338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078338, T32GM007175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the National Institutes of Health (GM078338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1007/BF00993379; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Fan R., 2005, J MACHINE LEARNING R, V6, P1918; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta M, 2003, J AM STAT ASSOC, V98, P55, DOI 10.1198/016214503388619094; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Idicula-Thomas S, 2005, PROTEIN ENG DES SEL, V18, P175, DOI 10.1093/protein/gzi022; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-140; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; Kornberg RD, 2002, CURR OPIN GENET DEV, V12, P249, DOI 10.1016/S0959-437X(02)00293-9; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Leslie C, 2004, J MACH LEARN RES, V5, P1435; Leslie C., 2003, ADV NEURAL INFORM PR, P1441; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Lin TH, 2011, IEEE ACM T COMPUT BI, V8, P441, DOI 10.1109/TCBB.2009.82; Ma PCH, 2010, J COMPUT BIOL, V17, P733, DOI 10.1089/cmb.2008.0213; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Rao A, 2007, EURASIP J BIOINFORMA, V3, P13; Ratsch G, 2005, BIOINFORMATICS, V21, pI369, DOI 10.1093/bioinformatics/bti1053; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schultheiss SJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S13-O1; Segal E, 2002, P 6 ANN INT C COMP B; Segal Mark R, 2008, Stat Appl Genet Mol Biol, V7, pArticle14, DOI 10.2202/1544-6115.1367; Shamim MTA, 2007, BIOINFORMATICS, V23, P3320, DOI 10.1093/bioinformatics/btm527; Shawe-Taylor J., 2000, INTRO SUPPORT VECTOR; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Sleator RD, 2010, ARCH MICROBIOL, V192, P151, DOI 10.1007/s00203-010-0549-9; Sonnenburg S, 2005, LECT NOTES COMPUT SC, V3500, P389; Sonnenburg S., 2007, LARGE SCALE KERNEL M, P73; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Teramoto R, 2005, FEBS LETT, V579, P2878, DOI 10.1016/j.febslet.2005.04.045; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vens C, 2011, BIOINFORMATICS, V27, P1231, DOI 10.1093/bioinformatics/btr110; Wang GD, 2005, NUCLEIC ACIDS RES, V33, pW412, DOI 10.1093/nar/gki492; Wang GD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r49; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27382	10.1371/journal.pone.0027382	http://dx.doi.org/10.1371/journal.pone.0027382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102890	Green Published, Green Submitted, gold			2022-12-25	WOS:000297348800023
J	Bremmer, SC; Hall, H; Martinez, JS; Eissler, CL; Hinrichsen, TH; Rossie, S; Parker, LL; Hall, MC; Charbonneau, H				Bremmer, Steven C.; Hall, Hana; Martinez, Juan S.; Eissler, Christie L.; Hinrichsen, Thomas H.; Rossie, Sandra; Parker, Laurie L.; Hall, Mark C.; Charbonneau, Harry			Cdc14 Phosphatases Preferentially Dephosphorylate a Subset of Cyclin-dependent kinase (Cdk) Sites Containing Phosphoserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; MITOTIC EXIT; BUDDING YEAST; MITOSIS; PHOSPHORYLATION; TIME; CYTOKINESIS; SEGREGATION; NUCLEOLUS; ACTIVATOR	Mitotic cell division is controlled by cyclin-dependent kinases (Cdks), which phosphorylate hundreds of protein substrates responsible for executing the division program. Cdk inactivation and reversal of Cdk-catalyzed phosphorylation are universal requirements for completing and exiting mitosis and resetting the cell cycle machinery. Mechanisms that define the timing and order of Cdk substrate dephosphorylation remain poorly understood. Cdc14 phosphatases have been implicated in Cdk inactivation and are thought to be generally specific for Cdk-type phosphorylation sites. We show that budding yeast Cdc14 possesses a strong and unusual preference for phosphoserine over phosphothreonine at Pro-directed sites in vitro. Using serine to threonine substitutions in the Cdk consensus sites of the Cdc14 substrate Acm1, we demonstrate that phosphoserine specificity exists in vivo. Furthermore, it appears to be a conserved property of all Cdc14 family phosphatases. An invariant active site residue was identified that sterically restricts phosphothreonine binding and is largely responsible for phosphoserine selectivity. Optimal Cdc14 substrates also possessed a basic residue at the +3 position relative to the phosphoserine, whereas substrates lacking this basic residue were not effectively hydrolyzed. The intrinsic selectivity of Cdc14 may help establish the order of Cdk substrate dephosphorylation during mitotic exit and contribute to roles in other cellular processes.	[Bremmer, Steven C.; Hall, Hana; Martinez, Juan S.; Eissler, Christie L.; Hinrichsen, Thomas H.; Rossie, Sandra; Hall, Mark C.; Charbonneau, Harry] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Parker, Laurie L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Bremmer, Steven C.; Hall, Hana; Martinez, Juan S.; Eissler, Christie L.; Hinrichsen, Thomas H.; Rossie, Sandra; Parker, Laurie L.; Hall, Mark C.; Charbonneau, Harry] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	mchall@purdue.edu; charb@purdue.edu	Parker, Laurie L/C-1510-2010; Hall, Mark C./D-1698-2011	Parker, Laurie L/0000-0002-6234-3346; Hall, Mark/0000-0001-6429-2506; Hall, Hana/0000-0002-7544-4437	National Science Foundation [MCB 0841748]; National Institutes of Health [CA59935]; Purdue University Center for Cancer Research; Purdue Research Foundation; NATIONAL CANCER INSTITUTE [R29CA059935, R01CA059935] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research; Purdue Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Science Foundation Grant MCB 0841748 (to M. C. H.), National Institutes of Health Grant CA59935 (to H. C.), funds from the Purdue University Center for Cancer Research Small Grants Program, and a Purdue Research Foundation fellowship (to J. S. M.).	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bembenek J, 2005, CELL CYCLE, V4, P961, DOI 10.4161/cc.4.7.1798; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Geil C, 2008, CURR BIOL, V18, P1001, DOI 10.1016/j.cub.2008.06.025; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jin FZ, 2008, P NATL ACAD SCI USA, V105, P16177, DOI 10.1073/pnas.0808719105; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Placzek EA, 2010, ANAL BIOCHEM, V397, P73, DOI 10.1016/j.ab.2009.09.048; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tomson BN, 2009, CURR BIOL, V19, P449, DOI 10.1016/j.cub.2009.02.024; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	30	61	63	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1662	1669		10.1074/jbc.M111.281105	http://dx.doi.org/10.1074/jbc.M111.281105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117071	hybrid, Green Published			2022-12-25	WOS:000299321000009
J	Jiao, Y; Berman, H; Kiehl, TR; Torquato, S				Jiao, Yang; Berman, Hal; Kiehl, Tim-Rasmus; Torquato, Salvatore			Spatial Organization and Correlations of Cell Nuclei in Brain Tumors	PLOS ONE			English	Article							PACKINGS; MECHANICS; BIOLOGY	Accepting the hypothesis that cancers are self-organizing, opportunistic systems, it is crucial to understand the collective behavior of cancer cells in their tumorous heterogeneous environment. In the present paper, we ask the following basic question: Is this self-organization of tumor evolution reflected in the manner in which malignant cells are spatially distributed in their heterogeneous environment? We employ a variety of nontrivial statistical microstructural descriptors that arise in the theory of heterogeneous media to characterize the spatial distributions of the nuclei of both benign brain white matter cells and brain glioma cells as obtained from histological images. These descriptors, which include the pair correlation function, structure factor and various nearest neighbor functions, quantify how pairs of cell nuclei are correlated in space in various ways. We map the centroids of the cell nuclei into point distributions to show that while commonly used local spatial statistics (e. g., cell areas and number of neighboring cells) cannot clearly distinguish spatial correlations in distributions of normal and abnormal cell nuclei, their salient structural features are captured very well by the aforementioned microstructural descriptors. We show that the tumorous cells pack more densely than normal cells and exhibit stronger effective repulsions between any pair of cells. Moreover, we demonstrate that brain gliomas are organized in a collective way rather than randomly on intermediate and large length scales. The existence of nontrivial spatial correlations between the abnormal cells strongly supports the view that cancer is not an unorganized collection of malignant cells but rather a complex emergent integrated system.	[Jiao, Yang; Torquato, Salvatore] Princeton Univ, Princeton Inst Sci & Technol Mat, Program Appl & Computat Math,Dept Chem & Phys, Princeton Ctr Theoret Sci,Phys Sci Oncol Ctr, Princeton, NJ 08544 USA; [Berman, Hal] Univ Toronto, Campbell Family Inst Canc Res, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kiehl, Tim-Rasmus] Univ Toronto, Toronto Dept Lab Med & Pathobiol, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	Princeton University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Jiao, Y (corresponding author), Princeton Univ, Princeton Inst Sci & Technol Mat, Program Appl & Computat Math,Dept Chem & Phys, Princeton Ctr Theoret Sci,Phys Sci Oncol Ctr, Princeton, NJ 08544 USA.	torquato@electron.princeton.edu	Jiao, Yang/H-3823-2011		National Cancer Institute [U54CA143803]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research described was supported by the National Cancer Institute under Award NO. U54CA143803. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PRINCIPLES CONDENSED; Broaddus WC, 1999, J NEUROSURG, V91, P997, DOI 10.3171/jns.1999.91.6.0997; Coffey DS, 1998, NAT MED, V4, P882, DOI 10.1038/nm0898-882; Conway J. H., 1998, SPHERE PACKINGS LATT; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gatenby RA, 1996, EUR J CANCER, V32A, P722, DOI 10.1016/0959-8049(95)00658-3; Gevertz JL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000152; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen J.-P., 1988, PHYS TODAY, V41, P89; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Jiao Y, 2009, P NATL ACAD SCI USA, V106, P17634, DOI 10.1073/pnas.0905919106; Khan MA, 2003, CANCER-AM CANCER SOC, V98, P2583, DOI 10.1002/cncr.11852; Khurd P, 2010, I S BIOMED IMAGING, P636, DOI 10.1109/ISBI.2010.5490096; Kinoshita M, 2008, NEUROIMAGE, V43, P29, DOI 10.1016/j.neuroimage.2008.06.041; Peebles P. J. E., 1993, PRINCIPLES PHYS COSM; Schmitz J. E., 2002, J THEOR MED, V4, P223; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; TORQUATO S, 1995, PHYS REV LETT, V74, P2156, DOI 10.1103/PhysRevLett.74.2156; TORQUATO S, 1990, J PHYS A-MATH GEN, V23, pL103, DOI 10.1088/0305-4470/23/3/005; Torquato S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041113; Torquato S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056109; Torquato S, 2010, REV MOD PHYS, V82, P2633, DOI 10.1103/RevModPhys.82.2633; Torquato S., 2002, APPL MECH REV, V55, pB62, DOI [10.1115/1.1483342, DOI 10.1115/1.1483342]; Torquato S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015017; Tsacopoulos M, 1996, J NEUROSCI, V16, P877	27	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27323	10.1371/journal.pone.0027323	http://dx.doi.org/10.1371/journal.pone.0027323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110626	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555400034
J	Stralberg, D; Brennan, M; Callaway, JC; Wood, JK; Schile, LM; Jongsomjit, D; Kelly, M; Parker, VT; Crooks, S				Stralberg, Diana; Brennan, Matthew; Callaway, John C.; Wood, Julian K.; Schile, Lisa M.; Jongsomjit, Dennis; Kelly, Maggi; Parker, V. Thomas; Crooks, Stephen			Evaluating Tidal Marsh Sustainability in the Face of Sea-Level Rise: A Hybrid Modeling Approach Applied to San Francisco Bay	PLOS ONE			English	Article							CLIMATE-CHANGE; VERTICAL ACCRETION; ECOSYSTEM SERVICES; COASTAL WETLANDS; SALT MARSHES; IMPACT; SEDIMENTATION; CALIFORNIA; EVOLUTION; ELEVATION	Background: Tidal marshes will be threatened by increasing rates of sea-level rise (SLR) over the next century. Managers seek guidance on whether existing and restored marshes will be resilient under a range of potential future conditions, and on prioritizing marsh restoration and conservation activities. Methodology: Building upon established models, we developed a hybrid approach that involves a mechanistic treatment of marsh accretion dynamics and incorporates spatial variation at a scale relevant for conservation and restoration decision-making. We applied this model to San Francisco Bay, using best-available elevation data and estimates of sediment supply and organic matter accumulation developed for 15 Bay subregions. Accretion models were run over 100 years for 70 combinations of starting elevation, mineral sediment, organic matter, and SLR assumptions. Results were applied spatially to evaluate eight Bay-wide climate change scenarios. Principal Findings: Model results indicated that under a high rate of SLR (1.65 m/century), short-term restoration of diked subtidal baylands to mid marsh elevations (-0.2 m MHHW) could be achieved over the next century with sediment concentrations greater than 200 mg/L. However, suspended sediment concentrations greater than 300 mg/L would be required for 100-year mid marsh sustainability (i.e., no elevation loss). Organic matter accumulation had minimal impacts on this threshold. Bay-wide projections of marsh habitat area varied substantially, depending primarily on SLR and sediment assumptions. Across all scenarios, however, the model projected a shift in the mix of intertidal habitats, with a loss of high marsh and gains in low marsh and mudflats. Conclusions/Significance: Results suggest a bleak prognosis for long-term natural tidal marsh sustainability under a high-SLR scenario. To minimize marsh loss, we recommend conserving adjacent uplands for marsh migration, redistributing dredged sediment to raise elevations, and concentrating restoration efforts in sediment-rich areas. To assist land managers, we developed a web-based decision support tool (www.prbo.org/sfbayslr).	[Stralberg, Diana; Wood, Julian K.; Jongsomjit, Dennis] PRBO Conservat Sci, Climate Change & Informat Grp, Petaluma, CA USA; [Stralberg, Diana] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Brennan, Matthew; Crooks, Stephen] ESA PWA, Estuaries & Wetlands Team, San Francisco, CA USA; [Callaway, John C.] Univ San Francisco, Dept Environm Sci, San Francisco, CA 94117 USA; [Schile, Lisa M.; Kelly, Maggi] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Parker, V. Thomas] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of Alberta; University of San Francisco; University of California System; University of California Berkeley; California State University System; San Francisco State University	Stralberg, D (corresponding author), PRBO Conservat Sci, Climate Change & Informat Grp, Petaluma, CA USA.	stralber@ualberta.ca	Stralberg, Diana/W-9267-2019	Stralberg, Diana/0000-0003-4900-024X; Parker, V. Thomas/0000-0002-6149-7140	San Francisco Foundation; California Landscape Conservation Cooperative; California Coastal Conservancy; California Bay-Delta Authority's CalFed program; United States Department of Energy's National Institute for Climate Change Research; Faucett Family Foundation;  [1816]	San Francisco Foundation(American Cancer Society); California Landscape Conservation Cooperative; California Coastal Conservancy; California Bay-Delta Authority's CalFed program; United States Department of Energy's National Institute for Climate Change Research; Faucett Family Foundation; 	Funding for this research was provided by the Bay Fund of the San Francisco Foundation, the California Landscape Conservation Cooperative, the California Coastal Conservancy, the California Bay-Delta Authority's CalFed program, the United States Department of Energy's National Institute for Climate Change Research, the Faucett Family Foundation, and an anonymous donor to PRBO Conservation Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The PRBO informatics team (especially M. Fitzgibbon, D. Moody, and S. Michaile) built the online application allowing users to visualize, query, and download model results. Justin Vandever and Lindsey Sheehan assisted with Marsh98 model runs. Ellen Herbert provided valuable input on organic accumulation assumptions. Noah Knowles (USGS), Kathleen Schaefer (FEMA), Tom Robinson (Sonoma County Open Space District), Stuart Siegel (Wetlands and Water Resources), Joel Dudas (DWR), and Michelle Mestrovich (County of Sonoma ISD/GIS Central) assisted with the acquisition of elevation data. Wendy Eliot, Beth Huning, Ellie Cohen, Grant Ballard, Nadav Nur, Sam Veloz, Melissa Pitkin, and John Baker were instrumental in providing feedback and support for the project. This is PRBO contribution # 1816.	*ACOE, 2009, 11652211 ACOE US ARM; ALLEN JRL, 1990, MAR GEOL, V95, P77, DOI 10.1016/0025-3227(90)90042-I; Allen JRL, 2000, QUATERNARY SCI REV, V19, P1155, DOI 10.1016/S0277-3791(99)00034-7; Andrews JE, 2006, SCI TOTAL ENVIRON, V371, P19, DOI 10.1016/j.scitotenv.2006.08.021; [Anonymous], 2011, MITIGATING CLIMATE C; Atwater B.F., 1979, AAAS PAC DIV, P347, DOI 10.21236/ada080490; ATWATER BF, 1976, 76389 US GEOL SURV, P41; ayan D., 2009, CEC5002009014D; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Brekke LD, 2004, J AM WATER RESOUR AS, V40, P149, DOI 10.1111/j.1752-1688.2004.tb01016.x; BUCHANAN PA, 2005, USGS DATA SERIES REP, V113; Callaway J.C., 1996, CURRENT TOPICS WETLA, V2, P2; Callaway John C., 2007, Madrono, V54, P234, DOI 10.3120/0024-9637(2007)54[234:EIFTRO]2.0.CO;2; CHAN Y, 2008, CALIFORNIA BIRD SPEC, P419; CHAPMAN V. J., 1977, ECOSYSTEMS WORLD, VI, P1; Cherry JA, 2009, J ECOL, V97, P67, DOI 10.1111/j.1365-2745.2008.01449.x; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Conomos T. J., 1979, SAN FRANCISCO BAY UR, P47; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; Day JW, 1999, ESTUAR COAST SHELF S, V49, P607, DOI 10.1006/ecss.1999.0522; Fagherazzi S, 2006, P NATL ACAD SCI USA, V103, P8337, DOI 10.1073/pnas.0508379103; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; FRENCH JR, 1993, EARTH SURF PROC LAND, V18, P63, DOI 10.1002/esp.3290180105; Fretwell J. D., 1996, 2425 US GEOL SURV; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; Ganju NK, 2004, ESTUAR COAST SHELF S, V60, P81, DOI 10.1016/j.ecss.2003.11.020; GARDALI T, 2008, CALIFORNIA BIRD SPEC, P346; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Goman M, 2008, J COASTAL RES, V24, P1126, DOI 10.2112/08A-0005.1; Greenberg R, 2006, BIOSCIENCE, V56, P675, DOI 10.1641/0006-3568(2006)56[675:TMAGPO]2.0.CO;2; Grewell BJ, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P124; HANSEN JE, 2011, CLIMATE CHANGE EVE S; HATTON RS, 1983, LIMNOL OCEANOGR, V28, P494, DOI 10.4319/lo.1983.28.3.0494; HEBERGER M, 2009, CEC5002009024F PAC I; Hornberger MI, 1999, MAR CHEM, V64, P39, DOI 10.1016/S0304-4203(98)80083-2; Jaffe BE, 2007, ESTUAR COAST SHELF S, V73, P175, DOI 10.1016/j.ecss.2007.02.017; JOSSELYN M, 1983, FWSOBS8323; KEARNEY MS, 1991, J COASTAL RES, V7, P403; Kirwan M, 2009, QUATERNARY SCI REV, V28, P1801, DOI 10.1016/j.quascirev.2009.02.022; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; KRONE RB, 1987, METHOD SIMULATING HI, P316; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Maurer EP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021462; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; NYMAN JA, 1990, ESTUAR COAST SHELF S, V31, P57, DOI 10.1016/0272-7714(90)90028-P; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; ORR M, 2003, SAN FRANCISCO ESTUAR, V1; *P WILL ASS FAB P, 2004, DES GUID TID WETL RE; Park R.A., 1989, EFFECTS SEA LEVEL RI; PATRICK WH, 1990, LIMNOL OCEANOGR, V35, P1389; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; PETHICK JS, 1981, J SEDIMENT PETROL, V51, P571; Pethick JS, 2000, ENVIRON CONSERV, V27, P359; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; REED DJ, 1990, PROG PHYS GEOG, V14, P465, DOI 10.1177/030913339001400403; Ruhl C.A., 2004, SAN FRANCISCO ESTUAR, V2; Rybczyk J.M., 2009, COASTAL WETLANDS INT, P835; SCHOELLHAMER D, 2009, SUSPENDED SEDIMENT B, P56; Schoellhamer DH, 2011, ESTUAR COAST, V34, P885, DOI 10.1007/s12237-011-9382-x; *SFEI, 2009, PULS EST MON MAN WAT; *SFEP, 1991, SAN FRANC EST PROJ S; SPAUTZ H, 2008, CALIFORNIA BIRD SPEC, P405; SPAUTZ H, 2008, CALIFORNIA BIRD SPEC, P412; Stevenson J.C., 1986, ESTUARINE VARIABILIT, P241, DOI [10.1016/B978-0-12-761890-6.50020-4, DOI 10.1016/B978-0-12-761890-6.50020-4]; STEVENSON JC, 1985, MAR GEOL, V67, P213, DOI 10.1016/0025-3227(85)90093-3; Stralberg D, 2009, BIOL CONSERV, V142, P94, DOI 10.1016/j.biocon.2008.10.013; Thompson B, 1999, MAR ENVIRON RES, V48, P285, DOI 10.1016/S0141-1136(99)00060-4; Townend I, 2002, PHILOS T R SOC A, V360, P1477, DOI 10.1098/rsta.2002.1011; Tuxen K, 2011, WETL ECOL MANAG, V19, P141, DOI 10.1007/s11273-010-9207-x; USGS, 1997, SUISUN MARSH V UNPUB; van Geen A, 1999, MAR CHEM, V64, P1, DOI 10.1016/S0304-4203(98)00080-2; VASEY MC, 2011, SAN FRANCIS IN PRESS; VELOZ S, 2011, SAN FRANCISCO BAY SE; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wasson K, 2011, WETLANDS, V31, P1, DOI 10.1007/s13157-011-0153-z; Watson EB, 2004, ESTUARIES, V27, P684, DOI 10.1007/BF02907653; Williams P., 2001, J COASTAL RES, V27, P203; Williams PB, 2002, RESTOR ECOL, V10, P527, DOI 10.1046/j.1526-100X.2002.02031.x; Wright SA, 2004, SAN FRANCISCO ESTUAR, V2; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; 1999, BAYLANDS ECOSYSTEM H	91	120	121	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2011	6	11							e27388	10.1371/journal.pone.0027388	http://dx.doi.org/10.1371/journal.pone.0027388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HV	22110638	Green Published, gold, Green Submitted			2022-12-25	WOS:000297555400042
J	Becker, PM; Tran, TS; Delannoy, MJ; He, CX; Shannon, JM; McGrath-Morrow, S				Becker, Patrice M.; Tran, Tracy S.; Delannoy, Michael J.; He, Chaoxia; Shannon, John M.; McGrath-Morrow, Sharon			Semaphorin 3A Contributes to Distal Pulmonary Epithelial Cell Differentiation and Lung Morphogenesis	PLOS ONE			English	Article							AXON GUIDANCE; BRANCHING MORPHOGENESIS; CIGARETTE-SMOKE; GENE-EXPRESSION; NEONATAL MICE; C/EBP-ALPHA; GROWTH; NEUROPILIN; EMPHYSEMA; APOPTOSIS	Rationale: Semaphorin 3A (Sema3A) is a neural guidance cue that also mediates cell migration, proliferation and apoptosis, and inhibits branching morphogenesis. Because we have shown that genetic deletion of neuropilin-1, which encodes an obligatory Sema3A co-receptor, influences airspace remodeling in the smoke-exposed adult lung, we sought to determine whether genetic deletion of Sema3A altered distal lung structure. Methods: To determine whether loss of Sema3A signaling influenced distal lung morphology, we compared pulmonary histology, distal epithelial cell morphology and maturation, and the balance between lung cell proliferation and death, in lungs from mice with a targeted genetic deletion of Sema3A (Sema3A(-/-)) and wild-type (Sema3A(+/+)) littermate controls. Results: Genetic deletion of Sema3A resulted in significant perinatal lethality. At E17.5, lungs from Sema3A(-/-) mice had thickened septae and reduced airspace size. Distal lung epithelial cells had increased intracellular glycogen pools and small multivesicular and lamellar bodies with atypical ultrastructure, as well as reduced expression of type I alveolar epithelial cell markers. Alveolarization was markedly attenuated in lungs from the rare Sema3A(-/-) mice that survived the immediate perinatal period. Furthermore, Sema3A deletion was linked with enhanced postnatal alveolar septal cell death. Conclusions: These data suggest that Sema3A modulates distal pulmonary epithelial cell development and alveolar septation. Defining how Sema3A influences structural plasticity of the developing lung is a critical first step for determining if this pathway can be exploited to develop innovative strategies for repair after acute or chronic lung injury.	[Becker, Patrice M.; He, Chaoxia] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Tran, Tracy S.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Delannoy, Michael J.] Johns Hopkins Univ, Sch Med, Cell Biol Imaging Facil, Baltimore, MD 21205 USA; [McGrath-Morrow, Sharon] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Pulm Med, Baltimore, MD 21205 USA; [Shannon, John M.] Childrens Hosp, Dept Pediat, Med Ctr, Cincinnati, OH 45229 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cincinnati Children's Hospital Medical Center	Becker, PM (corresponding author), Questcor Pharmaceut Inc, Ellicott City, MD USA.	Patrice.Becker@questcor.com	Tran, Tracy/M-2173-2019	Tran, Tracy/0000-0002-2179-5725	National Institutes of Health [RO1HL083286, RO1HL098319]; Flight Attendant Medical Research Institute [CIA 052365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098319, R01HL083286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1HL083286 (PMB), RO1HL098319 (JMS), and Flight Attendant Medical Research Institute CIA 052365 (PMB). No authors have any financial interests related to this work, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Bates D, 2003, DEV BIOL, V255, P77, DOI 10.1016/S0012-1606(02)00045-3; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chen H, 1998, NAT NEUROSCI, V1, P436, DOI 10.1038/2154; Chung L, 2007, DEVELOPMENT, V134, P2935, DOI 10.1242/dev.005066; Cimato T, 2009, CIRCULATION, V119, P2170, DOI 10.1161/CIRCULATIONAHA.109.849596; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Gagliardini V, 1999, MOL CELL NEUROSCI, V14, P301, DOI 10.1006/mcne.1999.0787; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Kagoshima M, 2001, GENES CELLS, V6, P559, DOI 10.1046/j.1365-2443.2001.00441.x; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Le A, 2009, AM J RESP CRIT CARE, V180, P396, DOI 10.1164/rccm.200809-1483OC; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; MASON RJ, 1976, J LIPID RES, V17, P281; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Metzger DE, 2008, DEV BIOL, V320, P149, DOI 10.1016/j.ydbio.2008.04.038; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Reidy KJ, 2009, DEVELOPMENT, V136, P3979, DOI 10.1242/dev.037267; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; Shoji W, 2003, DEVELOPMENT, V130, P3227, DOI 10.1242/dev.00516; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Taraseviciene-Stewart L, 2005, AM J RESP CRIT CARE, V171, P734, DOI 10.1164/rccm.200409-1275OC; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tufro A, 2008, MECH DEVELOP, V125, P558, DOI 10.1016/j.mod.2007.12.003; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC	51	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27449	10.1371/journal.pone.0027449	http://dx.doi.org/10.1371/journal.pone.0027449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096573	Green Submitted, gold, Green Published			2022-12-25	WOS:000297553900045
J	Gendoo, DMA; Harrison, PM				Gendoo, Deena M. A.; Harrison, Paul M.			Origins and Evolution of the HET-s Prion-Forming Protein: Searching for Other Amyloid-Forming Solenoids	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; WD-REPEAT; BETA; ORGANIZATION; SUPERFAMILY; ANNOTATIONS; HOMOLOGY; FIBRILS	The HET-s prion-forming domain from the filamentous fungus Podospora anserina is gaining considerable interest since it yielded the first well-defined atomic structure of a functional amyloid fibril. This structure has been identified as a left-handed beta solenoid with a triangular hydrophobic core. To delineate the origins of the HET-s prion-forming protein and to discover other amyloid-forming proteins, we searched for all homologs of the HET-s protein in a database of protein domains and fungal genomes, using a combined application of HMM, psi-blast and pGenThreader techniques, and performed a comparative evolutionary analysis of the N-terminal alpha-helical domain and the C-terminal prion-forming domain of HET-s. By assessing the tandem evolution of both domains, we observed that the prion-forming domain is restricted to Sordariomycetes, with a marginal additional sequence homolog in Arthroderma otae as a likely case of horizontal transfer. This suggests innovation and rapid evolution of the solenoid fold in the Sordariomycetes clade. In contrast, the N-terminal domain evolves at a slower rate (in Sordariomycetes) and spans many diverse clades of fungi. We performed a full three-dimensional protein threading analysis on all identified HET-s homologs against the HET-s solenoid fold, and present detailed structural annotations for identified structural homologs to the prion-forming domain. An analysis of the physicochemical characteristics in our set of structural models indicates that the HET-s solenoid shape can be readily adopted in these homologs, but that they are all less optimized for fibril formation than the P. anserina HET-s sequence itself, due chiefly to the presence of fewer asparagine ladders and salt bridges. Our combined structural and evolutionary analysis suggests that the HET-s shape has "limited scope" for amyloidosis across the wider protein universe, compared to the 'generic' left-handed beta helix. We discuss the implications of our findings on future identification of amyloid-forming proteins sharing the solenoid fold.	[Gendoo, Deena M. A.; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Gendoo, Deena M. A.; Harrison, Paul M.] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Gendoo, DMA (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca		Gendoo, Deena/0000-0001-8891-4138	PrioNet Canada Network of Centres of Excellence; CIHR McGill University	PrioNet Canada Network of Centres of Excellence; CIHR McGill University(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the PrioNet Canada Network of Centres of Excellence to PMH, and by a CIHR McGill University Systems Biology Training Program to DMAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Choi JH, 2008, PROTEINS, V73, P150, DOI 10.1002/prot.22051; Choi JH, 2009, BIOPHYS J, V97, P3187, DOI 10.1016/j.bpj.2009.09.042; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Cuomo CA, 2010, METHOD ENZYMOL, V470, P833, DOI 10.1016/S0076-6879(10)70034-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dobson CM, 2005, NATURE, V435, P747, DOI 10.1038/435747a; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar N., 2002, CURRENT PROTOCOLS BI; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Greenwald J, 2010, MOL CELL, V38, P889, DOI 10.1016/j.molcel.2010.05.019; Guo JT, 2004, PROTEINS, V57, P357, DOI 10.1002/prot.20222; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P1, DOI 10.1016/S0065-3233(06)73001-7; KAJAVA AV, 2004, SCIENCES, V101, P7885; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; SAUPE SJ, 2011, SEMINARS CE IN PRESS; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Zanuy D, 2006, J MOL BIOL, V358, P330, DOI 10.1016/j.jmb.2006.01.070	51	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27342	10.1371/journal.pone.0027342	http://dx.doi.org/10.1371/journal.pone.0027342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096554	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900033
J	Zhou, M; Geng, XL; Chen, J; Wang, XD; Wang, DB; Deng, JY; Zhang, ZP; Wang, WH; Zhang, XE; Wei, HP				Zhou, Man; Geng, Xuelei; Chen, Jun; Wang, Xude; Wang, Dianbing; Deng, Jiaoyu; Zhang, Zhiping; Wang, Weihua; Zhang, Xian-En; Wei, Hongping			Rapid Colorimetric Testing for Pyrazinamide Susceptibility of M. tuberculosis by a PCR-Based In-Vitro Synthesized Pyrazinamidase Method	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; PNCA MUTATIONS; MAJOR MECHANISM; GENE; SYSTEM; STRAINS; REGION	Pyrazinamide (PZA) is an important first-line anti-tuberculosis drug. But PZA susceptibility test is challenging because PZA activity is optimal only in an acid environment that inhibits the growth of M. tuberculosis. For current phenotypic methods, inconsistent results between different labs have been reported. Direct sequencing of pncA gene is being considered as an accurate predictor for PZA susceptibility, but this approach needs expensive sequencers and a mutation database to report the results. An in-vitro synthesized Pyrazinamidase (PZase) assay was developed based on PCR amplification of pncA gene and an in vitro wheat germ system to express the pncA gene into PZase. The activity of the synthesized PZase was used as an indicator for PZA susceptibility. Fifty-one clinical isolates were tested along with pncA sequencing and the BACTEC MGIT 960 methods. The in-vitro synthesized PZase assay was able to detect PZA susceptibility of M. tuberculosis within 24 h through observing the color difference either by a spectrometer or naked eyes. This method showed agreements of 100% (33/33) and 88% (14/16) with the pncA sequencing method, and agreements of 96% (27/28) and 65% (15/23) with the BACTEC MGIT 960 method, for susceptible and resistant strains, respectively. The novel in-vitro synthesized PZase assay has significant advantages over current methods, such as its fast speed, simplicity, no need for expensive equipment, and the potentials of being a direct test, predicting resistance level and easy reading results by naked eyes. After confirmation by more clinical tests, this method may provide a radical change to the current PZA susceptibility assays.	[Zhou, Man; Geng, Xuelei; Wang, Xude; Wang, Dianbing; Deng, Jiaoyu; Zhang, Zhiping; Zhang, Xian-En; Wei, Hongping] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China; [Chen, Jun; Wang, Weihua] Wuan TB Control Ctr, Wuhan, Peoples R China; [Zhou, Man; Geng, Xuelei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, M (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	x.zhang@wh.iov.cn; hpwei@wh.iov.cn	Wang, Dian-Bing/AFQ-6894-2022; ZHANG, Xian-En/AAJ-5579-2021	Wang, Dian-Bing/0000-0001-6225-7010; Zhou, Man/0000-0002-4790-0984	Ministry of Health of China [2008ZX10004-004, 2009ZX10003-019]; National Natural Science Foundation of China [2077508]	Ministry of Health of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the Infectious Disease Control Research Program of the Ministry of Health of China (2008ZX10004-004, 2009ZX10003-019) and the National Natural Science Foundation of China (2077508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov RZ, 2004, NUCLEIC ACIDS RES, V32, P239, DOI 10.1093/nar/gkh176; BUTLER WR, 1983, ANTIMICROB AGENTS CH, V24, P600, DOI 10.1128/AAC.24.4.600; Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Denkin S, 2005, J MED MICROBIOL, V54, P1127, DOI 10.1099/jmm.0.46129-0; Dormandy J, 2007, CHEST, V131, P497, DOI 10.1378/chest.06-1899; Gonzalez-Martin J, 2010, ARCH BRONCONEUMOL, V46, P255, DOI 10.1016/j.arbres.2010.02.010; Heifets L, 2000, J CLIN MICROBIOL, V38, P1498, DOI 10.1128/JCM.38.4.1498-1501.2000; Heifets L, 2002, J MED MICROBIOL, V51, P11, DOI 10.1099/0022-1317-51-1-11; Heifets LB, 1999, INT J TUBERC LUNG D, V3, P564; HEWLETT D, 1995, JAMA-J AM MED ASSOC, V273, P916, DOI 10.1001/jama.273.12.916; Hirano K, 1998, TUBERCLE LUNG DIS, V78, P117, DOI 10.1016/S0962-8479(98)80004-X; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Lee KW, 2001, J KOREAN MED SCI, V16, P537, DOI 10.3346/jkms.2001.16.5.537; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; MILLER MA, 1995, J CLIN MICROBIOL, V33, P2468, DOI 10.1128/JCM.33.9.2468-2470.1995; Miller MA, 1996, J CLIN MICROBIOL, V34, P84, DOI 10.1128/JCM.34.1.84-86.1996; Parsons LM, 2004, FRONT BIOSCI-LANDMRK, V9, P2086, DOI 10.2741/1290; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; SALFINGER M, 1989, RES MICROBIOL, V140, P301, DOI 10.1016/0923-2508(89)90022-3; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Sheen P, 2009, TUBERCULOSIS, V89, P109, DOI 10.1016/j.tube.2009.01.004; Somoskovi A, 2007, J CLIN MICROBIOL, V45, P595, DOI 10.1128/JCM.01454-06; Suzuki Y, 2002, J CLIN MICROBIOL, V40, P501, DOI 10.1128/JCM.40.2.501-507.2002; Tracevska T, 2004, ANTIMICROB AGENTS CH, V48, P3209, DOI 10.1128/AAC.48.8.3209-3210.2004; Zhang H, 2009, J INT MED RES, V37, P1430, DOI 10.1177/147323000903700517; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42	28	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27654	10.1371/journal.pone.0027654	http://dx.doi.org/10.1371/journal.pone.0027654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22102918	Green Published, gold, Green Submitted			2022-12-25	WOS:000297348800040
J	Singh, AV; Vyas, V; Patil, R; Sharma, V; Scopelliti, PE; Bongiorno, G; Podesta, A; Lenardi, C; Gade, WN; Milani, P				Singh, Ajay Vikram; Vyas, Varun; Patil, Rajendra; Sharma, Vimal; Scopelliti, Pasquale Emanuele; Bongiorno, Gero; Podesta, Alessandro; Lenardi, Cristina; Gade, Wasudev Namdev; Milani, Paolo			Quantitative Characterization of the Influence of the Nanoscale Morphology of Nanostructured Surfaces on Bacterial Adhesion and Biofilm Formation	PLOS ONE			English	Article							CLUSTER BEAM DEPOSITION; ADSORBED PROTEINS; QUANTIFICATION; CELLS; FILMS; TIO2	Bacterial infection of implants and prosthetic devices is one of the most common causes of implant failure. The nanostructured surface of biocompatible materials strongly influences the adhesion and proliferation of mammalian cells on solid substrates. The observation of this phenomenon has led to an increased effort to develop new strategies to prevent bacterial adhesion and biofilm formation, primarily through nanoengineering the topology of the materials used in implantable devices. While several studies have demonstrated the influence of nanoscale surface morphology on prokaryotic cell attachment, none have provided a quantitative understanding of this phenomenon. Using supersonic cluster beam deposition, we produced nanostructured titania thin films with controlled and reproducible nanoscale morphology respectively. We characterized the surface morphology; composition and wettability by means of atomic force microscopy, X-ray photoemission spectroscopy and contact angle measurements. We studied how protein adsorption is influenced by the physico-chemical surface parameters. Lastly, we characterized Escherichia coli and Staphylococcus aureus adhesion on nanostructured titania surfaces. Our results show that the increase in surface pore aspect ratio and volume, related to the increase of surface roughness, improves protein adsorption, which in turn downplays bacterial adhesion and biofilm formation. As roughness increases up to about 20 nm, bacterial adhesion and biofilm formation are enhanced; the further increase of roughness causes a significant decrease of bacterial adhesion and inhibits biofilm formation. We interpret the observed trend in bacterial adhesion as the combined effect of passivation and flattening effects induced by morphology-dependent protein adsorption. Our findings demonstrate that bacterial adhesion and biofilm formation on nanostructured titanium oxide surfaces are significantly influenced by nanoscale morphological features. The quantitative information, provided by this study about the relation between surface nanoscale morphology and bacterial adhesion points towards the rational design of implant surfaces that control or inhibit bacterial adhesion and biofilm formation.	[Singh, Ajay Vikram; Vyas, Varun; Sharma, Vimal] IFOM IEO, European Sch Mol Med SEMM, Milan, Italy; [Singh, Ajay Vikram; Vyas, Varun; Scopelliti, Pasquale Emanuele; Podesta, Alessandro; Lenardi, Cristina; Milani, Paolo] Univ Milan, Dept Phys, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Patil, Rajendra; Gade, Wasudev Namdev] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Sharma, Vimal; Scopelliti, Pasquale Emanuele; Bongiorno, Gero; Lenardi, Cristina; Milani, Paolo] Fdn Filarete, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; Savitribai Phule Pune University	Singh, AV (corresponding author), IFOM IEO, European Sch Mol Med SEMM, Milan, Italy.	wngade@unipune.ernet.in; pmilani@mi.infn.it	Lenardi, Cristina/J-5872-2012; Patil, Rajendra H/L-5521-2013; Singh, Ajay Vikram/AAM-3665-2020; Singh, Ajay/AAF-4414-2020; Milani, Paolo/AAN-5069-2021; Podestà, Alessandro/E-6568-2010; Vyas, Varun/AAA-7983-2021	Lenardi, Cristina/0000-0002-5522-6803; Podestà, Alessandro/0000-0002-4169-6679; Vyas, Varun/0000-0001-7008-7349; Patil, Rajendra/0000-0003-0534-7356; Singh, Abhalaxmi/0000-0003-0407-3154	European School of Molecular Medicine; Umberto Veronesi Foundation; University of Milan	European School of Molecular Medicine; Umberto Veronesi Foundation(Fondazione Umberto Veronesi); University of Milan	This work was financially supported by the European School of Molecular Medicine, by Umberto Veronesi Foundation and by the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/j.biomaterials.2006.03.004; Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0; Barborini E, 1999, J PHYS D APPL PHYS, V32, pL105, DOI 10.1088/0022-3727/32/21/102; Barborini E, 2003, EUR PHYS J D, V24, P277, DOI 10.1140/epjd/e2003-00189-2; Belicchi M, 2010, BIOMATERIALS, V31, P5385, DOI 10.1016/j.biomaterials.2010.03.021; Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056; Collins TJ, 2007, MICROSC MICROANAL, V13, P1674, DOI [10.1017/S1431927607072911, DOI 10.1017/S1431927607072911]; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p; Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HUNTER RJ, 1995, FDN COLLOID SCI; Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017; Kholmanov IN, 2003, NANOTECHNOLOGY, V14, P1168, DOI 10.1088/0957-4484/14/11/002; Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87; Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI [10.2217/nnm.10.54, 10.2217/NNM.10.54]; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Milani P, 2001, DIAM RELAT MATER, V10, P240, DOI 10.1016/S0925-9635(00)00474-X; Padial-Molina M, 2011, ACTA BIOMATER, V7, P771, DOI 10.1016/j.actbio.2010.08.024; Page AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.065701; Piseri P, 2001, REV SCI INSTRUM, V72, P2261, DOI 10.1063/1.1361082; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Podesta A, 2009, J PHYS CHEM C, V113, P18264, DOI 10.1021/jp905930r; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m; RONALD RM, 2004, HDB MICROBIOLOGICAL; Salmeron-Sanchez M, 2010, TISSUE ENGINEERING, P77; Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862; SCOPELLITI PE, 2011, COMB CHEM HIGH T SCR, V14, P10; Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186; Wegner K, 2006, J PHYS D APPL PHYS, V39, pR439, DOI 10.1088/0022-3727/39/22/R02; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.11.010; Whitehead KA, 2007, INT BIODETER BIODEGR, V60, P74, DOI 10.1016/j.ibiod.2006.11.009; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Xavier JB, 2003, WATER SCI TECHNOL, V47, P31, DOI 10.2166/wst.2003.0273	45	262	266	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25029	10.1371/journal.pone.0025029	http://dx.doi.org/10.1371/journal.pone.0025029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966403	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100012
J	Chen, YJ; Huang, WC; Wei, YL; Hsu, SC; Yuan, P; Lin, HY; Wistuba, II; Lee, JJ; Yen, CJ; Su, WC; Chang, KY; Chang, WC; Chou, TC; Chou, CK; Tsai, CH; Hung, MC				Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Yuan, Ping; Lin, Heather Y.; Wistuba, Ignacio I.; Lee, J. Jack; Yen, Chia-Jui; Su, Wu-Chou; Chang, Kwang-Yu; Chang, Wen-Chang; Chou, Tse-Chuan; Chou, Chao-Kai; Tsai, Chang-Hai; Hung, Mien-Chie			Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; GENE-MUTATIONS; PHASE-II; ERLOTINIB; PROTEIN	Background: The sensitivity of non-small cell lung cancer (NSCLC) patients to EGFR tyrosine kinase inhibitors (TKIs) is strongly associated with activating EGFR mutations. Although not as sensitive as patients harboring these mutations, some patients with wild-type EGFR (wtEGFR) remain responsive to EGFR TKIs, suggesting that the existence of unexplored mechanisms renders most of wtEGFR-expressing cancer cells insensitive. Methodology/Principal Findings: Here, we show that acquired resistance of wtEGFR-expressing cancer cells to an EGFR TKI, gefitinib, is associated with elevated expression of breast cancer resistance protein (BCRP/ABCG2), which in turn leads to gefitinib efflux from cells. In addition, BCRP/ABCG2 expression correlates with poor response to gefitinib in both cancer cell lines and lung cancer patients with wtEGFR. Co-treatment with BCRP/ABCG2 inhibitors enhanced the anti-tumor activity of gefitinib. Conclusions/Significance: Thus, BCRP/ABCG2 expression may be a predictor for poor efficacy of gefitinib treatment, and targeting BCRP/ABCG2 may broaden the use of gefitinib in patients with wtEGFR.	[Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yuan, Ping; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lin, Heather Y.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Su, Wu-Chou] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chou, Tse-Chuan] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chou, Tse-Chuan] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Tatung University	Chen, YJ (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council of Taiwan [NSC-96-2917-I-006-004, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002]; National Health Research Institutes of Taiwan [NHRI-EX-98-9812BC, NSC-2632-B-001]; Cancer Center Research of Excellence [DOH-TD-C-111-005]; National Institutes of Health [NIH PO1 CA099031, NIH RO1 CA109311]; National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Cancer Center Research of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council of Taiwan (NSC-96-2917-I-006-004 to Y.J. Chen; NSC-97-2320-B-039-033-MY3 and NSC-98-3112-B-039-002 to W.C. Huang), the National Health Research Institutes of Taiwan (NHRI-EX-98-9812BC to W.C. Huang), NSC-2632-B-001, and Cancer Center Research of Excellence (DOH-TD-C-111-005), National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Kadoorie Charitable Foundation, and The University of Texas MD Anderson Cancer Center and CMUH Sister Institution Fund (to M.C. Hung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang GC, 2006, J THORAC ONCOL, V1, P520, DOI 10.1097/01243894-200607000-00004; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; HUANG WC, 2011, J BIOL CHEM; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Lee DH, 2008, ANN ONCOL, V19, P2039, DOI 10.1093/annonc/mdn423; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Vasile E, 2008, J THORAC ONCOL, V3, P912, DOI 10.1097/JTO.0b013e318180275e; Wang XD, 2007, DRUG METAB DISPOS, V35, P268, DOI 10.1124/dmd.106.011684; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang CH, 2006, CANCER-AM CANCER SOC, V107, P1873, DOI 10.1002/cncr.22220; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhang SZ, 2005, DRUG METAB DISPOS, V33, P341, DOI 10.1124/dmd.104.002501; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	43	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21428	10.1371/journal.pone.0021428	http://dx.doi.org/10.1371/journal.pone.0021428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21437249	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400036
J	Chen, YT; Ross, DS; Chiu, R; Zhou, XK; Chen, YY; Lee, PS; Hoda, SA; Simpson, AJ; Old, LJ; Caballero, O; Neville, AM				Chen, Yao-Tseng; Ross, Dara S.; Chiu, Rita; Zhou, Xi K.; Chen, Yunn-Yi; Lee, Peishan; Hoda, Syed A.; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro			Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers	PLOS ONE			English	Article							T-CELL RESPONSES; NY-ESO-1 EXPRESSION; PROTEIN EXPRESSION; ANTIBODY; IMMUNOGENICITY; IDENTIFICATION; CARCINOMA; FAMILY; GENES; CT45	Background: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. Methodology/Principal Findings: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them-MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p < 0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p < 0.001 to p = 0.01) and larger in size (> 2 cm). Conclusions/Significance: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored.	[Chen, Yao-Tseng; Ross, Dara S.; Hoda, Syed A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, Rita; Lee, Peishan; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro] Ludwig Inst Canc Res, New York Branch, New York, NY USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Cornell University; Ludwig Institute for Cancer Research; Cornell University; University of California System; University of California San Francisco	Chen, YT (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	ytchen@med.cornell.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ludwig Institute for Cancer Research < http://www.licr.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandic D, 2006, CROAT MED J, V47, P32; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2010, P NATL ACAD SCI USA, V107, P3093, DOI 10.1073/pnas.0915050107; Chen YT, 2009, INT J CANCER, V124, P2893, DOI 10.1002/ijc.24296; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; CHEN YT, 1994, P NATL ACAD SCI USA, V91, P1004, DOI 10.1073/pnas.91.3.1004; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kurashige T, 2001, CANCER RES, V61, P4671; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Rimoldi D, 2000, INT J CANCER, V86, P749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhuang Ran, 2006, Cancer Immun, V6, P7	29	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17876	10.1371/journal.pone.0017876	http://dx.doi.org/10.1371/journal.pone.0017876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437249	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100041
